PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Holmberg, SD; Spradling, PR; Moorman, AC; Denniston, MM				Holmberg, Scott D.; Spradling, Philip R.; Moorman, Anne C.; Denniston, Maxine M.			Hepatitis C in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS-INFECTION; PREVALENCE; CARE		[Holmberg, Scott D.; Spradling, Philip R.; Moorman, Anne C.; Denniston, Maxine M.] Ctr Dis Control & Prevent, Epidemiol & Surveillance Branch, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Holmberg, SD (corresponding author), Ctr Dis Control & Prevent, Epidemiol & Surveillance Branch, Div Viral Hepatitis, Atlanta, GA 30333 USA.			Moorman, Anne/0000-0003-2411-2798	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Centers for Disease Control and Prevention (USA), 2012, MMWR RECOMM REP, V61, P886; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616	6	252	253	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1859	1861		10.1056/NEJMp1302973	http://dx.doi.org/10.1056/NEJMp1302973			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143VK	23675657	Green Accepted			2022-12-24	WOS:000318896200003
J	Gill, CJ; Young, M; Schroder, K; Carvajal-Velez, L; McNabb, M; Aboubaker, S; Qazi, S; Bhutta, ZA				Gill, Christopher J.; Young, Mark; Schroder, Kate; Carvajal-Velez, Liliana; McNabb, Marion; Aboubaker, Samira; Qazi, Shamim; Bhutta, Zulfiqar A.			Bottlenecks, barriers, and solutions: results from multicountry consultations focused on reduction of childhood pneumonia and diarrhoea deaths	LANCET			English	Article							INTEGRATED MANAGEMENT; ZINC SUPPLEMENTATION; MORTALITY; HEALTH; MORBIDITY; DISEASE; PREVENTION; COUNTRIES; COUNTDOWN; NEWBORN	Millions of children still die unnecessarily from pneumonia and diarrhoea, mainly in resource-poor settings. A series of collaborative consultations and workshops involving several hundred academic, public health, governmental and private sector stakeholders were convened to identify the key barriers to progress and to issue recommendations. Bottlenecks impairing access to commodities included antiquated supply management systems, insufficient funding for drugs, inadequate knowledge about interventions by clients and providers, health worker shortages, poor support for training or retention of health workers, and a failure to convert national policies into action plans. Key programmatic barriers included an absence of effective programme coordination between and within partner organisations, scarce financial resources, inadequate training and support for health workers, sporadic availability of key commodities, and suboptimal programme management. However, these problems are solvable. Advocacy could help to mobilise needed resources, raise awareness, and prioritise childhood pneumonia and diarrhoea deaths in the coming decade.	[Gill, Christopher J.; McNabb, Marion] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [Young, Mark; Carvajal-Velez, Liliana] UNICEF, New York, NY USA; [Schroder, Kate] Clinton Hlth Access Initiat, Boston, MA USA; [Aboubaker, Samira; Qazi, Shamim] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan	Boston University; UNICEF; World Health Organization; Aga Khan University	Gill, CJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Int Hlth, Ctr Global Hlth & Dev, 801 Massachusetts Ave, Boston, MA 02118 USA.	cgill@bu.edu		gill, christopher/0000-0003-3353-0617	Bill & Melinda Gates Foundation; Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto; WHO; UNICEF	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto; WHO(World Health Organization); UNICEF	The work summarised in this Series was supported by an unrestricted grant from the Bill & Melinda Gates Foundation to the Aga Khan University and through it to collaborating universities and institutions (Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; and Program for Global Pediatric Research, Hospital for Sick Children, Toronto). Additional support was provided by internal resources from WHO and UNICEF. The funding agency had no influence or control over the content and process for the development of this Series. We thank the following individuals for their work on these projects: Shams El Arifeen, Narendra Arora, Godfrey Biemba, William Brieger, Cathleen Cisse, Thomas Cherian, Alejandro Cravioto, Jai Das, Teshome Desta, Stalin Ewoigbokhan, Olivier Fontaine, Tracy Goodman, Duc Ha, Phanuel Habimana, Corrie Haley, Davidson Hamer, Cheryl Hendrickson, Rose Kamenwa, Rajesh Kumar, William Macharia, Carsten Mantel, Holly Newby, Ashok Patwari, Neena Raina, Affan Shaikh, Kira Skolos, Tazeen Tahsina, Samantha Xia, and Danzhen You. The opinions expressed in this paper are those of the authors, and do not necessarily represent those of their parent organisations.	[Anonymous], 2010, MILL DEV GOALS REP; [Anonymous], 2012, UNICEF PROGR REPORT; [Anonymous], 2011, UN INT GROUP CHILD M; [Anonymous], 2012, COMM REP; Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Bhutta ZA, 2013, LANCET, V381, P2207, DOI 10.1016/S0140-6736(12)61999-0; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI69, DOI 10.1093/heapol/czi053; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Butler JC, 1999, AM J MED, V107, P69, DOI 10.1016/S0002-9343(99)00105-9; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Chopra M, 2012, ARCH DIS CHILD, V97, P350, DOI 10.1136/archdischild-2011-301191; Clinton Health Access Initiative, 2011, PRIV SECT MARK DIARR; Goveia MG, 2011, ANN NY ACAD SCI, V1222, P14, DOI 10.1111/j.1749-6632.2011.05970.x; Haffejee I E, 1995, Glob Child Health New Rev, V3, P18; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, GLOB REP 2012; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Marshall GS, 2009, PEDIATR INFECT DIS J, V28, P355, DOI 10.1097/INF.0b013e318199494a; Mazumder S, 2010, B WORLD HEALTH ORGAN, V88, P754, DOI 10.2471/BLT.10.075986; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; National Population Commission and ICF, 2009, NIG DEM HLTH SURV 20; ONI GA, 1991, J DIARRHOEAL DIS RES, V9, P250; Poland GA, 2001, INFECT DIS CLIN N AM, V15, P97, DOI 10.1016/S0891-5520(05)70270-1; Soucat A, 2002, MARGINAL BUDGETTING; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; The UN Inter-agency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; UNICEF, 2006, MAN SICK CHILDR COMM; UNICEF, 2012, PNEUM DIARRH; UNICEF WHO, 2004, WHO UNICEF JOINT STA; UNICEF/WHO, 2009, DIARRH WHY CHILDR AR; UNICEF WHO, 2004, JOINT STAT CLIN MAN; UNICEF WHO, 2012, WHO UNICEF JOINT STA; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702; WHO/UNICEF, 2009, GLOB ACT PLAN PREV G; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23	44	55	55	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1487	1498		10.1016/S0140-6736(13)60314-1	http://dx.doi.org/10.1016/S0140-6736(13)60314-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23582720				2022-12-24	WOS:000318607300038
J	Song, CX; Szulwach, KE; Dai, Q; Fu, Y; Mao, SQ; Lin, L; Street, C; Li, YJ; Poidevin, M; Wu, H; Gao, J; Liu, P; Li, L; Xu, GL; Jin, P; He, C				Song, Chun-Xiao; Szulwach, Keith E.; Dai, Qing; Fu, Ye; Mao, Shi-Qing; Lin, Li; Street, Craig; Li, Yujing; Poidevin, Mickael; Wu, Hao; Gao, Juan; Liu, Peng; Li, Lin; Xu, Guo-Liang; Jin, Peng; He, Chuan			Genome-wide Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming	CELL			English	Article							EMBRYONIC STEM-CELLS; THYMINE DNA GLYCOSYLASE; BASE-RESOLUTION; MAMMALIAN DNA; TET PROTEINS; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; DEMETHYLATION; METHYLATION	TET proteins oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). 5fC and 5caC are excised by mammalian DNA glycosylase TDG, implicating 5mC oxidation in DNA demethylation. Here, we show that the genomic locations of 5fC can be determined by coupling chemical reduction with biotin tagging. Genome-wide mapping of 5fC in mouse embryonic stem cells (mESCs) reveals that 5fC preferentially occurs at poised enhancers among other gene regulatory elements. Application to Tdg null mESCs further suggests that 5fC production coordinates with p300 in remodeling epigenetic states of enhancers. This process, which is not influenced by 5hmC, appears to be associated with further oxidation of 5hmC and commitment to demethylation through 5fC. Finally, we resolved 5fC at base resolution by hydroxylamine-based protection from bisulfite-mediated deamination, thereby confirming sites of 5fC accumulation. Our results reveal roles of active 5mC/5hmC oxidation and TDG-mediated demethylation in epigenetic tuning at regulatory elements.	[Song, Chun-Xiao; Dai, Qing; Fu, Ye; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Song, Chun-Xiao; Dai, Qing; Fu, Ye; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Szulwach, Keith E.; Lin, Li; Street, Craig; Li, Yujing; Poidevin, Mickael; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Mao, Shi-Qing; Gao, Juan; Liu, Peng; Li, Lin; Xu, Guo-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Grp DNA Metab,State Key Lab Mol Biol, Shanghai 200031, Peoples R China	University of Chicago; University of Chicago; Emory University; Emory University; Rollins School Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	jin@emory.edu; chuanhe@uchicago.edu	Mao, Shiqing/AAV-1168-2020; Dai, Qing/ABD-8444-2021; Li, Yujing/AAJ-1411-2020; gao, juan/GXV-1381-2022; Wu, Hao/H-3899-2017; Li, yujing/GQA-4109-2022	Mao, Shiqing/0000-0001-9902-0199; Li, Yujing/0000-0002-4363-2484; Wu, Hao/0000-0003-1269-7354; Song, Chun-Xiao/0000-0002-7781-6521; Fu, Ye/0000-0002-3807-9717; Liu, Peng/0000-0002-6469-6460; Fu, Ye/0000-0003-4434-6014	National Institutes of Health [HG006827, NS079625/NS051630/HD073162/AG025688]; Ministry of Science and Technology of China [2011CB946102, 2012CB966903]; Emory Genetics Discovery Fund; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD073162] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699, R01HG006827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Emory Genetics Discovery Fund; Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (HG006827 to C.H. and NS079625/NS051630/HD073162/AG025688 to P.J.), grants from the Ministry of Science and Technology of China (2011CB946102 and 2012CB966903 to G.X.), the Emory Genetics Discovery Fund (P.J.), and the Simons Foundation Autism Research Initiative (P.J.). We thank Drs. Bing Ren and Gary Hon for sharing single-base maps of 5mC+5hmC and 5hmC. We thank S.F. Reichard for editing the manuscript. A patent application has been filed for the technology disclosed in this publication.	Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Wilder PJ, 1997, DEV BIOL, V192, P614, DOI 10.1006/dbio.1997.8777; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	405	421	3	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					678	691		10.1016/j.cell.2013.04.001	http://dx.doi.org/10.1016/j.cell.2013.04.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23602153	Green Accepted, Bronze			2022-12-24	WOS:000318063500019
J	Algra, AM				Algra, Annemijn M.			Towards a global brief on aspirin	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Algra, AM (corresponding author), The Lancet, London NW1 7BY, England.	annechien.algra@ndcn.ox.ac.uk						Chan AT, 2012, LANCET, V379, P1569, DOI 10.1016/S0140-6736(11)61654-1; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; George Mary G, 2012, MMWR Suppl, V61, P11; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Vandvik PO, 2012, CHEST, V141, P1129, DOI 10.1378/chest.11-2306; WHO, 2013, GLOB BRIEF HYP; World Heart Federation, 2012, 25 BY 2025 A GAME CH	7	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1344	1345		10.1016/S0140-6736(13)60772-2	http://dx.doi.org/10.1016/S0140-6736(13)60772-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130EF	23601936				2022-12-24	WOS:000317894800011
J	Mandyam, MC; Soliman, EZ; Heckbert, SR; Vittinghoff, E; Marcus, GM				Mandyam, Mala C.; Soliman, Elsayed Z.; Heckbert, Susan R.; Vittinghoff, Eric; Marcus, Gregory M.			Long-term Outcomes of Left Anterior Fascicular Block in the Absence of Overt Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							FIBROSIS		[Mandyam, Mala C.; Marcus, Gregory M.] Univ Calif San Francisco, Div Cardiol, Electrophysiol Sect, San Francisco, CA 94143 USA; [Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr, Winston Salem, NC USA; [Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wake Forest University; University of Washington; University of Washington Seattle	Mandyam, MC (corresponding author), Univ Calif San Francisco, Div Cardiol, Electrophysiol Sect, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021; Soliman, Elsayed Z/AAD-7135-2020	Marcus, Gregory/0000-0001-5197-7696; Soliman, Elsayed Z/0000-0001-5632-8150	NCRR NIH HHS [TL1 RR024129] Funding Source: Medline; NHLBI NIH HHS [N01HC85080, U01 HL080295, R01 HL068986, HL068986, N01HC85086, N01HC85081, N01 HC55222, N01 HC085079, N01HC55222, R01 HL080295, HHSN268201200036C, N01HC85239, N01 HC085083, HL080295, N01HC85083, N01HC85082, N01HC85079] Funding Source: Medline; NIA NIH HHS [R01 AG023629, R56 AG023629, AG023629] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085083, N01HC055222, N01HC085086, N01HC085079, N01HC085082, N01HC085081, N01HC085080] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085083, U01HL080295, R01HL080295, R01HL068986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG023629, R01AG023629] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		DAVIES M, 1969, BRIT HEART J, V31, P219; DEMOULIN JC, 1975, AM J CARDIOL, V36, P751, DOI 10.1016/0002-9149(75)90456-7; Elizari MV, 2007, CIRCULATION, V115, P1154, DOI 10.1161/CIRCULATIONAHA.106.637389; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Marcus GM, 2007, HEART RHYTHM, V4, P138, DOI 10.1016/j.hrthm.2006.10.017; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A	6	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1587	1588		10.1001/jama.2013.2729	http://dx.doi.org/10.1001/jama.2013.2729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23592102	Green Accepted, Bronze			2022-12-24	WOS:000317599500017
J	Kikwete, J; Jenkins, K; Whitbread, J				Kikwete, Jakaya; Jenkins, Kevin; Whitbread, Jasmine			Playing our part to save children's lives	LANCET			English	Editorial Material									[Kikwete, Jakaya] Presidents Off, Dar Es Salaam, Tanzania; [Jenkins, Kevin] World Vis Int, Uxbridge UB11 1FG, Middx, England; [Whitbread, Jasmine] Save Children Int, London, England	Save the Children	Jenkins, K (corresponding author), World Vis Int, Stockley Pk, Uxbridge UB11 1FG, Middx, England.	kevin_jenkins@wvi.org						[Anonymous], LEV TRENDS CHILD MOR; [Anonymous], 2012, UNICEF PROGR REPORT; Bhutta ZA, 2013, LANCET; Chopra M, 2013, LANCET; Fischer Walker CL, 2013, LANCET; Gill CJ, 2013, LANCET; Jonathan GE, 2013, LANCET, V381, P350, DOI 10.1016/S0140-6736(13)60111-7; WHO UNICEF(World Health Organization United Nations International Children's Emergency Fund), 2013, INT GLOB ACT PLAN PR; World Health Organization/United Nations Children's Fund, 2012, COUNTD 2015 BUILD FU	9	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1798	1799		10.1016/S0140-6736(13)60719-9	http://dx.doi.org/10.1016/S0140-6736(13)60719-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23582724				2022-12-24	WOS:000319443700008
J	Dewan, A; Pacifico, R; Zhan, R; Rinberg, D; Bozza, T				Dewan, Adam; Pacifico, Rodrigo; Zhan, Ross; Rinberg, Dmitry; Bozza, Thomas			Non-redundant coding of aversive odours in the main olfactory pathway	NATURE			English	Article							AMINE-ASSOCIATED RECEPTORS; CHEMOSENSORY RECEPTORS; MOUSE; SUBSYSTEM; EVOLUTION; ODORANTS; NEURONS; MICE; BULB	Many species are critically dependent on olfaction for survival. In the main olfactory system of mammals, odours are detected by sensory neurons that express a large repertoire of canonical odorant receptors and a much smaller repertoire of trace amine-associated receptors (TAARs)(1-4). Odours are encoded in a combinatorial fashion across glomeruli in the main olfactory bulb, with each glomerulus corresponding to a specific receptor(5-7). The degree to which individual receptor genes contribute to odour perception is unclear. Here we show that genetic deletion of the olfactory Taar gene family, or even a single Taar gene (Taar4), eliminates the aversion that mice display to low concentrations of volatile amines and to the odour of predator urine. Our findings identify a role for the TAARs in olfaction, namely, in the high-sensitivity detection of innately aversive odours. In addition, our data reveal that aversive amines are represented in a non-redundant fashion, and that individual main olfactory receptor genes can contribute substantially to odour perception.	[Dewan, Adam; Pacifico, Rodrigo; Zhan, Ross; Bozza, Thomas] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Rinberg, Dmitry] HHMI, Ashburn, VA USA	Northwestern University; Howard Hughes Medical Institute	Bozza, T (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	bozza@northwestern.edu	Pacifico, Rodrigo/L-6189-2017	Pacifico, Rodrigo/0000-0003-2581-6818; Dewan, Adam/0000-0003-1627-5730	NIH/NIDCD [R01DC009640, F32DC012004]; Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013797, R01DC009640, F32DC012004] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Schmidt, C. Waldron, L. Tunmer, V. Dewan and the staff of the Philadelphia Zoo for collecting predator urine and for providing images of the animals. We thank D. Ferster for help with video tracking, D. Cawley, A. Ge and T. Alconada for help analysing behavioural data, the Northwestern University Center for Comparative Medicine for behavioural space, and the Northwestern University Biostatistics Collaboration Center for advice on statistical analyses. T. B. was a participant in the Visiting Scientist Program at HHMI Janelia Farm Research Campus. This work was supported by grants from the NIH/NIDCD (R01DC009640 to T.B. and F32DC012004 to A.D.), The Whitehall Foundation and The Brain Research Foundation (T.B.).	Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060; Zhang JJ, 2013, J NEUROSCI, V33, P3228, DOI 10.1523/JNEUROSCI.4299-12.2013	27	124	142	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					486	+		10.1038/nature12114	http://dx.doi.org/10.1038/nature12114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23624375	Green Accepted			2022-12-24	WOS:000319254000047
J	Armstrong, AW				Armstrong, April W.			Do TNF Inhibitors Reduce the Risk of Myocardial Infarction in Psoriasis Patients?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE; COHORT		Univ Calif Davis, Dept Dermatol, Sacramento, CA 95816 USA	University of California System; University of California Davis	Armstrong, AW (corresponding author), Univ Calif Davis, Dept Dermatol, 3301 C St,Ste 1400, Sacramento, CA 95816 USA.	aprilarmstrong@post.harvard.edu						Abuabara K, 2011, BRIT J DERMATOL, V165, P1066, DOI 10.1111/j.1365-2133.2011.10525.x; Ahlehoff O, 2013, J INTERN MED, V273, P197, DOI 10.1111/j.1365-2796.2012.02593.x; Armstrong AW, 2013, JAMA DERMATOL, V149, P84, DOI 10.1001/2013.jamadermatol.406; Armstrong AW, 2012, AM J CARDIOL, V109, P976, DOI 10.1016/j.amjcard.2011.11.025; Armstrong AW, 2011, EXP DERMATOL, V20, P544, DOI 10.1111/j.1600-0625.2011.01308.x; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Kurd Shanu Kohli, 2007, Expert Rev Clin Immunol, V3, P171, DOI 10.1586/1744666X.3.2.171; Love TJ, 2011, ARCH DERMATOL, V147, P419, DOI 10.1001/archdermatol.2010.370; Wu JJ, 2012, ARCH DERMATOL, V148, P1244, DOI 10.1001/archdermatol.2012.2502	9	18	37	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					2043	2044		10.1001/jama.2013.4695	http://dx.doi.org/10.1001/jama.2013.4695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677316				2022-12-24	WOS:000318855500027
J	Cohen, JC; Hobbs, HH				Cohen, Jonathan C.; Hobbs, Helen H.			Simple Genetics for a Complex Disease	SCIENCE			English	Editorial Material							MOLECULAR CHARACTERIZATION; PCSK9; CHOLESTEROL; MUTATIONS		[Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Res Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu			NHLBI NIH HHS [P01 HL020948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	9	38	39	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					689	690		10.1126/science.1239101	http://dx.doi.org/10.1126/science.1239101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661745	Green Accepted			2022-12-24	WOS:000318619000021
J	Park, J; Al-Ramahi, I; Tan, QM; Mollema, N; Diaz-Garcia, JR; Gallego-Flores, T; Lu, HC; Lagalwar, S; Duvick, L; Kang, H; Lee, Y; Jafar-Nejad, P; Sayegh, LS; Richman, R; Liu, XY; Gao, Y; Shaw, CA; Arthur, JSC; Orr, HT; Westbrook, TF; Botas, J; Zoghbi, HY				Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Mollema, Nissa; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Lu, Hsiang-Chih; Lagalwar, Sarita; Duvick, Lisa; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Shaw, Chad A.; Arthur, J. Simon C.; Orr, Harry T.; Westbrook, Thomas F.; Botas, Juan; Zoghbi, Huda Y.			RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1	NATURE			English	Article							POLYGLUTAMINE-INDUCED NEURODEGENERATION; SPINOCEREBELLAR ATAXIA; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; KINASE INHIBITORS; LOCUS DUPLICATION; CAG REPEAT; MODEL	Many neurodegenerative disorders, such as Alzheimer's, Parkinson's and polyglutamine diseases, share a common pathogenic mechanism: the abnormal accumulation of disease-causing proteins, due to either the mutant protein's resistance to degradation or overexpression of the wild-type protein. We have developed a strategy to identify therapeutic entry points for such neurodegenerative disorders by screening for genetic networks that influence the levels of disease-driving proteins. We applied this approach, which integrates parallel cell-based and Drosophila genetic screens, to spinocerebellar ataxia type 1 (SCA1), a disease caused by expansion of a polyglutamine tract in ataxin 1 (ATXN1). Our approach revealed that downregulation of several components of the RAS-MAPK-MSK1 pathway decreases ATXN1 levels and suppresses neurodegeneration in Drosophila and mice. Importantly, pharmacological inhibitors of components of this pathway also decrease ATXN1 levels, suggesting that these components represent new therapeutic targets in mitigating SCA1. Collectively, these data reveal new therapeutic entry points for SCA1 and provide a proof-of-principle for tackling other classes of intractable neurodegenerative diseases.	[Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Shaw, Chad A.; Westbrook, Thomas F.; Botas, Juan; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Park, Jeehye; Al-Ramahi, Ismael; Tan, Qiumin; Diaz-Garcia, Javier R.; Gallego-Flores, Tatiana; Lu, Hsiang-Chih; Kang, Hyojin; Lee, Yoontae; Jafar-Nejad, Paymaan; Sayegh, Layal S.; Richman, Ronald; Liu, Xiuyun; Gao, Yan; Botas, Juan; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Park, Jeehye; Tan, Qiumin; Lee, Yoontae; Richman, Ronald; Liu, Xiuyun; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Mollema, Nissa; Lagalwar, Sarita; Duvick, Lisa; Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Mollema, Nissa; Lagalwar, Sarita; Duvick, Lisa; Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Lu, Hsiang-Chih; Westbrook, Thomas F.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; University of Dundee; Baylor College of Medicine	Orr, HT (corresponding author), Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA.	orrxx002@umn.edu; thomasw@bcm.edu; jbotas@bcm.edu; hzoghbi@bcm.edu	Woo, Jean/K-2625-2014; Al-Ramahi, Ismael/B-4000-2017	Woo, Jean/0000-0001-7593-3081; Al-Ramahi, Ismael/0000-0002-1275-1114; Tan, Qiumin/0000-0003-2266-3238; Zoghbi, Huda/0000-0002-0700-3349; Arthur, Simon/0000-0002-8135-1958; Gallego, Tatiana/0000-0003-0773-0578; Orr, Harry/0000-0001-6118-741X; Shaw, Chad/0000-0001-7267-5398	Howard Hughes Medical Institute Collaborative Innovation Awards grant; NIH Brain Disorders and Development training grant [NIH-NS42179]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS042179, R01NS027699, R01NS042179, T32NS043124] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12016/10, MC_U127081014] Funding Source: researchfish; MRC [MC_UU_12016/10, MC_U127081014] Funding Source: UKRI	Howard Hughes Medical Institute Collaborative Innovation Awards grant; NIH Brain Disorders and Development training grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the members of the Zoghbi, Botas, Orr and Westbrook laboratories for suggestions and discussions, and V. Brandt for editorial input. We also appreciate the help from CCSC and C-BASS cores at The Baylor College of Medicine (BCM) for FACS analysis and the confocal microscopy and mouse behavioural cores of the BCM Intellectual and Developmental Disabilities Research Center (HD024064). Thanks to J. Barrish at Texas Children's Hospital for help with scanning electron microscopy. This work was supported by a Howard Hughes Medical Institute Collaborative Innovation Awards grant and grant NIH-NS42179 (J. B.) I.A.-R. was supported by an NIH Brain Disorders and Development training grant.	Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; EVANS DA, 1990, MILBANK Q, V68, P267, DOI 10.2307/3350099; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Jafar-Nejad P, 2011, P NATL ACAD SCI USA, V108, P2142, DOI 10.1073/pnas.1018748108; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jorgensen ND, 2009, J NEUROCHEM, V110, P675, DOI 10.1111/j.1471-4159.2009.06164.x; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lorenzetti D, 2000, HUM MOL GENET, V9, P779, DOI 10.1093/hmg/9.5.779; MARSDEN CD, 1977, LANCET, V1, P345; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Scarpini E, 2003, LANCET NEUROL, V2, P539, DOI 10.1016/S1474-4422(03)00502-7; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Shaharabany M, 2008, FEBS J, V275, P1631, DOI 10.1111/j.1742-4658.2008.06318.x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Teixeira-Castro A, 2011, HUM MOL GENET, V20, P2996, DOI 10.1093/hmg/ddr203; van Ham TJ, 2009, EMBO MOL MED, V1, P360, DOI 10.1002/emmm.200900051; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	49	97	100	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					325	+		10.1038/nature12204	http://dx.doi.org/10.1038/nature12204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23719381	Green Accepted			2022-12-24	WOS:000320592900032
J	Wada-Katsumata, A; Silverman, J; Schal, C				Wada-Katsumata, Ayako; Silverman, Jules; Schal, Coby			Changes in Taste Neurons Support the Emergence of an Adaptive Behavior in Cockroaches	SCIENCE			English	Article							GERMAN-COCKROACH; BLATTELLA-GERMANICA; GLUCOSE AVERSION; BITTER TASTE; DROSOPHILA; DICTYOPTERA; INSECTS	In response to the anthropogenic assault of toxic baits, populations of the German cockroach have rapidly evolved an adaptive behavioral aversion to glucose (a phagostimulant component of baits). We hypothesized that changes in the peripheral gustatory system are responsible for glucose aversion. In both wild-type and glucose-averse (GA) cockroaches, D-fructose and D-glucose stimulated sugar gustatory receptor neurons (GRNs), whereas the deterrent caffeine stimulated bitter-GRNs. In contrast, in GA cockroaches, D-glucose also stimulated bitter-GRNs and suppressed the responses of sugar-GRNs. Thus, D-glucose is processed as both a phagostimulant and deterrent in GA cockroaches, and this newly acquired peripheral taste sensitivity underlies glucose aversion in multiple GA populations. The rapid emergence of this highly adaptive behavior underscores the plasticity of the sensory system to adapt to rapid environmental change.	[Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Schal, C (corresponding author), N Carolina State Univ, Dept Entomol, Campus Box 7613, Raleigh, NC 27695 USA.	coby@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Wada-Katsumata, Ayako/0000-0002-2895-1102	NSF [IOS-1052238]; U.S. Department of Housing and Urban Development [NCHHU0001-11]; Blanton J. Whitmire Endowment at North Carolina State University	NSF(National Science Foundation (NSF)); U.S. Department of Housing and Urban Development; Blanton J. Whitmire Endowment at North Carolina State University	We thank R. Santangelo, V. Knowlton, A. Ernst, J. Mahaffey, R. Anholt, N. Bao, D. Bieman, and D. Mukha for equipment and cockroach collections and T. Tanimura, F. Marion-Poll, A. A. Dahanukar, and three anonymous reviewers for constructive comments. This research was supported in part by NSF (IOS-1052238) and U.S. Department of Housing and Urban Development (NCHHU0001-11) awards to C.S. and by the Blanton J. Whitmire Endowment at North Carolina State University. Data associated with this manuscript have been archived in DRYAD Digital Repository (http://datadryad.org/).	Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; DETHIER VG, 1989, PHYSIOL ENTOMOL, V14, P127, DOI 10.1111/j.1365-3032.1989.tb00944.x; DETHIER VG, 1987, CHEM SENSES, V12, P251, DOI 10.1093/chemse/12.2.251; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; Masek P, 2010, P NATL ACAD SCI USA, V107, P14833, DOI 10.1073/pnas.1009318107; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meyerhof W, 2011, FLAVOUR FRAG J, V26, P260, DOI 10.1002/ffj.2041; Newland P, 2009, INSECT TASTE; Onstad D. W., 2008, INSECT RESISTANCE MA; Ramdya P, 2010, TRENDS GENET, V26, P307, DOI 10.1016/j.tig.2010.04.004; ROSS MH, 1995, J INSECT BEHAV, V8, P825, DOI 10.1007/BF02009509; Schaltegger CA, 2011, HANDBOOK ON THE SHADOW ECONOMY, P150; SILVERMAN J, 1995, ENTOMOL EXP APPL, V76, P7, DOI 10.1007/BF02382306; Silverman J, 1999, J ECON ENTOMOL, V92, P886, DOI 10.1093/jee/92.4.886; SILVERMAN J, 1993, J INSECT PHYSIOL, V39, P925, DOI 10.1016/0022-1910(93)90002-9; Tanimura T., 2009, INSECT TASTE, P59; Wada-Katsumata A, 2011, CHEM SENSES, V36, P589, DOI 10.1093/chemse/bjr023; Wada-Katsumata A, 2009, J INSECT PHYSIOL, V55, P742, DOI 10.1016/j.jinsphys.2009.04.014; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001	24	74	78	1	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					972	975		10.1126/science.1234854	http://dx.doi.org/10.1126/science.1234854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704571				2022-12-24	WOS:000319344100045
J	Czeisler, C				Czeisler, Charles			Casting light on sleep deficiency	NATURE			English	Editorial Material									[Czeisler, Charles] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Czeisler, Charles] Brigham & Womens Hosp, Dept Med, Div Sleep Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Czeisler, C (corresponding author), Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02115 USA.	charles_czeisler@hms.harvard.edu		Czeisler, Charles Andrew/0000-0002-7408-1849				Colten HR, 2006, SLEEP DISORDERS SLEE; Luckhaupt Sara E., 2012, Morbidity and Mortality Weekly Report, V61, P281; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; National Research Council, 2013, ASS ADV SOL STAT LIG	4	130	133	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S13	S13		10.1038/497S13a	http://dx.doi.org/10.1038/497S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698501				2022-12-24	WOS:000319254000007
J	Li, DF; Lyons, JA; Pye, VE; Vogeley, L; Aragao, D; Kenyon, CP; Shah, STA; Doherty, C; Aherne, M; Caffrey, M				Li, Dianfan; Lyons, Joseph A.; Pye, Valerie E.; Vogeley, Lutz; Aragao, David; Kenyon, Colin P.; Shah, Syed T. A.; Doherty, Christine; Aherne, Margaret; Caffrey, Martin			Crystal structure of the integral membrane diacylglycerol kinase	NATURE			English	Article							PROTEIN-STRUCTURE DETERMINATION; ESCHERICHIA-COLI; SN-1,2-DIACYLGLYCEROL KINASE; CRYSTALLOGRAPHY; ENZYME; SEQUENCE; DESIGN; SYSTEM; SITES; NMR	Diacylglycerol kinase catalyses the ATP-dependent phosphorylation of diacylglycerol to phosphatidic acid for use in shuttling water-soluble components to membrane-derived oligosaccharide and lipopolysaccharide in the cell envelope of Gram-negative bacteria(1). For half a century, this 121-residue kinase has served as a model for investigating membrane protein enzymology(1-6), folding(7,8), assembly(9-12) and stability(1,13). Here we present crystal structures for three functional forms of this unique and paradigmatic kinase, one of which is wild type. These reveal a homo-trimeric enzyme with three transmembrane helices and an amino-terminal amphiphilic helix per monomer. Bound lipid substrate and docked ATP identify the putative active site that is of the composite, shared site type. The crystal structures rationalize extensive biochemical and biophysical data on the enzyme. They are, however, at variance with a published solution NMR model(14) in that domain swapping, a key feature of the solution form, is not observed in the crystal structures.	[Li, Dianfan; Lyons, Joseph A.; Pye, Valerie E.; Vogeley, Lutz; Aragao, David; Shah, Syed T. A.; Doherty, Christine; Aherne, Margaret; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Li, Dianfan; Lyons, Joseph A.; Pye, Valerie E.; Vogeley, Lutz; Aragao, David; Shah, Syed T. A.; Doherty, Christine; Aherne, Margaret; Caffrey, Martin] Trinity Coll Dublin, Sch Med, Dublin 2, Ireland; [Kenyon, Colin P.] CSIR, ZA-0184 Pretoria, Gauteng, South Africa	Trinity College Dublin; Trinity College Dublin; Council for Scientific & Industrial Research (CSIR) - South Africa	Caffrey, M (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	martin.caffrey@tcd.ie	Aragao, David/A-1695-2012; Shah, Syed Tasadaque Ali/AAB-4890-2021; Lyons, Joseph/AAA-2528-2020; Li, Dianfan/AHC-2751-2022; Aragao, David/AAV-5514-2021	Aragao, David/0000-0002-6551-4657; Li, Dianfan/0000-0003-4729-4678; Aragao, David/0000-0002-6551-4657; Pye, Valerie E/0000-0001-9616-2992; Lyons, Joseph/0000-0003-0218-4862; Caffrey, Martin/0000-0002-2931-4551	Science Foundation Ireland [07/IN.1/B1836, 12/IA/1255]; National Institutes of Health [GM75915, P50GM073210, U54GM094599]; FP7 [COST CM0902]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094625, R01GM075915, U54GM094599, P50GM073210] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP7; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from Science Foundation Ireland (grants 07/IN.1/B1836 and 12/IA/1255) and the National Institutes of Health (grants GM75915, P50GM073210, U54GM094599) and FP7 (COST CM0902). We thank C. R. Sanders for providing E. coli strain WH1061 and for his collegiality. The assistance and support of beamline scientists at the Advanced Photon Source (23-ID) and Diamond Light Source (I24) are gratefully acknowledged. We thank R. Sanishvili for assistance with zinc analysis, C. Boland and J. Tan for help with diffraction data collection, and A. Coughlan for help with lipid synthesis.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Badola P, 1997, J BIOL CHEM, V272, P24176, DOI 10.1074/jbc.272.39.24176; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BOHNENBERGER E, 1983, EUR J BIOCHEM, V132, P645, DOI 10.1111/j.1432-1033.1983.tb07412.x; Caffrey M, 2009, CURR TOP MEMBR, V63, P83, DOI 10.1016/S1063-5823(09)63004-0; Caffrey M., 2010, JOVE-J VIS EXP, V45, pe1712, DOI DOI 10.3791/1712; Caffrey M, 2012, BIOCHEMISTRY-US, V51, P6266, DOI 10.1021/bi300010w; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans G, 2011, ACTA CRYSTALLOGR D, V67, P261, DOI 10.1107/S0907444911007608; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Lahiri S, 2011, ANGEW CHEM INT EDIT, V50, P3988, DOI 10.1002/anie.201006686; Lau FW, 1999, BIOCHEMISTRY-US, V38, P5521, DOI 10.1021/bi982763t; Li D., 2013, CRYST GROWTH DES; Li D, 2012, JOVE-J VIS EXP, DOI 10.3791/4000; Li DF, 2012, JOVE-J VIS EXP, DOI 10.3791/4001; Li DF, 2011, P NATL ACAD SCI USA, V108, P8639, DOI 10.1073/pnas.1101815108; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lorch M, 2005, CHEMBIOCHEM, V6, P1693, DOI 10.1002/cbic.200500054; Martin JW, 2011, J COMPUT BIOL, V18, P1507, DOI 10.1089/cmb.2011.0173; Martin JW, 2011, PROTEIN SCI, V20, P970, DOI 10.1002/pro.620; Matte A., 2010, ELS; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagy JK, 2000, BIOCHEMISTRY-US, V39, P4154, DOI 10.1021/bi991781n; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pilot JD, 2001, BIOCHEMISTRY-US, V40, P8188, DOI 10.1021/bi0103258; Sanders CR, 1996, BIOCHEMISTRY-US, V35, P8610, DOI 10.1021/bi9604892; SCHNEIDER EG, 1973, J BIOL CHEM, V248, P3739; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SMITH RL, 1994, J BACTERIOL, V176, P5459, DOI 10.1128/JB.176.17.5459-5465.1994; Stokes-Rees I, 2010, P NATL ACAD SCI USA, V107, P21476, DOI 10.1073/pnas.1012095107; Ullrich SJ, 2011, NAT CHEM BIOL, V7, P263, DOI 10.1038/nchembio.543; Van Horn WD, 2012, ANNU REV BIOPHYS, V41, P81, DOI [10.1146/annurev-biophys-050511-102330, 10.1146/annurev-biophys-050511-182330]; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vinogradova O, 1997, BIOPHYS J, V72, P2688, DOI 10.1016/S0006-3495(97)78912-4; WALSH JP, 1990, J BIOL CHEM, V265, P4374; WALSH JP, 1986, J BIOL CHEM, V261, P6239; Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zhou YF, 2000, J BIOL CHEM, V275, P6975, DOI 10.1074/jbc.275.10.6975	50	77	80	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					521	+		10.1038/nature12179	http://dx.doi.org/10.1038/nature12179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23676677	Green Accepted, Green Submitted			2022-12-24	WOS:000319254000055
J	Ho, JK; Batniji, R				Ho, Joyce K.; Batniji, Rajaie			Targets for non-communicable disease: what has happened since the UN summit?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ho, Joyce K.] Stanford NBC News Media & Global Hlth, Stanford, CA USA; [Batniji, Rajaie] Stanford Ctr Innovat Global Hlth, Stanford, CA USA		Ho, JK (corresponding author), Grant Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	joyceho613@gmail.com						[Anonymous], 2012, DRAFT COMPR GLOB MON; Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3768; Stuckler D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5336; WHO, 2012, ZER DRAFT GLOB ACT P; WHO, 2011, 1 WHO DISC PAP COMPR; WHO, 2012, 2 WHO DISC PAP COMPR; WHO, 2011, GLOB STAT REP NONC D; WHO, 2012, REP FORM M MEMB STAT	8	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3300	10.1136/bmj.f3300	http://dx.doi.org/10.1136/bmj.f3300			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23693060				2022-12-24	WOS:000319573300015
J	Malhotra, A				Malhotra, Aseem			The dietary advice on added sugar needs emergency surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-ACTIVITY		Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Malhotra, A (corresponding author), Royal Free Hosp, London, England.	aseem_malhotra@hotmail.com						[Anonymous], DIABETOLOGI IN PRESS; [Anonymous], SURG BITT TRUTH; Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; British Dietetic Association (BDA), FOOD FACT SHEET SUG; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Department of Health, 1991, DIET REF VAL FOOD EN; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Hamer M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6320; Harcombe Z., 2010, OBESITY EPIDEMIC WHA; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Metro, 2013, METRO; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Rayner M, 2004, PUBLIC HEALTH NUTR, V7, P549, DOI 10.1079/PHN2003552; Swinburn B., 2009, 2009 EUR C OB 6 9 MA; U.S. Department Agriculture (USDA), 2006, USDA DAT ADD SUG CON	15	3	3	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3199	10.1136/bmj.f3199	http://dx.doi.org/10.1136/bmj.f3199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23694809				2022-12-24	WOS:000319573300010
J	Xiong, XL; Coombs, PJ; Martin, SR; Liu, JF; Xiao, HX; McCauley, JW; Locher, K; Walker, PA; Collins, PJ; Kawaoka, Y; Skehel, JJ; Gamblin, SJ				Xiong, Xiaoli; Coombs, Peter J.; Martin, Stephen R.; Liu, Junfeng; Xiao, Haixia; McCauley, John W.; Locher, Kathrin; Walker, Philip A.; Collins, Patrick J.; Kawaoka, Yoshihiro; Skehel, John J.; Gamblin, Steven J.			Receptor binding by a ferret-transmissible H5 avian influenza virus	NATURE			English	Article							A VIRUS; HEMAGGLUTININ; SPECIFICITY; EVOLUTION; SELECTION; VARIANTS; MAMMALS; FUSION; CELL; H2	Cell-surface-receptor binding by influenza viruses is a key determinant of their transmissibility, both from avian and animal species to humans as well as from human to human. Highly pathogenic avian H5N1 viruses that are a threat to public health have been observed to acquire affinity for human receptors, and transmissible-mutant-selection experiments have identified a virus that is transmissible in ferrets(1-3), the generally accepted experimental model for influenza in humans. Here, our quantitative biophysical measurements of the receptor-binding properties of haemagglutinin (HA) from the transmissible mutant indicate a small increase in affinity for human receptor and a marked decrease in affinity for avian receptor. From analysis of virus and HA binding data we have derived an algorithm that predicts virus avidity from the affinity of individual HA-receptor interactions. It reveals that the transmissible-mutant virus has a 200-fold preference for binding human over avian receptors. The crystal structure of the transmissible-mutant HA in complex with receptor analogues shows that it has acquired the ability to bind human receptor in the same folded-back conformation as seen for HA from the 1918, 1957 (ref. 4), 1968 (ref. 5) and 2009 (ref. 6) pandemic viruses. This binding mode is substantially different from that by which non-transmissible wild-type H5 virus HA binds human receptor. The structure of the complex also explains how the change in preference from avian to human receptors arises from the Gln226Leu substitution, which facilitates binding to human receptor but restricts binding to avian receptor. Both features probably contribute to the acquisition of transmissibility by this mutant virus.	[Xiong, Xiaoli; Coombs, Peter J.; Martin, Stephen R.; Xiao, Haixia; McCauley, John W.; Walker, Philip A.; Collins, Patrick J.; Skehel, John J.; Gamblin, Steven J.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Liu, Junfeng] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing 100193, Peoples R China; [Locher, Kathrin] Novartis Inst BioMed Res, CH-4057 Basel, Switzerland; [Kawaoka, Yoshihiro] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI 53711 USA	MRC National Institute for Medical Research; China Agricultural University; Ministry of Agriculture & Rural Affairs; Novartis; University of Wisconsin System; University of Wisconsin Madison	Gamblin, SJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	skeheljj@nimr.mrc.ac.uk; sgambli@nimr.mrc.ac.uk	Xiao, Haixia/AAZ-3374-2020	Xiao, Haixia/0000-0003-0032-5430; liu, junfeng/0000-0001-5825-5397; Gamblin, Steve/0000-0001-5331-639X; Coombs, Peter/0000-0002-3711-5480; Xiong, Xiaoli/0000-0002-4632-9122	BBSRC [BB/E010806]; Medical Research Council [U117584222, U117512723, U117570592]; Medical Research Council [MC_U117512723, MC_U117584222] Funding Source: researchfish; MRC [MC_U117584222, MC_U117512723] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to staff at the Diamond Light Source Synchrotron for assistance and beamline access under proposal 7707, E. Christodoulou and S. Vachieri for discussions on protein expression, the staff of the NIMR Large Scale Laboratory, L Haire for assistance with crystallization experiments and S. Smerdon and P. Rosenthal for discussions. H. X. was supported by BBSRC (award number BB/E010806). This work was funded by the Medical Research Council through programmes U117584222, U117512723 and U117570592.	Arinaminpathy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015674; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Steinhauer DA, 1996, P NATL ACAD SCI USA, V93, P12873, DOI 10.1073/pnas.93.23.12873; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	30	156	168	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					392	+		10.1038/nature12144	http://dx.doi.org/10.1038/nature12144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23615615	Bronze			2022-12-24	WOS:000318952000043
J	Stinson, BM; Nager, AR; Glynn, SE; Schmitz, KR; Baker, TA; Sauer, RT				Stinson, Benjamin M.; Nager, Andrew R.; Glynn, Steven E.; Schmitz, Karl R.; Baker, Tania A.; Sauer, Robert T.			Nucleotide Binding and Conformational Switching in the Hexameric Ring of a AAA plus Machine	CELL			English	Article							DIFFRACTION DATA; PORE LOOPS; PROTEIN; CLPX; ATP; TRANSLOCATION; F-1-ATPASE	ClpX, a AAA+ ring homohexamer, uses the energy of ATP binding and hydrolysis to power conformational changes that unfold and translocate target proteins into the ClpP peptidase for degradation. In multiple crystal structures, some ClpX subunits adopt nucleotide-loadable conformations, others adopt unloadable conformations, and each conformational class exhibits substantial variability. Using mutagenesis of individual subunits in covalently tethered hexamers together with fluorescence methods to assay the conformations and nucleotide-binding properties of these subunits, we demonstrate that dynamic interconversion between loadable and unloadable conformations is required to couple ATP hydrolysis by ClpX to mechanical work. ATP binding to different classes of subunits initially drives staged allosteric changes, which set the conformation of the ring to allow hydrolysis and linked mechanical steps. Subunit switching between loadable and unloadable conformations subsequently isomerizes or resets the configuration of the nucleotide-loaded ring and is required for mechanical function.	[Stinson, Benjamin M.; Nager, Andrew R.; Glynn, Steven E.; Schmitz, Karl R.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399; Schmitz, Karl/0000-0003-1411-7624; Glynn, Steven/0000-0001-6247-8913	NIH [GM-101988]; NCRR [5P41RR015301-10]; NIGMS [8 P41 GM103403-10]; US DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988, P41GM103403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Drennan, Y. Goldman, R. Grant, K. Knockenhauer, M. Lang, C. Lukehart, A. Olivares, O. Yosefson, and T. Schwartz for help and discussions. This work was supported by NIH grant GM-101988. T.A.B. is an employee of the Howard Hughes Medical Institute. Studies using the NE-CAT beamline were supported by the NCRR (5P41RR015301-10) and NIGMS (8 P41 GM103403-10). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the US DOE (contract DE-AC02-06CH11357).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Zhou RB, 2011, NANO LETT, V11, P5482, DOI 10.1021/nl2032876	32	80	81	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					628	639		10.1016/j.cell.2013.03.029	http://dx.doi.org/10.1016/j.cell.2013.03.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622246	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000318063500015
J	Neubauer, P; Jensen, OP; Hutchings, JA; Baum, JK				Neubauer, Philipp; Jensen, Olaf P.; Hutchings, Jeffrey A.; Baum, Julia K.			Resilience and Recovery of Overexploited Marine Populations	SCIENCE			English	Article							FISHERIES-INDUCED EVOLUTION; FISH STOCKS; FORAGE FISH; CONSEQUENCES; DYNAMICS; IMPACTS; PLANS	Recovery of overexploited marine populations has been slow, and most remain below target biomass levels. A key question is whether this is due to insufficient reductions in harvest rates or the erosion of population resilience. Using a global meta-analysis of overfished stocks, we find that resilience of those stocks subjected to moderate levels of overfishing is enhanced, not compromised, offering the possibility of swift recovery. However, prolonged intense overexploitation, especially for collapsed stocks, not only delays rebuilding but also substantially increases the uncertainty in recovery times, despite predictable influences of fishing and life history. Timely and decisive reductions in harvest rates could mitigate this uncertainty. Instead, current harvest and low biomass levels render recovery improbable for the majority of the world's depleted stocks.	[Neubauer, Philipp; Jensen, Olaf P.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Hutchings, Jeffrey A.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Hutchings, Jeffrey A.] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Baum, Julia K.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada	Rutgers State University New Brunswick; Dalhousie University; University of Oslo; University of Victoria	Neubauer, P (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA.	neubauer.phil@gmail.com	Hutchings, Jeffrey/ABA-1098-2020	Hutchings, Jeffrey/0000-0003-1572-5429; Baum, Julia/0000-0002-9827-1612; Neubauer, Philipp/0000-0002-4150-848X	NFS/National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) [1041678]; Natural Sciences and Engineering Research Council; Sloan Fellowship	NFS/National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sloan Fellowship(Alfred P. Sloan Foundation)	We acknowledge financial support from NFS/National Oceanic and Atmospheric Administration Comparative Analysis of Marine Ecosystem Organization (CAMEO) grant 1041678, Natural Sciences and Engineering Research Council Discovery Grants to J.A.H. and J.K.B., and a Sloan Fellowship to J.K.B. We thank R. Hilborn, T. Branch, and the Jensen Laboratory group for insightful comments. Comments by three anonymous reviewers substantially improved the manuscript. Source data are available at http://ramlegacy.marinebiodiversity.ca.	[Anonymous], 2012, 2012 ATL BLUEF TUN S; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Enberg K, 2009, EVOL APPL, V2, P394, DOI 10.1111/j.1752-4571.2009.00077.x; European Commission, 2011, EUR CFP REF MAX SUST; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Hilborn Ray, 2009, Open Fish Science Journal, V2, P32; Holt CA, 2009, FISH RES, V100, P57, DOI 10.1016/j.fishres.2009.03.002; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jiao Y, 2009, REV FISH BIOL FISHER, V19, P177, DOI 10.1007/s11160-008-9096-8; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Keith DM, 2012, CAN J FISH AQUAT SCI, V69, P1150, DOI 10.1139/F2012-055; Kuparinen A, 2012, P ROY SOC B-BIOL SCI, V279, P2571, DOI 10.1098/rspb.2012.0120; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Safina C, 2005, SCIENCE, V309, P707, DOI 10.1126/science.1113725; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Swain DP, 2012, CAN J FISH AQUAT SCI, V69, P997, DOI 10.1139/F2012-045; United Nations, 2002, REP WORLD SUMM SUST; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters CJ, 2008, CAN J FISH AQUAT SCI, V65, P2536, DOI 10.1139/F08-170; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Ye YM, 2013, FISH FISH, V14, P174, DOI 10.1111/j.1467-2979.2012.00460.x	28	169	173	12	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					347	349		10.1126/science.1230441	http://dx.doi.org/10.1126/science.1230441			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599493				2022-12-24	WOS:000317657500054
J	Geibel, S; Procko, E; Hultgren, SJ; Baker, D; Waksman, G				Geibel, Sebastian; Procko, Erik; Hultgren, Scott J.; Baker, David; Waksman, Gabriel			Structural and energetic basis of folded-protein transport by the FimD usher	NATURE			English	Article							BACTERIAL OUTER-MEMBRANE; CRYSTAL-STRUCTURE; PILUS; CRYSTALLOGRAPHY; REFINEMENT	Type 1 pili, produced by uropathogenic Escherichia coli, are multi-subunit fibres crucial in recognition of and adhesion to host tissues(1). During pilus biogenesis, subunits are recruited to an outer membrane assembly platform, the FimD usher, which catalyses their polymerization and mediates pilus secretion(2). The recent determination of the crystal structure of an initiation complex provided insight into the initiation step of pilus biogenesis resulting in pore activation, but very little is known about the elongation steps that follow(3). Here, to address this question, we determine the structure of an elongation complex in which the tip complex assembly composed of FimC, FimF, FimG and FimH passes through FimD. This structure demonstrates the conformational changes required to prevent backsliding of the nascent pilus through the FimD pore and also reveals unexpected properties of the usher pore. We show that the circular binding interface between the pore lumen and the folded substrate participates in transport by defining a low-energy pathway along which the nascent pilus polymer is guided during secretion.	[Geibel, Sebastian; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Geibel, Sebastian; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Procko, Erik; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Procko, Erik; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Hultgren, Scott J.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63011 USA; [Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63011 USA	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL)	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	dabaker@u.washington.edu; g.waksman@ucl.ac.uk	Geibel, Sebastian/B-5607-2015; Baker, David/K-8941-2012	Geibel, Sebastian/0000-0003-0068-680X; Baker, David/0000-0001-7896-6217; Procko, Erik/0000-0002-0028-490X	Medical Research Council [85602]; National Institute of General Medical Studies at the US National Institutes of Health (NIH) [P41 GM103533]; National Institute of Allergy and Infectious Disease at the NIH [AI029549]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029549, R01AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; MRC [G0800002, MR/K018434/1] Funding Source: UKRI; Medical Research Council [MR/K018434/1, G0800002] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of General Medical Studies at the US National Institutes of Health (NIH); National Institute of Allergy and Infectious Disease at the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Medical Research Council grant 85602 to G. W. D. B. and E. P. are supported by grant P41 GM103533 from the National Institute of General Medical Studies at the US National Institutes of Health (NIH). S.J.H. was supported by grant AI029549 from the National Institute of Allergy and Infectious Disease at the NIH. We thank the staff of beamline ID23-1 at the European Synchrotron Radiation Facility, the staff of beamline IO2 at the Diamond Light source and A. Cole for technical assistance during data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Huang YH, 2009, P NATL ACAD SCI USA, V106, P7403, DOI 10.1073/pnas.0902789106; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; O'Donovan DJ, 2012, ACTA CRYSTALLOGR D, V68, P261, DOI 10.1107/S0907444912001163; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	26	72	72	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					243	+		10.1038/nature12007	http://dx.doi.org/10.1038/nature12007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579681	Green Accepted			2022-12-24	WOS:000317346300046
J	Lee, YS; Morinaga, H; Kim, JJ; Lagakos, W; Taylor, S; Keshwani, M; Perkins, G; Dong, H; Kayali, AG; Sweet, IR; Olefsky, J				Lee, Yun Sok; Morinaga, Hidetaka; Kim, Jane J.; Lagakos, William; Taylor, Susan; Keshwani, Malik; Perkins, Guy; Dong, Hui; Kayali, Ayse G.; Sweet, Ian R.; Olefsky, Jerrold			The Fractalkine/CX3CR1 System Regulates beta Cell Function and Insulin Secretion	CELL			English	Article							NECROSIS-FACTOR-ALPHA; PANCREATIC-ISLETS; CHEMOKINE FRACTALKINE; GENE-EXPRESSION; IN-VITRO; MICE; INFLAMMATION; RESISTANCE; ADHESION; GLUCOSE	Here, we demonstrate that the fractalkine (FKN)/CX3CR1 system represents a regulatory mechanism for pancreatic islet beta cell function and insulin secretion. CX3CR1 knockout (KO) mice exhibited a marked defect in glucose and GLP1-stimulated insulin secretion, and this defect was also observed in vitro in isolated islets from CX3CR1 KO mice. In vivo administration of FKN improved glucose tolerance with an increase in insulin secretion. In vitro treatment of islets with FKN increased intracellular Ca2+ and potentiated insulin secretion in both mouse and human islets. The KO islets exhibited reduced expression of a set of genes necessary for the fully functional, differentiated b cell state, whereas treatment of wild-type (WT) islets with FKN led to increased expression of these genes. Lastly, expression of FKN in islets was decreased by aging and high-fat diet/obesity, suggesting that decreased FKN/CX3CR1 signaling could be a mechanism underlying b cell dysfunction in type 2 diabetes.	[Lee, Yun Sok; Morinaga, Hidetaka; Lagakos, William; Olefsky, Jerrold] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Kim, Jane J.; Kayali, Ayse G.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Taylor, Susan; Keshwani, Malik] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Perkins, Guy] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Dong, Hui] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Olefsky, J (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Lee, Yun Sok/B-3265-2015; Lee, Yun Sok/ABC-9195-2021	Lee, Yun Sok/0000-0001-7967-4734; Lee, Yun Sok/0000-0001-7967-4734; Kim, Jane/0000-0002-0228-0128; Perkins, Guy/0000-0002-1834-6646	National Institutes of Health (NIH) [DK-033651, DK-074868, T32-DK-007494, DK-063491]; Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research [U54-HD-012303-25]; American Diabetes Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, P30DK017047, T32DK007494, R37DK033651, R01DK101395, R01DK033651, P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research; American Diabetes Association(American Diabetes Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grants DK-033651, DK-074868, T32-DK-007494, and DK-063491 and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH through cooperative agreement of U54-HD-012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. Y.S.L. was supported by a Mentor-Based Postdoctoral Fellowship Award from American Diabetes Association. Islet perifusions were carried out by the Diabetes and Endocrine Research Center Islet Core located at the University of Washington (P30 DK017047). We thank Dr. Ulupi Jhala (University of California, San Diego) for providing Min6 cells with permission from Dr. Miyazaki Jun-Ichi (Osaka University). H.D. is a cofounder of AddexBio.	Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Cho IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034860; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Eberhard D, 2010, TRENDS ENDOCRIN MET, V21, P457, DOI 10.1016/j.tem.2010.03.003; Favre D, 2011, DIABETOLOGIA, V54, P2337, DOI 10.1007/s00125-011-2165-x; Fong AM, 2002, J BIOL CHEM, V277, P19418, DOI 10.1074/jbc.M201396200; Garton KJ, 2001, J BIOL CHEM, V276, P37993; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hussain MA, 2000, DIABETES, V49, P1681, DOI 10.2337/diabetes.49.10.1681; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kayali AG, 2007, DIABETES, V56, P703, DOI 10.2337/db06-1545; Kutlu B, 2009, PHYSIOL GENOMICS, V39, P72, DOI 10.1152/physiolgenomics.00063.2009; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; MACLEAN N, 1955, Diabetes, V4, P367; Morris DL, 2012, OBESITY, V20, P1189, DOI 10.1038/oby.2012.7; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shah R, 2011, DIABETES, V60, P1512, DOI 10.2337/db10-0956; Sirois-Gagnon D, 2011, OBESITY, V19, P222, DOI 10.1038/oby.2010.125; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Zhou YP, 2003, J BIOL CHEM, V278, P51316, DOI 10.1074/jbc.M307972200	42	99	99	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					413	425		10.1016/j.cell.2013.03.001	http://dx.doi.org/10.1016/j.cell.2013.03.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582329	Green Accepted, Bronze			2022-12-24	WOS:000317349700019
J	Hunt, KA; Mistry, V; Bockett, NA; Ahmad, T; Ban, M; Barker, JN; Barrett, JC; Blackburn, H; Brand, O; Burren, O; Capon, F; Compston, A; Gough, SCL; Jostins, L; Kong, Y; Lee, JC; Lek, M; MacArthur, DG; Mansfield, JC; Mathew, CG; Mein, CA; Mirza, M; Nutland, S; Onengut-Gumuscu, S; Papouli, E; Parkes, M; Rich, SS; Sawcer, S; Satsangi, J; Simmonds, MJ; Trembath, RC; Walker, NM; Wozniak, E; Todd, JA; Simpson, MA; Plagnol, V; van Heel, DA				Hunt, Karen A.; Mistry, Vanisha; Bockett, Nicholas A.; Ahmad, Tariq; Ban, Maria; Barker, Jonathan N.; Barrett, Jeffrey C.; Blackburn, Hannah; Brand, Oliver; Burren, Oliver; Capon, Francesca; Compston, Alastair; Gough, Stephen C. L.; Jostins, Luke; Kong, Yong; Lee, James C.; Lek, Monkol; MacArthur, Daniel G.; Mansfield, John C.; Mathew, Christopher G.; Mein, Charles A.; Mirza, Muddassar; Nutland, Sarah; Onengut-Gumuscu, Suna; Papouli, Efterpi; Parkes, Miles; Rich, Stephen S.; Sawcer, Steven; Satsangi, Jack; Simmonds, Matthew J.; Trembath, Richard C.; Walker, Neil M.; Wozniak, Eva; Todd, John A.; Simpson, Michael A.; Plagnol, Vincent; van Heel, David A.			Negligible impact of rare autoimmune-locus coding-region variants on missing heritability	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; PSORIASIS SUSCEPTIBILITY LOCI; RHEUMATOID-ARTHRITIS; COMMON VARIANTS; LOW-FREQUENCY; GENES; RISK; ARCHITECTURE; REVEALS	Genome-wide association studies(GWAS) have identified common variants of modest-effect size at hundreds of loci for common autoimmune diseases; however, a substantial fraction of heritability remains unexplained, to which rare variants may contribute(1,2). To discover rare variants and test them for association with a phenotype, most studies re-sequence a small initial sample size and then genotype the discovered variants in a larger sample set(3-5). This approach fails to analyse a large fraction of the rare variants present in the entire sample set. Here we perform simultaneous amplicon-sequencing-based variant discovery and genotyping for coding exons of 25 GWAS risk genes in 41,911 UK residents of white European origin, comprising 24,892 subjects with six autoimmune disease phenotypes and 17,019 controls, and show that rare coding-region variants at known loci have a negligible role in common autoimmune disease susceptibility. These results do not support the rare-variant synthetic genome-wide-association hypothesis(6) (in which unobserved rare causal variants lead to association detected at common tag variants). Many known autoimmune disease risk loci contain multiple, independently associated, common and low-frequency variants, and so genes at these loci are a priori stronger candidates for harbouring rare coding-region variants than other genes. Our data indicate that the missing heritability for common autoimmune diseases may not be attributable to the rare coding-region variant portion of the allelic spectrum, but perhaps, as others have proposed, may be a result of many common-variant loci of weak effect(7-10).	[Hunt, Karen A.; Mistry, Vanisha; Bockett, Nicholas A.; van Heel, David A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Ahmad, Tariq] Peninsula Coll Med & Dent, Exeter EX2 5DW, Devon, England; [Ban, Maria; Compston, Alastair; Sawcer, Steven] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Barker, Jonathan N.; Capon, Francesca; Mathew, Christopher G.; Mirza, Muddassar; Papouli, Efterpi; Simpson, Michael A.] Kings Coll London, Sch Med, Div Genet & Mol Med, Guys Hosp, London SE1 9RT, England; [Barrett, Jeffrey C.; Blackburn, Hannah] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Brand, Oliver; Gough, Stephen C. L.; Simmonds, Matthew J.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Burren, Oliver; Nutland, Sarah; Walker, Neil M.; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; [Jostins, Luke] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Kong, Yong] Yale Univ, WM Keck Fdn Biotechnol Resource Lab, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Lee, James C.; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 0QQ, England; [Lek, Monkol; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Mansfield, John C.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Mein, Charles A.; Wozniak, Eva] Queen Mary Univ London, Barts & London Sch Med & Dent, John Vane Sci Ctr, Genome Ctr, London EC1M 6BQ, England; [Onengut-Gumuscu, Suna; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA; [Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Trembath, Richard C.] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 2AT, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England	University of London; Queen Mary University London; University of Exeter; University of Plymouth; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Wellcome Trust Sanger Institute; University of Oxford; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Yale University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Massachusetts General Hospital; Newcastle University - UK; University of London; Queen Mary University London; University of Virginia; University of Edinburgh; University of London; Queen Mary University London; University of London; University College London	van Heel, DA (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England.	v.plagnol@ucl.ac.uk; d.vanheel@qmul.ac.uk	Capon, Francesca/F-4763-2011; Lee, James/ABD-5920-2020; Mathew, Christopher G/G-3434-2015; Kong, Yong/B-5105-2014; Simpson, Michael/F-4737-2011; Todd, John A/A-3542-2010	Capon, Francesca/0000-0003-2432-5793; Lee, James/0000-0001-5711-9385; Mathew, Christopher G/0000-0003-4178-1838; Kong, Yong/0000-0002-2881-5274; Simpson, Michael/0000-0002-8539-8753; Todd, John A/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688; Barker, Jonathan/0000-0002-9030-183X; van Heel, David/0000-0002-0637-2265; Plagnol, Vincent/0000-0002-5597-9215; MacArthur, Daniel/0000-0002-5771-2290; Rich, Stephen/0000-0003-3872-7793; Bockett, Nicholas/0000-0002-7630-7637; Simmonds, Matt/0000-0003-3154-3510; Barrett, Jeffrey/0000-0002-1152-370X; Burren, Oliver/0000-0002-3388-5760; Mein, Charles/0000-0003-0811-9658; Parkes, Miles/0000-0002-6467-0631; Trembath, Richard/0000-0003-0550-3400	Medical Research Council [MRC G1001158]; Coeliac UK; MRC [G0601387]; National Institutes for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Cambridge NIHR Biomedical Research Centre; Wellcome Trust [076113/C/04/Z, 068545/Z/02, 068181, JDRF 4-2001-1008, WT061858]; NIHR [RP-PG-0310-1002]; UK MRC [G0000934]; British Society for Paediatric Endocrinology and Diabetes; Academy of Medical Sciences (AMS) [AMS-SGCL9-Lee] Funding Source: researchfish; Medical Research Council [G0600329, G0800675, G0601387, G1001158, G0800759, G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379, NF-SI-0508-10335, NF-SI-0508-10275] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/75, ETM/137] Funding Source: researchfish; MRC [G0000934, G0800759, G1001158, G0800675, G0600329] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Coeliac UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); NIHR(National Institute for Health Research (NIHR)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Society for Paediatric Endocrinology and Diabetes; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was primarily funded by the Medical Research Council (MRC G1001158 to D. A. v. H and V. P.), with further funding from Coeliac UK (to D. A. v. H). We thank C. Wijmenga and G. Trynka for sharing ImmunoChip data, and the International Multiple Sclerosis Genomics Consortium for ImmunoChip data and samples. J.N.B. and R. C. T. are supported by MRC grant G0601387. This research was supported by the National Institutes for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The study was supported by the Cambridge NIHR Biomedical Research Centre. We thank E. Gray and D. Jones (Wellcome Trust Sanger Institute) for sample preparation. We acknowledge use of DNA from The UK Blood Services collection of Common Controls (UKBS-CC collection), funded by the Wellcome Trust grant 076113/C/04/Z and by NIHR programme grant to NHS Blood and Transplant (RP-PG-0310-1002). The collection was established as part of the Wellcome Trust Case Control Consortium(WTCCC). We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the UK MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02. We thank nurses and doctors for recruiting autoimmune thyroid disease (AITD) subjects into the AITD National Collection, funded by the Wellcome Trust grant 068181. We acknowledge use of DNA from the Cambridge BioResource. We acknowledge use of DNA from the Juvenile Diabetes Research Foundation (JDRF)/Wellcome Trust Case-Series (GRID), funded by JDRF and the Wellcome Trust (grant references JDRF 4-2001-1008 and WT061858). The subjects were recruited in the UK by D. Dunger and his team with support from the British Society for Paediatric Endocrinology and Diabetes. The samples were prepared and provided by the JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, University of Cambridge, UK. Psoriasis samples used were based on the WTCCC2 GWAS clinical panel, for which we thank D. Burden, C. Griffiths, M. Cork and R. McManus. Finally, we would like to thank all autoimmune disease and control subjects for participating in this study.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Liu DJ, 2012, AM J HUM GENET, V91, P585, DOI 10.1016/j.ajhg.2012.08.008; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	30	142	150	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					232	+		10.1038/nature12170	http://dx.doi.org/10.1038/nature12170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23698362	Green Accepted			2022-12-24	WOS:000320283400049
J	Srivastava, R				Srivastava, Ranjana			The art of medicine Free-floating anxiety	LANCET			English	Editorial Material									Dandenong Hosp, Dept Med Oncol, Dandenong, Vic 3175, Australia		Srivastava, R (corresponding author), Dandenong Hosp, Dept Med Oncol, Dandenong, Vic 3175, Australia.	ranjana.srivastava@southernhealth.org.au						Srivastava R., 2012, DYING CHAT COMMUNICA	1	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1808	1809		10.1016/S0140-6736(13)61110-1	http://dx.doi.org/10.1016/S0140-6736(13)61110-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23717835				2022-12-24	WOS:000319443700014
J	Bird, J; Biggs, TC; Thomas, M; Salib, RJ				Bird, J.; Biggs, T. C.; Thomas, M.; Salib, R. J.			10-MINUTE CONSULTATION Adult acute rhinosinusitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bird, J.; Biggs, T. C.; Salib, R. J.] Univ Hosp Southampton NHS Fdn Trust, Dept Otolaryngol Head & Neck Surg, Southampton SO16 6YD, Hants, England; [Thomas, M.] Univ Southampton, Aldermoor Hlth Ctr, Southampton SO9 5NH, Hants, England; [Salib, R. J.] Univ Southampton, Fac Med, Clin Expt Sci Acad Unit, Southampton SO9 5NH, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton	Bird, J (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Dept Otolaryngol Head & Neck Surg, Southampton SO16 6YD, Hants, England.	jonathan.bird83@googlemail.com		Thomas, Mike/0000-0001-5939-1155; Salib, Rami/0000-0002-6753-7844					0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2013	346								f2687	10.1136/bmj.f2687	http://dx.doi.org/10.1136/bmj.f2687			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BV	23667070				2022-12-24	WOS:000318915300001
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA MMR, measles, and the South Wales Evening Post	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2013, S WALES EVENING 0409; BBC News, 2013, BBC NEWS; Demicheli V, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub3; Faasse K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5613; Godlee, 2011, BRIT MED J, V342, pd22, DOI [10.1136/bmj.d22, DOI 10.1136/BMJ.D22]; Goodyear-Smith F, 2002, CONTRACEPTION, V66, P163, DOI 10.1016/S0010-7824(02)00341-4; Hitchens Peter, 2013, DAILY MAIL; *HLTH PROT AG, CONF CAS MEASL REG A; Hookham M, 2013, SUNDAY TIMES, P1; Leveson Lord, 2012, INQUIRY CULTURE PRAC, VII; Mason B W, 2000, Commun Dis Public Health, V3, P67; Mason BW, 2000, J EPIDEMIOL COMMUN H, V54, P473, DOI 10.1136/jech.54.6.473; Payne C, 1998, LANCET, V351, P907, DOI 10.1016/S0140-6736(05)70319-6; Public Health Wales, 2013, VACC PLEA CONT MEASL; Szarewski A, 1999, HUM REPROD UPDATE, V5, P627, DOI 10.1093/humupd/5.6.627; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield W, 2013, INDEPENDENT; Wise J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2545	18	1	1	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2013	346								f2598	10.1136/bmj.f2598	http://dx.doi.org/10.1136/bmj.f2598			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PK	23610382				2022-12-24	WOS:000318224700007
J	Andreae, MO; Ramanathan, V				Andreae, Meinrat O.; Ramanathan, V.			Climate's Dark Forcings	SCIENCE			English	Editorial Material							BLACK CARBON; BROWN CARBON; ABSORPTION		[Andreae, Meinrat O.] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany; [Andreae, Meinrat O.; Ramanathan, V.] Univ Calif San Diego, Inst Oceanog Sci, La Jolla, CA 92093 USA; [Ramanathan, V.] TERI Univ, New Delhi 110070, India	Max Planck Society; University of California System; University of California San Diego; TERI University	Andreae, MO (corresponding author), Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany.	m.andreae@mpic.de	Andreae, Meinrat O./B-1068-2008	Andreae, Meinrat O./0000-0003-1968-7925				Allen RJ, 2012, NATURE, V485, P350, DOI 10.1038/nature11097; Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; [Anonymous], 2011, INTEGRATED ASSESSMEN; Bahadur R, 2012, P NATL ACAD SCI USA, V109, P17366, DOI 10.1073/pnas.1205910109; Bahadur R, 2011, ATMOS ENVIRON, V45, P1162, DOI 10.1016/j.atmosenv.2010.10.054; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Chung CE, 2012, P NATL ACAD SCI USA, V109, P11624, DOI 10.1073/pnas.1203707109; Jacobson MZ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013795; Kirchstetter TW, 2012, ATMOS CHEM PHYS, V12, P6067, DOI 10.5194/acp-12-6067-2012; Lau WKM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043255; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Manoj MG, 2011, CLIM DYNAM, V37, P2181, DOI 10.1007/s00382-010-0971-3; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]	15	95	98	2	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					280	281		10.1126/science.1235731	http://dx.doi.org/10.1126/science.1235731			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599469				2022-12-24	WOS:000317657500030
J	Teo, K; Lear, S; Islam, S; Mony, P; Dehghan, M; Li, W; Rosengren, A; Lopez-Jaramillo, P; Diaz, R; Oliveira, G; Miskan, M; Rangarajan, S; Iqbal, R; Ilow, R; Puone, T; Bahonar, A; Gulec, S; Darwish, EA; Lanas, F; Vijaykumar, K; Rahman, O; Chifamba, J; Hou, Y; Li, N; Yusuf, S				Teo, Koon; Lear, Scott; Islam, Shofiqul; Mony, Prem; Dehghan, Mahshid; Li, Wei; Rosengren, Annika; Lopez-Jaramillo, Patricio; Diaz, Rafael; Oliveira, Gustavo; Miskan, Maizatullifah; Rangarajan, Sumathy; Iqbal, Romaina; Ilow, Rafal; Puone, Thandi; Bahonar, Ahmad; Gulec, Sadi; Darwish, Ebtihal A.; Lanas, Fernando; Vijaykumar, Krishnapillai; Rahman, Omar; Chifamba, Jephat; Hou, Yan; Li, Ning; Yusuf, Salim		PURE Investigators	Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries The Prospective Urban Rural Epidemiology (PURE) Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD FREQUENCY QUESTIONNAIRES; MYOCARDIAL-INFARCTION; RISK-FACTORS; SECONDARY PREVENTION; DRUG THERAPIES; TOBACCO USE; INTERHEART; DIET; COMMUNITY; EXERCISE	Importance Little is known about adoption of healthy lifestyle behaviors among individuals with a coronary heart disease (CHD) or stroke event in communities across a range of countries worldwide. Objective To examine the prevalence of avoidance or cessation of smoking, eating a healthy diet, and undertaking regular physical activities by individuals with a CHD or stroke event. Design, Setting, and Participants Prospective Urban Rural Epidemiology (PURE) was a large, prospective cohort study that used an epidemiological survey of 153 996 adults, aged 35 to 70 years, from 628 urban and rural communities in 3 high-income countries (HIC), 7 upper-middle-income countries (UMIC), 3 lower-middle-income countries (LMIC), and 4 low-income countries (LIC), who were enrolled between January 2003 and December 2009. Main Outcome Measures Smoking status (current, former, never), level of exercise (low, <600 metabolic equivalent task [MET]-min/wk; moderate, 600-3000 MET-min/wk; high, >3000 MET-min/wk), and diet (classified by the Food Frequency Questionnaire and defined using the Alternative Healthy Eating Index). Results Among 7519 individuals with self-reported CHD (past event: median, 5.0 [interquartile range {IQR}, 2.0-10.0] years ago) or stroke (past event: median, 4.0 [IQR, 2.0-8.0] years ago), 18.5% (95% CI, 17.6%-19.4%) continued to smoke; only 35.1% (95% CI, 29.6%-41.0%) undertook high levels of work-or leisure-related physical activity, and 39.0% (95% CI, 30.0%-48.7%) had healthy diets; 14.3% (95% CI, 11.7%-17.3%) did not undertake any of the 3 healthy lifestyle behaviors and 4.3% (95% CI, 3.1%-5.8%) had all 3. Overall, 52.5% (95% CI, 50.7%-54.3%) quit smoking (by income country classification: 74.9% [95% CI, 71.1%-78.6%] in HIC; 56.5% [95% CI, 53.4%-58.6%] in UMIC; 42.6% [95% CI, 39.6%-45.6%] in LMIC; and 38.1% [95% CI, 33.1%-43.2%] in LIC). Levels of physical activity increased with increasing country income but this trend was not statistically significant. The lowest prevalence of eating healthy diets was in LIC (25.8%; 95% CI, 13.0%-44.8%) compared with LMIC (43.2%; 95% CI, 30.0%-57.4%), UMIC (45.1%, 95% CI, 30.9%-60.1%), and HIC (43.4%, 95% CI, 21.0%-68.7%). Conclusion and Relevance Among a sample of patients with a CHD or stroke event from countries with varying income levels, the prevalence of healthy lifestyle behaviors was low, with even lower levels in poorer countries. JAMA. 2013;309(15):1613-1621 www.jama.com	[Teo, Koon; Islam, Shofiqul; Dehghan, Mahshid; Rangarajan, Sumathy; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON, Canada; [Lear, Scott] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Vancouver, BC, Canada; [Lear, Scott] Providence Hlth Care, Vancouver, BC, Canada; [Mony, Prem] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Li, Wei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100730, Peoples R China; [Li, Wei] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Lopez-Jaramillo, Patricio] Fdn Oftalmol Sandander, Santander, Colombia; [Diaz, Rafael] Latinoamer ECLA, Estudios Clin, Rosario, Santa Fe, Argentina; [Oliveira, Gustavo] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Miskan, Maizatullifah] Univ Teknol MARA, Fac Med, Sungai Boloh, Malaysia; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Ilow, Rafal] Wroclaw Med Univ, Dept Food Sci & Dietet, Wroclaw, Poland; [Puone, Thandi] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Bahonar, Ahmad] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Gulec, Sadi] Ankara Univ, Dept Cardiol, TR-06100 Ankara, Turkey; [Darwish, Ebtihal A.] Dubai Med Coll, Dept Family Med, Dubai, U Arab Emirates; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Vijaykumar, Krishnapillai] Hlth Act People, Trivandrum, Kerala, India; [Rahman, Omar] Independent Univ Bangladesh, Dhaka, Bangladesh; [Chifamba, Jephat] Univ Zimbabwe, Dept Physiol, Coll Hlth Sci, Harare, Zimbabwe; [Hou, Yan] Beilingbridge Community Hlth Serv Ctr, Taiyuan, Shanxi Province, Peoples R China; [Li, Ning] Qingshanhu Community Hlth Serv Stn, Nanchang, Jiangxi, Peoples R China	McMaster University; Population Health Research Institute; Simon Fraser University; St. John's National Academy of Health Sciences; St. John's Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Gothenburg; Instituto Dante Pazzanese de Cardiologia; Aga Khan University; Wroclaw Medical University; University of the Western Cape; Isfahan University Medical Science; Ankara University; Universidad de La Frontera; Independent University Bangladesh (IUB); University of Zimbabwe	Teo, K (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, DBCVSRI, Room C2-106,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	koon.teo@phri.ca	Igumbor, Ehimario U/B-2652-2012; Ramli, Anis Safura/K-3322-2014; Bahonar, Ahmad/Q-7698-2019; Kelishadi, Roya/E-6154-2012; Ramli, Anis Safura/U-3548-2018; Mony, Prem K./GRF-4752-2022; Nawawi, Hapizah Mohd/J-8873-2019; Rahman, Omar/E-1329-2019; Chifamba, Jephat/AHE-4535-2022; Lanas, Fernando/AAE-8842-2022; Nor-Ashikin, Mohamed Noor Khan/P-2055-2015; Nawawi, Hapizah/N-7446-2019; Gomez-Arbelaez, Diego/K-1883-2013; Rozanska, Dorota/S-5239-2018; Corsi, Daniel J/S-4689-2018	Igumbor, Ehimario U/0000-0002-6313-6031; Ramli, Anis Safura/0000-0002-9517-1413; Kelishadi, Roya/0000-0001-7455-1495; Ramli, Anis Safura/0000-0002-9517-1413; Mony, Prem K./0000-0002-1399-0520; Nawawi, Hapizah Mohd/0000-0003-4462-8484; Rahman, Omar/0000-0002-0606-2507; Chifamba, Jephat/0000-0001-8166-1182; Nor-Ashikin, Mohamed Noor Khan/0000-0002-1325-9236; Nawawi, Hapizah/0000-0003-4462-8484; Iqbal, Romaina/0000-0002-5364-4366; Zatonska, Katarzyna/0000-0002-3772-5588; Jerling, Johann/0000-0003-2600-3536; Teo, Koon/0000-0002-3731-0956; Lanas, Fernando/0000-0003-3595-9759; Dehghan, Mahshid/0000-0003-2149-847X; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Gulec, Sadi/0000-0002-2685-2522; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Rosengren, Annika/0000-0002-5409-6605; Yusuf, Salim/0000-0003-4776-5601; Szuba, Andrzej/0000-0002-7555-6201; Wolyniec, Maria/0000-0003-2054-1691; Rozanska, Dorota/0000-0002-0561-2749; Regulska-Ilow, Bozena/0000-0002-5941-1715; Corsi, Daniel J/0000-0001-7063-3354	Population Health Research Institute (Hamilton, Ontario, Canada); Boehringer; Merck; Polish Minstry of Science and Higher Education; Population Health Research Institute; sanofi-aventis; AstraZeneca; Novartis; Pfizer; Bayer; Boehringer Ingelheim; Abdi Ibrahim (Turkey); Universidad de La Frontera; Mary W. Burke endowed chair of the Heart and Stroke Foundation of Ontario; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia; Sydney Medical Foundation; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; AstraZeneca in Sweden; AstraZeneca in Canada; sanofi-aventis in France; sanofi-aventis in Canada; Boehringer Ingelheim in Germany; Boehringer Ingelheim in Canada; Servier; King Pharma; GlaxoSmithKline; Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; National Center for Cardiovascular Diseases; Colciencias [6566-04-18062]; Indian Council of Medical Research; Ministry of Science, Technology, and Innovation of Malaysia [07-05-IFN-MEB010]; Universiti Teknologi MARA; Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Wroclaw Medical University; North-West University, SANPAD (South Africa and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of South Africa; South Africa Sugar Association; Faculty of Community and Health Sciences (University of Western Cape); Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish State under LakarUtbildningsAvtalet; Vastra Gotaland Region; Metabolic Syndrome Society; Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; Dubai Health Authority	Population Health Research Institute (Hamilton, Ontario, Canada); Boehringer(Boehringer Ingelheim); Merck(Merck & Company); Polish Minstry of Science and Higher Education; Population Health Research Institute; sanofi-aventis(Sanofi-Aventis); AstraZeneca(AstraZeneca); Novartis(Novartis); Pfizer(Pfizer); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Abdi Ibrahim (Turkey); Universidad de La Frontera; Mary W. Burke endowed chair of the Heart and Stroke Foundation of Ontario; National Heart and Medical Research Council of Australia; National Heart Foundation of Australia(National Heart Foundation of Australia); Sydney Medical Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); AstraZeneca in Sweden(AstraZeneca); AstraZeneca in Canada(AstraZeneca); sanofi-aventis in France; sanofi-aventis in Canada; Boehringer Ingelheim in Germany(Boehringer Ingelheim); Boehringer Ingelheim in Canada(Boehringer Ingelheim); Servier(Servier); King Pharma; GlaxoSmithKline(GlaxoSmithKline); Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil(Unilever); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; National Center for Cardiovascular Diseases; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Ministry of Science, Technology, and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Teknologi MARA; Universiti Kebangsaan Malaysia; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw Medical University; North-West University, SANPAD (South Africa and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of South Africa(South African Medical Research Council); South Africa Sugar Association; Faculty of Community and Health Sciences (University of Western Cape); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State under LakarUtbildningsAvtalet; Vastra Gotaland Region; Metabolic Syndrome Society; Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; Dubai Health Authority	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lear reported that the Population Health Research Institute (Hamilton, Ontario, Canada) provided funding support for travel to meetings for the Prospective Urban Rural Epidemiology (PURE) study. Dr Lopez-Jaramillo reported receiving speakers fees from Boehringer and Merck. Dr Ilow reported receiving research funding from the Polish Minstry of Science and Higher Education and the Population Health Research Institute. Dr Bahonar reported receiving institutional funding from the Population Health Research Institute for the costs of the study. Dr Gulec reported serving on the board of Pfizer, Novartis, AstraZeneca, and Boehringer Ingelheim; receiving speakers fees from sanofi-aventis, AstraZeneca, Novartis, Pfizer, Bayer, and Boehringer Ingelheim; receiving payment for the development of educational presentations from Abdi Ibrahim (Turkey); and receiving travel reimbursement from Boehringer Ingelheim and sanofi-aventis. Dr Lanas reported receiving a grant from the Universidad de La Frontera; and receiving travel reimbursement from the Population Health Research Institute. No other author reported disclosures.; Dr Yusuf is supported by the Mary W. Burke endowed chair of the Heart and Stroke Foundation of Ontario. Dr Chow is supported by a fellowship co-funded by the National Heart and Medical Research Council of Australia, the National Heart Foundation of Australia, and the Sydney Medical Foundation. The PURE study is funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca in Sweden and Canada, Novartis, sanofi-aventis in France and Canada, Boehringer Ingelheim in Germany and Canada, Servier, King Pharma, and GlaxoSmithKline), and additionally by contributions from various national or local organizations in the following countries: Bangladesh: Independent University, Bangladesh, Mitra and Associates. Brazil: Unilever Health Institute, Brazil. Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network. Chile: Universidad de la Frontera. China: National Center for Cardiovascular Diseases. Colombia: Colciencias grant 6566-04-18062. India: Indian Council of Medical Research. Malaysia: Ministry of Science, Technology, and Innovation of Malaysia grant 07-05-IFN-MEB010, Universiti Teknologi MARA, and Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010). Poland: Polish Ministry of Science and Higher Education grant Nr 290/W-PURE/2008/0, and Wroclaw Medical University. South Africa: North-West University, SANPAD (South Africa and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of South Africa, South Africa Sugar Association, and Faculty of Community and Health Sciences (University of Western Cape). Sweden: Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Heart and Lung Foundation, Swedish Research Council, grant from the Swedish State under LakarUtbildningsAvtalet agreement, and grant from the Vastra Gotaland Region. Turkey: Metabolic Syndrome Society, AstraZeneca, and sanofi-aventis. United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, and Dubai Health Authority.	Bharathi AV, 2008, ASIA PAC J CLIN NUTR, V17, P178; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Dehghan M, 2012, J HUM NUTR DIET, V25, P225, DOI 10.1111/j.1365-277X.2012.01240.x; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-18; Dehghan M, 2012, CIRCULATION, V126, P2705, DOI 10.1161/CIRCULATIONAHA.112.103234; Dehghan M, 2012, J NUTR EDUC BEHAV, V44, P609, DOI 10.1016/j.jneb.2010.10.001; IPAQ-International Physical Activity Questionnaire, GUID DAT PROC AN INT; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Kelemen LE, 2003, J AM DIET ASSOC, V103, P1178, DOI 10.1016/S0002-8223(03)00985-4; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kumra V, 2000, CLIN CHEST MED, V21, P1, DOI 10.1016/S0272-5231(05)70004-6; MacQueen KM, 2001, AM J PUBLIC HEALTH, V91, P1929, DOI 10.2105/AJPH.91.12.1929; McCullough ML, 2006, PUBLIC HEALTH NUTR, V9, P152, DOI 10.1079/PHN2005938; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Merchant AT, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-37; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; World Bank, DO WE CLASS COUNTR; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	24	186	196	1	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1613	1621		10.1001/jama.2013.3519	http://dx.doi.org/10.1001/jama.2013.3519			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126FY	23592106	Green Accepted, Bronze			2022-12-24	WOS:000317599500025
J	Savir, Y; Tlusty, T				Savir, Yonatan; Tlusty, Tsvi			The Ribosome as an Optimal Decoder: A Lesson in Molecular Recognition	CELL			English	Article							TRANSFER-RNA SELECTION; AMINOACYL-TRANSFER-RNA; INDUCED FIT; CONFORMATIONAL-CHANGES; ENERGY LANDSCAPES; GTPASE ACTIVATION; PROTEIN-SYNTHESIS; EF-TU; FIDELITY; TRANSLATION	The ribosome is a complex molecular machine that, in order to synthesize proteins, has to decode mRNAs by pairing their codons with matching tRNAs. Decoding is a major determinant of fitness and requires accurate and fast selection of correct tRNAs among many similar competitors. However, it is unclear whether the modern ribosome, and in particular its large conformational changes during decoding, are the outcome of adaptation to its task as a decoder or the result of other constraints. Here, we derive the energy landscape that provides optimal discrimination between competing substrates and thereby optimal tRNA decoding. We show that the measured landscape of the prokaryotic ribosome is sculpted in this way. This model suggests that conformational changes of the ribosome and tRNA during decoding are means to obtain an optimal decoder. Our analysis puts forward a generic mechanism that may be utilized broadly by molecular recognition systems.	[Savir, Yonatan] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Tlusty, Tsvi] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Harvard University; Harvard Medical School; Institute for Advanced Study - USA	Tlusty, T (corresponding author), Inst Adv Study, Simons Ctr Syst Biol, Olden Lane, Princeton, NJ 08540 USA.	tlusty@ias.edu	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725	Human Frontier Science Program fellowship	Human Frontier Science Program fellowship(Human Frontier Science Program)	We thank Marina Rodnina, Ada Yonath, Mans Ehrenberg, Jacques Ninio, Elisha Moses, Uri Alon, Rami Pugatch, Adam Lampert, Tamar Friedlander, Michel Springer, Tzachi Pilpel, Ron Milo, and Jean-Pierre Eckmann for valuable discussions. Y.S. is supported by the Human Frontier Science Program fellowship. T.T. thanks the Simons Foundation and Helen and Martin Chooljian for their generous support. T.T. is the Helen and Martin Chooljian Founders Circle Member in the Simons Center for Systems Biology of the Institute for Advanced Study, Princeton.	Bashan A, 2008, TRENDS MICROBIOL, V16, P326, DOI 10.1016/j.tim.2008.05.001; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; De Vlaminck I, 2012, MOL CELL, V46, P616, DOI 10.1016/j.molcel.2012.03.029; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; Ferreiro DU, 2011, P NATL ACAD SCI USA, V108, P3499, DOI 10.1073/pnas.1018980108; Fersht A., 1985, ENZYME STRUCTURE MEC; Fersht A., 1999, STRUCTURE MECH PROTE; Frank J, 2005, FEBS LETT, V579, P959, DOI 10.1016/j.febslet.2004.10.105; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Gromadski KB, 2004, NAT STRUCT MOL BIOL, V11, P316, DOI 10.1038/nsmb742; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Helstrom CW, 1995, ELEMENTS SIGNAL DETE; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Johansson M, 2008, CURR OPIN MICROBIOL, V11, P141, DOI 10.1016/j.mib.2008.02.015; Johansson M, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P225; Johansson M, 2012, P NATL ACAD SCI USA, V109, P131, DOI 10.1073/pnas.1116480109; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Lee TH, 2007, P NATL ACAD SCI USA, V104, P13661, DOI 10.1073/pnas.0705988104; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; MIKKOLA R, 1988, FEMS MICROBIOL LETT, V56, P265, DOI 10.1016/0378-1097(88)90071-7; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Ninio J, 2006, BIOCHIMIE, V88, P963, DOI 10.1016/j.biochi.2006.06.002; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Post CB, 1995, BIOCHEMISTRY-US, V34, P15881, DOI 10.1021/bi00049a001; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Savir Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000468; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; Savir Y, 2009, 2009 43RD ANNUAL CONFERENCE ON INFORMATION SCIENCES AND SYSTEMS, VOLS 1 AND 2, P835, DOI 10.1109/CISS.2009.5054833; Savir Y, 2008, IEEE J-STSP, V2, P390, DOI 10.1109/JSTSP.2008.923859; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Schug A, 2010, CURR OPIN PHARMACOL, V10, P709, DOI 10.1016/j.coph.2010.09.012; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Whitford PC, 2011, RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS, P303; Whitford PC, 2011, P NATL ACAD SCI USA, V108, P18943, DOI 10.1073/pnas.1108363108; Whitford PC, 2010, J AM CHEM SOC, V132, P13170, DOI 10.1021/ja1061399; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yarus M, 2003, RNA, V9, P384, DOI 10.1261/rna.2184703; Zaher HS, 2010, MOL CELL, V39, P110, DOI 10.1016/j.molcel.2010.06.009; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	50	34	34	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					471	479		10.1016/j.cell.2013.03.032	http://dx.doi.org/10.1016/j.cell.2013.03.032			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582332	Bronze			2022-12-24	WOS:000317349700024
J	Korf, BR; Rehm, HL				Korf, Bruce R.; Rehm, Heidi L.			New Approaches to Molecular Diagnosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHROMOSOMAL MICROARRAY; GENE; MEDICINE; EXOME; IDENTIFICATION; STRATEGIES; HEALTH	Advances in understanding the molecular basis of rare and common disorders, as well as in the technology of DNA analysis, are rapidly changing the landscape of molecular genetic and genomic testing. High-resolution molecular cytogenetic analysis can now detect deletions or duplications of DNA of a few hundred thousand nucleotides, well below the resolution of the light microscope. Diagnostic testing for "single-gene" disorders can be done by targeted analysis for specific mutations, by sequencing a specific gene to scan for mutations, or by analyzing multiple genes in which mutation may lead to a similar phenotype. The advent of massively parallel next-generation sequencing facilitates the analysis of multiple genes and now is being used to sequence the coding regions of the genome (the exome) for clinical testing. Exome sequencing requires bioinformatic analysis of the thousands of variants that are identified to find one that is contributing to the pathology; there is also a possibility of incidental identification of other medically significant variants, which may complicate genetic counseling. DNA testing can also be used to identify variants that influence drug metabolism or interaction of a drug with its cellular target, allowing customization of choice of drug and dosage. Exome and genome sequencing are being applied to identify specific gene changes in cancer cells to guide therapy, to identify inherited cancer risk, and to estimate prognosis. Genomic testing may be used to identify risk factors for common disorders, although the clinical utility of such testing is unclear. Genetic and genomic tests may raise new ethical, legal, and social issues, some of which may be addressed by existing genetic nondiscrimination legislation, but which also must be addressed in the course of genetic counseling. The purpose of this article is to assist physicians in recognizing where new approaches to genetic and genomic testing may be applied clinically and in being aware of the principles of interpretation of test results. JAMA. 2013;309(14):1511-1521 www.jama.com	[Korf, Bruce R.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Rehm, Heidi L.] Partners Healthcare Ctr Personalized Genet Med, Mol Med Lab, Cambridge, MA USA	University of Alabama System; University of Alabama Birmingham; Partners Healthcare System	Korf, BR (corresponding author), Univ Alabama Birmingham, Dept Genet, 1720 2nd Ave S,Kaul 230, Birmingham, AL 35294 USA.	bkorf@uab.edu	Korf, Bruce R/H-4882-2012	Rehm, Heidi L./0000-0002-6025-0015	National Institutes of Health; US Department of Defense; GeneInsight software development from Illumina; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC007183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); GeneInsight software development from Illumina; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Korf reported serving on the board for the Neurofibromatosis Therapeutic Acceleration Project, receiving grants from the National Institutes of Health and US Department of Defense, receiving payment for lectures to academic groups, receiving royalties from John Wiley and Elsevier, and receiving funds for travel for multiple academic meetings. Dr Rehm reported being employed by a fee-for-service nonprofit molecular diagnostic laboratory; having served on advisory boards for Knome, Complete Genomics, GenomeQuest, and Omicia; having consulted for Generation Health; having received honoraria for lectures to academic groups; having owned stock or stock options for Generation Health; and having received travel support for multiple academic meetings; she also reported that her institution has received support for GeneInsight software development from Illumina.	Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Angeli SI, 2011, OTOL NEUROTOL, V32, P1437, DOI 10.1097/MAO.0b013e31823387f9; [Anonymous], 1999, Genet Med, V1, P237; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bick D, 2011, CURR OPIN PEDIATR, V23, P594, DOI 10.1097/MOP.0b013e32834b20ec; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Boone PM, 2013, GENET MED, V15, P45, DOI 10.1038/gim.2012.95; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Burke W, 2009, CURR PROTOC HUM GENE, V60, P1; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen WT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023087; Cook-Deegan R, 2012, EUR J HUM GENET; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Eriksson N, 2012, PHARMACOGENOMICS, V13, P429, DOI [10.2217/pgs.11.184, 10.2217/PGS.11.184]; Evans JP, 2009, GENET MED, V11, P568, DOI 10.1097/GIM.0b013e3181afbaed; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Feldman EA, 2012, J GEN INTERN MED, V27, P743, DOI 10.1007/s11606-012-1988-6; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Giacomini KM, 2012, SCI TRANSL MED, V4; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Hanson EH, 2001, AM J EPIDEMIOL, V154, P193, DOI 10.1093/aje/154.3.193; Klee EW, 2011, EXPERT REV MOL DIAGN, V11, P703, DOI [10.1586/erm.11.58, 10.1586/ERM.11.58]; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; McBride CM, 2010, AM J PREV MED, V38, P556, DOI 10.1016/j.amepre.2010.01.027; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Miller DT, 2012, CURR PROTOC HUM GENE, P1; National Center for Biotechnology Information, GEN TEST REG; Ned RM, 2010, PLOS CURR, V2; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; PharmGKB, CLIN ANN LEV EV; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Rubinstein WS, 2013, NUCLEIC ACIDS RES, V41, pD925, DOI 10.1093/nar/gks1173; Scott SA, 2011, GENET MED, V13, P987, DOI 10.1097/GIM.0b013e318238b38c; Shendure J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-408; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; Vadakara J, 2012, PHARMACOGEN PERS MED, V5, P113, DOI 10.2147/PGPM.S24258; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158	49	87	90	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1511	1521		10.1001/jama.2013.3239	http://dx.doi.org/10.1001/jama.2013.3239			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571590				2022-12-24	WOS:000317271700029
J	Kachalia, A; Mello, MM				Kachalia, Allen; Mello, Michelle M.			Breast Cancer Screening Conflicting Guidelines and Medicolegal Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kachalia, Allen] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu		Mello, Michelle/0000-0003-2877-4270				American College of Obstetricians and Gynecologists Practice Bulletin, 2011, OBSTET GYNECOL, V118, P372, DOI DOI 10.1097/AOG.0B013E31822C98E5; [Anonymous], 2008, ACR PRACT GUID PERF; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bovbjerg R. R., 2012, VALUE CLIN PRACTICE; Gandhi TK, 2006, ANN INTERN MED, V145, P488, DOI 10.7326/0003-4819-145-7-200610030-00006; Mello MM, 2001, U PENN LAW REV, V149, P645, DOI 10.2307/3312867; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; 2009, ANN INTERN MED, V151, P716	8	14	14	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2555	2556		10.1001/jama.2013.7100	http://dx.doi.org/10.1001/jama.2013.7100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23722969				2022-12-24	WOS:000320848100022
J	Jamieson, AM; Pasman, L; Yu, S; Gamradt, P; Homer, RJ; Decker, T; Medzhitov, R				Jamieson, Amanda M.; Pasman, Lesley; Yu, Shuang; Gamradt, Pia; Homer, Robert J.; Decker, Thomas; Medzhitov, Ruslan			Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection	SCIENCE			English	Article							LEGIONELLA-PNEUMOPHILA INFECTION; INFLUENZA-VIRUS INFECTION; LUNG; TOLERANCE; RESISTANCE; DISEASE; MICE; IMMUNOPATHOLOGY; NEURAMINIDASE; RECOGNITION	Secondary bacterial pneumonia leads to increased morbidity and mortality from influenza virus infections. What causes this increased susceptibility, however, is not well defined. Host defense from infection relies not only on immune resistance mechanisms but also on the ability to tolerate a given level of pathogen burden. Failure of either resistance or tolerance can contribute to disease severity, making it hard to distinguish their relative contribution. We employ a coinfection mouse model of influenza virus and Legionella pneumophila in which we can separate resistance and tolerance. We demonstrate that influenza virus can promote susceptibility to lethal bacterial coinfection, even when bacterial infection is controlled by the immune system. We propose that this failure of host defense is due to impaired ability to tolerate tissue damage.	[Jamieson, Amanda M.; Pasman, Lesley; Yu, Shuang; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Jamieson, Amanda M.; Pasman, Lesley; Yu, Shuang; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA; [Jamieson, Amanda M.; Gamradt, Pia; Decker, Thomas] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Homer, Robert J.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Homer, Robert J.] VA Connecticut Healthcare Syst, Pathol & Lab Med Serv, West Haven, CT 06516 USA	Howard Hughes Medical Institute; Yale University; Yale University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Jamieson, AM (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, 171 Meeting St, Providence, RI 02912 USA.	amanda_jamieson@brown.edu; ruslan.medzhitov@yale.edu	Jamieson, Amanda/U-7169-2019; homer, robert/P-3884-2019	Jamieson, Amanda/0000-0002-5781-9231; homer, robert/0000-0002-2055-5885; Gamradt, Pia/0000-0002-5567-9722	Howard Hughes Medical Institute; NIH [R01 046688, AI R01 055502]; Ellison Foundation; New England Regional Center of Excellence; FWF (Austrian Science Fund) [P25235-B13]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R01AI055502, R37AI046688] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 25235] Funding Source: researchfish	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); New England Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FWF (Austrian Science Fund)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank S. Holley and C. Annicelli for technical assistance; T. Ichinohe, M. Linehan, and A. Iwasaki for viral strains and advice; T. Ren, M. Fontana, R. Vance, K. Archer, S. Shin, and C. Roy for L. pneumophila strains and advice; M. Gillum for assistance with experiments; and M. Mueller and C. Lassnig for mouse infection infrastructure. The data presented in the manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the Howard Hughes Medical Institute (R. M.), NIH grants R01 046688 and AI R01 055502 (R. M.), the Ellison Foundation (R. M.), the New England Regional Center of Excellence (R. M.), and FWF (Austrian Science Fund) grant P25235-B13 (A.M.J.). A.M.J. was a Berger Foundation fellow of the Damon Runyon Cancer Research Foundation. The authors have no conflicts of interest.	Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Fontana MF, 2012, INFECT IMMUN, V80, P3570, DOI 10.1128/IAI.00557-12; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Iannuzzi Michele, 2011, J Med Case Rep, V5, P520, DOI 10.1186/1752-1947-5-520; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Wong HR, 1997, AM J PHYSIOL-LUNG C, V273, pL1, DOI 10.1152/ajplung.1997.273.1.L1; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	31	185	190	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1230	1234		10.1126/science.1233632	http://dx.doi.org/10.1126/science.1233632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23618765	Green Accepted			2022-12-24	WOS:000319972800050
J	Eicken, H				Eicken, Hajo			Arctic sea ice needs better forecasts	NATURE			English	Editorial Material									Univ Alaska Fairbanks, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Eicken, H (corresponding author), Univ Alaska Fairbanks, Fairbanks, AK 99775 USA.	hajo.eicken@gi.alaska.edu	Eicken, Hajo/M-6901-2016					Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Calder J., 2011, UNDERSTANDING EARTHS, P405; Kauker F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036323; Lindsay R, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053576; Lovecraft AL, 2013, POLAR GEOGR, V36, P105, DOI 10.1080/1088937X.2012.733893; Markus T, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005436; National Research Council, 2012, SEAS DEC PRED ARCT S; Parsons MA, 2009, NATURE, V458, P830, DOI 10.1038/458830a; Rampal P, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005066; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051	10	77	80	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					431	433		10.1038/497431a	http://dx.doi.org/10.1038/497431a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698427	Bronze			2022-12-24	WOS:000319254000023
J	Gossett, DR; Kiley, JW; Hammond, C				Gossett, Dana R.; Kiley, Jessica W.; Hammond, Cassing			Contraception Is a Fundamental Primary Care Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNINTENDED PREGNANCY; UNITED-STATES		[Gossett, Dana R.; Kiley, Jessica W.; Hammond, Cassing] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Kiley, Jessica W.; Hammond, Cassing] Northwestern Univ, Feinberg Sch Med, Sect Family Planning, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Gossett, DR (corresponding author), Northwestern Univ, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1015, Chicago, IL 60611 USA.	dana.gossett@nmff.org	Gossett, Dana/AAI-2929-2021	Gossett, Dana/0000-0002-7306-3606				Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Frost JJ, 2013, CONTRACEPTION, V87, P465, DOI 10.1016/j.contraception.2012.08.012; HealthyPeople.gov, 2020 TOPICS AND OBJE; Jones R.K., 2011, COUNTERING CONVENTIO; Monea E, 2011, PERSPECT SEX REPRO H, V43, P88, DOI 10.1363/4308811; Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Trussell J, 2006, CONTRACEPTION, V73, P437, DOI 10.1016/j.contraception.2006.01.008; US Dept of Health and Human Services Health Resources and Services Administration, WOMENS PREVENTIVE SE	10	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					1997	1998		10.1001/jama.2013.4262	http://dx.doi.org/10.1001/jama.2013.4262			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143GQ	23677310				2022-12-24	WOS:000318855500019
J	Zimmer, EA; Welie, JVM; Rendell, MS				Zimmer, Eric A.; Welie, Jos V. M.; Rendell, Marc S.			Contraceptives and the Law A View From a Catholic Medical Institution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VENOUS THROMBOEMBOLISM; ORAL-CONTRACEPTIVES; HEALTH		Creighton Univ, Sch Med, Omaha, NE USA; Creighton Ctr Hlth Policy Eth, Omaha, NE USA	Creighton University	Rendell, MS (corresponding author), Creighton Diabet Ctr, 601 N 30th St, Omaha, NE 68131 USA.	Rendell@asndi.com						[Anonymous], FAST FACTS CAR PROV; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Jost TS, 2013, NEW ENGL J MED, V368, P4, DOI 10.1056/NEJMp1214605; Paul VI, 1968, HUMANAE VITAE ENCYCL; Pear Robert, NY TIMES; Samuelsson E, 2005, EUR J EPIDEMIOL, V20, P509, DOI 10.1007/s10654-005-4266-7; United States Conference of Catholic Bishops, 2009, ETH REL DIR CATH HLT, V5th; Wu O, 2005, THROMB HAEMOSTASIS, V94, P17, DOI 10.1160/TH04-11-0759	8	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					1999	2000		10.1001/jama.2013.3730	http://dx.doi.org/10.1001/jama.2013.3730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677311				2022-12-24	WOS:000318855500020
J	Solow, AR				Solow, Andrew R.			A call for peace on climate and conflict	NATURE			English	Editorial Material							CIVIL; WARS		Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Solow, AR (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	asolow@whoi.edu						Buhaug H., 2010, SENSITIVITY ANAL CLI; Buhaug H, 2010, P NATL ACAD SCI USA, V107, P16477, DOI 10.1073/pnas.1005739107; Burke MB, 2010, P NATL ACAD SCI USA, V107, pE185, DOI 10.1073/pnas.1014879107; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Deininger K, 2003, OXFORD ECON PAP, V55, P579, DOI 10.1093/oep/55.4.579; Homer-Dixon T.F., 1999, ENV SCARCITY VIOLENC; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Kalyvas S., 2008, ORDER CONFLICT VIOLE, P1, DOI [10.1017/CBO9780511755903.002, DOI 10.1017/CBO9780511755903.002]; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Theisen OM, 2011, INT SECURITY, V36, P79	10	41	43	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					179	180		10.1038/497179a	http://dx.doi.org/10.1038/497179a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	139CD	23657332	Bronze			2022-12-24	WOS:000318558200011
J	Birren, SJ; Marder, E				Birren, Susan J.; Marder, Eve			Plasticity in the Neurotransmitter Repertoire	SCIENCE			English	Editorial Material							RAT SYMPATHETIC NEURONS; MICROCULTURES; PHENOTYPE; RELEASE		[Birren, Susan J.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Birren, SJ (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	marder@brandeis.edu						Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; BURNSTOCK G, 1976, NEUROSCIENCE, V1, P239, DOI 10.1016/0306-4522(76)90054-3; DALE HENRY, 1935, PROC ROY SOC MED, V28, P319; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Dulcis D, 2013, SCIENCE, V340, P449, DOI 10.1126/science.1234152; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; Gutierrez R, 2005, TRENDS NEUROSCI, V28, P297, DOI 10.1016/j.tins.2005.04.005; JAN YN, 1979, P NATL ACAD SCI USA, V76, P1501, DOI 10.1073/pnas.76.3.1501; LANDIS SC, 1976, P NATL ACAD SCI USA, V73, P4220, DOI 10.1073/pnas.73.11.4220; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Praschak-Rieder Nicole, 2012, Curr Top Behav Neurosci, V11, P149, DOI 10.1007/7854_2011_174; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853	14	13	13	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					436	437		10.1126/science.1238518	http://dx.doi.org/10.1126/science.1238518			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620040				2022-12-24	WOS:000318016700026
J	Sartain, K				Sartain, Kate			An outstanding example of hospital care for patients with dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												katesartain@btinternet.com			Department of Health [RP-PG-0407-10147] Funding Source: Medline; National Institute for Health Research [RP-PG-0407-10147] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))			0	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2013	346								f2513	10.1136/bmj.f2513	http://dx.doi.org/10.1136/bmj.f2513			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131BG	23604085				2022-12-24	WOS:000317965000011
J	Sharp, PM; Rayner, JC; Hahn, BH				Sharp, Paul M.; Rayner, Julian C.; Hahn, Beatrice H.			Great Apes and Zoonoses	SCIENCE			English	Editorial Material							HUMAN MALARIA PARASITE; PLASMODIUM-FALCIPARUM; ORIGIN; RESERVOIRS; VIVAX		[Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Rayner, Julian C.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Hahn, Beatrice H.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Hahn, Beatrice H.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Edinburgh; Wellcome Trust Sanger Institute; University of Pennsylvania; University of Pennsylvania	Sharp, PM (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	bhahn@upenn.edu	Sharp, Paul M/F-5783-2010; Sharp, Paul M/GPX-1497-2022; Sharp, Paul/Y-3787-2019	Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Rayner, Julian/0000-0002-9835-1014; Hahn, Beatrice/0000-0002-9400-9887	NIAID NIH HHS [R01 AI091595] Funding Source: Medline; Wellcome Trust [095831] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091595] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayouba A, 2012, INT J PARASITOL, V42, P709, DOI 10.1016/j.ijpara.2012.05.004; Carter R, 2003, TRENDS PARASITOL, V19, P214, DOI 10.1016/S1471-4922(03)00070-9; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Kantele A, 2011, CLIN INFECT DIS, V52, P1356, DOI 10.1093/cid/cir180; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Pepin Jacques, 2011, ORIGINS AIDS; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Tanabe K, 2010, CURR BIOL, V20, P1283, DOI 10.1016/j.cub.2010.05.053	16	25	26	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					284	286		10.1126/science.1236958	http://dx.doi.org/10.1126/science.1236958			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599472	Green Accepted			2022-12-24	WOS:000317657500033
J	Yach, D				Yach, Derek			Can we leave industry to lead efforts to improve population health? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDREN		Vital Inst, New York, NY 10036 USA		Yach, D (corresponding author), Vital Inst, 1515 Broadway, New York, NY 10036 USA.	dyach@thevitalitygroup.com						American Beverage Alliance, 2010, ALL SCH BEV GUID FIN; An RP, 2013, AM J HEALTH BEHAV, V37, P56, DOI 10.5993/AJHB.37.1.6; Floud R., 2011, CHANGING BODY HLTH N; Hudson Institute Obesity Solutions Initiative, 2013, LOW CAL FOODS ITS JU; International Food and Beverage Alliance, OUR COMM; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099; Slining MM, 2013, AM J PREV MED, V44, P174, DOI 10.1016/j.amepre.2012.09.064; Sunstein CR, 2008, NUDGE IMPROVING DECI; Wansink B, 2012, PEDIATR OBES, V7, P121, DOI 10.1111/j.2047-6310.2011.00003.x; Wansink B, 2012, MARKET SCI, V31, P54, DOI 10.1287/mksc.1110.0699b	13	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2279	10.1136/bmj.f2279	http://dx.doi.org/10.1136/bmj.f2279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596215				2022-12-24	WOS:000317963400004
J	Watanabe, S; Radman-Livaja, M; Rando, OJ; Peterson, CL				Watanabe, Shinya; Radman-Livaja, Marta; Rando, Oliver J.; Peterson, Craig L.			A Histone Acetylation Switch Regulates H2A.Z Deposition by the SWR-C Remodeling Enzyme	SCIENCE			English	Article							H3K56 ACETYLATION; GENOME INTEGRITY; VARIANT; EXCHANGE; NUCLEOSOMES; ACTIVATION; PROMOTERS; TURNOVER; DYNAMICS; COMPLEX	The histone variant H2A.Z plays key roles in gene expression, DNA repair, and centromere function. H2A.Z deposition is controlled by SWR-C chromatin remodeling enzymes that catalyze the nucleosomal exchange of canonical H2A with H2A.Z. Here we report that acetylation of histone H3 on lysine 56 (H3-K56Ac) alters the substrate specificity of SWR-C, leading to promiscuous dimer exchange in which either H2A.Z or H2A can be exchanged from nucleosomes. This result was confirmed in vivo, where genome-wide analysis demonstrated widespread decreases in H2A.Z levels in yeast mutants with hyperacetylated H3K56. Our work also suggests that a conserved SWR-C subunit may function as a "lock" that prevents removal of H2A.Z from nucleosomes. Our study identifies a histone modification that regulates a chromatin remodeling reaction and provides insights into how histone variants and nucleosome turnover can be controlled by chromatin regulators.	[Watanabe, Shinya; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Radman-Livaja, Marta; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.peterson@umassmed.edu		Radman-Livaja, Marta/0000-0003-4987-0608	NIH [RO1 GM49650, R01 GM079205]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049650, R01GM079205, R01GM049650] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. D. Kaufman (University of Massachusetts Medical School) for the gift of purified Rtt109/Vps75. We apologize to colleagues whose work we could not cite due to space constraints. This work was supported by grants from the NIH to C.L.P. (RO1 GM49650) and to O.J.R. (R01 GM079205). Chip-Seq data sets have been assigned the Gene Expression Omnibus accession no. GSE43935.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lo KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019778; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Pollard KJ, 1998, BIOESSAYS, V20, P771, DOI 10.1002/(SICI)1521-1878(199809)20:9<771::AID-BIES10>3.0.CO;2-V; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Watanabe S, 2010, BBA-GENE REGUL MECH, V1799, P480, DOI 10.1016/j.bbagrm.2010.01.009; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	23	146	146	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					195	199		10.1126/science.1229758	http://dx.doi.org/10.1126/science.1229758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580526	Green Accepted			2022-12-24	WOS:000317341400055
J	Mozaffari-Jovin, S; Wandersleben, T; Santos, KF; Will, CL; Luhrmann, R; Wahl, MC				Mozaffari-Jovin, Sina; Wandersleben, Traudy; Santos, Karine F.; Will, Cindy L.; Luehrmann, Reinhard; Wahl, Markus C.			Inhibition of RNA Helicase Brr2 by the C-Terminal Tail of the Spliceosomal Protein Prp8	SCIENCE			English	Article							SPLICING FACTOR PRP8; RETINITIS-PIGMENTOSA; DESIGN PRINCIPLES; DOMAIN; YEAST; ACTIVATION; ATPASE; MUTATIONS; REQUIRES	The Ski2-like RNA helicase Brr2 is a core component of the spliceosome that must be tightly regulated to ensure correct timing of spliceosome activation. Little is known about mechanisms of regulation of Ski2-like helicases by protein cofactors. Here we show by crystal structure and biochemical analyses that the Prp8 protein, a major regulator of the spliceosome, can insert its C-terminal tail into Brr2's RNA-binding tunnel, thereby intermittently blocking Brr2's RNA-binding, adenosine triphosphatase, and U4/U6 unwinding activities. Inefficient Brr2 repression is the only recognizable phenotype associated with certain retinitis pigmentosa-linked Prp8 mutations that map to its C-terminal tail. Our data show how a Ski2-like RNA helicase can be reversibly inhibited by a protein cofactor that directly competes with RNA substrate binding.	[Mozaffari-Jovin, Sina; Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Wandersleben, Traudy; Santos, Karine F.; Wahl, Markus C.] Free Univ Berlin, Lab Struct Biochem, D-14195 Berlin, Germany	Max Planck Society; Free University of Berlin	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.	reinhard.luehrmann@mpi-bpc.mpg.de; mwahl@zedat.fu-berlin.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307; Mozaffari-Jovin, Sina/0000-0003-4410-0460	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck-Centrum; Leibniz-Institut fur Molekulare Pharmakologie; Deutsche Forschungsgemeinschaft [SFB 860, SFB 740/2]	Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck-Centrum; Leibniz-Institut fur Molekulare Pharmakologie; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank G. Heyne for excellent technical assistance, P. Fabrizio for help with yeast genetics, G. Weber and B. Loll for crystallographic support, J. D. Beggs for providing the antibody to yPrp8, and K.-L. Boon for helpful discussions. We acknowledge access to beamlines of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck-Centrum, and the Leibniz-Institut fur Molekulare Pharmakologie. This work was supported by the Deutsche Forschungsgemeinschaft (grants SFB 860 to R. L. and SFB 740/2 to M. C. W.). S.M.J.	Boon KL, 2007, NAT STRUCT MOL BIOL, V14, P1077, DOI 10.1038/nsmb1303; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kuhn AN, 2000, GENETICS, V155, P1667; Kuhn AN, 2002, P NATL ACAD SCI USA, V99, P9145, DOI 10.1073/pnas.102304299; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mordes D, 2006, MOL VIS, V12, P1259; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Pena V, 2009, MOL CELL, V35, P454, DOI 10.1016/j.molcel.2009.08.006; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Towns KV, 2010, HUM MUTAT, V31, pE1361, DOI 10.1002/humu.21236; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Weber G, 2011, GENE DEV, V25, P1601, DOI 10.1101/gad.635911; Zhang LD, 2007, PROTEIN SCI, V16, P1024, DOI 10.1110/ps.072872007; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625	20	94	97	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2013	341	6141					80	84		10.1126/science.1237515	http://dx.doi.org/10.1126/science.1237515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23704370				2022-12-24	WOS:000321291700053
J	Lukens, JR; Vogel, P; Johnson, GR; Kelliher, MA; Iwakura, Y; Lamkanfi, M; Kanneganti, TD				Lukens, John R.; Vogel, Peter; Johnson, Gordon R.; Kelliher, Michelle A.; Iwakura, Yoichiro; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			RIP1-driven autoinflammation targets IL-1 alpha independently of inflammasomes and RIP3	NATURE			English	Article							STERILE INFLAMMATION; MOTH-EATEN; CELL; GENE; ACTIVATION; DISEASE; MICE; IDENTIFICATION; AUTOIMMUNITY; PHOSPHATASES	The protein-tyrosine phosphatase SHP-1 has critical roles in immune signalling, but how mutations in SHP-1 cause inflammatory disease in humans remains poorly defined(1). Mice homozygous for the Tyr208Asn amino acid substitution in the carboxy terminus of SHP-1 (referred to as Ptpn6(spin) mice) spontaneously develop a severe inflammatory syndrome that resembles neutrophilic dermatosis in humans and is characterized by persistent footpad swelling and suppurative inflammation(2,3). Here we report that receptor-interacting protein 1 (RIP1)-regulated interleukin (IL)-1 alpha production by haematopoietic cells critically mediates chronic inflammatory disease in Ptpn6(spin) mice, whereas inflammasome signalling and IL-1 beta-mediated events are dispensable. IL-1 alpha was also crucial for exacerbated inflammatory responses and unremitting tissue damage upon footpad microabrasion of Ptpn6(spin) mice. Notably, pharmacological and genetic blockade of the kinase RIP1 protected against wound-induced inflammation and tissue damage in Ptpn6(spin) mice, whereas RIP3 deletion failed to do so. Moreover, RIP1-mediated inflammatory cytokine production was attenuated by NF-kappa B and ERK inhibition. Together, our results indicate that wound-induced tissue damage and chronic inflammation in Ptpn6(spin) mice are critically dependent on RIP1-mediated IL-1 alpha production, whereas inflammasome signalling and RIP3-mediated necroptosis are dispensable. Thus, we have unravelled a novel inflammatory circuit in which RIP1-mediated IL-1 alpha secretion in response to deregulated SHP-1 activity triggers an inflammatory destructive disease that proceeds independently of inflammasomes and programmed necrosis.	[Lukens, John R.; Johnson, Gordon R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; [Lamkanfi, Mohamed] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Iwakura, Yoichiro/E-5457-2011; Kanneganti, Thirumala-Devi/M-9435-2018; Vogel, Peter/N-2490-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Iwakura, Yoichiro/0000-0002-9934-5775; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vogel, Peter/0000-0002-7535-0545; Lukens, John/0000-0002-6795-0866	European Union [256432]; ERC [281600]; Fund for Scientific Research-Flanders [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00]; National Institutes of Health [AR056296, CA163507, AI101935]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA163507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI101935, R01AI075118, R01AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	European Union(European Commission); ERC(European Research Council (ERC)European Commission); Fund for Scientific Research-Flanders(FWO); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank B. A. Buetler, V. M. Dixit and D. R. Green for supply of mutant mice. We thank R. Weinlich for helpful discussions. We thank M. Johnson in the St Jude Small Animal Imaging Center for helping to evaluate embryonic development in fetal liver transplantation studies. M. L. is supported by European Union Marie-Curie grant 256432, ERC grant 281600, and grants G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00 from the Fund for Scientific Research-Flanders. This work was supported by grants from the National Institutes of Health (grants AR056296, CA163507 and AI101935) and the American Lebanese Syrian Associated Charities (ALSAC) to T.-D.K.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Cao HN, 2002, J HUM GENET, V47, P445, DOI 10.1007/s100380200062; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Croker BA, 2008, P NATL ACAD SCI USA, V105, P15028, DOI 10.1073/pnas.0806619105; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kranich J, 2011, SEMIN IMMUNOL, V23, P139, DOI 10.1016/j.smim.2011.01.011; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Lukens JR, 2011, DISCOV MED, V11, P65; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; Nesterovitch AB, 2011, AM J PATHOL, V178, P1701, DOI 10.1016/j.ajpath.2010.12.053; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4	27	127	132	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					224	+		10.1038/nature12174	http://dx.doi.org/10.1038/nature12174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23708968	Green Accepted			2022-12-24	WOS:000320283400047
J	Fleming, N				Fleming, Nic			Tell fans definitive calls are an impossible goal	NATURE			English	Editorial Material												nicfleming106@hotmail.com						COLLINS H, 2011, PUBLIC UNDERSTANDING	1	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					537	537		10.1038/497537a	http://dx.doi.org/10.1038/497537a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	152UF	23719426	Bronze			2022-12-24	WOS:000319556100006
J	Oh, MH; Yu, T; Yu, SH; Lim, B; Ko, KT; Willinger, MG; Seo, DH; Kim, BH; Cho, MG; Park, JH; Kang, K; Sung, YE; Pinna, N; Hyeon, T				Oh, Myoung Hwan; Yu, Taekyung; Yu, Seung-Ho; Lim, Byungkwon; Ko, Kyung-Tae; Willinger, Marc-Georg; Seo, Dong-Hwa; Kim, Byung Hyo; Cho, Min Gee; Park, Jae-Hoon; Kang, Kisuk; Sung, Yung-Eun; Pinna, Nicola; Hyeon, Taeghwan			Galvanic Replacement Reactions in Metal Oxide Nanocrystals	SCIENCE			English	Article							LITHIUM-ION BATTERIES; CATION-EXCHANGE; ANODE MATERIAL; NANOPARTICLES; HYBRID; SILVER; NANOSTRUCTURES; NANOCAPSULES; TEMPERATURE; DISSOLUTION	Galvanic replacement reactions provide a simple and versatile route for producing hollow nanostructures with controllable pore structures and compositions. However, these reactions have previously been limited to the chemical transformation of metallic nanostructures. We demonstrated galvanic replacement reactions in metal oxide nanocrystats as well. When manganese oxide (Mn3O4) nanocrystals were reacted with iron(II) perchlorate, hollow box-shaped nanocrystats of Mn3O4/gamma-Fe2O3 ("nanoboxes") were produced. These nanoboxes ultimately transformed into hollow cagetike nanocrystats of gamma-Fe2O3 ("nanocages"). Because of their nonequihbrium compositions and hollow structures, these nanoboxes and nanocages exhibited good performance as anode materials for lithium ion batteries. The generality of this approach was demonstrated with other metal pairs, including Co3O4/SnO2 and Mn3O4/SnO2.	[Oh, Myoung Hwan; Yu, Seung-Ho; Kim, Byung Hyo; Cho, Min Gee; Sung, Yung-Eun; Hyeon, Taeghwan] Seoul Natl Univ, Inst Basic Sci, Ctr Nanoparticle Res, Seoul 151742, South Korea; [Oh, Myoung Hwan; Yu, Seung-Ho; Kim, Byung Hyo; Cho, Min Gee; Sung, Yung-Eun; Pinna, Nicola; Hyeon, Taeghwan] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151742, South Korea; [Oh, Myoung Hwan; Yu, Seung-Ho; Kim, Byung Hyo; Cho, Min Gee; Sung, Yung-Eun; Pinna, Nicola; Hyeon, Taeghwan] Seoul Natl Univ, World Class Univ WCU Program Chem Convergence Ene, Seoul 151742, South Korea; [Yu, Taekyung] Kyung Hee Univ, Coll Engn, Dept Chem Engn, Yongin 446701, South Korea; [Lim, Byungkwon] Sungkyunkwan Univ, Sch Adv Mat Sci & Engn, Suwon 440746, South Korea; [Ko, Kyung-Tae; Park, Jae-Hoon] Pohang Univ Sci & Technol, Pohang 790784, South Korea; [Ko, Kyung-Tae; Park, Jae-Hoon] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Willinger, Marc-Georg] Max Planck Gesell, Fritz Haber Inst, Dept Inorgan Chem, D-14195 Berlin, Germany; [Seo, Dong-Hwa; Kang, Kisuk] Seoul Natl Univ, Dept Mat Sci & Engn, Res Inst Adv Mat, Seoul 151742, South Korea; [Park, Jae-Hoon] Pohang Univ Sci & Technol, Div Adv Mat Sci, Pohang 790784, South Korea; [Pinna, Nicola] Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal; [Pinna, Nicola] Univ Aveiro, Ctr Res Ceram & Composite Mat, P-3810193 Aveiro, Portugal; [Pinna, Nicola] Humboldt Univ, Inst Chem, D-12489 Berlin, Germany	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Sungkyunkwan University (SKKU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Max Planck Society; Fritz Haber Institute of the Max Planck Society; Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Universidade de Aveiro; Universidade de Aveiro; Humboldt University of Berlin	Pinna, N (corresponding author), Seoul Natl Univ, World Class Univ WCU Program Chem Convergence Ene, Seoul 151742, South Korea.	nicola.pinna@hu-berlin.de; thyeon@snu.ac.kr	Ko, Kyung-Tae/AAA-5417-2022; Yu, Taekyung/AAK-7417-2020; Pinna, Nicola/AAB-2638-2020; Willinger, Marc Georg G/C-1836-2015; Kang, Kisuk/B-5776-2011; Seo, Dong-Hwa/D-1446-2011; Yu, Seung-Ho/GLR-4572-2022; Pinna, Nicola/G-2307-2010; Lee, Junyoung/D-5463-2012	Ko, Kyung-Tae/0000-0003-3649-4594; Pinna, Nicola/0000-0003-1273-803X; Willinger, Marc Georg G/0000-0002-9996-7953; Seo, Dong-Hwa/0000-0002-7200-7186; Oh, Myoung Hwan/0000-0002-8338-3881; Kang, Kisuk/0000-0002-8696-1886; Lee, Junyoung/0000-0001-6689-2759; Yu, Seung-Ho/0000-0003-4833-3181	Research Center Program of the IBS in Korea; WCU Program of the National Research Foundation (NRF) of Korea [R31-10013]; Portuguese Fundacao para a Ciencia e a Tecnologia project for TEM work [PTD/CTM/100468/2008, REDE/1509/RME/2005]; Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning grant; Korea government Ministry of Trade, Industry and Energy [20124010203320]; National Creative Initiative [2009-0081576]; WCU [R31-2009-000-10059]; Max Plank POSTECH/KOREA Research Initiative programs though the NRF of Korea [2011-0031558]; POSTECH; Ministry of Science, ICT and Future Planning	Research Center Program of the IBS in Korea; WCU Program of the National Research Foundation (NRF) of Korea; Portuguese Fundacao para a Ciencia e a Tecnologia project for TEM work; Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning grant(Korea Institute of Energy Technology Evaluation & Planning (KETEP)); Korea government Ministry of Trade, Industry and Energy; National Creative Initiative; WCU; Max Plank POSTECH/KOREA Research Initiative programs though the NRF of Korea; POSTECH; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	We acknowledge financial support by the Research Center Program of the IBS in Korea (T.H. and Y.-E.S.); the WCU (R31-10013) Program of the National Research Foundation (NRF) of Korea (T.H., N.P., and Y.-E.S.); Portuguese Fundacao para a Ciencia e a Tecnologia project (PTD/CTM/100468/2008 and REDE/1509/RME/2005) for TEM work (M.-G.W. and N.P.); a Human Resources Development of the Korea Institute of Energy Technology Evaluation and Planning grant funded by the Korea government Ministry of Trade, Industry and Energy (20124010203320) (K.K. and D.-H.S); and National Creative Initiative (2009-0081576), WCU (R31-2009-000-10059), and Max Plank POSTECH/KOREA Research Initiative (2011-0031558) programs though the NRF of Korea (K.-T.K. and J.-H.P.). The Pohang Accelerator Laboratory is supported by POSTECH and the Ministry of Science, ICT and Future Planning.	Cabot A, 2007, J AM CHEM SOC, V129, P10358, DOI 10.1021/ja072574a; Cabot A, 2009, J AM CHEM SOC, V131, P11326, DOI 10.1021/ja903751p; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Fetisov VB, 2007, J SOLID STATE ELECTR, V11, P1205, DOI 10.1007/s10008-007-0269-5; Gonzalez E, 2011, SCIENCE, V334, P1377, DOI 10.1126/science.1212822; Kang JS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035121; Kim HS, 2010, ELECTROCHEM COMMUN, V12, P382, DOI 10.1016/j.elecom.2009.12.040; Kim J, 2009, ELECTROCHIM ACTA, V54, P5914, DOI 10.1016/j.electacta.2009.05.058; Koo B, 2012, NANO LETT, V12, P2429, DOI 10.1021/nl3004286; Li MX, 2012, CHEM COMMUN, V48, P410, DOI 10.1039/c1cc15322f; Macdonald JE, 2010, NAT MATER, V9, P810, DOI [10.1038/NMAT2848, 10.1038/nmat2848]; Metraux GS, 2003, NANO LETT, V3, P519, DOI 10.1021/nl034097+; Moon GD, 2011, NANO TODAY, V6, P186, DOI 10.1016/j.nantod.2011.02.006; Park J, 2009, J AM CHEM SOC, V131, P13943, DOI 10.1021/ja905732q; Peng S, 2007, ANGEW CHEM INT EDIT, V46, P4155, DOI 10.1002/anie.200700677; Peng ZM, 2010, NANO LETT, V10, P1492, DOI 10.1021/nl100559y; Piao Y, 2008, NAT MATER, V7, P242, DOI 10.1038/nmat2118; Skrabalak SE, 2008, ACCOUNTS CHEM RES, V41, P1587, DOI 10.1021/ar800018v; Son DH, 2004, SCIENCE, V306, P1009, DOI 10.1126/science.1103755; Sun YG, 2004, J AM CHEM SOC, V126, P3892, DOI 10.1021/ja039734c; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Villinski JE, 2001, ENVIRON SCI TECHNOL, V35, P1157, DOI 10.1021/es001356d; Wang HL, 2010, J AM CHEM SOC, V132, P13978, DOI 10.1021/ja105296a; Wang ZY, 2012, ADV MATER, V24, P1903, DOI 10.1002/adma.201200469; Wu X, 2012, ANGEW CHEM INT EDIT, V51, P3211, DOI 10.1002/anie.201108098; Xiao F, 2007, J AM CHEM SOC, V129, P10068, DOI 10.1021/ja073032w; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Yu T, 2009, CHEM MATER, V21, P2272, DOI 10.1021/cm900431b; Zhang Q, 2009, NANO TODAY, V4, P494, DOI 10.1016/j.nantod.2009.10.008	29	429	432	26	1157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					964	968		10.1126/science.1234751	http://dx.doi.org/10.1126/science.1234751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704569				2022-12-24	WOS:000319344100043
J	Hurley, R				Hurley, Richard			Angelina Jolie's double mastectomy and the question of who owns our genes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						[Anonymous], 2013, US TODAY; Boshoff A, 2013, MAIL ONLINE     0515; Cochran A, 2013, CBS NEWS; Funk Krist, 2013, PATIENTS JOURNEY A J; Jolie A., 2013, NEW YORK TIMES, V14, P2013; Kay B, 2013, NATL POST       0513; Marsden S., 2013, TELEGRAPH; McCarthy M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2446; Powledge TM, 2013, SCI BLOGS JOLIE 0517; Wieczner J, 2014, MARKET WATCH    0521	10	6	6	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2013	346								f3340	10.1136/bmj.f3340	http://dx.doi.org/10.1136/bmj.f3340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AV	23697674				2022-12-24	WOS:000319574400022
J	Doshi, P				Doshi, Peter			Influenza: marketing vaccine by marketing disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; RECOMMENDATIONS; PREVENTION; MORTALITY; RISK		Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Doshi, P (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	pdoshi@post.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS019488] Funding Source: NIH RePORTER; AHRQ HHS [#T32HS019488] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2011, EUR MED AG REC RESTR; Australian Government Department of Health, 2010, INV FEBR REACT YOUNG; Braun MM, 2007, NEW ENGL J MED, V357, P2730; Brownlee S, 2009, ATLANTIC; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; European Medicines Agency, 2012, EUR MED AG REV HYP P; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Gardam M, 2013, CANADIAN MED ASS J; Greene JA, 2005, B HIST MED, V79, P749, DOI 10.1353/bhm.2005.0153; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Immunization Action Coalition, 2013, HON ROLL PAT SAF HON; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; LANGMUIR AD, 1964, AM J PUBLIC HEALTH N, V54, P563, DOI 10.2105/AJPH.54.4.563; Layton C, 2005, INFLUENZA VACCINE DE; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; NBCNews.com video, 2013, VID CHURCH HOSP FLU; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Osterholm MT, 2011, INFLUENZA VACCINE EF; Reichert Tom, 2003, EROTIC HIST ADVERTIS; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, NEW ENGL J MED, V357, P2729; US Centers for Disease Control, 1984, MMWR-MORBID MORTAL W, V33, P253; US Centers for Disease Control, 1984, MMWR-MORBID MORTAL W, V33, P265; US Centers for Disease Control and Prevention, 2007 8 US INFL SEAS; US Centers for Disease Control and Prevention, INFL VIR IS WHO NREV; US Centers for Disease Control and Prevention, 2010, SHOTS AR JUST KIDS; US Centers for Disease Control and Prevention, 2013, PRESS BRIEF TRANSCR; US Centers for Disease Control and Prevention, 2012, SPREAD MUS NOT FLU; US Centers for Disease Control and Prevention, 2000 2001 LAB DAT SU; US Centers for Disease Control and Prevention, 2002, 1999 2000 INFL SEAS; US Centers for Disease Control and Prevention, 2006 07 US INFL SEAS	41	16	18	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2013	346								f3037	10.1136/bmj.f3037	http://dx.doi.org/10.1136/bmj.f3037			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OI	23682040				2022-12-24	WOS:000319254400002
J	Brewer, C				Brewer, Colin			Plain cigarette packets could reduce nicotine addiction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												brewerismo@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2013	346								f3105	10.1136/bmj.f3105	http://dx.doi.org/10.1136/bmj.f3105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OH	23676426				2022-12-24	WOS:000319254200016
J	Insel, TR; Landis, SC; Collins, FS				Insel, Thomas R.; Landis, Story C.; Collins, Francis S.			The NIH BRAIN Initiative	SCIENCE			English	Editorial Material							ACTIVITY MAP		[Insel, Thomas R.; Landis, Story C.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Insel, TR (corresponding author), NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	insel@mail.nih.gov; slandis@codon.nih.gov; collinsf@od.nih.gov						Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/nmeth.2434, 10.1038/NMETH.2434]; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Bloom DE, 2011, GLOBAL EC BURDEN NON; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	12	212	224	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					687	688		10.1126/science.1239276	http://dx.doi.org/10.1126/science.1239276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	139XR	23661744	Green Published			2022-12-24	WOS:000318619000020
J	Chan, M; Lake, A				Chan, Margaret; Lake, Anthony			Integrated action for the prevention and control of pneumonia and diarrhoea	LANCET			English	Editorial Material									[Chan, Margaret] WHO, CH-1211 Geneva, Switzerland; [Lake, Anthony] UNICEF, New York, NY 10017 USA	World Health Organization; UNICEF	Lake, A (corresponding author), UNICEF, New York, NY 10017 USA.	alake@unicef.org						Bhutta ZA, 2013, LANCET; Chopra M, 2013, LANCET; Fischer Walker CL, 2013, LANCET; Gill CJ, 2013, LANCET; WHO UNICEF(World Health Organization United Nations International Children's Emergency Fund), 2013, INT GLOB ACT PLAN PR; World Health Organization, 2009, DIARRH WHY CHILDR AR; World Health Organization and UNICEF, 2009, GLOB ACT PLAN PREV C	7	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1436	1437		10.1016/S0140-6736(13)60692-3	http://dx.doi.org/10.1016/S0140-6736(13)60692-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23582728				2022-12-24	WOS:000318607300010
J	Dasgupta, PS; Ehrlich, PR				Dasgupta, Partha S.; Ehrlich, Paul R.			Pervasive Externalities at the Population, Consumption, and Environment Nexus	SCIENCE			English	Article							FERTILITY	Growing concerns that contemporary patterns of economic development are unsustainable have given rise to an extensive empirical literature on population growth, consumption increases, and our growing use of nature's products and services. However, far less has been done to reach a theoretical understanding of the socio-ecological processes at work at the population-consumption-environment nexus. In this Research Article, we highlight the ubiquity of externalities ( which are the unaccounted for consequences for others, including future people) of decisions made by each of us on reproduction, consumption, and the use of our natural environment. Externalities, of which the "tragedy of the commons" remains the most widely discussed illustration, are a cause of inefficiency in the allocation of resources across space, time, and contingencies; in many situations, externalities accentuate inequity as well. Here, we identify and classify externalities in consumption and reproductive decisions and use of the natural environment so as to construct a unified theoretical framework for the study of data drawn from the nexus. We show that externalities at the nexus are not self-correcting in the marketplace. We also show that fundamental nonlinearities, built into several categories of externalities, amplify the socio-ecological processes operating at the nexus. Eliminating the externalities would, therefore, require urgent collective action at both local and global levels.	[Dasgupta, Partha S.] Univ Cambridge, Fac Econ, Cambridge CB3 9DD, England; [Dasgupta, Partha S.] Univ Manchester, Sustainable Consumpt Inst, Manchester M13 9PL, Lancs, England; [Ehrlich, Paul R.] Stanford Univ, Dept Biol, Ctr Conservat Biol, Stanford, CA 94305 USA	University of Cambridge; University of Manchester; Stanford University	Dasgupta, PS (corresponding author), Univ Cambridge, Fac Econ, Cambridge CB3 9DD, England.	partha.dasgupta@econ.cam.ac.uk; pre@stanford.edu			Mertz Gilmore Foundation; Winslow Foundation	Mertz Gilmore Foundation; Winslow Foundation	We thank K. Arrow, M. Campbell, G. Daily, A. Dasgupta, N. Diamond-Smith, A. Ehrlich, L. Goulder, D. Karp, D. Kennedy, M. Potts, A. Ulph, and, most especially, the editors and three anonymous referees for their comments. P. R. E. thanks the Mertz Gilmore Foundation, the Winslow Foundation, and P. Bing and H. Bing for their support.	Aggarwal R, 2001, ENVIRON DEV ECON, V6, P209, DOI 10.1017/S1355770X01000122; ARROW K. J., 1971, GEN COMPETITIVE ANAL; Arrow KJ, 2012, ENVIRON DEV ECON, V17, P317, DOI 10.1017/S1355770X12000137; Arrow KJ, 2009, ECON J, V119, pF497, DOI 10.1111/j.1468-0297.2009.02318.x; Ash N., 2005, ECOSYSTEMS WELL BEIN; Banerjee A., 2011, POOR EC; Barrett CB, 2011, P NATL ACAD SCI USA, V108, P13907, DOI 10.1073/pnas.1011521108; Blume L.E., 2011, HDB SOCIAL EC, V1, P853, DOI DOI 10.1016/B978-0-444-53707-2.00001-3; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Boserup Ester, 1981, POPULATION TECHNOLOG; Bourdieu P., 1984, DISTINCTION SOCIAL C; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3628, DOI 10.1073/pnas.1114772109; CALDWELL JC, 1987, POPUL DEV REV, V13, P409, DOI 10.2307/1973133; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Dasgupta P, 2002, NEW HOR ENV ECO, P118; Dasgupta P, 2000, EUR ECON REV, V44, P619, DOI 10.1016/S0014-2921(00)00039-8; Dasgupta P., 1993, INQUIRY WELL BEING D; Donati P., 2011, RELATIONAL SOCIOLOGY; Douglas Mary, 1996, WORLD GOODS ANTHR CO; Ehrlich PR, 2007, CONSERV BIOL, V21, P1145, DOI 10.1111/j.1523-1739.2007.00779.x; Ehrlich PR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2845; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Gadgil M., 1992, THIS FISSURED LAND; HAJNAL J, 1982, POPUL DEV REV, V8, P449, DOI 10.2307/1972376; Illife J., 2011, AFRICANS HIST CONTIN; Jensen R, 2009, Q J ECON, V124, P1057, DOI 10.1162/qjec.2009.124.3.1057; Jodha N. S., 2001, LIVING EDGE SUSTAINI; Kuhn P, 2011, AM ECON REV, V101, P2226, DOI 10.1257/aer.101.5.2226; Layard R., 2005, PROSPECT, V108; Lopez R, 1998, WORLD BANK ECON REV, V12, P105, DOI 10.1093/wber/12.1.105; Lutz W, 2011, SCIENCE, V333, P587, DOI 10.1126/science.1206964; Magrath W., 1989, WASTING ASSETS NATUR; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Ostrom E., 1990, GOVERNING COMMONS EV; Population Reference Bureau, 2012, 2012 WORLD POP DAT S; Rees W. E., 2001, ENCY BIODIVERSITY, V2, DOI DOI 10.1016/BO-12-226865-2/00080-8; Ridley M., 2010, RATIONAL OPTIMIST PR; Samuelson L, 2006, REPEATED GAMES REPUT; Schellnhuber H.J., 2004, GLOBAL CHANGE EARTH; Schor J., 1998, OVERSPENT AM UPSCALI; Speidel JJ, 2009, PHILOS T R SOC B, V364, P3049, DOI 10.1098/rstb.2009.0162; STARRETT DA, 1972, J ECON THEORY, V4, P180, DOI 10.1016/0022-0531(72)90148-2; Sunstein CR, 2001, J POLIT PHILOS, V9, P129, DOI 10.1111/1467-9760.00121; The Royal Society, 2012, PEOPL PLAN; Turner BL, 1996, P NATL ACAD SCI USA, V93, P14984, DOI 10.1073/pnas.93.25.14984; United Nations Development Programme, 2010, HUM DEV REP; Veblen T.B., 1925, THEORY LEISURE CLASS; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; World Bank, 2010, WORLD DEV REP DEV CL	49	57	59	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					324	328		10.1126/science.1224664	http://dx.doi.org/10.1126/science.1224664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599486				2022-12-24	WOS:000317657500047
J	Cao, Y; Pan, YP; Huang, H; Jin, XS; Levin, EJ; Kloss, B; Zhou, M				Cao, Yu; Pan, Yaping; Huang, Hua; Jin, Xiangshu; Levin, Elena J.; Kloss, Brian; Zhou, Ming			Gating of the TrkH ion channel by its associated RCK protein TrkA	NATURE			English	Article							MEMBRANE REGION M-2C2; K+-UPTAKE SYSTEM; ESCHERICHIA-COLI; KTRAB SYSTEM; MECHANISM; TRANSPORT; DOMAINS; BINDING; RING; FLUX	TrkH belongs to a superfamily of K+ transport proteins required for growth of bacteria in low external K+ concentrations. The crystal structure of TrkH from Vibrio parahaemolyticus showed that TrkH resembles a K+ channel and may have a gating mechanism substantially different from K+ channels. TrkH assembles with TrkA, a cytosolic protein comprising two RCK (regulate the conductance of K+) domains, which are found in certain K+ channels and control their gating. However, fundamental questions on whether TrkH is an ion channel and how it is regulated by TrkA remain unresolved. Here we show single-channel activity of TrkH that is upregulated by ATP via TrkA. We report two structures of the tetrameric TrkA ring, one in complex with TrkH and one in isolation, in which the ring assumes two markedly different conformations. These results suggest a mechanism for how ATP increases TrkH activity by inducing conformational changes in TrkA.	[Cao, Yu; Pan, Yaping; Huang, Hua; Levin, Elena J.; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Pan, Yaping; Huang, Hua; Levin, Elena J.; Zhou, Ming] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Jin, Xiangshu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kloss, Brian] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA	Columbia University; Baylor College of Medicine; National Institute of Biological Sciences, Beijing	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mzhou@bcm.edu	Cao, Yu/GNP-6653-2022	Cao, Yu/0000-0003-1409-2068; Jin, Xiangshu/0000-0002-6551-8850; Kloss, Brian/0000-0003-0130-8739	US National Institutes of Health [DK088057, GM098878, HL086392]; PSI: Biology grant [5808, U54GM095315]; American Heart Association [12EIA8850017, 0826067D]; Irma T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, U54GM075026, R01GM098878] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSI: Biology grant; American Heart Association(American Heart Association); Irma T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Diffraction data for this study were measured at beamlines X4A, X4C, X25 and X29 of the National Synchrotron Light Source, ID-17 and ID-24 at the Advanced Photon Source, 5.0.2 and 8.2.2 at the Advanced Light Source, and A1 and F1 at the Cornell High Energy Synchrotron Source. M.Z. thanks E. Bakker, I. Booth, R. Kramer and C. Slayman for discussions and insights, and K. R. Rajashankar for help with X-ray crystallography. This work was supported by the US National Institutes of Health (DK088057, GM098878 and HL086392 to M.Z., and a subcontract (sub 5808 to M.Z.) from the PSI: Biology grant U54GM095315 to W. Hendrickson), the American Heart Association (12EIA8850017 to M.Z. and 0826067D to Y.P.), and the Irma T. Hirschl Trust Award to M.Z. M.Z. was a Pew Scholar in Biomedical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAKKER EP, 1983, BIOCHIM BIOPHYS ACTA, V730, P379, DOI 10.1016/0005-2736(83)90355-3; BOSSEMEYER D, 1989, J BIOL CHEM, V264, P16403; BUEHNER M, 1973, P NATL ACAD SCI USA, V70, P3052, DOI 10.1073/pnas.70.11.3052; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; Hanelt I, 2010, J BIOL CHEM, V285, P28210, DOI 10.1074/jbc.M110.139311; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kong CG, 2012, ELIFE, V1, DOI 10.7554/eLife.00184; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; LONG WS, 1978, J BACTERIOL, V133, P995, DOI 10.1128/JB.133.2.995-1007.1978; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; RHOADS DB, 1977, J BIOL CHEM, V252, P1394; Roosild TP, 2010, P NATL ACAD SCI USA, V107, P19784, DOI 10.1073/pnas.1012716107; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; STEWART LMD, 1985, J GEN MICROBIOL, V131, P77; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	33	66	68	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					317	+		10.1038/nature12056	http://dx.doi.org/10.1038/nature12056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598339	Green Accepted			2022-12-24	WOS:000317599200028
J	Spong, CY				Spong, Catherine Y.			Defining "Term" Pregnancy Recommendations From the Defining "Term" Pregnancy Workgroup	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH; CARE		[Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Spong, CY (corresponding author), NICHHD, NIH, 6100 Execut Blvd,Room 4B03,MSC 7510, Bethesda, MD 20892 USA.	spongc@mail.nih.gov						[Anonymous], 2007, PRETERM BIRTH CAUSES; MacDorman MF, 2012, NATL VITAL STAT REP, V61; Oshiro BT, 2009, OBSTET GYNECOL, V113, P804, DOI 10.1097/AOG.0b013e31819b5c8c; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; World Health Organization, ICD 10 INT STAT CLAS, V2; 1970, ARCH DIS CHILD, V45, P730	8	302	318	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2445	2446		10.1001/jama.2013.6235	http://dx.doi.org/10.1001/jama.2013.6235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23645117				2022-12-24	WOS:000320505100023
J	Walls, RM; Zinner, MJ				Walls, Ron M.; Zinner, Michael J.			The Boston Marathon Response Why Did It Work So Well?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Walls, Ron M.; Zinner, Michael J.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Zinner, MJ (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	mzinner@partners.org							0	33	34	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2441	2442		10.1001/jama.2013.5965	http://dx.doi.org/10.1001/jama.2013.5965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23632605				2022-12-24	WOS:000320505100021
J	Goralnick, E; Gates, J				Goralnick, Eric; Gates, Jonathan			We Fight Like We Train	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goralnick, Eric] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Gates, Jonathan] Brigham & Womens Hosp, Dept Surg, Div Trauma Burns & Surg Crit Care, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Goralnick, E (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.								0	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1960	1961		10.1056/NEJMp1305359	http://dx.doi.org/10.1056/NEJMp1305359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194KD	23635019	Bronze			2022-12-24	WOS:000322630700005
J	Messier, V; Zenklusen, D; Michnick, SW				Messier, Vincent; Zenklusen, Daniel; Michnick, Stephen W.			A Nutrient-Responsive Pathway that Determines M Phase Timing through Control of B-Cyclin mRNA Stability	CELL			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; COTRANSCRIPTIONAL RECRUITMENT; ARGININE METHYLTRANSFERASE; POSITIVE FEEDBACK; PROTEIN-KINASES; NUCLEAR EXPORT; MITOTIC EXIT; POLO-KINASE; S-PHASE	The rate of cell-cycle progression must be tuned in response to nutrient levels to ensure that sufficient materials are synthesized to generate viable daughters. We report that accumulation of the yeast M phase B-cyclin CLB2 mRNA depends on assembly and activation of the heterogeneous nuclear RNA-binding protein (hnRNP) arginine methyltransferase Hmt1, which is promoted by the kinase Dbf2 and countered by the PP2A phosphatase Pph22. Activated Hmt1 methylates hnRNPs, which in turn stabilize CLB2 transcripts. Dbf2 activation of Hmt1 is highly cooperative, producing a sharp increase in CLB2, whereas Pph22 dephosphorylation is graded such that small changes in PP2A activity can cause large shifts in Dbf2-mediated Hmt1 activity. Starvation and rapamycin inhibition of TOR activate Pph22, causing a depletion of CLB2 and delay of M phase. We propose a general model wherein changes to Pph22 activity modulate cyclin mRNA stability to tune cell-cycle progression to environmental conditions.	[Messier, Vincent; Zenklusen, Daniel; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca	Zenklusen, Daniel/C-4503-2008	Zenklusen, Daniel/0000-0002-0067-0093	CIHR [MOP-GMX-152556, MOP-GMX- 231013, MOP-BMB-232642]; NSERC of Canada [194582]; Canadian Foundation for Innovation	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank Anne McBride for strains; Tatjana Trcek and Robert H. Singer (Albert Einstein College of Medicine) for CBL2 and ACT1 FISH probes, strains, and sharing data prior to publication; Raymond J. Deshaies and Tiffany K. J. Chang for providing us with Dbf2-expressing insect cell lines; Damien D'Amours for the gift of D754 strain and Tub1 immunostaining reagents; and Tatjana Trcek, Robert H. Singer, and Damien D'Amours for valuable discussions and comments. The authors acknowledge support from CIHR grants MOP-GMX-152556 and MOP-GMX-231013 and NSERC of Canada grant 194582 (to S.W.M.) and CIHR grant MOP-BMB-232642 and the Canadian Foundation for Innovation (to D.Z.). D.Z. holds a FRSQ Chercheur Boursier Junior I.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Enyenihi AH, 2003, GENETICS, V163, P47; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hotz M, 2012, CELL, V148, P958, DOI 10.1016/j.cell.2012.01.041; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Kerr SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018302; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Lord PW, 2002, BIOINFORMATICS, V18, P1402, DOI 10.1093/bioinformatics/18.10.1402; Luo GZ, 2011, J BIOL CHEM, V286, P8759, DOI 10.1074/jbc.M110.196030; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pestov DG, 2012, MOL CELL BIOL, V32, P2135, DOI 10.1128/MCB.06763-11; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	38	29	29	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1080	1093		10.1016/j.cell.2013.04.035	http://dx.doi.org/10.1016/j.cell.2013.04.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706744	Bronze			2022-12-24	WOS:000319456800015
J	Peplow, M				Peplow, Mark			THE ANATOMY OF SLEEP	NATURE			English	Editorial Material																			0	10	10	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S2	S3		10.1038/497S2a	http://dx.doi.org/10.1038/497S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698505	Bronze			2022-12-24	WOS:000319254000002
J	Rock, JM; Lim, D; Stach, L; Ogrodowicz, RW; Keck, JM; Jones, MH; Wong, CCL; Yates, JR; Winey, M; Smerdon, SJ; Yaffe, MB; Amon, A				Rock, Jeremy M.; Lim, Daniel; Stach, Lasse; Ogrodowicz, Roksana W.; Keck, Jamie M.; Jones, Michele H.; Wong, Catherine C. L.; Yates, John R., III; Winey, Mark; Smerdon, Stephen J.; Yaffe, Michael B.; Amon, Angelika			Activation of the Yeast Hippo Pathway by Phosphorylation-Dependent Assembly of Signaling Complexes	SCIENCE			English	Article							MITOTIC EXIT; SCAFFOLD PROTEINS; FHA DOMAIN; KINASE; INFORMATION; PHOSPHATASE; CENTROSOME; MITOSIS; TEM1	Scaffold-assisted signaling cascades guide cellular decision-making. In budding yeast, one such signal transduction pathway called the mitotic exit network (MEN) governs the transition from mitosis to the G(1) phase of the cell cycle. The MEN is conserved and in metazoans is known as the Hippo tumor-suppressor pathway. We found that signaling through the MEN kinase cascade was mediated by an unusual two-step process. The MEN kinase Cdc15 first phosphorylated the scaffold Nud1. This created a phospho-docking site on Nud1, to which the effector kinase complex Dbf2-Mob1 bound through a phosphoserine-threonine binding domain, in order to be activated by Cdc15. This mechanism of pathway activation has implications for signal transmission through other kinase cascades and might represent a general principle in scaffold-assisted signaling.	[Rock, Jeremy M.; Lim, Daniel; Yaffe, Michael B.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Rock, Jeremy M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Stach, Lasse; Ogrodowicz, Roksana W.; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Keck, Jamie M.; Jones, Michele H.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, UCB 347, Boulder, CO 80309 USA; [Wong, Catherine C. L.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); MRC National Institute for Medical Research; University of Colorado System; University of Colorado Boulder; Scripps Research Institute	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu		Ogrodowicz, Roksana/0000-0002-3176-7744; Smerdon, Stephen/0000-0001-5688-8465; Amon, Angelika/0000-0001-9837-0314; Wong, Catherine CL/0000-0001-7270-980X; Rock, Jeremy/0000-0002-9310-951X	NIH [GM056800, CA112967, ES015339, P41 RR011823, GM51312, F32 GM086038]; MRC UK [U117584228]; MRC; NSF; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312, F32GM086038, P41GM103533, R01GM056800, R29GM056800] Funding Source: NIH RePORTER; MRC [MC_U117584228] Funding Source: UKRI; Medical Research Council [MC_U117584228] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank I. Cheeseman, F. Solomon, and the Amon lab for comments and E. Schiebel for reagents. Coordinates and structure factors for the hMob1-phosphopeptide complex have been deposited with the Protein Data Bank (PDBID: 4JIZ). Supported by the NIH (GM056800 to A. A.; CA112967 and ES015339 to M.B.Y; P41 RR011823 to J.R.Y. III and T. N. Davis, principal investigator; and GM51312 to M. W.); MRC UK (U117584228) to S.J.S; MRC centenary fellowship to L. S.; NIH F32 GM086038 to J.M.K.; and NSF Predoctoral Fellowship to J.M.R. A. A. is an investigator of the Howard Hughes Medical Institute.	Caydasi AK, 2012, EXP CELL RES, V318, P1421, DOI 10.1016/j.yexcr.2012.03.031; Ding Z, 2007, BIOCHEMISTRY-US, V46, P2684, DOI 10.1021/bi061763n; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Geymonat M, 2009, J CELL BIOL, V187, P497, DOI 10.1083/jcb.200905114; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Gruneberg U, 2000, EMBO J, V19, P6475, DOI 10.1093/emboj/19.23.6475; Hergovich A, 2012, SEMIN CELL DEV BIOL, V23, P794, DOI 10.1016/j.semcdb.2012.04.001; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; Konig C, 2010, J CELL BIOL, V188, P351, DOI 10.1083/jcb.200911128; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Maekawa H, 2007, J CELL BIOL, V179, P423, DOI 10.1083/jcb.200705197; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Mrkobrada S, 2006, J MOL BIOL, V362, P430, DOI 10.1016/j.jmb.2006.07.007; Park CJ, 2008, EUKARYOT CELL, V7, P444, DOI 10.1128/EC.00283-07; Rock JM, 2011, GENE DEV, V25, P1943, DOI 10.1101/gad.17257711; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Valerio-Santiago M, 2011, J CELL BIOL, V192, P599, DOI 10.1083/jcb.201007044	19	76	78	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					871	875		10.1126/science.1235822	http://dx.doi.org/10.1126/science.1235822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23579499	Green Published, Green Accepted			2022-12-24	WOS:000318997400046
J	Allen, J; Weinrich, M; Hoppitt, W; Rendell, L				Allen, Jenny; Weinrich, Mason; Hoppitt, Will; Rendell, Luke			Network-Based Diffusion Analysis Reveals Cultural Transmission of Lobtail Feeding in Humpback Whales	SCIENCE			English	Article							BEHAVIOR	We used network-based diffusion analysis to reveal the cultural spread of a naturally occurring foraging innovation, lobtail feeding, through a population of humpback whales (Megaptera novaeangliae) over a period of 27 years. Support for models with a social transmission component was 6 to 23 orders of magnitude greater than for models without. The spatial and temporal distribution of sand lance, a prey species, was also important in predicting the rate of acquisition. Our results, coupled with existing knowledge about song traditions, show that this species can maintain multiple independently evolving traditions in its populations. These insights strengthen the case that cetaceans represent a peak in the evolution of nonhuman culture, independent of the primate lineage.	[Allen, Jenny; Rendell, Luke] Univ St Andrews, Sch Biol, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland; [Allen, Jenny; Rendell, Luke] Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 8LB, Fife, Scotland; [Allen, Jenny; Weinrich, Mason] Whale Ctr New England, Gloucester, MA 01931 USA; [Hoppitt, Will] Anglia Ruskin Univ, Dept Life Sci, Cambridge CB1 1PT, England	University of St Andrews; University of St Andrews; Anglia Ruskin University	Rendell, L (corresponding author), Univ St Andrews, Sch Biol, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland.	ler4@st-andrews.ac.uk	Rendell, Luke/AAF-9070-2019; Hoppitt, William/A-8216-2008; Rendell, Luke/G-2594-2010; Allen, Jennifer/AAQ-7333-2020; Allen, Jennifer/W-4610-2018	Hoppitt, William/0000-0003-0815-5720; Rendell, Luke/0000-0002-1121-9142; Allen, Jennifer/0000-0003-4658-7380; Allen, Jennifer/0000-0003-4658-7380	Stellwagen Bank National Marine Sanctuary, Office of National Marine Sanctuaries, National Oceanographic Partnership Program, National Marine Fisheries Service; MASTS pooling initiative (Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Stellwagen Bank National Marine Sanctuary, Office of National Marine Sanctuaries, National Oceanographic Partnership Program, National Marine Fisheries Service; MASTS pooling initiative (Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the WCNE staff, interns, and volunteers for the field collection of this data and the crews of the various whale-watching companies for the use of their vessels. We are grateful to K. Sardi-Sampson, S. Garland, and D. Brown for their assistance in compiling the WCNE data. Data were collected under a Marine Mammal Protection Act/Endangered Species Act Research and Enhancement Permit (current permit no. 605-1904). Funding was provided by the Stellwagen Bank National Marine Sanctuary, Office of National Marine Sanctuaries, National Oceanographic Partnership Program, National Marine Fisheries Service, and the MASTS pooling initiative (Marine Alliance for Science and Technology for Scotland), and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. We are grateful to V. Janik, D. Wiley, P. Tyack, and members of the Centre for Social Learning and Cognitive Evolution Behavioral Discussion Group for discussion, comments, and advice. We thank H. Whitehead, K. Laland, and four anonymous reviewers for comments that improved the manuscript. The data analyzed in this paper are included in the supplementary materials. M. W. led the collection of the behavior and association data, with assistance from J.A. J.A., M. W., W. H., and L. R. planned the study; J.A. performed the data processing; and J.A., W. H., and L. R. carried out the analyses and wrote the manuscript.	BORGATTI S. P., 2002, NETDRAW SOFTWARE FOR; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Donaldson R, 2012, ANIM CONSERV, V15, P427, DOI 10.1111/j.1469-1795.2012.00548.x; Fragaszy DM., 2003, BIOL TRADITIONS MODE, P1, DOI DOI 10.1017/CBO9780511584022.002; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; HAIN JHW, 1982, FISH B-NOAA, V80, P259; Hoppitt W, 2011, AM J PRIMATOL, V73, P834, DOI 10.1002/ajp.20920; Hoppitt W, 2010, J THEOR BIOL, V263, P544, DOI 10.1016/j.jtbi.2010.01.004; Kendal RL, 2010, LEARN BEHAV, V38, P220, DOI 10.3758/LB.38.3.220; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; National Marine Fisheries Service (NMFS) National Oceanic and Atmospheric Administration (NOAA), TABULAR DIGITAL DATA; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; PAYNE PM, 1990, FISH B-NOAA, V88, P687; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Ramp C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1563, DOI 10.1007/s00265-010-0970-8; Read AJ, 2001, P ROY SOC B-BIOL SCI, V268, P573, DOI 10.1098/rspb.2000.1419; Reader SM, 2004, LEARN BEHAV, V32, P90; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rendell L, 2001, BEHAV BRAIN SCI, V24, P324, DOI DOI 10.1017/S0140525X0100396X; Schwager S. J., 1987, ANIM BEHAV, V35, P1454; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; WEINRICH MT, 1992, ANIM BEHAV, V44, P1059, DOI 10.1016/S0003-3472(05)80318-5; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893	27	231	231	10	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					485	488		10.1126/science.1231976	http://dx.doi.org/10.1126/science.1231976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620054				2022-12-24	WOS:000318016700044
J	Bhaumik, S				Bhaumik, Soumyadeep			India's rejection of Novartis's patent is but a small step in the right direction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												soumyadeepbhaumik@rediffmail.com		Bhaumik, Soumyadeep/0000-0001-9579-4453				Ardal C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001827; Arie S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2099; D'Silva J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1605; Hitchings AW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7941; Jain A., 2013, BRIT MED J, V346, pf2218; Kumar Raman, 2012, J Family Med Prim Care, V1, P10, DOI 10.4103/2249-4863.94442; Mudur G., 2012, BMJ-BRIT MED J, V344; Planning Commission, FAST SUST MOR INCL G; World Health Organization (WHO), 2012, WORLD HLTH STAT 2012	9	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2412	10.1136/bmj.f2412	http://dx.doi.org/10.1136/bmj.f2412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596223				2022-12-24	WOS:000317963400015
J	Crotti, L; Tester, DJ; White, WM; Bartos, DC; Insolia, R; Besana, A; Kunic, JD; Will, ML; Velasco, EJ; Bair, JJ; Ghidoni, A; Cetin, I; Van Dyke, DL; Wick, MJ; Brost, B; Delisle, BP; Facchinetti, F; George, AL; Schwartz, PJ; Ackerman, MJ				Crotti, Lia; Tester, David J.; White, Wendy M.; Bartos, Daniel C.; Insolia, Roberto; Besana, Alessandra; Kunic, Jennifer D.; Will, Melissa L.; Velasco, Ellyn J.; Bair, Jennifer J.; Ghidoni, Alice; Cetin, Irene; Van Dyke, Daniel L.; Wick, Myra J.; Brost, Brian; Delisle, Brian P.; Facchinetti, Fabio; George, Alfred L., Jr.; Schwartz, Peter J.; Ackerman, Michael J.			Long QT Syndrome-Associated Mutations in Intrauterine Fetal Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC SODIUM-CHANNEL; GENE; SCN5A; STILLBIRTHS; HERG; PROGESTERONE; POLYMORPHISM; DYSFUNCTION; BRUGADA; R1193Q	Importance Intrauterine fetal death or stillbirth occurs in approximately 1 out of every 160 pregnancies and accounts for 50% of all perinatal deaths. Postmortem evaluation fails to elucidate an underlying cause in many cases. Long QT syndrome (LQTS) may contribute to this problem. Objective To determine the spectrum and prevalence of mutations in the 3 most common LQTS susceptible genes (KCNQ1, KCNH2, and SCN5A) for a cohort of unexplained cases. Design, Setting, and Patients In this case series, retrospective postmortem genetic testing was conducted on a convenience sample of 91 unexplained intrauterine fetal deaths (mean [SD] estimated gestational age at fetal death, 26.3 [8.7] weeks) that were collected from 2006-2012 by the Mayo Clinic, Rochester, Minnesota, or the Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. More than 1300 ostensibly healthy individuals served as controls. In addition, publicly available exome databases were assessed for the general population frequency of identified genetic variants. Main Outcomes and Measures Comprehensive mutational analyses of KCNQ1 (K(V)7.1, LQTS type 1), KCNH2 (HERG/K(V)11.1, LQTS type 2), and SCN5A (Na(V)1.5, LQTS type 3) were performed using denaturing high-performance liquid chromatography and direct DNA sequencing on genomic DNA extracted from decedent tissue. Functional analyses of novel mutations were performed using heterologous expression and patch-clamp recording. Results The 3 putative LQTS susceptibility missense mutations (KCNQ1, p.A283T; KCNQ1, p.R397W; and KCNH2[1b], p.R25W), with a heterozygous frequency of less than 0.05% in more than 10 000 publicly available exomes and absent in more than 1000 ethnically similar control patients, were discovered in 3 intrauterine fetal deaths (3.3% [95% CI, 0.68%-9.3%]). Both K(V)7.1-A283T (16-week male) and K(V)7.1-R397W (16-week female) mutations were associated with marked K(V)7.1 loss-of-function consistent with in utero LQTS type 1, whereas the HERG1b-R25W mutation (33.2-week male) exhibited a loss of function consistent with in utero LQTS type 2. In addition, 5 intrauterine fetal deaths hosted SCN5A rare nonsynonymous genetic variants (p.T220I, p.R1193Q, involving 2 cases, and p.P2006A, involving 2 cases) that conferred in vitro electrophysiological characteristics consistent with potentially pro-arrhythmic phenotypes. Conclusions and Relevance In this molecular genetic evaluation of 91 cases of intrauterine fetal death, missense mutations associated with LQTS susceptibility were discovered in 3 cases (3.3%) and overall, genetic variants leading to dysfunctional LQTS-associated ion channels in vitro were discovered in 8 cases (8.8%). These preliminary findings may provide insights into mechanisms of some cases of stillbirth. JAMA. 2013;309(14):1473-1482 www.jama.com	[Crotti, Lia; Insolia, Roberto; Ghidoni, Alice; Schwartz, Peter J.] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Crotti, Lia; Insolia, Roberto; Ghidoni, Alice; Schwartz, Peter J.] Fdn IRRCCS Policlin S Matteo, Mol Cardiol Lab, Pavia, Italy; [Crotti, Lia] Helmholtz Ctr, Inst Human Genet, Munich, Germany; [Tester, David J.; Will, Melissa L.; Ackerman, Michael J.] Mayo Clin, Windland Smith Rice Sudden Death Genom Lab, Dept Med Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Tester, David J.; Will, Melissa L.; Ackerman, Michael J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [White, Wendy M.; Wick, Myra J.; Brost, Brian] Mayo Clin, Div Maternal Fetal Med, Rochester, MN 55905 USA; [Ackerman, Michael J.] Mayo Clin, Dept Pediat, Div Pediat Cardiol, Rochester, MN 55905 USA; [Bair, Jennifer J.; Van Dyke, Daniel L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Bartos, Daniel C.; Velasco, Ellyn J.; Delisle, Brian P.] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Besana, Alessandra] IRCCS Insituto Auxol Italiano, Lab Cardiovasc Genet, Milan, Italy; [Kunic, Jennifer D.; George, Alfred L., Jr.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [George, Alfred L., Jr.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [George, Alfred L., Jr.] Vanderbilt Univ, Inst Integrat Genom, Nashville, TN USA; [Cetin, Irene] Univ Milan, Dept Clin Sci Luigi Sacco, I-20122 Milan, Italy; [Facchinetti, Fabio] Univ Modena & Reggio Emilia, Dept Obstet & Gynaecol, Modena, Italy; [Schwartz, Peter J.] Univ Cape Town, Cardiovasc Genet Lab, Hatter Inst Cardiovasc Res, Dept Med, ZA-7700 Rondebosch, South Africa; [Schwartz, Peter J.] Univ Stellenbosch, Dept Med, ZA-7600 Stellenbosch, South Africa; [Schwartz, Peter J.] King Saud Univ, Coll Med, Dept Family & Community Med, Riyadh 11461, Saudi Arabia	University of Pavia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Kentucky; IRCCS Istituto Auxologico Italiano; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Milan; Luigi Sacco Hospital; Universita di Modena e Reggio Emilia; University of Cape Town; Stellenbosch University; King Saud University	Ackerman, MJ (corresponding author), Mayo Clin, Long QT Syndrome Clin, Guggenheim 501,200 1st St SW, Rochester, MN 55905 USA.	ackerman.michael@mayo.edu	Schwartz, Peter J/J-4267-2016; cetin, irene/K-6112-2016; Facchinetti, Fabio/K-9929-2014; Crotti, Lia/AAB-3914-2019; Ghidoni, Alice/AAA-7556-2020	Schwartz, Peter J/0000-0003-0367-1048; cetin, irene/0000-0002-9217-3034; Facchinetti, Fabio/0000-0003-4694-9564; Ghidoni, Alice/0000-0003-3435-9823; Brost, Brian/0000-0002-4903-4186; Delisle, Brian/0000-0002-2146-327X; crotti, lia/0000-0001-8739-6527	Italian Ministry of Health [GR-2010-2305717]; American Heart Association; National Institutes of Health (NIH) [HD042569, HL087039, HL083374]; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca; European Community; T. Denny Sanford Endowed Collaborative Research Fund; National Heart, Lung, and Blood Institute; Institut Biochimique SA (IBSA) in Switzerland; Ferring SA in Switzerland; NIH; Allergan Inc; Gilead Sciences; Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program; Sheikh Zayed Saif Mohammed Al Nahyan Fund in Pediatric Cardiology Research; Dr Scholl Foundation; Hannah M. Wernke Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042569] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087039, R01HL083374] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); T. Denny Sanford Endowed Collaborative Research Fund; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Institut Biochimique SA (IBSA) in Switzerland; Ferring SA in Switzerland(Ferring Pharmaceuticals); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan Inc(AbbVieAllergan); Gilead Sciences(Gilead Sciences); Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program; Sheikh Zayed Saif Mohammed Al Nahyan Fund in Pediatric Cardiology Research; Dr Scholl Foundation; Hannah M. Wernke Memorial Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Crotti reported receiving an institutional grant from the Italian Ministry of Health. Mr Tester reported receiving royalties personally and to his institution from Transgenomic. Mr Bartos reported receiving a predoctoral grant from the American Heart Association. Dr Insolia reported receiving a grant to his institution from the Italian Ministry of Health, Ms Kunic reported receiving grant to her institution from the National Institutes of Health (NIH). Dr Ghidoni reported receiving a grant to her institution from the Italian Ministry of Health. Dr Cetin reported receiving a grant to her institution from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca and has grants to her institution pending from the European Community, Italian Ministry of Health, and Italian Ministero dell'Istruzione, dell'Universita e della Ricerca. Dr Van Dyke reported that he has grants to his institution pending from the National Institutes of Health and receives institutional support from the College of American Pathologists for which he serves as a consultant to the College of American Pathologists Cytogenices Resource Center. Dr Wick reported a pending grant to his institution from the T. Denny Sanford Endowed Collaborative Research Fund. Dr Delisle reported a grant to his insitution from the National Heart, Lung, and Blood Institute. Dr Facchinetti reported receiving consultancy fees from Institut Biochimique SA (IBSA) and lecture fees from Ferring SA, both in Switzerland, and travel expenses from Lo.Li. Pharma, Italy. Dr George reported receiving a grant to his institution from the NIH, has pending grants to his institution from Allergan Inc and Gilead Sciences, and receives royalties from Gilead Sciences Inc and Merck Inc. Dr Ackerman reported receiving royalties personally and to his institution from Transgenomic and received a grant from the NIH. Intellectual property derived from Dr Ackerman's research program resulted in license agreements in 2004 between Mayo Clinic Health Solutions (formerly Mayo Medical Ventures) and PGxHealth (formerly Genaissance Pharmaceuticals and now recently acquired by Transgenomic). However, Transgenomic did not contribute directly to this study in any manner. No other financial disclosures were reported.; Dr Spazzolini's work is supported by Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy. This research is supported by the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program (Dr Ackerman), the Sheikh Zayed Saif Mohammed Al Nahyan Fund in Pediatric Cardiology Research (Dr Ackerman), the Dr Scholl Foundation (Dr Ackerman), the Hannah M. Wernke Memorial Foundation (Dr Ackerman), the National Institutes of Health (grants HD042569 to MJA, HL087039 to BPD, and HL083374 to Dr George), and the Italian Ministry of Health (GR-2010-2305717 to Dr Crotti).	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; AISIEN AO, 1994, INT J GYNECOL OBSTET, V47, P27, DOI 10.1016/0020-7292(94)90457-X; [Anonymous], EX VAR SERV SEATTL G; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Bhuiyan ZA, 2008, HEART RHYTHM, V5, P553, DOI 10.1016/j.hrthm.2008.01.020; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Chia EL, 2005, PRENATAL DIAG, V25, P546, DOI 10.1002/pd.1184; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Hwang HW, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027995; Ishikawa S, 2013, FETAL DIAGN THER, V33, P1, DOI 10.1159/000339150; Kahler C, 2002, PRENATAL DIAG, V22, P408, DOI 10.1002/pd.322; Kapa S, 2009, CIRCULATION, V120, P1752, DOI 10.1161/CIRCULATIONAHA.109.863076; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; MacDorman Marian F, 2012, Natl Vital Stat Rep, V60, P1; Miller TE, 2004, CIRCULATION, V109, P3029, DOI 10.1161/01.CIR.0000130666.81539.9E; Murphy LL, 2012, HEART RHYTHM, V9, P590, DOI 10.1016/j.hrthm.2011.11.006; Nof E, 2010, CIRC-CARDIOVASC GENE, V3, P199, DOI 10.1161/CIRCGENETICS.109.898569; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Schwartz PJ, 2001, CIRCULATION, V103, P89; Schwartz PJ, 2004, CIRCULATION, V109, P2930, DOI 10.1161/01.CIR.0000133180.77213.43; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Tan BH, 2005, HEART RHYTHM, V2, P741, DOI 10.1016/j.hrthm.2005.04.021; Tester DJ, 2008, HEART RHYTHM, V5, P1282, DOI 10.1016/j.hrthm.2008.07.002; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; The R Fouridation for Statistical Computing, R PROJ STAT COMP; Van Norstrand DW, 2009, HEART RHYTHM, V6, P272, DOI 10.1016/j.hrthm.2008.07.028; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; WALSH S, 1995, MED HYPOTHESES, V45, P73, DOI 10.1016/0306-9877(95)90206-6; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; Wang Q, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013300; Wu ZY, 2011, J BIOL CHEM, V286, P22186, DOI 10.1074/jbc.M110.198853	40	106	111	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1473	1482		10.1001/jama.2013.3219	http://dx.doi.org/10.1001/jama.2013.3219			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571586	Green Accepted			2022-12-24	WOS:000317271700025
J	Tuckson, RV; Newcomer, L; De Sa, JM				Tuckson, Reed V.; Newcomer, Lee; De Sa, Jeanne M.			Accessing Genomic Medicine Affordability, Diffusion, and Disparities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tuckson, Reed V.] UnitedHlth Grp, Minnetonka, MN 55343 USA; [Newcomer, Lee] UnitedHealthcare, Minnetonka, MN USA; [De Sa, Jeanne M.] UnitedHlth Ctr Hlth Reform & Modernizat, Washington, DC USA		Tuckson, RV (corresponding author), UnitedHlth Grp, 9900 Bren Rd E,MN008-T902, Minnetonka, MN 55343 USA.	reed.v.tuckson@uhg.com						Congressional Budget Office, 2008, TECHN CHANG GROWTH H; *DEP HLTH HUM SERV, 2008, US SYST OV GEN TEST; Express Scripts, 2011, 2011 DRUG TREND REP; FederalReserve BankofStLouis, 2022, CAS SHILL US NAT HOM; Khoury MJ, 2012, AM J PREV MED, V42, P639, DOI 10.1016/j.amepre.2012.02.012; Smith M, 2012, BEST CARE LOWER COST; UnitedHealth, 2010, US DIAB CHALL OPP DE	7	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1469	1470		10.1001/jama.2013.1468	http://dx.doi.org/10.1001/jama.2013.1468			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571584				2022-12-24	WOS:000317271700023
J	Peljto, AL; Zhang, YZ; Fingerlin, TE; Ma, SF; Garcia, JGN; Richards, TJ; Silveira, LJ; Lindell, KO; Steele, MP; Loyd, JE; Gibson, KF; Seibold, MA; Brown, KK; Talbert, JL; Markin, C; Kossen, K; Seiwert, SD; Murphy, E; Noth, I; Schwarz, MI; Kaminski, N; Schwartz, DA				Peljto, Anna L.; Zhang, Yingze; Fingerlin, Tasha E.; Ma, Shwu-Fan; Garcia, Joe G. N.; Richards, Thomas J.; Silveira, Lori J.; Lindell, Kathleen O.; Steele, Mark P.; Loyd, James E.; Gibson, Kevin F.; Seibold, Max A.; Brown, Kevin K.; Talbert, Janet L.; Markin, Cheryl; Kossen, Karl; Seiwert, Scott D.; Murphy, Elissa; Noth, Imre; Schwarz, Marvin I.; Kaminski, Naftali; Schwartz, David A.			Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FORCED VITAL CAPACITY; DISEASE EXTENT; PROTEINS; VARIANT; SYSTEM; INDEX; MODEL	Importance Current prediction models of mortality in idiopathic pulmonary fibrosis (IPF), which are based on clinical and physiological parameters, have modest value in predicting which patients will progress. In addition to the potential for improving prognostic models, identifying genetic and molecular features that are associated with IPF mortality may provide insight into the underlying mechanisms of disease and inform clinical trials. Objective To determine whether the MUC5B promoter polymorphism (rs35705950), previously reported to be associated with the development of pulmonary fibrosis, is associated with survival in IPF. Design, Setting, and Participants Retrospective study of survival in 2 independent cohorts of patients with IPF: the INSPIRE cohort, consisting of patients enrolled in the interferon-gamma 1b trial (n=438; December 15, 2003-May 2, 2009; 81 centers in 7 European countries, the United States, and Canada), and the Chicago cohort, consisting of IPF participants recruited from the Interstitial Lung Disease Clinic at the University of Chicago (n= 148; 2007-2010). The INSPIRE cohort was used to model the association of the MUC5B genotype with survival, accounting for the effect of matrix metalloproteinase 7 (MMP-7) blood concentration and other demographic and clinical covariates. The Chicago cohort was used for replication of findings. Main Outcomes and Measures The primary end point was all-cause mortality. Results Thenumbers of patients in the GG, GT, and TT genotype groups were 148(34%), 259 (59%), and 31 (7%), respectively, in the INSPIRE cohort and 41 (28%), 98 (66%), and 9 (6%), respectively, in the Chicago cohort. The median follow-up period was 1.6 years for INSPIRE and 2.1 years for Chicago. During follow-up, there were 73 deaths (36 GG, 35 GT, and 2 TT) among INSPIRE patients and 64 deaths (26 GG, 36 GT, and 2 TT) among Chicago patients. The unadjusted 2-year cumulative incidence of death was lower among patients carrying 1 or more copies of the IPF risk allele (T) in both the INSPIRE cohort (0.25 [95% CI, 0.17-0.32] for GG, 0.17 [95% CI, 0.11-0.23] for GT, and 0.03 [95% CI, 0.00-0.09] for TT) and the Chicago cohort (0.50 [95% CI, 0.31-0.63] for GG, 0.22 [95% CI, 0.13-0.31] for GT, and 0.11 [95% CI, 0.00-0.28] for TT). In the INSPIRE cohort, the TT and GT genotypes (risk for IPF) were associated with improved survival compared with GG (hazardratios, 0.23[95% CI, 0.10-0.52] and 0.48[95% CI, 0.31-0.72], respectively; P <.001). This finding was replicated in the Chicago cohort (hazard ratios, 0.15[95% CI, 0.05-0.49] and 0.39[95% CI, 0.21-0.70], respectively; P<.002). The observed association of MUC5B with survival was independent of age, sex, forced vital capacity, diffusing capacity of carbon monoxide, MMP-7, and treatment status. The addition of the MUC5B genotype to the survival models significantly improved the predictive accuracy of the model in both the INSPIRE cohort (C = 0.71 [95% CI, 0.64-0.75] vs C = 0.68 [95% CI, 0.61-0.73]; P <.001) and the Chicago cohort (C = 0.73 [95% CI, 0.62-0.78] vs C = 0.69 [95% CI, 0.59-0.75]; P =. 01). Conclusions and Relevance Among patients with IPF, a common risk polymorphism in MUC5B was significantly associated with improved survival. Further research is necessary to refine the risk estimates and to determine the clinical implications of these findings.	[Peljto, Anna L.; Fingerlin, Tasha E.] Univ Colorado, Sch Publ Hlth, Dept Epidemiol, Denver, CO 80202 USA; [Zhang, Yingze; Fingerlin, Tasha E.] Univ Colorado, Sch Publ Hlth, Dept Biostat, Denver, CO 80202 USA; [Murphy, Elissa; Schwarz, Marvin I.; Schwartz, David A.] Univ Colorado, Sch Med, Dept Med, Denver, CO USA; [Silveira, Lori J.] Natl Jewish Hlth, Dept Biostat, Denver, CO USA; [Seibold, Max A.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Brown, Kevin K.; Talbert, Janet L.; Schwartz, David A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Ma, Shwu-Fan; Noth, Imre] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Garcia, Joe G. N.] Univ Illinois, Dept Med, Inst Personalized Resp Med, Chicago, IL USA; [Richards, Thomas J.; Lindell, Kathleen O.; Gibson, Kevin F.; Kaminski, Naftali] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Steele, Mark P.; Loyd, James E.; Markin, Cheryl] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Kossen, Karl; Seiwert, Scott D.] InterMune, Brisbane, CA USA	Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; National Jewish Health; National Jewish Health; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Schwartz, DA (corresponding author), Univ Colorado, 12631 E 17th Ave,B178, Aurora, CO 80045 USA.	david.schwartz@ucdenver.edu	Lindell, Kathleen Oare/GQQ-6372-2022; Brown, Kevin/ABF-2544-2020	Kaminski, Naftali/0000-0001-5917-4601; Loyd, James/0000-0002-5042-7390	National Heart, Lung, and Blood Institute [R01-HL095393, R01-HL097163, R01-HL095397, P50-HL0894932, P01-HL092870, RC1-HL09961, RC2-HL101715]; Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research (University of Pittsburgh School of Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095393, RC2HL101715, RC1HL099619, R01HL097163, F32HL009961, P01HL092870, P50HL084932, R01HL095397] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research (University of Pittsburgh School of Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Heart, Lung, and Blood Institute (grants R01-HL095393, R01-HL097163, R01-HL095397, P50-HL0894932, P01-HL092870, RC1-HL09961, and RC2-HL101715) and the Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research (University of Pittsburgh School of Medicine).	Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Boon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005134; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Collard HR, 2003, AM J RESP CRIT CARE, V168, P538, DOI 10.1164/rccm.200211-1311OC; Cosgrove GP., 2012, AM J RESP CRIT CARE, V185, pA6865, DOI DOI 10.1164/AJRCCM-C0NFERENCE.2012.185.1_; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P1382, DOI 10.1164/rccm.201105-0840OC; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Flaherty KR, 2003, AM J RESP CRIT CARE, V168, P543, DOI 10.1164/rccm.200209-1112OC; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Raghu G, 2012, LANCET, V380, P699, DOI 10.1016/S0140-6736(12)61256-2; Richards TJ, 2012, AM J RESP CRIT CARE, V185, P67, DOI 10.1164/rccm.201101-0058OC; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Stock CJ, 2013, THORAX, V68, P436, DOI 10.1136/thoraxjnl-2012-201786; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P1109, DOI 10.1164/ajrccm.162.3.9910080; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Zappala CJ, 2010, EUR RESPIR J, V35, P830, DOI 10.1183/09031936.00155108; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504	29	301	310	1	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2232	2239		10.1001/jama.2013.5827	http://dx.doi.org/10.1001/jama.2013.5827			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156YC	23695349	Green Accepted, Bronze			2022-12-24	WOS:000319859200027
J	Tosh, W				Tosh, William			It can be tough for families when patients choose to die at home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Russells Hall Hosp, Dept Anaesthesia, Dudley DY1 2HQ, W Midlands, England	Russells Hall Hospital	Tosh, W (corresponding author), Russells Hall Hosp, Dept Anaesthesia, Dudley DY1 2HQ, W Midlands, England.	w.tosh@doctors.org.uk							0	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3397	10.1136/bmj.f3397	http://dx.doi.org/10.1136/bmj.f3397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DG	23719642				2022-12-24	WOS:000319948200010
J	Fisher, SE; Ridley, M				Fisher, Simon E.; Ridley, Matt			Culture, Genes, and the Human Revolution	SCIENCE			English	Editorial Material							FOXP2; SPEECH; EVOLUTION		[Fisher, Simon E.] Max Planck Inst Psycholinguist, Dept Language & Genet, NL-6525 XD Nijmegen, Netherlands; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 EN Nijmegen, Netherlands; [Ridley, Matt] House Lords, London SW1A 0PW, England	Max Planck Society; Radboud University Nijmegen	Fisher, SE (corresponding author), Max Planck Inst Psycholinguist, Dept Language & Genet, Wundtlaan 1, NL-6525 XD Nijmegen, Netherlands.	simon.fisher@mpi.nl	Fisher, Simon E./E-9130-2012	Fisher, Simon E./0000-0002-3132-1996				[Anonymous], 1997, GUNS GERMS STEEL; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; French CA, 2012, MOL PSYCHIATR, V17, P1077, DOI 10.1038/mp.2011.105; Klein R., 2002, DAWN HUMAN CULTURE; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Maricic T, 2013, MOL BIOL EVOL, V30, P844, DOI 10.1093/molbev/mss271; McBrearty S, 2007, RETHINKING HUMAN REV, P133; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Richerson P.J., 2004, NOT GENES ALONE; Somel M, 2013, NAT REV NEUROSCI, V14, P112, DOI 10.1038/nrn3372; Vallender EJ, 2008, TRENDS NEUROSCI, V31, P637, DOI 10.1016/j.tins.2008.08.010; Wrangham RW, 2009, CATCHING FIRE COOKIN	15	38	39	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					929	930		10.1126/science.1236171	http://dx.doi.org/10.1126/science.1236171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	149TK	23704558				2022-12-24	WOS:000319344100028
J	Uehata, T; Iwasaki, H; Vandenbon, A; Matsushita, K; Hernandez-Cuellar, E; Kuniyoshi, K; Satoh, T; Mino, T; Suzuki, Y; Standley, DM; Tsujimura, T; Rakugi, H; Isaka, Y; Takeuchi, O; Akira, S				Uehata, Takuya; Iwasaki, Hidenori; Vandenbon, Alexis; Matsushita, Kazufumi; Hernandez-Cuellar, Eduardo; Kuniyoshi, Kanako; Satoh, Takashi; Mino, Takashi; Suzuki, Yutaka; Standley, Daron M.; Tsujimura, Tohru; Rakugi, Hiromi; Isaka, Yoshitaka; Takeuchi, Osamu; Akira, Shizuo			Malt1-Induced Cleavage of Regnase-1 in CD4(+) Helper T Cells Regulates Immune Activation	CELL			English	Article							MESSENGER-RNA; TRANSCRIPTION FACTORS; C-REL; ROLES; GENES; MALT1; MICRORNAS; STABILITY; ALPHA	Regnase-1 (also known as Zc3h12a and MCPIP1) is an RNase that destabilizes a set of mRNAs, including Il6 and Il12b, through cleavage of their 3' UTRs. Although Regnase-1 inactivation leads to development of an autoimmune disease characterized by T cell activation and hyperimmunoglobulinemia in mice, the mechanism of Regnase-1-mediated immune regulation has remained unclear. We show that Regnase-1 is essential for preventing aberrant effector CD4(+) T cell generation cell autonomously. Moreover, in T cells, Regnase-1 regulates the mRNAs of a set of genes, including c-Rel, Ox40, and Il2, through cleavage of their 30 UTRs. Interestingly, T cell receptor (TCR) stimulation leads to cleavage of Regnase-1 at R111 by Malt1/paracaspase, freeing T cells from Regnase-1-mediated suppression. Furthermore, Malt1 protease activity is critical for controlling the mRNA stability of T cell effector genes. Collectively, these results indicate that dynamic control of Regnase-1 expression in T cells is critical for controlling T cell activation.	[Uehata, Takuya; Iwasaki, Hidenori; Matsushita, Kazufumi; Hernandez-Cuellar, Eduardo; Kuniyoshi, Kanako; Satoh, Takashi; Takeuchi, Osamu; Akira, Shizuo] Osaka Univ, Lab Host Def, Suita, Osaka 5650871, Japan; [Vandenbon, Alexis; Standley, Daron M.] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Lab Syst Immunol, Suita, Osaka 5650871, Japan; [Kuniyoshi, Kanako; Satoh, Takashi; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Uehata, Takuya; Rakugi, Hiromi; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Iwasaki, Hidenori] Japan Tobacco, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5691125, Japan; [Mino, Takashi; Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 6068507, Japan; [Takeuchi, Osamu] JST, CREST, Sakyo Ku, Kyoto 6068507, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom, Kashiwa, Chiba 2778562, Japan; [Tsujimura, Tohru] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Japan Tobacco Inc.; Kyoto University; Japan Science & Technology Agency (JST); University of Tokyo; Hyogo College of Medicine	Akira, S (corresponding author), Osaka Univ, Lab Host Def, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Takeuchi, Osamu/AAG-9359-2019; Vandenbon, Alexis/A-8430-2017; Mino, Takashi/GRO-0332-2022; Standley, Daron/D-2343-2009; Vandenbon, Alexis/N-4428-2019; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; Mino, Takashi/0000-0002-9562-008X; Rakugi, Hiromi/0000-0001-6508-4338	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS); JSPS; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25860355, 22689016] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of our laboratory, E. Kamada and M. Kageyama for secretarial assistance, and Y. Fujiwara, M. Kumagai, K. Nojima, and N. Umano for technical assistance. We also thank I. Taniuchi for CD4-Cre mice, S.W. Morris and S. Yamasaki for Bcl10<SUP>-</SUP>/-mice, V.M. Dixit and N. Kayagaki for Malt1<SUP>-</SUP>/-mice, S. Gerondakis and T. Kurosaki for c-Rel<SUP>-</SUP>/-mice, and L.M. McAllister-Lucas for the Flag-API2-Malt1 plasmids. This work was supported by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the funding program for World-Leading Innovative R&D on Science and Technology (FIRST Program) and the Grant-in- Aid for Specially Promoted Research. This work was also supported by the JSPS Grant-in-Aid for Young Scientists (A) (OT) and a grant-in-aid for Scientific Research on Innovative Areas "Genome Science'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Campbell IK, 2000, J CLIN INVEST, V105, P1799, DOI 10.1172/JCI8298; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	35	232	242	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1036	1049		10.1016/j.cell.2013.04.034	http://dx.doi.org/10.1016/j.cell.2013.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706741	Bronze			2022-12-24	WOS:000319456800012
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Antibiotics for back pain: hope or hype?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE EDEMA					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Albert HB, 2008, BRIT J SPORT MED, V42, P969, DOI 10.1136/bjsm.2008.050369; Albert HB, 2013, EUR SPINE J, V22, P697, DOI 10.1007/s00586-013-2675-y; [Anonymous], 2013, SKY NEWS        0508; [Anonymous], 2013, DAILY MAIL; [Anonymous], 2013, GUARDIAN; Barton A., 2013, GLOBE MAIL; ClinicalTrials.gov, ANT TREATM PAT LOW B; Jensen RK, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-183; Laurance J., 2013, INDEPENDENT; O'Connell N, 2013, BODY MIND       0322; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Wedderkopp N, 2009, ACTA RADIOL, V50, P65, DOI 10.1080/02841850802524485	12	5	6	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f3122	10.1136/bmj.f3122	http://dx.doi.org/10.1136/bmj.f3122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674340				2022-12-24	WOS:000319253900015
J	Laine, CM; Joeng, KS; Campeau, PM; Kiviranta, R; Tarkkonen, K; Grover, M; Lu, JT; Pekkinen, M; Wessman, M; Heino, TJ; Nieminen-Pihala, V; Aronen, M; Laine, T; Kroger, H; Cole, WG; Lehesjoki, AE; Nevarez, L; Krakow, D; Curry, CJR; Cohn, DH; Gibbs, RA; Lee, BH; Makitie, O				Laine, Christine M.; Joeng, Kyu Sang; Campeau, Philippe M.; Kiviranta, Riku; Tarkkonen, Kati; Grover, Monica; Lu, James T.; Pekkinen, Minna; Wessman, Maija; Heino, Terhi J.; Nieminen-Pihala, Vappu; Aronen, Mira; Laine, Tero; Kroger, Heikki; Cole, William G.; Lehesjoki, Anna-Elina; Nevarez, Lisette; Krakow, Deborah; Curry, Cynthia J. R.; Cohn, Daniel H.; Gibbs, Richard A.; Lee, Brendan H.; Makitie, Outi			WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; DIFFERENTIATION; OSTEOBLASTS; PROTEIN; MOUSE; CELLS; FORM	This report identifies human skeletal diseases associated with mutations in WNT1. In 10 family members with dominantly inherited, early-onset osteoporosis, we identified a heterozygous missense mutation in WNT1, c.652T -> G (p.Cys218Gly). In a separate family with 2 siblings affected by recessive osteogenesis imperfecta, we identified a homozygous nonsense mutation, c.884C -> A, p.Ser295(star). In vitro, aberrant forms of the WNT1 protein showed impaired capacity to induce canonical WNT signaling, their target genes, and mineralization. In mice, Wnt1 was clearly expressed in bone marrow, especially in B-cell lineage and hematopoietic progenitors; lineage tracing identified the expression of the gene in a subset of osteocytes, suggesting the presence of altered cross-talk in WNT signaling between the hematopoietic and osteoblastic lineage cells in these diseases.	[Laine, Christine M.; Pekkinen, Minna; Wessman, Maija; Aronen, Mira; Lehesjoki, Anna-Elina; Makitie, Outi] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Wessman, Maija] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Makitie, Outi] Univ Helsinki, Dept Pediat, Helsinki, Finland; [Makitie, Outi] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Kiviranta, Riku; Tarkkonen, Kati; Nieminen-Pihala, Vappu] Univ Turku, Dept Med, Turku, Finland; [Heino, Terhi J.] Univ Turku, Dept Cell Biol & Anat, Turku, Finland; [Kiviranta, Riku] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Kroger, Heikki] Univ Eastern Finland, Bone & Cartilage Res Unit, Kuopio, Finland; [Kroger, Heikki] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Laine, Christine M.] Sahlgrens Univ Hosp, Dept Endocrinol, Inst Med, Gothenburg, Sweden; [Laine, Tero] Sahlgrens Univ Hosp, Dept Orthoped, Inst Clin Sci, Gothenburg, Sweden; Univ Gothenburg, Gothenburg, Sweden; [Joeng, Kyu Sang; Campeau, Philippe M.; Grover, Monica; Gibbs, Richard A.; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA; [Lu, James T.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX USA; [Lu, James T.] Baylor Coll Med, Dept Struct & Computat Biol & Mol Biophys, Houston, TX USA; [Lee, Brendan H.] Howard Hughes Med Inst, Houston, TX 77030 USA; [Cole, William G.] Univ Alberta, Div Pediat Surg, Edmonton, AB, Canada; [Nevarez, Lisette; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Curry, Cynthia J. R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Curry, Cynthia J. R.] Genet Med Cent Calif, Fresno, CA USA	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Turku; University of Turku; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Lee, BH (corresponding author), 1 Baylor Plaza,Rm R814, Houston, TX 77030 USA.	blee@bcm.edu	Krakow, Deborah/B-5778-2009; Campeau, Philippe/J-8614-2015	Krakow, Deborah/0000-0001-9906-4968; Campeau, Philippe/0000-0001-9713-7107; /0000-0002-7184-1945; Heino, Terhi/0000-0003-2274-6834; Makitie, Outi/0000-0002-4547-001X	Folkhalsan Research Foundation; Sigrid Juselius Foundation; Foundation for Pediatric Research; Waldemar von Frenckell Foundation; Helsinki University Research Funds; Rolanette and Berdon Lawrence Bone Disease Program of Texas; O'Malley Foundation; Academy of Finland [139165, 132894, 250780]; National Institutes of Health [R01 AR062651, R01 DE019567, PO1 HD22657, PO1 HD070394]; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center [HD024064]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Helsinki and European Calcified Tissue Society Career Establishment Award; Canadian Institutes of Health Research Clinician Scientist Training Award; National Research Service Award [F32 AR063616]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, P01HD070394] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062651, F32AR063616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019567] Funding Source: NIH RePORTER	Folkhalsan Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Foundation for Pediatric Research; Waldemar von Frenckell Foundation; Helsinki University Research Funds; Rolanette and Berdon Lawrence Bone Disease Program of Texas; O'Malley Foundation; Academy of Finland(Academy of Finland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Helsinki and European Calcified Tissue Society Career Establishment Award; Canadian Institutes of Health Research Clinician Scientist Training Award(Canadian Institutes of Health Research (CIHR)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by grants from the Folkhalsan Research Foundation (to Drs. Laine, Makitie, Wessman, and Lehesjoki), the Sigrid Juselius Foundation (to Drs. Kiviranta and Makitie), the Foundation for Pediatric Research (to Dr. Makitie), the Waldemar von Frenckell Foundation (to Dr. Laine), the Helsinki University Research Funds (to Dr. Makitie), the Rolanette and Berdon Lawrence Bone Disease Program of Texas (to Dr. Lee), the O'Malley Foundation (to Dr. Campeau), the Academy of Finland (139165, to Dr. Kiviranta; and 132894 and 250780, to Dr. Makitie), the National Institutes of Health (R01 AR062651, to Dr. Cohn; R01 DE019567, to Drs. Cohn and Krakow; and PO1 HD22657 and PO1 HD070394, to Drs. Lee, Krakow, and Cohn), and the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (HD024064, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development); and by a Helsinki and European Calcified Tissue Society Career Establishment Award (to Dr. Kiviranta), a Canadian Institutes of Health Research Clinician Scientist Training Award (to Dr. Campeau), and a National Research Service Award (F32 AR063616, to Dr. Joeng).	Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BRADLEY RS, 1995, MOL CELL BIOL, V15, P4616; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Byers PH, 2012, ANNU REV GENET, V46, P475, DOI 10.1146/annurev-genet-110711-155608; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Haver S, 2008, J BONE MINER RES, V23, P1650, DOI [10.1359/JBMR.080508, 10.1359/jbmr.080508]; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Ichii M, 2012, BLOOD, V119, P1683, DOI 10.1182/blood-2011-07-369199; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; van den Bergh JP, 2012, NAT REV RHEUMATOL, V8, P163, DOI 10.1038/nrrheum.2011.217; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9	22	238	253	2	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1809	1816		10.1056/NEJMoa1215458	http://dx.doi.org/10.1056/NEJMoa1215458			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656646	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000318540000009
J	Korhonen, N; Niemi, S; Parkkari, J; Sievanen, H; Kannus, P				Korhonen, Niina; Niemi, Seppo; Parkkari, Jari; Sievanen, Harri; Kannus, Pekka			Incidence of Fall-Related Traumatic Brain Injuries Among Older Finnish Adults Between 1970 and 2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Korhonen, Niina; Niemi, Seppo; Sievanen, Harri] UKK Inst Hlth Promot Res, Injury & Osteoporosis Res Ctr, Tampere, Finland; [Parkkari, Jari] UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, Tampere, Finland; [Kannus, Pekka] Tampere Univ Hosp, Dept Trauma Musculoskeletal Surg & Rehabil, Tampere, Finland	UKK Institute; UKK Institute; Tampere University; Tampere University Hospital	Korhonen, N (corresponding author), UKK Inst Hlth Promot Res, Injury & Osteoporosis Res Ctr, Tampere, Finland.	njkorhon@student.uef.fi		Korhonen, Niina/0000-0003-2990-679X				Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; Keskimaki I, 1991, J HEALTH SCI, V2, P15; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024	6	36	36	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1891	1892		10.1001/jama.2013.3356	http://dx.doi.org/10.1001/jama.2013.3356			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23652518	Bronze			2022-12-24	WOS:000318481900019
J	Young, GJ; Chou, CH; Alexander, J; Lee, SYD; Raver, E				Young, Gary J.; Chou, Chia-Hung; Alexander, Jeffrey; Lee, Shoou-Yih Daniel; Raver, Eli			Provision of Community Benefits by Tax-Exempt U.S. Hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPROFIT HOSPITALS	BACKGROUND The Patient Protection and Affordable Care Act (ACA) requires tax-exempt hospitals to conduct assessments of community needs and address identified needs. Most tax-exempt hospitals will need to meet this requirement by the end of 2013. METHODS We conducted a national study of the level and pattern of community benefits that tax-exempt hospitals provide. The study comprised more than 1800 tax-exempt hospitals, approximately two thirds of all such institutions. We used reports that hospitals filed with the Internal Revenue Service for fiscal year 2009 that provide expenditures for seven types of community benefits. We combined these reports with other data to examine whether institutional, community, and market characteristics are associated with the provision of community benefits by hospitals. RESULTS Tax-exempt hospitals spent 7.5% of their operating expenses on community benefits during fiscal year 2009. More than 85% of these expenditures were devoted to charity care and other patient care services. Of the remaining community-benefit expenditures, approximately 5% were devoted to community health improvements that hospitals undertook directly. The rest went to education in health professions, research, and contributions to community groups. The level of benefits provided varied widely among the hospitals (hospitals in the top decile devoted approximately 20% of operating expenses to community benefits; hospitals in the bottom decile devoted approximately 1%). This variation was not accounted for by indicators of community need. CONCLUSIONS In 2009, tax-exempt hospitals varied markedly in the level of community benefits provided, with most of their benefit-related expenditures allocated to patient care services. Little was spent on community health improvement.	[Young, Gary J.; Chou, Chia-Hung; Raver, Eli] Northeastern Univ, Ctr Hlth Policy & Healthcare Res, Boston, MA 02115 USA; [Young, Gary J.; Chou, Chia-Hung; Raver, Eli] Northeastern Univ, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Young, Gary J.] Northeastern Univ, DAmore McKim Sch Business, Boston, MA 02115 USA; [Chou, Chia-Hung] Univ Chicago, Chicago, IL 60637 USA; [Alexander, Jeffrey; Lee, Shoou-Yih Daniel] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Northeastern University; Northeastern University; Northeastern University; University of Chicago; University of Michigan System; University of Michigan	Young, GJ (corresponding author), Northeastern Univ, 360 Huntington Ave,137 Richards Hall, Boston, MA 02115 USA.	ga.young@neu.edu						[Anonymous], 2009, COMM BEN REP US STAT; [Anonymous], 2007, HLTH CAR COMM BEN CO; [Anonymous], 1969, REV RUL 69 545; Bazzoli GJ, 2010, J HEALTH POLIT POLIC, V35, P999, DOI 10.1215/03616878-2010-036; Colombo John D., 2007, SAINT LOUIS U LAW J, V51; Congressional Budget Office, 2006, NONPR HOSP PROV COMM; Congressional Budget Office, 2006, NONPR HOSP VAR STAND; Folkemer D. C., 2011, HOSP COMMUNITY BENEF; Gray BH, 2009, HEALTH AFFAIR, V28, pW809, DOI 10.1377/hlthaff.28.5.w809; Health Forum, 2009, AHA GUID HLTH CAR FI; Hellinger FJ, 2009, J HEALTH POLIT POLIC, V34, P37, DOI 10.1215/03616878-2008-991; Japsen B., 2011, NY TIMES; Kane NM, 2007, ST LOUIS U L J, V51, P459; Rosenbaum S, 2011, PUBLIC HEALTH REP, V126, P283, DOI 10.1177/003335491112600220	14	121	121	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1519	1527		10.1056/NEJMsa1210239	http://dx.doi.org/10.1056/NEJMsa1210239			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23594004				2022-12-24	WOS:000317603300009
J	Reisz, RR; Huang, TD; Roberts, EM; Peng, SR; Sullivan, C; Stein, K; LeBlanc, ARH; Shieh, D; Chang, RS; Chiang, CC; Yang, CW; Zhong, SM				Reisz, Robert R.; Huang, Timothy D.; Roberts, Eric M.; Peng, ShinRung; Sullivan, Corwin; Stein, Koen; LeBlanc, Aaron R. H.; Shieh, DarBin; Chang, RongSeng; Chiang, ChengCheng; Yang, Chuanwei; Zhong, Shiming			Embryology of Early Jurassic dinosaur from China with evidence of preserved organic remains	NATURE			English	Article							SOFT-TISSUE; THEROPODS	Fossil dinosaur embryos are surprisingly rare, being almost entirely restricted to Upper Cretaceous strata that record the late stages of non-avian dinosaur evolution(1,2). Notable exceptions are the oldest known embryos from the Early Jurassic South African sauropodomorph Massospondylus(3,4) and Late Jurassic embryos of a theropod from Portugal(5). The fact that dinosaur embryos are rare and typically enclosed in eggshells limits their availability for tissue and cellular level investigations of development. Consequently, little is known about growth patterns in dinosaur embryos, even though post-hatching ontogeny has been studied in several taxa(6). Here we report the discovery of an embryonic dinosaur bone bed from the Lower Jurassic of China, the oldest such occurrence in the fossil record. The embryos are similar in geological age to those of Massospondylus and are also assignable to a sauropodomorph dinosaur, probably Lufengosaurus(7). The preservation of numerous disarticulated skeletal elements and eggshells in this monotaxic bone bed, representing different stages of incubation and therefore derived from different nests, provides opportunities for new investigations of dinosaur embryology in a clade noted for gigantism. For example, comparisons among embryonic femora of different sizes and developmental stages reveal a consistently rapid rate of growth throughout development, possibly indicating that short incubation times were characteristic of sauropodomorphs. In addition, asymmetric radial growth of the femoral shaft and rapid expansion of the fourth trochanter suggest that embryonic muscle activation played an important role in the pre-hatching ontogeny of these dinosaurs. This discovery also provides the oldest evidence of in situ preservation of complex organic remains in a terrestrial vertebrate.	[Reisz, Robert R.; LeBlanc, Aaron R. H.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Huang, Timothy D.] Natl Chung Hsing Univ, Taichung 402, Taiwan; [Roberts, Eric M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Peng, ShinRung; Shieh, DarBin] Natl Cheng Kung Univ, Coll Med, Inst Oral Med, Tainan 701, Taiwan; [Sullivan, Corwin] Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Stein, Koen] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Chang, RongSeng] Natl Cent Univ, Dept Opt & Photon, Chungli 32001, Taiwan; [Chiang, ChengCheng] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Yang, Chuanwei] Lufeng Cty Dinosaur Museum, Lufeng, Yunnan, Peoples R China; [Zhong, Shiming] Chuxiong Prefectural Museum, Chuxiong 675000, Yunnan, Peoples R China	University of Toronto; University Toronto Mississauga; National Chung Hsing University; James Cook University; National Cheng Kung University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Bonn; National Central University; National Synchrotron Radiation Research Center	Reisz, RR (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	robert.reisz@utoronto.ca	Roberts, Eric/J-1836-2014; Stein, Koen HW/G-5731-2015	Roberts, Eric/0000-0002-8583-7437; Stein, Koen/0000-0003-4246-3225; Huang, Timothy/0000-0001-5381-2596; LeBlanc, Aaron/0000-0002-2497-1296; Sullivan, Corwin/0000-0002-5488-6797	NSERC Discovery and SRO Grants (Canada); University of Toronto; DFG (Germany) [FOR 533]; NSC (Taiwan) [100-2116-M-008-016]; Ministry of Education (Taiwan) under the NCKU Aim for the Top University Project; Chinese Academy of Sciences and National Natural Science Foundation of China [41150110341]	NSERC Discovery and SRO Grants (Canada); University of Toronto(University of Toronto); DFG (Germany)(German Research Foundation (DFG)); NSC (Taiwan)(Ministry of Science and Technology, Taiwan); Ministry of Education (Taiwan) under the NCKU Aim for the Top University Project; Chinese Academy of Sciences and National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)Chinese Academy of Sciences)	We thank D. Scott for specimen preparation, photography, and figure preparation; N. Campione for morphometric analysis; C. Apaldetti for the data matrix; O. Dulfer for thin sections; G. Grellet-Tinner, M. Sander, J. Steigler, P. Barrett and E. Prondvai for discussion; C. Chu and X. J. Lin for research support; S. P. Modesto and C. Brown for field assistance; J. Liu for assistance in Lufeng; and C. C. Wang, Y. F. Song, Y. C. Lee and H. S. Sheu for help with various experiments at the National Synchrotron Radiation Research Center, Taiwan. Research support was provided by NSERC Discovery and SRO Grants (Canada), University of Toronto, DFG FOR 533 (contribution 130) (Germany), NSC 100-2116-M-008-016 (Taiwan), Ministry of Education (Taiwan) under the NCKU Aim for the Top University Project, Chinese Academy of Sciences and National Natural Science Foundation of China (41150110341).	[Anonymous], 1990, SKELETAL BIOMINERALI, DOI DOI 10.1029/SC005P0175; Apaldetti C., 2012, PALAEONTOLOGY; Bien M. N., 1941, B GEOLOGICAL SOC CHI, V21, P159; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Carpenter K., 1994, DINOSAUR EGGS BABIES; Carpenter K., 1999, EGGS NESTS BABY DINO; Cheng, 2000, P 3 NAT STRAT C CHIN, P208; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; de Ricqles A, 2001, CR ACAD SCI II A, V332, P647, DOI 10.1016/S1251-8050(01)01580-4; Fleming A, 2001, J ANAT, V199, P177, DOI 10.1017/S0021878201008044; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kundrat M, 2008, ACTA ZOOL-STOCKHOLM, V89, P231, DOI 10.1111/j.1463-6395.2007.00311.x; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Muller GB, 2003, EVOL DEV, V5, P56, DOI 10.1046/j.1525-142X.2003.03009.x; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reisz RR, 2010, J VERTEBR PALEONTOL, V30, P1653, DOI 10.1080/02724634.2010.521604; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; ROGERS RR, 2007, BONEBEDS GENESIS ANA; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Sharir A, 2011, DEVELOPMENT, V138, P3247, DOI 10.1242/dev.063768; Sun A.L., 1986, P275; Weishampel DB., 2004, DINOSAURIA; Young C. C., 1941, Palaeontologia Sinica N S C, V7, P1	29	57	59	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					210	214		10.1038/nature11978	http://dx.doi.org/10.1038/nature11978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579680	Green Accepted			2022-12-24	WOS:000317346300039
J	Cotton, D				Cotton, Deborah			Boston Medicine, Before and After	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Cotton, D (corresponding author), Amer Coll Physicians, Philadelphia, PA 19106 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					145	+		10.7326/0003-4819-159-2-201307160-00650	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00650			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V38KJ	23698621				2022-12-24	WOS:000209342000001
J	Vikse, BE				Vikse, Bjorn Egil			Pre-eclampsia and the risk of kidney disease	LANCET			English	Editorial Material							HYPERTENSIVE DISORDERS; PREGNANCY; BIOPSY		[Vikse, Bjorn Egil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Vikse, Bjorn Egil] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Vikse, Bjorn Egil] Haugesund Hosp, Dept Med, N-5504 Haugesund, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Vikse, BE (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	bjorn.vikse@med.uib.no						Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; Garovic VD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.007; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; McDonald SD, 2010, AM J KIDNEY DIS, V55, P1026, DOI 10.1053/j.ajkd.2009.12.036; Nanjundan P, 2011, J OBSTET GYNAECOL, V31, P384, DOI 10.3109/01443615.2011.566389; Prakash J, 2010, RENAL FAILURE, V32, P309, DOI 10.3109/08860221003606265; Rasmussen S, 2007, HYPERTENSION, V49, P806, DOI 10.1161/01.HYP.0000259924.74947.aa; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P777, DOI 10.1016/0002-9378(90)91009-2; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Vikse BE, 2006, J AM SOC NEPHROL, V17, P837, DOI 10.1681/ASN.2005050492; Vikse BE, 2010, NEPHROL DIAL TRANSPL, V25, P3289, DOI 10.1093/ndt/gfq169; Wang IK, 2013, CAN MED ASSOC J, V185, P207, DOI 10.1503/cmaj.120230	15	35	37	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					104	106		10.1016/S0140-6736(13)60741-2	http://dx.doi.org/10.1016/S0140-6736(13)60741-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187JY	23727168				2022-12-24	WOS:000322115300005
J	Zhu, H; Wang, D; Kelvin, DJ; Li, L; Zheng, Z; Yoon, SW; Wong, SS; Farooqui, A; Wang, J; Banner, D; Chen, R; Zheng, R; Zhou, J; Zhang, Y; Hong, W; Dong, W; Cai, Q; Roehrl, MHA; Huang, SSH; Kelvin, AA; Yao, T; Zhou, B; Chen, X; Leung, GM; Poon, LLM; Webster, RG; Webby, RJ; Peiris, JSM; Guan, Y; Shu, Y				Zhu, H.; Wang, D.; Kelvin, D. J.; Li, L.; Zheng, Z.; Yoon, S. -W.; Wong, S. -S.; Farooqui, A.; Wang, J.; Banner, D.; Chen, R.; Zheng, R.; Zhou, J.; Zhang, Y.; Hong, W.; Dong, W.; Cai, Q.; Roehrl, M. H. A.; Huang, S. S. H.; Kelvin, A. A.; Yao, T.; Zhou, B.; Chen, X.; Leung, G. M.; Poon, L. L. M.; Webster, R. G.; Webby, R. J.; Peiris, J. S. M.; Guan, Y.; Shu, Y.			Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs	SCIENCE			English	Article							PATHOGENESIS; EVOLUTION	The emergence of the H7N9 influenza virus in humans in Eastern China has raised concerns that a new influenza pandemic could occur. Here, we used a ferret model to evaluate the infectivity and transmissibility of A/Shanghai/2/2013 (SH2), a human H7N9 virus isolate. This virus replicated in the upper and lower respiratory tracts of the ferrets and was shed at high titers for 6 to 7 days, with ferrets showing relatively mild clinical signs. SH2 was efficiently transmitted between ferrets via direct contact, but less efficiently by airborne exposure. Pigs were productively infected by SH2 and shed virus for 6 days but were unable to transmit the virus to naive pigs or ferrets. Under appropriate conditions, human-to-human transmission of the H7N9 virus may be possible.	[Zhu, H.; Li, L.; Zheng, Z.; Wang, J.; Chen, R.; Zheng, R.; Zhou, J.; Zhang, Y.; Hong, W.; Cai, Q.; Yao, T.; Guan, Y.] Shantou Univ, Joint Influenza Res Ctr SUMC HKU, Shantou, Peoples R China; [Zhu, H.; Zhou, J.; Zhou, B.; Chen, X.; Poon, L. L. M.; Peiris, J. S. M.; Guan, Y.] Shenzhen Third Peoples Hosp, State Key Lab Emerging Infect Dis, HKU Shenzhen Branch, Shenzhen, Peoples R China; [Zhu, H.; Wang, J.; Zhou, J.; Leung, G. M.; Poon, L. L. M.; Peiris, J. S. M.; Guan, Y.] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Kelvin, D. J.; Farooqui, A.; Dong, W.; Kelvin, A. A.] Shantou Univ Med Coll, Joint Vaccine Res Ctr SUMC UHN, Shantou, Peoples R China; [Kelvin, D. J.; Banner, D.; Roehrl, M. H. A.; Huang, S. S. H.; Kelvin, A. A.] Univ Hlth Network, Toronto, ON, Canada; [Kelvin, D. J.; Roehrl, M. H. A.; Huang, S. S. H.] Univ Toronto, Toronto, ON, Canada; [Yoon, S. -W.; Wong, S. -S.; Webster, R. G.; Webby, R. J.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Wang, D.] Natl Hlth & Family Planning Commiss, Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China	Shantou University; University of Hong Kong; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; St Jude Children's Research Hospital; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Guan, Y (corresponding author), Shantou Univ, Joint Influenza Res Ctr SUMC HKU, Shantou, Peoples R China.	yguan@hku.hk; yshu@cnic.org.cn	Zhu, Huachen/A-8252-2017; yoon, sun-woo/V-6285-2019; Webby, Richard J/N-5657-2018; Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Roehrl, Michael/AAU-8506-2020; LI, Loong/E-3107-2015	Zhu, Huachen/0000-0003-2711-0501; Poon, Leo Lit Man/0000-0002-9101-7953; Roehrl, Michael/0000-0003-4892-1098; LI, Loong/0000-0003-1670-4523; Bucalic, Leon/0000-0002-5913-0841; Leung, Gabriel/0000-0002-2503-6283; Guan, Yi/0000-0001-6057-9243; Farooqui, Amber/0000-0002-6031-9561	NIH (National Institute of Allergy and Infectious Diseases) [HSN266200700005C]; Li Ka Shing Foundation; Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR [AoE/M-12/06]; Shenzhen Peacock Plan High-End Talents Program [KQTD201203]; Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology [KJYJ-2013-01-01-01]	NIH (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Li Ka Shing Foundation; Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR; Shenzhen Peacock Plan High-End Talents Program; Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology	We gratefully acknowledge our colleagues from the Joint Influenza Research Center (SUMC/HKU) and the State Key Laboratory of Emerging Infectious Diseases for their excellent technical assistance and D. K. Smith for editorial assistance. This study was supported by the NIH (National Institute of Allergy and Infectious Diseases contract HSN266200700005C), Li Ka Shing Foundation, the Area of Excellence Scheme of the University Grants Committee of the Hong Kong SAR (grant AoE/M-12/06), Shenzhen Peacock Plan High-End Talents Program (KQTD201203), and Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology (no. KJYJ-2013-01-01-01 to Y.S.). The sequences generated by this study were deposited in GenBank under accession nos. KF0211594 to KF0211601; other data can be found in the supplementary materials.	Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Vijaykrishna D, 2011, NATURE, V473, P519, DOI 10.1038/nature10004; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07	16	248	277	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 12	2013	341	6142					183	186		10.1126/science.1239844	http://dx.doi.org/10.1126/science.1239844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23704376	Bronze			2022-12-24	WOS:000321965300045
J	Peterson, DC; Martin-Gill, C; Guyette, FX; Tobias, AZ; McCarthy, CE; Harrington, ST; Delbridge, TR; Yealy, DM				Peterson, Drew C.; Martin-Gill, Christian; Guyette, Francis X.; Tobias, Adam Z.; McCarthy, Catherine E.; Harrington, Scott T.; Delbridge, Theodore R.; Yealy, Donald M.			Outcomes of Medical Emergencies on Commercial Airline Flights	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIRCRAFT; AIR; DIVERSIONS; EXPERIENCE	BACKGROUND Worldwide, 2.75 billion passengers fly on commercial airlines annually. When in-flight medical emergencies occur, access to care is limited. We describe in-flight medical emergencies and the outcomes of these events. METHODS We reviewed records of in-flight medical emergency calls from five domestic and international airlines to a physician-directed medical communications center from January 1, 2008, through October 31, 2010. We characterized the most common medical problems and the type of on-board assistance rendered. We determined the incidence of and factors associated with unscheduled aircraft diversion, transport to a hospital, and hospital admission, and we determined the incidence of death. RESULTS There were 11,920 in-flight medical emergencies resulting in calls to the center (1 medical emergency per 604 flights). The most common problems were syncope or presyncope (37.4% of cases), respiratory symptoms (12.1%), and nausea or vomiting (9.5%). Physician passengers provided medical assistance in 48.1% of in-flight medical emergencies, and aircraft diversion occurred in 7.3%. Of 10,914 patients for whom postflight follow-up data were available, 25.8% were transported to a hospital by emergency-medical-service personnel, 8.6% were admitted, and 0.3% died. The most common triggers for admission were possible stroke (odds ratio, 3.36; 95% confidence interval [CI], 1.88 to 6.03), respiratory symptoms (odds ratio, 2.13; 95% CI, 1.48 to 3.06), and cardiac symptoms (odds ratio, 1.95; 95% CI, 1.37 to 2.77). CONCLUSIONS Most in-flight medical emergencies were related to syncope, respiratory symptoms, or gastrointestinal symptoms, and a physician was frequently the responding medical volunteer. Few in-flight medical emergencies resulted in diversion of aircraft or death; one fourth of passengers who had an in-flight medical emergency underwent additional evaluation in a hospital.	[Peterson, Drew C.; Martin-Gill, Christian; Guyette, Francis X.; Tobias, Adam Z.; McCarthy, Catherine E.; Harrington, Scott T.; Yealy, Donald M.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Delbridge, Theodore R.] E Carolina Univ, Brody Sch Med, Dept Emergency Med, Greenville, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; East Carolina University	Martin-Gill, C (corresponding author), Iroquois Bldg,Suite 400A,3600 Forbes Ave, Pittsburgh, PA 15261 USA.	martingillc2@upmc.edu	, Francis/AAE-1586-2022	Guyette, Francis/0000-0002-9151-4896	National Institutes of Health [UL1 RR024153, UL1 TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the National Institutes of Health (UL1 RR024153 and UL1 TR000005).; Funded by the National Institutes of Health.	[Anonymous], 2012, PASS NUMB REACH 2 75; [Anonymous], 2006, POL AC 121 33B EM ME; [Anonymous], 2009, OBSTET GYNECOL, V114, P954; Baltsezak S, 2008, J TRAVEL MED, V15, P391, DOI 10.1111/j.1708-8305.2008.00233.x; Brown AM, 2010, PREHOSP EMERG CARE, V14, P235, DOI 10.3109/10903120903572319; CUMMINS RO, 1989, JAMA-J AM MED ASSOC, V261, P1295, DOI 10.1001/jama.261.9.1295; DeJohn CA, 2000, EVALUATION IN FLIGHT; Delaune EF, 2003, AVIAT SPACE ENVIR MD, V74, P62; HORDINSKY JR, 1989, AVIAT SPACE ENVIR MD, V60, P1211; Hung KKC, 2010, ARCH INTERN MED, V170, P1401, DOI 10.1001/archinternmed.2010.267; Moore BR, 2005, PEDIATR EMERG CARE, V21, P725, DOI 10.1097/01.pec.0000186424.84764.94; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; RODENBERG H, 1987, ANN EMERG MED, V16, P1373, DOI 10.1016/S0196-0644(87)80422-5; Sand M, 2009, CRIT CARE, V13, DOI 10.1186/cc7690; Shepherd B, 2006, J ROY SOC MED, V99, P628, DOI 10.1258/jrsm.99.12.628; Szmajer M, 2001, RESUSCITATION, V50, P147, DOI 10.1016/S0300-9572(01)00347-1; TranStats: Research and Innovative Technology Administration Bureau of Transportation Statistics, LOAD FACT PASS MIL P	17	144	145	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2075	2083		10.1056/NEJMoa1212052	http://dx.doi.org/10.1056/NEJMoa1212052			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23718164	Bronze, Green Accepted			2022-12-24	WOS:000319574200005
J	DeWeerdt, S				DeWeerdt, Sarah			MOOD DISORDERS The dark night	NATURE			English	Editorial Material							SLEEP-DEPRIVATION; DEPRESSION; INSOMNIA; BRAIN; SYMPTOMS											Colombo C, 1999, PSYCHIAT RES, V86, P267, DOI 10.1016/S0165-1781(99)00036-0; Gillin JC, 2001, DEPRESS ANXIETY, V14, P37, DOI 10.1002/da.1045; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Landsness EC, 2011, J PSYCHIATR RES, V45, P1019, DOI 10.1016/j.jpsychires.2011.02.003; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Szklo-Coxe M, 2010, AM J EPIDEMIOL, V171, P709, DOI 10.1093/aje/kwp454; Troxel WM, 2012, J CLIN PSYCHIAT, V73, P478, DOI 10.4088/JCP.11m07184; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007	9	11	11	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S14	S15		10.1038/497S14a	http://dx.doi.org/10.1038/497S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698502	Bronze			2022-12-24	WOS:000319254000008
J	Moosmann, J; Ershov, A; Altapova, V; Baumbach, T; Prasad, MS; LaBonne, C; Xiao, XH; Kashef, J; Hofmann, R				Moosmann, Julian; Ershov, Alexey; Altapova, Venera; Baumbach, Tilo; Prasad, Maneeshi S.; LaBonne, Carole; Xiao, Xianghui; Kashef, Jubin; Hofmann, Ralf			X-ray phase-contrast in vivo microtomography probes new aspects of Xenopus gastrulation	NATURE			English	Article							SYNCHROTRON-RADIATION; EMBRYONIC-DEVELOPMENT; IMAGE-ANALYSIS; OPTICAL-FLOW; BOTTLE CELLS; LAEVIS; MICROSCOPY; INTERNALIZATION; EXTENSION; MOVEMENT	An ambitious goal in biology is to understand the behaviour of cells during development by imaging-in vivo and with subcellular resolution-changes of the embryonic structure. Important morphogenetic movements occur throughout embryogenesis, but in particular during gastrulation when a series of dramatic, coordinated cell movements drives the reorganization of a simple ball or sheet of cells into a complex multi-layered organism(1). In Xenopus laevis, the South African clawed frog and also in zebrafish, cell and tissue movements have been studied in explants(2,3), in fixed embryos(4), in vivo using fluorescence microscopy(5,6) or microscopic magnetic resonance imaging(7). None of these methods allows cell behaviours to be observed with micrometre-scale resolution throughout the optically opaque, living embryo over developmental time. Here we use non-invasive in vivo, time-lapse X-ray microtomography, based on single-distance phase contrast and combined with motion analysis, to examine the course of embryonic development. We demonstrate that this powerful four-dimensional imaging technique provides high-resolution views of gastrulation processes in wildtype X. laevis embryos, including vegetal endoderm rotation, archenteron formation, changes in the volumes of cavities within the porous interstitial tissue between archenteron and blastocoel, migration/confrontation of mesendoderm and closure of the blastopore. Differential flow analysis separates collective from relative cell motion to assign propulsion mechanisms. Moreover, digitally determined volume balances confirm that early archenteron inflation occurs through the uptake of external water. A transient ectodermal ridge, formed in association with the confrontation of ventral and head mesendoderm on the blastocoel roof, is identified. When combined with perturbation experiments to investigate molecular and biomechanical underpinnings of morphogenesis, our technique should help to advance our understanding of the fundamentals of development.	[Moosmann, Julian; Ershov, Alexey; Baumbach, Tilo; Hofmann, Ralf] Karlsruhe Inst Technol, Inst Photon Sci & Synchrotron Radiat, D-76344 Eggenstein Leopoldshafen, Germany; [Ershov, Alexey] Natl Res Tomsk Polytech Univ, Inst Phys & Technol, Dept Gen Phys, Tomsk 634050, Russia; [Altapova, Venera; Baumbach, Tilo] Karlsruhe Inst Technol, Lab Applicat Synchrotron Radiat, D-76128 Karlsruhe, Germany; [Prasad, Maneeshi S.; LaBonne, Carole] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Xiao, Xianghui] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Kashef, Jubin] Karlsruhe Inst Technol, Inst Zool 2, D-76131 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Tomsk Polytechnic University; Helmholtz Association; Karlsruhe Institute of Technology; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Helmholtz Association; Karlsruhe Institute of Technology	Hofmann, R (corresponding author), Karlsruhe Inst Technol, Inst Photon Sci & Synchrotron Radiat, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.	jubin.kashef@kit.edu; ralf.hofmann2@kit.edu	Moosmann, Julian/D-7075-2013; Baumbach, Tilo Gerd/K-5355-2013; Weinhardt, Venera/T-3932-2017	Moosmann, Julian/0000-0002-6761-7182; Weinhardt, Venera/0000-0002-9774-3833; Ershov, Alexey/0000-0002-5774-5068	US DOE [DE-AC02-06CH11357]; Karlsruhe Institute of Technology within the framework of the German Excellence Initiative; German Federal Ministry of Education and Research [05K12CK2, 05K12VH1]; NATIONAL CANCER INSTITUTE [R01CA114058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077288] Funding Source: NIH RePORTER	US DOE(United States Department of Energy (DOE)); Karlsruhe Institute of Technology within the framework of the German Excellence Initiative; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge discussions with J. Wittbrodt, H. Stein beisser, R. Winklbauer and D. Moss. R. Keller and D. Shook helped us with interpreting the data. D. Wedlich and M. Kohl commented on the manuscript. Discussions with M. Kohl on data analysis are gratefully acknowledged. We also would like to thank T. van de Kamp and D. Karpov for their help visualising the set-up, as well as F. de Carlo and K. Fezza for allocating beamtime at 2-BM-B station and at 32-ID, respectively, of Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under Contract No. DE-AC02-06CH11357. E. Becker, C. Huang, A. Merks and R. Langhe helped analysing blastopore radii. J.K.'s Young Investigator Group received financial support from the 'Concept for the Future' programme of Karlsruhe Institute of Technology within the framework of the German Excellence Initiative. This research partially was funded by the German Federal Ministry of Education and Research under grant numbers 05K12CK2 and 05K12VH1.	Baker S, 2011, INT J COMPUT VISION, V92, P1, DOI 10.1007/s11263-010-0390-2; Blanchard GB, 2011, CURR OPIN GENET DEV, V21, P653, DOI 10.1016/j.gde.2011.08.008; Brox T, 2004, LECT NOTES COMPUT SC, V2034, P25, DOI 10.1007/978-3-540-24673-2_3; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; Cloetens P, 1999, J PHYS D APPL PHYS, V32, pA145, DOI 10.1088/0022-3727/32/10A/330; Damm EW, 2011, DEVELOPMENT, V138, P565, DOI 10.1242/dev.056903; Deans S. R., 1983, RADON TRANSFORM SOME; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Ewald AJ, 2004, DEVELOPMENT, V131, P6195, DOI 10.1242/dev.01542; Ewald AJ, 2002, DEV DYNAM, V225, P369, DOI 10.1002/dvdy.10169; Greger K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2428277; HARDIN J, 1988, DEVELOPMENT, V103, P211; Hofmann R, 2011, OPT EXPRESS, V19, P25881, DOI 10.1364/OE.19.025881; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; KELLER R, 1988, DEVELOPMENT, V103, P193; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; KELLER RE, 1981, J EXP ZOOL, V216, P81, DOI 10.1002/jez.1402160109; Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961; Paganin D, 1998, PHYS REV LETT, V80, P2586, DOI 10.1103/PhysRevLett.80.2586; Papan C, 2001, DEV BIOL, V235, P189; Rohani N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000597; Ruffins SW, 2002, CURR OPIN NEUROBIOL, V12, P580, DOI 10.1016/S0959-4388(02)00366-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; TUFT PH, 1962, J EXP BIOL, V39, P1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; WEISZ PB, 1945, ANAT REC, V93, P161, DOI 10.1002/ar.1090930207; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Winklbauer R, 1999, DEVELOPMENT, V126, P3703	34	67	67	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					374	+		10.1038/nature12116	http://dx.doi.org/10.1038/nature12116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23676755	Green Accepted			2022-12-24	WOS:000318952000039
J	Sampson, TR; Saroj, SD; Llewellyn, AC; Tzeng, YL; Weiss, DS				Sampson, Timothy R.; Saroj, Sunil D.; Llewellyn, Anna C.; Tzeng, Yih-Ling; Weiss, David S.			A CRISPR/Cas system mediates bacterial innate immune evasion and virulence	NATURE			English	Article							FRANCISELLA-TULARENSIS; CAS SYSTEMS; SMALL RNAS; DNA; DEFENSE; BACTERIOPHAGE; IDENTIFICATION; LIPOPROTEINS; RECOGNITION; EVOLUTION	CRISPR/Cas (clustered regularly interspaced palindromic repeats/CRISPR-associated) systems are a bacterial defence against invading foreign nucleic acids derived from bacteriophages or exogenous plasmids(1-4). These systems use an array of small CRISPR RNAs (crRNAs) consisting of repetitive sequences flanking unique spacers to recognize their targets, and conserved Cas proteins to mediate target degradation(5-8). Recent studies have suggested that these systems may have broader functions in bacterial physiology, and it is unknown if they regulate expression of endogenous genes(9,10). Here we demonstrate that the Cas protein Cas9 of Francisella novicida uses a unique, small, CRISPR/Cas-associated RNA (scaRNA) to repress an endogenous transcript encoding a bacterial lipoprotein. As bacterial lipoproteins trigger a proinflammatory innate immune response aimed at combating pathogens(11,12), CRISPR/Cas-mediated repression of bacterial lipoprotein expression is critical for F. novicida to dampen this host response and promote virulence. Because Cas9 proteins are highly enriched in pathogenic and commensal bacteria, our work indicates that CRISPR/Cas-mediated gene regulation may broadly contribute to the regulation of endogenous bacterial genes, particularly during the interaction of such bacteria with eukaryotic hosts.	[Sampson, Timothy R.; Llewellyn, Anna C.] Emory Univ, Dept Microbiol & Immunol, Microbiol & Mol Genet Program, Atlanta, GA 30329 USA; [Sampson, Timothy R.; Llewellyn, Anna C.; Weiss, David S.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Sampson, Timothy R.; Llewellyn, Anna C.; Weiss, David S.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Saroj, Sunil D.; Tzeng, Yih-Ling; Weiss, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30329 USA	Emory University; Emory University; Emory University; Emory University	Weiss, DS (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.	david.weiss@emory.edu	Saroj, Sunil/R-8113-2019; Sampson, Tim/B-9061-2013	Saroj, Sunil D/0000-0002-8071-2731; Llewellyn, Anna/0000-0001-6712-7477; Sampson, Timothy/0000-0002-2486-8766	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54-AI057157]; NSF Graduate Research Fellowship; ARCS Foundation;  [R56-AI87673];  [R56-AI061031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061031, U54AI057157, R56AI087673] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); ARCS Foundation; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank R. Ahmed, G. Conn, C. Dunham, C. Moran, B. Napier, D. S. Stephens and the Stephens laboratory, and M. Swanson for discussions and critical reading of this manuscript. The project described was supported by National Institutes of Health (NIH) grant U54-AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense and R56-AI87673 to D. S. W., and R56-AI061031 to Y.-L.T. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. T. R. S. was supported by the NSF Graduate Research Fellowship, as well as the ARCS Foundation. T. R. S. and D. S. W. have filed a related provisional patent.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Bryksin AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013244; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; JANIK A, 1976, J CLIN MICROBIOL, V4, P71; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones CL, 2012, CELL MICROBIOL, V14, P1531, DOI 10.1111/j.1462-5822.2012.01816.x; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Kumar P, 2011, MOL MICROBIOL, V79, P1557, DOI 10.1111/j.1365-2958.2011.07546.x; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Louwen R, 2013, EUR J CLIN MICROBIOL, V32, P207, DOI 10.1007/s10096-012-1733-4; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MENARD R, 1993, J BACTERIOL, V175, P5899; Postic G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041999; Postic G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-625; Schaible UE, 2002, METHOD MICROBIOL, V31, P343, DOI 10.1016/S0580-9517(02)31020-1; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	32	279	339	12	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					254	+		10.1038/nature12048	http://dx.doi.org/10.1038/nature12048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23584588	Green Accepted			2022-12-24	WOS:000318558200039
J	Horby, P				Horby, Peter			H7N9 is a virus worth worrying about	NATURE			English	Editorial Material									Univ Oxford, Clin Res Unit, Wellcome Trust Programme Vietnam & Singapore Infe, Oxford OX1 2JD, England	University of Oxford	Horby, P (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Programme Vietnam & Singapore Infe, Oxford OX1 2JD, England.	phorby@oucru.org	Hay, Simon Iain/F-8967-2015	Hay, Simon Iain/0000-0002-0611-7272; Tatem, Andrew/0000-0002-7270-941X; Horby, Peter/0000-0002-9822-1586	Wellcome Trust [093724, 095066, 089276] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	38	48	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					399	399		10.1038/496399a	http://dx.doi.org/10.1038/496399a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131HU	23619655	Bronze, Green Published			2022-12-24	WOS:000317984400004
J	Rosell, R				Rosell, Rafael			Mediating Resistance in Oncogene-Driven Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TGF-BETA RECEPTOR; LUNG-CANCER		[Rosell, Rafael] Catalan Inst Oncol, Badalona, Spain; [Rosell, Rafael] Dexeus Univ Inst, Pangaea Biotech, Breakthrough Canc Res Unit, Barcelona, Spain	Catalan Institute of Oncology	Rosell, R (corresponding author), Catalan Inst Oncol, Badalona, Spain.							Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Yang X, 2012, P NATL ACAD SCI USA, V109, pE2813, DOI 10.1073/pnas.1204311109	5	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1551	1552		10.1056/NEJMcibr1214549	http://dx.doi.org/10.1056/NEJMcibr1214549			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126HC	23594009				2022-12-24	WOS:000317603300016
J	McGuire, AL; Joffe, S; Koenig, BA; Biesecker, BB; McCullough, LB; Blumenthal-Barby, JS; Caulfield, T; Terry, SF; Green, RC				McGuire, Amy L.; Joffe, Steven; Koenig, Barbara A.; Biesecker, Barbara B.; McCullough, Laurence B.; Blumenthal-Barby, Jennifer S.; Caulfield, Timothy; Terry, Sharon F.; Green, Robert C.			Ethics and Genomic Incidental Findings	SCIENCE			English	Editorial Material									[McGuire, Amy L.; McCullough, Laurence B.; Blumenthal-Barby, Jennifer S.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Joffe, Steven] Harvard Univ, Dana Farber Canc Inst, Boston Childrens Hosp, Sch Med,Dept Pediat Oncol,Dept Med, Boston, MA 02215 USA; [Koenig, Barbara A.] Univ Calif San Francisco, Inst Hlth & Aging, Dept Anthropol Hist & Social Med, Dept Social & Behav Sci, San Francisco, CA 94143 USA; [Biesecker, Barbara B.] NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Terry, Sharon F.] Genet Alliance, Washington, DC 20008 USA; [Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Green, Robert C.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Baylor College of Medicine; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alberta; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	amcguire@bcm.edu; steven_joffe@dfci.harvard.edu	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384; Biesecker, Barbara/0000-0001-9665-8963	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA154517, R01-CA154517, R01 CA154517] Funding Source: Medline; NHGRI NIH HHS [R01 HG003178, R01 HG006615, HG006485, HG02213, R01 HG002213, HG006615, R01 HG005092, U01 HG006500, HG006500, R21 HG006612, U01 HG006485, HG003178, HG005092, HG006612-02, U01 HG006492, P20 HG007243, HG006492] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA154517] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006615, R01HG002213, P20HG007243, U01HG006485, R21HG006612, U01HG006500, R01HG005092, U01HG006492, R01HG003178] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ACMG, 2013, GENET MED; Allyse M, 2013, TRENDS BIOTECHNOL, V31, P439, DOI 10.1016/j.tibtech.2013.04.006; Faden R., 1986, HIST THEORY INFORM C; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Green R. C., 2013, GENET MED; Green RC, 2013, GENOMIC AND PERSONALIZED MEDICINE, VOL 1-2, 2ND EDITION, P102, DOI 10.1016/B978-0-12-382227-7.00009-4; McGuire AL, 2013, JAMA-J AM MED ASSOC, V309, P1465, DOI 10.1001/jama.2013.1438; McGuire AL, 2012, J LAW MED ETHICS, V40, P1040, DOI 10.1111/j.1748-720X.2012.00731.x; NHGRI, 2012, CLIN SEQ EXPL RES; Rhodes R, 1998, J MED PHILOS, V23, P10, DOI 10.1076/jmep.23.1.10.2594; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119	11	135	136	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1047	1048		10.1126/science.1240156	http://dx.doi.org/10.1126/science.1240156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23686340	Green Accepted			2022-12-24	WOS:000319664500024
J	Spence, D				Spence, Des			Bad medicine: epilepsy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; SUDDEN UNEXPECTED DEATH; LAMOTRIGINE; TOPIRAMATE; SANAD					destwo@yahoo.co.uk						[Anonymous], 2012, TELEGRAPH; Beghi E, 2003, EPILEPSY RES, V57, P1, DOI 10.1016/j.eplepsyres.2003.09.007; Cohen SA, 2012, J PAEDIATR CHILD H, V48, P490, DOI 10.1111/j.1440-1754.2011.02223.x; Department of Justice, 2004, WARN LAMB PAY 430 MI; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Hixson JD, 2010, CURR TREAT OPTION NE, V12, P434, DOI 10.1007/s11940-010-0083-8; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Meeraus WH, 2013, ARCH DIS CHILD, V98, P195, DOI 10.1136/archdischild-2012-302237; National Institute for Health and Care Excellence, 2012, NICE CLIN GUID; Ryvlin P, 2011, LANCET NEUROL, V10, P961, DOI 10.1016/S1474-4422(11)70193-4; Scottish Intercollegiate Guideline Network Guidelines, 2005, SCOTT INT GUID NETW; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; US Department of Justice Office of Public Affairs, 2011, US SUBS BELG PHARM M; US Department of Justice Office of Public Affairs, 2010, 2 JOHNS JOHNS SUBS P; Wilson D., 2010, NY TIMES	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f3396	10.1136/bmj.f3396	http://dx.doi.org/10.1136/bmj.f3396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158CZ	23714678				2022-12-24	WOS:000319947500015
J	Magnus, D; Caplan, AL				Magnus, David; Caplan, Arthur L.			Risk, Consent, and SUPPORT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Magnus, David] Stanford Univ, Ctr Biomed Eth, Stanford, CA 94305 USA; [Caplan, Arthur L.] NYU, Langone Med Ctr, Div Med Eth, New York, NY USA	Stanford University; New York University; NYU Langone Medical Center	Magnus, D (corresponding author), Stanford Univ, Ctr Biomed Eth, Stanford, CA 94305 USA.							Carlo WA, 2013, NEW ENGL J MED, V368, P1949, DOI 10.1056/NEJMc1304827; Drazen JM, 2013, NEW ENGL J MED, V368, P1929, DOI 10.1056/NEJMe1304996; Fiore LD, 2011, CLIN TRIALS, V8, P183, DOI [10.1177/1740774510395635, 10.1177/1740774511398368]; Greenspan JS, 2006, PEDIATRICS, V118, P1740, DOI 10.1542/peds.2006-1834; Silverman WA, 1980, RETROLENAL FIBROPLAS	5	46	46	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1864	1865		10.1056/NEJMp1305086	http://dx.doi.org/10.1056/NEJMp1305086			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143VK	23597408				2022-12-24	WOS:000318896200005
J	Mossadegh-Keller, N; Sarrazin, S; Kandalla, PK; Espinosa, L; Stanley, ER; Nutt, SL; Moore, J; Sieweke, MH				Mossadegh-Keller, Noushine; Sarrazin, Sandrine; Kandalla, Prashanth K.; Espinosa, Leon; Stanley, E. Richard; Nutt, Stephen L.; Moore, Jordan; Sieweke, Michael H.			M-CSF instructs myeloid lineage fate in single haematopoietic stem cells	NATURE			English	Article							PROGENITOR CELLS; IN-VIVO; COMMITMENT; MACROPHAGE; DIVERSIFICATION; INFECTION; HIERARCHY; CYTOKINES; CHOICE; MICE	Under stress conditions such as infection or inflammation the body rapidly needs to generate new blood cells that are adapted to the challenge. Haematopoietic cytokines are known to increase output of specific mature cells by affecting survival, expansion and differentiation of lineage-committed progenitors(1,2), but it has been debated whether long-term haematopoietic stem cells (HSCs) are susceptible to direct lineage-specifying effects of cytokines. Although genetic changes in transcription factor balance can sensitize HSCs to cytokine instruction(3), the initiation of HSC commitment is generally thought to be triggered by stochastic fluctuation in cell-intrinsic regulators such as lineage-specific transcription factors(4-7), leaving cytokines to ensure survival and proliferation of the progeny cells(8,9). Here we show that macrophage colony-stimulating factor (M-CSF, also called CSF1), a myeloid cytokine released during infection and inflammation, can directly induce the myeloid master regulator PU.1 and instruct myeloid cell-fate change in mouse HSCs, independently of selective survival or proliferation. Video imaging and single-cell gene expression analysis revealed that stimulation of highly purified HSCs with M-CSF in culture resulted in activation of the PU.1 promoter and an increased number of PU.1(+) cells with myeloid gene signature and differentiation potential. In vivo, high systemic levels of M-CSF directly stimulated M-CSF-receptor-dependent activation of endogenous PU.1 protein in single HSCs and induced a PU.1-dependent myeloid differentiation preference. Our data demonstrate that lineage-specific cytokines can act directly on HSCs in vitro and in vivo to instruct a change of cell identity. This fundamentally changes the current view of how HSCs respond to environmental challenge and implicates stress-induced cytokines as direct instructors of HSC fate.	[Mossadegh-Keller, Noushine; Sarrazin, Sandrine; Kandalla, Prashanth K.; Sieweke, Michael H.] Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM2, F-13288 Marseille 09, France; [Mossadegh-Keller, Noushine; Sarrazin, Sandrine; Kandalla, Prashanth K.; Sieweke, Michael H.] INSERM, U1104, F-13288 Marseille 09, France; [Mossadegh-Keller, Noushine; Sarrazin, Sandrine; Kandalla, Prashanth K.; Sieweke, Michael H.] CNRS, UMR7280, F-13288 Marseille 09, France; [Espinosa, Leon] CNRS, Chim Bacterienne Lab, UMR 7283, F-13009 Marseille, France; [Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Moore, Jordan] Fluidigm Corp, San Francisco, CA 94080 USA; [Sieweke, Michael H.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Yeshiva University; Albert Einstein College of Medicine; Walter & Eliza Hall Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sieweke, MH (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM2, Campus Luminy,Case 906, F-13288 Marseille 09, France.	sarrazin@ciml.univ-mrs.fr; sieweke@ciml.univ-mrs.fr	Stanley, Evan R/J-9154-2013; Nutt, Stephen L/C-9256-2013; Sieweke, Michael/AAR-7515-2020; Espinosa, Leon/V-8410-2017	Stanley, Evan R/0000-0002-2910-2065; Nutt, Stephen L/0000-0002-0020-6637; Sieweke, Michael/0000-0002-3228-9537; Mossadegh-Keller, Noushin/0000-0002-7088-3676	Association pour la recherche sur le Cancer [3422]; Agence nationale de la Recherche [BLAN07-1_205752]; NIH [CA 32551]; NATIONAL CANCER INSTITUTE [R01CA032551] Funding Source: NIH RePORTER	Association pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge grants from the 'Association pour la recherche sur le Cancer' (3422) and the 'Agence nationale de la Recherche' (BLAN07-1_205752). We thank P. Kastner and S. Chan for PU.1-GFP reporter mice; T. P. VuManh and J. Maurizio for bioinformatics; M. Barad, A. Zouine and M.-L. Thibult for flow cytometry support; L. Razafindramanana for animal handling; and J. Favret, P. Perrin and L. Chasson for tissue sectioning. E. R. S. is supported by NIH grant CA 32551. S.L.N. is an Australian Research Council Future Fellow and received Victorian State Government Operational and Australian Government NHMRC Independent Research Institute Infrastructure Support. M. H. S. is a 'Fondation pour la Recherche Medicale' (DEQ20071210559; DEQ20110421320) and INSERM-Helmholtz group leader.	Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; CHEERS C, 1988, INFECT IMMUN, V56, P2972, DOI 10.1128/IAI.56.11.2972-2978.1988; CHEERS C, 1988, INFECT IMMUN, V56, P247, DOI 10.1128/IAI.56.1.247-251.1988; Cross MA, 1997, CURR OPIN GENET DEV, V7, P609, DOI 10.1016/S0959-437X(97)80007-X; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Metcalf D, 2007, IMMUNITY, V26, P669, DOI 10.1016/j.immuni.2007.05.012; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Niu C, 2009, BLOOD, V114, P2087, DOI 10.1182/blood-2009-01-197921; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; R Development Core Team, 2012, R LANG ENV STAT COMP; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Roth P, 1997, J IMMUNOL, V158, P3874; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/NMETH.1577, 10.1038/nmeth.1577]; Socolovsky M, 1998, P NATL ACAD SCI USA, V95, P6573, DOI 10.1073/pnas.95.12.6573; Sudo T, 1995, ONCOGENE, V11, P2469; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29	37	237	241	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					239	+		10.1038/nature12026	http://dx.doi.org/10.1038/nature12026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23575636	Green Accepted			2022-12-24	WOS:000318558200036
J	Dulcis, D; Jamshidi, P; Leutgeb, S; Spitzer, NC				Dulcis, Davide; Jamshidi, Pouya; Leutgeb, Stefan; Spitzer, Nicholas C.			Neurotransmitter Switching in the Adult Brain Regulates Behavior	SCIENCE			English	Article							FAT SAND RAT; TYROSINE-HYDROXYLASE; RECEPTOR SUBTYPES; DOPAMINE; SOMATOSTATIN; NUCLEUS; HYPOTHALAMUS; EXPRESSION; DEPRESSION; NEURONS	Neurotransmitters have been thought to be fixed throughout life, but whether sensory stimuli alter behaviorally relevant transmitter expression in the mature brain is unknown. We found that populations of interneurons in the adult rat hypothalamus switched between dopamine and somatostatin expression in response to exposure to short- and long-day photoperiods. Changes in postsynaptic dopamine receptor expression matched changes in presynaptic dopamine, whereas somatostatin receptor expression remained constant. Pharmacological blockade or ablation of these dopaminergic neurons led to anxious and depressed behavior, phenocopying performance after exposure to the long-day photoperiod. Induction of newly dopaminergic neurons through exposure to the short-day photoperiod rescued the behavioral consequences of lesions. Natural stimulation of other sensory modalities may cause changes in transmitter expression that regulate different behaviors.	[Dulcis, Davide; Jamshidi, Pouya; Leutgeb, Stefan; Spitzer, Nicholas C.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Dulcis, Davide; Jamshidi, Pouya; Leutgeb, Stefan; Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Dulcis, Davide; Leutgeb, Stefan; Spitzer, Nicholas C.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dulcis, D (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	ddulcis@gmail.com	Dulcis, Davide/GSN-9883-2022	Spitzer, Nicholas/0000-0002-3523-1103; Dulcis, Davide/0000-0003-4672-7996	Ellison Medical Foundation [AG-SS-2432-10, AG-NS-0724-10]; W. M. Keck Foundation grant	Ellison Medical Foundation(Lawrence Ellison Foundation); W. M. Keck Foundation grant	We thank D. Berg, M. Gorman, and M. Scanziani for comments on the manuscript; H. Karten and A. Brzozowska-Prechtl for their expert advice on hypothalamic neuroanatomy and immunostaining protocols; Y. Zou and K. Onishi for technical help with FFN511 confocal imaging; and U. Kumar for a generous gift of SST receptor and CRF antibodies. We are grateful to M. I. Bharmal and M. Kucharski for stereological quantification and A. Guemez-Gamboa for the CRF-immunoassay. This work was supported by Ellison Medical Foundation grants AG-SS-2432-10 to N.C.S. and D. D., AG-NS-0724-10 to S. L., and a W. M. Keck Foundation grant to N.C.S. and D. D. We declare no conflict of interest. The data are included in the main article and in the supplementary materials.	Arancibia S, 2000, EXP BRAIN RES, V134, P261, DOI 10.1007/s002210000462; Ashkenazy T, 2009, INT J NEUROPSYCHOPH, V12, P83, DOI 10.1017/S1461145708009115; Aumann TD, 2011, J NEUROCHEM, V116, P646, DOI 10.1111/j.1471-4159.2010.07151.x; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; BJORKLUND A, 1975, BRAIN RES, V89, P29, DOI 10.1016/0006-8993(75)90131-6; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; BUIJS RM, 1993, J COMP NEUROL, V335, P42, DOI 10.1002/cne.903350104; CUMMINGS S, 1983, J NEUROSCI, V3, P1355; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Dulcis D, 2012, DEV NEUROBIOL, V72, P465, DOI 10.1002/dneu.20920; Eagle DM, 2011, J NEUROSCI, V31, P7349, DOI 10.1523/JNEUROSCI.6182-10.2011; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Gubernator NG, 2009, SCIENCE, V324, P1441, DOI 10.1126/science.1172278; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Jeanneteau FD, 2012, P NATL ACAD SCI USA, V109, P1305, DOI 10.1073/pnas.1114122109; Kageyama K, 2009, ENDOCR J, V56, P335, DOI 10.1507/endocrj.K09E-075; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krivisky K, 2011, NEUROPSYCHOBIOLOGY, V63, P191, DOI 10.1159/000321805; Kumar U, 2007, J COMP NEUROL, V504, P185, DOI 10.1002/cne.21444; Lam RW, 2006, AM J PSYCHIAT, V163, P805, DOI 10.1176/appi.ajp.163.5.805; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; SAKANAKA M, 1990, BRAIN RES, V516, P313, DOI 10.1016/0006-8993(90)90933-3; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Swanson L., 2011, HDB PHYSL S4, P317; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44	41	178	179	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					449	453		10.1126/science.1234152	http://dx.doi.org/10.1126/science.1234152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620046				2022-12-24	WOS:000318016700034
J	Farroni, JS; Zwelling, L; Cortes, J; Kantarjian, H				Farroni, Jeffrey S.; Zwelling, Leonard; Cortes, Jorge; Kantarjian, Hagop			Saving Medicare through Patient-Centered Changes - The Case of Injectables	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Farroni, Jeffrey S.] Univ Texas MD Anderson Canc Ctr, Dept Crit Care, Houston, TX 77030 USA; [Zwelling, Leonard] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Cortes, Jorge; Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Farroni, JS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Crit Care, Houston, TX 77030 USA.			Cortes, Jorge/0000-0002-8636-1071	NCI NIH HHS [P30 CA016672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach P, 2012, NY TIMES; Centers for Medicare & Medicaid Services, CMS PUB, V10-02; Goldberg SL, 2010, J CLIN ONCOL, V28, P2847, DOI 10.1200/JCO.2009.25.2395; Himmelstein DU, 2012, ARCH INTERN MED, V172, P1764, DOI 10.1001/2013.jamainternmed.272	4	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1572	1573		10.1056/NEJMp1213485	http://dx.doi.org/10.1056/NEJMp1213485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130YK	23614583				2022-12-24	WOS:000317956300005
J	Sauaia, A; Miller, JI; Moore, EE; Partrick, D				Sauaia, Angela; Miller, Joshua I.; Moore, Ernest E.; Partrick, David			Firearm Injuries of Children and Adolescents in 2 Colorado Trauma Centers: 2000-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sauaia, Angela; Miller, Joshua I.] Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Denver, CO USA; [Partrick, David] Childrens Hosp Colorado, Denver, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Denver Health Medical Center; Children's Hospital Colorado	Sauaia, A (corresponding author), Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA.	angela.sauaia@ucdenver.edu						ANNEST JL, 1995, JAMA-J AM MED ASSOC, V273, P1749, DOI 10.1001/jama.273.22.1749; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Eber GB, 2004, PEDIATRICS, V113, P1686, DOI 10.1542/peds.113.6.1686; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Kellermann AL, 2013, JAMA-J AM MED ASSOC, V309, P549, DOI 10.1001/jama.2012.208207; Senger C, 2011, J PEDIATR SURG, V46, P927, DOI 10.1016/j.jpedsurg.2011.02.032	6	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1683	1685		10.1001/jama.2013.3354	http://dx.doi.org/10.1001/jama.2013.3354			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613070	Bronze			2022-12-24	WOS:000317906700019
J	Tachibana, M; Amato, P; Sparman, M; Gutierrez, NM; Tippner-Hedges, R; Ma, H; Kang, EJ; Fulati, A; Lee, HS; Sritanaudomchai, H; Masterson, K; Larson, J; Eaton, D; Sadler-Fredd, K; Battaglia, D; Lee, D; Wu, DA; Jensen, J; Patton, P; Gokhale, S; Stouffer, RL; Wolf, D; Mitalipov, S				Tachibana, Masahito; Amato, Paula; Sparman, Michelle; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Ma, Hong; Kang, Eunju; Fulati, Alimujiang; Lee, Hyo-Sang; Sritanaudomchai, Hathaitip; Masterson, Keith; Larson, Janine; Eaton, Deborah; Sadler-Fredd, Karen; Battaglia, David; Lee, David; Wu, Diana; Jensen, Jeffrey; Patton, Phillip; Gokhale, Sumita; Stouffer, Richard L.; Wolf, Don; Mitalipov, Shoukhrat			Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer	CELL			English	Article							PREIMPLANTATION DEVELOPMENT; TRICHOSTATIN-A; OOCYTES; CLONING; NUMBER; ACTIVATION; PRIMATES; MOUSE; MG132; IVF	Reprogramming somatic cells into pluripotent embryonic stem cells (ESCs) by somatic cell nuclear transfer (SCNT) has been envisioned as an approach for generating patient-matched nuclear transfer (NT)-ESCs for studies of disease mechanisms and for developing specific therapies. Past attempts to produce human NT-ESCs have failed secondary to early embryonic arrest of SCNT embryos. Here, we identified premature exit from meiosis in human oocytes and suboptimal activation as key factors that are responsible for these outcomes. Optimized SCNT approaches designed to circumvent these limitations allowed derivation of human NT-ESCs. When applied to premium quality human oocytes, NT-ESC lines were derived from as few as two oocytes. NT-ESCs displayed normal diploid karyotypes and inherited their nuclear genome exclusively from parental somatic cells. Gene expression and differentiation profiles in human NT-ESCs were similar to embryo-derived ESCs, suggesting efficient reprogramming of somatic cells to a pluripotent state.	[Tachibana, Masahito; Sparman, Michelle; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Ma, Hong; Kang, Eunju; Fulati, Alimujiang; Lee, Hyo-Sang; Jensen, Jeffrey; Stouffer, Richard L.; Wolf, Don; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Amato, Paula; Masterson, Keith; Larson, Janine; Eaton, Deborah; Sadler-Fredd, Karen; Battaglia, David; Lee, David; Wu, Diana; Patton, Phillip; Stouffer, Richard L.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, Portland, OR 97239 USA; [Sritanaudomchai, Hathaitip] Mahidol Univ, Fac Dent, Dept Oral Biol, Bangkok 10400, Thailand; [Jensen, Jeffrey] Oregon Hlth & Sci Univ, Womens Hlth Res Unit, Portland, OR 97239 USA; [Gokhale, Sumita] Boston Univ, Sch Med, Boston, MA 02118 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Mahidol University; Oregon Health & Science University; Boston University	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu	Jensen, Jeffrey T/C-7421-2014	Jensen, Jeffrey T/0000-0002-4733-1224	National Institutes of Health [HD063276, HD057121, HD059946, EY021214, 8P51OD011092]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD063276, R01HD057121, R01HD059946] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the OHSU Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance with human embryo and ESC studies. We thank egg donor volunteers and the staff at the Women's Health Research Unit at the Center for Women's Health, the Division of Reproductive Endocrinology & Infertility of the Department of Obstetrics & Gynecology of Oregon Health & Science University for their support and procurement of human gametes. The Division of Animal Resources, Surgery Team, Assisted Reproductive Technology & Embryonic Stem Cell Core, Endocrine Technology Core, and Imaging & Morphology Core at the Oregon National Primate Research Center provided expertise and services for the nonhuman primate studies. Hamilton Thorne donated the XYClone laser system for this study. We are grateful to Dr. Warren Sanger and Dianna Zaleski for karyotyping services, Dr. Cecilia Penedo for microsatellite analysis, and Dr. Cary Harding for assistance with nuclear donor cells. We are also indebted to Vanessa Domush, Elizabeth Smolens, Cathy Ramsey, Ying Li, Riffat Ahmed, Brittany Daughtry, and Erin Wolff for their technical support. The human oocyte/embryo research was supported by OHSU institutional funds and by the grant from Leducq Foundation. The nonhuman primate studies were supported by grants from the National Institutes of Health HD063276, HD057121, HD059946, EY021214, and 8P51OD011092.	Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Choi I, 2010, REPROD FERT DEVELOP, V22, P1000, DOI 10.1071/RD09144; Daley GQ, 2011, NATURE, V478, P40, DOI 10.1038/478040a; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Fan Y, 2011, STEM CELLS DEV, V20, P1951, DOI 10.1089/scd.2010.0451; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; Nakajima N, 2008, CLONING STEM CELLS, V10, P461, DOI 10.1089/clo.2008.0038; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; PELLICER A, 1989, HUM REPROD, V4, P536, DOI 10.1093/oxfordjournals.humrep.a136940; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; Sparman M, 2009, STEM CELLS, V27, P1255, DOI 10.1002/stem.60; Sparman ML, 2010, INT J DEV BIOL, V54, P1671, DOI 10.1387/ijdb.103196ms; SUSKOPARRISH JL, 1994, DEV BIOL, V166, P729, DOI 10.1006/dbio.1994.1351; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van der Gaast MH, 2006, REPROD BIOMED ONLINE, V13, P476, DOI 10.1016/S1472-6483(10)60633-5; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Wu YG, 2007, CLONING STEM CELLS, V9, P417, DOI 10.1089/clo.2006.0023; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	502	541	7	313	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1228	1238		10.1016/j.cell.2013.05.006	http://dx.doi.org/10.1016/j.cell.2013.05.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23683578	Bronze, Green Accepted			2022-12-24	WOS:000319979200009
J	Pollack, IF				Pollack, Ian F.			Tumor-Stromal Interactions in Medulloblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Pittsburgh, Sch Med, Dept Neurosurg, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pollack, IF (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurosurg, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15261 USA.							Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036	5	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1942	1943		10.1056/NEJMcibr1302851	http://dx.doi.org/10.1056/NEJMcibr1302851			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23675664				2022-12-24	WOS:000318896200017
J	Elliott, JE; Elliott, KH				Elliott, John E.; Elliott, Kyle H.			Tracking Marine Pollution	SCIENCE			English	Editorial Material							TEMPORAL TRENDS; SEABIRD EGGS; CONTAMINANTS; MERCURY		[Elliott, John E.] Environm Canada, Sci & Technol Branch, Delta, BC V4K 3N2, Canada; [Elliott, Kyle H.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB R3T 2N2, Canada	Environment & Climate Change Canada; University of Manitoba	Elliott, JE (corresponding author), Environm Canada, Sci & Technol Branch, Delta, BC V4K 3N2, Canada.	john.elliott@ec.gc.ca	Elliott, Kyle/S-9185-2019	Elliott, Kyle/0000-0001-5304-3993				ANDERSON DW, 1975, SCIENCE, V190, P806, DOI 10.1126/science.1239078; Braune BM, 2007, SCI TOTAL ENVIRON, V378, P403, DOI 10.1016/j.scitotenv.2007.03.003; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Crosse JD, 2012, ENVIRON POLLUT, V161, P93, DOI 10.1016/j.envpol.2011.10.003; Day RD, 2012, ENVIRON SCI TECHNOL, V46, P5327, DOI 10.1021/es2047156; Elliott J. E., 2012, ANN C N PAC MAR SCI, P83; Finkelstein M, 2006, ECOL APPL, V16, P678, DOI 10.1890/1051-0761(2006)016[0678:ASDRDI]2.0.CO;2; Gilbertson M., 1987, USES BIRDS, P231; Hebert CE, 2006, ENVIRON SCI TECHNOL, V40, P5624, DOI 10.1021/es0520621; Helgason LB, 2009, ENVIRON TOXICOL CHEM, V28, P1096, DOI 10.1897/08-404.1; Holmstrom KE, 2005, ENVIRON SCI TECHNOL, V39, P80, DOI 10.1021/es049257d; Muir D, 1999, SCI TOTAL ENVIRON, V230, P83, DOI 10.1016/S0048-9697(99)00037-6; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; van den Brink NW, 2011, MAR POLLUT BULL, V62, P128, DOI 10.1016/j.marpolbul.2010.09.002; Vo ATE, 2011, P NATL ACAD SCI USA, V108, P7466, DOI 10.1073/pnas.1013865108	15	121	133	2	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					556	558		10.1126/science.1235197	http://dx.doi.org/10.1126/science.1235197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641102				2022-12-24	WOS:000318268900033
J	Hennessy, ET; Betley, TA				Hennessy, Elisabeth T.; Betley, Theodore A.			Complex N-Heterocycle Synthesis via Iron-Catalyzed, Direct C-H Bond Amination	SCIENCE			English	Article							ARYL AZIDES; FUNCTIONALIZATION; HYDROXYLATION; ACTIVATION; MECHANISMS	The manipulation of traditionally unreactive functional groups is of paramount importance in modern chemical synthesis. We have developed an iron-dipyrrinato catalyst that leverages the reactivity of iron-borne metal-ligand multiple bonds to promote the direct amination of aliphatic C-H bonds. Exposure of organic azides to the iron dipyrrinato catalyst furnishes saturated, cyclic amine products (N-heterocycles) bearing complex core-substitution patterns. This study highlights the development of C-H bond functionalization chemistry for the formation of saturated, cyclic amine products and should find broad application in the context of both pharmaceuticals and natural product synthesis.	[Hennessy, Elisabeth T.; Betley, Theodore A.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Betley, TA (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	betley@chemistry.harvard.edu			NSF [CHE-0955885]; Harvard University; U.S. Department of Energy Office of Science Graduate Fellowship Program [DE-AC05-060R23100]	NSF(National Science Foundation (NSF)); Harvard University; U.S. Department of Energy Office of Science Graduate Fellowship Program	This work was supported by a grant from the NSF (CHE-0955885) and Harvard University. E. T. H. is grateful for a predoctoral fellowship from the U.S. Department of Energy Office of Science Graduate Fellowship Program (DE-AC05-060R23100) administered by Oak Ridge Institute for Science Education-Oak Ridge Associated Universities. T. A. B. is grateful for a George W. Merck Fellowship. We thank S.-L. Zheng for assistance with crystallography; J. Hong, A. Saghatelian, and B. Milgram for helpful discussions; and E. N. Jacobsen and T. Ritter for the generous use of their high-performance liquid chromatography and GC/MS instruments, respectively. The crystallographic data CCDC-905454 - 905461 can be obtained free of charge from the Cambridge Crystallographic Data Centre (www.ccdc.cam.ac.uk/data_request/cif).	Au SM, 1999, J AM CHEM SOC, V121, P9120, DOI 10.1021/ja9913481; Badiei YM, 2008, ANGEW CHEM INT EDIT, V47, P9961, DOI 10.1002/anie.200804304; BARTON DHR, 1965, J CHEM SOC, P2444, DOI 10.1039/jr9650002444; Beesley RM, 1915, J CHEM SOC, V107, P1080, DOI 10.1039/ct9150701080; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Dick AR, 2006, TETRAHEDRON, V62, P2439, DOI 10.1016/j.tet.2005.11.027; Driver TG, 2010, ORG BIOMOL CHEM, V8, P3831, DOI 10.1039/c005219c; DROUIN J, 1980, TETRAHEDRON, V36, P1195, DOI 10.1016/0040-4020(80)87018-9; Fiori KW, 2009, TETRAHEDRON, V65, P3042, DOI 10.1016/j.tet.2008.11.073; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Hoffman A. W., 1885, BERICHTE, V18, P109; King AO, 2004, TOP ORGANOMETAL CHEM, V6, P205; King ER, 2011, J AM CHEM SOC, V133, P4917, DOI 10.1021/ja110066j; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Laskowski CA, 2011, J AM CHEM SOC, V133, P771, DOI 10.1021/ja1101213; Liang CG, 2008, J AM CHEM SOC, V130, P343, DOI 10.1021/ja076519d; Lyaskovskyy V, 2011, J AM CHEM SOC, V133, P12264, DOI 10.1021/ja204800a; Mukaiyama T, 2010, HETEROCYCLES, V80, P63, DOI 10.3987/REV-09-SR(S)1; Newcomb M, 2000, ACCOUNTS CHEM RES, V33, P449, DOI 10.1021/ar960058b; Nugent W. A., 1988, METAL LIGAND MULTIPL; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Paradine SM, 2012, J AM CHEM SOC, V134, P2036, DOI 10.1021/ja211600g; Que L, 2007, ACCOUNTS CHEM RES, V40, P493, DOI 10.1021/ar700024g; Nguyen Q, 2013, J AM CHEM SOC, V135, P620, DOI 10.1021/ja3113565; Nguyen Q, 2012, J AM CHEM SOC, V134, P7262, DOI 10.1021/ja301519q; RYABOV AD, 1990, CHEM REV, V90, P403, DOI 10.1021/cr00100a004; SOROKIN A, 1993, J AM CHEM SOC, V115, P7293, DOI 10.1021/ja00069a031; Wiese S, 2012, J AM CHEM SOC, V134, P10114, DOI 10.1021/ja302149k; Zalatan DN, 2010, TOP CURR CHEM, V292, P347, DOI 10.1007/128_2009_19	31	426	426	8	416	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					591	595		10.1126/science.1233701	http://dx.doi.org/10.1126/science.1233701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641113				2022-12-24	WOS:000318268900043
J	Allen, V; Bates, KT; Li, ZH; Hutchinson, JR				Allen, Vivian; Bates, Karl T.; Li, Zhiheng; Hutchinson, John R.			Linking the evolution of body shape and locomotor biomechanics in bird-line archosaurs	NATURE			English	Article							ELECTROMYOGRAPHIC ANALYSIS; LIMB FUNCTION; PERFORMANCE; THEROPODS; MECHANICS; WALKING; FLIGHT	Locomotion in living birds (Neornithes) has two remarkable features: feather-assisted flight, and the use of unusually crouched hindlimbs for bipedal support and movement. When and how these defining functional traits evolved remains controversial(1-8). However, the advent of computer modelling approaches and the discoveries of exceptionally preserved key specimens now make it possible to use quantitative data on whole-body morphology to address the biomechanics underlying this issue. Here we use digital body reconstructions to quantify evolutionary trends in locomotor biomechanics (whole-body proportions and centre-of-mass position) across the clade Archosauria. We use three-dimensional digital reconstruction to estimate body shape from skeletal dimensions for 17 archosaurs along the ancestral bird line, including the exceptionally preserved, feathered taxa Microraptor, Archaeopteryx, Pengornis and Yixia-nornis, which represent key stages in the evolution of the avian body plan. Rather than a discrete transition from more-upright postures in the basal-most birds (Avialae) and their immediate outgroup deinonychosauria(5,6), our results support hypotheses of a gradual, stepwise acquisition of more-crouched limb postures across much of theropod evolution(1-4), although we find evidence of an accelerated change within the clade Maniraptora (birds and their closest relatives, such as deinonychosaurs). In addition, whereas reduction of the tail is widely accepted to be the primary morphological factor correlated with centre-of-mass position and, hence, evolution of hindlimb posture(1-8), we instead find that enlargement of the pectoral limb and several associated trends have a much stronger influence. Intriguingly, our support for the onset of accelerated morpho-functional trends within Maniraptora is closely correlated with the evolution of flight. Because we find that the evolution of enlarged forelimbs is strongly linked, via whole-body centre of mass, to hindlimb function during terrestrial locomotion, we suggest that the evolution of avian flight is linked to anatomical novelties in the pelvic limb as well as the pectoral.	[Allen, Vivian] Univ Jena, Inst Spezielle Zool & Evolut Biol, D-07743 Jena, Germany; [Allen, Vivian; Hutchinson, John R.] Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Bates, Karl T.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol 2, Liverpool L69 3GA, Merseyside, England; [Li, Zhiheng] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100034, Peoples R China; [Li, Zhiheng] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA	Friedrich Schiller University of Jena; University of London; University of London Royal Veterinary College; University of Liverpool; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Texas System; University of Texas Austin	Hutchinson, JR (corresponding author), Univ London Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	jrhutch@rvc.ac.uk	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038	NERC [NE/G005877/1]; Royal Society International Joint Project; Sam and Doris Welles Fund (University of California); Natural Environment Research Council [NE/G005877/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society International Joint Project(Royal Society of London); Sam and Doris Welles Fund (University of California); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the following people and institutions for access to fossil specimens: S. Chapman, A. Milner, P. Holroyd, M. Goodwin, K. Padian, M. Ryan, G. Jackson, D. Chapman, H.-J. Siber, B. Pabst, Z. Zhou and M. Norell; and the NHM (UK), UCMP (USA), CMNH (USA), IVPP (Canada); Sauriermuseum Aathal (Switzerland) and AMNH (USA). We wish to thank the following people, institutions and companies for providing digitized specimens, reconstructed specimens or both: O. Grillo, H. Mallison, J. Hertel, J. Brougham, M. Davis, J. A. Bannister; and the Universidade Federal do Rio de Janeiro (Brazil), MNB (Germany), Crescendo Games (Canada), NOVA/WGBH (USA) and Mechanimal (USA). We thank J. Molnar and RVC for invaluable assistance in processing computed tomography and laser-scandata, and for video editing. This work was supported by the following grants and institutions: NERC grant no. NE/G005877/1 to J.R.H., a Royal Society International Joint Project to J. R. H. and Z. Zhou (not a co-author), and the Sam and Doris Welles Fund (University of California) as part of PhD funding to V.A.	Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; Carrano MT, 1999, J MORPHOL, V240, P237, DOI 10.1002/(SICI)1097-4687(199906)240:3<237::AID-JMOR3>3.3.CO;2-E; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Christiansen P, 2002, J ORNITHOL, V143, P356; CLARK J, 1975, J ZOOL, V176, P87; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Gatesy SM, 1999, J MORPHOL, V240, P127, DOI 10.1002/(SICI)1097-4687(199905)240:2<127::AID-JMOR4>3.0.CO;2-Q; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gatesy SM, 1997, J VERTEBR PALEONTOL, V17, P308, DOI 10.1080/02724634.1997.10010977; Gatesy SM, 1997, J MORPHOL, V234, P197, DOI 10.1002/(SICI)1097-4687(199711)234:2<197::AID-JMOR6>3.0.CO;2-9; GATESY SM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P219; Hancock JA, 2007, IBIS, V149, P605, DOI 10.1111/j.1474-919X.2007.00688.x; Herr H, 2008, J EXP BIOL, V211, P467, DOI 10.1242/jeb.008573; Hutchinson J. R., 2001, COMP BIOCH PHYSL A, V131, P169; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026037; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Hutchinson JR, 2004, J MORPHOL, V262, P421, DOI 10.1002/jmor.10241; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Marsh RL, 2006, J EXP BIOL, V209, P2050, DOI 10.1242/jeb.02226; Persons WS, 2011, ANAT REC, V294, P119, DOI 10.1002/ar.21290; Roberts TJ, 2002, J EXP BIOL, V205, P1485; Roberts TJ, 1998, J EXP BIOL, V201, P2753; TARSITANO S, 1983, Acta Palaeontologica Polonica, V28, P251; Turner AH, 2007, SCIENCE, V317, P1721, DOI 10.1126/science.1145076	30	87	87	2	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					104	107		10.1038/nature12059	http://dx.doi.org/10.1038/nature12059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615616	Green Published			2022-12-24	WOS:000318221500042
J	Ball, P				Ball, Philip			Celebrate the unknowns	NATURE			English	Editorial Material												p.ball@btinternet.com						Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Lynch M, 2012, P NATL ACAD SCI USA, V109, P18851, DOI 10.1073/pnas.1216130109; Mattick JS, 2012, P NATL ACAD SCI USA, V109, P16400, DOI 10.1073/pnas.1214129109; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Wagner A, 2011, TRENDS ECOL EVOL, V26, P577, DOI 10.1016/j.tree.2011.07.001; Wagner A, 2011, TRENDS GENET, V27, P397, DOI 10.1016/j.tig.2011.06.002	10	33	33	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					419	420		10.1038/496419a	http://dx.doi.org/10.1038/496419a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131HU	23619675	Bronze			2022-12-24	WOS:000317984400013
J	Fine, PEM; Goldacre, BM; Haines, A				Fine, P. E. M.; Goldacre, B. M.; Haines, A.			Epidemiology-a science for the people	LANCET			English	Editorial Material							EDUCATION; NEED		[Fine, P. E. M.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Goldacre, B. M.] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Haines, A.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Haines, A.] Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Fine, PEM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	paul.fine@lshtm.ac.uk		Goldacre, Ben/0000-0002-5127-4728; Haines, Andy/0000-0002-8053-4605				[Anonymous], 1948, Br Med J, V2, P769; Banerjee AV, 2007, Q J ECON, V122, P1235, DOI 10.1162/qjec.122.3.1235; Bell CC, 2002, J NATL MED ASSOC, V94, P602; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Cooper BEJ, 2012, PUBLIC UNDERST SCI, V21, P664, DOI 10.1177/0963662511401782; Duflo, 2012, POOR EC BAREFOOT HED; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Greenwood M., 1935, EPIDEMICS CROWD DIS; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Haynes L., 2012, TEST LEARN ADAPT DEV; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Karlan D., 2012, MORE GOOD INTENTIONS; LILIENFELD DE, 1978, AM J EPIDEMIOL, V107, P87, DOI 10.1093/oxfordjournals.aje.a112521; MacMahon B., 1960, EPIDEMIOLOGIC METHOD; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Oxman AD, 2010, LANCET, V375, P427, DOI 10.1016/S0140-6736(09)61251-4; Panum, 1940, OBSERVATIONS MADE EP; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; Ranson MK, 2007, BRIT MED J, V334, P1309, DOI 10.1136/bmj.39192.719583.AE; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Snow J., 1855, MODE COMMUNICATION C; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Timmermann V., 2011, Bulletin OEPP, V41, P14, DOI 10.1111/j.1365-2338.2010.02429.x; Torgerson C, 2011, SCIENCE, V333, P1220, DOI 10.1126/science.333.6047.1220-b; WILESMITH JW, 1988, VET REC, V123, P638; Wortley R, 2011, SECUR J, V24, P149, DOI 10.1057/sj.2009.22; [No title captured]; [No title captured]	29	19	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2013	381	9874					1249	1252		10.1016/S0140-6736(13)60766-7	http://dx.doi.org/10.1016/S0140-6736(13)60766-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122XD	23582383				2022-12-24	WOS:000317351000005
J	Dekker, J; Wysocka, J; Mattaj, I; Aiden, EL; Pikaard, C				Dekker, Job; Wysocka, Joanna; Mattaj, Iain; Aiden, Erez Lieberman; Pikaard, Craig			Nuclear Biology: What's Been Most Surprising?	CELL			English	Editorial Material									[Dekker, Job] Univ Massachusetts, Sch Med, Amherst, MA 01003 USA; [Wysocka, Joanna] Stanford Univ, Stanford, CA 94305 USA; [Mattaj, Iain] European Mol Biol Lab, Heidelberg, Germany; [Aiden, Erez Lieberman] Harvard Univ, Cambridge, MA 02138 USA; [Pikaard, Craig] Indiana Univ, Bloomington, IN 47405 USA	University of Massachusetts System; University of Massachusetts Amherst; Stanford University; European Molecular Biology Laboratory (EMBL); Harvard University; Indiana University System; Indiana University Bloomington	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Amherst, MA 01003 USA.		Aiden, Erez Lieberman/A-2908-2010; Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459; Mattaj, Iain/0000-0002-5537-8284	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008540] Funding Source: NIH RePORTER; NIH HHS [DP2 OD008540] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)			0	1	1	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 14	2013	152	6					1207	1208						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	107CO	23616995				2022-12-24	WOS:000316192500001
J	Jafar, TH; Haaland, BA; Rahman, A; Razzak, JA; Bilger, M; Naghavi, M; Mokdad, AH; Hyder, AA				Jafar, Tazeen H.; Haaland, Benjamin A.; Rahman, Atif; Razzak, Junaid A.; Bilger, Marcel; Naghavi, Mohsen; Mokdad, Ali H.; Hyder, Adnan A.			Non-communicable diseases and injuries in Pakistan: strategic priorities	LANCET			English	Article							NATIONAL DIABETES SURVEY; MIDDLE-INCOME COUNTRIES; BLOOD-PRESSURE CONTROL; ROAD TRAFFIC INJURIES; RISK-FACTORS; PSYCHIATRIC-DISORDER; GLUCOSE-INTOLERANCE; MOUNTAIN VILLAGES; MENTAL-DISORDERS; HEALTH	Non-communicable diseases, including cardiovascular diseases, cancers, respiratory diseases, diabetes, and mental disorders, and injuries have become the major causes of morbidity and mortality in Pakistan. Tobacco use and hypertension are the leading attributable risk factors for deaths due to cardiovascular diseases, cancers, and respiratory diseases. Pakistan has the sixth highest number of people in the world with diabetes; every fourth adult is overweight or obese; cigarettes are cheap; antismoking and road safety laws are poorly enforced; and a mixed public-private health-care system provides suboptimum care. Furthermore, almost three decades of exposure to sociopolitical instability, economic uncertainty, violence, regional conflict, and dislocation have contributed to a high prevalence of mental health disorders. Projection models based on the Global Burden of Disease 2010 data suggest that there will be about 3.87 million premature deaths by 2025 from cardiovascular diseases, cancers, and chronic respiratory diseases in people aged 30-69 years in Pakistan, with serious economic consequences. Modelling of risk factor reductions also indicate that Pakistan could achieve at least a 20% reduction in the number of these deaths by 2025 by targeting of the major risk factors. We call for policy and legislative changes, and health-system interventions to target readily preventable non-communicable diseases in Pakistan.	[Jafar, Tazeen H.; Bilger, Marcel] Duke NUS Grad Med Sch, 8 Coll Rd, Singapore 169857, Singapore; [Haaland, Benjamin A.] Duke NUS Grad Med Sch, Ctr Quantitat Med, Off Clin Sci, Singapore 169857, Singapore; [Jafar, Tazeen H.] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Jafar, Tazeen H.] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Haaland, Benjamin A.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Rahman, Atif] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Rahman, Atif] Inst Psychiat, Rawalpindi, Pakistan; [Razzak, Junaid A.; Hyder, Adnan A.] Aga Khan Univ, Dept Emergency Med, Karachi, Pakistan; [Razzak, Junaid A.] Aman Hlth Care Serv, Karachi, Pakistan; [Naghavi, Mohsen; Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Baltimore, MD USA	National University of Singapore; National University of Singapore; Aga Khan University; Aga Khan University; National University of Singapore; University of Liverpool; Aga Khan University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jafar, TH (corresponding author), Duke NUS Grad Med Sch, 8 Coll Rd, Singapore 169857, Singapore.	tazeen.jafar@duke-nus.edu.sg	Hyder, Adnan/AAT-9503-2021; Razzak, Junaid/ABE-3549-2020; Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339; Bilger, Marcel/0000-0002-2872-6597; Razzak, Junaid/0000-0003-0735-9094; Hyder, Adnan/0000-0002-7292-577X				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P77, DOI 10.1076/icsp.10.1.77.14113; Ali Badar Sabir, 2003, American Journal of Psychotherapy, V57, P324; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bishai D, 2003, HEALTH POLICY PLANN, V18, P232, DOI 10.1093/heapol/czg028; Bloom DE, 2011, GLOBAL EC BURDEN NON; Bradbury K, 1999, J PEDIATR PSYCHOL, V24, P423, DOI 10.1093/jpepsy/24.5.423; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Chisholm D, 2000, BRIT J PSYCHIAT, V176, P581, DOI 10.1192/bjp.176.6.581; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Engelgau MM, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-9; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gadit A A, 2004, J Pak Med Assoc, V54, P43; Ghaffar A, 2004, PUBLIC HEALTH, V118, P211, DOI 10.1016/j.puhe.2003.05.003; Govt of Pakistan, 2010, PAK EC SURV; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Heartfile Ministry of Health WHO, MEM UND DEV NAT ACT; Husain N, 2007, BRIT J PSYCHIAT, V190, P36, DOI 10.1192/bjp.bp.106.022913; Husain N, 2000, PSYCHOL MED, V30, P395, DOI 10.1017/S0033291700001707; Institute of Medicine, PROMOTING CARDIOVASC; Islam A, 2002, J Pak Med Assoc, V52, P2; Ismail J, 2004, HEART, V90, P259, DOI 10.1136/hrt.2003.013631; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Jafar TH, 2012, AM J KIDNEY DIS, V60, P731, DOI 10.1053/j.ajkd.2012.08.007; Jafar TH, 2011, CIRCULATION, V124, P1615, DOI 10.1161/CIRCULATIONAHA.111.039990; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jafar TH, 2005, CIRCULATION, V111, P1278, DOI 10.1161/01.CIR.0000157698.78949.D7; Jafar TH, 2003, J HYPERTENS, V21, P905, DOI 10.1097/00004872-200305000-00014; Levy DT, 2008, TOB CONTROL, V17, P53, DOI 10.1136/tc.2007.022319; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MACKAY JM, 1986, BRIT MED J, V292, P1435, DOI 10.1136/bmj.292.6533.1435; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mumford DB, 1997, BRIT J PSYCHIAT, V170, P473, DOI 10.1192/bjp.170.5.473; Mumford DB, 1996, BRIT J PSYCHIAT, V168, P299, DOI 10.1192/bjp.168.3.299; Nishtar S., HLTH INDICATORS PAKI; Nishtar S, 2013, LANCET; Nishtar Sania, 2006, Prev Chronic Dis, V3, pA14; Nishtar S, 2010, LANCET, V376, P874, DOI 10.1016/S0140-6736(10)61413-4; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Peden M, 2002, INJURY CHART BOOK GR, P5; Poureslami Iraj M, 2004, MedGenMed, V6, P51; Rahman A, 2009, CHILD CARE HLTH DEV, V35, P56, DOI 10.1111/j.1365-2214.2008.00897.x; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Razzak JA, 2004, PUBLIC HEALTH, V118, P114, DOI 10.1016/S0033-3506(03)00147-1; Razzak JA, 2011, J PAK MED ASSOC, V61, P640; Shah SM, 2004, TROP MED INT HEALTH, V9, P526, DOI 10.1111/j.1365-3156.2004.01220.x; Shah SMA, 2001, J HUM HYPERTENS, V15, P107, DOI 10.1038/sj.jhh.1001131; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Shamim Muhammad S, 2011, J Emerg Trauma Shock, V4, P147, DOI 10.4103/0974-2700.76817; Shera AS, 2007, DIABETES RES CLIN PR, V76, P219, DOI 10.1016/j.diabres.2006.08.011; Shera AS, 1999, DIABETES RES CLIN PR, V44, P49, DOI 10.1016/S0168-8227(99)00017-0; Shera AS, 1995, DIABETIC MED, V12, P1116, DOI 10.1111/j.1464-5491.1995.tb00430.x; UN, 2011, 2011 HIGH LEV M PREV; Unal B, 2003, TOB INDUC DIS, V3, P185; WHO, REP PAK; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willett W. C., 2006, Disease control priorities in developing countries, P833; World Bank, 2009, WORLD DEV IND; World Health Organization, 2019, WHO REPORT GLOBAL TO; World Health Organization (WHO), ACT PLAN PR IN PRESS; Yach D, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-10	74	60	60	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2281	2290		10.1016/S0140-6736(13)60646-7	http://dx.doi.org/10.1016/S0140-6736(13)60646-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23684257				2022-12-24	WOS:000321100300033
J	Racoosin, JA; Roberson, DW; Pacanowski, MA; Nielsen, DR				Racoosin, Judith A.; Roberson, David W.; Pacanowski, Michael A.; Nielsen, David R.			New Evidence about an Old Drug - Risk with Codeine after Adenotonsillectomy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHILDREN; TONSILLECTOMY		[Racoosin, Judith A.; Pacanowski, Michael A.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Roberson, David W.; Nielsen, David R.] Amer Acad Otolaryngol Head & Neck Surg, Alexandria, VA USA; [Roberson, David W.] Boston Childrens Hosp, Dept Otolaryngol, Boston, MA USA; [Roberson, David W.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA	US Food & Drug Administration (FDA); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Racoosin, JA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Brown KA, 2006, ANESTHESIOLOGY, V105, P665, DOI 10.1097/00000542-200610000-00009; Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; Davies L, LARYNGOSCOP IN PRESS; Kelly LE, 2012, PEDIATRICS, V129, pE1343, DOI 10.1542/peds.2011-2538	5	52	54	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2155	2157		10.1056/NEJMp1302454	http://dx.doi.org/10.1056/NEJMp1302454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23614474				2022-12-24	WOS:000319948900003
J	Adler, JN; Colbert, JA				Adler, Jonathan N.; Colbert, James A.			Medicinal Use of Marijuana - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2013, N ENGL J MED, V368, P866	1	54	55	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					E30	E30		10.1056/NEJMclde1305159	http://dx.doi.org/10.1056/NEJMclde1305159			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23718175				2022-12-24	WOS:000319574200015
J	Crow, JM				Crow, James Mitchell			INSOMNIA Chasing the dream	NATURE			English	Editorial Material							COGNITIVE-BEHAVIORAL THERAPY											Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Lin JS, 2011, J PHARMACOL EXP THER, V336, P17, DOI 10.1124/jpet.110.170134; Lopez-Munoz Francisco, 2005, Neuropsychiatr Dis Treat, V1, P329; Mets MAJ, 2011, SLEEP, V34, P1327, DOI 10.5665/SLEEP.1272; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Uslaner JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005213; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307	11	4	5	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					S16	S18		10.1038/497S16a	http://dx.doi.org/10.1038/497S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698503				2022-12-24	WOS:000319254000009
J	Kellermann, AL; Peleg, K				Kellermann, Arthur L.; Peleg, Kobi			Lessons from Boston	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kellermann, Arthur L.] RAND Corp, Arlington, VA USA; [Peleg, Kobi] Tel Aviv Univ, Natl Ctr Trauma & Emergency Med Res, Disaster Med Dept, IL-69978 Tel Aviv, Israel	RAND Corporation; Tel Aviv University	Kellermann, AL (corresponding author), RAND Corp, Arlington, VA USA.							Gawande A., 2013, NEW YORKER; Golan R, 2013, INJURY; Peleg K, 2009, JAMA-J AM MED ASSOC, V302, P565, DOI 10.1001/jama.2009.1119; Smith JF, 2009, BOSTON GLOBE	4	46	50	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1956	1957		10.1056/NEJMp1305304	http://dx.doi.org/10.1056/NEJMp1305304			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194KD	23614472				2022-12-24	WOS:000322630700003
J	Salazar-Ciudad, I; Marin-Riera, M				Salazar-Ciudad, Isaac; Marin-Riera, Miquel			Adaptive dynamics under development-based genotype-phenotype maps	NATURE			English	Article							PATTERN-FORMATION; EVOLUTION; MODEL; ADAPTATION; MECHANISMS; RNA	It is not known whether natural selection can encounter any given phenotype that can be produced by genetic variation. There has been a long-lasting debate about the processes that limit adaptation(1-6) and, consequently, about how well adapted phenotypes are. Here we examine how development may affect adaptation, by decomposing the genotype-fitness map-the association between each genotype and its fitness-into two: one mapping genotype to phenotype by means of a computational model of organ development(7), and one mapping phenotype to fitness. In the map of phenotype and fitness, the fitness of each individual is based on the similarity between realized morphology and optimal morphology. We use three different simulations to map phenotype to fitness, and these differ in the way in which similarity is calculated: similarity is calculated for each trait (in terms of each cell position individually), for a large or a small number of phenotypic landmarks (the 'many-traits' and 'few-traits' phenotype-fitness maps), and by measuring the overall surface roughness of morphology (the 'roughness' phenotype-fitness map). Evolution is simulated by applying the genotype-phenotype map and one phenotype-fitness map to each individual in the population, as well as random mutation and drift. We show that the complexity of the genotype-phenotype map prevents substantial adaptation in some of the phenotype-fitness maps: sustained adaptation is only possible using 'roughness' or 'few-traits' phenotype-fitness maps. The results contribute developmental understanding to the long-standing question of which aspects of phenotype can be effectively optimized by natural selection.	[Salazar-Ciudad, Isaac] Univ Helsinki, Inst Biotechnol, Dev Biol Program, Evolutionary Phen Grp, FIN-00014 Helsinki, Finland; [Salazar-Ciudad, Isaac; Marin-Riera, Miquel] Univ Autonoma Barcelona, Dept Genet & Microbiol, Genom Bioinformat & Evolut Grp, Cerdanyola Del Valles 08193, Spain	University of Helsinki; Autonomous University of Barcelona	Salazar-Ciudad, I (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Program, Evolutionary Phen Grp, POB 56, FIN-00014 Helsinki, Finland.	isaac.salazar@uab.cat	Salazar-Ciudad, Isaac/R-2238-2018	Salazar Ciudad, Isaac/0000-0003-1607-0962	Finnish Academy [WBS 1250271]; Spanish Ministry of Science and Innovation [BFU2010-17044]	Finnish Academy(Academy of Finland); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank J. Jernvall, M. Brun Usan, I. Salvador Martinez, A. Matamoro, S. Newman and R. Zimm for comments and the CSC (IT Center for Science). This research was funded by the Finnish Academy (WBS 1250271) and the Spanish Ministry of Science and Innovation (BFU2010-17044).	Alberch P., 1982, EVOL DEV, P313, DOI DOI 10.1007/978-3-642-45532-2-15; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; Bunn JM, 2011, AM J PHYS ANTHROPOL, V145, P247, DOI 10.1002/ajpa.21489; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Ferrada E, 2012, BIOPHYS J, V102, P1916, DOI 10.1016/j.bpj.2012.01.047; Fontana W, 2002, BIOESSAYS, V24, P1164, DOI 10.1002/bies.10190; Godfrey LR, 2012, AM J PHYS ANTHROPOL, V148, P215, DOI 10.1002/ajpa.21615; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Haldane J. B. S., 1932, CAUSES EVOLUTION; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kauffman S. A., 1993, ORIGINS ORDER; Klingenberg CP, 2002, GENE, V287, P3, DOI 10.1016/S0378-1119(01)00867-8; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Orr HA, 2006, EVOLUTION, V60, P1113; ORZACK SH, 1994, AM NAT, V143, P361, DOI 10.1086/285608; Polly P. David, 2005, Journal of Mammalian Evolution, V12, P283, DOI 10.1007/s10914-005-4866-8; Salazar-Ciudad I, 2006, J EXP ZOOL PART B, V306B, P107, DOI 10.1002/jez.b.21078; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Tenaillon O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000217; Waddington C., 1957, STRATEGY GENES; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	29	65	69	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					361	+		10.1038/nature12142	http://dx.doi.org/10.1038/nature12142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23636325				2022-12-24	WOS:000318952000036
J	Nick, FM; Vieli, A; Andersen, ML; Joughin, I; Payne, A; Edwards, TL; Pattyn, F; van de Wal, RSW				Nick, Faezeh M.; Vieli, Andreas; Andersen, Morten Langer; Joughin, Ian; Payne, Antony; Edwards, Tamsin L.; Pattyn, Frank; van de Wal, Roderik S. W.			Future sea-level rise from Greenland's main outlet glaciers in a warming climate	NATURE			English	Article							JAKOBSHAVN ISBRAE; ICE; STABILITY; ACCELERATION; DYNAMICS	Over the past decade, ice loss from the Greenland Ice Sheet increased as a result of both increased surface melting and ice discharge to the ocean(1,2). The latter is controlled by the acceleration of ice flow and subsequent thinning of fast-flowing marine-terminating outlet glaciers(3). Quantifying the future dynamic contribution of such glaciers to sea-level rise (SLR) remains a major challenge because outlet glacier dynamics are poorly understood(4). Here we present a glacier flow model that includes a fully dynamic treatment of marine termini. We use this model to simulate behaviour of four major marine-terminating outlet glaciers, which collectively drain about 22 per cent of the Greenland Ice Sheet. Using atmospheric and oceanic forcing from a mid-range future warming scenario that predicts warming by 2.8 degrees Celsius by 2100, we project a contribution of 19 to 30 millimetres to SLR from these glaciers by 2200. This contribution is largely (80 per cent) dynamic in origin and is caused by several episodic retreats past overdeepenings in outlet glacier troughs. After initial increases, however, dynamic losses from these four outlets remain relatively constant and contribute to SLR individually at rates of about 0.01 to 0.06 millimetres per year. These rates correspond to ice fluxes that are less than twice those of the late 1990s, well below previous upper bounds(5). For a more extreme future warming scenario (warming by 4.5 degrees Celsius by 2100), the projected losses increase by more than 50 per cent, producing a cumulative SLR of 29 to 49 millimetres by 2200.	[Nick, Faezeh M.; Pattyn, Frank] Univ Libre Bruxelles, Lab Glaciol, B-1050 Brussels, Belgium; [Nick, Faezeh M.; van de Wal, Roderik S. W.] Univ Utrecht, Inst Marine & Atmospher Res, NL-3508 TA Utrecht, Netherlands; [Nick, Faezeh M.] Univ Ctr Svalbard, Dept Geol, NO-9171 Longyearbyen, Norway; [Vieli, Andreas] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Vieli, Andreas] Univ Zurich, Dept Geog, CH-8057 Zurich, Switzerland; [Andersen, Morten Langer] Geol Survey Denmark & Greenland, DK-1350 Copenhagen, Denmark; [Joughin, Ian] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98108 USA; [Payne, Antony; Edwards, Tamsin L.] Univ Bristol, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England	Universite Libre de Bruxelles; Utrecht University; University Centre Svalbard (UNIS); Durham University; University of Zurich; Geological Survey Of Denmark & Greenland; University of Washington; University of Washington Seattle; University of Bristol	Nick, FM (corresponding author), Univ Libre Bruxelles, Lab Glaciol, B-1050 Brussels, Belgium.	faezeh.nick@unis.no	Joughin, Ian/AAR-7778-2021; Joughin, Ian R/A-2998-2008; Pattyn, Frank/AAA-9640-2019; van de wal, roderik/D-1705-2011; Edwards, Tamsin/H-6462-2019; payne, antony/A-8916-2008; Andersen, Morten/E-5509-2012	Joughin, Ian/0000-0001-6229-679X; Joughin, Ian R/0000-0001-6229-679X; Pattyn, Frank/0000-0003-4805-5636; van de wal, roderik/0000-0003-2543-3892; Edwards, Tamsin/0000-0002-4760-4704; payne, antony/0000-0001-8825-8425; Vieli, Andreas/0000-0002-2870-5921	ice2sea programme of the European Union 7th Framework Programme [226375]; Netherlands Polar Programme (NPP); European Union 6th Framework Programme Integrated Project ENSEMBLES [505539]; US NSF [ANT-0424589]	ice2sea programme of the European Union 7th Framework Programme; Netherlands Polar Programme (NPP); European Union 6th Framework Programme Integrated Project ENSEMBLES; US NSF(National Science Foundation (NSF))	This research was financially supported by the ice2sea programme of the European Union 7th Framework Programme, grant number 226375 (ice2sea publication 118), and the Netherlands Polar Programme (NPP), and contributes to the Knowledge for Climate (KvK) programme in the Netherlands. The ENSEMBLES data used in this work was funded by the European Union 6th Framework Programme Integrated Project ENSEMBLES (contract number 505539). Support for I.J. was provided by US NSF grant ANT-0424589.	Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Cuffey K. M., 2010, PHYS GLACIERS, P575; Fettweis X, 2013, CRYOSPHERE, V7, P469, DOI 10.5194/tc-7-469-2013; Gogineni P., 2012, CRESIS RADAR DEPTH S; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047565; Jamieson SSR, 2012, NAT GEOSCI, V5, P799, DOI [10.1038/ngeo1600, 10.1038/NGEO1600]; Jenkins A, 2011, J PHYS OCEANOGR, V41, P2279, DOI 10.1175/JPO-D-11-03.1; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000837; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001023; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Motyka RJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2009JF001632; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Nick FM, 2012, J GLACIOL, V58, P229, DOI 10.3189/2012JoG11J242; Nick FM, 2010, J GLACIOL, V56, P781, DOI 10.3189/002214310794457344; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Pattyn F, 2012, CRYOSPHERE, V6, P573, DOI 10.5194/tc-6-573-2012; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Price SF, 2011, P NATL ACAD SCI USA, V108, P8978, DOI 10.1073/pnas.1017313108; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031765; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; van der Veen CJ, 2011, J GLACIOL, V57, P770, DOI 10.3189/002214311797409776; van der Veen CJ, 1998, COLD REG SCI TECHNOL, V27, P31, DOI 10.1016/S0165-232X(97)00022-0; Vieli A, 2011, SURV GEOPHYS, V32, P437, DOI 10.1007/s10712-011-9132-4; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	30	198	202	1	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					235	238		10.1038/nature12068	http://dx.doi.org/10.1038/nature12068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23657350	Green Accepted			2022-12-24	WOS:000318558200035
J	Behrman, S				Behrman, Sophie			PERSONAL VIEW Have you heard the one about the man with Alzheimer's disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Littlemore Mental Hlth Ctr, Oxford Clin, Oxford OX4 4XN, England		Behrman, S (corresponding author), Littlemore Mental Hlth Ctr, Oxford Clin, Oxford OX4 4XN, England.	sophie.behrman@doctors.org.uk						Blake W, 2006, CARE GIVING DEMENTIA, V4; Flynn, 2012, WINTERBOURNE VIEW HO; Hulse J R, 1994, Geriatr Nurs, V15, P88; Low LF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002072; Moos I, 2011, AGEING SOC, V31, P328, DOI 10.1017/S0144686X10001054; Reisberg B, 1999, Int Psychogeriatr, V11, P7, DOI 10.1017/S1041610299005554; Reisberg Barry, 2002, Am J Alzheimers Dis Other Demen, V17, P202, DOI 10.1177/153331750201700411; Saunders PA, 1998, HEALTH COMMUN, V10, P357, DOI 10.1207/s15327027hc1004_4	8	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2013	346								f2872	10.1136/bmj.f2872	http://dx.doi.org/10.1136/bmj.f2872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BQ	23653137				2022-12-24	WOS:000318914800006
J	Schwarz, FW; Toth, J; van Aelst, K; Cui, GS; Clausing, S; Szczelkun, MD; Seidel, R				Schwarz, Friedrich W.; Toth, Julia; van Aelst, Kara; Cui, Guanshen; Clausing, Sylvia; Szczelkun, Mark D.; Seidel, Ralf			The Helicase-Like Domains of Type III Restriction Enzymes Trigger Long-Range Diffusion Along DNA	SCIENCE			English	Article							TRANSLOCATION; RECOGNITION; MECHANISM; DISSOCIATION; FILAMENTS; TRACKING; INSIGHTS; SITES; HEAD; MUTS	Helicases are ubiquitous adenosine triphosphatases (ATPases) with widespread roles in genome metabolism. Here, we report a previously undescribed functionality for ATPases with helicase-like domains; namely, that ATP hydrolysis can trigger ATP-independent long-range protein diffusion on DNA in one dimension (1D). Specifically, using single-molecule fluorescence microscopy we show that the Type III restriction enzyme EcoP15I uses its ATPase to switch into a distinct structural state that diffuses on DNA over long distances and long times. The switching occurs only upon binding to the target site and requires hydrolysis of similar to 30 ATPs. We define the mechanism for these enzymes and show how ATPase activity is involved in DNA target site verification and 1D signaling, roles that are common in DNA metabolism: for example, in nucleotide excision and mismatch repair.	[Schwarz, Friedrich W.; Clausing, Sylvia; Seidel, Ralf] Tech Univ Dresden, Ctr Biotechnol, DNA Motors Grp, D-01062 Dresden, Germany; [Toth, Julia; van Aelst, Kara; Cui, Guanshen; Szczelkun, Mark D.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Seidel, Ralf] Univ Munster, Inst Mol & Cell Biol, D-48149 Munster, Germany	Technische Universitat Dresden; University of Bristol; University of Munster	Szczelkun, MD (corresponding author), Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	mark.szczelkun@bristol.ac.uk; ralf.seidel@uni-muenster.de	Seidel, Ralf/A-6531-2010	Seidel, Ralf/0000-0002-6642-053X; Szczelkun, Mark/0000-0002-2501-6602	Wellcome Trust [084086]; Deutsche Forschungsgemeinschaft (DFG) [SE 1646/1-1, SE 1646/7-1]; European Research Council [261224]; Dresden International Graduate School for Biomedicine and Bioengineering; DFG	Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Dresden International Graduate School for Biomedicine and Bioengineering; DFG(German Research Foundation (DFG))	This work was supported by The Wellcome Trust (084086), the Deutsche Forschungsgemeinschaft (DFG, SE 1646/1-1, SE 1646/7-1), a starting grant of the European Research Council (261224), and the Dresden International Graduate School for Biomedicine and Bioengineering, funded by the DFG (to F.W.S.). We thank N. Savery and S. Halford for comments on the manuscript. The authors declare no conflict of interest.	Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Brutzer H, 2012, NANO LETT, V12, P473, DOI 10.1021/nl203876w; Cho WK, 2012, STRUCTURE, V20, P1264, DOI 10.1016/j.str.2012.04.017; Crampton N, 2007, EMBO J, V26, P3815, DOI 10.1038/sj.emboj.7601807; Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gupta YK, 2012, J MOL BIOL, V420, P261, DOI 10.1016/j.jmb.2012.04.026; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; McClelland SE, 2005, J MOL BIOL, V348, P895, DOI 10.1016/j.jmb.2005.03.018; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Qiu RY, 2012, EMBO J, V31, P2528, DOI 10.1038/emboj.2012.95; Raghavendra NK, 2012, FRONT BIOSCI-LANDMRK, V17, P1094, DOI 10.2741/3975; Ramanathan SP, 2009, P NATL ACAD SCI USA, V106, P1748, DOI 10.1073/pnas.0807193106; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schwarz FW, 2011, NUCLEIC ACIDS RES, V39, P8042, DOI 10.1093/nar/gkr502; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Stanley LK, 2006, EMBO J, V25, P2230, DOI 10.1038/sj.emboj.7601104; Toth J, 2012, NUCLEIC ACIDS RES, V40, P6752, DOI 10.1093/nar/gks328; van Aelst K, 2010, P NATL ACAD SCI USA, V107, P9123, DOI 10.1073/pnas.1001637107; Webb MR, 2007, MOL BIOSYST, V3, P249, DOI 10.1039/b614154d; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	25	53	55	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					353	356		10.1126/science.1231122	http://dx.doi.org/10.1126/science.1231122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599494	Green Accepted			2022-12-24	WOS:000317657500056
J	Amaral, M; Levy, C; Heyes, DJ; Lafite, P; Outeiro, TF; Giorgini, F; Leys, D; Scrutton, NS				Amaral, Marta; Levy, Colin; Heyes, Derren J.; Lafite, Pierre; Outeiro, Tiago F.; Giorgini, Flaviano; Leys, David; Scrutton, Nigel S.			Structural basis of kynurenine 3-monooxygenase inhibition	NATURE			English	Article							3-HYDROXYLASE INHIBITION; ENDOGENOUS METABOLITE; QUINOLINIC ACID; PATHWAY; MODEL; BRAIN; HYDROXYLASE; MICROGLIA; CATALYSIS; FLAVIN	Inhibition of kynurenine 3-monooxygenase (KMO), an enzyme in the eukaryotic tryptophan catabolic pathway (that is, kynurenine pathway), leads to amelioration of Huntington's-disease-relevant phenotypes in yeast, fruitfly and mouse models(1-5), as well as in a mouse model of Alzheimer's disease(3). KMO is a flavin adenine dinucleotide (FAD)-dependent monooxygenase and is located in the outer mitochondrial membrane where it converts L-kynurenine to 3-hydroxykynurenine. Perturbations in the levels of kynurenine pathway metabolites have been linked to the pathogenesis of a spectrum of brain disorders(6), as well as cancer(7,8) and several peripheral inflammatory conditions(9). Despite the importance of KMO as a target for neurodegenerative disease, the molecular basis of KMO inhibition by available lead compounds has remained unknown. Here we report the first crystal structure of Saccharomyces cerevisiae KMO, in the free form and in complex with the tight-binding inhibitor UPF 648. UPF 648 binds close to the FAD cofactor and perturbs the local active-site structure, preventing productive binding of the substrate L-kynurenine. Functional assays and targeted mutagenesis reveal that the active-site architecture and UPF 648 binding are essentially identical in human KMO, validating the yeast KMO-UPF 648 structure as a template for structure-based drug design. This will inform the search for new KMO inhibitors that are able to cross the blood-brain barrier in targeted therapies against neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's diseases.	[Amaral, Marta; Levy, Colin; Heyes, Derren J.; Leys, David; Scrutton, Nigel S.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Amaral, Marta; Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Amaral, Marta; Outeiro, Tiago F.] Inst Mol Med, Cell & Mol Neurosci Unit, P-1659028 Lisbon, Portugal; [Amaral, Marta; Outeiro, Tiago F.] Univ Lisbon, Fac Med, Inst Fisiol, P-1649028 Lisbon, Portugal; [Lafite, Pierre] Univ Orleans, Inst Chim Organ & Analyt, CNRS, UMR7311, F-45067 Orleans 2, France; [Outeiro, Tiago F.] Univ Med Ctr Gottingen, Ctr Nanoscale Microscopy & Mol Physiol Brain, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany	University of Manchester; University of Leicester; Universidade de Lisboa; Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; University of Gottingen	Scrutton, NS (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk	Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019; Lafite, Pierre/F-6806-2011; Outeiro, Tiago F/C-1067-2008	Outeiro, Tiago/0000-0003-1679-1727; Lafite, Pierre/0000-0003-1637-4966; Outeiro, Tiago F/0000-0003-1679-1727; Levy, Colin/0000-0002-9724-310X; amaral, marta/0000-0002-3503-9963; Heyes, Derren/0000-0002-7453-1571; Giorgini, Flaviano/0000-0001-7881-9508	EPSRC [EP/I037253/1, EP/J020192/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J020192/1, EP/I037253/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: Medline	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Ceresoli-Borroni G, 2007, J NEUROSCI RES, V85, P845, DOI 10.1002/jnr.21183; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; Copeland CS, 2013, NEUROPHARMACOLOGY, V66, P133, DOI 10.1016/j.neuropharm.2012.03.009; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cozzi A, 1999, J CEREBR BLOOD F MET, V19, P771, DOI 10.1097/00004647-199907000-00007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fazio F, 2012, MOL PHARMACOL, V81, P643, DOI 10.1124/mol.111.074765; Filippini P, 2012, CURR MED CHEM, V19, P5381, DOI 10.2174/092986712803833353; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F, 2008, J BIOL CHEM, V283, P7390, DOI 10.1074/jbc.M708192200; Green EW, 2012, FLY, V6, P117, DOI 10.4161/fly.19999; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liu XD, 2009, STUD FUZZ SOFT COMP, V244, P3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; McCulloch KM, 2009, BIOCHEMISTRY-US, V48, P4139, DOI 10.1021/bi900149f; Moroni F, 2003, ADV EXP MED BIOL, V527, P127; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Ortiz-Maldonado M, 2001, BIOCHEMISTRY-US, V40, P1091, DOI 10.1021/bi002139s; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Platten M, 2012, ONCOIMMUNOLOGY, V1, P395, DOI 10.4161/onci.19071; Reinhart PH, 2011, CELL, V145, P813, DOI 10.1016/j.cell.2011.05.031; Richter A, 2003, EUR J PHARMACOL, V478, P47, DOI 10.1016/j.ejphar.2003.08.038; Samadi P, 2005, MOVEMENT DISORD, V20, P792, DOI 10.1002/mds.20596; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Uemura T, 1998, J BIOCHEM, V123, P253; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	40	98	102	0	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					382	+		10.1038/nature12039	http://dx.doi.org/10.1038/nature12039			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23575632	Green Submitted, Green Accepted			2022-12-24	WOS:000317599200042
J	de Ruiter, DJ; DeWitt, TJ; Carlson, KB; Brophy, JK; Schroeder, L; Ackermann, RR; Churchill, SE; Berger, LR				de Ruiter, Darryl J.; DeWitt, Thomas J.; Carlson, Keely B.; Brophy, Juliet K.; Schroeder, Lauren; Ackermann, Rebecca R.; Churchill, Steven E.; Berger, Lee R.			Mandibular Remains Support Taxonomic Validity of Australopithecus sediba	SCIENCE			English	Article							HOMINID	Since the announcement of the species Australopithecus sediba, questions have been raised over whether the Malapa fossils represent a valid taxon or whether inadequate allowance was made for intraspecific variation, in particular with reference to the temporally and geographically proximate species Au. africanus. The morphology of mandibular remains of Au. sediba, including newly recovered material discussed here, shows that it is not merely a late-surviving morph of Au. africanus. Rather-as is seen elsewhere in the cranium, dentition, and postcranial skeleton-these mandibular remains share similarities with other australopiths but can be differentiated from the hypodigm of Au. africanus in both size and shape as well as in their ontogenetic growth trajectory.	[de Ruiter, Darryl J.; Carlson, Keely B.; Brophy, Juliet K.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [de Ruiter, Darryl J.; Brophy, Juliet K.; Churchill, Steven E.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [DeWitt, Thomas J.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Brophy, Juliet K.] Loyola Univ, Dept Anthropol, Chicago, IL 60660 USA; [Schroeder, Lauren; Ackermann, Rebecca R.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA	Texas A&M University System; Texas A&M University College Station; University of Witwatersrand; Texas A&M University System; Texas A&M University College Station; Loyola University Chicago; University of Cape Town; Duke University	de Ruiter, DJ (corresponding author), Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA.	deruiter@tamu.edu	Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352; DeWitt, Thomas/0000-0001-7405-3904	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation; Institute for Human Evolution (IHE); Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; L. S. B. Leakey Foundation Baldwin Fellowship; United States Diplomatic Mission to South Africa; French Embassy in South Africa; National Geographic Society; A. H. Schultz Foundation; Oppenheimer and Ackerman families; Program to Enhance Scholarly and Creative Activities; Texas A M University	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution (IHE); Palaeontological Scientific Trust (PAST); Andrew W. Mellon Foundation; L. S. B. Leakey Foundation Baldwin Fellowship; United States Diplomatic Mission to South Africa; French Embassy in South Africa; National Geographic Society(National Geographic Society); A. H. Schultz Foundation; Oppenheimer and Ackerman families; Program to Enhance Scholarly and Creative Activities; Texas A M University	We thank the South African Heritage Resource agency for the permits to work on the Malapa site and the Nash family for granting access to the Malapa site and continued support of research on their reserve. The South African Department of Science and Technology, and the African Origins Platform (AOP), the South African National Research Foundation, the Institute for Human Evolution (IHE), the Palaeontological Scientific Trust (PAST), the Andrew W. Mellon Foundation, the L. S. B. Leakey Foundation Baldwin Fellowship, the United States Diplomatic Mission to South Africa, the French Embassy in South Africa, the National Geographic Society, the A. H. Schultz Foundation, the Oppenheimer and Ackerman families, Sir Richard Branson, and the Program to Enhance Scholarly and Creative Activities and the International Research Travel Award Grant of Texas A& M University all provided funding for this research. D. J. d. R. holds a Ray A. Rothrock ' 77 Fellowship at Texas A& M University, which provided additional funding. The University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology provided support and facilities. The authors declare that they have no real or apparent conflicts of interest. We thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; P. Msemwa and the National Museum and House of Culture of Tanzania; S. Potze of the Ditsong Museum; B. Billings of the School of Anatomical Sciences of the University of the Witwatersrand; W. Seconna of the Iziko South African Museum; and L. M. Jellema of the Cleveland Museum of Natural History for access to comparative fossil and extant primate and human materials in their care. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, B. Eloff, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given substantial support to this project include B. de Klerk, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, M. Peltier, J. Cheverud, and D. Roach. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens, by bona fide scientists.	Ackermann Rebecca Rogers, 2002, Anatomical Record, V269, P142, DOI 10.1002/ar.10119; Balter M, 2010, SCIENCE, V328, P154, DOI 10.1126/science.328.5975.154; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Cherry M., 2010, NATURE, DOI [10.1038/news.2010.171, DOI 10.1038/NEWS.2010.171]; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Irish JD, 2013, SCIENCE, V340, DOI 10.1126/science.1233062; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kimbel W. H., 2004, HUMAN EVOLUTION SERI; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Lague MR, 2008, J ANAT, V213, P670, DOI 10.1111/j.1469-7580.2008.00989.x; LELE S, 1995, AM J PHYS ANTHROPOL, V98, P73, DOI 10.1002/ajpa.1330980107; Moggi-Cecchi J, 1998, AM J PHYS ANTHROPOL, V106, P425, DOI 10.1002/(SICI)1096-8644(199808)106:4<425::AID-AJPA2>3.0.CO;2-I; Plavcan JM, 1997, J HUM EVOL, V32, P345, DOI 10.1006/jhev.1996.0096; Richtsmeier JT, 1998, J CRAN GENET DEV BIO, V18, P64; RICHTSMEIER JT, 1993, BIOL REV, V68, P381, DOI 10.1111/j.1469-185X.1993.tb00737.x; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Sokal RR, 1995, BIOMETRY; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	24	30	30	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1232997	10.1126/science.1232997	http://dx.doi.org/10.1126/science.1232997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580533				2022-12-24	WOS:000317341400002
J	Neuman, MD; Bosk, CL				Neuman, Mark D.; Bosk, Charles L.			The art of medicine Medicine and the radiant city	LANCET			English	Editorial Material							PERFORMANCE		[Neuman, Mark D.; Bosk, Charles L.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Neuman, Mark D.; Bosk, Charles L.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Bosk, Charles L.] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Neuman, MD (corresponding author), Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	neumanm@mail.med.upenn.edu						Bowker GC., 2000, SORTING THINGS OUT C; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Feinstein A. R, 1967, CLIN JUDGMENT; FEINSTEIN AR, 1994, ANN INTERN MED, V120, P799, DOI 10.7326/0003-4819-120-9-199405010-00012; Hughes Robert, 1991, THE SHOCK OF THE NEW; Latour B., 1998, SCIENCE IN ACTION HO; Le Corbusier, 1967, THE RADIANT CITY ELE; Scott James, 1998, SEEING STATE; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007	9	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 6	2013	381	9873					1176	1177		10.1016/S0140-6736(13)60788-6	http://dx.doi.org/10.1016/S0140-6736(13)60788-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122WU	23573526				2022-12-24	WOS:000317350100014
J	Britton, J; McNeill, A				Britton, John; McNeill, Ann			Nicotine regulation and tobacco harm reduction in the UK	LANCET			English	Editorial Material							CIGARETTES; SMOKING		[Britton, John] Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England; [McNeill, Ann] Kings Coll London, Inst Psychiat, UK Ctr Tobacco Control Studies, London WC2R 2LS, England	University of Nottingham; University of London; King's College London	Britton, J (corresponding author), Univ Nottingham, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England.	j.britton@virgin.net		McNeill, Ann/0000-0002-6223-4000				Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Gartner CE, 2007, LANCET, V369, P2010, DOI 10.1016/S0140-6736(07)60677-1; Medicines and Healthcare Products Regulatory Agency (MHRA), 2005, REP COMM SAF MED WOR; Moore D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1024; *ROYAL COLL PHYS T, 2007, HARM RED NIC ADD; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; Scientific Committee on Emerging and Newly Identified Health Risks, 2008, HLTH EFF SMOK TOB PR; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; West R, 2013, MONTHL TRACK KEY PER	10	5	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1879	1880		10.1016/S0140-6736(13)61122-8	http://dx.doi.org/10.1016/S0140-6736(13)61122-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163EV	23725716				2022-12-24	WOS:000320319500005
J	Freynhagen, R; Geisslinger, G; Schug, SA				Freynhagen, Rainer; Geisslinger, Gerd; Schug, Stephan A.			Opioids for chronic non-cancer pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS ASIPP GUIDELINES; NEUROPATHIC PAIN; CONTROLLED-RELEASE; CONTROLLED-TRIALS; AMERICAN SOCIETY; ACTING OPIOIDS; UNITED-STATES; MANAGEMENT; RISK; DEPENDENCE		[Freynhagen, Rainer] Benedictus Hosp Tutzing, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, D-82327 Tutzing, Germany; [Freynhagen, Rainer] Tech Univ Munich, Dept Anaesthesiol, D-80290 Munich, Germany; [Geisslinger, Gerd] Goethe Univ Frankfurt, Univ Hosp, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany; [Schug, Stephan A.] Univ Western Australia, Royal Perth Hosp, Sch Med & Pharmacol, Pharmacol Pharm & Anaesthesiol Unit, Perth, WA 6847, Australia	Technical University of Munich; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Royal Perth Hospital; University of Western Australia	Freynhagen, R (corresponding author), Benedictus Hosp Tutzing, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, Bahnhofstr 5, D-82327 Tutzing, Germany.	r.freynhagen@krankenhaus-tutzing.de	Schug, Stephan/G-1432-2010	Schug, Stephan/0000-0002-0302-2315; Freynhagen, Rainer/0000-0002-3759-1508				Anastassopoulos KP, 2012, J MANAGE CARE PHARM, V18, P615, DOI 10.18553/jmcp.2012.18.8.615; Annemans L, 2011, CLIN DRUG INVEST, V31, P73, DOI 10.2165/11536290-000000000-00000; Avouac J, 2007, OSTEOARTHR CARTILAGE, V15, P957, DOI 10.1016/j.joca.2007.02.006; Beaulieu AD, 2008, PAIN RES MANAG, V13, P103, DOI 10.1155/2008/903784; Birnbaum HG, 2011, PAIN MED, V12, P657, DOI 10.1111/j.1526-4637.2011.01075.x; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Brennan F, 2007, ANESTH ANALG, V105, P205, DOI 10.1213/01.ane.0000268145.52345.55; British Pain Society, 2010, OPIOIDS FOR PERSISTE; Camilleri M, 2011, AM J GASTROENTEROL, V106, P835, DOI 10.1038/ajg.2011.30; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Edlund MJ, 2007, PAIN, V129, P355, DOI 10.1016/j.pain.2007.02.014; Eisenberg E, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006146; Elliott Jennifer A, 2011, J Opioid Manag, V7, P145; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Freynhagen R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3002; Hollingshead J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651828.CD003726.pub3; Katz Nathaniel P, 2010, J Pain Palliat Care Pharmacother, V24, P141, DOI 10.3109/15360281003799098; Leider HL, 2011, AM J MANAG CARE, V17, P32; Li L, 2013, PAIN PHYSICIAN, V16, P77; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS1; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pS67; Manchikanti L, 2011, PAIN PHYSICIAN, V14, P91; Mercadante S, 2013, EXPERT OPIN INV DRUG, V22, P161, DOI 10.1517/13543784.2013.752460; Mercadante S, 2012, DRUGS, V72, P2327, DOI 10.2165/11642230-000000000-00000; Modesto-Lowe V, 2010, J GEN INTERN MED, V25, P305, DOI 10.1007/s11606-009-1225-0; National Institute for Health and Clinical Excellence, 2010, NEUROPATHIC PAIN THE, V96; National Opioid Use Guideline Group Canadian guideline for safe and effective use of opioids for chronic non cancer pain National Opioid Use Guideline Group (NOUGG), 2010, CANADIAN GUIDELINE F; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Nuesch E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003115.pub3; O'Donnell JB, 2009, J INT MED RES, V37, P1789, DOI 10.1177/147323000903700615; Obradovic M, 2012, CLIN THER, V34, P926, DOI 10.1016/j.clinthera.2012.02.011; Office of National Drug Control Policy, PRESCRIPTION DRUG AB; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Scharnagel R, 2013, SCHMERZ, V27, P7, DOI 10.1007/s00482-012-1278-6; Skurtveit S, 2011, PAIN, V152, P1555, DOI 10.1016/j.pain.2011.02.045; Soyka M, 2011, WORLD J BIOL PSYCHIA, V12, P160, DOI 10.3109/15622975.2011.561872; Tompkins DA, 2011, CURR PAIN HEADACHE R, V15, P129, DOI 10.1007/s11916-010-0171-1; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x; Webster Lynn, 2011, J Opioid Manag, V7, P235; Webster LR, 2008, PAIN MED, V9, P425, DOI 10.1111/j.1526-4637.2007.00343.x	45	21	21	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f2937	10.1136/bmj.f2937	http://dx.doi.org/10.1136/bmj.f2937			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DG	23719636				2022-12-24	WOS:000319948200005
J	Jangi, S				Jangi, Sushrut			Under the Medical Tent at the Boston Marathon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Jangi, S (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	10	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1953	1955		10.1056/NEJMp1305299	http://dx.doi.org/10.1056/NEJMp1305299			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194KD	23611490				2022-12-24	WOS:000322630700002
J	Shirey, KA; Lai, WD; Scott, AJ; Lipsky, M; Mistry, P; Pletneva, LM; Karp, CL; McAlees, J; Gioannini, TL; Weiss, J; Chen, WH; Ernst, RK; Rossignol, DP; Gusovsky, F; Blanco, JCG; Vogel, SN				Shirey, Kari Ann; Lai, Wendy; Scott, Alison J.; Lipsky, Michael; Mistry, Pragnesh; Pletneva, Lioubov M.; Karp, Christopher L.; McAlees, Jaclyn; Gioannini, Theresa L.; Weiss, Jerrold; Chen, Wilbur H.; Ernst, Robert K.; Rossignol, Daniel P.; Gusovsky, Fabian; Blanco, Jorge C. G.; Vogel, Stefanie N.			The TLR4 antagonist Eritoran protects mice from lethal influenza infection	NATURE			English	Article							1918 SPANISH INFLUENZA; ENDOTOXIN ANTAGONIST; TETRASODIUM E5564; CRYSTAL-STRUCTURE; UNITED-STATES; SEVERE SEPSIS; VIRUS; LIPOPOLYSACCHARIDE; ACTIVATION; INHIBITORS	There is a pressing need to develop alternatives to annual influenza vaccines and antiviral agents licensed for mitigating influenza infection. Previous studies reported that acute lung injury caused by chemical or microbial insults is secondary to the generation of host-derived, oxidized phospholipid that potently stimulates Toll-like receptor 4 (TLR4)-dependent inflammation(1). Subsequently, we reported that Tlr4(-/-) mice are highly refractory to influenza-induced lethality(2), and proposed that therapeutic antagonism of TLR4 signalling would protect against influenza-induced acute lung injury. Here we report that therapeutic administration of Eritoran (also known as E5564)-a potent, well-tolerated, synthetic TLR4 antagonist(3,4)-blocks influenza-induced lethality in mice, as well as lung pathology, clinical symptoms, cytokine and oxidized phospholipid expression, and decreases viral titres. CD14 and TLR2 are also required for Eritoran-mediated protection, and CD14 directly binds Eritoran and inhibits ligand binding to MD2. Thus, Eritoran blockade of TLR signalling represents a novel therapeutic approach for inflammation associated with influenza, and possibly other infections.	[Shirey, Kari Ann; Lai, Wendy; Mistry, Pragnesh; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Scott, Alison J.; Ernst, Robert K.] Univ Maryland, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Lipsky, Michael] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA; [Pletneva, Lioubov M.; Blanco, Jorge C. G.] Sigmovir Biosyst Inc, Rockville, MD 20850 USA; [Karp, Christopher L.; McAlees, Jaclyn] Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA; [Gioannini, Theresa L.; Weiss, Jerrold] Univ Iowa, Inflammat Program, Coralville, IA 52241 USA; [Gioannini, Theresa L.] Dept Vet Affairs Med Ctr, Iowa City, IA 52241 USA; [Chen, Wilbur H.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Rossignol, Daniel P.; Gusovsky, Fabian] Eisai Inc, Andover, MA 01810 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University System of Maryland; University of Maryland Baltimore; Eisai Co Ltd	Vogel, SN (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu	Blanco, Jorge/AAW-3752-2020	Karp, Christopher/0000-0002-0832-2659; Weiss, Jerrold/0000-0003-1476-4485; Ernst, Robert/0000-0001-5016-8694; Scott, Alison/0000-0001-6969-4707; Blanco, Jorge/0000-0002-6173-0213	National Institutes of Health [AI057575, AI018797, AI059372]; NCRR [K12-RR-023250]; VA Merit Award [1I01BX0000949-01A1]; Cystic Fibrosis Foundation RDP Center; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057575, R37AI018797, R01AI059372, R01AI018797, R56AI018797, T32AI007540] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Award(US Department of Veterans Affairs); Cystic Fibrosis Foundation RDP Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grants AI057575 (J.C.G.B.), AI018797 (S.N.V.), AI059372 (J.W.) and NCRR K12-RR-023250 (W. H. C.), VA Merit Award 1I01BX0000949-01A1 (T. L. G.) and Cystic Fibrosis Foundation RDP Center Grant (C.L.K.).	Blanco JCG, 2013, J VIROL, V87, P2036, DOI 10.1128/JVI.00638-12; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Esparza GA, 2012, INNATE IMMUN-LONDON, V18, P478, DOI 10.1177/1753425911422723; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; GOLDBLUM SE, 1993, J CELL PHYSIOL, V157, P13, DOI 10.1002/jcp.1041570103; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kalil AC, 2011, SHOCK, V36, P327, DOI 10.1097/SHK.0b013e318227980e; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lee RM, 2006, SCAND J IMMUNOL, V63, P81, DOI 10.1111/j.1365-3083.2005.01714.x; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Means TK, 1999, J IMMUNOL, V163, P6748; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Nhu QM, 2010, MUCOSAL IMMUNOL, V3, P29, DOI 10.1038/mi.2009.120; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Pauligk C, 2004, IMMUNOBIOLOGY, V209, P3, DOI 10.1016/j.imbio.2004.04.002; Polakos NK, 2006, AM J PATHOL, V168, P1169, DOI 10.2353/ajpath.2006.050875; Reid AH, 2001, MICROBES INFECT, V3, P81, DOI 10.1016/S1286-4579(00)01351-4; Shinya K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-97; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; Wong YN, 2003, J CLIN PHARMACOL, V43, P735, DOI 10.1177/0091270003254804; Yoon SI, 2010, P NATL ACAD SCI USA, V107, P10990, DOI 10.1073/pnas.1004153107	30	314	328	3	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					498	+		10.1038/nature12118	http://dx.doi.org/10.1038/nature12118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23636320	Green Accepted, Bronze			2022-12-24	WOS:000319254000050
J	Pham, JC; Pronovost, PJ; Skipper, GE				Pham, Julius Cuong; Pronovost, Peter J.; Skipper, Gregory E.			Identification of Physician Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pham, Julius Cuong] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD 21202 USA; [Pham, Julius Cuong; Pronovost, Peter J.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21202 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Surg & Hlth Policy & Management, Baltimore, MD 21202 USA; [Pham, Julius Cuong; Pronovost, Peter J.] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Skipper, Gregory E.] Promises Treatment Ctr, Profess Hlth Serv, Santa Monica, CA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Pham, JC (corresponding author), Johns Hopkins Univ, Sch Med, Armstrong Inst Patient Safety & Qual, 750 E Pratt St,15th Floor, Baltimore, MD 21202 USA.	jpham3@jhmi.edu						Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Fitzsimons MG, 2008, ANESTH ANALG, V107, P630, DOI 10.1213/ane.0b013e318176fefa; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; SHORE J H, 1987, Journal of the American Medical Association, V257, P2931, DOI 10.1001/jama.257.21.2931; Substance Abuse and Mental Health Services Administration, 2010, FED REG, V75, P22809; Zacher JL, 2004, ANN PHARMACOTHER, V38, P1525, DOI 10.1345/aph.1D632; ZWERLING C, 1992, JAMA-J AM MED ASSOC, V267, P91, DOI 10.1001/jama.267.1.91	8	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2101	2102		10.1001/jama.2013.4635	http://dx.doi.org/10.1001/jama.2013.4635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23629590				2022-12-24	WOS:000319229600022
J	Kao, D; Bartelson, BB; Khatri, V; Dart, R; Mehler, PS; Katz, D; Krantz, MJ				Kao, David; Bartelson, Becki Bucher; Khatri, Vaishali; Dart, Richard; Mehler, Philip S.; Katz, David; Krantz, Mori J.			Trends in Reporting Methadone-Associated Cardiac Arrhythmia, 1997-2011 An Analysis of Registry Data	ANNALS OF INTERNAL MEDICINE			English	Article							TORSADE-DE-POINTES; DATA-MINING ALGORITHMS; PHARMACOVIGILANCE DATABASES; QT PROLONGATION; LONG QT; OVERDOSE; INTERVAL; MAINTENANCE; RISK; SERTINDOLE	Background: Long-acting opioids are a leading cause of accidental death in the United States, and methadone is associated with greater mortality rates. Whether this increase is related to the proarrhythmic properties of methadone is unclear. Objective: To describe methadone-associated arrhythmia events reported in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Design: Description of national adverse event registry data before and after publication of a 2002 report describing an association between methadone and arrhythmia. Setting: FAERS, November 1997 and June 2011. Patients: Adults with QTc prolongation or torsade de pointes and ventricular arrhythmia or cardiac arrest. Measurements: FAERS reports before and after the 2002 report. Results: 1646 cases of ventricular arrhythmia or cardiac arrest and 379 cases of QTc prolongation or torsade de pointes were associated with methadone. Monthly reports of QTc prolongation or torsade de pointes increased from a mean of 0.3 (95% CI, 0.1 to 0.5) before the 2002 publication to a mean of 3.5 (CI, 2.5 to 4.8) after it. After 2000, methadone was the second-most common primary suspect in cases of QTc prolongation or torsade de pointes after dofetilide (a known proarrhythmic drug) and was associated with disproportionate reporting similar to that of antiarrhythmic agents known to promote torsade de pointes. Antiretroviral drugs for HIV were the most common coadministered drugs. Limitation: Reports to FAERs are voluntary and selective, and incidence rates cannot be determined from spontaneously reported data. Conclusion: Since 2002, reports to FAERS of methadone-associated arrhythmia have increased substantially and are disproportionately represented relative to other events with the drug. Coadministration of methadone with antiretrovirals in patients with HIV may pose particular risk.	Univ Colorado, Sch Med, Aurora, CO 80045 USA; Colorado Prevent Ctr Community Hlth, Aurora, CO USA; Rocky Mt Poison & Drug Ctr, Denver, CO 80204 USA; Denver Hlth, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Krantz, MJ (corresponding author), Denver Hlth Med Ctr, 777 Bannock St,MC 0960, Denver, CO 80204 USA.	mori.krantz@dhha.org	Kao, David P/K-3288-2013	Kao, David P/0000-0002-2832-9348; Dart, Richard/0000-0001-5989-9354	Colorado Clinical and Translational Sciences Institute; National Institutes of Health [2 T32 HL007822-12]; Leaffer family; University of Colorado Center for Women's Health Research; Agency for Healthcare Research and Quality [1 P01 HS021138-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS021138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007822] Funding Source: NIH RePORTER	Colorado Clinical and Translational Sciences Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leaffer family; University of Colorado Center for Women's Health Research; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: Data management and statistical analysis was supported by the Colorado Clinical and Translational Sciences Institute. Dr. Kao is supported by the National Institutes of Health (grant 2 T32 HL007822-12), a grant from the Leaffer family, and the University of Colorado Center for Women's Health Research. Dr. Krantz is partially supported by the Agency for Healthcare Research and Quality (grant 1 P01 HS021138-01).	Alvarez Y, 2010, DRUG SAFETY, V33, P475, DOI 10.2165/11534410-000000000-00000; [Anonymous], 2010, BET SOT HCI PACK INS; [Anonymous], DRUGS FDA DAT FIL; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Castillo R, 2002, ANN PHARMACOTHER, V36, P1006; Chugh SS, 2008, AM J MED, V121, P66, DOI 10.1016/j.amjmed.2007.10.009; Cruciani RA, 2008, J PAIN SYMPTOM MANAG, V36, P545, DOI 10.1016/j.jpainsymman.2007.11.003; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Falconer M, 2007, Ir Med J, V100, P631; Florian J, 2012, CLIN PHARMACOL THER, V91, P666, DOI 10.1038/clpt.2011.273; Food And Drug Administration Public Health Service U S Department Of Health And Human Services, 2011, J Pain Palliat Care Pharmacother, V25, P80, DOI 10.3109/15360288.2010.549553; Gourevitch MN, 2009, ANN INTERN MED, V150, P417, DOI 10.7326/0003-4819-150-6-200903170-00111; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Hauben M, 2007, DRUG SAFETY, V30, P143, DOI 10.2165/00002018-200730020-00004; Hillebrand J, 2001, J SUBST ABUSE TREAT, V21, P155, DOI 10.1016/S0740-5472(01)00198-2; Johnson K, 2012, BIOINFORMATICS, V28, P3123, DOI 10.1093/bioinformatics/bts576; Kao DP, 2012, PHARMACOTHERAPY, V32, P767, DOI 10.1002/j.1875-9114.2012.01118.x; Katchman AN, 2002, J PHARMACOL EXP THER, V303, P688, DOI 10.1124/jpet.102.038240; Kocheril AG, 1997, PACE, V20, P2810, DOI 10.1111/j.1540-8159.1997.tb05439.x; Krantz MJ, 2005, J ADDICT DIS, V24, P53, DOI 10.1300/J069v24n01_05; Krantz MJ, 2002, ANN INTERN MED, V137, P501, DOI 10.7326/0003-4819-137-6-200209170-00010; Krantz MJ, 2007, J ADDICT DIS, V26, P79, DOI 10.1300/J069v26n04_10; Krantz MJ, 2009, ANN INTERN MED, V150, P387, DOI 10.7326/0003-4819-150-6-200903170-00103; Martin JA, 2011, J ADDICT DIS, V30, P283, DOI 10.1080/10550887.2011.610710; McAdams M, 2008, PHARMACOEPIDEM DR S, V17, P229, DOI 10.1002/pds.1535; Moore N, 2003, PHARMACOEPIDEM DR S, V12, P271, DOI 10.1002/pds.848; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Paulozzi Leonard J., 2012, Morbidity and Mortality Weekly Report, V61, P493; Paulozzi LJ, 2009, ADDICTION, V104, P1541, DOI 10.1111/j.1360-0443.2009.02650.x; Pearson RK, 2009, INT J MED INFORM, V78, pE97, DOI 10.1016/j.ijmedinf.2009.01.001; Reinsch N, 2009, HIV CLIN TRIALS, V10, P261, DOI 10.1310/hct1004-261; Riera Andres Ricardo Perez, 2008, Cardiol J, V15, P209; Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics, 2010, JOINT M AN LIF SUPP; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Roxane Laboratories, 2006, DOL HYDR PACK INS; Sani Mahmoud U, 2005, J Natl Med Assoc, V97, P1657; Starrels JL, 2011, J GEN INTERN MED, V26, P958, DOI 10.1007/s11606-011-1648-2; Tseng ZH, 2012, J AM COLL CARDIOL, V59, P1891, DOI 10.1016/j.jacc.2012.02.024; U.S. Food and Drug Administration, 2012, MEDWATCH ONL VOL REP; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2012, FD ADV EV REP SYST A; Viskin S, 2005, HEART RHYTHM, V2, P569, DOI 10.1016/j.hrthm.2005.02.011; Von Korff M, 2011, ANN INTERN MED, V155, P325, DOI 10.7326/0003-4819-155-5-201109060-00011; Waller P, 2003, PHARMACOEPIDEM DR S, V12, P283, DOI 10.1002/pds.849; Warner Margaret, 2011, NCHS Data Brief, P1; Wedam EF, 2007, ARCH INTERN MED, V167, P2469, DOI 10.1001/archinte.167.22.2469; World Health Organization, WHO MOD LISTS ESS ME	46	39	39	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					735	+		10.7326/0003-4819-158-10-201305210-00008	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689766	Green Accepted			2022-12-24	WOS:000319666200016
J	Mendelsohn, BA				Mendelsohn, Bryce A.			What Is Natural?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mendelsohn, BA (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	mendelsohnb@peds.ucsf.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1783	1784		10.1001/jama.2012.205105	http://dx.doi.org/10.1001/jama.2012.205105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632721				2022-12-24	WOS:000318235600025
J	Luyckx, VA; Naicker, S; McKee, M				Luyckx, Valerie A.; Naicker, Saraladevi; McKee, Martin			Equity and economics of kidney disease in sub-Saharan Africa	LANCET			English	Editorial Material							DIALYSIS; BURDEN		[Luyckx, Valerie A.; McKee, Martin] London Sch Hyg & Trop Med, London WC1, England; [Luyckx, Valerie A.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Naicker, Saraladevi] Univ Witwatersrand, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Alberta; University of Witwatersrand	Luyckx, VA (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	vluyckx@ualberta.ca	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Luyckx, Valerie/J-9747-2019	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Luyckx, Valerie/0000-0001-7066-8135; Naicker, Saraladevi/0000-0002-7058-9725				Abu-Aisha H, 2010, PERITON DIALYSIS INT, V30, P23, DOI 10.3747/pdi.2008.00226; Arogundade FA, 2011, AFR HEALTH SCI, V11, P594; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dreyer G., 2012, BR J RENAL MED, V17, P24; Fresenius Medical Care, 2012, ESRD PAT 2011 GLOB P; Garcia GG, 2012, SAUDI J KIDNEY DIS T, V23, P215; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Naicker S, 2010, CLIN NEPHROL, V74, pS13; Pozo ME, 2012, TRANSPL INT, V25, P652, DOI 10.1111/j.1432-2277.2012.01468.x; Tantivess S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f462; The World Bank, GNI PER CAP ATL METH; WHO, 2011, WORLD GLOB EXP ATL	14	26	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 13	2013	382	9887					103	104		10.1016/S0140-6736(13)60817-X	http://dx.doi.org/10.1016/S0140-6736(13)60817-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187JY	23727172				2022-12-24	WOS:000322115300004
J	Lin, SJ; Foley, J; Jiang, TX; Yeh, CY; Wu, P; Foley, A; Yen, CM; Huang, YC; Cheng, HC; Chen, CF; Reeder, B; Jee, SH; Widelitz, RB; Chuong, CM				Lin, S. J.; Foley, J.; Jiang, T. X.; Yeh, C. Y.; Wu, P.; Foley, A.; Yen, C. M.; Huang, Y. C.; Cheng, H. C.; Chen, C. F.; Reeder, B.; Jee, S. H.; Widelitz, R. B.; Chuong, C. M.			Topology of Feather Melanocyte Progenitor Niche Allows Complex Pigment Patterns to Emerge	SCIENCE			English	Article							COLOR PATTERNS; AGOUTI; REGENERATION; PROTEIN; SKIN; DIFFERENTIATION; EXPRESSION; MODEL	Color patterns of bird plumage affect animal behavior and speciation. Diverse patterns are present in different species and within the individual. Here, we study the cellular and molecular basis of feather pigment pattern formation. Melanocyte progenitors are distributed as a horizontal ring in the proximal follicle, sending melanocytes vertically up into the epithelial cylinder, which gradually emerges as feathers grow. Different pigment patterns form by modulating the presence, arrangement, or differentiation of melanocytes. A layer of peripheral pulp further regulates pigmentation via patterned agouti expression. Lifetime feather cyclic regeneration resets pigment patterns for physiological needs. Thus, the evolution of stem cell niche topology allows complex pigment patterning through combinatorial co-option of simple regulatory mechanisms.	[Lin, S. J.; Jiang, T. X.; Yeh, C. Y.; Wu, P.; Widelitz, R. B.; Chuong, C. M.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Lin, S. J.; Yen, C. M.; Huang, Y. C.] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Lin, S. J.; Yen, C. M.; Huang, Y. C.] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Lin, S. J.; Yen, C. M.; Jee, S. H.] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Lin, S. J.; Yen, C. M.; Jee, S. H.] Coll Med, Taipei, Taiwan; [Lin, S. J.; Chuong, C. M.] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Lin, S. J.] Natl Taiwan Univ, Genomes & Syst Biol Program, Taipei 10764, Taiwan; [Lin, S. J.] Natl Taiwan Univ, Ctr Syst Biol, Taipei 10764, Taiwan; [Foley, J.] Indiana Univ Sch Med, Dept Med Sci, Bloomington, IN USA; [Foley, J.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Foley, A.] Foley Family Farm, Unionville, IN USA; [Cheng, H. C.] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Cheng, H. C.; Chen, C. F.; Chuong, C. M.] Natl Chung Hsing Univ, IEGG Ctr, Ctr Integrat & Evolutionary Galliformes Genom, Taichung 40227, Taiwan; [Chen, C. F.] Natl Chung Hsing Univ, Dept Anim Sci, Coll Agr & Nat Resources, Taichung 40227, Taiwan	University of Southern California; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Chuong, CM (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	cmchuong@usc.edu		Lin, Sung-Jan/0000-0003-1325-3464; Cheng, Hsu-Chen/0000-0002-6586-6425; JEE, SHIOU-HWA/0000-0001-6737-6297; Yeh, Chao-Yuan/0000-0002-1947-1596	U.S. NIH [AR42177, AR47364, AR060306]; Taiwan National Health Research Institutes [PS9803]; Taiwan National Science Council [NSC99-2320-B-002-004-MY3, NSC101-2325-B-002-081]; National Taiwan University [101R7602D4, 100S-1580, 101S-1857, UN102-047]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060306, R01AR042177, R01AR047364] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan National Health Research Institutes; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by U.S. NIH grants AR42177, AR47364, and AR060306 (C.M.C., R.B.W., and T.X.J.); Taiwan National Health Research Institutes grant PS9803 (S.J.L.); Taiwan National Science Council grants NSC99-2320-B-002-004-MY3 and NSC101-2325-B-002-081 (S.J.L.); National Taiwan University grant 101R7602D4 and Hospital grants 100S-1580, 101S-1857, and UN102-047 (S.J.L.). The authors thank G. S. Barsh, S. Kondo, and E. K. Nishimura for comments. We dedicate this paper to the memory of Anne Foley and Gien-Sum Lin.	Aberdam E, 1998, J BIOL CHEM, V273, P19560, DOI 10.1074/jbc.273.31.19560; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; Chuong CM, 2009, INT J DEV BIOL, V53, P653, DOI 10.1387/ijdb.082594cc; Darwin C, 1859, ORIGINS SPECIES MEAN; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; Hellstrom AR, 2010, PIGM CELL MELANOMA R, V23, P521, DOI 10.1111/j.1755-148X.2010.00700.x; Hill GE, 2006, DIGIT SIGNAL PROCESS; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Lillie F. R., 1941, Physiological Zoology Chicago, V14, P103; Lin SJ, 2013, DEV GROWTH DIFFER, V55, P139, DOI 10.1111/dgd.12024; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Lucas A.M., 1972, AGR HDB, V362; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Montalenti G, 1934, J EXP ZOOL, V69, P269, DOI 10.1002/jez.1400690205; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Prum RO, 2002, P ROY SOC B-BIOL SCI, V269, P781, DOI 10.1098/rspb.2001.1896; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Stettenheim P, 2011, SCIENCE, V333, P939, DOI 10.1126/science.1209682; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Yu MK, 2004, INT J DEV BIOL, V48, P181, DOI 10.1387/ijdb.15272383; Yue ZC, 2005, NATURE, V438, P1026, DOI 10.1038/nature04222; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	28	80	81	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1442	1445		10.1126/science.1230374	http://dx.doi.org/10.1126/science.1230374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23618762	Green Accepted			2022-12-24	WOS:000320647000039
J	Zeitlin, C; Hassler, DM; Cucinotta, FA; Ehresmann, B; Wimmer-Schweingruber, RF; Brinza, DE; Kang, S; Weigle, G; Bottcher, S; Bohm, E; Burmeister, S; Guo, J; Kohler, J; Martin, C; Posner, A; Rafkin, S; Reitz, G				Zeitlin, C.; Hassler, D. M.; Cucinotta, F. A.; Ehresmann, B.; Wimmer-Schweingruber, R. F.; Brinza, D. E.; Kang, S.; Weigle, G.; Boettcher, S.; Boehm, E.; Burmeister, S.; Guo, J.; Koehler, J.; Martin, C.; Posner, A.; Rafkin, S.; Reitz, G.			Measurements of Energetic Particle Radiation in Transit to Mars on the Mars Science Laboratory	SCIENCE			English	Article							SPACE EXPLORATION; TRANSPORT	The Mars Science Laboratory spacecraft, containing the Curiosity rover, was launched to Mars on 26 November 2011, and for most of the 253-day, 560-minion-kilometer cruise to Mars, the Radiation Assessment Detector made detailed measurements of the energetic particle radiation environment inside the spacecraft. These data provide insights into the radiation hazards that would be associated with a human mission to Mars. We report measurements of the radiation dose, dose equivalent, and linear energy transfer spectra. The dose equivalent for even the shortest round-trip with current propulsion systems and comparable shielding is found to be 0.66 +/- 0.12 sievert.	[Zeitlin, C.; Hassler, D. M.; Ehresmann, B.; Rafkin, S.] SW Res Inst, Boulder, CO USA; [Cucinotta, F. A.; Guo, J.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Wimmer-Schweingruber, R. F.; Boettcher, S.; Boehm, E.; Burmeister, S.; Koehler, J.; Martin, C.] Univ Kiel, Kiel, Germany; [Brinza, D. E.; Kang, S.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Weigle, G.] SW Res Inst, San Antonio, TX USA; [Posner, A.] NASA Headquarters, Washington, DC USA; [Reitz, G.] German Aerosp Ctr DLR, Cologne, Germany	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Kiel; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Southwest Research Institute; National Aeronautics & Space Administration (NASA); Helmholtz Association; German Aerospace Centre (DLR)	Zeitlin, C (corresponding author), SW Res Inst, Boulder, CO USA.	zeitlin@boulder.swri.edu	Cucinotta, Francis/AAZ-5941-2020; Guo, Jingnan/ABB-3749-2021; Wimmer-Schweingruber, Robert/AAQ-5794-2021; Reitz, Guenther/ABC-8921-2021	Guo, Jingnan/0000-0002-8707-076X; Wimmer-Schweingruber, Robert/0000-0002-7388-173X; Posner, Arik/0000-0003-1572-8734	NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL) [1273039]; German Aerospace Center (DLR); DLR's Space Administration [50QM0501, 50 QM1201]; NASA	NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); DLR's Space Administration; NASA(National Aeronautics & Space Administration (NASA))	The RAD is supported by NASA (Human Exploration and Operations Mission Directorate) under Jet Propulsion Laboratory (JPL) subcontract 1273039 to the Southwest Research Institute and in Germany by the German Aerospace Center (DLR) and DLR's Space Administration, grant numbers 50QM0501 and 50 QM1201, to the Christian Albrechts University, Kid. Part of this research was carried out at JPL, California Institute of Technology, under a contact with NASA. We appreciate discussions with P. O'Neill and M. Kim at NASA's JSC and with S. Blattnig, F. Badavi, T. Slaba, and C. Mertens of NASA's Langley Research Center. We extend thanks to I. Simmonds, I. Grotzinger, I. Crisp, A. Vasvada, H. Mortensen, and the Operations Product Generation Subsystem team at NASA-JPL. We also thank M. Meyer, E. Stolper, G. Allen, C. Moore, and V. Friedensen at NASA headquarters and H. Witte at DLR in Germany for their support of the RAD over the years. The data used in this paper are archived in the NASA Planetary Data System's Planetary Plasma Interactions Node at the University of California, Los Angeles. The archival volume includes the full binary raw data files, detailed descriptions of the structures therein, and higher-level data products in human-readable form. The PPI node is hosted at http://ppi.pds.nasa.gov/.	Aghara SK, 2009, NUCL INSTRUM METH B, V267, P1115, DOI 10.1016/j.nimb.2009.01.136; [Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 1996, RADIATION HAZARDS TO; [Anonymous], 2006, NCRP REPORT NO 153; [Anonymous], 1993, ICRU REPORT 51; [Anonymous], 2000, NCRP REPORT NO 132; [Anonymous], 2006, HEALTH RISKS FROM EX; BADHWAR GD, 1992, NUCL TRACKS RAD MEAS, V20, P403; Cucinotta F. A., 2011, NASA TECHNICAL PAPER; Cucinotta F. A., 2013, NASA TECHNICAL PAPER; Cucinotta FA, 2006, RADIAT MEAS, V41, P1235, DOI 10.1016/j.radmeas.2006.03.012; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2011, RADIAT RES, V176, P102, DOI 10.1667/RR2540.1; Drake B. G., 2010, AER C 2010 IEEE, P1, DOI [DOI 10.1109/AERO.2010.5446736, 10.1109/AERO.2010.5446736]; Hassler DM, 2012, SPACE SCI REV, V170, P503, DOI 10.1007/s11214-012-9913-1; Kohler J, 2011, NUCL INSTRUM METH B, V269, P2641, DOI 10.1016/j.nimb.2011.07.021; Koontz SL, 2005, NSREC: 2005 IEEE Radiation Effects Data Workshop, Workshop Record, P110; McKenna-Lawlor S, 2012, PLANET SPACE SCI, V63-64, P123, DOI 10.1016/j.pss.2011.06.017; Mrigakshi AI, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017611; Norman RB, 2012, ADV SPACE RES, V50, P146, DOI 10.1016/j.asr.2012.03.023; O'Neill PM, 2010, IEEE T NUCL SCI, V57, P3148, DOI 10.1109/TNS.2010.2083688; Onsager TG, 1996, P SOC PHOTO-OPT INS, V2812, P281, DOI 10.1117/12.254075; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; Posner A, 2005, ADV SPACE RES, V36, P1426, DOI 10.1016/j.asr.2004.11.040; Posner A, 2007, SPACE WEATHER, V5, DOI 10.1029/2006SW000268; Sato T, 2011, RADIAT ENVIRON BIOPH, V50, P115, DOI 10.1007/s00411-010-0330-0; Schwadron NA, 2010, SPACE WEATHER, V8, DOI 10.1029/2010SW000567; Slaba TC, 2010, J COMPUT PHYS, V229, P9397, DOI 10.1016/j.jcp.2010.09.010; Usoskin IG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011250; Wilson J., 1995, NASA TECHNICAL PAPER; Wilson J. W., 1997, NASA TECHNICAL PAPER	31	368	382	8	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1080	1084		10.1126/science.1235989	http://dx.doi.org/10.1126/science.1235989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723233				2022-12-24	WOS:000319664500040
J	Kasuga, H; Fukuyama, M; Kitazawa, A; Kontani, K; Katada, T				Kasuga, Hidefumi; Fukuyama, Masamitsu; Kitazawa, Aya; Kontani, Kenji; Katada, Toshiaki			The microRNA miR-235 couples blast-cell quiescence to the nutritional state	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; STEM-CELL; NUCLEAR FACTOR; ARREST; LIN-4; EXPRESSION; GERMLINE; LINEAGES; BEHAVIOR	The coordination of stem-and blast-cell behaviours, such as self-renewal, differentiation and quiescence, with physiological changes underlies growth, regeneration and tissue homeostasis(1-3). Germline stem and somatic blast cells in newly hatched Caenorhabditis elegans larvae can suspend postembryonic development, which consists of diverse cellular events such as migration, proliferation and differentiation, until the nutritional state becomes favourable (termed L1 diapause(4-6)). Although previous studies showed that the insulin/insulin-like growth factor (IGF) signalling (IIS) pathway regulates this developmental quiescence(5-8), the detailed mechanism by which the IIS pathway enables these multipotent cells to respond to nutrient availability is unknown. Here we show in C. elegans that the microRNA (miRNA) miR-235, a sole orthologue of mammalian miR-92 from the oncogenicmiR-17-92 cluster(9,10), acts in the hypodermis and glial cells to arrest postembryonic developmental events in both neuroblasts and mesoblasts. Expression of mir-235 persists during L1 diapause, and decreases upon feeding in a manner dependent on the IIS pathway. Upregulation of one of the miR-235 targets, nhr-91, which encodes an orthologue of mammalian germ cell nuclear factor, is responsible for defects caused by loss of the miRNA. Our findings establish a novel role of a miR-92 orthologue in coupling blast-cell behaviours to the nutritional state.	[Kasuga, Hidefumi; Fukuyama, Masamitsu; Kitazawa, Aya; Kontani, Kenji; Katada, Toshiaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Physiol Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Fukuyama, M (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Physiol Chem Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mfukuyam@mol.f.u-tokyo.ac.jp			National Institutes of Health National Center for Research Resources; MITANI Lab through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science KAKENHI [23229001, 23370083]; MEXT KAKENHI [24657081, 23116703]	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MITANI Lab through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Fire, A. Frand, Y. Iino, S. Mitani, X. Wei and K. Shen for reagents and strains, and K. Iki for comments on the manuscript. Some C. elegans strains used in this study were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources, and the MITANI Lab through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was supported by Japan Society for the Promotion of Science KAKENHI grant numbers 23229001 (T. K.), 23370083 (K. K.), and MEXT KAKENHI grant numbers 24657081 (T. K.), 23116703 (M.F.).	Ables ET, 2011, CELL STEM CELL, V8, P352, DOI 10.1016/j.stem.2011.03.004; Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Fukuyama M, 2012, BIOL OPEN, V1, P929, DOI 10.1242/bio.2012836; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gems D, 1998, GENETICS, V150, P129; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hong Y, 1998, DEVELOPMENT, V125, P3585; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Jasper H, 2010, CELL METAB, V12, P561, DOI 10.1016/j.cmet.2010.11.010; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Meli VS, 2010, MOL BIOL CELL, V21, P1648, DOI 10.1091/mbc.E08-07-0708; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	29	38	39	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					503	+		10.1038/nature12117	http://dx.doi.org/10.1038/nature12117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644454				2022-12-24	WOS:000319254000051
J	Park, S; Li, XM; Kim, HM; Singh, CR; Tian, G; Hoyt, MA; Lovell, S; Battaile, KP; Zolkiewski, M; Coffino, P; Roelofs, J; Cheng, YF; Finley, D				Park, Soyeon; Li, Xueming; Kim, Ho Min; Singh, Chingakham Ranjit; Tian, Geng; Hoyt, Martin A.; Lovell, Scott; Battaile, Kevin P.; Zolkiewski, Michal; Coffino, Philip; Roelofs, Jeroen; Cheng, Yifan; Finley, Daniel			Reconfiguration of the proteasome during chaperone-mediated assembly	NATURE			English	Article							YEAST 26S PROTEASOME; REGULATORY PARTICLE; STRUCTURAL BASIS; 20S PROTEASOMES; S PROTEASOME; ATPASES; SUBUNIT; PATHWAY; CORE; GATE	The proteasomal ATPase ring, comprising Rpt1-Rpt6, associates with the heptameric alpha-ring of the proteasome core particle (CP) in the mature proteasome, with the Rpt carboxy-terminal tails inserting into pockets of the alpha-ring(1-4). Rpt ring assembly is mediated by four chaperones, each binding a distinct Rpt subunit(5-10). Here we report that the base subassembly of the Saccharomyces cerevisiae proteasome, which includes the Rpt ring, forms a high-affinity complex with the CP. This complex is subject to active dissociation by the chaperones Hsm3, Nas6 and Rpn14. Chaperone-mediated dissociation was abrogated by a non-hydrolysable ATP analogue, indicating that chaperone action is coupled to nucleotide hydrolysis by the Rpt ring. Unexpectedly, synthetic Rpt tail peptides bound alpha-pockets with poor specificity, except for Rpt6, which uniquely bound the alpha 2/alpha 3-pocket. Although the Rpt6 tail is not visualized within an alpha-pocket in mature proteasomes(2-4), it inserts into the alpha 2/alpha 3-pocket in the base-CP complex and is important for complex formation. Thus, the Rpt-CP interface is reconfigured when the lid complex joins the nascent proteasome to form the mature holoenzyme.	[Park, Soyeon; Tian, Geng; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Park, Soyeon] Univ Colorado, MCD Biol, Boulder, CO 80309 USA; [Li, Xueming; Kim, Ho Min; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, WM Keck Adv Microscopy Lab, San Francisco, CA 94158 USA; [Singh, Chingakham Ranjit; Roelofs, Jeroen] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Hoyt, Martin A.; Coffino, Philip] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lovell, Scott] Univ Kansas, Del Shankel Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66047 USA; [Battaile, Kevin P.] IMCA CAT Hauptman Woodward Med Res Inst, Argonne, IL 60439 USA; [Zolkiewski, Michal] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Francisco; Kansas State University; University of California System; University of California San Francisco; University of Kansas; Hauptman Woodward Medical Research Institute; Kansas State University	Roelofs, J (corresponding author), Kansas State Univ, Div Biol, 338 Ackert Hall, Manhattan, KS 66506 USA.	jroelofs@ksu.edu; ycheng@ucsf.edu; daniel_finley@hms.harvard.edu	Kim, Ho Min/G-2712-2011; Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465; Cheng, Yifan/0000-0001-9535-0369; Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health (NIH) [R01GM082893, 1S10RR026814-01]; University of California San Francisco Program for Breakthrough Biomedical Research (New Technology Award); Johnson Cancer Research Center; National Center for Research Resources [5P20RR017708, P20 RR016475]; NIH [8 P20 GM103420, P20 GM103418, R01GM045335, R37GM043601]; Charles A. King Trust Postdoctoral Research Fellowship Program of the Medical Foundation; US Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814, P20RR017708, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420, P20GM103418, R01GM098672, R37GM043601, R01GM082893, R01GM045335] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Program for Breakthrough Biomedical Research (New Technology Award); Johnson Cancer Research Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust Postdoctoral Research Fellowship Program of the Medical Foundation; US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schmidt, T. Walz, C. Chen, and Finley laboratory members for suggestions, and C. Mann for antibodies. This work was supported in part by grants from the National Institutes of Health (NIH; R01GM082893 and 1S10RR026814-01), the University of California San Francisco Program for Breakthrough Biomedical Research (New Technology Award) to Y.C.; the Johnson Cancer Research Center, the National Center for Research Resources (5P20RR017708 and P20 RR016475) and NIH (8 P20 GM103420 and P20 GM103418) to J.R.; and grants from the NIH to P. C. (R01GM045335) and D. F. (R37GM043601). S. P. was supported by the Charles A. King Trust Postdoctoral Research Fellowship Program of the Medical Foundation. Use of IMCA-CAT was supported by the Industrial Macromolecular Crystallography Association though a contract with the Hauptman-Woodward MRI. Use of the Advanced Photon Source was supported by the US Department of Energy (contract no. DE-AC02-06CH11357).	Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Takagi K, 2012, J BIOL CHEM, V287, P12172, DOI 10.1074/jbc.M112.345876; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035	25	54	55	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					512	516		10.1038/nature12123	http://dx.doi.org/10.1038/nature12123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644457	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000319254000053
J	Fromm, G; Gilchrist, DA; Adelman, K				Fromm, George; Gilchrist, Daniel A.; Adelman, Karen			SnapShot! Transcription Regulation: Pausing	CELL			English	Editorial Material							ELONGATION; COMPLEX		[Fromm, George; Gilchrist, Daniel A.; Adelman, Karen] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Fromm, G (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA.		Fromm, George/GYA-1316-2022	Fromm, George/0000-0002-7049-0274; Gilchrist, Daniel/0000-0003-1668-2790; Adelman, Karen/0000-0001-5364-334X	Intramural NIH HHS Funding Source: Medline; NIEHS NIH HHS [Z01 ES101987] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987, ZIAES101987] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	11	6	6	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					930	+		10.1016/j.cell.2013.04.011	http://dx.doi.org/10.1016/j.cell.2013.04.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663787	Bronze			2022-12-24	WOS:000318844000020
J	Garrett, WS				Garrett, Wendy S.			Kwashiorkor and the Gut Microbiota	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Garrett, WS (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Garrett, Wendy/0000-0002-5092-0150	NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA154426] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Oren A, 2011, NAT REV MICROBIOL, V9, P279; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	5	12	12	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1746	1747		10.1056/NEJMcibr1301297	http://dx.doi.org/10.1056/NEJMcibr1301297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134MN	23635056				2022-12-24	WOS:000318214400013
J	Roed, C; Omland, LH; Skinhoj, P; Rothman, KJ; Sorensen, HT; Obel, N				Roed, Casper; Omland, Lars Haukali; Skinhoj, Peter; Rothman, Kenneth J.; Sorensen, Henrik Toft; Obel, Niels			Educational Achievement and Economic Self-sufficiency in Adults After Childhood Bacterial Meningitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM MORTALITY; MENINGOCOCCAL DISEASE; BIRTH-WEIGHT; FOLLOW-UP; CHILDREN; OUTCOMES; AGE; RISK; DENMARK; INFANCY	Importance To our knowledge, no previous study has examined functioning in adult life among persons who had bacterial meningitis in childhood. Objective To study educational achievement and economic self-sufficiency in adults diagnosed as having bacterial meningitis in childhood. Design, Setting, and Participants Nationwide population-based cohort study using national registries of Danish-born children diagnosed as having meningococcal, pneumococcal, or Haemophilus influenzae meningitis in the period 1977-2007 (n=2784 patients). Comparison cohorts from the same population individually matched on age and sex were identified, as were siblings of all study participants. End of study period was 2010. Main Outcomes and Measures Cumulative incidences of completed vocational education, high school education, higher education, time to first full year of economic self-sufficiency, and receipt of disability pension and differences in these outcomes at age 35 years among meningitis patients, comparison cohorts, and siblings. Results By age 35 years, among persons who had a history of childhood meningococcal (n=1338), pneumococcal (n=455), and H influenzae (n=991) meningitis, an estimated 11.0% (41.5% vs 52.5%; 95% CI, 7.3%-14.7%), 10.2% (42.6% vs 52.8%; 95% CI, 3.8%-16.6%), and 5.5% (47.7% vs 53.2%; 95% CI, 1.9%-9.1%) fewer persons, respectively, had completed high school and 7.9% (29.3% vs 37.2%; 95% CI, 1.6%-14.2%), 8.9% (28.1% vs 37.0%; 95% CI, 0.6%-17.2%), and 6.5% (33.5% vs 40.0%; 95% CI, 1.4%-11.6%) fewer had attained a higher education compared with individuals from the comparison cohort. Siblings of meningococcal meningitis patients also had lower educational achievements, while educational achievements of siblings of pneumococcal and H influenzae meningitis patients did not differ substantially from those in the general population. At end of follow-up, 3.8% (90.3% vs 94.1%; 95% CI, 1.1%-6.5%), 10.6% (84.0% vs 94.6%; 95% CI, 5.1%-16.1%), and 4.3% (90.6% vs 94.9%; 95% CI, 2.0%-6.6%) fewer meningococcal, pneumococcal, and H influenzae meningitis patients were economically self-sufficient and 1.5% (3.7% vs 2.3%; 95% CI, -0.2% to 3.2%), 8.7% (10.0% vs 1.3%; 95% CI, 5.0%-12.4%), and 3.7% (6.2% vs 2.5%; 95% CI, 1.6%-5.8%) more received disability pension compared with individuals from the comparison cohort. Conclusions and Relevance In a Danish population, bacterial meningitis in childhood was associated with lower educational achievement and economic self-sufficiency in adult life. This association may apply particularly to pneumococcal and H influenzae meningitis, whereas for meningococcal meningitis the lower educational achievement may be family-related. JAMA. 2013;309(16):1714-1721 www.jama.com	[Roed, Casper; Omland, Lars Haukali; Skinhoj, Peter; Obel, Niels] Copenhagen Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Rothman, Kenneth J.] RTI Hlth Solut, Res Triangle Inst, Res Triangle Pk, NC USA; [Rothman, Kenneth J.; Sorensen, Henrik Toft] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark	University of Copenhagen; Research Triangle Institute; Boston University; Aarhus University	Roed, C (corresponding author), Copenhagen Univ Hosp, Dept Infect Dis, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	casper.roed@rh.regionh.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Obel, Niels/0000-0002-5031-0045; Roed, Casper/0000-0001-8987-5230; Rothman, Kenneth/0000-0003-2398-1705; Omland, Lars Haukali/0000-0002-5338-8948	Faculty of Health Sciences, Copenhagen University; NOVO Nordisk Foundation	Faculty of Health Sciences, Copenhagen University; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The work was supported by the Faculty of Health Sciences, Copenhagen University, and the NOVO Nordisk Foundation.	Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Bedford H, 2001, BRIT MED J, V323, P533, DOI 10.1136/bmj.323.7312.533; Carter JA, 2003, BRAIN RES REV, V43, P57, DOI 10.1016/S0165-0173(03)00192-9; Christiansen AH, 1993, PURULENT MENINGITIS; Christiansen AH, 1989, HAEMOPHILUS INFLUENZ; Christie D, 2011, EUR J PEDIATR, V170, P997, DOI 10.1007/s00431-010-1390-5; de Louvois J, 2007, ARCH DIS CHILD, V92, P959, DOI 10.1136/adc.2006.105916; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; Gianinazzi C, 2003, ACTA NEUROPATHOL, V105, P499, DOI 10.1007/s00401-003-0672-7; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Hansen ABE, 2007, J INFECT DIS, V195, P230, DOI 10.1086/510246; Heyderman RS, 2004, ARCH DIS CHILD, V89, P1064, DOI 10.1136/adc.2003.036004; Howitz MF, 2008, EPIDEMIOL INFECT, V136, P1088, DOI 10.1017/S0950268807009466; Howitz M, 2008, SCAND J INFECT DIS, V40, P881, DOI 10.1080/00365540802325914; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lee CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000374; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mathiasen R, 2010, PEDIATRICS, V126, pE1553, DOI 10.1542/peds.2009-0829; Olowokure B, 2006, J INFECTION, V52, P61, DOI 10.1016/j.jinf.2005.01.013; Pedersen CB, 2006, DAN MED BULL, V53, P441; Roed C, 2011, PEDIATR INFECT DIS J, V30, pE147, DOI 10.1097/INF.0b013e3182191a63; Roed C, 2010, AM J EPIDEMIOL, V172, P309, DOI 10.1093/aje/kwq126; Roed C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009662; Sorensen H T, 1995, Int J Risk Saf Med, V7, P179, DOI 10.3233/JRS-1995-7303; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Sorensen HT, 2004, INT J EPIDEMIOL, V33, P816, DOI 10.1093/ije/dyh169; StatisticsDenmark, EMPL CLASS MOD; Valentiner-Branth P, CONJUGATED PNEUMOCOC; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1; Wang WL, 2008, J PEDIATR-US, V153, P333, DOI 10.1016/j.jpeds.2008.04.017; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4	35	31	32	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1714	1721		10.1001/jama.2013.3792	http://dx.doi.org/10.1001/jama.2013.3792			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613076	Bronze			2022-12-24	WOS:000317906700028
J	Kono, N; Ohto, U; Hiramatsu, T; Urabe, M; Uchida, Y; Satow, Y; Arai, H				Kono, Nozomu; Ohto, Umeharu; Hiramatsu, Tatsufumi; Urabe, Michiko; Uchida, Yasunori; Satow, Yoshinori; Arai, Hiroyuki			Impaired alpha-TTP-PIPs Interaction Underlies Familial Vitamin E Deficiency	SCIENCE			English	Article							RETINALDEHYDE-BINDING PROTEIN; MOLECULAR-MECHANISMS; LIPID TRANSPORT; TOCOPHEROL; ATAXIA; SECRETION	alpha-Tocopherol (vitamin E) transfer protein (alpha-7P) regulates the secretion of a-tocopherol from liver cells. Missense mutations of some arginine residues at the surface of alpha-TIP cause severe vitamin E deficiency in humans, but the role of these residues is unclear. Here, we found that wild-type a-UP bound phosphatidylinositol phosphates (PIPs), whereas the arginine mutants did not. In addition, PIPs in the target membrane promoted the intermembrane transfer of alpha-tocopherot by alpha-UP. The crystal structure of the alpha-UP PIPs complex revealed that the disease-related arginine residues interacted with phosphate groups of the PIPs and that the PIPs binding caused the lid of the alpha-tocopherol binding pocket to open. Thus, PIPs have a rote in promoting the release of a ligand from a lipid-transfer protein.	[Kono, Nozomu; Ohto, Umeharu; Hiramatsu, Tatsufumi; Urabe, Michiko; Uchida, Yasunori; Satow, Yoshinori; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kono, Nozomu; Arai, Hiroyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Arai, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp	KONO, nozomu/AAM-3178-2020		Core Research for Evolutional Science and Technology; Japan Science and Technology Agency (CREST, JST); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology [20370045]; Japanese Ministry of Health, Labor, and Welfare	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (CREST, JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	We thank P. T. Hawkins for providing PI(3,4)P<INF>2</INF>-derivatized beads; K. Yamamoto for providing Ricinus communis agglutinin 120; the beamline staffs at Photon Factory for their assistance with data collection; and J. Raymond for English proofreading. This work was supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (CREST, JST) (to H.A.); the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to H.A.), Grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (20370045 to H.A.); and the Japanese Ministry of Health, Labor, and Welfare (to H.A.). The coordinate and structure factor data of alpha-TTP-PI(3,4)P<INF>2</INF> and alpha-TTP-PI(4,5)P<INF>2</INF> complexes have been deposited to the Protein Data Bank under the accession codes 3W67 and 3W68, respectively.	Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Arita M, 1997, P NATL ACAD SCI USA, V94, P12437, DOI 10.1073/pnas.94.23.12437; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Di Donato I, 2010, NEUROL SCI, V31, P511, DOI 10.1007/s10072-010-0261-1; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huynh H, 2003, J IMMUNOL, V171, P6661, DOI 10.4049/jimmunol.171.12.6661; Katoh Y, 2009, J BIOL CHEM, V284, P27646, DOI 10.1074/jbc.M109.034884; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Merkulova M, 2005, FEBS J, V272, P5595, DOI 10.1111/j.1742-4658.2005.04955.x; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Saari JC, 2009, MOL VIS, V15, P844; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Suh BC, 1996, EUR J PHARMACOL, V314, P235, DOI 10.1016/S0014-2999(96)00555-9; Takada T, 2010, MOL NUTR FOOD RES, V54, P616, DOI 10.1002/mnfr.200900481; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; VOELKER DR, 1990, EXPERIENTIA, V46, P569, DOI 10.1007/BF01939695	22	89	93	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1106	1110		10.1126/science.1233508	http://dx.doi.org/10.1126/science.1233508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23599266				2022-12-24	WOS:000319664500047
J	Mulcahy, A; Harris, K; Finegold, K; Kellermann, A; Edelman, L; Sommers, BD				Mulcahy, Andrew; Harris, Katherine; Finegold, Kenneth; Kellermann, Arthur; Edelman, Laurel; Sommers, Benjamin D.			Insurance Coverage of Emergency Care for Young Adults under Health Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; ACT; ECONOMICS; POLICIES; ACCESS	BACKGROUND The Affordable Care Act (ACA) established nationwide eligibility for young adults 19 to 25 years of age to retain coverage under their parents' private health plans. We conducted a study to determine how the implementation of this provision changed rates of insurance coverage for young adults seeking medical care for major emergencies. METHODS We evaluated more than 480,000 nondiscretionary visits made to emergency departments from 2009 through 2011, as recorded in a large, geographically diverse data set of hospital claims, to estimate how the ACA provision affected private insurance coverage of such visits by young adults (19 to 25 years of age). To adjust for underlying trends in insurance coverage, we compared changes in the target age group with changes among adults 26 to 31 years of age, who were unaffected by the provision (control group). RESULTS After the ACA provision took effect, private coverage of nondiscretionary visits to emergency departments by young adults increased by 3.1 percentage points (95% confidence interval [CI], 2.3 to 3.9; relative increase, 5.2%; P<0.001), as compared with similar visits in the control group. The percentage of visits by uninsured young adults also fell significantly (-1.7 percentage points; 95% CI, -2.8 to -0.7; relative decrease, 9.1%; P<0.001). The rates of nondiscretionary visits that were covered by Medicaid or other nonprivate insurers remained relatively steady throughout the study period. The coverage expansion led to an estimated 22,072 visits to emergency departments by newly insured young adults and $147 million in associated costs that were covered by private insurance plans during a 1-year period. CONCLUSIONS Enactment of the dependent-coverage provision was associated with a significant increase in the proportion of young adults who were protected from the financial consequences of a serious medical emergency.	[Mulcahy, Andrew; Harris, Katherine; Kellermann, Arthur] RAND, Arlington, VA USA; [Finegold, Kenneth; Sommers, Benjamin D.] Off Assistant Secretary Planning & Evaluat, Dept Hlth & Human Serv, Washington, DC USA; [Edelman, Laurel] IMS Hlth, Plymouth Meeting, PA USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	RAND Corporation; Harvard University; Harvard T.H. Chan School of Public Health	Mulcahy, A (corresponding author), 1200 S Hayes St, Arlington, VA 22202 USA.	amulcahy@rand.org			Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services [HHSP23320095649WC]	Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services	Funded by the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services.; Supported by a contract with the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services (HHSP23320095649WC).	[Anonymous], 2009, NAT EM DEP SAMPL; [Anonymous], 2009, ANN SURV DAT FISC YE; Antwi YA, 2012, EFFECTS FEDERAL POLI; Bureau of Labor Statistics, LAB FORC STAT CURR P; Callahan ST, 2005, PEDIATRICS, V116, P88, DOI 10.1542/peds.2004-1449; Cantor JC, 2012, HEALTH SERV RES, V47, P1773, DOI 10.1111/j.1475-6773.2012.01458.x; DeNavas-Walt C., 2012, INCOME POVERTY HLTH; DeNavas-Walt C., 2009, INCOME POVERTY HLTH; Hadley J, 2008, HEALTH AFFAIR, V27, pW399, DOI 10.1377/hlthaff.27.5.w399; Hsia RY, 2011, JAMA-J AM MED ASSOC, V305, P1978, DOI 10.1001/jama.2011.620; Institute of Medicine Committee on the Consequences of Uninsurance, 2002, HLTH INS IS FAM MATT; Institute of Medicine (US) Committee on the Consequences of Uninsurance, 2001, COV MATT INS HLTH CA; Levine PB, 2011, AM ECON J-ECON POLIC, V3, P129, DOI 10.1257/pol.3.1.129; MANNING WG, 1987, AM ECON REV, V77, P251; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Monheit AC, 2011, HEALTH SERV RES, V46, P251, DOI 10.1111/j.1475-6773.2010.01200.x; National Conference of State Legislatures, COV YOUNG AD THEIR P; Nicholson JL, 2009, RITE PASSAGE WHY YOU; PAULY MV, 1968, AM ECON REV, V58, P531; Sommers BD, 2011, 2 5 MILLION YOUNG AD; Sommers BD, 2012, NUMBER YOUNG ADULTS; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P913, DOI 10.1001/jama.307.9.913; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112	24	67	67	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2105	2112		10.1056/NEJMsa1212779	http://dx.doi.org/10.1056/NEJMsa1212779			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23718165	Green Published			2022-12-24	WOS:000319574200008
J	Dolgin, E				Dolgin, Elie			DEPRIVATION A wake-up call	NATURE			English	Editorial Material							SLEEP RESTRICTION; DURATION											Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Goel N, 2010, NEUROLOGY, V75, P1509, DOI 10.1212/WNL.0b013e3181f9615d; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Haack M, 2013, J SLEEP RES, V22, P295, DOI 10.1111/jsr.12011; Luckhaupt Sara E., 2012, Morbidity and Mortality Weekly Report, V61, P281; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Prather AA, 2012, SLEEP, V35, P1063, DOI 10.5665/sleep.1990; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	10	15	15	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S6	S7		10.1038/497S6a	http://dx.doi.org/10.1038/497S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698507				2022-12-24	WOS:000319254000004
J	Rey, FA				Rey, Felix A.			DENGUE VIRUS Two hosts, two structures	NATURE			English	Editorial Material							WEST-NILE-VIRUS; ENVELOPE GLYCOPROTEIN; CRYSTAL-STRUCTURE; ANTIBODIES; EPITOPES		[Rey, Felix A.] Inst Pasteur, Unite Virol Struct, F-75724 Paris 15, France; [Rey, Felix A.] CNRS, UMR 3569, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Rey, FA (corresponding author), Inst Pasteur, Unite Virol Struct, F-75724 Paris 15, France.	rey@pasteur.fr	Rey, Felix/B-6497-2012	Rey, Felix/0000-0002-9953-7988				Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Fibriansah G., 2013, J VIROL; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Morens D. M., 2013, ECOHEALTH; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Simmons CP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001752; World Health Organization, 2012, DENG SEV DENG; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	20	23	26	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					443	444		10.1038/497443a	http://dx.doi.org/10.1038/497443a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698439				2022-12-24	WOS:000319254000034
J	Zolla-Pazner, S				Zolla-Pazner, Susan			Saving Specimens after Sandy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zolla-Pazner, Susan] Dept Vet Affairs New York Harbor Healthcare Syst, Res Serv, New York, NY USA; [Zolla-Pazner, Susan] NYU, Sch Med, Dept Pathol, New York, NY USA	New York University	Zolla-Pazner, S (corresponding author), Dept Vet Affairs New York Harbor Healthcare Syst, Res Serv, New York, NY USA.		Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					E27	E27		10.1056/NEJMp1303024	http://dx.doi.org/10.1056/NEJMp1303024			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194KD	23656587	Bronze			2022-12-24	WOS:000322630700001
J	Reinke, AW; Baek, J; Ashenberg, O; Keating, AE				Reinke, Aaron W.; Baek, Jiyeon; Ashenberg, Orr; Keating, Amy E.			Networks of bZIP Protein-Protein Interactions Diversified Over a Billion Years of Evolution	SCIENCE			English	Article							DNA-BINDING SPECIFICITY; TRANSCRIPTION; DIMERIZATION; DIVERGENCE	Differences in biomolecular sequence and function underlie dramatic ranges of appearance and behavior among species. We studied the basic region-leucine zipper (bZIP) transcription factors and quantified bZIP dimerization networks for five metazoan and two single-cell species, measuring interactions in vitro for 2891 protein pairs. Metazoans have a higher proportion of heteromeric bZIP interactions and more network complexity than the single-cell species. The metazoan bZIP interactomes have broadly similar structures, but there has been extensive rewiring of connections compared to the last common ancestor, and each species network is highly distinct. Many metazoan bZIP orthologs and paralogs have strikingly different interaction specificities, and some differences arise from minor sequence changes. Our data show that a shifting landscape of biochemical functions related to signaling and gene expression contributes to species diversity.	[Reinke, Aaron W.; Baek, Jiyeon; Ashenberg, Orr; Keating, Amy E.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Keating, AE (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keating@mit.edu		Reinke, Aaron/0000-0001-7612-5342; Keating, Amy/0000-0003-4074-8980	NIH [GM067681]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH award GM067681. We thank the MIT BioMicro center for use of the Tecan liquid-handling robot, J.J. Sims for guidance with intein protein labeling chemistry, L. Reich for analytical models for curve fitting, and A. M. Safer for the C. elegans used for making cDNA. All interaction data are available in the supplementary materials in table S2.	Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Baker CR, 2011, P NATL ACAD SCI USA, V108, P7493, DOI 10.1073/pnas.1019177108; Brayer KJ, 2011, P NATL ACAD SCI USA, V108, pE414, DOI 10.1073/pnas.1100990108; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Grigoryan G, 2006, J MOL BIOL, V355, P1125, DOI 10.1016/j.jmb.2005.11.036; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Kuo D, 2010, GENOME RES, V20, P1672, DOI 10.1101/gr.111765.110; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	16	109	111	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					730	734		10.1126/science.1233465	http://dx.doi.org/10.1126/science.1233465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661758	Green Accepted, Green Submitted			2022-12-24	WOS:000318619000035
J	Ajamian, M; Kosofsky, BE; Wormser, GP; Rajadhyaksha, AM; Alaedini, A				Ajamian, Mary; Kosofsky, Barry E.; Wormser, Gary P.; Rajadhyaksha, Anjali M.; Alaedini, Armin			Serologic Markers of Lyme Disease in Children With Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ajamian, Mary; Alaedini, Armin] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Kosofsky, Barry E.; Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Wormser, Gary P.] New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA	Columbia University; Cornell University; New York Medical College	Ajamian, M (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.	aa819@columbia.edu		Ajamian, Mary/0000-0001-5819-7078	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000457, UL1 TR000457-06] Funding Source: Medline; NIAID NIH HHS [1R56 AI093763-01, R56 AI093763] Funding Source: Medline; NIMH NIH HHS [U24 MH081810, 1U24MH081810] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bransfield RC, 2008, MED HYPOTHESES, V70, P967, DOI 10.1016/j.mehy.2007.09.006; Centers for Disease Control and Prevention (CDC), 1995, MMWR MORB MORTAL WKL, V44, P590; Chandra A, 2011, CLIN IMMUNOL, V141, P103, DOI 10.1016/j.clim.2011.06.005; Kuhn M, 2012, MED HYPOTHESES, V78, P606, DOI 10.1016/j.mehy.2012.01.037	4	8	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1771	1773		10.1001/jama.2013.618	http://dx.doi.org/10.1001/jama.2013.618			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632714	Bronze, Green Accepted			2022-12-24	WOS:000318235600018
J	Ali, H; Donovan, B; Wand, H; Read, TRH; Regan, DG; Grulich, AE; Fairley, CK; Guy, RJ				Ali, Hammad; Donovan, Basil; Wand, Handan; Read, Tim R. H.; Regan, David G.; Grulich, Andrew E.; Fairley, Christopher K.; Guy, Rebecca J.			Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HPV VACCINATION; COVERAGE; TRANSMISSION; ADOLESCENT; TYPE-16; WOMEN; BOYS	Objective To measure the effect on genital warts of the national human papillomavirus vaccination programme in Australia, which started in mid-2007. Design Trend analysis of national surveillance data. Setting Data collated from eight sexual health services from 2004 to 2011; the two largest clinics also collected self reported human papillomavirus vaccination status from 2009. Participants Between 2004 and 2011, 85 770 Australian born patients were seen for the first time; 7686 (9.0%) were found to have genital warts. Main outcome measure Rate ratios comparing trends in proportion of new patients diagnosed as having genital warts in the pre-vaccination period (2004 to mid-2007) and vaccination period (mid-2007 to the end of 2011). Results Large declines occurred in the proportions of under 21 year old (92.6%) and 21-30 year old (72.6%) women diagnosed as having genital warts in the vaccination period-from 11.5% in 2007 to 0.85% in 2011 (P<0.001) and from 11.3% in 2007 to 3.1% in 2011 (P<0.001), respectively. No significant decline in wart diagnoses was seen in women over 30 years of age. Significant declines occurred in proportions of under 21 year old (81.8%) and 21-30 year old (51.1%) heterosexual men diagnosed as having genital warts in the vaccination period-from 12.1% in 2007 to 2.2% in 2011 (P<0.001) and from 18.2% in 2007 to 8.9% in 2011 (P<0.001), respectively. No significant decline in genital wart diagnoses was seen in heterosexual men over 30 years of age. In 2011 no genital wart diagnoses were made among 235 women under 21 years of age who reported prior human papillomavirus vaccination. Conclusions The significant declines in the proportion of young women found to have genital warts and the absence of genital warts in vaccinated women in 2011 suggests that the human papillomavirus vaccine has a high efficacy outside of the trial setting. Large declines in diagnoses of genital warts in heterosexual men are probably due to herd immunity.	[Ali, Hammad; Donovan, Basil; Wand, Handan; Regan, David G.; Grulich, Andrew E.; Guy, Rebecca J.] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia; [Donovan, Basil] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW 2000, Australia; [Read, Tim R. H.; Fairley, Christopher K.] Melbourne Sexual Hlth Ctr, Carlton, Vic 3053, Australia; [Read, Tim R. H.; Fairley, Christopher K.] Univ Melbourne, Sch Populat Hlth, Parkville, Vic 3010, Australia	University of New South Wales Sydney; Kirby Institute; University of Melbourne	Donovan, B (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia.	bdonovan@kirby.unsw.edu.au	Donovan, Basil J/K-1246-2012	Donovan, Basil J/0000-0001-8851-4126; Guy, Rebecca/0000-0002-2929-4634; Christopher, Fairley/0000-0001-9081-1664	CSL Biotherapies	CSL Biotherapies	CSL Biotherapies funded the surveillance network but had no role in study design; data collection, analysis, or interpretation; or writing the report. Only the Kirby Institute had access to the study data, and the authors had sole responsibility of decision for publication.	Australian Government Department of Health and Ageing, 2012, FACT SHEET NAT IMM P; Ball SLR, 2011, J MED VIROL, V83, P1345, DOI 10.1002/jmv.22111; Bauer HM, 2012, AM J PUBLIC HEALTH, V102, P833, DOI 10.2105/AJPH.2011.300465; Brill D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f924; Brotherton J, 2011, COMMUN DIS INTELL, V35, P197; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brotherton JML, 2008, COMMUN DIS INTELL, V32, P457; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Dowdle WJ., 1999, MMWR MORB MORTAL S1, V48, P23; Forster AS, 2012, VACCINE, V30, P4505, DOI 10.1016/j.vaccine.2012.04.066; Garland SM, 2011, PREV MED, V53, pS29, DOI 10.1016/j.ypmed.2011.08.015; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Leval A, 2012, J INFECT DIS, V206, P860, DOI 10.1093/infdis/jis405; Oliphant J, 2011, NEW ZEAL MED J, V124, P51; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Pedrana A, 2012, SEX TRANSM DIS, V39, P651, DOI 10.1097/OLQ.0b013e318255df06; Regan DG, 2007, SEX HEALTH, V4, P147, DOI 10.1071/SH07042; Ryder N, 2011, INT J STD AIDS, V22, P335, DOI 10.1258/ijsa.2010.010458; The Hon Tanya Plibersek MP Minister for Health Australia, 2012, HPV VACCINE EXTENDED; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7	22	289	300	1	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 18	2013	346								f2032	10.1136/bmj.f2032	http://dx.doi.org/10.1136/bmj.f2032			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AZ	23599298	Green Submitted, hybrid			2022-12-24	WOS:000317964200001
J	Vieira-Pires, RS; Szollosi, A; Morais-Cabral, JH				Vieira-Pires, Ricardo S.; Szollosi, Andras; Morais-Cabral, Joao H.			The structure of the KtrAB potassium transporter	NATURE			English	Article							K+-UPTAKE SYSTEM; CRYSTAL-STRUCTURE; GLYCINE RESIDUES; GATING RING; CHANNEL; SELECTIVITY; MECHANISM; ADAPTATION; PCC-6803; COMPLEX	In bacteria, archaea, fungi and plants the Trk, Ktr and HKT ion transporters are key components of osmotic regulation, pH homeostasis and resistance to drought and high salinity. These ion transporters are functionally diverse: they can function as Na+ or K+ channels and possibly as cation/K+ symporters. They are closely related to potassium channels both at the level of the membrane protein and at the level of the cytosolic regulatory domains. Here we describe the crystal structure of a Ktr K+ transporter, the KtrAB complex from Bacillus subtilis. The structure shows the dimeric membrane protein KtrB assembled with a cytosolic octameric KtrA ring bound to ATP, an activating ligand. A comparison between the structure of KtrAB-ATP and the structures of the isolated full-length KtrA protein with ATP or ADP reveals a ligand-dependent conformational change in the octameric ring, raising new ideas about the mechanism of activation in these transporters.	[Vieira-Pires, Ricardo S.; Szollosi, Andras; Morais-Cabral, Joao H.] Univ Porto, IBMC, P-4150180 Oporto, Portugal	Universidade do Porto	Morais-Cabral, JH (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jcabral@ibmc.up.pt	Szollosi, Andras/P-4278-2019; Morais-Cabral, Joao H/J-4914-2013; Szollosi, Andras/J-5097-2013; Vieira-Pires, Ricardo/J-5232-2013	Szollosi, Andras/0000-0002-5570-4609; Morais-Cabral, Joao H/0000-0002-4461-9716; Vieira-Pires, Ricardo/0000-0003-1830-3715	FEBS; EMBO; FEDER funds through the Operational Competitiveness Program-COMPETE; FCT-Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011), FCOMP-01-0124-FEDER-009028 (PTDC/BIA-PRO/099861/2008) FCOMP-01-0124-FEDER-010781 (PTDC/QUI-BIQ/105342/2008)]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-PRO/099861/2008, PTDC/QUI-BIQ/105342/2008] Funding Source: FCT	FEBS; EMBO(European Molecular Biology Organization (EMBO)); FEDER funds through the Operational Competitiveness Program-COMPETE; FCT-Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	We are grateful for access to ID14-1/ID14-4/ID-29 at ESRF (through the Portuguese BAG), PXII at SLS, XRD1 at ELETTRA and PROXIMA1 at SOLEIL and thank the respective support staff. A.S. was supported by FEBS (Long term fellowship). This work was funded by EMBO (Installation grant), by FEDER funds through the Operational Competitiveness Program-COMPETE and by National Funds through FCT-Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011), FCOMP-01-0124-FEDER-009028 (PTDC/BIA-PRO/099861/2008) and FCOMP-01-0124-FEDER-010781 (PTDC/QUI-BIQ/105342/2008). We also thank G. Gabant and M. Cadene at the 'Plateforme de Spectrometrie de Masse' at CBM, CNRS, Orleans for mass spectrometry analysis, and C. Harley for critical reading of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Corratge-Faillie C, 2010, CELL MOL LIFE SCI, V67, P2511, DOI 10.1007/s00018-010-0317-7; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hanelt I, 2011, EUR J CELL BIOL, V90, P696, DOI 10.1016/j.ejcb.2011.04.010; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kroning N, 2007, J BIOL CHEM, V282, P14018, DOI 10.1074/jbc.M609084200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Nimigean CM, 2006, NAT PROTOC, V1, P1207, DOI 10.1038/nprot.2006.166; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Trudeau MC, 2012, J GEN PHYSIOL, V140, P457, DOI 10.1085/jgp.201210898; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414	42	82	83	3	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					323	+		10.1038/nature12055	http://dx.doi.org/10.1038/nature12055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598340	Green Submitted			2022-12-24	WOS:000317599200029
J	Kiely, DG; Elliot, CA; Sabroe, I; Condliffe, R				Kiely, David G.; Elliot, Charlie A.; Sabroe, Ian; Condliffe, Robin			Pulmonary hypertension: diagnosis and management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CALCIUM-CHANNEL BLOCKERS; 6-MINUTE WALK TEST; ARTERIAL-HYPERTENSION; ECHOCARDIOGRAPHIC-ASSESSMENT; ORAL TREPROSTINIL; EJECTION FRACTION; HEART-FAILURE; DOUBLE-BLIND; THERAPY; SURVIVAL		[Kiely, David G.; Elliot, Charlie A.; Sabroe, Ian; Condliffe, Robin] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Pulm Vasc Dis Unit, Natl Pulm Hypertens Serv Sheffield, Sheffield S10 2JF, S Yorkshire, England; [Sabroe, Ian] Univ Sheffield, Sch Med, Fac Med Dent & Hlth, Acad Unit Resp Med,Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Kiely, DG (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Pulm Vasc Dis Unit, Natl Pulm Hypertens Serv Sheffield, Sheffield S10 2JF, S Yorkshire, England.	david.kiely@sth.nhs.uk	Sabroe, Ian/AAE-5858-2019; Sabroe, Ian/I-5981-2013	Sabroe, Ian/0000-0001-9750-8975; Condliffe, Robin/0000-0002-3492-4143	Actelion; Bayer; Pfizer; United Therapeutics; Lily; GSK	Actelion; Bayer(Bayer AG); Pfizer(Pfizer); United Therapeutics; Lily; GSK(GlaxoSmithKline)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; DGK has received speaker fees, attended advisory boards, and received funding to attend meetings from Actelion, Bayer, Pfizer, United Therapeutics, Lily, and GSK; CAE has received speaker fees and attended advisory boards for Actelion, Bayer, and GSK; IS has received travel funding from Actelion and GSK; RC has received speaker fees from Actelion and GSK and has attended advisory boards for Actelion, Bayer, and GSK. The department has received funding for research and education through unrestricted grants from Actelion, Bayer, and Pfizer.	Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; Armstrong I, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000806; Avouac J, 2010, J RHEUMATOL, V37, P2290, DOI 10.3899/jrheum.100245; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Barst RJ, 2003, J AM COLL CARDIOL, V41, P2119, DOI 10.1016/S0735-1097(03)00463-7; Bedard E, 2009, EUR HEART J, V30, P256, DOI 10.1093/eurheartj/ehn597; Bonderman D, 2002, CIRCULATION, V105, P265, DOI 10.1161/hc0202.100239; Castro M, 1996, MAYO CLIN PROC, V71, P543, DOI 10.4065/71.6.543; Christie JD, 2012, J HEART LUNG TRANSPL; Colle IO, 2003, HEPATOLOGY, V37, P401, DOI 10.1053/jhep.2003.50060; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Damy T, 2010, EUR HEART J, V31, P2280, DOI 10.1093/eurheartj/ehq245; Fessel Joshua P, 2011, Pulm Circ, V1, P305, DOI 10.4103/2045-8932.87293; Frank H, 1997, CHEST, V112, P714, DOI 10.1378/chest.112.3.714; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Gatzoulis MA, 2009, EUR RESPIR REV, V18, P154, DOI 10.1183/09059180.00003309; Ghofrani HA, 2012, CHEST, V142, P1027; Ghofrani HA, 2012, CHEST, V142, p1023A; Guazzi M, 2012, EUR RESPIR REV, V21, P338, DOI 10.1183/09059180.00004612; HADENGUE A, 1991, GASTROENTEROLOGY, V100, P520, DOI 10.1016/0016-5085(91)90225-A; Hatano S, 1975, WHO M OCT 15 17; Hiremath J, 2010, J HEART LUNG TRANSPL, V29, P137, DOI 10.1016/j.healun.2009.09.005; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Hoeper MM, 2005, EUR RESPIR J, V26, P858, DOI 10.1183/09031936.05.00075305; Howard LS, 2012, EUR RESPIR REV, V21, P239, DOI 10.1183/09059180.00003912; Humbert M, 2007, EUR RESPIR J, V30, P338, DOI 10.1183/09031936.00138706; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411; Jing ZC, 2013, CIRCULATION, V127, P624, DOI 10.1161/CIRCULATIONAHA.112.124388; Johnson SR, 2006, EUR RESPIR J, V28, P999, DOI 10.1183/09031936.06.00015206; Kalogeropoulos Andreas P, 2011, Congest Heart Fail, V17, P189, DOI 10.1111/j.1751-7133.2011.00234.x; Keogh AM, 2009, J AM COLL CARDIOL, V54, pS67, DOI 10.1016/j.jacc.2009.04.016; Kiely DG, 2010, BJOG-INT J OBSTET GY, V117, P565, DOI 10.1111/j.1471-0528.2009.02492.x; Klok FA, 2010, HAEMATOL-HEMATOL J, V95, P970, DOI 10.3324/haematol.2009.018960; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027; Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Nagaya N, 2000, CIRCULATION, V102, P865; Nickel N, 2012, EUR RESPIR J, V39, P589, DOI 10.1183/09031936.00092311; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Paciocco G, 2001, EUR RESPIR J, V17, P647, DOI 10.1183/09031936.01.17406470; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Rajaram S, 2013, THORAX; Rajaram S, 2012, EUR RADIOL, V22, P310, DOI 10.1007/s00330-011-2252-x; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Rubin LJ, 2012, CHEST, V142, p1026A; Sandoval J, EUR RESP J, V38, P1343; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Simonneau G, 2012, EUR RESPIR J, V40, P874, DOI 10.1183/09031936.00137511; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Stewart DJ, 2004, CIRCULATION, V109, pE172, DOI 10.1161/01.CIR.0000121684.52920.0E; Sun CG, 2003, J AM COLL CARDIOL, V41, P1028, DOI 10.1016/S0735-1097(02)02964-9; Swift AJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-40; Tapson V, 2013, CHEST IN PRESS; Tapson VE, 2012, CHEST, V142, P1383, DOI 10.1378/chest.11-2212; Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tongers J, 2007, AM HEART J, V153, P127, DOI 10.1016/j.ahj.2006.09.008; Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Wensel R, 2002, CIRCULATION, V106, P319, DOI 10.1161/01.CIR.0000022687.18568.2A; WORSLEY DF, 1994, J NUCL MED, V35, P793	77	81	84	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f2028	10.1136/bmj.f2028	http://dx.doi.org/10.1136/bmj.f2028			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AO	23592451				2022-12-24	WOS:000317962900015
J	Pardey, PG; Beddow, JM; Kriticos, DJ; Hurley, TM; Park, RF; Duveiller, E; Sutherst, RW; Burdon, JJ; Hodson, D				Pardey, P. G.; Beddow, J. M.; Kriticos, D. J.; Hurley, T. M.; Park, R. F.; Duveiller, E.; Sutherst, R. W.; Burdon, J. J.; Hodson, D.			Right-Sizing Stem-Rust Research	SCIENCE			English	Editorial Material									[Pardey, P. G.; Beddow, J. M.; Kriticos, D. J.; Hurley, T. M.] Univ Minnesota, Int Sci & Technol Practice & Policy Ctr, Dept Appl Econ, St Paul, MN 55108 USA; [Pardey, P. G.; Beddow, J. M.; Hurley, T. M.] Univ Minnesota, Stakman Borlaug Cereal Rust Ctr, St Paul, MN 55108 USA; [Pardey, P. G.; Beddow, J. M.; Kriticos, D. J.; Hurley, T. M.; Burdon, J. J.] Commonwealth Sci & Ind Res Org, Canberra, ACT 3190, Australia; [Pardey, P. G.] Univ Pretoria, Dept Agr Econ Extens & Rural Dev, ZA-0028 Pretoria, South Africa; [Kriticos, D. J.] Charles Sturt Univ Wagga Wagga, EH Graham Ctr, Sydney, NSW 2678, Australia; [Park, R. F.] Univ Sydney, Australian Cereal Rust Control Program, Plant Breeding Inst, Eveleigh, NSW 2015, Australia; [Duveiller, E.; Hodson, D.] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Mexico; [Sutherst, R. W.] Univ Queensland, Ctr Excellence Environm Decis, St Lucia, Qld 4072, Australia	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Pretoria; Charles Sturt University; University of Sydney; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Queensland	Pardey, PG (corresponding author), Univ Minnesota, Int Sci & Technol Practice & Policy Ctr, Dept Appl Econ, St Paul, MN 55108 USA.	ppardey@umn.edu	Burdon, Jeremy J/B-9913-2009; Kriticos, Darren J/A-4170-2008	Kriticos, Darren J/0000-0003-2599-8105; Hurley, Terrance/0000-0003-2135-7570; Park, Robert/0000-0002-9145-5371				Agrios G. N., 2005, PLANT PATHOL; Beddow J.M., 2010, POTENTIAL GLOBAL CRO; Beddow J. M., 2012, MEASURING WORLDWIDE; Dubin H. J., 2009, 00910 INT FOOD POL R; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; National Association of Wheat Growers, 2012, W FARM PRESS    0320; Rao X., 2012, RECALIBRATING REPORT; Saari E. E., 1985, CEREAL RUSTS, V2; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Sutherst R W, 2007, CLIMEX VERSION 3 USE; US Department of Agriculture, COMM COSTS RET	13	59	61	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					147	148		10.1126/science.122970	http://dx.doi.org/10.1126/science.122970			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580514				2022-12-24	WOS:000317341400038
J	Loggers, ET; Starks, H; Shannon-Dudley, M; Back, AL; Appelbaum, FR; Stewart, FM				Loggers, Elizabeth Trice; Starks, Helene; Shannon-Dudley, Moreen; Back, Anthony L.; Appelbaum, Frederick R.; Stewart, F. Marc			Implementing a Death with Dignity Program at a Comprehensive Cancer Center	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICIAN-ASSISTED SUICIDE; OREGON DEATH; ATTITUDES; EXPERIENCES; CARE; AID	BACKGROUND The majority of Death with Dignity participants in Washington State and Oregon have received a diagnosis of terminal cancer. As more states consider legislation regarding physician-assisted death, the experience of a comprehensive cancer center may be informative. METHODS We describe the implementation of a Death with Dignity program at Seattle Cancer Care Alliance, the site of care for the Fred Hutchinson-University of Washington Cancer Consortium, a comprehensive cancer center in Seattle that serves the Pacific Northwest. Institution-level data were compared with publicly available state-wide data from Oregon and Washington. RESULTS A total of 114 patients inquired about our Death with Dignity program between March 5, 2009, and December 31, 2011. Of these, 44 (38.6%) did not pursue the program, and 30 (26.3%) initiated the process but either elected not to continue or died before completion. Of the 40 participants who, after counseling and upon request, received a prescription for a lethal dose of secobarbital (35.1% of the 114 patients who inquired about the program), all died, 24 after medication ingestion (60% of those obtaining prescriptions). The participants at our center accounted for 15.7% of all participants in the Death with Dignity program in Washington (255 persons) and were typically white, male, and well educated. The most common reasons for participation were loss of autonomy (97.2%), inability to engage in enjoyable activities (88.9%), and loss of dignity (75.0%). Eleven participants lived for more than 6 months after prescription receipt. Qualitatively, patients and families were grateful to receive the lethal prescription, whether it was used or not. CONCLUSIONS Overall, our Death with Dignity program has been well accepted by patients and clinicians.	[Loggers, Elizabeth Trice; Appelbaum, Frederick R.; Stewart, F. Marc] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Loggers, Elizabeth Trice] Univ Washington, Grp Hlth Res Inst, Seattle, WA 98195 USA; [Loggers, Elizabeth Trice; Shannon-Dudley, Moreen; Back, Anthony L.; Appelbaum, Frederick R.; Stewart, F. Marc] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle	Loggers, ET (corresponding author), 825 Eastlake Ave E, Seattle, WA 98109 USA.	eloggers@seattlecca.org		Loggers, Elizabeth/0000-0003-3432-0443	University of Washington Palliative Care Center of Excellence	University of Washington Palliative Care Center of Excellence	We thank Barbara Glidewell, M.B.S., C.E.C., former patient relations director, ombudsman, and assistant professor, Oregon Health and Science University (OHSU), and Linda Ganzini, M.D., M.P.H., professor of psychiatry and medicine, OHSU, for their consultation and expertise early in the formation of our Death with Dignity program; Danika Kubota for her administrative assistance; and the University of Washington Palliative Care Center of Excellence for its support.	Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Dobscha Steven K, 2004, J Palliat Med, V7, P451, DOI 10.1089/1096621041349374; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 1996, AM J PSYCHIAT, V153, P1469; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Ganzini L, 1997, NEW ENGL J MED, V336, P1824, DOI 10.1056/NEJM199706193362511; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; Ganzini L, 2009, J PAIN SYMPTOM MANAG, V38, P807, DOI 10.1016/j.jpainsymman.2009.04.026; Ganzini L, 2009, ARCH INTERN MED, V169, P489, DOI 10.1001/archinternmed.2008.579; Ganzini L, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1682; Hafner K., 2012, NY TIMES, pA1; Hawaii State Legislature, REL DEATH DIGN; Smith KA, 2011, J PALLIAT MED, V14, P445, DOI 10.1089/jpm.2010.0425; Starks H, 2005, J PAIN SYMPTOM MANAG, V30, P215, DOI 10.1016/j.jpainsymman.2005.03.012; State and County QuickFacts, 2012, CODATA DER POP EST A; State of Vermont, 2011, ACT REL PAT CHOIC CO; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822	20	77	79	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1417	1424		10.1056/NEJMsa1213398	http://dx.doi.org/10.1056/NEJMsa1213398			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574120				2022-12-24	WOS:000317333600009
J	Ilani, T; Alon, A; Grossman, I; Horowitz, B; Kartvelishvily, E; Cohen, SR; Fass, D				Ilani, Tal; Alon, Assaf; Grossman, Iris; Horowitz, Ben; Kartvelishvily, Elena; Cohen, Sidney R.; Fass, Deborah			A Secreted Disulfide Catalyst Controls Extracellular Matrix Composition and Function	SCIENCE			English	Article							QUIESCIN-SULFHYDRYL OXIDASE; GENE-EXPRESSION; QSOX; INVASION	Disulfide bond formation in secretory proteins occurs primarily in the endoplasmic reticulum (ER), where multiple enzyme families catalyze cysteine cross-linking. Quiescin sulfhydryl oxidase 1 (QSOX1) is an atypical disulfide catalyst, localized to the Golgi apparatus or secreted from cells. We examined the physiological function for extracellular catalysis of de novo disulfide bond formation by QSOX1. QSOX1 activity was required for incorporation of laminin into the extracellular matrix (ECM) synthesized by fibroblasts, and ECM produced without QSOX1 was defective in supporting cell-matrix adhesion. We developed an inhibitory monoclonal antibody against QSOX1 that could modulate ECM properties and undermine cell migration.	[Ilani, Tal; Alon, Assaf; Grossman, Iris; Horowitz, Ben; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Kartvelishvily, Elena] Weizmann Inst Sci, Irving & Cherna Moskowitz Ctr Nano & Bionano Imag, IL-76100 Rehovot, Israel; [Cohen, Sidney R.] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Ilani, T (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	tal.ilani@weizmann.ac.il; deborah.fass@weizmann.ac.il	Cohen, Sidney R./J-7153-2012	Cohen, Sidney R./0000-0003-4255-3351; Alon, Assaf/0000-0001-8102-5290; Ilani, Tal/0000-0003-2806-4455	Israel Science Foundation; Israel Cancer Association; Abisch-Frenkel Foundation; Kimmelman Center for Macromolecular Assemblies; European Research Council under the European Union [310649]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Abisch-Frenkel Foundation; Kimmelman Center for Macromolecular Assemblies; European Research Council under the European Union(European Research Council (ERC))	Y. Yarden provided valued advice and guidance throughout this project. We also thank V. Rotter, S. Feigelson, R. Alon, G. Shakhar, N. Friedman, M. Oren, and B. Geiger for reagents and advice. O. Leitner, Z. Landau, and H. Hamawi from the Weizmann Institute Antibody Unit performed technical aspects of antibody production. T. Mehlman provided mass spectrometry service. K. Shakhar provided statistics support. This work was supported by the Israel Science Foundation, Israel Cancer Association, Abisch-Frenkel Foundation, Kimmelman Center for Macromolecular Assemblies, and European Research Council under the European Union's Seventh Framework Programme (ERC grant agreement 310649). T. I., A. A., I. G., and D. F. have applied for a patent concerning the QSOX1 inhibitory antibody and its use in modulating assembly of laminin in the basement membrane.	Alon A, 2012, NATURE, V488, P414, DOI 10.1038/nature11267; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Chakravarthi S, 2007, BIOCHEM J, V404, P403, DOI 10.1042/BJ20061510; Coppock D, 2000, BIOCHEM BIOPH RES CO, V269, P604, DOI 10.1006/bbrc.2000.2324; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Givant-Horwitz V, 2005, CANCER LETT, V223, P1, DOI 10.1016/j.canlet.2004.08.030; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Hoober KL, 1996, J BIOL CHEM, V271, P30510, DOI 10.1074/jbc.271.48.30510; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; JANOLINO VG, 1975, J BIOL CHEM, V250, P2532; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Limor-Waisberg K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-70; Mairet-Coello G, 2005, J COMP NEUROL, V484, P403, DOI 10.1002/cne.20411; OSTROWSKI MC, 1980, BIOCHEMISTRY-US, V19, P2639, DOI 10.1021/bi00553a016; OSTROWSKI MC, 1979, BIOCHEM BIOPH RES CO, V87, P171, DOI 10.1016/0006-291X(79)91662-0; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Portes KF, 2008, J MOL HISTOL, V39, P217, DOI 10.1007/s10735-007-9156-8; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Soloviev M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057327; Tury A, 2006, CELL TISSUE RES, V323, P91, DOI 10.1007/s00441-005-0043-x; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	26	106	111	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					74	76		10.1126/science.1238279	http://dx.doi.org/10.1126/science.1238279			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23704371				2022-12-24	WOS:000321291700051
J	Hayes, D; Griffin, GB; Engel, GS				Hayes, Dugan; Griffin, Graham B.; Engel, Gregory S.			Engineering Coherence Among Excited States in Synthetic Heterodimer Systems	SCIENCE			English	Article							2-DIMENSIONAL ELECTRONIC SPECTROSCOPY; LIGHT-HARVESTING COMPLEXES; QUANTUM COHERENCE; ENERGY-TRANSFER; DYNAMICS; PHOTOSYNTHESIS; TEMPERATURE	The design principles that support persistent electronic coherence in biological light-harvesting systems are obscured by the complexity of such systems. Some electronic coherences in these systems survive for hundreds of femtoseconds at physiological temperatures, suggesting that coherent dynamics may play a role in photosynthetic energy transfer. Coherent effects may increase energy transfer efficiency relative to strictly incoherent transfer mechanisms. Simple, tractable, manipulable model systems are required in order to probe the fundamental physics underlying these persistent electronic coherences, but to date, these quantum effects have not been observed in small molecules. We have engineered a series of rigid synthetic heterodimers that can serve as such a model system and observed quantum beating signals in their two-dimensional electronic spectra consistent with the presence of persistent electronic coherences.	[Engel, Gregory S.] Univ Chicago, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Engel, GS (corresponding author), Univ Chicago, Dept Chem, Inst Biophys Dynam, 5735 S Ellis Ave, Chicago, IL 60637 USA.	gsengel@uchicago.edu	Engel, Gregory/C-1108-2012	Engel, Gregory/0000-0002-6740-5243; Hayes, Dugan/0000-0003-4171-5179	NSF Materials Research and Engineering Center [DMR 08-02054]; Air Force Office of Scientific Research [FA9550-09-1-0117]; Defense Threat Reduction Agency [HDTRA1-10-1-0091 P00002]; Defense Advanced Research Projects Agency QuBE program [N66001-10-1-4060]; Searle Foundation; NSF [CHE-1048528]; Direct For Mathematical & Physical Scien [1048528] Funding Source: National Science Foundation	NSF Materials Research and Engineering Center; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Defense Advanced Research Projects Agency QuBE program; Searle Foundation; NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Details of the synthesis, spectroscopy, and data analysis are included in the supplementary materials. The authors would like to thank the NSF Materials Research and Engineering Center (grant DMR 08-02054), Air Force Office of Scientific Research (grant FA9550-09-1-0117), Defense Threat Reduction Agency (HDTRA1-10-1-0091 P00002), the Defense Advanced Research Projects Agency QuBE program (grant N66001-10-1-4060), and the Searle Foundation for supporting this work. D.H. thanks the NSF Graduate Research Fellowship Program program for funding. The mass spectrometry facility used for this work is supported by NSF grant CHE-1048528. The authors gratefully acknowledge the experimental efforts of R. McGillicuddy, P. Dahlberg, K. A. Fransted, T. Jarvis, and C. J. Qin and thank S. Viswanathan and A. Fidler for useful discussions.	ARBELOA IL, 1981, J CHEM SOC FARAD T 2, V77, P1725, DOI 10.1039/f29817701725; Balevicius V, 2012, CHEM PHYS, V404, P94, DOI 10.1016/j.chemphys.2012.02.021; Bixner O, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4720492; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Calhoun TR, 2009, J PHYS CHEM B, V113, P16291, DOI 10.1021/jp908300c; Caram JR, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733710; Caycedo-Soler F, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3703504; Cheng YC, 2007, CHEM PHYS, V341, P285, DOI 10.1016/j.chemphys.2007.07.049; Cho S, 2011, J PHYS CHEM A, V115, P3990, DOI 10.1021/jp109174f; Christensson N, 2011, J PHYS CHEM B, V115, P5383, DOI 10.1021/jp109442b; Christensson N, 2012, J PHYS CHEM B, V116, P7449, DOI 10.1021/jp304649c; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Engel GS, 2011, PROCEDIA CHEM, V3, DOI 10.1016/j.proche.2011.08.029; Harel E, 2012, P NATL ACAD SCI USA, V109, P706, DOI 10.1073/pnas.1110312109; Hayes D, 2011, FARADAY DISCUSS, V150, P459, DOI 10.1039/c0fd00030b; Hayes D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065042; Hybl JD, 2001, J CHEM PHYS, V115, P6606, DOI 10.1063/1.1398579; Ishizaki A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3155214; KNAPP EW, 1984, CHEM PHYS, V85, P73, DOI 10.1016/S0301-0104(84)85174-5; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Milota F, 2009, ACCOUNTS CHEM RES, V42, P1364, DOI 10.1021/ar800282e; Panitchayangkoon G, 2011, P NATL ACAD SCI USA, V108, P20908, DOI 10.1073/pnas.1105234108; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Prall BS, 2005, J PHYS CHEM A, V109, P10870, DOI 10.1021/jp054225d; Sun WC, 1997, J ORG CHEM, V62, P6469, DOI 10.1021/jo9706178; Tiwari V, 2013, P NATL ACAD SCI USA, V110, P1203, DOI 10.1073/pnas.1211157110; Walkup GK, 2000, J AM CHEM SOC, V122, P5644, DOI 10.1021/ja000868p; Wood RW, 1932, PHYS REV, V42, P0386, DOI 10.1103/PhysRev.42.386	30	110	111	1	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1431	1434		10.1126/science.1233828	http://dx.doi.org/10.1126/science.1233828			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23599263				2022-12-24	WOS:000320647000036
J	Gordon, DM				Gordon, Deborah M.			The rewards of restraint in the collective regulation of foraging by harvester ant colonies	NATURE			English	Article							POGONOMYRMEX-RUGOSUS; PLASTICITY; METABOLISM; ECOLOGY; SIZE; MASS	Collective behaviour, arising from local interactions(1), allows groups to respond to changing conditions. Long-term studies have shown that the traits of individual mammals and birds are associated with their reproductive success(2-6), but little is known about the evolutionary ecology of collective behaviour in natural populations. An ant colony operates without central control, regulating its activity through a network of local interactions(7). This work shows that variation among harvester ant (Pogonomyrmex barbatus) colonies in collective response to changing conditions(8) is related to variation in colony lifetime reproductive success in the production of offspring colonies. Desiccation costs are high for harvester ants foraging in the desert(9,10). More successful colonies tend to forage less when conditions are dry, and show relatively stable foraging activity when conditions are more humid. Restraint from foraging does not compromise a colony's long-term survival; colonies that fail to forage at all on many days survive as long, over the colony's 20-30-year lifespan, as those that forage more regularly. Sensitivity to conditions in which to reduce foraging activity may be transmissible from parent to offspring colony. These results indicate that natural selection is shaping the collective behaviour that regulates foraging activity, and that the selection pressure, related to climate, may grow stronger if the current drought in their habitat persists.	Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Gordon, DM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dmgordon@stanford.edu			Stanford Office of the Dean of Research; Stanford Emergence of Cooperation Project; National Science Foundation [IOS-0718631]	Stanford Office of the Dean of Research; Stanford Emergence of Cooperation Project; National Science Foundation(National Science Foundation (NSF))	Thanks to the many people who helped with field work: in 1986 and 1987, K. Roth; in 2011, X. Ampuero, K. Dektar, M. Greene, J. Hickman, A. Merrell and N. Pinter-Wollman; in 2012, J. Queirolo, J. Rasiel, C. Wayne; in both 2011 and 2012, S. Crow, L. Howard and E. Pless. Many thanks to M. Coram for statistical advice and help. I am grateful to D. Kennedy and J. Ober for helpful discussions and to M. Feldman and W. Flesch for comments on the manuscript. The work was funded by the Stanford Office of the Dean of Research, Stanford Emergence of Cooperation Project and the National Science Foundation grant IOS-0718631.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; ALTMANN SA, 1991, P NATL ACAD SCI USA, V88, P420, DOI 10.1073/pnas.88.2.420; [Anonymous], 2010, ANT ENCOUNTERS INTER; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; CASSILL DL, 1995, ANIM BEHAV, V50, P801, DOI 10.1016/0003-3472(95)80140-5; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; DAVIDSON DW, 1980, AM NAT, V116, P92, DOI 10.1086/283613; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; GORDON D M L, 1987, Psyche (Cambridge), V94, P341, DOI 10.1155/1987/63930; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; GORDON DM, 1992, BEHAV ECOL SOCIOBIOL, V31, P417, DOI 10.1007/BF00170609; Gordon DM, 1998, J ANIM ECOL, V67, P141, DOI 10.1046/j.1365-2656.1998.00169.x; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; GORDON DM, 1995, ANIM BEHAV, V49, P649, DOI 10.1016/0003-3472(95)80198-7; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; GORDON DM, 1993, OECOLOGIA, V95, P479, DOI 10.1007/BF00317431; Ingram KK, 2013, J ANIM ECOL, V82, P540, DOI 10.1111/1365-2656.12036; Ingram Krista K., 2011, BMC Ecology, V11, P19, DOI 10.1186/1472-6785-11-19; Johnson RA, 2004, J INSECT PHYSIOL, V50, P943, DOI 10.1016/j.jinsphys.2004.07.006; LIGHTON JRB, 1988, P NATL ACAD SCI USA, V85, P4765, DOI 10.1073/pnas.85.13.4765; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Moyes K, 2009, J ANIM ECOL, V78, P406, DOI 10.1111/j.1365-2656.2008.01497.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Prabhakar B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002670; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103	27	98	98	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					91	+		10.1038/nature12137	http://dx.doi.org/10.1038/nature12137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23676676				2022-12-24	WOS:000319947800039
J	Liu, D; Shi, WF; Shi, Y; Wang, DY; Xiao, HX; Li, W; Bi, YH; Wu, Y; Li, XB; Yan, JH; Liu, WJ; Zhao, GP; Yang, WZ; Wang, Y; Ma, JC; Shu, YL; Lei, FM; Gao, GF				Liu, Di; Shi, Weifeng; Shi, Yi; Wang, Dayan; Xiao, Haixia; Li, Wei; Bi, Yuhai; Wu, Ying; Li, Xianbin; Yan, Jinghua; Liu, Wenjun; Zhao, Guoping; Yang, Weizhong; Wang, Yu; Ma, Juncai; Shu, Yuelong; Lei, Fumin; Gao, George F.			Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses	LANCET			English	Article								Background On March 30, 2013, a novel avian influenza A H7N9 virus that infects human beings was identified. This virus had been detected in six provinces and municipal cities in China as of April 18, 2013. We correlated genomic sequences from avian influenza viruses with ecological information and did phylogenetic and coalescent analyses to extrapolate the potential origins of the virus and possible routes of reassortment events. Methods We downloaded H7N9 virus genome sequences from the Global Initiative on Sharing Avian Influenza Data (GISAID) database and public sequences used from the Influenza Virus Resource. We constructed phylogenetic trees and did 1000 bootstrap replicates for each tree. Two rounds of phylogenetic analyses were done. We used at least 100 closely related sequences for each gene to infer the overall topology, removed suspicious sequences from the trees, and focused on the closest clades to the novel H7N9 viruses. We compared our tree topologies with those from a bayesian evolutionary analysis by sampling trees (BEAST) analysis. We used the bayesian Markov chain Monte Carlo method to jointly estimate phylogenies, divergence times, and other evolutionary parameters for all eight gene fragments. We used sequence alignment and homology-modelling methods to study specific mutations regarding phenotypes, specifically addressing the human receptor binding properties. Findings The novel avian influenza A H7N9 virus originated from multiple reassortment events. The HA gene might have originated from avian influenza viruses of duck origin, and the NA gene might have transferred from migratory birds infected with avian influenza viruses along the east Asian flyway. The six internal genes of this virus probably originated from two different groups of H9N2 avian influenza viruses, which were isolated from chickens. Detailed analyses also showed that ducks and chickens probably acted as the intermediate hosts leading to the emergence of this virulent H7N9 virus. Genotypic and potential phenotypic differences imply that the isolates causing this outbreak form two separate subclades. Interpretation The novel avian influenza A H7N9 virus might have evolved from at least four origins. Diversity among isolates implies that the H7N9 virus has evolved into at least two different lineages. Unknown intermediate hosts involved might be implicated, extensive global surveillance is needed, and domestic-poultry-to-person transmission should be closely watched in the future.	[Liu, Di; Shi, Yi; Bi, Yuhai; Wu, Ying; Yan, Jinghua; Liu, Wenjun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Liu, Di; Li, Wei; Ma, Juncai] Chinese Acad Sci, Inst Microbiol, Network Informat Ctr, Beijing 100101, Peoples R China; [Shi, Weifeng] Taishan Med Coll, Sch Basic Med Sci, Taishan, Shandong, Peoples R China; [Shi, Weifeng; Lei, Fumin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing 100101, Peoples R China; [Wang, Dayan; Shu, Yuelong; Gao, George F.] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xiao, Haixia] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Li, Xianbin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Li, Xianbin; Gao, George F.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Weizhong; Wang, Yu; Gao, George F.] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, 1 West Beichen Rd, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Liu, Di/G-6135-2014; Xiao, Haixia/AAZ-3374-2020; Liu, Di/ABD-2729-2021; Gao, George Fu/ABD-5229-2021	Liu, Di/0000-0003-3693-2726; Xiao, Haixia/0000-0003-0032-5430; Liu, Di/0000-0003-3693-2726; Zhao, Guo-Ping/0000-0002-7621-6620; Bi, Yuhai/0000-0002-5595-363X	China Ministry of Science and Technology Project 973; National Natural Science Foundation of China; China Health and Family Planning Commission; Chinese Academy of Sciences	China Ministry of Science and Technology Project 973; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Health and Family Planning Commission; Chinese Academy of Sciences(Chinese Academy of Sciences)	China Ministry of Science and Technology Project 973, National Natural Science Foundation of China, China Health and Family Planning Commission, Chinese Academy of Sciences.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Cheng TX, 1979, FAUNA SINICA AVES; COLMAN PM, 1992, IMMUNOL CELL BIOL, V70, P209, DOI 10.1038/icb.1992.26; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Kageyama T, 2013, EURO SURVEILL, V18; Kim HR, 2012, J GEN VIROL, V93, P1278, DOI 10.1099/vir.0.041269-0; Kiso M, 2011, J VIROL, V85, P4667, DOI 10.1128/JVI.00047-11; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Nguyen-Van-Tam JS, 2006, EUROSURVEILLANCE, V11; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583	19	429	501	7	289	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2013	381	9881					1926	1932		10.1016/S0140-6736(13)60938-1	http://dx.doi.org/10.1016/S0140-6736(13)60938-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23643111				2022-12-24	WOS:000320319500033
J	Haruki, H; Pedersen, MG; Gorska, KI; Pojer, F; Johnsson, K				Haruki, Hirohito; Pedersen, Miriam Gronlund; Gorska, Katarzyna Irena; Pojer, Florence; Johnsson, Kai			Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs	SCIENCE			English	Article							PNEUMOCYSTIS-JIROVECII PNEUMONIA; REDUCTASE DEFICIENCY; TRIMETHOPRIM; SULFONAMIDE; PHARMACOKINETICS; SULFAMETHOXAZOLE; SULFASALAZINE; DISCOVERY; PSYCHOSIS; REVEALS	The introduction of sulfa drugs for the chemotherapy of bacterial infections in 1935 revolutionized medicine. Although their mechanism of action is understood, the molecular bases for most of their side effects remain obscure. Here, we report that sulfamethoxazole and other sulfa drugs interfere with tetrahydrobiopterin biosynthesis through inhibition of sepiapterin reductase. Crystal structures of sepiapterin reductase with bound sulfa drugs reveal how structurally diverse sulfa drugs achieve specific inhibition of the enzyme. The effect of sulfa drugs on tetrahydrobiopterin-dependent neurotransmitter biosynthesis in cell-based assays provides a rationale for some of their central nervous system related side effects, particularly in high-dose sutfamethoxazole therapy of Pneumorystis pneumonia. Our findings reveal an unexpected aspect of the pharmacology of sulfa drugs and might translate into their improved medical use.	[Haruki, Hirohito; Pedersen, Miriam Gronlund; Gorska, Katarzyna Irena; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland; [Pojer, Florence] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Johnsson, K (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland.	kai.johnsson@epfl.ch	johnsson, kai/P-4222-2014	johnsson, kai/0000-0002-8002-1981	EPFL; Swiss National Science Foundation; NCCR Chemical Biology	EPFL; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Chemical Biology(Swiss National Science Foundation (SNSF))	The authors thank G. Turcatti, M. Chambon, M. Busquets, and M. Rengifo Gonzalez for technical assistance; the Swiss Light Source for support during x-ray data collection; and G. Lukinavicius, O. Sallin, P. Hauser, and C. Woolf for helpful discussions. This work was supported by EPFL, the Swiss National Science Foundation, and the NCCR Chemical Biology. Coordinates and structure factors for the crystal structures have been deposited in the Protein Data Bank (PDB), and the PDB accession codes are listed in table S8.	Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; BIEDLER JL, 1978, CANCER RES, V38, P3751; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; BRAUTIGAM M, 1984, J NEUROCHEM, V42, P390, DOI 10.1111/j.1471-4159.1984.tb02690.x; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Cribb AE, 1996, ADVERSE DRUG REACT T, V15, P9; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Friedman J, 2012, ANN NEUROL, V71, P520, DOI 10.1002/ana.22685; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; Helweg-Larsen J, 2009, J ANTIMICROB CHEMOTH, V64, P1282, DOI 10.1093/jac/dkp372; Hong YL, 1996, J EUKARYOT MICROBIOL, V43, pS40, DOI 10.1111/j.1550-7408.1996.tb04976.x; Keefer CS, 1942, NEW ENGL J MED, V226, P266, DOI 10.1056/NEJM194202122260705; Kenakin T., 2009, PHARM PRIMER, P184; Lacombe O, 2011, MOL PHARMACEUT, V8, P651, DOI 10.1021/mp1004614; Lee KY, 2012, J ANTIMICROB CHEMOTH, V67, P2749, DOI 10.1093/jac/dks283; Macartney D. W., 1942, LANCET, V239, P639; Marshall EK, 1939, J PHARMACOL EXP THER, V67, P454; PULLAR T, 1992, ADVERSE DRUG REACT T, V11, P93; Rowland RS, 1996, J PHYS CHEM-US, V100, P7384, DOI 10.1021/jp953141+; SADUSK JOSEPH F., 1941, YALE JOUR BIOL AND MED, V13, P351; SAKAI T, 1995, J NEURAL TRANSM-GEN, V102, P159, DOI 10.1016/0022-3093(95)00013-5; Seeliger D, 2007, PROTEINS, V68, P595, DOI 10.1002/prot.21447; STEVENS RC, 1991, ANTIMICROB AGENTS CH, V35, P1884, DOI 10.1128/AAC.35.9.1884; SUGITA O, 1982, J PHARMACOKINET BIOP, V10, P297, DOI 10.1007/BF01059263; van Dyke H. B., 1943, ANN NY ACAD SCI, V44, P477; Walker LE, 2011, J ANTIMICROB CHEMOTH, V66, P1117, DOI 10.1093/jac/dkr050; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; WOODY RC, 1990, DEV MED CHILD NEUROL, V32, P639	29	67	72	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					987	991		10.1126/science.1232972	http://dx.doi.org/10.1126/science.1232972			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704574	Green Published			2022-12-24	WOS:000319344100050
J	Owens, B				Owens, Brian			OBESITY Heavy sleepers	NATURE			English	Editorial Material																		Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Cizza G, 2010, CLIN TRIALS, V7, P274, DOI 10.1177/1740774510368298; Pamidi S., 2013, AM THOR SOC M 20 MAY; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750	5	6	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					S8	S9		10.1038/497S8a	http://dx.doi.org/10.1038/497S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698508	Bronze			2022-12-24	WOS:000319254000005
J	Serenius, F; Kallen, K; Blennow, M; Ewald, U; Fellman, V; Holmstrom, G; Lindberg, E; Lundqvist, P; Marsal, K; Norman, M; Olhager, E; Stigson, L; Stjernqvist, K; Vollmer, B; Stromberg, B				Serenius, Fredrik; Kallen, Karin; Blennow, Mats; Ewald, Uwe; Fellman, Vineta; Holmstrom, Gerd; Lindberg, Eva; Lundqvist, Pia; Marsal, Karel; Norman, Mikael; Olhager, Elisabeth; Stigson, Lennart; Stjernqvist, Karin; Vollmer, Brigitte; Stromberg, Bo		EXPRESS Grp	Neurodevelopmental Outcome in Extremely Preterm Infants at 2.5 Years After Active Perinatal Care in Sweden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; COGNITIVE-DEVELOPMENT; DEVELOPMENTAL DELAY; EXTREMELY PREMATURE; GENDER-DIFFERENCES; CHILDREN BORN; FOLLOW-UP; GROWTH; AGE; DISABILITY	Importance Active perinatal care increases survival of extremely preterm infants; however, improved survival might be associated with increased disability among survivors. Objective To determine neurodevelopmental outcome in extremely preterm children at 2.5 years (corrected age). Design, Setting, and Participants Population-based prospective cohort of consecutive extremely preterm infants born before 27 weeks of gestation in Sweden between 2004 and 2007. Of 707 live-born infants, 491 (69%) survived to 2.5 years. Survivors were assessed and compared with singleton control infants who were born at term and matched by sex, ethnicity, and municipality. Assessments ended in February 2010 and comparison estimates were adjusted for demographic differences. Main Outcomes and Measures Cognitive, language, and motor development was assessed with Bayley Scales of Infant and Toddler Development (3rd edition; Bayley-III), which are standardized to mean (SD) scores of 100 (15). Clinical examination and parental questionnaires were used for diagnosis of cerebral palsy and visual and hearing impairments. Assessments were made by week of gestational age. Results At a median age of 30.5 months (corrected), 456 of 491 (94%) extremely preterm children were evaluated (41 by chart review only). For controls, 701 had information on health status and 366 had Bayley-III assessments. Mean (SD) composite Bayley-III scores (cognition, 94 [12.3]; language, 98 [16.5]; motor, 94 [15.9]) were lower than the corresponding mean scores for controls (cognition, 104 [10.6]; P < .001; adjusted difference in mean scores, 9.2 [99% CI, 6.9-11.5]; language, 109 [12.3]; P < .001; adjusted difference in mean scores, 9.3 [99% Cl, 6.4-12.3]; and motor, 107 [13.7]; P < .001; adjusted difference in mean scores, 12.6 [99% Cl, 9.5-15.6]). Cognitive disability was moderate in 5% of the extremely preterm group vs 0.3% in controls (P < .001) and it was severe in 6.3% of the extremely preterm group vs 0.3% in controls (P < .001). Language disability was moderate in 9.4% of the extremely preterm group vs 2.5% in controls (P < .001) and severe in 6.6% of the extremely preterm group vs 0% in controls (P < .001). Other comparisons between the extremely preterm group vs controls were for cerebral palsy (7.0% vs 0.1%; P < .001), for blindness (0.9% vs 0%; P = .02), and for hearing impairment (moderate and severe, 0.9% vs 0%; P = .02, respectively). Overall, 42% (99% CI, 36%-48%) of extremely preterm children had no disability, 31% (99% CI, 25%-36%) had mild disability, 16% (99% CI, 12%-21%) had moderate disability, and 11% (99% CI, 7.2%-15%) had severe disability. Moderate or severe overall disability decreased with gestational age at birth (22 weeks, 60%; 23 weeks, 51%; 24 weeks, 34%; 25 weeks, 27%; and 26 weeks, 17%; P for trend < .001). Conclusions and Relevance Of children born extremely preterm and receiving active perinatal care, 73% had mild or no disability and neurodevelopmental outcome improved with each week of gestational age. These results are relevant for clinicians counseling families facing extremely preterm birth. JAMA. 2013;309(17):1810-1820	[Serenius, Fredrik; Ewald, Uwe; Stromberg, Bo] Uppsala Univ, Dept Womens & Childrens Hlth, Sect Pediat, S-75185 Uppsala, Sweden; [Holmstrom, Gerd] Uppsala Univ, Dept Neurosci Ophthalmol, S-75185 Uppsala, Sweden; [Serenius, Fredrik] Umea Univ, Dept Pediat, Inst Clin Sci, Umea, Sweden; [Kallen, Karin] Lund Univ, Ctr Reprod Epidemiol, Lund, Sweden; [Fellman, Vineta] Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden; [Lundqvist, Pia] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Marsal, Karel] Lund Univ, Dept Obstet & Gynecol, Clin Sci Lund, Lund, Sweden; [Stjernqvist, Karin] Lund Univ, Dept Psychol, Lund, Sweden; [Blennow, Mats; Norman, Mikael] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Vollmer, Brigitte] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Lindberg, Eva] Univ Orebro, Dept Pediat, Orebro, Sweden; [Olhager, Elisabeth] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Stigson, Lennart] Gothenburg Univ, Dept Pediat, Inst Clin Sci, Sahlgrenska Acad, S-41124 Gothenburg, Sweden	Uppsala University; Uppsala University; Umea University; Lund University; Lund University; Lund University; Lund University; Lund University; Karolinska Institutet; Karolinska Institutet; Orebro University; Linkoping University; University of Gothenburg	Serenius, F (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Sect Pediat, S-75185 Uppsala, Sweden.	fredrik.serenius@kbh.uu.se	Blennow, Mats/AAX-6202-2021; vollmer, brigitte/AAB-3132-2020	vollmer, brigitte/0000-0003-4088-5336; Hellstrom-Westas, Lena/0000-0003-3498-6069; Norman, Mikael/0000-0003-4191-3781; Blennow, Mats/0000-0001-9517-0261; Hellstrom, Ann/0000-0002-9259-1244	Swedish Research Council [2006-3855, 2009-4250]; Uppsala-Orebro Regional Research Council [RFR-10324]; Research Council South East Region of Sweden; Swedish government; University of Umea; Vasterbotten County Council; Stockholm County Council; Karolinska Institute; "Lilla Barnets Fond" Children's fund; Evy and Gunnar Sandberg Foundation; Birgit and Hakan Ohlsson Foundation; EU	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala-Orebro Regional Research Council; Research Council South East Region of Sweden; Swedish government; University of Umea; Vasterbotten County Council; Stockholm County Council(Stockholm County Council); Karolinska Institute(Karolinska Institutet); "Lilla Barnets Fond" Children's fund; Evy and Gunnar Sandberg Foundation; Birgit and Hakan Ohlsson Foundation; EU(European Commission)	This study was supported by the Swedish Research Council grants 2006-3855 and 2009-4250, the Uppsala-Orebro Regional Research Council grant RFR-10324, a grant from the Research Council South East Region of Sweden, and grants to Researchers in the Public Health Care from the Swedish government. Financial support was also provided through a regional agreement between the University of Umea and Vasterbotten County Council and through a regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institute. The study also received support from The "Lilla Barnets Fond" Children's fund. Dr Kallen reported support from the Evy and Gunnar Sandberg and from the Birgit and Hakan Ohlsson Foundations and Dr Vollmer was supported by the Marie Curie Individual Intra-European Fellowship within the EU FP6 Framework Program.	Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Bayley N, 1993, BAYLEY SCALES INFANT; Bayley N., 2019, BAYLEY SCALES INFANT; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Claas MJ, 2011, ARCH DIS CHILD-FETAL, V96, pF169, DOI 10.1136/adc.2009.174433; COCKBURN F, 1993, LANCET, V342, P193; De Groote I, 2007, OBSTET GYNECOL, V110, P855, DOI 10.1097/01.AOG.0000284447.43442.55; Delobel-Ayoub M, 2009, PEDIATRICS, V123, P1485, DOI 10.1542/peds.2008-1216; Doyle LW, 2010, J PEDIATR-US, V156, P49, DOI 10.1016/j.jpeds.2009.07.013; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Gargus RA, 2009, PEDIATRICS, V124, P112, DOI 10.1542/peds.2008-2742; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Hack M, 2000, Semin Neonatol, V5, P89, DOI 10.1053/siny.1999.0001; Hindmarsh GJ, 2000, EARLY HUM DEV, V60, P115, DOI 10.1016/S0378-3782(00)00105-5; Hintz SR, 2006, ACTA PAEDIATR, V95, P1239, DOI 10.1080/08035250600599727; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McCarton CM, 1997, JAMA-J AM MED ASSOC, V277, P126, DOI 10.1001/jama.277.2.126; Ment LR, 2003, JAMA-J AM MED ASSOC, V289, P705, DOI 10.1001/jama.289.6.705; Mercier CE, 2010, NEONATOLOGY, V97, P329, DOI 10.1159/000260136; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Msall ME, 2010, J PEDIATR-US, V157, P863, DOI 10.1016/j.jpeds.2010.09.022; Rattihalli RR, 2011, ARCH DIS CHILD-FETAL, V96, pF329, DOI 10.1136/adc.2010.192559; Shepherd EG, 2012, J PERINATOL, V32, P33, DOI 10.1038/jp.2011.45; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Stjernqvist K, 1999, ACTA PAEDIATR, V88, P557, DOI 10.1080/08035259950169594; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; THOMAS DG, 1971, APPLIED STATISTICS, V20, P105, DOI DOI 10.2307/2346643; Tommiska V, 2003, ARCH DIS CHILD-FETAL, V88, P29; Tommiska V, 2007, PEDIATRICS, V119, P29, DOI 10.1542/peds.2006-1472; UNESCO Institute for Statistics, 2006, INT STAND CLASS ED I; Vohr BR, 2006, PEDIATRICS, V118, pE115, DOI 10.1542/peds.2005-2382; Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Walden RV, 2007, PEDIATRICS, V120, pE1512, DOI 10.1542/peds.2007-0354; WEISGLASKUPERUS N, 1993, PEDIATRICS, V92, P658; Weiss B, 1997, MENT RETARD DEV D R, V3, P246, DOI 10.1002/(SICI)1098-2779(1997)3:3<246::AID-MRDD5>3.0.CO;2-N; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	44	343	354	4	66	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1810	1820		10.1001/jama.2013.3786	http://dx.doi.org/10.1001/jama.2013.3786			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632725	Bronze			2022-12-24	WOS:000318235600029
J	Spence, D				Spence, Des			Bad medicine: the way we manage diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSULIN					destwo@yahoo.co.uk						Black C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004654.pub2; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7139; Davidson MB, 2005, DIABETES CARE, V28, P1531, DOI 10.2337/diacare.28.6.1531; Gale EAM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3974; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; National Institute for Health and Care Excellence (NICE), 2013, BLOOD GLUC LOW THER; Ooi CP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009361.pub2; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Van de Laar FA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003639.pub2	14	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2013	346								f2695	10.1136/bmj.f2695	http://dx.doi.org/10.1136/bmj.f2695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139DK	23628877				2022-12-24	WOS:000318561600006
J	van de Waal, E; Borgeaud, C; Whiten, A				van de Waal, Erica; Borgeaud, Christele; Whiten, Andrew			Potent Social Learning and Conformity Shape a Wild Primate's Foraging Decisions	SCIENCE			English	Article							CULTURE; TRANSMISSION; EVOLUTION; CHIMPANZEES; INFORMATION; DIFFUSION; INSIGHTS	Conformity to local behavioral norms reflects the pervading role of culture in human life. Laboratory experiments have begun to suggest a role for conformity in animal social learning, but evidence from the wild remains circumstantial. Here, we show experimentally that wild vervet monkeys will abandon personal foraging preferences in favor of group norms new to them. Groups first learned to avoid the bitter-tasting alternative of two foods. Presentations of these options untreated months later revealed that all new infants naive to the foods adopted maternal preferences. Males who migrated between groups where the alternative food was eaten switched to the new local norm. Such powerful effects of social learning represent a more potent force than hitherto recognized in shaping group differences among wild animals.	[van de Waal, Erica; Whiten, Andrew] Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland; [van de Waal, Erica; Whiten, Andrew] Univ St Andrews, Sch Psychol & Neurosci, Scottish Primate Res Grp, St Andrews KY16 9JP, Fife, Scotland; [van de Waal, Erica; Borgeaud, Christele; Whiten, Andrew] Mawana Game Reserve, Inkawu Vervet Project, ZA-3115 Swart Mfolozi, KwaZulu Natal, South Africa; [Borgeaud, Christele] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of St Andrews; University of St Andrews; University of Neuchatel	Whiten, A (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland.	aw2@st-andrews.ac.uk		van de Waal, Erica/0000-0001-7778-418X; Whiten, Andrew/0000-0003-2426-5890	Swiss National Science Foundation [CRSI33_133040]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by a Sinergia grant (CRSI33_133040) from the Swiss National Science Foundation to R. Bshary, C. P. van Schaik, and A. W. We are grateful to K. van der Walt for permission to conduct the study in his reserve and A. Driescher for support in the field. The study was registered with Ezemvelo KZN Wildlife in South Africa and gained approval from the Ethics Committee of the School of Psychology and Neuroscience, University of St Andrews. We are grateful to J. Arsenau, A. Brotz, S. Delley, K. Gordon, M. Mignini, Z. Mills, S. Salcedo, T. Sharky, A. Taucher, K. Vega, L. Violetti, and J. Watzek for assistance in data collection during experimental trials. We thank C. van Schaik, R. Bshary, N. Claidiere, and E. Willems for comments on the manuscript. All data are publically available in the supplementary materials.	ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Battesti M, 2012, CURR BIOL, V22, P309, DOI 10.1016/j.cub.2011.12.050; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Galef BG, 2008, ANIM BEHAV, V75, P2035, DOI 10.1016/j.anbehav.2007.11.012; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; HINDE R. A., 1951, British Birds, V44, P393; Hopper LM, 2011, ANIM BEHAV, V81, P1195, DOI 10.1016/j.anbehav.2011.03.002; Kawamura S., 1959, Primates, V2, P43, DOI 10.1007/BF01666110; Kendal RL, 2010, LEARN BEHAV, V38, P220, DOI 10.3758/LB.38.3.220; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Pagel M, 2012, NATURE, V482, P297, DOI 10.1038/482297a; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rendell L, 2001, BEHAV BRAIN SCI, V24, P324, DOI DOI 10.1017/S0140525X0100396X; Richerson P. J, 2005, NOT GENES ALONE; Schnoell AV, 2012, ANIM COGN, V15, P505, DOI 10.1007/s10071-012-0477-y; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thornton A, 2009, ANIM BEHAV, V78, P255, DOI 10.1016/j.anbehav.2009.04.021; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; van Schaik CP, 2012, CURR BIOL, V22, pR402, DOI 10.1016/j.cub.2012.04.001; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031; Whiten A, 2011, PHILOS T R SOC B, V366, P938, DOI 10.1098/rstb.2010.0372	34	250	251	10	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					483	485		10.1126/science.1232769	http://dx.doi.org/10.1126/science.1232769			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620053				2022-12-24	WOS:000318016700043
J	Li, SB; Liu, L; Zhuang, XH; Yu, Y; Liu, XG; Cui, X; Ji, LJ; Pan, ZQ; Cao, XF; Mo, BX; Zhang, FC; Raikhel, N; Jiang, LW; Chen, XM				Li, Shengben; Liu, Lin; Zhuang, Xiaohong; Yu, Yu; Liu, Xigang; Cui, Xia; Ji, Lijuan; Pan, Zhiqiang; Cao, Xiaofeng; Mo, Beixin; Zhang, Fuchun; Raikhel, Natasha; Jiang, Liwen; Chen, Xuemei			MicroRNAs Inhibit the Translation of Target mRNAs on the Endoplasmic Reticulum in Arabidopsis	CELL			English	Article							TRANS-ACTING SIRNAS; DECAPPING COMPLEX; FREE POLYSOMES; GENE; PROTEIN; REPRESSION; MUTATIONS; AMP1; COMPONENTS; ARGONAUTE1	Translation inhibition is a major but poorly understood mode of action of microRNAs (miRNAs) in plants and animals. In particular, the subcellular location where this process takes place is unknown. Here, we show that the translation inhibition, but not the mRNA cleavage activity, of Arabidopsis miRNAs requires ALTERED MERISTEM PROGRAM1 (AMP1). AMP1 encodes an integral membrane protein associated with endoplasmic reticulum (ER) and ARGONAUTE1, the miRNA effector and a peripheral ER membrane protein. Large differences in polysome association of miRNA target RNAs are found between wild-type and the amp1 mutant for membrane-bound, but not total, polysomes. This, together with AMP1-independent recruitment of miRNA target transcripts to membrane fractions, shows that miRNAs inhibit the translation of target RNAs on the ER. This study demonstrates that translation inhibition is an important activity of plant miRNAs, reveals the subcellular location of this activity, and uncovers a previously unknown function of the ER.	[Li, Shengben; Liu, Lin; Yu, Yu; Liu, Xigang; Ji, Lijuan; Raikhel, Natasha; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Chen, Xuemei] Univ Calif Riverside, Howard Hughes Med Inst, Riverside, CA 92521 USA; [Liu, Lin; Zhang, Fuchun] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi 830046, Peoples R China; [Zhuang, Xiaohong; Jiang, Liwen] Chinese Univ Hong Kong, Sch Life Sci, Ctr Cell & Dev Biol, Shatin, Hong Kong, Peoples R China; [Yu, Yu; Mo, Beixin] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen 518060, Peoples R China; [Cui, Xia; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Pan, Zhiqiang] Univ Mississippi, ARS, USDA, University, MS 38677 USA	University of California System; University of California Riverside; Howard Hughes Medical Institute; University of California System; University of California Riverside; Xinjiang University; Chinese University of Hong Kong; Shenzhen University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; United States Department of Agriculture (USDA); University of Mississippi	Chen, XM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	xuemei.chen@ucr.edu	ZHUANG, Xiaohong/J-3915-2014; JIANG, Liwen/S-6046-2018	ZHUANG, Xiaohong/0000-0002-2480-8210; JIANG, Liwen/0000-0002-7829-1472; Ji, Lijuan/0000-0003-0678-6131; Chen, Xuemei/0000-0002-5209-1157	National Institutes of Health [GM061146]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3046]; Research Grants Council of Hong Kong [CUHK466610, CUHK466011, CUHK2/CRF/11G]; National Science Foundation of China; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Julia Bailey-Serres for technical advice on polysome profiling. We thank Drs. Kathryn Barton, Nam-Hai Chua, Daniel Kleibenstein, Elliot Meyerowitz, and Zhiyong Wang for sharing plasmids, seeds, or antibodies. We thank Julia Bailey-Serres, Theresa Dinh, Elizabeth Luscher, Kestrel Rogers, and Yuanyuan Zhao for comments on the manuscript. The work was funded by National Institutes of Health (GM061146) and by Howard Hughes Medical Institute and Gordon and Betty Moore Foundation (through Grant GBMF3046) to X.Chen, by the Research Grants Council of Hong Kong (CUHK466610, CUHK466011, and CUHK2/CRF/11G) to L.J., and by National Science Foundation of China to X. Cao and B.M. L.L. was supported by a fellowship from China Scholarship Council.	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; BIRCKBICHLER PJ, 1973, EUR J BIOCHEM, V33, P368, DOI 10.1111/j.1432-1033.1973.tb02692.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; Carbonell A, 2012, PLANT CELL, V24, P3613, DOI 10.1105/tpc.112.099945; CHAUDHURY AM, 1993, PLANT J, V4, P907, DOI 10.1046/j.1365-313X.1993.04060907.x; Chen J, 2004, PLANT CELL, V16, P1302, DOI 10.1105/tpc.018986; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Conway LJ, 1997, P NATL ACAD SCI USA, V94, P10209, DOI 10.1073/pnas.94.19.10209; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; HOU YM, 1993, PLANT CELL, V5, P329, DOI 10.1105/tpc.5.3.329; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; JURGENS G, 1991, DEVELOPMENT, P27; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kraut-Cohen J, 2010, TRENDS BIOCHEM SCI, V35, P459, DOI 10.1016/j.tibs.2010.02.006; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Lee BH, 2009, J MICROBIOL BIOTECHN, V19, P542, DOI 10.4014/jmb.0901.0082; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mordhorst AP, 1998, GENETICS, V149, P549; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Mustroph A, 2009, METHODS MOL BIOL, V553, P109, DOI 10.1007/978-1-60327-563-7_6; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; NOLL M, 1974, J MOL BIOL, V90, P215, DOI 10.1016/0022-2836(74)90369-6; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; SCHWARTZ BW, 1994, DEVELOPMENT, V120, P3235; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Won S.Y., 2012, SILENCE, V3, DOI [10.1186/1758-907X-3-6, DOI 10.1186/1758-907X-3-6]; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yang L, 2012, P NATL ACAD SCI USA, V109, P315, DOI 10.1073/pnas.1114673109	56	326	349	11	230	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					562	574		10.1016/j.cell.2013.04.005	http://dx.doi.org/10.1016/j.cell.2013.04.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622241	Bronze, Green Accepted			2022-12-24	WOS:000318063500010
J	Yartsev, MM; Ulanovsky, N				Yartsev, Michael M.; Ulanovsky, Nachum			Representation of Three-Dimensional Space in the Hippocampus of Flying Bats	SCIENCE			English	Article							SPATIAL REPRESENTATION; PLACE CELLS; GRID CELLS; COGNITIVE MAP; DYNAMICS; NEURONS; INCREASES; CODE	Many animals, on air, water, or land, navigate in three-dimensional (3D) environments, yet it remains unclear how brain circuits encode the animal's 3D position. We recorded single neurons in freely flying bats, using a wireless neural-telemetry system, and studied how hippocampal place cells encode 3D volumetric space during flight. Individual place cells were active in confined 3D volumes, and in >90% of the neurons, all three axes were encoded with similar resolution. The 3D place fields from different neurons spanned different locations and collectively represented uniformly the available space in the room. Theta rhythmicity was absent in the firing patterns of 3D place cells. These results suggest that the bat hippocampus represents 3D volumetric space by a uniform and nearly isotropic rate code.	[Yartsev, Michael M.; Ulanovsky, Nachum] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ulanovsky, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	nachum.ulanovsky@weizmann.ac.il		Ulanovsky, Nachum/0000-0001-8598-4667; Yartsev, Michael/0000-0003-0952-2801	European Research Council (ERC-NEUROBAT); Human Frontiers Science Program [HFSP RGP0062/2009-C]; Israel Science Foundation [ISF 1017/08]; Minerva Foundation; Lev-Zion predoctoral excellence fellowship	European Research Council (ERC-NEUROBAT); Human Frontiers Science Program(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Lev-Zion predoctoral excellence fellowship	We thank A. Treves, D. Derdikman, J.-M. Fellous, L. Las, Y. Yovel, M. Ahrens, and C. Brody for comments on the manuscript; R. Raz, K. Kamenitz, and M. Geva-Sagiv for the 3D trajectory reconstruction system; C. Stengel for the neural telemetry system; B. Pasmantirer and G. Ankaoua for mechanical designs; A. Rubin and A. Averkin for assistance with neural recordings and video calibrations; S. Kaufman, T. Dayan, and S. Dror for bat training; M. Weinberg and A. Tuval for veterinary oversight; C. Ra'anan and R. Eilam for histology; and M. P. Witter for advice on reconstruction of tetrode-track locations. This study was supported by research grants from the European Research Council (ERC-NEUROBAT), the Human Frontiers Science Program (HFSP RGP0062/2009-C), the Israel Science Foundation (ISF 1017/08), and the Minerva Foundation to N.U. and a Lev-Zion predoctoral excellence fellowship to M.M.Y.	Andersen P., 2007, HIPPOCAMPUS BOOK; Brown WM, 2006, NEURAL COMPUT, V18, P1511, DOI 10.1162/neco.2006.18.7.1511; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Hori E, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00036; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jeffery KJ, 2006, EXP BRAIN RES, V169, P218, DOI 10.1007/s00221-005-0138-3; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Knierim JJ, 2000, NAT NEUROSCI, V3, P209, DOI 10.1038/72910; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Ludvig N, 2004, BRAIN RES, V1014, P97, DOI 10.1016/j.brainres.2004.03.071; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Taube JS, 2013, HIPPOCAMPUS, V23, P14, DOI 10.1002/hipo.22074; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Ulanovsky N, 2011, CURR BIOL, V21, pR886, DOI 10.1016/j.cub.2011.09.031; Ulanoysky N, 2011, HIPPOCAMPUS, V21, P150, DOI 10.1002/hipo.20731; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	28	188	190	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					367	372		10.1126/science.1235338	http://dx.doi.org/10.1126/science.1235338			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599496				2022-12-24	WOS:000317657500060
J	Wuestefeld, T; Pesic, M; Rudalska, R; Dauch, D; Longerich, T; Kang, TW; Yevsa, T; Heinzmann, F; Hoenicke, L; Hohmeyer, A; Potapova, A; Rittelmeier, I; Jarek, M; Geffers, R; Scharfe, M; Klawonn, F; Schirmacher, P; Malek, NP; Ott, M; Nordheim, A; Vogel, A; Manns, MP; Zender, L				Wuestefeld, Torsten; Pesic, Marina; Rudalska, Ramona; Dauch, Daniel; Longerich, Thomas; Kang, Tae-Won; Yevsa, Tetyana; Heinzmann, Florian; Hoenicke, Lisa; Hohmeyer, Anja; Potapova, Anna; Rittelmeier, Ina; Jarek, Michael; Geffers, Robert; Scharfe, Maren; Klawonn, Frank; Schirmacher, Peter; Malek, Nisar P.; Ott, Michael; Nordheim, Alfred; Vogel, Arndt; Manns, Michael P.; Zender, Lars			A Direct In Vivo RNAi Screen Identifies MKK4 as a Key Regulator of Liver Regeneration	CELL			English	Article							TYROSINEMIA TYPE-I; PARTIAL-HEPATECTOMY; MICE; EXPRESSION; FIBROSIS; REVEALS; PROTEIN; MODEL; JNK	The liver harbors a distinct capacity for endogenous regeneration; however, liver regeneration is often impaired in disease and therefore insufficient to compensate for the loss of hepatocytes and organ function. Here we describe a functional genetic approach for the identification of gene targets that can be exploited to increase the regenerative capacity of hepatocytes. Pools of small hairpin RNAs (shRNAs) were directly and stably delivered into mouse livers to screen for genes modulating liver regeneration. Our studies identify the dual-specific kinase MKK4 as a master regulator of liver regeneration. MKK4 silencing robustly increased the regenerative capacity of hepatocytes in mouse models of liver regeneration and acute and chronic liver failure. Mechanistically, induction of MKK7 and a JNK1-dependent activation of the AP1 transcription factor ATF2 and the Ets factor ELK1 are crucial for increased regeneration of hepatocytes with MKK4 silencing.	[Wuestefeld, Torsten; Yevsa, Tetyana; Hohmeyer, Anja; Rittelmeier, Ina; Ott, Michael; Vogel, Arndt; Manns, Michael P.; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Wuestefeld, Torsten; Pesic, Marina; Rudalska, Ramona; Dauch, Daniel; Kang, Tae-Won; Heinzmann, Florian; Hoenicke, Lisa; Potapova, Anna; Jarek, Michael; Geffers, Robert; Scharfe, Maren; Klawonn, Frank; Zender, Lars] Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany; [Wuestefeld, Torsten; Pesic, Marina; Rudalska, Ramona; Dauch, Daniel; Kang, Tae-Won; Heinzmann, Florian; Hoenicke, Lisa; Hohmeyer, Anja; Zender, Lars] Univ Tubingen, Div Translat Gastrointestinal Oncol, Dept Internal Med 1, D-72076 Tubingen, Germany; [Malek, Nisar P.] Univ Tubingen, Dept Internal Med 1, D-72076 Tubingen, Germany; [Longerich, Thomas; Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Rittelmeier, Ina; Ott, Michael] Twincore Ctr Expt & Clin Infect Res, D-30625 Hannover, Germany; [Nordheim, Alfred] Univ Tubingen, Dept Mol Biol, Interfac Inst Cell Biol, D-72076 Tubingen, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center for Infection Research; Eberhard Karls University of Tubingen	Zender, L (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.	lars.zender@med.uni-tuebingen.de	Vogel, Arndt/A-8437-2012; Klawonn, Frank/HFH-5887-2022; Kang, Tae Won/S-4864-2019	Klawonn, Frank/0000-0001-9613-182X; Kang, Tae Won/0000-0003-1497-8926; /0000-0002-2430-4397; Hoenicke, Lisa/0000-0003-0613-8337; Nordheim, Alfred/0000-0003-4680-0778; Vogel, Arndt/0000-0003-0560-5538; Yevsa, Tetyana/0000-0003-0377-9198	German Research Foundation (DFG) [ZE 545/2-1, SFB/TRR77]; Helmholtz Association of German Research Centers [VH-NG-424]; European Commission; Wilhelm Sander Stiftung [2009.005.2]; Bear Necessities Pediatric Cancer Foundation; Federal German Ministry for Education and Research (BMBF)	German Research Foundation (DFG)(German Research Foundation (DFG)); Helmholtz Association of German Research Centers(Helmholtz Association); European Commission(European CommissionEuropean Commission Joint Research Centre); Wilhelm Sander Stiftung; Bear Necessities Pediatric Cancer Foundation; Federal German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank Drs. M. Kay and D. Largaespada for providing transposon vectors and transposase-encoding vectors; Dr. L. Grobe, A. Rinkel, N. Struever, Dr. H. Riedesel, and the team of the HZI animal facility for technical assistance; and Drs. J. Gil, K. Schulze-Osthoff, and J. Zuber for advice and discussions. This work was supported by grants of the German Research Foundation (DFG) to L. Z. (Emmy Noether Programme ZE 545/2-1, SFB/TRR77, project B4, "REBIRTH" cluster of Excellence, project "Liver regeneration"); the Helmholtz Association of German Research Centers (VH-NG-424 to L. Z.); the European Commission (project "HEPTROMIC" to L. Z.); the Wilhelm Sander Stiftung (2009.005.2 to L. Z.); the Bear Necessities Pediatric Cancer Foundation; and the Federal German Ministry for Education and Research (BMBF) (ARCHES AWARD to L. Z. and the project "virtual liver network" to A. N.). L. Z. holds an adjunct assistant professorship with the Cold Spring Harbor Laboratory, 11724 Cold Spring Harbor, USA. M. P., R. R., and D. D. contributed equally to this manuscript.	Ahn YH, 2011, MOL CELL BIOL, V31, P4270, DOI 10.1128/MCB.05562-11; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Cesari F, 2004, GENESIS, V38, P87, DOI 10.1002/gene.20003; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chistiakov DA, 2012, CELLS TISSUES ORGANS, V196, P291, DOI 10.1159/000335697; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; GAUB J, 1984, HEPATOLOGY, V4, P902, DOI 10.1002/hep.1840040519; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; HICKMAN MA, 1994, HUM GENE THER, V5, P1477, DOI 10.1089/hum.1994.5.12-1477; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; McCusker C, 2011, GERONTOLOGY, V57, P565, DOI 10.1159/000323761; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Overturf K, 1997, HUM GENE THER, V8, P513, DOI 10.1089/hum.1997.8.5-513; Overturf K, 1997, AM J PATHOL, V151, P1273; PIERCE RA, 1987, J BIOL CHEM, V262, P1652; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Sakamoto T, 1999, HEPATOLOGY, V29, P403, DOI 10.1002/hep.510290244; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; STARZL TE, 1975, AM J SURG, V129, P587, DOI 10.1016/0002-9610(75)90323-2; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Teoh NC, 2009, J GASTROEN HEPATOL, V24, P1817, DOI 10.1111/j.1440-1746.2009.06121.x; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; World Health Organization, 2011, DEATHS EST 2008 CAUS; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yeasmin S, 2011, TUMOR BIOL, V32, P661, DOI 10.1007/s13277-011-0166-5; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	34	105	110	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					389	401		10.1016/j.cell.2013.03.026	http://dx.doi.org/10.1016/j.cell.2013.03.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582328	Bronze			2022-12-24	WOS:000317349700017
J	Biddinger, PD; Baggish, A; Harrington, L; d'Hemecourt, P; Hooley, J; Jones, J; Kue, R; Troyanos, C; Dyer, KS				Biddinger, Paul D.; Baggish, Aaron; Harrington, Lori; d'Hemecourt, Pierre; Hooley, James; Jones, Jerrilyn; Kue, Ricky; Troyanos, Chris; Dyer, K. Sophia			Be Prepared - The Boston Marathon and Mass-Casualty Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Biddinger, Paul D.; Baggish, Aaron] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Biddinger, Paul D.; Baggish, Aaron] Harvard Univ, Sch Med, Boston, MA USA; [Biddinger, Paul D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Harrington, Lori; Hooley, James; Jones, Jerrilyn; Kue, Ricky; Dyer, K. Sophia] Boston EMS Police & Fire, Boston, MA USA; [Harrington, Lori; Jones, Jerrilyn; Kue, Ricky; Dyer, K. Sophia] Boston Med Ctr, Boston, MA USA; [Harrington, Lori; Jones, Jerrilyn; Kue, Ricky; Dyer, K. Sophia] Boston Univ, Sch Med, Boston, MA 02118 USA; [Baggish, Aaron; d'Hemecourt, Pierre; Troyanos, Chris; Dyer, K. Sophia] Boston Athlet Assoc, Boston, MA USA; [Hooley, James] Boston Publ Hlth Commiss, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston Medical Center; Boston University	Biddinger, PD (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.			Kue, Ricky/0000-0002-2295-1101				Cheney Kyle, 2013, POLITICO; Gawande A., 2013, NEW YORKER; Kotz Deborah, 2013, BOSTON GLOBE, pB3; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022	4	78	78	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1958	1960		10.1056/NEJMp1305480	http://dx.doi.org/10.1056/NEJMp1305480			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194KD	23635020				2022-12-24	WOS:000322630700004
J	Kawatani, Y; Hamilton, K				Kawatani, Yoshio; Hamilton, Kevin			Weakened stratospheric quasibiennial oscillation driven by increased tropical mean upwelling	NATURE			English	Article							BREWER-DOBSON CIRCULATION; CHANGING CLIMATE; QBO; PERIOD; MODEL; MODULATION; AIR; AGE	The zonal wind in the tropical stratosphere switches between prevailing easterlies and westerlies with a period of about 28 months(1). In the lowermost stratosphere, the vertical structure of this quasibiennial oscillation (QBO) is linked to the mean upwelling(2-4), which itself is a key factor in determining stratospheric composition. Evidence for changes in the QBO have until now been equivocal, raising questions as to the extent of stratospheric circulation changes in a global warming context. Here we report an analysis of near-equatorial radiosonde observations for 1953-2012, and reveal a long-term trend of weakening amplitude in the zonal wind QBO in the tropical lower stratosphere. The trend is particularly notable at the 70-hectopascal pressure level (an altitude of about 19 kilometres), where the QBO amplitudes dropped by roughly one-third over the period. This trend is also apparent in the global warming simulations of the four models in the Coupled Model Intercomparison Project Phase 5 (CMIP5) that realistically simulate the QBO. The weakening is most reasonably explained as resulting from a trend of increased mean tropical upwelling in the lower stratosphere. Almost all comprehensive climate models have projected an intensifying tropical upwelling in global warming scenarios(5-7), but attempts to estimate changes in the upwelling by using observational data have yielded ambiguous, inconclusive or contradictory results(8-10). Our discovery of a weakening trend in the lower-stratosphere QBO amplitude provides strong support for the existence of a long-term trend of enhanced upwelling near the tropical tropopause.	[Kawatani, Yoshio] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Hamilton, Kevin] Univ Hawaii Manoa, SOEST, Int Pacific Res Ctr, Honolulu, HI 96822 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Hawaii System; University of Hawaii Manoa	Kawatani, Y (corresponding author), Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Kanazawa Ku, 3173-25 Showamachi, Yokohama, Kanagawa 2360001, Japan.	yoskawatani@jamstec.go.jp	; Kawatani, Yoshio/B-1777-2013	Hamilton, Kevin/0000-0002-3560-8097; Kawatani, Yoshio/0000-0003-3260-8830	Japan Agency for Marine-Earth Science and Technology through International Pacific Research Center; Ministry of the Environment, Japan [A-1201]; JSPS KAKENHI [23740363, 24340113]; NASA [NNX07AG53G]; NOAA [NA11NMF4320128]; International Pacific Research Center; Data Integration and Analysis System (DIAS) Fund for National Key Technology from MEXT	Japan Agency for Marine-Earth Science and Technology through International Pacific Research Center; Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NASA(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); International Pacific Research Center; Data Integration and Analysis System (DIAS) Fund for National Key Technology from MEXT	This work was supported by the Japan Agency for Marine-Earth Science and Technology through its support of the International Pacific Research Center, by the Environment Research and Technology Development Fund (A-1201) of the Ministry of the Environment, Japan and by JSPS KAKENHI grant nos 23740363 and 24340113. This work was also supported by NASA (grant no. NNX07AG53G) and by NOAA (grant no. NA11NMF4320128), organisations that sponsor research at the International Pacific Research Center. We thank A. Noda, H. Tokinaga, M. Fujiwara, K. Miyazaki, M. Takahashi, T. Hirooka, K. Sato, H. Nakamura and Y. N. Takayabu for suggestions. We also thank O. Arakawa and N. Hirota for handling the CMIP5 data archive. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for making available their model output. For CMIP, the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We also acknowledge the Data Integration and Analysis System (DIAS) Fund for National Key Technology from MEXT.	Andrews D. G., 1987, MIDDLE ATMOSPHERE DY; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; Butchart N, 2006, CLIM DYNAM, V27, P727, DOI 10.1007/s00382-006-0162-4; Butchart N, 2001, NATURE, V410, P799, DOI 10.1038/35071047; DUNKERTON TJ, 1985, J ATMOS SCI, V42, P376, DOI 10.1175/1520-0469(1985)042<0376:COTELS>2.0.CO;2; Engel A, 2009, NAT GEOSCI, V2, P28, DOI 10.1038/NGEO388; Garcia RR, 2008, J ATMOS SCI, V65, P2731, DOI 10.1175/2008JAS2712.1; Garfinkel CI, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008481; Geller MA, 1997, J ATMOS SCI, V54, P883, DOI 10.1175/1520-0469(1997)054<0883:COTSQB>2.0.CO;2; Hamilton K, 2004, J ATMOS SCI, V61, P383, DOI 10.1175/1520-0469; Hamilton K, 1999, J ATMOS SCI, V56, P3829, DOI 10.1175/1520-0469(1999)056<3829:MASWHV>2.0.CO;2; Hamilton K, 2002, J CLIMATE, V15, P2562, DOI 10.1175/1520-0442(2002)015<2562:OTQDMO>2.0.CO;2; KAROLY DJ, 1994, CLIM DYNAM, V10, P97, DOI 10.1007/s003820050038; Kawatani Y, 2011, J ATMOS SCI, V68, P265, DOI 10.1175/2010JAS3623.1; Kawatani Y, 2010, J ATMOS SCI, V67, P963, DOI 10.1175/2009JAS3222.1; LINDZEN RS, 1968, J ATMOS SCI, V25, P1095, DOI 10.1175/1520-0469(1968)025<1095:ATOTQB>2.0.CO;2; McLandress C, 2009, J CLIMATE, V22, P1516, DOI 10.1175/2008JCLI2679.1; NAUJOKAT B, 1986, J ATMOS SCI, V43, P1873, DOI 10.1175/1520-0469(1986)043<1873:AUOTOQ>2.0.CO;2; PLUMB RA, 1977, J ATMOS SCI, V34, P1847, DOI 10.1175/1520-0469(1977)034<1847:TIOTIW>2.0.CO;2; QUIROZ RS, 1981, MON WEATHER REV, V109, P665, DOI 10.1175/1520-0493(1981)109<0665:PMOTSQ>2.0.CO;2; Salby M, 2000, J CLIMATE, V13, P2652, DOI 10.1175/1520-0442(1999)012<2652:CBTSCA>2.0.CO;2; SARAVANAN R, 1990, J ATMOS SCI, V47, P2465, DOI 10.1175/1520-0469(1990)047<2465:AMMOTQ>2.0.CO;2; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Stiller GP, 2012, ATMOS CHEM PHYS, V12, P3311, DOI 10.5194/acp-12-3311-2012; Taguchi M, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014325; Takahashi M, 1996, GEOPHYS RES LETT, V23, P661, DOI 10.1029/95GL03413; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Watanabe S, 2012, J METEOROL SOC JPN, V90A, P351, DOI 10.2151/jmsj.2012-A20; Young PJ, 2012, J CLIMATE, V25, P1759, DOI 10.1175/2011JCLI4048.1	29	87	87	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					478	+		10.1038/nature12140	http://dx.doi.org/10.1038/nature12140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698448				2022-12-24	WOS:000319254000045
J	Kolodkin, AL; Pasterkamp, RJ				Kolodkin, Alex L.; Pasterkamp, R. Jeroen			SnapShot: Axon Guidance II	CELL			English	Editorial Material									[Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, HHMI, Dept Neurosci, Baltimore, MD 21212 USA; [Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, NL-3584 CG Utrecht, Netherlands	Howard Hughes Medical Institute; Johns Hopkins University; Utrecht University; Utrecht University Medical Center	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, HHMI, Dept Neurosci, Baltimore, MD 21212 USA.			Pasterkamp, Jeroen/0000-0003-1631-6440	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bashaw G. J., 2012, COLD SPRING HARB PER, V2; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Salinas PC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008003; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zou YM, 2012, CURR TOP DEV BIOL, V101, P141, DOI 10.1016/B978-0-12-394592-1.00009-0	8	13	13	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					722	U2	722.e1	10.1016/j.cell.2013.04.004	http://dx.doi.org/10.1016/j.cell.2013.04.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622251	Bronze			2022-12-24	WOS:000318063500022
J	Kouider, S; Stahlhut, C; Gelskov, SV; Barbosa, LS; Dutat, M; de Gardelle, V; Christophe, A; Dehaene, S; Dehaene-Lambertz, G				Kouider, Sid; Stahlhut, Carsten; Gelskov, Sofie V.; Barbosa, Leonardo S.; Dutat, Michel; de Gardelle, Vincent; Christophe, Anne; Dehaene, Stanislas; Dehaene-Lambertz, Ghislaine			A Neural Marker of Perceptual Consciousness in Infants	SCIENCE			English	Article							RECOGNITION MEMORY; BRAIN; FACE; MATURATION	Infants have a sophisticated behavioral and cognitive repertoire suggestive of a capacity for conscious reflection. Yet, demonstrating conscious access in infants remains challenging, mainly because they cannot report their thoughts. Here, to circumvent this problem, we studied whether an electrophysiological signature of consciousness found in adults, corresponding to a late nonlinear cortical response [similar to 300 milliseconds (ms)] to brief pictures, already exists in infants. We recorded event-related potentials while 5-, 12-, and 15-month-old infants (N = 80) viewed masked faces at various levels of visibility. In all age groups, we found a late slow wave showing a nonlinear profile at the expected perceptual thresholds. However, this late component shifted from a weak and delayed response in 5-month-olds (starting around 900 ms) to a more sustained and faster response in older infants (around 750 ms). These results reveal that the brain mechanisms underlying the threshold for conscious perception are already present in infancy but undergo a slow acceleration during development.	[Kouider, Sid; Gelskov, Sofie V.; Barbosa, Leonardo S.; Dutat, Michel; de Gardelle, Vincent; Christophe, Anne] EHESS CNRS ENS DEC, Lab Sci Cognit & Psycholinguist, F-75005 Paris, France; [Kouider, Sid; Stahlhut, Carsten] Tech Univ Denmark, Dept Informat & Math Modeling, Sect Cognit Syst, DK-2800 Lyngby, Denmark; [Gelskov, Sofie V.] Copenhagen Univ Hosp, Danish Res Ctr Magnet Res, DK-2650 Hvidovre, Denmark; [Dehaene, Stanislas] Coll France, F-75231 Paris, France; [Dehaene, Stanislas; Dehaene-Lambertz, Ghislaine] INSERM, U992, Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas; Dehaene-Lambertz, Ghislaine] CEA, NeuroSpin Ctr, F-91191 Gif Sur Yvette, France; [Dehaene, Stanislas; Dehaene-Lambertz, Ghislaine] Univ Paris 11, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Technical University of Denmark; University of Copenhagen; UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Kouider, S (corresponding author), EHESS CNRS ENS DEC, Lab Sci Cognit & Psycholinguist, F-75005 Paris, France.	sid.kouider@ens.fr	Dehaene, Ghislaine/O-3633-2017; de Gardelle, Vincent/I-1226-2014; Christophe, Anne/B-9797-2008	Dehaene, Ghislaine/0000-0003-2221-9081; de Gardelle, Vincent/0000-0001-5977-5597; Christophe, Anne/0000-0001-7695-7528	Agence National de la Recherche; European Research Council; Lundbeck Foundation; McDonnell foundation	Agence National de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); McDonnell foundation	This research was supported by funding from the Agence National de la Recherche and from the European Research Council ("DynaMind" project) to S.K., from the Lundbeck Foundation (CIMBI project) to C.S. and from the McDonnell foundation to G.D.-L. We thank C. Summerfield for suggestions on the manuscript; A.-C. Fievet, and I. Vendelin for help with the data collection; and C. Billard (CHU Kremlin-Bicetre), D. Chabrol (Hopital Cochin), and L. K. Hansen (Danish Technical University) for their support to our research.	Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; Csibra G., 2008, HDB DEV COGNITIVE NE, V2nd ed., P247; de Haan M, 1999, DEV PSYCHOL, V35, P1113, DOI 10.1037/0012-1649.35.4.1113; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; Dubois J, 2006, NEUROIMAGE, V30, P1121, DOI 10.1016/j.neuroimage.2005.11.022; Friederici AD, 2002, NEUROREPORT, V13, P1251, DOI 10.1097/00001756-200207190-00006; Gelskov SV, 2010, COGNITION, V114, P285, DOI 10.1016/j.cognition.2009.09.012; KOENDERINK MJT, 1995, BRAIN RES, V678, P233, DOI 10.1016/0006-8993(95)00206-6; Kouider S., 2007, MENTAL PROCESSES HUM, P155; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Nelson CA, 1998, INT J PSYCHOPHYSIOL, V29, P145, DOI 10.1016/S0167-8760(98)00014-2; Quiroga RQ, 2008, P NATL ACAD SCI USA, V105, P3599, DOI 10.1073/pnas.0707043105; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Takahashi E, 2012, CEREB CORTEX, V22, P455, DOI 10.1093/cercor/bhr126; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Weiskrantz L., 1997, CONSCIOUSNESS LOST F; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	28	97	97	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					376	380		10.1126/science.1232509	http://dx.doi.org/10.1126/science.1232509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126XZ	23599498	Green Published			2022-12-24	WOS:000317657500062
J	Sleeman, KE; Collis, E				Sleeman, Katherine E.; Collis, Emily			Caring for a dying patient in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Sleeman, Katherine E.] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London SE5 9PJ, England; [Collis, Emily] Cent London Community Healthcare Trust, St Charless Hosp, Pembridge Palliat Care Ctr, London W10 6DZ, England	University of London; King's College London	Sleeman, KE (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London SE5 9PJ, England.	katherine.sleeman@kcl.ac.uk	Sleeman, Katherine/C-4941-2014	Sleeman, Katherine/0000-0002-9777-4373	National Institute for Health Research [CL-2010-17-009] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Association for Palliative Medicine, 2009, APM POS DOUBL EFF DE; Department of Health, 2012, 1 NAT VOICES SURV BE; Department of Health, 2008, END LIF CAR STRAT PR; General Medical Council, 2010, TREATM CAR END LIF G; Guy's and St Thomas' NHS Foundation Trust, AMBER CAR BUNDL; Jennings AL, 2002, THORAX, V57, P939, DOI 10.1136/thorax.57.11.939; Kamal AH, 2012, J PALLIAT MED, V15, P106, DOI 10.1089/jpm.2011.0110; Linklater GT, 2010, J ROY COLL PHYS EDIN, V40, P13, DOI 10.4997/JRCPE.2010.104; Liverpool Care Pathway for the Dying Patient (LCP), 2009, LIV CAR PATHW DYING; Mayor S, 2007, BRIT MED J, V334, P278, DOI 10.1136/bmj.39118.686100.DB; McCartney M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7316; National Care of the Dying Audit-Hospitals (NCDAH), 2012, NAT CAR DYING AUD HO; National Institute for Health and Clinical Excellence, 2011, QUAL STAND END LIF C; NHS Scotland, 2008, LIV DYING WELL NAT A; NHS UK. National end of life care programme, 2012, NAT END LIF CAR PROG; Royal College of Physicians and British Society of Gastroenterology, 2010, OR FEED DIFF DIL GUI; Simon ST, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub2; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007	18	15	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2174	10.1136/bmj.f2174	http://dx.doi.org/10.1136/bmj.f2174			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596214				2022-12-24	WOS:000317963400014
J	Hamilton, C				Hamilton, Clive			No, we should not just 'at least do the research'	NATURE			English	Editorial Material									Charles Sturt Univ, Canberra, ACT, Australia	Charles Sturt University	Hamilton, C (corresponding author), Charles Sturt Univ, Canberra, ACT, Australia.	e-mail@clivehamilton.com							0	19	20	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					139	139		10.1038/496139a	http://dx.doi.org/10.1038/496139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	122VM	23579641	Bronze			2022-12-24	WOS:000317346300004
J	McNamara, JM; Fawcett, TW; Houston, AI				McNamara, John M.; Fawcett, Tim W.; Houston, Alasdair I.			An Adaptive Response to Uncertainty Generates Positive and Negative Contrast Effects	SCIENCE			English	Article							DECISIONS; BEHAVIOR; REWARD; RISK	Successive contrast effects, in which behavior is dependent on whether conditions are currently better or worse than they were before, are a striking illustration of the fact that animals evaluate the world in relative terms. Existing explanations for these effects are based on descriptive models of psychological and physiological processes, but little attention has been paid to the factors promoting their evolution. Using a simple and general optimality model, we show that contrast effects can result from an adaptive response to uncertainty in a changing, unpredictable world. A wide range of patterns of environmental change will select for sensitivity to past conditions, generating positive and negative contrast effects. Our analysis reveals the importance of incorporating uncertainty and environmental stochasticity into models of adaptive behavior.	[McNamara, John M.] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Fawcett, Tim W.; Houston, Alasdair I.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Bristol; University of Bristol	Fawcett, TW (corresponding author), Univ Bristol, Sch Biol Sci, Woodland Rd, Bristol BS8 1UG, Avon, England.	tim.fawcett@cantab.net	Fawcett, Tim/A-5439-2010	Fawcett, Tim/0000-0001-6337-901X	European Research Council [250209]	European Research Council(European Research Council (ERC)European Commission)	We thank A. Higginson, A. Radford, D. Mallpress, and P. Trimmer for discussion and the European Research Council for funding (Advanced Grant 250209 to A.I.H.). J.M.M. and A.I.H. conceived the project, J.M.M. built the model, and T.W.F. analyzed the model and wrote the paper with input from the other authors.	Amsel A., 1992, FRUSTRATION THEORY; Bentosela M, 2009, J COMP PSYCHOL, V123, P125, DOI 10.1037/a0013340; CAPALDI EJ, 1967, J EXP PSYCHOL, V75, P226, DOI 10.1037/h0024986; COUVILLON PA, 1984, J COMP PSYCHOL, V98, P100, DOI 10.1037/0735-7036.98.1.100; Crespi LP, 1942, AM J PSYCHOL, V55, P467, DOI 10.2307/1417120; Flaherty C.F., 1996, INCENTIVE RELATIVITY; Freidin E, 2009, ANIM BEHAV, V77, P857, DOI 10.1016/j.anbehav.2008.12.010; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Higginson AD, 2012, AM NAT, V180, P589, DOI 10.1086/667885; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Houston AI, 1999, MODELS ADAPTIVE BEHA; HUBER J, 1982, J CONSUM RES, V9, P90, DOI 10.1086/208899; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KOBRE KR, 1972, J EXP CHILD PSYCHOL, V14, P81, DOI 10.1016/0022-0965(72)90033-1; MCHOSE JH, 1975, ANIM LEARN BEHAV, V3, P239, DOI 10.3758/BF03213438; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; McNamara J. M., 2011, ECOL LETT, V14, P58; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Morgan KV, 2012, BEHAV PROCESS, V89, P115, DOI 10.1016/j.beproc.2011.08.017; Mustaca AE, 2000, LEARN MOTIV, V31, P272, DOI 10.1006/lmot.2000.1055; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; PAPINI MR, 1988, ANIM LEARN BEHAV, V16, P53, DOI 10.3758/BF03209043; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Tversky A., 1991, SUBJECTIVE WELL BEIN, P101; ZEAMAN D, 1949, J EXP PSYCHOL, V39, P466, DOI 10.1037/h0060477	27	45	45	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1084	1086		10.1126/science.1230599	http://dx.doi.org/10.1126/science.1230599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23723234				2022-12-24	WOS:000319664500041
J	Willcox, ML; Mant, J; O'Dempsey, T				Willcox, Merlin L.; Mant, Jill; O'Dempsey, Tim			Imported malaria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE FALCIPARUM-MALARIA; RAPID DIAGNOSTIC-TESTS; RETURNING TRAVELERS; RANDOMIZED-TRIAL; CHILDREN; ARTESUNATE; QUININE		[Willcox, Merlin L.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2EP, England; [Mant, Jill] Luton Hosp, Dept Paediat, Luton, Beds, England; [O'Dempsey, Tim] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool	Willcox, ML (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2EP, England.	merlin.willcox@phc.ox.ac.uk	Willcox, Merlin/I-6255-2019	Willcox, Merlin/0000-0002-5227-3444; O'Dempsey, Tim/0000-0002-9596-9687				Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; [Anonymous], 2007, MAIL ONLINE     0110; Batwala V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-349; Bottieau E, 2007, EUR J CLIN MICROBIOL, V26, P181, DOI 10.1007/s10096-007-0264-x; British Medical Association, 2013, BRIT NATL FORMULARY, V65, p[422, 428]; Centers for Disease Control and Prevention, 2012, DOM REF HLTH GUID MA; Checkley AM, 2012, BRIT MED J, V344; D'Acremont V, 2002, AM J TROP MED HYG, V66, P481, DOI 10.4269/ajtmh.2002.66.481; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dubos F, 2010, DIAGN MICR INFEC DIS, V66, P169, DOI 10.1016/j.diagmicrobio.2009.08.018; Faiz MA, 2005, LANCET, V366, P717; Green ST, 2009, J INFECTION, V58, P172, DOI 10.1016/j.jinf.2008.12.001; Health Protection Agency, 2012, IMP MAL CAS DEATHS U; Kiang KM, 2013, ARCH DIS CHILDHOOD-E, V98, P7, DOI 10.1136/archdischild-2011-301530; Ladhani S, 2003, PEDIATR INFECT DIS J, V22, P814, DOI 10.1097/01.inf.0000086401.13592.79; Ladhani S, 2007, LANCET INFECT DIS, V7, P349, DOI 10.1016/S1473-3099(07)70110-X; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Rossi IA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-377; SVENSON JE, 1995, ARCH INTERN MED, V155, P861, DOI 10.1001/archinte.155.8.861; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, GUID TREATM MAL, V2nd	22	2	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 30	2013	346								f3214	10.1136/bmj.f3214	http://dx.doi.org/10.1136/bmj.f3214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DM	23723453				2022-12-24	WOS:000319948800005
J	Burn, J				Burn, John			Should we sequence everyone's genome? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Newcastle University - UK	Burn, J (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	john.burn@newcastle.ac.uk		Burn, John/0000-0002-9823-2322	Cancer Research UK [15934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10282] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))		Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Chief Medical Officer, 2010, 2009 ANN REP CHIEF M; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	5	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3133	10.1136/bmj.f3133	http://dx.doi.org/10.1136/bmj.f3133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23694691				2022-12-24	WOS:000319573300008
J	Daskivich, TJ; Fan, KH; Koyama, T; Albertsen, PC; Goodman, M; Hamilton, AS; Hoffman, RM; Stanford, JL; Stroup, AM; Litwin, MS; Penson, DF				Daskivich, Timothy J.; Fan, Kang-Hsien; Koyama, Tatsuki; Albertsen, Peter C.; Goodman, Michael; Hamilton, Ann S.; Hoffman, Richard M.; Stanford, Janet L.; Stroup, Antoinette M.; Litwin, Mark S.; Penson, David F.			Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in a U.S. Population-Based Cohort of Men With Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							RADICAL PROSTATECTOMY; RADIATION-THERAPY; LIFE EXPECTANCY; SUBDISTRIBUTION; VALIDATION; OUTCOMES	Background: Accurate estimation of life expectancy is essential to offering appropriate care to men with early-stage prostate cancer, but mortality risks associated with comorbidity are poorly defined. Objective: To determine the effect of age, comorbidity, and tumor risk on other-cause and prostate cancer-specific mortality in men with early-stage disease. Design: Prospective cohort study. Setting: A nationally representative, population-based cohort. Patients: 3183 men with nonmetastatic prostate cancer at diagnosis. Measurements: Baseline self-reported comorbidity (scored as a count of 12 major comorbid conditions), tumor characteristics, initial treatment, and overall and disease-specific mortality through 14 years of follow-up. Survival analyses that accounted for competing risks were performed. Results: Fourteen-year cumulative other-cause mortality rates were 24%, 33%, 46%, and 57% for men with 0, 1, 2, and 3 or more comorbid conditions, respectively. For men diagnosed at age 65 years, subhazard ratios for other-cause mortality among those with 1, 2, or 3 or more comorbid conditions (vs. none) were 1.2 (95% CI, 1.0 to 1.4), 1.7 (CI, 1.4 to 2.0), and 2.4 (CI, 2.0 to 2.8), respectively. Among men with 3 or more comorbid conditions, 10-year other-cause mortality rates were 26%, 40%, and 71% for those aged 60 years or younger, 61 to 74 years, and 75 years or older at diagnosis, respectively. Prostate cancer-specific mortality was minimal in patients with low-risk (3%) and intermediate-risk (7%) disease but appreciable in those with high-risk disease (18%) and did not vary by number of comorbid conditions (10% to 11% in all groups). Limitation: Comorbid conditions were self-reported. Conclusion: Older men with multiple major comorbid conditions are at high risk for other-cause mortality within 10 years of diagnosis and should consider this information when deciding between conservative management and aggressive treatment for low-or intermediate-risk prostate cancer.	Univ Calif Los Angeles, Los Angeles, CA USA; Univ So Calif, Los Angeles, CA 90089 USA; Vanderbilt Univ, Nashville, TN 37203 USA; Vet Affairs Tennessee Valley Geriatr Res Educ & C, Nashville, TN USA; Univ Connecticut, Farmington, CT 06030 USA; Emory Univ, Atlanta, GA 30322 USA; Univ New Mexico, Albuquerque, NM 87131 USA; New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; Univ Utah, Salt Lake City, UT 84108 USA	University of California System; University of California Los Angeles; University of Southern California; Vanderbilt University; Geriatric Research Education & Clinical Center; University of Connecticut; Emory University; University of New Mexico; Fred Hutchinson Cancer Center; Utah System of Higher Education; University of Utah	Penson, DF (corresponding author), Vanderbilt Univ, Med Ctr, 2525 West End Ave,Suite 600, Nashville, TN 37203 USA.			Litwin, Mark/0000-0002-2318-344X; Penson, David/0000-0002-2580-2697; Fan, Kang-hsien/0000-0003-0121-3959; Hoffman, Richard/0000-0002-4714-7726	National Cancer Institute of the National Institutes of Health [R01CA114524]; Robert Wood Johnson Clinical Scholars Foundation; American Cancer Society; American Urological Association; NATIONAL CANCER INSTITUTE [R01CA114524] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert Wood Johnson Clinical Scholars Foundation; American Cancer Society(American Cancer Society); American Urological Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By grant R01CA114524 from the National Cancer Institute of the National Institutes of Health. Dr. Daskivich is supported by grants from the Robert Wood Johnson Clinical Scholars Foundation, American Cancer Society, and American Urological Association.	Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Boorjian SA, 2008, J UROLOGY, V179, P1354, DOI 10.1016/j.juro.2007.11.061; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cowen ME, 2006, J UROLOGY, V175, P99, DOI 10.1016/S0022-5347(05)00018-2; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P4642, DOI 10.1002/cncr.26104; Daskivich TJ, 2011, CANCER-AM CANCER SOC, V117, P2058, DOI 10.1002/cncr.25751; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fowler JE, 1996, J UROLOGY, V156, P1714, DOI 10.1016/S0022-5347(01)65489-2; Grambauer N, 2010, STAT MED, V29, P875, DOI 10.1002/sim.3786; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gray RJ, 2011, CMPRSK SUBDISTRIBUTI; Klabunde CN, 2005, MED CARE, V43, P391, DOI 10.1097/01.mlr.0000156851.80900.d1; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Tewari A, 2004, J UROLOGY, V171, P1513, DOI 10.1097/01.ju.0000117975.40782.95; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Walz J, 2008, BJU INT, V102, P33, DOI 10.1111/j.1464-410X.2008.07614.x; Walz J, 2007, J CLIN ONCOL, V25, P3576, DOI 10.1200/JCO.2006.10.3820; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683	25	121	124	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2013	158	10					709	+		10.7326/0003-4819-158-10-201305210-00005	http://dx.doi.org/10.7326/0003-4819-158-10-201305210-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154HY	23689764	Green Accepted			2022-12-24	WOS:000319666200013
J	Mitsnefes, MM; Laskin, BL; Dahhou, M; Zhang, X; Foster, BJ				Mitsnefes, Mark M.; Laskin, Benjamin L.; Dahhou, Mourad; Zhang, Xun; Foster, Bethany J.			Mortality Risk Among Children Initially Treated With Dialysis for End-Stage Kidney Disease, 1990-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; RENAL-DISEASE; YOUNG-ADULTS; SURVIVAL; HEMODIALYSIS; INFANTS; ANEMIA	Importance Most children with end-stage kidney disease (ESKD) are treated with dialysis prior to transplant. It is not known whether their outcomes have changed in recent years. Objective To determine if all-cause, cardiovascular, and infection-related mortality rates for children and adolescents beginning dialysis improved between 1990 and 2010. Design, Setting, and Participants Retrospective cohort study of patients younger than 21 years initially treated with dialysis for ESKD, recorded in the United States Renal Data System between 1990 and 2010. Children with a prior kidney transplant were excluded. We used Cox proportional hazard models to estimate the hazard ratios (HRs) for mortality associated with a 5-year increment in year of ESKD treatment initiation. Primary analyses censored observation at kidney transplant. Main Outcomes and Measures All-cause, cardiovascular, and infection-related mortality. Results A total of 23 401 children and adolescents who initiated ESKD treatment with dialysis at younger than 21 years between 1990 and 2010 were identified. Crude mortality rates during dialysis treatment were higher among children younger than 5 years at the start of dialysis compared with those who were 5 years and older. Mortality rates for both children and adolescents being treated for ESKD with dialysis decreased significantly between 1990 and 2010. [GRAPHICS] Conclusions and Relevance In the United States, there was a substantial decrease in mortality rates over time among children and adolescents initiating ESKD treatment with dialysis between 1990 and 2010. Further research is needed to determine the specific factors responsible for this decrease. JAMA. 2013;309(18):1921-1929 Published online May 4, 2013. doi:10.1001/jama.2013.4208 www.jama.com	[Mitsnefes, Mark M.] Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH USA; [Laskin, Benjamin L.] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA; [Dahhou, Mourad; Zhang, Xun; Foster, Bethany J.] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Foster, Bethany J.] McGill Univ, Fac Med, Dept Pediat, Div Nephrol, Montreal, PQ, Canada; [Foster, Bethany J.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McGill University; McGill University; McGill University	Foster, BJ (corresponding author), Montreal Childrens Hosp, 2300 Tupper St,E-222, Montreal, PQ H3H 1P3, Canada.	beth.foster@muhc.mcgill.ca	Zhang, Xun/HHM-9059-2022	Zhang, Xun/0000-0001-5411-2727	National Institutes of Health [R01DK07695, K24DK090070, U01DK-03-012]; Career Development Award in Comparative Effectiveness Research [1KM1CA156715-01]; Fonds de la recherche en sante du Quebec [FRSQ]; FRSQ; Health Resources and Services Administration [234-2005-370011C]; NATIONAL CANCER INSTITUTE [KM1CA156715] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066143, K24DK090070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award in Comparative Effectiveness Research; Fonds de la recherche en sante du Quebec [FRSQ](Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Mitsnefes is supported by the National Institutes of Health (R01DK07695, K24DK090070, and U01DK-03-012). Dr Laskin is supported by a Career Development Award in Comparative Effectiveness Research (1KM1CA156715-01). Dr Foster, a member of the McGill University Health Centre Research Institute (supported in part by the Fonds de la recherche en sante du Quebec [FRSQ]), received salary support from the FRSQ. This work was supported in part by Health Resources and Services Administration contract 234-2005-370011C. Data were supplied by the USRDS.	[Anonymous], 2006, AM J KIDNEY DIS, V48, pS4, DOI 10.1053/j.ajkd.2006.07.015; [Anonymous], DRUG APPR DAT DRUGS; [Anonymous], 2012 ANN DAT REP ATL; Balas EA, YB MED INFORM 2000 P; Bond TC, 2012, AM J KIDNEY DIS, V60, P959, DOI 10.1053/j.ajkd.2012.04.018; Borzych-Duzalka D, 2013, J AM SOC NEPHROL, V24, P665, DOI 10.1681/ASN.2012050433; Chavers BM, 2007, J AM SOC NEPHROL, V18, P952, DOI 10.1681/ASN.2006040406; Chavers BM, 2002, KIDNEY INT, V62, P648, DOI 10.1046/j.1523-1755.2002.00472.x; Dell'Aquila R, 2007, PERITON DIALYSIS INT, V27, pS130; DEVRIES JPPM, 1993, KIDNEY INT, V44, P851, DOI 10.1038/ki.1993.321; Eisenstein I, 2011, CLIN J AM SOC NEPHRO, V6, P793, DOI 10.2215/CJN.04810610; Fischbach M, 2005, PEDIATR NEPHROL, V20, P1054, DOI 10.1007/s00467-005-1876-y; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; Foster BJ, 2011, AM J TRANSPLANT, V11, P2432, DOI 10.1111/j.1600-6143.2011.03691.x; Groothoff JW, 2002, KIDNEY INT, V61, P621, DOI 10.1046/j.1523-1755.2002.00156.x; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hoyert D, 2012, NATL VITAL STAT REP, V61; Ing TS, 2012, DIALYSIS: HISTORY, DEVELOPMENT AND PROMISE, pVII; Kucirka LM, 2011, JAMA-J AM MED ASSOC, V306, P620, DOI 10.1001/jama.2011.1127; Leonard MB, 2003, KIDNEY INT, V63, P744, DOI 10.1046/j.1523-1755.2003.00788.x; Matas AJ, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/ajt.12019; Mathews TJ, 2011, PEDIATRICS, V127, P146, DOI 10.1542/peds.2010-3175; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Miskulin DC, 2003, AM J KIDNEY DIS, V41, P149, DOI 10.1053/ajkd.2003.50034; Mitsnefes MM, 2012, J AM SOC NEPHROL, V23, P578, DOI 10.1681/ASN.2011111115; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Parekh RS, 2002, J PEDIATR-US, V141, P191, DOI 10.1067/mpd.2002.125910; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Sebestyen JF, 2011, ADV CHRONIC KIDNEY D, V18, P376, DOI 10.1053/j.ackd.2011.07.003; Tetta C, 2011, EXPERT REV CARDIOVAS, V9, P155, DOI [10.1586/erc.10.194, 10.1586/ERC.10.194]; Verrina E, 2009, PEDIATR NEPHROL, V24, P1453, DOI 10.1007/s00467-008-0848-4; Vidal E, 2012, NEPHROL DIAL TRANSPL, V27, P388, DOI 10.1093/ndt/gfr322; Warady BA, 2012, PEDIATRIC DIALYSIS, SECOND EDITION, P1, DOI 10.1007/978-1-4614-0721-8; Warady BA, 2003, PEDIATR NEPHROL, V18, P1055, DOI 10.1007/s00467-003-1214-1; Wedekin M, 2010, CLIN J AM SOC NEPHRO, V5, P18, DOI 10.2215/CJN.03670609; Woodward R S, 2008, Am J Transplant, V8, P2636, DOI 10.1111/j.1600-6143.2008.02422.x	37	119	119	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1921	1929		10.1001/jama.2013.4208	http://dx.doi.org/10.1001/jama.2013.4208			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23645144	Bronze, Green Accepted			2022-12-24	WOS:000318481900027
J	Moore, A; Derry, S; Eccleston, C; Kalso, E				Moore, Andrew; Derry, Sheena; Eccleston, Christopher; Kalso, Eija			Expect analgesic failure; pursue analgesic success	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; CHRONIC PAIN; POSTHERPETIC NEURALGIA; RANDOMIZED-TRIAL; FIBROMYALGIA; IMPROVEMENT; PREGABALIN; EFFICACY; ETORICOXIB; WITHDRAWAL		[Moore, Andrew; Derry, Sheena] Univ Oxford, Churchill Hosp, Oxford OX3 7LJ, England; [Moore, Andrew; Derry, Sheena] Univ Oxford, Churchill Hosp, Nuffield Div Anaesthet, Oxford OX3 7LJ, England; [Eccleston, Christopher] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England; [Kalso, Eija] Univ Helsinki, Cent Hosp, Dept Anaesthesiol, Pain Clin, FIN-00014 Helsinki, Finland	University of Oxford; University of Oxford; University of Bath; University of Helsinki; Helsinki University Central Hospital	Moore, A (corresponding author), Univ Oxford, Churchill Hosp, S Parks Rd, Oxford OX3 7LJ, England.	andrew.moore@ndcn.ox.ac.uk		Kalso, Eija/0000-0002-4899-605X; Eccleston, Christopher/0000-0003-0698-1543				Arnold LM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3359; CONNOR S, 2003, INDEPENDENT; Crofford LJ, 2008, PAIN, V136, P419, DOI 10.1016/j.pain.2008.02.027; Farmer K., 2010, EFFECT VOLUNATARY EX; Hoffman DL, 2010, PAIN, V149, P194, DOI 10.1016/j.pain.2009.09.017; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Lin HY, 2010, INT J RHEUM DIS, V13, P144, DOI 10.1111/j.1756-185X.2010.01468.x; McQuay HJ, 2008, PAIN, V135, P217, DOI 10.1016/j.pain.2008.01.014; Moore RA, 2013, ANAESTHESIA, V68, P400, DOI 10.1111/anae.12148; Moore RA, 2010, PAIN, V149, P173, DOI 10.1016/j.pain.2009.08.007; Moore RA, 2010, ANN RHEUM DIS, V69, P374, DOI 10.1136/ard.2009.107805; Moore RA, 2012, PAIN, V153, P265, DOI 10.1016/j.pain.2011.10.004; Moore RA, 2011, PAIN, V152, P982, DOI 10.1016/j.pain.2010.11.030; Moore RA, 2010, PAIN, V151, P592, DOI 10.1016/j.pain.2010.07.013; Moore RA, 2010, PAIN, V150, P386, DOI 10.1016/j.pain.2010.05.011; Moore RA, 2010, PAIN, V149, P360, DOI 10.1016/j.pain.2010.02.039; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; National Collaborating Centre for Chronic Conditions, 2008, OST NAT CLIN GUID CA; Simon G, 2001, JAMA-J AM MED ASSOC, V286, P3003, DOI 10.1001/jama.286.23.3003; Smith R., 2003, BRIT MED J, V327, P09; Stacey BR, 2008, J PAIN, V9, P1006, DOI 10.1016/j.jpain.2008.05.014; Straube S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-125; Wang FJ, 2011, J PAIN, V12, P1088, DOI 10.1016/j.jpain.2011.05.002; Watson CPN, 1998, NEUROLOGY, V51, P1166, DOI 10.1212/WNL.51.4.1166	24	162	163	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2013	346								f2690	10.1136/bmj.f2690	http://dx.doi.org/10.1136/bmj.f2690			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139FC	23645858	Green Accepted, Green Published			2022-12-24	WOS:000318566200003
J	Heymann, DL; Mackenzie, JS; Peiris, M				Heymann, David L.; Mackenzie, John S.; Peiris, Malik			SARS legacy: outbreak reporting is expected and respected	LANCET			English	Editorial Material							CORONAVIRUS		[Heymann, David L.] Ctr Global Hlth Secur, London, England; [Heymann, David L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Mackenzie, John S.] Curtin Univ Technol, Fac Hlth Sci, Perth, WA, Australia; [Mackenzie, John S.] Burnet Inst, Melbourne, Vic, Australia; [Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China	University of London; London School of Hygiene & Tropical Medicine; Curtin University; Burnet Institute; University of Hong Kong	Heymann, DL (corresponding author), Ctr Global Hlth Secur, Chatham House, London, England.	david.heymann@lshtm.ac.uk	/S-4986-2019	/0000-0002-5918-2190				Annan A, 2013, EMERG INFECT DIS; Fleck F, 2003, B WORLD HEALTH ORGAN, V81, P625; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Heymann DL, 2004, EMERG INFECT DIS, V10, P173, DOI 10.3201/eid1002.031038; Heymann DL, 2004, PHILOS T ROY SOC B, V359, P1127, DOI 10.1098/rstb.2004.1484; Liang GD, 2004, EMERG INFECT DIS, V10, P1774, DOI 10.3201/eid1010.040445; Mackenzie JS, 2004, LEARNING FROM SARS, P41; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; The FAO-OIE-WHO Collaboration, 2010, SHAR RESP COORD GLOB; WHO, GLOB AL RESP SEV AC; WHO Regional Office for the Western Pacific, 2006, SARS GLOB EP WAS STO; Wong YCR, 2005, SEVERE ACUTE RESPIRATORY SYNDROME, P213; World Health Organization, 2008, INT HLTH REG 2005, V2nd; World Health Organization, BACKGR SUMM NOV COR; World Health Organization, 2003, SEV AC RESP SYNDR SA; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	17	27	31	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					779	781		10.1016/S0140-6736(13)60185-3	http://dx.doi.org/10.1016/S0140-6736(13)60185-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105IL	23668493	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000316060600005
J	Spence, D				Spence, Des			Bad medicine: statins	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; DECLINE					destwo@yahoo.co.uk						Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P649; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3	8	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2013	346								f3566	10.1136/bmj.f3566	http://dx.doi.org/10.1136/bmj.f3566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DQ	23729321				2022-12-24	WOS:000319949200007
J	Darroch, JE; Singh, S				Darroch, Jacqueline E.; Singh, Susheela			Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys	LANCET			English	Article								Background Data for trends in contraceptive use and need are necessary to guide programme and policy decisions and to monitor progress towards Millennium Development Goal 5, which calls for universal access to contraceptive services. We therefore aimed to estimate trends in contraceptive use and unmet need in developing countries in 2003, 2008, and 2012. Methods We obtained data from national surveys for married and unmarried women aged 15-49 years in regions and subregions of developing countries. We estimated trends in the numbers and proportions of women wanting to avoid pregnancy, according to whether they were using modern contraceptives, or had unmet need for modern methods (ie, using no methods or a traditional method). We used comparable data sources and methods for three reference years (2003, 2008, and 2012). National survey data were available for 81-98% of married women using and with unmet need for modern methods. Findings The number of women wanting to avoid pregnancy and therefore needing effective contraception increased substantially, from 716 million (54%) of 1321 million in 2003, to 827 million (57%) of 1448 million in 2008, to 867 million (57%) of 1520 million in 2012. Most of this increase (108 million) was attributable to population growth. Use of modern contraceptive methods also increased, and the overall proportion of women with unmet need for modern methods among those wanting to avoid pregnancy decreased from 29% (210 million) in 2003, to 26% (222 million) in 2012. However, unmet need for modern contraceptives was still very high in 2012, especially in sub-Saharan Africa (53 million [60%] of 89 million), south Asia (83 million [34%] of 246 million), and western Asia (14 million [50%] of 27 million). Moreover, a shift in the past decade away from sterilisation, the most effective method, towards injectable drugs and barrier methods, might have led to increases in unintended pregnancies in women using modern methods. Interpretation Achievement of the desired number and healthy timing of births has important benefits for women, families, and societies. To meet the unmet need for modern contraception, countries need to increase resources, improve access to contraceptive services and supplies, and provide high-quality services and large-scale public education interventions to reduce social barriers. Our findings confirm a substantial and unfinished agenda towards meeting of couples' reproductive needs.	[Darroch, Jacqueline E.; Singh, Susheela] Guttmacher Inst, New York, NY 10038 USA		Darroch, JE (corresponding author), Guttmacher Inst, New York, NY 10038 USA.	jedarroch@guttmacher.org			UK Department for International Development; Bill & Melinda Gates Foundation; UN Population Fund (UNFPA)	UK Department for International Development; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UN Population Fund (UNFPA)	UK Department for International Development, the Bill & Melinda Gates Foundation, and the UN Population Fund (UNFPA).	Ametepi P, 2012, DHS ANAL STUD; [Anonymous], 2011, CONTRACEPTIVE TECHNO; [Anonymous], 2003, ADDING IT BENEFITS I; Bankole A, 1998, INT FAM PLAN PERSPEC, V24, P15, DOI 10.2307/2991915; Baschieri A, 2012, J BIOSOC SCI, V20, P1; Bill & Melinda Gates Foundation Department for International Development, 2012, LANDM SUMM FAM PLANN; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Croft TV, 2012, SPECIAL TABULATIONS; Darroch JE, 2013, CONTRACEPTION, V87, P259, DOI 10.1016/j.contraception.2012.08.029; Darroch JacquelineE., 2011, ADDING IT COSTS BENE; Darroch JacquelineE., 2011, CONTRACEPTIVE TECHNO; DFID and Bill and Melinda Gates Foundation, 2013, LOND SUMM FAM PLANN; FishelJoy D, 2012, DHS ANAL STUDIES, V25; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Ross JA, 2002, INT FAM PLAN PERSPEC, V28, P138, DOI 10.2307/3088256; Save the Children, 2012, EV WOM RIGHT FAM PLA; Sedgh G., 2007, WOMEN UNMET NEED CON; Singh S, 2012, ADDING IT COSTS BENE; Singh S, 2009, ADDING IT COSTS BENE; The World Bank, GNI PER CAP ATL METH; UN Department of Economic and Social Affairs Population Division, 2006, LEV TRENDS CONTR US; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2011; United Nations Statistics Division, 2009, COMP MACR CONT REG G; Vlassoff M., 2004, ASSESSING COSTS BENE; Westoff C., 2012, DHS ANAL STUDIES, V28; Westoff CF, 2010, DHS COMP REP, V25	27	177	179	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1756	1762		10.1016/S0140-6736(13)60597-8	http://dx.doi.org/10.1016/S0140-6736(13)60597-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683642				2022-12-24	WOS:000319112800040
J	Zaba, B; Calvert, C; Marston, M; Isingo, R; Nakiyingi-Miiro, J; Lutalo, T; Crampin, A; Robertson, L; Herbst, K; Newell, ML; Todd, J; Byass, P; Boerma, T; Ronsmans, C				Zaba, Basia; Calvert, Clara; Marston, Milly; Isingo, Raphael; Nakiyingi-Miiro, Jessica; Lutalo, Tom; Crampin, Amelia; Robertson, Laura; Herbst, Kobus; Newell, Marie-Louise; Todd, Jim; Byass, Peter; Boerma, Ties; Ronsmans, Carine			Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA)	LANCET			English	Article							RURAL RAKAI DISTRICT; MATERNAL MORTALITY; SEXUAL-BEHAVIOR; SOUTH-AFRICA; IMPACT; TRENDS; DEATH; PREVALENCE; ZIMBABWE; MALAWI	Background Model-based estimates of the global proportions of maternal deaths that are in HIV-infected women range from 7% to 21%, and the effects of HIV on the risk of maternal death is highly uncertain. We used longitudinal data from the Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA) network to estimate the excess mortality associated with HIV during pregnancy and the post-partum period in sub-Saharan Africa. Methods The ALPHA network pooled data gathered between June, 1989 and April, 2012 in six community-based studies in eastern and southern Africa with HIV serological surveillance and verbal-autopsy reporting. Deaths occurring during pregnancy and up to 42 days post partum were defined as pregnancy related. Pregnant or postpartum person-years were calculated for HIV-infected and HIV-uninfected women, and HIV-infected to HIV-uninfected mortality rate ratios and HIV-attributable rates were compared between pregnant or post-partum women and women who were not pregnant or post partum. Findings 138 074 women aged 15-49 years contributed 636 213 person-years of observation. 49 568 women had 86 963 pregnancies. 6760 of these women died, 235 of them during pregnancy or the post-partum period. Mean prevalence of HIV infection across all person-years in the pooled data was 17.2% (95% CI 17.0-17.3), but 60 of 118 (50.8%) of the women of known HIV status who died during pregnancy or post partum were HIV infected. The mortality rate ratio of HIV-infected to HIV-uninfected women was 20.5 (18.9-22.4) in women who were not pregnant or post partum and 8.2 (5.7-11.8) in pregnant or post-partum women. Excess mortality attributable to HIV was 51.8 (47.8-53.8) per 1000 person-years in women who were not pregnant or post partum and 11.8 (8.4-15.3) per 1000 person-years in pregnant or post-partum women. Interpretation HIV-infected pregnant or post-partum women had around eight times higher mortality than did their HIV-uninfected counterparts. On the basis of this estimate, we predict that roughly 24% of deaths in pregnant or post-partum women are attributable to HIV in sub-Saharan Africa, suggesting that safe motherhood programmes should pay special attention to the needs of HIV-infected pregnant or post-partum women.	[Zaba, Basia; Calvert, Clara; Marston, Milly; Crampin, Amelia; Todd, Jim; Ronsmans, Carine] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Isingo, Raphael] Natl Inst Med Res, Mwanza, Tanzania; [Nakiyingi-Miiro, Jessica] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Lutalo, Tom] Rakai Hlth Sci Program, Rakai, Uganda; [Crampin, Amelia] Karonga Prevent Study, Karonga, Malawi; [Robertson, Laura] Univ London Imperial Coll Sci Technol & Med, London, England; [Herbst, Kobus; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; [Byass, Peter] Umea Univ, Umea, Sweden; [Byass, Peter] INDEPTH Network, Accra, Ghana; [Boerma, Ties] WHO, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Rakai Health Sciences Program; Malawi Epidemiology and Intervention Research Unit; Imperial College London; University of Kwazulu Natal; Umea University; INDEPTH Network; World Health Organization	Zaba, B (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	basia.zaba@lshtm.ac.uk	Newell, Marie-Louise/AAE-8222-2019; Herbst, Abraham J/E-4848-2010	Newell, Marie-Louise/0000-0002-1074-7699; Herbst, Abraham J/0000-0002-5436-9386; Todd, Jim/0000-0001-5918-4914; Crampin, Amelia/0000-0002-1513-4330; Byass, Peter/0000-0001-5474-4361	ALPHA Network; Wellcome Trust; Global Fund to Fight AIDS, Tuberculosis and Malaria; US National Institutes of Health; UK Medical Research Council; Health Metrics Network (WHO); Economic and Social Research Council; Economic and Social Research Council [1081714] Funding Source: researchfish	ALPHA Network; Wellcome Trust(Wellcome TrustEuropean Commission); Global Fund to Fight AIDS, Tuberculosis and Malaria; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Metrics Network (WHO); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	All authors received travel grants through the ALPHA Network to attend short workshops hosted at the study sites, at which they prepared and analysed the data and discussed the provisional results. We declare that we have no conflicts of interest.; The ALPHA network is funded by the Wellcome Trust. The six study sites contributing data (the ALPHA network members) are funded by the Wellcome Trust, Global Fund to Fight AIDS, Tuberculosis and Malaria, US National Institutes of Health, and UK Medical Research Council. Workshops at which the data were collated, cleaned, and analysed were funded by the Health Metrics Network (WHO). CC was supported by an Economic and Social Research Council PhD fellowship.	Ahmed Y, 1999, INT J TUBERC LUNG D, V3, P675; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; Black V, 2009, OBSTET GYNECOL, V114, P292, DOI 10.1097/AOG.0b013e3181af33e6; Boerma JT, 1999, AIDS, V13, P1233, DOI 10.1097/00002030-199907090-00013; Calvert C, 2013, AIDS, V27, P1631, DOI 10.1097/QAD.0b013e32835fd940; Chweneyagae D, 2012, SAJOG-S AFR J OBSTET, V18, P70, DOI 10.7196/SAJOG.581; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; KengeyaKayondo JF, 1996, INT J EPIDEMIOL, V25, P1077, DOI 10.1093/ije/25.5.1077; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kirkwood B. R., 2003, MED STAT; KondeLule JK, 1997, AIDS, V11, P791, DOI 10.1097/00002030-199706000-00012; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Maher D, 2010, TROP MED INT HEALTH, V15, P321, DOI 10.1111/j.1365-3156.2009.02456.x; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; National Committee on Confidential Enquiries into Maternal Deaths, SAV MOTH 2005 2007 4; Nyirenda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012370; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; Ronsmans C, 2001, INT J EPIDEMIOL, V30, P467, DOI 10.1093/ije/30.3.467; Rosen JE, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/958262; Setel PW, 2006, PLOS MED, V3, P1282, DOI 10.1371/journal.pmed.0030268; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; UNAIDS, 2012, GLOB REP UNAID UNPUB; UNAIDS, 2011, COUNTD ZER GLOB PLAN; Van Dillen J, 2006, ACTA OBSTET GYN SCAN, V85, P499, DOI 10.1080/00016340600555884; Welz T, 2008, SEX TRANSM DIS, V35, P372, DOI 10.1097/OLQ.0b013e31815fd3fc; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; WHO, 2010, INT STAT CLASS DIS R; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26	40	83	83	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2013	381	9879					1763	1771		10.1016/S0140-6736(13)60803-X	http://dx.doi.org/10.1016/S0140-6736(13)60803-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23683643	Green Accepted, Green Published			2022-12-24	WOS:000319112800041
J	Weiss, RA; Stoye, JP				Weiss, Robin A.; Stoye, Jonathan P.			Our Viral Inheritance	SCIENCE			English	Editorial Material							ENDOGENOUS RETROVIRUSES; HUMAN GENOME; EVOLUTION; GENES		[Weiss, Robin A.] UCL, Div Infect & Immun, London WC1E 6BT, England; [Stoye, Jonathan P.] Natl Inst Med Res, MRC, Div Virol, London NW7 1AA, England	University of London; University College London; MRC National Institute for Medical Research	Weiss, RA (corresponding author), UCL, Div Infect & Immun, Gower St, London WC1E 6BT, England.	rweiss@ucl.ac.uk; jstoye@nimr.mrc.ac.uk		Stoye, Jonathan/0000-0003-3377-323X	Medical Research Council [MC_U117512710] Funding Source: Medline; MRC [MC_U117512710] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Haig D, 2012, CURR BIOL, V22, pR609, DOI 10.1016/j.cub.2012.06.002; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; TING CN, 1992, GENE DEV, V6, P1457, DOI 10.1101/gad.6.8.1457; Young GR, 2012, NATURE, V491, P774, DOI 10.1038/nature11599	15	26	26	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					820	821		10.1126/science.1235148	http://dx.doi.org/10.1126/science.1235148			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687035				2022-12-24	WOS:000318997400029
J	Gillan, E				Gillan, Evelyn			DOCTORS AND THE ALCOHOL INDUSTRY The meaning of "partnership working" to the alcohol industry	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Alcohol Focus Scotland, Glasgow G1 2LW, Lanark, Scotland		Gillan, E (corresponding author), Alcohol Focus Scotland, Glasgow G1 2LW, Lanark, Scotland.	evelyn.gillan@alcohol-focus-scotland.org.uk						Babor T., 2010, ALCOHOL NO ORDINARY, V2nd; Babor TF, 2013, AM J PUBLIC HEALTH, V103, P206, DOI 10.2105/AJPH.2012.300847; Gornall J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1889; Jernigan DH, 2012, AM J PUBLIC HEALTH, V102, P80, DOI 10.2105/AJPH.2011.300269; Parsons R, 2013, MARKETING WEEK	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2013	346								f2655	10.1136/bmj.f2655	http://dx.doi.org/10.1136/bmj.f2655			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139EK	23635538				2022-12-24	WOS:000318564300012
J	Elliman, D; Bedford, H				Elliman, David; Bedford, Helen			Should the UK introduce compulsory vaccination?	LANCET			English	Editorial Material							IMMUNIZATION; MEASLES; RUBELLA; MUMPS		[Elliman, David] Whittington Hlth, Community Child Hlth, London, England; [Bedford, Helen] UCL Inst Child Hlth, Ctr Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Bedford, H (corresponding author), UCL Inst Child Hlth, Ctr Epidemiol & Biostat, London WC1N 1EH, England.	h.bedford@ucl.ac.uk	Elliman, David/AAK-4595-2020					Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Centers for Disease Control and Prevention, 2012, NAT IMM SURV NIS CHI; Haverkate M, 2012, EUROSURVEILLANCE, V17; Health and Social Care Information Centre Screening and Immunisations Team, 2011, NHS IMM STAT ENGL 20; Health Protection Agency, 1966, COMPL PRIM COURS 2 Y; Offit PA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2434; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; PELTOLA H, 1994, NEW ENGL J MED, V331, P1397, DOI 10.1056/NEJM199411243312101; Petrovic M, 2001, BRIT MED J, V322, P82, DOI 10.1136/bmj.322.7278.82; Public Health Wales, 2013, MEASL OUTBR; ROBBINS KB, 1981, AM J PUBLIC HEALTH, V71, P270, DOI 10.2105/AJPH.71.3.270; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Samad L, 2006, VACCINE, V24, P6823, DOI 10.1016/j.vaccine.2006.06.039; Samad L, 2006, BMJ-BRIT MED J, V332, P1312, DOI 10.1136/bmj.332.7553.1312; Strebel P, 2008, VACCINES, P355	15	11	11	1	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1434	1436		10.1016/S0140-6736(13)60907-1	http://dx.doi.org/10.1016/S0140-6736(13)60907-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23623214				2022-12-24	WOS:000318607300009
J	Lomas, A				Lomas, Alex			I'm a patient: show me the trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												alex@alexlomas.com						Adalimumab, BRIT NATL FORMULARY; Alrubaiy L, 2013, P422 BIOL REGISTER I, P422; Behm BW, 2008, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD006893; Goodyear M, 2006, BRIT MED J; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1636; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; NACC, 2010, GOOD DEC NICE ANTITN	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f2336	10.1136/bmj.f2336	http://dx.doi.org/10.1136/bmj.f2336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AO	23596128				2022-12-24	WOS:000317962900009
J	Goldberger, JJ; Buxton, AE				Goldberger, Jeffrey J.; Buxton, Alfred E.			Personalized Medicine vs Guideline-Based Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ACUTE MYOCARDIAL-INFARCTION; RISK STRATIFICATION		[Goldberger, Jeffrey J.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Goldberger, Jeffrey J.] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Buxton, Alfred E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Beth Israel Deaconess Medical Center	Goldberger, JJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 251 E Huron St,Feinberg 8-503, Chicago, IL 60611 USA.	j-goldberger@northwestern.edu	Goldberger, Jeffrey J/AAB-3684-2020					[Anonymous], PRIOR PERS MED; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Goldberger JJ, 2011, CIRCULATION, V123, P2423, DOI 10.1161/CIRCULATIONAHA.110.959734; Goldberger JJ, 2009, J AM COLL CARDIOL, V54, P2001, DOI 10.1016/j.jacc.2009.08.018; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P288, DOI 10.1016/j.jacc.2007.08.058; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; VanderWeele TJ, 2011, ANN INTERN MED, V154, P680, DOI 10.7326/0003-4819-154-10-201105170-00008; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07	10	67	70	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2559	2560		10.1001/jama.2013.6629	http://dx.doi.org/10.1001/jama.2013.6629			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23712449				2022-12-24	WOS:000320848100024
J	Dowell, D; Kunins, HV; Farley, TA				Dowell, Deborah; Kunins, Hillary V.; Farley, Thomas A.			Opioid Analgesics-Risky Drugs, Not Risky Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC PAIN		[Dowell, Deborah; Kunins, Hillary V.; Farley, Thomas A.] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Dowell, D (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,8th Floor, Queens, NY 11101 USA.	ddowell1@health.nyc.gov						Alam A, 2012, ARCH INTERN MED, V172, P425, DOI 10.1001/archinternmed.2011.1827; American Academy of Pain Medicine the American Pain Society and the American Society of Addition Medicine, 2001, WMJ, V100, P28; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Centers for Disease Control and Prevention, PRIM CAR PUBL HLTH I; Haddox JD, 1997, CLIN J PAIN, V13, P6; Purdue Pharma LP, MED GUID OXYCONTIN T; Sehgal N, 2012, PAIN PHYSICIAN, V15, pES67; Stanos SP, 2012, APPROPRIATE USE OPIO; WEISSMAN DE, 1989, PAIN, V36, P363, DOI 10.1016/0304-3959(89)90097-3; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	10	48	48	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2013	309	21					2219	2220		10.1001/jama.2013.5794	http://dx.doi.org/10.1001/jama.2013.5794			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	156YC	23700072				2022-12-24	WOS:000319859200024
J	Hashem, Y; Georges, AD; Dhote, V; Langlois, R; Liao, HY; Grassucci, RA; Hellen, CUT; Pestova, TV; Frank, J				Hashem, Yaser; Georges, Amedee des; Dhote, Vidya; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Hellen, Christopher U. T.; Pestova, Tatyana V.; Frank, Joachim			Structure of the Mammalian Ribosomal 43S Preinitiation Complex Bound to the Scanning Factor DHX29	CELL			English	Article							EUKARYOTIC TRANSLATION INITIATION; CRYO-EM STRUCTURE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; TRANSFER-RNA; CRYOELECTRON MICROSCOPY; START CODON; ESCHERICHIA-COLI; 26S PROTEASOME; ALPHA-SUBUNIT	Eukaryotic translation initiation begins with assembly of a 43S preinitiation complex. First, methionylated initiator methionine transfer RNA (Met-tRNA(i)(Met)), eukaryotic initiation factor (eIF) 2, and guanosine triphosphate form a ternary complex (TC). The TC, eIF3, eIF1, and eIF1A cooperatively bind to the 40S subunit, yielding the 43S preinitiation complex, which is ready to attach to messenger RNA (mRNA) and start scanning to the initiation codon. Scanning on structured mRNAs additionally requires DHX29, a DExH-box protein that also binds directly to the 40S subunit. Here, we present a cryo-electron microscopy structure of the mammalian DHX29-bound 43S complex at 11.6 angstrom resolution. It reveals that eIF2 interacts with the 40S subunit via its a subunit and supports Met-tRNA(i)(Met) in an unexpected P/I orientation (eP/I). The structural core of eIF3 resides on the back of the 40S subunit, establishing two principal points of contact, whereas DHX29 binds around helix 16. The structure provides insights into eukaryote-specific aspects of translation, including the mechanism of action of DHX29.	[Dhote, Vidya; Hellen, Christopher U. T.; Pestova, Tatyana V.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Hashem, Yaser; Georges, Amedee des; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, HHMI, New York, NY 10032 USA; [Hashem, Yaser; Georges, Amedee des; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Frank, J (corresponding author), Columbia Univ, HHMI, New York, NY 10032 USA.	jf2192@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781	HHMI; NIH [R01 GM29169, R01 GM59660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, R01GM059660] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Melissa Thomas for the assistance in preparation of figures and Assen Marintchev and Trevor Sweeney for critical reading of the manuscript. This work was supported by HHMI and NIH grant R01 GM29169 (to J.F.) and NIH grant R01 GM59660 (to T.V.P.).	Abaeva IS, 2011, EMBO J, V30, P115, DOI 10.1038/emboj.2010.302; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Dhote V., 2012, P NATL ACAD SCI US, V109, pE3150; Dmitriev SE, 2011, J MOL BIOL, V413, P106, DOI 10.1016/j.jmb.2011.08.026; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Herrmannova A, 2012, NUCLEIC ACIDS RES, V40, P2294, DOI 10.1093/nar/gkr765; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lumsden T, 2010, NUCLEIC ACIDS RES, V38, P1261, DOI 10.1093/nar/gkp1113; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Naveau M, 2013, NUCLEIC ACIDS RES, V41, P1047, DOI 10.1093/nar/gks1180; Nika J, 2001, J BIOL CHEM, V276, P1051, DOI 10.1074/jbc.M007398200; Parsyan A, 2009, P NATL ACAD SCI USA, V106, P22217, DOI 10.1073/pnas.0909773106; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmitt E, 2002, EMBO J, V21, P1821, DOI 10.1093/emboj/21.7.1821; Schmitt E, 2012, NAT STRUCT MOL BIOL, V19, P450, DOI 10.1038/nsmb.2259; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Stolboushkina E, 2008, J MOL BIOL, V382, P680, DOI 10.1016/j.jmb.2008.07.039; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Taylor KA, 2008, J STRUCT BIOL, V163, P214, DOI 10.1016/j.jsb.2008.06.004; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Yatime L, 2006, STRUCTURE, V14, P119, DOI 10.1016/j.str.2005.09.020; Yatime L, 2007, P NATL ACAD SCI USA, V104, P18445, DOI 10.1073/pnas.0706784104; Yu YP, 2011, EMBO J, V30, P4423, DOI 10.1038/emboj.2011.306; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	72	142	145	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1108	1119		10.1016/j.cell.2013.04.036	http://dx.doi.org/10.1016/j.cell.2013.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706745	Green Accepted, Bronze			2022-12-24	WOS:000319456800017
J	McIntyre, H				McIntyre, Hugh			Admission to hospital could be considered a disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							30-DAY READMISSIONS		Conquest Hosp, Hastings TN37 7RD, E Sussex, England		McIntyre, H (corresponding author), Conquest Hosp, Hastings TN37 7RD, E Sussex, England.	hugh.mcintyre@esht.nhs.uk						[Anonymous], MEDLINE PLUS MEDICAL; Billings J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001667; Centers for Medicare and Medicaid Services, 2013, READMISSIONS REDUCTI; Clarke A, 2012, J EPIDEMIOL COMMUN H, V66, pA45, DOI 10.1136/jech-2012-201753.117; Department of Health, 2011, PAYMENT BY RESULTS P; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; McHugh MD, 2013, MED CARE, V51, P52, DOI [10.1097/MLR.0b013e3182763284, 10.1097/01.NNA.0000435146.46961.d1]	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2013	346								f3242	10.1136/bmj.f3242	http://dx.doi.org/10.1136/bmj.f3242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AA	23690462				2022-12-24	WOS:000319572300004
J	Meissner, F; Scheltema, RA; Mollenkopf, HJ; Mann, M				Meissner, Felix; Scheltema, Richard A.; Mollenkopf, Hans-Joachim; Mann, Matthias			Direct Proteomic Quantification of the Secretome of Activated Immune Cells	SCIENCE			English	Article							IDENTIFICATION; MYD88	Protein secretion allows communication of distant cells in an organism and controls a broad range of physiological functions. We describe a quantitative, high-resolution mass spectrometric workflow to detect and quantify proteins that are released from immune cells upon receptor ligation. We quantified the time-resolved release of 775 proteins, including 52 annotated cytokines from only 150,000 primary Toll-like receptor 4-activated macrophages per condition. Achieving low picogram sensitivity, we detected secreted proteins whose abundance increased by a factor of more than 10,000 upon stimulation. Secretome to transcriptome comparisons revealed the transcriptionally decoupled release of lysosomal proteins. From genetic models, we defined secretory profiles that depended on distinct intracellular signaling adaptors and showed that secretion of many proinflammatory proteins is safeguarded by redundant mechanisms, whereas signaling adaptor synergy promoted the release of anti-inflammatory proteins.	[Meissner, Felix; Scheltema, Richard A.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Microarray Core Facil, Berlin, Germany	Max Planck Society; Max Planck Society	Mann, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18A, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	MEISSNER, Felix/C-8767-2015; Mollenkopf, Hans-Joachim/AAH-2500-2019; Mann, Matthias/A-3454-2013; Scheltema, Richard A/I-3856-2016	MEISSNER, Felix/0000-0003-1000-7989; Mann, Matthias/0000-0003-1292-4799; Scheltema, Richard A/0000-0002-1668-0253; Mollenkopf, Hans-Joachim/0000-0003-1167-4783				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Azuma YT, 2011, J PHARMACOL SCI, V115, P105, DOI 10.1254/jphs.10R02CR; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Buchholz BM, 2010, AM J PHYSIOL-GASTR L, V299, pG531, DOI 10.1152/ajpgi.00060.2010; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Esparza GA, 2012, INNATE IMMUN-LONDON, V18, P478, DOI 10.1177/1753425911422723; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Papin JA, 2004, J THEOR BIOL, V227, P283, DOI 10.1016/j.jtbi.2003.11.016; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watarai H, 2005, PROTEOMICS, V5, P4001, DOI 10.1002/pmic.200401258	24	147	147	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					475	478		10.1126/science.1232578	http://dx.doi.org/10.1126/science.1232578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620052				2022-12-24	WOS:000318016700041
J	Houben, AJP; Bijl, PK; Pross, J; Bohaty, SM; Passchier, S; Stickley, CE; Rohl, U; Sugisaki, S; Tauxe, L; van de Flierdt, T; Olney, M; Sangiorgi, F; Sluijs, A; Escutia, C; Brinkhuis, H; Brinkhuis, H; Dotti, CE; Klaus, A; Fehr, A; Williams, T; Bendle, JA; Bijl, PK; Bohaty, SM; Carr, SA; Dunbar, RB; Flores, JA; Gonzalez, JJ; Hayden, TG; Iwai, M; Jimenez-Espejo, FJ; Katsuki, K; Kong, GS; Mckay, RM; Nakai, M; Olney, MP; Passchier, S; Pekar, SF; Pross, J; Riesselman, C; Rohl, U; Sakai, T; Salzmann, U; Shrivastava, PK; Stickley, CE; Sugisaki, S; Tauxe, L; Tuo, S; van de Flierdt, T; Welsh, K; Yamane, M				Houben, Alexander J. P.; Bijl, Peter K.; Pross, Joerg; Bohaty, Steven M.; Passchier, Sandra; Stickley, Catherine E.; Roehl, Ursula; Sugisaki, Saiko; Tauxe, Lisa; van de Flierdt, Tina; Olney, Matthew; Sangiorgi, Francesca; Sluijs, Appy; Escutia, Carlota; Brinkhuis, Henk; Brinkhuis, Henk; Dotti, Carlota Escutia; Klaus, Adam; Fehr, Annick; Williams, Trevor; Bendle, James A. P.; Bijl, Peter K.; Bohaty, Steven M.; Carr, Stephanie A.; Dunbar, Robert B.; Flores, Jose-Abel; Gonzalez, Jhon J.; Hayden, Travis G.; Iwai, Masao; Jimenez-Espejo, Francisco J.; Katsuki, Kota; Kong, Gee Soo; McKay, Robert M.; Nakai, Mutsumi; Olney, Matthew P.; Passchier, Sandra; Pekar, Stephen F.; Pross, Jorg; Riesselman, Christina; Rohl, Ursula; Sakai, Toyosaburo; Salzmann, Ulrich; Shrivastava, Prakash K.; Stickley, Catherine E.; Sugisaki, Saiko; Tauxe, Lisa; Tuo, Shouting; van de Flierdt, Tina; Welsh, Kevin; Yamane, Masako		Expedition 318 Scientists	Reorganization of Southern Ocean Plankton Ecosystem at the Onset of Antarctic Glaciation	SCIENCE			English	Article							ICE-SHEET EXPANSION; SEA-ICE; SEDIMENTOLOGICAL EVIDENCE; DINOFLAGELLATE CYSTS; INDICATORS; ICEHOUSE	The circum-Antarctic Southern Ocean is an important region for global marine food webs and carbon cycling because of sea-ice formation and its unique plankton ecosystem. However, the mechanisms underlying the installation of this distinct ecosystem and the geological timing of its development remain unknown. Here, we show, on the basis of fossil marine dinoflagellate cyst records, that a major restructuring of the Southern Ocean plankton ecosystem occurred abruptly and concomitant with the first major Antarctic glaciation in the earliest Oligocene (similar to 33.6 million years ago). This turnover marks a regime shift in zooplankton-phytoplankton interactions and community structure, which indicates the appearance of eutrophic and seasonally productive environments on the Antarctic margin. We conclude that earliest Oligocene cooling, ice-sheet expansion, and subsequent sea-ice formation were important drivers of biotic evolution in the Southern Ocean.	[Houben, Alexander J. P.; Bijl, Peter K.; Sangiorgi, Francesca; Sluijs, Appy; Brinkhuis, Henk] Univ Utrecht, Fac Geosci, Dept Earth Sci, LPP, NL-3584 CD Utrecht, Netherlands; [Pross, Joerg] Goethe Univ Frankfurt, Inst Geosci, Paleoenvironm Dynam Grp, D-60438 Frankfurt, Germany; [Pross, Joerg] Biodivers & Climate Res Ctr, D-60325 Frankfurt, Germany; [Bohaty, Steven M.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Passchier, Sandra] Montclair State Univ, Dept Earth & Environm Studies, Montclair, NJ 07043 USA; [Stickley, Catherine E.] Univ Tromso, Dept Geol, N-9037 Tromso, Norway; [Roehl, Ursula] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Sugisaki, Saiko; Tauxe, Lisa] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [van de Flierdt, Tina] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Olney, Matthew] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Escutia, Carlota] Inst Andaluz Ciencias Terra, Armilla 18100, Granada, Spain; [Brinkhuis, Henk; Bijl, Peter K.] Univ Utrecht, Lab Palaeobot & Palynol, Fac Geosci, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; [Dotti, Carlota Escutia; Gonzalez, Jhon J.; Jimenez-Espejo, Francisco J.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18002, Spain; [Klaus, Adam] Texas A&M Univ, Integrated Ocean Drilling Program, US Implementing Org, College Stn, TX 77845 USA; [Fehr, Annick] Univ Aachen, Inst Appl Geophys & Geothermal Energy, D-52074 Aachen, Germany; [Williams, Trevor] Columbia Univ, Lamont Doherty Earth Observ, Borehole Res Grp, Palisades, NY 10964 USA; [Bendle, James A. P.] Univ Glasgow, Geog & Earth Sci, Glasgow G12 8QQ, Lanark, Scotland; [Bohaty, Steven M.] Univ Southampton, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Carr, Stephanie A.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA; [Dunbar, Robert B.; Riesselman, Christina] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Flores, Jose-Abel] Univ Salamanca, Fac Ciencias, Dept Geol, Geosci Grp, Salamanca 37008, Spain; [Hayden, Travis G.] Western Michigan Univ, Dept Geol, Kalamazoo, MI 49008 USA; [Iwai, Masao] Kochi Univ, Dept Nat Sci, Kochi 7808520, Japan; [Jimenez-Espejo, Francisco J.] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; [Katsuki, Kota] Kochi Univ, Marine Ctr Adv Core Res, Kochi 7838502, Japan; [Kong, Gee Soo] Korea Inst Geosci & Mineral Resources, Petrol & Marine Res Div, Daejeon 305350, South Korea; [McKay, Robert M.] Victoria Univ Wellington, Antarct Res Ctr, Wellington 6140, New Zealand; [Nakai, Mutsumi] Daito Bunka Univ, Educ Dept, Tokyo 1758571, Japan; [Nakai, Mutsumi] Univ S Florida, Dept Geol, Tampa, FL 33620 USA; [Passchier, Sandra] Montclair State Univ, Earth & Environm Studies, Montclair, NJ 07043 USA; [Pekar, Stephen F.] CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA; [Pross, Jorg] Goethe Univ Frankfurt, Inst Geosci, Paleoenvironm Dynam Grp, D-60438 Frankfurt, Germany; [Riesselman, Christina] US Geol Survey, Eastern Geol & Paleoclimate Sci Ctr, Reston, VA 20192 USA; [Rohl, Ursula] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Sakai, Toyosaburo] Utsunomiya Univ, Dept Geol, Utsunomiya, Tochigi 3218505, Japan; [Salzmann, Ulrich] Northumbria Univ, Sch Built & Nat Environm, Earth & Environm, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Shrivastava, Prakash K.] NIT, NH5P, Geol Survey India, Antarct Div, Faridabad 121001, Haryana, India; [Stickley, Catherine E.] Univ Tromso, Dept Geol, N-9037 Tromso, Norway; [Sugisaki, Saiko] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Sugisaki, Saiko; Tauxe, Lisa] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Tuo, Shouting] Tongji Univ, Sch Ocean & Earth Sci, Shanghai 200092, Peoples R China; [van de Flierdt, Tina] Imperial Coll London, Dept Earth Sci & Engn, London SW7 2AZ, England; [Welsh, Kevin] Univ Queensland, Sch Earth Sci, Brisbane, Qld 4072, Australia; [Yamane, Masako] Univ Tokyo, Earth & Planetary Sci, Tokyo 1130033, Japan	Utrecht University; Goethe University Frankfurt; NERC National Oceanography Centre; University of Southampton; Montclair State University; UiT The Arctic University of Tromso; University of Bremen; University of California System; University of California San Diego; Scripps Institution of Oceanography; Imperial College London; State University System of Florida; University of South Florida; Utrecht University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Texas A&M University System; Texas A&M University College Station; RWTH Aachen University; Columbia University; University of Glasgow; NERC National Oceanography Centre; University of Southampton; Colorado School of Mines; Stanford University; University of Salamanca; Western Michigan University; Kochi University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kochi University; Korea Institute of Geoscience & Mineral Resources (KIGAM); Victoria University Wellington; State University System of Florida; University of South Florida; Montclair State University; City University of New York (CUNY) System; Queens College NY (CUNY); Goethe University Frankfurt; United States Department of the Interior; United States Geological Survey; University of Bremen; Utsunomiya University; Northumbria University; Geological Survey India; UiT The Arctic University of Tromso; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of California System; University of California San Diego; Scripps Institution of Oceanography; Tongji University; Imperial College London; University of Queensland; University of Tokyo	Houben, AJP (corresponding author), Netherlands Org Appl Sci Res TNO, Princetonlaan 6, NL-3584 CB Utrecht, Netherlands.	Alexander.Houben@TNO.nl	Flores, José-Abel/D-4218-2009; Passchier, Sandra/B-1993-2008; Passchier, Sandra/GYU-2381-2022; Salzmann, Ulrich/H-9929-2017; Passchier, Sandra/AAQ-2243-2021; Jimenez-Espejo, Francisco J./AAR-2318-2020; Sluijs, Appy/B-3726-2009; McKay, Robert/N-2449-2015; Jimenez-Espejo, Francisco J/F-4486-2016; Escutia, Carlota/B-8614-2015; Röhl, Ursula/G-5986-2011; Welsh, Kevin/A-9808-2012	Flores, José-Abel/0000-0003-1909-293X; Passchier, Sandra/0000-0001-7204-7025; Salzmann, Ulrich/0000-0001-5598-5327; Passchier, Sandra/0000-0001-7204-7025; Sluijs, Appy/0000-0003-2382-0215; McKay, Robert/0000-0002-5602-6985; Jimenez-Espejo, Francisco J/0000-0002-0335-8580; Escutia, Carlota/0000-0002-4932-8619; Röhl, Ursula/0000-0001-9469-7053; Yamane, Masako/0000-0002-5063-0719; Bijl, Peter/0000-0002-1710-4012; Riesselman, Christina/0000-0002-2436-4306; Bendle, James/0000-0002-6826-8658; Dunbar, Robert/0000-0002-9728-5609; Houben, Alexander/0000-0002-9497-1048; Welsh, Kevin/0000-0002-4834-4190; Brinkhuis, Henk/0000-0003-0253-6610	NSF [ANT-1245283, OCE 1058858, OCE 1054497]; Statoil; Netherlands Organisation for Scientific Research (NWO) [86610110]; LPP Foundation; German Research Foundation [PR 651/10, RO 1113/6]; Biodiversity and Climate Research Center within the Hessian Initiative for Scientific and Economic Excellence (LOEWE); Post-Expedition Activity award; Natural Environmental Research Council (UK) [NE/H025162/1, NE/H020098/1, NE/J019801/1]; European Commission [IRG 230828]; UK IODP [NE/I006257/1]; European Research Council [259627]; Spanish Ministry for Science and Innovation [CTM2011-2079]; Directorate For Geosciences [1245283] Funding Source: National Science Foundation; Division Of Ocean Sciences [1058858] Funding Source: National Science Foundation; Natural Environment Research Council [NE/H014616/1, NE/I006257/1, NE/I00646X/2, NE/I00646X/1, NE/J019801/1, NE/H025162/1, NE/H020098/1] Funding Source: researchfish; NERC [NE/H014616/1, NE/I006257/1, NE/I00646X/2, NE/H020098/1, NE/H025162/1, NE/I00646X/1, NE/J019801/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); Statoil; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); LPP Foundation; German Research Foundation(German Research Foundation (DFG)); Biodiversity and Climate Research Center within the Hessian Initiative for Scientific and Economic Excellence (LOEWE); Post-Expedition Activity award; Natural Environmental Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Commission(European CommissionEuropean Commission Joint Research Centre); UK IODP; European Research Council(European Research Council (ERC)European Commission); Spanish Ministry for Science and Innovation(Spanish Government); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research used samples from the ODP and the IODP. The ODP was sponsored by the NSF and participating countries under management of Joint Oceanographic Institutions (JOI) Incorporated. A.J.P.H. and H.B. thank Statoil for funding. P.K.B., F.S., and H.B. thank the Netherlands Organisation for Scientific Research (NWO) (grant 86610110) and the LPP Foundation for funding. J.P. and U.R. acknowledge support through the German Research Foundation (grants PR 651/10 and RO 1113/6). J.P. thanks the Biodiversity and Climate Research Center within the Hessian Initiative for Scientific and Economic Excellence (LOEWE) for support. S.P. acknowledges financial support from a Post-Expedition Activity award administered by the U.S. Science Support Program and research support from NSF award ANT-1245283. T.v.d.F. acknowledges the Natural Environmental Research Council (UK) for a cruise participation grant (NE/H025162/1) and the European Commission for a Marie Curie Reintegration grant (IRG 230828). S.M.B. and T.v.d.F. further acknowledge UK IODP funding (grant NE/I006257/1). S.M.B. acknowledges the Natural Environmental Research Council (UK) for a cruise participation grant (NE/H020098/1) and postcruise research support (NE/J019801/1). L.T. acknowledges support from NSF grants OCE 1058858 and OCE 1054497. A.S. thanks the European Research Council for ERC Starting Grant 259627. C.E. thanks the Spanish Ministry for Science and Innovation (grant CTM2011-2079). The reported data are available in the supplementary materials.	Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Baker AJ, 2006, P ROY SOC B-BIOL SCI, V273, P11, DOI 10.1098/rspb.2005.3260; Balech E., 1968, ANTARCTIC MAP FOLIO; BARRON JA, 1989, LIFE SCI R, V44, P341; Bijl PK, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2009PA001905; Bohaty SM, 2012, EARTH PLANET SC LETT, V317, P251, DOI 10.1016/j.epsl.2011.11.037; Bouimetarhan I, 2009, MAR MICROPALEONTOL, V71, P113, DOI 10.1016/j.marmicro.2009.02.001; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; Dieckmann G. S., 2010, SEA ICE; EHRMANN WU, 1992, PALAEOGEOGR PALAEOCL, V93, P85, DOI 10.1016/0031-0182(92)90185-8; Escutia C., 2011, INTEGRATED OCEAN DRI, V318; Hannah M. J., 2001, TERRA ANTARTICA, V8, P383; Harland R, 1999, MAR MICROPALEONTOL, V37, P77, DOI 10.1016/S0377-8398(99)00016-X; Houben AJP, 2011, REV PALAEOBOT PALYNO, V165, P175, DOI 10.1016/j.revpalbo.2011.03.002; JACOBSON DM, 1986, J PHYCOL, V22, P249, DOI 10.1111/j.1529-8817.1986.tb00021.x; Kopczynska EE, 2007, POLAR BIOL, V31, P77, DOI 10.1007/s00300-007-0335-6; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Leventer A, 1998, ANTARCT RES SER, V73, P121; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Marret F, 1997, MAR MICROPALEONTOL, V29, P367, DOI 10.1016/S0377-8398(96)00049-7; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Reichart GJ, 2003, MAR MICROPALEONTOL, V49, P303, DOI 10.1016/S0377-8398(03)00050-1; Scher HD, 2011, GEOLOGY, V39, P383, DOI 10.1130/G31726.1; Sluijs A, 2005, EARTH-SCI REV, V68, P281, DOI 10.1016/j.earscirev.2004.06.001; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Stickley C. E., 2004, PALEOCEONOGRAPHY, V19; Tauxe L, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002308; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Wilson DS, 2012, PALAEOGEOGR PALAEOCL, V335, P24, DOI 10.1016/j.palaeo.2011.05.028; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2	34	81	83	7	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					341	344		10.1126/science.1223646	http://dx.doi.org/10.1126/science.1223646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599491	Green Published			2022-12-24	WOS:000317657500052
J	Ravichandran, B; Lustig, R				Ravichandran, Balaji; Lustig, Robert			Robert Lustig: The no candy man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ravichandran, Balaji] Univ Oxford Queens Coll, Oxford OX1 4AW, England	University of Oxford	Ravichandran, B (corresponding author), Univ Oxford Queens Coll, Oxford OX1 4AW, England.	balaji.ravichandran@mod-langs.ox.ac.uk	Lustig, Robert/O-9380-2019	Lustig, Robert/0000-0001-6983-2639				Ravichandran B., 2013, SUGAR IS NEW TOBACCO	1	0	0	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2013	346								f2287	10.1136/bmj.f2287	http://dx.doi.org/10.1136/bmj.f2287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131AT	23596216				2022-12-24	WOS:000317963400005
J	Austin, AT; Bustamante, MMC; Nardoto, GB; Mitre, SK; Perez, T; Ometto, JPHB; Ascarrunz, NL; Forti, MC; Longo, K; Gavito, ME; Enrich-Prast, A; Martinelli, LA				Austin, A. T.; Bustamante, M. M. C.; Nardoto, G. B.; Mitre, S. K.; Perez, T.; Ometto, J. P. H. B.; Ascarrunz, N. L.; Forti, M. C.; Longo, K.; Gavito, M. E.; Enrich-Prast, A.; Martinelli, L. A.			Latin America's Nitrogen Challenge	SCIENCE			English	Editorial Material							CYCLE; STREAMS; FOREST; TRENDS		[Austin, A. T.] Univ Buenos Aires, IFEVA CONICET, Buenos Aires, DF, Argentina; [Bustamante, M. M. C.; Nardoto, G. B.; Mitre, S. K.] Univ Brasilia, Brasilia, DF, Brazil; [Perez, T.] Inst Venezolano Invest Cient, Caracas, Venezuela; [Ometto, J. P. H. B.; Forti, M. C.; Longo, K.] Inst Nacl Pesquisas Espaciais, BR-12201 Sao Jose Dos Campos, Brazil; [Ascarrunz, N. L.] Inst Boliviano Invest Forestal, Santa Cruz, Bolivia; [Gavito, M. E.] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Enrich-Prast, A.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Martinelli, L. A.] CENA Univ Sao Paulo, Piracicaba, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidade de Brasilia; Venezuelan Institute Science Research; Instituto Nacional de Pesquisas Espaciais (INPE); Universidad Nacional Autonoma de Mexico; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Martinelli, LA (corresponding author), CENA Univ Sao Paulo, Piracicaba, Brazil.	martinelli@cena.usp.br	Prast, Alex Enrich/AAL-4722-2021; Austin, Amy/E-7988-2011; MITRE, SIMONE/F-1789-2019; Ometto, Jean Pierre/B-3351-2013; Bustamante, Mercedes/AAQ-7231-2020; Bustamante, Mercedes/GQZ-8625-2022; Nardoto, Gabriela Bielefeld/J-7459-2012; Libardoni, Bruno G/P-3873-2014; Bustamante, Mercedes MC/H-7597-2015; Gavito, Mayra E/K-1639-2019; Martinelli, Luiz Antonio/F-7870-2011; Enrich-Prast, Alex/H-5391-2012	Prast, Alex Enrich/0000-0003-3561-0936; Austin, Amy/0000-0002-7468-5861; Ometto, Jean Pierre/0000-0002-4221-1039; Bustamante, Mercedes/0000-0003-1008-452X; Nardoto, Gabriela Bielefeld/0000-0001-8062-7417; Bustamante, Mercedes MC/0000-0003-1008-452X; Gavito, Mayra E/0000-0003-3556-7886; Martinelli, Luiz Antonio/0000-0002-7103-7551; 				Acemoglu D, 2012, WHY NATIONS FAIL; Acemoglu D, 2012, J ECON THEORY, V147, P570, DOI 10.1016/j.jet.2010.09.001; Alonso MF, 2010, ATMOS ENVIRON, V44, P5072, DOI 10.1016/j.atmosenv.2010.09.013; Austin AT, 2006, BIOGEOCHEMISTRY, V79, P45, DOI 10.1007/s10533-006-9002-1; Bleeker A, 2011, ENVIRON POLLUT, V159, P2280, DOI 10.1016/j.envpol.2010.10.036; Cerdeira AL, 2011, J AGR FOOD CHEM, V59, P5799, DOI 10.1021/jf102652y; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chuvieco E, 2008, ECOL APPL, V18, P64, DOI 10.1890/06-2148.1; Daniel MHB, 2002, WATER AIR SOIL POLL, V136, P189, DOI 10.1023/A:1015287708170; Ferreira J, 2012, J APPL ECOL, V49, P535, DOI 10.1111/j.1365-2664.2012.02145.x; Filoso S, 2006, BIOGEOCHEMISTRY, V79, P61, DOI 10.1007/s10533-006-9003-0; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; Hotez P. J., 2008, PLOS NEGLECT TROP D, V2, pe1757; Janssen R, 2011, ENERG POLICY, V39, P5717, DOI 10.1016/j.enpol.2011.01.047; Kay C, 2001, THIRD WORLD Q, V22, P741, DOI 10.1080/01436590120084584; Martinelli LA, 2006, BIOGEOCHEMISTRY, V79, P3, DOI 10.1007/s10533-006-9000-3; Martinelli LA, 2011, AGR SYST, V104, P419, DOI 10.1016/j.agsy.2011.01.006; Martinelli LA, 2011, NATURE, V474, P579, DOI 10.1038/474579a; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Ometo JPHB, 2000, FRESHWATER BIOL, V44, P327, DOI 10.1046/j.1365-2427.2000.00557.x; Salvagiotti F, 2008, FIELD CROP RES, V108, P1, DOI 10.1016/j.fcr.2008.03.001; Smaling EMA, 2008, AGR ECOSYST ENVIRON, V128, P185, DOI 10.1016/j.agee.2008.06.005; Trebs I, 2006, ATMOS CHEM PHYS, V6, P447, DOI 10.5194/acp-6-447-2006; van der Struijk LF, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003572	25	29	33	0	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					149	149		10.1126/science.1231679	http://dx.doi.org/10.1126/science.1231679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580515				2022-12-24	WOS:000317341400039
J	Hondele, M; Stuwe, T; Hassler, M; Halbach, F; Bowman, A; Zhang, ET; Nijmeijer, B; Kotthoff, C; Rybin, V; Amlacher, S; Hurt, E; Ladurner, AG				Hondele, Maria; Stuwe, Tobias; Hassler, Markus; Halbach, Felix; Bowman, Andrew; Zhang, Elisa T.; Nijmeijer, Bianca; Kotthoff, Christiane; Rybin, Vladimir; Amlacher, Stefan; Hurt, Ed; Ladurner, Andreas G.			Structural basis of histone H2A-H2B recognition by the essential chaperone FACT	NATURE			English	Article							TRANSCRIPT ELONGATION; DNA; REVEALS; BINDING; DOMAIN; SPT16; HETERODIMER; REPLICATION; INITIATION; COMPLEX	Facilitates chromatin transcription (FACT) is a conserved histone chaperone that reorganizes nucleosomes and ensures chromatin integrity during DNA transcription, replication and repair(1-6). Key to the broad functions of FACT is its recognition of histones H2A-H2B (ref. 2). However, the structural basis for how histones H2A-H2B are recognized and how this integrates with the other functions of FACT, including the recognition of histones H3-H4 and other nuclear factors, is unknown. Here we reveal the crystal structure of the evolutionarily conserved FACT chaperone domain Spt16M from Chaetomium thermophilum, in complex with the H2A-H2B heterodimer. A novel 'U-turn' motif scaffolded onto a Rtt106-like module(7-10) embraces the alpha 1 helix of H2B. Biochemical and in vivo assays validate the structure and dissect the contribution of histone tails and H3-H4 towards Spt16M binding. Furthermore, we report the structure of the FACT heterodimerization domain that connects FACT to replicative polymerases. Our results show that Spt16M makes several interactions with histones, which we suggest allow the module to invade the nucleosome gradually and block the strongest interaction of H2B with DNA. FACT would thus enhance 'nucleosome breathing' by re-organizing the first 30 base pairs of nucleosomal histone-DNA contacts. Our snapshot of the engagement of the chaperone with H2A-H2B and the structures of all globular FACT domains enable the high-resolution analysis of the vital chaperoning functions of FACT, shedding light on how the complex promotes the activity of enzymes that require nucleosome reorganization.	[Hondele, Maria; Hassler, Markus; Bowman, Andrew; Kotthoff, Christiane; Ladurner, Andreas G.] Univ Munich, Butenandt Inst, Dept Physiol Chem, D-81377 Munich, Germany; [Hondele, Maria; Hassler, Markus; Bowman, Andrew; Kotthoff, Christiane; Ladurner, Andreas G.] Univ Munich, Fac Med, LMU Biomed Ctr, D-81377 Munich, Germany; [Hondele, Maria; Stuwe, Tobias; Hassler, Markus; Zhang, Elisa T.; Nijmeijer, Bianca; Rybin, Vladimir; Ladurner, Andreas G.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Hondele, Maria; Stuwe, Tobias; Hassler, Markus; Zhang, Elisa T.; Nijmeijer, Bianca; Rybin, Vladimir; Ladurner, Andreas G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Halbach, Felix] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Amlacher, Stefan; Hurt, Ed] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Ladurner, Andreas G.] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Ladurner, Andreas G.] Ctr Integrated Prot Sci Munich CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Max Planck Society; Ruprecht Karls University Heidelberg; University of Munich	Ladurner, AG (corresponding author), Univ Munich, Butenandt Inst, Dept Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	andreas.ladurner@med.lmu.de	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Hassler, Markus/0000-0001-9827-3477; Bowman, Andrew/0000-0002-5507-669X; Nijmeijer-Winter, Bianca/0000-0002-9429-8439; Ladurner, Andreas/0000-0003-3835-232X; Hondele, Maria/0000-0002-2733-2561	EMBL; LMU Munich; EC FP6 Marie Curie RTN Chromatin Plasticity; Boehringer Ingelheim Fonds	EMBL; LMU Munich; EC FP6 Marie Curie RTN Chromatin Plasticity; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank J. Basquin, E. Conti, the MPI for Biochemistry and staff at beamlines Swiss Light Source PXII and European Synchrotron Radiation Facility ID23 for crystallographic support, P. Becker, S. Hake, J. Muller and G. Schotta for H3 peptides, and F. Bonneau, P. Cramer, T. Gibson, D. Gilmour, J. Griesen beck, C. Haring, M. Hothorn, G. Jankevicius, D. Mokranjac, R. Russell, I. Schafer, K. Scheffzek, C. Schultz, F. Wieland, M. Winter and E. Wolf for discussion. EMBL, LMU Munich, EC FP6 Marie Curie RTN Chromatin Plasticity (to A. G. L.) and Boehringer Ingelheim Fonds (to M. Ho. and F. H.) funded this research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Capozzo C, 2000, YEAST, V16, P1089, DOI 10.1002/1097-0061(20000915)16:12<1089::AID-YEA600>3.3.CO;2-7; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hondele M, 2011, CURR OPIN STRUC BIOL, V21, P698, DOI 10.1016/j.sbi.2011.10.003; Hsieh F.-K., 2013, P NATL ACAD SCI US; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Killian JL, 2012, CURR OPIN STRUC BIOL, V22, P80, DOI 10.1016/j.sbi.2011.11.003; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; Kulaeva OI, 2009, NAT STRUCT MOL BIOL, V16, P1272, DOI 10.1038/nsmb.1689; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Liu YW, 2010, J BIOL CHEM, V285, P4251, DOI 10.1074/jbc.M109.055996; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Sumathi K, 2006, NUCLEIC ACIDS RES, V34, pW128, DOI 10.1093/nar/gkl036; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Zunder RM, 2012, P NATL ACAD SCI USA, V109, pE144, DOI 10.1073/pnas.1119095109	42	128	130	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					111	+		10.1038/nature12242	http://dx.doi.org/10.1038/nature12242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23698368				2022-12-24	WOS:000321285600044
J	Eisenstein, M				Eisenstein, Michael			CHRONOBIOLOGY Stepping out of time	NATURE			English	Editorial Material																		Barger LK, 2012, SLEEP, V35, P1423, DOI 10.5665/sleep.2128; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Rajaratnam SMW, 2009, LANCET, V373, P482, DOI 10.1016/S0140-6736(08)61812-7; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030	8	17	19	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					S10	S12		10.1038/497S10a	http://dx.doi.org/10.1038/497S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	148OG	23698500	Bronze			2022-12-24	WOS:000319254000006
J	Cheetham, SW; Brand, AH				Cheetham, Seth W.; Brand, Andrea H.			Insulin Finds Its Niche	SCIENCE			English	Editorial Material							ADULT HIPPOCAMPUS; STEM-CELLS; IGF-I; GROWTH; NEUROGENESIS; MECHANISMS; DROSOPHILA		[Cheetham, Seth W.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Cheetham, SW (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	a.brand@gurdon.cam.ac.uk	Cheetham, Seth/C-8842-2018; Brand, Andrea H/F-8220-2014	Cheetham, Seth/0000-0001-6428-3175; Brand, Andrea H/0000-0002-2089-6954	Wellcome Trust [092096] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aberg MAI, 2000, J NEUROSCI, V20, P2896; Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Britton JS, 1998, DEVELOPMENT, V125, P2149; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG1307, DOI 10.1152/ajpgi.2000.279.6.G1307; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zygar CA, 2005, DEV BRAIN RES, V154, P91, DOI 10.1016/j.devbrainres.2004.10.009	16	9	9	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					817	818		10.1126/science.1238525	http://dx.doi.org/10.1126/science.1238525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687033				2022-12-24	WOS:000318997400027
J	Kim, SE; Huang, H; Zhao, M; Zhang, XJ; Zhang, AL; Semonov, MV; MacDonald, BT; Zhang, XW; Abreu, JG; Peng, LL; He, X				Kim, Sung-Eun; Huang, He; Zhao, Ming; Zhang, Xinjun; Zhang, Aili; Semonov, Mikhail V.; MacDonald, Bryan T.; Zhang, Xiaowu; Abreu, Jose Garcia; Peng, Leilei; He, Xi			Wnt Stabilization of beta-Catenin Reveals Principles for Morphogen Receptor-Scaffold Assemblies	SCIENCE			English	Article							DUAL-KINASE MECHANISM; NEGATIVE REGULATOR; SIGNALING PATHWAY; CORECEPTOR LRP6; AXIN; PHOSPHORYLATION; COMPLEX; INHIBITION; DEGRADATION; ACTIVATION	Wnt signaling stabilizes beta-catenin through the LRP6 receptor signaling complex, which antagonizes the beta-catenin destruction complex. The Axin scaffold and associated glycogen synthase kinase-3 (GSK3) have central roles in both assemblies, but the transduction mechanism from the receptor to the destruction complex is contentious. We report that Wnt signaling is governed by phosphorylation regulation of the Axin scaffolding function. Phosphorylation by GSK3 kept Axin activated ("open") for beta-catenin interaction and poised for engagement of LRP6. Formation of the Wnt-induced LRP6-Axin signaling complex promoted Axin dephosphorylation by protein phosphatase-1 and inactivated ("closed") Axin through an intramolecular interaction. Inactivation of Axin diminished its association with beta-catenin and LRP6, thereby inhibiting beta-catenin phosphorylation and enabling activated LRP6 to selectively recruit active Axin for inactivation reiteratively. Our findings reveal mechanisms for scaffold regulation and morphogen signaling.	[Kim, Sung-Eun; Huang, He; Zhang, Xinjun; Semonov, Mikhail V.; MacDonald, Bryan T.; Abreu, Jose Garcia; He, Xi] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Ctr, Boston, MA 02115 USA; [Zhao, Ming; Zhang, Aili; Peng, Leilei] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA; [Abreu, Jose Garcia] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Zhang, Aili] Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Zhang, Xiaowu] Cell Signaling Technol, Danvers, MA 01923 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Arizona; Universidade Federal do Rio de Janeiro; Shanghai Jiao Tong University	He, X (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Ctr, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu	Abreu, Jose G/ABB-1199-2021; Kim, Sung-Eun/ABC-8837-2020; Zhao, Ming/M-7930-2014; Abreu, Jose G/G-6159-2010	Abreu, Jose G/0000-0002-1363-1755; Kim, Sung-Eun/0000-0001-8667-3887; Zhao, Ming/0000-0001-9695-7322; Abreu, Jose G/0000-0002-9875-7786	National Research Foundation of Korea [KRF-2009-357-C00096]; Canadian Institute of Health Research; National Council for Scientific and Technological Development (CNPq, Brazil); NIH [R00EB008737, R01EB015481, RO1 GM074241]; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015481, R00EB008737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Wu for the BCD2 construct; X. Yu for figs. S11 and S13; B. Doble and J. Woodgett for Gsk3-null mouse embryonic stem cells; A. Klein, M. Kirschner, T. Schwarz, J.-h. Wang, and X. H. laboratory members for comments; and M. Lin, B. Yu, M. Wan, X. Cao, and W. Wei for help. S.-E. K. and H. H. were supported partially by postdoctoral fellowships from National Research Foundation of Korea (KRF-2009-357-C00096) and Canadian Institute of Health Research, respectively. J. G. A. was funded partially by the National Council for Scientific and Technological Development (CNPq, Brazil) as a visiting scientist to the X. H. laboratory. L. P. acknowledges support by NIH (R00EB008737 and R01EB015481). X. H. acknowledges support by NIH (RO1 GM074241) and Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (P30 HD-18655).	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	30	164	167	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					867	870		10.1126/science.1232389	http://dx.doi.org/10.1126/science.1232389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23579495	Green Accepted			2022-12-24	WOS:000318997400045
J	Kennedy, A; Bower, P; Reeves, D; Blakeman, T; Bowen, R; Chew-Graham, C; Eden, M; Fullwood, C; Gaffney, H; Gardner, C; Lee, V; Morris, R; Protheroe, J; Richardson, G; Sanders, C; Swallow, A; Thompson, D; Rogers, A				Kennedy, Anne; Bower, Peter; Reeves, David; Blakeman, Tom; Bowen, Robert; Chew-Graham, Carolyn; Eden, Martin; Fullwood, Catherine; Gaffney, Hannah; Gardner, Caroline; Lee, Victoria; Morris, Rebecca; Protheroe, Joanne; Richardson, Gerry; Sanders, Caroline; Swallow, Angela; Thompson, David; Rogers, Anne		Salford Natl Inst Hlth Res Gastroi	Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC CONTROL; PRACTICE NURSES; CHRONIC DISEASE; ULCERATIVE-COLITIS; COST-EFFECTIVENESS; HEALTH-CARE; FOLLOW-UP; PROGRAMS; INTERVENTION; PERFORMANCE	Objective To determine the effectiveness of an intervention to enhance self management support for patients with chronic conditions in UK primary care. Design Pragmatic, two arm, cluster randomised controlled trial. Setting General practices, serving a population in northwest England with high levels of deprivation. Participants 5599 patients with a diagnosis of diabetes (n=2546), chronic obstructive pulmonary disease (n=1634), and irritable bowel syndrome (n=1419) from 43 practices (19 intervention and 22 control practices). Intervention Practice level training in a whole systems approach to self management support. Practices were trained to use a range of resources: a tool to assess the support needs of patients, guidebooks on self management, and a web based directory of local self management resources. Training facilitators were employed by the health management organisation. Main outcome measures Primary outcomes were shared decision making, self efficacy, and generic health related quality of life measured at 12 months. Secondary outcomes were general health, social or role limitations, energy and vitality, psychological wellbeing, self care activity, and enablement. Results We randomised 44 practices and recruited 5599 patients, representing 43% of the eligible population on the practice lists. 4533 patients (81.0%) completed the six month follow-up and 4076 (72.8%) the 12 month follow-up. No statistically significant differences were found between patients attending trained practices and those attending control practices on any of the primary or secondary outcomes. All effect size estimates were well below the prespecified threshold of clinically important difference. Conclusions An intervention to enhance self management support in routine primary care did not add noticeable value to existing care for long term conditions. The active components required for effective self management support need to be better understood, both within primary care and in patients' everyday lives. Trial registration Current Controlled Trials ISRCTN90940049.	[Kennedy, Anne; Rogers, Anne] Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England; [Bower, Peter; Reeves, David; Blakeman, Tom; Bowen, Robert; Eden, Martin; Gaffney, Hannah; Gardner, Caroline; Lee, Victoria; Morris, Rebecca; Sanders, Caroline; Swallow, Angela] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Primary Care, Natl Inst Hlth Res,Sch Primary Care Res, Manchester, Lancs, England; [Chew-Graham, Carolyn; Protheroe, Joanne; Swallow, Angela] Keele Univ, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England; [Fullwood, Catherine] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Biomed Res Ctr, Manchester, Lancs, England; [Richardson, Gerry] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Richardson, Gerry] Univ York, NIHR Res Design Serv Yorkshire & Humber, York YO10 5DD, N Yorkshire, England; [Thompson, David] Univ Manchester, Salford Royal Hosp, Fac Med & Human Sci, Inst Inflammat & Repair, Salford, Lancs, England	University of Southampton; University of Manchester; Keele University; University of Manchester; University of York - UK; University of York - UK; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester	Kennedy, A (corresponding author), Univ Southampton, Fac Hlth Sci, Highfield Campus, Southampton SO17 1BJ, Hants, England.	a.kennedy@soton.ac.uk	Sanders, Caroline/G-8021-2014; Reeves, David/H-6203-2014; Fullwood, Catherine/AAM-7281-2020; Bower, Peter/A-1508-2011; Morris, Rebecca/A-1940-2019	Sanders, Caroline/0000-0002-0539-928X; Reeves, David/0000-0001-6377-6859; Bower, Peter/0000-0001-9558-3349; Eden, Martin/0000-0002-1542-2527; Gaffney, Hannah/0000-0001-9561-2488; Fullwood, Catherine/0000-0003-4136-2027; Lee, Victoria/0000-0001-9578-3260; Morris, Rebecca/0000-0003-1587-0802; Gardner, Caroline/0000-0003-0487-3979	National Primary Care Research and Development Centre; Department of Health; National Institute for Health Research [RP-PG-0407-10136]; National Institute for Health Research [CL-2009-06-004] Funding Source: researchfish	National Primary Care Research and Development Centre; Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The trial was funded by the National Institute for Health Research and The National Primary Care Research and Development Centre (funded by the Department of Health). This paper presents independent research commissioned by the National Institute for Health Research under its programme grants for applied research funding scheme (RP-PG-0407-10136). The views expressed in this paper are those of the authors and not necessarily those of the National Health Service, National Institute for Health Research, or the Department of Health.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Blakeman T, 2006, BRIT J GEN PRACT, V56, P407; Bodenheimar T, 2005, HELPING PATIENTS MAN; Bodenheimer T, 2008, NEW ENGL J MED, V359, P2086, DOI 10.1056/NEJMp0805631; Bodenheimer Thomas, 2003, Dis Manag, V6, P63, DOI 10.1089/109350703321908441; Bower P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-7; Campbell SA, 2008, ANN FAM MED, V6, P228, DOI 10.1370/afm.844; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Communities and Local Government (CLG), 2013, IND DEPR 2007 DAT PR; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Department of Health, 2010, EQ EXC LIB NHS; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Egginton JS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-72; Furler J, 2011, CHRONIC ILLN, V7, P3, DOI 10.1177/1742395310386978; Goodyear-Smith F, 2009, FAM PRACT, V26, P128, DOI 10.1093/fampra/cmp015; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; Hornsten A, 2008, DIABETES RES CLIN PR, V81, P50, DOI 10.1016/j.diabres.2008.02.005; Jones R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-5; Kennedy A, 2003, PATIENT EDUC COUNS, V50, P303, DOI 10.1016/S0738-3991(03)00054-5; Kennedy A, 2003, HEALTH SOC CARE COMM, V11, P64, DOI 10.1046/j.1365-2524.2003.00399.x; Kennedy A, 2007, BMJ-BRIT MED J, V335, P968, DOI 10.1136/bmj.39372.540903.94; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kennedy A, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-7; Kennedy AP, 2004, GUT, V53, P1639, DOI 10.1136/gut.2003.034256; Kind P, 1996, QUALITY LIFE PHARMAC; Lorig K., 1996, OUTCOME MEASURES HLT, VVol. 2019; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Macdonald W, 2008, J ADV NURS, V62, P191, DOI 10.1111/j.1365-2648.2007.04585.x; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; McCall N, 2011, NEW ENGL J MED, V365, P1704, DOI 10.1056/NEJMsa1011785; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; McDonald R, 2009, SOC SCI MED, V68, P1206, DOI 10.1016/j.socscimed.2009.01.039; McGregor W, 2008, BRIT J GEN PRACT, V58, P711, DOI 10.3399/bjgp08X342183; Motheral Brenda R, 2011, Am J Manag Care, V17, pe10; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; Parchman ML, 2006, ANN FAM MED, V4, P40, DOI 10.1370/afm.422; Partners in Salford, 2013, OUR VIS HLTH CIT; Powell LH, 2010, JAMA-J AM MED ASSOC, V304, P1331, DOI 10.1001/jama.2010.1362; Protheroe J, 2012, J HLTH PSYCHOL; Protheroe J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-206; Protheroe J, 2009, BRIT J GEN PRACT, V59, P721, DOI 10.3399/bjgp09X472584; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Robinson A, 2006, GUT, V55, P643, DOI 10.1136/gut.2004.062901; Robinson A, 2001, LANCET, V358, P976, DOI 10.1016/S0140-6736(01)06105-0; Ryan A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-96; Salmon P, 2007, FAM PRACT, V24, P269, DOI 10.1093/fampra/cmm015; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Stange KC, 2010, J GEN INTERN MED, V25, P601, DOI 10.1007/s11606-010-1291-3; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Steventon A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3874; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; Trento M, 2010, DIABETES CARE, V33, P745, DOI 10.2337/dc09-2024; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; Williams AM, 2011, CHRONIC ILLN, V7, P20, DOI 10.1177/1742395310383339; Williams GC, 2005, PATIENT EDUC COUNS, V57, P39, DOI 10.1016/j.pec.2004.04.001; Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58; Woolhandler S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5015; Zwar N, 2006, SYSTEMATIC REV CHRON	60	151	157	1	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2013	346								f2882	10.1136/bmj.f2882	http://dx.doi.org/10.1136/bmj.f2882			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OC	23670660	Green Published, Green Accepted			2022-12-24	WOS:000319253600002
J	Leppek, K; Schott, J; Reitter, S; Poetz, F; Hammond, MC; Stoecklin, G				Leppek, Kathrin; Schott, Johanna; Reitter, Sonja; Poetz, Fabian; Hammond, Ming C.; Stoecklin, Georg			Roquin Promotes Constitutive mRNA Decay via a Conserved Class of Stem-Loop Recognition Motifs	CELL			English	Article							TUMOR-NECROSIS-FACTOR; T-CELLS; AUTOIMMUNITY; DEGRADATION; TRISTETRAPROLIN; EXPRESSION; REPRESSION; MICRORNAS; STABILITY; PROTEIN	Tumor necrosis factor-alpha (INF-alpha) is the most potent proinflammatory cytokine in mammals. The degradation of TNF-alpha mRNA is critical for restricting TNF-alpha synthesis and involves a constitutive decay element (CDE) in the 3' UTR of the mRNA. Here, we demonstrate that the CDE folds into an RNA stem-loop motif that is specifically recognized by Roquin and Roquin2. Binding of Roquin initiates degradation of TNF-alpha mRNA and limits TNF- alpha production in macrophages. Roquin proteins promote mRNA degradation by recruiting the Ccr4-Caf1-Not deadenylase complex. CDE sequences are highly conserved and are found in more than 50 vertebrate mRNAs, many of which encode regulators of development and inflammation. In macrophages, CDE-containing mRNAs were identified as the primary targets of Roquin on a transcriptome-wide scale. Thus, Roquin proteins act broadly as mediators of mRNA deadenylation by recognizing a conserved class of stem-loop RNA degradation motifs.	[Leppek, Kathrin; Schott, Johanna; Reitter, Sonja; Poetz, Fabian; Stoecklin, Georg] DKFZ ZMBH Alliance, German Canc Res Ctr, Helmholtz Jr Res Grp Posttranscript Control Gene, D-69120 Heidelberg, Germany; [Hammond, Ming C.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hammond, Ming C.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stoecklin, G (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr, Helmholtz Jr Res Grp Posttranscript Control Gene, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.stoecklin@dkfz.de		Leppek, Kathrin/0000-0002-8012-8076; Stoecklin, Georg/0000-0001-9284-9834; Poetz, Fabian/0000-0002-5278-8931	Helmholtz Gemeinschaft [HZ-NG-210]; Deutsche Forschungsgemeinschaft [SFB 1036/TP07, STO 859/2-1, STO 859/3-1]; Helmholtz International Graduate School for Cancer Research; CASI (Career Awards at the Scientific Interface) award from the Burroughs Wellcome Fund	Helmholtz Gemeinschaft(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz International Graduate School for Cancer Research; CASI (Career Awards at the Scientific Interface) award from the Burroughs Wellcome Fund	We would like to thank Bernd Rattenbacher and Christoph Moroni (University of Basel, Basel, Switzerland) for sharing unpublished information. We are grateful to Vigo Heissmeyer (Helmholtz Center Munich, Munich, Germany) for providing the Dicer mouse embryonic fibroblasts (MEFs) and the plasmids encoding EGFP-Roquin and His-Roquin-N; Witold Filipowicz (Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland) for the Dicer antibody; Ann-Bin Shyu (University of Texas Medical School at Houston, Houston, TX, USA) for the Caf1a antibody and the NIH 3T3 B2A2 cell line; Takbum Ohn, Nancy Kedersha, and Paul Anderson (Harvard Medical School, Boston, MA, USA) for Flag-Roquin plasmids; Adelheid Cerwenka (German Cancer Research Center, Heidelberg, Germany) for providing mouse bone marrow; Ivana Cado for generating stable cell lines; and Alexandra Kurz (German Cancer Research Center, Heidelberg) for help with ELISA. We would like to thank David Ibberson and Sasithorn Chotewutmontri of the Heidelberg University Deep Sequencing Core Facility, the Genomics Core Facility at the European Molecular Biology Laboratory, and Thomas Ruppert from the ZMBH (Zentrum fur Molekulare Biologie der Universitat Heidelberg) Mass Spectrometry Core Facility for extensive support. We also thank Ingrid Grummt and Aurelio Teleman (German Cancer Research Center, Heidelberg) for critical reading of the manuscript. This work was supported by Young Investigator Grant HZ-NG-210 from the Helmholtz Gemeinschaft to G.S.; SFB 1036/TP07 as well as research grants STO 859/2-1 and STO 859/3-1 from the Deutsche Forschungsgemeinschaft to G.S.; a PhD stipend from the Helmholtz International Graduate School for Cancer Research to K.L.; and a CASI (Career Awards at the Scientific Interface) award from the Burroughs Wellcome Fund to M.C.H. K.L. designed and performed experiments, analyzed the data, prepared figures, and cowrote the manuscript; J.S. carried out bioinformatics analysis and performed experiments; S.R. and F.P. performed experiments; M.C.H. performed in-line probing; and G.S. supervised the study, designed experiments, analyzed the data, and cowrote the manuscript.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ji YR, 2012, J BIOL CHEM, V287, P42269, DOI 10.1074/jbc.M112.374835; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shu ZY, 1999, BIOCHEMISTRY-US, V38, P15369, DOI 10.1021/bi991774z; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	28	203	217	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					869	881		10.1016/j.cell.2013.04.016	http://dx.doi.org/10.1016/j.cell.2013.04.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663784	Bronze			2022-12-24	WOS:000318844000015
J	Roland, M; Paddison, C				Roland, Martin; Paddison, Charlotte			Better management of patients with multimorbidity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INVERSE CARE LAW; CLINICAL GUIDELINES; CONTINUITY; OUTCOMES; QUALITY; PAY; EPIDEMIOLOGY; PHYSICIANS; DISEASES; ENGLAND		[Roland, Martin; Paddison, Charlotte] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge CB2 0SR, England.	mr108@cam.ac.uk		Roland, Martin/0000-0002-8533-3060				Aboulghate A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653624; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss EA, 2007, ANN FAM MED, V5, P395, DOI 10.1370/afm.722; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Campbell SM, 2010, ANN FAM MED, V8, P499, DOI 10.1370/afm.1145; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2405; Fletcher KE, 2011, J HOSP MED, V6, P438, DOI 10.1002/jhm.916; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Haggerty JL, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5915; Hill A, 2012, PROMOTING CONTINUITY; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Hsiao CJ, 2008, AM J MED QUAL, V23, P302, DOI 10.1177/1062860608315643; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Jamous H, 1970, PROFESSIONS PROFESSI, P115; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Ridd M, 2006, FAM PRACT, V23, P461, DOI 10.1093/fampra/cml010; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; Rubin G, 2006, BRIT J GEN PRACT, V56, P743; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Stokes T, 2005, ANN FAM MED, V3, P353, DOI 10.1370/afm.351; Turner David, 2007, J Health Serv Res Policy, V12, P132, DOI 10.1258/135581907781543021; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7; Weyrauch K F, 1996, J Am Board Fam Pract, V9, P31	29	84	87	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2013	346								f2510	10.1136/bmj.f2510	http://dx.doi.org/10.1136/bmj.f2510			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139ET	23641032				2022-12-24	WOS:000318565300001
J	Wachman, EM; Hayes, MJ; Brown, MS; Paul, J; Harvey-Wilkes, K; Terrin, N; Huggins, GS; Aranda, JV; Davis, JM				Wachman, Elisha M.; Hayes, Marie J.; Brown, Mark S.; Paul, Jonathan; Harvey-Wilkes, Karen; Terrin, Norma; Huggins, Gordon S.; Aranda, Jacob V.; Davis, Jonathan M.			Association of OPRM1 and COMT Single-Nucleotide Polymorphisms With Hospital Length of Stay and Treatment of Neonatal Abstinence Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETIC-VARIABILITY; A118G POLYMORPHISM; CLINICAL-EFFICACY; CANCER PAIN; METHADONE; MORPHINE; REQUIREMENTS; DEPENDENCE; BINDING	Importance Neonatal abstinence syndrome (NAS) caused by in utero opioid exposure is a growing problem; genetic factors influencing the incidence and severity have not been previously examined. Single-nucleotide polymorphisms (SNPs) in the mu-opioid receptor (OPRM1), multidrug resistance (ABCB1), and catechol-o-methyltransferase (COMT) genes are associated with risk for opioid addiction in adults. Objective To determine whether SNPs in the OPRM1, ABCB1, and COMT genes are associated with length of hospital stay and the need for treatment of NAS. Design, Setting, and Participants Prospective multicenter cohort study conducted at 5 tertiary care centers and community hospitals in Massachusetts and Maine between July 2011 and July 2012. DNA samples were genotyped for SNPs, and then NAS outcomes were correlated with genotype. Eighty-six of 140 eligible mother-infant dyads were enrolled. Infants were eligible if they were 36 weeks' gestational age or older and exposed to methadone or buprenorphine in utero. Main Outcomes and Measures Primary outcome measure was length of hospital stay, with between-group differences expressed as beta and calculated with linear regression models. Secondary outcome measures included need for any medical treatment for NAS and treatment with 2 or more medications. Results Infants with the OPRM1 118A > G AG/GG genotype had shortened length of stay (beta = -8.5 days; 95% CI, -14.9 to -2.1 days; P = .009) and were less likely to receive any treatment than AA infants (48% vs 72%; adjusted odds ratio, 0.76; 95% CI, 0.63-0.96; P = .006). The COMT 158A > G AG/GG genotype was associated with shortened length of stay (beta = -10.8 days; 95% CI, -18.2 to -3.4 days; P = .005) and less treatment with 2 or more medications (18% vs 56%; adjusted odds ratio, 0.68; 95% CI, 0.55-0.86; P = .001) than the AA genotype. Associations with the ABCB1 SNPs were not significant. Conclusions and Relevance Among infants with NAS, variants in the OPRM1 and COMT genes were associated with a shorter length of hospital stay and less need for treatment. These preliminary findings may provide insight into the mechanisms underlying NAS. JAMA. 2013;309(17):1821-1827	[Wachman, Elisha M.; Harvey-Wilkes, Karen; Davis, Jonathan M.] Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Boston, MA 02111 USA; [Terrin, Norma] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Huggins, Gordon S.] Tufts Med Ctr, Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Terrin, Norma; Davis, Jonathan M.] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Hayes, Marie J.] Univ Maine, Orono, ME USA; [Hayes, Marie J.] Univ Maine, Grad Sch Biomed Sci, Orono, ME USA; [Brown, Mark S.] Eastern Maine Med Ctr, Dept Pediat, Bangor, Gwynedd, Wales; [Paul, Jonathan] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Aranda, Jacob V.] SUNY Downstate Brooklyn, Brooklyn, NY USA	Floating Hospital For Children; Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Tufts University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Texas System; University of Texas Medical Branch Galveston; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Davis, JM (corresponding author), Tufts Med Ctr, Floating Hosp Children, TMC 44, Div Newborn Med, 800 Washington St, Boston, MA 02111 USA.	jdavis@tuftsmedicalcenter.org			Winchester Hospital; Medical University of South Carolina; National Institutes of Health (NIH) [DA024806-01A2, R01DA032889-01A1]; Tufts Medical Center; National Research Service from the Eunice Kennedy Shriver National Institute of Child Health [T32HD055163]; National Center for Advancing Translational Sciences NIH through the Tufts Clinical and Translational Science Institute [UL1 TR000073]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024806, R01DA032889] Funding Source: NIH RePORTER	Winchester Hospital; Medical University of South Carolina; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Medical Center; National Research Service from the Eunice Kennedy Shriver National Institute of Child Health; National Center for Advancing Translational Sciences NIH through the Tufts Clinical and Translational Science Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Davis reported receiving payment for lectures at Winchester Hospital and the Medical University of South Carolina. No other disclosures were reported.; This study was supported in part by National Institutes of Health (NIH) funding of data collection, single-nucleotide polymorphism genotyping, and data analyses (DA024806-01A2 to Dr Hayes and R01DA032889-01A1 to Dr Davis); the Tufts Medical Center's Natalie Zucker and Susan Saltonstall Grants to Dr Wachman, which supported laboratory analyses; National Research Service Award T32HD055163 from the Eunice Kennedy Shriver National Institute of Child Health to Dr Paul, which supported graduate education and training; and a National Center for Advancing Translational Sciences NIH grant UL1 TR000073 through the Tufts Clinical and Translational Science Institute to Drs Terrin and Davis.	[Anonymous], 2009, PAXGENE BLOOD DNA KI; [Anonymous], 2011, OR DNA COLL KIT PROT; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Finnegan LP., 1992, PRIMARY PEDIAT CARE, P1367; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P261, DOI 10.1001/archpsyc.57.3.261; Klepstad P, 2005, ACTA ANAESTH SCAND, V49, P902, DOI 10.1111/j.1399-6576.2005.00772.x; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Lotsch J, 2004, CLIN PHARMACOKINET, V43, P983; Mague SD, 2010, DRUG ALCOHOL DEPEN, V108, P172, DOI 10.1016/j.drugalcdep.2009.12.016; Mague SD, 2009, P NATL ACAD SCI USA, V106, P10847, DOI 10.1073/pnas.0901800106; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Pritham UA, 2012, JOGNN-J OBST GYN NEO, V41, P180, DOI 10.1111/j.1552-6909.2011.01330.x; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; Ray R, 2011, P NATL ACAD SCI USA, V108, P9268, DOI 10.1073/pnas.1018699108; Reyes-Gibby CC, 2007, PAIN, V130, P25, DOI 10.1016/j.pain.2006.10.023; Seligman NS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.088; US Department of Health and Human Services Substance Abuse and Mental Health Administration, 2009, RES 2009 NAT SURV DR; Zhang W, 2011, MINERVA ANESTESIOL, V77, P33; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	23	134	135	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1821	1827		10.1001/jama.2013.3411	http://dx.doi.org/10.1001/jama.2013.3411			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632726	Green Accepted, Bronze			2022-12-24	WOS:000318235600030
J	Wilusz, JE; Sharp, PA				Wilusz, Jeremy E.; Sharp, Phillip A.			A Circuitous Route to Noncoding RNA	SCIENCE			English	Editorial Material							CIRCULAR RNAS		[Wilusz, Jeremy E.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Wilusz, JE (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wilusz@mit.edu; sharppa@mit.edu		Wilusz, Jeremy/0000-0001-6929-8755	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM104166, R01GM034277] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034277, K99 GM104166] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; WANG KS, 1986, NATURE, V323, P508, DOI 10.1038/323508a0; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112	14	376	418	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					440	441		10.1126/science.1238522	http://dx.doi.org/10.1126/science.1238522			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620042	Green Submitted, Green Accepted			2022-12-24	WOS:000318016700029
J	Klompas, M				Klompas, Michael			Complications of Mechanical Ventilation - The CDC's New Surveillance Paradigm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Klompas, Michael] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Klompas, Michael] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Klompas, Michael] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital	Klompas, M (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA.		Klompas, Michael/Z-2415-2019					Centers for Disease Control and Prevention (CDC), SURV VENT ASS EV; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; Hayashi Y, 2013, CLIN INFECT DIS, V56, P471, DOI 10.1093/cid/cis926; Klompas M, 2012, CRIT CARE MED, V40, P3154, DOI 10.1097/CCM.0b013e318260c6d9; Klompas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018062	5	119	129	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2013	368	16					1472	1475		10.1056/NEJMp1300633	http://dx.doi.org/10.1056/NEJMp1300633			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126HC	23594002				2022-12-24	WOS:000317603300004
J	Kamerow, D				Kamerow, Douglas			Science trumps politics on emergency contraception	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				[Anonymous], 2004, SCIENTIFIC INTEGRITY; Belluck Pam, 2013, NY TIMES        0917, pA1; Davidoff F, 2006, JAMA-J AM MED ASSOC, V296, P1775, DOI 10.1001/jama.296.14.1775; Editorial, 2013, NY TIMES, pA16; Kamerow D., 2011, VERY BAD PLAN SEBELI; Kamerow D., 2008, BMJ-BRIT MED J, V337, pa2093; Kliff S., 2013, WASHINGTON POST	7	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2013	346								f2217	10.1136/bmj.f2217	http://dx.doi.org/10.1136/bmj.f2217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125ZC	23571743				2022-12-24	WOS:000317579800008
J	McCormack, RP; Williams, AR; Goldfrank, LR; Caplan, AL; Ross, S; Rotrosen, J				McCormack, Ryan P.; Williams, Arthur R.; Goldfrank, Lewis R.; Caplan, Arthur L.; Ross, Stephen; Rotrosen, John			Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders	LANCET			English	Editorial Material							ADDICTION; DEPENDENCE; COERCION; ABUSE		[McCormack, Ryan P.; Goldfrank, Lewis R.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Williams, Arthur R.; Caplan, Arthur L.] NYU, Sch Med, Dept Populat Hlth, Div Med Eth, New York, NY USA; [Ross, Stephen; Rotrosen, John] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Ross, Stephen] NYU, Coll Dent, New York, NY USA; [Rotrosen, John] VA New York Harbor Healthcare Syst, New York, NY USA	New York University; New York University; New York University; New York University	McCormack, RP (corresponding author), Bellevue Hosp, 462 1st Ave,OBV 345A, New York, NY 10016 USA.	ryan.mccormack@nyumc.org	McCormack, Ryan/AAF-4325-2022; McCormack, Ryan/AFI-8740-2022; Williams, Arthur Robin/H-8511-2019	McCormack, Ryan/0000-0002-7210-4736; McCormack, Ryan/0000-0002-7210-4736; Williams, Arthur Robin/0000-0002-7380-6203				Caplan A, 2008, ADDICTION, V103, P1919, DOI 10.1111/j.1360-0443.2008.02369.x; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; GAYLIN W, 2003, PERVERSION AUTONOMY; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Israelsson M, 2012, EUR ADDICT RES, V18, P302, DOI 10.1159/000341716; Janssens MJPA, 2004, J MED ETHICS, V30, P453, DOI 10.1136/jme.2002.002212; Macavoy M G, 1990, Drug Alcohol Rev, V9, P267, DOI 10.1080/09595239000185351; Murphy L, 2012, NATL VITAL STAT REPO, V69; Pritchard E, 2007, 14 ANCD; Rosenman S, 1998, AUST NZ J PSYCHIAT, V32, P785, DOI 10.3109/00048679809073867; Schaub M, 2010, EUR ADDICT RES, V16, P53, DOI 10.1159/000265938; Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089; Stone AA., 1984, LAW PSYCHIAT MORALIT, P133; Sullivan MA, 2008, AM J ADDICTION, V17, P36, DOI 10.1080/10550490701756369; Treffert Darold A, 1974, Prism, V2, P49; Wild TC, 2002, EUR ADDICT RES, V8, P84, DOI 10.1159/000052059; Williamson Laura, 2012, Am J Public Health, V102, pe5, DOI 10.2105/AJPH.2011.300629; World Health Organization, 2001, M MOSC RUSS 22 23 AP	18	19	21	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					995	997		10.1016/S0140-6736(12)62206-5	http://dx.doi.org/10.1016/S0140-6736(12)62206-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VD	23602314				2022-12-24	WOS:000324238000032
J	Pavia, AT				Pavia, Andrew T.			Influenza A(H7N9): From Anxiety to Preparedness	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRANSMISSION; FERRETS; VIRUS		Univ Utah, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Pavia, AT (corresponding author), Univ Utah, 295 Chipeta Way, Salt Lake City, UT 84108 USA.	andy.pavia@hsc.utah.edu						[Anonymous], 2013, HUM INF INFL A H7N9; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050830; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Infectious Diseases Society of America, 2012, PAND SEAS INFL PRINC; Ison MG, 2012, J INFECT DIS, V206, P1806, DOI 10.1093/infdis/jis623; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0	9	4	5	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					219	+		10.7326/0003-4819-159-3-201308060-00653	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00653			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201RD	23697995				2022-12-24	WOS:000323159800008
J	Gao, HN; Lu, HZ; Cao, B; Du, B; Shang, H; Gan, JH; Lu, SH; Yang, YD; Fang, Q; Shen, YZ; Xi, XM; Gu, Q; Zhou, XM; Qu, HP; Yan, Z; Li, FM; Zhao, W; Gao, ZC; Wang, GF; Ruan, LX; Wang, WH; Ye, J; Cao, HF; Li, XW; Zhang, WH; Fang, XC; He, J; Liang, WF; Xie, J; Zeng, M; Wu, XZ; Li, J; Xia, Q; Jin, ZC; Chen, Q; Tang, C; Zhang, ZY; Hou, BM; Feng, ZX; Sheng, JF; Zhong, NS; Li, LJ				Gao, Hai-Nv; Lu, Hong-Zhou; Cao, Bin; Du, Bin; Shang, Hong; Gan, Jian-He; Lu, Shui-Hua; Yang, Yi-Da; Fang, Qiang; Shen, Yin-Zhong; Xi, Xiu-Ming; Gu, Qin; Zhou, Xian-Mei; Qu, Hong-Ping; Yan, Zheng; Li, Fang-Ming; Zhao, Wei; Gao, Zhan-Cheng; Wang, Guang-Fa; Ruan, Ling-Xiang; Wang, Wei-Hong; Ye, Jun; Cao, Hui-Fang; Li, Xing-Wang; Zhang, Wen-Hong; Fang, Xu-Chen; He, Jian; Liang, Wei-Feng; Xie, Juan; Zeng, Mei; Wu, Xian-Zheng; Li, Jun; Xia, Qi; Jin, Zhao-Chen; Chen, Qi; Tang, Chao; Zhang, Zhi-Yong; Hou, Bao-Min; Feng, Zhi-Xian; Sheng, Ji-Fang; Zhong, Nan-Shan; Li, Lan-Juan			Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							H5N1; THAILAND; HUMANS; CHINA	BACKGROUND During the spring of 2013, a novel avian-origin influenza A (H7N9) virus emerged and spread among humans in China. Data were lacking on the clinical characteristics of the infections caused by this virus. METHODS Using medical charts, we collected data on 111 patients with laboratory-confirmed avian-origin influenza A (H7N9) infection through May 10, 2013. RESULTS Of the 111 patients we studied, 76.6% were admitted to an intensive care unit (ICU), and 27.0% died. The median age was 61 years, and 42.3% were 65 years of age or older; 31.5% were female. A total of 61.3% of the patients had at least one underlying medical condition. Fever and cough were the most common presenting symptoms. On admission, 108 patients (97.3%) had findings consistent with pneumonia. Bilateral ground-glass opacities and consolidation were the typical radiologic findings. Lymphocytopenia was observed in 88.3% of patients, and thrombo-cytopenia in 73.0%. Treatment with antiviral drugs was initiated in 108 patients (97.3%) at a median of 7 days after the onset of illness. The median times from the onset of illness and from the initiation of antiviral therapy to a negative viral test result on real-time reverse-transcriptase-polymerase-chain-reaction assay were 11 days (interquartile range, 9 to 16) and 6 days (interquartile range, 4 to 7), respectively. Multivariate analysis revealed that the presence of a coexisting medical condition was the only independent risk factor for the acute respiratory distress syndrome (ARDS) (odds ratio, 3.42; 95% confidence interval, 1.21 to 9.70; P = 0.02). CONCLUSIONS During the evaluation period, the novel H7N9 virus caused severe illness, including pneumonia and ARDS, with high rates of ICU admission and death. (Funded by the National Natural Science Foundation of China and others.)	[Gao, Hai-Nv; Yang, Yi-Da; Fang, Qiang; Ruan, Ling-Xiang; Liang, Wei-Feng; Xia, Qi; Feng, Zhi-Xian; Sheng, Ji-Fang; Li, Lan-Juan] Zhejiang Univ, Affiliated Coll Med 1, Dept Infect Dis, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Wei-Hong] Huzhou Cent Hosp, Huzhou, Peoples R China; [Lu, Hong-Zhou; Lu, Shui-Hua; Shen, Yin-Zhong; Zhang, Zhi-Yong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Qu, Hong-Ping] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China; [Li, Fang-Ming; Xie, Juan] Fifth Hosp Shanghai, Shanghai, Peoples R China; [Ye, Jun] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Shanghai, Peoples R China; [Cao, Hui-Fang] Jingan Dist Cent Hosp, Shanghai, Peoples R China; [Zhang, Wen-Hong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Fang, Xu-Chen] Yangpu Dist Shidong Hosp Shanghai, Shanghai, Peoples R China; [He, Jian] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China; [Zeng, Mei] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Wu, Xian-Zheng] Tongji Univ, Tongji Hosp, Shanghai 200092, Peoples R China; [Cao, Bin] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Du, Bin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Intens Care Unit, Beijing 100730, Peoples R China; [Xi, Xiu-Ming] Capital Med Univ, Fuxing Hosp, Beijing, Peoples R China; [Gao, Zhan-Cheng] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Wang, Guang-Fa] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Li, Xing-Wang] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing, Peoples R China; [Shang, Hong] China Med Univ, Hosp 1, Shenyang, Peoples R China; [Gan, Jian-He] Soochow Univ, Coll Med, Affiliated Hosp 1, Suzhou, Peoples R China; [Gu, Qin] Nanjing Univ, Sch Med, Affiliated Hosp, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Xian-Mei] Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Zhao, Wei] Southeast Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Li, Jun] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Yan, Zheng] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Wuxi, Peoples R China; [Jin, Zhao-Chen] First Hosp Zhenjiang, Zhenjiang, Peoples R China; [Chen, Qi] First Hosp Yancheng, Yancheng, Peoples R China; [Tang, Chao] Peoples Hosp Bozhou, Bozhou, Peoples R China; [Hou, Bao-Min] Zhoukou Infect Dis Hosp, Zhoukou, Peoples R China; [Zhong, Nan-Shan] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China	Zhejiang University; Huzhou University; Fudan University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine; Fudan University; Naval Medical University; Fudan University; Tongji University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; Peking University; Peking University; Capital Medical University; China Medical University; Soochow University - China; Nanjing University; Nanjing University of Chinese Medicine; Southeast University - China; Nanjing Medical University; Nanjing Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Li, LJ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	nanshan@vip.163.com; ljli@zju.edu.cn	gao, hainv/H-3868-2013	gao, hainv/0000-0003-4590-9181; LI, Lanjuan/0000-0001-6945-0593	National Natural Science Foundation of China [81070005/H0104, 81030032/H19]; National Program for the Prevention and Control of Human Infections by Avian-Origin H7N9 Influenza A Virus [KJYJ-2013-01]; National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China [2012ZX10004-206, 2012ZX10004-210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for the Prevention and Control of Human Infections by Avian-Origin H7N9 Influenza A Virus; National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China	Supported by grants from the National Natural Science Foundation of China (81070005/H0104 and 81030032/H19), the National Program for the Prevention and Control of Human Infections by Avian-Origin H7N9 Influenza A Virus (KJYJ-2013-01), and the National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases in China (2012ZX10004-206 and 2012ZX10004-210).	Bai L, 2011, CHEST, V139, P1156, DOI 10.1378/chest.10-1036; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chen Y, 2013, LANCET; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; D'Silva D, 2009, PEDIATR INFECT DIS J, V28, P1138, DOI 10.1097/INF.0b013e3181c03cf2; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; World Health Organization, 2013, NUMB CONF HUM CAS AV; World Health Organization, 2009, CLIN MAN HUM INF PAN; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035836, 10.1371/journal.pone.0029652]; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985	19	493	589	7	336	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2277	2285		10.1056/NEJMoa1305584	http://dx.doi.org/10.1056/NEJMoa1305584			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161YN	23697469				2022-12-24	WOS:000320230500003
J	George, NT; Irving, TC; Williams, CD; Daniel, TL				George, N. T.; Irving, T. C.; Williams, C. D.; Daniel, T. L.			The Cross-Bridge Spring: Can Cool Muscles Store Elastic Energy?	SCIENCE			English	Article							TEMPERATURE-GRADIENTS; FLIGHT-MUSCLE; DYNAMICS; FORCE	Muscles not only generate force. They may act as springs, providing energy storage to drive locomotion. Although extensible myofilaments are implicated as sites of energy storage, we show that intramuscular temperature gradients may enable molecular motors (cross-bridges) to store elastic strain energy. By using time-resolved small-angle x-ray diffraction paired with in situ measurements of mechanical energy exchange in flight muscles of Manduca sexta, we produced high-speed movies of x-ray equatorial reflections, indicating cross-bridge association with myofilaments. A temperature gradient within the flight muscle leads to lower cross-bridge cycling in the cooler regions. Those cross-bridges could elastically return energy at the extrema of muscle lengthening and shortening, helping drive cyclic wing motions. These results suggest that cross-bridges can perform functions other than contraction, acting as molecular links for elastic energy storage.	[George, N. T.; Williams, C. D.; Daniel, T. L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Irving, T. C.] IIT, Ctr Synchrotron Radiat Res & Instrument, Chicago, IL 60616 USA; [Irving, T. C.] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Williams, C. D.] Harvard Univ, Dept Organism & Evolutionary Biol, Concord Field Stn, Cambridge, MA 01451 USA	University of Washington; University of Washington Seattle; Illinois Institute of Technology; Illinois Institute of Technology; Harvard University	Daniel, TL (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	danielt@uw.edu			NSF [DGE-0718124, IOS-1022471, EEC 1028725]; University of Washington Komen Endowed Chair; U.S. Department of Energy [DE-AC02-06CH11357]; NIH [2P41RR008630-17, 9 P41 GM103622-17]; Direct For Biological Sciences [1022058] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); University of Washington Komen Endowed Chair; U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H.-M. Hsu, E. Carrington, and R. Huey for their contributions. This research was supported by NSF Graduate Research Fellowship no. DGE-0718124 to N.T.G., NSF grant IOS-1022471 to T. L. D and T. C. I., NSF grant EEC 1028725 to T. L. D., and the University of Washington Komen Endowed Chair to T. L. D. Use of the Advanced Photon Source was supported by the U.S. Department of Energy under contract no. DE-AC02-06CH11357. Use of BioCAT was supported by grants from the NIH (2P41RR008630-17 and 9 P41 GM103622-17). The data reported in this paper are deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.cg873). For inquiries about materials, please contact N.T.G. (ntgeorge@uw.edu).	ALEXANDER RM, 1984, AM ZOOL, V24, P85; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; BENNETT AF, 1985, J EXP BIOL, V115, P333; CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464; Dickinson M, 2005, NATURE, V433, P330, DOI 10.1038/nature03230; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; ELLINGTON CP, 1985, J EXP BIOL, V115, P293; George NT, 2012, J EXP BIOL, V215, P471, DOI 10.1242/jeb.062901; George NT, 2011, J EXP BIOL, V214, P894, DOI 10.1242/jeb.047969; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1994, BIOPHYS J, V67, P2411, DOI 10.1016/S0006-3495(94)80728-3; Irving TC, 2006, MOL B INT U, P197; JENSEN M, 1962, PHILOS T ROY SOC B, V245, P137, DOI 10.1098/rstb.1962.0008; JOSEPHSON RK, 1984, J EXP BIOL, V108, P77; MILLER A, 1970, NATURE, V226, P1060, DOI 10.1038/2261060a0; Nishikawa KC, 2012, P ROY SOC B-BIOL SCI, V279, P981, DOI 10.1098/rspb.2011.1304; TIDBALL JG, 1986, AM J PHYSIOL, V250, pR56, DOI 10.1152/ajpregu.1986.250.1.R56; Tu MS, 2004, J EXP BIOL, V207, P2455, DOI 10.1242/jeb.01039; Wang G, 2001, J PHYSIOL-LONDON, V531, P219, DOI 10.1111/j.1469-7793.2001.0219j.x; Williams CD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002770	20	25	25	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1217	1220		10.1126/science.1229573	http://dx.doi.org/10.1126/science.1229573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23618763	Green Accepted			2022-12-24	WOS:000319972800046
J	Fang, LH; Choi, SH; Baek, JS; Liu, C; Almazan, F; Ulrich, F; Wiesner, P; Taleb, A; Deer, E; Pattison, J; Torres-Vazquez, J; Li, AC; Miller, YI				Fang, Longhou; Choi, Soo-Ho; Baek, Ji Sun; Liu, Chao; Almazan, Felicidad; Ulrich, Florian; Wiesner, Philipp; Taleb, Adam; Deer, Elena; Pattison, Jennifer; Torres-Vazquez, Jesus; Li, Andrew C.; Miller, Yury I.			Control of angiogenesis by AIBP-mediated cholesterol efflux	NATURE			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; CASSETTE TRANSPORTER 1; I BINDING-PROTEIN; ENDOTHELIAL-CELLS; TANGIER-DISEASE; ZEBRAFISH; EXPRESSION; ABCG1; GENE; ACTIVATION	Cholesterol is a structural component of the cell and is indispensable for normal cellular function, although its excess often leads to abnormal proliferation, migration, inflammatory responses and/or cell death. To prevent cholesterol overload, ATP-binding cassette (ABC) transporters mediate cholesterol efflux from the cells to apolipoprotein A-I (apoA-I) and the apoA-I-containing high-density lipoprotein (HDL)(1-3). Maintaining efficient cholesterol efflux is essential for normal cellular function(4-6). However, the role of cholesterol efflux in angiogenesis and the identity of its local regulators are poorly understood. Here we show that apoA-I binding protein (AIBP) accelerates cholesterol efflux from endothelial cells to HDL and thereby regulates angiogenesis. AIBP- and HDL-mediated cholesterol depletion reduces lipid rafts, interferes with VEGFR2 (also known as KDR) dimerization and signalling and inhibits vascular endothelial growth factor-induced angiogenesis in vitro and mouse aortic neovascularization ex vivo. Notably, Aibp, a zebrafish homologue of human AIBP, regulates the membrane lipid order in embryonic zebrafish vasculature and functions as a non-cell-autonomous regulator of angiogenesis. aibp knockdown results in dysregulated sprouting/branching angiogenesis, whereas forced Aibp expression inhibits angiogenesis. Dysregulated angiogenesis is phenocopied in Abca1 (also known as Abca1a) Abcg1-deficient embryos, and cholesterol levels are increased in Aibp-deficient and Abca1Abcg1-deficient embryos. Our findings demonstrate that secreted AIBP positively regulates cholesterol efflux from endothelial cells and that effective cholesterol efflux is critical for proper angiogenesis.	[Fang, Longhou; Choi, Soo-Ho; Baek, Ji Sun; Liu, Chao; Almazan, Felicidad; Wiesner, Philipp; Taleb, Adam; Deer, Elena; Pattison, Jennifer; Li, Andrew C.; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ulrich, Florian; Torres-Vazquez, Jesus] NYU, Langone Med Ctr, Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA	University of California System; University of California San Diego; New York University; NYU Langone Medical Center	Miller, YI (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yumiller@ucsd.edu	Fang, Longhou/G-6582-2013	Fang, Longhou/0000-0003-1653-5221; Torres-Vazquez, Jesus/0000-0002-3808-3978	NIH [HL093767, HL055798, HL114734]; UC Tobacco-Related Disease Program [18FT-0137]; UCSD [P30NS047101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL114734, R01HL093767, R00HL114734, P01HL088093, P01HL055798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Tobacco-Related Disease Program; UCSD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Traver, N. Chi, J. Witztum, R. Klemke, D. Yelon, T. Handel, K. Stoletov, W. Clements, C. Pouget, Z. Garavito-Aguilar, A. Ablooglu, R. Zhang, X. Yang, M. Angert, K. Pestonjamasp and J. Santini (University of California, San Diego), C. Hedrick, K. Ley, D. Sag, P. Sundd and A. Wu (La Jolla Institute for Allergy and Immunology), S. Trzaska (New York University), S. J. Du (University of Maryland), B. Schmid and C. Haass (Ludwig-Maximilians-University Munchen), D. Owen and A. Magenau (University of New South Wales), A. Siekmann (Max Planck Institute for Molecular Biomedicine) and C. Binder (Medical University of Vienna) for discussions, technical assistance and/or for providing reagents and access to equipment for this study. The project was supported by the NIH grants HL093767 (Y.I.M.), HL055798 (Y.I.M.) and HL114734 (L. F.), and the fellowship 18FT-0137 from the UC Tobacco-Related Disease Program (L. F.), as well as the UCSD Neuroscience Microscopy Facility Grant P30NS047101. The authors declare no conflicts of interests.	Archer A, 2008, DEV DYNAM, V237, P1090, DOI 10.1002/dvdy.21476; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Avraham-Davidi I, 2012, NAT MED, V18, P967, DOI 10.1038/nm.2759; Bellacen Keren, 2009, J Vis Exp, DOI 10.3791/1564; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Chung TW, 2009, GLYCOBIOLOGY, V19, P229, DOI 10.1093/glycob/cwn114; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Fang LH, 2010, J BIOL CHEM, V285, P32343, DOI 10.1074/jbc.M110.137257; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Gao F, 2011, INTEGR BIOL-UK, V3, P479, DOI 10.1039/c0ib00147c; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liao WX, 2009, MOL ENDOCRINOL, V23, P1428, DOI 10.1210/me.2008-0475; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Noghero A, 2012, ARTERIOSCL THROM VAS, V32, P2280, DOI 10.1161/ATVBAHA.112.250621; O'Connell BJ, 2004, CIRCULATION, V110, P2881, DOI 10.1161/01.CIR.0000146333.20727.2B; Oshikawa J, 2012, AM J PHYSIOL-HEART C, V302, pH724, DOI 10.1152/ajpheart.00739.2011; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Ritter M, 2002, GENOMICS, V79, P693, DOI 10.1006/geno.2002.6761; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schwend T, 2011, J LIPID RES, V52, P1328, DOI 10.1194/jlr.M012377; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	42	132	138	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					118	+		10.1038/nature12166	http://dx.doi.org/10.1038/nature12166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23719382	Green Accepted			2022-12-24	WOS:000319947800045
J	Sharon, M				Sharon, Michal			Structural MS Pulls Its Weight	SCIENCE			English	Editorial Material							IONIZATION-MASS-SPECTROMETRY; PROTEIN COMPLEXES; ARCHITECTURE		Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Sharon, M (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	michal.sharon@weizmann.ac.il		Sharon, Michal/0000-0003-3933-0595				Baldwin AJ, 2011, STRUCTURE, V19, P1855, DOI 10.1016/j.str.2011.09.015; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Ben-Nissan G, 2011, CHEM SOC REV, V40, P3627, DOI 10.1039/c1cs15052a; Dyachenko A, 2013, P NATL ACAD SCI USA, V110, P7235, DOI 10.1073/pnas.1302395110; Ferguson CN, 2011, ANAL CHEM, V83, P6468, DOI 10.1021/ac201390w; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Mellors JS, 2010, ANAL CHEM, V82, P967, DOI 10.1021/ac902218y; Rosati S, 2012, ANGEW CHEM INT EDIT, V51, P12992, DOI 10.1002/anie.201206745; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/nmeth.2208, 10.1038/NMETH.2208]; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; Urban PL, 2011, ANAL CHEM, V83, P1843, DOI 10.1021/ac102702m; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	15	50	50	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1059	1060		10.1126/science.1236303	http://dx.doi.org/10.1126/science.1236303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723227				2022-12-24	WOS:000319664500032
J	Goodnough, LT				Goodnough, Lawrence T.			Blood management: transfusion medicine comes of age	LANCET			English	Editorial Material							ANEMIA		[Goodnough, Lawrence T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Goodnough, Lawrence T.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Goodnough, LT (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	ltgoodno@stanford.edu						[Anonymous], 2012, NY TIMES; Despotis GJ, 1997, CLIN CHEM, V43, P1684; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 2013, ANESTH ANALG, V116, P15, DOI 10.1213/ANE.0b013e318273f4ae; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; Goodnough LT, 2011, BLOOD, V117, P6091, DOI 10.1182/blood-2010-11-316075; Goodnough LT, 2010, BLOOD, V116, P4754, DOI 10.1182/blood-2010-05-286260; McCullough J, 2010, TRANSFUSION, V50, P2542, DOI 10.1111/j.1537-2995.2010.02787.x; Murphy WG, 2012, TRANSFUSION, V52, P2278, DOI 10.1111/j.1537-2995.2012.03931.x; Pattakos G, 2012, ARCH INTERN MED, V172, P1154, DOI 10.1001/archinternmed.2012.2449; Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x; Salisbury AC, 2011, ARCH INTERN MED, V171, P1646, DOI 10.1001/archinternmed.2011.361; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; The Joplin Globe, DECL NEED BLOOD LEAD; US Food and Drug Administration, FAT REP FDA FOLL BLO; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; World Health Organization (WHO), 63 WORLD HLTH ASS AV; ZUCK TF, 1990, ARCH PATHOL LAB MED, V114, P309	18	53	55	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1791	1792		10.1016/S0140-6736(13)60673-X	http://dx.doi.org/10.1016/S0140-6736(13)60673-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151EO	23706789	Green Published, Bronze			2022-12-24	WOS:000319443700004
J	Ahmed, QA; Nishtar, S; Memish, ZA				Ahmed, Qanta A.; Nishtar, Sania; Memish, Ziad A.			Poliomyelitis in Pakistan: time for the Muslim world to step in	LANCET			English	Editorial Material							HEALTH; ERADICATION; WORKERS; HAJJ		[Ahmed, Qanta A.] SUNY Stony Brook, Dept Med, Winthrop Univ Hosp, Div Pulm Dis & Crit Care Med, Stony Brook, NY 11794 USA; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Memish, Ziad A.] WHO, Collaborating Ctr Mass Gathering Med, Publ Hlth Directorate, Minist Hlth, Riyadh 11179, Saudi Arabia; [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Winthrop University Hospital; World Health Organization; Alfaisal University	Memish, ZA (corresponding author), WHO, Collaborating Ctr Mass Gathering Med, Publ Hlth Directorate, Minist Hlth, Riyadh 11179, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				Ahmed QA, 2006, LANCET, V367, P1025, DOI 10.1016/S0140-6736(06)68431-6; Al-Tawfiq JA, 2012, EUROSURVEILLANCE, V17, P6; Al-Tawfiq JA, 2012, INFECT DIS CLIN N AM, V26, P725, DOI 10.1016/j.idc.2012.05.005; Albar M, 2012, SAUDI J KIDNEY DIS T, V23, P817, DOI 10.4103/1319-2442.98169; [Anonymous], 2013, LANCET, V381, P1; Arie S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f954; Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210; Gulland A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5061; Larson HJ, 2011, NATURE, V473, P446, DOI 10.1038/473446a; Memish ZA, 2009, LANCET, V374, P1786, DOI 10.1016/S0140-6736(09)61927-9; Nature Reviews Microbiology, 2013, NAT REV MICROBIOL, V11, P67; Pew Research Center, 2009, PEW FORUM RELIG PUBL; The Lancet Infectious Diseases, 2013, LANCET INFECT DIS, V13, P183; Webster PC, 2013, CAN MED ASSOC J, V185, pE101, DOI 10.1503/cmaj.109-4364	14	13	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1521	1523		10.1016/S0140-6736(13)60764-3	http://dx.doi.org/10.1016/S0140-6736(13)60764-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23623055				2022-12-24	WOS:000318609600009
J	Lowenthal, ED; Ellenberg, JH; Machine, E; Sagdeo, A; Boiditswe, S; Steenhoff, AP; Rutstein, R; Anabwani, G; Gross, R				Lowenthal, Elizabeth D.; Ellenberg, Jonas H.; Machine, Edwin; Sagdeo, Aditi; Boiditswe, Sefelani; Steenhoff, Andrew P.; Rutstein, Richard; Anabwani, Gabriel; Gross, Robert			Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE PROGRESSION; THERAPY; OUTCOMES; SUBTYPE; COHORT; ADULTS	Importance Worldwide, the nonnucleoside reverse transcriptase inhibitors (NNRTIs) efavirenz and nevirapine are commonly used in first-line antiretroviral regimens in both adults and children with human immunodeficiency virus (HIV) infection. Data on the comparative effectiveness of these medications in children are limited. Objective To investigate whether virological failure is more likely among children who initiated 1 or the other NNRTI-based HIV treatment. Design, Setting, and Participants Retrospective cohort study of children (aged 3-16 years) who initiated efavirenz-based (n=421) or nevirapine-based (n=383) treatment between April 2002 and January 2011 at a large pediatric HIV care setting in Botswana. Main Outcomes and Measures The primary outcome was time from initiation of therapy to virological failure. Virological failure was defined as lack of plasma HIV RNA suppression to less than 400 copies/mL by 6 months or confirmed HIV RNA of 400 copies/mL or greater after suppression. Cox proportional hazards regression analysis compared time to virological failure by regimen. Multivariable Cox regression controlled for age, sex, baseline immunologic category, baseline clinical category, baseline viral load, nutritional status, NRTIs used, receipt of single-dose nevirapine, and treatment for tuberculosis. Results With a median follow-up time of 69 months (range, 6-112 months; inter-quartile range, 23-87 months), 57 children (13.5%; 95% CI, 10.4%-17.2%) initiating treatment with efavirenz and 101 children (26.4%; 95% CI, 22.0%-31.1%) initiating treatment with nevirapine had virological failure. There were 11 children (2.6%; 95% CI, 1.3%-4.6%) receiving efavirenz and 20 children (5.2%; 95% CI, 3.2%-7.9%) receiving nevirapine who never achieved virological suppression. The Cox proportional hazard ratio for the combined virological failure end point was 2.0 (95% CI, 1.4-2.7; log rank P < .001, favoring efavirenz). None of the measured covariates affected the estimated hazard ratio in the multivariable analyses. Conclusions and Relevance Among children aged 3 to 16 years infected with HIV and treated at a clinic in Botswana, the use of efavirenz compared with nevirapine as initial antiretroviral treatment was associated with less virological failure. These findings may warrant additional research evaluating the use of efavirenz and nevirapine for pediatric patients. JAMA. 2013;309(17):1803-1809	[Lowenthal, Elizabeth D.; Sagdeo, Aditi; Steenhoff, Andrew P.; Rutstein, Richard] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.; Ellenberg, Jonas H.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Gross, Robert] Univ Penn, Perelman Sch Med, Dept Med & Epidemiol, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.; Steenhoff, Andrew P.; Rutstein, Richard] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.; Steenhoff, Andrew P.; Gross, Robert] Botswana UPenn Partnership, Gaborone, Botswana; [Machine, Edwin; Boiditswe, Sefelani; Anabwani, Gabriel] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Machine, Edwin; Anabwani, Gabriel] Baylor Coll Med, Houston, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; Baylor College of Medicine	Lowenthal, ED (corresponding author), Univ Penn, Perelman Sch Med, 3535 Market St,Room 1513, Philadelphia, PA 19104 USA.	lowenthale@email.chop.edu	Anabwani, Gabriel/I-2371-2016	Anabwani, Gabriel/0000-0002-8555-4373; Machine, Edwin/0000-0001-8564-6000	Bristol-Myers Squibb; National Institutes of Health; Boehringer Ingelheim; Viral Ed; International Association of Providers of AIDS Care; Health Resources and Services Administration [T32 HP10026]; Penn Center for AIDS Research [P30 AI 045008]; National Institute of Mental Health [K23 MH095669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH095669] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); Viral Ed; International Association of Providers of AIDS Care; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Penn Center for AIDS Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lowenthal reported receiving grant support from Bristol-Myers Squibb. Dr Ellenberg reported serving on data and safety monitoring boards and mock advisory committees for Bristol-Myers Squibb, Eli Lilly, Pfizer, EMD Serono, and Roche; and receiving grants from the National Institutes of Health. Dr Anabwani reported receiving research support from Boehringer Ingelheim. Dr Gross reported receiving grant support from the National Institutes of Health; serving on a data and safety monitoring board for Pfizer; providing expert testimony to Lewis Saul LLP; receiving payment for lectures from Viral Ed; and receiving honoraria and reimbursement for travel expenses from the International Association of Providers of AIDS Care. No other author reported disclosures.; This study was supported in part by Health Resources and Services Administration grant T32 HP10026 (funding to Dr Lowenthal), funding from Bristol-Myers Squibb (awarded to Dr Lowenthal and provided funding to Drs Lowenthal and Gross), and grant P30 AI 045008 from the Penn Center for AIDS Research (awarded to Dr Gross). Dr Lowenthal is currently receiving research career development support from National Institute of Mental Health grant K23 MH095669.	[Anonymous], 1994, MMWR Recomm Rep, V43, P1; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Botswana Ministry of Health, 2008, BOTSWANA NATIONAL HI; Botswana Ministry of Health, 2005, BOTSWANA GUIDELINES; Carlin JB, 2008, STATA J, V8, P49, DOI 10.1177/1536867X0800800104; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Hartmann M, 2005, INT J STD AIDS, V16, P404, DOI 10.1258/0956462054094060; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Lapphra K, 2008, INT J INFECT DIS, V12, pE33, DOI 10.1016/j.ijid.2007.10.008; Little K, 2007, CURR HIV RES, V5, P139, DOI 10.2174/157016207780077002; Lowenthal ED, 2005, SOUTH AFR J HIV MED, V6, P42; Manosuthi W, 2009, CLIN INFECT DIS, V48, P1752, DOI 10.1086/599114; Mbuagbaw LCE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004246.pub3; Nachega JB, 2008, AIDS, V22, P2117, DOI 10.1097/QAD.0b013e328310407e; Ouattara EN, 2012, AIDS, V26, P625, DOI 10.1097/QAD.0b013e328350fbfb; Patel A K, 2006, J Assoc Physicians India, V54, P915; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Southern African Journal of HIV Medicine, SOUTHERN AFRICAN JOU; Tolle Michael, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P260, DOI 10.1177/1545109711422273; UNAIDS and WHO, AIDS EPIDEMIC UPDATE; UNICEF, 2010, CHILDREN AND AIDS FI; Uthman O, 2012, AIDS, V26, P639, DOI 10.1097/QAD.0b013e3283509a40; Walters E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-1; WHO UNAIDS UNICEF, GLOBAL HIV AIDS RESP; Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, GUIDELINES FOR THE U; World Health Organization, 2010, ANTIRETROVIRAL THERA	31	37	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1803	1809		10.1001/jama.2013.3710	http://dx.doi.org/10.1001/jama.2013.3710			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632724	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000318235600028
J	Ali, MK; Bullard, KM; Saaddine, JB; Cowie, CC; Imperatore, G; Gregg, EW				Ali, Mohammed K.; Bullard, Kai McKeever; Saaddine, Jinan B.; Cowie, Catherine C.; Imperatore, Giuseppina; Gregg, Edward W.			Achievement of Goals in U.S. Diabetes Care, 1999-2010	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERFORMANCE-MEASURES; GLYCEMIC TARGETS; US ADULTS; FOLLOW-UP; HEALTH; MORTALITY; QUALITY; DISEASE; INTERVENTION; MANAGEMENT	Background Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. Methods We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. Results From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). Conclusions Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.	[Ali, Mohammed K.; Bullard, Kai McKeever; Saaddine, Jinan B.; Imperatore, Giuseppina; Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; [Ali, Mohammed K.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Cowie, Catherine C.] NIDDK, NIH, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ali, MK (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Mailstop K10,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	ise1@cdc.gov	Ali, Mohammed K/N-9833-2013	Gregg, Edward/0000-0003-2381-6822; Ali, Mohammed/0000-0001-7266-2503				Ahmann AJ, 2007, AM J MANAG CARE, V13, pS41; Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; [Anonymous], 2013, PERF MEAS END DIAB; [Anonymous], 2012, DIAB DAT TRENDS HOSP; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gary TL, 2003, ETHNIC DIS, V13, P47; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ismail-Beigi F, 2011, ANN INTERN MED, V154, P554, DOI 10.7326/0003-4819-154-8-201104190-00007; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kralewski JE, 2012, HEALTH AFFAIR, V31, P1830, DOI 10.1377/hlthaff.2011.0887; Laiteerapong N, 2013, DIABETES CARE, V36, P84, DOI 10.2337/dc11-2344; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; Mohiuddin SM, 2007, CHEST, V131, P446, DOI 10.1378/chest.06-1587; Moritz T, 2009, NEW ENGL J MED, V361, P1024, DOI 10.1056/NEJMc096250; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Committee for Quality Assurance, 2012, STAT HLTH CAR QUAL; O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pogach L, 2011, JAMA-J AM MED ASSOC, V305, P709, DOI 10.1001/jama.2011.153; Ratner RE, 2011, DIABETES CARE, V34, P1054, DOI 10.2337/dc10-1987; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Rossi MCE, 2011, DIABETES CARE, V34, P347, DOI 10.2337/dc10-1709; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stevens RJ, 2002, CLIN SCI, V102, P679, DOI 10.1042/cs1020679; TRIAD Study Grp, 2010, DIABETES CARE, V33, P940, DOI 10.2337/dc09-1802; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	40	665	683	0	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1613	1624		10.1056/NEJMsa1213829	http://dx.doi.org/10.1056/NEJMsa1213829			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614587				2022-12-24	WOS:000317956300010
J	Nishizawa, T; Kita, S; Maturana, AD; Furuya, N; Hirata, K; Kasuya, G; Ogasawara, S; Dohmae, N; Iwamoto, T; Ishitani, R; Nureki, O				Nishizawa, Tomohiro; Kita, Satomi; Maturana, Andres D.; Furuya, Noritaka; Hirata, Kunio; Kasuya, Go; Ogasawara, Satoshi; Dohmae, Naoshi; Iwamoto, Takahiro; Ishitani, Ryuichiro; Nureki, Osamu			Structural Basis for the Counter-Transport Mechanism of a H+/Ca2+ Exchanger	SCIENCE			English	Article							SODIUM-CALCIUM EXCHANGE; HOMEOSTASIS; GENE	Ca2+/cation antiporters catalyze the exchange of Ca2+ with various cations across biological membranes to regulate cytosolic calcium levels. The recently reported structure of a prokaryotic Na+/Ca2+ exchanger (NCX_Mj) revealed its overall architecture in an outward-facing state. Here, we report the crystal structure of a H+/Ca2+ exchanger from Archaeoglobus fulgidus (CAX_Af) in the two representatives of the inward-facing conformation at 2.3 angstrom resolution. The structures suggested Ca2+ or H+ binds to the cation-binding site mutually exclusively. Structural comparison of CAX_Af with NCX_Mj revealed that the first and sixth transmembrane helices alternately create hydrophilic cavities on the intra-and extracellular sides. The structures and functional analyses provide insight into the mechanism of how the inward- to outward-facing state transition is triggered by the Ca2+ and H+ binding.	[Nishizawa, Tomohiro; Furuya, Noritaka; Kasuya, Go; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Nishizawa, Tomohiro; Dohmae, Naoshi; Ishitani, Ryuichiro; Nureki, Osamu] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Kita, Satomi; Iwamoto, Takahiro] Fukuoka Univ, Fac Med, Dept Pharmacol, Jonan Ku, Fukuoka 8140180, Japan; [Maturana, Andres D.] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hirata, Kunio] RIKEN SPring 8 Ctr, Mikazuki, Hyogo 6795148, Japan; [Ogasawara, Satoshi] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Ogasawara, Satoshi] Kyoto Univ, Fac Med, Sakyo Ku, Kyoto 6068501, Japan	University of Tokyo; RIKEN; Fukuoka University; Nagoya University; RIKEN; Kyoto University; Kyoto University	Ishitani, R (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	ishitani@biochem.s.u-tokyo.ac.jp; nureki@biochem.s.u-tokyo.ac.jp	Furuya, Noritaka/AAG-5224-2019; NUREKI, OSAMU/G-4960-2014; Dohmae, Naoshi/C-2040-2011	Furuya, Noritaka/0000-0002-6815-479X; Dohmae, Naoshi/0000-0002-5242-9410; Kasuya, Go/0000-0003-1756-5764	Radioisotope Center, University of Tokyo; Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) Program "The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation" of Japan Science and Technology Agency (JST); MEXT; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23136517]; JSPS [23590319]; MEXT [24227004, 22687007]; Grants-in-Aid for Scientific Research [23590319] Funding Source: KAKEN	Radioisotope Center, University of Tokyo; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) Program "The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation" of Japan Science and Technology Agency (JST); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Nishimasu and M. Hattori for useful discussions and critical comments on the manuscript; T. Tsukazaki for sharing beamtime and useful discussion; A. Kurabayashi for technical assistance; the beam-line staffs at BL32XU and BL41XU of SPring-8 for assistance in data collection; and the RIKEN BioResource Center (Ibaraki, Japan) for providing the Archaeoglobus fulgidus genomic DNA. The diffraction experiments were performed at SPring-8 BL32XU and BL41XU (proposals 2012A1093, 2012A1201, and 2012A1087) and with the approval of RIKEN. Part of this work was performed with the support of the Radioisotope Center, University of Tokyo. This work was supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)" to O.N., by the Core Research for Evolutional Science and Technology (CREST) Program "The Creation of Basic Medical Technologies to Clarify and Control the Mechanisms Underlying Chronic Inflammation" of Japan Science and Technology Agency (JST) to O.N., by a grant for HPCI STRATEGIC PROGRAM Computational Life Science and Application in Drug Discovery and Medical Development by MEXT to R. I., by a Grant-in-Aid for Scientific Research on Innovative Areas (23136517) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) to S. K., by a Grant-in-Aid for Scientific Research (C) (23590319) from JSPS to T. I., and by a Grant-in-Aid for Scientific Research (S) (24227004) and a Grant-in-Aid for Young Scientists (A) (22687007) from the MEXT to O.N. and R. I., respectively. T.N. expressed and purified CAX_Af for crystallization, collected the diffraction data, solved the structures, and performed functional analyses in liposomes. N.F. screened CaCA genes and identified CAX_Af. S. K. and T. I. performed transport assays in E. coli cells. A. D. M. performed transport assays in E. coli spheloplasts. G. K. made mutants. K. H. assisted with data collection. S.O. supported crystallization. N.D. analyzed the purified protein by mass spectrometry. T.N., R. I., and O.N. wrote the manuscript. R. I. and O.N. directed and supervised all of the research. The coordinates and the structure factors have been deposited in the Protein Data Bank (PDB) under accession codes 4KPP.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Emery L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00001; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249	13	54	55	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2013	341	6142					168	172		10.1126/science.1239002	http://dx.doi.org/10.1126/science.1239002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185KA	23704374				2022-12-24	WOS:000321965300041
J	Ludwig, DS				Ludwig, David S.			Examining the Health Effects of Fructose	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLYCEMIC INDEX; DISEASE; METAANALYSIS; CONSUMPTION; RISK		[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730, K24 DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; DUNNIGAN MG, 1970, CLIN SCI, V38, P1; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; HILL JO, 1995, AM J CLIN NUTR, V62, p264S, DOI 10.1093/ajcn/62.1.264S; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Lustig RH, 2013, ADV NUTR, V4, P226, DOI 10.3945/an.112.002998; MEYER B J, 1971, South African Medical Journal, V45, P253; Sievenpiper JL, 2012, J AM COLL NUTR, V31, P149, DOI 10.1080/07315724.2012.10720021; White JS, 2013, ADV NUTR, V4, P246, DOI 10.3945/an.112.003137	10	33	34	0	47	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	2013	310	1					33	34		10.1001/jama.2013.6562	http://dx.doi.org/10.1001/jama.2013.6562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175SK	23732692				2022-12-24	WOS:000321253000015
J	Gale, EAM				Gale, Edwin A. M.			Is type 2 diabetes a category error?	LANCET			English	Editorial Material									[Gale, Edwin A. M.] Univ Bristol, Bristol, Avon, England	University of Bristol	Gale, EAM (corresponding author), Southmead Hosp, Bristol BS10 5NB, Avon, England.	edwin.gale@bristol.ac.uk						Faber K, 1923, NOSOGRAPHY MODERN IN; Gale EAM, 2006, DIABETOLOGIA, V49, P1989, DOI 10.1007/s00125-006-0348-7; Gale EAM, 2001, DIABETES, V50, P217, DOI 10.2337/diabetes.50.2.217; Ryle G, CONCEPT MIND; Von Noorden C., 1907, METABOLISM PRACTICAL, P527	5	31	31	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1956	1957		10.1016/S0140-6736(12)62207-7	http://dx.doi.org/10.1016/S0140-6736(12)62207-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23725732				2022-12-24	WOS:000320319500036
J	Bergonzi, S; Albani, MC; van Themaat, EVL; Nordstrom, KJV; Wang, RH; Schneeberger, K; Moerland, PD; Coupland, G				Bergonzi, Sara; Albani, Maria C.; van Themaat, Emiel Ver Loren; Nordstroem, Karl J. V.; Wang, Renhou; Schneeberger, Korbinian; Moerland, Perry D.; Coupland, George			Mechanisms of Age-Dependent Response to Winter Temperature in Perennial Flowering of Arabis alpina	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; TARGET GENES; MICRORNA; APETALA2; INDUCTION; PATHWAYS; MUTANT; MIR172; SPL3	Perennial plants live for more than 1 year and flower only after an extended vegetative phase. We used Arabis alpina, a perennial relative of annual Arabidopsis thaliana, to study how increasing age and exposure to winter cold (vernalization) coordinate to establish competence to flower. We show that the APETALA2 transcription factor, a target of microRNA miR172, prevents flowering before vernalization. Additionally, miR156 levels decline as A. alpina ages, causing increased production of SPL (SQUAMOSA PROMOTER BINDING PROTEIN LIKE) transcription factors and ensuring that flowering occurs in response to cold. The age at which plants respond to vernalization can be altered by manipulating miR156 levels. Although miR156 and miR172 levels are uncoupled in A. alpina, miR156 abundance represents the timer controlling age-dependent flowering responses to cold.	[Bergonzi, Sara; Albani, Maria C.; van Themaat, Emiel Ver Loren; Nordstroem, Karl J. V.; Wang, Renhou; Schneeberger, Korbinian; Coupland, George] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [van Themaat, Emiel Ver Loren; Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1100 DE Amsterdam, Netherlands	Max Planck Society; University of Amsterdam; Academic Medical Center Amsterdam	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 10, D-50829 Cologne, Germany.	coupland@mpipz.mpg.de	Moerland, Perry/AAG-1425-2020; Schneeberger, Korbinian/U-6329-2019; Coupland, George/AAP-8609-2020	Moerland, Perry/0000-0002-2357-3659; Schneeberger, Korbinian/0000-0002-5512-0443; Coupland, George/0000-0001-6988-4172; Nordstrom, Karl/0000-0001-6231-4417; Albani, Maria/0000-0002-8215-020X	Deutsche Forschungsgemeinschaft [SPP1530]; Max Planck Genome Centre; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Genome Centre; Max Planck Society(Max Planck Society)	We thank E. Willing, G. Velikkakam, and the "A. alpina genome consortium" for access to genomic information and Y. Zeng for technical support. We thank members of CC's laboratory and P. Huijser for critical reading of the manuscript and D. Weigel for MIR156 constructs and comments on the manuscript. We acknowledge funding from Deutsche Forschungsgemeinschaft SPP1530 grants to G.C. and M.C.A., the Max Planck Genome Centre, and a core grant from the Max Planck Society. GenBank accession numbers are GSE40455 (microarray data), KC815948 to KC815963 (AaSPLs), KC831439 (PEP2), and KC848668 (Aapre-miR156a). Materials described here are available from G.C. subject to a Material Transfer Agreement with the Max Planck Institute for Plant Breeding Research.	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bergonzi S, 2011, J EXP BOT, V62, P4415, DOI 10.1093/jxb/err192; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; MOZLEY D, 1995, J EXP BOT, V46, P173, DOI 10.1093/jxb/46.2.173; Nordstrom KJV, 2013, NAT BIOTECHNOL, V31, P325, DOI 10.1038/nbt.2515; Poethig RS, 2010, PLANT PHYSIOL, V154, P541, DOI 10.1104/pp.110.161620; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang RH, 2011, PLANT CELL, V23, P1307, DOI 10.1105/tpc.111.083451; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wollmann H, 2010, DEVELOPMENT, V137, P3633, DOI 10.1242/dev.036673; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	26	141	156	1	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1094	1097		10.1126/science.1234116	http://dx.doi.org/10.1126/science.1234116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723236				2022-12-24	WOS:000319664500044
J	Costandi, M				Costandi, Moheb			NEURODEGENERATION Amyloid awakenings	NATURE			English	Editorial Material							SLEEP-WAKE CYCLE; DISEASE											Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Krishnan N, 2012, NEUROBIOL DIS, V45, P1129, DOI 10.1016/j.nbd.2011.12.034; Lim ASP, 2012, ANN NEUROL, V72, P324, DOI 10.1002/ana.23636; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115	7	12	12	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S19	S20		10.1038/497S19a	http://dx.doi.org/10.1038/497S19a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698504				2022-12-24	WOS:000319254000010
J	Houtkooper, RH; Mouchiroud, L; Ryu, D; Moullan, N; Katsyuba, E; Knott, G; Williams, RW; Auwerx, J				Houtkooper, Riekelt H.; Mouchiroud, Laurent; Ryu, Dongryeol; Moullan, Norman; Katsyuba, Elena; Knott, Graham; Williams, Robert W.; Auwerx, Johan			Mitonuclear protein imbalance as a conserved longevity mechanism	NATURE			English	Article							EXTENDS LIFE-SPAN; SYSTEMATIC RNAI SCREEN; CAENORHABDITIS-ELEGANS; DIETARY RESTRICTION; GENE-EXPRESSION; C-ELEGANS; MITOCHONDRIAL-FUNCTION; CALORIC RESTRICTION; MICE; EXTENSION	Longevity is regulated by a network of closely linked metabolic systems. We used a combination of mouse population genetics and RNA interference in Caenorhabditis elegans to identify mitochondrial ribosomal protein S5 (Mrps5) and other mitochondrial ribosomal proteins as metabolic and longevity regulators. MRP knockdown triggers mitonuclear protein imbalance, reducing mitochondrial respiration and activating the mitochondrial unfolded protein response. Specific antibiotics targeting mitochondrial translation and ethidium bromide (which impairs mitochondrial DNA transcription) pharmacologically mimic mrp knockdown and extend worm lifespan by inducing mitonuclear protein imbalance, a stoichiometric imbalance between nuclear and mitochondrially encoded proteins. This mechanism was also conserved in mammalian cells. In addition, resveratrol and rapamycin, longevity compounds acting on different molecular targets, similarly induced mitonuclear protein imbalance, the mitochondrial unfolded protein response and lifespan extension in C. elegans. Collectively these data demonstrate that MRPs represent an evolutionarily conserved protein family that ties the mitochondrial ribosome and mitonuclear protein imbalance to the mitochondrial unfolded protein response, an overarching longevity pathway across many species.	[Houtkooper, Riekelt H.; Mouchiroud, Laurent; Ryu, Dongryeol; Moullan, Norman; Katsyuba, Elena; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Houtkooper, Riekelt H.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Knott, Graham] Ecole Polytech Fed Lausanne, BioEM Facil, CH-1015 Lausanne, Switzerland; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Williams, Robert W.] Ctr Integrat & Translat Genom, Memphis, TN 38163 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Tennessee System; University of Tennessee Health Science Center	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	admin.auwerx@epfl.ch	Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019; Ryu, Dongryeol/AAQ-3642-2020; Auwerx, Johan/ABE-9307-2021; Williams, Robert W./H-8789-2016	Houtkooper, Riekelt H/0000-0001-9961-0842; Ryu, Dongryeol/0000-0001-5905-6760; Auwerx, Johan/0000-0002-5065-5393; Williams, Robert W./0000-0001-8924-4447; Knott, Graham W/0000-0002-2956-9052	NWO-Rubicon; AMC; FRM fellowship; EPFL; ERC [2008-AdG-23138]; Velux Stiftung; SNSF; National Institutes of Health (NIH) [P20-DA 21131, UO1AA13499, U01AA14425]; UT Center for Integrative and Translational Genomics; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499, U01AA014425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	NWO-Rubicon(Netherlands Organization for Scientific Research (NWO)); AMC; FRM fellowship(Fondation pour la Recherche Medicale); EPFL; ERC(European Research Council (ERC)European Commission); Velux Stiftung; SNSF(Swiss National Science Foundation (SNSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Center for Integrative and Translational Genomics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Gonczy and the Caenorhabditis Genetics Center for sharing or providing reagents. R. H. H. is supported by fellowships from NWO-Rubicon and AMC, and L.M. by an FRM fellowship. J.A. is the Nestle Chair in Energy Metabolism and supported by EPFL, ERC (2008-AdG-23138), Velux Stiftung and SNSF. R. W. W. and GeneNetwork are supported by the National Institutes of Health (NIH) (P20-DA 21131, UO1AA13499 and U01AA14425), and the UT Center for Integrative and Translational Genomics. R. W. W. and J.A. are supported by NIH grant R01AG043930.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Argmann CA, 2005, CELL METAB, V2, P349, DOI 10.1016/j.cmet.2005.11.002; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Geisert EE, 2009, MOL VIS, V15, P1730; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mouchiroud L, 2011, AGING CELL, V10, P39, DOI 10.1111/j.1474-9726.2010.00640.x; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; WONG A, 1995, GENETICS, V139, P1247; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; ZYLBER E, 1969, J MOL BIOL, V44, P195, DOI 10.1016/0022-2836(69)90414-8	48	650	662	12	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					451	+		10.1038/nature12188	http://dx.doi.org/10.1038/nature12188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698443	Green Accepted			2022-12-24	WOS:000319254000039
J	Hannan, FM; Thakker, RV				Hannan, Fadil M.; Thakker, Rajesh V.			RATIONAL TESTING Investigating hypocalcaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VITAMIN-D DEFICIENCY; CALCIUM; SERUM; DIAGNOSIS; MANAGEMENT		[Hannan, Fadil M.; Thakker, Rajesh V.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Acad Endocrine Unit,Nuffield Dept Clin Med, Oxford OX3 7LJ, England; [Hannan, Fadil M.] John Radcliffe Hosp, Dept Clin Biochem, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Thakker, RV (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Acad Endocrine Unit,Nuffield Dept Clin Med, S Parks Rd, Oxford OX3 7LJ, England.	rajesh.thakker@ndm.ox.ac.uk		Hannan, Fadil/0000-0002-2975-5170; Thakker, Rajesh/0000-0002-1438-3220	Medical Research Council [G1000467] Funding Source: Medline; MRC [G1000467] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agus ZS, 1999, J AM SOC NEPHROL, V10, P1616; Barth JH, 1996, ANN CLIN BIOCHEM, V33, P55, DOI 10.1177/000456329603300108; BOINK ABTJ, 1991, J AUTOM CHEM, V13, P235, DOI 10.1155/S1463924691000391; Cooper MS, 2008, BRIT MED J, V336, P1298, DOI 10.1136/bmj.39582.589433.BE; Hashemipour S, 2006, J BONE MINER METAB, V24, P213, DOI 10.1007/s00774-005-0674-8; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; KRAPF R, 1992, KIDNEY INT, V42, P727, DOI 10.1038/ki.1992.340; Langman CB, 2010, CLIN J AM SOC NEPHRO, V5, pS1, DOI 10.2215/CJN.06140809; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Liamis G, 2009, J BONE MINER METAB, V27, P635, DOI 10.1007/s00774-009-0119-x; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; POCOCK SJ, 1989, J CLIN PATHOL, V42, P172, DOI 10.1136/jcp.42.2.172; Slomp J, 2003, CRIT CARE MED, V31, P1389, DOI 10.1097/01.CCM.0000063044.55669.3C; Thakker R., 2003, OXFORD TXB MED; Thomusch O, 2003, SURGERY, V133, P180, DOI 10.1067/msy.2003.61	16	27	27	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2013	346								f2213	10.1136/bmj.f2213	http://dx.doi.org/10.1136/bmj.f2213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144BU	23661111				2022-12-24	WOS:000318915200001
J	Zhang, M; Schekman, R				Zhang, Min; Schekman, Randy			Unconventional Secretion, Unconventional Solutions	SCIENCE			English	Editorial Material							PROTEIN SECRETION; MURINE MACROPHAGES; IL-1-BETA; RELEASE; INTERLEUKIN-1-BETA; ACTIVATION; MECHANISMS; AUTOPHAGY; TRANSPORT; GRASP		[Zhang, Min; Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Zhang, M (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	schekman@berkeley.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Giuliani F, 2011, CURR OPIN CELL BIOL, V23, P498, DOI 10.1016/j.ceb.2011.04.005; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728	19	123	126	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					559	561		10.1126/science.1234740	http://dx.doi.org/10.1126/science.1234740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641104				2022-12-24	WOS:000318268900035
J	Jakab, Z; Salisbury, DM				Jakab, Zsuzsanna; Salisbury, David M.			Back to basics: the miracle and tragedy of measles vaccine	LANCET			English	Editorial Material									[Jakab, Zsuzsanna] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Salisbury, David M.] Dept Hlth, London SE1 6TE, England	World Health Organization	Jakab, Z (corresponding author), WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark.	zja@euro.who.int						Measles and Rubella Initiative, 2013, FACT SHEET; PAHO, 2012, PLAN OF ACTION FOR M; Perry RT, 2013, MMWR-MORBID MORTAL W, V62, P27; Public Health England, 2013, NUMBER OF LABORATORY; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; WHO, 2010, SIXTIETH SESSION REN; WHO, 2010, GLOBAL ERADICATION O; WHO Regional Office for Europe, CENTRALIZED INFORMAT	8	10	10	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1433	1434		10.1016/S0140-6736(13)60908-3	http://dx.doi.org/10.1016/S0140-6736(13)60908-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23623213				2022-12-24	WOS:000318607300008
J	Edmiston, R; Mitchell, C				Edmiston, Rachel; Mitchell, Caroline			Hearing loss in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Edmiston, Rachel] Tameside Gen Hosp, ENT Dept, Ashton Under Lyne OL6 9RW, England; [Mitchell, Caroline] Univ Sheffield, Community Sci Ctr, No Gen Hosp, Inst Gen Practice & Primary Care, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital; University of Sheffield	Edmiston, R (corresponding author), Tameside Gen Hosp, ENT Dept, Ashton Under Lyne OL6 9RW, England.	rachel.edmiston@nhs.net		Mitchell, Caroline/0000-0002-4790-0095				Boatman DF, 2007, NEUROLOGY, V68, P1311, DOI 10.1212/01.wnl.0000259524.08148.16; Faulconbridge RL, 2011, HEARING AIDS GET ONE; Pirozzo S, 2003, BRIT MED J, V327, P967, DOI 10.1136/bmj.327.7421.967; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449	4	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2013	346								f2496	10.1136/bmj.f2496	http://dx.doi.org/10.1136/bmj.f2496			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PN	23618723	Green Accepted			2022-12-24	WOS:000318225000004
J	Eurich, DT; Simpson, S; Senthilselvan, A; Asche, CV; Sandhu-Minhas, JK; McAlister, FA				Eurich, D. T.; Simpson, S.; Senthilselvan, A.; Asche, C. V.; Sandhu-Minhas, J. K.; McAlister, F. A.			Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITORS; INCRETIN-BASED THERAPIES; CARDIOVASCULAR OUTCOMES; ACUTE-PANCREATITIS; GLYCEMIC CONTROL; MORTALITY; METFORMIN; RISK; SULFONYLUREA; EXENATIDE	Objective To determine if the use of sitagliptin in newly treated patients with type 2 diabetes is associated with any changes in clinical outcomes. Design Retrospective population based cohort study. Setting Large national commercially insured US claims and integrated laboratory database. Participants Inception cohort of new users of oral antidiabetic drugs between 2004 and 2009 followed until death, termination of medical insurance, or December 31 2010. Main outcome measure Composite endpoint of all cause hospital admission and all cause mortality, assessed with time varying Cox proportional hazards regression after adjustment for demographics, clinical and laboratory data, pharmacy claims data, healthcare use, and time varying propensity scores. Results The cohort included 72 738 new users of oral antidiabetic drugs (8032 (11%) used sitagliptin; 7293 (91%) were taking it in combination with other agents) followed for a total of 182 409 patient years. The mean age was 52 (SD 9) years, 54% (39 573) were men, 11% (8111) had ischemic heart disease, and 9% (6378) had diabetes related complications at the time their first antidiabetic drug was prescribed. 14 215 (20%) patients met the combined endpoint. Sitagliptin users showed similar rates of all cause hospital admission or mortality to patients not using sitagliptin (adjusted hazard ratio 0.98, 95% confidence interval 0.91 to 1.06), including patients with a history of ischemic heart disease (adjusted hazard ratio 1.10, 0.94 to 1.28) and those with estimated glomerular filtration rate below 60 mL/min (1.11, 0.88 to 1.41). Conclusions Sitagliptin use was not associated with an excess risk of all cause hospital admission or death compared with other glucose lowering agents among newly treated patients with type 2 diabetes. Most patients prescribed sitagliptin in this cohort were concordant with clinical practice guidelines, in that it was used as add-on treatment.	[Eurich, D. T.; Senthilselvan, A.] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada; [Eurich, D. T.; Simpson, S.; Sandhu-Minhas, J. K.] Univ Alberta, Alliance Canadian Hlth Outcomes Res Diabet, Edmonton, AB T6G 2E1, Canada; [Simpson, S.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2B7, Canada; [Asche, C. V.] Univ Illinois, Coll Med Peoria, Ctr Hlth Outcomes, Peoria, IL 61656 USA; [Asche, C. V.] Univ Illinois, Coll Pharm, Dept Pharm Adm, Chicago, IL 60612 USA; [McAlister, F. A.] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB T6G 2B7, Canada; [McAlister, F. A.] Univ Alberta, Edmonton, AB T6G 2B7, Canada	University of Alberta; University of Alberta; University of Alberta; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Alberta; University of Alberta	Eurich, DT (corresponding author), Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat 2 040, Edmonton, AB T6G 2E1, Canada.	deurich@ualberta.ca	; McAlister, Finlay/C-4151-2013	Simpson, Scot/0000-0002-9880-2129; McAlister, Finlay/0000-0001-7435-3341	Canadian Diabetes Association [OG-2-09-2691-DE]; Canadian Institutes of Health Research (CIHR) [MOP-126093]; Alberta Innovates Health Solution (AIHS); CIHR	Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solution (AIHS); CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by operating grants from the Canadian Diabetes Association (OG-2-09-2691-DE) and the Canadian Institutes of Health Research (CIHR) (MOP-126093). DTE receives salary support from Alberta Innovates Health Solution (AIHS) and the CIHR. FAM is a senior health scholar with AIHS. The study sponsors played no role in study design or conduct; collection, analysis, or interpretation of data; writing of the report; or the decision to submit the paper for publication.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Austin PC, 2011, MED CARE, V49, P940, DOI 10.1097/MLR.0b013e318229360e; Borah BJ, 2009, CLIN THER, V31, P623, DOI 10.1016/j.clinthera.2009.03.005; Bowker SL, 2010, DIABETOLOGIA, V53, P1631, DOI 10.1007/s00125-010-1750-8; Burgmaier M, 2013, DIABETIC MED, V30, P289, DOI 10.1111/j.1464-5491.2012.03746.x; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Dore DD, 2009, CURR MED RES OPIN, V25, P1019, DOI [10.1185/03007990902820519, 10.1185/03007990902820519 ]; Drucker DJ, 2010, DIABETES CARE, V33, P428, DOI 10.2337/dc09-1499; Duh MS, 2009, AM J MANAG CARE, V15, P681; Eurich DT, 2005, DIABETES CARE, V28, P2345, DOI 10.2337/diacare.28.10.2345; Evans JMM, 2006, DIABETOLOGIA, V49, P930, DOI 10.1007/s00125-006-0176-9; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Garg R, 2010, DIABETES CARE, V33, P2349, DOI 10.2337/dc10-0482; Huberman M, 1999, AM J EPIDEMIOL, V150, P1340; Inzucchi SE, 2008, CIRCULATION, V117, P574, DOI 10.1161/CIRCULATIONAHA.107.735795; Johns Hopkins University, 2012, J HOPK ACG SYST; Johnson JA, 2005, DIABETIC MED, V22, P497, DOI 10.1111/j.1464-5491.2005.01448.x; Johnson JA, 2002, DIABETES CARE, V25, P2244, DOI 10.2337/diacare.25.12.2244; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; McAlister FA, 2008, EUR J HEART FAIL, V10, P703, DOI 10.1016/j.ejheart.2008.05.013; Monami M, 2011, CURR MED RES OPIN, V27, P57, DOI 10.1185/03007995.2011.602964; National Institute for Health and Clinical Excellence, 2011, QUAL STAT 4 GLYC CON; Okerson T, 2012, CARDIOVASC THER, V30, pe146, DOI 10.1111/j.1755-5922.2010.00256.x; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Pendergrass M, 2012, DIABETES OBES METAB, V14, P596, DOI 10.1111/j.1463-1326.2012.01567.x; Penson DF, 2001, J CLIN EPIDEMIOL, V54, P350, DOI 10.1016/S0895-4356(00)00312-7; Peters A, 2010, AM J MED, V123, pS28, DOI 10.1016/j.amjmed.2009.12.007; Ranganath LR, 2008, J CLIN PATHOL, V61, P401, DOI 10.1136/jcp.2006.043232; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Riedel AA, 2007, PHARMACOTHERAPY, V27, P1102, DOI 10.1592/phco.27.8.1102; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Segal JB, 2007, CLIN THER, V29, P1784, DOI 10.1016/j.clinthera.2007.08.021; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Willemen MJ, 2011, DIABETES CARE, V34, P369, DOI 10.2337/dc10-1771; Winkelmayer WC, 2008, ARCH INTERN MED, V168, P2368, DOI 10.1001/archinte.168.21.2368	36	59	62	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2013	346								f2267	10.1136/bmj.f2267	http://dx.doi.org/10.1136/bmj.f2267			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PN	23618722	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000318225000001
J	Li, F; Mao, GG; Tong, D; Huang, J; Gu, LY; Yang, W; Li, GM				Li, Feng; Mao, Guogen; Tong, Dan; Huang, Jian; Gu, Liya; Yang, Wei; Li, Guo-Min			The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutS alpha	CELL			English	Article							IDENTIFIES FREQUENT MUTATION; CELL NUCLEAR ANTIGEN; PWWP DOMAIN; REPLICATION; RECOGNITION; CANCER; DEFICIENCY; EXTRACTS; MSH6; GENE	DNA mismatch repair (MMR) ensures replication fidelity by correcting mismatches generated during DNA replication. Although human MMR has been reconstituted in vitro, how MMR occurs in vivo is unknown. Here, we show that an epigenetic histone mark, H3K36me3, is required in vivo to recruit the mismatch recognition protein hMutS alpha (hMSH2-hMSH6) onto chromatin through direct interactions with the hMSH6 PWWP domain. The abundance of H3K36me3 in G1 and early S phases ensures that hMutS alpha is enriched on chromatin before mispairs are introduced during DNA replication. Cells lacking the H3K36 trimethyltransferase SETD2 display microsatellite instability (MSI) and an elevated spontaneous mutation frequency, characteristic of MMR-deficient cells. This work reveals that a histone mark regulates MMR in human cells and explains the long-standing puzzle of MSI-positive cancer cells that lack detectable mutations in known MMR genes.	[Li, Feng; Mao, Guogen; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40506 USA; [Tong, Dan; Huang, Jian] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Tong, Dan; Li, Guo-Min] Tsinghua Univ, Sch Med, Beijing 10084, Peoples R China; [Yang, Wei] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Kentucky; Wuhan University; Tsinghua University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gu, LY (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40506 USA.	lgu0@uky.edu; gmli@uky.edu	Li, Guo-Min/I-5016-2014; Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Li, Feng/0000-0002-9201-1668; Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [CA167181, CA115942, GM089684, CA104333]; National Institute of Diabetes and Digestive and Kidney Diseases intramural research fund; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA167181, R01CA115942, R01CA104333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases intramural research fund; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Kolodner, Tom Misteli, Jeffrey Parvin, Youfeng Yang, and Akira Yasui for reagents and Yang Shi, Dangsheng Li, Charles Ensor, and Nathan Vanderford for stimulating discussions and helpful comments. This work was supported in part by grants from the National Institutes of Health (CA167181, CA115942, and GM089684 to G.-M.L.) (CA104333 to L.G.), the National Institute of Diabetes and Digestive and Kidney Diseases intramural research fund (to W.Y.), and a grant from the Kentucky Lung Cancer Research Program. G.-M.L. holds the James-Gardner Chair in Cancer Research.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gu LY, 2002, ONCOGENE, V21, P5758, DOI 10.1038/sj.onc.1205695; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; Kane MF, 1997, CANCER RES, V57, P808; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Li F, 2009, J BIOL CHEM, V284, P33056, DOI 10.1074/jbc.M109.049874; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; UMAR A, 1994, J BIOL CHEM, V269, P14367; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; WANSINK DG, 1994, J CELL SCI, V107, P1449; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	59	394	414	1	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					590	600		10.1016/j.cell.2013.03.025	http://dx.doi.org/10.1016/j.cell.2013.03.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622243	Green Accepted, Bronze			2022-12-24	WOS:000318063500012
J	Maxwell, E				Maxwell, Elaine			Francis inquiry: compulsory work as healthcare assistants won't make better nurses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Hlth Fdn, London WC2E 9RA, England		Maxwell, E (corresponding author), Hlth Fdn, London WC2E 9RA, England.	Elaine.Maxwell@health.org.uk						Aiken LH, 2008, J NURS ADMIN, V38, P223, DOI 10.1097/01.NNA.0000312773.42352.d7; Buchan J, 2012, OVERSTRETCHED UNDER; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Nursing and Midwifery Council, STAT AN REG 1 APR 20; Royal College of Nursing, 2012, QUAL COMP FUT NURS E	5	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2013	346								f2480	10.1136/bmj.f2480	http://dx.doi.org/10.1136/bmj.f2480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PN	23620583				2022-12-24	WOS:000318225000003
J	Eappen, S; Lane, BH; Rosenberg, B; Lipsitz, SA; Sadoff, D; Matheson, D; Berry, WR; Lester, M; Gawande, AA				Eappen, Sunil; Lane, Bennett H.; Rosenberg, Barry; Lipsitz, Stuart A.; Sadoff, David; Matheson, Dave; Berry, William R.; Lester, Mark; Gawande, Atul A.			Relationship Between Occurrence of Surgical Complications and Hospital Finances	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LENGTH-OF-STAY; POSTOPERATIVE COMPLICATIONS; SAFETY CHECKLIST; ADVERSE EVENTS; RISK-FACTORS; QUALITY; SURGERY; COSTS; PROGRAM; PERFORMANCE	Importance The effect of surgical complications on hospital finances is unclear. Objective To determine the relationship between major surgical complications and per-encounter hospital costs and revenues by payer type. Design, Setting, and Participants Retrospective analysis of administrative data for all inpatient surgical discharges during 2010 from a nonprofit 12-hospital system in the southern United States. Discharges were categorized by principal procedure and occurrence of 1 or more postsurgical complications, using International Classification of Diseases, Ninth Revision, diagnosis and procedure codes. Nine common surgical procedures and 10 major complications across 4 payer types were analyzed. Hospital costs and revenue at discharge were obtained from hospital accounting systems and classified by payer type. Main Outcomes and Measures Hospital costs, revenues, and contribution margin (defined as revenue minus variable expenses) were compared for patients with and without surgical complications according to payer type. Results Of 34 256 surgical discharges, 1820 patients (5.3%; 95% CI, 4.4%-6.4%) experienced 1 or more postsurgical complications. Compared with absence of complications, complications were associated with a $39 017 (95% CI, $20 069-$50 394; P<.001) higher contribution margin per patient with private insurance ($55 953 vs $16 936) and a $1749 (95% CI, $976-$3287; P<.001) higher contribution margin per patient with Medicare ($3629 vs $1880). For this hospital system in which private insurers covered 40% of patients (13 544), Medicare covered 45% (15 406), Medicaid covered 4% (1336), and self-payment covered 6% (2202), occurrence of complications was associated with an $8084 (95% CI, $4903-$9740; P<.001) higher contribution margin per patient ($15 726 vs $7642) and with a $7435 lower per-patient total margin (95% CI, $5103-$10 507; P<.001) ($1013 vs -$6422). Conclusions and Relevance In this hospital system, the occurrence of postsurgical complications was associated with a higher per-encounter hospital contribution margin for patients covered by Medicare and private insurance but a lower one for patients covered by Medicaid and who self-paid. Depending on payer mix, many hospitals have the potential for adverse near-term financial consequences for decreasing postsurgical complications. JAMA. 2013;309(15):1599-1606 www.jama.com	[Eappen, Sunil] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02115 USA; [Lane, Bennett H.; Rosenberg, Barry; Sadoff, David; Matheson, Dave] Boston Consulting Grp Inc, Boston, MA USA; [Lipsitz, Stuart A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Berry, William R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lester, Mark] Texas Hlth Resources, Arlington, TX USA; [Gawande, Atul A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Gawande, Atul A.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Boston Consulting Group (BCG); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Gawande, AA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Kresge Bldg,Room 400, Boston, MA 02115 USA.	agawande@hsph.harvard.edu		Gawande, Atul/0000-0002-1824-9176; Lane, Bennett/0000-0001-9860-2285	Boston Consulting Group; Texas Health Resources	Boston Consulting Group; Texas Health Resources	This research was supported by funding from the Boston Consulting Group and Texas Health Resources.	Agency for Healthcare Research and Quality, 2008, HEALTHC COST UT PROJ; Andrews RM., 2011, NATL HOSP BILL MOST; Bazzoli GJ, 2003, HEALTH AFFAIR, V22, P40, DOI 10.1377/hlthaff.22.6.40; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Center for Medicare and Medicaid Services, 2010, NAT HLTH CAR EXP DAT; Centers for Medicare & Medicaid Services (CMS), HHS MED PROGR CHANG, P33; Centers for Medicare & Medicaid Services (CMS), 2008, HHS MED PROGR CHANG; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Conley DM, 2011, J AM COLL SURGEONS, V212, P873, DOI 10.1016/j.jamcollsurg.2011.01.052; Davenport DL, 2005, ANN SURG, V242, P463, DOI 10.1097/01.sla.0000183348.15117.ab; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Delia D, 2008, HEALTH AFFAIR, V27, P1688, DOI 10.1377/hlthaff.27.6.1688; DiCiccio TJ, 1996, STAT SCI, V11, P189; Dimick JB, 2006, J AM COLL SURGEONS, V202, P933, DOI 10.1016/j.jamcollsurg.2006.02.015; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Dimick JB, 2003, J AM COLL SURGEONS, V196, P671, DOI 10.1016/S1072-7515(03)00122-4; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Farley DO, 2002, MED CARE RES REV, V59, P319, DOI 10.1177/1077558702059003005; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Goodman DC, 2009, HYP IM SIGN PROC EV, P1; Gordon HS, 2005, MED CARE, V43, P159, DOI 10.1097/00005650-200502000-00009; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Horton NJ, 1999, STAT MED, V18, P213, DOI 10.1002/(SICI)1097-0258(19990130)18:2<213::AID-SIM999>3.0.CO;2-E; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Khan NA, 2006, J GEN INTERN MED, V21, P177, DOI 10.1111/j.1525-1497.2006.00319.x; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Korn E. L., 1999, ANAL HLTH SURVEYS; Krupka DC, 2012, HEALTH AFFAIR, V31, P2571, DOI 10.1377/hlthaff.2011.0605; Librero J, 2004, INT J QUAL HEALTH C, V16, P51, DOI 10.1093/intqhc/mzh008; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; Medicare program, 2007, FED REGISTER, V72, P47379; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Penel N, 2008, INT J ORAL MAX SURG, V37, P135, DOI 10.1016/j.ijom.2007.08.002; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rajakaruna C, 2005, J THORAC CARDIOV SUR, V130, P1270, DOI 10.1016/j.jtcvs.2005.06.050; Rosenberg BL, 2005, SURGERY, V137, P285, DOI 10.1016/j.surg.2004.09.007; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Schauffler HH, 2001, ANNU REV PUBL HEALTH, V22, P69, DOI 10.1146/annurev.publhealth.22.1.69; Sisko AM, 2010, HEALTH AFFAIR, V29, P1933, DOI 10.1377/hlthaff.2010.0788; The DRG Handbook, 2006, DRG HDB; Thompson DA, 2006, ANN SURG, V243, P547, DOI 10.1097/01.sla.0000207097.38963.3b; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885; Wright SB, 2003, INFECT CONT HOSP EP, V24, P946, DOI 10.1086/502164	46	143	144	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2013	309	15					1599	1606		10.1001/jama.2013.2773	http://dx.doi.org/10.1001/jama.2013.2773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	126FY	23592104	Green Published			2022-12-24	WOS:000317599500023
J	Waight, AB; Pedersen, BP; Schlessinger, A; Bonomi, M; Chau, BH; Roe-Zurz, Z; Risenmay, AJ; Sali, A; Stroud, RM				Waight, Andrew B.; Pedersen, Bjorn Panyella; Schlessinger, Avner; Bonomi, Massimiliano; Chau, Bryant H.; Roe-Zurz, Zygy; Risenmay, Aaron J.; Sali, Andrej; Stroud, Robert M.			Structural basis for alternating access of a eukaryotic calcium/proton exchanger	NATURE			English	Article							CATION/H+ EXCHANGER; MOLECULAR-DYNAMICS; MEMBRANE-PROTEINS; INTERNAL REPEATS; VACUOLAR; CA2+; IDENTIFICATION; TRANSPORT; RESIDUES; YEAST	Eukaryotic Ca2+ regulation involves sequestration into intracellular organelles, and expeditious Ca2+ release into the cytosol is a hallmark of key signalling transduction pathways. Bulk removal of Ca2+ after such signalling events is accomplished by members of the Ca2+: cation (CaCA) superfamily(1-5). The CaCA superfamily includes the Na+/Ca2+ (NCX) and Ca2+/H+ (CAX) antiporters, and in mammals the NCX and related proteins constitute families SLC8 and SLC24, and are responsible for the re-establishment of Ca2+ resting potential in muscle cells, neuronal signalling and Ca2+ reabsorption in the kidney(1,6). The CAX family members maintain cytosolic Ca2+ homeostasis in plants and fungi during steep rises in intracellular Ca2+ due to environmental changes, or following signal transduction caused by events such as hyperosmotic shock, hormone response and response to mating pheromones(7-13). The cytosol-facing conformations within the CaCA superfamily are unknown, and the transport mechanism remains speculative. Here we determine a crystal structure of the Saccharomyces cerevisiae vacuolar Ca2+/H+ exchanger (Vcx1) at 2.3 angstrom resolution in a cytosol-facing, substrate-bound conformation. Vcx1 is the first structure, to our knowledge, within the CAX family, and it describes the key cytosol-facing conformation of the CaCA superfamily, providing the structural basis for a novel alternating access mechanism by which the CaCA superfamily performs high-throughput Ca2+ transport across membranes.	[Waight, Andrew B.; Pedersen, Bjorn Panyella; Chau, Bryant H.; Roe-Zurz, Zygy; Risenmay, Aaron J.; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Schlessinger, Avner; Bonomi, Massimiliano; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Pharmaceut Chem, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	stroud@msg.ucsf.edu	Pedersen, Bjørn/H-4128-2017; Pedersen, Bjørn/AAT-2409-2021	Pedersen, Bjørn/0000-0001-7860-7230; Pedersen, Bjørn/0000-0001-7860-7230; Bonomi, Massimiliano/0000-0002-7321-0004	Carlsberg Foundation; Danish Cancer Society; NIH [U54 GM094625, U01 GM61390, GM24485, GM073210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, T32GM008284, R01GM024485, P50GM073210, U54GM094625, R37GM024485, U19GM061390] Funding Source: NIH RePORTER	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Holton, G. Meigs, C. Ogata, N. Venugopalan and T. Doukov for assistance with synchrotron data collection at Advanced Light Source, Advanced Photon Source and Stanford Synchrotron Radiation Lightsource; and C. Waddling and P. Wassam for technical assistance. B. P. P. was supported by a postdoctoral fellowship from the Carlsberg Foundation and later by a fellowship from the Danish Cancer Society; A. S. by NIH grants U54 GM094625 and U01 GM61390; R. M. S. by NIH grants U54 GM094625, GM24485 and GM073210.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Cho D, 2012, PLANT PHYSIOL, V160, P1293, DOI 10.1104/pp.112.201442; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; Cui J, 2009, CELL CALCIUM, V45, P123, DOI 10.1016/j.ceca.2008.07.005; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; DUNN T, 1994, J BIOL CHEM, V269, P7273; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya T, 2004, J BIOL CHEM, V279, P812, DOI 10.1074/jbc.M309726200; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Li M, 2009, J MOL BIOL, V385, P820, DOI 10.1016/j.jmb.2008.11.021; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pittman JK, 2002, PLANT PHYSIOL, V130, P1054, DOI 10.1104/pp.008193; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Ridilla M, 2012, BIOCHEMISTRY-US, V51, P9603, DOI 10.1021/bi3012109; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	53	66	68	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					107	110		10.1038/nature12233	http://dx.doi.org/10.1038/nature12233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23685453	Green Accepted, Green Submitted			2022-12-24	WOS:000321285600043
J	Clarke, J				Clarke, Julia			Feathers Before Flight	SCIENCE			English	Editorial Material							EVOLUTION; ARCHOSAURS; DINOSAUR; PLUMAGE		Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Clarke, J (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	julia_clarke@jsg.utexas.edu						Chinsamy A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2377; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Hutchinson JR, 2006, CR PALEVOL, V5, P519, DOI 10.1016/j.crpv.2005.09.002; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; Persons WS, 2014, ACTA PALAEONTOL POL, V59, P553, DOI 10.4202/app.2012.0093; Prum RO, 1999, J EXP ZOOL, V285, P291; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	15	37	38	1	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					690	692		10.1126/science.1235463	http://dx.doi.org/10.1126/science.1235463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661746				2022-12-24	WOS:000318619000022
J	Song, YM; Xie, YZ; Malyarchuk, V; Xiao, JL; Jung, I; Choi, KJ; Liu, ZJ; Park, H; Lu, CF; Kim, RH; Li, R; Crozier, KB; Huang, YG; Rogers, JA				Song, Young Min; Xie, Yizhu; Malyarchuk, Viktor; Xiao, Jianliang; Jung, Inhwa; Choi, Ki-Joong; Liu, Zhuangjian; Park, Hyunsung; Lu, Chaofeng; Kim, Rak-Hwan; Li, Rui; Crozier, Kenneth B.; Huang, Yonggang; Rogers, John A.			Digital cameras with designs inspired by the arthropod eye	NATURE			English	Article							SUPERPOSITION EYE; OPTICS	In arthropods, evolution has created a remarkably sophisticated class of imaging systems, with a wide-angle field of view, low aberrations, high acuity to motion and an infinite depth of field(1-3). A challenge in building digital cameras with the hemispherical, compound apposition layouts of arthropod eyes is that essential design requirements cannot be met with existing planar sensor technologies or conventional optics. Here we present materials, mechanics and integration schemes that afford scalable pathways to working, arthropod-inspired cameras with nearly full hemispherical shapes (about 160 degrees). Their surfaces are densely populated by imaging elements (artificial ommatidia), which are comparable in number (180) to those of the eyes of fire ants (Solenopsis fugax) and bark beetles(4,5) (Hylastes nigrinus). The devices combine elastomeric compound optical elements with deformable arrays of thin silicon photodetectors into integrated sheets that can be elastically transformed from the planar geometries in which they are fabricated to hemispherical shapes for integration into apposition cameras. Our imaging results and quantitative ray-tracing-based simulations illustrate key features of operation. These general strategies seem to be applicable to other compound eye devices, such as those inspired by moths and lacewings(6,7) (refracting superposition eyes), lobster and shrimp(8) (reflecting superposition eyes), and houseflies(9) (neural superposition eyes).	[Song, Young Min; Xie, Yizhu; Malyarchuk, Viktor; Kim, Rak-Hwan; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, 1304 W Green St, Urbana, IL 61801 USA; [Song, Young Min; Xie, Yizhu; Malyarchuk, Viktor; Kim, Rak-Hwan; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Xiao, Jianliang] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Jung, Inhwa] Kyung Hee Univ, Dept Mech Engn, Yongin 446701, Gyeonggi Do, South Korea; [Choi, Ki-Joong; Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Liu, Zhuangjian] ASTAR, Inst High Performance Comp, Singapore 138632, Singapore; [Park, Hyunsung; Crozier, Kenneth B.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Lu, Chaofeng] Zhejiang Univ, Dept Civil Engn, Hangzhou 310058, Zhejiang, Peoples R China; [Lu, Chaofeng] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310058, Zhejiang, Peoples R China; [Lu, Chaofeng; Li, Rui; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Dept Mech Engn, Evanston, IL 60208 USA; [Li, Rui] Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; Kyung Hee University; University of Illinois System; University of Illinois Urbana-Champaign; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Harvard University; Zhejiang University; Zhejiang University; Northwestern University; Dalian University of Technology	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, 1304 W Green St, Urbana, IL 61801 USA.	jrogers@illinois.edu	Xiao, Jianliang/B-4535-2008; Kim, Rak-Hwan/A-6155-2012; Song, Young Min/B-2215-2010; Rogers, John/L-2798-2016; Jung, Inhwa/AAI-8615-2020; Huang, Yonggang/B-6998-2009; huang, yonggang/O-6236-2019; Li, Rui/C-2155-2009; CROZIER, KENNETH/J-7143-2016	Song, Young Min/0000-0002-4473-6883; Jung, Inhwa/0000-0002-0235-7383; Li, Rui/0000-0001-6051-4204; CROZIER, KENNETH/0000-0003-0947-001X	Defense Advanced Research Projects Agency (DARPA) Nanoelectromechanical /Microelectromechanical Science AMP; Technology (N/MEMS SAMP;T) Fundamentals programme by the Space and Naval Warfare Systems Center Pacific (SPAWAR) [N66001-10-1-4008]; National Science Foundation through an Emerging Frontiers in Research and Innovation (EFRI) programme	Defense Advanced Research Projects Agency (DARPA) Nanoelectromechanical /Microelectromechanical Science AMP; Technology (N/MEMS SAMP;T) Fundamentals programme by the Space and Naval Warfare Systems Center Pacific (SPAWAR); National Science Foundation through an Emerging Frontiers in Research and Innovation (EFRI) programme	The work on integration schemes and mechanical designs was supported by the Defense Advanced Research Projects Agency (DARPA) Nanoelectromechanical /Microelectromechanical Science & Technology (N/MEMS S&T) Fundamentals programme under grant number N66001-10-1-4008 issued by the Space and Naval Warfare Systems Center Pacific (SPAWAR). The work on materials, optical modelling and imaging aspects was supported by the National Science Foundation through an Emerging Frontiers in Research and Innovation (EFRI) programme.	Afshari H., 2012, J SIGN PROCESS SYST; BARROSPITA JC, 1970, Z VERGL PHYSIOL, V67, P79, DOI 10.1007/BF00298120; CHAPMAN JA, 1972, ANN ENTOMOL SOC AM, V65, P550, DOI 10.1093/aesa/65.3.550; Dinyari R., 2008, APPL PHYS LETT, V92; Dudley R., 2000, BIOMECHANICS INSECT; Duparre J, 2005, OPT EXPRESS, V13, P10539, DOI 10.1364/OPEX.13.010539; Floreano D, 2009, FLYING INSECTS AND ROBOTS, P1; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; HORRIDGE GA, 1977, PROC R SOC SER B-BIO, V196, P233, DOI 10.1098/rspb.1977.0039; Hung PJ, 2004, APPL PHYS LETT, V85, P6051, DOI 10.1063/1.1835553; Jeong KH, 2006, SCIENCE, V312, P557, DOI 10.1126/science.1123053; Jung IW, 2011, P NATL ACAD SCI USA, V108, P1788, DOI 10.1073/pnas.1015440108; Ko HC, 2008, NATURE, V454, P748, DOI 10.1038/nature07113; Kral K, 1998, EUR J ENTOMOL, V95, P327; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAND MF, 1988, CONTEMP PHYS, V29, P435, DOI 10.1080/00107518808222601; Land MF, 2002, ANIMAL EYES; Li L, 2010, OPT EXPRESS, V18, P18125, DOI 10.1364/OE.18.018125; Lu CF, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4023962; NILSSON DE, 1988, NATURE, V332, P76, DOI 10.1038/332076a0; NILSSON DE, 1989, BIOSCIENCE, V39, P298, DOI 10.2307/1311112; Someya T., 2013, STRETCHABLE ELECT; Street RA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3129315; Tanida J, 2001, APPL OPTICS, V40, P1806, DOI 10.1364/AO.40.001806; Wang SD, 2010, SOFT MATTER, V6, P5757, DOI 10.1039/c0sm00579g; Warrant E, 2006, INVERTEBRATE VISION, pXIX; Wheeler W.M., 1910, ANTS THEIR STRUCTURE; Wild A, 2007, TAXONOMIC REVISION A; Xu X, 2008, ORG ELECTRON, V9, P1122, DOI 10.1016/j.orgel.2008.07.011; ZEIL J, 1979, NATURE, V278, P249, DOI 10.1038/278249a0	30	758	794	41	796	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					95	99		10.1038/nature12083	http://dx.doi.org/10.1038/nature12083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636401				2022-12-24	WOS:000318221500040
J	Whitty, CJM; Jones, M; Tollervey, A; Wheeler, T				Whitty, Christopher J. M.; Jones, Monty; Tollervey, Alan; Wheeler, Tim			Africa and Asia need a rational debate on GM crops	NATURE			English	Editorial Material							BETA-CAROTENE; VITAMIN-A; CHILDREN		[Whitty, Christopher J. M.] UK Dept Int Dev DFID, London, England; [Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London, England; [Jones, Monty] Forum Agr Res Africa, Accra, Ghana; [Wheeler, Tim] Univ Reading, Reading RG6 2AH, Berks, England	University of London; London School of Hygiene & Tropical Medicine; University of Reading	Whitty, CJM (corresponding author), UK Dept Int Dev DFID, London, England.	c-whitty@dfid.gov.uk		Whitty, Christopher/0000-0002-6076-5027				Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; Kijima Y, 2006, DEV ECON, V44, P252, DOI 10.1111/j.1746-1049.2006.00016.x; Owino O, 2012, NATURE; Renkow M, 2010, FOOD POLICY, V35, P391, DOI 10.1016/j.foodpol.2010.04.006; Tang GW, 2012, AM J CLIN NUTR, V96, P658, DOI 10.3945/ajcn.111.030775; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004	6	20	23	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					31	33		10.1038/497031a	http://dx.doi.org/10.1038/497031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	134OK	23636380	Bronze			2022-12-24	WOS:000318221500016
J	Riou, P; Kjaer, S; Garg, R; Purkiss, A; George, R; Cain, RJ; Bineva, G; Reymond, N; McColl, B; Thompson, AJ; O'Reilly, N; McDonald, NQ; Parker, PJ; Ridley, AJ				Riou, Philippe; Kjaer, Svend; Garg, Ritu; Purkiss, Andrew; George, Roger; Cain, Robert J.; Bineva, Ganka; Reymond, Nicolas; McColl, Brad; Thompson, Andrew J.; O'Reilly, Nicola; McDonald, Neil Q.; Parker, Peter J.; Ridley, Anne J.			14-3-3 Proteins Interact with a Hybrid Prenyl-Phosphorylation Motif to Inhibit G Proteins	CELL			English	Article							RHO-FAMILY; CELL-MIGRATION; CAAX MOTIF; BINDING; RAS; ORGANIZATION; GTPASES; KINASE; RAP1A; CYTOSKELETON	Signaling through G proteins normally involves conformational switching between GTP- and GDP-bound states. Several Rho GTPases are also regulated by RhoGDI binding and sequestering in the cytosol. Rnd proteins are atypical constitutively GTP- bound Rho proteins, whose regulation remains elusive. Here, we report a high-affinity 14-3-3-binding site at the C terminus of Rnd3 consisting of both the Cys241-farnesyl moiety and a Rho-associated coiled coil containing protein kinase (ROCK)-dependent Ser240 phosphorylation site. 14-3-3-binding to Rnd3 also involves phosphorylation of Ser218 by ROCK and/or Ser210 by protein kinase C (PKC). The crystal structure of a phosphorylated, farnesylated Rnd3 peptide with 14-3-3 reveals a hydrophobic groove in 14-3-3 proteins accommodating the farnesyl moiety. Functionally, 14-3-3 inhibits Rnd3-induced cell rounding by translocating it from the plasma membrane to the cytosol. Rnd1, Rnd2, and geranylgeranylated Rap1A interact similarly with 14-3-3. In contrast to the canonical GTP/GDP switch that regulates most Ras superfamily members, our results reveal an unprecedented mechanism for G protein inhibition by 14-3-3 proteins.	[Riou, Philippe; Garg, Ritu; Cain, Robert J.; Reymond, Nicolas; McColl, Brad; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, London SE1 1UL, England; [Thompson, Andrew J.] Kings Coll London, MRC, Ctr Neurodegenerat Res, London SE5 8AF, England; [Riou, Philippe; Parker, Peter J.] Canc Res UK London Res Inst, Prot Phosphorylat Lab, London WC2A 3LY, England; [Kjaer, Svend; George, Roger] Canc Res UK London Res Inst, Prot Purificat Facil, London WC2A 3LY, England; [Purkiss, Andrew; McDonald, Neil Q.] Canc Res UK London Res Inst, Struct Biol Lab, London WC2A 3LY, England; [Bineva, Ganka; O'Reilly, Nicola] Canc Res UK London Res Inst, Peptide Synth Lab, London WC2A 3LY, England; [Thompson, Andrew J.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [McDonald, Neil Q.] Univ London Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 7HX, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Birkbeck University London	Parker, PJ (corresponding author), Kings Coll London, Div Canc Studies, New Hunts House,Guys Campus, London SE1 1UL, England.	peter.parker@cancer.org.uk; anne.ridley@kcl.ac.uk	Thompson, Andrew/B-1463-2014; Parker, Peter j/D-5192-2013	Thompson, Andrew/0000-0003-2413-3281; Bineva-Todd, Ganka/0000-0001-8926-9417; parker, peter/0000-0002-6218-2933; Ridley, Anne/0000-0001-8186-5708; O'Reilly, Nicola/0000-0002-4204-6491	BBSRC; MRC; King's College London Wellcome Trust VIP Award; Cancer Research UK; King's College London BHF Centre of Excellence; CJ Martin fellowship; BBSRC [BB/E004083/2, BB/E004083/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E004083/1, BB/E004083/2] Funding Source: researchfish; Cancer Research UK [10747, 15683, 15961] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King's College London Wellcome Trust VIP Award; Cancer Research UK(Cancer Research UK); King's College London BHF Centre of Excellence; CJ Martin fellowship(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank Michael Yaffe (MIT) for communicating the interaction between 14-3-3 epsilon and Rnd3, providing 14-3-3 constructs, and discussions; Steen Hansen for the p190RhoGAP-B construct; Steve Lynham (Centre for Excellence in Mass Spectrometry, King's College London) for expert mass spectrometry assistance; Gavin Kelly (Cancer Research UK London Research Laboratories) for help with statistical analysis; and Jeroen Claus for designing the graphical abstract. We are grateful to members of the Ridley laboratory for helpful discussions. This work was supported by the BBSRC, MRC, a King's College London Wellcome Trust VIP Award, Cancer Research UK, and the King's College London BHF Centre of Excellence. B.M. was supported by a CJ Martin fellowship.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Foster R, 1996, MOL CELL BIOL, V16, P2689; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4	37	69	71	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					640	653		10.1016/j.cell.2013.03.044	http://dx.doi.org/10.1016/j.cell.2013.03.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622247	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000318063500016
J	Lynch, J; Maslin, M; Balzter, H; Sweeting, M				Lynch, Jim; Maslin, Mark; Balzter, Heiko; Sweeting, Martin			Choose satellites to monitor deforestation	NATURE			English	Editorial Material							FORESTS		[Lynch, Jim] Univ Surrey, Ctr Environm Strategy, Guildford GU2 5XH, Surrey, England; [Maslin, Mark] UCL, Dept Geog, London WC1E 6BT, England; [Balzter, Heiko] Univ Leicester, Ctr Landscape & Climate Res, Leicester LE1 7RH, Leics, England; [Sweeting, Martin] Univ Surrey, Surrey Space Ctr, Guildford GU2 5XH, Surrey, England	University of Surrey; University of London; University College London; University of Leicester; University of Surrey	Lynch, J (corresponding author), Univ Surrey, Ctr Environm Strategy, Guildford GU2 5XH, Surrey, England.	j.lynch@surrey.ac.uk	Balzter, Heiko/B-5976-2008	Balzter, Heiko/0000-0002-9053-4684; Maslin, Mark/0000-0001-9957-3463				[Anonymous], 2012, GREEN CARBON BLACK T; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Global Observation of Forest and Land Cover Dynamics, 2012, RED GREENH GAS EM DE; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Herold Martin, 2011, Carbon Balance Manag, V6, P13, DOI 10.1186/1750-0680-6-13; Maslin M, 2011, NATURE, V475, P445, DOI 10.1038/475445a	7	54	54	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2013	496	7445					293	294		10.1038/496293a	http://dx.doi.org/10.1038/496293a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	126FV	23598323				2022-12-24	WOS:000317599200012
J	Zhang, W; Shi, Y; Lu, XS; Shu, YL; Qi, JX; Gao, GF				Zhang, Wei; Shi, Yi; Lu, Xishan; Shu, Yuelong; Qi, Jianxun; Gao, George F.			An Airborne Transmissible Avian Influenza H5 Hemagglutinin Seen at the Atomic Level	SCIENCE			English	Article							A VIRUSES; RECEPTOR-BINDING; SWINE-ORIGIN	Recent studies have identified several mutations in the hemagglutinin (HA) protein that allow the highly pathogenic avian H5N1 influenza A virus to transmit between mammals by airborne route. Here, we determined the complex structures of wild-type and mutant HAs derived from an Indonesia H5N1 virus bound to either avian or human receptor sialic acid analogs. A cis/trans conformational change in the glycosidic linkage of the receptor analog was observed, which explains how the H5N1 virus alters its receptor-binding preference. Furthermore, the mutant HA possessed low affinities for both avian and human receptors. Our findings provide a structural and biophysical basis for the H5N1 adaptation to acquire human, but maintain avian, receptor-binding properties.	[Zhang, Wei; Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth RNIH, Beijing 100101, Peoples R China; [Zhang, Wei; Gao, George F.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lu, Xishan; Gao, George F.] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Shu, Yuelong; Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021		National 973 Project [2011CB504703]; National Natural Science Foundation of China (NSFC) [81290342]; China National Grand S&T Special Project [2013ZX10004-611]; NSFC [81021003]	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China National Grand S&T Special Project; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Project (grant 2011CB504703), the National Natural Science Foundation of China (NSFC, grant 81290342), and the China National Grand S&T Special Project (grant 2013ZX10004-611). G.F.G. is a leading principal investigator of the NSFC Innovative Research Group (grant 81021003). Assistance by the staff at the Shanghai Synchrotron Radiation Facility (SSRF-beamline 17U) and the KEK Synchrotron Radiation Facility (beamline 17A) is acknowledged. We are grateful to the Consortium for Functional Glycomics for providing the biotinylated SA analogs. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB code 4K62 for InH5, 4K63 for InH5/LSTa, 4K64 for InH5/LSTc, 4K65 for InH5mut, 4K66 for InH5mut/LSTa, and 4K67 for InH5mut/LSTc).	Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bragstad K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-43; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao RB., 2013, NEW ENGL J MED, V368, P1888; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhang W, 2013, J VIROL, V87, P5949, DOI 10.1128/JVI.00545-13; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1	25	96	110	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1463	1467		10.1126/science.1236787	http://dx.doi.org/10.1126/science.1236787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23641058				2022-12-24	WOS:000320647000045
J	Ashby, M				Ashby, Michael			Caring for dying patients is not about prolonging life at all costs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Ashby, Michael] Univ Tasmania, Royal Hobart Hosp, Southern Tasmania Area Hlth Serv, Hobart, Tas 7001, Australia; [Ashby, Michael] Univ Tasmania, Fac Hlth Sci, Hobart, Tas 7001, Australia	Royal Hobart Hospital; University of Tasmania; University of Tasmania	Ashby, M (corresponding author), Univ Tasmania, Royal Hobart Hosp, Southern Tasmania Area Hlth Serv, Hobart, Tas 7001, Australia.	michael.ashby@dhhs.tas.gov.au						[Anonymous], 1996, HASTINGS CTR REPOR S, V26, pS1; Ashby MA, 2013, MED J AUSTRALIA, V198, P188, DOI 10.5694/mja12.10498; Ashby MA, 2011, J BIOETHIC INQ, V8, P151, DOI 10.1007/s11673-011-9291-5; Breen E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1837; Economist Intelligence Unit, 2010, QUAL DEATH RANK END; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; Hanson MJ, 1999, GOALS MED FORGOTTEN; Hastings Center, J LYNN CALLS REF END; Kellehear A, 1999, HLTH PROMOTING PALLI	9	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2013	346								f3027	10.1136/bmj.f3027	http://dx.doi.org/10.1136/bmj.f3027			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158CZ	23714191				2022-12-24	WOS:000319947500004
J	Leprivier, G; Remke, M; Rotblat, B; Dubuc, A; Mateo, ARF; Kool, M; Agnihotri, S; El-Naggar, A; Yu, B; Somasekharan, SP; Faubert, B; Bridon, G; Tognon, CE; Mathers, J; Thomas, R; Li, A; Barokas, A; Kwok, B; Bowden, M; Smith, S; Wu, XC; Korshunov, A; Hielscher, T; Northcott, PA; Galpin, JD; Ahern, CA; Wang, Y; McCabe, MG; Collins, VP; Jones, RG; Pollak, M; Delattre, O; Gleave, ME; Jan, E; Pfister, SM; Proud, CG; Derry, WB; Taylor, MD; Sorensen, PH				Leprivier, Gabriel; Remke, Marc; Rotblat, Barak; Dubuc, Adrian; Mateo, Abigail-Rachele F.; Kool, Marcel; Agnihotri, Sameer; El-Naggar, Amal; Yu, Bin; Somasekharan, Syam Prakash; Faubert, Brandon; Bridon, Gaelle; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Bowden, Mary; Smith, Stephanie; Wu, Xiaochong; Korshunov, Andrey; Hielscher, Thomas; Northcott, Paul A.; Galpin, Jason D.; Ahern, Christopher A.; Wang, Ye; McCabe, Martin G.; Collins, V. Peter; Jones, Russell G.; Pollak, Michael; Delattre, Olivier; Gleave, Martin E.; Jan, Eric; Pfister, Stefan M.; Proud, Christopher G.; Derry, W. Brent; Taylor, Michael D.; Sorensen, Poul H.			The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation	CELL			English	Article							ETV6-NTRK3 GENE FUSION; TUMOR-CELL SURVIVAL; MESSENGER-RNA; PATHWAY; GROWTH; INHIBITION; PHOSPHORYLATION; PROLIFERATION; HOMEOSTASIS; METABOLISM	Metabolic adaptation is essential for cell survival during nutrient deprivation. We report that eukaryotic elongation factor 2 kinase (eEF2K), which is activated by AMP-kinase (AMPK), confers cell survival under acute nutrient depletion by blocking translation elongation. Tumor cells exploit this pathway to adapt to nutrient deprivation by reactivating the AMPK-eEF2K axis. Adaptation of transformed cells to nutrient withdrawal is severely compromised in cells lacking eEF2K. Moreover, eEF2K knockdown restored sensitivity to acute nutrient deprivation in highly resistant human tumor cell lines. In vivo, overexpression of eEF2K rendered murine tumors remarkably resistant to caloric restriction. Expression of eEF2K strongly correlated with overall survival in human medulloblastoma and glioblastoma multiforme. Finally, C. elegans strains deficient in efk-1, the eEF2K ortholog, were severely compromised in their response to nutrient depletion. Our data highlight a conserved role for eEF2K in protecting cells from nutrient deprivation and in conferring tumor cell adaptation to metabolic stress.	[Leprivier, Gabriel; Rotblat, Barak; El-Naggar, Amal; Somasekharan, Syam Prakash; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Sorensen, Poul H.] Univ British Columbia, British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L4, Canada; [Leprivier, Gabriel; Rotblat, Barak; El-Naggar, Amal; Somasekharan, Syam Prakash; Tognon, Cristina E.; Mathers, Joan; Thomas, Ryan; Li, Amy; Barokas, Adi; Kwok, Brian; Sorensen, Poul H.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1L4, Canada; [Remke, Marc; Dubuc, Adrian; Agnihotri, Sameer; Wu, Xiaochong; Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1L7, Canada; [Remke, Marc; Dubuc, Adrian; Agnihotri, Sameer; Wu, Xiaochong; Northcott, Paul A.; Taylor, Michael D.] Univ Toronto, Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1L7, Canada; [Remke, Marc; Dubuc, Adrian; Mateo, Abigail-Rachele F.; Wu, Xiaochong; Derry, W. Brent; Taylor, Michael D.] Univ Toronto, HSC, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Remke, Marc; Kool, Marcel; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Hielscher, Thomas] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany; [Mateo, Abigail-Rachele F.; Yu, Bin; Taylor, Michael D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 2M9, Canada; [Faubert, Brandon; Jones, Russell G.] McGill Univ, Dept Physiol, Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Bridon, Gaelle] McGill Univ, Goodman Canc Res Ctr, Metabol Core Facil, Montreal, PQ H3A 1A3, Canada; [Bowden, Mary; Smith, Stephanie; Gleave, Martin E.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V6H 3Z6, Canada; [Bowden, Mary; Smith, Stephanie; Gleave, Martin E.] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; [Korshunov, Andrey] Heidelberg Univ, DKFZ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Galpin, Jason D.; Ahern, Christopher A.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Wang, Ye; Pollak, Michael] Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada; [Wang, Ye; Pollak, Michael] McGill Univ, Montreal, PQ H3T 1E2, Canada; [McCabe, Martin G.] Univ Manchester, Sch Canc & Enabling Sci, Manchester M20 4BX, Lancs, England; [McCabe, Martin G.; Collins, V. Peter] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Delattre, Olivier] Inst Curie, INSERM, U830, Lab Genet & Biol Canc, F-75248 Paris, France; [Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Proud, Christopher G.] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; McGill University; McGill University; University of British Columbia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Iowa; McGill University; McGill University; University of Manchester; University of Cambridge; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of British Columbia; Ruprecht Karls University Heidelberg; University of Southampton	Sorensen, PH (corresponding author), Univ British Columbia, British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L4, Canada.	psor@mail.ubc.ca	Derry, Brent/CAF-4503-2022; Jones, Russell/AAC-2861-2022; McCabe, Martin/P-5896-2015; Jones, Russell Graham/ABD-5261-2021; Rotblat, Barak/H-5970-2019; AGNIHOTRI, SAMEER/HHS-2255-2022; Northcott, Paul A/N-4022-2018; Kool, Marcel/H-2541-2013; Pfister, Stefan M/F-6860-2013; Jan, Eric/O-1923-2019; EL-Naggar, Amal/AAE-5565-2022	McCabe, Martin/0000-0002-5138-0707; Jones, Russell Graham/0000-0003-2250-4675; Rotblat, Barak/0000-0003-2985-7115; AGNIHOTRI, SAMEER/0000-0001-6584-3795; Northcott, Paul A/0000-0002-1220-5252; Pfister, Stefan M/0000-0002-5447-5322; Gleave, Martin/0000-0003-4235-0167; Korshunov, Andrey/0000-0002-5257-3623; delattre, olivier/0000-0002-8730-2276; Somasekharan, Syam/0000-0002-9006-8206; EL-Naggar, Amal/0000-0002-3202-6171; Derry, Brent/0000-0002-1977-8475; Pollak, Michael/0000-0003-3047-0604; Ahern, Christopher/0000-0002-7975-2744; Remke, Marc/0000-0002-9404-9993; Proud, Christopher/0000-0003-0704-6442; Faubert, Brandon/0000-0002-2886-886X; Taylor, Michael/0000-0001-7009-3466; Galpin, Jason/0000-0003-1923-5312	Canadian Cancer Society Research Institute; British Columbia Cancer Foundation; National Institutes of Health [CA159859]; Terry Fox Research Institute; Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA159859] Funding Source: NIH RePORTER; The Brain Tumour Charity [10/106] Funding Source: researchfish	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); British Columbia Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Fox Research Institute; Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Brain Tumour Charity	We thank T. Tang, M. Robertson, and C. Chow for technical assistance and B. Fonseca (McGill University), S. Aparicio, S. Mullaly, T. Ng (UBC), J.A. Pospisilik, and R. Teperino (Max Planck Institute, Freiburg) for helpful discussions. This work was supported by the Canadian Cancer Society Research Institute and the British Columbia Cancer Foundation (to P.H.S.) through generous donations from Team Finn and other riders in the Ride to Conquer Cancer and by the National Institutes of Health (CA159859), the Terry Fox Research Institute, and the Pediatric Brain Tumor Foundation (to M.D.T.).	Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; BRENNER S, 1974, GENETICS, V77, P71; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Caro-Maldonado A., 2011, OPEN CELL SIGNAL J, V3, P42, DOI DOI 10.2174/1876390101103010042; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Sakagami H, 2002, NEUROSCI LETT, V330, P41, DOI 10.1016/S0304-3940(02)00715-2; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Somasekharan Syam Prakash, 2012, J Proteomics, V77, pe1, DOI 10.1016/j.jprot.2012.08.019; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wu H, 2006, CANCER RES, V66, P3015, DOI 10.1158/0008-5472.CAN-05-1554; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	276	289	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1064	1079		10.1016/j.cell.2013.04.055	http://dx.doi.org/10.1016/j.cell.2013.04.055			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706743	Green Accepted, Bronze			2022-12-24	WOS:000319456800014
J	Benner, EJ; Luciano, D; Jo, R; Abdi, K; Paez-Gonzalez, P; Sheng, HX; Warner, DS; Liu, CL; Eroglu, C; Kuo, CT				Benner, Eric J.; Luciano, Dominic; Jo, Rebecca; Abdi, Khadar; Paez-Gonzalez, Patricia; Sheng, Huaxin; Warner, David S.; Liu, Chunlei; Eroglu, Cagla; Kuo, Chay T.			Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4	NATURE			English	Article							ADULT SUBVENTRICULAR ZONE; CEREBRAL-ISCHEMIA; STEM-CELL; ASTROCYTES; THROMBOSPONDIN-4; GLIOGENESIS; NEUROBLASTS; RECOVERY; REVEALS; REPAIR	Postnatal/adult neural stem cells (NSCs) within the rodent subventricular zone (SVZ; also called subependymal zone) generate doublecortin (Dcx)(+) neuroblasts that migrate and integrate into olfactory bulb circuitry(1,2). Continuous production of neuroblasts is controlled by the SVZ microenvironmental niche(3,4). It is generally thought that enhancing the neurogenic activities of endogenous NSCs may provide needed therapeutic options for disease states and after brain injury. However, SVZ NSCs can also differentiate into astrocytes. It remains unclear whether there are conditions that favour astrogenesis over neurogenesis in the SVZ niche, and whether astrocytes produced there have different properties compared with astrocytes produced elsewhere in the brain(5). Here we show in mice that SVZ-generated astrocytes express high levels of thrombospondin 4 (Thbs4)(6,7), a secreted homopentameric glycoprotein, in contrast to cortical astrocytes, which express low levels of Thbs4. We found that localized photothrombotic/ischaemic cortical injury initiates a marked increase in Thbs4(hi) astrocyte production from the postnatal SVZ niche. Tamoxifen-inducible nestin-creER(tm)4 lineage tracing demonstrated that it is these SVZ-generated Thbs4(hi) astrocytes, and not Dcx(+) neuroblasts, that home-in on the injured cortex. This robust post-injury astrogenic response required SVZ Notch activation modulated by Thbs4 via direct Notch1 receptor binding and endocytosis to activate downstream signals, including increased Nfia transcription factor expression important for glia production(8). Consequently, Thbs4 homozygous knockout mice (Thbs4(KO/KO)) showed severe defects in cortical-injury-induced SVZ astrogenesis, instead producing cells expressing Dcx migrating from SVZ to the injury sites. These alterations in cellular responses resulted in abnormal glial scar formation after injury, and significantly increased microvascular haemorrhage into the brain parenchyma of Thbs4(KO/KO) mice. Taken together, these findings have important implications for post-injury applications of endogenous and transplanted NSCs in the therapeutic setting, as well as disease states where Thbs family members have important roles(9,10).	[Benner, Eric J.; Jo, Rebecca; Kuo, Chay T.] Duke Univ, Sch Med, Dept Pediat, George & Jean Brumley Neonatal Perinatal Res Inst, Durham, NC 27710 USA; [Luciano, Dominic; Jo, Rebecca; Abdi, Khadar; Paez-Gonzalez, Patricia; Eroglu, Cagla; Kuo, Chay T.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Luciano, Dominic; Eroglu, Cagla; Kuo, Chay T.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA; [Sheng, Huaxin; Warner, David S.] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC 27710 USA; [Liu, Chunlei] Duke Univ, Sch Med, Dept Radiol, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; [Liu, Chunlei] Duke Univ, Sch Med, Dept Radiol, Durham, NC 27710 USA; [Eroglu, Cagla; Kuo, Chay T.] Duke Univ, Sch Med, Duke Inst Brain Sci, Durham, NC 27710 USA; [Kuo, Chay T.] Duke Univ, Sch Med, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Kuo, CT (corresponding author), Duke Univ, Sch Med, Dept Pediat, George & Jean Brumley Neonatal Perinatal Res Inst, Durham, NC 27710 USA.	chay.kuo@duke.edu	Eroglu, Cagla/P-5315-2014; Paez-Gonzalez, Patricia/E-5069-2018	Eroglu, Cagla/0000-0002-7204-0218; Paez-Gonzalez, Patricia/0000-0002-6786-3869; Liu, Chunlei/0000-0001-8816-4832	National Biomedical Technology Resource Center [P41 RR005959, P41 EB015897]; George and Jean Brumley Endowment; Sontag Foundation; David and Lucile Packard Foundation; March of Dimes; NIH [1 DP2 OD004453-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031833] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004453] Funding Source: NIH RePORTER	National Biomedical Technology Resource Center; George and Jean Brumley Endowment; Sontag Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Melton (Harvard) for R26R-NICD mice; T. Honjo (Kyoto) for RBPjk-flox mice; F. Wang for R26R-tdTomato mice; E. Rawlins (Cambridge) for Foxj1-creER<SUP>t2</SUP> mice; B. Deneen (B. C. M.) and S. Singh for discussions; G. Lyons, R. Andersen, P. Heine, D. Fromme and S. Collins for project assistance; Duke Flow Cytometry Facility for help with FACS; W. Li and Duke Center for In vivo microscopy/brain imaging for MRI analyses; and T. Lechler, A. West and B. Hogan for comments on manuscript. This work was supported by National Biomedical Technology Resource Center Grant P41 RR005959 (C. L.) of P41 EB015897 to Duke Center for In Vivo Microscopy; George and Jean Brumley Endowment, Sontag Foundation, David and Lucile Packard Foundation, March of Dimes, and NIH Director's New Innovator Award 1 DP2 OD004453-01 (C.T.K.).	Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Eroglu C, 2009, J CELL COMMUN SIGNAL, V3, P167, DOI 10.1007/s12079-009-0078-y; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Johnson GA, 2002, RADIOLOGY, V222, P789, DOI 10.1148/radiol.2223010531; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; Lee JK, 2007, SURG NEUROL, V67, P620, DOI 10.1016/j.surneu.2006.08.077; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxwell KA, 2005, DEV NEUROSCI-BASEL, V27, P121, DOI 10.1159/000085983; McDowell KA, 2010, J NEUROSCI, V30, P7453, DOI 10.1523/JNEUROSCI.3997-09.2010; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; MOSELEY ME, 1993, STROKE, V24, pI60; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Paez-Gonzalez P, 2011, NEURON, V71, P61, DOI 10.1016/j.neuron.2011.05.029; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X	39	189	198	2	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					369	+		10.1038/nature12069	http://dx.doi.org/10.1038/nature12069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23615612	Green Accepted, Green Submitted			2022-12-24	WOS:000318952000038
J	McCartney, M				McCartney, Margaret			The private clinics that advertise unlicensed measles jabs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Advertising Standards Authority, 2012, ASA ADJ BABYJABS LTD; Beck S, 2006, DAILY MAIL; Bignell P., 2012, INDEPENDENT; Bloom Sharon, 2005, BMJ, V331, pE363, DOI 10.1136/bmj.331.7508.E363; Children's Immunisation Centre, AUTISM; Clarion Health, MMR SINGL VACC; General Medical Council, 2013, GOOD MED PRACTICE; Independent Family Healthcare, YOUR HLTH YOUR CHOIC; MHRA, ADV COMPL BREAKSP ME; MHRA, 2012, MED MUMPS VACC; MHRA, 2008, ADV COMPL SINGL COMP; MMR Single Vaccination Clinic, WELC; Reid S, 2012, DAILY MAIL	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2013	346								f2830	10.1136/bmj.f2830	http://dx.doi.org/10.1136/bmj.f2830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139EK	23635546				2022-12-24	WOS:000318564300022
J	Shen, L; Wu, H; Diep, D; Yamaguchi, S; D'Alessio, AC; Fung, HL; Zhang, K; Zhang, Y				Shen, Li; Wu, Hao; Diep, Dinh; Yamaguchi, Shinpei; D'Alessio, Ana C.; Fung, Ho-Lim; Zhang, Kun; Zhang, Yi			Genome-wide Analysis Reveals TET- and TDG-Dependent 5-Methylcytosine Oxidation Dynamics	CELL			English	Article							EMBRYONIC STEM-CELLS; THYMINE DNA GLYCOSYLASE; GENE-EXPRESSION; POSTNATAL-DEVELOPMENT; METHYLATION PATTERNS; BASE-RESOLUTION; MAMMALIAN DNA; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; CHROMATIN	TET dioxygenases successively oxidize 5-methylcytosine (5mC) in mammalian genomes to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). 5fC/5caC can be excised and repaired to regenerate unmodified cytosines by thymine-DNA glycosylase (TDG) and base excision repair (BER) pathway, but it is unclear to what extent and at which part of the genome this active demethylation process takes place. Here, we have generated genome-wide distribution maps of 5hmC/5fC/5caC using modification-specific antibodies in wild-type and Tdg-deficient mouse embryonic stem cells (ESCs). In wild-type mouse ESCs, 5fC/5caC accumulates to detectable levels at major satellite repeats but not at nonrepetitive loci. In contrast, Tdg depletion in mouse ESCs causes marked accumulation of 5fC and 5caC at a large number of proximal and distal gene regulatory elements. Thus, these results reveal the genome-wide view of iterative 5mC oxidation dynamics and indicate that TET/TDG-dependent active DNA demethylation process occurs extensively in the mammalian genome.	[Shen, Li; Wu, Hao; Yamaguchi, Shinpei; D'Alessio, Ana C.; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Shen, Li; Wu, Hao; Yamaguchi, Shinpei; D'Alessio, Ana C.; Zhang, Yi] Harvard Univ, Sch Med, Program Cellular & Mol Med, Boston, MA 02115 USA; [Shen, Li; Wu, Hao; Yamaguchi, Shinpei; D'Alessio, Ana C.; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Wu, Hao] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Diep, Dinh; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; University of California System; University of California San Diego	Wu, H (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, WAB-149G,200 Longwood Ave, Boston, MA 02115 USA.	haowu7@gmail.com; yzhang@genetics.med.harvard.edu	Wu, Hao/G-4145-2013; Zhang, Kun/ABE-6349-2020; Yamaguchi, Shinpei/HCH-5553-2022; Wu, Hao/H-3899-2017	Wu, Hao/0000-0002-1256-6891; Zhang, Kun/0000-0002-7596-5224; Wu, Hao/0000-0003-1269-7354; Yamaguchi, Shinpei/0000-0002-9377-4835; Wu, Hao/0000-0003-4395-6929; Zhang, Yi/0000-0002-2789-0811	NIH [U01DK089565, R01GM097253]; Jane Coffin Childs Funds for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Funds for Medical Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Jin He and Falong Lu for their helpful discussions. This project is supported by NIH grant U01DK089565 (to Y.Z.) and R01GM097253 (to K.Z.). H.W. is supported by a postdoctoral fellowship (Merck Fellow) from Jane Coffin Childs Funds for Medical Research. D.D. is a CIRM predoctoral fellow. Y.Z. is an investigator of the Howard Hughes Medical Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nakamura J, 1998, CANCER RES, V58, P222; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Song CX, 2012, NAT BIOTECHNOL, V30, P1107, DOI 10.1038/nbt.2398; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	73	362	374	4	108	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					692	706		10.1016/j.cell.2013.04.002	http://dx.doi.org/10.1016/j.cell.2013.04.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23602152	Bronze, Green Accepted			2022-12-24	WOS:000318063500020
J	Suteewong, T; Sai, H; Hovden, R; Muller, D; Bradbury, MS; Gruner, SM; Wiesner, U				Suteewong, Teeraporn; Sai, Hiroaki; Hovden, Robert; Muller, David; Bradbury, Michelle S.; Gruner, Sol M.; Wiesner, Ulrich			Multicompartment Mesoporous Silica Nanoparticles with Branched Shapes: An Epitaxial Growth Mechanism	SCIENCE			English	Article							INDUCED PHASE-TRANSFORMATION; CAGE-TYPE; CRYSTALS; P6MM; PM(3)OVER-BARN; PACKING	Mesoporous nanomaterials have attracted widespread interest because of their structural versatility for applications including catalysis, separation, and nanomedicine. We report a one-pot synthesis method for a class of mesoporous silica nanoparticles (MSNs) containing both cubic and hexagonally structured compartments within one particle. These multicompartment MSNs (mc-MSNs) consist of a core with cage-like cubic mesoporous morphology and up to four branches with hexagonally packed cylindrical mesopores epitaxially growing out of the cubic core vertices. The extent of cylindrical mesostructure growth can be controlled via a single additive in the synthesis. Results suggest a path toward high levels of architectural complexity in locally amorphous, mesostructured nanoparticles, which could enable tuning of different pore environments of the same particle for specific chemistries in catalysis or drug delivery.	[Suteewong, Teeraporn; Sai, Hiroaki; Wiesner, Ulrich] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Suteewong, Teeraporn; Bradbury, Michelle S.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Hovden, Robert; Muller, David] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Muller, David; Gruner, Sol M.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, CHESS, Ithaca, NY 14853 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Wiesner, U (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	ubw1@cornell.edu	Gruner, Sol/G-2924-2010; Muller, David/A-7745-2010; Sai, Hiroaki/C-9970-2014	Gruner, Sol/0000-0002-1171-4426; Muller, David/0000-0003-4129-0473; Sai, Hiroaki/0000-0002-4268-2148	NSF [DMR-1104773]; Partnership for Research and Education in Materials (PREM) program at Norfolk State University through NSF [DMR-1205457]; Cornell Center for Materials Research; NSF Materials Research Science and Engineering Centers program [DMR-1120296]; National Institute of General Medical Sciences under NSF [DMR-0936384]; Thai Government Scholarship under the Ministry of Science and Technology; NATIONAL CANCER INSTITUTE [R01CA161280] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1104773] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Partnership for Research and Education in Materials (PREM) program at Norfolk State University through NSF; Cornell Center for Materials Research; NSF Materials Research Science and Engineering Centers program; National Institute of General Medical Sciences under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Thai Government Scholarship under the Ministry of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by NSF single-investigator grant DMR-1104773 and by a Partnership for Research and Education in Materials (PREM) program at Norfolk State University through NSF grant DMR-1205457. We thank L. Estroff, R. Dieckmann, and K. Hur (Cornell University) for discussions on multiple branch growth and K. W. Tan (Cornell University) for assistance with EM. This work made use of the TEM and STEM supported by the Cornell Center for Materials Research with support from the NSF Materials Research Science and Engineering Centers program (DMR-1120296), and CHESS, which is supported by the NSF and the National Institute of General Medical Sciences under NSF award DMR-0936384. T.S. is grateful for a Thai Government Scholarship under the Ministry of Science and Technology.	Atluri R, 2010, MICROPOR MESOPOR MAT, V133, P27, DOI 10.1016/j.micromeso.2010.04.007; Atluri R, 2009, LANGMUIR, V25, P3189, DOI 10.1021/la803727u; Chandrawati R, 2011, J PHYS CHEM LETT, V2, P2639, DOI 10.1021/jz200994n; Che SN, 2001, J AM CHEM SOC, V123, P12089, DOI 10.1021/ja0118237; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; DITTERT LW, 1963, J PHARM SCI, V52, P852, DOI 10.1002/jps.2600520908; Han L, 2011, J AM CHEM SOC, V133, P11524, DOI 10.1021/ja200683t; Han L, 2009, CHEM-EUR J, V15, P2818, DOI 10.1002/chem.200801688; Hoffmann F, 2006, ANGEW CHEM INT EDIT, V45, P3216, DOI 10.1002/anie.200503075; Kamiya S, 2003, SOLID STATE SCI, V5, P197, DOI 10.1016/S1293-2558(02)00094-8; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; Manna L, 2003, NAT MATER, V2, P382, DOI 10.1038/nmat902; Ogura M, 2004, J AM CHEM SOC, V126, P10937, DOI 10.1021/ja047785j; Schulz-Ekloff G, 1999, INT J INORG MATER, V1, P97, DOI 10.1016/S1463-0176(99)00015-0; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Srinivasu P, 2006, CATAL TODAY, V111, P379, DOI 10.1016/j.cattod.2005.10.049; Suteewong T, 2012, CHEM MATER, V24, P3895, DOI 10.1021/cm301857e; Suteewong T, 2011, J AM CHEM SOC, V133, P172, DOI 10.1021/ja1061664; Suteewong T, 2010, J MATER CHEM, V20, P7807, DOI 10.1039/c0jm01002b; Talapin DV, 2007, NANO LETT, V7, P2951, DOI 10.1021/nl072003g; Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Xiao CH, 2012, NATURE, V487, P349, DOI 10.1038/nature11230; YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165	26	131	133	11	433	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					337	341		10.1126/science.1231391	http://dx.doi.org/10.1126/science.1231391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599490	Green Accepted			2022-12-24	WOS:000317657500051
J	Malinowski, JT; Sharpe, RJ; Johnson, JS				Malinowski, Justin T.; Sharpe, Robert J.; Johnson, Jeffrey S.			Enantioselective Synthesis of Pactamycin, a Complex Antitumor Antibiotic	SCIENCE			English	Article							ASYMMETRIC MANNICH REACTIONS; NATURAL-PRODUCTS; ACYL IMINES; CORE	Medicinal application of many complex natural products is precluded by the impracticality of their chemical synthesis. Pactamycin, the most structurally intricate aminocyclopentitol antibiotic, displays potent antiproliferative properties across multiple phylogenetic domains, but it is highly cytotoxic. A limited number of analogs produced by genetic engineering technologies show reduced cytotoxicity against mammalian cells, renewing promise for therapeutic applications. For decades, an efficient synthesis of pactamycin amenable to analog derivatizations has eluded researchers. Here, we present a short asymmetric total synthesis of pactamycin. An enantioselective Mannich reaction and symmetry-breaking reduction sequence was designed to enable assembly of the entire carbon core skeleton in under five steps and control critical three-dimensional (stereochemical) functional group relationships. This modular route totals 15 steps and is immediately amenable for structural analog synthesis.	[Malinowski, Justin T.; Sharpe, Robert J.; Johnson, Jeffrey S.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Johnson, JS (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	jsj@unc.edu			National Institute of General Medical Sciences [R01 GM084927]; American Chemical Society Division of Organic Chemistry; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084927] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Chemical Society Division of Organic Chemistry(American Chemical Society); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by award no. R01 GM084927 from the National Institute of General Medical Sciences. J.T.M. acknowledges an American Chemical Society Division of Organic Chemistry graduate fellowship. R.J.S acknowledges an NSF graduate research fellowship. X-ray crystallography was performed by P. White (University of North Carolina). The Cambridge Crystallographic Data Centre (CCDC) contains the supplementary crystallographic data for this paper, under deposition no. 914582. These data can be obtained free of charge from via www.ccdc.cam.ac.uk/data_request/cif. A patent application on the route and compounds presented in this paper has been filed through the University of North Carolina.	Argoudelis A. D., 1962, ANTIMICROB AGENTS CH, V1962, P191; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; DOBASHI K, 1986, J ANTIBIOT, V39, P1779, DOI 10.7164/antibiotics.39.1779; Drahl C, 2005, ANGEW CHEM INT EDIT, V44, P5788, DOI 10.1002/anie.200500900; Duchamp D. J., 1972, AM CRYST ASS WINT M; Hanessian S, 2011, ANGEW CHEM INT EDIT, V50, P3497, DOI 10.1002/anie.201008079; Hanessian S, 2012, J ORG CHEM, V77, P9458, DOI 10.1021/jo301638z; Haussener TJ, 2012, ORG LETT, V14, P3632, DOI 10.1021/ol301461e; Iwatsuki M, 2012, J ANTIBIOT, V65, P169, DOI 10.1038/ja.2011.136; Keasling JD, 2012, NATURE, V492, P188, DOI 10.1038/492188a; Knapp S, 2007, ORG LETT, V9, P1359, DOI 10.1021/ol0702472; Li Y, 2007, J ORG CHEM, V72, P2344, DOI 10.1021/jo061456n; Lou S, 2005, J AM CHEM SOC, V127, P11256, DOI 10.1021/ja0537373; Lu WL, 2011, CHEM BIOL, V18, P425, DOI 10.1016/j.chembiol.2011.01.016; Malinowski JT, 2012, ORG LETT, V14, P2878, DOI 10.1021/ol301140c; Matsumoto N, 2012, RSC ADV, V2, P9448, DOI 10.1039/c2ra21060f; Nakanishi K., 1999, COMPREHENSIVE NATURA, V1, P23; Otoguro K, 2010, J ANTIBIOT, V63, P381, DOI 10.1038/ja.2010.50; PEARLMAN WM, 1967, TETRAHEDRON LETT, P1663; Serrano P, 2002, J ORG CHEM, V67, P7165, DOI 10.1021/jo0261146; Shi L, 2010, ANGEW CHEM INT EDIT, V49, P9250, DOI 10.1002/anie.201005156; Ting A, 2006, ORG LETT, V8, P2003, DOI 10.1021/ol060304b; Trost BM, 1999, J AM CHEM SOC, V121, P6183, DOI 10.1021/ja9901821; Tsujimoto T, 2005, SYNLETT, P433, DOI 10.1055/s-2004-837223; VERLAAK JMJ, 1982, TETRAHEDRON LETT, V23, P5463; von Nussbaum F, 2006, ANGEW CHEM INT EDIT, V45, P5072, DOI 10.1002/anie.200600350; WELLER DD, 1978, J ANTIBIOT, V31, P997, DOI 10.7164/antibiotics.31.997; WILEY PF, 1970, J ORG CHEM, V35, P1420, DOI 10.1021/jo00830a035	30	78	78	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					180	182		10.1126/science.1234756	http://dx.doi.org/10.1126/science.1234756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580525	Green Accepted, Green Submitted			2022-12-24	WOS:000317341400051
J	Callen, E; Di Virgilio, M; Kruhlak, MJ; Nieto-Soler, M; Wong, N; Chen, HT; Faryabi, RB; Polato, F; Santos, M; Starnes, LM; Wesemann, DR; Lee, JE; Tubbs, A; Sleckman, BP; Daniel, JA; Ge, K; Alt, FW; Fernandez-Capetillo, O; Nussenzweig, MC; Nussenzweig, A				Callen, Elsa; Di Virgilio, Michela; Kruhlak, Michael J.; Nieto-Soler, Maria; Wong, Nancy; Chen, Hua-Tang; Faryabi, Robert B.; Polato, Federica; Santos, Margarida; Starnes, Linda M.; Wesemann, Duane R.; Lee, Ji-Eun; Tubbs, Anthony; Sleckman, Barry P.; Daniel, Jeremy A.; Ge, Kai; Alt, Frederick W.; Fernandez-Capetillo, Oscar; Nussenzweig, Michel C.; Nussenzweig, Andre			53BP1 Mediates Productive and Mutagenic DNA Repair through Distinct Phosphoprotein Interactions	CELL			English	Article							CLASS SWITCH RECOMBINATION; LYSINE-4 METHYLTRANSFERASE COMPLEX; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; END RESECTION; BRCT-DOMAIN; DYSFUNCTIONAL TELOMERES; B-CELLS; PTIP; RIF1	The DNA damage response (DDR) protein 53BP1 protects DNA ends from excessive resection in G1, and thereby favors repair by nonhomologous end-joining (NHEJ) as opposed to homologous recombination (HR). During S phase, BRCA1 antagonizes 53BP1 to promote HR. The pro-NHEJ and antirecombinase functions of 53BP1 are mediated in part by RIF1, the only known factor that requires 53BP1 phosphorylation for its recruitment to double-strand breaks (DSBs). Here, we show that a 53BP1 phosphomutant, 53BP1(8A), comprising alanine substitutions of the eight most N-terminal S/TQ phosphorylation sites, mimics 53BP1 deficiency by restoring genome stability in BRCA1-deficient cells yet behaves like wild-type 53BP1 with respect to immunoglobulin class switch recombination (CSR). 53BP1(8A) recruits RIF1 but fails to recruit the DDR protein PTIP to DSBs, and disruption of PTIP phenocopies 53BP1(8A). We conclude that 53BP1 promotes productive CSR and suppresses mutagenic DNA repair through distinct phosphodependent interactions with RIF1 and PTIP.	[Callen, Elsa; Wong, Nancy; Chen, Hua-Tang; Faryabi, Robert B.; Polato, Federica; Santos, Margarida; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Di Virgilio, Michela; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Di Virgilio, Michela; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Nieto-Soler, Maria; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Gen Instabil Grp, Madrid 28029, Spain; [Santos, Margarida; Daniel, Jeremy A.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Wesemann, Duane R.; Alt, Frederick W.] Childrens Hosp, Program Cellular & Mol Med, Immune Dis Inst, Boston, MA 02115 USA; [Wesemann, Duane R.; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lee, Ji-Eun; Ge, Kai] NIDDKD, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Tubbs, Anthony; Sleckman, Barry P.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Copenhagen; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Washington University (WUSTL)	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Faryabi, Robert/AAN-5512-2020; Fernandez-Capetillo, Oscar/H-3508-2015; Nussenzweig, Michel/AAE-7292-2019; Faryabi, Robert B/H-3544-2015; Santos, Margarida/GWR-2285-2022; Polato, Federica/Q-1803-2018; Lee, Ji-Eun/F-7891-2011; Ge, Kai/H-2810-2019; Daniel, Jeremy/S-4729-2016; Di Virgilio, Michela/AAE-9298-2022	Faryabi, Robert/0000-0002-7931-2175; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Faryabi, Robert B/0000-0002-7931-2175; Lee, Ji-Eun/0000-0002-3768-7016; Ge, Kai/0000-0002-7442-5138; Daniel, Jeremy/0000-0002-1981-5571; Tubbs, Anthony/0000-0002-5605-8231; Nieto-Soler, Maria/0000-0002-4334-6533; Wesemann, Duane/0000-0002-6690-944X; Starnes, Linda/0000-0002-7322-9928; Di Virgilio, Michela/0000-0001-5189-0793	NIH [AI89972]; American Association of Allergy Asthma and Immunology and CSL Behring; Career Award for Medical Scientists (Burroughs Wellcome Fund); Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; Department of Defense grant [BC102335]; NATIONAL CANCER INSTITUTE [ZICBC010915, ZICBC009255, Z01BC010959, ZIABC010283, Z01BC010283, ZIABC010959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074953, R01AI047829, K08AI089972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075017, ZIADK047055, ZIADK075003] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Allergy Asthma and Immunology and CSL Behring; Career Award for Medical Scientists (Burroughs Wellcome Fund); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the A. Nussenzweig lab and Davide Robbiani for discussions; Titia de Lange for RIF1f/f mice; Susan Sharrow for flow cytometry; and Sandy Chang for the TRF2 shRNA construct. M.C.N., F.W.A and O.F.-C. are HHMI investigators. D.R.W. was supported by NIH grants AI89972, the American Association of Allergy Asthma and Immunology and CSL Behring, and a Career Award for Medical Scientists (Burroughs Wellcome Fund). This work was supported by the Intramural Research Program of the NIH, the National Cancer Institute, and the Center for Cancer Research, and by a Department of Defense grant to A.N. (BC102335).	Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Boboila C, 2010, P NATL ACAD SCI USA, V107, P3034, DOI 10.1073/pnas.0915067107; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bowman-Colin C, 2013, P NATL ACAD SCI USA, V110, P8632, DOI 10.1073/pnas.1305362110; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Callen E, 2012, IMMUNITY, V37, P971, DOI 10.1016/j.immuni.2012.10.007; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Lottersberger F., 2013, P NATL ACAD SCI US; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wang X, 2010, GENES CELLS, V15, P243, DOI 10.1111/j.1365-2443.2009.01379.x; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wesemann DR, 2011, J EXP MED, V208, P2733, DOI 10.1084/jem.20111155; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	53	246	249	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 6	2013	153	6					1266	1280		10.1016/j.cell.2013.05.023	http://dx.doi.org/10.1016/j.cell.2013.05.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23727112	Green Accepted, Bronze			2022-12-24	WOS:000319979200012
J	Kay, M				Kay, Meera			Unsafe abortion: why restricting abortive drugs only makes a bad situation worse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDIA					meerakay@ymail.com						AHMAN E., 2011, UNSAFE ABORTION GLOB; Banerjee S, 2009, EXPLORING PATHWAYS U; Duggal R, 2004, REPROD HEALTH MATTER, V12, P122, DOI 10.1016/S0968-8080(04)24009-5; Ganatra B, 2005, REPROD HEALTH MATTER, V13, P65, DOI 10.1016/S0968-8080(05)26215-8; Indian Council of Medical Research, 1989, ILL AB RUR AR TASK F; International Consortium for Medical Abortion, COUNTR AB PROF IND; International Pregnancy Advisory Services (Ipas) India, DIS MED AB DRUGS FAC; Jain A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1957; Ministry of Health and Family Welfare, 2011, FAM WELF STAT IND	9	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2013	346								f3159	10.1136/bmj.f3159	http://dx.doi.org/10.1136/bmj.f3159			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	158DQ	23729428				2022-12-24	WOS:000319949200002
J	Smith, K				Smith, Kerri			NEUROSCIENCE Off to night school	NATURE			English	Editorial Material							SLEEP; COHERENCE; REPLAY; MEMORY											Aton SJ, 2013, P NATL ACAD SCI USA, V110, P3101, DOI 10.1073/pnas.1208093110; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Mander BA, 2013, NAT NEUROSCI, V16, P357, DOI 10.1038/nn.3324; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Wamsley EJ, 2012, BIOL PSYCHIAT, V71, P154, DOI 10.1016/j.biopsych.2011.08.008; Wilhelm I, 2013, NAT NEUROSCI, V16, P391, DOI 10.1038/nn.3343	9	5	5	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					S4	S5		10.1038/497S4a	http://dx.doi.org/10.1038/497S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23698506				2022-12-24	WOS:000319254000003
J	Bleich, SN; Rutkow, L				Bleich, Sara N.; Rutkow, Lainie			Improving Obesity Prevention at the Local Level - Emerging Opportunities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bleich, Sara N.; Rutkow, Lainie] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bleich, SN (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.			Rutkow, Helaine/0000-0001-6423-7291				Agency for Healthcare Research and Quality, 2011, AHRQ PUBLICATION, V10; Bleich SN, 2012, AM J PUBLIC HEALTH, V102, P329, DOI 10.2105/AJPH.2011.300350; Downs JS, 2009, AM ECON REV, V99, P159, DOI 10.1257/aer.99.2.159; Dowray S, 2013, APPETITE, V62, P173, DOI 10.1016/j.appet.2012.11.013; Jargon J., 2009, WALL STREET J	5	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1761	1763		10.1056/NEJMp1301685	http://dx.doi.org/10.1056/NEJMp1301685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138WA	23656641				2022-12-24	WOS:000318540000001
J	Fletcher, JM; Harniman, RL; Barnes, FRH; Boyle, AL; Collins, A; Mantell, J; Sharp, TH; Antognozzi, M; Booth, PJ; Linden, N; Miles, MJ; Sessions, RB; Verkade, P; Woolfson, DN				Fletcher, Jordan M.; Harniman, Robert L.; Barnes, Frederick R. H.; Boyle, Aimee L.; Collins, Andrew; Mantell, Judith; Sharp, Thomas H.; Antognozzi, Massimo; Booth, Paula J.; Linden, Noah; Miles, Mervyn J.; Sessions, Richard B.; Verkade, Paul; Woolfson, Derek N.			Self-Assembling Cages from Coiled-Coil Peptide Modules	SCIENCE			English	Article							SYNTHETIC BIOLOGY; PROTEIN; DESIGN; OLIGOMERS; SYSTEMS; CORE	An ability to mimic the boundaries of biological compartments would improve our understanding of self-assembly and provide routes to new materials for the delivery of drugs and biologicals and the development of protocells. We show that short designed peptides can be combined to form unilamellar spheres approximately 100 nanometers in diameter. The design comprises two, noncovalent, heterodimeric and homotrimeric coiled-coil bundles. These are joined back to back to render two complementary hubs, which when mixed form hexagonal networks that close to form cages. This design strategy offers control over chemistry, self-assembly, reversibility, and size of such particles.	[Fletcher, Jordan M.; Harniman, Robert L.; Barnes, Frederick R. H.; Boyle, Aimee L.; Collins, Andrew; Sharp, Thomas H.; Woolfson, Derek N.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Harniman, Robert L.; Antognozzi, Massimo; Miles, Mervyn J.] Univ Bristol, HH Wills Phys Lab, Sch Phys, Bristol BS8 1TL, Avon, England; [Harniman, Robert L.; Antognozzi, Massimo; Miles, Mervyn J.] Univ Bristol, Ctr Nanosci & Quantum Informat NSQI, Bristol BS8 1FD, Avon, England; [Collins, Andrew] Univ Bristol, NSQI, Bristol Ctr Funct Nanomat, Bristol BS8 1FD, Avon, England; [Mantell, Judith; Sharp, Thomas H.; Booth, Paula J.; Sessions, Richard B.; Verkade, Paul; Woolfson, Derek N.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Linden, Noah] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Verkade, Paul] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol	Woolfson, DN (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	d.n.woolfson@bristol.ac.uk	Verkade, Paul/N-7240-2014; Harniman, Robert/A-6355-2012; Woolfson, Dek Neil/ABC-4338-2021	Verkade, Paul/0000-0002-2497-1026; Harniman, Robert/0000-0002-3452-1213; Antognozzi, Massimo/0000-0001-5396-0564; Sessions, Richard/0000-0003-0320-0895; Sharp, Thomas/0000-0002-1990-2333; Booth, Paula Jane/0000-0003-3893-360X; Boyle, Aimee/0000-0003-4176-6080; Collins, Andrew/0000-0003-3088-1710; Fletcher, Jordan/0000-0003-3203-4355; Woolfson, Derek/0000-0002-0394-3202	BBSRC [BB/G008833/1]; EPSRC; Wellcome University Award; Biotechnology and Biological Sciences Research Council [BB/G008833/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J501426/1, GR/T03727/01, EP/K03927X/1] Funding Source: researchfish; EPSRC [EP/K03927X/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome University Award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Woolfson group for valuable discussions; the BBSRC for funding to D.N.W. and P.J.B. (BB/G008833/1) and for a studentship to A. L. B.; and the EPSRC for studentships to R. L. H. and T. H. S. J.M. is supported by a Wellcome University Award. We are grateful to the University of Bristol Advanced Computing Research Centre and the eInfraStructureSouth Consortium for high-performance computing; and Jonathan Jones and the EM Unit (EMU) School of Chemistry University of Bristol for EM access. The peptides described have been added to the Pcomp database for synthetic biology (http://coiledcoils.chm.bris.ac.uk/pcomp/index.php).	Agapakis CM, 2012, NAT CHEM BIOL, V8, P527, DOI [10.1038/NCHEMBIO.975, 10.1038/nchembio.975]; Antognozzi M, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384002; Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Bromley EHC, 2008, ACS CHEM BIOL, V3, P38, DOI 10.1021/cb700249v; Bromley EHC, 2009, J AM CHEM SOC, V131, P928, DOI 10.1021/ja804231a; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Hammer DA, 2012, FEBS LETT, V586, P2882, DOI 10.1016/j.febslet.2012.07.044; Harniman RL, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/8/085703; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Lodish H., 2008, MOL CELL BIOL, V6th ed.; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Pires MM, 2012, LANGMUIR, V28, P1993, DOI 10.1021/la203848r; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2	24	375	389	12	641	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					595	599		10.1126/science.1233936	http://dx.doi.org/10.1126/science.1233936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23579496	Green Accepted			2022-12-24	WOS:000318268900044
J	Ferrier, KL; Huppert, KL; Perron, JT				Ferrier, Ken L.; Huppert, Kimberly L.; Perron, J. Taylor			Climatic control of bedrock river incision	NATURE			English	Article							EROSION RATES; LANDSCAPE RESPONSE; SIERRA-NEVADA; MODEL; KAUAI; PRECIPITATION; VARIABILITY; TECTONICS; EVOLUTION; VOLCANISM	Bedrock river incision drives the development of much of Earth's surface topography(1-3), and thereby shapes the structure of mountain belts(4) and modulates Earth's habitability through its effects on soil erosion(5), nutrient fluxes(6) and global climate(7). Although it has long been expected that river incision rates should depend strongly on precipitation rates, quantifying the effects of precipitation rates on bedrock river incision rates has proved difficult, partly because river incision rates are difficult to measure and partly because non-climatic factors can obscure climatic effects at sites where river incision rates have been measured(8,9). Here we present measurements of river incision rates across one of Earth's steepest rainfall gradients, which show that precipitation rates do indeed influence long-term bedrock river incision rates. We apply a widely used empirical law for bedrock river incision(3,9-11) to a series of rivers on the Hawaiian island of Kaua'i, where mean annual precipitation ranges from 0.5 metres to 9.5 metres (ref. 12)-over 70 per cent of the global range(13)-and river incision rates averaged over millions of years can be inferred from the depth of river canyons and the age of the volcanic bedrock. Both a time-averaged analysis and numerical modelling of transient river incision reveal that the long-term efficiency of bedrock river incision across Kaua'i is positively correlated with upstream-averaged mean annual precipitation rates. We provide theoretical context for this result by demonstrating that our measurements are consistent with a linear dependence of river incision rates on stream power, the rate of energy expenditure by the flow on the riverbed. These observations provide rare empirical evidence for the long-proposed coupling between climate and river incision, suggesting that previously proposed feed-backs among topography, climate and tectonics may occur.	[Ferrier, Ken L.; Huppert, Kimberly L.; Perron, J. Taylor] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Ferrier, KL (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	ferrier@fas.harvard.edu	Perron, J. Taylor/D-8983-2012	Perron, J. Taylor/0000-0002-0404-8701; Huppert, Kimberly/0000-0002-2130-8499; Ferrier, Ken/0000-0003-4098-166X	Massachusetts Institute of Technology	Massachusetts Institute of Technology	This study was supported by the Massachusetts Institute of Technology. We thank M. Slosberg for assistance with topographic analyses, S. Willett for comments that improved the manuscript and M. Rosener, S. Mukhopadhyay, M. Lamb, B. Mackey, J. Scheingross, J. Stock and C. Blay for field assistance and discussions. We thank the State of Hawaii Agribusiness Development Corporation, Landis Ignacio of the Kekaha Agriculture Association, the State of Hawaii Department of Land and Natural Resources, Divisions of State Parks and of Forestry and Wildlife, the US Fish and Wildlife Service and the Alapai and Napolis families for field access.	Bookhagen B, 2012, EARTH PLANET SC LETT, V327, P97, DOI 10.1016/j.epsl.2012.02.005; Brocklehurst SH, 2002, GEOMORPHOLOGY, V42, P1, DOI 10.1016/S0169-555X(01)00069-1; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Chadwick OA, 2003, CHEM GEOL, V202, P195, DOI 10.1016/j.chemgeo.2002.09.001; CLAGUE DA, 1988, CONTRIB MINERAL PETR, V99, P202, DOI 10.1007/BF00371461; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dunne T., 1978, WATER ENV PLANNING; Fernandes NF, 1997, WATER RESOUR RES, V33, P1307, DOI 10.1029/97WR00534; Ferrier K. L., GEOL SOC AM IN PRESS; Garcia MO, 2010, J PETROL, V51, P1507, DOI 10.1093/petrology/egq027; Gayer E, 2008, EARTH PLANET SC LETT, V266, P303, DOI 10.1016/j.epsl.2007.11.019; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; HOWARD AD, 1983, GEOL SOC AM BULL, V94, P739, DOI 10.1130/0016-7606(1983)94<739:CCIB>2.0.CO;2; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; Leopold L.B., 1953, US GEOLOGICAL SURVEY; MCDOUGALL I, 1979, EARTH PLANET SC LETT, V46, P31, DOI 10.1016/0012-821X(79)90063-3; Montgomery DR, 2001, WATER RESOUR RES, V37, P1841, DOI 10.1029/2000WR900393; Moon S, 2011, NAT GEOSCI, V4, P469, DOI [10.1038/NGEO1159, 10.1038/ngeo1159]; OCALLAGHAN JF, 1984, COMPUT VISION GRAPH, V28, P323, DOI 10.1016/0734-189X(89)90053-4; Poveda G, 2000, GEOPHYS RES LETT, V27, P1675, DOI 10.1029/1999GL006091; Press W. H., 1992, ART SCI COMPUTING; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Reiners PW, 2003, NATURE, V426, P645, DOI 10.1038/nature02111; Riebe CS, 2004, EARTH PLANET SC LETT, V224, P547, DOI 10.1016/j.epsl.2004.05.019; Riebe CS, 2001, GEOLOGY, V29, P447, DOI 10.1130/0091-7613(2001)029<0447:MCCOER>2.0.CO;2; Roe GH, 2008, AM J SCI, V308, P815, DOI 10.2475/07.2008.01; Seidl M.A., 1992, FUNCTIONAL GEOMORPHO, V23, P101; SEIDL MA, 1994, J GEOL, V102, P457, DOI 10.1086/629686; Sherrod DR, 2007, 20071089 US GEOL SUR; Snyder NP, 2000, GEOL SOC AM BULL, V112, P1250, DOI 10.1130/0016-7606(2000)112<1250:LRTTFD>2.3.CO;2; Stock JD, 1999, J GEOPHYS RES-SOL EA, V104, P4983, DOI 10.1029/98JB02139; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; Walling DE, 1983, BACKGROUND PALAEOHYD, V158, P69; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Whipple KX, 2004, ANNU REV EARTH PL SC, V32, P151, DOI 10.1146/annurev.earth.32.101802.120356; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248; Wobus C, 2006, GEOL SOC AM SPEC PAP, V398, P55, DOI 10.1130/2006.2398(04); Wohl E, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF000989	39	142	146	4	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					206	+		10.1038/nature11982	http://dx.doi.org/10.1038/nature11982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23579679				2022-12-24	WOS:000317346300038
J	Marmot, MG				Marmot, Michael G.			Sorting Through the Arguments on Breast Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER		UCL, Inst Hlth Equ, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England	University of London; University College London	Marmot, MG (corresponding author), UCL, Inst Hlth Equ, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0601647, G0902037, G1000616, G0701830] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0902037, G19/35, G0701830, G0100222, G8802774, G0601647, G1000616] Funding Source: Medline	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Independent UK Panel on Breast Cancer Screening, 2013, Lancet, V381, P803, DOI 10.1016/S0140-6736(13)60628-5; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703	6	24	24	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2553	2554		10.1001/jama.2013.6822	http://dx.doi.org/10.1001/jama.2013.6822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23722915				2022-12-24	WOS:000320848100021
J	Sultan, F; Khan, A				Sultan, Faisal; Khan, Aamir			Infectious diseases in Pakistan: a clear and present danger	LANCET			English	Editorial Material									[Sultan, Faisal] Shaukat Khanum Mem Canc Hosp & Res Ctr, Lahore 54770, Pakistan; [Khan, Aamir] Interact Res & Dev, Karachi, Pakistan	Shaukat Khanum Memorial Cancer Hospital & Research Centre	Sultan, F (corresponding author), Shaukat Khanum Mem Canc Hosp & Res Ctr, Lahore 54770, Pakistan.	faisal@skm.org.pk						Burki T, 2008, LANCET INFECT DIS, V8, P413, DOI 10.1016/S1473-3099(08)70145-2; Creswell J, 2012, LANCET INFECT DIS, V12, P909, DOI 10.1016/S1473-3099(12)70262-1; Directorate of Malaria Control Ministry of Interprovincial Coordination Islamabad, MAL CONTR PROGR PAK; Global Polio Eradication Initiative, 2012, INF COUNTR PAK; Kassi M, 2011, TRANSFUSION MED, V21, P57, DOI 10.1111/j.1365-3148.2010.01042.x; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; National AIDS Control Program Ministry of Health Islamabad, 2008, REP RAP SIT AN HIV O; Nishtar S, 2013, LANCET; PMRC, 2009, PREV HEP B C PAK; Qureshi H, 2010, East Mediterr Health J, V16 Suppl, pS15; UNAIDS, COUNTR PROGR REP PAK; WHO, GLOB TUB REP 2012 AN; WHO Regional Office of the Eastern Mediterranean, 2011, WHO SUPP PAK DENG FE	14	25	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2138	2140		10.1016/S0140-6736(13)60248-2	http://dx.doi.org/10.1016/S0140-6736(13)60248-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23684256				2022-12-24	WOS:000320925600006
J	Kanamori, T; Kanai, MI; Dairyo, Y; Yasunaga, K; Morikawa, RK; Emoto, K				Kanamori, Takahiro; Kanai, Makoto I.; Dairyo, Yusuke; Yasunaga, Kei-ichiro; Morikawa, Rei K.; Emoto, Kazuo			Compartmentalized Calcium Transients Trigger Dendrite Pruning in Drosophila Sensory Neurons	SCIENCE			English	Article							INDICATORS; MECHANISMS; CELLS	Dendrite pruning is critical for sculpting the final connectivity of neural circuits as it removes inappropriate projections, yet how neurons can selectively eliminate unnecessary dendritic branches remains elusive. Here, we show that calcium transients that are compartmentalized in specific dendritic branches act as temporal and spatial cues to trigger pruning in Drosophila sensory neurons. Calcium transients occurred in local dendrites at similar to 3 hours before branch elimination. In dendritic branches, intrinsic excitability increased locally to activate calcium influx via the voltage-gated calcium channels (VGCCs), and blockade of the VGCC activities impaired pruning. Further genetic analyses suggest that the calcium-activated protease calpain functions downstream of the calcium transients. Our findings reveal the importance of the compartmentalized subdendritic calcium signaling in spatiotemporally selective elimination of dendritic branches.	[Kanamori, Takahiro; Kanai, Makoto I.; Dairyo, Yusuke; Yasunaga, Kei-ichiro; Morikawa, Rei K.; Emoto, Kazuo] Osaka Biosci Inst, Dept Cell Biol, Suita, Osaka 5650872, Japan; [Emoto, Kazuo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Dairyo, Yusuke] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	University of Tokyo; Nara Institute of Science & Technology	Emoto, K (corresponding author), Osaka Biosci Inst, Dept Cell Biol, 6-2-4 Furuedai, Suita, Osaka 5650872, Japan.	emoto@biol.s.u-tokyo.ac.jp	EMOTO, KAZUO/G-4992-2014		Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Strategic Research Program for Brain Science, CREST; Takeda Science Foundation	Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Research Program for Brain Science, CREST; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Y. N. Jan, C. Montel, M. Miura, L. L Looger, K. Deisseroth, Bloomington Stock Center, and Kyoto Stock Center for reagents; Riken BSI-Olympus collaboration center for measuring the blue-light intensity; W. Sugano and A. Kawasaki for technical assistance; S. Nakanishi and J. Z. Parrish for helpful comments on the manuscript. This work was supported by grants-in-aid for Science and Technology from the Japanese Government Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Strategic Research Program for Brain Science, CREST, and Takeda Science Foundation.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Emoto K, 2012, CURR OPIN NEUROBIOL, V22, P805, DOI 10.1016/j.conb.2012.04.005; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	17	81	82	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1475	1478		10.1126/science.1234879	http://dx.doi.org/10.1126/science.1234879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23722427				2022-12-24	WOS:000320647000048
J	McLean, PF; Cooley, L				McLean, Peter F.; Cooley, Lynn			Protein Equilibration Through Somatic Ring Canals in Drosophila	SCIENCE			English	Article							INTERCELLULAR BRIDGES; OVARIAN-FOLLICLE; CELLS; MELANOGASTER; DIFFERENTIATION; ORGANIZATION; SPERMATIDS; LEG	Although intercellular bridges resulting from incomplete cytokinesis were discovered in somatic Drosophila tissues decades ago, the impact of these structures on intercellular communication and tissue biology is largely unknown. In this work, we demonstrate that the similar to 250-nanometer-diameter somatic ring canals permit diffusion of cytoplasmic contents between connected cells and across mitotic clone boundaries and enable the equilibration of protein between transcriptionally mosaic follicle cells in the Drosophila ovary. We obtained similar, although more restricted, results in the larval imaginal discs. Our work illustrates the lack of cytoplasmic autonomy in these tissues and suggests a role for somatic ring canals in promoting homogeneous protein expression within the tissue.	[McLean, Peter F.; Cooley, Lynn] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Cooley, Lynn] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Cooley, Lynn] Yale Univ, Dept Mol Cellular & Dev Biol MCDB, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Cooley, L (corresponding author), Yale Univ, Dept Genet, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	lynn.cooley@yale.edu	McLean, Peter F/G-5751-2012	McLean, Peter/0000-0001-7938-5713	NIH from the National Center for Research Resources [P41 GM103313]; NIH [T32 GM007499, GM091791, GM043301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499, P41GM103313, R01GM043301, RC1GM091791] Funding Source: NIH RePORTER	NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Zimmerman, N. Peters, and C. Berg (Genome Sciences, University of Washington) for their assistance in troubleshooting the FISH protocol; N. Woodward and J. Carlson (MCDB, Yale University) for providing reagents and support for the FISH experiments; C. Tsai (Neuroscience and Cell Biology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School) for the SMRTER reagents; T. Xu (Genetics, Yale University) for the use of the upright Zeiss LSM510 META microscope; and the Bloomington Drosophila Stock Center for flies. For their support in the development of the VCell models, we thank A. Cowan and B. Slepchenko; the described VCell models are available at www.vcell.org under the shared username peterfoster. The Virtual Cell is supported by NIH grant P41 GM103313 from the National Center for Research Resources. We also thank the Center for Cellular and Molecular Imaging core facility (Yale University) for the use of their microscopes and for assistance with EM acquisition. P.F.M. received support from NIH Genetics training grant T32 GM007499. This work was supported by grants to L.C. from NIH (GM091791 and GM043301).	Airoldi SJ, 2011, J CELL SCI, V124, P4077, DOI 10.1242/jcs.090456; BRAND AH, 1993, DEVELOPMENT, V118, P401; DYM M, 1971, BIOL REPROD, V4, P195, DOI 10.1093/biolreprod/4.2.195; GIORGI F, 1978, CELL TISSUE RES, V186, P413; GONDOS B, 1973, Differentiation, V1, P177, DOI 10.1111/j.1432-0436.1973.tb00112.x; Greenbaum MP, 2009, BIOL REPROD, V80, P449, DOI 10.1095/biolreprod.108.070649; Haglund K, 2010, CURR BIOL, V20, P944, DOI 10.1016/j.cub.2010.03.068; Kramerova IA, 1999, DEV DYNAM, V216, P349, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<349::AID-DVDY4>3.0.CO;2-X; LARSEN EW, 1989, T AM MICROSC SOC, V108, P159, DOI 10.2307/3226372; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Minestrini G, 2002, J CELL SCI, V115, P725; Nystul T, 2010, GENETICS, V184, P503, DOI 10.1534/genetics.109.109538; Pepling ME, 1998, DEVELOPMENT, V125, P3323; POODRY CA, 1970, ROUX ARCH DEV BIOL, V166, P1, DOI 10.1007/BF00576805; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Skora AD, 2010, P NATL ACAD SCI USA, V107, P7389, DOI 10.1073/pnas.1003180107; Thakar R, 2005, J CELL SCI, V118, P951, DOI 10.1242/jcs.01684; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Woodruff RI, 1998, DEV BIOL, V200, P82, DOI 10.1006/dbio.1998.8948	21	32	32	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1445	1447		10.1126/science.1234887	http://dx.doi.org/10.1126/science.1234887			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23704373	Green Accepted			2022-12-24	WOS:000320647000040
J	Dantzer, B; Newman, AEM; Boonstra, R; Palme, R; Boutin, S; Humphries, MM; McAdam, AG				Dantzer, Ben; Newman, Amy E. M.; Boonstra, Rudy; Palme, Rupert; Boutin, Stan; Humphries, Murray M.; McAdam, Andrew G.			Density Triggers Maternal Hormones That Increase Adaptive Offspring Growth in a Wild Mammal	SCIENCE			English	Article							FEMALE RED SQUIRRELS; CORTICOSTEROID RECEPTORS; STRESS-RESPONSE; PRENATAL STRESS; NATURAL-POPULATION; BEHAVIOR; SELECTION; SURVIVAL; REPRODUCTION; LACTATION	In fluctuating environments, mothers may enhance the fitness of their offspring by adjusting offspring phenotypes to match the environment they will experience at independence. In free-ranging red squirrels, natural selection on offspring postnatal growth rates varies according to population density, with selection favoring faster-growing offspring under high-density conditions. We show that exposing mothers to high-density cues, accomplished via playbacks of territorial vocalizations, led to increased offspring growth rates in the absence of additional food resources. Experimental elevation of actual and perceived density induced higher maternal glucocorticoid levels, and females with naturally or experimentally increased glucocorticoids produced offspring that grew faster than controls. Therefore, social cues reflecting population density were sufficient to elicit increased offspring growth through an adaptive hormone-mediated maternal effect.	[Dantzer, Ben; McAdam, Andrew G.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Newman, Amy E. M.; McAdam, Andrew G.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Boonstra, Rudy] Univ Toronto Scarborough, Ctr Neurobiol Stress, Toronto, ON M1C 1A4, Canada; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci Biochem, A-1210 Vienna, Austria; [Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Humphries, Murray M.] McGill Univ, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Michigan State University; University of Guelph; University of Toronto; University Toronto Scarborough; University of Veterinary Medicine Vienna; University of Alberta; McGill University	Dantzer, B (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	bendantzer@gmail.com	McAdam, Andrew G/G-1802-2010; Boutin, Stan A/A-2619-2014; Palme, Rupert/A-3499-2008; Dantzer, Ben/E-9779-2011	McAdam, Andrew G/0000-0001-7323-2572; Boutin, Stan A/0000-0001-6317-038X; Palme, Rupert/0000-0001-9466-3662; Dantzer, Ben/0000-0002-3058-265X; Newman, Amy E. M./0000-0003-1005-8380	Natural Sciences and Engineering Research Council of Canada; NSF [DEB-0515849, IOS-1110436]; Ontario Ministry of Research Innovation; Kluane Red Squirrel Project [69]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF(National Science Foundation (NSF)); Ontario Ministry of Research Innovation(Ministry of Research and Innovation, Ontario); Kluane Red Squirrel Project	We thank Agnes Moose and family for access to their traditional trapping area; F. E. Stewart, S. E. Evans, S. E. McFarlane, Q. E. Fletcher, S. Hossain, R. W. Taylor, and all squirrelers for assistance; A. Sykes and E. Anderson for data management; and A. Charmantier, T. Getty, K. E. Holekamp, J. S. Lonstein, C. T. Williams, T. D. Williams, and three anonymous reviewers for incisive comments. Funded by Natural Sciences and Engineering Research Council of Canada, NSF (DEB-0515849 and IOS-1110436), and Ontario Ministry of Research Innovation. Data have been deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.b3h4q). This is publication no. 69 of the Kluane Red Squirrel Project.	Bates D., 2008, LME4 LINEAR MIXED EF; BECKER CD, 1993, CAN J ZOOL, V71, P1326, DOI 10.1139/z93-183; Berteaux D, 2000, ECOLOGY, V81, P1311, DOI 10.1890/0012-9658(2000)081[1311:BDIFNA]2.0.CO;2; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; BOUTIN S, 1993, J ANIM ECOL, V62, P364, DOI 10.2307/5367; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Boutin S, 2006, SCIENCE, V314, P1928, DOI 10.1126/science.1135520; Casolini P, 1997, NEUROSCIENCE, V79, P1005, DOI 10.1016/S0306-4522(96)00668-9; Catalani A, 2000, NEUROSCIENCE, V100, P319, DOI 10.1016/S0306-4522(00)00277-3; Catalani A, 2002, PHARMACOL BIOCHEM BE, V73, P105, DOI 10.1016/S0091-3057(02)00755-4; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Dantzer B, 2012, BEHAV ECOL SOCIOBIOL, V66, P865, DOI 10.1007/s00265-012-1335-2; Dantzer B, 2011, GEN COMP ENDOCR, V174, P124, DOI 10.1016/j.ygcen.2011.08.010; Dantzer B, 2011, ANIM BEHAV, V81, P469, DOI 10.1016/j.anbehav.2010.11.021; Dantzer B, 2010, GEN COMP ENDOCR, V167, P279, DOI 10.1016/j.ygcen.2010.03.024; Descamps S, 2008, J ANIM ECOL, V77, P305, DOI 10.1111/j.1365-2656.2007.01340.x; Descamps S, 2009, P ROY SOC B-BIOL SCI, V276, P1129, DOI 10.1098/rspb.2008.1401; Digweed SM, 2012, CURR ZOOL, V58, P758, DOI 10.1093/czoolo/58.5.758; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Elton CS, 1924, BR J EXP BIOL, V2, P119; Fletcher QE, 2010, ECOLOGY, V91, P2673, DOI 10.1890/09-1816.1; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Humphries MM, 1996, J ANIM ECOL, V65, P332, DOI 10.2307/5879; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; KUHN CM, 1990, DEV PSYCHOBIOL, V23, P395, DOI 10.1002/dev.420230503; Lamontagne JM, 2007, J ECOL, V95, P991, DOI 10.1111/j.1365-2745.2007.01266.x; LARSEN KW, 1994, ECOLOGY, V75, P214, DOI 10.2307/1939395; LEVINS R, 1968, EVOLUT CHANGING ENV; Love OP, 2008, AM NAT, V172, pE135, DOI 10.1086/590959; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Mateo JM, 2008, NEUROBIOL LEARN MEM, V89, P582, DOI 10.1016/j.nlm.2007.11.002; McAdam AG, 2004, P ROY SOC B-BIOL SCI, V271, P75, DOI 10.1098/rspb.2003.2572; McAdam AG, 2003, EVOLUTION, V57, P1689; McAdam AG, 2002, EVOLUTION, V56, P846; Mcadam AG, 2007, ECOSCIENCE, V14, P362, DOI 10.2980/1195-6860(2007)14[362:LHOFRS]2.0.CO;2; MOORE CL, 1986, DEV PSYCHOBIOL, V19, P235, DOI 10.1002/dev.420190309; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; Pinheiro JC, 2009, MIXED EFFECTS MODELS; *R DEV COR TEAM, 2008, R LANGUAGE ENVIRON; Reale D, 2003, EVOLUTION, V57, P2416; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Shonfield J., 2010, THESIS; SMITH CC, 1968, ECOL MONOGR, V38, P31, DOI 10.2307/1948536; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; WADE MJ, 1990, EVOLUTION, V44, P1947, DOI [10.2307/2409605, 10.1111/j.1558-5646.1990.tb04301.x]; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x	53	264	265	3	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1215	1217		10.1126/science.1235765	http://dx.doi.org/10.1126/science.1235765			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23599265				2022-12-24	WOS:000319972800045
J	Stevens, B; Bony, S				Stevens, Bjorn; Bony, Sandrine			What Are Climate Models Missing?	SCIENCE			English	Editorial Material							EARTH SYSTEM MODELS; SENSITIVITY		[Stevens, Bjorn] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Bony, Sandrine] Univ Paris 06, CNRS, Meteorol Dynam Lab, Inst Pierre Simon Laplace, Paris, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Stevens, B (corresponding author), Max Planck Inst Meteorol, Bundesstr 53, D-20146 Hamburg, Germany.	bjorn.stevens@mpimet.mpg.de	Stevens, Bjorn/A-1757-2013; Bony, Sandrine/AAG-5804-2019	Stevens, Bjorn/0000-0003-3795-0475; Bony, Sandrine/0000-0002-4791-4438				Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; Bony S, 2013, CLIMATE SCI SERVING; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; Eliassen A., 1949, TELLUS, V1, P38, DOI [DOI 10.3402/TELLUSA.V1I2.8500, 10.3402/tellusa.v1i2.8500]; Flato GM, 2011, WIRES CLIM CHANGE, V2, P783, DOI 10.1002/wcc.148; Good P, 2013, J CLIMATE, V26, P495, DOI 10.1175/JCLI-D-11-00366.1; Medeiros B, 2008, J CLIMATE, V21, P4974, DOI 10.1175/2008JCLI1995.1; Min QL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032398; Ocko IB, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018019; Oueslati B, 2013, J CLIMATE, V26, P2931, DOI 10.1175/JCLI-D-12-00314.1; Popke D, 2013, J ADV MODEL EARTH SY, V5, P1, DOI 10.1029/2012MS000191; Simmons AJ, 2002, Q J ROY METEOR SOC, V128, P647, DOI 10.1256/003590002321042135; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2]	14	262	266	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1053	1054		10.1126/science.1237554	http://dx.doi.org/10.1126/science.1237554			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154HJ	23723223				2022-12-24	WOS:000319664500028
J	Osotimehin, B				Osotimehin, Babatunde			Obstetric fistula: ending the health and human rights tragedy	LANCET			English	Editorial Material									UN Populat Fund, New York, NY 10158 USA	United Nations Population Fund	Osotimehin, B (corresponding author), UN Populat Fund, New York, NY 10158 USA.	osotimehin@unfpa.org						[Anonymous], 2012, LANCET, V380, P1881; Harland-Scott C., 2013, ADDRESSING INEQUALIT; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Stanton C, 2007, INT J GYNECOL OBSTET, V99, pS4, DOI 10.1016/j.ijgo.2007.06.010; UN, UNITED NATIONS SECRE; UN, 2012, SUPPORTING EFFORTS T; van Beekhuizen, 2006, LANCET, V368, P1210; Wall LL, 2006, LANCET, V368, P1201, DOI 10.1016/S0140-6736(06)69476-2; WHO, 2010, 10 FACTS ON OBSTETRI; WHO U. UNFPA The World Bank, 2012, TRENDS MAT MORT 1990	10	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1702	1703		10.1016/S0140-6736(13)61001-6	http://dx.doi.org/10.1016/S0140-6736(13)61001-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683623				2022-12-24	WOS:000319112800014
J	Chan, M				Chan, Margaret			Linking child survival and child development for health, equity, and sustainable development	LANCET			English	Editorial Material									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	porria@who.int						Hill Z, 2004, FAMILY AND COMMUNITY; Irwin L, 2007, EARLY CHILD DEVELOPM; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Shonkoff JP, 2012, PEDIATRICS, V129, pE460, DOI 10.1542/peds.2011-0366; UNICEF World Health Organization World Bank United Nations, 2012, REPORT 2012; WHO UNICEF, 2012, CARE FOR CHILD DEVEL; World Health Organization, 1999, CRIT LINK INT PHYS G	7	35	37	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1514	1515		10.1016/S0140-6736(13)60944-7	http://dx.doi.org/10.1016/S0140-6736(13)60944-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23642687				2022-12-24	WOS:000318609600005
J	Chopra, M; Mason, E; Borrazzo, J; Campbell, H; Rudan, I; Liu, L; Black, RE; Bhutta, ZA				Chopra, Mickey; Mason, Elizabeth; Borrazzo, John; Campbell, Harry; Rudan, Igor; Liu, Li; Black, Robert E.; Bhutta, Zulfiqar A.			Ending of preventable deaths from pneumonia and diarrhoea: an achievable goal	LANCET			English	Article							CHILD-MORTALITY; INTEGRATED MANAGEMENT; BANGLADESH; COUNTDOWN; ILLNESS; TRENDS; IMPACT; CARE	Global under-5 mortality has fallen rapidly from 12 million deaths in 1990, to 6.9 million in 2011; however, this number still falls short of the target of a two-thirds reduction or a maximum of 4 million deaths by 2015. Acceleration of reductions in deaths due to pneumonia and diarrhoea, which together account for about 2 million child deaths every year, is essential if the target is to be met. Scaling up of existing interventions against the two diseases to 80% and immunisation to 90% would eliminate more than two-thirds of deaths from these two diseases at a cost of US$6.715 billion by 2025. Modelling in this report shows that if all countries could attain the rates of decline of the regional leaders, then cause-specific death rates of fewer than three deaths per 1000 livebirths from pneumonia and less than one death per 1000 livebirths from diarrhoea could be achieved by 2025. These rates are those at which preventable deaths have been avoided. Increasing of awareness of the size of the problem; strengthening of leadership, intersectoral collaboration, and resource mobilisation; and increasing of efficiency through the selection of the optimum mix of a growing set of cost-effective interventions depending on local contexts are the priority actions needed to achieve the goal of ending preventable deaths from pneumonia and diarrhoea by 2025.	[Chopra, Mickey] UNICEF, New York, NY 10017 USA; [Mason, Elizabeth] WHO, CH-1211 Geneva, Switzerland; [Borrazzo, John] US Agcy Int Dev, Washington, DC 20523 USA; [Campbell, Harry; Rudan, Igor] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Liu, Li; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Karachi, Pakistan	UNICEF; World Health Organization; United States Agency for International Development (USAID); University of Edinburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aga Khan University	Chopra, M (corresponding author), UNICEF, 3 United Nations Plaza, New York, NY 10017 USA.	mchopra@unicef.org	Campbell, Harry/E-2959-2010; liu, li/HGC-0900-2022; Rudan, Igor/I-1467-2012	Campbell, Harry/0000-0002-6169-6262; Rudan, Igor/0000-0001-6993-6884; Black, Robert/0000-0001-9926-7984	Bill & Melinda Gates Foundation; Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto	The work summarised in this Series was supported by an unrestricted grant from the Bill & Melinda Gates Foundation to the Aga Khan University and through it to collaborating universities and institutions (Bloomberg School of Public Health Johns Hopkins University; Boston University School of Public Health; and Program for Global Pediatric Research, Hospital for Sick Children, Toronto). The funding agency had no influence or control over the content and process for the development of this Series. The contents of this article are the responsibility of the authors and do not necessarily reflect the views of the United States Agency for International Development or the United States Government.	Amaral J, 2005, HEALTH POLICY PLANN, V20, pI42, DOI 10.1093/heapol/czi058; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES H; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fischer Walker CL, 2013, LANCET; Fontaine O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000041; Gill CJ, 2013, LANCET; Institute of Development Studies, 2011, COMM LED TOT SAN; Isanaka S, 2012, B WORLD HEALTH ORGAN, V90, P635, DOI 10.2471/BLT.12.109504; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Matlin SA, 2009, MONITORING FINANCIAL; Nannine N, 2010, UNDER 5 MORTALITY ST; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Rudan I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000308; Sayem AM, 2011, J HEALTH POPUL NUTR, V29, P92; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; UNICEF, 2011, LEV TRENDS CHILD MOR; UNICEF and WHO, 2012, PROGR DRINKING WATER; UNICEF Press Centre, 2015, NIG LAUNCH IN SAV ON; USAID, PUBL PRIV PARTN INTR; USAID, 2010, INTR IMPR TREATM CHI; Waters Donald, 2012, J Glob Health, V2, P020402, DOI 10.7189/jogh.02.020402; Wegman ME, 2001, J NUTR, V131, p401S, DOI 10.1093/jn/131.2.401S; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8	28	77	78	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1499	1506		10.1016/S0140-6736(13)60319-0	http://dx.doi.org/10.1016/S0140-6736(13)60319-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23582721				2022-12-24	WOS:000318607300039
J	Gostin, LO; Buckley, GJ; Kelley, PW				Gostin, Lawrence O.; Buckley, Gillian J.; Kelley, Patrick W.			Stemming the Global Trade in Falsified and Substandard Medicines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DRUGS		[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, Washington, DC 20001 USA; [Buckley, Gillian J.; Kelley, Patrick W.] Natl Acad Sci, Inst Med, Board Global Hlth, Washington, DC 20418 USA	Georgetown University; National Academies of Sciences, Engineering & Medicine	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Arie S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e951; Bate R, 2013, INT J TUBERC LUNG D, V17, P308, DOI 10.5588/ijtld.12.0355; Centers for Disease Control and Prevention, MULTISTATE FUNGAL ME; Institute of Medicine of the National Academies, 2013, COUNTERING THE PROBL; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; United Nations Office on Drugs and Crime, 2009, TRANSNATIONAL TRAFFI; World Health Organization, 2012, BUILDING GLOBAL CAPA	7	23	23	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1693	1694		10.1001/jama.2013.3048	http://dx.doi.org/10.1001/jama.2013.3048			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23579391	Green Published			2022-12-24	WOS:000317906700024
J	Osterholm, MT; Ballering, KS; Kelley, NS				Osterholm, Michael T.; Ballering, Katie S.; Kelley, Nicholas S.			Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS-VACCINE; TRIAL		[Osterholm, Michael T.; Ballering, Katie S.; Kelley, Nicholas S.] Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA; [Osterholm, Michael T.; Kelley, Nicholas S.] Univ Minnesota, Minnesota Ctr Excellence Influenza Res & Surveill, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Ctr Infect Dis Res & Policy, 420 Delaware St,SE MMC263, Minneapolis, MN 55455 USA.	mto@umn.edu			PHS HHS [HHSN266200700007C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], MMWR; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Osterholm MT, 2012, CIDRAP           OCT; Partridge J, 2013, VACCINE, V31, P728, DOI 10.1016/j.vaccine.2012.10.111; Schnirring L., 2013, CIDRAP NEWS     0508; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; US Food and Drug Administration, 2007, GUID IND CLIN DAT NE; World Health Organization, 2013, VACC RESP AV INFL H7	9	28	32	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	2013	309	24					2557	2558		10.1001/jama.2013.6589	http://dx.doi.org/10.1001/jama.2013.6589			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170KD	23700117				2022-12-24	WOS:000320848100023
J	Godefroit, P; Cau, A; Hu, DY; Escuillie, F; Wu, WH; Dyke, G				Godefroit, Pascal; Cau, Andrea; Hu Dong-Yu; Escuillie, Franois; Wu Wenhao; Dyke, Gareth			A Jurassic avialan dinosaur from China resolves the early phylogenetic history of birds	NATURE			English	Article							LONG FEATHERS; THEROPOD; ARCHAEOPTERYX; MANIRAPTORAN; EVOLUTION	The recent discovery of small paravian theropod dinosaurs with well-preserved feathers in the Middle-Late Jurassic Tiaojishan Formation of Liaoning Province (northeastern China)(1-4) has challenged the pivotal position of Archaeopteryx(3,4), regarded from its discovery to be the most basal bird. Removing Archaeopteryx from the base of Avialae to nest within Deinonychosauria implies that typical bird flight, powered by the forelimbs only, either evolved at least twice, or was subsequently lost or modified in some deinonychosaurians(3,5). Here we describe the complete skeleton of a new paravian from the Tiaojishan Formation of Liaoning Province, China. Including this new taxon in a comprehensive phylogenetic analysis for basal Paraves does the following: (1) it recovers it as the basal-most avialan; (2) it confirms the avialan status of Archaeopteryx; (3) it places Troodontidae as the sister-group to Avialae; (4) it supports a single origin of powered flight within Paraves; and (5) it implies that the early diversification of Paraves and Avialae took place in the Middle-Late Jurassic period.	[Godefroit, Pascal] Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, B-1000 Brussels, Belgium; [Cau, Andrea] Museo Geol Giovanni Capellini, I-40127 Bologna, Italy; [Hu Dong-Yu] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Hu Dong-Yu] NE Normal Univ, Minist Educ, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China; [Escuillie, Franois] Eldonia, F-3800 Gannat, France; [Wu Wenhao] Jilin Univ, Res Ctr Paleontol & Stratig, Changchun 130021, Peoples R China; [Dyke, Gareth] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Royal Belgian Institute of Natural Sciences; Shenyang Normal University; Northeast Normal University - China; Jilin University; NERC National Oceanography Centre; University of Southampton	Godefroit, P (corresponding author), Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, Rue Vautier 29, B-1000 Brussels, Belgium.	Pascal.Godefroit@naturalsciences.be	Dyke, Gareth/AAJ-9320-2020; Cau, Andrea/S-8546-2016; Wu, Wenhao/AAU-4325-2020; Cau, Andrea/ABB-7972-2021	Dyke, Gareth/0000-0002-8390-7817; Cau, Andrea/0000-0001-8761-3720	SPP Politique scientifique (Belgium) [BL/36/62]; Key Laboratory of Evolutionary Systematics of Vertebrates [CAS2011LESV011]; National Natural Science Foundation of China [41172026]	SPP Politique scientifique (Belgium); Key Laboratory of Evolutionary Systematics of Vertebrates; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank B. Pohl for making fossils available for study, S. Ge for help and comments on the manuscript and T. Hubin for photographs. This study was supported by a grant (BL/36/62) to P. G. from the SPP Politique scientifique (Belgium). D. H. was supported by the Key Laboratory of Evolutionary Systematics of Vertebrates (CAS2011LESV011) and by the National Natural Science Foundation of China (41172026).	Chiappe LM, 1999, B AM MUS NAT HIST, P3; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; EVANS SE, 1994, IN THE SHADOW OF THE DINOSAURS, P303; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; Godefroit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2389; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Lee MSY, 2012, BIOL LETTERS, V8, P299, DOI 10.1098/rsbl.2011.0884; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; van der Lubbe T, 2009, ACTA PALAEONTOL POL, V54, P401, DOI 10.4202/app.2008.0007; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753; Zheng XT, 2010, P ROY SOC B-BIOL SCI, V277, P211, DOI 10.1098/rspb.2009.1178; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179	28	120	127	1	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					359	362		10.1038/nature12168	http://dx.doi.org/10.1038/nature12168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23719374				2022-12-24	WOS:000320592900039
J	Jones, BRT; Renowden, SA; Lowis, SP; Kurian, KM				Jones, Benjamin R. T.; Renowden, Shelley A.; Lowis, Stephen P.; Kurian, Kathreena M.			Early morning headache with vomiting in a 5 year old boy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TUMORS		[Jones, Benjamin R. T.] Univ Bristol, Sch Med, Bristol BS8 1TH, Avon, England; [Renowden, Shelley A.] Frenchay Hosp, Dept Neuroradiol, Bristol BS16 1LE, Avon, England; [Lowis, Stephen P.] Bristol Royal Hosp Children, Dept Paediat Haematol, Bristol, Avon, England; [Lowis, Stephen P.] Bristol Royal Hosp Children, BMT, Bristol, Avon, England; [Kurian, Kathreena M.] Frenchay Hosp, Dept Neuropathol, Brain Tumour Res Grp, Bristol BS16 1LE, Avon, England	University of Bristol; Bristol Royal Hospital For Children; Bristol Royal Hospital For Children	Jones, BRT (corresponding author), Univ Bristol, Sch Med, Bristol BS8 1TH, Avon, England.	bjones7392@gmail.com		Kurian, Kathreena/0000-0003-0303-3716				Catsman-Berrevoets CE, 2010, CORTEX, V46, P933, DOI 10.1016/j.cortex.2009.10.007; Gandola L, 2009, J CLIN ONCOL, V27, P566, DOI 10.1200/JCO.2008.18.4176; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Lannering B, 2012, J CLIN ONCOL, V30, P3187, DOI 10.1200/JCO.2011.39.8719; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Souweidane MM, 2010, J NEUROSURG-PEDIATR, V5, P325, DOI 10.3171/2009.11.PEDS09369; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3	9	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 29	2013	346								f3315	10.1136/bmj.f3315	http://dx.doi.org/10.1136/bmj.f3315			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DG	23719641				2022-12-24	WOS:000319948200009
J	Hamilton, W; Coleman, MG; Rubin, G				Hamilton, William; Coleman, Mark G.; Rubin, Greg			Colorectal cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; MISSED OPPORTUNITIES; DIAGNOSIS; ANEMIA; SYMPTOMS; RECORDS; COHORT; RISK		[Hamilton, William] Univ Exeter, Exeter EX2 4SG, Devon, England; [Coleman, Mark G.] Derriford Hosp, Lapco Natl Training Programme Laparoscop Colorect, Plymouth PL6 8DH, Devon, England; [Rubin, Greg] Univ Durham, Wolfson Res Inst, Stockton On Tees, England	University of Exeter; Derriford Hospital; Durham University	Hamilton, W (corresponding author), Univ Exeter, Veysey Bldg, Exeter EX2 4SG, Devon, England.	w.hamilton@exeter.ac.uk		Hamilton, William/0000-0003-1611-1373	Medical Research Council [MR/K02325X/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Astin Margaret, 2011, Br J Gen Pract, V61, pe231, DOI 10.3399/bjgp11X572427; Atkin W, 2013, LANCET; Cancer Research UK, 2012, CANCERSTATS KEY FACT; Damery S, 2011, COLORECTAL DIS, V13, pE53, DOI 10.1111/j.1463-1318.2010.02488.x; Dominguez-Ayala M, 2012, REV ESP ENFERM DIG, V104, P343, DOI 10.4321/s1130-01082012000700002; Ellis BG, 2005, BRIT J GEN PRACT, V55, P949; Elliss-Brookes L, BR J CANC, V107, P1220; Halligan S, 2013, LANCET; Hamilton W, 2008, BRIT J CANCER, V98, P323, DOI 10.1038/sj.bjc.6604165; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Hamilton W, 2010, BRIT J GEN PRACT, V60, P121, DOI 10.3399/bjgp10X483175; Hamilton W, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-17; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Masson S, 2007, COLORECTAL DIS, V9, P736, DOI 10.1111/j.1463-1318.2006.01200.x; National Institute for Health and Clinical Excellence, 2011, CG131 NICE; NHS Scotland, 2021, SCOTT REF GUID SUSP; Rodriguez LAG, 2000, SCAND J GASTROENTERO, V35, P306; Sawhney MS, 2007, AM J GASTROENTEROL, V102, P82, DOI 10.1111/j.1572-0241.2006.00908.x; Singh H, 2009, AM J GASTROENTEROL, V104, P2543, DOI 10.1038/ajg.2009.324; Stapley S, 2006, BRIT J CANCER, V95, P1321, DOI 10.1038/sj.bjc.6603439; Thompson MR, 2007, BRIT J SURG, V94, P1260, DOI 10.1002/bjs.5826; Thompson MR, 2011, COLORECTAL DIS, V13, P6, DOI 10.1111/j.1463-1318.2009.01986.x; Torring ML, 2011, BRIT J CANCER, V104, P934, DOI 10.1038/bjc.2011.60	23	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f3172	10.1136/bmj.f3172	http://dx.doi.org/10.1136/bmj.f3172			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AK	23693056	Green Submitted, Green Accepted			2022-12-24	WOS:000319573300009
J	Stratta, P; Rossi, A				Stratta, Paolo; Rossi, Alessandro			Misreporting of suicide after the L'Aquila earthquake	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AFTERMATH; DISASTERS		[Stratta, Paolo] ASL 1, Dept Mental Hlth, I-67100 Laquila, Italy; [Stratta, Paolo] Univ Pisa, Dept Clin & Expt Med, PhD Programme, I-56100 Pisa, Italy; [Rossi, Alessandro] Univ Aquila, Dept Appl Clin Sci & Biotechnol, I-67100 Laquila, Italy	University of Pisa; University of L'Aquila	Stratta, P (corresponding author), ASL 1, Dept Mental Hlth, Via Bellisari, I-67100 Laquila, Italy.	psystr@tin.it		ROSSI, Alessandro/0000-0001-8723-7622; Stratta, Paolo/0000-0002-3337-1225				[Anonymous], AQ DIM; [Anonymous], MAL VIV AQ AUM NUM S; [Anonymous], ANS ABB OR SISM SCUO; Dell'Osso L, 2011, J AFFECT DISORDERS, V131, P79, DOI 10.1016/j.jad.2010.11.023; Istat.it, SUIC TENT SUIC; Kolves K, 2013, J AFFECT DISORDERS, V146, P1, DOI 10.1016/j.jad.2012.07.037; Stratta P, 2013, CRISIS, V34, P142, DOI 10.1027/0227-5910/a000166; Stratta P, 2012, ANN I SUPER SANITA, V48, P132, DOI 10.4415/ANN_12_02_05; Vasterman P, 2005, EPIDEMIOL REV, V27, P107, DOI 10.1093/epirev/mxi002; World Health Organization, 2000, PREV SUIC RES MED PR	10	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2013	346								f3179	10.1136/bmj.f3179	http://dx.doi.org/10.1136/bmj.f3179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OK	23687102				2022-12-24	WOS:000319254600001
J	Ota, H; Sakurai, M; Gupta, R; Valente, L; Wulff, BE; Ariyoshi, K; Iizasa, H; Davuluri, RV; Nishikura, K				Ota, Hiromitsu; Sakurai, Masayuki; Gupta, Ravi; Valente, Louis; Wulff, Bjorn-Erik; Ariyoshi, Kentaro; Iizasa, Hisashi; Davuluri, Ramana V.; Nishikura, Kazuko			ADAR1 Forms a Complex with Dicer to Promote MicroRNA Processing and RNA-Induced Gene Silencing	CELL			English	Article							DOUBLE-STRANDED-RNA; INDUCED APOPTOSIS; DEAMINASES; DOMAIN; TRBP; CLEAVAGE; INTERFERENCE; DIMERIZATION; SUPPRESSION; BIOGENESIS	Adenosine deaminases acting on RNA (ADARs) are involved in RNA editing that converts adenosine residues to inosine specifically in double-stranded RNAs. In this study, we investigated the interaction of the RNA editing mechanism with the RNA interference (RNAi) machinery and found that ADAR1 forms a complex with Dicer through direct protein-protein interaction. Most importantly, ADAR1 increases the maximum rate (V-max) of pre-microRNA (miRNA) cleavage by Dicer and facilitates loading of miRNA onto RNA-induced silencing complexes, identifying a new role of ADAR1 in miRNA processing and RNAi mechanisms. ADAR1 differentiates its functions in RNA editing and RNAi by the formation of either ADAR1/ADAR1 homodimer or Dicer/ADAR1 heterodimer complexes, respectively. As expected, the expression of miRNAs is globally inhibited in ADAR1(-/-) mouse embryos, which, in turn, alters the expression of their target genes and might contribute to their embryonic lethal phenotype.	[Ota, Hiromitsu; Sakurai, Masayuki; Gupta, Ravi; Valente, Louis; Wulff, Bjorn-Erik; Ariyoshi, Kentaro; Iizasa, Hisashi; Davuluri, Ramana V.; Nishikura, Kazuko] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Nishikura, K (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	kazuko@wistar.org	Iizasa, Hisashi/A-9821-2012; Sakurai, Masayuki/AAR-8939-2021; Ariyoshi, Kentaro/L-8742-2018	Sakurai, Masayuki/0000-0002-6920-1746; Ariyoshi, Kentaro/0000-0002-4639-6130; Gupta, Ravi/0000-0001-5242-9528	National Institutes of Health [GM040536, HL070045, HL099342]; Ellison Medical Foundation [AG-55-2281-09]; Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health; University of Pennsylvania, Vagelos scholarship; Japan Society for the Promotion of Science (JSPS) [2010-22]; National Cancer Institute [P30 CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070045, RC1HL099342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health; University of Pennsylvania, Vagelos scholarship; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Jennifer A. Doudna for the pre-let-7a template plasmid, Zissimos Mourelatos for discussion on RISC loading analysis, and John M. Murray for discussion on enzyme kinetics analysis and also critical reading of the manuscript. This work was supported by grants from the National Institutes of Health (GM040536, HL070045, and HL099342), the Ellison Medical Foundation (AG-55-2281-09), and the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (to K.N.). B.-E.W. is a recipient of a University of Pennsylvania, Vagelos scholarship. M.S. is supported in part by a fellowship from the Japan Society for the Promotion of Science (JSPS 2010-22). We are also grateful for services provided by the Protein Expression, Genomics, and Bioinformatics Shared Facilities of The Wistar Cancer Center, which are supported by the National Cancer Institute (P30 CA010815).	Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Dlakic M, 2006, BIOINFORMATICS, V22, P2711, DOI 10.1093/bioinformatics/btl468; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hitti EG, 2004, FEBS LETT, V574, P25, DOI 10.1016/j.febslet.2004.07.080; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; Iizasa H, 2010, J BIOL CHEM, V285, P33358, DOI 10.1074/jbc.M110.138362; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wu CN, 2012, J LIPID RES, V53, P2355, DOI 10.1194/jlr.M028878; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684	39	223	231	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					575	589		10.1016/j.cell.2013.03.024	http://dx.doi.org/10.1016/j.cell.2013.03.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622242	Green Accepted, Bronze			2022-12-24	WOS:000318063500011
J	Irish, JD; Guatelli-Steinberg, D; Legge, SS; de Ruiter, DJ; Berger, LR				Irish, Joel D.; Guatelli-Steinberg, Debbie; Legge, Scott S.; de Ruiter, Darryl J.; Berger, Lee R.			Dental Morphology and the Phylogenetic "Place" of Australopithecus sediba	SCIENCE			English	Article							ORIGINS; PLIOPLEISTOCENE; TEETH	To characterize further the Australopithecus sediba hypodigm, we describe 22 dental traits in specimens MH1 and MH2. Like other skeletal elements, the teeth present a mosaic of primitive and derived features. The new nonmetric data are then qualitatively and phenetically compared with those in eight other African hominin samples, before cladistic analyses using a gorilla outgroup. There is some distinction, largely driven by contrasting molar traits, from East African australopiths. However, Au. sediba links with Au. africanus to form a South African australopith clade. These species present five apomorphies, including shared expressions of Carabelli's upper first molar (UM1) and protostylid lower first molar (LM1). Five synapomorphies are also evident between them and monophyletic Homo habilis/rudolfensis + H. erectus. Finally, a South African australopith + Homo clade is supported by four shared derived states, including identical LM1 cusp 7 expression.	[Irish, Joel D.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 3AF, Merseyside, England; [Guatelli-Steinberg, Debbie] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Guatelli-Steinberg, Debbie] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Legge, Scott S.] Macalester Coll, Dept Anthropol, St Paul, MN 55105 USA; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa	Liverpool John Moores University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Macalester College; Texas A&M University System; Texas A&M University College Station; University of Witwatersrand	Irish, JD (corresponding author), Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 3AF, Merseyside, England.	j.d.irish@ljmu.ac.uk	Legge, Scott S/I-4162-2019; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352; Irish, Joel D./0000-0001-7857-8847	National Science Foundation [BCS-0840674, BNS-0104731, BNS-9013942]; National Geographic Society; Wenner-Gren Foundation; Institute for Bioarchaeology; University of Alaska; Combined Prehistoric and Hierakonpolis Expeditions; Leakey Foundation; Ohio State University; Wallace Travel Fund; Macalester College; Paul Anderson Interdisciplinary Summer Research Fund; Texas AM University	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Wenner-Gren Foundation; Institute for Bioarchaeology; University of Alaska; Combined Prehistoric and Hierakonpolis Expeditions; Leakey Foundation; Ohio State University(Ohio State University); Wallace Travel Fund; Macalester College; Paul Anderson Interdisciplinary Summer Research Fund; Texas AM University	Collection of the recent African comparative data was funded by monies to J. D. I. from the National Science Foundation (BCS-0840674, BNS-0104731, BNS-9013942), National Geographic Society, Wenner-Gren Foundation, Institute for Bioarchaeology, University of Alaska, and the Combined Prehistoric and Hierakonpolis Expeditions. The innumerable individuals at >25 institutions from which the data were collected cannot be listed in this restricted space, but their help is greatly appreciated. These and the Au. sediba ASUDAS raw data are in the possession of J. D. I. Collection of the early hominin comparative data was funded by grants to D. G.-S. from the Leakey Foundation and Ohio State University. The authors thank D. Johanson and W. Kimbel for allowing D. G.-S. to study the Hadar fossils, M. Yilma of the National Museum of Ethiopia, C. Kiarie of the National Museums of Kenya, P. Msemwa and E. Maro of the National Museum of Tanzania, the Ethiopian government, and the governments of Kenya and Tanzania. H. Fourie and F. Thackery provided access to fossils at the Transvaal Museum in Pretoria; P. Tobias, B. Kramer, and K. Kuykendall provided access to the fossils at the University of the Witwatersrand. I. Tattersall, J. Schwartz, J. Lukacs, H. McHenry, I. Pike, J. McKee, and T. Harrison advised D. G.-S. regarding the logistics of her research in east and South Africa. The ASUDAS hominin data are in the possession of D. G.-S. The assistance of A. Gill and M. Harman at the Powell-Cotton Museum, Birchington, UK, from which the gorilla crown data (in the possession of S. S. L.) were recorded, is greatly appreciated. Funding for S. S. L. was provided by the Wallace Travel Fund, Macalester College, and the Paul Anderson Interdisciplinary Summer Research Fund; funding for D. J. D. was provided by the Ray A. Rothrock Fellowship, Texas A&M University.	Abbott S.A., 1984, THESIS U LONDON; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; Falk D., 1988, P85; Grine Frederick E., 2009, P49, DOI 10.1007/978-1-4020-9980-9_6; Guatelli-Steinberg D, 2005, AM J PHYS ANTHROPOL, V128, P477, DOI 10.1002/ajpa.20194; Hunter JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011844; Irish JD, 2005, AM J PHYS ANTHROPOL, V128, P520, DOI 10.1002/ajpa.20109; Irish JD, 2003, J HUM EVOL, V45, P113, DOI 10.1016/S0047-2484(03)00090-3; Irish JD, 1998, J HUM EVOL, V34, P81, DOI 10.1006/jhev.1997.0191; IRISH JD, 1993, THESIS ARIZONA STATE; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Kupczik K., 2003, THESIS U LONDON; Olson T.R., 1985, P102; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Smith HF, 2008, J HUM EVOL, V54, P684, DOI 10.1016/j.jhevol.2007.10.012; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Strait DS, 1997, J HUM EVOL, V32, P17, DOI 10.1006/jhev.1996.0097; Swofford DL, 2002, PHYLOGENETIC ANAL US; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; Ungar PS, 2011, YEARB PHYS ANTHROPOL, V54, P47; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	30	55	55	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1233062	10.1126/science.1233062	http://dx.doi.org/10.1126/science.1233062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580535				2022-12-24	WOS:000317341400004
J	Franco, M; Bilal, U; Ordunez, P; Benet, M; Morejon, A; Caballero, B; Kennelly, JF; Cooper, RS				Franco, Manuel; Bilal, Usama; Ordunez, Pedro; Benet, Mikhail; Morejon, Alain; Caballero, Benjamin; Kennelly, Joan F.; Cooper, Richard S.			Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; RISK-FACTORS; OBESITY; DISEASE; ADULTS; HEALTH; PREVENTION; PREVALENCE; OVERWEIGHT; SMOKING	Objective To evaluate the associations between population-wide loss and gain in weight with diabetes prevalence, incidence, and mortality, as well as cardiovascular and cancer mortality trends, in Cuba over a 30 year interval. Design Repeated cross sectional surveys and ecological comparison of secular trends. Setting Cuba and the province of Cienfuegos, from 1980 to 2010. Participants Measurements in Cienfuegos included a representative sample of 1657, 1351, 1667, and 1492 adults in 1991, 1995, 2001, and 2010, respectively. National surveys included a representative sample of 14 304, 22 851, and 8031 participants in 1995, 2001, and 2010, respectively. Main outcome measures Changes in smoking, daily energy intake, physical activity, and body weight were tracked from 1980 to 2010 using national and regional surveys. Data for diabetes prevalence and incidence were obtained from national population based registries. Mortality trends were modelled using national vital statistics. Results Rapid declines in diabetes and heart disease accompanied an average population-wide loss of 5.5 kg in weight, driven by an economic crisis in the mid-1990s. A rebound in population weight followed in 1995 (33.5% prevalence of overweight and obesity) and exceeded pre-crisis levels by 2010 (52.9% prevalence). The population-wide increase in weight was immediately followed by a 116% increase in diabetes prevalence and 140% increase in diabetes incidence. Six years into the weight rebound phase, diabetes mortality increased by 49% (from 9.3 deaths per 10 000 people in 2002 to 13.9 deaths per 10 000 people in 2010). A deceleration in the rate of decline in mortality from coronary heart disease was also observed. Conclusions In relation to the Cuban experience in 1980-2010, there is an association at the population level between weight reduction and death from diabetes and cardiovascular disease; the opposite effect on the diabetes and cardiovascular burden was seen on population-wide weight gain.	[Franco, Manuel; Bilal, Usama] Univ Alcala de Henares, Sch Med, Social & Cardiovasc Epidemiol Res Grp, Madrid, Spain; [Franco, Manuel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ordunez, Pedro] Pan Amer Hlth Org, Project Chron Dis Prevent & Control, Washington, DC USA; [Ordunez, Pedro; Benet, Mikhail; Morejon, Alain] Univ Ciencias Med, Ctr Estudios Enfermedades Cron, Cienfuegos, Cuba; [Caballero, Benjamin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD USA; [Kennelly, Joan F.] Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL USA; [Cooper, Richard S.] Loyola Univ, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA	Universidad de Alcala; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pan American Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Loyola University Chicago	Franco, M (corresponding author), Ctr Nacl Invest Cardiovasc Madrid, Dept Epidemiol Atherothrombosis & Cardiovasc Imag, Madrid, Spain.	mfranco@uah.es	Benet, Marta/H-4168-2017; Benet, Mikhail/AAS-2086-2020; Morejon, Alain/AAS-4280-2020; FRANCO, MANUEL/T-5409-2018	Morejon, Alain/0000-0002-4652-1771; Bilal, Usama/0000-0002-9868-7773; FRANCO, MANUEL/0000-0003-1366-9398				Arnold AM, 2010, J GERONTOL A-BIOL, V65, P63, DOI 10.1093/gerona/glp050; Arnold Y, 2012, REV PERU EPIDEMIOL, V16, P6; Barcelo A, 1993, REV CUB ENDOCRINOL, V4, P59; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Benet Rodríguez Mikhail, 2010, Medisur, V8, P56; BERN C, 1995, NEW ENGL J MED, V333, P1176; Borowy I, 2013, J CLEAN PROD, V38, P17, DOI 10.1016/j.jclepro.2011.11.057; Borowy I, 2011, SOC SCI MED, V72, P1489, DOI 10.1016/j.socscimed.2011.03.008; Campion EW, 2013, NEW ENGL J MED, V368, P297, DOI 10.1056/NEJMp1215226; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Colditz GA, 2012, ANNU REV PUBL HEALTH, V33, P137, DOI 10.1146/annurev-publhealth-031811-124627; Cooper RS, 2008, INT J OBESITY, V32, pS47, DOI 10.1038/ijo.2008.85; Cooper RS, 2006, AM J PUBLIC HEALTH, V96, P94, DOI 10.2105/AJPH.2004.051417; Durazo-Arvizu RA, 1998, AM J EPIDEMIOL, V147, P739, DOI 10.1093/oxfordjournals.aje.a009518; Espinosa-Brito A, 2004, BRIT MED J, V328, P166, DOI 10.1136/bmj.328.7432.166-a; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Field AE, 2004, OBES RES, V12, P267, DOI 10.1038/oby.2004.34; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Franco M, 2008, CAN MED ASSOC J, V178, P1032, DOI 10.1503/cmaj.071677; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Houston TK, 2006, BMJ-BRIT MED J, V332, P1064, DOI 10.1136/bmj.38779.584028.55; Keck C William, 2012, Am J Public Health, V102, pe13, DOI 10.2105/AJPH.2012.300822; Lazo M, 2006, LANCET, V367, P985, DOI 10.1016/S0140-6736(06)68422-5; National Cancer Institute, 2012, JOINPOINT REGRESSION; National Institutes of Health, 2012, WEIGHT LOSS DOES NOT; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; OrdunezGarcia PO, 1996, AM J PUBLIC HEALTH, V86, P738, DOI 10.2105/AJPH.86.5.738; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Rios Massabot NE, 2005, REV CUB SALUD PUBLIC, V31, P345; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Rzehak P, 2007, EUR J EPIDEMIOL, V22, P665, DOI 10.1007/s10654-007-9167-5; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Stevens VL, 2012, AM J EPIDEMIOL, V175, P785, DOI 10.1093/aje/kwr378; Stuckler D, 2012, J EPIDEMIOL COMMUN H, V66, P410, DOI 10.1136/jech.2010.121376; Taing KY, 2012, OBESITY, V20, P407, DOI 10.1038/oby.2011.207; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wannamethee SG, 2002, ARCH INTERN MED, V162, P2575, DOI 10.1001/archinte.162.22.2575; Waring ME, 2010, AM J EPIDEMIOL, V171, P550, DOI 10.1093/aje/kwp433; West KM, 1978, EPIDEMIOLOGY OF DIAB; World Bank, 2012, WORLD BANK DATA CUBA; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005	43	102	106	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 9	2013	346								f1515	10.1136/bmj.f1515	http://dx.doi.org/10.1136/bmj.f1515			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	125ZC	23571838	Green Published, hybrid			2022-12-24	WOS:000317579800001
J	Hu, YW; Lu, SH; Song, ZG; Wang, W; Hao, P; Li, JH; Zhang, XN; Yen, HL; Shi, BS; Li, T; Guan, WC; Xu, L; Liu, Y; Wang, S; Zhang, XL; Tian, D; Zhu, ZQ; He, J; Huang, K; Chen, HJ; Zheng, LL; Li, X; Ping, J; Kang, B; Xi, XH; Zha, LJ; Li, YX; Zhang, ZY; Peiris, M; Yuan, ZH				Hu, Yunwen; Lu, Shuihua; Song, Zhigang; Wang, Wei; Hao, Pei; Li, Jianhua; Zhang, Xiaonan; Yen, Hui-Ling; Shi, Bisheng; Li, Tao; Guan, Wencai; Xu, Lei; Liu, Yi; Wang, Sen; Zhang, Xiaoling; Tian, Di; Zhu, Zhaoqin; He, Jing; Huang, Kai; Chen, Huijie; Zheng, Lulu; Li, Xuan; Ping, Jie; Kang, Bin; Xi, Xiuhong; Zha, Lijun; Li, Yixue; Zhang, Zhiyong; Peiris, Malik; Yuan, Zhenghong			Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance	LANCET			English	Article							MUTATIONS	Background On March 30, a novel influenza A subtype H7N9 virus (A/H7N9) was detected in patients with severe respiratory disease in eastern China. Virological factors associated with a poor clinical outcome for this virus remain unclear. We quantified the viral load and analysed antiviral resistance mutations in specimens from patients with A/H7N9. Methods We studied 14 patients with A/H7N9 disease admitted to the Shanghai Public Health Clinical Centre (SPHCC), China, between April 4, and April 20, 2013, who were given antiviral treatment (oseltamivir or peramivir) for less than 2 days before admission. We investigated the viral load in throat, stool, serum, and urine specimens obtained sequentially from these patients. We also sequenced viral RNA from these specimens to study the mutations associated with resistance to neuraminidase inhibitors and their association with disease outcome. Findings All patients developed pneumonia, seven of them required mechanical ventilation, and three of them further deteriorated to become dependent on extracorporeal membrane oxygenation (ECMO), two of whom died. Antiviral treatment was associated with a reduction of viral load in throat swab specimens in 11 surviving patients. Three patients with persistently high viral load in the throat in spite of antiviral therapy became ECMO dependent. An Arg292Lys mutation in the virus neuraminidase (NA) gene known to confer resistance to both zanamivir and oseltamivir was identified in two of these patients, both also received corticosteroid treatment. In one of them, wild-type sequence Arg292 was noted 2 days after start of antiviral treatment, and the resistant mutant Lys292 dominated 9 days after start of treatment. Interpretation Reduction of viral load following antiviral treatment correlated with improved outcome. Emergence of NA Arg292Lys mutation in two patients who also received corticosteroid treatment led to treatment failure and a poor clinical outcome. The emergence of antiviral resistance in A/H7N9 viruses, especially in patients receiving corticosteroid therapy, is concerning, needs to be closely monitored, and considered in pandemic preparedness planning.	[Hu, Yunwen; Song, Zhigang; Wang, Wei; Zhang, Xiaonan; Shi, Bisheng; Guan, Wencai; Xu, Lei; Liu, Yi; Zhang, Xiaoling; Tian, Di; Zhu, Zhaoqin; He, Jing; Kang, Bin; Zhang, Zhiyong] Fudan Univ, Shanghai Med Coll, Dept Pathogen Diag & Biosafety, Shanghai Publ Hlth Clin Ctr,Key Lab Med Mol Virol, Shanghai 200030, Peoples R China; [Wang, Sen; Li, Yixue; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai 200030, Peoples R China; [Lu, Shuihua; Li, Tao; Xi, Xiuhong; Zha, Lijun] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 200030, Peoples R China; [Hao, Pei; Ping, Jie] Chinese Acad Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Huang, Kai; Chen, Huijie; Zheng, Lulu; Li, Xuan; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Yen, Hui-Ling; Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Hong Kong	Yuan, ZH (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, 138 Yi Xue Yuan Rd, Shanghai 200030, Peoples R China.	malik@hkucc.hku.hk; zhyuan@shaphc.org	Yen, Hui-Ling/GNH-5083-2022; Yen, Hui-Ling/C-4501-2009; zheng, lu/GXH-7035-2022; Peiris, Joseph Sriyal Malik/C-4380-2009	Yen, Hui-Ling/0000-0003-2493-3609; Hao, Pei/0000-0002-1498-7059; Zhang, Xiaonan/0000-0002-1286-7280; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Li, Jianhua/0000-0001-7329-5688	National Megaprojects of China for Infectious Diseases [2012ZX10004211]; National Natural Science Foundation of China [81341004]; Ministry of Science and Technology [KJYJ-2013-01-01]; Shanghai Municipal Health and Family Planning Commission; National Key Basic Research Program of China [2012CB519000]; Area of Excellence Scheme of the University Grants Committee [AoE/M-12/06]; Hong Kong SAR Government; National Institutes of Health (NIAID) [HHSN266200700005C]	National Megaprojects of China for Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Municipal Health and Family Planning Commission; National Key Basic Research Program of China(National Basic Research Program of China); Area of Excellence Scheme of the University Grants Committee; Hong Kong SAR Government; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Yumei Wen (Shanghai Medical College of Fudan University) and Guoping Zhao (Shanghai Institutes for Biological Sciences, CAS) for their valuable suggestions and useful discussion. We thank B J Cowling for help with statistical analysis for supplementary figure S2 (appendix). This research was supported by the National Megaprojects of China for Infectious Diseases (2012ZX10004211), National Natural Science Foundation of China (81341004), Ministry of Science and Technology (KJYJ-2013-01-01), Shanghai Municipal Health and Family Planning Commission, and the National Key Basic Research Program of China (2012CB519000). H-LY and MP are supported by Funding from the Area of Excellence Scheme of the University Grants Committee (AoE/M-12/06), Hong Kong SAR Government and National Institutes of Health (NIAID contract HHSN266200700005C).	Chan MCW, 2011, EMERG INFECT DIS, V17, P2038, DOI 10.3201/eid1711.110205; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321	15	253	290	3	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2273	2279		10.1016/S0140-6736(13)61125-3	http://dx.doi.org/10.1016/S0140-6736(13)61125-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23726392				2022-12-24	WOS:000321100300031
J	Staal, JB; Nelemans, PJ; de Bie, RA				Staal, J. Bart; Nelemans, Patty J.; de Bie, Rob A.			Spinal Injection Therapy for Low Back Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT		[Staal, J. Bart] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6500 HB Nijmegen, Netherlands; [Nelemans, Patty J.; de Bie, Rob A.] Univ Limburg, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; [Nelemans, Patty J.; de Bie, Rob A.] Caphri Res Sch, Maastricht, Netherlands	Radboud University Nijmegen; Hasselt University; Maastricht University	Staal, JB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, POB 9101,114 IQ Healthcare, NL-6500 HB Nijmegen, Netherlands.	b.staal@iq.umcn.nl	Staal, J. Bart/A-9632-2014; Staal, Bart/ABA-4313-2020	Staal, J. Bart/0000-0002-0083-6380; Staal, Bart/0000-0002-0083-6380				Abbott ZI, 2012, SPINE J, V12, P35, DOI 10.1016/j.spinee.2011.10.005; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564; Staal JB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001824.pub3; Wilson LE, 2012, JAMA-J AM MED ASSOC, V308, P2461, DOI 10.1001/jama.2012.47932	7	13	13	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2439	2440		10.1001/jama.2013.5892	http://dx.doi.org/10.1001/jama.2013.5892			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23681274				2022-12-24	WOS:000320505100020
J	Delamothe, T				Delamothe, Tony			Slip an extra locust on the barbie?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						Dicke Marcel, 2010, WHY NOT EAT INSECTS; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445	2	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2013	346								f3293	10.1136/bmj.f3293	http://dx.doi.org/10.1136/bmj.f3293			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AA	23690504				2022-12-24	WOS:000319572300012
J	Ferner, R				Ferner, Robin			DRUG TALES AND OTHER STORIES Piquancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TOPICAL CAPSAICIN; RECEPTOR		Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Derry S, 2009, COCHRANE DB SYST REV, V4; Derry S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007393.pub3; DIB B, 1990, PHARMACOL BIOCHEM BE, V37, P649, DOI 10.1016/0091-3057(90)90541-O; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Lefebvre T, 2006, REV HIST PHARM, V350, P288; Mason L, 2004, BMJ-BRIT MED J, V328, P991, DOI 10.1136/bmj.38042.506748.EE; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2938	10.1136/bmj.f2938	http://dx.doi.org/10.1136/bmj.f2938			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148OF	23674333				2022-12-24	WOS:000319253900008
J	Young, K				Young, Kelly			PERSONAL VIEW Doctors' understanding of rheumatoid disease does not align with patients' experiences	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Rheumatoid Patient Fdn, Cocoa, FL 32923 USA		Young, K (corresponding author), Rheumatoid Patient Fdn, POB 235251, Cocoa, FL 32923 USA.	kelly@rheum4us.org						Calleja M., 2011, RHEUMATOID ARTHRITIS; Rheumatoid Patient Foundation, 2013, BEL PAT VOIC; Rheumatoid Patient Foundation, 2013, UNM RHEUM DIS PAT EX; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Strand V, 2010, AM COLL RHEUM ASS RH; Wolfe F., 2011, AM I DOING ARE WE DO; Young K., 2010, UNWILLING E PATIENT; Young K., 2012, 10 FUNDAMENTALS CARE; Young K., 2012, J PARTICIPATORY MED, V4; Young K., 2009, WHAT IS 1 SYMPTOM RH; Young K., 2012, SUSTAINED RHEUMATOID; Young K., 2011, DOES IT MATTER WHETH	12	5	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2901	10.1136/bmj.f2901	http://dx.doi.org/10.1136/bmj.f2901			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674140	Bronze			2022-12-24	WOS:000319253900006
J	Lynch, HF				Lynch, Holly Fernandez			Discrimination at the Doctor's Office	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA	Harvard University	Lynch, HF (corresponding author), Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA.							Cross P, 2012, WCVB            0824; Korn Jane, 2010, VA J SOC POLY L, V17, P209; Michon K., HLTH CARE ANTIDISCRI; Rhode DL, 2009, STANFORD LAW REV, V61, P1033; Sabin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048448	5	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1668	1670		10.1056/NEJMp1211375	http://dx.doi.org/10.1056/NEJMp1211375			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134MN	23635047				2022-12-24	WOS:000318214400015
J	Zhao, K; Tseng, BS; Beckerman, B; Jin, F; Gibiansky, ML; Harrison, JJ; Luijten, E; Parsek, MR; Wong, GCL				Zhao, Kun; Tseng, Boo Shan; Beckerman, Bernard; Jin, Fan; Gibiansky, Maxsim L.; Harrison, Joe J.; Luijten, Erik; Parsek, Matthew R.; Wong, Gerard C. L.			Psl trails guide exploration and microcolony formation in Pseudomonas aeruginosa biofilms	NATURE			English	Article							POWER LAWS; BACTERIAL BIOFILMS; CYSTIC-FIBROSIS; IV PILI; MATRIX; EXOPOLYSACCHARIDE; POLYSACCHARIDE; INVOLVEMENT; INFECTIONS; ADHESION	Bacterial biofilms are surface-associated, multicellular, morphologically complex microbial communities(1-7). Biofilm-forming bacteria such as the opportunistic pathogen Pseudomonas aeruginosa are phenotypically distinct from their free-swimming, planktonic counterparts(7-10). Much work has focused on factors affecting surface adhesion, and it is known that P. aeruginosa secretes the Psl exopolysaccharide, which promotes surface attachment by acting as 'molecular glue'(11-15). However, how individual surface-attached bacteria self-organize into microcolonies, the first step in communal biofilm organization, is not well understood. Here we identify a new role for Psl in early biofilm development using a massively parallel cell-tracking algorithm to extract the motility history of every cell on a newly colonized surface(16). By combining this technique with fluorescent Psl staining and computer simulations, we show that P. aeruginosa deposits a trail of Psl as it moves on a surface, which influences the surface motility of subsequent cells that encounter these trails and thus generates positive feedback. Both experiments and simulations indicate that the web of secreted Psl controls the distribution of surface visit frequencies, which can be approximated by a power law. This Pareto-type(17) behaviour indicates that the bacterial community self-organizes in a manner analogous to a capitalist economic system(18), a 'rich-get-richer' mechanism of Psl accumulation that results in a small number of 'elite' cells becoming extremely enriched in communally produced Psl. Using engineered strains with inducible Psl production, we show that local Psl concentrations determine post-division cell fates and that high local Psl concentrations ultimately allow elite cells to serve as the founding population for initial microcolony development.	[Zhao, Kun; Gibiansky, Maxsim L.; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Tseng, Boo Shan; Harrison, Joe J.; Parsek, Matthew R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Beckerman, Bernard; Luijten, Erik] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Jin, Fan] Univ Sci & Technol China, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Luijten, Erik] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Wong, Gerard C. L.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Northwestern University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Northwestern University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Wong, GCL (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	luijten@northwestern.edu; parsem@u.washington.edu; gclwong@seas.ucla.edu	zhao, kun/A-1998-2011; Harrison, Joe/AAV-6071-2021; Luijten, Erik/E-3899-2010; Tseng, Boo Shan/M-6279-2018	Luijten, Erik/0000-0003-2364-1866; Tseng, Boo Shan/0000-0001-7563-0232; ZHAO, KUN/0000-0003-3928-1981; fan, jin/0000-0003-2313-0388; Harrison, Joe/0000-0003-0368-9539	US National Institutes of Health [NIH 1RO1HL087920]; US National Science Foundation [NSF DMR1106106]; UCLA Transdisciplinary Seed Grant; NIH [R01AI077628, R01AI081983, R56AI061396]; NSF [MCB0822405, DMR-1006430, DGE-0824162]; Cystic Fibrosis Foundation [TSENG11F0]; Natural Sciences and Engineering Research Council of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061396, R01AI081983, R01AI061396, R01AI077628, R01AI097511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1006430] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); UCLA Transdisciplinary Seed Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	K.Z., B. S. T., M. R. P. and G. C. L. W. are supported by the US National Institutes of Health (NIH 1RO1HL087920). K.Z. and G. C. L. W. also acknowledge support from the US National Science Foundation (NSF DMR1106106) and a UCLA Transdisciplinary Seed Grant. B. S. T., J.J.H. and M. R. P. also acknowledge support from the NIH (R01AI077628, R01AI081983, R56AI061396) and NSF (MCB0822405). B. S. T. is supported by the Cystic Fibrosis Foundation Postdoctoral Fellowship (TSENG11F0). J.J.H. was supported by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. B. B. and E. L. acknowledge support from the NSF under DMR-1006430 (E. L.) and DGE-0824162 (B. B.). The authors would like to thank J. Copic for discussions and R. J. Siehnel for technical assistance. We dedicate this paper to the memory of M. Shannon.	Byrd MS, 2010, MBIO, V1, DOI 10.1128/mBio.00140-10; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; EAGON RG, 1962, CAN J MICROBIOL, V8, P585, DOI 10.1139/m62-075; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Gabaix X, 2009, ANNU REV ECON, V1, P255, DOI 10.1146/annurev.economics.050708.142940; Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Monroe D, 2007, PLOS BIOL, V5, P2458, DOI 10.1371/journal.pbio.0050307; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Solomon S, 2001, PHYSICA A, V299, P188, DOI 10.1016/S0378-4371(01)00295-3; Sternberg Claus, 2006, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b02s00; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Tatterson LE, 2001, FRONT BIOSCI-LANDMRK, V6, pD890, DOI 10.2741/Tatterso; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	32	209	221	7	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					388	+		10.1038/nature12155	http://dx.doi.org/10.1038/nature12155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23657259	Green Accepted			2022-12-24	WOS:000318952000042
J	Yang, LX; Luquette, LJ; Gehlenborg, N; Xi, RB; Haseley, PS; Hsieh, CH; Zhang, CS; Ren, XJ; Protopopov, A; Chin, L; Kucherlapati, R; Lee, C; Park, PJ				Yang, Lixing; Luquette, Lovelace J.; Gehlenborg, Nils; Xi, Ruibin; Haseley, Psalm S.; Hsieh, Chih-Heng; Zhang, Chengsheng; Ren, Xiaojia; Protopopov, Alexei; Chin, Lynda; Kucherlapati, Raju; Lee, Charles; Park, Peter J.			Diverse Mechanisms of Somatic Structural Variations in Human Cancer Genomes	CELL			English	Article							DOUBLE-STRAND BREAKS; DOUBLE-MINUTE CHROMOSOMES; GENE; REARRANGEMENTS; SEQUENCES; PATTERNS; MUTATION; REPAIR; RECOMBINATION; AMPLIFICATION	Identification of somatic rearrangements in cancer genomes has accelerated through analysis of high-throughput sequencing data. However, characterization of complex structural alterations and their underlying mechanisms remains inadequate. Here, applying an algorithm to predict structural variations from short reads, we report a comprehensive catalog of somatic structural variations and the mechanisms generating them, using high-coverage whole-genome sequencing data from 140 patients across ten tumor types. We characterize the relative contributions of different types of rearrangements and their mutational mechanisms, find that 20% of the somatic deletions are complex deletions formed by replication errors, and describe the differences between the mutational mechanisms in somatic and germline alterations. Importantly, we provide detailed reconstructions of the events responsible for loss of CDKN2A/B and gain of EGFR in glioblastoma, revealing that these alterations can result from multiple mechanisms even in a single genome and that both DNA double-strand breaks and replication errors drive somatic rearrangements.	[Yang, Lixing; Luquette, Lovelace J.; Gehlenborg, Nils; Xi, Ruibin; Haseley, Psalm S.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Informat Biol, Boston, MA 02115 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gehlenborg, Nils] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Xi, Ruibin] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Xi, Ruibin] Peking Univ, Ctr Stat Sci, Beijing 100871, Peoples R China; [Haseley, Psalm S.; Ren, Xiaojia; Kucherlapati, Raju; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Hsieh, Chih-Heng; Zhang, Chengsheng; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Haseley, Psalm S.; Hsieh, Chih-Heng; Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Protopopov, Alexei; Chin, Lynda] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Protopopov, Alexei; Chin, Lynda] Univ Texas Houston, MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77054 USA; [Lee, Charles] Seoul Natl Univ, Coll Med, Dept Med, Seoul 110799, South Korea; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Peking University; Peking University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Seoul National University (SNU); Harvard University; Boston Children's Hospital	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Informat Biol, Boston, MA 02115 USA.	peter_park@harvard.edu	Kucherlapati, Raju/ABC-8807-2021	Gehlenborg, Nils/0000-0003-0327-8297; Park, Peter/0000-0001-9378-960X; Xi, Ruibin/0000-0001-7545-7361	NIH [RC1HG005482, U24CA144025, UO1HG005209, UO1HG005725, U24CA143845]; NATIONAL CANCER INSTITUTE [U24CA143845, U24CA144025] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005482, U01HG005209, U01HG005725] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from NIH (RC1HG005482 to P.J.P., U24CA144025 to R.K., UO1HG005209 and UO1HG005725 to C.L. and U24CA143845 to L.C.). We thank The Cancer Genome Atlas project for providing the whole-genome data, the Information Technology Department at Harvard Medical School for providing computational resources, and Michael Talkowski and members of the Park laboratory for a careful reading of the manuscript. L.C. is founder and/or consultant for AVEO, Metamark, Karyopharm, and Eden. R.K. is on the board of directors of AVEO, Metamark, Enlight, and KEW Group.	Arlt MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002981; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Haviv-Chesner A, 2007, NUCLEIC ACIDS RES, V35, P5192, DOI 10.1093/nar/gkm521; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; LISKAY RM, 1987, GENETICS, V115, P161; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Thomas L, 2004, AM J HEMATOL, V77, P55, DOI 10.1002/ajh.20151; Van Roy N, 2006, GENE CHROMOSOME CANC, V45, P107, DOI 10.1002/gcc.20272; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vogt N, 2004, P NATL ACAD SCI USA, V101, P11368, DOI 10.1073/pnas.0402979101; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	49	208	211	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					919	929		10.1016/j.cell.2013.04.010	http://dx.doi.org/10.1016/j.cell.2013.04.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663786	Green Accepted, Bronze			2022-12-24	WOS:000318844000019
J	Schroeder, JI; Delhaize, E; Frommer, WB; Guerinot, ML; Harrison, MJ; Herrera-Estrella, L; Horie, T; Kochian, LV; Munns, R; Nishizawa, NK; Tsay, YF; Sanders, D				Schroeder, Julian I.; Delhaize, Emmanuel; Frommer, Wolf B.; Guerinot, Mary Lou; Harrison, Maria J.; Herrera-Estrella, Luis; Horie, Tomoaki; Kochian, Leon V.; Munns, Rana; Nishizawa, Naoko K.; Tsay, Yi-Fang; Sanders, Dale			Using membrane transporters to improve crops for sustainable food production	NATURE			English	Article							POTASSIUM UPTAKE; ABC TRANSPORTER; SALT TOLERANCE; NICOTIANAMINE-SYNTHASE; FUNCTIONAL EXPRESSION; PHOSPHATE TRANSPORTER; IRON BIOFORTIFICATION; ALUMINUM RESISTANCE; BACTERIAL-BLIGHT; NA+/H+ ANTIPORT	With the global population predicted to grow by at least 25 per cent by 2050, the need for sustainable production of nutritious foods is critical for human and environmental health. Recent advances show that specialized plant membrane transporters can be used to enhance yields of staple crops, increase nutrient content and increase resistance to key stresses, including salinity, pathogens and aluminium toxicity, which in turn could expand available arable land.	[Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Food & Fuel 21st Century Ctr, La Jolla, CA 92093 USA; [Delhaize, Emmanuel; Munns, Rana] CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Guerinot, Mary Lou] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Harrison, Maria J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Herrera-Estrella, Luis] Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Irapuato 36500, Mexico; [Horie, Tomoaki] Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Nagano 3868567, Japan; [Kochian, Leon V.] Cornell Univ, USDA ARS, Robert Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Munns, Rana] Univ Western Australia, Sch Plant Biol, Crawley 6009, Australia; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Tsay, Yi-Fang] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Sanders, Dale] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	University of California System; University of California San Diego; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Carnegie Institution for Science; Dartmouth College; Cornell University; Boyce Thompson Institute for Plant Research; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Shinshu University; Cornell University; United States Department of Agriculture (USDA); University of Western Australia; Ishikawa Prefecture University; Academia Sinica - Taiwan; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, Food & Fuel 21st Century Ctr, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu; dale.sanders@jic.ac.uk	Tsay, Yi-Fang/ABB-3662-2021; Herrera-Estrella, Luis/AAL-2472-2020; Frommer, Wolf B/K-5042-2017; Frommer, Wolf B/A-8256-2008; Kochian, Leon/ABH-6148-2020; Herrera-Estrella, Luis/ABC-7431-2020; Delhaize, Emmanuel/I-6536-2013; Munns, Rana E/B-4237-2013	Tsay, Yi-Fang/0000-0003-4271-0687; Herrera-Estrella, Luis/0000-0001-7936-3856; Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Kochian, Leon/0000-0003-3416-089X; Munns, Rana E/0000-0002-7519-2698; Schroeder, Julian/0000-0002-3283-5972; Delhaize, Emmanuel/0000-0002-0529-7160; Harrison, Maria J/0000-0001-8716-1875	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE) [DE-FG02-03ER15449, DE-FG02-04ER15542, DE-FG-2-06ER15809]; Grains Research and Development Corporation, Australia; US National Science Foundation [IOS:0842720, MCB0918220, IOS-091994, DBI 0701119]; UK Biotechnology and Biological Sciences Research Council [BB/J004561/1]; National Institutes of Health [GM060396-P42ES010337, GM078536, P42ES007373]; US Department of Agriculture [2009-02273]; Generation Challenge Grant [G7010.03.06]; Howard Hughes Medical Institute [55005946]; CREST Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan [23119507]; Academia Sinica, Taiwan; National Science Council, Taiwan [NSC 101-2321-B-001-005]; Grants-in-Aid for Scientific Research [23248011] Funding Source: KAKEN; Direct For Biological Sciences [0919941] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373, P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536, R01GM060396] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0651, BBS/E/J/000C0662] Funding Source: researchfish; BBSRC [BBS/E/J/000C0662, BBS/E/J/000C0651] Funding Source: UKRI	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE)(United States Department of Energy (DOE)); Grains Research and Development Corporation, Australia(Grains R&D Corp); US National Science Foundation(National Science Foundation (NSF)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); Generation Challenge Grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); CREST Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Research in our laboratories was supported by: the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE) under grant numbers DE-FG02-03ER15449 (to J.I.S.), DE-FG02-04ER15542 (to W.B.F.) and DE-FG-2-06ER15809 (to M. L. G.); by the Grains Research and Development Corporation, Australia (to R. M. and E. D.); by the US National Science Foundation under grant numbers IOS:0842720 (to M.J.H.), MCB0918220 (to J.I.S.) and IOS-091994 and DBI 0701119 (to M. L. G.); by the UK Biotechnology and Biological Sciences Research Council under grant number BB/J004561/1 (to D. S.); by the National Institutes of Health under grant numbers GM060396-P42ES010337 (to J.I.S.) and GM078536 and P42ES007373 (to M. L. G.); by the US Department of Agriculture under grant number 2009-02273 (to L. V. K.); by a Generation Challenge Grant under grant number G7010.03.06 (to L. V. K.); by the Howard Hughes Medical Institute under grant number 55005946 (to L. H. E.); the CREST Japan Science and Technology Agency (to N.K.N.); by the Ministry of Education, Culture, Sports, Science and Technology, Japan under grant number 23119507 (to T. H.); and by the Academia Sinica, Taiwan and the National Science Council, Taiwan under grant number NSC 101-2321-B-001-005 (to Y.F.T.).	[Anonymous], 2011, FOR FUT FOOD FARM; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Arpat AB, 2012, PLANT J, V71, P479, DOI 10.1111/j.1365-313X.2012.05004.x; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Beebe SE, 2006, CROP SCI, V46, P413, DOI 10.2135/cropsci2005.0226; BLUMWALD E, 1985, PLANT PHYSIOL, V78, P163, DOI 10.1104/pp.78.1.163; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Connor DJ, 2008, FIELD CROP RES, V106, P187, DOI 10.1016/j.fcr.2007.11.010; Conway G., 2012, ONE BILLION HUNGRY C, P125; Delhaize E, 2007, FEBS LETT, V581, P2255, DOI 10.1016/j.febslet.2007.03.057; Delhaize E, 2009, PLANT BIOTECHNOL J, V7, P391, DOI 10.1111/j.1467-7652.2009.00403.x; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT FOOD INS WORLD; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Horie T, 2007, EMBO J, V26, P3003, DOI 10.1038/sj.emboj.7601732; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kusumi K, 2012, J EXP BOT, V63, P5635, DOI 10.1093/jxb/ers216; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lee S, 2012, MOL CELLS, V33, P269, DOI 10.1007/s10059-012-2231-3; Lee S, 2011, PLANT BIOTECHNOL J, V9, P865, DOI 10.1111/j.1467-7652.2011.00606.x; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Li CY, 2012, PLANT CELL REP, V31, P851, DOI 10.1007/s00299-011-1206-8; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu QS, 2011, PLANT CELL ENVIRON, V34, P1958, DOI 10.1111/j.1365-3040.2011.02391.x; Lopez-Arredondo DL, 2012, NAT BIOTECHNOL, V30, P889, DOI 10.1038/nbt.2346; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Maron LG, 2010, PLANT J, V61, P728, DOI 10.1111/j.1365-313X.2009.04103.x; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Masuda H, 2008, RICE, V1, P100, DOI 10.1007/s12284-008-9007-6; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; Mian A, 2011, PLANT J, V68, P468, DOI 10.1111/j.1365-313X.2011.04701.x; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Nagarajan VK, 2011, PLANT PHYSIOL, V156, P1149, DOI 10.1104/pp.111.174805; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Remy E, 2012, NEW PHYTOL, V195, P356, DOI 10.1111/j.1469-8137.2012.04167.x; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; RIESMEIER JW, 1994, EMBO J, V13, P1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; The World Bank, 2006, REP NUTR CENTR DEV S, P42; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; US Geological Survey, 2012, MIN COMM SUMM 2012, P118; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Weber A. P., 2012, CURR OPIN BIOTECHNOL; Wirth J, 2009, PLANT BIOTECHNOL J, V7, P631, DOI 10.1111/j.1467-7652.2009.00430.x; World Health Organization/FAO, 2003, DIET NUTR PREV CHRON, P4; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901; Zhang Y, 2012, PLANT J, V72, P400, DOI 10.1111/j.1365-313X.2012.05088.x	93	318	341	14	752	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					60	66		10.1038/nature11909	http://dx.doi.org/10.1038/nature11909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636397	Green Accepted, Green Submitted			2022-12-24	WOS:000318221500034
J	Zhang, B; Gaiteri, C; Bodea, LG; Wang, Z; McElwee, J; Podtelezhnikov, AA; Zhang, CS; Xie, T; Tran, L; Dobrin, R; Fluder, E; Clurman, B; Melquist, S; Narayanan, M; Suver, C; Shah, H; Mahajan, M; Gillis, T; Mysore, J; MacDonald, ME; Lamb, JR; Bennett, DA; Molony, C; Stone, DJ; Gudnason, V; Myers, AJ; Schadt, EE; Neumann, H; Zhu, J; Emilsson, V				Zhang, Bin; Gaiteri, Chris; Bodea, Liviu-Gabriel; Wang, Zhi; McElwee, Joshua; Podtelezhnikov, Alexei A.; Zhang, Chunsheng; Xie, Tao; Tran, Linh; Dobrin, Radu; Fluder, Eugene; Clurman, Bruce; Melquist, Stacey; Narayanan, Manikandan; Suver, Christine; Shah, Hardik; Mahajan, Milind; Gillis, Tammy; Mysore, Jayalakshmi; MacDonald, Marcy E.; Lamb, John R.; Bennett, David A.; Molony, Cliona; Stone, David J.; Gudnason, Vilmundur; Myers, Amanda J.; Schadt, Eric E.; Neumann, Harald; Zhu, Jun; Emilsson, Valur			Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer's Disease	CELL			English	Article							MOLECULAR NETWORKS; EXPRESSION; DYSFUNCTION; MICROGLIA; RISK	The genetics of complex disease produce alterations in the molecular interactions of cellular pathways whose collective effect may become clear through the organized structure of molecular networks. To characterize molecular systems associated with late-onset Alzheimer's disease (LOAD), we constructed gene-regulatory networks in 1,647 postmortem brain tissues from LOAD patients and nondemented subjects, and we demonstrate that LOAD reconfigures specific portions of the molecular interaction structure. Through an integrative network-based approach, we rank-ordered these network structures for relevance to LOAD pathology, highlighting an immune- and microglia-specific module that is dominated by genes involved in pathogen phagocytosis, contains TYROBP as a key regulator, and is upregulated in LOAD. Mouse microglia cells overexpressing intact or truncated TYROBP revealed expression changes that significantly overlapped the human brain TYROBP network. Thus the causal network structure is a useful predictor of response to gene perturbations and presents a framework to test models of disease mechanisms underlying LOAD.	[Zhang, Bin; Shah, Hardik; Mahajan, Milind; Schadt, Eric E.; Zhu, Jun] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zhang, Bin; Shah, Hardik; Mahajan, Milind; Schadt, Eric E.; Zhu, Jun] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Zhang, Bin; Mahajan, Milind; Schadt, Eric E.; Zhu, Jun] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Zhang, Bin; Gaiteri, Chris; Wang, Zhi; Tran, Linh; Suver, Christine] Sage Bionetworks, Seattle, WA 98109 USA; [Bodea, Liviu-Gabriel; Neumann, Harald] Univ Bonn, Neural Regenerat Grp, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [McElwee, Joshua; Zhang, Chunsheng; Xie, Tao; Dobrin, Radu; Fluder, Eugene; Melquist, Stacey; Narayanan, Manikandan; Molony, Cliona] Merck & Co Inc, Merck Res Labs, Boston, MA 02115 USA; [Podtelezhnikov, Alexei A.; Stone, David J.] Merck & Co Inc, Merck Res Labs, West Point, PA 19486 USA; [Clurman, Bruce] Fred Hutch Canc Res Ctr, Seattle, WA 98109 USA; [Gillis, Tammy; Mysore, Jayalakshmi; MacDonald, Marcy E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Lamb, John R.] GNF Novartis, San Diego, CA 92121 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimer Dis Ctr, Chicago, IL 60612 USA; [Gudnason, Vilmundur; Emilsson, Valur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Gudnason, Vilmundur; Emilsson, Valur] Univ Iceland, IS-201 Kopavogur, Iceland; [Myers, Amanda J.] Univ Miami, Miller Sch Med, Div Neurosci, Dept Psychiat & Behav Sci, Miami, FL 33136 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Bonn; Merck & Company; Merck & Company; Fred Hutchinson Cancer Center; Harvard University; Massachusetts General Hospital; Rush University; Icelandic Heart Association; University of Iceland; University of Miami	Zhang, B (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave, New York, NY 10029 USA.	bin.zhang@mssm.edu; valur@hjarta.is	Neumann, Harald/A-9718-2010; Myers, Amanda J/B-1796-2010; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Bodea, Liviu-Gabriel/F-9480-2012; Clurman, Bruce/AAV-3854-2021	Neumann, Harald/0000-0002-5071-5202; Myers, Amanda J/0000-0002-3100-9396; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Bodea, Liviu-Gabriel/0000-0002-9604-9524; Emilsson, Valur/0000-0001-9982-0524; Narayanan, Manikandan/0000-0002-8490-4087; Dobrin, Radu/0000-0002-3336-0091; Gaiteri, Chris/0000-0001-7838-8664; Suver, Christine/0000-0002-2986-385X	Hertie-Foundation; Deutsche Forschungsgemeinschaft [FOR1336, SFB704, KFO177]; DFG; National Institutes of Health [R01 AG034504, R01 AG030146, P30 AG10161, R01 AG17917, R01 AG15819, K08 AG034290, R01 AG11101, NS032765]; Illinois Department of Public Health; University of Miami; Miller School of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG034290, R01AG011101, R01AG034504, R01AG017917, P30AG010161, R01AG015819, R01AG030146] Funding Source: NIH RePORTER	Hertie-Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Department of Public Health; University of Miami; Miller School of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	H.N. and L.-G.B. were supported by the Hertie-Foundation and the Deutsche Forschungsgemeinschaft (FOR1336, SFB704, KFO177). H.N. is a member of the DFG-funded excellence cluster ImmunoSensation. We thank Jessica Schumacher and Rita Hass for technical assistance. We are grateful to the HBTRC for the generous gift of human postmortem brain samples. The authors are also grateful to the participants in the Religious Orders Study and the Memory and Aging Project. This work is supported by the National Institutes of Health (R01 AG034504, R01 AG030146, P30 AG10161, R01 AG17917, R01 AG15819, K08 AG034290, P30 AG10161, R01 AG11101, and NS032765), the Illinois Department of Public Health, and start-up funding from the University of Miami, Miller School of Medicine. J.M., A.A.P., C.Z., T.X., R.D., E.F., S.M., M.N., C.M., and D.J.S. are employees and shareholders of Merck & Co., Inc. J.R.L. is an employee and shareholder of Novartis.	Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Bianchin MM, 2010, NAT REV NEUROL, V6, P1, DOI 10.1038/nrneurol.2010.17-c1; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Cechetto David F, 2008, Expert Rev Neurother, V8, P743, DOI 10.1586/14737175.8.5.743; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Dodel RC, 2003, LANCET NEUROL, V2, P215, DOI 10.1016/S1474-4422(03)00349-1; Duda R.O., 2000, PATTERN CLASSIFICATI; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Luchsinger JA, 2008, EUR J PHARMACOL, V585, P119, DOI 10.1016/j.ejphar.2008.02.048; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Morawski M, 2012, BRAIN PATHOL, V22, P547, DOI 10.1111/j.1750-3639.2011.00557.x; Murray IVJ, 2011, EXP BIOL MED, V236, P772, DOI 10.1258/ebm.2011.010355; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schafer S, 2008, DRUG DISCOV TODAY, V13, P913, DOI 10.1016/j.drudis.2008.03.026; Schiffman SS, 2002, NEUROBIOL AGING, V23, P397, DOI 10.1016/S0197-4580(01)00337-2; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Webber KM, 2005, MECH AGEING DEV, V126, P1019, DOI 10.1016/j.mad.2005.03.024; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	41	1032	1054	4	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					707	720		10.1016/j.cell.2013.03.030	http://dx.doi.org/10.1016/j.cell.2013.03.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622250	Green Accepted, Bronze			2022-12-24	WOS:000318063500021
J	Wallace, DJ; Greenberg, DS; Sawinski, J; Rulla, S; Notaro, G; Kerr, JND				Wallace, Damian J.; Greenberg, David S.; Sawinski, Juergen; Rulla, Stefanie; Notaro, Giuseppe; Kerr, Jason N. D.			Rats maintain an overhead binocular field at the expense of constant fusion	NATURE			English	Article							HEAD MOVEMENTS; EYE; EXPERIENCE; REFLEX; SEE	Fusing left and right eye images into a single view is dependent on precise ocular alignment, which relies on coordinated eye movements. During movements of the head this alignment is maintained by numerous reflexes. Although rodents share with other mammals the key components of eye movement control, the coordination of eye movements in freely moving rodents is unknown. Here we show that movements of the two eyes in freely moving rats differ fundamentally from the precisely controlled eye movements used by other mammals to maintain continuous binocular fusion. The observed eye movements serve to keep the visual fields of the two eyes continuously overlapping above the animal during free movement, but not continuously aligned. Overhead visual stimuli presented to rats freely exploring an open arena evoke an immediate shelter-seeking behaviour, but are ineffective when presented beside the arena. We suggest that continuously overlapping visual fields overhead would be of evolutionary benefit for predator detection by minimizing blind spots.	[Wallace, Damian J.; Greenberg, David S.; Sawinski, Juergen; Rulla, Stefanie; Notaro, Giuseppe; Kerr, Jason N. D.] Max Planck Inst Biol Cybernet, Network Imaging Grp, D-72076 Tubingen, Germany; [Notaro, Giuseppe; Kerr, Jason N. D.] Bernstein Ctr Computat Neurosci Tubingen, D-72076 Tubingen, Germany	Max Planck Society	Kerr, JND (corresponding author), Max Planck Inst Biol Cybernet, Network Imaging Grp, Spemannstr 41, D-72076 Tubingen, Germany.	jason@tuebingen.mpg.de		Greenberg, David/0000-0002-8515-0459; Notaro, Giuseppe/0000-0002-5355-6577; Kerr, Jason/0000-0001-9459-883X	German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]; Max Planck Society	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank W. Denk, R. Hahnloser, K. Kirchfeld, K. Martin, A. Schwartz and F. Wolf for comments on earlier versions of this manuscript and M. Rictis for help with electronics fabrication. We also thank A. Benali, A. Brauer, U. Czubayko, M.-L. Silva, V. Pawlak, V. Ramachandra and T. Senkova from the Network Imaging Group for data processing, A. Schaefer and M. Kollo for loan of the spherical treadmill, and F. Wolf for advice on the modelling and discussions throughout the project. We thank N. Logothetis for support and C. Sakmann for insights. G.N.'s salary was financed by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002). The Max Planck Society financed research. We apologize to all authors whom we have not been able to cite because of space restrictions.	Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Artal P, 1998, VISUAL NEUROSCI, V15, P597, DOI 10.1017/S0952523898154020; Berardi N, 1999, J NEUROBIOL, V41, P119, DOI 10.1002/(SICI)1097-4695(199910)41:1<119::AID-NEU15>3.0.CO;2-N; CHELAZZI L, 1989, EUR J NEUROSCI, V1, P639, DOI 10.1111/j.1460-9568.1989.tb00369.x; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.1999, 10.1006/anbe.2002.999]; Dell'Osso LF, 1998, J NEURO-OPHTHALMOL, V18, P112; DONCASTER CP, 1990, J MAMMAL, V71, P188, DOI 10.2307/1382166; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; DUWAER AL, 1981, PERCEPT PSYCHOPHYS, V29, P295, DOI 10.3758/BF03207338; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; Fernandez-Juricic E, 2011, BRAIN BEHAV EVOLUT, V77, P147, DOI 10.1159/000326053; FULLER JH, 1985, VISION RES, V25, P1121, DOI 10.1016/0042-6989(85)90101-4; HESS BJM, 1990, EUR J NEUROSCI, V2, P909, DOI 10.1111/j.1460-9568.1990.tb00003.x; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; HUGHES A, 1977, VISION RES, V17, P927, DOI 10.1016/0042-6989(77)90068-2; LEGG CR, 1990, BEHAV BRAIN RES, V41, P11, DOI 10.1016/0166-4328(90)90049-K; LYLE T K, 1955, Br J Ophthalmol, V39, P474, DOI 10.1136/bjo.39.8.474; MORRIS P, 1979, J ZOOL, V189, P540, DOI 10.1111/j.1469-7998.1979.tb03983.x; Munz M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00191; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Quinn KJ, 1998, J NEUROSCI METH, V80, P201, DOI 10.1016/S0165-0270(98)00005-3; Russell JT, 1932, PEDAGOG SEMIN J GEN, V40, P136; Wallace DG, 2002, BEHAV BRAIN RES, V131, P185, DOI 10.1016/S0166-4328(01)00384-9; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; Zee DS., 1999, NEUROLOGY EYE MOVEME; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	27	166	168	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					65	69		10.1038/nature12153	http://dx.doi.org/10.1038/nature12153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23708965				2022-12-24	WOS:000319947800033
J	Xu, CC; Wang, SY; Thibault, G; Ng, DTW				Xu, Chengchao; Wang, Songyu; Thibault, Guillaume; Ng, Davis T. W.			Futile Protein Folding Cycles in the ER Are Terminated by the Unfolded Protein O-Mannosylation Pathway	SCIENCE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; GREEN FLUORESCENT PROTEIN; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; YEAST; TRANSLOCON; MECHANISMS; CHAPERONES; PRINCIPLES	Newly synthesized polypeptides fold and assemble with assistance from protein chaperones. Full maturation can take multiple attempts, exchanging chaperones at each round. Improperly folded molecules must exit folding cycles and be degraded. In the endoplasmic reticulum (ER), prolonged substrate cycling is detrimental because it expends chaperone and energy resources and increases toxic reactive oxygen species. In budding yeast, we found that unfolded protein O-mannosylation terminated failed folding attempts through the Pmt1/Pmt2 complex. O-mannosylation incapacitated target molecule folding and removed them from folding cycles by reducing engagement with the Kar2 chaperone. In an in vitro protein refolding assay, the modification intrinsically and irreversibly disabled the folding potential of the substrate. Thus, protein folding termination can involve a covalent glycosylation event.	[Xu, Chengchao; Wang, Songyu; Thibault, Guillaume; Ng, Davis T. W.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Xu, Chengchao; Wang, Songyu; Ng, Davis T. W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ng, Davis T. W.] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore	National University of Singapore; National University of Singapore	Ng, DTW (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	davis@tll.org.sg	Thibault, Guillaume/J-9730-2013	Thibault, Guillaume/0000-0002-7926-4812; Xu, Chengchao/0000-0003-4558-7581	Temasek Trust; Singapore Millennium Foundation; National University of Singapore Graduate Research Scholarship	Temasek Trust; Singapore Millennium Foundation(Singapore Millennium Foundation); National University of Singapore Graduate Research Scholarship(National University of Singapore)	We thank M. DeLisa for providing the P7-GFP construct. We thank W. Xie, S. Vashist, C. Blackman, and M. T. Toh for discussion and technical assistance. This work was supported by funds from the Temasek Trust and grants from the Singapore Millennium Foundation to S.W. (predoctoral fellowship) and G.T. (postdoctoral fellowship). C.X. is a recipient of The National University of Singapore Graduate Research Scholarship. Research funding agencies played no rule in project conception, experimental design and analysis, manuscript preparation, or decision to publish. C.X., S.W., G.T., and D.T.W.N. performed molecular, genetic, and imaging analyses. C.X., S.W., and G.T. performed biochemical and quantitative analyses. D.T.W.N. conceived and supervised the project. C.X., S.W., G.T. and D.T.W.N. wrote the paper.	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goder V, 2011, J CELL SCI, V124, P144, DOI 10.1242/jcs.072181; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Li SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041119; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rodrigo-Brenni MC, 2012, DEV CELL, V23, P896, DOI 10.1016/j.devcel.2012.10.012; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; SWEET DJ, 1992, EMBO J, V11, P423, DOI 10.1002/j.1460-2075.1992.tb05071.x; Thibault G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013193; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9	28	56	60	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					978	981		10.1126/science.1234055	http://dx.doi.org/10.1126/science.1234055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704572				2022-12-24	WOS:000319344100047
J	Teng, SW; Mukherji, S; Moffitt, JR; de Buyl, S; O'Shea, EK				Teng, Shu-Wen; Mukherji, Shankar; Moffitt, Jeffrey R.; de Buyl, Sophie; O'Shea, Erin K.			Robust Circadian Oscillations in Growing Cyanobacteria Require Transcriptional Feedback	SCIENCE			English	Article							KAIC PHOSPHORYLATION; MOLECULAR-BASES; GENE-EXPRESSION; CLOCK; RHYTHMS; SYSTEM; CELLS	The remarkably stable circadian oscillations of single cyanobacteria enable a population of growing cells to maintain synchrony for weeks. The cyanobacterial pacemaker is a posttranslational regulation (PTR) circuit that generates circadian oscillations in the phosphorylation state of the clock protein KaiC. Layered on top of the PTR is transcriptional-translational feedback regulation (TTR), common to all circadian systems, consisting of a negative feedback loop in which KaiC regulates its own production. We found that the PTR circuit is sufficient to generate oscillations in growing cyanobacteria. However, in the absence of TTR, individual oscillators were less stable and synchrony was not maintained in a population of cells. Experimentally constrained mathematical modeling reproduced sustained oscillations in the PTR circuit alone and demonstrated the importance of TTR for oscillator synchrony.	[Teng, Shu-Wen; Mukherji, Shankar; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Teng, Shu-Wen; Mukherji, Shankar; Moffitt, Jeffrey R.; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [de Buyl, Sophie] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu		de Buyl, Sophie/0000-0002-3314-9616	National Institute of Allergy and Infections Diseases [1R21AI094363-01A1]; Helen Hay Whitney Postdoctoral Fellowship; Fonds National de la Recherche Scientifique Belgium; Wallonie-Bruxelles International; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094363] Funding Source: NIH RePORTER	National Institute of Allergy and Infections Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Helen Hay Whitney Postdoctoral Fellowship; Fonds National de la Recherche Scientifique Belgium(Fonds de la Recherche Scientifique - FNRS); Wallonie-Bruxelles International; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Cluzel for the development of the microfluidics platform upon which the device used in this paper is based (funded via National Institute of Allergy and Infections Diseases award 1R21AI094363-01A1); B. Goetze and J. Wailes for assistance with microscopy; D. Zwicker, P. R. ten Wolde, and A. Subramaniam for stochastic simulation; J. Markson, A. Gutu, V. Vijayan, and A. Puszynska for strain construction and Western blotting; P. Cluzel, D. Gonze, and P. de Buyl for helpful discussion; and B. Stern, J. Markson, V. Vijayan, A. Rizvi, M. Rust, and A. Subramaniam for comments on the manuscript. Supported by the Helen Hay Whitney Postdoctoral Fellowship (J. R. M.), Fonds National de la Recherche Scientifique Belgium (postdoctoral researcher) (S.d.B.), Wallonie-Bruxelles International (S.d.B.), Wallonie-Bruxelles International (S.d.B.), and the Howard Hughes Medical Institute (E.K.O.).	Amdaoud M, 2007, P NATL ACAD SCI USA, V104, P7051, DOI 10.1073/pnas.0609315104; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hosokawa N, 2011, P NATL ACAD SCI USA, V108, P15396, DOI 10.1073/pnas.1019612108; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Nakahira Y, 2004, P NATL ACAD SCI USA, V101, P881, DOI 10.1073/pnas.0307411100; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	26	78	83	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					737	740		10.1126/science.1230996	http://dx.doi.org/10.1126/science.1230996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661759	Green Submitted, Green Accepted			2022-12-24	WOS:000318619000037
J	Jaffe, R; Ding, Y; Niggemann, J; Vahatalo, AV; Stubbins, A; Spencer, RGM; Campbell, J; Dittmar, T				Jaffe, Rudolf; Ding, Yan; Niggemann, Jutta; Vahatalo, Anssi V.; Stubbins, Aron; Spencer, Robert G. M.; Campbell, John; Dittmar, Thorsten			Global Charcoal Mobilization from Soils via Dissolution and Riverine Transport to the Oceans	SCIENCE			English	Article							DISSOLVED BLACK CARBON; ORGANIC-MATTER	Global biomass burning generates 40 million to 250 million tons of charcoal every year, part of which is preserved for millennia in soils and sediments. We have quantified dissolution products of charcoal in a wide range of rivers worldwide and show that globally, a major portion of the annual charcoal production is lost from soils via dissolution and subsequent transport to the ocean. The global flux of soluble charcoal accounts to 26.5 +/- 1.8 million tons per year, which is similar to 10% of the global riverine flux of dissolved organic carbon (DOC). We suggest that the mobilization of charcoal and DOC out of soils is mechanistically coupled. This study closes a major gap in the global charcoal budget and provides critical information in the context of geoengineering.	[Jaffe, Rudolf; Ding, Yan] Florida Int Univ, SERC, Miami, FL 33199 USA; [Jaffe, Rudolf; Ding, Yan] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Niggemann, Jutta; Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Max Planck Res Grp Marine Geochem, D-29129 Oldenburg, Germany; [Vahatalo, Anssi V.] Univ Helsinki, Dept Environm Sci, FIN-00014 Helsinki, Finland; [Vahatalo, Anssi V.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40500, Finland; [Stubbins, Aron] Skidaway Inst Oceanog, Savannah, GA 31411 USA; [Spencer, Robert G. M.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Campbell, John] US Forest Serv, USDA, No Res Stn, Durham, NH 03824 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; University of Helsinki; University of Jyvaskyla; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Woods Hole Research Center; United States Department of Agriculture (USDA); United States Forest Service	Jaffe, R (corresponding author), Florida Int Univ, SERC, Miami, FL 33199 USA.	jaffer@fiu.edu; tdittmar@mpi-bremen.de	Stubbins, Aron/M-8801-2014; Dittmar, Thorsten/L-7796-2013	Stubbins, Aron/0000-0002-3994-1946; Dittmar, Thorsten/0000-0002-3462-0107; Campbell, John/0000-0002-6752-3493; Vahatalo, Anssi/0000-0003-3434-5915; Campbell, John/0000-0003-4956-1696	NSF [DBI-0620409, ETBC-0851101, DEB-1145932, ANT-1203885, OPP-1107774, DEB-1146161]; SERC Barley Chair; FIU-University Graduate School; Academy of Finland; Hanse Institute for Advanced Studies (HWK, Delmenhorst, Germany); Direct For Biological Sciences [1146161] Funding Source: National Science Foundation; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); SERC Barley Chair; FIU-University Graduate School; Academy of Finland(Academy of Finland); Hanse Institute for Advanced Studies (HWK, Delmenhorst, Germany); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	R.J. and Y.D. thank the NSF [grant DBI-0620409; Florida Coast Everglades-LTER program], the SERC Barley Chair, and the FIU-University Graduate School for financial support. The Academy of Finland funded A.V.V. and the collection of samples from large rivers. R.G.M.S. was supported by NSF grants (ETBC-0851101, DEB-1145932, ANT-1203885, and OPP-1107774). A.S. was supported by the NSF (DEB-1146161) and a Fellowship from the Hanse Institute for Advanced Studies (HWK, Delmenhorst, Germany). R. Max Holmes, James W. McClelland, and the rest of the Arctic Great Rivers Observatory (www.arcticgreatrivers.org) team are thanked for providing Arctic river samples (NSF OPP-0732522, OPP-0732821, and OPP-1107774). We thank Y. Yamashita, J. Jones (Bonanza Creek-LTER), W. Dodds (Konza Prairie-LTER), C. Craft (Georgia Coastal Ecosystems-LTER), N. Jaffe, C. Nunes, K. Cawley, P. Wolski, R. Price, C. Rezende, E. M. Paolucci, E. Musibono, A. Shantz, Y. Gelinas, S. R. Khan, Q. Huang, W. Schneider, E. Petrescu and H. E. Reader for providing samples and for field support and M. Friebe and I. Ulber for analytical support. This is SERC Contribution 593. Original data will be available at http://fcelter.fiu.edu/data/public_data_access/RJaffe_Global_DissolvedBlack_Corg.xls.	Abiven S, 2011, SOIL BIOL BIOCHEM, V43, P1615, DOI 10.1016/j.soilbio.2011.03.027; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Bird MI, 1999, GLOBAL BIOGEOCHEM CY, V13, P923, DOI 10.1029/1999GB900067; Cusack DF, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004109; Czimczik CI, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001956; Czimczik CI, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002798; Ding Y, 2013, CHEMOSPHERE, V90, P2557, DOI 10.1016/j.chemosphere.2012.10.098; Dittmar T, 2008, ORG GEOCHEM, V39, P396, DOI 10.1016/j.orggeochem.2008.01.015; Dittmar T, 2006, MAR CHEM, V102, P208, DOI 10.1016/j.marchem.2006.04.003; Dittmar T, 2012, NAT GEOSCI, V5, P618, DOI [10.1038/ngeo1541, 10.1038/NGEO1541]; Dittmar T, 2012, LIMNOL OCEANOGR, V57, P1171, DOI 10.4319/lo.2012.57.4.1171; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Glaser B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002019; Goldberg E.D., 1985, BLACK CARBON ENV PRO; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Hockaday WC, 2007, GEOCHIM COSMOCHIM AC, V71, P3432, DOI 10.1016/j.gca.2007.02.023; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Levine J. S., 1996, BIOMASS BURNING GLOB; Mannino A, 2004, LIMNOL OCEANOGR, V49, P735, DOI 10.4319/lo.2004.49.3.0735; Masiello CA, 1998, SCIENCE, V280, P1911, DOI 10.1126/science.280.5371.1911; Masiello CA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015050; Masiello CA, 2004, MAR CHEM, V92, P201, DOI 10.1016/j.marchem.2004.06.043; Mitra S, 2002, ENVIRON SCI TECHNOL, V36, P2296, DOI 10.1021/es015834b; Nguyen BT, 2010, ENVIRON SCI TECHNOL, V44, P3324, DOI 10.1021/es903016y; Ohlson M, 2009, NAT GEOSCI, V2, P692, DOI 10.1038/NGEO617; Schmidt MWI, 2004, NATURE, V427, P305, DOI 10.1038/427305a; Schneider MPW, 2010, ORG GEOCHEM, V41, P1082, DOI 10.1016/j.orggeochem.2010.07.001; Singh N, 2012, BIOGEOSCIENCES, V9, P2847, DOI 10.5194/bg-9-2847-2012; Skjemstad JO, 2002, SOIL SCI SOC AM J, V66, P1249, DOI 10.2136/sssaj2002.1249	30	327	340	37	489	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					345	347		10.1126/science.1231476	http://dx.doi.org/10.1126/science.1231476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599492				2022-12-24	WOS:000317657500053
J	Zou, Y; Chiu, H; Zinovyeva, A; Ambros, V; Chuang, CF; Chang, C				Zou, Yan; Chiu, Hui; Zinovyeva, Anna; Ambros, Victor; Chuang, Chiou-Fen; Chang, Chieh			Developmental Decline in Neuronal Regeneration by the Progressive Change of Two Intrinsic Timers	SCIENCE			English	Article							ELEGANS; MICRORNA; ENCODES; PATHWAY; PROTEIN; LIN-14; RNA	Like mammalian neurons, Caenorhabditis elegans neurons lose axon regeneration ability as they age, but it is not known why. Here, we report that let-7 contributes to a developmental decline in anterior ventral microtubule (AVM) axon regeneration. In older AVM axons, let-7 inhibits regeneration by down-regulating LIN-41, an important AVM axon regeneration-promoting factor. Whereas let-7 inhibits lin-41 expression in older neurons through the lin-41 3' untranslated region, lin-41 inhibits let-7 expression in younger neurons through Argonaute ALG-1. This reciprocal inhibition ensures that axon regeneration is inhibited only in older neurons. These findings show that a let-7-lin-41 regulatory circuit, which was previously shown to control timing of events in mitotic stem cell lineages, is reutilized in postmitotic neurons to control postdifferentiation events.	[Zou, Yan; Chiu, Hui; Chuang, Chiou-Fen; Chang, Chieh] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; [Zinovyeva, Anna; Ambros, Victor] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA 01605 USA; [Zinovyeva, Anna; Ambros, Victor] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Chang, Chieh] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1B1, Canada	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; McGill University	Chuang, CF (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA.	chiou-fen.chuang@cchmc.org; chieh.chang@cchmc.org	Zou, Yan/AAR-2564-2020	Zou, Yan/0000-0002-4743-4995; Chiu, Hui (Vivian)/0000-0002-1820-8411; Chuang, Chiou-Fen/0000-0001-7469-076X	Whitehall Foundation; March of Dimes Foundation; Canada Foundation for Innovation; Alfred P. Sloan Research Fellowships; NIH [R01 GM098026, R01 GM034028-25]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034028, R01GM098026] Funding Source: NIH RePORTER	Whitehall Foundation; March of Dimes Foundation(March of Dimes); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alfred P. Sloan Research Fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the C. elegans Genetic Center for C. elegans strains; the WormBase for readily accessible information; F. Ciamacco, B. Bayne, and C. Carrelli for technical assistance; A. Fire for C. elegans vectors; and V. Cleghon for critical reading of the manuscript. This work was funded by grants from the Whitehall Foundation (C.C. and C.-F.C.), the March of Dimes Foundation (C.C.), the Canada Foundation for Innovation (C.C.), by Alfred P. Sloan Research Fellowships to C.-F.C., by NIH grant R01 GM098026 to C.-F.C., and by NIH grant R01 GM034028-25 to V.A.	Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chiu H, 2011, CELL ADHES MIGR, V5, P387, DOI 10.4161/cam.5.5.17985; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Gabel CV, 2008, DEVELOPMENT, V135, P3623, DOI 10.1242/dev.030817; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hsieh YW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002864; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; ROUGVIE AE, 1995, DEVELOPMENT, V121, P2491; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Zou Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002437	19	104	109	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2013	340	6130					372	376		10.1126/science.1231321	http://dx.doi.org/10.1126/science.1231321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126XZ	23599497	Green Accepted			2022-12-24	WOS:000317657500061
J	Paeschke, K; Bochman, ML; Garcia, PD; Cejka, P; Friedman, KL; Kowalczykowski, SC; Zakian, VA				Paeschke, Katrin; Bochman, Matthew L.; Garcia, P. Daniela; Cejka, Petr; Friedman, Katherine L.; Kowalczykowski, Stephen C.; Zakian, Virginia A.			Pif1 family helicases suppress genome instability at G-quadruplex motifs	NATURE			English	Article							GROSS-CHROMOSOMAL REARRANGEMENTS; REPLICATION FORK PROGRESSION; SACCHAROMYCES-CEREVISIAE; DNA HELICASE; YEAST; RRM3P; TELOMERASE; PROTEINS; GENES; LOCI	The Saccharomyces cerevisiae Pif1 helicase is the prototypical member of the Pif1 DNA helicase family, which is conserved from bacteria to humans. Here we show that exceptionally potent G-quadruplex unwinding is conserved among Pif1 helicases. Moreover, Pif1 helicases from organisms separated by more than 3 billion years of evolution suppressed DNA damage at G-quadruplex motifs in yeast. The G-quadruplex-induced damage generated in the absence of Pif1 helicases led to new genetic and epigenetic changes. Furthermore, when expressed in yeast, human PIF1 suppressed both G-quadruplex-associated DNA damage and telomere lengthening.	[Paeschke, Katrin; Bochman, Matthew L.; Garcia, P. Daniela; Zakian, Virginia A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Cejka, Petr; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Cejka, Petr; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol Genet, Davis, CA 95616 USA; [Cejka, Petr; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Friedman, Katherine L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA	Princeton University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Vanderbilt University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	vzakian@princeton.edu	Bochman, Matthew L./I-2033-2019	Bochman, Matthew L./0000-0002-2807-0452; Cejka, Petr/0000-0002-9087-032X	National Institutes of Health; National Science Foundation; DFG; NJCCR; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041347, R01GM043265, R01GM026938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); NJCCR; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. B. Boule for early work on S. cerevisiae Pif1 biochemistry, P. Opresko for the gift of purified human WRN, E. Allen-Vercoe, K. Bidle, C. Parker, R. Johnson, H. L. Ayala-del-Rio and E. Sockett for materials and for cloning non-yeast Pif1 helicases, and M. Platts for multiplex PCR and Southern analysis methods to characterize GCR clones. We acknowledge financial support from the National Institutes of Health (V.A.Z., S. C. K.), National Science Foundation (K. L. F.), DFG and NJCCR (K. P.) and American Cancer Society (M.L.B.).	APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bochman ML, 2011, MOL BIOL CELL, V22, P1955, DOI 10.1091/mbc.E11-01-0045; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Brosh RM, 2006, METHOD ENZYMOL, V409, P52, DOI 10.1016/S0076-6879(05)09004-X; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chisholm KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030748; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Mondoux M., 2005, TELOMERES, P261; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Piazza A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003033; Pinter SF, 2008, MOL CELL BIOL, V28, P6594, DOI 10.1128/MCB.00191-08; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; RUNGE KW, 1989, MOL CELL BIOL, V9, P1488, DOI 10.1128/MCB.9.4.1488; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schmidt KH, 2006, METHOD ENZYMOL, V409, P462, DOI 10.1016/S0076-6879(05)09027-0; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	45	312	325	3	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					458	+		10.1038/nature12149	http://dx.doi.org/10.1038/nature12149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23657261	Green Submitted, Green Accepted			2022-12-24	WOS:000319254000040
J	Xu, HP; Li, XY; Liu, D; Li, JF; Zhang, X; Chen, X; Hou, SY; Peng, LX; Xu, CG; Liu, WL; Zhang, LF; Qi, H				Xu, Heping; Li, Xuanying; Liu, Dan; Li, Jianfu; Zhang, Xu; Chen, Xin; Hou, Shiyue; Peng, Lixia; Xu, Chenguang; Liu, Wanli; Zhang, Lianfeng; Qi, Hai			Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility	NATURE			English	Article							INDUCIBLE COSTIMULATOR; LYMPH-NODE; DIFFERENTIATION; CHEMOTAXIS; RECEPTOR; 3-KINASE; PROTEIN; B7RP-1; BCL6	Germinal centres support antibody affinity maturation and memory formation(1). Follicular T-helper cells promote proliferation and differentiation of antigen-specific B cells inside the follicle(2,3). A genetic deficiency in the inducible co-stimulator (ICOS), a classic CD28 family co-stimulatory molecule highly expressed by follicular T-helper cells, causes profound germinal centre defects(4,5), leading to the view that ICOS specifically co-stimulates the follicular T-helper cell differentiation program(2,6,7). Here we show that ICOS directly controls follicular recruitment of activated T-helper cells in mice. This effect is independent from ICOS ligand (ICOSL)-mediated co-stimulation provided by antigen-presenting dendritic cells or cognate B cells, and does not rely on Bcl6-mediated programming as an intermediate step. Instead, it requires ICOSL expression by follicular bystander B cells, which do not present cognate antigen to T-helper cells but collectively form an ICOS-engaging field. Dynamic imaging reveals ICOS engagement drives coordinated pseudopod formation and promotes persistent T-cell migration at the border between the T-cell zone and the B-cell follicle in vivo. When follicular bystander B cells cannot express ICOSL, otherwise competent T-helper cells fail to develop into follicular T-helper cells normally, and fail to promote optimal germinal centre responses. These results demonstrate a co-stimulation-independent function of ICOS, uncover a key role for bystander B cells in promoting the development of follicular T-helper cells, and reveal unsuspected sophistication in dynamic T-cell positioning in vivo.	[Xu, Heping; Li, Xuanying; Liu, Dan; Zhang, Xu; Chen, Xin; Hou, Shiyue; Peng, Lixia; Qi, Hai] Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Li, Jianfu] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Xu, Chenguang; Liu, Wanli] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100021, Peoples R China; [Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qi, H (corresponding author), Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	qihai@biomed.tsinghua.edu.cn	liu, wanli/H-5690-2011; Chen, Xin/GNH-1799-2022	liu, wanli/0000-0003-2624-6802; Chen, Xin/0000-0001-6212-2335; Liu, Wanli/0000-0003-0395-2800; Qi, Hai/0000-0001-5475-3989; Xu, Heping/0000-0003-2149-7004	National Natural Science Foundation of China [81072464, 81161120405]; Program for New Century Excellent Talents in University [20091042000]; Tsinghua-Yu-Yuan Medical Sciences Fund [20240000585]; Tsinghua University Initiative Scientific Research Program [2010Z02150]; Institut Merieux; Tsinghua-Peking Center for Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Tsinghua-Yu-Yuan Medical Sciences Fund; Tsinghua University Initiative Scientific Research Program; Institut Merieux; Tsinghua-Peking Center for Life Sciences	H. Q. is indebted to his late mother J. Wang for inspiration, and thanks Y. Hong for support. H. Q. was a Tsinghua-Bayer Investigator and a Tsinghua-Janssen Investigator. This work was funded in part by the National Natural Science Foundation of China (grant no. 81072464 and 81161120405), the Program for New Century Excellent Talents in University (no. 20091042000), Tsinghua-Yu-Yuan Medical Sciences Fund (no. 20240000585), Tsinghua University Initiative Scientific Research Program (no. 2010Z02150), Institut Merieux, and the Tsinghua-Peking Center for Life Sciences.	Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Liu WL, 2010, J IMMUNOL, V184, P1977, DOI 10.4049/jimmunol.0902334; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Norman P, 2011, EXPERT OPIN THER PAT, V21, P1773, DOI 10.1517/13543776.2011.629606; Nukada Y, 2006, INT IMMUNOL, V18, P1815, DOI 10.1093/intimm/dxl115; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Okamoto N, 2004, INT IMMUNOL, V16, P1515, DOI 10.1093/intimm/dxh153; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Simpson TR, 2010, CURR OPIN IMMUNOL, V22, P326, DOI 10.1016/j.coi.2010.01.001; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Yoshinaga SK, 2000, INT IMMUNOL, V12, P1439, DOI 10.1093/intimm/12.10.1439; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	29	278	308	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					523	+		10.1038/nature12058	http://dx.doi.org/10.1038/nature12058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619696				2022-12-24	WOS:000317984400045
J	Kim, TI; McCall, JG; Jung, YH; Huang, X; Siuda, ER; Li, YH; Song, JZ; Song, YM; Pao, HA; Kim, RH; Lu, CF; Lee, SD; Song, IS; Shin, G; Al-Hasani, R; Kim, S; Tan, MP; Huang, YG; Omenetto, FG; Rogers, JA; Bruchas, MR				Kim, Tae-il; McCall, Jordan G.; Jung, Yei Hwan; Huang, Xian; Siuda, Edward R.; Li, Yuhang; Song, Jizhou; Song, Young Min; Pao, Hsuan An; Kim, Rak-Hwan; Lu, Chaofeng; Lee, Sung Dan; Song, Il-Sun; Shin, Gunchul; Al-Hasani, Ream; Kim, Stanley; Tan, Meng Peun; Huang, Yonggang; Omenetto, Fiorenzo G.; Rogers, John A.; Bruchas, Michael R.			Injectable, Cellular-Scale Optoelectronics with Applications for Wireless Optogenetics	SCIENCE			English	Article							IN-VIVO CONTROL; DOPAMINERGIC-NEURONS; TRANSISTORS; MODULATION; CIRCUITS; ARRAYS; REWARD; MODEL; FILMS	Successful integration of advanced semiconductor devices with biological systems will accelerate basic scientific discoveries and their translation into clinical technologies. In neuroscience generally, and in optogenetics in particular, the ability to insert light sources, detectors, sensors, and other components into precise locations of the deep brain yields versatile and important capabilities. Here, we introduce an injectable class of cellular-scale optoelectronics that offers such features, with examples of unmatched operational modes in optogenetics, including completely wireless and programmed complex behavioral control over freely moving animals. The ability of these ultrathin, mechanically compliant, biocompatible devices to afford minimally invasive operation in the soft tissues of the mammalian brain foreshadow applications in other organ systems, with potential for broad utility in biomedical science and engineering.	[Kim, Tae-il; Jung, Yei Hwan; Huang, Xian; Song, Young Min; Pao, Hsuan An; Kim, Rak-Hwan; Shin, Gunchul; Kim, Stanley; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Kim, Tae-il] Sungkyunkwan Univ SKKU, Sch Chem Engn, Suwon 440746, South Korea; [McCall, Jordan G.; Siuda, Edward R.; Al-Hasani, Ream; Bruchas, Michael R.] Washington Univ, Sch Med, Basic Res Div, Dept Anesthesiol, St Louis, MO 63110 USA; [McCall, Jordan G.; Siuda, Edward R.; Al-Hasani, Ream; Bruchas, Michael R.] Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; [McCall, Jordan G.; Siuda, Edward R.; Al-Hasani, Ream; Bruchas, Michael R.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [McCall, Jordan G.; Siuda, Edward R.; Bruchas, Michael R.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Li, Yuhang] Northwestern Univ, Dept Civil & Environm Engn, Dept Mech Engn, Evanston, IL 60208 USA; [Li, Yuhang] Northwestern Univ, Inst Publ Hlth & Med, Evanston, IL 60208 USA; [Song, Jizhou] Univ Miami, Dept Mech & Aerosp Engn, Coral Gables, FL 33146 USA; [Lu, Chaofeng] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China; [Lu, Chaofeng] Zhejiang Univ, Dept Civil Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Lee, Sung Dan; Tan, Meng Peun; Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61802 USA; [Song, Il-Sun; Rogers, John A.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61802 USA; [Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02115 USA; [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys, Medford, MA 02115 USA; [Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61802 USA	University of Illinois System; University of Illinois Urbana-Champaign; Sungkyunkwan University (SKKU); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Northwestern University; Northwestern University; University of Miami; Zhejiang University; Zhejiang University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Tufts University; Tufts University; University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Frederick Seitz Mat Res Lab, 1304 W Green St, Urbana, IL 61801 USA.	jrogers@uiuc.edu; bruchasm@wustl.edu	Li, Yuhang/N-6104-2019; Song, Young Min/B-2215-2010; Song, Jizhou/B-1935-2008; Kim, Tae-il/C-4769-2015; Kim, Rak-Hwan/A-6155-2012; McCall, Jordan/O-4795-2016; Al-Hasani, Ream/GPX-3398-2022; Bruchas, Michael/G-7616-2012; Huang, Xian/H-1820-2013; huang, yonggang/O-6236-2019; Huang, Yonggang/B-6998-2009; Rogers, John/L-2798-2016	Song, Young Min/0000-0002-4473-6883; Song, Jizhou/0000-0003-2821-9429; Kim, Tae-il/0000-0002-6667-5356; McCall, Jordan/0000-0001-8295-0664; Huang, Xian/0000-0002-8788-9185	NIH; National Institute of Neurological Disorders and Stroke, NIH [R01NS081707]; National Institute on Drug Abuse, NIH [R00DA025182]; McDonnell Center for Systems Neuroscience; National Security Science and Engineering Faculty Fellowship of Energy; Division of Materials Sciences, U.S. Department of Energy [DE-FG02-07ER46471]; Materials Research Laboratory; Center for Microanalysis of Materials [DE-FG02-07ER46453]; Division of Biology and Biomedical Sciences, Washington University in St. Louis (WUSTL); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA025182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); McDonnell Center for Systems Neuroscience; National Security Science and Engineering Faculty Fellowship of Energy; Division of Materials Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Materials Research Laboratory; Center for Microanalysis of Materials; Division of Biology and Biomedical Sciences, Washington University in St. Louis (WUSTL); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the NIH Common Fund; National Institute of Neurological Disorders and Stroke, NIH, R01NS081707 (M.R.B., J.A.R.); National Institute on Drug Abuse, NIH, R00DA025182 (M.R.B.); McDonnell Center for Systems Neuroscience (M.R.B.); National Security Science and Engineering Faculty Fellowship of Energy (J.A.R.); Division of Materials Sciences, U. S. Department of Energy, under award no. DE-FG02-07ER46471 (J.A.R.), and the Materials Research Laboratory and Center for Microanalysis of Materials (DE-FG02-07ER46453) (J.A.R.); and the Division of Biology and Biomedical Sciences, Washington University in St. Louis (WUSTL) (J.G.M.). We thank H. Tao (Tufts University) and S. Hwang (University of Illinois at Urbana-Champaign) for their help in preparation of silk solution and valuable discussions; the Bruchas laboratory and the laboratories of R. W. Gereau IV (WUSTL) and G. D. Stuber (University of North Carolina at Chapel Hill) for helpful discussions; K. Deisseroth (Stanford University) for the channelrhodopsin-2 (H134) and OPTO-beta 2 constructs; G. D. Stuber for the TH-IRES-Cre mice; the WUSTL Bakewell Neuroimaging Laboratory Core; and the WUSTL Hope Center Viral Vector Core.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Anikeeva P, 2012, NAT NEUROSCI, V15, P163, DOI 10.1038/nn.2992; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Cao H, 2013, IEEE T BIO-MED ENG, V60, P225, DOI 10.1109/TBME.2012.2217395; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Coque L, 2011, NEUROPSYCHOPHARMACOL, V36, P1478, DOI 10.1038/npp.2011.33; Elwassif MM, 2006, J NEURAL ENG, V3, P306, DOI 10.1088/1741-2560/3/4/008; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kim TI, 2012, SMALL, V8, P1643, DOI 10.1002/smll.201200382; Kim YT, 2012, MRS BULL, V37, P573, DOI 10.1557/mrs.2012.99; Kozai TDY, 2009, J NEUROSCI METH, V184, P199, DOI 10.1016/j.jneumeth.2009.08.002; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/nmat2834, 10.1038/NMAT2834]; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; McGranahan TM, 2011, J NEUROSCI, V31, P10891, DOI 10.1523/JNEUROSCI.0937-11.2011; Ordonez J, 2012, MRS BULL, V37, P590, DOI 10.1557/mrs.2012.117; Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107; Sekitani T, 2012, MRS BULL, V37, P236, DOI 10.1557/mrs.2012.42; Sekitani T, 2009, SCIENCE, V326, P1516, DOI 10.1126/science.1179963; Stark E, 2012, J NEUROPHYSIOL, V108, P349, DOI 10.1152/jn.00153.2012; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Takeuchi S, 2004, J MICROMECH MICROENG, V14, P104, DOI 10.1088/0960-1317/14/1/014; Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/NMAT3404, 10.1038/nmat3404]; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zorzos AN, 2012, OPT LETT, V37, P4841, DOI 10.1364/OL.37.004841	32	792	822	33	679	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					211	216		10.1126/science.1232437	http://dx.doi.org/10.1126/science.1232437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580530	Green Accepted, Green Submitted			2022-12-24	WOS:000317341400059
J	Wilson, EB; Yamada, DH; Elsaesser, H; Herskovitz, J; Deng, JN; Cheng, GH; Aronow, BJ; Karp, CL; Brooks, DG				Wilson, Elizabeth B.; Yamada, Douglas H.; Elsaesser, Heidi; Herskovitz, Jonathan; Deng, Jane; Cheng, Genhong; Aronow, Bruce J.; Karp, Christopher L.; Brooks, David G.			Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection	SCIENCE			English	Article							CHRONIC HEPATITIS-C; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC VIRAL-INFECTION; T-CELLS; INTERLEUKIN-10 RECEPTOR; EXPRESSION; IL-10; GAMMA; PROGRESSION	Type I interferons (IFN-I) are critical for antiviral immunity; however, chronic IFN-I signaling is associated with hyperimmune activation and disease progression in persistent infections. We demonstrated in mice that blockade of IFN-I signaling diminished chronic immune activation and immune suppression, restored lymphoid tissue architecture, and increased immune parameters associated with control of virus replication, ultimately facilitating clearance of the persistent infection. The accelerated control of persistent infection induced by blocking IFN-I signaling required CD4 T cells and was associated with enhanced IFN-gamma production. Thus, we demonstrated that interfering with chronic IFN-I signaling during persistent infection redirects the immune environment to enable control of infection.	[Wilson, Elizabeth B.; Yamada, Douglas H.; Elsaesser, Heidi; Herskovitz, Jonathan; Cheng, Genhong; Brooks, David G.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Wilson, Elizabeth B.; Yamada, Douglas H.; Elsaesser, Heidi; Herskovitz, Jonathan; Cheng, Genhong; Brooks, David G.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Deng, Jane] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Res Fdn, Div Biomed Informat, Cincinnati, OH 45267 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45267 USA; [Aronow, Bruce J.; Karp, Christopher L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Karp, Christopher L.] Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45267 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Brooks, DG (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	dbrooks@microbio.ucla.edu		Karp, Christopher/0000-0002-0832-2659; Brooks, David/0000-0001-7763-8764	NIH [AI085043, AI082975, AI060567, HL108949]; Institutional Clinical and Translational Science Award [NIH/NCATS 8UL1TR000077-04]; UCLA Center for AIDS Research [P30 AI028697]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082975, R01AI085043, R01AI047868, P30AI028697, T32AI060567, R01AI056154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Clinical and Translational Science Award; UCLA Center for AIDS Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank S. Bensinger for insightful discussion and critical review of the manuscript, all the members of the Brooks laboratory for discussions and technical assistance, and the UCLA Translational Pathology Core Facility for expert histological tissue processing and analysis. The data presented in the manuscript are tabulated in the main paper and in the supplementary materials. D.G.B. and E.B.W. are named inventors on a provisional patent assigned to The Regents of the University of California relating in part to methods of treating chronic viral infections by administering agents that inhibit IFN. The microarray data set from this study is available at www.ncbi.nlm.nih.gov/geo/ (accession no. GSE44322). Our work was supported by the NIH (grants AI085043 and AI082975 to D.G.B., AI060567 to E.B.W., and HL108949 to J.D.), an Institutional Clinical and Translational Science Award (NIH/NCATS 8UL1TR000077-04 to B.J.A.), and the UCLA Center for AIDS Research (P30 AI028697).	AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bolen CR, 2013, J INTERF CYTOK RES, V33, P15, DOI 10.1089/jir.2012.0037; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Flynn JK, 2011, J VIRAL HEPATITIS, V18, P549, DOI 10.1111/j.1365-2893.2010.01335.x; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Landay AL, 1996, J INFECT DIS, V173, P1085, DOI 10.1093/infdis/173.5.1085; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Muller S, 2002, J VIROL, V76, P2375, DOI 10.1128/JVI.76.5.2375-2383.2002; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Rigopoulou EI, 2005, CLIN IMMUNOL, V117, P57, DOI 10.1016/j.clim.2005.06.003; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; TISHON A, 1993, VIROLOGY, V195, P397, DOI 10.1006/viro.1993.1389; TISHON A, 1995, VIROLOGY, V212, P244, DOI 10.1006/viro.1995.1477; VonHerrath MG, 1997, VIROLOGY, V229, P349, DOI 10.1006/viro.1997.8442; Wilson EB, 2012, CELL HOST MICROBE, V11, P481, DOI 10.1016/j.chom.2012.03.009; Wilson EB, 2010, IMMUNOL RES, V48, P3, DOI 10.1007/s12026-010-8162-1	28	494	506	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129					202	207		10.1126/science.1235208	http://dx.doi.org/10.1126/science.1235208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580528	Green Accepted			2022-12-24	WOS:000317341400057
J	Mejdahl, MK; Andersen, KG; Gartner, R; Kroman, N; Kehlet, H				Mejdahl, Mathias Kvist; Andersen, Kenneth Geving; Gartner, Rune; Kroman, Niels; Kehlet, Henrik			Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTOPERATIVE PAIN; IMMPACT RECOMMENDATIONS; FUNCTIONAL IMPAIRMENT; COOPERATIVE GROUP; CLINICAL-TRIALS; RISK-FACTORS; HEALTH; DBCG; AGE; RADIOTHERAPY	Objective To examine the development of persistent pain after treatment for breast cancer and to examine risk factors associated with continuing pain. Design Repeated cross sectional study in a previously examined nationwide cohort. All eligible women who underwent surgery for primary breast cancer in Denmark in 2005 and 2006 and were examined in 2008 were surveyed again with the same questionnaire. Setting Surgical centres in Denmark. Main outcome measures Prevalence, location, and severity of persistent pain after treatment for breast cancer in well defined treatment groups and changes in pain reporting and sensory disturbances from 2008 to 2012. Participants In 2012, 2828 women were eligible in our database, and 108 were excluded. Exclusion criteria were death; new, recurrent, or other cancer; reconstructive breast surgery; and emigration. Results 2411 (89%) women returned the questionnaire. Prevalence of persistent pain after treatment for breast cancer ranged from 22% to 53% depending on treatment. In 2012, 903 (37%) women reported such pain, a fall from 45% in 2008. Of these, 378 (16%) reported pain of >= 4 on a numerical rating scale (scale 0-10), a fall from 19%. Among women reporting pain in 2008, 36% no longer reported it in 2012. In contrast, 15% of the women who did not report pain in 2008 reported it in 2012. Risk factors for having pain were axillary lymph node dissection rather than sentinel lymph node biopsy (odds ratio 2.04, 95% confidence interval 1.60 to 2.61; P<0.001) and age <= 49 (1.78, 1.25 to 2.54; P<0.001). No particular method of treatment or age was associated with an increase in pain from 2008 to 2012. Conclusions Persistent pain after treatment for breast cancer remains an important problem five to seven years later. The problem is not static as it can either progress or regress with time.	[Mejdahl, Mathias Kvist; Andersen, Kenneth Geving; Kehlet, Henrik] Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark; [Gartner, Rune; Kroman, Niels] Univ Copenhagen, Rigshosp, Dept Breast Surg, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Mejdahl, MK (corresponding author), Univ Copenhagen, Rigshosp, Sect Surg Pathophysiol, 7621,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	mathias.kvist.mejdahl@rh.regionh.dk; kenneth.geving.andersen@rh.regionh.dk	Andersen, Kenneth Geving/G-9486-2011; Andersen, Kenneth G/D-4965-2013	Andersen, Kenneth G/0000-0001-8371-2326; Kehlet, Henrik/0000-0002-2209-1711; Mejdahl, Mathias Kvist/0000-0002-4286-1533	Danish Cancer Society; Innovative Medicines Initiative from the European Union [115007]; EFPIA	Danish Cancer Society(Danish Cancer Society); Innovative Medicines Initiative from the European Union; EFPIA	This study was partially funded by a grant from the Danish Cancer Society and the research leading to these results is part of the Europain Collaboration, which has received support from the Innovative Medicines Initiative Joint Undertaking, under grant agreement no 115007, which receives financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.	Aasvang E K, 2006, Hernia, V10, P316, DOI 10.1007/s10029-006-0098-y; Andersen KG, 2012, ACTA ONCOL, V51, P1036, DOI 10.3109/0284186X.2012.692884; Andersen KG, 2011, J PAIN, V12, P725, DOI 10.1016/j.jpain.2010.12.005; Bajrovic A, 2004, RADIOTHER ONCOL, V71, P297, DOI 10.1016/j.radonc.2004.03.005; Bender R, 2007, STAT MED, V26, P5586, DOI 10.1002/sim.3061; Bergh I, 2000, AGING CLIN EXP RES, V12, P380, DOI 10.1007/BF03339864; Blichert-Toft M, 2008, ACTA ONCOL, V47, P497, DOI 10.1080/02841860802068615; Blyth FM, 2004, PAIN, V111, P51, DOI 10.1016/j.pain.2004.05.020; Blyth FM, 2003, MED J AUSTRALIA, V179, P84, DOI 10.5694/j.1326-5377.2003.tb05441.x; Cronin-Fenton DP, 2007, BRIT J CANCER, V96, P1462, DOI 10.1038/sj.bjc.6603717; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Deimling GT, 2005, CANCER NURS, V28, P415, DOI 10.1097/00002820-200511000-00002; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Gagliese L, 2003, PAIN, V103, P11, DOI 10.1016/S0304-3959(02)00327-5; Gartner R, 2010, BREAST, V19, P506, DOI 10.1016/j.breast.2010.05.015; Gartner R, 2009, JAMA-J AM MED ASSOC, V302, P1985, DOI 10.1001/jama.2009.1568; Gerbershagen HJ, 2011, BRIT J ANAESTH, V107, P619, DOI 10.1093/bja/aer195; Gibson SJ, 2001, CLIN GERIATR MED, V17, P433, DOI 10.1016/S0749-0690(05)70079-3; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Grant AM, 2004, BRIT J SURG, V91, P1570, DOI 10.1002/bjs.4799; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Johansson S, 2000, INT J RADIAT ONCOL, V48, P745, DOI 10.1016/S0360-3016(00)00674-X; Jung BF, 2003, PAIN, V104, P1, DOI 10.1016/S0304-3959(03)00241-0; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; Lundeberg T, 2001, J REHABIL MED, V33, P279; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Macdonald L, 2005, BRIT J CANCER, V92, P225, DOI 10.1038/sj.bjc.6602304; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Moller S, 2008, ACTA ONCOL, V47, P506, DOI 10.1080/02841860802059259; Mouridsen HT, 2008, ACTA ONCOL, V47, P525, DOI 10.1080/02841860802027009; Peuckmann V, 2009, EUR J PAIN, V13, P478, DOI 10.1016/j.ejpain.2008.05.015; Smith BH, 1999, FAM PRACT, V16, P475, DOI 10.1093/fampra/16.5.475; Smith WCS, 1999, PAIN, V83, P91, DOI 10.1016/S0304-3959(99)00076-7; Tryggvadottir L, 2010, ACTA ONCOL, V49, P624, DOI 10.3109/02841860903575323	37	145	151	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 11	2013	346								f1865	10.1136/bmj.f1865	http://dx.doi.org/10.1136/bmj.f1865			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125ZP	23580693	hybrid			2022-12-24	WOS:000317581200001
J	Whyte, WA; Orlando, DA; Hnisz, D; Abraham, BJ; Lin, CY; Kagey, MH; Rahl, PB; Lee, TI; Young, RA				Whyte, Warren A.; Orlando, David A.; Hnisz, Denes; Abraham, Brian J.; Lin, Charles Y.; Kagey, Michael H.; Rahl, Peter B.; Lee, Tong Ihn; Young, Richard A.			Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes	CELL			English	Article							RNAI SCREEN; COACTIVATOR COMPLEX; EXPRESSION; CIRCUITRY; NETWORK; PLURIPOTENCY; BINDING; IDENTIFICATION; LYMPHOPOIESIS; TROPHECTODERM	Master transcription factors Oct4, Sox2, and Nanog bind enhancer elements and recruit Mediator to activate much of the gene expression program of pluripotent embryonic stem cells (ESCs). We report here that the ESC master transcription factors form unusual enhancer domains at most genes that control the pluripotent state. These domains, which we call super-enhancers, consist of clusters of enhancers that are densely occupied by the master regulators and Mediator. Super-enhancers differ from typical enhancers in size, transcription factor density and content, ability to activate transcription, and sensitivity to perturbation. Reduced levels of Oct4 or Mediator cause preferential loss of expression of super-enhancer-associated genes relative to other genes, suggesting how changes in gene expression programs might be accomplished during development. In other more differentiated cells, super-enhancers containing cell-type-specific master transcription factors are also found at genes that define cell identity. Super-enhancers thus play key roles in the control of mammalian cell identity.	[Whyte, Warren A.; Orlando, David A.; Hnisz, Denes; Abraham, Brian J.; Lin, Charles Y.; Kagey, Michael H.; Rahl, Peter B.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	; Abraham, Brian/C-2230-2019	/0000-0001-8855-8647; Hnisz, Denes/0000-0002-6256-1693; Abraham, Brian/0000-0001-8085-3027	National Institutes of Health [HG002668, CA146445]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA146445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Tom Volkert, Jennifer Love, Sumeet Gupta, and Jeong-Ah Kwon at the Whitehead Genome Technologies Core for Solexa sequencing; Lee M. Lawton, Jessica Reddy, Ana D'Alessio, and Jasmine M. De Cock for experimental assistance; and Alla A. Sigova, Alan C. Mullen, Roshan M. Kumar, and members of the Young lab for helpful discussion. This work was supported by the National Institutes of Health grants HG002668 (R.A.Y.) and CA146445 (R.A.Y. and T.I.L.). R.A.Y. is a founder and D.A.O. and P.B.R. have become employees of Syros Pharmaceuticals.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Alinikula J, 2010, EUR J IMMUNOL, V40, P2599, DOI 10.1002/eji.200940002; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Risley MD, 2010, DEV BIOL, V342, P146, DOI 10.1016/j.ydbio.2010.03.019; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wlodarski P, 2007, J BIOL CHEM, V282, P6316, DOI 10.1074/jbc.M607526200; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xue HH, 2012, ANN NY ACAD SCI, V1247, P16, DOI 10.1111/j.1749-6632.2011.06302.x; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	75	2210	2259	9	304	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					307	319		10.1016/j.cell.2013.03.035	http://dx.doi.org/10.1016/j.cell.2013.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582322	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000317349700011
J	O'Malley, J; Skylaki, S; Iwabuchi, KA; Chantzoura, E; Ruetz, T; Johnsson, A; Tomlinson, SR; Linnarsson, S; Kaji, K				O'Malley, James; Skylaki, Stavroula; Iwabuchi, Kumiko A.; Chantzoura, Eleni; Ruetz, Tyson; Johnsson, Anna; Tomlinson, Simon R.; Linnarsson, Sten; Kaji, Keisuke			High-resolution analysis with novel cell-surface markers identifies routes to iPS cells	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SOMATIC-CELLS; REPROGRAMMING FACTORS; PLURIPOTENCY; BIOINFORMATICS; TRANSPOSITION; BIOCONDUCTOR; INDUCTION; PIGGYBAC; MURINE	The generation of induced pluripotent stem (iPS) cells presents a challenge to normal developmental processes. The low efficiency and heterogeneity of most methods have hindered understanding of the precise molecular mechanisms promoting, and roadblocks preventing, efficient reprogramming. Although several intermediate populations have been described(1-7), it has proved difficult to characterize the rare, asynchronous transition from these intermediate stages to iPS cells. The rapid expansion of minor reprogrammed cells in the heterogeneous population can also obscure investigation of relevant transition processes. Understanding the biological mechanisms essential for successful iPS cell generation requires both accurate capture of cells undergoing the reprogramming process and identification of the associated global gene expression changes. Here we demonstrate that in mouse embryonic fibroblasts, reprogramming follows an orderly sequence of stage transitions, marked by changes in the cell-surface markers CD44 and ICAM1, and a Nanog-enhanced green fluorescent protein (Nanog-eGFP) reporter. RNA-sequencing analysis of these populations demonstrates two waves of pluripotency gene upregulation, and unexpectedly, transient upregulation of several epidermis-related genes, demonstrating that reprogramming is not simply the reversal of the normal developmental processes. This novel high-resolution analysis enables the construction of a detailed reprogramming route map, and the improved understanding of the reprogramming process will lead to new reprogramming strategies.	[O'Malley, James; Iwabuchi, Kumiko A.; Chantzoura, Eleni; Ruetz, Tyson; Tomlinson, Simon R.; Kaji, Keisuke] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh BioQuarter, Edinburgh EH16 4UU, Midlothian, Scotland; [Skylaki, Stavroula] Helmholtz Ctr Munich, Stem Cell Dynam Res Unit, D-85764 Neuherberg, Germany; [Johnsson, Anna; Linnarsson, Sten] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, SE-17177 Stockholm, Sweden	University of Edinburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Karolinska Institutet	Kaji, K (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh BioQuarter, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	keisuke.kaji@ed.ac.uk	Linnarsson, Sten/HCH-3909-2022	Kaji, Keisuke/0000-0001-5946-8415; Ruetz, Tyson/0000-0002-3568-7717	ERC grant ROADTOIPS [261075]; ERC grant BRAINCELL [261063]; Anne Rowling Regenerative Neurology Clinic; MRC PhD Studentship; Darwin Trust of Edinburgh Scholarship; Medical Research Council [G0700711B] Funding Source: researchfish	ERC grant ROADTOIPS; ERC grant BRAINCELL; Anne Rowling Regenerative Neurology Clinic; MRC PhD Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Darwin Trust of Edinburgh Scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Nagy and K. Woltjen for providing the 6c iPS cell line, I. Chambers for providing TNG mice, S. Monard and O. Rodrigues for assistance with flow cytometry, and T. Kunath, T. Burdon, S. Lowell and N. Festuccia for discussions and comments on the manuscript. We also thank L. Robertson for technical assistance, and Biomed unit staff for mouse husbandry. This work was supported by ERC grants ROADTOIPS (no. 261075) and BRAINCELL (no. 261063), and the Anne Rowling Regenerative Neurology Clinic. J.O.'M. and T. R. are funded by an MRC PhD Studentship and a Darwin Trust of Edinburgh Scholarship, respectively.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fu HQ, 2006, NAT BIOTECHNOL, V24, P572, DOI 10.1038/nbt1202; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Halbritter F, 2012, NAT METHODS, V9, P7, DOI 10.1038/nmeth.1809; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Ligges U., 2003, J STAT SOFTW, V8, P1, DOI [DOI 10.18637/JSS.V008.I11, 10.18637/jss.v008.i11]; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nemajerova A, 2012, CELL DEATH DIFFER, V19, P1268, DOI 10.1038/cdd.2012.45; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu HL, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-173	38	108	108	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					88	+		10.1038/nature12243	http://dx.doi.org/10.1038/nature12243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23728301	Green Accepted			2022-12-24	WOS:000321285600039
J	Lagha, M; Bothma, JP; Esposito, E; Ng, S; Stefanik, L; Tsui, C; Johnston, J; Chen, K; Gilmour, DS; Zeitlinger, J; Levine, MS				Lagha, Mounia; Bothma, Jacques P.; Esposito, Emilia; Ng, Samuel; Stefanik, Laura; Tsui, Chiahao; Johnston, Jeffrey; Chen, Kai; Gilmour, David S.; Zeitlinger, Julia; Levine, Michael S.			Paused Pol II Coordinates Tissue Morphogenesis in the Drosophila Embryo	CELL			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; SPATIAL RANGE; GAGA FACTOR; IN-VIVO; GASTRULATION; SNAIL; DYNAMICS; ELONGATION; ACTIVATION	Paused RNA polymerase (Pol II) is a pervasive feature of Drosophila embryos and mammalian stem cells, but its role in development is uncertain. Here, we demonstrate that a spectrum of paused Pol II determines the "time to synchrony''-the time required to achieve coordinated gene expression across the cells of a tissue. To determine whether synchronous patterns of gene activation are significant in development, we manipulated the timing of snail expression, which controls the coordinated invagination of similar to 1,000 mesoderm cells during gastrulation. Replacement of the strongly paused snail promoter with moderately paused or nonpaused promoters causes stochastic activation of snail expression and increased variability of mesoderm invagination. Computational modeling of the dorsal-ventral patterning network recapitulates these variable and bistable gastrulation profiles and emphasizes the importance of timing of gene activation in development. We conclude that paused Pol II and transcriptional synchrony are essential for coordinating cell behavior during morphogenesis.	[Lagha, Mounia; Esposito, Emilia; Ng, Samuel; Tsui, Chiahao; Levine, Michael S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bothma, Jacques P.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Stefanik, Laura; Gilmour, David S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA; [Johnston, Jeffrey; Chen, Kai; Zeitlinger, Julia] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stowers Institute for Medical Research	Levine, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mlevine@berkeley.edu	Lagha, Mounia/T-7351-2018	Lagha, Mounia/0000-0002-7082-1950; Johnston, Jeff/0000-0002-8962-6186; ESPOSITO, EMILIA/0000-0003-3664-8063; Levine, Michael/0000-0001-7629-0081	Human Frontier fellowship; NIH [GM46638, GM47477]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047477, R01GM046638, R37GM046638] Funding Source: NIH RePORTER	Human Frontier fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Alistair Boettiger for sharing his ideas about Snail autoregulation. We also thank Mike Perry and Valerie Hilgers for their insightful discussions, Didier Rocancourt for help with artwork, and Lily Mirels and Eileen Wagner for comments on the manuscript. M.L. is the recipient of a Human Frontier fellowship. This work was funded by grants from the NIH, GM46638 to M.S.L. and GM47477 to D.S.G. M.L. and J.P.B. initiated efforts to create a stochastic pattern of snail activation. They also worked closely to determine activation profiles of both endogenous genes and transgenes containing minimal promoter sequences. J.P.B. conceived the use of esg as a means for identifying sna<SUP>-</SUP>/sna<SUP>-</SUP> mutant embryos. M.L. worked with L.S. and D.S.G. to document the sufficiency of minimal promoter sequences in establishing paused RNA polymerase II via permanganate protection assays. She also worked with E.E., K.C., J.J., and J.Z. to document the spectrum of Pol II binding at different promoters via whole-genome ChIP-seq assays. J.P.B. performed the imaging and developed the segmentation algorithms needed to determine t50 activation profiles. He also performed imaging to count mRNAs and analyzed the models exploring the relationship between timing and levels of gene expression. J.P.B. modeled the dynamics of Snail protein expression. M.L. and E.E. designed and created minigenes and BAC transgenes. M.L. performed the genetic crosses. C.T. injected all the plasmid transgenes, and BestGene injected all the BAC transgenes. S.N. helped M.L. and J.P.B. to collect and stain embryos. M.L., J.P.B., and M.S.L wrote the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ashe HL, 2000, DEVELOPMENT, V127, P3305; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Boettiger AN, 2013, CELL REP, V3, P8, DOI 10.1016/j.celrep.2012.12.015; Bothma JP, 2011, CURR BIOL, V21, P1571, DOI 10.1016/j.cub.2011.08.019; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Dunipace L, 2011, DEVELOPMENT, V138, P4075, DOI 10.1242/dev.069146; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fay A, 2011, CURR BIOL, V21, P1624, DOI 10.1016/j.cub.2011.08.036; Gaertner B, 2012, CELL REP, V2, P1670, DOI 10.1016/j.celrep.2012.11.024; Gilchrist DA, 2012, GENE DEV, V26, P933, DOI 10.1101/gad.187781.112; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Guenther MG, 2012, CELL STEM CELL, V10, P484, DOI 10.1016/j.stem.2012.04.016; Hemavathy K, 1997, DEVELOPMENT, V124, P3683; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kanodia JS, 2011, DEVELOPMENT, V138, P4867, DOI 10.1242/dev.071571; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Leptin M, 2005, DEV CELL, V8, P305, DOI 10.1016/j.devcel.2005.02.007; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Morachis JM, 2010, GENE DEV, V24, P135, DOI 10.1101/gad.1856710; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; Rushlow CA, 2012, CURR OPIN GENET DEV, V22, P542, DOI 10.1016/j.gde.2012.08.005; Saga Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008201; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; SWEETON D, 1991, DEVELOPMENT, V112, P775; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	46	120	121	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					976	987		10.1016/j.cell.2013.04.045	http://dx.doi.org/10.1016/j.cell.2013.04.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706736	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000319456800007
J	Zhang, Y; Ling, JL; Yuan, CY; Dubruille, R; Emery, P				Zhang, Yong; Ling, Jinli; Yuan, Chunyan; Dubruille, Raphaelle; Emery, Patrick			A Role for Drosophila ATX2 in Activation of PER Translation and Circadian Behavior	SCIENCE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; EYE-MOVEMENT SLEEP; TRANSGENIC RNAI; CLOCK; PROTEIN; PERIOD; ABNORMALITIES; MELANOGASTER; MECHANISMS; PACEMAKER	A negative transcriptional feedback loop generates circadian rhythms in Drosophila. PERIOD (PER) is a critical state-variable in this mechanism, and its abundance is tightly regulated. We found that the Drosophila homolog of ATAXIN-2 (ATX2)-an RNA-binding protein implicated in human neurodegenerative diseases-was required for circadian locomotor behavior. ATX2 was necessary for PER accumulation in circadian pacemaker neurons and thus determined period length of circadian behavior. ATX2 was required for the function of TWENTY-FOUR (TYF), a crucial activator of PER translation. ATX2 formed a complex with TYF and promoted its interaction with polyadenylate-binding protein (PABP). Our work uncovers a role for ATX2 in circadian timing and reveals that this protein functions as an activator of PER translation in circadian neurons.	[Zhang, Yong; Ling, Jinli; Yuan, Chunyan; Dubruille, Raphaelle; Emery, Patrick] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Ling, Jinli; Emery, Patrick] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Program Neurosci, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Emery, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	patrick.emery@umassmed.edu			R01 grants [GM66777, GM79182, GM100091]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100091, R01GM066777, R01GM079182] Funding Source: NIH RePORTER	R01 grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Wentworth and D. Szydlik for technical assistance; the Allada lab for communicating results before publication and for fly stocks and plasmids; M. Moore and her lab, as well as M. Ramaswami for helpful discussions and reagents; D. Weaver for critical reading of our manuscript; M. Rosbash for PER and PDF antibodies; N. Sonenberg for PABP antibody; the Vienna Drosophila RNAi Center (VDRC) for Atx2 RNAi lines; R. Stanewsky for fly stocks; the Drosophila Genomics Research Center for the Atx2 cDNA; and the Developmental Studies Hybridoma Bank for PDF antibodies. This work was supported by R01 grants GM66777, GM79182, and GM100091 to P.E.	Boesch SM, 2006, MOVEMENT DISORD, V21, P1751, DOI 10.1002/mds.21036; Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Langer CCH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008928; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Lim C, 2011, NATURE, V470, P399, DOI 10.1038/nature09728; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rodriguez-Labrada R, 2011, MOVEMENT DISORD, V26, P347, DOI 10.1002/mds.23409; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stanewsky R, 2002, J BIOL RHYTHM, V17, P293, DOI 10.1177/074873002129002609; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Tuin I, 2006, NEUROLOGY, V67, P1966, DOI 10.1212/01.wnl.0000247054.90322.14; Velazquez-Perez L, 2011, NEURODEGENER DIS, V8, P447, DOI 10.1159/000324374; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Zhang Y, 2013, NEURON, V78, P152, DOI 10.1016/j.neuron.2013.01.035	30	92	96	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					879	882		10.1126/science.1234746	http://dx.doi.org/10.1126/science.1234746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687048	Green Accepted			2022-12-24	WOS:000318997400048
J	de Vet, HCW; Mokkink, LB; Terwee, CB; Hoekstra, OS; Knol, DL				de Vet, Henrica C. W.; Mokkink, Lidwine B.; Terwee, Caroline B.; Hoekstra, Otto S.; Knol, Dirk L.			Clinicians are right not to like Cohen's kappa	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH AGREEMENT; RELIABILITY; COEFFICIENT; PARADOXES	Clinicians are interested in observer variation in terms of the probability of other raters (interobserver) or themselves (intraobserver) obtaining the same answer. Cohen's. is commonly used in the medical literature to express such agreement in categorical outcomes. The value of Cohen's kappa, however, is not sufficiently informative because it is a relative measure, while the clinician's question of observer variation calls for an absolute measure. Using an example in which the observed agreement and. lead to different conclusions, we illustrate that percentage agreement is an absolute measure (a measure of agreement) and that kappa is a relative measure (a measure of reliability). For the data to be useful for clinicians, measures of agreement should be used. The proportion of specific agreement, expressing the agreement separately for the positive and the negative ratings, is the most appropriate measure for conveying the relevant information in a 2x2 table and is most informative for clinicians.	[de Vet, Henrica C. W.; Mokkink, Lidwine B.; Terwee, Caroline B.; Knol, Dirk L.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Hoekstra, Otto S.] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	de Vet, HCW (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	hcw.devet@vumc.nl		Mokkink, Lidwine/0000-0001-6489-2827; Hoekstra, Otto S/0000-0003-0767-2734; Terwee, Caroline/0000-0003-4570-2826; de Vet, Henrica/0000-0002-5454-2804				Altman D.G., 1991, PRACTICAL STAT MED R, DOI [DOI 10.1002/SIM.4780101015, 10.1002/sim.4780101015]; Bruynesteyn K, 2002, J RHEUMATOL, V29, P2306; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Robinson PJA, 1997, BRIT J RADIOL, V70, P1085, DOI 10.1259/bjr.70.839.9536897; Sackett D, 1991, CLIN EPIDEMIOLOGY BA, P25	12	166	167	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2013	346								f2125	10.1136/bmj.f2125	http://dx.doi.org/10.1136/bmj.f2125			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126AB	23585065	Bronze			2022-12-24	WOS:000317582400002
J	Spence, PJ; Jarra, W; Levy, P; Reid, AJ; Chappell, L; Brugat, T; Sanders, M; Berriman, M; Langhorne, J				Spence, Philip J.; Jarra, William; Levy, Prisca; Reid, Adam J.; Chappell, Lia; Brugat, Thibaut; Sanders, Mandy; Berriman, Matthew; Langhorne, Jean			Vector transmission regulates immune control of Plasmodium virulence	NATURE			English	Article							MOSQUITO-TRANSMISSION; RODENT MALARIA; EXPRESSION ANALYSIS; ANTIGENIC VARIANTS; CHABAUDI-CHABAUDI; MULTIGENE FAMILY; FALCIPARUM; INFECTIONS; DIVERSITY; PARASITES	Defining mechanisms by which Plasmodium virulence is regulated is central to understanding the pathogenesis of human malaria. Serial blood passage of Plasmodium through rodents(1-3), primates(4) or humans(5) increases parasite virulence, suggesting that vector transmission regulates Plasmodium virulence within the mammalian host. In agreement, disease severity can be modified by vector transmission(6-8), which is assumed to 'reset' Plasmodium to its original character(3). However, direct evidence that vector transmission regulates Plasmodium virulence is lacking. Here we use mosquito transmission of serially blood passaged (SBP) Plasmodium chabaudi chabaudi(9) to interrogate regulation of parasite virulence. Analysis of SBP P.c. chabaudi before and after mosquito transmission demonstrates that vector transmission intrinsically modifies the asexual blood-stage parasite, which in turn modifies the elicited mammalian immune response, which in turn attenuates parasite growth and associated pathology. Attenuated parasite virulence associates with modified expression of the pir multi-gene family. Vector transmission of Plasmodium therefore regulates gene expression of probable variant antigens in the erythrocytic cycle, modifies the elicited mammalian immune response, and thus regulates parasite virulence. These results place the mosquito at the centre of our efforts to dissect mechanisms of protective immunity to malaria for the development of an effective vaccine.	[Spence, Philip J.; Jarra, William; Levy, Prisca; Brugat, Thibaut; Langhorne, Jean] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Reid, Adam J.; Chappell, Lia; Sanders, Mandy; Berriman, Matthew] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	MRC National Institute for Medical Research; Wellcome Trust Sanger Institute	Langhorne, J (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, Mill Hill, London NW7 1AA, England.	jlangho@nimr.mrc.ac.uk	Berriman, Matthew/A-7618-2011	Berriman, Matthew/0000-0002-9581-0377; Reid, Adam/0000-0002-5926-7768; Chappell, Lia/0000-0002-2317-3524; Langhorne, Jean/0000-0002-2257-9733; Spence, Phil/0000-0002-5506-2773	Medical Research Council [U117584248]; Wellcome Trust [089553, 098051]; Leverhulme Trust; MRC [MC_U117584248] Funding Source: UKRI; Medical Research Council [MC_U117584248] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (U117584248) and the Wellcome Trust (089553 and 098051). P.J.S. is the recipient of a Leverhulme Trust Early Career Fellowship. The authors thank R. Sinden, K. Baker and M. Tunnicliff for provision of Anopheles stephensi, and Biological Services at NIMR. M. Blackman, G. Kassiotis and G. Stockinger are thanked for critical reading of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; ALGER NE, 1971, J PROTOZOOL, V18, P598, DOI 10.1111/j.1550-7408.1971.tb03382.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BRANNAN LR, 1993, PARASITE IMMUNOL, V15, P135, DOI 10.1111/j.1365-3024.1993.tb00593.x; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Cunningham D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/j.molbiopara.2009.12.010; DEARSLY AL, 1990, PARASITOLOGY, V100, P359, DOI 10.1017/S0031182000078628; del Portillo HA, 2012, CELL MICROBIOL, V14, P343, DOI 10.1111/j.1462-5822.2011.01741.x; GLYNN JR, 1995, T ROY SOC TROP MED H, V89, P281, DOI 10.1016/0035-9203(95)90540-5; HARTLEY EG, 1969, T ROY SOC TROP MED H, V63, P411, DOI 10.1016/0035-9203(69)90023-6; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; KNOWLES G, 1980, PARASITOLOGY, V81, P211, DOI 10.1017/S0031182000055165; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lawton J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-125; Mackinnon MJ, 2005, INT J PARASITOL, V35, P145, DOI 10.1016/j.ijpara.2004.11.011; Mackinnon MJ, 1999, P ROY SOC B-BIOL SCI, V266, P741, DOI 10.1098/rspb.1999.0699; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; MCLEAN SA, 1987, PARASITOLOGY, V94, P443, DOI 10.1017/S0031182000055797; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Spence PJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-407; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173, DOI 10.1080/00034983.1975.11686998	31	103	103	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					228	+		10.1038/nature12231	http://dx.doi.org/10.1038/nature12231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23719378	Green Accepted			2022-12-24	WOS:000320283400048
J	Bolze, A; Mahlaoui, N; Byun, M; Turner, B; Trede, N; Ellis, SR; Abhyankar, A; Itan, Y; Patin, E; Brebner, S; Sackstein, P; Puel, A; Picard, C; Abel, L; Quintana-Murci, L; Faust, SN; Williams, AP; Baretto, R; Duddridge, M; Kini, U; Pollard, AJ; Gaud, C; Frange, P; Orbach, D; Emile, LF; Stephan, JL; Sorensen, R; Plebani, A; Hammarstrom, L; Mary, E; Selleri, L; Casanova, JL				Bolze, Alexandre; Mahlaoui, Nizar; Byun, Minji; Turner, Bridget; Trede, Nikolaus; Ellis, Steven R.; Abhyankar, Avinash; Itan, Yuval; Patin, Etienne; Brebner, Samuel; Sackstein, Paul; Puel, Anne; Picard, Capucine; Abel, Laurent; Quintana-Murci, Lluis; Faust, Saul N.; Williams, Anthony P.; Baretto, Richard; Duddridge, Michael; Kini, Usha; Pollard, Andrew J.; Gaud, Catherine; Frange, Pierre; Orbach, Daniel; Emile, Lean-Francois; Stephan, Jean-Louis; Sorensen, Ricardo; Plebani, Alessandro; Hammarstrom, Lennart; Conley, Mary Ellen; Selleri, Licia; Casanova, Jean-Laurent			Ribosomal Protein SA Haploinsufficiency in Humans with Isolated Congenital Asplenia	SCIENCE			English	Article							DIAMOND-BLACKFAN ANEMIA; MUTATIONS; DISCOVERY; SPLEEN	Isolated congenital asplenia (ICA) is characterized by the absence of a spleen at birth in individuals with no other developmental defects. The patients are prone to life-threatening bacterial infections. The unbiased analysis of exomes revealed heterozygous mutations in RPSA in 18 patients from eight kindreds, corresponding to more than half the patients and over one-third of the kindreds studied. The clinical penetrance in these kindreds is complete. Expression studies indicated that the mutations carried by the patients-a nonsense mutation, a frameshift duplication, and five different missense mutations-cause autosomal dominant ICA by haploinsufficiency. RPSA encodes ribosomal protein SA, a component of the small subunit of the ribosome. This discovery establishes an essential rote for RPSA in human spleen development.	[Bolze, Alexandre; Byun, Minji; Abhyankar, Avinash; Itan, Yuval; Brebner, Samuel; Sackstein, Paul; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Bolze, Alexandre; Puel, Anne; Picard, Capucine; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, Imagine Inst, Sorbonne Paris Cite, F-75006 Paris, France; [Mahlaoui, Nizar] Hop Necker Enfants Malad, French Natl Reference Ctr Primary Immune Deficien, Pediat Hematol Immunol & Rheumatol Unit, F-75015 Paris, France; [Turner, Bridget; Trede, Nikolaus] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Ellis, Steven R.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, Dept Genomes & Genet, Unit Human Evolutionary Genet, CNRS,URA3012, F-75015 Paris, France; [Puel, Anne; Picard, Capucine; Abel, Laurent; Casanova, Jean-Laurent] INSERM, Lab Human Genet Infect Dis, U980, Necker Branch, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiency, F-75015 Paris, France; [Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, NIHR Wellcome Trust Clin Res Facil, Southampton S016 6YD, Hants, England; [Faust, Saul N.; Williams, Anthony P.] Univ Southampton, Fac Med, Southampton S016 6YD, Hants, England; [Faust, Saul N.; Williams, Anthony P.] Univ Southampton, Inst Life Sci, Southampton S016 6YD, Hants, England; [Williams, Anthony P.] Univ Hosp Southampton NHS Fdn Trust, Southampton S016 6YD, Hants, England; [Baretto, Richard; Duddridge, Michael] Univ Hosp Leicester NHS Trust, Dept Immunol, Leicester LE1 5WW, Leics, England; [Kini, Usha] Oxford Univ Hosp NHS Trust, Dept Clin Genet, Oxford OX3 7LE, England; [Pollard, Andrew J.] Univ Oxford, Dept Pediat, Oxford OX3 9DU, England; [Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, England; [Gaud, Catherine] CHU Reun Site Nord, Dept Clin Immunol, F-97405 St Denis, Reunion, France; [Frange, Pierre; Casanova, Jean-Laurent] Hop Necker Enfants Malad, AP HP, Pediat Immunol Hematol Unit, F-75015 Paris, France; [Frange, Pierre] Univ Paris 05, EA 3620, Sorbonne Paris Cite, F-75015 Paris, France; [Orbach, Daniel] Inst Curie, Dept Pediat, F-75005 Paris, France; [Emile, Lean-Francois] Univ Versailles SOY, EA 4340, F-92104 Boulogne, France; [Emile, Lean-Francois] Hop Ambroise Pare, AP HP, F-92104 Boulogne, France; [Stephan, Jean-Louis] CHU Nord, Dept Pediat, F-42055 St Etienne, France; [Sorensen, Ricardo] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Jeffrey Modell Diagnost Ctr Primary Immunodeficie, New Orleans, LA 70118 USA; [Sorensen, Ricardo] Childrens Hosp, New Orleans, LA 70118 USA; [Plebani, Alessandro] Univ Brescia, Spedali Civili Brescia, Dept Pediat, I-25123 Brescia, Italy; [Plebani, Alessandro] Univ Brescia, Spedali Civili Brescia, Inst Mol Med A Nocivelti, I-25123 Brescia, Italy; [Hammarstrom, Lennart] Karolinska Univ Hosp Huddnge, Dept Lab Med, Div Clin Immunol, Karolinska Inst, SE-14186 Stockholm, Sweden; [Conley, Mary Ellen] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38101 USA; [Selleri, Licia] Cornell Univ, Dept Cell & Dev Biol, Weill Med Coll, New York, NY 10065 USA	Rockefeller University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Louisville; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University Hospitals of Leicester NHS Trust; University of Leicester; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; CHU Reunion; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU de St Etienne; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Hospital Spedali Civili Brescia; University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; Karolinska Institutet; University of Tennessee System; University of Tennessee Health Science Center; Cornell University	Bolze, A (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA.	albo719@rockefeller.edu	Picard, Capucine/H-3914-2017; Frange, Pierre/O-6311-2017; MAHLAOUI, Nizar/AAH-6103-2020; Abel, Laurent/H-8888-2017; Puel, Anne/H-7305-2017; Mahlaoui, Nizar/J-7928-2017; Quintana-Murci, Lluis/AAB-7468-2022; Casanova, Jean-Laurent/I-3418-2017; Faust, Saul/J-9779-2014	Picard, Capucine/0000-0001-8788-5056; MAHLAOUI, Nizar/0000-0002-0030-8094; Abel, Laurent/0000-0001-7016-6493; Puel, Anne/0000-0003-2603-0323; Mahlaoui, Nizar/0000-0002-0030-8094; Faust, Saul/0000-0003-3410-7642; Casanova, Jean-Laurent/0000-0002-7782-4169; Byun, Minji/0000-0002-2830-4079; Quintana-Murci, Lluis/0000-0003-2429-6320; Patin, Etienne/0000-0002-9911-4459; Bolze, Alexandre/0000-0001-7399-2766	March of Dimes [1-FY12-440]; St. Cites Foundation; National Center for Research Resources and the National Center for Advancing Sciences (NCATS) [8UL1TR000043]; NIH [R01HD061403]; Rockefeller University; Institut National de la Saute et de la Recherche Medicate; Fondazione C. Golgi of Brescia; Paris Descartes University;  [SRP018839]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061403] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); St. Cites Foundation; National Center for Research Resources and the National Center for Advancing Sciences (NCATS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Institut National de la Saute et de la Recherche Medicate; Fondazione C. Golgi of Brescia; Paris Descartes University; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the patients and their families. We thank A. Belkadi, M. Bensifi, M. Chrabieh, T. Kochetkov, and N. Wang for technical help and I. Ionita-Laza, V. Lougaris, and all members of the laboratory for fruitful. discussions. This work was supported in part by the March of Dimes (no. 1-FY12-440), St. Cites Foundation, National Center for Research Resources and the National Center for Advancing Sciences (NCATS) grant no. 8UL1TR000043, and grant no R01HD061403 from the NIH, Rockefeller University, Institut National de la Saute et de la Recherche Medicate, Fondazione C. Golgi of Brescia, and Paris Descartes University. The raw sequence data are available on the Sequence Read Archive (SRA) database: Bioproject SRP018839.	Almoznino-Sarafian D, 2007, ACTA HAEMATOL-BASEL, V118, P226, DOI 10.1159/000112308; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Eilertson KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002806; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Imashuku S, 2012, INT J HEMATOL, V95, P702, DOI 10.1007/s12185-012-1082-1; Koss M, 2012, DEV CELL, V22, P913, DOI 10.1016/j.devcel.2012.02.009; Lipton JM, 2010, CURR OPIN PEDIATR, V22, P12, DOI 10.1097/MOP.0b013e328334573b; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Mahlaoui N., 2011, J PEDIAT, V142, pe1; MYERSON RM, 1956, NEW ENGL J MED, V254, P1131, DOI 10.1056/NEJM195606142542406; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Uchida Y, 2012, J INFECT CHEMOTHER, V18, P576, DOI 10.1007/s10156-011-0341-z; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359	22	129	134	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					976	978		10.1126/science.1234864	http://dx.doi.org/10.1126/science.1234864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23579497	Green Accepted, Green Submitted			2022-12-24	WOS:000319344100046
J	Shen, J; Xia, WY; Khotskaya, YB; Huo, LF; Nakanishi, K; Lim, SO; Du, Y; Wang, Y; Chang, WC; Chen, CH; Hsu, JL; Wu, Y; Lam, YC; James, BP; Liu, XP; Liu, CG; Patel, DJ; Hung, MC				Shen, Jia; Xia, Weiya; Khotskaya, Yekaterina B.; Huo, Longfei; Nakanishi, Kotaro; Lim, Seung-Oe; Du, Yi; Wang, Yan; Chang, Wei-Chao; Chen, Chung-Hsuan; Hsu, Jennifer L.; Wu, Yun; Lam, Yung Carmen; James, Brian P.; Liu, Xiuping; Liu, Chang-Gong; Patel, Dinshaw J.; Hung, Mien-Chie			EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2	NATURE			English	Article							PROTEINS; ENDOCYTOSIS; COMPLEX; CANCER	MicroRNAs (miRNAs) are generated by two-step processing to yield small RNAs that negatively regulate target gene expression at the post-transcriptional level(1). Deregulation of miRNAs has been linked to diverse pathological processes, including cancer(2,3). Recent studies have also implicated miRNAs in the regulation of cellular response to a spectrum of stresses(4), such as hypoxia, which is frequently encountered in the poorly angiogenic core of a solid tumour(5). However, the upstream regulators of miRNA biogenesis machineries remain obscure, raising the question of how tumour cells efficiently coordinate and impose specificity on miRNA expression and function in response to stresses. Here we show that epidermal growth factor receptor (EGFR), which is the product of a well-characterized oncogene in human cancers, suppresses the maturation of specific tumour-suppressor-like miRNAs in response to hypoxic stress through phosphorylation of argonaute 2 (AGO2) at Tyr 393. The association between EGFR and AGO2 is enhanced by hypoxia, leading to elevated AGO2-Y393 phosphorylation, which in turn reduces the binding of Dicer to AGO2 and inhibits miRNA processing from precursor miRNAs to mature miRNAs. We also identify a long-loop structure in precursor miRNAs as a critical regulatory element in phospho-Y393-AGO2-mediated miRNA maturation. Furthermore, AGO2-Y393 phosphorylation mediates EGFR-enhanced cell survival and invasiveness under hypoxia, and correlates with poorer overall survival in breast cancer patients. Our study reveals a previously unrecognized function of EGFR in miRNA maturation and demonstrates how EGFR is likely to function as a regulator of AGO2 through novel post-translational modification. These findings suggest that modulation of miRNA biogenesis is important for stress response in tumour cells and has potential clinical implications.	[Shen, Jia; Xia, Weiya; Khotskaya, Yekaterina B.; Huo, Longfei; Lim, Seung-Oe; Du, Yi; Wang, Yan; Hsu, Jennifer L.; Lam, Yung Carmen; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Shen, Jia; Du, Yi; Hung, Mien-Chie] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Nakanishi, Kotaro; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Chang, Wei-Chao; Hsu, Jennifer L.; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 402, Taiwan; [Chang, Wei-Chao; Hsu, Jennifer L.; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 402, Taiwan; [Chang, Wei-Chao; Chen, Chung-Hsuan] Acad Sinica, Genom Res Ctr, Taipei 105, Taiwan; [Hsu, Jennifer L.; Hung, Mien-Chie] Asia Univ, Taichung 413, Taiwan; [Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [James, Brian P.; Liu, Xiuping; Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Chen, Chung-Hsuan/F-7940-2012; Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; Nakanishi, Kotaro/0000-0002-9857-6010	US National Institutes of Health [CA109311, CA099031, CA16672]; US National Breast Cancer Foundation; Center for Biological Pathway at the UT MD Anderson Cancer Center, S. G. Komen [SAC110016]; Sister Institution Fund of China Medical University and Hospital; UT MD Anderson Cancer Center; Cancer Research Center of Excellence, Taiwan [D0H102-TD-C-111-005]; Private University grant, Taiwan [NSC99-2632-B-039-001-MY3]; Program for Stem Cell and Regenerative Medicine Frontier Research, Taiwan [NSC101-2321-B-039-001]; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA099031, P30CA016672, R01CA109311] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Breast Cancer Foundation; Center for Biological Pathway at the UT MD Anderson Cancer Center, S. G. Komen; Sister Institution Fund of China Medical University and Hospital; UT MD Anderson Cancer Center; Cancer Research Center of Excellence, Taiwan; Private University grant, Taiwan; Program for Stem Cell and Regenerative Medicine Frontier Research, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Pickering, D. Yu, and A.-B. Shyu for suggestions and technical assistance with northern blot analysis. This work was supported by the US National Institutes of Health (CA109311 and CA099031 to M.-C. H., and CCSG Core Grant CA16672), the US National Breast Cancer Foundation, The Center for Biological Pathway at the UT MD Anderson Cancer Center, S. G. Komen (SAC110016 to M.-C. H.), The Sister Institution Fund of China Medical University and Hospital and the UT MD Anderson Cancer Center, the Cancer Research Center of Excellence (D0H102-TD-C-111-005, Taiwan), a Private University grant (NSC99-2632-B-039-001-MY3, Taiwan), and the Program for Stem Cell and Regenerative Medicine Frontier Research (NSC101-2321-B-039-001, Taiwan).	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee OH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001628; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922	27	264	271	2	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					383	387		10.1038/nature12080	http://dx.doi.org/10.1038/nature12080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23636329	Green Accepted			2022-12-24	WOS:000318952000041
J	Harris, E; Sinha, B; van Pinxteren, D; Tilgner, A; Fomba, KW; Schneider, J; Roth, A; Gnauk, T; Fahlbusch, B; Mertes, S; Lee, T; Collett, J; Foley, S; Borrmann, S; Hoppe, P; Herrmann, H				Harris, Eliza; Sinha, Baerbel; van Pinxteren, Dominik; Tilgner, Andreas; Fomba, Khanneh Wadinga; Schneider, Johannes; Roth, Anja; Gnauk, Thomas; Fahlbusch, Benjamin; Mertes, Stephan; Lee, Taehyoung; Collett, Jeffrey; Foley, Stephen; Borrmann, Stephan; Hoppe, Peter; Herrmann, Hartmut			Enhanced Role of Transition Metal Ion Catalysis During In-Cloud Oxidation of SO2	SCIENCE			English	Article							SULFUR ISOTOPE FRACTIONATION; AEROSOL LIGHT-SCATTERING; HETEROGENEOUS OXIDATION; SULFATE PRODUCTION; GLOBAL-MODEL; CHEMISTRY; IRON; IMPACT; CYCLE; DUST	Global sulfate production plays a key role in aerosol radiative forcing; more than half of this production occurs in clouds. We found that sulfur dioxide oxidation catalyzed by natural transition metal ions is the dominant in-cloud oxidation pathway. The pathway was observed to occur primarily on coarse mineral dust, so the sulfate produced will have a short lifetime and little direct or indirect climatic effect. Taking this into account will lead to large changes in estimates of the magnitude and spatial distribution of aerosol forcing. Therefore, this oxidation pathway-which is currently included in only one of the 12 major global climate models-will have a significant impact on assessments of current and future climate.	[Harris, Eliza; Sinha, Baerbel; Schneider, Johannes; Roth, Anja; Borrmann, Stephan; Hoppe, Peter] Max Planck Inst Chem, Particle Chem Dept, D-55128 Mainz, Germany; [Sinha, Baerbel] IISER Mohali, Dept Earth Sci, Manauli 140306, India; [van Pinxteren, Dominik; Tilgner, Andreas; Fomba, Khanneh Wadinga; Gnauk, Thomas; Fahlbusch, Benjamin; Mertes, Stephan; Herrmann, Hartmut] Leibniz Inst Tropospher Res TROPOS, D-04318 Leipzig, Germany; [Lee, Taehyoung; Collett, Jeffrey] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Foley, Stephen] Johannes Gutenberg Univ Mainz, Inst Geosci, Earth Syst Sci Res Ctr, D-55128 Mainz, Germany; [Borrmann, Stephan] Johannes Gutenberg Univ Mainz, Inst Atmospher Phys, D-55128 Mainz, Germany	Max Planck Society; Indian Institute of Science Education & Research (IISER) - Mohali; Leibniz Institut fur Tropospharenforschung (TROPOS); Colorado State University; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Harris, E (corresponding author), MIT, Cambridge, MA 02142 USA.	elizah@mit.edu; baerbel.sinha@mpic.de	Lee, Taehyoung/I-6246-2015; Sinha, Baerbel/H-1250-2012; Tilgner, Andreas/AAS-4610-2021; Borrmann, Stephan/E-3868-2010; Hoppe, Peter/B-3032-2015; Herrmann, Hartmut/C-2486-2009; Harris, Eliza/AAM-7953-2020; Schneider, Johannes/A-2674-2010; Mertes, Stephan/Y-4487-2018; Collett, Jeffrey L/F-2862-2010; Foley, Stephen/I-1759-2013; Borrmann, Steffen/G-1838-2013	Lee, Taehyoung/0000-0003-3792-0663; Sinha, Baerbel/0000-0001-8614-7473; Tilgner, Andreas/0000-0003-4021-4874; Borrmann, Stephan/0000-0002-4774-9380; Hoppe, Peter/0000-0003-3681-050X; Herrmann, Hartmut/0000-0001-7044-2101; Harris, Eliza/0000-0002-7102-8305; Schneider, Johannes/0000-0001-7169-3973; Collett, Jeffrey L/0000-0001-9180-508X; Foley, Stephen/0000-0001-7510-0223; Borrmann, Steffen/0000-0001-9189-4393	Max Planck Society; Max Planck Graduate Centre; Deutsche Forschungsgemeinschaft [HE 3086/15-1]; TROPOS Leipzig; NSF [AGS 1050052]; Directorate For Geosciences [1050052] Funding Source: National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Graduate Centre; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TROPOS Leipzig; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank E. Groner for his support with the NanoSIMS analyses, J. Huth for his help with the scanning electron microscopy and energy-dispersive x-ray spectroscopy analyses, and all the participants of HCCT-2010 for an interesting and successful campaign. This research was funded by the Max Planck Society and the Max Planck Graduate Centre. The HCCT-2010 campaign was partially funded by the Deutsche Forschungsgemeinschaft under contract HE 3086/15-1. Participation of Colorado State University scientists was supported by grants from TROPOS Leipzig and by NSF grant AGS 1050052.	Alexander B, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010486; Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Barrie LA, 2001, TELLUS B, V53, P615, DOI 10.1034/j.1600-0889.2001.530507.x; Berglen TF, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003948; BOTHA CF, 1994, ATMOS ENVIRON, V28, P3207, DOI 10.1016/1352-2310(94)00174-J; Bower KN, 1997, ATMOS ENVIRON, V31, P2527, DOI 10.1016/S1352-2310(96)00317-2; Chin M, 1996, J GEOPHYS RES-ATMOS, V101, P18667, DOI 10.1029/96JD01221; GERVAT GP, 1988, NATURE, V333, P241, DOI 10.1038/333241a0; Goto D, 2011, ATMOS CHEM PHYS, V11, P10889, DOI 10.5194/acp-11-10889-2011; GRAEDEL TE, 1986, J GEOPHYS RES-ATMOS, V91, P5205, DOI 10.1029/JD091iD04p05205; GRGIC I, 1991, ATMOS ENVIRON A-GEN, V25, P1591, DOI 10.1016/0960-1686(91)90017-2; Harris E, 2012, ATMOS CHEM PHYS, V12, P4619, DOI 10.5194/acp-12-4619-2012; Harris E, 2012, ATMOS CHEM PHYS, V12, P4867, DOI 10.5194/acp-12-4867-2012; Harris E, 2012, ATMOS CHEM PHYS, V12, P407, DOI 10.5194/acp-12-407-2012; Hegg DA, 2004, TELLUS B, V56, P285, DOI 10.1111/j.1600-0889.2004.00099.x; Hegg DA, 1996, GEOPHYS RES LETT, V23, P2613, DOI 10.1029/96GL02419; IBUSUKI T, 1987, ATMOS ENVIRON, V21, P1555, DOI 10.1016/0004-6981(87)90317-9; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kulmala M, 2000, NATURE, V404, P66, DOI 10.1038/35003550; Laj P, 1997, ATMOS ENVIRON, V31, P2589, DOI 10.1016/S1352-2310(97)00040-X; Laj P, 1997, ATMOS ENVIRON, V31, P2503, DOI 10.1016/S1352-2310(96)00217-8; LANGNER J, 1992, NATURE, V359, P712, DOI 10.1038/359712a0; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; McCabe JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025164; Mertes S, 2005, ATMOS ENVIRON, V39, P4233, DOI 10.1016/j.atmosenv.2005.02.009; Plessow K, 2001, ATMOS ENVIRON, V35, P367, DOI 10.1016/S1352-2310(00)00134-5; Pozzoli L, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009007; RANI A, 1992, ATMOS ENVIRON A-GEN, V26, P667, DOI 10.1016/0960-1686(92)90178-N; Redington AL, 2009, ATMOS ENVIRON, V43, P3227, DOI 10.1016/j.atmosenv.2009.03.041; Rotstayn LD, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002128; Sedlak DL, 1997, ATMOS ENVIRON, V31, P2515, DOI 10.1016/S1352-2310(96)00080-5; Sofen ED, 2011, ATMOS CHEM PHYS, V11, P3565, DOI 10.5194/acp-11-3565-2011; TILLY J, 1991, J CHEM TECHNOL BIOT, V52, P301	33	228	236	11	377	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					727	730		10.1126/science.1230911	http://dx.doi.org/10.1126/science.1230911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661757				2022-12-24	WOS:000318619000034
J	Reed, TE; Grotan, V; Jenouvrier, S; Saether, BE; Visser, ME				Reed, Thomas E.; Grotan, Vidar; Jenouvrier, Stephanie; Saether, Bernt-Erik; Visser, Marcel E.			Population Growth in a Wild Bird Is Buffered Against Phenological Mismatch	SCIENCE			English	Article							CLIMATE-CHANGE; DENSITY-DEPENDENCE; GREAT TITS; SELECTION; EVOLUTION; ADAPTATION; FITNESS; DYNAMICS; BIOLOGY; SHIFTS	Broad-scale environmental changes are altering patterns of natural selection in the wild, but few empirical studies have quantified the demographic cost of sustained directional selection in response to these changes. We tested whether population growth in a wild bird is negatively affected by climate change-induced phenological mismatch, using almost four decades of individual-level life-history data from a great tit population. In this population, warmer springs have generated a mismatch between the annual breeding time and the seasonal food peak, intensifying directional selection for earlier laying dates. Interannual variation in population mismatch has not, however, affected population growth. We demonstrated a mechanism contributing to this uncoupling, whereby fitness losses associated with mismatch are counteracted by fitness gains due to relaxed competition. These findings imply that natural populations may be able to tolerate considerable maladaptation driven by shifting climatic conditions without undergoing immediate declines.	[Reed, Thomas E.; Visser, Marcel E.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, NL-6700 AB Wageningen, Netherlands; [Grotan, Vidar; Saether, Bernt-Erik] Norwegian Univ Sci & Technol, Dept Biol, Ctr Conservat Biol, NO-7491 Trondheim, Norway; [Jenouvrier, Stephanie] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Jenouvrier, Stephanie] CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Norwegian University of Science & Technology (NTNU); Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS)	Reed, TE (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, POB 50, NL-6700 AB Wageningen, Netherlands.	t.reed@nioo.knaw.nl	Grøtan, Vidar/O-9453-2019; Grøtan, Vidar/A-4056-2008; Visser, Marcel E/A-9151-2009; Reed, Thomas E/A-5788-2012; KNAW, NIOO-KNAW/A-4320-2012	Grøtan, Vidar/0000-0003-1222-0724; Grøtan, Vidar/0000-0003-1222-0724; Visser, Marcel E/0000-0002-1456-1939; Reed, Thomas E/0000-0002-2993-0477; jenouvrier, stephanie/0000-0003-3324-2383; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research-VICI grant	Netherlands Organisation for Scientific Research-VICI grant	Stichting Nationaal Park De Hoge Veluwe kindly gave permission to work in their woodlands. The authors thank the many fieldworkers who have contributed to data collection over the years. M. Kinnison, R. Waples, K. Lessells, and P. Gienapp provided valuable comments. M. E. V. is supported by a Netherlands Organisation for Scientific Research-VICI grant. M. E. V. supervised the long-term population study; T. E. R., M. E. V., B.-E. S., V. G., and S.J. conceived the questions and analyses; T. E. R. and V. G. analyzed the data; and T. E. R. and M. E. V. wrote the paper. Data, results, and the R code for the simulation model are available on Dryad (http://datadryad.org).	Bauchau V, 1995, J APPL STAT, V22, P1031, DOI 10.1080/02664769524775; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Boyce MS, 1999, OIKOS, V87, P419, DOI 10.2307/3546808; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Burger R, 2004, EVOLUTIONARY CONSERV, P171; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Falconer DS, 1996, INTRO QUANTITATIVE G, V4; Gienapp P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0289; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gosler A, 1993, GREAT TIT; Grotan V, 2009, J ANIM ECOL, V78, P447, DOI 10.1111/j.1365-2656.2008.01488.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hellmann JJ, 2007, BIOL CONSERV, V137, P599, DOI 10.1016/j.biocon.2007.03.018; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; Lande R, 2007, EVOLUTION, V61, P1835, DOI 10.1111/j.1558-5646.2007.00170.x; Lande R, 2009, PHILOS T R SOC B, V364, P1511, DOI 10.1098/rstb.2009.0017; Lane JE, 2012, NATURE, V489, P554, DOI 10.1038/nature11335; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; Reed TE, 2013, J ANIM ECOL, V82, P131, DOI 10.1111/j.1365-2656.2012.02020.x; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Wilson S, 2003, P NATL ACAD SCI USA, V100, P11139, DOI 10.1073/pnas.1931407100	32	131	139	3	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					488	491		10.1126/science.1232870	http://dx.doi.org/10.1126/science.1232870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620055				2022-12-24	WOS:000318016700045
J	Schmid, P; Churchill, SE; Nalla, S; Weissen, E; Carlson, KJ; de Ruiter, DJ; Berger, LR				Schmid, Peter; Churchill, Steven E.; Nalla, Shahed; Weissen, Eveline; Carlson, Kristian J.; de Ruiter, Darryl J.; Berger, Lee R.			Mosaic Morphology in the Thorax of Australopithecus sediba	SCIENCE			English	Article							ARDIPITHECUS-RAMIDUS; COSTAL SKELETON; AL 288-1; EVOLUTION; HOMO; LOCOMOTION; POSTURE; WALKING; PELVIS; RIB	The shape of the thorax of early hominins has been a point of contention for more than 30 years. Owing to the generally fragmentary nature of fossil hominin ribs, few specimens have been recovered that have rib remains complete enough to allow accurate reassembly of thoracic shape, thus leaving open the question of when the cylindrical-shaped chest of humans and their immediate ancestors evolved. The ribs of Australopithecus sediba exhibit a mediolaterally narrow, ape-like upper thoracic shape, which is unlike the broad upper thorax of Homo that has been related to the locomotor pattern of endurance walking and running. The lower thorax, however, appears less laterally flared than that of apes and more closely approximates the morphology found in humans.	[Schmid, Peter; Weissen, Eveline] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Schmid, Peter; Churchill, Steven E.; Nalla, Shahed; Carlson, Kristian J.; de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Nalla, Shahed] Univ Johannesburg, Fac Hlth Sci, Dept Human Anat & Phys, Johannesburg, South Africa; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA	University of Zurich; University of Witwatersrand; Duke University; University of Johannesburg; Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Schmid, P (corresponding author), Univ Zurich, Anthropol Inst & Museum, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	smidi@aim.uzh.ch	Churchill, Steven/AAA-9386-2022; Nalla, Shahed/U-2213-2017; Berger, Lee Rogers/AAC-3484-2020	Nalla, Shahed/0000-0002-0957-1067; Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation; Institute for Human Evolution; University of the Witwatersrand; University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Duke University; Texas AM University; Oppenheimer and Ackerman families; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation(National Research Foundation - South Africa); Institute for Human Evolution; University of the Witwatersrand; University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Duke University; Texas AM University; Oppenheimer and Ackerman families; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	We thank the South African Heritage Resource agency for permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology and the African Origins Platform (AOP), the South African National Research Foundation, the Institute for Human Evolution, University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the A. H. Schultz Foundation, Duke University, Ray A. Rothrock '77 Fellowship and IRTAG of Texas A&M University, and the Oppenheimer and Ackerman families and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We thank the Virtual Image Processing Lab and the Microfocus X-ray CT facility of the Palaeosciences Centre at Wits, and for funding these facilities, we thank the University of the Witwatersrand Office of Research and the NRF Strategic Research Infrastructure Grant and AOP funding programs. For access to comparative specimens, we thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; B. Billings, B. Zipfel, and the School of Anatomical Sciences at the University of the Witwatersrand; S. Potze and L. C. Kgasi at the Ditsong Museum; and M. Ponce de Le~n and C. Zollikofer at the Anthropological Institute and Museum. For technical and material support, we thank Duke University and the University of Zurich 2009 and 2010 Field Schools. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given notable support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated computed tomography scanning of the specimens. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens, by bona fide scientists.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Cachel S., 1996, ASPECTS AFRICAN ARCH, P3; Chan LK, 2007, FOLIA PRIMATOL, V78, P19, DOI 10.1159/000095683; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; Franciscus RG, 2002, J HUM EVOL, V42, P303, DOI 10.1006/jhev.2001.0528; GEHR P, 1981, RESP PHYSIOL, V44, P61, DOI 10.1016/0034-5687(81)90077-3; Gomez-Olivencia A, 2010, J HUM EVOL, V59, P620, DOI 10.1016/j.jhevol.2010.07.023; Gomez-Olivencia A, 2009, J HUM EVOL, V57, P75, DOI 10.1016/j.jhevol.2009.02.009; Haeusler M, 2011, J HUM EVOL, V61, P575, DOI 10.1016/j.jhevol.2011.07.004; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HILL W. C. OSMAN, 1939, AMER JOUR PHYS ANTHROPOL, V24, P449, DOI 10.1002/ajpa.1330240324; HUNT KD, 1991, AM J PHYS ANTHROPOL, V86, P521, DOI 10.1002/ajpa.1330860408; Jellema Lyman M., 1993, P294; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; Kagaya M, 2008, PRIMATES, V49, P89, DOI 10.1007/s10329-007-0064-z; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Kramer Patricia Ann, 2009, Paleoanthropology, V2009, P238; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; OHMAN JC, 1986, AM J PHYS ANTHROPOL, V70, P209, DOI 10.1002/ajpa.1330700208; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Preuschoft H, 2004, J ANAT, V204, P363, DOI 10.1111/j.0021-8782.2004.00303.x; Robinson J.T., 1972, EARLY HOMINID POSTUR; Ruff Christopher B., 1993, P234; Schmid P, 2004, FROM BIPED TO STRIDER, P49; SCHMID P, 1983, FOLIA PRIMATOL, V40, P283, DOI 10.1159/000156111; Schmid P., 1991, CAHIERS PALEOANTHROP, P225; Schultz A. H., 1961, pUnpaginated; SHAPIRO LJ, 1988, AM J PHYS ANTHROPOL, V77, P201, DOI 10.1002/ajpa.1330770208; Shaw CN, 2011, AM J PHYS ANTHROPOL, V144, P22, DOI 10.1002/ajpa.21363; WARD CV, 1993, AM J PHYS ANTHROPOL, V92, P291, DOI 10.1002/ajpa.1330920306; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	40	50	50	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1234598	10.1126/science.1234598	http://dx.doi.org/10.1126/science.1234598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580537				2022-12-24	WOS:000317341400006
J	Natkanski, E; Lee, WY; Mistry, B; Casal, A; Molloy, JE; Tolar, P				Natkanski, Elizabeth; Lee, Wing-Yiu; Mistry, Bhakti; Casal, Antonio; Molloy, Justin E.; Tolar, Pavel			B Cells Use Mechanical Energy to Discriminate Antigen Affinities	SCIENCE			English	Article							SUBCAPSULAR SINUS MACROPHAGES; MYOSIN-II; DYNAMICS; ADHESION; CAPTURE	The generation of high-affinity antibodies depends on the ability of B cells to extract antigens from the surfaces of antigen-presenting cells. B cells that express high-affinity B cell receptors (BCRs) acquire more antigen and obtain better T cell help. However, the mechanisms by which B cells extract antigen remain unclear. Using fluid and flexible membrane substrates to mimic antigen-presenting cells, we showed that B cells acquire antigen by dynamic myosin IIa-mediated contractions that pull out and invaginate the presenting membranes. The forces generated by myosin IIa contractions ruptured most individual BCR-antigen bonds and promoted internalization of only high-affinity, multivalent BCR microclusters. Thus, B cell contractility contributes to affinity discrimination by mechanically testing the strength of antigen binding.	[Natkanski, Elizabeth; Lee, Wing-Yiu; Mistry, Bhakti; Casal, Antonio; Tolar, Pavel] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England; [Molloy, Justin E.] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Tolar, P (corresponding author), Natl Inst Med Res, MRC, Div Immune Cell Biol, Mill Hill, London NW7 1AA, England.	ptolar@nimr.mrc.ac.uk	Lee, Wing-Yiu/AAC-8824-2019	Lee, Wing-Yiu/0000-0002-8524-3874; Molloy, Justin/0000-0002-8307-2450; Tolar, Pavel/0000-0003-4693-7299	Medical Research Council UK [U117597138, U117570592]; MRC [MC_U117570592, MC_U117597138] Funding Source: UKRI; Medical Research Council [MC_U117570592, MC_U117597138] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Martin for help with binding studies. B1-8<SUP>flox/flox</SUP> mice were a gift from K. Rajewsky, obtained under material transfer agreement with Mouse Genetics Cologne Foundation. This work was supported by Medical Research Council UK (Unit Programmes numbers U117597138 and U117570592).	Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; Cureton DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001127; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Yuseff MI, 2011, IMMUNITY, V35, P361, DOI 10.1016/j.immuni.2011.07.008	28	160	163	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1587	1590		10.1126/science.1237572	http://dx.doi.org/10.1126/science.1237572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23686338	Green Accepted			2022-12-24	WOS:000321007000046
J	Shalek, AK; Satija, R; Adiconis, X; Gertner, RS; Gaublomme, JT; Raychowdhury, R; Schwartz, S; Yosef, N; Malboeuf, C; Lu, DN; Trombetta, JJ; Gennert, D; Gnirke, A; Goren, A; Hacohen, N; Levin, JZ; Park, H; Regev, A				Shalek, Alex K.; Satija, Rahul; Adiconis, Xian; Gertner, Rona S.; Gaublomme, Jellert T.; Raychowdhury, Raktima; Schwartz, Schraga; Yosef, Nir; Malboeuf, Christine; Lu, Diana; Trombetta, John J.; Gennert, Dave; Gnirke, Andreas; Goren, Alon; Hacohen, Nir; Levin, Joshua Z.; Park, Hongkun; Regev, Aviv			Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells	NATURE			English	Article							MESSENGER-RNA-SEQ; PATHWAY; LEVEL	Recent molecular studies have shown that, even when derived from a seemingly homogenous population, individual cells can exhibit substantial differences in gene expression, protein levels and phenotypic output(1-5), with important functional consequences(4,5). Existing studies of cellular heterogeneity, however, have typically measured only a few pre-selected RNAs1,2 or proteins(5,6) simultaneously, because genomic profiling methods(3) could not be applied to single cells until very recently(7-10). Here we use single-cell RNA sequencing to investigate heterogeneity in the response of mouse bone-marrow-derived dendritic cells (BMDCs) to lipopolysaccharide. We find extensive, and previously unobserved, bimodal variation in messenger RNA abundance and splicing patterns, which we validate by RNA-fluorescence in situ hybridization for select transcripts. In particular, hundreds of key immune genes are bimodally expressed across cells, surprisingly even for genes that are very highly expressed at the population average. Moreover, splicing patterns demonstrate previously unobserved levels of heterogeneity between cells. Some of the observed bimodality can be attributed to closely related, yet distinct, known maturity states of BMDCs; other portions reflect differences in the usage of key regulatory circuits. For example, we identify a module of 137 highly variable, yet co-regulated, antiviral response genes. Using cells from knockout mice, we show that variability in this module may be propagated through an interferon feedback circuit, involving the transcriptional regulators Stat2 and Irf7. Our study demonstrates the power and promise of single-cell genomics in uncovering functional diversity between cells and in deciphering cell states and circuits.	[Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Satija, Rahul; Adiconis, Xian; Raychowdhury, Raktima; Schwartz, Schraga; Yosef, Nir; Malboeuf, Christine; Lu, Diana; Trombetta, John J.; Gennert, Dave; Gnirke, Andreas; Goren, Alon; Hacohen, Nir; Levin, Joshua Z.; Park, Hongkun; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Goren, Alon] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; [Goren, Alon] Massachusetts Gen Hosp, Ctr Syst Biol, Charlestown, MA 02129 USA; [Goren, Alon] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Park, H (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	Hongkun_Park@harvard.edu; aregev@broad.mit.edu	Shalek, Alex/Y-2434-2019; Satija, Rahul/AAF-9564-2019; Park, Hongkun/R-9842-2019	Shalek, Alex/0000-0001-5670-8778; Park, Hongkun/0000-0001-9576-8829; Goren, Alon/0000-0001-5669-9357; Levin, Joshua/0000-0002-0170-3598; Schwartz, Schraga/0000-0002-3671-9709	National Institutes of Health (NIH) [1F32HD075541-01, U54 AI057159, DP2 OD002230, 5DP1OD003893-03, DP1OD003958-01]; Charles H. Hood Foundation; NIH CEGS Award [1P50HG006193-01]; Broad Institute; HHMI; Klarman Cell Observatory at the Broad Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA035083] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003893, DP2OD002230, DP1OD003958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Hood Foundation; NIH CEGS Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; HHMI(Howard Hughes Medical Institute); Klarman Cell Observatory at the Broad Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Chevrier, C. Villani, M. Jovanovic, M. Bray and J. Shuga for scientific discussions; N. Friedman and E. Lander for comments on the manuscript; B. Tilton, T. Rogers and M. Tam for assistance with cell sorting; J. Bochicchio, E. Shefler and C. Guiducci for project management; the Broad Genomics Platform for all sequencing work; K. Fitzgerald for the Irf7<SUP>-/-</SUP> bone marrow; and L. Gaffney for help with artwork. Work was supported by a National Institutes of Health (NIH) Postdoctoral Fellowship (1F32HD075541-01, to R. S.), a Charles H. Hood Foundation Postdoctoral Fellowship (to A. Goren), an NIH grant (U54 AI057159, to N. H.), an NIH New Innovator Award (DP2 OD002230, to N. H.), an NIH CEGS Award (1P50HG006193-01, to H. P., A. R. and N. H.), NIH Pioneer Awards (5DP1OD003893-03 to H. P., DP1OD003958-01 to A. R.), the Broad Institute (to H. P. and A. R.), HHMI (to A. R.), and the Klarman Cell Observatory at the Broad Institute (to A.R.).	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gurskaya NG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1314; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/NMETH.1778, 10.1038/nmeth.1778]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Waks Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.32; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	30	771	826	15	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					236	240		10.1038/nature12172	http://dx.doi.org/10.1038/nature12172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23685454	Green Accepted, Green Submitted			2022-12-24	WOS:000320283400050
J	Mathews, JD; Forsythe, AV; Brady, Z; Butler, MW; Goergen, SK; Byrnes, GB; Giles, GG; Wallace, AB; Anderson, PR; Guiver, TA; McGale, P; Cain, TM; Dowty, JG; Bickerstaffe, AC; Darby, SC				Mathews, John D.; Forsythe, Anna V.; Brady, Zoe; Butler, Martin W.; Goergen, Stacy K.; Byrnes, Graham B.; Giles, Graham G.; Wallace, Anthony B.; Anderson, Philip R.; Guiver, Tenniel A.; McGale, Paul; Cain, Timothy M.; Dowty, James G.; Bickerstaffe, Adrian C.; Darby, Sarah C.			Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATOMIC-BOMB SURVIVORS; IONIZING-RADIATION; CT SCANS; ATAXIA-TELANGIECTASIA; LEUKEMIA; TUMORS	Objective To assess the cancer risk in children and adolescents following exposure to low dose ionising radiation from diagnostic computed tomography (CT) scans. Design Population based, cohort, data linkage study in Australia. Cohort members 10.9 million people identified from Australian Medicare records, aged 0-19 years on 1 January 1985 or born between 1 January 1985 and 31 December 2005; all exposures to CT scans funded by Medicare during 1985-2005 were identified for this cohort. Cancers diagnosed in cohort members up to 31 December 2007 were obtained through linkage to national cancer records. Main outcome Cancer incidence rates in individuals exposed to a CT scan more than one year before any cancer diagnosis, compared with cancer incidence rates in unexposed individuals. Results 60 674 cancers were recorded, including 3150 in 680 211 people exposed to a CT scan at least one year before any cancer diagnosis. The mean duration of follow-up after exposure was 9.5 years. Overall cancer incidence was 24% greater for exposed than for unexposed people, after accounting for age, sex, and year of birth (incidence rate ratio (IRR) 1.24 (95% confidence interval 1.20 to 1.29); P<0.001). We saw a dose-response relation, and the IRR increased by 0.16 (0.13 to 0.19) for each additional CT scan. The IRR was greater after exposure at younger ages (P<0.001 for trend). At 1-4, 5-9, 10-14, and 15 or more years since first exposure, IRRs were 1.35 (1.25 to 1.45), 1.25 (1.17 to 1.34), 1.14 (1.06 to 1.22), and 1.24 (1.14 to 1.34), respectively. The IRR increased significantly for many types of solid cancer (digestive organs, melanoma, soft tissue, female genital, urinary tract, brain, and thyroid); leukaemia, myelodysplasia, and some other lymphoid cancers. There was an excess of 608 cancers in people exposed to CT scans (147 brain, 356 other solid, 48 leukaemia or myelodysplasia, and 57 other lymphoid). The absolute excess incidence rate for all cancers combined was 9.38 per 100 000 person years at risk, as of 31 December 2007. The average effective radiation dose per scan was estimated as 4.5 mSv. Conclusions The increased incidence of cancer after CT scan exposure in this cohort was mostly due to irradiation. Because the cancer excess was still continuing at the end of follow-up, the eventual lifetime risk from CT scans cannot yet be determined. Radiation doses from contemporary CT scans are likely to be lower than those in 1985-2005, but some increase in cancer risk is still likely from current scans. Future CT scans should be limited to situations where there is a definite clinical indication, with every scan optimised to provide a diagnostic CT image at the lowest possible radiation dose.	[Mathews, John D.; Forsythe, Anna V.; Brady, Zoe; Dowty, James G.; Bickerstaffe, Adrian C.] Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic 3053, Australia; [Brady, Zoe] Alfred Hlth, Dept Radiol, Prahran, Vic, Australia; [Butler, Martin W.] Dept Hlth & Ageing, Med Benefits Scheme Analyt Sect, Canberra, ACT, Australia; [Goergen, Stacy K.] Southern Hlth, Dept Diagnost Imaging, Clayton, Vic, Australia; [Goergen, Stacy K.] Monash Univ, Southern Clin Sch, Clayton, Vic, Australia; [Byrnes, Graham B.] Int Agcy Res Canc, Biostat Grp, F-69372 Lyon, France; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Wallace, Anthony B.] Australian Radiat Protect & Nucl Safety Agcy, Diagnost Imaging & Nucl Med Sect, Yallambie, Vic, Australia; [Anderson, Philip R.; Guiver, Tenniel A.] Australian Inst Hlth & Welf, Data Linkage Unit, Canberra, ACT, Australia; [Anderson, Philip R.] Univ Canberra, Fac Hlth, Canberra, ACT 2601, Australia; [McGale, Paul; Darby, Sarah C.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [McGale, Paul; Darby, Sarah C.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Cain, Timothy M.] Royal Childrens Hosp Melbourne, Parkville, Vic, Australia	University of Melbourne; Monash University; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Council Victoria; University of Canberra; University of Oxford; University of Oxford; Royal Children's Hospital Melbourne	Mathews, JD (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Carlton, Vic 3053, Australia.	mathewsj@unimelb.edu.au		Mathews, John/0000-0001-9029-7140; Dowty, James/0000-0003-2383-0886; Byrnes, Graham/0000-0003-3893-7539; Forsythe, Anna/0000-0002-6677-8478; Giles, Graham/0000-0003-4946-9099; Brady, Zoe/0000-0001-9991-757X	Australian government via the National Health and Medical Research Council; Cancer Research Campaign UK; Medical Research Council [MC_U137686858] Funding Source: researchfish	Australian government via the National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research Campaign UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Australian government via the National Health and Medical Research Council, and supported by in-kind contributions of people funded by the Cancer Research Campaign UK or employed by other agencies. The funding bodies had no role in study design, data analysis, or reporting; government agencies contributed to data collection and data linkage, but did not control data analysis, interpretation, or writing of the report. The corresponding author had full access to all data in the study, and had ultimate responsibility for data integrity, statistical analysis, and the decision to submit for publication.	[Anonymous], 2000, IARC MONOGR EVAL C 1, V75, P1; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Brady Z, 2012, THESIS ROYAL MELBOUR; Brady Z, 2012, MED J AUSTRALIA, V197, P95, DOI 10.5694/mja11.11124; Brady Z, 2011, J MED IMAG RADIAT ON, V55, P132, DOI 10.1111/j.1754-9485.2011.02242.x; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2012, RADIOLOGY, V265, P330, DOI 10.1148/radiol.12121248; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Einstein AJ, 2012, LANCET, V380, P455, DOI 10.1016/S0140-6736(12)60897-6; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Frush DP, 2003, RADIOLOGY, V229, P289, DOI 10.1148/radiol.2291030373; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Galanski M, 2006, PAEDIATRICCT EXPOSUR; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Huda W, 1997, RADIOLOGY, V203, P417, DOI 10.1148/radiology.203.2.9114097; Huda W, 2008, PEDIATR RADIOL, V38, P415, DOI 10.1007/s00247-007-0732-6; ICRP, 1990, ANN ICRP, V21, P1; Jackson D, 2012, AS OC C RAD; Kim KP, 2012, RADIAT PROT DOSIM, V150, P415, DOI 10.1093/rpd/ncr429; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; Lee Y, 2003, CANCER RES, V63, P5428; Linet MS, 2009, PEDIATR RADIOL, V39, pS4, DOI 10.1007/s00247-008-1026-3; McLean Donald, 2003, Australas Radiol, V47, P135, DOI 10.1046/j.0004-8461.2003.01141.x; Moss M, 2006, Australas Radiol, V50, P33, DOI 10.1111/j.1440-1673.2005.01544.x; National Council on Radiation Protection and Measurements, 2012, 171 NCRP; National Research Council (US) Committee on the Biological Effects of Ionizing Radiation, 2006, HLTH RISKS EXP LOW L; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Olsen JH, 2001, JNCI-J NATL CANCER I, V93, P121, DOI 10.1093/jnci/93.2.121; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pearce MS, 2011, J MED IMAG RADIAT ON, V55, P107, DOI 10.1111/j.1754-9485.2011.02240.x; Picano E, 2004, BMJ-BRIT MED J, V329, P849, DOI 10.1136/bmj.329.7470.849; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893; Remedios DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1951; SHIMIZU Y, 1990, RADIAT RES, V121, P120, DOI 10.2307/3577495; Shrimpton P.C., 2003, NRPBW67; Shrimpton PC, 1991, NRPBR249; Singh G, 2005, BRAIN, V128, P7, DOI 10.1093/brain/awh363; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Socio-economic indexes for areas (SEIFA), 2006, SOC EC IND AR SEIFA; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, UNSCEAR 2008 REP GEN; White KS, 1996, PEDIATR RADIOL, V26, P5, DOI 10.1007/BF01403695	50	1213	1264	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2013	346								f2360	10.1136/bmj.f2360	http://dx.doi.org/10.1136/bmj.f2360			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AK	23694687	Green Published, hybrid			2022-12-24	WOS:000319573300002
J	Georgiev, IS; Doria-Rose, NA; Zhou, TQ; Do Kwon, Y; Staupe, RP; Moquin, S; Chuang, GY; Louder, MK; Schmidt, SD; Altae-Tran, HR; Bailer, RT; McKee, K; Nason, M; O'Dell, S; Ofek, G; Pancera, M; Srivatsan, S; Shapiro, L; Connors, M; Migueles, SA; Morris, L; Nishimura, Y; Martin, MA; Mascola, JR; Kwong, PD				Georgiev, Ivelin S.; Doria-Rose, Nicole A.; Zhou, Tongqing; Do Kwon, Young; Staupe, Ryan P.; Moquin, Stephanie; Chuang, Gwo-Yu; Louder, Mark K.; Schmidt, Stephen D.; Altae-Tran, Han R.; Bailer, Robert T.; McKee, Krisha; Nason, Martha; O'Dell, Sijy; Ofek, Gilad; Pancera, Marie; Srivatsan, Sanjay; Shapiro, Lawrence; Connors, Mark; Migueles, Stephen A.; Morris, Lynn; Nishimura, Yoshiaki; Martin, Malcolm A.; Mascola, John R.; Kwong, Peter D.			Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; HEPATITIS-C VIRUS; MEMORY B-CELLS; POTENT NEUTRALIZATION; INFLUENZA-VIRUS; STRUCTURAL DEFINITION; BROAD NEUTRALIZATION; CD4-BINDING SITE; RATIONAL DESIGN	Serum characterization and antibody isolation are transforming our understanding of the humoral immune response to viral infection. Here, we show that epitope specificities of HIV-1-neutralizing antibodies in serum can be elucidated from the serum pattern of neutralization against a diverse panel of HIV-1 isolates. We determined "neutralization fingerprints" for 30 neutralizing antibodies on a panel of 34 diverse HIV-1 strains and showed that similarity in neutralization fingerprint correlated with similarity in epitope. We used these fingerprints to delineate specificities of polyclonal sera from 24 HIV-1-infected donors and a chimeric siman-human immunodeficiency virus-infected macaque. Delineated specificities matched published specificities and were further confirmed by antibody isolation for two sera. Patterns of virus-isolate neutralization can thus afford a detailed epitope-specific understanding of neutralizing-antibody responses to viral infection.	[Georgiev, Ivelin S.; Doria-Rose, Nicole A.; Zhou, Tongqing; Do Kwon, Young; Staupe, Ryan P.; Moquin, Stephanie; Chuang, Gwo-Yu; Louder, Mark K.; Schmidt, Stephen D.; Altae-Tran, Han R.; Bailer, Robert T.; McKee, Krisha; Nason, Martha; O'Dell, Sijy; Ofek, Gilad; Pancera, Marie; Srivatsan, Sanjay; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Connors, Mark; Migueles, Stephen A.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Morris, Lynn] Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa; [Morris, Lynn] Univ Witwatersrand, ZA-2001 Johannesburg, South Africa; [Morris, Lynn] Ctr AIDS Programme Res South Africa CAPRISA, ZA-4013 Durban, South Africa; [Nishimura, Yoshiaki; Martin, Malcolm A.] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@nih.gov; pdkwong@nih.gov	Mascola, John/AAI-7193-2021; Schmidt, Stephen/AAC-6967-2019; Morris, Lynn/V-3941-2018; Zhou, Tongqing/A-6880-2010; Schmidt, Stephen/B-5398-2012; Shapiro, Lawrence/AAE-7172-2019; Do Kwon, Young/A-6957-2010	Morris, Lynn/0000-0003-3961-7828; Zhou, Tongqing/0000-0002-3935-4637; Do Kwon, Young/0000-0002-1188-7458; Staupe, Ryan/0000-0003-0793-524X; Moquin, Stephanie/0000-0002-8696-4315	Intramural Research Program of the Vaccine Research Center, NIAID, NIH; International AIDS Vaccine Initiative; NIAID, NIH [U19 AI51794]; South African Department of Science and Technology; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005111, ZIAAI005022, ZIAAI005089, U19AI051794, ZIAAI000415, ZIAAI005010, ZIAAI001090] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); South African Department of Science and Technology; U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH, and by the International AIDS Vaccine Initiative. The CAPRISA cohort was established through grants from NIAID, NIH (U19 AI51794) and the South African Department of Science and Technology. The authors are grateful to J. Stuckey for assistance with graphics and thank B. Korber, D. Montefiori, and M. Roederer and members of the Structural Biology Section, Structural Bioinformatics Core, Humoral Immunology Section, and Humoral Immunology Core at the NIH Vaccine Research Center for helpful discussions or comments on the manuscript. We thank J. Baalwa, D. Ellenberger, D. Gabuzda, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 Envelope plasmids used in our neutralization panels. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The NIH has filed a patent relating to neutralizing antibodies in this manuscript: WIPO no. WO 2011/038290 A2, titled "Neutralizing antibodies to HIV-1 and their use," with inventors J. R. M., P. D. K., M. C., L. S., and G.O. Structure factors and coordinates for the VRC06 and VRC23 antibody cocrystal structures with HIV-1 gp120 have been deposited with the Protein Data Bank under accession codes 4JB9 and 4J6R, respectively. Scripts for the neutralization-based antibody clustering and serologic analysis are included in the online supplementary material and methods (appendix S2) and are available from I. S. G. or P. D. K. upon request. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-38.	Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2012, TRENDS MICROBIOL, V20, P532, DOI 10.1016/j.tim.2012.08.011; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P17107, DOI 10.1073/pnas.1002717107; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Sattentau Quentin J, 2010, F1000 Biol Rep, V2, P60, DOI 10.3410/B2-60; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou T, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-P57; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11	50	157	183	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					751	756		10.1126/science.1233989	http://dx.doi.org/10.1126/science.1233989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661761	Green Published			2022-12-24	WOS:000318619000041
J	Kim, YJ; Hofmann, KP; Ernst, OP; Scheerer, P; Choe, HW; Sommer, ME				Kim, Yong Ju; Hofmann, Klaus Peter; Ernst, Oliver P.; Scheerer, Patrick; Choe, Hui-Woog; Sommer, Martha E.			Crystal structure of pre-activated arrestin p44	NATURE			English	Article							SPLICE VARIANT; RHODOPSIN INTERACTIONS; VISUAL ARRESTIN; 48-KDA PROTEIN; BETA-ARRESTIN; BINDING; DYNAMICS; MECHANISM; MODEL	Arrestins interact with G-protein-coupled receptors (GPCRs) to block interaction with G proteins(1,2) and initiate G-protein-independent signalling(3). Arrestins have a bi-lobed structure that is stabilized by a long carboxy-terminal tail (C-tail), and displacement of the C-tail by receptor-attached phosphates activates arrestins for binding active GPCRs(4). Structures of the inactive state of arrestin are available(5,6), but it is not known how C-tail displacement activates arrestin for receptor coupling. Here we present a 3.0 angstrom crystal structure of the bovine arrestin-1 splice variant p44, in which the activation step is mimicked by C-tail truncation. The structure of this pre-activated arrestin is profoundly different from the basal state and gives insight into the activation mechanism. p44 displays breakage of the central polar core and other interlobe hydrogen-bond networks, leading to a 216 rotation of the two lobes as compared to basal arrestin-1. Rearrangements in key receptor-binding loops in the central crest region include the finger loop(7-9), loop 139 (refs 8, 10, 11) and the sequence Asp 296-Asn 305 (or gate loop), here identified as controlling the polar core. We verified the role of these conformational alterations in arrestin activation and receptor binding by site-directed fluorescence spectroscopy. The data indicate a mechanism for arrestin activation in which C-tail displacement releases critical central-crest loops from restricted to extended receptor-interacting conformations. In parallel, increased flexibility between the two lobes facilitates a proper fitting of arrestin to the active receptor surface. Our results provide a snapshot of an arrestin ready to bind the active receptor, and give an insight into the role of naturally occurring truncated arrestins in the visual system.	[Kim, Yong Ju; Hofmann, Klaus Peter; Choe, Hui-Woog; Sommer, Martha E.] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany; [Ernst, Oliver P.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Ernst, Oliver P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Scheerer, Patrick] Charite, AG Prot Xray Crystallog, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju 561756, South Korea	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of Toronto; University of Toronto; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jeonbuk National University	Sommer, ME (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	patrick.scheerer@charite.de; hwchoe@chonbuk.ac.kr; martha.sommer@charite.de		Sommer, Martha E./0000-0003-0493-8584; Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft [SFB449, SFB740, SFB1078-B6, SO1037/1-2]; DFG Cluster of Excellence 'Unifying Concepts in Catalysis' [D3/E3-1]; European Research Council [ERC-2009/249910-TUDOR]; Canada Excellence Research Chair program; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012R1A1A2044752]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Cluster of Excellence 'Unifying Concepts in Catalysis'(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Canada Excellence Research Chair program; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank J. H. Park for help at the early stage of the project and B. Bauer, J. Engelmann, C. Koch and H. Seibel for technical assistance. We are grateful to U. Muller, M. Weiss and the scientific staff of the BESSY-MX/Helmholtz Zentrum Berlin fur Materialien und Energie at beamlines BL 14.1, BL 14.2 and BL 14.3 operated by the Joint Berlin MX-Laboratory at the BESSY II electron storage ring (Berlin-Adlershof, Germany) and the scientific staff of the European Synchrotron Radiation Facility (ESRF, Grenoble) at beamlines ID14-1, ID 23-1, ID 23-2, ID 29S, ID 29 and ID 14-4 for continuous support. The data presented here were recorded at beamline ID 14-4 (ESRF, Grenoble). This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB449 to O.P.E., SFB740 to K. P. H. and O.P.E., SFB1078-B6 to P. S., SO1037/1-2 to M. E. S.), DFG Cluster of Excellence 'Unifying Concepts in Catalysis' (Research Field D3/E3-1 to P. S.), European Research Council (Advanced Investigator Grant (ERC-2009/249910-TUDOR to K. P. H.)), the Canada Excellence Research Chair program (to O.P.E.) and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012R1A1A2044752 to H.-W.C.). O.P.E. holds The Anne and Max Tanenbaum Chair in Neuroscience at the University of Toronto.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AZARIAN SM, 1995, J BIOL CHEM, V270, P24375, DOI 10.1074/jbc.270.41.24375; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Granzin J, 2012, J MOL BIOL, V416, P611, DOI 10.1016/j.jmb.2012.01.028; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schroder K, 2002, J BIOL CHEM, V277, P43987, DOI 10.1074/jbc.M206211200; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; SMITH WC, 1994, J BIOL CHEM, V269, P15407; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Sommer ME, 2011, J BIOL CHEM, V286, P7359, DOI 10.1074/jbc.M110.204941; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vishnivetskiy S. A., 2013, J BIOL CHEM; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	47	106	109	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					142	+		10.1038/nature12133	http://dx.doi.org/10.1038/nature12133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23604253				2022-12-24	WOS:000318221500050
J	Loven, J; Hoke, HA; Lin, CY; Lau, A; Orlando, DA; Vakoc, CR; Bradner, JE; Lee, TI; Young, RA				Loven, Jakob; Hoke, Heather A.; Lin, Charles Y.; Lau, Ashley; Orlando, David A.; Vakoc, Christopher R.; Bradner, James E.; Lee, Tong Ihn; Young, Richard A.			Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers	CELL			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; MULTIPLE-MYELOMA; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; C-MYC; THERAPEUTIC TARGET; CANCER EPIGENETICS; BET BROMODOMAINS; MEDIATOR COMPLEX	Chromatin regulators have become attractive targets for cancer therapy, but it is unclear why inhibition of these ubiquitous regulators should have gene-specific effects in tumor cells. Here, we investigate how inhibition of the widely expressed transcriptional coactivator BRD4 leads to selective inhibition of the MYC oncogene in multiple myeloma (MM). BRD4 and Mediator were found to co-occupy thousands of enhancers associated with active genes. They also co-occupied a small set of exceptionally large super-enhancers associated with genes that feature prominently in MM biology, including the MYC oncogene. Treatment of MM tumor cells with the BET-bromodomain inhibitor JQ1 led to preferential loss of BRD4 at super-enhancers and consequent transcription elongation defects that preferentially impacted genes with super-enhancers, including MYC. Super-enhancers were found at key oncogenic drivers in many other tumor cells. These observations have implications for the discovery of cancer therapeutics directed at components of super-enhancers in diverse tumor types.	[Loven, Jakob; Hoke, Heather A.; Lin, Charles Y.; Lau, Ashley; Orlando, David A.; Lee, Tong Ihn; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hoke, Heather A.; Lau, Ashley; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lin, Charles Y.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lin, Charles Y.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Vakoc, Christopher/0000-0002-1158-7180	Swedish Research Council [VR-B0086301]; Damon-Runyon Cancer Research Foundation; Burroughs-Welcome CAMS award; NCI Cancer Center Support Grant Development Fund [CA45508]; National Institutes of Health [HG002668, CA146445]; NATIONAL CANCER INSTITUTE [R01CA146445, P30CA045508, P30CA014051, R01CA174793] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Damon-Runyon Cancer Research Foundation; Burroughs-Welcome CAMS award; NCI Cancer Center Support Grant Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Zi Peng Fan for bioinformatics support; Michael R. McKeown for help with cell viability assays; Jun Qi for providing JQ1; Tom Volkert, Jennifer Love, Sumeet Gupta, and Jeong-Ah Kwon at the Whitehead Genome Technologies Core for Solexa sequencing; and members of the Young, Bradner, and Vakoc labs for helpful discussion. This work was supported by a Swedish Research Council Postdoctoral Fellowship VR-B0086301 (J.L.), the Damon-Runyon Cancer Research Foundation (J.E.B.), a Burroughs-Welcome CAMS award and NCI Cancer Center Support Grant Development Fund CA45508 (C.R.V.), and National Institutes of Health grants HG002668 (R.A.Y.) and CA146445 (R.A.Y., T. I. L.). R.A.Y. and J.E.B. are founders, J.L. and D.A.O. have become employees, and C.R.V. is a scientific advisor of Syros Pharmaceuticals.	Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Borggrefe T, 2011, SEMIN CELL DEV BIOL, V22, P759, DOI 10.1016/j.semcdb.2011.07.022; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dib Amel, 2008, J Natl Cancer Inst Monogr, P25, DOI 10.1093/jncimonographs/lgn011; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Geutjes EJ, 2012, ONCOGENE, V31, P3827, DOI 10.1038/onc.2011.552; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pedersen N, 2003, CANCER RES, V63, P1943; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	74	1741	1813	9	278	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					320	334		10.1016/j.cell.2013.03.036	http://dx.doi.org/10.1016/j.cell.2013.03.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582323	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000317349700012
J	Kanekiyo, M; Wei, CJ; Yassine, HM; McTamney, PM; Boyington, JC; Whittle, JRR; Rao, SS; Kong, WP; Wang, LS; Nabel, GJ				Kanekiyo, Masaru; Wei, Chih-Jen; Yassine, Hadi M.; McTamney, Patrick M.; Boyington, Jeffrey C.; Whittle, James R. R.; Rao, Srinivas S.; Kong, Wing-Pui; Wang, Lingshu; Nabel, Gary J.			Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies	NATURE			English	Article							A VIRUSES; HEMAGGLUTININ; EPITOPE; IMMUNOGENICITY; VACCINATION; RECOGNIZES; INDUCTION; FERRITIN; IMMUNITY; PROTEIN	Influenza viruses pose a significant threat to the public and are a burden on global health systems(1,2). Each year, influenza vaccines must be rapidly produced to match circulating viruses, a process constrained by dated technology and vulnerable to unexpected strains emerging from humans and animal reservoirs. Here we use knowledge of protein structure to design self-assembling nanoparticles that elicit broader and more potent immunity than traditional influenza vaccines. The viral haemagglutinin was genetically fused to ferritin, a protein that naturally forms nanoparticles composed of 24 identical polypeptides(3). Haemagglutinin was inserted at the interface of adjacent subunits so that it spontaneously assembled and generated eight trimeric viral spikes on its surface. Immunization with this influenza nanoparticle vaccine elicited haemagglutination inhibition antibody titres more than tenfold higher than those from the licensed inactivated vaccine. Furthermore, it elicited neutralizing antibodies to two highly conserved vulnerable haemagglutinin structures that are targets of universal vaccines: the stem(4,5) and the receptor binding site on the head(6,7). Antibodies elicited by a 1999 haemagglutinin-nanoparticle vaccine neutralized H1N1 viruses from 1934 to 2007 and protected ferrets from an unmatched 2007 H1N1 virus challenge. This structure-based, self-assembling synthetic nanoparticle vaccine improves the potency and breadth of influenza virus immunity, and it provides a foundation for building broader vaccine protection against emerging influenza viruses and other pathogens.	[Kanekiyo, Masaru; Wei, Chih-Jen; Yassine, Hadi M.; McTamney, Patrick M.; Boyington, Jeffrey C.; Whittle, James R. R.; Rao, Srinivas S.; Kong, Wing-Pui; Wang, Lingshu; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), Sanofi, 640 Mem Dr, Cambridge, MA 02139 USA.	Gary.Nabel@sanofi.com	YASSINE, HADI M./AAW-6475-2020; Wei, Chih/GVT-5734-2022; Kanekiyo, Masaru/Y-9820-2018; Cheng, Yushao/E-6256-2011	YASSINE, HADI M./0000-0001-7592-2788; Kanekiyo, Masaru/0000-0001-5767-1532; 	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Andersen, A. Taylor, A. Zajac and C. Chiedi for help with the animal studies; U. Baxa, K. Nagashima and A. Harned for electron microscopy studies; X. Chen for technical support; A. Panet, B. Graham, R. Schwartz and members of the Nabel lab for discussions; S. Sun and M. Rossmann for technical and conceptual advice; A. Tislerics, B. Hartman and J. Farrar for manuscript preparation. The MF59 adjuvant was kindly provided by Novartis. This work was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health.	Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Cho KJ, 2009, J MOL BIOL, V390, P83, DOI 10.1016/j.jmb.2009.04.078; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Jaaskelainen A, 2007, SMALL, V3, P1362, DOI 10.1002/smll.200700011; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Kong WP, 2003, J VIROL, V77, P12764, DOI 10.1128/JVI.77.23.12764-12772.2003; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Lee LA, 2006, NANOMED-NANOTECHNOL, V2, P137, DOI 10.1016/j.nano.2006.07.009; Li C.Q., 2006, IND BIOTECHNOL, V2, P143, DOI [DOI 10.1089/IND.2006.2.143, 10.1089/ind.2006.2.143]; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/erv.12.140, 10.1586/ERV.12.140]; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Yamashita I, 2010, BBA-GEN SUBJECTS, V1800, P846, DOI 10.1016/j.bbagen.2010.03.005; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	33	482	545	14	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 4	2013	499	7456					102	+		10.1038/nature12202	http://dx.doi.org/10.1038/nature12202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23698367	Green Accepted			2022-12-24	WOS:000321285600042
J	Kim, SV; Xiang, WKV; Kwak, C; Yang, Y; Lin, XYW; Ota, M; Sarpel, U; Rifkin, DB; Xu, RL; Littman, DR				Kim, Sangwon V.; Xiang, Wenkai V.; Kwak, Changsoo; Yang, Yi; Lin, Xiyao W.; Ota, Mitsuhiko; Sarpel, Umut; Rifkin, Daniel B.; Xu, Ruliang; Littman, Dan R.			GPR15-Mediated Homing Controls Immune Homeostasis in the Large Intestine Mucosa	SCIENCE			English	Article							REGULATORY T-CELLS; RECEPTORS; INDUCTION; BREAKDOWN	Lymphocyte homing, which contributes to inflammation, has been studied extensively in the small intestine, but there is little known about homing to the large intestine, the site most commonly affected in inflammatory bowel disease. GPR15, an orphan heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor, controlled the specific homing of T cells, particularly FOXP3(+) regulatory T cells (T-regs), to the large intestine lamina propria (LILP). GPR15 expression was modulated by gut microbiota and transforming growth factor-beta 1, but not by retinoic acid. GPR15-deficient mice were prone to develop more severe large intestine inflammation, which was rescued by the transfer of GPR15-sufficient T-regs. Our findings thus describe a T cell-homing receptor for LILP and indicate that GPR15 plays a role in mucosal immune tolerance largely by regulating the influx of T-regs.	[Kim, Sangwon V.; Xiang, Wenkai V.; Kwak, Changsoo; Yang, Yi; Lin, Xiyao W.; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Ota, Mitsuhiko; Rifkin, Daniel B.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Sarpel, Umut] Mt Sinai Sch Med, Div Surg Oncol, New York, NY 10029 USA; [Xu, Ruliang; Littman, Dan R.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; Icahn School of Medicine at Mount Sinai; New York University; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10016 USA.	dan.littman@med.nyu.edu	; Kim, Sangwon V./S-1166-2016	Sarpel, Umut/0000-0002-4346-3641; xu, ruliang/0000-0002-9165-4610; Kwak, Changsoo/0000-0003-1503-5671; Kim, Sangwon V./0000-0001-8453-7080	Irvington Institute fellowship program of the Cancer Research Institute; NIH National Research Service [1T32AI100853-01]; Arthritis National Research Foundation; National Cancer Institute (NCI), NIH [5P30CA016087-32]; NCI-NIH [5P30CA016087-33, P30 CA016087-30]; National Center for Research Resources, NIH [UL1RR029893]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100853] Funding Source: NIH RePORTER	Irvington Institute fellowship program of the Cancer Research Institute; NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank R. Min and P. Oh for technical assistance; M. Sellars for a critical reading of the manuscript; J. M. Weiss, J. J. Lafaille, and A. Y. Rudensky for their advice; and E. Newman (NYU School of Medicine, New York) for providing surgical specimens. Foxp3<SUP>ires</SUP> <SUP>mrfp</SUP> mice were provided by R. A. Flavell (Yale University School of Medicine, Howard Hughes Medical Institute) and subject to a Materials Transfer Agreement. A patent application related to the work in this paper has been filed (S.V.K. and D.R.L. as inventors). The data in this paper are tabulated in the main paper and in the supplementary materials, and are deposited in National Center for Biotechnology Information's Gene Expression Omnibus (GSE45773). S.V.K. was supported by the Irvington Institute fellowship program of the Cancer Research Institute and by NIH National Research Service Award grant 1T32AI100853-01. Y.Y. was supported by the Arthritis National Research Foundation. D.R.L. is a Howard Hughes Medical Institute Investigator. This work was supported in part by National Cancer Institute (NCI), NIH, grant 5P30CA016087-32 (BioRepository Center, Genome Technology Center, and Histopathology Core), NCI-NIH grant 5P30CA016087-33 (Cytometry and Cell Sorting Core), National Center for Research Resources, NIH, grant UL1RR029893 (BioRepository Center), and NCI-NIH P30 CA016087-30 (for data collected on the Affymetrix GeneChip System).	Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hansen W, 2006, J IMMUNOL, V177, P209, DOI 10.4049/jimmunol.177.1.209; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105	28	185	192	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1456	1459		10.1126/science.1237013	http://dx.doi.org/10.1126/science.1237013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23661644	Green Accepted			2022-12-24	WOS:000320647000043
J	Dvinge, H; Git, A; Graf, S; Salmon-Divon, M; Curtis, C; Sottoriva, A; Zhao, YJ; Hirst, M; Armisen, J; Miska, EA; Chin, SF; Provenzano, E; Turashvili, G; Green, A; Ellis, I; Aparicio, S; Caldas, C				Dvinge, Heidi; Git, Anna; Graef, Stefan; Salmon-Divon, Mali; Curtis, Christina; Sottoriva, Andrea; Zhao, Yongjun; Hirst, Martin; Armisen, Javier; Miska, Eric A.; Chin, Suet-Feung; Provenzano, Elena; Turashvili, Gulisa; Green, Andrew; Ellis, Ian; Aparicio, Sam; Caldas, Carlos			The shaping and functional consequences of the microRNA landscape in breast cancer	NATURE			English	Article							GENE-EXPRESSION; ESTROGEN-RECEPTOR; MESSENGER-RNA; METASTASIS; REVEALS; INDUCE; TUMORS	MicroRNAs (miRNAs) show differential expression across breast cancer subtypes, and have both oncogenic and tumour-suppressive roles(1-6). Here we report the miRNA expression profiles of 1,302 breast tumours with matching detailed clinical annotation, long-term follow-up and genomic and messenger RNA expression data(7). This provides a comprehensive overview of the quantity, distribution and variation of the miRNA population and provides information on the extent to which genomic, transcriptional and post-transcriptional events contribute to miRNA expression architecture, suggesting an important role for post-transcriptional regulation. The key clinical parameters and cellular pathways related to the miRNA landscape are characterized, revealing context-dependent interactions, for example with regards to cell adhesion and Wnt signalling. Notably, only prognostic miRNA signatures derived from breast tumours devoid of somatic copy-number aberrations (CNA-devoid) are consistently prognostic across several other subtypes and can be validated in external cohorts. We then use a data-driven approach(8) to seek the effects of miRNAs associated with differential co-expression of mRNAs, and find that miRNAs act as modulators of mRNA-mRNA interactions rather than as on-off molecular switches. We demonstrate such an important modulatory role for miRNAs in the biology of CNA-devoid breast cancers, a common subtype in which the immune response is prominent. These findings represent a new framework for studying the biology of miRNAs in human breast cancer.	[Dvinge, Heidi; Git, Anna; Graef, Stefan; Chin, Suet-Feung; Caldas, Carlos] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Dvinge, Heidi; Git, Anna; Graef, Stefan; Chin, Suet-Feung; Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England; [Salmon-Divon, Mali] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Salmon-Divon, Mali] Ariel Univ, Ctr Samaria, Dept Mol Biol, IL-40700 Ariel, Israel; [Curtis, Christina; Sottoriva, Andrea] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90033 USA; [Zhao, Yongjun; Hirst, Martin] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Zhao, Yongjun; Hirst, Martin; Turashvili, Gulisa; Aparicio, Sam] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Armisen, Javier; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Armisen, Javier; Miska, Eric A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Provenzano, Elena; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge CB2 2QQ, England; [Provenzano, Elena; Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Turashvili, Gulisa; Aparicio, Sam] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Green, Andrew; Ellis, Ian] Univ Nottingham, Sch Mol Med Sci, Dept Histopathol, Nottingham NG5 1PB, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; CRUK Cambridge Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL); Ariel University; University of Southern California; British Columbia Cancer Agency; University of British Columbia; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; British Columbia Cancer Agency; University of Nottingham	Git, A (corresponding author), Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	anna.git@cruk.cam.ac.uk; saparicio@bccrc.ca; carlos.caldas@cruk.cam.ac.uk	Hirst, Martin/B-7684-2016; Salmon-Divon, Mali/AAG-4479-2019; Caldas, Carlos/U-7250-2019; Green, Andrew/AAF-1991-2020	Salmon-Divon, Mali/0000-0002-7272-0846; Caldas, Carlos/0000-0003-3547-1489; Green, Andrew/0000-0002-0488-5913; Ellis, Ian/0000-0001-5292-8474; Turashvili, Gulisa/0000-0001-6125-5865; Sottoriva, Andrea/0000-0001-6709-9533; chin, suet-feung/0000-0001-5697-1082; Miska, Eric/0000-0002-4450-576X; Dvinge, Heidi/0000-0003-1741-0738; Aparicio, Samuel/0000-0002-0487-9599; Curtis, Christina/0000-0003-0166-3802	Cancer Research UK; British Columbia Cancer Foundation; University of Cambridge; Hutchinson Whampoa; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Cancer Research UK [11832, 16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Columbia Cancer Foundation; University of Cambridge(University of Cambridge); Hutchinson Whampoa; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by Cancer Research UK and the British Columbia Cancer Foundation. The authors also acknowledge the support of the University of Cambridge, Hutchinson Whampoa, the NIHR Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre. We thank S. McGuire for help in sample management; S. Fulmer-Smentek and T. Hill for help with array design; L. Goldstein for initial processing of sequencing data; O. Rueda for statistical advice; and O. Rueda, J. Carroll and R. Ali for reading of the manuscript. We are very grateful to the patients who donated tissue and associated pseudo-anonymized clinical data.	Andreopoulos B, 2012, CANCER INFORM, V11, P61, DOI 10.4137/CIN.S9037; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Guo HY, 2012, INT J BIOCHEM CELL B, V44, P1465, DOI 10.1016/j.biocel.2012.05.015; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Le Quesne J, 2010, MOL ONCOL, V4, P230, DOI 10.1016/j.molonc.2010.04.009; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Lyng MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036170; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Xu WD, 2012, INFLAMMATION, V35, P1525, DOI 10.1007/s10753-012-9467-0	30	314	328	0	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					378	382		10.1038/nature12108	http://dx.doi.org/10.1038/nature12108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23644459				2022-12-24	WOS:000318952000040
J	Potok, ME; Nix, DA; Parnell, TJ; Cairns, BR				Potok, Magdalena E.; Nix, David A.; Parnell, Timothy J.; Cairns, Bradley R.			Reprogramming the Maternal Zebrafish Genome after Fertilization to Match the Paternal Methylation Pattern	CELL			English	Article							PROMOTER DNA METHYLATION; PREIMPLANTATION DEVELOPMENT; HISTONE MODIFICATIONS; GENE-EXPRESSION; CHROMATIN; EMBRYOGENESIS; EMBRYO; CELLS; DEMETHYLATION; PLURIPOTENT	Early vertebrate embryos must achieve totipotency and prepare for zygotic genome activation (ZGA). To understand this process, we determined the DNA methylation (DNAme) profiles of zebrafish gametes, embryos at different stages, and somatic muscle and compared them to gene activity and histone modifications. Sperm chromatin patterns are virtually identical to those at ZGA. Unexpectedly, the DNA of many oocyte genes important for germline functions (i.e., piwil1) or early development (i.e., hox genes) is methylated, but the loci are demethylated during zygotic cleavage stages to precisely the state observed in sperm, even in parthenogenetic embryos lacking a replicating paternal genome. Furthermore, this cohort constitutes the genes and loci that acquire DNAme during development (i.e., ZGA to muscle). Finally, DNA methyltransferase inhibition experiments suggest that DNAnne silences particular gene and chromatin cohorts at ZGA, preventing their precocious expression. Thus, zebrafish achieve a totipotent chromatin state at ZGA through paternal genome competency and maternal genonne DNAme reprogramming.	[Potok, Magdalena E.; Parnell, Timothy J.; Cairns, Bradley R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Potok, Magdalena E.; Nix, David A.; Parnell, Timothy J.; Cairns, Bradley R.] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	brad.cairns@hci.utah.edu		Parnell, Timothy/0000-0002-3632-3691	NICHD [5R01HD058506]; HHMI; NHLBI [U01HL0981];  [CA24014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000981] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); HHMI(Howard Hughes Medical Institute); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Brian Daily for genomics advice and Mengyao Tan, Meesha Last, and Minhtu Nguyen for help in oocyte collection. We thank Kazuyiki Hoshijima, Timothy Dahlem, and David Grunwald for homozygous golden fish and for advice regarding maternal haploid fish. We thank Saher Sue Hammoud, Shan-Fu Wu, Rod Stewart, David Jones, and Cairns lab members for advice. This work is supported by NICHD 5R01HD058506 (support of M.E.P. and supplies), HHMI (support of B.R.C. and T.J.P.), NHLBI U01HL0981 (support of T.J.P.), and CA24014 to the Huntsman Cancer Institute (for core facilities).	Almeida RD, 2012, EPIGENETICS-US, V7, P383, DOI 10.4161/epi.19375; Andersen IS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r65; Arpanahi A, 2009, GENOME RES, V19, P1338, DOI 10.1101/gr.094953.109; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Bogdanovic O, 2011, GENOME RES, V21, P1313, DOI 10.1101/gr.114843.110; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Goll MG, 2011, PROG MOL BIOL TRANSL, V101, P193, DOI 10.1016/B978-0-12-387685-0.00005-6; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hoffman TL, 2007, J EXP ZOOL PART B, V308B, P679, DOI 10.1002/jez.b.21189; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KANE DA, 1993, DEVELOPMENT, V119, P447; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Martin CC, 1999, DEV BIOL, V206, P189, DOI 10.1006/dbio.1998.9105; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McGowan RA, 1997, BIOCHEM CELL BIOL, V75, P499, DOI 10.1139/bcb-75-5-499; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Thisse B., 2001, R01RR15402 NIH ZFIN; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wu SF, 2011, METHOD CELL BIOL, V104, P327, DOI 10.1016/B978-0-12-374814-0.00018-5; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	48	258	269	1	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					759	772		10.1016/j.cell.2013.04.030	http://dx.doi.org/10.1016/j.cell.2013.04.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663776	Bronze, Green Accepted			2022-12-24	WOS:000318844000007
J	Kamat, SS; Williams, HJ; Dangott, LJ; Chakrabarti, M; Raushel, FM				Kamat, Siddhesh S.; Williams, Howard J.; Dangott, Lawrence J.; Chakrabarti, Mrinmoy; Raushel, Frank M.			The catalytic mechanism for aerobic formation of methane by bacteria	NATURE			English	Article							CARBON-PHOSPHORUS LYASE; STRUCTURAL BASIS; RADICAL SAM; GLYCYL; DEGRADATION; PHOSPHATE; ENZYME; ACID	Methane is a potent greenhouse gas that is produced in significant quantities by aerobic marine organisms(1). These bacteria apparently catalyse the formation of methane through the cleavage of the highly unreactive carbon-phosphorus bond inmethylphosphonate(MPn), but the biological or terrestrial source of this compound is unclear(2). However, the ocean-dwelling bacterium Nitrosopumilus maritimus catalyses the biosynthesis of MPn from 2-hydroxyethyl phosphonate(3) and the bacterial C-P lyase complex is known to convert MPn to methane(4-7). In addition to MPn, the bacterial C-P lyase complex catalyses C-P bond cleavage of many alkyl phosphonates when the environmental concentration of phosphate is low(4-7). PhnJ from the C-P lyase complex catalyses an unprecedented C-P bond cleavage reaction of ribose-1-phosphonate-5-phosphate to methane and ribose-1,2-cyclic-phosphate-5-phosphate. This reaction requires a redox-active [4Fe-4S]-cluster and S-adenosyl-L-methionine, which is reductively cleaved to L-methionine and 5'-deoxyadenosine(8). Here we show that PhnJ is a novel radical S-adenosyl-L-methionine enzyme that catalyses C-P bond cleavage through the initial formation of a 5'-deoxyadenosyl radical and two protein-based radicals localized at Gly 32 and Cys 272. During this transformation, the pro-R hydrogen from Gly 32 is transferred to the 5'-deoxyadenosyl radical to form 5'-deoxyadenosine and the pro-S hydrogen is transferred to the radical intermediate that ultimately generates methane. A comprehensive reaction mechanism is proposed for cleavage of the C-P bond by the C-P lyase complex that uses a covalent thiophosphate intermediate for methane and phosphate formation.	[Kamat, Siddhesh S.; Williams, Howard J.; Chakrabarti, Mrinmoy; Raushel, Frank M.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Dangott, Lawrence J.] Texas A&M Univ, Dept Biochem & Biophys, Prot Chem Lab, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Raushel, FM (corresponding author), Texas A&M Univ, Dept Chem, POB 30012, College Stn, TX 77843 USA.	raushel@tamu.edu	Raushel, Frank/B-7125-2015	Raushel, Frank/0000-0002-5918-3089; Kamat, Siddhesh/0000-0001-6132-7574	Robert A. Welch Foundation [A-840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266] Funding Source: NIH RePORTER	Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Barondeau for use of the anaerobic chamber, R. Stipanovic for use of the gas chromatography mass spectrometer, A. Mehta and T. Begley for use of the liquid chromatography mass spectrometer, and C. Hilty for use of the <SUP>31</SUP>P-NMR spectrometer. We thank P. A. Lindahl for help with the EPR measurements (GM084266). This work was supported by the Robert A. Welch Foundation (A-840).	Becker A, 1999, NAT STRUCT BIOL, V6, P969; Booker Squire J, 2010, F1000 Biol Rep, V2, P52, DOI 10.3410/B2-52; Cicchillo RM, 2005, J AM CHEM SOC, V127, P7310, DOI 10.1021/ja051369x; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; Eklund H, 1999, STRUCT FOLD DES, V7, pR257, DOI 10.1016/S0969-2126(00)80019-2; FREY M, 1994, J BIOL CHEM, V269, P12432; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; FROST JW, 1987, J AM CHEM SOC, V109, P2166, DOI 10.1021/ja00241a039; Ghanem E, 2007, BIOCHEMISTRY-US, V46, P9032, DOI 10.1021/bi700561k; Kamat SS, 2011, NATURE, V480, P570, DOI 10.1038/nature10622; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; Metcalf WW, 2012, SCIENCE, V337, P1104, DOI 10.1126/science.1219875; METCALF WW, 1993, J BACTERIOL, V175, P3430, DOI 10.1128/jb.175.11.3430-3442.1993; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; WACKETT LP, 1987, J BACTERIOL, V169, P710, DOI 10.1128/jb.169.2.710-717.1987; WACKETT LP, 1987, J BACTERIOL, V169, P1753, DOI 10.1128/jb.169.4.1753-1756.1987; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	22	65	66	8	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					132	136		10.1038/nature12061	http://dx.doi.org/10.1038/nature12061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615610				2022-12-24	WOS:000318221500048
J	Wu, H				Wu, Hao			Higher-Order Assemblies in a New Paradigm of Signal Transduction	CELL			English	Article							CRYSTAL-STRUCTURE; RECEPTOR; COMPLEX; ACTIVATION; APOPTOSIS; MECHANISM; REVEALS; KINASE; TRAF6; FORMS	Recent studies have revealed that multiple intracellular signaling proteins may assemble into structured, yet sometimes infinite, higher-order signaling machines for transmission of receptor activation information to cellular responses. These studies advance our understanding of cell signaling and implicate new molecular mechanisms in proximity-driven enzyme activation, threshold behavior, signal amplification, reduction of biological noise, and temporal and spatial control of signal transduction.	[Wu, Hao] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Wu, H (corresponding author), Childrens Hosp, Program Cellular & Mol Med, 300 Longwood Ave, Boston, MA 02115 USA.	hao.wu@childrens.harvard.edu			National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937, R01AI076927, R01AI079260, R01AI089882, R01AI050872, R37AI050872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I apologize for incomplete citations due to space limitation and thank my colleagues and lab members for many insightful discussions, in particular Kai Wucherpfennig, Hong Qian, Qi Qiao, Qian Yin, and Neer Asherie. This work is supported by the National Institutes of Health.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; FLORESRIVEROS JR, 1989, J BIOL CHEM, V264, P21557; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lohse MJ, 2008, BRIT J PHARMACOL, V153, pS125, DOI 10.1038/sj.bjp.0707656; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Qian H, 2012, ANNU REV BIOPHYS, V41, P179, DOI 10.1146/annurev-biophys-050511-102240; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Siegel RM, 2004, J CELL BIOL, V167, P735, DOI 10.1083/jcb.200406101; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104	24	230	232	1	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					287	292		10.1016/j.cell.2013.03.013	http://dx.doi.org/10.1016/j.cell.2013.03.013			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582320	Green Accepted, Bronze			2022-12-24	WOS:000317349700009
J	Loman, NJ; Constantinidou, C; Christner, M; Rohde, H; Chan, JZM; Quick, J; Weir, JC; Quince, C; Smith, GP; Betley, JR; Aepfelbacher, M; Pallen, MJ				Loman, Nicholas J.; Constantinidou, Chrystala; Christner, Martin; Rohde, Holger; Chan, Jacqueline Z. -M.; Quick, Joshua; Weir, Jacqueline C.; Quince, Christopher; Smith, Geoffrey P.; Betley, Jason R.; Aepfelbacher, Martin; Pallen, Mark J.			A Culture-Independent Sequence-Based Metagenomics Approach to the Investigation of an Outbreak of Shiga-Toxigenic Escherichia coli O104:H4	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Importance Identification of the bacterium responsible for an outbreak can aid in disease management. However, traditional culture-based diagnosis can be difficult, particularly if no specific diagnostic test is available for an outbreak strain. Objective To explore the potential of metagenomics, which is the direct sequencing of DNA extracted from microbiologically complex samples, as an open-ended clinical discovery platform capable of identifying and characterizing bacterial strains from an outbreak without laboratory culture. Design, Setting, and Patients In a retrospective investigation, 45 samples were selected from fecal specimens obtained from patients with diarrhea during the 2011 outbreak of Shiga-toxigenic Escherichia coli (STEC) O104:H4 in Germany. Samples were subjected to high-throughput sequencing (August-September 2012), followed by a 3-phase analysis (November 2012-February 2013). In phase 1, a de novo assembly approach was developed to obtain a draft genome of the outbreak strain. In phase 2, the depth of coverage of the outbreak strain genome was determined in each sample. In phase 3, sequences from each sample were compared with sequences from known bacteria to identify pathogens other than the outbreak strain. Main Outcomes and Measures The recovery of genome sequence data for the purposes of identification and characterization of the outbreak strain and other pathogens from fecal samples. Results During phase 1, a draft genome of the STEC outbreak strain was obtained. During phase 2, the outbreak strain genome was recovered from 10 samples at greater than 10-fold coverage and from 26 samples at greater than 1-fold coverage. Sequences from the Shiga-toxin genes were detected in 27 of 40 STEC-positive samples (67%). In phase 3, sequences from Clostridium difficile, Campylobacter jejuni, Campylobacter concisus, and Salmonella enterica were recovered. Conclusions and Relevance These results suggest the potential of metagenomics as a culture-independent approach for the identification of bacterial pathogens during an outbreak of diarrheal disease. Challenges include improving diagnostic sensitivity, speeding up and simplifying workflows, and reducing costs. JAMA. 2013;309(14):1502-1510 www.jama.com	[Loman, Nicholas J.; Quick, Joshua] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Constantinidou, Chrystala; Chan, Jacqueline Z. -M.; Pallen, Mark J.] Univ Warwick, Div Microbiol & Infect, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Christner, Martin; Rohde, Holger; Aepfelbacher, Martin] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Quince, Christopher] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Weir, Jacqueline C.; Smith, Geoffrey P.; Betley, Jason R.] Illumina Inc, Chesterford Res Pk, Essex, England	University of Birmingham; University of Warwick; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Glasgow; Illumina	Pallen, MJ (corresponding author), Univ Warwick, Div Microbiol & Infect, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	m.pallen@warwick.ac.uk	Loman, Nicholas/Z-1573-2019	Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657; Rohde, Holger/0000-0001-8587-4433; Quince, Christopher/0000-0003-1884-8440	Novartis; Gilead; Germany by the Medical Faculty of the University Medical Center Hamburg-Eppendorf; UK's Biotechnology and Biological Sciences Research Council; UK's National Institute for Health Research; MRC Special Training Fellowship in Biomedical Informatics; Illumina Inc.; Biotechnology and Biological Sciences Research Council [BB/E011179/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H003851/1] Funding Source: researchfish; Medical Research Council [MR/J014370/1, G0901717] Funding Source: researchfish; BBSRC [BB/E011179/1] Funding Source: UKRI; EPSRC [EP/H003851/1] Funding Source: UKRI; MRC [G0901717, MR/J014370/1] Funding Source: UKRI	Novartis(Novartis); Gilead(Gilead Sciences); Germany by the Medical Faculty of the University Medical Center Hamburg-Eppendorf; UK's Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK's National Institute for Health Research; MRC Special Training Fellowship in Biomedical Informatics(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Illumina Inc.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Rohde reported receiving speakers fees from Novartis and Gilead; and receiving travel reimbursement from Novartis and Merck Sharp Dohme. Ms Weir and Drs Smith and Betley are employees of and own stock in Illumina Inc, which manufactures the MiSeq and HiSeq 2500 instruments. No other authors reported disclosures.; This work was supported in Germany by the Medical Faculty of the University Medical Center Hamburg-Eppendorf. Work in Birmingham, England, was supported by a grant from the UK's Biotechnology and Biological Sciences Research Council supporting the xBASE project, by a grant from the UK's National Institute for Health Research awarded to the Surgical Reconstruction and Microbiology Research Centre (MRC), and by an MRC Special Training Fellowship in Biomedical Informatics to Dr Loman. The HiSeq2500 sequencing was supported by Illumina Inc.	Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Chan JZM, 2012, NAT BIOTECHNOL, V30, P1068, DOI 10.1038/nbt.2410; de Boer RF, 2010, J CLIN MICROBIOL, V48, P4140, DOI 10.1128/JCM.01124-10; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Garcia LS, 2010, CLINICAL MICROBIOLOG; Kaakoush NO, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00004; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Nitschke M, 2012, JAMA-J AM MED ASSOC, V307, P1046, DOI 10.1001/jama.2012.264; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Rogers GB, 2010, TRENDS MICROBIOL, V18, P357, DOI 10.1016/j.tim.2010.04.005; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Snyder LAS, 2009, MICROB ECOL, V57, P1, DOI 10.1007/s00248-008-9465-9; Vonberg RP, 2013, CLIN INFECT DIS, V56, P1132, DOI 10.1093/cid/cis1218; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4	18	203	214	2	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2013	309	14					1502	1510		10.1001/jama.2013.3231	http://dx.doi.org/10.1001/jama.2013.3231			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121VD	23571589	Bronze			2022-12-24	WOS:000317271700028
J	Lam, MTY; Cho, H; Lesch, HP; Gosselin, D; Heinz, S; Tanaka-Oishi, Y; Benner, C; Kaikkonen, MU; Kim, AS; Kosaka, M; Lee, CY; Watt, A; Grossman, TR; Rosenfeld, MG; Evans, RM; Glass, CK				Lam, Michael T. Y.; Cho, Han; Lesch, Hanna P.; Gosselin, David; Heinz, Sven; Tanaka-Oishi, Yumiko; Benner, Christopher; Kaikkonen, Minna U.; Kim, Aneeza S.; Kosaka, Mika; Lee, Cindy Y.; Watt, Andy; Grossman, Tamar R.; Rosenfeld, Michael G.; Evans, Ronald M.; Glass, Christopher K.			Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription	NATURE			English	Article							ALPHA; OLIGONUCLEOTIDES; COREPRESSOR; METABOLISM; INITIATION; RECEPTORS; DOMAINS; CELLS	Rev-Erb-alpha and Rev-Erb-beta are nuclear receptors that regulate the expression of genes involved in the control of circadian rhythm(1,2), metabolism(3,4) and inflammatory responses(5). Rev-Erbs function as transcriptional repressors by recruiting nuclear receptor co-repressor (NCoR)-HDAC3 complexes to Rev-Erb response elements in enhancers and promoters of target genes(6-8), but the molecular basis for cell-specific programs of repressionis not known. Here we present evidence that in mouse macrophages Rev-Erbs regulate target gene expression by inhibiting the functions of distal enhancers that are selected by macrophage-lineage-determining factors, thereby establishing a macrophage-specific program of repression. Remarkably, the repressive functions of Rev-Erbs are associated with their ability to inhibit the transcription of enhancer-derived RNAs (eRNAs). Furthermore, targeted degradation of eRNAs at two enhancers subject to negative regulation by Rev-Erbs resulted in reduced expression of nearby messenger RNAs, suggesting a direct role of these eRNAs in enhancer function. By precisely defining eRNA start sites using a modified form of global run-on sequencing that quantifies nascent 5' ends, we show that transfer of full enhancer activity to a target promoter requires both the sequences mediating transcription-factor binding and the specific sequences encoding the eRNA transcript. These studies provide evidence for a direct role of eRNAs in contributing to enhancer functions and suggest that Rev-Erbs act to suppress gene expression at a distance by repressing eRNA transcription.	[Lam, Michael T. Y.; Lesch, Hanna P.; Gosselin, David; Heinz, Sven; Tanaka-Oishi, Yumiko; Benner, Christopher; Kaikkonen, Minna U.; Kosaka, Mika; Lee, Cindy Y.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Cho, Han; Evans, Ronald M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Kim, Aneeza S.; Watt, Andy; Grossman, Tamar R.] Isis Pharmaceut Inc, Carlsbad, CA 92010 USA; [Rosenfeld, Michael G.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.; Evans, Ronald M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Diego; Salk Institute; Isis Pharmaceuticals Inc; University of California System; University of California San Diego; Howard Hughes Medical Institute	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Kaikkonen, Minna U/AAK-3612-2020; Evans, Ronald/AAF-4001-2019; Glass, Christopher/AAI-3933-2021	Kaikkonen, Minna U/0000-0001-6294-0979; Evans, Ronald/0000-0002-9986-5965; Glass, Christopher/0000-0003-4344-3592; Benner, Christopher/0000-0002-4618-0719; Heinz, Sven/0000-0002-4665-1007; Lesch, Hanna P./0000-0002-2463-5567	National Institutes of Health [CA17390, U19DK62434, DK091183, DK063491, CA014195, DK057978, HL088093, HL105278, CA52599]; University of California, San Diego Medical Scientist Training Program [T32 GM007198-37]; University of California, San Diego Genetics Training Program [T32 GM008666]; National Institute of General Medical Sciences; LeDucq Foundation Fellowship; Finnish Cultural Foundation; Instumentarium Foundation; Paulo Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Maud Kuistila Memorial Foundation; Fulbright Center; Leona M. and Harry B. Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Glenn Foundation for Medical Research; Ellison Medical Foundation; Ipsen/Biomeasure; NATIONAL CANCER INSTITUTE [R01CA052599, P30CA014195, R01CA173903] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R37DK057978, U19DK062434, R01DK091183, R01DK018477, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198, T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Medical Scientist Training Program; University of California, San Diego Genetics Training Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); LeDucq Foundation Fellowship(Leducq Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Instumentarium Foundation; Paulo Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Maud Kuistila Memorial Foundation; Fulbright Center; Leona M. and Harry B. Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Glenn Foundation for Medical Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Ipsen/Biomeasure(Ipsen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Bautista for assistance with figure preparation. These studies were supported by National Institutes of Health grants CA17390, U19DK62434, DK091183, DK063491, CA014195, DK057978, HL088093, HL105278 and CA52599. M. G. R. and R. M. E. are Investigators of the Howard Hughes Medical Institute. M.T.Y.L. is supported by the University of California, San Diego Medical Scientist Training Program T32 GM007198-37, and Genetics Training Program T32 GM008666, National Institute of General Medical Sciences. M. U. K. was supported by a LeDucq Foundation Fellowship. H. P. L. was supported by the Finnish Cultural Foundation, Instumentarium Foundation, The Paulo Foundation, Paavo Nurmi Foundation, Finnish Foundation for Cardiovascular Research, The Maud Kuistila Memorial Foundation and The Fulbright Center. These studies were also supported by grants from the Leona M. and Harry B. Helmsley Charitable Trust, Samuel Waxman Cancer Research Foundation, the Glenn Foundation for Medical Research, the Ellison Medical Foundation and Ipsen/Biomeasure.	Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schanke J T, 1997, Methods Mol Biol, V67, P203; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Seth Punit P, 2008, Nucleic Acids Symp Ser (Oxf), P553, DOI 10.1093/nass/nrn280; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zamir I, 1996, MOL CELL BIOL, V16, P5458	30	397	407	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					511	+		10.1038/nature12209	http://dx.doi.org/10.1038/nature12209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728303	Green Accepted			2022-12-24	WOS:000320929400058
J	Civril, F; Deimling, T; Mann, CCD; Ablasser, A; Moldt, M; Witte, G; Hornung, V; Hopfner, KP				Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Ablasser, Andrea; Moldt, Manuela; Witte, Gregor; Hornung, Veit; Hopfner, Karl-Peter			Structural mechanism of cytosolic DNA sensing by cGAS	NATURE			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; I INTERFERON; RECOGNITION RECEPTORS; 2ND-MESSENGER; INFLAMMASOME; SURVEILLANCE; HELICASE; ADAPTER	Cytosolic DNA arising from intracellular bacterial or viral infections is a powerful pathogen-associated molecular pattern (PAMP) that leads to innate immune host defence by the production of type I interferon and inflammatory cytokines. Recognition of cytosolic DNA by the recently discovered cyclic-GMP-AMP (cGAMP) synthase (cGAS) induces the production of cGAMP to activate the stimulator of interferon genes (STING). Here we report the crystal structure of cGAS alone and in complex with DNA, ATP and GTP along with functional studies. Our results explain the broad DNA sensing specificity of cGAS, show how cGAS catalyses dinucleotide formation and indicate activation by a DNA-induced structural switch. cGAS possesses a remarkable structural similarity to the antiviral cytosolic double-stranded RNA sensor 2'-5'oligoadenylate synthase (OAS1), but contains a unique zinc thumb that recognizes B-form double-stranded DNA. Our results mechanistically unify dsRNA and dsDNA innate immune sensing by OAS1 and cGAS nucleotidyl transferases.	[Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Moldt, Manuela; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Civril, Filiz; Deimling, Tobias; Mann, Carina C. de Oliveira; Moldt, Manuela; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Ablasser, Andrea; Hornung, Veit] Univ Bonn, Univ Hosp, Unit Clin Biochem, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Munich; University of Munich; University of Bonn; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany.	hopfner@genzentrum.lmu.de	Witte, Gregor/B-4635-2011; Hornung, Veit/C-3565-2012; Hopfner, Karl-Peter/B-6864-2014	Witte, Gregor/0000-0003-0313-0962; Hornung, Veit/0000-0002-4150-194X; Hopfner, Karl-Peter/0000-0002-4528-8357; de Oliveira Mann, Carina/0000-0002-1852-9880	National Institutes of Health [U19AI083025]; European Research Council [322869]; Center for Integrated Protein Science Munich (CIPSM); DFG [3717/2-1, SFB670]; ERC [243046];  [GRK1721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Center for Integrated Protein Science Munich (CIPSM); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Butryn for comments on the manuscript. We thank the Max-Planck-Crystallization facility for initial crystal screening and the Swiss Light Source, European Synchrotron Radiation Facility and the German electron synchrotron Petra III for beam time and on-site assistance. This work was funded by the National Institutes of Health (U19AI083025), the European Research Council Advanced Grant 322869, and the Center for Integrated Protein Science Munich (CIPSM) to K.-P. H., by DFG grant 3717/2-1 to G. W., by GRK1721 to K.-P. H. and G. W., by DFG grant SFB670 and ERC grant 243046 to V. H.; C.C.O.M. is supported by GRK1721.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A., 2013, NATURE, DOI 10.1038/nature12640.; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Krug Anne, 2008, V183, P129; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Rathinam VAK, 2011, CURR OPIN VIROL, V1, P455, DOI 10.1016/j.coviro.2011.11.004; Rathinam VAK, 2011, VIROLOGY, V411, P153, DOI 10.1016/j.virol.2011.02.003; Stagno J, 2007, J MOL BIOL, V366, P882, DOI 10.1016/j.jmb.2006.11.065; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	42	432	465	8	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					332	+		10.1038/nature12305	http://dx.doi.org/10.1038/nature12305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23722159	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000320592900033
J	Diaz, JM; Hansel, CM; Voelker, BM; Mendes, CM; Andeer, PF; Zhang, T				Diaz, Julia M.; Hansel, Colleen M.; Voelker, Bettina M.; Mendes, Chantal M.; Andeer, Peter F.; Zhang, Tong			Widespread Production of Extracellular Superoxide by Heterotrophic Bacteria	SCIENCE			English	Article							IRON REDOX CHEMISTRY; HYDROGEN-PEROXIDE; GENERATION; REDUCTION; SUNLIGHT; MERCURY; OCEAN; H2O2	Superoxide and other reactive oxygen species (ROS) originate from several natural sources and profoundly influence numerous elemental cycles, including carbon and trace metals. In the deep ocean, the permanent absence of light precludes currently known ROS sources, yet ROS production mysteriously occurs. Here, we show that taxonomically and ecologically diverse heterotrophic bacteria from aquatic and terrestrial environments are a vast, unrecognized, and light-independent source of superoxide, and perhaps other ROS derived from superoxide. Superoxide production by a model bacterium within the ubiquitous Roseobacter clade involves an extracellular oxidoreductase that is stimulated by the reduced form of nicotinamide adenine dinucleotide (NADH), suggesting a surprising homology with eukaryotic organisms. The consequences of ROS cycling in immense aphotic zones representing key sites of nutrient regeneration and carbon export must now be considered, including potential control of carbon remineralization and metal bioavailability.	[Diaz, Julia M.; Hansel, Colleen M.; Mendes, Chantal M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Hansel, Colleen M.; Andeer, Peter F.; Zhang, Tong] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Voelker, Bettina M.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA	Harvard University; Woods Hole Oceanographic Institution; Colorado School of Mines	Hansel, CM (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	chansel@whoi.edu	Voelker, Bettina M/C-1815-2013	Zhang, Tong/0000-0002-8151-3697	National Science Foundation [OCE-1129594, OCE-1131734, EAR-1024817, EAR-1025077]; Radcliffe Institute for Advanced Study at Harvard University; Ford Foundation Fellowship Program	National Science Foundation(National Science Foundation (NSF)); Radcliffe Institute for Advanced Study at Harvard University; Ford Foundation Fellowship Program	This study was supported by the National Science Foundation under grants OCE-1129594, OCE-1131734, EAR-1024817, and EAR-1025077 and by the Radcliffe Institute for Advanced Study at Harvard University and the Ford Foundation Fellowship Program. We thank E. D. Ingall for manuscript comments, D. W. King for technical assistance, and the thoughtful comments of four anonymous reviewers. We also thank the following individuals for contributing bacterial isolates for analysis in this study: H. Ehrlich, D. Emerson, S. Fendorf, Y. Masue-Slowey, T. Mincer, M. A. Moran, B. Tebo, R. Belas, and A. Templeton. The GenBank accession numbers for 16S ribosomal RNA (rRNA) gene sequences generated in this study are as follows: Bacillus sp. AzsLept-1c, JX515653; Tencibaculum sp. UAzPsLept-5, JX515654; Marinobacter sp. AzsJAc-4c, JX515655; Marinobacter sp. AzsJAc-4, JX515656; Halomonas sp. VMMm1-3c, JX515657; Microbulbifer sp. HLm1-1, JX515658; Paracoccus sp. HIJAc-3c, JX515659; Alteromonas sp. BIII82, JX524853; Alteromonas sp. BIII45, JX524854; Pseudoalteromonas sp. SSW22, JX524855; Marinobacter sp. LCB-12, JX524856; Halomonas sp. LOB-22, JX524857; and Citreicella sp. LOB-21, JX524858.	Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Chen C, 2008, ECOHEALTH, V5, P399, DOI 10.1007/s10393-008-0201-1; Cooper W.J., 1989, ADV CHEM SER, P333; Croot P., 2010, OCEANS, V115; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Hansard SP, 2010, DEEP-SEA RES PT I, V57, P1111, DOI 10.1016/j.dsr.2010.05.007; Huycke MM, 2001, MOL MICROBIOL, V42, P729, DOI 10.1046/j.1365-2958.2001.02638.x; Kim D, 2000, BBA-GEN SUBJECTS, V1524, P220, DOI 10.1016/S0304-4165(00)00161-6; Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06; Kustka AB, 2005, LIMNOL OCEANOGR, V50, P1172, DOI 10.4319/lo.2005.50.4.1172; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Lin PC, 2007, J BACTERIOL, V189, P3902, DOI 10.1128/JB.01651-06; Marshall JA, 2005, MAR BIOL, V147, P533, DOI 10.1007/s00227-005-1596-7; Minibayeva FV, 2001, PROTOPLASMA, V217, P125, DOI 10.1007/BF01289421; Oda T, 1997, BIOSCI BIOTECH BIOCH, V61, P1658, DOI 10.1271/bbb.61.1658; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; PALENIK B, 1988, LIMNOL OCEANOGR, V33, P1606, DOI 10.4319/lo.1988.33.6_part_2.1606; Pullin MJ, 2004, LIMNOL OCEANOGR, V49, P2011, DOI 10.4319/lo.2004.49.6.2011; Rose AL, 2005, ENVIRON SCI TECHNOL, V39, P3708, DOI 10.1021/es048766c; Rose AL, 2008, ENVIRON SCI TECHNOL, V42, P2387, DOI 10.1021/es7024609; Rose AL, 2008, ANAL CHEM, V80, P1215, DOI 10.1021/ac7018975; Rose AL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00124; Siciliano SD, 2002, ENVIRON SCI TECHNOL, V36, P3064, DOI 10.1021/es010774v; Vermilyea AW, 2010, ENVIRON SCI TECHNOL, V44, P3066, DOI 10.1021/es100209h; Yuan JC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018439; Yuan JC, 2001, DEEP-SEA RES PT II, V48, P2947, DOI 10.1016/S0967-0645(01)00026-1; Zhang H, 2001, ENVIRON SCI TECHNOL, V35, P928, DOI 10.1021/es001521p	29	174	186	34	404	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1223	1226		10.1126/science.1237331	http://dx.doi.org/10.1126/science.1237331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23641059				2022-12-24	WOS:000319972800048
J	Ho, CY; Jaalouk, DE; Vartiainen, MK; Lammerding, J				Ho, Chin Yee; Jaalouk, Diana E.; Vartiainen, Maria K.; Lammerding, Jan			Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics	NATURE			English	Article							A-TYPE LAMINS; NUCLEAR-ENVELOPE; DILATED CARDIOMYOPATHY; TRANSCRIPTION FACTORS; MUSCLE REGENERATION; MUSCULAR-DYSTROPHY; CELL-NUCLEUS; RPEL MOTIFS; BINDING; LOCALIZATION	Laminopathies, caused by mutations in the LMNA gene encoding the nuclear envelope proteins lamins A and C, represent a diverse group of diseases that include Emery-Dreifuss muscular dystrophy (EDMD), dilated cardiomyopathy (DCM), limb-girdle muscular dystrophy, and Hutchison-Gilford progeria syndrome(1). Most LMNA mutations affect skeletal and cardiac muscle by mechanisms that remain incompletely understood. Loss of structural function and altered interaction of mutant lamins with (tissue-specific) transcription factors have been proposed to explain the tissue-specific phenotypes(1). Here we report in mice that lamin-A/C-deficient (Lmna(-/-)) and Lmna(N195K/N195K) mutant cells have impaired nuclear translocation and downstream signalling of the mechanosensitive transcription factor megakaryoblastic leukaemia 1 (MKL1), a myocardin family member that is pivotal in cardiac development and function(2). Altered nucleo-cytoplasmic shuttling of MKL1 was caused by altered actin dynamics in Lmna(-/-) and Lmna(N195K/N195K) mutant cells. Ectopic expression of the nuclear envelope protein emerin, which is mislocalized in Lmna mutant cells and also linked to EDMD and DCM, restored MKL1 nuclear translocation and rescued actin dynamics in mutant cells. These findings present a novel mechanism that could provide insight into the disease aetiology for the cardiac phenotype in many laminopathies, whereby lamin A/C and emerin regulate gene expression through modulation of nuclear and cytoskeletal actin polymerization.	[Ho, Chin Yee; Lammerding, Jan] Cornell Univ, Dept Biomed Engn, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Ho, Chin Yee; Jaalouk, Diana E.; Lammerding, Jan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Vartiainen, Maria K.] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland	Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Helsinki	Lammerding, J (corresponding author), Cornell Univ, Dept Biomed Engn, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	jan.lammerding@cornell.edu	Vartiainen, Maria K/F-4767-2013; Vartiainen, Maria/P-7043-2019; Lammerding, Jan/A-9498-2016	Vartiainen, Maria K/0000-0002-2017-0475; Vartiainen, Maria/0000-0002-2017-0475; Lammerding, Jan/0000-0003-4335-8611	National Institutes of Health [R01 NS059348, R01 HL082792]; Department of Defense Breast Cancer Idea Award [BC102152]; Progeria Research Foundation [PRF 2011-035]; American Heart Association [09POST2320042]; Academy of Finland; Sigrid Juselius Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Idea Award(United States Department of Defense); Progeria Research Foundation; American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Stewart for the mouse models and cell lines. We thank J. Gannon for TAC surgeries and M. Cupesi for collecting the cardiac samples from the pressure-overload model. This work was supported by National Institutes of Health awards (R01 NS059348 and R01 HL082792); the Department of Defense Breast Cancer Idea Award (BC102152); an award from the Progeria Research Foundation (PRF 2011-035); and a postdoctoral fellowship from the American Heart Association to D. E. J. (AHA award 09POST2320042). The work in the laboratory of M. K. V. is funded by the Academy of Finland and the Sigrid Juselius Foundation.	Cupesi M, 2010, J MOL CELL CARDIOL, V48, P1290, DOI 10.1016/j.yjmcc.2009.10.024; Fairley EAL, 1999, J CELL SCI, V112, P2571; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Hirano H, 2011, BIOCHEM BIOPH RES CO, V414, P373, DOI 10.1016/j.bbrc.2011.09.079; Ho CY, 2012, J CELL SCI, V125, P2087, DOI 10.1242/jcs.087288; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; KNOWLES GC, 1992, J HISTOCHEM CYTOCHEM, V40, P1605, DOI 10.1177/40.10.1527379; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Nikolova-Krstevski V, 2011, J MOL CELL CARDIOL, V50, P479, DOI 10.1016/j.yjmcc.2010.12.001; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rowat AC, 2006, BIOPHYS J, V91, P4649, DOI 10.1529/biophysj.106.086454; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Simon DN, 2010, NUCLEUS-PHILA, V1, P264, DOI 10.4161/nucl.1.3.11799; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042	33	314	321	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					507	+		10.1038/nature12105	http://dx.doi.org/10.1038/nature12105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644458	Green Submitted, Green Accepted			2022-12-24	WOS:000319254000052
J	Regev-Rudzki, N; Wilson, DW; Carvalho, TG; Sisquella, X; Coleman, BM; Rug, M; Bursac, D; Angrisano, F; Gee, M; Hill, AF; Baum, J; Cowman, AF				Regev-Rudzki, Neta; Wilson, Danny W.; Carvalho, Teresa G.; Sisquella, Xavier; Coleman, Bradley M.; Rug, Melanie; Bursac, Dejan; Angrisano, Fiona; Gee, Michelle; Hill, Andrew F.; Baum, Jake; Cowman, Alan F.			Cell-Cell Communication between Malaria-Infected Red Blood Cells via Exosome-like Vesicles	CELL			English	Article							PLASMODIUM-FALCIPARUM; MICROPARTICLES; MEMBRANE; PROTEINS; NANOTUBES; MECHANISM; BINDING; DIFFERENTIATION; PFEMP1; GENE	Cell-cell communication is an important mechanism for information exchange promoting cell survival for the control of features such as population density and differentiation. We determined that Plasmodium falciparum-infected red blood cells directly communicate between parasites within a population using exosome-like vesicles that are capable of delivering genes. Importantly, communication via exosome-like vesicles promotes differentiation to sexual forms at a rate that suggests that signaling is involved. Furthermore, we have identified a P. falciparum protein, PfPTP2, that plays a key role in efficient communication. This study reveals a previously unidentified pathway of P. falciparum biology critical for survival in the host and transmission to mosquitoes. This identifies a pathway for the development of agents to block parasite transmission from the human host to the mosquito.	[Regev-Rudzki, Neta; Wilson, Danny W.; Carvalho, Teresa G.; Sisquella, Xavier; Rug, Melanie; Bursac, Dejan; Angrisano, Fiona; Baum, Jake; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia; [Regev-Rudzki, Neta; Wilson, Danny W.; Carvalho, Teresa G.; Sisquella, Xavier; Rug, Melanie; Bursac, Dejan; Angrisano, Fiona; Baum, Jake; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Coleman, Bradley M.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Coleman, Bradley M.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Gee, Michelle] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia.	cowman@wehi.edu.au	Hill, Andrew F/B-4527-2009; Wilson, Danny W/E-6186-2019; Rug, Melanie/B-5417-2015; Carvalho, Teresa/P-4333-2019; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020	Hill, Andrew F/0000-0001-5581-2354; Wilson, Danny W/0000-0002-5073-1405; Carvalho, Teresa/0000-0002-4947-371X; Hill, Andrew F./0000-0001-5581-2354; Angrisano, Fiona/0000-0002-0457-5982; Baum, Jake/0000-0002-0275-352X	National Health and Medical Research Council (NHMRC) of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank the Red Cross Blood Service for erythrocytes and M. O'Neill, A. Maier, D. Dorin-Semblat, and C. Doerig for transgenic lines. We thank F. Fowkes for statistical advice and N. Dahan, M. Duffy, and J. Thompson for their advice in carrying out various assays. We thank the Advanced Microscopy Facility, Bio21 Molecular Science and Biotechnology Institute, and the Melbourne Materials Institute (MMI) for microscopy equipment. 3D-SIM was performed at the Biological Optical Microscopy Platform, University of Melbourne (http://www.microscopy.unimelb.edu.au/bomp.html). This work was supported by National Health and Medical Research Council (NHMRC) of Australia and Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. N.R.-R. is supported by a Rothschild Fellowship and the Hebrew University of Jerusalem. D.W. and N.R.-R. are supported by Early Career Fellowships from NHMRC. A.F.H. is an ARC Future Fellow and honorary NHMRC Senior Research Fellow. A.F.C. is a Howard Hughes International Scholar.	Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Ataide R., 2010, PLOS ONE, V5; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Campos FMF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-327; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; Delabranche X, 2012, MED MALADIES INFECT, V42, P335, DOI 10.1016/j.medmal.2012.05.011; DIECKMANN A, 1986, PARASITOLOGY, V93, P275, DOI 10.1017/S0031182000051441; DIECKMANNSCHUPPERT A, 1989, CELL BIOL INT REP, V13, P207, DOI 10.1016/0309-1651(89)90067-2; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; GUPTA SK, 1985, J PROTOZOOL, V32, P91, DOI 10.1111/j.1550-7408.1985.tb03020.x; Hanssen E, 2010, INT J PARASITOL, V40, P1127, DOI 10.1016/j.ijpara.2010.04.012; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Lopez MA, 2011, CURR OPIN MICROBIOL, V14, P642, DOI 10.1016/j.mib.2011.09.012; MacGregor P, 2011, CELL HOST MICROBE, V9, P310, DOI 10.1016/j.chom.2011.03.013; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; Marzo L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00072; Nantakomol D, 2011, J INFECT DIS, V203, P700, DOI 10.1093/infdis/jiq104; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reuner B, 1997, MOL BIOCHEM PARASIT, V90, P269, DOI 10.1016/S0166-6851(97)00160-6; Rupp I, 2011, CELL RES, V21, P683, DOI 10.1038/cr.2010.176; Shaw MK, 2000, J CELL SCI, V113, P1241; Sustar V, 2009, BLOOD CELL MOL DIS, V42, P223, DOI 10.1016/j.bcmd.2009.01.012; Vassella E, 1997, J CELL SCI, V110, P2661; Volz J, 2010, INT J PARASITOL, V40, P109, DOI 10.1016/j.ijpara.2009.09.002; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	42	358	372	2	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1120	1133		10.1016/j.cell.2013.04.029	http://dx.doi.org/10.1016/j.cell.2013.04.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23683579	Bronze, Green Submitted			2022-12-24	WOS:000319456800018
J	Znamenskiy, P; Zador, AM				Znamenskiy, Petr; Zador, Anthony M.			Corticostriatal neurons in auditory cortex drive decisions during auditory discrimination	NATURE			English	Article							SUPERIOR COLLICULUS; BASAL GANGLIA; SUBSTANTIA NIGRA; OVERLYING AREAS; ALBINO-RAT; IN-VIVO; STRIATUM; MICROSTIMULATION; ORGANIZATION; PERFORMANCE	The neural pathways by which information about the acoustic world reaches the auditory cortex are well characterized, but how auditory representations are transformed into motor commands is not known. Here we use a perceptual decision-making task in rats to study this transformation. We demonstrate the role of corticostriatal projection neurons in auditory decisions by manipulating the activity of these neurons in rats performing an auditory frequency-discriminationtask. Targeted channelrhodopsin-2(ChR2)(1,2)-mediated stimulation of corticostriatal neurons during the task biased decisions in the direction predicted by the frequency tuning of the stimulated neurons, whereas archaerhodopsin-3 (Arch)(3)-mediated inactivation biased decisions in the opposite direction. Striatal projections are widespread in cortex and may provide a general mechanism for the control of motor decisions by sensory cortex.	[Znamenskiy, Petr] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Znamenskiy, Petr; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136; Znamenskiy, Petr/0000-0002-4658-6807	Swartz Foundation; National Institutes of Health [25041001, 55120101]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012565, R01DC005415] Funding Source: NIH RePORTER	Swartz Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Burbach for technical assistance, A. Reid for generating the AAV-FLEX-Arch-GFP construct and members of the Kepecs laboratory (CSHL) for the tetrode and fibre drive design. We thank K. Britten for comments and suggestions on the manuscript. AAV-CAGGS-ChR2-Venus plasmid was provided by K. Svoboda. AAV-CAGGS-FLEX-ChR2-tdTomato virus was a gift from A. Kepecs. AAV-CAG-Arch-GFP plasmid was provided by E. Boyden. AAV-EF1a-FLEX-ChR2-YFP was provided by K. Deisseroth. HSV-iCre-2A-Venus and HSV-mCherry-IRES-iCre constructs were provided by A. Luthi and packaged by BioVex. This work was supported by grants from the Swartz Foundation and the National Institutes of Health (grant numbers 25041001 and 55120101).	Allen Brain Institute, 2012, ALL MOUS CONN ATL; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; BORDI F, 1993, BEHAV NEUROSCI, V107, P757, DOI 10.1037/0735-7044.107.5.757; BORDI F, 1992, J NEUROSCI, V12, P2493; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; HOPKINS DA, 1976, NEUROSCI LETT, V2, P253, DOI 10.1016/0304-3940(76)90156-7; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jiang H, 2011, J PHYSIOL-LONDON, V589, P5785, DOI 10.1113/jphysiol.2011.213553; KELLY JB, 1977, J COMP PHYSIOL PSYCH, V91, P930, DOI 10.1037/h0077356; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lilley CE, 2001, J VIROL, V75, P4343, DOI 10.1128/JVI.75.9.4343-4356.2001; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; REALE RA, 1983, NEUROSCIENCE, V8, P67, DOI 10.1016/0306-4522(83)90026-X; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142	29	204	207	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					482	+		10.1038/nature12077	http://dx.doi.org/10.1038/nature12077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23636333	Green Accepted			2022-12-24	WOS:000319254000046
J	Vilcinskas, A; Stoecker, K; Schmidtberg, H; Rohrich, CR; Vogel, H				Vilcinskas, Andreas; Stoecker, Kilian; Schmidtberg, Henrike; Roehrich, Christian R.; Vogel, Heiko			Invasive Harlequin Ladybird Carries Biological Weapons Against Native Competitors	SCIENCE			English	Article							HARMONIA-AXYRIDIS	Invasive species that proliferate after colonizing new habitats have a negative environmental and economic impact. The reason why some species become successful invaders, whereas others, even closely related species, remain noninvasive is often unclear. The harlequin ladybird Harmonia axyridis, introduced for biological pest control, has become an invader that is outcompeting indigenous ladybird species in many countries. Here, we show that Harmonia carries abundant spores of obligate parasitic microsporidia closely related to Nosema thompsoni. These microsporidia, while not harming the carrier Harmonia, are lethal pathogens for the native ladybird Coccinella septempunctata. We propose that intraguild predation, representing a major selective force among competing ladybird species, causes the infection and ultimate death of native ladybirds when they feed on microsporidia-contaminated Harmonia eggs or larvae.	[Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35392 Giessen, Germany; [Stoecker, Kilian] Bundeswehr Inst Microbiol, D-80937 Munich, Germany; [Vilcinskas, Andreas; Stoecker, Kilian; Schmidtberg, Henrike; Roehrich, Christian R.] Fraunhofer Inst Mol Biol & Appl Ecol, D-35394 Giessen, Germany; [Vogel, Heiko] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Justus Liebig University Giessen; Bundeswehr Institute of Microbiology (IMB); Fraunhofer Gesellschaft; Max Planck Society	Vilcinskas, A (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	andreas.vilcinskas@agrar.uni-giessen.de			excellence initiative of the Hessian Ministry of Science and Art via the LOEWE research focus "Insect Biotechnology"	excellence initiative of the Hessian Ministry of Science and Art via the LOEWE research focus "Insect Biotechnology"	We acknowledge project funding provided by the excellence initiative of the Hessian Ministry of Science and Art via the LOEWE research focus "Insect Biotechnology." We thank J. Rolff for critical reading and R. M. Twyman for editing of the manuscript.	Alpert P, 2006, BIOL INVASIONS, V8, P1523, DOI 10.1007/s10530-005-5844-z; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Gardiner MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023576; Kajita Y, 2010, OECOLOGIA, V163, P313, DOI 10.1007/s00442-009-1551-2; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Rohrich CR, 2012, BIOL LETTERS, V8, P308, DOI 10.1098/rsbl.2011.0760; Roy H, 2008, BIOCONTROL, V53, P1, DOI 10.1007/s10526-007-9127-8; Roy HE, 2008, BIOCONTROL, V53, P265, DOI 10.1007/s10526-007-9122-0; Vilcinskas A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2113; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Weiss Louis M., 1999, P129	12	116	124	5	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2013	340	6134					862	863		10.1126/science.1234032	http://dx.doi.org/10.1126/science.1234032			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687046				2022-12-24	WOS:000318997400043
J	Wang, HY; Yang, H; Shivalila, CS; Dawlaty, MM; Cheng, AW; Zhang, F; Jaenisch, R				Wang, Haoyi; Yang, Hui; Shivalila, Chikdu S.; Dawlaty, Meelad M.; Cheng, Albert W.; Zhang, Feng; Jaenisch, Rudolf			One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering	CELL			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; POSTNATAL-DEVELOPMENT; KNOCKOUT RATS; BACTERIA; SYSTEMS; CELLS; CAS9; TET2; ENDONUCLEASE	Mice carrying mutations in multiple genes are traditionally generated by sequential recombination in embryonic stem cells and/or time-consuming inter-crossing of mice with a single mutation. The CRISPR/Cas system has been adapted as an efficient gene-targeting technology with the potential for multiplexed genome editing. We demonstrate that CRISPR/Cas-mediated gene editing allows the simultaneous disruption of five genes (Tet1, 2, 3, Sry, Uty - 8 alleles) in mouse embryonic stem (ES) cells with high efficiency. Coinjection of Cas9 mRNA and single-guide RNAs (sgRNAs) targeting Tet1 and Tet2 into zygotes generated mice with biallelic mutations in both genes with an efficiency of 80%. Finally, we show that coinjection of Cas9 mRNA/sgRNAs with mutant oligos generated precise point mutations simultaneously in two target genes. Thus, the CRISPR/Cas system allows the one-step generation of animals carrying mutations in multiple genes, an approach that will greatly accelerate the in vivo study of functionally redundant genes and of epistatic gene interactions.	[Wang, Haoyi; Yang, Hui; Shivalila, Chikdu S.; Dawlaty, Meelad M.; Cheng, Albert W.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shivalila, Chikdu S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert W.; Jaenisch, Rudolf] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol Engn, Cambridge, MA 02139 USA; [Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Macrae, Rhiannon/AAX-1536-2020	Cheng, Albert/0000-0003-2653-5743; yang, hui/0000-0003-3590-722X	Croucher scholarship; NIH [R37-HD045022, R01-CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	Croucher scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Ruth Flannery and Kibibi Ganz for support with animal care and experiments. We thank Jaenisch lab members for helpful discussions on the manuscript. We are also grateful to G. Grant Welstead and Daniel B. Dadon for the help of editing the manuscript. M.M.D is a Damon Runyon Postdoctoral Fellow. A.W.C. is supported by a Croucher scholarship. R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics. This work was supported by NIH grants R37-HD045022 and R01-CA084198 to RJ.	Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll Dana, 2008, V435, P63, DOI 10.1007/978-1-59745-232-8_5; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Shen B., 2013, CELL RES IN PRESS; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	34	2385	2881	32	1477	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					910	918		10.1016/j.cell.2013.04.025	http://dx.doi.org/10.1016/j.cell.2013.04.025			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23643243	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000318844000018
J	Cho-Park, PF; Steller, H				Cho-Park, Park F.; Steller, Hermann			Proteasome Regulation by ADP-Ribosylation	CELL			English	Article							26S PROTEASOME; POLY(ADP-RIBOSE) POLYMERASE; STRUCTURAL BASIS; UBIQUITIN SYSTEM; ASSEMBLY PATHWAY; TELOMERE LENGTH; CDNA CLONING; TANKYRASE; PROTEIN; SUBUNIT	Protein degradation by the ubiquitin-proteasome system is central to cell homeostasis and survival. Defects in this process are associated with diseases such as cancer and neurodegenerative disorders. The 26S proteasome is a large protease complex that degrades ubiquitinated proteins. Here, we show that ADP-ribosylation promotes 26S proteasome activity in both Drosophila and human cells. We identify the ADP-ribosyltransferase tankyrase (TNKS) and the 19S assembly chaperones dp27 and dS5b as direct binding partners of the proteasome regulator PI31. TNKS-mediated ADP-ribosylation of PI31 drastically reduces its affinity for 20S proteasome alpha subunits to relieve 20S repression by PI31. Additionally, PI31 modification increases binding to and sequestration of dp27 and dS5b from 19S regulatory particles, promoting 26S assembly. Inhibition of TNKS by either RNAi or a small-molecule inhibitor, XAV939, blocks this process to reduce 26S assembly. These results unravel a mechanism of proteasome regulation that can be targeted with existing small-molecule inhibitors.	[Cho-Park, Park F.; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, Strang Lab Apoptosis & Canc Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Steller, H (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Strang Lab Apoptosis & Canc Biol, 1230 York Ave, New York, NY 10021 USA.	steller@rockefeller.edu			National Institutes of Health [RO1GM60124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	In alphabetical order, we thank J. Belote for providing fly strains; G. DeMartino, A. Goldberg, and S. Larisch for critical comments on the manuscript; S. Benjamin-Hong, O. Cho, I.B. Cho-Park, Y.A. Cho-Park, D. Ferres-Marco, N. Gandagar, T. Hsiao, A. Kelkar, L.I. Park, C. Pham, J. Rodriguez, I. Sachrai, C. Sandu, and members of our lab for valuable discussions; and J. Gee-Esposito, T. Gorenc, O. Matthew, and A. Persaud for logistical support. H.S. is an investigator of the Howard Hughes Medical Institute. This work was supported by National Institutes of Health grant RO1GM60124 to H.S.	Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Besche HC, 2009, CELL, V138, P25, DOI 10.1016/j.cell.2009.06.035; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2007, NEW ENGL J MED, V357, P1150, DOI 10.1056/NEJMcibr073962; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kurucz E, 2002, BIOCHEM J, V365, P527, DOI 10.1042/BJ20011520; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Narwal M, 2012, J MED CHEM, V55, P1360, DOI 10.1021/jm201510p; Nickell S, 2007, BIOCHEM BIOPH RES CO, V353, P115, DOI 10.1016/j.bbrc.2006.11.141; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Princiotta MF, 2001, P NATL ACAD SCI USA, V98, P513, DOI 10.1073/pnas.021132398; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Shim SM, 2012, CELL REP, V2, P603, DOI 10.1016/j.celrep.2012.07.013; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Takagi K, 2012, J BIOL CHEM, V287, P12172, DOI 10.1074/jbc.M112.345876; Tanahashi N, 1999, MOL BIOL REP, V26, P3, DOI 10.1023/A:1006909522731; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299	65	103	120	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					614	627		10.1016/j.cell.2013.03.040	http://dx.doi.org/10.1016/j.cell.2013.03.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622245	Green Accepted, Bronze			2022-12-24	WOS:000318063500014
J	Ding, N; Yu, RT; Subramaniam, N; Sherman, MH; Wilson, C; Rao, R; Leblanc, M; Coulter, S; He, MX; Scott, C; Lau, SL; Atkins, AR; Barish, GD; Gunton, JE; Liddle, C; Downes, M; Evans, RM				Ding, Ning; Yu, Ruth T.; Subramaniam, Nanthakumar; Sherman, Mara H.; Wilson, Caroline; Rao, Renuka; Leblanc, Mathias; Coulter, Sally; He, Mingxiao; Scott, Christopher; Lau, Sue L.; Atkins, Annette R.; Barish, Grant D.; Gunton, Jenny E.; Liddle, Christopher; Downes, Michael; Evans, Ronald M.			A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response	CELL			English	Article							FAT-STORING CELLS; NUCLEAR RECEPTOR; LIVER FIBROSIS; TGF-BETA; MOLECULAR-MECHANISMS; STELLATE CELLS; LYSYL OXIDASE; EXPRESSION; DISEASE; METALLOPROTEINASES	Liver fibrosis is a reversible wound-healing response involving TGF beta 1/SMAD activation of hepatic stellate cells (HSCs). It results from excessive deposition of extracellular matrix components and can lead to impairment of liver function. Here, we show that vitamin D receptor (VDR) ligands inhibit HSC activation by TGF beta 1 and abrogate liver fibrosis, whereas Vdr knockout mice spontaneously develop hepatic fibrosis. Mechanistically, we show that TGF beta 1 signaling causes a redistribution of genome-wide VDR-binding sites (VDR cistrome) in HSCs and facilitates VDR binding at SMAD3 profibrotic target genes via TGF beta 1-dependent chromatin remodeling. In the presence of VDR ligands, VDR binding to the coregulated genes reduces SMAD3 occupancy at these sites, inhibiting fibrosis. These results reveal an intersecting VDR/SMAD genomic circuit that regulates hepatic fibrogenesis and define a role for VDR as an endocrine checkpoint to modulate the wound-healing response in liver. Furthermore, the findings suggest VDR ligands as a potential therapy for liver fibrosis.	[Ding, Ning; Yu, Ruth T.; Sherman, Mara H.; Leblanc, Mathias; He, Mingxiao; Atkins, Annette R.; Barish, Grant D.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Subramaniam, Nanthakumar; Wilson, Caroline; Rao, Renuka; Coulter, Sally; Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Subramaniam, Nanthakumar; Wilson, Caroline; Rao, Renuka; Coulter, Sally; Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Scott, Christopher; Lau, Sue L.; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW 2010, Australia	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Garvan Institute of Medical Research	Downes, M (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	Evans, Ronald/AAF-4001-2019; Gunton, Jenny E/AAH-7719-2021	Evans, Ronald/0000-0002-9986-5965; Yu, Ruth/0000-0002-9527-9627; , Caroline/0000-0002-9016-6025; Atkins, Annette/0000-0003-2558-7058	Genentech Foundation; National Institutes of Health [DK057978, HL105278, DK090962, HL088093, ES010337, CA014195]; National Health and Medical Research Council of Australia [512354, 632886]; Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Ipsen/Biomeasure; Stand Up to Cancer Dream Team translational cancer research grant, a Program of the Entertainment Industry Foundation [SU2C-AACR-DT0509];  [K08HL092298]; NATIONAL CANCER INSTITUTE [P30CA060553, T32CA009370, P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093, K08HL092298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, P30DK063491, R24DK090962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	Genentech Foundation(Roche HoldingGenentech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Ipsen/Biomeasure(Ipsen); Stand Up to Cancer Dream Team translational cancer research grant, a Program of the Entertainment Industry Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Brondos and E. Ong for administrative assistance, J. Nery for assistance with DNA sequencing, C. Benner for assistance with HOMER software, and H. Juguilon and J. Alvarez for technical assistance. N.D. was supported by a postdoctoral fellowship from Genentech Foundation. G.D.B. was supported by grant K08HL092298. This work was funded by grants from the National Institutes of Health (DK057978, HL105278, DK090962, HL088093, ES010337, and CA014195) and National Health and Medical Research Council of Australia project grants 512354 and 632886 (to C.L. and M.D.), as well as by the Helmsley Charitable Trust, Samuel Waxman Cancer Research Foundation, and Ipsen/Biomeasure. R.M.E. and M.D. are supported in part by a Stand Up to Cancer Dream Team translational cancer research grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0509). R.M.E is an investigator of the Howard Hughes Medical Institute and March of Dimes chair in molecular and developmental biology at the Salk Institute.	Abramovitch S, 2011, GUT, V60, P1728, DOI 10.1136/gut.2010.234666; Agmon-Levin N, 2013, CLIN REV ALLERG IMMU, V45, P256, DOI 10.1007/s12016-012-8342-y; Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Baur K, 2012, LIVER INT, V32, P635, DOI 10.1111/j.1478-3231.2011.02674.x; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman Scott L., 1999, American Journal of Medicine, V107, p27S; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Goltzman D, 2004, J STEROID BIOCHEM, V89-90, P485, DOI 10.1016/j.jsbmb.2004.03.058; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Janssens W, 2011, VITAM HORM, V86, P379, DOI 10.1016/B978-0-12-386960-9.00017-4; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; KNOOK DL, 1982, EXP CELL RES, V139, P468, DOI 10.1016/0014-4827(82)90283-X; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Lim Lei Yuan, 2012, Curr Gastroenterol Rep, V14, P67, DOI 10.1007/s11894-011-0231-7; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Patsenker E, 2011, AM J PHYSIOL-GASTR L, V301, pG425, DOI 10.1152/ajpgi.00050.2011; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Ramagopalan SV, 2011, ANN NEUROL, V70, P881, DOI 10.1002/ana.22678; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Siegmund SV, 2005, DIGEST DIS, V23, P264, DOI 10.1159/000090174; Tanaka A, 2009, J HEPATOL, V50, P1202, DOI 10.1016/j.jhep.2009.01.015; Terrier B, 2011, J HEPATOL, V55, P756, DOI 10.1016/j.jhep.2011.01.041; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625	64	418	437	4	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					601	613		10.1016/j.cell.2013.03.028	http://dx.doi.org/10.1016/j.cell.2013.03.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622244	Green Accepted, Bronze			2022-12-24	WOS:000318063500013
J	Kettleborough, RNW; Busch-Nentwich, EM; Harvey, SA; Dooley, CM; de Bruijn, E; van Eeden, F; Sealy, I; White, RJ; Herd, C; Nijman, IJ; Fenyes, F; Mehroke, S; Scahill, C; Gibbons, R; Wali, N; Carruthers, S; Hall, A; Yen, J; Cuppen, E; Stemple, DL				Kettleborough, Ross N. W.; Busch-Nentwich, Elisabeth M.; Harvey, Steven A.; Dooley, Christopher M.; de Bruijn, Ewart; van Eeden, Freek; Sealy, Ian; White, Richard J.; Herd, Colin; Nijman, Isaac J.; Fenyes, Fruzsina; Mehroke, Selina; Scahill, Catherine; Gibbons, Richard; Wali, Neha; Carruthers, Samantha; Hall, Amanda; Yen, Jennifer; Cuppen, Edwin; Stemple, Derek L.			A systematic genome-wide analysis of zebrafish protein-coding gene function	NATURE			English	Article							EMBRYONIC STEM-CELLS; IDENTIFICATION; INACTIVATION; MUTAGENESIS; DISRUPTION; REPORTER; SCREEN	Since the publication of the human reference genome, the identities of specific genes associated with human diseases are being discovered at a rapid rate. A central problem is that the biological activity of these genes is often unclear. Detailed investigations in model vertebrate organisms, typically mice, have been essential for understanding the activities of many orthologues of these disease-associated genes. Although gene-targeting approaches(1-3) and phenotype analysis have led to a detailed understanding of nearly 6,000 protein-coding genes(3,4), this number falls considerably short of the more than 22,000 mouse protein-coding genes(5). Similarly, in zebrafish genetics, one-by-one gene studies using positional cloning(6), insertional mutagenesis(7-9), antisense morpholino oligonucleotides(10), targeted re-sequencing(11-13), and zinc finger and TAL endonucleases(14-17) have made substantial contributions to our understanding of the biological activity of vertebrate genes, but again the number of genes studied falls well short of the more than 26,000 zebrafish protein-coding genes(18). Importantly, for both mice and zebrafish, none of these strategies are particularly suited to the rapid generation of knockouts in thousands of genes and the assessment of their biological activity. Here we describe an active project that aims to identify and phenotype the disruptive mutations in every zebrafish protein-coding gene, using a well-annotated zebrafish reference genome sequence(18,19), high-throughput sequencing and efficient chemical mutagenesis. So far we have identified potentially disruptive mutations in more than 38% of all known zebrafish protein-coding genes. We have developed a multi-allelic phenotyping scheme to efficiently assess the effects of each allele during embryogenesis and have analysed the phenotypic consequences of over 1,000 alleles. All mutant alleles and data are available to the community and our phenotyping scheme is adaptable to phenotypic analysis beyond embryogenesis.	[Kettleborough, Ross N. W.; Busch-Nentwich, Elisabeth M.; Harvey, Steven A.; Dooley, Christopher M.; Sealy, Ian; White, Richard J.; Herd, Colin; Fenyes, Fruzsina; Mehroke, Selina; Scahill, Catherine; Gibbons, Richard; Wali, Neha; Carruthers, Samantha; Hall, Amanda; Yen, Jennifer; Stemple, Derek L.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [de Bruijn, Ewart; Nijman, Isaac J.; Cuppen, Edwin] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [de Bruijn, Ewart; Nijman, Isaac J.; Cuppen, Edwin] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van Eeden, Freek] Univ Sheffield, Dept Biomed Sci, MRC CDBG, Sheffield S10 2TN, S Yorkshire, England	Wellcome Trust Sanger Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Sheffield	Stemple, DL (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	e.cuppen@hubrecht.eu; ds4@sanger.ac.uk	Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; White, Richard/0000-0003-1842-412X; Stemple, Derek/0000-0002-8296-9928; Nijman, Isaac/0000-0002-1840-1158	Wellcome Trust [098051]; US National Institutes of Health [5R01HG004819]; EU Sixth Framework Programme (ZF-MODELS) [LSHG-CT-2003-503496]; EU Seventh Framework Programme (ZF-HEALTH); UK Medical Research Council [G0777791]; SmartMix program from the Dutch government [SSM06010]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004819, R01HG000481] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU Sixth Framework Programme (ZF-MODELS); EU Seventh Framework Programme (ZF-HEALTH); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SmartMix program from the Dutch government; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank P. Ellis, E. Markham, H. van Roekel, P. Toonen, J. van de Belt, J. Mudde and S. Widaa for technical assistance, and B. Novak, Y. Yi and E. LeProust from Agilent Technologies. We thank everyone at The Zebrafish International Resource Center and the European Zebrafish Resource Center for stocking and distributing alleles. We thank members of the Wellcome Trust Sanger Institute RSF and DNA pipelines. We also thank G. Powell, J. Collins and F. L. Marlow for critical reading of the manuscript. This work was funded through a core grant to the Sanger Institute by the Wellcome Trust (grant number 098051), the US National Institutes of Health (5R01HG004819), the EU Sixth Framework Programme (ZF-MODELS, contract number LSHG-CT-2003-503496) and the EU Seventh Framework Programme (ZF-HEALTH). F. v. E. is supported by the UK Medical Research Council (grant number G0777791) and E. C. is supported by the SmartMix program (SSM06010) from the Dutch government.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Driever W, 1996, DEVELOPMENT, V123, P37; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Haffter P, 1996, DEVELOPMENT, V123, P1; Howe K., NATURE IN PRESS; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kettleborough RNW, 2011, METHOD CELL BIOL, V104, P121, DOI 10.1016/B978-0-12-374814-0.00006-9; Manfroid I, 2012, DEV BIOL, V366, P268, DOI 10.1016/j.ydbio.2012.04.002; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Steffen LS, 2007, DEV BIOL, V309, P180, DOI 10.1016/j.ydbio.2007.06.015; Stemple DL, 2004, NAT REV GENET, V5, P145, DOI 10.1038/nrg1273; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	30	402	424	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					494	+		10.1038/nature11992	http://dx.doi.org/10.1038/nature11992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23594742	Green Accepted			2022-12-24	WOS:000317984400039
J	Bath, SC; Steer, CD; Golding, J; Emmett, P; Rayman, MP				Bath, Sarah C.; Steer, Colin D.; Golding, Jean; Emmett, Pauline; Rayman, Margaret P.			Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC)	LANCET			English	Article							URINARY IODINE; DEFICIENCY; SAMPLES; SUPPLEMENTATION; CHILDHOOD; DIET	Background As a component of thyroid hormones, iodine is essential for fetal brain development. Although the UK has long been considered iodine replete, increasing evidence suggests that it might now be mildly iodine deficient. We assessed whether mild iodine deficiency during early pregnancy was associated with an adverse effect on child cognitive development. Methods We analysed mother-child pairs from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort by measuring urinary iodine concentration (and creatinine to correct for urine volume) in stored samples from 1040 first-trimester pregnant women. We selected women on the basis of a singleton pregnancy and availability of both a urine sample from the first trimester (defined as <= 13 weeks' gestation; median 10 weeks [IQR 9-12]) and a measure of intelligence quotient (IQ) in the off spring at age 8 years. Women's results for iodine-to-creatinine ratio were dichotomised to less than 150 mu g/g or 150 mu g/g or more on the basis of WHO criteria for iodine deficiency or sufficiency in pregnancy. We assessed the association between maternal iodine status and child IQ at age 8 years and reading ability at age 9 years. We included 21 socioeconomic, parental, and child factors as confounders. Findings The group was classified as having mild-to-moderate iodine deficiency on the basis of a median urinary iodine concentration of 91.1 mu g/L (IQR 53.8-143; iodine-to-creatinine ratio 110 mu g/g, IQR 74-170). After adjustment for confounders, children of women with an iodine-to-creatinine ratio of less than 150 mu g/g were more likely to have scores in the lowest quartile for verbal IQ (odds ratio 1.58, 95% CI 1.09-2.30; p=0.02), reading accuracy (1.69, 1.15-2.49; p=0.007), and reading comprehension (1.54, 1.06-2.23; p=0.02) than were those of mothers with ratios of 150 mu g/g or more. When the less than 150 mu g/g group was subdivided, scores worsened ongoing from 150 mu g/g or more, to 50-150 mu g/g, to less than 50 mu g/g. Interpretation Our results show the importance of adequate iodine status during early gestation and emphasise the risk that iodine deficiency can pose to the developing infant, even in a country classified as only mildly iodine deficient. Iodine deficiency in pregnant women in the UK should be treated as an important public health issue that needs attention.	[Bath, Sarah C.; Rayman, Margaret P.] Univ Surrey, Fac Hlth & Med Sci, Dept Nutr Sci, Guildford GU2 7XH, Surrey, England; [Steer, Colin D.; Golding, Jean; Emmett, Pauline] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England	University of Surrey; University of Bristol	Rayman, MP (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Dept Nutr Sci, Guildford GU2 7XH, Surrey, England.	m.rayman@surrey.ac.uk	Emmett, Pauline/AAL-6815-2021	Golding, Jean/0000-0003-2826-3307; Bath, Sarah/0000-0001-5391-9932; Emmett, Pauline/0000-0003-1076-4779	Wassen International; Waterloo Foundation; Commission of the European Communities, Quality of Life and Management of Living Resources, within the 7th Framework Programme Nutrimenthe [FP7-212652]; US National Oceanographic and Atmospheric Administration; Wellcome Trust [092731]; Medical Research Council [G9815508] Funding Source: researchfish	Wassen International; Waterloo Foundation; Commission of the European Communities, Quality of Life and Management of Living Resources, within the 7th Framework Programme Nutrimenthe; US National Oceanographic and Atmospheric Administration; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A PhD studentship for SCB, funded by Wassen International and the Waterloo Foundation, enabled the costs of this investigation to be covered. PE was funded by Commission of the European Communities, Quality of Life and Management of Living Resources, within the 7th Framework Programme Nutrimenthe (reference FP7-212652). CDS was funded by the US National Oceanographic and Atmospheric Administration. We thank Christine Sieniawska (Trace Element Unit, Southampton University Hospital NHS Trust, UK) for analysis of urine samples, and Alex Richardson for introducing the Surrey and Bristol groups. We thank all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. The UK Medical Research Council, the Wellcome Trust (grant number 092731), and the University of Bristol provide core support for ALSPAC. MPR is the guarantor for the contents of this paper.	Andersen S, 2008, BRIT J NUTR, V99, P813, DOI 10.1017/S0007114507842292; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2007, ASS IOD DEF DIS MON; Bath S., 2008, Journal of Human Nutrition and Dietetics, V21, P379, DOI 10.1111/j.1365-277X.2008.00881_9.x; Bath S, 2010, P NUTR SOC, V69, pE483, DOI 10.1017/S0029665110003460; Bath S, 2010, P NUTR SOC, V69; Bowen E, 2005, BJOG-INT J OBSTET GY, V112, P1083, DOI 10.1111/j.1471-0528.2005.00653.x; Caldwell B.M., 1979, HOME OBSERVATION MEA; Department of Health, 1991, DIET REF VAL FOOD EN; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; *I MED FOOD NUTR B, 2001, DIET REF INT VIT A V; Jones G, 2006, J ECON GROWTH, V11, P71, DOI 10.1007/s10887-006-7407-2; Jones G, EC GROWTH; Knudsen N, 2000, EUR J CLIN NUTR, V54, P361, DOI 10.1038/sj.ejcn.1600935; Konig F, 2011, J NUTR, V141, P2049, DOI 10.3945/jn.111.144071; Lazarus JH, 2008, LANCET, V372, P888, DOI 10.1016/S0140-6736(08)61390-2; Melse-Boonstra A, 2012, J TRACE ELEM MED BIO, V26, P134, DOI 10.1016/j.jtemb.2012.03.005; Neale M. D., 1997, NEALE ANAL READING A; NHS Choices, 2009, YOUR HLTH PREGN VIT; Nunes T, 2003, SCI STUD READ, V7, P289, DOI 10.1207/S1532799XSSR0703_6; Pearce EN, 2010, J CLIN ENDOCR METAB, V95, P3207, DOI 10.1210/jc.2010-0014; Pearce EN, 2009, THYROID, V19, P919, DOI 10.1089/thy.2009.0120; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; Rasmussen LB, 1999, EUR J CLIN NUTR, V53, P401, DOI 10.1038/sj.ejcn.1600762; Rayman MP, 2008, P NUTR SOC, V67, DOI DOI 10.1017/S0029665108000736; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Rose M, 2001, J ENVIRON MONITOR, V3, P361, DOI 10.1039/b105695f; Spierto FW, 1997, CLIN CHIM ACTA, V264, P227, DOI 10.1016/S0009-8981(97)00080-6; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Vanderpump MPJ, 2011, LANCET, V377, P2007, DOI 10.1016/S0140-6736(11)60693-4; Wechsler D., 1992, WISC IIIUK WECHSLER; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751; Zimmermann M, 2004, EUR J CLIN NUTR, V58, P979, DOI 10.1038/sj.ejcn.1601933; Zimmermann MB, 2007, THYROID, V17, P829, DOI 10.1089/thy.2007.0108; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	36	463	491	16	142	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 27	2013	382	9889					331	337		10.1016/S0140-6736(13)60436-5	http://dx.doi.org/10.1016/S0140-6736(13)60436-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FT	23706508				2022-12-24	WOS:000322544900030
J	Yadlapalli, S; Yamashita, YM				Yadlapalli, Swathi; Yamashita, Yukiko M.			Chromosome-specific nonrandom sister chromatid segregation during stem-cell division	NATURE			English	Article							DROSOPHILA OOGENESIS; NUCLEAR MIGRATION; DNA METHYLATION; DOMAIN PROTEIN; GERMLINE; CENTROSOME; GENE; RETROTRANSPOSON; ENCODES; DNMT2	Adult stem cells undergo asymmetric cell division to self-renew and give rise to differentiated cells that comprise mature tissue(1). Sister chromatids may be distinguished and segregated nonrandomly in asymmetrically dividing stem cells(2), although the underlying mechanism and the purpose it may serve remain elusive. Here we develop the CO-FISH(chromosome orientation fluorescence in situ hybridization) technique(3) with single-chromosome resolution and show that sister chromatids of X and Y chromosomes, but not autosomes, are segregated nonrandomly during asymmetric divisions of Drosophila male germline stem cells. This provides the first direct evidence, to our knowledge, that two sister chromatids containing identical genetic information can be distinguished and segregated nonrandomly during asymmetric stem-cell divisions. We further show that the centrosome, SUN-KASH nuclear envelope proteins and Dnmt2 (also known as Mt2) are required for nonrandom sister chromatid segregation. Our data indicate that the information on X and Y chromosomes that enables nonrandom segregation is primed during gametogenesis in the parents. Moreover, we show that sister chromatid segregation is randomized in germline stem cell overproliferation and dedifferentiated germline stem cells. We propose that nonrandom sister chromatid segregation may serve to transmit distinct information carried on two sister chromatids to the daughters of asymmetrically dividing stem cells.	[Yadlapalli, Swathi; Yamashita, Yukiko M.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Yadlapalli, Swathi; Yamashita, Yukiko M.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Yamashita, Yukiko M.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yadlapalli, S (corresponding author), Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	swathi@umich.edu; yukikomy@umich.edu		Yamashita, Yukiko/0000-0001-5541-0216	University of Michigan (Life Sciences Institute and Office of the Provost and Executive Vice President for Academic Affairs); AHA [12PRE9630000]; NIH [1F31HD071727-01]; MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD071727] Funding Source: NIH RePORTER	University of Michigan (Life Sciences Institute and Office of the Provost and Executive Vice President for Academic Affairs); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank F. Lyko, M. Schaefer, G. Reuter, P. Zamore, A. Aravin, D. Glover, L. Cooley, J. Kim, V. Gvozdev, M. Pia Bozzetti, the Bloomington Drosophila Stock Center and the Vienna Drosophila RNAi Center for reagents and helpful information, and Yamashita laboratory members for discussions. This study was supported by the University of Michigan (Life Sciences Institute and Office of the Provost and Executive Vice President for Academic Affairs) (to Y.M.Y.) and AHA (12PRE9630000) and NIH grants (1F31HD071727-01) (to S.Y.). Y.M.Y. is supported by the MacArthur Foundation.	Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Dernburg A. F., 2000, DROSOPHILA PROTOCOLS; Falconer E, 2010, NATURE, V463, P93, DOI 10.1038/nature08644; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fung JC, 1998, J CELL BIOL, V141, P5, DOI 10.1083/jcb.141.1.5; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Makunin IV, 1999, MOL GEN GENET, V261, P381, DOI 10.1007/s004380050979; Minestrini G, 2002, J CELL SCI, V115, P725; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; Tajbakhsh S, 2009, NAT REV MOL CELL BIO, V10, P804, DOI 10.1038/nrm2784; Tulin AV, 1997, GENETICS, V146, P253; Tran V, 2012, SCIENCE, V338, P679, DOI 10.1126/science.1226028; Yadlapalli S, 2011, J CELL SCI, V124, P933, DOI 10.1242/jcs.079798; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	30	88	92	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					251	+		10.1038/nature12106	http://dx.doi.org/10.1038/nature12106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23644460	Green Accepted			2022-12-24	WOS:000320283400053
J	McLellan, JS; Chen, M; Leung, S; Graepel, KW; Du, XL; Yang, YP; Zhou, TQ; Baxa, U; Yasuda, E; Beaumont, T; Kumar, A; Modjarrad, K; Zheng, ZZ; Zhao, M; Xia, NS; Kwong, PD; Graham, BS				McLellan, Jason S.; Chen, Man; Leung, Sherman; Graepel, Kevin W.; Du, Xiulian; Yang, Yongping; Zhou, Tongqing; Baxa, Ulrich; Yasuda, Etsuko; Beaumont, Tim; Kumar, Azad; Modjarrad, Kayvon; Zheng, Zizheng; Zhao, Min; Xia, Ningshao; Kwong, Peter D.; Graham, Barney S.			Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody	SCIENCE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; F-GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; PROTEIN; INFECTION; SEQUENCE; EPITOPE; FORM	The prefusion state of respiratory syncytiat virus (RSV) fusion (F) glycoprotein is the target of most RSV-neutralizing activity in human sera, but its metastability has hindered characterization. To overcome this obstacle, we identified prefusion-specific antibodies that were substantially more potent than the prophylactic antibody palivizumab. The cocrystal structure for one of these antibodies, D25, in complex with the F glycoprotein revealed D25 to lock F in its prefusion state by binding to a quaternary epitope at the trimer apex. Electron microscopy showed that two other antibodies, AM22 and 5C4, also bound to the newly identified site of vulnerability, which we named antigenic site empty set. These studies should enable design of improved vaccine antigens and define new targets for passive prevention of RSV-induced disease,	[McLellan, Jason S.; Chen, Man; Leung, Sherman; Graepel, Kevin W.; Du, Xiulian; Yang, Yongping; Zhou, Tongqing; Kumar, Azad; Modjarrad, Kayvon; Kwong, Peter D.; Graham, Barney S.] NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Baxa, Ulrich] SAIC Frederick Inc, Electron Microscopy Lab, Adv Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Yasuda, Etsuko; Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, AIMM Therapeut, NL-1105 AZ Amsterdam, Netherlands; [Zheng, Zizheng; Zhao, Min; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen 361005, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Amsterdam; Academic Medical Center Amsterdam; Xiamen University	McLellan, JS (corresponding author), NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mclellanja@niaid.nih.gov; pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010; Kumar, Azad/AAD-2093-2020; Graham, Barney S./AAC-5898-2019	Zhou, Tongqing/0000-0002-3935-4637; Graham, Barney S./0000-0001-8112-0853; Baxa, Ulrich/0000-0002-7263-5078; Xia, Ningshao/0000-0003-0179-5266; McLellan, Jason/0000-0003-3991-542X	Intramural Research Program (National Institute of Allergy and Infectious Diseases); National Natural Science Foundation of China [81161120419]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024, ZIAAI005023, ZIAAI005061] Funding Source: NIH RePORTER	Intramural Research Program (National Institute of Allergy and Infectious Diseases); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Structural Biology Section, Structural Bioinformatics Core Section, and Viral Pathogenesis Laboratory at the Vaccine Research Center for helpful comments, and J. Chrzas, J. Gonczy, U. Chinte, and staff at SER-CAT (Southeast Regional Collaborative Access Team) for help with x-ray diffraction data collection. The data presented in this manuscript are tabulated in the main paper and supplementary materials. Atomic coordinates and structure factors of the reported crystal structures have been deposited in the Protein Data Bank under accession codes 4JHA and 4JHW. Support for this work was provided by the Intramural Research Program (National Institute of Allergy and Infectious Diseases) and the National Natural Science Foundation of China (81161120419). Use of insertion device 22 (SER-CAT) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. T.B. is an inventor on an international patent application describing the technology used to isolate D25 and AM22 (Means and methods for influencing the stability of antibody producing cells, WO2007067046A1). E.Y. and T.B. are inventors on international patent applications for antibody D25 (RSV-specific binding molecules and means for producing them, WO2008147196A2) and antibody AM22 (RSV-specific binding molecule, WO2011043643A1). J.S.M., P.D.K, and B.S.G. are inventors on a U.S. patent application describing the use of prefusion-stabilized RSV F glycoproteins as vaccine antigens (Prelusion RSV F proteins and their use, 61(798,389). J.S.M, MC., Z.Z., M.Z., N.X., and B.S.G. are inventors on a Chinese patent application for antibody 5C4 and its epitope (Anti-RSV high neutralization antibody and the peptide can be used for prevention of RSV infection and related disease, 201310082338.1).	ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Beaumont T., 2012, Patent Application, Patent No. [12/898,325, 12898325]; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Chaiwatpongsakorn S, 2011, J VIROL, V85, P3968, DOI 10.1128/JVI.01813-10; CHAMBERS P, 1992, J GEN VIROL, V73, P1717, DOI 10.1099/0022-1317-73-7-1717; Collarini EJ, 2009, J IMMUNOL, V183, P6338, DOI 10.4049/jimmunol.0901373; Connor AL, 2001, J MED VIROL, V63, P168, DOI 10.1002/1096-9071(20000201)63:2&lt;168::AID-JMV1012&gt;3.0.CO;2-U; Corvaisier C, 1997, ARCH VIROL, V142, P1073, DOI 10.1007/s007050050143; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; LOPEZ JA, 1990, J VIROL, V64, P927; Lopez JA, 1998, J VIROL, V72, P6922; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Pancera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055701; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Spits H., 2010, Patent Application, Patent No. [12/600,950, 12600950]; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; WALSH EE, 1983, J VIROL, V47, P171, DOI 10.1128/JVI.47.1.171-177.1983; Welch BD, 2012, P NATL ACAD SCI USA, V109, P16672, DOI 10.1073/pnas.1213802109; Wen XL, 2012, NAT STRUCT MOL BIOL, V19, P461, DOI 10.1038/nsmb.2250; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wu H, 2007, J MOL BIOL, V368, P652, DOI 10.1016/j.jmb.2007.02.024; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	34	475	558	8	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1113	1117		10.1126/science.1234914	http://dx.doi.org/10.1126/science.1234914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23618766	Green Accepted			2022-12-24	WOS:000319664500049
J	Chung, K; Wallace, J; Kim, SY; Kalyanasundaram, S; Andalman, AS; Davidson, TJ; Mirzabekov, JJ; Zalocusky, KA; Mattis, J; Denisin, AK; Pak, S; Bernstein, H; Ramakrishnan, C; Grosenick, L; Gradinaru, V; Deisseroth, K				Chung, Kwanghun; Wallace, Jenelle; Kim, Sung-Yon; Kalyanasundaram, Sandhiya; Andalman, Aaron S.; Davidson, Thomas J.; Mirzabekov, Julie J.; Zalocusky, Kelly A.; Mattis, Joanna; Denisin, Aleksandra K.; Pak, Sally; Bernstein, Hannah; Ramakrishnan, Charu; Grosenick, Logan; Gradinaru, Viviana; Deisseroth, Karl			Structural and molecular interrogation of intact biological systems	NATURE			English	Article							MOUSE-BRAIN; FLUORESCENT PROTEINS; NERVOUS-SYSTEM; SELF-AVOIDANCE; TOMOGRAPHY; MICROSCOPY; LOCALIZATION; ORGANIZATION; ARCHITECTURE; CONNECTOME	Obtaining high-resolution information from a complex system, while maintaining the global perspective needed to understand system function, represents a key challenge in biology. Here we address this challenge with a method (termed CLARITY) for the transformation of intact tissue into a nanoporous hydrogel-hybridized form (crosslinked to a three-dimensional network of hydrophilic polymers) that is fully assembled but optically transparent and macromolecule-permeable. Using mouse brains, we show intact-tissue imaging of long-range projections, local circuit wiring, cellular relationships, subcellular structures, protein complexes, nucleic acids and neurotransmitters. CLARITY also enables intact-tissue in situ hybridization, immunohistochemistry with multiple rounds of staining and de-staining in non-sectioned tissue, and antibody labelling throughout the intact adult mouse brain. Finally, we show that CLARITY enables fine structural analysis of clinical samples, including non-sectioned human tissue from a neuropsychiatric-disease setting, establishing a path for the transmutation of human tissue into a stable, intact and accessible form suitable for probing structural and molecular underpinnings of physiological function and disease.	[Chung, Kwanghun; Wallace, Jenelle; Kim, Sung-Yon; Andalman, Aaron S.; Davidson, Thomas J.; Mirzabekov, Julie J.; Zalocusky, Kelly A.; Mattis, Joanna; Denisin, Aleksandra K.; Pak, Sally; Bernstein, Hannah; Ramakrishnan, Charu; Grosenick, Logan; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chung, Kwanghun; Kalyanasundaram, Sandhiya; Andalman, Aaron S.; Davidson, Thomas J.; Zalocusky, Kelly A.; Gradinaru, Viviana; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Andalman, Aaron S/C-7694-2011; Chung, Kwanghun/H-7714-2014; Denisin, Aleksandra/N-4715-2018; Kim, Sung-Yon/AAO-8405-2020	Chung, Kwanghun/0000-0002-8167-3340; Denisin, Aleksandra/0000-0002-4262-9371; Kim, Sung-Yon/0000-0003-0791-7308; Mattis, Joanna/0000-0003-0341-1270; Bernstein, Hannah/0000-0002-6512-1378; Ramakrishnan, Charu/0000-0002-3474-6332; Wallace, Jenelle/0000-0002-9565-2751	National Institutes of Health (NIH) from NIMH [TR01]; NSF; Simons Foundation; Stanford University; NIDA; DARPA REPAIR program; Wiegers Foundation; Snyder Foundation; Reeves Foundation; Gatsby Foundation; Yu Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface; Samsung Scholarship; Helen Hay Whitney Foundation; NSF Graduate Research Fellowship; NIH MSTP; Deisseroth laboratory; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA035377, R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from NIMH; NSF(National Science Foundation (NSF)); Simons Foundation; Stanford University(Stanford University); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR program; Wiegers Foundation; Snyder Foundation; Reeves Foundation; Gatsby Foundation; Yu Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Samsung Scholarship(Samsung); Helen Hay Whitney Foundation; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deisseroth laboratory; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a National Institutes of Health (NIH) Director's Transformative Research Award (TR01) to K. D. from NIMH, as well as by NSF, the Simons Foundation, and the President and Provost of Stanford University. K. D. is also funded by NIDA, the DARPA REPAIR program, and the Wiegers, Snyder, Reeves, Gatsby, and Yu Foundations. K. C. is supported by the Burroughs Wellcome Fund Career Award at the Scientific Interface. S.-Y.K. is supported by a Samsung Scholarship, A. S. A. by the Helen Hay Whitney Foundation, K.A.Z. and A. K. D. by an NSF Graduate Research Fellowship and J.M. by the NIH MSTP. We acknowledge H. Vogel, L. Luo, L. Schwarz, M. Monje, S. Hestrin and D. Castaneda for advice, and the Autism Tissue Program for providing human brain tissue, as well as J. J. Perrino, J. Mulholland and the Cell Sciences Imaging Facility at Stanford for electron microscopy imaging and advice. We would also like to thank the entire Deisseroth laboratory for discussions and support. CLARITY resources and protocols are freely supported online (http://CLARITYresourcecenter.org).	Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Botcherby EJ, 2012, P NATL ACAD SCI USA, V109, P2919, DOI 10.1073/pnas.1111662109; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chen XB, 2008, P NATL ACAD SCI USA, V105, P4453, DOI 10.1073/pnas.0800897105; Cheng CM, 1998, J NEUROSCI, V18, P5673; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Drobizhev M, 2011, NAT METHODS, V8, P393, DOI [10.1038/NMETH.1596, 10.1038/nmeth.1596]; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GOLDENTHAL KL, 1985, J HISTOCHEM CYTOCHEM, V33, P813, DOI 10.1177/33.8.3894499; GROSSFELD RM, 1971, J NEUROCHEM, V18, P2265, DOI 10.1111/j.1471-4159.1971.tb00183.x; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Kasthuri N, 2007, NAT METHODS, V4, P307, DOI 10.1038/nmeth0407-307; KOLODZIEJCZYK E, 1986, J HISTOCHEM CYTOCHEM, V34, P1725, DOI 10.1177/34.12.3023476; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Macdonald R, 1999, METH MOL B, V127, P77, DOI 10.1385/1-59259-678-9:77; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; TRAMU G, 1978, J HISTOCHEM CYTOCHEM, V26, P322, DOI 10.1177/26.4.207771; Wahlby C, 2002, CYTOMETRY, V47, P32, DOI 10.1002/cyto.10026; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	46	1271	1374	34	764	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					332	+		10.1038/nature12107	http://dx.doi.org/10.1038/nature12107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23575631	Green Accepted			2022-12-24	WOS:000318952000030
J	Mukherji, A; Kobiita, A; Ye, T; Chambon, P				Mukherji, Atish; Kobiita, Ahmad; Ye, Tao; Chambon, Pierre			Homeostasis in Intestinal Epithelium Is Orchestrated by the Circadian Clock and Microbiota Cues Transduced by TLRs	CELL			English	Article							REV-ERB-ALPHA; GLUCOCORTICOID-RECEPTOR; GUT MICROBIOTA; C-JUN; METABOLISM; EXPRESSION; RECOGNITION; REPRESSION; COMPONENTS; ADIPOSITY	Alterations of symbiosis between microbiota and intestinal epithelial cells (IEC) are associated with intestinal and systemic pathologies. Interactions between bacterial products (MAMPs) and Toll-like receptors (TLRs) are known to be mandatory for IEC homeostasis, but how TLRs may time homeostatic functions with circadian changes is unknown. Our functional and molecular dissections of the IEC circadian clock demonstrate that its integrity is required for microbiota-IEC dialog. In IEC, the antiphasic expression of the ROR alpha activator and RevErb alpha repressor clock output regulators generates a circadian rhythmic TLR expression that converts the temporally arrhythmic microbiota signaling into circadian rhythmic JNK and IKK beta activities, which prevents RevErba activation by PPAR alpha that would disrupt the circadian clock. Moreover, through activation of AP1 and NF-kappa B, these activities, together with ROR alpha and RevErb alpha, enable timing homeostatic functions of numerous genes with IEC circadian events. Interestingly, microbiota signaling deficiencies induce a prediabetic syndrome due to ileal corticosterone overproduction consequent to clock disruption.	[Mukherji, Atish; Kobiita, Ahmad; Ye, Tao; Chambon, Pierre] Univ Strasbourg, Coll France, CNRS,UMR7104,Inserm,U964, Inst Genet & Biol Mol & Cellulaire,Inst Etud Avan, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chambon, P (corresponding author), Univ Strasbourg, Coll France, CNRS,UMR7104,Inserm,U964, Inst Genet & Biol Mol & Cellulaire,Inst Etud Avan, F-67404 Illkirch Graffenstaden, France.	chambon@igbmc.fr			CNRS; INSERM; ANR [ANR 07-Physio 002-01]; University of Strasbourg Institute for Advanced Studies (USIAS); Association pour la Recherche a l'IGBMC (ARI); ARI fellowships	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); University of Strasbourg Institute for Advanced Studies (USIAS); Association pour la Recherche a l'IGBMC (ARI); ARI fellowships	We thank Dr. Daniel Metzger for discussions, Dr. Patricia Lopez (CDTA) for GF mice, and Mrs. Estelle Meyer for secretariat help. We are grateful to Marie-France Champy (ICS) for metabolism analysis, and Armelle Van Es for bacterial scoring. We are grateful to S. Akira for floxed MyD88 mice. We also thank the staff of the animal facilities of the IGBMC/ICS. This work was supported by the CNRS, the INSERM, the ANR (ANR 07-Physio 002-01), the University of Strasbourg Institute for Advanced Studies (USIAS), and the Association pour la Recherche a l'IGBMC (ARI). A.M. and A.K. were supported by ARI fellowships.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; Cross HS, 2011, MOL CELL ENDOCRINOL, V347, P70, DOI 10.1016/j.mce.2011.07.022; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Drosatos K, 2011, J BIOL CHEM, V286, P36331, DOI 10.1074/jbc.M111.272146; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Froy O, 2007, MOL IMMUNOL, V44, P1954, DOI 10.1016/j.molimm.2006.09.026; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	42	337	354	1	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					812	827		10.1016/j.cell.2013.04.020	http://dx.doi.org/10.1016/j.cell.2013.04.020			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663780	Bronze			2022-12-24	WOS:000318844000011
J	Zhang, Y; Zhang, QY; Kong, HH; Jiang, YP; Gao, YW; Deng, GH; Shi, JZ; Tian, GB; Liu, LL; Liu, JX; Guan, YT; Bu, ZG; Chen, HL				Zhang, Ying; Zhang, Qianyi; Kong, Huihui; Jiang, Yongping; Gao, Yuwei; Deng, Guohua; Shi, Jianzhong; Tian, Guobin; Liu, Liling; Liu, Jinxiong; Guan, Yuntao; Bu, Zhigao; Chen, Hualan			H5N1 Hybrid Viruses Bearing 2009/H1N1 Virus Genes Transmit in Guinea Pigs by Respiratory Droplet	SCIENCE			English	Article							INFLUENZA-A VIRUS; AVIAN FLU TRANSMISSION; H1N1 2009 VIRUS; RECEPTOR SPECIFICITY; MAMMALIAN HOST; MOUSE MODEL; HEMAGGLUTININ; FERRETS; HUMANS; ORIGIN	In the past, avian influenza viruses have crossed species barriers to trigger human pandemics by reassorting with mammal-infective viruses in intermediate livestock hosts. H5N1 viruses are able to infect pigs, and some of them have affinity for the mammalian type alpha-2,6-linked sialic acid airway receptor. Using reverse genetics, we systematically created 127 reassortant viruses between a duck isolate of H5N1, specifically retaining its hemagglutinin (HA) gene throughout, and a highly transmissible, human-infective H1N1 virus. We tested the virulence of the reassortants in mice as a correlate for virulence in humans and tested transmissibility in guinea pigs, which have both avian and mammalian types of airway receptor. Transmission studies showed that the H1N1 virus genes encoding acidic polymerase and nonstructural protein made the H5N1 virus transmissible by respiratory droplet between guinea pigs without killing them. Further experiments implicated other H1N1 genes in the enhancement of mammal-to-mammal transmission, including those that encode nucleoprotein, neuraminidase, and matrix, as well as mutations in H5 HA that improve affinity for humanlike airway receptors. Hence, avian H5N1 subtype viruses do have the potential to acquire mammalian transmissibility by reassortment in current agricultural scenarios.	[Zhang, Ying; Zhang, Qianyi; Kong, Huihui; Jiang, Yongping; Gao, Yuwei; Deng, Guohua; Shi, Jianzhong; Tian, Guobin; Liu, Liling; Liu, Jinxiong; Guan, Yuntao; Bu, Zhigao; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Zhang, Qianyi; Chen, Hualan] Gansu Agr Univ, Coll Vet Med, Lanzhou 730030, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Gansu Agricultural University	Chen, HL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.	chenhualan@caas.cn			National Natural Science Foundation of China [30825032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank S. Watson for editing the manuscript, Y. Shu of the China Centers for Disease Control and Prevention for providing the 2009/H1N1 virus A/Sichuan/1/2009, and the Consortium for Functional Glycomics (Department of Molecular Biology, Scripps Research Institute) for providing the glycans. Supported by National Natural Science Foundation of China grant 30825032. Virus sequence data from this study were deposited in GISAID with accession numbers EPI1431518 to EPI1432533 and EPI438129 to EPI438136.	Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; Fouchier RAM, 2012, NATURE, V481, P443, DOI 10.1038/481443a; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Sreta D, 2010, EMERG INFECT DIS, V16, P1587, DOI 10.3201/eid1610.100665; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Yan JH, 2012, EMERG INFECT DIS, V18, P357, DOI 10.3201/eid1802.111346; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12; Zhu QY, 2008, J VIROL, V82, P220, DOI 10.1128/JVI.00978-07; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	40	170	189	5	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1459	1463		10.1126/science.1229455	http://dx.doi.org/10.1126/science.1229455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23641061				2022-12-24	WOS:000320647000044
J	Ravassard, P; Kees, A; Willers, B; Ho, D; Aharoni, D; Cushman, J; Aghajan, ZM; Mehta, MR				Ravassard, Pascal; Kees, Ashley; Willers, Bernard; Ho, David; Aharoni, Daniel; Cushman, Jesse; Aghajan, Zahra M.; Mehta, Mayank R.			Multisensory Control of Hippocampal Spatiotemporal Selectivity	SCIENCE			English	Article							THETA-RHYTHM; PLACE CELLS; VIRTUAL NAVIGATION; ENTORHINAL CORTEX; PHASE PRECESSION; RAT HIPPOCAMPUS; UNIT-ACTIVITY; SPATIAL MAP; GRID CELLS; INTERFERENCE	The hippocampal cognitive map is thought to be driven by distal visual cues and self-motion cues. However, other sensory cues also influence place cells. Hence, we measured rat hippocampal activity in virtual reality (VR), where only distal visual and nonvestibular self-motion cues provided spatial information, and in the real world (RW). In VR, place cells showed robust spatial selectivity; however, only 20% were track active, compared with 45% in the RW. This indicates that distal visual and nonvestibular self-motion cues are sufficient to provide selectivity, but vestibular and other sensory cues present in RW are necessary to fully activate the place-cell population. In addition, bidirectional cells preferentially encoded distance along the track in VR, while encoding absolute position in RW. Taken together, these results suggest the differential contributions of these sensory cues in shaping the hippocampal population code. Theta frequency was reduced, and its speed dependence was abolished in VR, but phase precession was unaffected, constraining mechanisms governing both hippocampal theta oscillations and temporal coding. These results reveal cooperative and competitive interactions between sensory cues for control over hippocampal spatiotemporal selectivity and theta rhythm.	[Ravassard, Pascal; Kees, Ashley; Willers, Bernard; Ho, David; Aharoni, Daniel; Cushman, Jesse; Aghajan, Zahra M.; Mehta, Mayank R.] Univ Calif Los Angeles, WM Keck Ctr Neurophys, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Ravassard, Pascal; Kees, Ashley; Willers, Bernard; Ho, David; Aharoni, Daniel; Cushman, Jesse; Aghajan, Zahra M.; Mehta, Mayank R.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Ravassard, Pascal; Willers, Bernard; Aharoni, Daniel; Cushman, Jesse; Aghajan, Zahra M.; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Kees, Ashley; Ho, David; Mehta, Mayank R.] Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mehta, MR (corresponding author), Univ Calif Los Angeles, WM Keck Ctr Neurophys, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA.	mayankmehta@ucla.edu		Kees, Ashley/0000-0002-1611-2803; Aharoni, Daniel/0000-0003-4931-8514; Mehta, Mayank/0000-0003-2005-2468; M. Aghajan, Zahra/0000-0003-4245-3975; Ravassard, Pascal/0000-0002-7500-3623	NSF; NIH [5R01MH092925-02]; W. M. Keck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NSF Career award and grants from NIH 5R01MH092925-02 and the W. M. Keck foundation. These findings were presented as two abstracts and posters at the Society for Neuroscience Meeting entitled: P. Ravassard, B. Willers, A. L. Kees, D. Ho, D. Aharoni, M. R. Mehta, "Directional tuning of place cells in rats performing a virtual landmark navigation task," Soc. Neurosci. Abs. no. 812.05 (2012); and A. Kees, B. Willers, P. M. Ravassard, D. Ho, D. Aharoni, M. R. Mehta, "Hippocampal rate and temporal codes in a virtual visual navigation task," Soc. Neurosci. Abs. no. 812.07 (2012). We thank L. Acharya, Z. Chen, and J. Moore for technical help. Author contributions: P. R., A. K., D. H., and J. C. performed data collection; B. W. and D. A. A. developed the virtual reality system; B. W. and Z. M. A. performed analysis; P. R., A. K., B. W., and Z. M. A. wrote the manuscript; P. R., A. K., B. W., D. H., D. A. A., and J.C.	Battaglia FP, 2004, J NEUROSCI, V24, P4541, DOI 10.1523/JNEUROSCI.4896-03.2004; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hahn TTG, 2012, NAT NEUROSCI, V15, P1531, DOI 10.1038/nn.3236; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Itskov PM, 2012, J NEUROPHYSIOL, V107, P1822, DOI 10.1152/jn.00404.2011; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Resnik E, 2012, J NEUROSCI, V32, P8952, DOI 10.1523/JNEUROSCI.6460-11.2012; Russell NA, 2006, J NEUROPHYSIOL, V96, P4, DOI 10.1152/jn.00953.2005; Save E, 2000, HIPPOCAMPUS, V10, P64, DOI 10.1002/(SICI)1098-1063(2000)10:1<64::AID-HIPO7>3.3.CO;2-P; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; YOUNG BJ, 1994, J NEUROSCI, V14, P6553	31	182	188	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1342	1346		10.1126/science.1232655	http://dx.doi.org/10.1126/science.1232655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23641063	Green Accepted			2022-12-24	WOS:000320320200048
J	Ibarra-Laclette, E; Lyons, E; Hernandez-Guzman, G; Perez-Torres, CA; Carretero-Paulet, L; Chang, TH; Lan, TY; Welch, AJ; Juarez, MJA; Simpson, J; Fernandez-Cortes, A; Arteaga-Vazquez, M; Gongora-Castillo, E; Acevedo-Hernandez, G; Schuster, SC; Himmelbauer, H; Minoche, AE; Xu, S; Lynch, M; Oropeza-Aburto, A; Cervantes-Perez, SA; Ortega-Estrada, MD; Cervantes-Luevano, JI; Michael, TP; Mockler, T; Bryant, D; Herrera-Estrella, A; Albert, VA; Herrera-Estrella, L				Ibarra-Laclette, Enrique; Lyons, Eric; Hernandez-Guzman, Gustavo; Anahi Perez-Torres, Claudia; Carretero-Paulet, Lorenzo; Chang, Tien-Hao; Lan, Tianying; Welch, Andreanna J.; Abraham Juarez, Maria Jazmin; Simpson, June; Fernandez-Cortes, Araceli; Arteaga-Vazquez, Mario; Gongora-Castillo, Elsa; Acevedo-Hernandez, Gustavo; Schuster, Stephan C.; Himmelbauer, Heinz; Minoche, Andre E.; Xu, Sen; Lynch, Michael; Oropeza-Aburto, Araceli; Alan Cervantes-Perez, Sergio; de Jesus Ortega-Estrada, Maria; Israel Cervantes-Luevano, Jacob; Michael, Todd P.; Mockler, Todd; Bryant, Douglas; Herrera-Estrella, Alfredo; Albert, Victor A.; Herrera-Estrella, Luis			Architecture and evolution of a minute plant genome	NATURE			English	Article							BLADDERWORT UTRICULARIA; ARABIDOPSIS; SEQUENCE; SIZE; LENTIBULARIACEAE; IDENTIFICATION; GENES	It has been argued that the evolution of plant genome size is principally unidirectional and increasing owing to the varied action of whole-genome duplications (WGDs) and mobile element proliferation(1). However, extreme genome size reductions have been reported in the angiosperm family tree. Here we report the sequence of the 82-megabase genome of the carnivorous bladderwort plant Utricularia gibba. Despite its tiny size, the U. gibba genome accommodates a typical number of genes for a plant, with the main difference from other plant genomes arising from a drastic reduction in non-genic DNA. Unexpectedly, we identified at least three rounds of WGD in U. gibba since common ancestry with tomato (Solanum) and grape (Vitis). The compressed architecture of the U. gibba genome indicates that a small fraction of intergenic DNA, with few or no active retrotransposons, is sufficient to regulate and integrate all the processes required for the development and reproduction of a complex organism.	[Ibarra-Laclette, Enrique; Hernandez-Guzman, Gustavo; Anahi Perez-Torres, Claudia; Fernandez-Cortes, Araceli; Oropeza-Aburto, Araceli; Alan Cervantes-Perez, Sergio; de Jesus Ortega-Estrada, Maria; Israel Cervantes-Luevano, Jacob; Herrera-Estrella, Alfredo; Herrera-Estrella, Luis] CINVESTAV, Lab Nacl Genom Biodiversidad LANGEBI, Guanajuato 36821, Mexico; [Lyons, Eric] Univ Arizona, Sch Plant Sci & iPlant Collaborat, Tucson, AZ 85721 USA; [Hernandez-Guzman, Gustavo] Univ Guanajuato, Dept Alimentos, Div Ciencias Vida, Guanajuato 36500, Mexico; [Carretero-Paulet, Lorenzo; Chang, Tien-Hao; Lan, Tianying; Welch, Andreanna J.; Albert, Victor A.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Lan, Tianying] Chongqing Univ Sci & Technol, Dept Biol, Chongqing 4000042, Peoples R China; [Abraham Juarez, Maria Jazmin; Simpson, June] CINVESTAV, Dept Genet, Unidad Irapuato, Guanajuato 36821, Mexico; [Arteaga-Vazquez, Mario] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada, Xalapa 91090, Veracruz, Mexico; [Gongora-Castillo, Elsa] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Acevedo-Hernandez, Gustavo] Univ Guadalajara, Ctr Univ Cienega, Ocotlan 47840, Jalisco, Mexico; [Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Himmelbauer, Heinz; Minoche, Andre E.] CRG, Barcelona 08003, Spain; [Himmelbauer, Heinz; Minoche, Andre E.] UPF, Barcelona 08018, Spain; [Minoche, Andre E.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Xu, Sen; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Michael, Todd P.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, Piscataway, NJ 08854 USA; [Mockler, Todd; Bryant, Douglas] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Arizona; Universidad de Guanajuato; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Chongqing University of Science & Technology; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Veracruzana; Michigan State University; Universidad de Guadalajara; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Max Planck Society; Indiana University System; Indiana University Bloomington; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Donald Danforth Plant Science Center	Albert, VA (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	vaalbert@buffalo.edu; lherrera@langebio.cinvestav.mx	Herrera-Estrella, Luis/AAL-2472-2020; Herrera-Estrella, Alfredo/J-8210-2019; Herrera-Estrella, Alfredo/F-3185-2011; Arteaga-Vazquez, Mario Alberto/AAB-7979-2022; Cervantes-Pérez, Sergio Alan/AAQ-6317-2021; Góngora-Castillo, Elsa B/R-8854-2016; Acevedo-Hernandez, Gustavo J./D-5745-2011; Simpson, June/I-1057-2012; Abraham-Juarez, Maria Jazmin/AAG-2539-2020; Carretero-Paulet, Lorenzo/Z-2744-2019; Herrera-Estrella, Luis/ABC-7431-2020; Oropeza-Aburto, Araceli/ABD-1331-2020; Mockler, Todd C/L-2609-2013; Cervantes-Pérez, Sergio Alan/AAD-2822-2019; Arteaga-Vazquez, Mario/M-1545-2019	Herrera-Estrella, Luis/0000-0001-7936-3856; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Arteaga-Vazquez, Mario Alberto/0000-0002-9435-0049; Góngora-Castillo, Elsa B/0000-0001-6327-6993; Acevedo-Hernandez, Gustavo J./0000-0002-3959-9220; Simpson, June/0000-0002-1891-4914; Abraham-Juarez, Maria Jazmin/0000-0002-5468-8176; Carretero-Paulet, Lorenzo/0000-0001-6697-827X; Oropeza-Aburto, Araceli/0000-0002-1222-906X; Mockler, Todd C/0000-0002-0462-5775; Hernandez-Guzman, Gustavo/0000-0002-3686-8122; Xu, Sen/0000-0002-1304-9968; Lyons, Eric/0000-0002-3348-8845; Michael, Todd/0000-0001-6272-2875; Himmelbauer, Heinz/0000-0001-8897-2928	CONACyT (Mexico) [4367]; College of Arts and Sciences, University at Buffalo; NSF [0922742]; CONACyT (Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0922742] Funding Source: National Science Foundation	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); College of Arts and Sciences, University at Buffalo; NSF(National Science Foundation (NSF)); CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank I. Bravo-Carmona for growing plants for this research. We also thank T. Mailund for discussion and critical comments on the manuscript, M. Stanke and K. Hoff for their assistance in the use of AUGUSTUS software, and P. Guzman-Villate for providing the cell suspension used for transient expression assays. Special thanks goes to the members of the 'laboratorio de servicios genomicos' of LANGEBIO, CINVESTAV for sequencing services and their help. This research was supported by CONACyT (Mexico) via general support to LANGEBIO, HHMI grant 4367 (to L. H.-E.), the College of Arts and Sciences, University at Buffalo (to V. A. A.), and the NSF (0922742 to V. A. A.). E. I.-L. is indebted to CONACyT (Mexico) for a PhD fellowship. We acknowledge the US Department of Energy Joint Genome Institute for Mimulus data (available at http://www.phytozome.net/mimulus).	Aagaard JE, 2005, AM J BOT, V92, P1284, DOI 10.3732/ajb.92.8.1284; Albert VA, 2010, J EXP BOT, V61, P5, DOI 10.1093/jxb/erp349; Assis R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002508; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Ibarra-Laclette E, 2011, PLANT SIGNAL BEHAV, V6, P1631, DOI 10.4161/psb.6.11.17657; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kibriya S, 2007, FRESHWATER BIOL, V52, P500, DOI 10.1111/j.1365-2427.2006.01719.x; Kirik A, 2000, EMBO J, V19, P5562, DOI 10.1093/emboj/19.20.5562; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Nam K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002680; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Plachno BJ, 2010, PROTOPLASMA, V239, P69, DOI 10.1007/s00709-009-0084-1; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Taylor P, 1989, GENUS UTRICULARIA TA; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409	25	227	232	5	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					94	+		10.1038/nature12132	http://dx.doi.org/10.1038/nature12132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23665961	Green Accepted, hybrid, Green Submitted			2022-12-24	WOS:000319947800040
J	Phillips-Cremins, JE; Sauria, MEG; Sanyal, A; Gerasimova, TI; Lajoie, BR; Bell, JSK; Ong, CT; Hookway, TA; Guo, CY; Sun, YH; Bland, MJ; Wagstaff, W; Dalton, S; McDevitt, TC; Sen, RJ; Dekker, J; Taylor, J; Corces, VG				Phillips-Cremins, Jennifer E.; Sauria, Michael E. G.; Sanyal, Amartya; Gerasimova, Tatiana I.; Lajoie, Bryan R.; Bell, Joshua S. K.; Ong, Chin-Tong; Hookway, Tracy A.; Guo, Changying; Sun, Yuhua; Bland, Michael J.; Wagstaff, William; Dalton, Stephen; McDevitt, Todd C.; Sen, Ranjan; Dekker, Job; Taylor, James; Corces, Victor G.			Architectural Protein Subclasses Shape 3D Organization of Genomes during Lineage Commitment	CELL			English	Article							CHROMATIN CONFORMATION; NUCLEAR ARCHITECTURE; GENE-EXPRESSION; CTCF; TRANSCRIPTION; MEDIATOR; BINDING; PLURIPOTENT; PRINCIPLES; PROXIMITY	Understanding the topological configurations of chromatin may reveal valuable insights into how the genome and epigenome act in concert to control cell fate during development. Here, we generate high-resolution architecture maps across seven genomic loci in embryonic stem cells and neural progenitor cells. We observe a hierarchy of 3D interactions that undergo marked reorganization at the submegabase scale during differentiation. Distinct combinations of CCCTC-binding factor (CTCF), Mediator, and cohesin show widespread enrichment in chromatin interactions at different length scales. CTCF/cohesin anchor long-range constitutive interactions that might form the topological basis for invariant subdomains. Conversely, Mediator/cohesin bridge short-range enhancer-promoter interactions within and between larger subdomains. Knockdown of Smc1 or Med12 in embryonic stem cells results in disruption of spatial architecture and downregulation of genes found in cohesin-mediated interactions. We conclude that cell-type-specific chromatin organization occurs at the submegabase scale and that architectural proteins shape the genome in hierarchical length scales.	[Phillips-Cremins, Jennifer E.; Sauria, Michael E. G.; Bell, Joshua S. K.; Ong, Chin-Tong; Bland, Michael J.; Wagstaff, William; Taylor, James; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Sauria, Michael E. G.; Taylor, James] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA; [Gerasimova, Tatiana I.; Guo, Changying; Sen, Ranjan] NIA, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Sun, Yuhua; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Phillips-Cremins, Jennifer E.; Sanyal, Amartya; Lajoie, Bryan R.; Dekker, Job] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Phillips-Cremins, Jennifer E.; Sanyal, Amartya; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Georgia; University of Georgia; University System of Georgia; Georgia Institute of Technology; University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Program Syst Biol, Worcester, MA 01605 USA.	job.dekker@umassmed.edu; james.taylor@emory.edu; vcorces@emory.edu	Hookway, Tracy/P-7674-2019; Taylor, James/F-1026-2011; 孙, 玉华/AAS-2506-2020; chang-ying, guo/F-2770-2018; Sun, Yuhua/J-7547-2013; SANYAL, AMARTYA/D-7240-2015	Hookway, Tracy/0000-0003-2781-0911; Taylor, James/0000-0001-5079-840X; 孙, 玉华/0000-0001-7902-9022; SANYAL, AMARTYA/0000-0002-2109-4478; Dalton, Stephen/0000-0002-3450-1263; Sauria, Michael/0000-0001-5556-9446; Corces, Victor/0000-0001-5140-4337; Ong, Chin-Tong/0000-0002-5450-4760; Phillips-Cremins, Jennifer/0000-0002-4702-0450	National Institute of General Medical Sciences of the NIH [R01GM035463]; National Human Genome Research Institute of the NIH [R01HG003143]; National Institute of Diabetes and Digestive and Kidney Diseases of the NIH [R01DK065806]; W.M. Keck Foundation Distinguished Young Scholar in Biomedical Research Award [RC2HG005542]; American Recovery and Reinvestment Act (ARRA); NIH NRSA postdoctoral fellowship [5F32NS065603]; NIH [PO1GM85354]; Intramural Research Program of the National Institute on Aging (Baltimore, MD); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005542, R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, T32GM008490, R01GM035463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS065603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000372, ZIAAG000373] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); W.M. Keck Foundation Distinguished Young Scholar in Biomedical Research Award; American Recovery and Reinvestment Act (ARRA); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute on Aging (Baltimore, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the NIH under award number R01GM035463 (V.G.C), the National Human Genome Research Institute of the NIH under award number R01HG003143 (J.D.), the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH under award number R01DK065806 (J.T.), a W.M. Keck Foundation Distinguished Young Scholar in Biomedical Research Award (J.D.), and award number RC2HG005542 (J.T.) provided by funds from the American Recovery and Reinvestment Act (ARRA). J.E.P.C. was supported by an NIH NRSA postdoctoral fellowship (5F32NS065603). Funds from NIH grant PO1GM85354 also contributed to this work (S.D.). T.I.G., C.G. and R.S. are supported by the Intramural Research Program of the National Institute on Aging (Baltimore, MD). J.E.P.C. and V.G.C. conceived the project. J.E.P.C. and T.C.M. designed stem cell differentiation experiments. J.E.P.C., A.S., B.R.L., and J.D. designed 5C experiments. J.E.P.C., S.D., and Y.S. designed lentiviral experiments. J.E.P.C., T.I.G., C.G., V.G.C., J.D., and R.S. designed FISH experiments. J.E.P.C., A.S., W.W., J.S.K.B., M.J.B., C.T.O., T.A.H., T.I.G., C.G., and Y.S. performed experiments. M.E.G.S., J.E.P.C., and J.T. developed concepts and code for 5C peak calling pipeline and HMM model. J.E.P.C. performed postpeak calling computational analyses and wrote the paper with input from J.D., M.E.G.S., J.T., and V.G.C.	Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gilbert DM, 2010, COLD SH Q B, V75, P143, DOI 10.1101/sqb.2010.75.011; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/nmeth.2148, 10.1038/NMETH.2148]; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Nora EP, 2010, COLD SH Q B, V75, P333, DOI 10.1101/sqb.2010.75.032; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van Berkum NL, 2009, METHODS MOL BIOL, V567, P189, DOI 10.1007/978-1-60327-414-2_13; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	49	769	787	1	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1281	1295		10.1016/j.cell.2013.04.053	http://dx.doi.org/10.1016/j.cell.2013.04.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23706625	Bronze, Green Accepted			2022-12-24	WOS:000319979200013
J	Boos, D; Yekezare, M; Diffley, JFX				Boos, Dominik; Yekezare, Mona; Diffley, John F. X.			Identification of a Heteromeric Complex That Promotes DNA Replication Origin Firing in Human Cells	SCIENCE			English	Article							BUDDING YEAST; SLD3; MTBP; PHOSPHORYLATION; MDM2; ACTIVATION; INITIATION; CDK; CHECKPOINT; DAMAGE	Treslin/TICRR (TopBP1-interacting, replication stimulating protein/TopBP1-interacting, checkpoint, and replication regulator), the human ortholog of the yeast Sld3 protein, is an essential DNA replication factor that is regulated by cyclin-dependent kinases and the DNA damage checkpoint. We identified MDM two binding protein (MTBP) as a factor that interacts with Treslin/TICRR throughout the cell cycle. We show that MTBP depletion by means of small interfering RNA inhibits DNA replication by preventing assembly of the CMG (Cdc45-MCM-GINS) holoheticase during origin firing. Although MTBP has been implicated in the function of the p53 tumor suppressor, we found MTBP is required for DNA replication irrespective of a cell's p53 status. We propose that MTBP acts with Treslin/TICRR to integrate signals from cell cycle and DNA damage response pathways to control the initiation of DNA replication in human cells.	[Boos, Dominik; Yekezare, Mona; Diffley, John F. X.] Canc Res UK London Res Inst LRI, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst LRI, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	john.diffley@cancer.org.uk		Boos, Dominik/0000-0003-0018-4375; Diffley, John/0000-0001-5184-7680	Cancer Research UK; European Research Council [249883-EUKDNAREP]; Association for International Cancer Research grant [10-0270]; European Molecular Biology Organization Long Term Fellowship; Cancer Research UK [15669] Funding Source: researchfish; Worldwide Cancer Research [10-0270] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Association for International Cancer Research grant; European Molecular Biology Organization Long Term Fellowship(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	We are grateful to the LRI Protein Analysis and Proteomics facility for mass spectrometry analysis; M. Petronczki and colleagues for help with time lapse experiments; L. Sanchez-Pulido and C. P. Pouting for help with bioinformatics; J. Mendez, H.-P. Nasheuer, F. Grosse, and H. Pospiech for antibodies; and LRI Cell Services for assistance with cell lines. This work was supported by Cancer Research UK, European Research Council grant 249883-EUKDNAREP, Association for International Cancer Research grant 10-0270 (J.F.X.D.), and a European Molecular Biology Organization Long Term Fellowship (D.B).	Agarwal N, 2011, CELL DEATH DIFFER, V18, P1208, DOI 10.1038/cdd.2010.189; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Boyd MT, 2000, CYTOGENET CELL GENET, V90, P64, DOI 10.1159/000015663; Boyd MT, 2000, J BIOL CHEM, V275, P31883, DOI 10.1074/jbc.M004252200; Brady M, 2005, MOL CELL BIOL, V25, P545, DOI 10.1128/MCB.25.2.545-553.2005; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; Iwakuma T, 2008, ONCOGENE, V27, P1813, DOI 10.1038/sj.onc.1210827; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Mantiero D, 2011, EMBO J, V30, P4805, DOI 10.1038/emboj.2011.404; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Odvody J, 2010, ONCOGENE, V29, P3287, DOI 10.1038/onc.2010.82; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tanaka T, 2011, EMBO J, V30, P2019, DOI 10.1038/emboj.2011.115; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373	26	59	60	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					981	984		10.1126/science.1237448	http://dx.doi.org/10.1126/science.1237448			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704573				2022-12-24	WOS:000319344100048
J	Fritsch, R; de Krijger, I; Fritsch, K; George, R; Reason, B; Kumar, MS; Diefenbacher, M; Stamp, G; Downward, J				Fritsch, Ralph; de Krijger, Inge; Fritsch, Kornelia; George, Roger; Reason, Beth; Kumar, Madhu S.; Diefenbacher, Markus; Stamp, Gordon; Downward, Julian			RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms	CELL			English	Article							G-BETA-GAMMA; P110-BETA ISOFORM; BINDING DOMAIN; ACTIVATION; KINASE; ROLES; TRANSFORMATION; P110-GAMMA; P110-ALPHA; MUTATIONS	RAS proteins are important direct activators of p110 alpha, p110 gamma, and p110 delta type I phosphoinositide 3-kinases (PI3Ks), interacting via an amino-terminal RAS-binding domain (RBD). Here, we investigate the regulation of the ubiquitous p110 beta isoform of PI3K, implicated in G-protein-coupled receptor (GPCR) signaling, PTEN-loss-driven cancers, and thrombocyte function. Unexpectedly, RAS is unable to interact with p110 beta, but instead RAC1 and CDC42 from the RHO subfamily of small GTPases bind and activate p110 beta via its RBD. In fibroblasts, GPCRs couple to PI3K through Dock180/Elmo1-mediated RAC activation and subsequent interaction with p110 beta. Cells from mice carrying mutations in the p110b RBD show reduced PI3K activity and defective chemotaxis, and these mice are resistant to experimental lung fibrosis. These findings revise our understanding of the regulation of type I PI3K by showing that both RAS and RHO family GTPases directly regulate distinct ubiquitous PI3K isoforms and that RAC activates p110 beta downstream of GPCRs.	[Fritsch, Ralph; de Krijger, Inge; Reason, Beth; Kumar, Madhu S.; Downward, Julian] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3LY, England; [Fritsch, Kornelia; Stamp, Gordon] Canc Res UK London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [George, Roger] Canc Res UK London Res Inst, Prot Purificat Facil, London WC2A 3LY, England; [Diefenbacher, Markus] Canc Res UK London Res Inst, Mammalian Genet Lab, London WC2A 3LY, England; [Downward, Julian] Inst Canc Res, Div Canc Biol, Lung Canc Grp, London SW3 6JB, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	julian.downward@cancer.org.uk	Diefenbacher, Markus Elmar/AAY-8650-2021; Fritsch, Ralph/Q-8836-2019	Diefenbacher, Markus Elmar/0000-0002-7402-7949; Fritsch, Ralph/0000-0001-9639-3213; Downward, Julian/0000-0002-2331-4729	Worldwide Cancer Research [13-0142] Funding Source: Medline; Cancer Research UK [15680] Funding Source: researchfish	Worldwide Cancer Research; Cancer Research UK(Cancer Research UK)		Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Yan JS, 2012, DEV CELL, V22, P92, DOI 10.1016/j.devcel.2011.11.007; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	40	188	195	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1050	1063		10.1016/j.cell.2013.04.031	http://dx.doi.org/10.1016/j.cell.2013.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706742	Green Published, hybrid			2022-12-24	WOS:000319456800013
J	Qian, MX; Pang, Y; Liu, CH; Haratake, K; Du, BY; Ji, DY; Wang, GF; Zhu, QQ; Song, W; Yu, YD; Zhang, XX; Huang, HT; Miao, SY; Chen, LB; Zhang, ZH; Liang, YN; Liu, S; Cha, HH; Yang, D; Zhai, YG; Komatsu, T; Tsuruta, F; Li, HT; Cao, C; Li, W; Li, GH; Cheng, YF; Chiba, T; Wang, LF; Goldberg, AL; Shen, Y; Qiu, XB				Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Haratake, Kousuke; Du, Bo-Yu; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Song, Wei; Yu, Yadong; Zhang, Xiao-Xu; Huang, Hai-Tao; Miao, Shiying; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Komatsu, Takuo; Tsuruta, Fuminori; Li, Haitao; Cao, Cheng; Li, Wei; Li, Guo-Hong; Cheng, Yifan; Chiba, Tomoki; Wang, Linfang; Goldberg, Alfred L.; Shen, Yan; Qiu, Xiao-Bo			Acetylation-Mediated Proteasomal Degradation of Core Histones during DNA Repair and Spermatogenesis	CELL			English	Article							DOUBLE-STRAND BREAKS; ACTIVATOR PA200; SACCHAROMYCES-CEREVISIAE; CHROMATIN; PROTEINS; TURNOVER; BINDING; YEAST; UBIQUITYLATION; RECOGNITION	Histone acetylation plays critical roles in chromatin remodeling, DNA repair, and epigenetic regulation of gene expression, but the underlying mechanisms are unclear. Proteasomes usually catalyze ATP- and polyubiquitin-dependent proteolysis. Here, we show that the proteasomes containing the activator PA200 catalyze the polyubiquitin-independent degradation of histones. Most proteasomes in mammalian testes ("spermatoproteasomes'') contain a spermatid/sperm-specific alpha subunit alpha 4 s/PSMA8 and/or the catalytic beta subunits of immuno-proteasomes in addition to PA200. Deletion of PA200 in mice abolishes acetylation-dependent degradation of somatic core histones during DNA double-strand breaks and delays core histone disappearance in elongated spermatids. Purified PA200 greatly promotes ATP-independent proteasomal degradation of the acetylated core histones, but not polyubiquitinated proteins. Furthermore, acetylation on histones is required for their binding to the bromodomain-like regions in PA200 and its yeast ortholog, Blm10. Thus, PA200/Blm10 specifically targets the core histones for acetylation-mediated degradation by proteasomes, providing mechanisms by which acetylation regulates histone degradation, DNA repair, and spermatogenesis.	[Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Zhang, Xiao-Xu; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Qiu, Xiao-Bo] Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Qian, Min-Xian; Pang, Ye; Liu, Cui Hua; Ji, Dan-Yang; Wang, Guang-Fei; Zhu, Qian-Qian; Zhang, Xiao-Xu; Chen, Lian-Bin; Zhang, Zi-Hui; Liang, Ya-Nan; Liu, Shan; Cha, Hwangho; Yang, Dong; Zhai, Yonggong; Qiu, Xiao-Bo] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Cui Hua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Li, Wei] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; [Li, Guo-Hong] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Haratake, Kousuke; Komatsu, Takuo; Tsuruta, Fuminori; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Du, Bo-Yu; Song, Wei; Huang, Hai-Tao; Miao, Shiying; Wang, Linfang; Shen, Yan; Qiu, Xiao-Bo] Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Du, Bo-Yu; Song, Wei; Huang, Hai-Tao; Miao, Shiying; Wang, Linfang; Shen, Yan; Qiu, Xiao-Bo] Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Yu, Yadong; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Li, Haitao] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, Beijing 100084, Peoples R China; [Li, Haitao] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Cao, Cheng] Beijing Inst Biotechnol, Beijing 100850, Peoples R China; [Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Tsukuba; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; University of California System; University of California San Francisco; Tsinghua University; Tsinghua University; Harvard University; Harvard Medical School	Qiu, XB (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, 19 Xinjiekouwai Ave, Beijing 100875, Peoples R China.	xqiu@bnu.edu.cn	Li, Haitao/B-2668-2012; Cao, Cheng/GNP-6156-2022	Li, Haitao/0000-0001-6741-293X; Qian, Minxian/0000-0002-1763-2325; Qiu, Xiao-Bo/0000-0003-2608-9376; Cheng, Yifan/0000-0001-9535-0369	Ministry of Science and Technology of China [2012CB910300]; National Natural Science Foundation of China [30525033, 30730024]; Fundamental Research Funds for the Central Universities of China; National Basic Research Program of China [2012CB518700]; MEX, Japan; NIGMS [5R01 GM51923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Basic Research Program of China(National Basic Research Program of China); MEX, Japan; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Finley for critical comments on the manuscript, Y. Cong, D. Finley, and O.J. Rando for reagents, T. Walz for providing the original EM images of Blm10 and PA28, H. Matsumoto and C. Xiong for technical assistance, as well as O. Gozani, D. Patel, H. Wang, and Z. Wang for assistance in the acetyl-peptide binding assay. T.C. thanks K. Tanaka for support and encouragement. This work was supported by grants from the Ministry of Science and Technology of China (2012CB910300); the National Natural Science Foundation of China (30525033 and 30730024); and the Fundamental Research Funds for the Central Universities of China to X.-B.Q.; a National Basic Research Program of China (2012CB518700) to C.H.L.; grants-in-aid for Scientific Research on Priority Areas, MEX, Japan to T.C.; and a grant from NIGMS (5R01 GM51923) to A.L. G.X.-B.Q. conceived the project. M.-X.Q., C.H.L., D.-Y.J., G.-F.W., and X.-B.Q. contributed to protein purification, characterization of proteasomal subunits and activities, and the studies on mutant mouse materials and yeast mutants. Y.P., M.-X.Q., X.-X.Z., H.C., D.Y., H.L., and X.-B.Q. performed acetylation-related studies. B.-Y.D., W.S., Z.-H.Z., H.-T.H., S.M., and L.W. contributed to purification and characterization of proteasomal subunits. K.H., T.K., F.T., and T.C. constructed PA200-deficient mice. Y.Y. and Y.C. conducted electron microscopic studies. Q.-Q.Z., L.-B.C., Y.-N.L., S.L., Y.Z., W.L., G.-H. L., and C.C. contributed to plasmid construction, antibody production, animal handling, or immunohistochemical studies. A.L.G., Y.S., and X.-B.Q. wrote the manuscript.	Blickwedehl J, 2008, P NATL ACAD SCI USA, V105, P16165, DOI 10.1073/pnas.0803145105; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Chen YS, 2012, J GENET GENOMICS, V39, P575, DOI 10.1016/j.jgg.2012.09.001; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; MILLS NC, 1977, BIOL REPROD, V17, P760, DOI 10.1095/biolreprod17.5.760; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shabason JE, 2011, J CELL MOL MED, V15, P2735, DOI 10.1111/j.1582-4934.2011.01296.x; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Toulmay A, 2006, YEAST, V23, P825, DOI 10.1002/yea.1397; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Ustrell V, 2005, METHOD ENZYMOL, V398, P321, DOI 10.1016/S0076-6879(05)98026-9; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	46	197	223	4	116	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1012	1024		10.1016/j.cell.2013.04.032	http://dx.doi.org/10.1016/j.cell.2013.04.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706739	Green Accepted, Bronze			2022-12-24	WOS:000319456800010
J	Bian, GW; Joshi, D; Dong, YM; Lu, P; Zhou, GL; Pan, XL; Xu, Y; Dimopoulos, G; Xi, ZY				Bian, Guowu; Joshi, Deepak; Dong, Yuemei; Lu, Peng; Zhou, Guoli; Pan, Xiaoling; Xu, Yao; Dimopoulos, George; Xi, Zhiyong			Wolbachia Invades Anopheles stephensi Populations and Induces Refractoriness to Plasmodium Infection	SCIENCE			English	Article							AEDES-ALBOPICTUS; DENGUE VIRUS; MOSQUITO; ESTABLISHMENT; SYMBIONT; MALARIA	Wolbachia is a maternally transmitted symbiotic bacterium of insects that has been proposed as a potential agent for the control of insect-transmitted diseases. One of the major limitations preventing the development of Wolbachia for malaria control has been the inability to establish inherited infections of Wolbachia in anopheline mosquitoes. Here, we report the establishment of a stable Wolbachia infection in an important malaria vector, Anopheles stephensi. In A. stephensi, Wolbachia strain wAlbB displays both perfect maternal transmission and the ability to induce high levels of cytoplasmic incompatibility. Seeding of naturally uninfected A. stephensi populations with infected females repeatedly resulted in Wolbachia invasion of laboratory mosquito populations. Furthermore, wAlbB conferred resistance in the mosquito to the human malaria parasite Plasmodium falciparum.	[Bian, Guowu; Joshi, Deepak; Lu, Peng; Zhou, Guoli; Pan, Xiaoling; Xu, Yao; Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Bian, Guowu] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Dept Parasitol,Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Dong, Yuemei; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Xi, Zhiyong] Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou 510080, Guangdong, Peoples R China	Michigan State University; Sun Yat Sen University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sun Yat Sen University	Xi, ZY (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	xizy@msu.edu	Xi, Zhiyong/AAD-7936-2022; Pan, Xiaoling/AAH-1387-2021	Xi, Zhiyong/0000-0001-7786-012X; Dimopoulos, George/0000-0001-6755-8111; Dong, Yuemei/0000-0002-7902-2899	NIH [R01AI080597, R21AI082141, R01AI061576]; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080597, R21AI082141, R01AI061576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01AI080597, R21AI082141, and R01AI061576 and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation. We are grateful to the Johns Hopkins Malaria Research Institute Parasitology and Insectary Core Facilities and thank S. O'Neill, A. A. Hoffmann, and S. L. Dobson for their comments and suggestions and D. McClellan and S. Thiem for editorial assistance. Z.X. is also affiliated with Guangzhou WolbaKi Biotech Co., LTD. Data for this report are archived as supplementary materials on Science Online.	Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Dobson SL, 2002, GENETICS, V160, P1087; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hughes GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036277; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; malERA Consultative Group on Vector Control, 2011, PLoS Med, V8, pe1000401, DOI 10.1371/journal.pmed.1000401; McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Sinden RE, 2004, INSECT BIOCHEM MOLEC, V34, P625, DOI 10.1016/j.ibmb.2004.03.015; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Tram U, 2003, MICROBES INFECT, V5, P999, DOI 10.1016/S1286-4579(03)00192-8; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607	22	307	337	9	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					748	751		10.1126/science.1236192	http://dx.doi.org/10.1126/science.1236192			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661760				2022-12-24	WOS:000318619000040
J	Lee, KA; Kim, SH; Kim, EK; Ha, EM; You, H; Kim, B; Kim, MJ; Kwon, Y; Ryu, JH; Lee, WJ				Lee, Kyung-Ah; Kim, Sung-Hee; Kim, Eun-Kyoung; Ha, Eun-Mi; You, Hyejin; Kim, Boram; Kim, Min-Ji; Kwon, Youngjoo; Ryu, Ji-Hwan; Lee, Won-Jae			Bacterial-Derived Uracil as a Modulator of Mucosal Immunity and Gut-Microbe Homeostasis in Drosophila	CELL			English	Article							HOST-DEFENSE; COMMENSAL BACTERIA; DUAL OXIDASE; SYSTEM; MELANOGASTER; RECOGNITION; ACTIVATION; INFECTION; PATHWAYS; MODEL	All metazoan guts are subjected to immunologically unique conditions in which an efficient antimicrobial system operates to eliminate pathogens while tolerating symbiotic commensal microbiota. However, the molecular mechanisms controlling this process are only partially understood. Here, we show that bacterial-derived uracil acts as a ligand for dual oxidase (DUOX)-dependent reactive oxygen species generation in Drosophila gut and that the uracil production in bacteria causes inflammation in the gut. The acute and controlled uracil-induced immune response is required for efficient elimination of bacteria, intestinal cell repair, and host survival during infection of nonresident species. Among resident gut microbiota, uracil production is absent in symbionts, allowing harmonious colonization without DUOX activation, whereas uracil release from opportunistic pathobionts provokes chronic inflammation. These results reveal that bacteria with distinct abilities to activate uracil-induced gut inflammation, in terms of intensity and duration, act as critical factors that determine homeostasis or pathogenesis in gut microbe interactions.	[Lee, Kyung-Ah; Kim, Sung-Hee; Kim, Eun-Kyoung; You, Hyejin; Kim, Boram; Lee, Won-Jae] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Lee, Kyung-Ah; Kim, Sung-Hee; Kim, Eun-Kyoung; You, Hyejin; Kim, Boram; Lee, Won-Jae] Natl Creat Res Initiat Ctr Symbiosyst, Seoul 151742, South Korea; [Ha, Eun-Mi] Catholic Univ, Coll Pharm, Taegu 712702, South Korea; [You, Hyejin; Kwon, Youngjoo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kim, Min-Ji; Ryu, Ji-Hwan] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul 120752, South Korea	Seoul National University (SNU); Catholic University of Korea; Ewha Womans University; Yonsei University; Yonsei University Health System	Lee, WJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	lwj@snu.ac.kr	Kwon, Youngjoo/AAF-6120-2020	Kwon, Youngjoo/0000-0001-6256-3042; Kim, Minji/0000-0002-8484-6817	National Creative Research Initiative Program [2006-0050687]; BK 21 program; SNU research grant [3344-20110017]	National Creative Research Initiative Program(Ministry of Science & Technology (MOST), Republic of Korea); BK 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); SNU research grant	This study was supported by the National Creative Research Initiative Program (grant no. 2006-0050687 to W.-J.L), the BK 21 program, and an SNU research grant (no. 3344-20110017). We are grateful to S.-J. Lee, B. Seo, and J. Lee for assistance with the C. elegans work. We thank J. Yoon, S.W. Kang, J.-F. Gavin, Z. Zheng, Y.Y. Seo, D. Kim, and Y.M. Park for assistance with laboratory analyses and D. Daffonchio (supported by the Italy-Korea Researcher Exchange Program) for valuable discussion.	Andoh A, 2009, CURR PHARM DESIGN, V15, P2066, DOI 10.2174/138161209788489186; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Attila C, 2009, APPL MICROBIOL BIOT, V82, P525, DOI 10.1007/s00253-009-1860-8; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Charroux B, 2012, SEMIN IMMUNOL, V24, P17, DOI 10.1016/j.smim.2011.11.003; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; Lee WJ, 2009, GENE DEV, V23, P2260, DOI 10.1101/gad.1858709; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; MERGEAY M, 1974, MOL GEN GENET, V133, P299, DOI 10.1007/BF00332706; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; RINAS U, 1995, APPL ENVIRON MICROB, V61, P4147, DOI 10.1128/AEM.61.12.4147-4151.1995; Roh SW, 2008, APPL ENVIRON MICROB, V74, P6171, DOI 10.1128/AEM.00301-08; Rokutan K, 2008, SEMIN IMMUNOPATHOL, V30, P315, DOI 10.1007/s00281-008-0124-5; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x	52	231	249	1	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					797	811		10.1016/j.cell.2013.04.009	http://dx.doi.org/10.1016/j.cell.2013.04.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663779	Bronze			2022-12-24	WOS:000318844000010
J	Rambo, RP; Tainer, JA				Rambo, Robert P.; Tainer, John A.			Accurate assessment of mass, models and resolution by small-angle scattering	NATURE			English	Article							X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; STRUCTURAL-ANALYSES; SAXS; RNA; CRYSTALLOGRAPHY; COMPUTATION; PROTEINS; QUALITY; SCALE	Modern small-angle scattering (SAS) experiments with X-rays or neutrons provide a comprehensive, resolution-limited observation of the thermodynamic state. However, methods for evaluating mass and validating SAS-based models and resolution have been inadequate. Here we define the volume of correlation, V-c, a SAS invariant derived from the scattered intensities that is specific to the structural state of the particle, but independent of concentration and the requirements of a compact, folded particle. We show that V-c defines a ratio, Q(R), that determines the molecular mass of proteins or RNA ranging from 10 to 1,000 kilodaltons. Furthermore, we propose a statistically robust method for assessing model-data agreements (chi(2)(free)) akin to cross-validation. Our approach prevents over-fitting of the SAS data and can be used with a newly defined metric, R-SAS, for quantitative evaluation of resolution. Together, these metrics (V-c, Q(R), chi(2)(free) and R-SAS) provide analytical tools for unbiased and accurate macromolecular structural characterizations in solution.	[Rambo, Robert P.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Div Life Sci, Berkeley, CA 94720 USA; [Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute	Rambo, RP (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Div Life Sci, Berkeley, CA 94720 USA.	rprambo@lbl.gov; jat@scripps.edu	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429	Office of Science, US Department of Energy on Novel Technology for Structural Biology; United States Department of Energy program Integrated Diffraction Analysis Technologies [DEAC02-05CH11231]; National Institutes of Health [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Office of Science, US Department of Energy on Novel Technology for Structural Biology(United States Department of Energy (DOE)); United States Department of Energy program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. L. Hura, M. Hammel, R. T. Batey, J. Tanamachi and the staff of SIBYLS Beamline 12.3.1 at the Advanced Light Source for discussions and P. Adams for suggestions regarding simulations with CNS. We thank E. Rambo, G. Williams and E. D. Getzoff for manuscript comments. This work is supported in part by funding to foster collaboration with Bruker and the Berkeley Laboratory Directed Research and Development (LDRD) program provided by the Director, Office of Science, US Department of Energy on Novel Technology for Structural Biology. The SIBYLS Beamline 12.3.1 facility and team at the Advanced Light Source is supported by United States Department of Energy program Integrated Diffraction Analysis Technologies (DEAC02-05CH11231) and by National Institutes of Health grant R01GM105404.	Bai Y, 2005, P NATL ACAD SCI USA, V102, P1035, DOI 10.1073/pnas.0404448102; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fulle S, 2008, BIOPHYS J, V94, P4202, DOI 10.1529/biophysj.107.113415; Glatter O., 1982, SMALL ANGLE X RAY SC; Hammond JA, 2010, J MOL BIOL, V399, P450, DOI 10.1016/j.jmb.2010.04.016; Harrison SC, 2007, STRUCTURE, V15, P1344, DOI 10.1016/j.str.2007.10.004; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jie Y., 2006, IEEE SOC C COMP VIS; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keel AY, 2012, RNA, V18, P88, DOI 10.1261/rna.030007.111; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rambo RP, 2010, CURR OPIN STRUC BIOL, V20, P128, DOI 10.1016/j.sbi.2009.12.015; Rambo RP, 2010, RNA, V16, P638, DOI 10.1261/rna.1946310; Rambo RP, 2004, BIOCHEMISTRY-US, V43, P6486, DOI 10.1021/bi049912u; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sosnick TR, 2011, BIOPOLYMERS, V95, P503, DOI 10.1002/bip.21643; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	32	517	519	6	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					477	+		10.1038/nature12070	http://dx.doi.org/10.1038/nature12070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619693	Green Accepted			2022-12-24	WOS:000317984400035
J	Vale, CL; Tierney, JF; Burdett, S				Vale, Claire L.; Tierney, Jayne F.; Burdett, Sarah			Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIALS; METHODOLOGICAL QUALITY; CONSORT STATEMENT; METAANALYSIS; PUBLICATION; EXPLANATION; INFORMATION	Objective To evaluate the reliability of risk of bias assessments based on published trial reports, for determining trial inclusion in meta-analyses. Design Reliability evaluation of risk of bias assessments. Data sources 13 published individual participant data (IPD) meta-analyses in cancer were used to source 95 randomised controlled trials. Review methods Risk of bias was assessed using the Cochrane risk of bias tool (RevMan5.1) and accompanying guidance. Assessments were made for individual risk of bias domains and overall for each trial, using information from either trial reports alone or trial reports with additional information collected for IPD meta-analyses. Percentage agreements were calculated for individual domains and overall (<66%=low, >= 66%=fair, >= 90%=good). The two approaches were considered similarly reliable only when agreement was good. Results Percentage agreement between the two methods for sequence generation and incomplete outcome data was fair (69.5% (95% confidence interval 60.2% to 78.7%) and 80.0% (72.0% to 88.0%), respectively). However, percentage agreement was low for allocation concealment, selective outcome reporting, and overall risk of bias (48.4% (38.4% to 58.5%), 42.1% (32.2% to 52.0%), and 54.7% (44.7% to 64.7%), respectively). Supplementary information reduced the proportion of unclear assessments for all individual domains, consequently increasing the number of trials assessed as low risk of bias (and therefore available for inclusion in meta-analyses) from 23 (23%) based on publications alone to 66 (66%) based on publications with additional information. Conclusions Using cancer trial publications alone to assess risk of bias could be unreliable; thus, reviewers should be cautious about using them as a basis for trial inclusion, particularly for those trials assessed as unclear risk. Supplementary information from trialists should be sought to enable appropriate assessments and potentially reduce or overcome some risks of bias. Furthermore, guidance should ensure clarity on what constitutes risk of bias, particularly for the more subjective domains.	[Vale, Claire L.; Tierney, Jayne F.; Burdett, Sarah] MRC Clin Trials Unit, Metaanal Grp, London WC2B 6NH, England	Medical Research Council Clinical Trials Unit	Vale, CL (corresponding author), MRC Clin Trials Unit, Metaanal Grp, London WC2B 6NH, England.	cv@ctu.mrc.ac.uk		Vale, Claire/0000-0001-5157-0634; Tierney, Jayne/0000-0002-4734-3014	United Kingdom's Medical Research Council; Medical Research Council; MRC [MC_EX_G0800814] Funding Source: UKRI; Medical Research Council [MC_EX_G0800814] Funding Source: researchfish	United Kingdom's Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the United Kingdom's Medical Research Council.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the Medical Research Council for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Abol-Enein H, 2003, LANCET, V361, P1927; ALBERTI W, 1995, BRIT MED J, V311, P899; Altman DG, 1996, BRIT MED J, V313, P570; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Arnott SJ, 1998, INT J RADIAT ONCOL, V41, P579, DOI 10.1016/S0360-3016(97)00569-5; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Benedetti-Panici P, 2003, EUR J CANCER, V39, P2470, DOI 10.1016/S0959-8049(03)00425-8; Bono AV, 2005, EUR UROL, V48, P189, DOI 10.1016/j.eururo.2005.04.005; Burdett S, 1998, LANCET, V352, P257; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Dwan K, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-52; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Glioma Meta-analysis Trialists Group, 2002, COCHRANE DB SYST REV, V3; Hartling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017242; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.b2700, 10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; McAuley L, 2000, LANCET, V356, P1228, DOI 10.1016/S0140-6736(00)02786-0; McMinn AM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-81; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Non-small Cell Lung Cancer Collaborative Group, 2000, COCHRANE DB SYST REV, V2; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tierney JF, 1997, LANCET, V350, P1647; Vale C, 2008, J CLIN ONCOL, V26, P5802, DOI 10.1200/JCO.2008.16.4368; Viergever RF, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-210	34	38	39	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2013	346								f1798	10.1136/bmj.f1798	http://dx.doi.org/10.1136/bmj.f1798			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PK	23610376	Green Published, hybrid			2022-12-24	WOS:000318224700001
J	Kvitsiani, D; Ranade, S; Hangya, B; Taniguchi, H; Huang, JZ; Kepecs, A				Kvitsiani, D.; Ranade, S.; Hangya, B.; Taniguchi, H.; Huang, J. Z.; Kepecs, A.			Distinct behavioural and network correlates of two interneuron types in prefrontal cortex	NATURE			English	Article							GABAERGIC NEURONS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; IN-VIVO; INHIBITION; INFORMATION; COMPUTATION; RESPONSES; FEATURES; SUBTYPES	Neurons in the prefrontal cortex exhibit diverse behavioural correlates(1-4), an observation that has been attributed to cell-type diversity. To link identified neuron types with network and behavioural functions, we recorded from the two largest genetically defined inhibitory interneuron classes, the perisomatically targeting parvalbumin (PV) and the dendritically targeting somatostatin (SOM) neurons(5-8) in anterior cingulate cortex of mice performing a reward foraging task. Here we show that PV and a subtype of SOM neurons form functionally homogeneous populations showing a double dissociation between both their inhibitory effects and behavioural correlates. Out of several events pertaining to behaviour, a subtype of SOM neurons selectively responded at reward approach, whereas PV neurons responded at reward leaving and encoded preceding stay duration. These behavioural correlates of PV and SOM neurons defined a behavioural epoch and a decision variable important for foraging (whether to stay or to leave), a crucial function attributed to the anterior cingulate cortex(9-11). Furthermore, PV neurons could fire in millisecond synchrony, exerting fast and powerful inhibition on principal cell firing, whereas the inhibitory effect of SOM neurons on firing output was weak and more variable, consistent with the idea that they respectively control the outputs of, and inputs to, principal neurons(12-16). These results suggest a connection between the circuit-level function of different interneuron types in regulating the flow of information and the behavioural functions served by the cortical circuits. Moreover, these observations bolster the hope that functional response diversity during behaviour can in part be explained by cell-type diversity.	[Kvitsiani, D.; Ranade, S.; Hangya, B.; Taniguchi, H.; Huang, J. Z.; Kepecs, A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Kepecs, A (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	kepecs@cshl.edu	Core, Vector/CAF-4832-2022; Hangya, Balazs/H-5964-2019	Hangya, Balazs/0000-0003-2709-7407; Kvitsiani, Duda/0000-0003-3175-1774; Ranade, Sachin/0000-0002-5150-5776; Huang, Z. Josh/0000-0003-0592-028X; Kepecs, Adam/0000-0003-0049-8120	Klingenstein Foundation; John Merck Foundation; Sloan Foundation; Whitehall Foundation; National Institute of Neurological Disorders and Stroke (National Institutes of Health) [R01NS075531]; Swartz Foundation; The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Human Frontier Science Program; Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075531] Funding Source: NIH RePORTER	Klingenstein Foundation(Klingenstein Philanthropies); John Merck Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Whitehall Foundation; National Institute of Neurological Disorders and Stroke (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swartz Foundation; The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship; Human Frontier Science Program(Human Frontier Science Program); Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Klingenstein, John Merck, Sloan and Whitehall Foundations to A. K. and the National Institute of Neurological Disorders and Stroke (National Institutes of Health) grant R01NS075531. B. H. received support from the Swartz Foundation and Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development (2007-2013). D. K. received support from The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship and Human Frontier Science Program(2008-2011). We are grateful to K. Deisseroth, E. Boyden, A. Reid and A. Zador for constructs, B. Burbach and R. Eifert for technical assistance, and to J. Lisman, B. Mensh, S. Shea and A. Zador for comments and discussions.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Hangya B, 2010, J PHYSIOL-LONDON, V588, P4165, DOI 10.1113/jphysiol.2010.194274; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Marshall L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0001.2002; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Nikolic D, 2012, EUR J NEUROSCI, V35, P742, DOI 10.1111/j.1460-9568.2011.07987.x; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	44	280	280	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					363	+		10.1038/nature12176	http://dx.doi.org/10.1038/nature12176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708967	Green Accepted			2022-12-24	WOS:000320592900040
J	Zhao, GP; Perilla, JR; Yufenyuy, EL; Meng, X; Chen, B; Ning, JY; Ahn, J; Gronenborn, AM; Schulten, K; Aiken, C; Zhang, PJ				Zhao, Gongpu; Perilla, Juan R.; Yufenyuy, Ernest L.; Meng, Xin; Chen, Bo; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Schulten, Klaus; Aiken, Christopher; Zhang, Peijun			Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics	NATURE			English	Article							PROTEIN; CORE; RECONSTRUCTIONS; DOMAIN	Retroviral capsid proteins are conserved structurally but assemble into different morphologies(1). The mature human immunodeficiency virus-1 (HIV-1) capsid is best described by a 'fullerene cone' model(2,3), in which hexamers of the capsid protein are linked to form a hexagonal surface lattice that is closed by incorporating 12 capsid-protein pentamers. HIV-1 capsid protein contains an amino-terminal domain (NTD) comprising seven alpha-helices and a beta-hairpin(4,5), a carboxy-terminal domain (CTD) comprising four alpha-helices(6,7), and a flexible linker with a 3(10)-helix connecting the two structural domains(8). Structures of the capsid-protein assembly units have been determined by X-ray crystallography(9,10); however, structural information regarding the assembled capsid and the contacts between the assembly units is incomplete. Here we report the cryo-electron microscopy structure of a tubular HIV-1 capsid-protein assembly at 8 angstrom resolution and the three-dimensional structure of a native HIV-1 core by cryo-electron tomography. The structure of the tubular assembly shows, at the three-fold interface(11), a three-helix bundle with critical hydrophobic interactions. Mutagenesis studies confirm that hydrophobic residues in the centre of the three-helix bundle are crucial for capsid assembly and stability, and for viral infectivity. The cryo-electron-microscopy structures enable modelling by large-scale molecular dynamics simulation, resulting in all-atom models for the hexamer-of-hexamer and pentamer-of-hexamer elements as well as for the entire capsid. Incorporation of pentamers results in closer trimer contacts and induces acute surface curvature. The complete atomic HIV-1 capsid model provides a platform for further studies of capsid function and for targeted pharmacological intervention.	[Zhao, Gongpu; Meng, Xin; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Zhang, Peijun] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Zhao, Gongpu; Yufenyuy, Ernest L.; Meng, Xin; Ning, Jiying; Ahn, Jinwoo; Gronenborn, Angela M.; Aiken, Christopher; Zhang, Peijun] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; [Perilla, Juan R.; Schulten, Klaus] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Perilla, Juan R.; Schulten, Klaus] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Yufenyuy, Ernest L.; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Chen, Bo] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Zhang, Peijun] Univ Pittsburgh, Swanson Sch Engn, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Vanderbilt University; State University System of Florida; University of Central Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, PJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	kschulte@ks.uiuc.edu; chris.aiken@vanderbilt.edu; pez7@pitt.edu	Chen, Bo/F-3573-2015; Aiken, Christopher/Y-9252-2019; Chen, Bo/AID-6923-2022; zhao, gongpu/B-8151-2012; NING, JIYING/L-3899-2016	Chen, Bo/0000-0001-5589-2075; Gronenborn, Angela M/0000-0001-9072-3525; Perilla, Juan/0000-0003-1171-6816	National Institutes of Health [GM082251, GM085043, GM104601]; National Science Foundation [PHY0822613, MCB0744057, OCI 07-25070]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601, P50GM082251, R01GM085043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Schwerdtfeger for access to his software for creating fullerene models, T. Brosenitsch for reading the manuscript, and M. DeLucia and J. Mehrens for technical assistance. This work was supported by the National Institutes of Health (GM082251, GM085043 and GM104601) and the National Science Foundation (PHY0822613, MCB0744057). Large-scale molecular dynamics simulations were performed on the Blue Waters Computer, financed by the National Science Foundation (OCI 07-25070).	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Byeon IJL, 2012, J AM CHEM SOC, V134, P6455, DOI 10.1021/ja300937v; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen B, 2011, BIOPHYS J, V100, P3035, DOI 10.1016/j.bpj.2011.05.025; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Jiang JY, 2011, VIROLOGY, V421, P253, DOI 10.1016/j.virol.2011.09.012; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Meng X, 2011, JOVE-J VIS EXP, V54, pe3041, DOI 3010.3791/3041; Meng X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002886; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Yeager M, 2011, J MOL BIOL, V410, P534, DOI 10.1016/j.jmb.2011.04.073	28	556	568	4	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					643	646		10.1038/nature12162	http://dx.doi.org/10.1038/nature12162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23719463	Green Accepted			2022-12-24	WOS:000319556100049
J	Subramanian, N; Natarajan, K; Clatworthy, MR; Wang, Z; Germain, RN				Subramanian, Naeha; Natarajan, Kannan; Clatworthy, Menna R.; Wang, Ze; Germain, Ronald N.			The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation	CELL			English	Article							ANTIVIRAL SIGNALING PROTEIN; CASPASE-1 ACTIVATION; REPERFUSION INJURY; OXIDATIVE STRESS; IMMUNE-RESPONSE; CELLS; FORMS; ATP; ASC; EXPRESSION	NLRP3 is a key component of the macromolecular signaling complex called the inflammasome that promotes caspase 1-dependent production of IL-1 beta. The adaptor ASC is necessary for NLRP3-dependent inflammasome function, but it is not known whether ASC is a sufficient partner and whether inflammasome formation occurs in the cytosol or in association with mitochondria is controversial. Here, we show that the mitochondria-associated adaptor molecule, MAVS, is required for optimal NLRP3 inflammasome activity. MAVS mediates recruitment of NLRP3 to mitochondria, promoting production of IL-1b and the pathophysiologic activity of the NLRP3 inflammasome in vivo. Our data support a more complex model of NLRP3 inflammasome activation than previously appreciated, with at least two adapters required for maximal function. Because MAVS is a mitochondria-associated molecule previously considered to be uniquely involved in type 1 interferon production, these findings also reveal unexpected polygamous involvement of PYD/CARD-domain-containing adapters in innate immune signaling events.	[Subramanian, Naeha; Clatworthy, Menna R.; Wang, Ze; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Natarajan, Kannan] NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Clatworthy, Menna R.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 0XY, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Subramanian, N (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	subramaniann@niaid.nih.gov; rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Subramanian, Naeha/0000-0003-3754-0521	Intramural Research Program, NIAID, NIH; Wellcome Trust [WT081020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000622, ZIAAI000974] Funding Source: NIH RePORTER	Intramural Research Program, NIAID, NIH; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program, NIAID, NIH, and a Wellcome Trust Intermediate Fellowship (WT081020) to M. R. C. We are grateful to Drs. Daniel Kastner, Michael Lenardo, and Iain Fraser for critical reading of the manuscript. We thank the Biological Imaging Section, NIAID, NIH for excellent imaging support; Dr. Vishva Dixit and Dr. Zhijian Chen for kindly providing mouse strains; Dr. Eicke Latz for generously providing HEK-293-ASC-YFP cells; Dr. Iain Fraser for providing lentiviral constructs; and Drs. Wolfgang Kastenmuller, Marlene Brandes, and Jae Jin Chae for helpful discussions. The authors declare that they have no competing financial interests.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Berry M, 2012, IMMUNOTHERAPY-UK, V4, P323, DOI [10.2217/IMT.11.175, 10.2217/imt.11.175]; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Cheng J, 2010, J CELL PHYSIOL, V222, P738, DOI 10.1002/jcp.22005; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Faubel S, 2004, KIDNEY INT, V66, P2202, DOI 10.1111/j.1523-1755.2004.66010.x; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Haq M, 1998, J AM SOC NEPHROL, V9, P614; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li XD, 2011, P NATL ACAD SCI USA, V108, P17390, DOI 10.1073/pnas.1107114108; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	41	420	437	3	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					348	361		10.1016/j.cell.2013.02.054	http://dx.doi.org/10.1016/j.cell.2013.02.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582325	Bronze, Green Accepted			2022-12-24	WOS:000317349700014
J	DeGennaro, M; McBride, CS; Seeholzer, L; Nakagawa, T; Dennis, EJ; Goldman, C; Jasinskiene, N; James, AA; Vosshall, LB				DeGennaro, Matthew; McBride, Carolyn S.; Seeholzer, Laura; Nakagawa, Takao; Dennis, Emily J.; Goldman, Chloe; Jasinskiene, Nijole; James, Anthony A.; Vosshall, Leslie B.			orco mutant mosquitoes lose strong preference for humans and are not repelled by volatile DEET	NATURE			English	Article							DROSOPHILA ODORANT RECEPTORS; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; CHANNELS; FEMALE	Female mosquitoes of some species are generalists and will blood-feed on a variety of vertebrate hosts, whereas others display marked host preference. Anopheles gambiae and Aedes aegypti have evolved a strong preference for humans, making them dangerously efficient vectors of malaria and Dengue haemorrhagic fever(1). Specific host odours probably drive this strong preference because other attractive cues, including body heat and exhaled carbon dioxide (CO2), are common to all warm-blooded hosts(2,3). Insects sense odours via several chemosensory receptor families, including the odorant receptors (ORs), membrane proteins that form heteromeric odour-gated ion channels(4,5) comprising a variable ligand-selective subunit and an obligate co-receptor called Orco (ref. 6). Here we use zinc-finger nucleases to generate targeted mutations in the orco gene of A. aegypti to examine the contribution of Orco and the odorant receptor pathway to mosquito host selection and sensitivity to the insect repellent DEET (N,N-diethyl-meta-toluamide). orco mutant olfactory sensory neurons have greatly reduced spontaneous activity and lack odour-evoked responses. Behaviourally, orco mutant mosquitoes have severely reduced attraction to honey, an odour cue related to floral nectar, and do not respond to human scent in the absence of CO2. However, in the presence of CO2, female orco mutant mosquitoes retain strong attraction to both human and animal hosts, but no longer strongly prefer humans. orco mutant females are attracted to human hosts even in the presence of DEET, but are repelled upon contact, indicating that olfactory- and contact-mediated effects of DEET are mechanistically distinct. We conclude that the odorant receptor pathway is crucial for an anthropophilic vector mosquito to discriminate human from non-human hosts and to be effectively repelled by volatile DEET.	[DeGennaro, Matthew; McBride, Carolyn S.; Seeholzer, Laura; Nakagawa, Takao; Dennis, Emily J.; Goldman, Chloe; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [DeGennaro, Matthew; Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Jasinskiene, Nijole; James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet & Mol Biol & Biochem, Irvine, CA 92697 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Irvine; University of California System; University of California Irvine	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	Leslie.Vosshall@rockefeller.edu	; DeGennaro, Matthew/H-4975-2015	Dennis, Emily/0000-0002-9858-7190; James, Anthony/0000-0001-5577-3308; DeGennaro, Matthew/0000-0003-3837-4430; Vosshall, Leslie/0000-0002-6060-8099	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health [DC012069, AI29746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029746, R01AI029746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC012069, R00DC012069] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. J. Lee and members of the Vosshall lab for comments on the manuscript. F. Urnov of Sangamo BioSciences suggested the experiments in Supplementary Fig. 1. We thank C. McMeniman for initiating the A. aegypti GFP ZFN disruption project together with M. D. and for establishing mosquito microinjection at Genetic Services Inc. S. Dewell of the Rockefeller University Genomics Resource Center provided bioinformatic assistance. W. Takken and N. Verhulst suggested the use of nylon stockings in Figs 4 and 5. Roman Corfas provided advice on imaging in Fig. 5b. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative. This work was supported in part by grants from the National Institutes of Health to C. S. M. (DC012069) and N. J. and A. A. J. (AI29746). L. B. V. is an investigator of the Howard Hughes Medical Institute.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Ghaninia M, 2007, EUR J NEUROSCI, V26, P1611, DOI 10.1111/j.1460-9568.2007.05786.x; GOUCK HK, 1972, B WORLD HEALTH ORGAN, V47, P680; Grant AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021785; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Remy S, 2010, TRANSGENIC RES, V19, P363, DOI 10.1007/s11248-009-9323-7; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; SKINNER WA, 1965, NATURE, V207, P661, DOI 10.1038/207661a0; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	29	238	249	10	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 27	2013	498	7455					487	491		10.1038/nature12206	http://dx.doi.org/10.1038/nature12206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23719379	Green Accepted, Green Submitted			2022-12-24	WOS:000320929400053
J	Trempe, JF; Sauve, V; Grenier, K; Seirafi, M; Tang, MY; Menade, M; Al-Abdul-Wahid, S; Krett, J; Wong, K; Kozlov, G; Nagar, B; Fon, EA; Gehring, K				Trempe, Jean-Francois; Sauve, Veronique; Grenier, Karl; Seirafi, Marjan; Tang, Matthew Y.; Menade, Marie; Al-Abdul-Wahid, Sameer; Krett, Jonathan; Wong, Kathy; Kozlov, Guennadi; Nagar, Bhushan; Fon, Edward A.; Gehring, Kalle			Structure of Parkin Reveals Mechanisms for Ubiquitin Ligase Activation	SCIENCE			English	Article							RING DOMAIN; DISEASE; MITOCHONDRIA; PHOSPHORYLATION; ASSOCIATION; DYSFUNCTION; MUTATIONS	Mutations in the PARK2 (parkin) gene are responsible for an autosomal recessive form of Parkinson's disease. The parkin protein is a RING-in-between-RING E3 ubiquitin ligase that exhibits low basal activity. We describe the crystal structure of full-length rat parkin. The structure shows parkin in an autoinhibited state and provides insight into how it is activated. RING0 occludes the ubiquitin acceptor site Cys(431) in RING2, whereas a repressor element of parkin binds RING1 and blocks its E2-binding site. Mutations that disrupted these inhibitory interactions activated parkin both in vitro and in cells. Parkin is neuroprotective, and these findings may provide a structural and mechanistic framework for enhancing parkin activity.	[Trempe, Jean-Francois; Grenier, Karl; Tang, Matthew Y.; Krett, Jonathan; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada; [Sauve, Veronique; Seirafi, Marjan; Menade, Marie; Al-Abdul-Wahid, Sameer; Wong, Kathy; Kozlov, Guennadi; Nagar, Bhushan; Gehring, Kalle] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 1Y6, Canada; [Sauve, Veronique; Seirafi, Marjan; Menade, Marie; Al-Abdul-Wahid, Sameer; Wong, Kathy; Kozlov, Guennadi; Nagar, Bhushan; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada.	ted.fon@mcgill.ca; kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Al-Abdul-Wahid, Mohamed Sameer/0000-0001-7925-5863; Krett, Jonathan/0000-0003-4964-3341	Parkinson Society Canada; Canadian Institutes of Health Research [MOP-62714, MOP-14219]	Parkinson Society Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank C. Arrowsmith for the His<INF>6</INF>-UbcH7 construct, the Canadian Light Source and CHESS for data acquisition, and group members for insights and helpful discussion. We acknowledge support from Parkinson Society Canada and from Canadian Institutes of Health Research grants MOP-62714 (E.A.F.) and MOP-14219 (K.G.). Coordinates and structure factors of the R0-RBR and full-length parkin crystal structures were deposited in the Protein Data Bank under accession codes 4K7D and 4K95.	Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mata IF, 2004, HUM MOL GENET, V13, pR127, DOI 10.1093/hmg/ddh089; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Safadi SS, 2010, J BIOL CHEM, V285, P1424, DOI 10.1074/jbc.M109.041970; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Walden H, 2012, CELL MOL LIFE SCI, V69, P3053, DOI 10.1007/s00018-012-0978-5; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	29	346	355	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1451	1455		10.1126/science.1237908	http://dx.doi.org/10.1126/science.1237908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23661642				2022-12-24	WOS:000320647000042
J	Chiu, CQ; Lur, G; Morse, TM; Carnevale, NT; Ellis-Davies, GCR; Higley, MJ				Chiu, Chiayu Q.; Lur, Gyorgy; Morse, Thomas M.; Carnevale, Nicholas T.; Ellis-Davies, Graham C. R.; Higley, Michael J.			Compartmentalization of GABAergic Inhibition by Dendritic Spines	SCIENCE			English	Article							CALCIUM SIGNALS; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; CEREBRAL-CORTEX; VISUAL-CORTEX; PLASTICITY; INTERNEURONS; SYNAPSES; GABA; POTENTIATION	gamma-aminobutyric acid-mediated (GABAergic) inhibition plays a critical role in shaping neuronal activity in the neocortex. Numerous experimental investigations have examined perisomatic inhibitory synapses, which control action potential output from pyramidal neurons. However, most inhibitory synapses in the neocortex are formed onto pyramidal cell dendrites, where theoretical studies suggest they may focally regulate cellular activity. The precision of GABAergic control over dendritic electrical and biochemical signaling is unknown. By using cell type-specific optical stimulation in combination with two-photon calcium (Ca2+) imaging, we show that somatostatin-expressing interneurons exert compartmentalized control over postsynaptic Ca2+ signals within individual dendritic spines. This highly focal inhibitory action is mediated by a subset of GABAergic synapses that directly target spine heads. GABAergic inhibition thus participates in localized control of dendritic electrical and biochemical signaling.	[Chiu, Chiayu Q.; Lur, Gyorgy; Morse, Thomas M.; Carnevale, Nicholas T.; Higley, Michael J.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Chiu, Chiayu Q.; Lur, Gyorgy; Higley, Michael J.] Yale Univ, Sch Med, Yale Program Cellular Neurosci Neurodegenerat & R, New Haven, CT 06510 USA; [Ellis-Davies, Graham C. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Yale University; Yale University; Icahn School of Medicine at Mount Sinai	Higley, MJ (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	m.higley@yale.edu		Chiu, Chiayu/0000-0001-5809-6306	Epilepsy Foundation; Yale Brown-Coxe Memorial Fund; Klingenstein Foundation; Sloan Foundation; Human Frontier Science Project; NIH [NS011613, DC009977, MH099045, GM053395, NS069720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099045, K01MH097961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720, R01NS011613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009977] Funding Source: NIH RePORTER	Epilepsy Foundation; Yale Brown-Coxe Memorial Fund; Klingenstein Foundation(Klingenstein Philanthropies); Sloan Foundation(Alfred P. Sloan Foundation); Human Frontier Science Project(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank G. M. Shepherd for discussions of spine function and P. DeCamilli, S. Tomita, J. Cardin, and members of the Higley laboratory for comments during the preparation of this manuscript. ChR2 plasmids were a gift from K. Deisseroth, Stanford University; TTA-A2 was a gift from B. Bean, Harvard Medical School; SOM-Cre mice were provided by J. Huang, Cold Spring Harbor Laboratory. The work was funded by grants from the Epilepsy Foundation (C. Q. C. and M. J. H.), the Yale Brown-Coxe Memorial Fund (G. L.), the Klingenstein Foundation (M. J. H.), the Sloan Foundation (M. J. H.), the Human Frontier Science Project (G.C.R.E.-D.), and awards from the NIH: NS011613 (N.T.C.), DC009977 (N.T.C. and T. M. M.), MH099045 (M. J. H.), and GM053395 and NS069720 (G.C.R.E.-D.).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Baho E, 2012, J NEUROSCI, V32, P911, DOI 10.1523/JNEUROSCI.4352-11.2012; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Ellis-Davies GCR, 2007, J NEUROSCI, V27, P6601, DOI 10.1523/JNEUROSCI.1519-07.2007; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Jadi M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002550; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1983, PROC R SOC SER B-BIO, V218, P455, DOI 10.1098/rspb.1983.0051; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Lu H, 2010, NEURON, V67, P821, DOI 10.1016/j.neuron.2010.08.012; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; QIAN N, 1990, P NATL ACAD SCI USA, V87, P8145, DOI 10.1073/pnas.87.20.8145; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	37	179	179	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					759	762		10.1126/science.1234274	http://dx.doi.org/10.1126/science.1234274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661763	Green Accepted			2022-12-24	WOS:000318619000043
J	Chang, HM; Triboulet, R; Thornton, JE; Gregory, RI				Chang, Hao-Ming; Triboulet, Robinson; Thornton, James E.; Gregory, Richard I.			A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway	NATURE			English	Article							MICRORNA BIOGENESIS; RNA DEGRADATION; 3' URIDYLATION; MESSENGER-RNA; LET-7; EXOSOME; EXPRESSION; MATURATION; RECRUITS; ZCCHC11	The pluripotency factor Lin28 blocks the expression of let-7 microRNAs in undifferentiated cells during development, and functions as an oncogene in a subset of cancers(1). Lin28 binds to let-7 precursor (pre-let-7) RNAs and recruits 39 terminal uridylyl transferases to selectively inhibit let-7 biogenesis(2-4). Uridylated pre-let-7 is refractory to processing by Dicer, and is rapidly degraded by an unknown RNase(5). Here we identify Dis3l2 as the 3'-5' exonuclease responsible for the decay of uridylated pre-let-7 in mouse embryonic stem cells. Biochemical reconstitution assays show that 3' oligouridylation stimulates Dis3l2 activity in vitro, and knockdown of Dis3l2 in mouse embryonic stem cells leads to the stabilization of pre-let-7. Our study establishes 3' oligouridylation as an RNA decay signal for Dis3l2, and identifies the first physiological RNA substrate of this new exonuclease, which is mutated in the Perlman syndrome of fetal overgrowth and causes a predisposition to Wilms' tumour development(6).	[Chang, Hao-Ming; Triboulet, Robinson; Thornton, James E.; Gregory, Richard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Chang, Hao-Ming; Triboulet, Robinson; Thornton, James E.; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Chang, Hao-Ming; Triboulet, Robinson; Thornton, James E.; Gregory, Richard I.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Gregory, RI (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	rgregory@enders.tch.harvard.edu			US National Institute of General Medical Sciences (NIGMS) [R01GM086386]; American Cancer Society [121635-RSG-11-175-01-RMC]; National Science Foundation; Boston Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Boston Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. LaPierre for technical assistance and F.-L. Meng for Rrp44 and Exosc10 shRNA. Thanks to the Children's Hospital Boston/IDDRC Proteomics Core for mass spectrometry. R. I. G. was supported by grants from the US National Institute of General Medical Sciences (NIGMS) (R01GM086386) and The American Cancer Society (121635-RSG-11-175-01-RMC). J.E.T. was supported by a pre-doctoral fellowship from the National Science Foundation. R. T. was supported by the Wolbach fellowship from Boston Children's Hospital.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Chang HM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1909; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Norbury CJ, 2010, BIOCHEM SOC T, V38, P1150, DOI 10.1042/BST0381150; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Renard BY, 2009, PROTEOMICS, V9, P4978, DOI 10.1002/pmic.200900326; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	30	230	237	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					244	+		10.1038/nature12119	http://dx.doi.org/10.1038/nature12119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23594738	Green Submitted, Green Accepted			2022-12-24	WOS:000318558200037
J	Fisher, JK; Bourniquel, A; Witz, G; Weiner, B; Prentiss, M; Kleckner, N				Fisher, Jay K.; Bourniquel, Aude; Witz, Guillaume; Weiner, Beth; Prentiss, Mara; Kleckner, Nancy			Four-Dimensional Imaging of E. coli Nucleoid Organization and Dynamics in Living Cells	CELL			English	Article							ESCHERICHIA-COLI; CHROMOSOME SEGREGATION; SPATIAL-ORGANIZATION; DNA; COMPACTION; SEPARATION; DIVISOME; PROTEIN	Visualization of living E. coli nucleoids, defined by HupA-mCherry, reveals a discrete, dynamic helical ellipsoid. Three basic features emerge. (1) Nucleoid density coalesces into longitudinal bundles, giving a stiff, low-DNA-density ellipsoid. (2) This ellipsoid is radially confined within the cell cylinder. Radial confinement gives helical shape and directs global nucleoid dynamics, including sister segregation. (3) Longitudinal density waves flux back and forth along the nucleoid, with 5%-10% of density shifting within 5 s, enhancing internal nucleoid mobility. Furthermore, sisters separate end-to-end in sequential discontinuous pulses, each elongating the nucleoid by 5%-15%. Pulses occur at 20 min intervals, at defined cell-cycle times. This progression includes sequential installation and release of programmed tethers, implying cyclic accumulation and relief of intranucleoid mechanical stress. These effects could comprise a chromosome-based cell-cycle engine. Overall, the presented results suggest a general conceptual framework for bacterial nucleoid nnorphogenesis and dynamics.	[Fisher, Jay K.; Bourniquel, Aude; Witz, Guillaume; Weiner, Beth; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Prentiss, Mara] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu	Prentiss, Mara/AAU-2940-2021	Witz, Guillaume/0000-0003-1562-4265	NIH [NIH/NIGMS-R01-GM025326, NIBEB-5-P41-EB002025]; Swiss National Science Foundation [PBELP3-135860]; Center for Nanoscale Systems (CNS) at Harvard University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326, R01GM044794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center for Nanoscale Systems (CNS) at Harvard University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Guidotti, K. Mizuuchi, E. Garner, and Kleckner laboratory members for helpful comments; D. Jeruzalmi and J. Vertrees for adaptation of PyMOL to nucleoid images; and R. Johnson for a FIS-GFP plasmid. Research was supported by NIH grant NIH/NIGMS-R01-GM025326 to N.K. and Swiss National Science Foundation grant PBELP3-135860 to G.W. We acknowledge the Center for Computer Integrated Systems for Microscopy and Manipulation at UNC Chapel Hill, funded by NIH grant NIBEB-5-P41-EB002025, and the Center for Nanoscale Systems (CNS) at Harvard University, a member of the National Nanotechnology Infrastructure Network.	Adams M, 1998, BIOPHYS J, V74, P669, DOI 10.1016/S0006-3495(98)77826-9; Banigan EJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002145; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bates D, 2005, MOL MICROBIOL, V57, P380, DOI 10.1111/j.1365-2958.2005.04693.x; Bates D, 2008, MOL MICROBIOL, V69, P1341, DOI 10.1111/j.1365-2958.2008.06378.x; Berlatzky IA, 2008, P NATL ACAD SCI USA, V105, P14136, DOI 10.1073/pnas.0804982105; Chaudhuri D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268305; Cunha S, 2001, J STRUCT BIOL, V136, P53, DOI 10.1006/jsbi.2001.4420; Espeli O, 2012, EMBO J, V31, P3198, DOI 10.1038/emboj.2012.128; Joshi MC, 2011, P NATL ACAD SCI USA, V108, P2765, DOI 10.1073/pnas.1019593108; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; NORRIS V, 1995, MOL MICROBIOL, V16, P1051, DOI 10.1111/j.1365-2958.1995.tb02330.x; Odijk T, 1998, BIOPHYS CHEM, V73, P23, DOI 10.1016/S0301-4622(98)00115-X; Reyes-Larnothe R, 2008, TRENDS MICROBIOL, V16, P238, DOI 10.1016/j.tim.2008.02.003; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Swulius MT, 2012, J BACTERIOL, V194, P6382, DOI 10.1128/JB.00505-12; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wiggins PA, 2010, P NATL ACAD SCI USA, V107, P4991, DOI 10.1073/pnas.0912062107; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071	32	190	191	0	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					882	895		10.1016/j.cell.2013.04.006	http://dx.doi.org/10.1016/j.cell.2013.04.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23623305	Bronze, Green Accepted			2022-12-24	WOS:000318844000016
J	Shukla, AK; Manglik, A; Kruse, AC; Xiao, KH; Reis, RI; Tseng, WC; Staus, DP; Hilger, D; Uysal, S; Huang, LY; Paduch, M; Tripathi-Shukla, P; Koide, A; Koide, S; Weis, WI; Kossiakoff, AA; Kobilka, BK; Lefkowitz, RJ				Shukla, Arun K.; Manglik, Aashish; Kruse, Andrew C.; Xiao, Kunhong; Reis, Rosana I.; Tseng, Wei-Chou; Staus, Dean P.; Hilger, Daniel; Uysal, Serdar; Huang, Li-Yin; Paduch, Marcin; Tripathi-Shukla, Prachi; Koide, Akiko; Koide, Shohei; Weis, William I.; Kossiakoff, Anthony A.; Kobilka, Brian K.; Lefkowitz, Robert J.			Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide	NATURE			English	Article							CRYSTAL-STRUCTURE; BETA-ARRESTIN; TERNARY COMPLEX; LIGAND-BINDING; CONFORMATION; STATE; ENDOCYTOSIS; MECHANISM; DOMAIN	The functions of G-protein-coupled receptors (GPCRs) are primarily mediated and modulated by three families of proteins: the heterotrimeric G proteins, the G-protein-coupled receptor kinases (GRKs) and the arrestins(1). G proteins mediate activation of second-messenger-generating enzymes and other effectors, GRKs phosphorylate activated receptors(2), and arrestins subsequently bind phosphorylated receptors and cause receptor desensitization(3). Arrestins activated by interaction with phosphorylated receptors can also mediate G-protein-independent signalling by serving as adaptors to link receptors to numerous signalling pathways(4). Despite their central role in regulation and signalling of GPCRs, a structural understanding of beta-arrestin activation and interaction with GPCRs is still lacking. Here we report the crystal structure of beta-arrestin-1 (also called arrestin-2) in complex with a fully phosphorylated 29-amino-acid carboxy-terminal peptide derived from the human V2 vasopressin receptor (V2Rpp). This peptide has previously been shown to functionally and conformationally activate beta-arrestin-1 (ref. 5). To capture this active conformation, we used a conformationally selective synthetic antibody fragment (Fab30) that recognizes the phosphopeptide-activated state of beta-arrestin-1. The structure of the beta-arrestin-1-V2Rpp-Fab30 complex shows marked conformational differences in beta-arrestin-1 compared to its inactive conformation. These include rotation of the amino- and carboxy-terminal domains relative to each other, and a major reorientation of the 'lariat loop' implicated in maintaining the inactive state of beta-arrestin-1. These results reveal, at high resolution, a receptor-interacting interface on beta-arrestin, and they indicate a potentially general molecular mechanism for activation of these multifunctional signalling and regulatory proteins.	[Shukla, Arun K.; Xiao, Kunhong; Reis, Rosana I.; Tseng, Wei-Chou; Staus, Dean P.; Huang, Li-Yin; Tripathi-Shukla, Prachi; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Manglik, Aashish; Kruse, Andrew C.; Hilger, Daniel; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Uysal, Serdar; Paduch, Marcin; Koide, Akiko; Koide, Shohei; Kossiakoff, Anthony A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27706 USA	Duke University; Stanford University; University of Chicago; Stanford University; Duke University; Howard Hughes Medical Institute; Duke University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	kobilka@stanford.edu; lefko001@receptor-biol.duke.edu	Weis, William I/G-1437-2011; Xiao, Kunhong/AAG-4275-2020; Lefkowitz, Robert/AAW-2649-2021; Hilger, Daniel/C-7297-2019; dos Reis, Rosana Maria/E-3346-2012	Weis, William I/0000-0002-5583-6150; Xiao, Kunhong/0000-0002-1069-1226; Hilger, Daniel/0000-0001-5179-1357; shukla, arun/0000-0003-2910-8288; Kobilka, Brian/0000-0001-5958-3990; Koide, Shohei/0000-0001-5473-4358; dos Reis, Rosana Maria/0000-0001-9631-4167; Reis, Rosana/0000-0002-0465-8331	Stanford Medical Scientist Training Program; American Heart Association; National Science Foundation; National Institutes of Health [NS028471, HL16037, HL70631, GM072688, GM087519, HL 075443]; Mathers Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R37HL016037, R01HL016037, P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688, U54GM074946, U01GM094588, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Capel for technical assistance and V. Ronk, D. Addison and Q. Lennon for administrative and secretarial support. We thank S. Ahn and L. Wingler for critical reading of the manuscript. We acknowledge support from the Stanford Medical Scientist Training Program and the American Heart Association (A. M.), from the National Science Foundation (A. C. K.), from the National Institutes of Health Grants NS028471 (B. K. K.), HL16037 and HL70631 (R.J.L.), GM072688 and GM087519 (A. A. K. and S. K.), HL 075443 (K. X.) and from the Mathers Foundation (B. K. K. and W. I. W.). R. I. R is supported by a post-doctoral fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES. R.J.L. is an investigator with the Howard Hughes Medical Institute.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P15334; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Schrodinger L., 2020, PYMOL; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	38	275	280	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					137	+		10.1038/nature12120	http://dx.doi.org/10.1038/nature12120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23604254	Green Accepted, Green Submitted			2022-12-24	WOS:000318221500049
J	Fenton, JJ; Xing, GB; Elmore, JG; Bang, H; Chen, SL; Lindfors, KK; Baldwin, LM				Fenton, Joshua J.; Xing, Guibo; Elmore, Joann G.; Bang, Heejung; Chen, Steven L.; Lindfors, Karen K.; Baldwin, Laura-Mae			Short-Term Outcomes of Screening Mammography Using Computer-Aided Detection A Population-Based Study of Medicare Enrollees	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER DETECTION; DIGITAL MAMMOGRAPHY; ASSISTED DETECTION; UNITED-STATES; PERFORMANCE; VALIDATION; IMPACT; CLAIMS; THERAPY; PROGRAM	Background: Computer-aided detection (CAD) has rapidly diffused into screening mammography practice despite limited and conflicting data on its clinical effect. Objective: To determine associations between CAD use during screening mammography and the incidence of ductal carcinoma in situ (DCIS) and invasive breast cancer, invasive cancer stage, and diagnostic testing. Design: Retrospective cohort study. Setting: Medicare program. Participants: Women aged 67 to 89 years having screening mammography between 2001 and 2006 in U. S. SEER (Surveillance, Epidemiology and End Results) regions (409 459 mammograms from 163 099 women). Measurements: Incident DCIS and invasive breast cancer within 1 year after mammography, invasive cancer stage, and diagnostic testing within 90 days after screening among women without breast cancer. Results: From 2001 to 2006, CAD prevalence increased from 3.6% to 60.5%. Use of CAD was associated with greater DCIS incidence (adjusted odds ratio [OR], 1.17 [95% CI, 1.11 to 1.23]) but no difference in invasive breast cancer incidence (adjusted OR, 1.00 [CI, 0.97 to 1.03]). Among women with invasive cancer, CAD was associated with greater likelihood of stage I to II versus III to IV cancer (adjusted OR, 1.27 [CI, 1.14 to 1.41]). In women without breast cancer, CAD was associated with increased odds of diagnostic mammography (adjusted OR, 1.28 [CI, 1.27 to 1.29]), breast ultrasonography (adjusted OR, 1.07 [CI, 1.06 to 1.09]), and breast biopsy (adjusted OR, 1.10 [CI, 1.08 to 1.12]). Limitation: Short follow-up for cancer stage, potential unmeasured confounding, and uncertain generalizability to younger women. Conclusion: Use of CAD during screening mammography among Medicare enrollees is associated with increased DCIS incidence, the diagnosis of invasive breast cancer at earlier stages, and increased diagnostic testing among women without breast cancer.	Univ Calif Davis, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA; Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; City Hope Natl Med Ctr, Duarte, CA 91010 USA; Univ Washington, Seattle, WA 98195 USA	University of California System; University of California Davis; University of California System; University of California Davis; City of Hope; University of Washington; University of Washington Seattle	Fenton, JJ (corresponding author), Univ Calif Davis, Dept Family & Community Med, 4860 Y St,Suite 2300, Sacramento, CA 95817 USA.	joshua.fenton@ucdmc.ucdavis.edu	Fenton, Joshua/AAD-4114-2021	Fenton, Joshua/0000-0002-0581-835X	Center for Healthcare Policy and Research, University of California, Davis; Clinical and Translational Science Center; National Cancer Institute [K05 CA-104699]; NATIONAL CANCER INSTITUTE [K05CA104699, P30CA093373] Funding Source: NIH RePORTER	Center for Healthcare Policy and Research, University of California, Davis; Clinical and Translational Science Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Center for Healthcare Policy and Research, University of California, Davis.; By the Clinical and Translational Science Center and Center for Healthcare Policy and Research, University of California, Davis, and the National Cancer Institute (K05 CA-104699).	Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Baldwin LM, 2002, MED CARE, V40, P82; Bazzocchi M, 2007, RADIOL MED, V112, P329, DOI 10.1007/s11547-007-0145-5; Brancato B, 2008, BREAST CANCER RES TR, V111, P373, DOI 10.1007/s10549-007-9786-2; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Cupples TE, 2005, AM J ROENTGENOL, V185, P944, DOI 10.2214/AJR.04.1300; Duffy SW, 2003, EUR J CANCER, V39, P1755, DOI 10.1016/S0959-8049(03)00259-4; Edge SB, 2010, AJCC CANC STAGING MA; Fenton JJ, 2012, MED CARE; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Fenton JJ, 2012, CANCER EPIDEM BIOMAR, V21, P1344, DOI 10.1158/1055-9965.EPI-12-0406; Fenton JJ, 2011, J NATL CANCER I, V103, P1152, DOI 10.1093/jnci/djr206; Fenton JJ, 2010, ARCH INTERN MED, V170, P987, DOI 10.1001/archinternmed.2010.104; Fenton JJ, 2009, CANCER EPIDEM BIOMAR, V18, P2186, DOI 10.1158/1055-9965.EPI-09-0338; Freer TW, 2001, RADIOLOGY, V220, P781, DOI 10.1148/radiol.2203001282; Gilbert FJ, 2008, NEW ENGL J MED, V359, P1675, DOI 10.1056/NEJMoa0803545; Gromet M, 2008, AM J ROENTGENOL, V190, P854, DOI 10.2214/AJR.07.2812; Gross CP, 2013, JAMA INTERN MED, V173, P220, DOI 10.1001/jamainternmed.2013.1397; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Jiang YL, 2007, RADIOLOGY, V243, P360, DOI 10.1148/radiol.2432060253; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Karssemeijer N, 2009, RADIOLOGY, V253, P353, DOI 10.1148/radiol.2532090225; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Miglioretti DL, 2009, RADIOLOGY, V253, P632, DOI 10.1148/radiol.2533090070; Morton MJ, 2006, RADIOLOGY, V239, P375, DOI 10.1148/radiol.2392042121; Nelson HD, 2009, AHRQ PUBLICATION, V10-05142-EF-1; Neuhaus JM, 2001, ANNU REV PUBL HEALTH, V22, P115, DOI 10.1146/annurev.publhealth.22.1.115; Povyakalo AA, 2013, MED DECIS MAKING, V33, P98, DOI 10.1177/0272989X12465490; Rao VM, 2010, J AM COLL RADIOL, V7, P802, DOI 10.1016/j.jacr.2010.05.019; Romero C, 2011, AM J ROENTGENOL, V197, P1492, DOI 10.2214/AJR.09.3408; Taplin SH, 2006, AM J ROENTGENOL, V187, P1475, DOI 10.2214/AJR.05.0940; Taylor P, 2008, EUR J CANCER, V44, P798, DOI 10.1016/j.ejca.2008.02.016; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; van den Biggelaar FJHM, 2010, BREAST CANCER RES TR, V120, P499, DOI 10.1007/s10549-009-0409-y; Warren JL, 2002, MED CARE, V40, P3; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048; Yasmeen S, 2011, CANCER-AM CANCER SOC, V117, P3252, DOI 10.1002/cncr.25857; Zheng B, 2001, RADIOLOGY, V221, P633, DOI 10.1148/radiol.2213010308	42	46	47	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2013	158	8					580	+		10.7326/0003-4819-158-8-201304160-00002	http://dx.doi.org/10.7326/0003-4819-158-8-201304160-00002			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132IW	23588746	Green Accepted			2022-12-24	WOS:000318062100014
J	Williams, SA; Ostrofsky, KR; Frater, N; Churchill, SE; Schmid, P; Berger, LR				Williams, Scott A.; Ostrofsky, Kelly R.; Frater, Nakita; Churchill, Steven E.; Schmid, Peter; Berger, Lee R.			The Vertebral Column of Australopithecus sediba	SCIENCE			English	Article							LUMBAR LORDOSIS; STANDING POSITION; PARTIAL SKELETON; HOMO-ERECTUS; AFRICAN APES; SOUTH-AFRICA; EVOLUTION; HOMININS; PELVIS; SPINE	Two partial vertebral columns of Australopithecus sediba grant insight into aspects of early hominin spinal mobility, lumbar curvature, vertebral formula, and transitional vertebra position. Au. sediba likely possessed five non-rib-bearing lumbar vertebrae and five sacral elements, the same configuration that occurs modally in modern humans. This finding contrasts with other interpretations of early hominin regional vertebral numbers. Importantly, the transitional vertebra is distinct from and above the last rib-bearing vertebra in Au. sediba, resulting in a functionally longer lower back. This configuration, along with a strongly wedged last lumbar vertebra and other indicators of lordotic posture, would have contributed to a highly flexible spine that is derived compared with earlier members of the genus Australopithecus and similar to that of the Nariokotome Homo erectus skeleton.	[Williams, Scott A.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Williams, Scott A.] New York Consortium Evolutionary Primatol, New York, NY 10024 USA; [Ostrofsky, Kelly R.; Churchill, Steven E.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Frater, Nakita; Schmid, Peter] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Churchill, Steven E.; Schmid, Peter; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa	New York University; Duke University; University of Zurich; University of Witwatersrand	Williams, SA (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, 25 Waverly Pl, New York, NY 10003 USA.	sawilliams@nyu.edu	Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629	University of the Witwatersrand; Ray A. Rothrock '77 Fellowship; South African Department of Science and Technology; Gauteng Provincial Government; South African National Research Foundation; African Origins Platform; Institute for Human Origins; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U. S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Duke University; Texas AM University; Oppenheimer family; Ackerman family	University of the Witwatersrand; Ray A. Rothrock '77 Fellowship; South African Department of Science and Technology; Gauteng Provincial Government; South African National Research Foundation(National Research Foundation - South Africa); African Origins Platform; Institute for Human Origins; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U. S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation; Duke University; Texas AM University; Oppenheimer family; Ackerman family	We thank the South African Heritage Resource agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology, the Gauteng Provincial Government, the South African National Research Foundation and the African Origins Platform, the Institute for Human Origins, University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U. S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the A. H. Schultz Foundation, Duke University, the Ray A. Rothrock '77 Fellowship and International Research Travel Assistance Grant of Texas A&M University, and the Oppenheimer and Ackerman families and R. Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, and the Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We thank E. Mbua, P. Kiura, V. Iminjili, the National Museums of Kenya, B. Billings, B. Zipfel, the School of Anatomical Sciences at the University of the Witwatersrand, S. Potze, L. C. Kgasi, and the Ditsong Museum for access to comparative specimens; the Virtual Image Processing lab of the Palaeosciences Centre and the Microfocus X-ray CT facility of the Palaeosciences Centre at Wits for funding these facilities; the University of the Witwatersrand Office of Research and the National Research Fund Strategic Research Infrastructure Grant and African Origins Platform funding programs; and Duke University and the University of Zurich 2009 and 2010 Field Schools for technical and material support. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given substantial support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated computed tomography scanning of the specimens, A. Val provided information of CT slices, W. Sanders and K. Whitcome made data on fossil specimens and casts available, M. Grabowski provided helpful comments on the manuscript, and M. Shattuck provided valuable comments and assisted substantially with the revision of this manuscript. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens. Data reported in this study are available in the supplementary materials.	ABITBOL MM, 1995, J HUM EVOL, V28, P211, DOI 10.1006/jhev.1995.1017; ABITBOL MM, 1987, AM J PHYS ANTHROPOL, V72, P361; Been E, 2012, AM J PHYS ANTHROPOL, V147, P64, DOI 10.1002/ajpa.21633; Benade M. M., 1990, THESIS U WITWATERSAN; Berge C, 2010, J HUM EVOL, V58, P262, DOI 10.1016/j.jhevol.2009.11.006; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Betsch M, 2011, ARTHRIT CARE RES, V63, P1758, DOI 10.1002/acr.20601; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; DICKSON RA, 1987, J BONE JOINT SURG BR, V69, P690, DOI 10.1302/0301-620X.69B5.3680325; Duval K, 2010, GAIT POSTURE, V32, P637, DOI 10.1016/j.gaitpost.2010.09.007; Grabowski MW, 2011, EVOLUTION, V65, P1336, DOI 10.1111/j.1558-5646.2011.01226.x; Haeusler M, 2002, J HUM EVOL, V43, P621, DOI 10.1006/jhev.2002.0595; Haeusler M, 2012, J HUM EVOL, V63, P557, DOI 10.1016/j.jhevol.2012.05.011; Haeusler M, 2011, J HUM EVOL, V61, P575, DOI 10.1016/j.jhevol.2011.07.004; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Khamis S, 2007, GAIT POSTURE, V25, P127, DOI 10.1016/j.gaitpost.2006.02.005; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Latimer Bruce, 1993, P266; Levine D, 1996, J ORTHOP SPORT PHYS, V24, P130, DOI 10.2519/jospt.1996.24.3.130; Lewton KL, 2012, EVOL BIOL, V39, P126, DOI 10.1007/s11692-011-9143-6; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lovejoy CO, 2010, PHILOS T R SOC B, V365, P3289, DOI 10.1098/rstb.2010.0112; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Mccollum MA, 2010, J EXP ZOOL PART B, V314B, P123, DOI 10.1002/jez.b.21316; Meyer M.R., 2005, THESIS U PENNSYLVANI; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pilbeam D, 2004, J EXP ZOOL PART B, V302B, P241, DOI 10.1002/jez.b.22; Robinson J.T., 1972, EARLY HOMINID POSTUR; Rockwell H, 1938, J MORPHOL, V63, P87, DOI 10.1002/jmor.1050630105; Rosenman BA, 2008, THESIS KENT STATE U; Russo GA, 2010, AM J PHYS ANTHROPOL, V142, P600, DOI 10.1002/ajpa.21283; Sanders Rob, 2018, PRIDE STORY HARVEY M; Sanders WJ, 1998, J HUM EVOL, V34, P249, DOI 10.1006/jhev.1997.0193; SHAPIRO L, 1993, J HUM EVOL, V25, P433, DOI 10.1006/jhev.1993.1061; Shapiro Liza, 1993, P121; TOBIAS PV, 1992, T ROY SOC S AFR, V48, P1, DOI 10.1080/00359199209520253; Tobias PV, 1998, J ROY ANTHROPOL INST, V4, P283, DOI 10.2307/3034503; Toussaint M, 2003, S AFR J SCI, V99, P215; WALKER A, 1982, NATURE, V296, P248, DOI 10.1038/296248a0; Walker Alan, 1993, P95; Ward CV, 2005, SPINE, V30, P1808, DOI 10.1097/01.brs.0000174273.85164.67; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; Whitcome KK, 2012, J HUM EVOL, V62, P486, DOI 10.1016/j.jhevol.2012.01.008; Williams SA, 2011, THESIS U ILLINOIS UR; Williams SA, 2012, J HUM EVOL, V63, P552, DOI 10.1016/j.jhevol.2012.01.007; Williams SA, 2012, J EXP ZOOL PART B, V318B, P134, DOI 10.1002/jezb.21451; Williams SA, 2012, AM J PHYS ANTHROPOL, V148, P111, DOI 10.1002/ajpa.22049; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703; [No title captured]	51	57	57	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2013	340	6129								10.1126/science.1232996	http://dx.doi.org/10.1126/science.1232996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580532				2022-12-24	WOS:000317341400001
J	Heredia, JE; Mukundan, L; Chen, FM; Mueller, AA; Deo, RC; Locksley, RM; Rando, TA; Chawla, A				Heredia, Jose E.; Mukundan, Lata; Chen, Francis M.; Mueller, Alisa A.; Deo, Rahul C.; Locksley, Richard M.; Rando, Thomas A.; Chawla, Ajay			Type 2 Innate Signals Stimulate Fibro/Adipogenic Progenitors to Facilitate Muscle Regeneration	CELL			English	Article							IMMUNE-SYSTEM; MACROPHAGE; CELLS; INJURY; ACTIVATION; TISSUE; IL-4; HYPERTROPHY; EXPRESSION; REGULATOR	In vertebrates, activation of innate immunity is an early response to injury, implicating it in the regenerative process. However, the mechanisms by which innate signals might regulate stem cell functionality are unknown. Here, we demonstrate that type 2 innate immunity is required for regeneration of skeletal muscle after injury. Muscle damage results in rapid recruitment of eosinophils, which secrete IL-4 to activate the regenerative actions of muscle resident fibro/adipocyte progenitors (FAPs). In FAPs, IL-4/IL-13 signaling serves as a key switch to control their fate and functions. Activation of IL-4/IL-13 signaling promotes proliferation of FAPs to support myogenesis while inhibiting their differentiation into adipocytes. Surprisingly, type 2 cytokine signaling is also required in FAPs, but not in myeloid cells, for rapid clearance of necrotic debris, a process that is necessary for timely and complete regeneration of tissues.	[Heredia, Jose E.; Mukundan, Lata; Chen, Francis M.; Deo, Rahul C.; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Deo, Rahul C.; Locksley, Richard M.; Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Mueller, Alisa A.; Rando, Thomas A.] Stanford Univ, Paul F Glenn Labs Biol Aging, Sch Med, Stanford, CA 94305 USA; [Mueller, Alisa A.; Rando, Thomas A.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Deo, Rahul C.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Deo, Rahul C.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA; [Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Rehabil Res & Dev Ctr Excellence, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu		Chen, Francis M./0000-0002-6615-4155; Rando, Thomas/0000-0001-5843-8564; Mueller, Alisa/0000-0002-1342-6962	NIH [DK081405, DP1AR064158, AG023806, AG036695, DP1 OD000392, 5T32HL007731]; California Institute for Regenerative Medicine Predoctoral Fellowship [TG2-01159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731, K08HL098361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158, R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R37AG023806, R01AG023806] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000392, DP1OD006415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine Predoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chawla laboratory and B. Black for discussions and A. Loh for comments on the manuscript. This work was supported by NIH grant DK081405 and an NIH Director's Pioneer Award (DP1AR064158) to A. C.; by NIH grants R37 Merit Award (AG023806) and P01 (AG036695) and NIH Director's Pioneer Award (DP1 OD000392) to T. A. R.; by California Institute for Regenerative Medicine Predoctoral Fellowship (TG2-01159) to A. A. M.; by the NIH Training Grant (5T32HL007731) to J.E.M. All animal care and procedures were performed in accordance with Stanford University's A-PLAC and UCSF's IACUC guidelines.	Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brunelli S, 2008, PHARMACOL RES, V58, P117, DOI 10.1016/j.phrs.2008.06.008; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Karp CL, 2012, J EXP MED, V209, P427, DOI 10.1084/jem.20120295; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; MCGARRY MP, 1991, J LEUKOCYTE BIOL, V50, P471, DOI 10.1002/jlb.50.5.471; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rosen ED, 2000, GENE DEV, V14, P1293; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wynes MW, 2003, J IMMUNOL, V171, P3550, DOI 10.4049/jimmunol.171.7.3550; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	45	480	489	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					376	388		10.1016/j.cell.2013.02.053	http://dx.doi.org/10.1016/j.cell.2013.02.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582327	Green Accepted, Bronze			2022-12-24	WOS:000317349700016
J	Pasterkamp, RJ; Kolodkin, AL				Pasterkamp, R. Jeroen; Kolodkin, Alex L.			SnapShot: Axon Guidance	CELL			English	Editorial Material							PROTOCADHERINS		[Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; [Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, HHMI, Dept Neurosci, Baltimore, MD 21212 USA	Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; Johns Hopkins University	Pasterkamp, RJ (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands.			Pasterkamp, Jeroen/0000-0003-1631-6440				Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Derijck AAHA, 2010, TRENDS CELL BIOL, V20, P568, DOI 10.1016/j.tcb.2010.06.007; Dickson BJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002055; Feldheim D.A., 2010, COLD SPRING HARB PER, V2; Kolodkin AL, 2011, COLD SPRING HARB PER, V3; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	10	15	15	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					494	+	494.e1	10.1016/j.cell.2013.03.031	http://dx.doi.org/10.1016/j.cell.2013.03.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582334	Bronze			2022-12-24	WOS:000317349700027
J	Bar-Peled, L; Chantranupong, L; Cherniack, AD; Chen, WW; Ottina, KA; Grabiner, BC; Spear, ED; Carter, SL; Meyerson, M; Sabatini, DM				Bar-Peled, Liron; Chantranupong, Lynne; Cherniack, Andrew D.; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Spear, Eric D.; Carter, Scott L.; Meyerson, Matthew; Sabatini, David M.			A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1	SCIENCE			English	Article							HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; PTEN-DEFICIENT; SENSITIVITY; INHIBITION; ACTIVATION; RAGULATOR; AUTOPHAGY; TARGET; CANCER	The mTOR complex 1 (mTORC1) pathway promotes cell growth in response to many cues, including amino acids, which act through the Rag guanosine triphosphatases (GTPases) to promote mTORC1 translocation to the lysosomal surface, its site of activation. Although progress has been made in identifying positive regulators of the Rags, it is unknown if negative factors also exist. Here, we identify GATOR as a complex that interacts with the Rags and is composed of two subcomplexes we call GATOR1 and -2. Inhibition of GATOR1 subunits (DEPDC5, Nprl2, and Nprl3) makes mTORC1 signaling resistant to amino acid deprivation. In contrast, inhibition of GATOR2 subunits (Mios, WDR24, WDR59, Seh1L, and Sec13) suppresses mTORC1 signaling, and epistasis analysis shows that GATOR2 negatively regulates DEPDC5. GATOR1 has GTPase-activating protein (GAP) activity for RagA and RagB, and its components are mutated in human cancer. In cancer cells with inactivating mutations in GATOR1, mTORC1 is hyperactive and insensitive to amino acid starvation, and such cells are hypersensitive to rapamycin, an mTORC1 inhibitor. Thus, we identify a key negative regulator of the Rag GTPases and reveal that, like other mTORC1 regulators, Rag function can be deregulated in cancer.	[Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Chantranupong, Lynne; Chen, Walter W.; Ottina, Kathleen A.; Grabiner, Brian C.; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Cherniack, Andrew D.; Carter, Scott L.; Meyerson, Matthew; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Spear, Eric D.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Cherniack, Andrew D./AAY-8132-2020	Cherniack, Andrew D./0000-0003-0470-0111; Meyerson, Matthew/0000-0002-9133-8108; /0000-0002-1446-7256; Chen, Walter/0000-0002-7752-9581	NIH [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; National Cancer Institute (NIH) [U24CA143867]; David H. Koch Graduate Fellowship Fund; NSF; Harvard-MIT Health, Sciences, and Technology IDEA2 program; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA103866, P30CA014051, U24CA143867, F31CA180271, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); David H. Koch Graduate Fellowship Fund; NSF(National Science Foundation (NSF)); Harvard-MIT Health, Sciences, and Technology IDEA2 program; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Sabatini lab fur helpful suggestions, E. Spooner fur the mass spectrometric analysis of samples, and N. Kory for technical assistance. This work was supported by grants from the NIH (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D.M.S. and the National Cancer Institute (NIH) (U24CA143867) to M.M. and awards from the David H. Koch Graduate Fellowship Fund to L.B.-P.; the NSF Graduate Research Fellowship Program to L.C.; the Harvard-MIT Health, Sciences, and Technology IDEA<SUP>2</SUP> program to W.W.C.; and the American Cancer Society to B.C.G. D.M.S. is an investigator of the Howard Hughes Medical Institute.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Dokudovskaya S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006478; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Iida T, 2004, DEVELOPMENT, V131, P1029, DOI 10.1242/dev.01001; Ji L, 2002, CANCER RES, V62, P2715; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leksa NC, 2010, NUCLEUS-PHILA, V1, P314, DOI 10.4161/nucl.1.4.11798; Lerman MI, 2000, CANCER RES, V60, P6116; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Seng TJ, 2005, GENE CHROMOSOME CANC, V43, P181, DOI 10.1002/gcc.20181; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	26	662	715	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1100	1106		10.1126/science.1232044	http://dx.doi.org/10.1126/science.1232044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723238	Green Submitted, Green Accepted			2022-12-24	WOS:000319664500046
J	Galetti, M; Guevara, R; Cortes, MC; Fadini, R; Von Matter, S; Leite, AB; Labecca, F; Ribeiro, T; Carvalho, CS; Collevatti, RG; Pires, MM; Guimaraes, PR; Brancalion, PH; Ribeiro, MC; Jordano, P				Galetti, Mauro; Guevara, Roger; Cortes, Marina C.; Fadini, Rodrigo; Von Matter, Sandro; Leite, Abraao B.; Labecca, Fabio; Ribeiro, Thiago; Carvalho, Carolina S.; Collevatti, Rosane G.; Pires, Mathias M.; Guimaraes, Paulo R., Jr.; Brancalion, Pedro H.; Ribeiro, Milton C.; Jordano, Pedro			Functional Extinction of Birds Drives Rapid Evolutionary Changes in Seed Size	SCIENCE			English	Article							PALM EUTERPE-EDULIS; AVIAN FRUGIVORES; GERMINATION; PREDATORS; DISPERSAL; SURVIVAL; DENSITY; TREE	Local extinctions have cascading effects on ecosystem functions, yet little is known about the potential for the rapid evolutionary change of species in human-modified scenarios. We show that the functional extinction of large-gape seed dispersers in the Brazilian Atlantic forest is associated with the consistent reduction of the seed size of a keystone palm species. Among 22 palm populations, areas deprived of large avian frugivores for several decades present smaller seeds than nondefaunated forests, with negative consequences for palm regeneration. Coalescence and phenotypic selection models indicate that seed size reduction most Likely occurred within the past 100 years, associated with human-driven fragmentation. The fast-paced defaunation of large vertebrates is most Likely causing unprecedented changes in the evolutionary trajectories and community composition of tropical forests.	[Galetti, Mauro; Cortes, Marina C.; Leite, Abraao B.; Labecca, Fabio; Ribeiro, Thiago; Ribeiro, Milton C.] Univ Estadual Paulista, Dept Ecol, BR-13506900 Sao Paulo, Brazil; [Guevara, Roger] AC Red Biol Evolut, Inst Ecol, Xalapa 91070, Veracruz, Mexico; [Fadini, Rodrigo] Univ Fed Oeste Para, Inst Biodiversidade & Florestas, BR-68035110 Santarem, Para, Brazil; [Von Matter, Sandro] Univ Fed Rural Estado Rio de Janeiro, Dept Biol Anim, BR-23897000 Rio De Janeiro, Brazil; [Carvalho, Carolina S.; Collevatti, Rosane G.] Univ Fed Goias, Lab Genet & Biodiversidade, BR-74001970 Goiania, Go, Brazil; [Pires, Mathias M.; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Dept Ecol, BR-0550890 Sao Paulo, Brazil; [Brancalion, Pedro H.] Univ Sao Paulo, Esco Super Agr Luiz de Queiroz, Dept Ciencias Florestais, BR-13418900 Sao Paulo, Brazil; [Jordano, Pedro] CSIC, EBD, Integrat Ecol Grp, E-41092 Seville, Spain	Universidade Estadual Paulista; Instituto de Ecologia - Mexico; Universidade Federal do Oeste do Para; Universidade Federal de Goias; Universidade de Sao Paulo; Universidade de Sao Paulo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Galetti, M (corresponding author), Univ Estadual Paulista, Dept Ecol, BR-13506900 Sao Paulo, Brazil.	mgaletti@rc.unesp.br	Guevara, Roger/F-3287-2010; Brancalion, Pedro/D-6995-2012; Galetti, Mauro/M-8751-2013; Fadini, Rodrigo/C-7574-2013; Collevatti, Rosane/D-8673-2013; Guimarães-Junior, Paulo R/M-1298-2016; Leite, Abraão/AAE-2362-2020; Pires, Mathias/I-4489-2012; Jordano, Pedro/A-5162-2008; Côrtes, Marina Corrêa/I-2155-2012; Galetti, Mauro/C-5275-2008; Carvalho, Carolina/E-9746-2013; Von Matter, Sandro/M-7151-2013; Guimaraes, Paulo R./E-1915-2016	Guevara, Roger/0000-0003-0768-3580; Brancalion, Pedro/0000-0001-8245-4062; Galetti, Mauro/0000-0002-8187-8696; Fadini, Rodrigo/0000-0002-6873-1438; Collevatti, Rosane/0000-0002-3733-7059; Pires, Mathias/0000-0003-2500-4748; Jordano, Pedro/0000-0003-2142-9116; Côrtes, Marina Corrêa/0000-0003-3389-5050; Galetti, Mauro/0000-0002-8187-8696; Carvalho, Carolina/0000-0002-0063-2185; Von Matter, Sandro/0000-0002-0412-3820; Guimaraes, Paulo R./0000-0001-9161-8305	Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia); Programa Iberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED)	Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia); Programa Iberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED)	We thank the Fundacao de Amparo do Estado de Sao Paulo (BIOTA - FAPESP); Conselho Nacional de Desenvolvimento Cientifico (CNPq), (Excellence Grant-Junta Andalucia (to P.J.); and Programa lberoamericano de Ciencia y Tecnologia para el Desarollo (CYTED) for funding support. We thank J. Bascompte, R. Dirzo, D. Hansen, D. Levey, E. Bruna, D. Lapola, D. McCauley, M. A. Pizo, and three reviewers for useful comments and suggestions; T. A. Ferreira, E. Cazetta,	Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Dean W., 1976, RIO CLARO BRAZILIAN; Falconer D. S, 1996, INTRO QUANTITATIVE G; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Holbrook KM, 2009, ECOLOGY, V90, P1449, DOI 10.1890/08-1332.1; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; Leite AD, 2012, J TROP ECOL, V28, P615, DOI 10.1017/S0266467412000594; LEVEY DJ, 1987, AM NAT, V129, P471, DOI 10.1086/284652; Marengo JA, 2010, CLIMATIC CHANGE, V98, P509, DOI 10.1007/s10584-009-9743-7; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; Matos DMS, 1999, ECOLOGY, V80, P2635, DOI 10.2307/177246; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pizo MA, 2001, ACTA OECOL, V22, P229, DOI 10.1016/S1146-609X(01)01108-0; Pizo MA, 2006, ACTA OECOL, V29, P311, DOI 10.1016/j.actao.2005.11.011; Roels SAB, 2011, EVOLUTION, V65, P2541, DOI 10.1111/j.1558-5646.2011.01326.x; Sodhi NS, 2004, ANNU REV ECOL EVOL S, V35, P323, DOI 10.1146/annurev.ecolsys.35.112202.130209	22	452	473	10	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2013	340	6136					1086	1090		10.1126/science.1233774	http://dx.doi.org/10.1126/science.1233774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723235				2022-12-24	WOS:000319664500042
J	Mersch, DP; Crespi, A; Keller, L				Mersch, Danielle P.; Crespi, Alessandro; Keller, Laurent			Tracking Individuals Shows Spatial Fidelity Is a Key Regulator of Ant Social Organization	SCIENCE			English	Article							DIVISION-OF-LABOR; TEMPORAL POLYETHISM	Ants live in organized societies with a marked division of labor among workers, but little is known about how this division of labor is generated. We used a tracking system to continuously monitor individually tagged workers in six colonies of the ant Camponotus fellah over 41 days. Network analyses of more than 9 million interactions revealed three distinct groups that differ in behavioral repertoires. Each group represents a functional behavioral unit with workers moving from one group to the next as they age. The rate of interactions was much higher within groups than between groups. The precise information on spatial and temporal distribution of all individuals allowed us to calculate the expected rates of within- and between-group interactions. These values suggest that the network of interaction within colonies is primarily mediated by age-induced changes in the spatial location of workers.	[Mersch, Danielle P.; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Crespi, Alessandro] Ecole Polytech Fed Lausanne, Biorobot Lab, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Mersch, DP (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	danielle.mersch@unil.ch; laurent.keller@unil.ch	keller, laurent/AAI-7175-2020; Crespi, Alessandro/M-6777-2014	Crespi, Alessandro/0000-0001-9863-5220; keller, laurent/0000-0002-5046-9953	advanced European Research Council grant; Swiss National Science Foundation; Societe Academique Vaudoise; Fondation Erna Hamburger	advanced European Research Council grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Societe Academique Vaudoise; Fondation Erna Hamburger	This work was funded by an advanced European Research Council grant, several grants from the Swiss National Science Foundation, the Societe Academique Vaudoise, and the Fondation Erna Hamburger. We declare no conflicts of interest. We thank M. Fiala for advice on the use of the ARTag library; A. Hefetz for collecting queens; B. Hollis for help with the information spread analysis; R. James for discussions on network analysis; the Swiss Institute of Bioinformatics for data storage; and M. Chapuisat, B. Hollis, T. Kawecki, E. Lucas, N. Stroeymeyt, T. Richardson, and three anonymous reviewers for comments on the manuscript. Electronic schematics and software are available upon request. Data (social networks, behavior, spatial structure, observed and expected interaction frequencies, and information spread) that pertain to the experiments and analyses reported in this paper can be accessed at DOI: 10.5061/dryad.8d8h7.	Blonder B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020298; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Camazine S., 2003, SELF ORG BIOL SYSTEM; Fiala M., 2005, HAVE 2005 IEEE INT W; Holldobler B., 1990, pi; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Lenoir A, 1979, B BIOL FR BELG, V2-3, P80; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P4373, DOI 10.1098/rspb.2009.1244; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Vonshak Merav, 2010, Israel Journal of Entomology, V39, P165	18	244	247	8	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1090	1093		10.1126/science.1234316	http://dx.doi.org/10.1126/science.1234316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23599264	Green Published			2022-12-24	WOS:000319664500043
J	Gifford, CA; Ziller, MJ; Gu, HC; Trapnell, C; Donaghey, J; Tsankov, A; Shalek, AK; Kelley, DR; Shishkin, AA; Issner, R; Zhang, XL; Coyne, M; Fostel, JL; Holmes, L; Meldrim, J; Guttman, M; Epstein, C; Park, H; Kohlbacher, O; Rinn, J; Gnirke, A; Lander, ES; Bernstein, BE; Meissner, A				Gifford, Casey A.; Ziller, Michael J.; Gu, Hongcang; Trapnell, Cole; Donaghey, Julie; Tsankov, Alexander; Shalek, Alex K.; Kelley, David R.; Shishkin, Alexander A.; Issner, Robbyn; Zhang, Xiaolan; Coyne, Michael; Fostel, Jennifer L.; Holmes, Laurie; Meldrim, Jim; Guttman, Mitchell; Epstein, Charles; Park, Hongkun; Kohlbacher, Oliver; Rinn, John; Gnirke, Andreas; Lander, Eric S.; Bernstein, Bradley E.; Meissner, Alexander			Transcriptional and Epigenetic Dynamics during Specification of Human Embryonic Stem Cells	CELL			English	Article							DNA METHYLATION; MAMMALIAN DEVELOPMENT; HISTONE MODIFICATIONS; REGULATORY REGIONS; HUMAN ES; DIFFERENTIATION; CHROMATIN; EXPRESSION; GENERATION; ENHANCERS	Differentiation of human embryonic stem cells (hESCs) provides a unique opportunity to study the regulatory mechanisms that facilitate cellular transitions in a human context. To that end, we performed comprehensive transcriptional and epigenetic profiling of populations derived through directed differentiation of hESCs representing each of the three embryonic germ layers. Integration of whole-genome bisulfite sequencing, chromatin immunoprecipitation sequencing, and RNA sequencing reveals unique events associated with specification toward each lineage. Lineage-specific dynamic alterations in DNA methylation and H3K4me1 are evident at putative distal regulatory elements that are frequently bound by pluripotency factors in the undifferentiated hESCs. In addition, we identified germ-layer-specific H3K27me3 enrichment at sites exhibiting high DNA methylation in the undifferentiated state. A better understanding of these initial specification events will facilitate identification of deficiencies in current approaches, leading to more faithful differentiation strategies as well as providing insights into the rewiring of human regulatory programs during cellular transitions.	[Gifford, Casey A.; Ziller, Michael J.; Gu, Hongcang; Trapnell, Cole; Donaghey, Julie; Tsankov, Alexander; Kelley, David R.; Shishkin, Alexander A.; Issner, Robbyn; Zhang, Xiaolan; Coyne, Michael; Fostel, Jennifer L.; Holmes, Laurie; Meldrim, Jim; Guttman, Mitchell; Epstein, Charles; Rinn, John; Gnirke, Andreas; Lander, Eric S.; Bernstein, Bradley E.; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gifford, Casey A.; Ziller, Michael J.; Donaghey, Julie; Tsankov, Alexander; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Gifford, Casey A.; Ziller, Michael J.; Trapnell, Cole; Donaghey, Julie; Tsankov, Alexander; Kelley, David R.; Rinn, John; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Park, Hongkun] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA; [Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, D-72076 Tubingen, Germany; [Kohlbacher, Oliver] Univ Tubingen, Quantitat Biol Ctr, D-72076 Tubingen, Germany; [Rinn, John] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Kohlbacher, Oliver/B-7310-2008; Kohlbacher, Oliver/AAF-3297-2021; Park, Hongkun/R-9842-2019; Shalek, Alex/Y-2434-2019	Kohlbacher, Oliver/0000-0003-1739-4598; Kohlbacher, Oliver/0000-0003-1739-4598; Park, Hongkun/0000-0001-9576-8829; Shalek, Alex/0000-0001-5670-8778; Epstein, Charles B./0000-0001-8358-8345; Gifford, Casey/0000-0002-7757-573X; Gu, Hongcang/0000-0002-1439-7606; Rinn, John/0000-0002-7231-7539; Issner, Robbyn/0000-0003-4132-9219	Pew Charitable Trusts; US National Institutes of Health (NIH) [U01ES017155, P01GM099117]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	Pew Charitable Trusts; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Kendell Clement for support of the WGBS data visualization and Loyal Goff for RNA-seq visualization, as well as Zachary Smith and Jing Liao for critical reading of the manuscript, and the SCRB FACS Core for advice regarding FACS analysis. We also thank other members of the Meissner Lab and Epigenomics Platform at the Broad Institute for helpful discussion. A. M. is supported by the Pew Charitable Trusts and is a New York Stem Cell Foundation (NYSCF) Robertson Investigator. The work was funded by the US National Institutes of Health (NIH) grants (U01ES017155 and P01GM099117) and The New York Stem Cell Foundation.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Gifford CA, 2012, CURR OPIN GENET DEV, V22, P409, DOI 10.1016/j.gde.2012.08.002; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wei HM, 2012, STEM CELL RES, V9, P87, DOI 10.1016/j.scr.2012.04.003; Wendling O, 2000, DEVELOPMENT, V127, P1553; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yu XY, 2001, DEVELOPMENT, V128, P1005; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	48	303	309	1	82	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1149	1163		10.1016/j.cell.2013.04.037	http://dx.doi.org/10.1016/j.cell.2013.04.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23664763	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000319456800020
J	Haimovich, G; Medina, DA; Causse, SZ; Garber, M; Millan-Zambrano, G; Barkai, O; Chavez, S; Perez-Ortin, JE; Darzacq, X; Choder, M				Haimovich, Gal; Medina, Daniel A.; Causse, Sebastien Z.; Garber, Manuel; Millan-Zambrano, Gonzalo; Barkai, Oren; Chavez, Sebastian; Perez-Ortin, Jose E.; Darzacq, Xavier; Choder, Mordechai			Gene Expression Is Circular: Factors for mRNA Degradation Also Foster mRNA Synthesis	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; POLYMERASE-II; GENOME-WIDE; IN-VIVO; TRANSCRIPTION ELONGATION; YEAST; DECAY; COMPLEX; TRANSLATION; CYTOPLASM	Maintaining proper mRNA levels is a key aspect in the regulation of gene expression. The balance between mRNA synthesis and decay determines these levels. We demonstrate that most yeast mRNAs are degraded by the cytoplasmic 50-to-30 pathway (the "decaysome''), as proposed previously. Unexpectedly, the level of these mRNAs is highly robust to perturbations in this major pathway because defects in various decaysome components lead to transcription downregulation. Moreover, these components shuttle between the cytoplasm and the nucleus, in a manner dependent on proper mRNA degradation. In the nucleus, they associate with chromatin-preferentially similar to 30 bp upstream of transcription start-sites-and directly stimulate transcription initiation and elongation. The nuclear role of the decaysome in transcription is linked to its cytoplasmic role in mRNA decay; linkage, in turn, seems to depend on proper shuttling of its components. The gene expression process is therefore circular, whereby the hitherto first and last stages are interconnected.	[Haimovich, Gal; Barkai, Oren; Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel; [Medina, Daniel A.; Perez-Ortin, Jose E.] Univ Valencia, Dept Bioquim & Biol Mol, Fac Biol, E-46100 Valencia, Spain; [Medina, Daniel A.; Perez-Ortin, Jose E.] Univ Valencia, ERI Biotecmed, E-46100 Valencia, Spain; [Causse, Sebastien Z.; Darzacq, Xavier] Ecole Normale Super, CNRS, UMR 8197, IBENS,Inst Biol, F-75005 Paris, France; [Garber, Manuel] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Millan-Zambrano, Gonzalo; Chavez, Sebastian] Univ Seville, Fac Biol, Dept Genet, E-41012 Seville, Spain	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Valencia; University of Valencia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Massachusetts System; University of Massachusetts Worcester; University of Sevilla	Choder, M (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel.	choder@technion.ac.il	Pérez-Ortín, José E./K-8582-2014; Chavez, Sebastian S/F-7574-2011; Chávez, Sebastián/GXF-7069-2022; Causse, Sebastien Zwe/AAZ-7365-2021; Haimovich, Gal/H-3316-2019; Millan-Zambrano, Gonzalo/AAA-5562-2020; Medina, Daniel A./AAC-8572-2019; IBIS, GENICA/O-1906-2015	Pérez-Ortín, José E./0000-0002-1992-513X; Chavez, Sebastian S/0000-0002-8064-4839; Haimovich, Gal/0000-0002-3360-5108; Millan-Zambrano, Gonzalo/0000-0002-4530-6359; Darzacq, Xavier/0000-0003-2537-8395; Causse, Sebastien/0000-0003-3246-3491; Medina, Daniel/0000-0002-8183-0043	Israel Science Foundation [1283/07]; Ministry of Health, and Rappaport Foundation [ANR JC 0118-01]; la Ligue; Spanish MCINN; European Union ERDF [BFU2010-21975-C03-01, BFU2010-21975-C03-02]; Regional Valencian Government [GV PROMETEO/2011/088]; Junta de Andalucia [P07-CVI02623, P08-CVI-03508]; MICINN GV; EU; DARPA [D12AP00004]; Center for Excellence in Genome Science from the NHGRI [1P50HG006193]; Gruss-Lipper family postdoctoral fellowship; GV; FPU MICINN; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Ministry of Health, and Rappaport Foundation; la Ligue; Spanish MCINN(Spanish Government); European Union ERDF(European Commission); Regional Valencian Government; Junta de Andalucia(Junta de Andalucia); MICINN GV; EU(European Commission); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Center for Excellence in Genome Science from the NHGRI; Gruss-Lipper family postdoctoral fellowship; GV; FPU MICINN(Spanish Government); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Roy Parker, Tatjana Trcek-Pulisic, Daniel Larson, and Robert Singer for critically reading the manuscript. Roy Parker, Wolf Heyer, Karsten Weis, Tien-Hsien Chang, Arlen Johnson, Shay Ben-Aroya, and Daniel Kornitzer generously shared strains and plasmids. We thank Laboratorio de Chips de DNA (S.C.S.I.E., Universitat de Valencia) for the GRO and the 3'/5' macroarrays and Daniel Larson for sharing algorithms. This work was supported by Israel Science Foundation (1283/07), Ministry of Health, and Rappaport Foundation (to M.C.), ANR JC 0118-01 and la Ligue (to X.D.), the Spanish MCINN and European Union ERDF (BFU2010-21975-C03-01 and BFU2010-21975-C03-02) to J.E.P.-O. and S.C., respectively, and the Regional Valencian Government (GV PROMETEO/2011/088) (to J.E.P.-O.) and from Junta de Andalucia (JA grants P07-CVI02623 and P08-CVI-03508) to S.C., MICINN GV and JA grants involve EDRF resources from the EU. DARPA D12AP00004 and Center for Excellence in Genome Science from the NHGRI 1P50HG006193 to M.G. G.H. is currently a recipient of the Gruss-Lipper family postdoctoral fellowship. D.A.M. is a recipient of a Santiago Grisolia fellowship from GV. G.M.-Z. is a recipient of a FPU MICINN fellowship. G.H. and M.C. conceived the main hypothesis. G.H. constructed strains and plasmids and performed and analyzed the transcription, decay and tethering experiments, shuttling assays, proliferation assays, and PBs analysis. S.Z.C. and X.D. designed, performed and analyzed the FISH experiments. D.A.M. and J.E.P.-O. designed, performed, and analyzed the GRO, RPCC and thiolutin shut-off experiments. G.H. and O.B. designed, performed, and analyzed the ChIP-TAP. G.Z.M and S.C. contributed to design 5'/3' GRO and RPCC experiments. G.Z.M. and S.C. designed, performed, and analyzed the Pol II and phosphoser-2 ChIP of GAL1 in glucose and galactose. M.G. and M.C. analyzed the ChIP-exo data. G.H. and M.C. wrote the manuscript. J.E.P.-O. and S.C. critically read and edited the manuscript. M.C. coordinated the project.	Alberola TM, 2004, INT MICROBIOL, V7, P199; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Badis G, 2004, MOL CELL, V15, P5, DOI 10.1016/j.molcel.2004.06.028; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Dahan N, 2013, BBA-GENE REGUL MECH, V1829, P169, DOI 10.1016/j.bbagrm.2012.08.004; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Esberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020829; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2011, METHODS MOL BIOL, V734, P25, DOI 10.1007/978-1-61779-086-7_2; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Gomez-Herreros F, 2012, NUCLEIC ACIDS RES, V40, P6508, DOI 10.1093/nar/gks340; Haimovich G, 2013, BBA-GENE REGUL MECH, V1829, P643, DOI 10.1016/j.bbagrm.2013.01.004; Harel-Sharvit L, 2010, CELL, V143, P552, DOI 10.1016/j.cell.2010.10.033; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Malagon F, 2006, GENETICS, V172, P2201, DOI 10.1534/genetics.105.052415; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Morillo-Huesca M, 2006, FEBS J, V273, P756, DOI 10.1111/j.1742-4658.2005.05108.x; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Page AM, 1998, NUCLEIC ACIDS RES, V26, P3707, DOI 10.1093/nar/26.16.3707; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pelechano V, 2008, YEAST, V25, P85, DOI 10.1002/yea.1548; Pelechano V, 2010, YEAST, V27, P413, DOI 10.1002/yea.1768; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Perez-Ortin JE, 2013, J MOL BIOL, V425, P3750, DOI 10.1016/j.jmb.2013.02.029; Perez-Ortin JE, 2012, BBA-GENE REGUL MECH, V1819, P604, DOI 10.1016/j.bbagrm.2011.12.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Solinger JA, 1999, MOL CELL BIOL, V19, P5930; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Thompson NL, 2002, CURR OPIN STRUC BIOL, V12, P634, DOI 10.1016/S0959-440X(02)00368-8; Titz B, 2006, NUCLEIC ACIDS RES, V34, P955, DOI 10.1093/nar/gkj493; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	57	224	225	7	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1000	1011		10.1016/j.cell.2013.05.012	http://dx.doi.org/10.1016/j.cell.2013.05.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706738	Green Submitted, Bronze			2022-12-24	WOS:000319456800009
J	Shirley, MD; Tang, H; Gallione, CJ; Baugher, JD; Frelin, LP; Cohen, B; North, PE; Marchuk, DA; Comi, AM; Pevsner, J				Shirley, Matthew D.; Tang, Hao; Gallione, Carol J.; Baugher, Joseph D.; Frelin, Laurence P.; Cohen, Bernard; North, Paula E.; Marchuk, Douglas A.; Comi, Anne M.; Pevsner, Jonathan			Sturge-Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GTPASE-ACTIVATING PROTEINS; PHAKOMATOSIS PIGMENTOVASCULARIS; PHOSPHOLIPASE-C; UVEAL MELANOMA; ALPHA; RECEPTORS; GAIP; RGS4	BACKGROUND The Sturge-Weber syndrome is a sporadic congenital neurocutaneous disorder characterized by a port-wine stain affecting the skin in the distribution of the ophthalmic branch of the trigeminal nerve, abnormal capillary venous vessels in the leptomeninges of the brain and choroid, glaucoma, seizures, stroke, and intellectual disability. It has been hypothesized that somatic mosaic mutations disrupting vascular development cause both the Sturge-Weber syndrome and port-wine stains, and the severity and extent of presentation are determined by the developmental time point at which the mutations occurred. To date, no such mutation has been identified. METHODS We performed whole-genome sequencing of DNA from paired samples of visibly affected and normal tissue from 3 persons with the Sturge-Weber syndrome. We tested for the presence of a somatic mosaic mutation in 97 samples from 50 persons with the Sturge-Weber syndrome, a port-wine stain, or neither (controls), using amplicon sequencing and SNaPshot assays, and investigated the effects of the mutation on downstream signaling, using phosphorylation-specific antibodies for relevant effectors and a luciferase reporter assay. RESULTS We identified a nonsynonymous single-nucleotide variant (c.548G -> A, p.Arg183Gln) in GNAQ in samples of affected tissue from 88% of the participants (23 of 26) with the Sturge-Weber syndrome and from 92% of the participants (12 of 13) with apparently nonsyndromic port-wine stains, but not in any of the samples of affected tissue from 4 participants with an unrelated cerebrovascular malformation or in any of the samples from the 6 controls. The prevalence of the mutant allele in affected tissues ranged from 1.0 to 18.1%. Extracellular signal-regulated kinase activity was modestly increased during transgenic expression of mutant G alpha(q). CONCLUSIONS The Sturge-Weber syndrome and port-wine stains are caused by a somatic activating mutation in GNAQ. This finding confirms a long-standing hypothesis.	[Shirley, Matthew D.; Baugher, Joseph D.; Pevsner, Jonathan] Johns Hopkins Sch Med, Biochem Cellular & Mol Biol Program, Baltimore, MD USA; [Cohen, Bernard] Johns Hopkins Sch Med, Dept Dermatol, Baltimore, MD USA; [Comi, Anne M.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Comi, Anne M.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Pevsner, Jonathan] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Shirley, Matthew D.; Baugher, Joseph D.; Frelin, Laurence P.; Comi, Anne M.; Pevsner, Jonathan] Hugo W Moser Res Inst Kennedy Krieger, Dept Neurol & Dev Med, Baltimore, MD USA; [Tang, Hao; Gallione, Carol J.; Marchuk, Douglas A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [North, Paula E.] Med Coll Wisconsin, Dept Pathol, Div Pediat Pathol, Milwaukee, WI 53226 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Medical College of Wisconsin	Pevsner, J (corresponding author), Kennedy Krieger Inst, Dept Neurol, 707 N Broadway, Baltimore, MD 21205 USA.	pevsner@kennedykrieger.org		Marchuk, Douglas/0000-0002-3110-6671; Baugher, Joseph/0000-0003-2466-3047; Shirley, Matthew/0000-0003-0855-9274	National Institutes of Health; Hunter's Dream for a Cure Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hunter's Dream for a Cure Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health and Hunter's Dream for a Cure Foundation.	Al Robaee A, 2004, PEDIATR DERMATOL, V21, P642, DOI 10.1111/j.0736-8046.2004.21605.x; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Ch'ng S, 2008, J PLAST RECONSTR AES, V61, P889, DOI 10.1016/j.bjps.2007.05.011; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Comi Anne M., 2007, Lymphatic Research and Biology, V5, P257, DOI 10.1089/lrb.2007.1016; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Greene AK, 2009, J CRANIOFAC SURG, V20, P617, DOI 10.1097/SCS.0b013e318192988e; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kajio F, 1997, HEART VESSELS, V12, P300, DOI 10.1007/BF02766807; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; Piram M, 2012, PEDIATR DERMATOL, V29, P32, DOI 10.1111/j.1525-1470.2011.01485.x; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P746, DOI 10.1001/archophthalmol.2011.135; Shirazi Farheen, 2007, Lymphatic Research and Biology, V5, P233, DOI 10.1089/lrb.2007.1012; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Vissers W, 2003, EUR J DERMATOL, V13, P238; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	22	545	576	6	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1971	1979		10.1056/NEJMoa1213507	http://dx.doi.org/10.1056/NEJMoa1213507			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194KD	23656586	Green Accepted, Bronze			2022-12-24	WOS:000322630700007
J	Lima, S; Guo, MS; Chaba, R; Gross, CA; Sauer, RT				Lima, Santiago; Guo, Monica S.; Chaba, Rachna; Gross, Carol A.; Sauer, Robert T.			Dual Molecular Signals Mediate the Bacterial Response to Outer-Membrane Stress	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; LIPOPOLYSACCHARIDE EXPORT; CRYSTAL-STRUCTURE; PEPTIDE SIGNALS; ENVELOPE; PROTEIN; SIGMA(E); DEGS; COMPLEX; RSEB	In Gram-negative bacteria, outer-membrane integrity is essential for survival and is monitored by the sigma(E) stress-response system, which initiates damage-repair pathways. One activating signal is unassembled outer-membrane proteins. Using biochemical and genetic experiments in Escherichia coli, we found that off-pathway intermediates in lipopolysaccharide transport and assembly provided an additional required signal. These distinct signals, arising from disruptions in the transport and assembly of the major outer-membrane components, jointly determined the rate of proteolytic destruction of a negative regulator of the sigma(E) transcription factor, thereby modulating the expression of stress-response genes. This dual-signal system permits a rapid response to dysfunction in outer-membrane biogenesis, while buffering responses to transient fluctuations in individual components, and may represent a broad strategy for bacteria to monitor their interface with the environment.	[Lima, Santiago; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Guo, Monica S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Chaba, Rachna; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399; Guo, Monica/0000-0002-6720-2323	NIH [AI-16892, GM-36278, AI-084442]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892, F32AI084442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036278, R01GM036278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Cezairliyan, S. Chng, D. Kahne, C. Raetz, and D. Six for discussions and strains. Supported by NIH grants AI-16892 and GM-36278. S. L. was supported by an NIH postdoctoral fellowship (AI-084442). The data reported in this paper are presented in the main text and supplementary materials.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; AMES GF, 1974, J BACTERIOL, V117, P406, DOI 10.1128/JB.117.2.406-416.1974; AUSTIN EA, 1990, J BACTERIOL, V172, P5312, DOI 10.1128/jb.172.9.5312-5325.1990; Campbell EA, 2003, MOL CELL, V11, P1067, DOI 10.1016/S1097-2765(03)00148-5; Cezairliyan BO, 2007, P NATL ACAD SCI USA, V104, P3771, DOI 10.1073/pnas.0611567104; Cezairliyan BO, 2009, MOL MICROBIOL, V72, P368, DOI 10.1111/j.1365-2958.2009.06654.x; Chaba R, 2011, P NATL ACAD SCI USA, V108, P2106, DOI 10.1073/pnas.1019277108; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4	25	123	128	0	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					837	841		10.1126/science.1235358	http://dx.doi.org/10.1126/science.1235358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687042	Green Submitted, Green Accepted			2022-12-24	WOS:000318997400037
J	Wang, C; Wu, HX; Katritch, V; Han, GW; Huang, XP; Liu, W; Siu, FY; Roth, BL; Cherezov, V; Stevens, RC				Wang, Chong; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Liu, Wei; Siu, Fai Yiu; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.			Structure of the human smoothened receptor bound to an antitumour agent	NATURE			English	Article							RESOLUTION CRYSTAL-STRUCTURE; PROTEIN-COUPLED RECEPTOR; OPIOID RECEPTOR; INTERNATIONAL UNION; LIPIDIC MESOPHASES; FRIZZLED RECEPTORS; MEMBRANE-PROTEINS; HEDGEHOG; ACTIVATION; PATHWAY	The smoothened (SMO) receptor, a key signal transducer in the hedgehog signalling pathway, is responsible for the maintenance of normal embryonic development and is implicated in carcinogenesis. It is classified as a class frizzled (class F) G-protein-coupled receptor (GPCR), although the canonical hedgehog signalling pathway involves the GLI transcription factors and the sequence similarity with class A GPCRs is less than 10%. Here we report the crystal structure of the transmembrane domain of the human SMO receptor bound to the small-molecule antagonist LY2940680 at 2.5 angstrom resolution. Although the SMO receptor shares the seven-transmembrane helical fold, most of the conserved motifs for class A GPCRs are absent, and the structure reveals an unusually complex arrangement of long extracellular loops stabilized by four disulphide bonds. The ligand binds at the extracellular end of the seven-transmembrane-helix bundle and forms extensive contacts with the loops.	[Wang, Chong; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Siu, Fai Yiu; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina Chapel Hill, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Dept Pharmacol, Sch Med, Chapel Hill, NC 27514 USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27514 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stevens, RC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Roth, Bryan L/F-3928-2010; Stevens, Raymond/K-7272-2015; Wu, Huixian/N-6353-2014; Katritch, Vsevolod/Y-2721-2019; Roth, Bryan/ABE-7032-2020; Han, Gye Won/GLQ-8673-2022; Katritch, Vsevolod/Q-8357-2016; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022	Stevens, Raymond/0000-0002-4522-8725; Wu, Huixian/0000-0003-1357-9747; Roth, Bryan/0000-0002-0561-6520; Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Huang, Xi-Ping/0000-0002-2585-653X	National Institutes of Health [P50 GM073197, U54 GM094618]; NIMH Psychoactive Drug Screening Program; Michael Hooker Chair of Pharmacology; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104];  [F32 DK088392];  [R01 MH61887];  [U19 MH82441];  [R01 DA27170]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH061887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R01DA027170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair of Pharmacology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health Common Fund grant P50 GM073197 for technology development (V. C. and R. C. S.), PSI:Biology grant U54 GM094618 for biological studies and structure production (target GPCR-131) (V. K., V. C. and R. C. S.); F32 DK088392 (F.Y.S.); R01 MH61887, U19 MH82441, R01 DA27170 and the NIMH Psychoactive Drug Screening Program (X.-P. H. and B. L. R.) and the Michael Hooker Chair of Pharmacology (B. L. R.). We thank J. Velasquez for help with molecular biology, T. Trinh and M. Chu for help with baculovirus expression, K. Kadyshevskaya for assistance with figure preparation, A. Walker for assistance with manuscript preparation, D. Wacker for assistance with SAD data collection and processing and J. Smith, R. Fischetti and N. Sanishvili for assistance in development and use of the minibeam and beamtime at beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104.	Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bender MH, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-2819; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Carroll CE, 2012, DEVELOPMENT, V139, P612, DOI 10.1242/dev.075614; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Heretsch P, 2010, BIOORGAN MED CHEM, V18, P6613, DOI 10.1016/j.bmc.2010.07.038; Hipskind P. A., 2010, US patent, Patent No. [8,273,742 B2, 8273742]; Huang HC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-234; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Rominger CM, 2009, J PHARMACOL EXP THER, V329, P995, DOI 10.1124/jpet.109.152090; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schwartz TW, 1996, TRENDS PHARMACOL SCI, V17, P213, DOI 10.1016/0165-6147(96)10017-1; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	49	369	382	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					338	+		10.1038/nature12167	http://dx.doi.org/10.1038/nature12167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23636324	Green Accepted, Green Submitted			2022-12-24	WOS:000318952000031
J	Chen, Y; Dorn, GW				Chen, Yun; Dorn, Gerald W., II			PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MECHANISMS; DISEASE	Senescent and damaged mitochondria undergo selective mitophagic elimination through mechanisms requiring two Parkinson's disease factors, the mitochondrial kinase PINK1 (PTEN-induced putative kinase protein 1; PTEN is phosphatase and tensin homolog) and the cytosolic ubiquitin ligase Parkin. The nature of the PINK-Parkin interaction and the identity of key factors directing Parkin to damaged mitochondria are unknown. We show that the mitochondrial outer membrane guanosine triphosphatase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged mitochondria. Parkin bound to Mfn2 in a PINK1-dependent manner; PINK1 phosphorylated Mfn2 and promoted its Parkin-mediated ubiqitination. Ablation of Mfn2 in mouse cardiac myocytes prevented depolarization-induced translocation of Parkin to the mitochondria and suppressed mitophagy. Accumulation of morphologically and functionally abnormal mitochondria induced respiratory dysfunction in Mfn2-deficient mouse embryonic fibroblasts and cardiomyocytes and in Parkin-deficient Drosophila heart tubes, causing dilated cardiomyopathy. Thus, Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac mitochondria.	[Chen, Yun; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA	Washington University (WUSTL)	Dorn, GW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	gdorn@dom.wustl.edu			NIH [R01 HL059888, R21 HL107276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL107276, R01HL059888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Y.C. performed experiments and analyzed data. G. W. D. designed the studies, analyzed data, and wrote the manuscript. We thank P. Bhandaria and S. Anwar for assistance with Drosophila studies and Y. Liu, Q. Huang, and Y. Zhang for technical assistance. Supported by NIH grants R01 HL059888 and R21 HL107276.	Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zesiewicz TA, 2004, PARKINSONISM RELAT D, V10, P417, DOI 10.1016/j.parkreldis.2004.04.001	16	857	893	8	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					471	475		10.1126/science.1231031	http://dx.doi.org/10.1126/science.1231031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620051	Green Accepted			2022-12-24	WOS:000318016700040
J	Kim, HK; Hanson, GW; Geller, DA				Kim, Hong Koo; Hanson, George W.; Geller, David A.			Are Gold Clusters in RF Fields Hot or Not?	SCIENCE			English	Editorial Material							NANOPARTICLES		[Kim, Hong Koo] Univ Pittsburgh, Petersen Inst Nanosci & Engn, Dept Elect & Comp Engn, Pittsburgh, PA 15261 USA; [Hanson, George W.] Univ Wisconsin, Dept Elect Engn, Milwaukee, WI 53211 USA; [Geller, David A.] Univ Pittsburgh, Dept Surg, UPMC Liver Canc Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Milwaukee; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, HK (corresponding author), Univ Pittsburgh, Petersen Inst Nanosci & Engn, Dept Elect & Comp Engn, Pittsburgh, PA 15261 USA.	gellerda@upmc.edu	Hanson, George/T-5018-2019					Cardinal J, 2008, SURGERY, V144, P125, DOI 10.1016/j.surg.2008.03.036; GRIFFITHS H, 1984, BRIT J RADIOL, V57, P254, DOI 10.1259/0007-1285-57-675-254; Hanson GW, 2011, J APPL PHYS, V109, DOI 10.1063/1.3600222; Kruse DE, 2011, IEEE T BIO-MED ENG, V58, P2002, DOI 10.1109/TBME.2011.2124460; Li DX, 2012, IEEE T BIO-MED ENG, V59, P3468, DOI 10.1109/TBME.2012.2219049; Li DX, 2011, J COLLOID INTERF SCI, V358, P47, DOI 10.1016/j.jcis.2011.01.059; Liu XM, 2012, NANOSCALE, V4, P3945, DOI 10.1039/c2nr30166k; Mccoy RS, 2013, ACS NANO, V7, P2610, DOI 10.1021/nn306015c; Moran CH, 2009, NANO RES, V2, P400, DOI [10.1007/S12274-009-9048-1, 10.1007/s12274-009-9048-1]	9	33	33	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					441	442		10.1126/science.1237303	http://dx.doi.org/10.1126/science.1237303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620043				2022-12-24	WOS:000318016700030
J	Fukuda, T; Takeda, S; Xu, R; Ochi, H; Sunamura, S; Sato, T; Shibata, S; Yoshida, Y; Gu, ZR; Kimura, A; Ma, CS; Xu, C; Bando, W; Fujita, K; Shinomiya, K; Hirai, T; Asou, Y; Enomoto, M; Okano, H; Okawa, A; Itoh, H				Fukuda, Toru; Takeda, Shu; Xu, Ren; Ochi, Hiroki; Sunamura, Satoko; Sato, Tsuyoshi; Shibata, Shinsuke; Yoshida, Yutaka; Gu, Zirong; Kimura, Ayako; Ma, Chengshan; Xu, Cheng; Bando, Waka; Fujita, Koji; Shinomiya, Kenichi; Hirai, Takashi; Asou, Yoshinori; Enomoto, Mitsuhiro; Okano, Hideyuki; Okawa, Atsushi; Itoh, Hiroshi			Sema3A regulates bone-mass accrual through sensory innervations	NATURE			English	Article							SYMPATHETIC INNERVATION; IMMUNE-RESPONSES; SEMAPHORIN; CELLS; MAINTENANCE; EXPRESSION; ABLATION; ROLES	Semaphorin 3A (Sema3A) is a diffusible axonal chemorepellent that has an important role in axon guidance(1-5). Previous studies have demonstrated that Sema3a(-/-) mice have multiple developmental defects due to abnormal neuronal innervations(6,7). Here we show in mice that Sema3A is abundantly expressed in bone, and cell-based assays showed that Sema3A affected osteoblast differentiation in a cell-autonomous fashion. Accordingly, Sema3a(-/-) mice had a low bone mass due to decreased bone formation. However, osteoblast-specific Sema3A-deficient mice (Sema3a(coli)(-/-) and Sema3a(osx)(-/-) mice) had normal bone mass, even though the expression of Sema3A in bone was substantially decreased. In contrast, mice lacking Sema3A in neurons (Sema3a(synapsin)(-/-) and Sema3a(nestin)(-/-) mice) had low bone mass, similar to Sema3a(-/-) mice, indicating that neuron-derived Sema3A is responsible for the observed bone abnormalities independent of the local effect of Sema3A in bone. Indeed, the number of sensory innervations of trabecular bone was significantly decreased in Sema3a(synapsin)(-/-) mice, whereas sympathetic innervations of trabecular bone were unchanged. Moreover, ablating sensory nerves decreased bone mass in wild-type mice, whereas it did not reduce the low bone mass in Sema3a(nestin)(-/-) mice further, supporting the essential role of the sensory nervous system in normal bone homeostasis. Finally, neuronal abnormalities in Sema3a(-/-) mice, such as olfactory development, were identified in Sema3a(synasin)(-/-) mice, demonstrating that neuron-derived Sema3A contributes to the abnormal neural development seen in Sema3a(-/-) mice, and indicating that Sema3A produced in neurons regulates neural development in an autocrine manner. This study demonstrates that Sema3A regulates bone remodelling indirectly by modulating sensory nerve development, but not directly by acting on osteoblasts.	[Fukuda, Toru; Takeda, Shu; Ochi, Hiroki; Sunamura, Satoko] Keio Univ, Sch Med, Dept Internal Med, Shinjyuku Ku, Tokyo 1608582, Japan; [Xu, Ren; Kimura, Ayako; Ma, Chengshan; Xu, Cheng; Fujita, Koji; Shinomiya, Kenichi; Hirai, Takashi; Asou, Yoshinori; Enomoto, Mitsuhiro; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ku, Tokyo 1138549, Japan; [Xu, Ren; Ma, Chengshan; Xu, Cheng; Fujita, Koji; Okawa, Atsushi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Bunkyo Ku, Tokyo 1138549, Japan; [Sato, Tsuyoshi] Saitama Med Univ, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Shibata, Shinsuke; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjyuku Ku, Tokyo 1608582, Japan; [Yoshida, Yutaka; Gu, Zirong] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Kimura, Ayako] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Bunkyo Ku, Tokyo 1138549, Japan; [Bando, Waka; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Sect Nephrol Endocrinol & Metab,Shinjyuku Ku, Tokyo 1608582, Japan	Keio University; Tokyo Medical & Dental University (TMDU); Saitama Medical University; Keio University; Cincinnati Children's Hospital Medical Center; Tokyo Medical & Dental University (TMDU); Keio University	Takeda, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjyuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	shu-tky@umin.ac.jp	Okano, Hideyuki/I-7584-2019; Fujita, Koji/K-3905-2019; Shibata, Shinsuke/AAM-6620-2020	Fujita, Koji/0000-0003-3733-0188; Xu, Cheng/0000-0002-2076-6527	Funding Program for Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science; National Institute of Neurological Disorders and Stroke [NS065048]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Taniguchi and G. Karsenty for discussions; F. Suto and H. Fujisawa for Plxna4<SUP>-/-</SUP> mice; M. Ukegawa, H. Inose, M. Iwata, S. Ohba, T. Hara and G. Itai for technical assistance. This work was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) to S. T., a grant-in-aid for scientific research from the Japan Society for the Promotion of Science to S. T. and T. F., and grants from the National Institute of Neurological Disorders and Stroke (NS065048) to Y.Y.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Ieda M, 2007, NAT MED, V13, P604, DOI 10.1038/nm1570; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kusano K, 2011, NEUROSCI LETT, V492, P64, DOI 10.1016/j.neulet.2011.01.058; Maayan C, 2002, OSTEOPOROSIS INT, V13, P429, DOI 10.1007/s001980200050; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moret F, 2007, DEVELOPMENT, V134, P4491, DOI 10.1242/dev.011452; Nakamura F, 2009, J COMP NEUROL, V516, P360, DOI 10.1002/cne.22125; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Offley SC, 2005, J BONE MINER RES, V20, P257, DOI 10.1359/JBMR.041108; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okuda N, 2007, BONE, V40, P281, DOI 10.1016/j.bone.2006.08.017; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Potiron V, 2007, ADV EXP MED BIOL, V600, P132; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Shibata S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-31; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Takeda S, 2008, J NEUROENDOCRINOL, V20, P802, DOI 10.1111/j.1365-2826.2008.01732.x; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	36	237	262	5	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					490	+		10.1038/nature12115	http://dx.doi.org/10.1038/nature12115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644455				2022-12-24	WOS:000319254000048
J	Zhu, J; Peng, T; Johnston, C; Phasouk, K; Kask, AS; Klock, A; Jin, L; Diem, K; Koelle, DM; Wald, A; Robins, H; Corey, L				Zhu, Jia; Peng, Tao; Johnston, Christine; Phasouk, Khamsone; Kask, Angela S.; Klock, Alexis; Jin, Lei; Diem, Kurt; Koelle, David M.; Wald, Anna; Robins, Harlan; Corey, Lawrence			Immune surveillance by CD8 alpha alpha(+) skin-resident T cells in human herpes virus infection	NATURE			English	Article							SIMPLEX-VIRUS; REACTIVATION; TISSUE; EXIT	Most herpes simplex virus 2 (HSV-2) reactivations in humans are subclinical and associated with rapid expansion and containment of virus. Previous studies have shown that CD8(+) T cells persist in genital skin and mucosa at the dermal-epidermal junction (DEJ)-the portal of neuronal release of reactivating virus-for prolonged time periods after herpes lesions are cleared(1,2). The phenotype and function of this persistent CD8(+) T-cell population remain unknown. Here, using cell-type-specific laser capture microdissection, transcriptional profiling and T-cell antigen receptor beta-chain (TCR beta) genotyping on sequential genital skin biopsies, we show that CD8 alpha alpha(+) T cells are the dominant resident population of DEJ CD8(+) T cells that persist at the site of previous HSV-2 reactivation. CD8 alpha alpha(+) T cells located at the DEJ lack chemokine-receptor expression required for lymphocyte egress and recirculation, express gene signatures of T-cell activation and antiviral activity, and produce cytolytic granules during clinical and virological quiescent time periods. Sequencing of the TCR beta-chain repertoire reveals that the DEJ CD8 alpha alpha(+) T cells are oligoclonal with diverse usage of TCR variable-beta genes, which differ from those commonly described for mucosa-associated invariant T cells and natural killer T cells. Dominant clonotypes are shown to overlap among multiple recurrences over a period of two-and-a-half years. Episodes of rapid asymptomatic HSV-2 containment were also associated with a high CD8 effector-to-target ratio and focal enrichment of CD8 alpha alpha(+) T cells. These studies indicate that DEJ CD8 alpha alpha(+) T cells are tissue-resident cells that seem to have a fundamental role in immune surveillance and in initial containment of HSV-2 reactivation in human peripheral tissue. Elicitation of CD8 alpha alpha(+) T cells may be a critical component for developing effective vaccines against skin and mucosal infections.	[Zhu, Jia; Kask, Angela S.; Klock, Alexis; Jin, Lei; Diem, Kurt; Koelle, David M.; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Zhu, Jia; Peng, Tao; Phasouk, Khamsone; Koelle, David M.; Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Peng, Tao; Johnston, Christine; Koelle, David M.; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Koelle, David M.; Corey, Lawrence] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; [Koelle, David M.] Benaroya Res Inst, Seattle, WA 98104 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Robins, Harlan] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Benaroya Research Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Zhu, J (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	jiazhu@u.washington.edu; lcorey@fhcrc.org	Koelle, David/Q-6529-2016; Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Koelle, David/0000-0003-1255-9023; Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Zhu, Jia/0000-0002-8676-5105; Johnston, Christine/0000-0002-3073-0843	National Institutes of Health [R37AI042528, R01AI04252815, P01AI030731, R56AI093746]; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042528, P01AI030731, R37AI042528, R56AI093746, R01AI094019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Huang, H. Xie, J. Vazquez and D. McDonald for technical assistance; M. Prlic and C. Desmarais for discussion and reading the manuscript and M. Miner for editing. We also thank our study participants and S. Kuntz and M. Stern for clinical assistance. This work was supported by grants from the National Institutes of Health (R37AI042528, R01AI04252815, P01AI030731 and R56AI093746) and the James B. Pendleton Charitable Trust.	Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Huang YJ, 2011, NAT IMMUNOL, V12, P1086, DOI 10.1038/ni.2106; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jing LC, 2012, J CLIN INVEST, V122, P654, DOI 10.1172/JCI60556; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; RIDDELL SR, 1992, SCIENCE, V257, P238; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	30	202	224	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					494	+		10.1038/nature12110	http://dx.doi.org/10.1038/nature12110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23657257	Green Accepted			2022-12-24	WOS:000319254000049
J	Cebula, A; Seweryn, M; Rempala, GA; Pabla, SS; McIndoe, RA; Denning, TL; Bry, L; Kraj, P; Kisielow, P; Ignatowicz, L				Cebula, Anna; Seweryn, Michal; Rempala, Grzegorz A.; Pabla, Simarjot Singh; McIndoe, Richard A.; Denning, Timothy L.; Bry, Lynn; Kraj, Piotr; Kisielow, Pawel; Ignatowicz, Leszek			Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota	NATURE			English	Article							SELF; SELECTION; ANTIGEN	Peripheral mechanisms preventing autoimmunity and maintaining tolerance to commensal microbiota involve CD4(+) Foxp3(+) regulatory T (T-reg) cells(1,2) generated in the thymus or extrathymically by induction of naive CD4(+) Foxp3(-) T cells. Previous studies suggested that the T-cell receptor repertoires of thymic T-reg cells and induced T-reg cells are biased towards self and non-self antigens, respectively(3-6), but their relative contribution in controlling immunopathology, such as colitis and other untoward inflammatory responses triggered by different types of antigens, remains unresolved(7). The intestine, and especially the colon, is a particularly suitable organ to study this question, given the variety of self-, microbiota- and food-derived antigens to which T-reg cells and other T-cell populations are exposed. Intestinal environments can enhance conversion to a regulatory lineage(8,9) and favour tolerogenic presentation of antigens to naive CD4(+) T cells(10,11), suggesting that intestinal homeostasis depends on microbiota-specific induced T-reg cells(12-15). Here, to identify the origin and antigen-specificity of intestinal T-reg cells, we performed single-cell and high-throughput sequencing of the T-cell receptor repertoires of CD4(+) Foxp3(+) and CD4(+) Foxp3(-) T cells, and analysed their reactivity against specific commensal species. We show that thymus-derived T-reg cells constitute most T-reg cells in all lymphoid and intestinal organs, including the colon, where their repertoire is heavily influenced by the composition of the microbiota. Our results suggest that thymic T-reg cells, and not induced T-reg cells, dominantly mediate tolerance to antigens produced by intestinal commensals.	[Cebula, Anna; Pabla, Simarjot Singh; McIndoe, Richard A.; Kraj, Piotr; Ignatowicz, Leszek] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Seweryn, Michal; Rempala, Grzegorz A.] Ohio State Univ, Coll Publ Hlth, Math Biosci Inst, Columbus, OH 43210 USA; [Seweryn, Michal] Univ Lodz, Fac Math & Comp Sci, PL-90238 Lodz, Poland; [Denning, Timothy L.] Emory Univ, Dept Pediat, Atlanta, GA 30329 USA; [Bry, Lynn] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kisielow, Pawel] Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Tumor Immunol, PL-53114 Wroclaw, Poland	University System of Georgia; Augusta University; University System of Ohio; Ohio State University; University of Lodz; Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Ignatowicz, L (corresponding author), Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	lignatowicz@gru.edu		Seweryn, Michal/0000-0002-9090-3435; McIndoe, Richard/0000-0002-3040-3631; Denning, Timothy/0000-0002-1072-7444; Bry, Lynn/0000-0002-8792-8527	National Institutes of Health (NIH) [AI 5R01AI079277, DMS1106485, R01CA152158]; Brigham and Women's Hospital in Boston, Massachusetts;  [P30-DK034854]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA152158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [1318886] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital in Boston, Massachusetts; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by basic research grants from the National Institutes of Health (NIH; AI 5R01AI079277 to L. I., and DMS1106485 and R01CA152158 to G. A. R.). The Harvard Digestive Disease Center (HDDC) Microbiome Core facility is supported by P30-DK034854 and Brigham and Women's Hospital in Boston, Massachusetts. Microbiological analyses were performed by M. Delaney, A. Dubois and Q. Liu in the HDDC Microbiome Core, with additional review of findings by A. B. Onderdonk. We thank J. Pihkala and H. Ignatowicz for technical assistance, M. Kuczma, L. Wojciech, E. Szurek, A. Miazek and P. Muranski for discussion and R. Markowitz for editing the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coutinho A, 2005, CURR TOP MICROBIOL, V293, P43, DOI 10.1007/3-540-27702-1_3; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kuczma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013623; Kuczma M, 2009, J IMMUNOL, V183, P3731, DOI 10.4049/jimmunol.0800601; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Rempala G. A., 2012, J MATH BIOL; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Ribot J, 2006, J IMMUNOL, V177, P1101, DOI 10.4049/jimmunol.177.2.1101; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Singh N, 2011, METHODS MOL BIOL, V707, P39, DOI 10.1007/978-1-61737-979-6_3; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822	30	264	273	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					258	+		10.1038/nature12079	http://dx.doi.org/10.1038/nature12079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23624374	Green Accepted, Green Submitted			2022-12-24	WOS:000318558200040
J	Kato, H; Jiang, JS; Zhou, BR; Rozendaal, M; Feng, HQ; Ghirlando, R; Xiao, TS; Straight, AF; Bai, YW				Kato, Hidenori; Jiang, Jiansheng; Zhou, Bing-Rui; Rozendaal, Marieke; Feng, Hanqiao; Ghirlando, Rodolfo; Xiao, T. Sam; Straight, Aaron F.; Bai, Yawen			A Conserved Mechanism for Centromeric Nucleosome Recognition by Centromere Protein CENP-C	SCIENCE			English	Article							A NUCLEOSOMES; FUNCTIONAL DISSECTION; KINETOCHORE PROTEIN; CHROMATIN; COMPLEX; DNA; DOMAIN; NMR	Chromosome segregation during mitosis requires assembly of the kinetochore complex at the centromere. Kinetochore assembly depends on specific recognition of the histone variant CENP-A in the centromeric nucteosome by centromere protein C (CENP-C). We have defined the determinants of this recognition mechanism and discovered that CENP-C binds a hydrophobic region in the CENP-A tail and docks onto the acidic patch of histone H2A and H2B. We further found that the more broadly conserved CENP-C motif uses the same mechanism for CENP-A nucteosome recognition. Our findings reveal a conserved mechanism for protein recruitment to centromeres and a histone recognition mode whereby a disordered peptide binds the histone tail through hydrophobic interactions facilitated by nucleosome docking.	[Kato, Hidenori; Zhou, Bing-Rui; Feng, Hanqiao; Bai, Yawen] NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA; [Jiang, Jiansheng; Xiao, T. Sam] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Rozendaal, Marieke; Straight, Aaron F.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bai, YW (corresponding author), NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA.	yawen@helix.nih.gov	Xiao, Tsan Sam/A-8590-2010; Xiao, Tsan/I-7616-2013	Xiao, Tsan Sam/0000-0001-9688-475X; Xiao, Tsan/0000-0001-9688-475X; Zhou, Bing-Rui/0000-0002-5375-7977; Straight, Aaron/0000-0001-5885-7881; Jiang, Jiansheng/0000-0003-0964-5481	National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; NIH [R01 GM074728]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZIABC010808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074728] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source (APS) (23-ID beamline) for technical support; C. Carroll for initial participation of the project; J. Barrowman for manuscript editing; A. Kelly, C. Wu, and C. Klee for comments; H. Kurumizaka and K. Morikawa for human histone plasmids and advice for CENP-A nucleosome reconstitution; and S. Tan for the 601 DNA prasmid. Supported by the intramural programs of the National Cancer Institute (H.K., H.F., B.-R.Z, and Y.B.); the National Institute of Allergy and Infectious Diseases (J.J. and T.S.X.); the National Institute of Diabetes and Digestive and Kidney Diseases (R.G.); NIH grant R01 GM074728 (M.R. and A.F.S.); and National Cancer Institute grant Y1-CO-1020, National Institute of General Medical Sciences grant Y1-GM-1104, and U.S. Department of Energy grant DE-AC02-06CH11357 (APS). The structure PDB ID is 4INM.	Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bock LJ, 2012, NAT CELL BIOL, V14, P614, DOI 10.1038/ncb2495; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Khorasanizadeh S, 2011, CURR OPIN STRUC BIOL, V21, P744, DOI 10.1016/j.sbi.2011.10.001; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Song K, 2002, EXP CELL RES, V275, P81, DOI 10.1006/excr.2002.5495; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Trazzi S, 2002, J STRUCT BIOL, V140, P39, DOI 10.1016/S1047-8477(02)00506-3; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004	28	221	222	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1110	1113		10.1126/science.1235532	http://dx.doi.org/10.1126/science.1235532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723239	Green Accepted			2022-12-24	WOS:000319664500048
J	Zimmermann, G; Papke, B; Ismail, S; Vartak, N; Chandra, A; Hoffmann, M; Hahn, SA; Triola, G; Wittinghofer, A; Bastiaens, PIH; Waldmann, H				Zimmermann, Gunther; Papke, Bjoern; Ismail, Shehab; Vartak, Nachiket; Chandra, Anchal; Hoffmann, Maike; Hahn, Stephan A.; Triola, Gemma; Wittinghofer, Alfred; Bastiaens, Philippe I. H.; Waldmann, Herbert			Small molecule inhibition of the KRAS-PDE delta interaction impairs oncogenic KRAS signalling	NATURE			English	Article							K-RAS; PROTEIN PRENYLATION; CANCER-THERAPY; ACTIVATION; DISCOVERY; MEMBRANE; LIGANDS; BIND; FLIM; ERK	The KRAS oncogene product is considered a major target in anticancer drug discovery(1-3). However, direct interference with KRAS signalling has not yet led to clinically useful drugs(3-8). Correct localization and signalling by farnesylated KRAS is regulated by the prenyl-binding protein PDE delta, which sustains the spatial organization of KRAS by facilitating its diffusion in the cytoplasm(9-11). Here we report that interfering with binding of mammalian PDEd to KRAS by means of small molecules provides a novel opportunity to suppress oncogenic RAS signalling by altering its localization to endomembranes. Biochemical screening and subsequent structure-based hit optimization yielded inhibitors of the KRAS-PDE delta interaction that selectively bind to the prenyl-binding pocket of PDE delta with nanomolar affinity, inhibit oncogenic RAS signalling and suppress in vitro and in vivo proliferation of human pancreatic ductal adenocarcinoma cells that are dependent on oncogenic KRAS. Our findings may inspire novel drug discovery efforts aimed at the development of drugs targeting oncogenic RAS.	[Zimmermann, Gunther; Triola, Gemma; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Chem Biol, D-44227 Dortmund, Germany; [Papke, Bjoern; Vartak, Nachiket; Chandra, Anchal; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Ismail, Shehab; Wittinghofer, Alfred] Max Planck Inst Mol Physiol, Struct Biol Grp, D-44227 Dortmund, Germany; [Hoffmann, Maike; Hahn, Stephan A.] Ruhr Univ Bochum, Dept Mol Gastrointestinal Oncol, D-44801 Bochum, Germany; [Bastiaens, Philippe I. H.; Waldmann, Herbert] TU Dortmund, Fac Chem, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Ruhr University Bochum; Dortmund University of Technology	Waldmann, H (corresponding author), Max Planck Inst Mol Physiol, Dept Chem Biol, D-44227 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de; philippe.bastiaens@mpi-dortmund.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Hahn, Stephan A./AAV-6062-2021; Triola, Gemma/E-2235-2017; Hahn, Stephan/E-3880-2010; Waldmann, Herbert/B-7406-2017; Vartak, Nachiket/A-2979-2009; Chandra, Anchal/AAT-5644-2021	Hahn, Stephan A./0000-0003-0855-9741; Triola, Gemma/0000-0003-4177-8989; Hahn, Stephan/0000-0003-0855-9741; Waldmann, Herbert/0000-0002-9606-7247; Vartak, Nachiket/0000-0002-2966-4631; Chandra, Anchal/0000-0003-4096-4771; Ismail, Shehab/0000-0002-4150-1077; Papke, Bjoern/0000-0001-8156-7508; Vartak, Nachiket/0000-0001-8813-4799	European Research Council under the European Union [268309, 268782]; Fonds der Chemischen Industrie	European Research Council under the European Union(European Research Council (ERC)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no. 268309 to H. W., and no. 268782 to A.W. The Compound Management und Screening Center (COMAS), Dortmund, Germany, is acknowledged for carrying out high-throughput screening and data analysis. G.Z. acknowledges the Fonds der Chemischen Industrie for a Kekule Scholarship. We thank K. Michel for help with western blot analysis. We are grateful to C. Degenhart, A. Wolf, S. Baumann and A. Choidas for help with screening assay development and for the determination of solubility, membrane permeability and stability of deltarasin.	Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; Chandra A, 2012, NAT CELL BIOL, V14, P329, DOI 10.1038/ncb2462; Chen YX, 2010, ANGEW CHEM INT EDIT, V49, P6090, DOI 10.1002/anie.201001884; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; Grecco HE, 2010, NAT METHODS, V7, P467, DOI [10.1038/NMETH.1458, 10.1038/nmeth.1458]; Grecco HE, 2009, OPT EXPRESS, V17, P6493, DOI 10.1364/OE.17.006493; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Monovich LG, 2009, J MED CHEM, V52, P3523, DOI 10.1021/jm801394m; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835	26	442	459	4	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					638	642		10.1038/nature12205	http://dx.doi.org/10.1038/nature12205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23698361				2022-12-24	WOS:000319556100048
J	Freund, J; Brandmaier, AM; Lewejohann, L; Kirste, I; Kritzler, M; Kruger, A; Sachser, N; Lindenberger, U; Kempermann, G				Freund, Julia; Brandmaier, Andreas M.; Lewejohann, Lars; Kirste, Imke; Kritzler, Mareike; Krueger, Antonio; Sachser, Norbert; Lindenberger, Ulman; Kempermann, Gerd			Emergence of Individuality in Genetically Identical Mice	SCIENCE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; LABORATORY MICE; MOUSE BEHAVIOR; NEURONS; ENVIRONMENT; ENRICHMENT; MODEL	Brain plasticity as a neurobiological reflection of individuality is difficult to capture in animal models. Inspired by behavioral-genetic investigations of human monozygotic twins reared together, we obtained dense longitudinal activity data on 40 inbred mice living in one large enriched environment. The exploratory activity of the mice diverged over time, resulting in increasing individual differences with advancing age. Individual differences in cumulative roaming entropy, indicating the active coverage of territory, correlated positively with individual differences in adult hippocampal neurogenesis. Our results show that factors unfolding or emerging during development contribute to individual differences in structural brain plasticity and behavior. The paradigm introduced here serves as an animal model for identifying mechanisms of plasticity underlying nonshared environmental contributions to individual differences in behavior.	[Freund, Julia; Kirste, Imke; Kempermann, Gerd] Tech Univ Dresden, CRTD DFG Res Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Brandmaier, Andreas M.; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany; [Lewejohann, Lars; Sachser, Norbert] Univ Munster, Dept Behav Biol, D-48149 Munster, Germany; [Kritzler, Mareike; Krueger, Antonio] Univ Munster, Inst Geoinformat, D-48151 Munster, Germany; [Krueger, Antonio] German Res Ctr Artificial Intelligence, D-66123 Saarbrucken, Germany; [Kempermann, Gerd] German Ctr Neurodegenerat Dis DZNE Dresden, D-01307 Dresden, Germany	Technische Universitat Dresden; Max Planck Society; University of Munster; University of Munster; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Kempermann, G (corresponding author), Tech Univ Dresden, CRTD DFG Res Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany.	gerd.kempermann@dzne.de	Kempermann, Gerd/F-5416-2010; Lewejohann, Lars/H-3717-2013; Brandmaier, Andreas M/E-9096-2014	Kempermann, Gerd/0000-0002-5304-4061; Lewejohann, Lars/0000-0002-0202-4351; Brandmaier, Andreas M/0000-0001-8765-6982; Lindenberger, Ulman/0000-0001-8428-6453	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was financed from basic institutional funds. J.F. and I. K. were fellows of the International Max Planck Research School on the Life Course (LIFE), Berlin. M. K. has been supported by the International Research Training Group on Semantic Integration of Geospatial Information, funded by the German Research Foundation (DFG). The authors thank S. Vogler for drawing the cage in Fig. 1A and D. Lasse for technical support. G. K. and U. L. would also like to thank J. Nesselroade for inspiring discussions that helped shape the ideas presented in this report.	Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; BAILEY DW, 1982, IMMUNOL TODAY, V3, P210, DOI 10.1016/0167-5699(82)90093-7; BALTES PB, 1978, MULTIVAR BEHAV RES, V13, P127, DOI 10.1207/s15327906mbr1302_1; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Friston KJ, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00044; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Jang KL, 1998, J PERS SOC PSYCHOL, V74, P1556, DOI 10.1037/0022-3514.74.6.1556; JULIER C, 1990, P NATL ACAD SCI USA, V87, P4585, DOI 10.1073/pnas.87.12.4585; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Lathe R, 2004, GENES BRAIN BEHAV, V3, P317, DOI 10.1111/j.1601-183X.2004.00083.x; Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x; Lewejohann L, 2011, DEV PSYCHOBIOL, V53, P624, DOI 10.1002/dev.20553; Lewejohann L, 2009, BEHAV RES METHODS, V41, P850, DOI 10.3758/BRM.41.3.850; Lewin K., 1935, DYNAMIC THEORY PERS; Molenaar P. C. M., 1991, PROBLEMS METHODS LON, P250; MOLENAAR PCM, 1993, BEHAV GENET, V23, P519, DOI 10.1007/BF01068142; Raijmakers MEJ, 2004, DEVELOPMENTAL SCI, V7, P149, DOI 10.1111/j.1467-7687.2004.00332.x; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Turkheimer E, 2011, PSYCHOL BULL, V137, P825, DOI 10.1037/a0024306; Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; WHIMBEY AE, 1967, BEHAVIOUR, V29, P296, DOI 10.1163/156853967X00163; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a	29	272	275	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					756	759		10.1126/science.1235294	http://dx.doi.org/10.1126/science.1235294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661762	Green Submitted			2022-12-24	WOS:000318619000042
J	Csibi, A; Fendt, SM; Li, CG; Poulogiannis, G; Choo, AY; Chapski, DJ; Jeong, SM; Dempsey, JM; Parkhitko, A; Morrison, T; Henske, EP; Haigis, MC; Cantley, LC; Stephanopoulos, G; Yu, J; Blenis, J				Csibi, Alfred; Fendt, Sarah-Maria; Li, Chenggang; Poulogiannis, George; Choo, Andrew Y.; Chapski, Douglas J.; Jeong, Seung Min; Dempsey, Jamie M.; Parkhitko, Andrey; Morrison, Tasha; Henske, Elizabeth P.; Haigis, Marcia C.; Cantley, Lewis C.; Stephanopoulos, Gregory; Yu, Jane; Blenis, John			The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4	CELL			English	Article							GREEN TEA POLYPHENOLS; CALORIE RESTRICTION; RAG GTPASES; ATF4; CANCER; SURVIVAL; COMPLEX; STRESS; LYMPHANGIOLEIOMYOMATOSIS; TRANSCRIPTION	Proliferating mammalian cells use glutamine as a source of nitrogen and as a key anaplerotic source to provide metabolites to the tricarboxylic acid cycle (TCA) for biosynthesis. Recently, mammalian target of rapamycin complex 1 (mTORC1) activation has been correlated with increased nutrient uptake and metabolism, but no molecular connection to glutaminolysis has been reported. Here, we show that mTORC1 promotes glutamine anaplerosis by activating glutamate dehydrogenase (GDH). This regulation requires transcriptional repression of SIRT4, the mitochondrial-localized sirtuin that inhibits GDH. Mechanistically, mTORC1 represses SIRT4 by promoting the proteasome-mediated destabilization of cAMP-responsive element binding 2 (CREB2). Thus, a relationship between mTORC1, SIRT4, and cancer is suggested by our findings. Indeed, SIRT4 expression is reduced in human cancer, and its overexpression reduces cell proliferation, transformation, and tumor development. Finally, our data indicate that targeting nutrient metabolism in energy-addicted cancers with high nnTORC1 signaling may be an effective therapeutic approach.	[Csibi, Alfred; Choo, Andrew Y.; Chapski, Douglas J.; Jeong, Seung Min; Dempsey, Jamie M.; Haigis, Marcia C.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Fendt, Sarah-Maria; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Li, Chenggang; Parkhitko, Andrey; Morrison, Tasha; Henske, Elizabeth P.; Yu, Jane] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Poulogiannis, George; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Poulogiannis, George; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	john_blenis@hms.harvard.edu	Poulogiannis, George/AAY-2210-2021; Cantley, Lewis C/D-1800-2014; Poulogiannis, George/AAE-1966-2019	Cantley, Lewis C/0000-0002-1298-7653; Poulogiannis, George/0000-0002-0529-8614; Fendt, Sarah-Maria/0000-0001-6018-9296; Chapski, Douglas/0000-0002-6730-7627; Parkhitko, Andrey/0000-0001-9852-8329	National Research Foundation of Korea; Korean Government; National Heart, Lung, and Blood Institute [HL098216]; NIH [AG032375, GM51405]; Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE [R01CA160458] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032375] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Blenis laboratory for critical discussions and technical assistance. We are also grateful to Li-Huei Tsai (MIT), David Kwiatkowski (BWH), Brendan Manning (HSPH), Wade Harper (HMS), Chi V. Dang (U.Penn), and Takashi Tsukamoto (John Hopkins) for providing critical reagents. We thank Alexandra Grassian and Jonathan Coloff in Joan Brugge's lab (HMS). We thank the Nikon Imaging Center for advice and assistance with microscopy. A.C. is a LAM Foundation Postdoctoral Fellow. S.-M.F. is a German Research Foundation Fellow (FE-1185). G.P. is a Pfizer Fellow of the Life Sciences Research Foundation. S.M.J. was supported in part by a National Research Foundation of Korea Grant funded by the Korean Government. This work was funded by the National Heart, Lung, and Blood Institute grant HL098216 to J.Y., NIH grant AG032375 and Glenn Foundation for Medical Research to M.C.H., and NIH Grant GM51405 to J.B.	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Khan N, 2008, CANCER LETT, V269, P269, DOI 10.1016/j.canlet.2008.04.014; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Lieberman BP, 2011, J NUCL MED, V52, P1947, DOI 10.2967/jnumed.111.093815; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; XU Y, 1992, CANCER RES, V52, P3875; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Young LR, 2009, CHEST, V136, P926, DOI 10.1378/chest.09-0336; Zhang D, 2010, AM J OBSTET GYNECOL, V289, pe1; Zhang D, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.885; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	395	428	2	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					840	854		10.1016/j.cell.2013.04.023	http://dx.doi.org/10.1016/j.cell.2013.04.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663782	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000318844000013
J	Mahmoud, AI; Kocabas, F; Muralidhar, SA; Kimura, W; Koura, AS; Thet, S; Porrello, ER; Sadek, HA				Mahmoud, Ahmed I.; Kocabas, Fatih; Muralidhar, Shalini A.; Kimura, Wataru; Koura, Ahmed S.; Thet, Suwannee; Porrello, Enzo R.; Sadek, Hesham A.			Meis1 regulates postnatal cardiomyocyte cell cycle arrest	NATURE			English	Article							ZEBRAFISH HEART REGENERATION; HEMATOPOIETIC STEM-CELLS; CARDIAC MYOCYTES; PROLIFERATION; INJURY; PHENOTYPE; PROTEINS; RENEWAL; HUMANS; GROWTH	The neonatal mammalian heart is capable of substantial regeneration following injury through cardiomyocyte proliferation(1,2). However, this regenerative capacity is lost by postnatal day 7 and the mechanisms of cardiomyocyte cell cycle arrest remain unclear. The homeodomain transcription factor Meis1 is required for normal cardiac development but its role in cardiomyocytes is unknown(3,4). Here we identify Meis1 as a critical regulator of the cardiomyocyte cell cycle. Meis1 deletion in mouse cardiomyocytes was sufficient for extension of the postnatal proliferative window of cardiomyocytes, and for re-activation of cardiomyocyte mitosis in the adult heart with no deleterious effect on cardiac function. In contrast, overexpression of Meis1 in cardiomyocytes decreased neonatal myocyte proliferation and inhibited neonatal heart regeneration. Finally, we show that Meis1 is required for transcriptional activation of the synergistic CDK inhibitors p15, p16 and p21. These results identify Meis1 as a critical transcriptional regulator of cardiomyocyte proliferation and a potential therapeutic target for heart regeneration.	[Mahmoud, Ahmed I.; Kocabas, Fatih; Muralidhar, Shalini A.; Kimura, Wataru; Thet, Suwannee; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Koura, Ahmed S.] Ain Shams Univ, Sch Med, Cairo 1156, Egypt; [Porrello, Enzo R.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia	University of Texas System; University of Texas Southwestern Medical Center Dallas; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Queensland	Sadek, HA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.	hesham.sadek@utsouthwestern.edu	Kocabas, Fatih/AAM-6391-2021; Kocabas, Fatih/B-2975-2012	Kocabas, Fatih/0000-0001-8096-6056; Kocabas, Fatih/0000-0001-8096-6056; Mahmoud, Ahmed/0000-0003-1528-7393; Kocabas, Fatih/0000-0002-2854-9180; Kimura, Wataru/0000-0001-6548-6353; Porrello, Enzo/0000-0001-6105-7463	American Heart Association; Gilead Research Scholars Program in Cardiovascular Disease; Foundation for Heart Failure Research, NY; National Institutes of Health [1R01HL115275-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115275] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Gilead Research Scholars Program in Cardiovascular Disease; Foundation for Heart Failure Research, NY; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Shelton for help with histology, J. Cabrera for help with figures, N. Copeland and N. Jenkins for providing the Meis1 KO mice, S. Das for statistics consultation, K. Luby-Phelps for help with microscopy, A. Bugde for confocal assistance, D. Farrar for discussions, H. Nguyen for help with echocardiography, as well as K. Sheth, A. Mercadel and Z. Sadek for technical assistance. This work is supported by grants from the American Heart Association (Grant in Aid) (H. A. S.), the Gilead Research Scholars Program in Cardiovascular Disease (H. A. S.), the Foundation for Heart Failure Research, NY, and the National Institutes of Health (1R01HL115275-01) (H.A.S.).	Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Gude N, 2006, CIRC RES, V99, P381, DOI 10.1161/01.RES.0000236754.21499.1c; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035	28	343	353	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					249	253		10.1038/nature12054	http://dx.doi.org/10.1038/nature12054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23594737	Green Accepted			2022-12-24	WOS:000318558200038
J	Stahl, R; Walcher, T; Romero, CD; Pilz, GA; Cappello, S; Irmler, M; Sanz-Aquela, JM; Beckers, J; Blum, R; Borrell, V; Gotz, M				Stahl, Ronny; Walcher, Tessa; De Juan Romero, Camino; Pilz, Gregor Alexander; Cappello, Silvia; Irmler, Martin; Miguel Sanz-Aquela, Jose; Beckers, Johannes; Blum, Robert; Borrell, Victor; Goetz, Magdalena			Trnp1 Regulates Expansion and Folding of the Mammalian Cerebral Cortex by Control of Radial Glial Fate	CELL			English	Article							DEVELOPING MOUSE NEOCORTEX; OUTER SUBVENTRICULAR ZONE; LISSENCEPHALIC PRIMATE; EMBRYONIC NEOCORTEX; PROGENITOR-CELL; GERMINAL ZONES; EVOLUTION; NEUROGENESIS; EXPRESSION; DIFFERENTIATION	Evolution of the mammalian brain encompassed a remarkable increase in size of the cerebral cortex, which includes tangential and radial expansion. However, the mechanisms underlying these key features are still largely unknown. Here, we identified the DNA-associated protein Trnp1 as a regulator of cerebral cortex expansion in both of these dimensions. Gain- and loss-of-function experiments in the mouse cerebral cortex in vivo demonstrate that high Trnp1 levels promote neural stem cell self-renewal and tangential expansion. In contrast, lower levels promote radial expansion, with a potent increase of the number of intermediate progenitors and basal radial glial cells leading to folding of the otherwise smooth murine cerebral cortex. Remarkably, TRNP1 expression levels exhibit regional differences in the cerebral cortex of human fetuses, anticipating radial or tangential expansion. Thus, the dynamic regulation of Trnp1 is critical to control tangential and radial expansion of the cerebral cortex in mammals.	[Stahl, Ronny; Blum, Robert; Goetz, Magdalena] Univ Munich, Inst Physiol, D-80336 Munich, Germany; [Stahl, Ronny; Goetz, Magdalena] Munich Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Stahl, Ronny; Walcher, Tessa; Pilz, Gregor Alexander; Cappello, Silvia; Goetz, Magdalena] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Irmler, Martin; Beckers, Johannes] Helmholtz Ctr Munich, Inst Expt Genet, D-85764 Neuherberg, Germany; [De Juan Romero, Camino; Borrell, Victor] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Sant Joan dAlacant, Spain; [Miguel Sanz-Aquela, Jose] Hosp Univ Principe de Asturias, Serv Pathol, Alcala De Henares 28805, Spain; [Beckers, Johannes] Tech Univ Munich, Chair Expt Genet, D-85350 Freising Weihenstephan, Germany; [Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Prince of Asturias University Hospital; Technical University of Munich; University of Munich	Gotz, M (corresponding author), Univ Munich, Inst Physiol, Schillerstr 46, D-80336 Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de	Cappello, Silvia/AAQ-4590-2021; Blum, Robert/E-8899-2013; Borrell, Victor/U-1802-2017; Irmler, Martin/B-3317-2013; Beckers, Johannes/K-7237-2012; de Juan Romero, Camino/G-9934-2015	Cappello, Silvia/0000-0003-1553-6775; Blum, Robert/0000-0002-5270-3854; Borrell, Victor/0000-0002-7833-3978; Irmler, Martin/0000-0003-3169-479X; Beckers, Johannes/0000-0001-7874-3822; de Juan, Camino/0000-0001-7890-8447	MICINN; "Juan de la Cierva" contract; CONSOLIDER [CSD2007-00023]; DFG via the Gottfried-Wilhelm Leibniz Award; German Excellence Program (LMU Excellent, CIPS);  [SAF2009-07367];  [SFB 870]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); "Juan de la Cierva" contract; CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); DFG via the Gottfried-Wilhelm Leibniz Award(Fondazione Telethon); German Excellence Program (LMU Excellent, CIPS); ; 	We are particularly grateful to Gabriele Jager, Andrea Steiner-Mezzadri, and Emily Violette Baumgart for excellent technical support and to Alexandra Lepier and Simone Bauer for support in regard to viral vector production. We thank Judith Fischer-Sternjak for help with flow cytometry. Particular thanks to Atsunori Shitamukai and Fumio Matsuzaki for the constructs used for electroporation to visualize the morphology of basal radial glial cells by live imaging. We also thank Paolo Malatesta for the pCAG destination vectors. Special thanks to Olga Diez Jambrina (Service of Pathology, Hospital Universitario Principe de Asturias, Alcala de Henares, Spain) for invaluable help in processing the tissue from human fetal brains and to Wolfgang Enard for great discussions and very helpful comments on the manuscript. This work was funded by MICINN with a "Juan de la Cierva" contract to C.D.J.R. and grants SAF2009-07367 and CONSOLIDER CSD2007-00023 to V.B., and by the DFG via the Gottfried-Wilhelm Leibniz Award, the German Excellence Program (LMU Excellent, CIPS), and the SFB 870 to M.G.	Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Borrell V, 2012, NEURON, V76, P338, DOI 10.1016/j.neuron.2012.08.003; Borrell V, 2012, DEV NEUROBIOL, V72, P955, DOI 10.1002/dneu.22013; Cappello S, 2012, NEURON, V73, P911, DOI 10.1016/j.neuron.2011.12.030; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Garcia-Moreno F, 2012, CEREB CORTEX, V22, P482, DOI 10.1093/cercor/bhr312; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Kelava I, 2012, CEREB CORTEX, V22, P469, DOI 10.1093/cercor/bhr301; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030178, 10.1371/journal.pone.0041386]; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Plageman TF, 2011, DEVELOPMENT, V138, P5177, DOI 10.1242/dev.067868; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Reillo I, 2012, CEREB CORTEX, V22, P2039, DOI 10.1093/cercor/bhr284; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Volpe M, 2006, DNA CELL BIOL, V25, P331, DOI 10.1089/dna.2006.25.331; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807	38	184	188	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					535	549		10.1016/j.cell.2013.03.027	http://dx.doi.org/10.1016/j.cell.2013.03.027			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622239	Bronze			2022-12-24	WOS:000318063500008
J	Tang, WHW; Wang, ZE; Levison, BS; Koeth, RA; Britt, EB; Fu, XM; Wu, YP; Hazen, SL				Tang, W. H. Wilson; Wang, Zeneng; Levison, Bruce S.; Koeth, Robert A.; Britt, Earl B.; Fu, Xiaoming; Wu, Yuping; Hazen, Stanley L.			Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUT MICROBIOTA; TRIMETHYLAMINE; ATHEROSCLEROSIS; MODULATION; ENZYMES; BOWEL; MOUSE; OXIDE	Background Recent studies in animals have shown a mechanistic link between intestinal microbial metabolism of the choline moiety in dietary phosphatidylcholine (lecithin) and coronary artery disease through the production of a proatherosclerotic metabolite, trimethylamine-N-oxide (TMAO). We investigated the relationship among intestinal microbiota-dependent metabolism of dietary phosphatidylcholine, TMAO levels, and adverse cardiovascular events in humans. Methods We quantified plasma and urinary levels of TMAO and plasma choline and betaine levels by means of liquid chromatography and online tandem mass spectrometry after a phosphatidylcholine challenge (ingestion of two hard-boiled eggs and deuterium [d9]-labeled phosphatidylcholine) in healthy participants before and after the suppression of intestinal microbiota with oral broad-spectrum antibiotics. We further examined the relationship between fasting plasma levels of TMAO and incident major adverse cardiovascular events (death, myocardial infarction, or stroke) during 3 years of follow-up in 4007 patients undergoing elective coronary angiography. Results Time-dependent increases in levels of both TMAO and its d9 isotopologue, as well as other choline metabolites, were detected after the phosphatidylcholine challenge. Plasma levels of TMAO were markedly suppressed after the administration of antibiotics and then reappeared after withdrawal of antibiotics. Increased plasma levels of TMAO were associated with an increased risk of a major adverse cardiovascular event (hazard ratio for highest vs. lowest TMAO quartile, 2.54; 95% confidence interval, 1.96 to 3.28; P<0.001). An elevated TMAO level predicted an increased risk of major adverse cardiovascular events after adjustment for traditional risk factors (P<0.001), as well as in lower-risk subgroups. Conclusions The production of TMAO from dietary phosphatidylcholine is dependent on metabolism by the intestinal microbiota. Increased TMAO levels are associated with an increased risk of incident major adverse cardiovascular events. (Funded by the National Institutes of Health and others.)	[Tang, W. H. Wilson; Wang, Zeneng; Levison, Bruce S.; Koeth, Robert A.; Britt, Earl B.; Fu, Xiaoming; Wu, Yuping; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin, 9500 Euclid Ave NC 10, Cleveland, OH 44195 USA.	hazens@ccf.org	Wang, Zeneng/AAK-6119-2021; Hazen, Stanley L/ABD-5845-2021; Tang, Wai Hong Wilson/I-1238-2013	Tang, W. H. Wilson/0000-0002-8335-735X; Levison, Bruce/0000-0002-1816-368X	National Institutes of Health [R01HL103866, 1P20HL113452, P01HL098055, P01HL076491, R01HL103931, R01DK080732]; Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award [UL1TR000439]; Leonard Krieger Fund; Center of Innovation by AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113452, R01HL103931, R01HL103866, P01HL098055, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award; Leonard Krieger Fund; Center of Innovation by AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health and its Office of Dietary Supplements (R01HL103866 and 1P20HL113452). The clinical study GeneBank was supported by grants from the National Institutes of Health (P01HL098055, P01HL076491, R01HL103931, and R01DK080732) and a Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award (UL1TR000439). Dr. Hazen was supported by a gift from the Leonard Krieger Fund. Mass spectrometry instrumentation used was housed within the Cleveland Clinic Mass Spectrometry Facility with partial support through a Center of Innovation by AB SCIEX.	ALWAIZ M, 1987, TOXICOLOGY, V43, P117, DOI 10.1016/0300-483X(87)90001-1; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bain MA, 2005, CURR DRUG METAB, V6, P227, DOI 10.2174/1389200054021807; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; DELAHUERGA J, 1951, J CLIN INVEST, V30, P463, DOI 10.1172/JCI102463; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Erdmann CC, 1910, J BIOL CHEM, V8, P57; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; IHLE BU, 1984, CLIN NEPHROL, V22, P82; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Loscalzo J, 2011, CIRC RES, V109, P127, DOI 10.1161/RES.0b013e3182290620; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; MOLLER B, 1986, ARCH MICROBIOL, V145, P85, DOI 10.1007/BF00413032; Patterson KY, 2008, USDA DATABASE CHOLIN; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; SIMENHOFF ML, 1976, LANCET, V2, P818; Stella C, 2006, J PROTEOME RES, V5, P2780, DOI 10.1021/pr060265y; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yancey PH, 2004, CELL MOL BIOL, V50, P371; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9	27	1906	2022	18	375	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2013	368	17					1575	1584		10.1056/NEJMoa1109400	http://dx.doi.org/10.1056/NEJMoa1109400			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130YK	23614584	Green Accepted			2022-12-24	WOS:000317956300006
J	London, MJ; Hur, K; Schwartz, GG; Henderson, WG				London, Martin J.; Hur, Kwan; Schwartz, Gregory G.; Henderson, William G.			Association of Perioperative beta-Blockade With Mortality and Cardiovascular Morbidity Following Major Noncardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VASCULAR-SURGERY; AMERICAN-COLLEGE; OUTCOMES; RISK; QUALITY; CARE; GUIDELINES; THERAPY; PROGRAM; IMPACT	Importance The effectiveness of perioperative beta-blockade in patients undergoing noncardiac surgery remains controversial. Objective To determine the associations of early perioperative exposure to beta-blockers with 30-day postoperative outcome in patients undergoing noncardiac surgery. Design, Setting, and Patients A retrospective cohort analysis evaluating exposure to beta-blockers on the day of or following major noncardiac surgery among a population-based sample of 136 745 patients who were 1: 1 matched on propensity scores (37 805 matched pairs) treated at 104 VA medical centers from January 2005 through August 2010. Main Outcomes and Measures All cause 30-day mortality and cardiac morbidity (cardiac arrest or Q-wave myocardial infarction). Results Overall 55 138 patients (40.3%) were exposed to beta-blockers. Exposure was higher in the 66.7% of 13 863 patients undergoing vascular surgery (95% CI, 65.9%-67.5%) than in the 37.4% of 122 882 patients undergoing nonvascular surgery (95% CI, 37.1%-37.6%; P<.001). Exposure increased as Revised Cardiac Risk Index factors increased, with 25.3% (95% CI, 24.9%-25.6%) of those with no risk vs 71.3% (95% CI, 69.5%-73.2%) of those with 4 risk factors or more exposed to beta-blockers (P<.001). Death occurred among 1.1% (95% CI, 1.1%-1.2%) and cardiac morbidity occurred among 0.9% (95% CI, 0.8%-0.9%) of patients. In the propensity matched cohort, exposure was associated with lower mortality (relative risk [RR], 0.73; 95% CI, 0.65-0.83; P<.001; number need to treat [NNT], 241; 95% CI, 173-397). When stratified by cumulative numbers of Revised Cardiac Risk Index factors, beta-blocker exposure was associated with significantly lower mortality among patients with 2 factors (RR, 0.63 [95% CI, 0.50-0.80]; P<.001; NNT, 105 [95% CI, 69-212]), 3 factors (RR, 0.54 [95% CI, 0.39-0.73]; P<.001; NNT, 41 [95% CI, 28-80]), or 4 factors or more (RR, 0.40 [95% CI, 0.25-0.73]; P<.001; NNT, 18 [95% CI, 12-34]). This association was limited to patients undergoing nonvascular surgery. beta-Blocker exposure was also associated with a lower rate of nonfatal Q-wave infarction or cardiac arrest (RR, 0.67 [95% CI, 0.57-0.79]; P<.001; NNT, 339 [95% CI, 240-582]), again limited to patients undergoing nonvascular surgery. Conclusions and Relevance Among propensity-matched patients undergoing noncardiac, nonvascular surgery, perioperative beta-blocker exposure was associated with lower rates of 30-day all-cause mortality in patients with 2 or more Revised Cardiac Risk Index factors. Our findings support use of a cumulative number of Revised Cardiac Risk Index predictors in decision making regarding institution and continuation of perioperative beta-blockade. A multicenter randomized trial involving patients at a low to intermediate risk by these factors would be of interest to validate these observational findings. JAMA. 0;0(16):1704-1713 www.jama.com	[London, Martin J.] US Dept Vet Affairs Med Ctr, Dept Anesthesia & Perioperat Care, San Francisco, CA USA; [London, Martin J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hur, Kwan] US Dept Vet Affairs Med Ctr, Ctr Medicat Safety, Pharm Benefits Management Serv, Hines, IL USA; [Schwartz, Gregory G.] US Dept Vet Affairs Med Ctr, Cardiol Sect, Denver, CO USA; [Schwartz, Gregory G.] Univ Colorado, Denver, CO 80202 USA; [Henderson, William G.] Colorado Sch Publ Hlth, Hlth Outcomes Program, Aurora, CO USA; [Henderson, William G.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	University of California System; University of California San Francisco; University of Colorado System; University of Colorado Denver; Colorado School of Public Health; Colorado School of Public Health	London, MJ (corresponding author), San Francisco VA Med Ctr, Dept Anesthesia & Perioperat Care, 4150 Clement St, San Francisco, CA 94121 USA.	londonm@anesthesia.ucsf.edu			Anesthesia Patient Safety Foundation	Anesthesia Patient Safety Foundation	This study was supported by a grant from the Anesthesia Patient Safety Foundation.	Agresti A, 2004, STAT MED, V23, P65, DOI 10.1002/sim.1589; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Badgett RG, 2010, ANESTHESIOLOGY, V113, P585, DOI 10.1097/ALN.0b013e3181e73eea; Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; Bateman BT, 2009, ANESTHESIOLOGY, V110, P231, DOI 10.1097/ALN.0b013e318194b5ff; Bertges DJ, 2010, J VASC SURG, V52, P674, DOI 10.1016/j.jvs.2010.03.031; Davenport DL, 2007, J AM COLL SURGEONS, V204, P1199, DOI 10.1016/j.jamcollsurg.2007.02.065; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Ellenberger C, 2011, ANESTHESIOLOGY, V114, P817, DOI 10.1097/ALN.0b013e31820fca0b; Fleisher LA, 2009, CIRCULATION, V120, pE169, DOI 10.1161/CIRCULATIONAHA.109.192690; Flu WJ, 2010, J AM COLL CARDIOL, V56, P1922, DOI 10.1016/j.jacc.2010.05.056; Hamel MB, 2005, J AM GERIATR SOC, V53, P424, DOI 10.1111/j.1532-5415.2005.53159.x; Hamilton BH, 2010, J AM COLL SURGEONS, V210, P125, DOI 10.1016/j.jamcollsurg.2009.10.021; Hammill BG, 2008, ANESTHESIOLOGY, V108, P559, DOI 10.1097/ALN.0b013e31816725ef; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Kwon S, 2012, ARCH SURG-CHICAGO, V147, P467, DOI 10.1001/archsurg.2011.1698; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Levy M, 2011, ANESTHESIOLOGY, V114, P796, DOI 10.1097/ALN.0b013e31820ad503; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Maynard C, 2004, DIABETES CARE, V27, pB22, DOI 10.2337/diacare.27.suppl_2.B22; Poldermans D, 2006, J AM COLL CARDIOL, V48, P964, DOI 10.1016/j.jacc.2006.03.059; Poldermans D, 2009, ANESTHESIOLOGY, V111, P940, DOI 10.1097/ALN.0b013e3181ba3bf4; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sales MM, 2005, AM J MANAG CARE, V11, P104; Smith MW, 2003, MED CARE RES REV, V60, p92S, DOI 10.1177/1077558703256726; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; van Klei WA, 2009, ANESTHESIOLOGY, V111, P717, DOI 10.1097/ALN.0b013e3181b6a761; Wallace AW, 2010, ANESTHESIOLOGY, V113, P794, DOI 10.1097/ALN.0b013e3181f1c061; Wijeysundera DN, 2012, CIRC-CARDIOVASC QUAL, V5, P558, DOI 10.1161/CIRCOUTCOMES.112.965632; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481	37	153	154	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1704	1713		10.1001/jama.2013.4135	http://dx.doi.org/10.1001/jama.2013.4135			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130IG	23613075	Bronze			2022-12-24	WOS:000317906700027
J	Bhutta, ZA; Das, JK; Walker, N; Rizvi, A; Campbell, H; Rudan, I; Black, RE				Bhutta, Zulfiqar A.; Das, Jai K.; Walker, Neff; Rizvi, Arjumand; Campbell, Harry; Rudan, Igor; Black, Robert E.		Lancet Diarrhoea Pneumonia Interve	Childhood Pneumonia and Diarrhoea 2 Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost?	LANCET			English	Article							HEALTH RESEARCH INVESTMENTS; MIDDLE-INCOME COUNTRIES; SETTING PRIORITIES; ROTAVIRUS VACCINE; DOUBLE-BLIND; ECONOMIC-BENEFITS; ORAL REHYDRATION; CASE-MANAGEMENT; NALIDIXIC-ACID; MORTALITY	Global mortality in children younger than 5 years has fallen substantially in the past two decades from more than 12 million in 1990, to 6.9 million in 2011, but progress is inconsistent between countries. Pneumonia and diarrhoea are the two leading causes of death in this age group and have overlapping risk factors. Several interventions can effectively address these problems, but are not available to those in need. We systematically reviewed evidence showing the effectiveness of various potential preventive and therapeutic interventions against childhood diarrhoea and pneumonia, and relevant delivery strategies. We used the Lives Saved Tool model to assess the effect on mortality when these interventions are applied. We estimate that if implemented at present annual rates of increase in each of the 75 Countdown countries, these interventions and packages of care could save 54% of diarrhoea and 51% of pneumonia deaths by 2025 at a cost of US$3.8 billion. However, if coverage of these key evidence-based interventions were scaled up to at least 80%, and that for immunisations to at least 90%, 95% of diarrhoea and 67% of pneumonia deaths in children younger than 5 years could be eliminated by 2025 at a cost of $6.715 billion. New delivery platforms could promote equitable access and community platforms are important catalysts in this respect. Furthermore, several of these interventions could reduce morbidity and overall burden of disease, with possible benefits for developmental outcomes.	[Bhutta, Zulfiqar A.; Das, Jai K.; Rizvi, Arjumand] Aga Khan Univ, Div Woman & Child Hlth, Karachi 74800, Pakistan; [Bhutta, Zulfiqar A.; Walker, Neff; Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Campbell, Harry; Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Edinburgh	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Woman & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Rudan, Igor/I-1467-2012; Campbell, Harry/E-2959-2010	Rudan, Igor/0000-0001-6993-6884; Campbell, Harry/0000-0002-6169-6262; Das, Jai/0000-0002-2966-7162; Black, Robert/0000-0001-9926-7984	Bill & Melinda Gates Foundation; Bloomberg School of Public Health; Johns Hopkins University, Boston; University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Bloomberg School of Public Health; Johns Hopkins University, Boston; University School of Public Health; Program for Global Pediatric Research, Hospital for Sick Children, Toronto	Funding was provided by an unrestricted grant from the Bill & Melinda Gates Foundation to Aga Khan University and to collaborating universities and institutions (Bloomberg School of Public Health, Johns Hopkins University, Boston; University School of Public Health and Program for Global Pediatric Research, Hospital for Sick Children, Toronto). The funding source had no role or control over the content and process of development of these papers, or in drafting of the report. The views expressed in this report are solely those of the authors. We thank Yvonne Tam (Johns Hopkins University) for assisting with LiST modelling, Margaret Manley (Program for Global Pediatric Research, Toronto), and Asghar Ali (Aga Khan University, Karachi) for administrative support.	Addo-Yobo E, 2011, TROP MED INT HEALTH, V16, P995, DOI 10.1111/j.1365-3156.2011.02787.x; ALAM AN, 1994, SCAND J GASTROENTERO, V29, P313, DOI 10.3109/00365529409094842; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P451; [Anonymous], 2001, Indian Pediatr, V38, P565; [Anonymous], LEV TRENDS CHILD MOR; [Anonymous], 2012, BUILDING FUTURE WOME; [Anonymous], 2009, DIARRH WHY CHILDR AR; Applegate JA, BMCPH IN PRESS; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Bassani DG, BMCPH IN PRESS; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2008, MATERN CHILD NUTR, V4, P1, DOI 10.1111/j.1740-8709.2007.00132.x; Bhutta ZA, 2008, BMJ-BRIT MED J, V336, P948, DOI 10.1136/bmj.39520.680718.94; Bhutta ZA, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010302; Bhutta ZA, 2009, PEDIATR INFECT DIS J, V28, pS22, DOI 10.1097/INF.0b013e31819588ac; Bruce N, BMCPH IN PRESS; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Chandani Y, 2012, AM J TROP MED HYG, V87, P120, DOI 10.4269/ajtmh.2012.11-0781; CHATTERJEE A, 1978, ARCH DIS CHILD, V53, P284, DOI 10.1136/adc.53.4.284; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Cunliffe NA, 2012, VACCINE, V30, pA36, DOI 10.1016/j.vaccine.2011.09.120; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Das JK, BMCPH IN PRESS; Duke T, 2008, LANCET, V372, P1328, DOI 10.1016/S0140-6736(08)61164-2; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Fischer Walker CL, 2012, BMC PUBLIC HEALTH, V12, P220, DOI DOI 10.1186/1471-2458-12-220; Fischer Walker CL, 2013, LANCET; Fontaine O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000041; Gaffey MF, BMCPH IN PRESS; Gu B, 2012, INT J ANTIMICROB AG, V40, P9, DOI 10.1016/j.ijantimicag.2012.02.005; Haider BA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005976.pub2; Haroon S, BMCPH IN PRESS; Imdad A, 2013, J PEDIATR-US, V162, pS107, DOI 10.1016/j.jpeds.2012.11.060; International Health Partnership, 2013, ONEHEALTH TOOL; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kabir I, 1996, J DIARRHOEAL DIS RES, V14, P243; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kosek M, 2009, J HEALTH POPUL NUTR, V27, P319; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Lassi ZS, 2012, J DEV EFFECT, V4, P151, DOI 10.1080/19439342.2012.655911; Lenters LM, BMCPH IN PRESS; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Munos MK, 2010, INT J EPIDEMIOL, V39, P56, DOI 10.1093/ije/dyq022; Nair H, 2013, LANCET; Noriega FR, 1999, INFECT IMMUN, V67, P782, DOI 10.1128/IAI.67.2.782-788.1999; Ozawa S, 2012, VACCINE, V31, P96, DOI 10.1016/j.vaccine.2012.10.103; Ozawa S, 2011, HEALTH AFFAIR, V30, P1010, DOI 10.1377/hlthaff.2011.0381; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Punpanich W, 2011, PEDIATR INFECT DIS J, V30, pE192, DOI 10.1097/INF.0b013e31822d989c; Rossignol JFA, 2001, J INFECT DIS, V184, P103, DOI 10.1086/321008; Roy SK, 1998, T ROY SOC TROP MED H, V92, P460, DOI 10.1016/S0035-9203(98)91094-X; Rudan I, 2008, CROAT MED J, V49, P307, DOI 10.3325/cmj.2008.3.307; Rudan I, 2007, CROAT MED J, V48, P595; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Rudan I, 2008, CROAT MED J, V49, P720, DOI 10.3325/cmj.2008.49.720; Salam MA, 1998, LANCET, V352, P522, DOI 10.1016/S0140-6736(97)11457-X; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Sow SO, 2012, VACCINE, V30, pA71, DOI 10.1016/j.vaccine.2011.11.094; Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382; Sudfeld CR, 2010, INT J EPIDEMIOL, V39, P48, DOI 10.1093/ije/dyq021; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P172, DOI 10.1093/ije/dyq033; Thompson LM, 2011, ENVIRON HEALTH PERSP, V119, P1489, DOI 10.1289/ehp.1002928; Traa BS, 2010, INT J EPIDEMIOL, V39, P70, DOI 10.1093/ije/dyq024; United Nations Children's Fund (UNICEF), 2012, PNEUM DIARRH TACKL D; VandeVerg LL, 1996, VACCINE, V14, P1062, DOI 10.1016/0264-410X(96)00006-0; VARSANO I, 1991, J PEDIATR-US, V118, P627, DOI 10.1016/S0022-3476(05)83392-X; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Waddington H., 2009, WATER SANITATION HYG; Walker CLF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000428; Walker CLF, 2010, INT J EPIDEMIOL, V39, P63, DOI 10.1093/ije/dyq023; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; Wazny K, PLOS MED IN PRESS; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; WHO, GUID HIV INF FEED 20; WITTENBERG DF, 1989, J INFECT DIS, V159, P131, DOI 10.1093/infdis/159.1.131; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23; Zaidi AKM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S13; ZIMBASA Dysentery Study Grp, 2002, PEDIATR INFECT DIS J, V21, P1136, DOI [10.1097/00006454-200212000-00010, 10.1097/01.inf.0000040824.83814.a9]	87	312	315	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2013	381	9875					1417	1429		10.1016/S0140-6736(13)60648-0	http://dx.doi.org/10.1016/S0140-6736(13)60648-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	130EF	23582723				2022-12-24	WOS:000317894800039
J	Carlin, LM; Stamatiades, EG; Auffray, C; Hanna, RN; Glover, L; Vizcay-Barrena, G; Hedrick, CC; Cook, HT; Diebold, S; Geissmann, F				Carlin, Leo M.; Stamatiades, Efstathios G.; Auffray, Cedric; Hanna, Richard N.; Glover, Leanne; Vizcay-Barrena, Gema; Hedrick, Catherine C.; Cook, H. Terence; Diebold, Sandra; Geissmann, Frederic			Nr4a1-Dependent Ly6C(low) Monocytes Monitor Endothelial Cells and Orchestrate Their Disposal	CELL			English	Article							BONE-MARROW; FRACTALKINE EXPRESSION; LUPUS NEPHRITIS; RECRUITMENT; LIGAND; REVEALS; SUBSETS; LFA-1; ACCUMULATION; INITIATION	The functions of Nr4a1-dependent Ly6C(low) monocytes remain enigmatic. We show that they are enriched within capillaries and scavenge microparticles from their lumenal side in a steady state. In the kidney cortex, perturbation of homeostasis by a TLR7-dependent nucleic acid "danger" signal, which may signify viral infection or local cell death, triggers Gai-dependent intravascular retention of Ly6C(low) monocytes by the endothelium. Then, monocytes recruit neutrophils in a TLR7-dependent manner to mediate focal necrosis of endothelial cells, whereas the monocytes remove cellular debris. Prevention of Ly6C(low) monocyte development, crawling, or retention in Nr4a1(-/-), Itgal(-/-), and Tlr7(host-/-BM+/+) and Cx3cr1(-/-) mice, respectively, abolished neutrophil recruitment and endothelial killing. Prevention of neutrophil recruitment in Tlr7(host+/+BM-/-) mice or by neutrophil depletion also abolished endothelial cell necrosis. Therefore, Ly6C(low) monocytes are intravascular housekeepers that orchestrate the necrosis by neutrophils of endothelial cells that signal a local threat sensed via TLR7 followed by the in situ phagocytosis of cellular debris.	[Carlin, Leo M.; Stamatiades, Efstathios G.; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Carlin, Leo M.; Stamatiades, Efstathios G.; Diebold, Sandra; Geissmann, Frederic] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 1UL, England; [Glover, Leanne; Vizcay-Barrena, Gema] Kings Coll London, Ctr Ultrastruct Imaging, London SE1 1UL, England; [Auffray, Cedric; Geissmann, Frederic] Paris Descartes Univ, Inst Necker, INSERM, U838, F-75015 Paris, France; [Hanna, Richard N.; Hedrick, Catherine C.] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Cook, H. Terence] Univ London Imperial Coll Sci Technol & Med, Ctr Complement & Inflammat Res, London W12 0NN, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; La Jolla Institute for Immunology; Imperial College London	Geissmann, F (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England.	frederic.geissmann@kcl.ac.uk	Carlin, Leo Marc/E-3434-2012; Auffray, Cedric/M-3225-2017	Carlin, Leo Marc/0000-0001-7172-5234; geissmann, frederic/0000-0001-5029-2468; Stamatiades, Efstathios/0000-0002-2785-9005; Allison, Leanne/0000-0003-2954-9892	Oliver Bird Rheumatism Programme, Nuffield Foundation, UK; Medical Research Council, UK [MRCG0900867]; European Research Council [ERC-2010-StG-261299 MPS2010]; European Science Foundation (ERC EURYI Award); Medical Research Council [G0900867] Funding Source: researchfish; MRC [G0900867] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118765] Funding Source: NIH RePORTER	Oliver Bird Rheumatism Programme, Nuffield Foundation, UK; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); European Science Foundation (ERC EURYI Award); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	I. Charo, B. Engelhardt and J.V. Stein, and R. Alon kindly provided Ccr2<SUP>-/-</SUP>, Icam1<SUP>-/-</SUP> and Icam2<SUP>-/-</SUP>, and Igal<SUP>-/-</SUP> mice, respectively. The authors are also indebted to G. Burn and A. Fischer for helpful discussions, to C. Trouillet for the management of the Geissmann lab, and to A. McGuigan and her colleagues from the Biological Service Unit at King's College London, Guy's Campus, for support with mouse husbandry. E.G.S. is supported by a PhD fellowship from the Oliver Bird Rheumatism Programme, Nuffield Foundation, UK. Work was supported by grants to F. G. from the Medical Research Council, UK (MRCG0900867), the European Research Council (ERC-2010-StG-261299 MPS2010), and the European Science Foundation (ERC EURYI Award).	Amano H, 2005, ARTHRITIS RHEUM-US, V52, P2790, DOI 10.1002/art.21365; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Biburger M, 2011, IMMUNITY, V35, P932, DOI 10.1016/j.immuni.2011.11.009; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; DEFOUGEROLLES AR, 1993, J EXP MED, V177, P1187, DOI 10.1084/jem.177.4.1187; Devi S, 2013, NAT MED, V19, P107, DOI 10.1038/nm.3024; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Green DR, 2011, IMMUNITY, V35, P441, DOI 10.1016/j.immuni.2011.10.003; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hill GS, 2001, KIDNEY INT, V59, P304, DOI 10.1046/j.1523-1755.2001.00492.x; Hill GS, 2000, KIDNEY INT, V58, P1160, DOI 10.1046/j.1523-1755.2000.00272.x; Inoue A, 2005, ARTHRITIS RHEUM-US, V52, P1522, DOI 10.1002/art.21007; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Li WJ, 2012, J CLIN INVEST, V122, P2499, DOI 10.1172/JCI62970; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Metchnikoff E., 1893, LECT 9 LECT COMP PAT, P144; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakatani K, 2010, AM J PHYSIOL-RENAL, V299, pF207, DOI 10.1152/ajprenal.00482.2009; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Santiago-Raber ML, 2009, ARTHRITIS RHEUM-US, V60, P2408, DOI 10.1002/art.24787; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Sumagin R, 2010, J IMMUNOL, V185, P7057, DOI 10.4049/jimmunol.1001638; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; WESTLIN WF, 1993, AM J PATHOL, V142, P117; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012	48	490	504	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					362	375		10.1016/j.cell.2013.03.010	http://dx.doi.org/10.1016/j.cell.2013.03.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582326	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000317349700015
J	Papenfort, K; Sun, Y; Miyakoshi, M; Vanderpool, CK; Vogel, J				Papenfort, Kai; Sun, Yan; Miyakoshi, Masatoshi; Vanderpool, Carin K.; Vogel, Joerg			Small RNA-Mediated Activation of Sugar Phosphatase mRNA Regulates Glucose Homeostasis	CELL			English	Article							BACTERIAL SMALL RNA; ESCHERICHIA-COLI; ALPHA-METHYLGLUCOSIDE; STREPTOCOCCUS-LACTIS; TARGET RECOGNITION; TRANSPORT; EXPRESSION; TRANSCRIPTION; EFFLUX; GROWTH	Glucose homeostasis is strictly controlled in all domains of life. Bacteria that are unable to balance intracellular sugar levels and deal with potentially toxic phosphosugars cease growth and risk being outcompeted. Here, we identify the conserved haloacid dehalogenase (HAD)-like enzyme YigL as the previously hypothesized phosphatase for detoxification of phosphosugars and reveal that its synthesis is activated by an Hfq-dependent small RNA in Salmonella typhimurium. We show that the glucose-6-P-responsive small RNA SgrS activates YigL synthesis in a translation-independent fashion by the selective stabilization of a decay intermediate of the dicistronic pldB-yigL messenger RNA (mRNA). Intriguingly, the major endoribonuclease RNase E, previously known to function together with small RNAs to degrade mRNA targets, is also essential for this process of mRNA activation. The exploitation of and targeted interference with regular RNA turnover described here may constitute a general route for small RNAs to rapidly activate both coding and noncoding genes.	[Papenfort, Kai; Miyakoshi, Masatoshi; Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Papenfort, Kai] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA; [Sun, Yan; Vanderpool, Carin K.] Univ Illinois, Dept Microbiol, Urbana, IL 61802 USA	University of Wurzburg; Princeton University; University of Illinois System; University of Illinois Urbana-Champaign	Vanderpool, CK (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61802 USA.	cvanderp@life.illinois.edu; joerg.vogel@uni-wuerzburg.de	Papenfort, Kai/L-3187-2017; Vogel, Jörg/D-5574-2011; Miyakoshi, Masatoshi/H-5256-2018	Papenfort, Kai/0000-0002-5560-9804; Vogel, Jörg/0000-0003-2220-1404; Miyakoshi, Masatoshi/0000-0002-4901-2809	American Cancer Society [ACS2008-01868]; DFG [SPP1258 (Vo875/2-2), SPP1316 (Vo875/6-1)]; BMBF NGFN program [01GS0806]; Bavarian BioSysNet program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092830] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); DFG(German Research Foundation (DFG)); BMBF NGFN program(Federal Ministry of Education & Research (BMBF)); Bavarian BioSysNet program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. L. Bassler and B. F. Luisi for comments on the manuscript, B. Plaschke for excellent technical assistance, D. Podkaminski for help with cloning and growth curves, B. F. Luisi for the gift of RNase E preparations, S. A. Gorski for help with the manuscript, and K. Forstner for help with phylogenetic analysis. K. P. is supported by a postdoctoral fellowship from the Human Frontiers in Science Program. The Vanderpool lab received support from the American Cancer Society (research scholar grant ACS2008-01868), and the Vogel lab received support from DFG Priority Programs SPP1258 (Vo875/2-2) and SPP1316 (Vo875/6-1), the BMBF NGFN program (grant 01GS0806), and the Bavarian BioSysNet program.	Adhya Sankar, 2003, Sci STKE, V2003, ppe22, DOI 10.1126/stke.2003.185.pe22; Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Bandyra KJ, 2012, MOL CELL, V47, P943, DOI 10.1016/j.molcel.2012.07.015; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; BUCALA R, 1985, P NATL ACAD SCI USA, V82, P8439, DOI 10.1073/pnas.82.24.8439; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Chou JY, 2010, NAT REV ENDOCRINOL, V6, P676, DOI 10.1038/nrendo.2010.189; Corcoran CP, 2012, MOL MICROBIOL, V84, P428, DOI 10.1111/j.1365-2958.2012.08031.x; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; HAGIHIRA H, 1963, BIOCHIM BIOPHYS ACTA, V78, P505, DOI 10.1016/0006-3002(63)90912-0; HAGUENAUER R, 1972, BIOCHIMIE, V54, P505, DOI 10.1016/S0300-9084(72)80235-9; HUBER RE, 1980, BIOCHEM BIOPH RES CO, V96, P656, DOI 10.1016/0006-291X(80)91405-9; IRANI MH, 1977, J BACTERIOL, V132, P398, DOI 10.1128/JB.132.2.398-410.1977; Jahreis K, 2008, FEMS MICROBIOL REV, V32, P891, DOI 10.1111/j.1574-6976.2008.00125.x; Jorgensen MG, 2012, MOL MICROBIOL, V84, P36, DOI 10.1111/j.1365-2958.2012.07976.x; KAASEN I, 1992, J BACTERIOL, V174, P889, DOI 10.1128/jb.174.3.889-898.1992; KADNER RJ, 1992, J GEN MICROBIOL, V138, P2007, DOI 10.1099/00221287-138-10-2007; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kimata K, 2001, EMBO J, V20, P3587, DOI 10.1093/emboj/20.13.3587; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; Liu JY, 1999, J BIOL CHEM, V274, P22977, DOI 10.1074/jbc.274.33.22977; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2003, J BIOL CHEM, V278, P15608, DOI 10.1074/jbc.M300177200; Nilsson P, 1996, J BACTERIOL, V178, P683, DOI 10.1128/jb.178.3.683-690.1996; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Papenfort K, 2012, P NATL ACAD SCI USA, V109, pE757, DOI 10.1073/pnas.1119414109; Papenfort K, 2009, MOL MICROBIOL, V74, P139, DOI 10.1111/j.1365-2958.2009.06857.x; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Pikis A, 2006, J BIOL CHEM, V281, P17900, DOI 10.1074/jbc.M601183200; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reichenbach B, 2008, NUCLEIC ACIDS RES, V36, P2570, DOI 10.1093/nar/gkn091; REIZER J, 1983, J BACTERIOL, V156, P236, DOI 10.1128/JB.156.1.236-242.1983; Rice JB, 2011, NUCLEIC ACIDS RES, V39, P3806, DOI 10.1093/nar/gkq1219; Roberts A, 2005, PROTEINS, V58, P790, DOI 10.1002/prot.20267; ROGERS D, 1962, J BACTERIOL, V84, P877, DOI 10.1128/JB.84.5.877-881.1962; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Sun Y, 2011, J BACTERIOL, V193, P143, DOI 10.1128/JB.01008-10; Svetlov V, 2012, CELL, V150, P243, DOI 10.1016/j.cell.2012.06.025; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Thomason MK, 2012, MOL MICROBIOL, V84, P17, DOI 10.1111/j.1365-2958.2012.07965.x; THOMPSON J, 1983, J BACTERIOL, V154, P819, DOI 10.1128/JB.154.2.819-830.1983; THOMPSON J, 1982, J BACTERIOL, V151, P1454, DOI 10.1128/JB.151.3.1454-1465.1982; Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vanderpool CK, 2007, J BACTERIOL, V189, P2238, DOI 10.1128/JB.01689-06; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; WINKLER HH, 1971, J BACTERIOL, V106, P362, DOI 10.1128/JB.106.2.362-368.1971	61	149	154	0	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					426	437		10.1016/j.cell.2013.03.003	http://dx.doi.org/10.1016/j.cell.2013.03.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582330	Bronze, Green Accepted			2022-12-24	WOS:000317349700020
J	Findley, K; Oh, J; Yang, J; Conlan, S; Deming, C; Meyer, JA; Schoenfeld, D; Nomicos, E; Park, M; Kong, HH; Segre, JA				Findley, Keisha; Oh, Julia; Yang, Joy; Conlan, Sean; Deming, Clayton; Meyer, Jennifer A.; Schoenfeld, Deborah; Nomicos, Effie; Park, Morgan; Kong, Heidi H.; Segre, Julia A.		NIH Intramural Sequencing Ctr Comp	Topographic diversity of fungal and bacterial communities in human skin	NATURE			English	Article							RIBOSOMAL-RNA SEQUENCES; HUMAN MICROBIOME; RISK-FACTORS; TINEA-PEDIS; PREVALENCE; ALIGNMENT; ACCURACY; DISEASES; PROJECT; SAMPLES	Traditional culture-based methods have incompletely defined the microbial landscape of common recalcitrant human fungal skin diseases, including athlete's foot and toenail infections. Skin protects humans from invasion by pathogenic microorganisms and provides a home for diverse commensal microbiota(1). Bacterial genomic sequence data have generated novel hypotheses about species and community structures underlying human disorders(2-4). However, microbial diversity is not limited to bacteria; microorganisms such as fungi also have major roles in microbial community stability, human health and disease(5). Genomic methodologies to identify fungal species and communities have been limited compared with those that are available for bacteria(6). Fungal evolution can be reconstructed with phylogenetic markers, including ribosomal RNA gene regions and other highly conserved genes(7). Here we sequenced and analysed fungal communities of 14 skin sites in 10 healthy adults. Eleven core-body and arm sites were dominated by fungi of the genus Malassezia, with only species-level classifications revealing fungal-community composition differences between sites. By contrast, three foot sites-plantar heel, toenail and toe web-showed high fungal diversity. Concurrent analysis of bacterial and fungal communities demonstrated that physiologic attributes and topography of skin differentially shape these two microbial communities. These results provide a framework for future investigation of the contribution of interactions between pathogenic and commensal fungal and bacterial communities to the maintainenace of human health and to disease pathogenesis.	[Findley, Keisha; Oh, Julia; Yang, Joy; Conlan, Sean; Deming, Clayton; Meyer, Jennifer A.; Segre, Julia A.] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Schoenfeld, Deborah; Nomicos, Effie; Kong, Heidi H.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Park, Morgan] NHGRI, NIH Intramural Sequencing Ctr, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kong, HH (corresponding author), NCI, Dermatol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	konghe@mail.nih.gov; jsegre@nhgri.nih.gov	Conlan, Sean/B-4401-2008; Kong, Heidi H/L-4856-2018	Conlan, Sean/0000-0001-6848-3465; Kong, Heidi H/0000-0003-4424-064X; Yang, Joy/0000-0002-3385-9490	US National Institutes of Health (NIH) NHGRI and NCI Intramural Research Programs; NIH [1K99AR059222, 1UH2AR057504-01, 4UH3AR057504-02]; NATIONAL CANCER INSTITUTE [ZIABC010938] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG000180] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) NHGRI and NCI Intramural Research Programs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank J. Heitman, A. Amend, Y. Shea, M. Turner, I. Brownell and M. Udey for helpful discussions. We thank J. Fekecs for assistance with the figures. This work was supported by the US National Institutes of Health (NIH) NHGRI and NCI Intramural Research Programs, and in part by NIH grant no. 1K99AR059222 (to H. H. K.). Sequencing was funded by grants from the NIH (1UH2AR057504-01 and 4UH3AR057504-02).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; Bruns TD, 1992, MOL PHYLOGENET EVOL, V1, P231, DOI 10.1016/1055-7903(92)90020-H; Cohen AD, 2005, INT J DERMATOL, V44, P1002, DOI 10.1111/j.1365-4632.2005.02281.x; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Larone DH, 2002, MED IMPORTANT FUNGI; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Marples M. J., 1965, ECOLOGY HUMAN SKIN; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Perea S, 2000, J CLIN MICROBIOL, V38, P3226, DOI 10.1128/JCM.38.9.3226-3230.2000; PERFECT JR, 1992, DRUG SAFETY, V7, P323, DOI 10.2165/00002018-199207050-00003; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	41	666	705	24	367	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					367	+		10.1038/nature12171	http://dx.doi.org/10.1038/nature12171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23698366	Green Accepted			2022-12-24	WOS:000320592900041
J	Mishra, SK; Hoon, MA				Mishra, Santosh K.; Hoon, Mark A.			The Cells and Circuitry for Itch Responses in Mice	SCIENCE			English	Article							GASTRIN-RELEASING-PEPTIDE; BEHAVIORAL-RESPONSES; RECEPTOR; AFFERENTS; SENSATION; PAIN	Itch is triggered by somatosensory neurons expressing the ion channel TRPV1 (transient receptor potential cation channel subfamily V member 1), but the mechanisms underlying this nociceptive response remain poorly understood. Here, we show that the neuropeptide natriuretic polypeptide b (Nppb) is expressed in a subset of TRPV1 neurons and found that Nppb(-/-) mice selectively lose almost all behavioral responses to itch-inducing agents. Nppb triggered potent scratching when injected intrathecally in wild-type and Nppb(-/-) mice, showing that this neuropeptide evokes itch when released from somatosensory neurons. Itch responses were blocked by toxin-mediated ablation of Nppb-receptor-expressing cells, but a second neuropeptide, gastrin-releasing peptide, still induced strong responses in the toxin-treated animals. Thus, our results define the primary pruriceptive neurons, characterize Nppb as an itch-selective neuropeptide, and reveal the next two stages of this dedicated neuronal pathway.	[Mishra, Santosh K.; Hoon, Mark A.] NIDCR, Mol Genet Unit, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Hoon, MA (corresponding author), NIDCR, Mol Genet Unit, Lab Sensory Biol, NIH, Bldg 49,Room 1A16,49 Convent Dr, Bethesda, MD 20892 USA.	mark.hoon@nih.gov	Mishra, Santosh/S-7516-2017	Mishra, Santosh/0000-0001-8616-2606	NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000721] Funding Source: NIH RePORTER	NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to N. Ryba for encouragement and helpful advice and fur valuable suggestions. The Nppb<SUP>-/-</SUP> mice used for this research project were generated from embryonic stem cells obtained from the National Center for Research Resources (NCRR)-NIH-supported KOMP repository (www.komp.org) and engineered by the Wellcome Trust Sanger Institute and the Mouse Biology Program (www.mousebiology.org). We thank NIDCR Gene Targeting Facility for help generating Nppb mutant mice. The mouse strain STOCK Tg(GRP-EGFP) was obtained (rein the Mutant Mouse Regional Resource Center (MMRRC), a NCRR-NIH-funded strain repository, and was donated to the MMRRC by the National Institute of Neurological Disorders and Stroke-funded GENSAT RAC transgenic project. This research was supported by the intramural research program of the NIH, NIDCR.	Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Davidson S, 2012, J NEUROPHYSIOL, V108, P1711, DOI 10.1152/jn.00206.2012; Fleming MS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-52; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; McNeil B, 2012, NEUROSCI BULL, V28, P100, DOI 10.1007/s12264-012-1202-1; Mishra SK, 2011, EMBO J, V30, P582, DOI 10.1038/emboj.2010.325; Misono KS, 2011, FEBS J, V278, P1818, DOI 10.1111/j.1742-4658.2011.08083.x; Namer B, 2008, J NEUROPHYSIOL, V100, P2062, DOI 10.1152/jn.90482.2008; Patel KN, 2010, NEURON, V68, P334, DOI 10.1016/j.neuron.2010.10.018; Schmelz M., 1997, J NEUROSCI, V17, P8003; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Wiley RG, 2003, ADV DRUG DELIVER REV, V55, P1043, DOI 10.1016/S0169-409X(03)00102-9	21	312	333	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					968	971		10.1126/science.1233765	http://dx.doi.org/10.1126/science.1233765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704570	Green Accepted			2022-12-24	WOS:000319344100044
J	Styrkarsdottir, U; Thorleifsson, G; Sulem, P; Gudbjartsson, DF; Sigurdsson, A; Jonasdottir, A; Jonasdottir, A; Oddsson, A; Helgason, A; Magnusson, OT; BragiWalters, G; Frigge, ML; Helgadottir, HT; Johannsdottir, H; Bergsteinsdottir, K; Ogmundsdottir, MH; Center, JR; Nguyen, TV; Eisman, JA; Christiansen, C; Steingrimsson, E; Jonasson, JG; Tryggvadottir, L; Eyjolfsson, GI; Theodors, A; Jonsson, T; Ingvarsson, T; Olafsson, I; Rafnar, T; Kong, A; Sigurdsson, G; Masson, G; Thorsteinsdottir, U; Stefansson, K				Styrkarsdottir, Unnur; Thorleifsson, Gudmar; Sulem, Patrick; Gudbjartsson, Daniel F.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Oddsson, Asmundur; Helgason, Agnar; Magnusson, Olafur T.; BragiWalters, G.; Frigge, Michael L.; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Bergsteinsdottir, Kristin; Ogmundsdottir, Margret H.; Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.; Christiansen, Claus; Steingrimsson, Erikur; Jonasson, Jon G.; Tryggvadottir, Laufey; Eyjolfsson, Gudmundur I.; Theodors, Asgeir; Jonsson, Thorvaldur; Ingvarsson, Thorvaldur; Olafsson, Isleifur; Rafnar, Thorunn; Kong, Augustine; Sigurdsson, Gunnar; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari			Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits	NATURE			English	Article							BONE-MINERAL DENSITY; OSTEOPOROSIS; GPR48; RECEPTORS; KNOCKOUT; LEADS; LOCI	Low bone mineral density (BMD) is used as a parameter of osteoporosis. Genome-wide association studies of BMD have hitherto focused on BMD as a quantitative trait, yielding common variants of small effects that contribute to the population diversity in BMD1-7. Here we use BMD as a dichotomous trait, searching for variants that may have a direct effect on the risk of pathologically low BMD rather than on the regulation of BMD in the healthy population. Through whole-genome sequencing of Icelandic individuals, we found a rare nonsense mutation within the leucinerich-repeat-containing G-protein-coupled receptor 4 (LGR4) gene (c.376C>T) that is strongly associated with low BMD, and with osteoporotic fractures. This mutation leads to termination of LGR4 at position 126 and fully disrupts its function. The c.376C>T mutation is also associated with electrolyte imbalance, late onset of menarche and reduced testosterone levels, as well as an increased risk of squamous cell carcinoma of the skin and biliary tract cancer. Interestingly, the phenotype of carriers of the c.376C>T mutation overlaps that of Lgr4 mutant mice.	[Styrkarsdottir, Unnur; Thorleifsson, Gudmar; Sulem, Patrick; Gudbjartsson, Daniel F.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Oddsson, Asmundur; Helgason, Agnar; Magnusson, Olafur T.; BragiWalters, G.; Frigge, Michael L.; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Rafnar, Thorunn; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen, IS-101 Reykjavik, Iceland; [Oddsson, Asmundur] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Bergsteinsdottir, Kristin; Ogmundsdottir, Margret H.; Steingrimsson, Erikur] Univ Iceland, Biomed Ctr, Fac Med, Dept Biochem & Mol Biol, IS-101 Reykjavik, Iceland; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Center, Jacqueline R.; Eisman, John A.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] Univ New S Wales, Sydney, NSW 2010, Australia; [Eisman, John A.] UNDA, Sydney, NSW 2010, Australia; [Christiansen, Claus] CCBR, DK-2750 Ballerup, Denmark; [Jonasson, Jon G.] Natl Univ Hosp Iceland, Landspitali, Dept Pathol, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey; Jonsson, Thorvaldur; Sigurdsson, Gunnar; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey] Iceland Canc Registry, IS-105 Reykjavik, Iceland; [Eyjolfsson, Gudmundur I.] Iceland Med Ctr Laeknasetrid, Lab Mjodd RAM, IS-109 Reykjavik, Iceland; [Theodors, Asgeir] Natl Univ Hosp Iceland, Landspitali, Dept Gastroenterol, IS-101 Reykjavik, Iceland; [Jonsson, Thorvaldur] Natl Univ Hosp Iceland, Landspitali, Dept Surg, IS-101 Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Akureyri Hosp, Dept Orthoped Surg, IS-600 Akureyri, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, IS-600 Akureyri, Iceland; [Olafsson, Isleifur] Natl Univ Hosp Iceland, Landspitali, Dept Clin Biochem, IS-101 Reykjavik, Iceland; [Sigurdsson, Gunnar] Natl Univ Hosp Iceland, Landspitali, Dept Endocrinol & Metab, IS-101 Reykjavik, Iceland	Karolinska Institutet; University of Iceland; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Notre Dame Australia; Center Clinical & Basic Research; Synarc; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; University of Akureyri; Landspitali National University Hospital; Landspitali National University Hospital	Thorsteinsdottir, U (corresponding author), deCODE Genet Amgen, IS-101 Reykjavik, Iceland.	unnurth@decode.is; kstefans@decode.is	Center, Jacqueline/AAY-8712-2021; Eisman, John A/C-2886-2014; Walters, G. Bragi/L-4215-2013; Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015; Nguyen, Tuan V./AAD-9503-2020	Center, Jacqueline/0000-0002-5278-4527; Walters, G. Bragi/0000-0002-5415-6487; Nguyen, Tuan V./0000-0002-3246-6281; Steingrimsson, Eirikur/0000-0001-5826-7486; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Tryggvadottir, Laufey/0000-0001-8067-9030; Helgason, Agnar/0000-0002-8545-3767; Styrkarsdottir, Unnur/0000-0001-8146-8278; Oddsson, Asmundur/0000-0002-4606-5163; Helgadottir, Hafdis/0000-0003-4352-152X; Jonasson, Jon G./0000-0002-2635-5032	European Commission [HEALTH-F2-2008-201865-GEFOS]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]	European Commission(European CommissionEuropean Commission Joint Research Centre); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project	We thank the subjects of the Icelandic deCODE study, the Danish PERF study and the Australian DOES study for their participation. We also thank the staff at deCODE Genetics core facilities and all our colleagues for their important contribution to this work. The authors would like to thank the NHLBI GO Exome Sequencing Project and its continuing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923); the WHI Sequencing Project (HL-102924); the Broad GO Sequencing Project (HL-102925); the Seattle GO Sequencing Project (HL-102926); and the Heart GO Sequencing Project (HL-103010). This work was supported in part by the European Commission (HEALTH-F2-2008-201865-GEFOS).	Bagger YZ, 2007, OSTEOPOROSIS INT, V18, P505, DOI 10.1007/s00198-006-0255-2; Balasubramanian S, 2011, GENE DEV, V25, P1, DOI 10.1101/gad.1968411; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Nguyen TV, 1997, J BONE MINER RES, V12, P124, DOI 10.1359/jbmr.1997.12.1.124; NHLBI. Exome Sequencing Project, 2012, EX SEQ PROJ EX VAR S; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023	29	183	194	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					517	520		10.1038/nature12124	http://dx.doi.org/10.1038/nature12124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644456				2022-12-24	WOS:000319254000054
J	Lim, C; Allada, R				Lim, Chunghun; Allada, Ravi			ATAXIN-2 Activates PERIOD Translation to Sustain Circadian Rhythms in Drosophila	SCIENCE			English	Article							GENE; CLOCK; NEURONS; REPEAT; TYPE-2; EXPANSION; PATHOLOGY; HOMOLOG; PROTEIN; CLONING	Evidence for transcriptional feedback in circadian timekeeping is abundant, yet little is known about the mechanisms underlying translational control. We found that ATAXIN-2 (ATX2), an RNA-associated protein involved in neurodegenerative disease, is a translational activator of the rate-limiting clock component PERIOD (PER) in Drosophila. ATX2 specifically interacted with TWENTY-FOUR (TYF), an activator of PER translation. RNA interference-mediated depletion of Atx2 or the expression of a mutant ATX2 protein that does not associate with polyadenylate-binding protein (PABP) suppressed behavioral rhythms and decreased abundance of PER. Although ATX2 can repress translation, depletion of Atx2 from Drosophila S2 cells inhibited translational activation by RNA-tethered TYF and disrupted the association between TYF and PABP. Thus, ATX2 coordinates an active translation complex important for PER expression and circadian rhythms.	[Lim, Chunghun; Allada, Ravi] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	r-allada@northwestern.edu	Lim, Chunghun/AAB-1253-2020	Lim, Chunghun/0000-0001-8473-9272	National Institute of Neurological Disorders and Stroke [R01NS059042]; Defense Advanced Research Projects Agency (DARPA) [D12AP00023]; DARPA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059042] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Choe, P. Hardin, E. Izaurralde, G. P. McNeil, A. Nakamura, L. Pallanck, M. Ramaswami, M. Rosbash, H. Saumweber, M. C. Siomi, N. Sonenberg, Bloomington Drosophila stock center, and Vienna Drosophila RNAi center for reagents; D. Nanavati (Northwestern Proteomics Core) for assistance and helpful comments on proteomics data; G. Auburger for helpful comments; and P. Emery for communicating results before publication. This work was supported by National Institute of Neurological Disorders and Stroke (R01NS059042) and Defense Advanced Research Projects Agency (DARPA) (D12AP00023). This effort was in part sponsored by DARPA; the content of the information does not necessarily reflect the position or the policy of the government, and no official endorsement should be inferred.	Bradley S, 2012, GENETICS, V192, P943, DOI 10.1534/genetics.112.143248; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; Lim C, 2011, NATURE, V470, P399, DOI 10.1038/nature09728; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Ross OA, 2011, HUM MOL GENET, V20, P3207, DOI 10.1093/hmg/ddr227; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Satterfield TF, 2002, GENETICS, V162, P1687; Staiger D, 2011, TRENDS PLANT SCI, V16, P517, DOI 10.1016/j.tplants.2011.06.002; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tuin I, 2006, NEUROLOGY, V67, P1966, DOI 10.1212/01.wnl.0000247054.90322.14; Velazquez-Perez L, 2011, NEURODEGENER DIS, V8, P447, DOI 10.1159/000324374; Zheng XZ, 2012, TRENDS NEUROSCI, V35, P574, DOI 10.1016/j.tins.2012.05.007	28	94	98	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					875	879		10.1126/science.1234785	http://dx.doi.org/10.1126/science.1234785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687047				2022-12-24	WOS:000318997400047
J	Teijaro, JR; Ng, C; Lee, AM; Sullivan, BM; Sheehan, KCF; Welch, M; Schreiber, RD; de la Torre, JC; Oldstone, MBA				Teijaro, John R.; Cherie Ng; Lee, Andrew M.; Sullivan, Brian M.; Sheehan, Kathleen C. F.; Welch, Megan; Schreiber, Robert D.; de la Torre, Juan Carlos; Oldstone, Michael B. A.			Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling	SCIENCE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; VIRAL PERSISTENCE; DENDRITIC CELLS; IMMUNE ACTIVATION; GENOMIC ANALYSIS; T-CELLS; IMMUNOSUPPRESSION; MICE; VIVO; GLYCOPROTEIN	During persistent viral infections, chronic immune activation, negative immune regulator expression, an elevated interferon signature, and lymphoid tissue destruction correlate with disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased expression of negative immune regulatory molecules, and restored lymphoid architecture in mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and after establishment of persistent virus infection resulted in enhanced virus clearance and was CD4 T cell-dependent. Hence, we demonstrate a direct causal link between IFN-I signaling, immune activation, negative immune regulator expression, lymphoid tissue disorganization, and virus persistence. Our results suggest that therapies targeting IFN-I may help control persistent virus infections.	[Teijaro, John R.; Cherie Ng; Lee, Andrew M.; Sullivan, Brian M.; Welch, Megan; de la Torre, Juan Carlos; Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sheehan, Kathleen C. F.; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Scripps Research Institute; Washington University (WUSTL)	Oldstone, MBA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mbaobo@scripps.edu	Lee, Andrew/G-5470-2011; Schreiber, Robert/Q-7550-2019	Sullivan, Brian/0000-0003-4277-6037; Schreiber, Robert/0000-0003-1590-2341	NIH [AI09484]; National Cancer Institute [NCI CA43059, U54AI057160]; American Heart fellowships [11POST7430106, HL007195, NS041219];  [AI077719];  [AI047140];  [AI007354]; NATIONAL CANCER INSTITUTE [R37CA043059, R01CA043059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007354, R01AI077719, R01AI047140, R01AI009484, R37AI009484, R56AI077719, U54AI057160, R56AI047140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041219] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart fellowships; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank D. Fremgen, C. Cubitt, N. Ngo, and S. Rice for technical excellence. Data reported in the manuscript are tabulated in the main paper and in the supplementary materials. This research was supported by NIH grant AI09484 (M.B.A.O.); National Cancer Institute grants NCI CA43059 (R.D.S.) and U54AI057160 to the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MRCE) (R.D.S. and M.B.A.O.); grants AI077719 and AI047140 (J.C.d.l.T.), postdoctoral training grants AI007354; and American Heart fellowships 11POST7430106 (J.R.T.), HL007195 (C.N.), and NS041219 (B.M.S.).	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berger DP, 1999, VIROLOGY, V260, P136, DOI 10.1006/viro.1999.9811; Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chang JJ, 2010, J INFECT DIS, V202, pS297, DOI 10.1086/655657; d'Ettorre G, 2011, AIDS RES HUM RETROV, V27, P355, DOI 10.1089/aid.2010.0342; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; EVANS CF, 1994, J VIROL, V68, P7367, DOI 10.1128/JVI.68.11.7367-7373.1994; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Manches O, 2009, J CLIN INVEST, V119, P3512, DOI 10.1172/JCI41509; Muller S, 2002, J VIROL, V76, P2375, DOI 10.1128/JVI.76.5.2375-2383.2002; Oldstone MBA, 2011, VIROLOGY, V411, P170, DOI 10.1016/j.virol.2010.11.023; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; SALVATO M, 1991, J VIROL, V65, P1863, DOI 10.1128/JVI.65.4.1863-1869.1991; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Suresh M, 2002, J VIROL, V76, P3943, DOI 10.1128/JVI.76.8.3943-3951.2002; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	36	522	534	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					207	211		10.1126/science.1235214	http://dx.doi.org/10.1126/science.1235214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580529	Green Accepted			2022-12-24	WOS:000317341400058
J	Kaplon, J; Zheng, L; Meissl, K; Chaneton, B; Selivanov, VA; Mackay, G; van der Burg, SH; Verdegaal, EME; Cascante, M; Shlomi, T; Gottlieb, E; Peeper, DS				Kaplon, Joanna; Zheng, Liang; Meissl, Katrin; Chaneton, Barbara; Selivanov, Vitaly A.; Mackay, Gillian; van der Burg, Sjoerd H.; Verdegaal, Elizabeth M. E.; Cascante, Marta; Shlomi, Tomer; Gottlieb, Eyal; Peeper, Daniel S.			A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence	NATURE			English	Article							CELL SENESCENCE; KINASE; COMPLEX; CANCER	In response to tenacious stress signals, such as the unscheduled activation of oncogenes, cells can mobilize tumour suppressor networks to avert the hazard of malignant transformation. A large body of evidence indicates that oncogene-induced senescence (OIS) acts as such a break, withdrawing cells from the proliferative pool almost irreversibly, thus crafting a vital pathophysiological mechanism that protects against cancer(1-5). Despite the widespread contribution of OIS to the cessation of tumorigenic expansion in animal models and humans, we have only just begun to define the underlying mechanism and identify key players(6). Although deregulation of metabolism is intimately linked to the proliferative capacity of cells(7-10), and senescent cells are thought to remain metabolically active(11), little has been investigated in detail about the role of cellular metabolism in OIS. Here we show, by metabolic profiling and functional perturbations, that the mitochondrial gatekeeper pyruvate dehydrogenase (PDH) is a crucial mediator of senescence induced by BRAF(V600E), an oncogene commonly mutated in melanoma and other cancers. BRAF(V600E)-induced senescence was accompanied by simultaneous suppression of the PDH-inhibitory enzyme pyruvate dehydrogenase kinase 1 (PDK1) and induction of the PDH-activating enzyme pyruvate dehydrogenase phosphatase 2 (PDP2). The resulting combined activation of PDH enhanced the use of pyruvate in the tricarboxylic acid cycle, causing increased respiration and redox stress. Abrogation of OIS, a rate-limiting step towards oncogenic transformation, coincided with reversion of these processes. Further supporting a crucial role of PDH in OIS, enforced normalization of either PDK1 or PDP2 expression levels inhibited PDH and abrogated OIS, thereby licensing BRAF(V600E)-driven melanoma development. Finally, depletion of PDK1 eradicated melanoma subpopulations resistant to targeted BRAF inhibition, and caused regression of established melanomas. These results reveal a mechanistic relationship between OIS and a key metabolic signalling axis, which may be exploited therapeutically.	[Kaplon, Joanna; Meissl, Katrin; Peeper, Daniel S.] Netherlands Canc Inst, Div Mol Oncol, NL-1066 CX Amsterdam, Netherlands; [Zheng, Liang; Chaneton, Barbara; Mackay, Gillian; Gottlieb, Eyal] Canc Res UK, Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Fac Biol, IBUB, E-08028 Barcelona, Spain; [Selivanov, Vitaly A.; Cascante, Marta] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain; [van der Burg, Sjoerd H.; Verdegaal, Elizabeth M. E.] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2333 ZA Leiden, Netherlands; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Shlomi, Tomer] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ USA	Netherlands Cancer Institute; Beatson Institute; Cancer Research UK; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Technion Israel Institute of Technology; Princeton University	Gottlieb, E (corresponding author), Canc Res UK, Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk; d.peeper@nki.nl	CASCANTE, MARTA/AAG-4355-2022; Peeper, Daniel/AAA-2430-2020; van der Burg, Sjoerd H/T-1875-2017; Gottlieb, Eyal/G-6450-2010; Verdegaal, Elizabeth/Y-2597-2018; CASCANTE, MARTA/AFK-5991-2022	CASCANTE, MARTA/0000-0002-2062-4633; van der Burg, Sjoerd H/0000-0002-6556-0354; Gottlieb, Eyal/0000-0002-9770-0956; Verdegaal, Elizabeth/0000-0002-4449-8707; CASCANTE, MARTA/0000-0002-2062-4633; Meissl, Katrin/0000-0003-2731-6657; Selivanov, Vitaly/0000-0002-7937-9249; Zheng, Liang/0000-0002-5346-4111	Cancer Research UK, Spanish Government-EU-FEDER [SAF2011-25726, ISCIII-RTICC-RD6/0020/0046]; ICREA-Academia; Israel Cancer Research Foundation; Israel Science Foundation; Netherlands Organization for Scientific Research (NWO); Dutch Cancer Society (KWF Kankerbestrijding)	Cancer Research UK, Spanish Government-EU-FEDER; ICREA-Academia(ICREA); Israel Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding)	We thank J.-Y. Song for pathological analysis, M. McMahon for providing Braf<SUP>CA</SUP> mice, C. Vogel for sharing cell lines, R. van Amerongen for critical reading of the manuscript, and all members of the Gottlieb and Peeper laboratories for their input. This work was supported by Cancer Research UK, Spanish Government-EU-FEDER (grants SAF2011-25726 and ISCIII-RTICC-RD6/0020/0046) and ICREA-Academia to M. C., Israel Cancer Research Foundation and Israel Science Foundation to T. S., a Vici grant from the Netherlands Organization for Scientific Research (NWO) and a Queen Wilhelmina Award grant from the Dutch Cancer Society (KWF Kankerbestrijding) to D.S.P.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Flaherty KT, 2011, NAT REV DRUG DISCOV, V10, P811, DOI 10.1038/nrd3579; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sviderskaya EV, 1997, J INVEST DERMATOL, V108, P30, DOI 10.1111/1523-1747.ep12285621; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008	33	403	416	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					109	+		10.1038/nature12154	http://dx.doi.org/10.1038/nature12154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23685455				2022-12-24	WOS:000319947800043
J	Dykhuizen, EC; Hargreaves, DC; Miller, EL; Cui, KR; Korshunov, A; Kool, M; Pfister, S; Cho, YJ; Zhao, KJ; Crabtree, GR				Dykhuizen, Emily C.; Hargreaves, Diana C.; Miller, Erik L.; Cui, Kairong; Korshunov, Andrey; Kool, Marcel; Pfister, Stefan; Cho, Yoon-Jae; Zhao, Keji; Crabtree, Gerald R.			BAF complexes facilitate decatenation of DNA by topoisomerase II alpha	NATURE			English	Article							CHROMATIN REMODELING COMPLEX; GENETIC LANDSCAPE; GENOME; ESBAF; BETA; PLURIPOTENCY; RESOLUTION; MUTATIONS; POLYCOMB; EXOME	Recent exon-sequencing studies of human tumours have revealed that subunits of BAF (mammalian SWI/SNF) complexes are mutated in more than 20% of all human malignancies(1,2), but the mechanisms involved in tumour suppression are unclear. BAF chromatin-remodelling complexes are polymorphic assemblies that use energy provided by ATP hydrolysis to regulate transcription through the control of chromatin structure(3) and the placement of Polycomb repressive complex 2 (PRC2) across the genome(4,5). Several proteins dedicated to this multisubunit complex, including BRG1 (also known as SMARCA4) and BAF250a (also known as ARID1A), are mutated at frequencies similar to those of recognized tumour suppressors. In particular, the core ATPase BRG1 is mutated in 5-10% of childhood medulloblastomas(6-9) and more than 15% of Burkitt's lymphomas(10,11). Here we show a previously unknown function of BAF complexes in decatenating newly replicated sister chromatids, a requirement for proper chromosome segregation during mitosis. We find that deletion of Brg1 in mouse cells, as well as the expression of BRG1 point mutants identified in human tumours, leads to anaphase bridge formation (in which sister chromatids are linked by catenated strands of DNA) and a G2/M-phase block characteristic of the decatenation checkpoint. Endogenous BAF complexes interact directly with endogenous topoisomerase II alpha (TOP2A) through BAF250a and are required for the binding of TOP2A to approximately 12,000 sites across the genome. Our results demonstrate that TOP2A chromatin binding is dependent on the ATPase activity of BRG1, which is compromised in oncogenic BRG1 mutants. These studies indicate that the ability of TOP2A to prevent DNA entanglement at mitosis requires BAF complexes and suggest that this activity contributes to the role of BAF subunits as tumour suppressors.	[Dykhuizen, Emily C.; Hargreaves, Diana C.; Miller, Erik L.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Dykhuizen, Emily C.; Hargreaves, Diana C.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Miller, Erik L.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Cui, Kairong; Zhao, Keji] NIH, Bethesda, MD 20892 USA; [Korshunov, Andrey] German Canc Res Ctr, CCU Neuropathol, D-69120 Heidelberg, Germany; [Kool, Marcel; Pfister, Stefan] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Pfister, Stefan] Univ Heidelberg Hosp, Dept Pediat Oncol, D-69120 Heidelberg, Germany; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol & Neurosurg, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu	Pfister, Stefan M/F-6860-2013; Kool, Marcel/H-2541-2013	Pfister, Stefan M/0000-0002-5447-5322; Crabtree, Robert/0000-0002-6639-8707; Korshunov, Andrey/0000-0002-5257-3623; dykhuizen, emily/0000-0003-3072-1469	NIH; American Cancer Society; Helen Hay Whitney Foundation; NHLBI; NATIONAL CANCER INSTITUTE [R01CA163915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZICHL006058, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789, R37NS046789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032469] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Helen Hay Whitney Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to acknowledge the DNA Sequencing Core facility of the National Heart, Lung, and Blood Institute (NHLBI) for sequencing the ChIP-seq libraries. This work was supported by the NIH (G.R.C.), The American Cancer Society (E.C.D.), The Helen Hay Whitney Foundation (D.C.H.) and the Division of Intramural Research program of NHLBI (K.Z.). G.R.C. is an investigator at the Howard Hughes Medical Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Bultman SJ, 2005, GENE DEV, V19, P2849, DOI 10.1101/gad.1364105; CAPRANICO G, 1990, NUCLEIC ACIDS RES, V18, P4553, DOI 10.1093/nar/18.15.4553; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Johnson M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp480; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kadoch C., 2013, NATURE GENET; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramamoorthy M, 2012, NUCLEIC ACIDS RES, V40, P1621, DOI 10.1093/nar/gkr844; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; Sperling AS, 2011, P NATL ACAD SCI USA, V108, P12693, DOI 10.1073/pnas.1106834108; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	37	182	184	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					624	+		10.1038/nature12146	http://dx.doi.org/10.1038/nature12146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23698369	Green Accepted			2022-12-24	WOS:000319556100045
J	Gao, P; Ascano, M; Wu, Y; Barchet, W; Gaffney, BL; Zillinger, T; Serganov, AA; Liu, YZ; Jones, RA; Hartmann, G; Tuschl, T; Patel, DJ				Gao, Pu; Ascano, Manuel; Wu, Yang; Barchet, Winfried; Gaffney, Barbara L.; Zillinger, Thomas; Serganov, Artem A.; Liu, Yizhou; Jones, Roger A.; Hartmann, Gunther; Tuschl, Thomas; Patel, Dinshaw J.			Cyclic [G(2 ',5 ') pA(3 ',5 ')p] Is the Metazoan Second Messenger Produced by DNA-Activated Cyclic GMP-AMP Synthase	CELL			English	Article							C-DI-GMP; STRUCTURAL BASIS; CYTOSOLIC DNA; INTRACELLULAR DNA; I INTERFERON; BACTERIAL 2ND-MESSENGER; DIGUANYLIC ACID; LIGAND-BINDING; SENSOR; INFLAMMASOME	Recent studies identified cyclic GMP-AMP (cGAMP) as a metazoan second messenger triggering an interferon response. cGAMP is generated from GTP and ATP by cytoplasmic dsDNA sensor cGAMP synthase (cGAS). Wecombined structural, chemical, biochemical, and cellular assays to demonstrate that this second messenger contains G(2',5')pA and A(3',5')pG phosphodiester linkages, designated c[G(2',5') pA(3',5')p]. We show that, upon dsDNA binding, cGAS is activated through conformational transitions, resulting in formation of a catalytically competent and accessible nucleotide-binding pocket for generation of c[G(2',5')pA(3',5')p]. We demonstrate that cyclization occurs in a stepwise manner through initial generation of 5'-pppG(2',5') pA prior to cyclization to c[G(2',5')pA(3',5')p], with the latter positioned precisely in the catalytic pocket. Mutants of cGAS dsDNA-binding or catalytic pocket residues exhibit reduced or abrogated activity. Our studies have identified c[G(2',5')pA(3',5')p] as a founding member of a family of metazoan 2',5'-containing cyclic heterodinucleotide second messengers distinct from bacterial 3',5' cyclic dinucleotides.	[Gao, Pu; Wu, Yang; Liu, Yizhou; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Ascano, Manuel; Serganov, Artem A.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA; [Barchet, Winfried; Zillinger, Thomas; Hartmann, Gunther] Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Gaffney, Barbara L.; Jones, Roger A.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University; University of Bonn; Rutgers State University New Brunswick	Tuschl, T (corresponding author), Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA.	ttuschl@mail.rockefeller.edu; pateld@mskcc.org	Ascano, Manuel/ABA-3586-2020; Hartmann, Gunther/P-7492-2017; Zillinger, Thomas/AAD-7320-2020; Wu, Yang/N-8460-2014; Jones, Roger A./GRY-0637-2022	Ascano, Manuel/0000-0002-9370-5493; Hartmann, Gunther/0000-0003-1021-2018; Zillinger, Thomas/0000-0002-0866-4835; Wu, Yang/0000-0002-1544-1947; Barchet, Winfried/0000-0002-6745-6606; Jones, Roger A./0000-0002-6835-6615	Abby Rockefeller Trust; Maloris; STARR Foundations; HHMI; DFG [BA3544/1-1]; NIH [GM79760];  [SFB670];  [SFB704]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079760] Funding Source: NIH RePORTER	Abby Rockefeller Trust; Maloris; STARR Foundations; HHMI(Howard Hughes Medical Institute); DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the synchrotron beam line staffs at the Brookhaven and Argonne National laboratories for their assistance. D.J.P. is supported by grants from the Abby Rockefeller Trust and the Maloris and STARR Foundations. T.T. is supported by HHMI. W.B. and G.H. are members of the DFG Excellence Cluster ImmunoSensation. W.B. is supported by DFG grant BA3544/1-1, G.H. by SFB670, and both by SFB704. R.A.J. is supported by NIH GM79760.	Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gaffney B.L., 2012, CURR PROTOC NUCL ACI, V14; Gaffney BL, 2010, ORG LETT, V12, P3269, DOI 10.1021/ol101236b; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Krasteva PV, 2012, PROTEIN SCI, V21, P929, DOI 10.1002/pro.2093; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wolkowicz UM, 2012, NUCLEIC ACIDS RES, V40, P9356, DOI 10.1093/nar/gks696; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	37	580	627	5	106	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1094	1107		10.1016/j.cell.2013.04.046	http://dx.doi.org/10.1016/j.cell.2013.04.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23647843	Green Accepted, Bronze			2022-12-24	WOS:000319456800016
J	Wang, TL; Fu, GB; Pan, XJ; Wu, JP; Gong, XQ; Wang, JW; Shi, YG				Wang, Tingliang; Fu, Guobin; Pan, Xiaojing; Wu, Jianping; Gong, Xinqi; Wang, Jiawei; Shi, Yigong			Structure of a bacterial energy-coupling factor transporter	NATURE			English	Article							MULTIDRUG ABC TRANSPORTER; MALTOSE TRANSPORTER; CRYSTAL-STRUCTURE; BINDING; PROKARYOTES; INTERMEDIATE; MECHANISM; SOFTWARE; DYNAMICS; AFFINITY	The energy-coupling factor (ECF) transporters constitute a novel family of conserved membrane transporters in prokaryotes that have a similar domain organization to the ATP-binding cassette transporters(1-3). Each ECF transporter comprises a pair of cytosolic ATPases (the A and A' components, or EcfA and EcfA'), a membrane-embedded substrate-binding protein (the S component, or EcfS) and a transmembrane energy-coupling component (the T component, or EcfT) that links the EcfA-EcfA' subcomplex to EcfS. The structure and transport mechanism of the quaternary ECF transporter remain largely unknown. Here we report the crystal structure of a nucleotide-free ECF transporter from Lactobacillus brevis at a resolution of 3.5 angstrom. The T component has a horseshoe-shaped open architecture, with five alpha-helices as transmembrane segments and two cytoplasmic alpha-helices as coupling modules connecting to the A and A' components. Strikingly, the S component, thought to be specific for hydroxymethyl pyrimidine, lies horizontally along the lipid membrane and is bound exclusively by the five transmembrane segments and the two cytoplasmic helices of the T component. These structural features suggest a plausible working model for the transport cycle of the ECF transporters.	[Wang, Tingliang; Fu, Guobin; Pan, Xiaojing; Wu, Jianping; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Minist Educ Key Lab Prot Sci, Beijing 100084, Peoples R China; [Wang, Tingliang; Fu, Guobin; Pan, Xiaojing; Wu, Jianping; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Wang, Tingliang; Fu, Guobin; Pan, Xiaojing; Wu, Jianping; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ Key Lab Prot Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology (973 Programs) [2009CB918801, 2013CB910602]; National Natural Science Foundation of China [31021002, 31130002]	Ministry of Science and Technology (973 Programs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank S. Huang and J. He at SSRF beamline BL17U for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (973 Programs 2009CB918801 and 2013CB910602) and the National Natural Science Foundation of China (31021002 and 31130002).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berntsson RPA, 2012, P NATL ACAD SCI USA, V109, P13990, DOI 10.1073/pnas.1203219109; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erkens GB, 2012, BIOCHEMISTRY-US, V51, P4390, DOI 10.1021/bi300504v; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Erkens GB, 2010, BIOCHEMISTRY-US, V49, P3203, DOI 10.1021/bi100154r; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Lezon TR, 2012, BIOPHYS J, V102, P1331, DOI 10.1016/j.bpj.2012.02.028; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seyedarabi A, 2010, FEBS LETT, V584, P4163, DOI 10.1016/j.febslet.2010.09.006; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	32	53	56	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					272	+		10.1038/nature12045	http://dx.doi.org/10.1038/nature12045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23584587				2022-12-24	WOS:000318558200043
J	Zhang, G; Li, JX; Purkayastha, S; Tang, YZ; Zhang, H; Yin, Y; Li, B; Liu, G; Cai, DS				Zhang, Guo; Li, Juxue; Purkayastha, Sudarshana; Tang, Yizhe; Zhang, Hai; Yin, Ye; Li, Bo; Liu, Gang; Cai, Dongsheng			Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappa B and GnRH	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; EXTENDS LIFE-SPAN; MOUSE MODEL; NEURONS; MICROGLIA; LONGEVITY; OBESITY; MICE; INFLAMMATION; NEUROGENESIS	Ageing is a result of gradual and overall functional deteriorations across the body; however, it is unknown whether an individual tissue primarily works to mediate the ageing progress and control lifespan. Here we show that the hypothalamus is important for the development of whole-body ageing in mice, and that the underlying basis involves hypothalamic immunity mediated by I kappa B kinase-beta (IKK-beta), nuclear factor kappa B (NF-kappa B) and related microglianeuron immune crosstalk. Several interventional models were developed showing that ageing retardation and lifespan extension are achieved in mice by preventing ageing-related hypothalamic or brain IKK-beta and NF-kappa B activation. Mechanistic studies further revealed that IKK-beta and NF-kappa B inhibit gonadotropin-releasing hormone (GnRH) to mediate ageing-related hypothalamic GnRH decline, and GnRH treatment amends ageing-impaired neurogenesis and decelerates ageing. In conclusion, the hypothalamus has a programmatic role in ageing development via immune-neuroendocrine integration, and immune inhibition or GnRH restoration in the hypothalamus/brain represent two potential strategies for optimizing lifespan and combating ageing-related health problems.	[Zhang, Guo; Li, Juxue; Purkayastha, Sudarshana; Tang, Yizhe; Zhang, Hai; Yin, Ye; Li, Bo; Liu, Gang; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Zhang, Guo; Li, Juxue; Purkayastha, Sudarshana; Tang, Yizhe; Zhang, Hai; Yin, Ye; Li, Bo; Liu, Gang; Cai, Dongsheng] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA; [Zhang, Guo; Li, Juxue; Purkayastha, Sudarshana; Tang, Yizhe; Zhang, Hai; Yin, Ye; Li, Bo; Liu, Gang; Cai, Dongsheng] Albert Einstein Coll Med, Inst Aging, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu	Tang, Yizhe/A-8682-2014; Zhang, Guo/Q-8513-2016	Tang, Yizhe/0000-0001-5354-478X; Li, Bo/0000-0003-2783-9300; Zhang, Guo/0000-0002-3880-6996; Zhang, Guo/0000-0003-0841-4710	National Institutes of Health (NIH) [R01 AG031774, R01 DK078750]; American Diabetes Association [1-12-BS-20]; Irma T. Hirschl Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Irma T. Hirschl Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank other Cai laboratory members for technical assistance, and L. Farhana, D. Stocco, L. Eckhardt, T. Ohshima, A. Lin and D. Tantin for reagents. This study was supported by National Institutes of Health (NIH) grants R01 AG031774, R01 DK078750, and American Diabetes Association grant 1-12-BS-20 (all to D. C.). D. C. is a recipient of Irma T. Hirschl Scholarship.	Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Banks WA, 2010, P NATL ACAD SCI USA, V107, P22272, DOI 10.1073/pnas.1016369107; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Finch C E, 2002, Adv Gerontol, V10, P35; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Martin GM, 2009, AGING CELL, V8, P761, DOI 10.1111/j.1474-9726.2009.00515.x; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Miller RA, 2012, J GERONTOL A-BIOL, V67, P495, DOI 10.1093/gerona/gls082; Mueller JM, 2000, METH MOL B, V99, P205; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Peng BL, 2010, P NATL ACAD SCI USA, V107, P15193, DOI 10.1073/pnas.1005533107; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Taoufik E, 2011, BRAIN, V134, P2722, DOI 10.1093/brain/awr203; Tillerson JL, 2003, J NEUROSCI METH, V123, P189, DOI 10.1016/S0165-0270(02)00360-6; Villeda S, 2008, NEURON, V59, P527, DOI 10.1016/j.neuron.2008.08.005; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zitnik G, 2002, J NEUROSCI RES, V70, P258, DOI 10.1002/jnr.10384	44	574	600	6	189	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					211	+		10.1038/nature12143	http://dx.doi.org/10.1038/nature12143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23636330	Green Accepted			2022-12-24	WOS:000318558200030
J	Anger, AM; Armache, JP; Berninghausen, O; Habeck, M; Subklewe, M; Wilson, DN; Beckmann, R				Anger, Andreas M.; Armache, Jean-Paul; Berninghausen, Otto; Habeck, Michael; Subklewe, Marion; Wilson, Daniel N.; Beckmann, Roland			Structures of the human and Drosophila 80S ribosome	NATURE			English	Article							SECONDARY STRUCTURE; ELECTRON-MICROSCOPY; ATOMIC STRUCTURES; CRYSTAL-STRUCTURE; MESSENGER-RNA; SEQUENCE; SUBUNIT; INITIATION; VISUALIZATION; TRANSLATION	Protein synthesis in all cells is carried out by macromolecular machines called ribosomes. Although the structures of prokaryotic, yeast and protist ribosomes have been determined, the more complex molecular architecture of metazoan 80S ribosomes has so far remained elusive. Here we present structures of Drosophila melanogaster and Homo sapiens 80S ribosomes in complex with the translation factor eEF2, E-site transfer RNA and Stm1-like proteins, based on high-resolution cryo-electron-microscopy density maps. These structures not only illustrate the co-evolution of metazoan-specific ribosomal RNA with ribosomal proteins but also reveal the presence of two additional structural layers in metazoan ribosomes, a well-ordered inner layer covered by a flexible RNA outer layer. The human and Drosophila ribosome structures will provide the basis for more detailed structural, biochemical and genetic experiments.	[Anger, Andreas M.; Armache, Jean-Paul; Berninghausen, Otto; Wilson, Daniel N.; Beckmann, Roland] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany; [Anger, Andreas M.; Armache, Jean-Paul; Berninghausen, Otto; Wilson, Daniel N.; Beckmann, Roland] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany; [Habeck, Michael] Max Planck Inst Biol Cybernet, Dept Empir Inference, D-72076 Tubingen, Germany; [Habeck, Michael] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Subklewe, Marion] Klinikum Univ Munchen, Dept Internal Med 3, D-81377 Munich, Germany; [Subklewe, Marion] Helmholtz Inst Munich, Clin Cooperat Grp Immunotherapy, D-81377 Munich, Germany	University of Munich; University of Munich; Max Planck Society; Max Planck Society; University of Munich	Beckmann, R (corresponding author), Univ Munich, Dept Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	beckmann@lmb.uni-muenchen.de	Subklewe, Marion/N-5873-2014; Armache, Jean-Paul/U-3113-2019; Wilson, Daniel/AAE-8504-2019	Subklewe, Marion/0000-0001-9154-9469; Wilson, Daniel/0000-0003-3816-3828; Armache, Jean-Paul/0000-0001-9195-2282; Habeck, Michael/0000-0002-2188-5667	Deutsche Forschungsgemeinschaft [SFB594, SFB646, GRK 1721, FOR1805]; European Molecular Biology Organization (EMBO); European Research Council (ERC)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Research Council (ERC)(European Research Council (ERC))	We thank C. Ungewickell for assistance with cryo-EM data collection and P. Palluch for preparation of peripheral blood mononucleic cells. We thank M. Yusupov, A. Ben-Shem, N. Garreau de Loubresse and S. Melnikov for sharing S. cerevisiae X-ray data before publication. We thank P. Becker for access to his fly facility and help with embryo collection, and V. Marquez, T. Frohlich, G. Arnold, I. Forne and A. Imhof for mass-spectrometry analysis. This research was supported by grants from the Deutsche Forschungsgemeinschaft SFB594, SFB646 and GRK 1721 (to R.B.), and FOR1805 (to R. B. and D. N. W.). D. N. W. is supported by the European Molecular Biology Organization (EMBO) young investigator program. This work was supported by a European Research Council (ERC) Advanced Grant (to R.B.).	Alkemar G, 2006, BIOCHEMISTRY-US, V45, P8067, DOI 10.1021/bi052149z; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fields DS, 1996, FOLD DES, V1, P419, DOI 10.1016/S1359-0278(96)00058-2; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fuss IJ, 2009, CURR PROTOC IMMUNOL, V85, DOI DOI 10.1002/0471142735.IM0701S85; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; Greber BJ, 2012, NAT STRUCT MOL BIOL, V19, P1228, DOI 10.1038/nsmb.2425; HAGA JY, 1970, J CELL BIOL, V47, P211, DOI 10.1083/jcb.47.1.211; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hirsch M, 2011, J COMPUT BIOL, V18, P335, DOI 10.1089/cmb.2010.0264; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Koyama Y, 1999, GENE, V226, P339, DOI 10.1016/S0378-1119(98)00529-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Leidig C, 2013, NAT STRUCT MOL BIOL, V20, P23, DOI 10.1038/nsmb.2447; Lu H, 2004, J PROTEOME RES, V3, P949, DOI 10.1021/pr0499592; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; Marquez V, 2011, J MOL BIOL, V405, P1215, DOI 10.1016/j.jmb.2010.11.055; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; Norousi R., 2013, J STRUCT BIOL; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; ROUSSET F, 1991, P NATL ACAD SCI USA, V88, P10032, DOI 10.1073/pnas.88.22.10032; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; SWEENEY R, 1994, MOL CELL BIOL, V14, P4203, DOI 10.1128/MCB.14.6.4203; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; THOMPSON JF, 1981, J MOL BIOL, V147, P417, DOI 10.1016/0022-2836(81)90493-9; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Yu YP, 2011, NUCLEIC ACIDS RES, V39, P4851, DOI 10.1093/nar/gkr045	72	356	509	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					80	+		10.1038/nature12104	http://dx.doi.org/10.1038/nature12104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636399				2022-12-24	WOS:000318221500037
J	Rai, D; Lee, BK; Dalman, C; Golding, J; Lewis, G; Magnusson, C				Rai, Dheeraj; Lee, Brian K.; Dalman, Christina; Golding, Jean; Lewis, Glyn; Magnusson, Cecilia			Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; PSYCHIATRIC-DISORDERS; FETAL-GROWTH; EXPOSURE; BIRTH; MISCLASSIFICATION; REGISTER; OUTCOMES	Objective To study the association between parental depression and maternal antidepressant use during pregnancy with autism spectrum disorders in offspring. Design Population based nested case-control study. Setting Stockholm County, Sweden, 2001-07. Participants 4429 cases of autism spectrum disorder (1828 with and 2601 without intellectual disability) and 43 277 age and sex matched controls in the full sample (1679 cases of autism spectrum disorder and 16 845 controls with data on maternal antidepressant use nested within a cohort (n=589 114) of young people aged 0-17 years. Main outcome measure A diagnosis of autism spectrum disorder, with or without intellectual disability. Exposures Parental depression and other characteristics prospectively recorded in administrative registers before the birth of the child. Maternal antidepressant use, recorded at the first antenatal interview, was available for children born from 1995 onwards. Results A history of maternal (adjusted odds ratio 1.49, 95% confidence interval 1.08 to 2.08) but not paternal depression was associated with an increased risk of autism spectrum disorders in offspring. In the subsample with available data on drugs, this association was confined to women reporting antidepressant use during pregnancy (3.34, 1.50 to 7.47, P=0.003), irrespective of whether selective serotonin reuptake inhibitors (SSRIs) or non-selective monoamine reuptake inhibitors were reported. All associations were higher in cases of autism without intellectual disability, there being no evidence of an increased risk of autism with intellectual disability. Assuming an unconfounded, causal association, antidepressant use during pregnancy explained 0.6% of the cases of autism spectrum disorder. Conclusions In utero exposure to both SSRIs and non-selective monoamine reuptake inhibitors (tricyclic antidepressants) was associated with an increased risk of autism spectrum disorders, particularly without intellectual disability. Whether this association is causal or reflects the risk of autism with severe depression during pregnancy requires further research. However, assuming causality, antidepressant use during pregnancy is unlikely to have contributed significantly towards the dramatic increase in observed prevalence of autism spectrum disorders as it explained less than 1% of cases.	[Rai, Dheeraj; Lewis, Glyn] Univ Bristol, Sch Social & Community Med, Ctr Mental Hlth Addict & Suicide Res, Bristol BS8 2BN, Avon, England; [Rai, Dheeraj; Dalman, Christina; Magnusson, Cecilia] Karolinska Inst, Dept Publ Hlth Sci, Div Publ Hlth Epidemiol, Stockholm, Sweden; [Rai, Dheeraj] Avon & Wiltshire Partnership Mental Hlth NHS Trus, Bristol, Avon, England; [Lee, Brian K.] Drexel Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Golding, Jean] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol BS8 2BN, Avon, England	University of Bristol; Karolinska Institutet; Drexel University; University of Bristol	Rai, D (corresponding author), Univ Bristol, Sch Social & Community Med, Ctr Mental Hlth Addict & Suicide Res, Bristol BS8 2BN, Avon, England.	dheeraj.rai@bristol.ac.uk	Lewis, Glyn/E-9944-2012	Lewis, Glyn/0000-0001-5205-8245; Dalman, Christina/0000-0002-3579-2357; Golding, Jean/0000-0003-2826-3307; Rai, Dheeraj/0000-0002-7239-3523; Lee, Brian/0000-0002-3635-8034; Magnusson, Cecilia/0000-0002-8567-6725	Swedish Research Council [2012-3017, 523-2010-1052]; Stockholm County Council [2007008]; Swedish Council for Working Life and Social Research [2007-2064]; Swedish Regional agreement on medical training and clinical research (ALF); Medical Research Council [G0400085] Funding Source: researchfish; MRC [G0400085] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Regional agreement on medical training and clinical research (ALF); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Swedish Research Council (grant No 2012-3017). The data linkages and staff costs have also been supported by grants from the Stockholm County Council (2007008), Swedish Council for Working Life and Social Research (2007-2064), Swedish Research Council (523-2010-1052), and Swedish Regional agreement on medical training and clinical research (ALF). No funder had any role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication. The views expressed are those of the authors and not necessarily those of any of the funders or organisations they represent.	Abel KM, 2013, AM J PSYCHIAT, V170, P391, DOI 10.1176/appi.ajp.2012.12040543; [Anonymous], 2009, QUAL DAT REP PROC NA; Ax?n MBAHE., 2010, STOCKHOLM LANS LANDS; Axelsson O, 2003, ACTA OBSTET GYN SCAN, V82, P491, DOI 10.1034/j.1600-0412.2003.00172.x; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Chadman KK, 2011, PHARMACOL BIOCHEM BE, V97, P586, DOI 10.1016/j.pbb.2010.09.012; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; Daniels JL, 2008, PEDIATRICS, V121, pE1357, DOI 10.1542/peds.2007-2296; Darling RD, 2011, J NEUROSCI, V31, P16709, DOI 10.1523/JNEUROSCI.3736-11.2011; DeLong GR, 1999, NEUROLOGY, V52, P911, DOI 10.1212/WNL.52.5.911; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Jokiranta E, 2013, PSYCHIAT RES; Jorgensen L, 2010, ACTA PSYCHIAT SCAND, V121, P389, DOI 10.1111/j.1600-0447.2009.01500.x; Kallen B, 2011, EUR J CLIN PHARMACOL, V67, P839, DOI 10.1007/s00228-011-1021-8; Kinney DK, 2008, NEUROSCI BIOBEHAV R, V32, P1519, DOI 10.1016/j.neubiorev.2008.06.004; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Lee BK, 2012, J AUTISM DEV DISORD, V42, P2000, DOI 10.1007/s10803-011-1425-4; Levitt P, 2011, ARCH GEN PSYCHIAT, V68, P1093, DOI 10.1001/archgenpsychiatry.2011.98; Lund N, 2009, ARCH PEDIAT ADOL MED, V163, P949, DOI 10.1001/archpediatrics.2009.164; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Magnusson C, 2012, BRIT J PSYCHIAT, V201, P109, DOI 10.1192/bjp.bp.111.095125; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Occhiogrosso M, 2012, AM J PSYCHIAT, V169, P134, DOI 10.1176/appi.ajp.2011.11040553; Ogburn EL, 2012, EPIDEMIOLOGY, V23, P433, DOI 10.1097/EDE.0b013e31824d1f63; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Rahimi R, 2006, REPROD TOXICOL, V22, P571, DOI 10.1016/j.reprotox.2006.03.019; Rai D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038893; Rai D, 2012, J AM ACAD CHILD PSY, V51, P467, DOI 10.1016/j.jaac.2012.02.012; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Rodriguez-Porcel F, 2011, ANAT REC, V294, P1726, DOI 10.1002/ar.21402; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Spinelli M, 2012, AM J PSYCHIAT, V169, P121, DOI 10.1176/appi.ajp.2011.11111622; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Stewart DE, 2011, NEW ENGL J MED, V365, P1605, DOI 10.1056/NEJMcp1102730; WHO, 2012, ICD 10 CLASS MENT BE; Yirmiya N, 2005, J CHILD PSYCHOL PSYC, V46, P69, DOI 10.1111/j.1469-7610.2004.00334.x; Zafeiriou DI, 2009, CURR NEUROPHARMACOL, V7, P150, DOI 10.2174/157015909788848848	46	178	179	2	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2013	346								f2059	10.1136/bmj.f2059	http://dx.doi.org/10.1136/bmj.f2059			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131BG	23604083	Green Published, hybrid			2022-12-24	WOS:000317965000001
J	Wager, TD; Atlas, LY; Lindquist, MA; Roy, M; Woo, CW; Kross, E				Wager, Tor D.; Atlas, Lauren Y.; Lindquist, Martin A.; Roy, Mathieu; Woo, Choong-Wan; Kross, Ethan			An fMRI-Based Neurologic Signature of Physical Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN BRAIN; NOCICEPTIVE NEURONS; INSULAR CORTEX; ACTIVATION; RESPONSES; ANTICIPATION; ORGANIZATION; PERCEPTION; EXPERIENCE; TRIAL	BACKGROUND Persistent pain is measured by means of self-report, the sole reliance on which hampers diagnosis and treatment. Functional magnetic resonance imaging (fMRI) holds promise for identifying objective measures of pain, but brain measures that are sensitive and specific to physical pain have not yet been identified. METHODS In four studies involving a total of 114 participants, we developed an fMRI-based measure that predicts pain intensity at the level of the individual person. In study 1, we used machine-learning analyses to identify a pattern of fMRI activity across brain regions - a neurologic signature - that was associated with heat-induced pain. The pattern included the thalamus, the posterior and anterior insulae, the secondary somatosensory cortex, the anterior cingulate cortex, the periaqueductal gray matter, and other regions. In study 2, we tested the sensitivity and specificity of the signature to pain versus warmth in a new sample. In study 3, we assessed specificity relative to social pain, which activates many of the same brain regions as physical pain. In study 4, we assessed the responsiveness of the measure to the analgesic agent remifentanil. RESULTS In study 1, the neurologic signature showed sensitivity and specificity of 94% or more (95% confidence interval [CI], 89 to 98) in discriminating painful heat from nonpainful warmth, pain anticipation, and pain recall. In study 2, the signature discriminated between painful heat and nonpainful warmth with 93% sensitivity and specificity (95% CI, 84 to 100). In study 3, it discriminated between physical pain and social pain with 85% sensitivity (95% CI, 76 to 94) and 73% specificity (95% CI, 61 to 84) and with 95% sensitivity and specificity in a forced-choice test of which of two conditions was more painful. In study 4, the strength of the signature response was substantially reduced when remifentanil was administered. CONCLUSIONS It is possible to use fMRI to assess pain elicited by noxious heat in healthy persons. Future studies are needed to assess whether the signature predicts clinical pain. (Funded by the National Institute on Drug Abuse and others.)	[Wager, Tor D.; Roy, Mathieu; Woo, Choong-Wan] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80305 USA; [Atlas, Lauren Y.] NYU, Dept Psychol, New York, NY 10003 USA; [Lindquist, Martin A.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Kross, Ethan] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	University of Colorado System; University of Colorado Boulder; New York University; Johns Hopkins University; University of Michigan System; University of Michigan	Wager, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, 345 UCB, Boulder, CO 80305 USA.	tor.wager@colorado.edu	Atlas, Lauren/W-9619-2019; Woo, Choong-Wan/J-2030-2019; Roy, Mathieu/H-1963-2017; Atlas, Lauren Yvette/GXV-6811-2022	Woo, Choong-Wan/0000-0002-7423-5422; , Ethan/0000-0002-8664-2711; Atlas, Lauren/0000-0001-5693-4169	National Institute on Drug Abuse [1RC1DA028608, R01DA027794]; National Institute of Mental Health [R01MH076136]; National Science Foundation [0631637]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027794, R01DA035484, RC1DA028608] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by the National Institute on Drug Abuse and others.; Supported by grants from the National Institute on Drug Abuse (1RC1DA028608 and R01DA027794), the National Institute of Mental Health (R01MH076136), and the National Science Foundation (0631637, to Dr. Wager).	Atlas LY, 2012, J NEUROSCI, V32, P8053, DOI 10.1523/JNEUROSCI.0383-12.2012; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Bingel U, 2003, NEUROIMAGE, V18, P740, DOI 10.1016/S1053-8119(02)00033-2; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Brodersen KH, 2012, NEUROIMAGE, V63, P1162, DOI 10.1016/j.neuroimage.2012.08.035; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Brown JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024124; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Cohen SP, 2012, ANN INTERN MED, V156, P551, DOI [10.7326/0003-4819-156-8-201204170-00397, 10.7326/0003-4819-156-8-201204170-00002]; Craig AD, 2001, J NEUROPHYSIOL, V86, P1459, DOI 10.1152/jn.2001.86.3.1459; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; Derbyshire SWG, 2002, NEUROIMAGE, V16, P158, DOI 10.1006/nimg.2002.1066; DONG WK, 1989, BRAIN RES, V484, P314, DOI 10.1016/0006-8993(89)90375-2; Flor H., 2011, CHRONIC PAIN INTEGRA; Hastie T., 2009, UNSUPERVISED LEARNIN; Hua LH, 2005, AM J PHYSIOL-REG I, V289, pR319, DOI 10.1152/ajpregu.00123.2005; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kenshalo DR, 2000, J NEUROPHYSIOL, V84, P719, DOI 10.1152/jn.2000.84.2.719; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Lindquist MA, 2009, NEUROIMAGE, V45, pS187, DOI 10.1016/j.neuroimage.2008.10.065; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Meier ML, 2012, J CLIN PERIODONTOL, V39, P441, DOI 10.1111/j.1600-051X.2012.01863.x; Minto CF, 1997, ANESTHESIOLOGY, V86, P10, DOI 10.1097/00000542-199701000-00004; Mitchell TM, 1997, AI MAG, V18, P11; Rish I, 2010, P INT C BRAIN INF TO; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Schulz E, 2012, CEREB CORTEX, V22, P1118, DOI 10.1093/cercor/bhr186; SIKES RW, 1992, J NEUROPHYSIOL, V68, P1720, DOI 10.1152/jn.1992.68.5.1720; Strigo IA, 2003, J NEUROPHYSIOL, V89, P3294, DOI 10.1152/jn.01048.2002; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, WALL MELZACKS TXB PA; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/nmeth.1635, 10.1038/NMETH.1635]	37	858	879	10	201	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2013	368	15					1388	1397		10.1056/NEJMoa1204471	http://dx.doi.org/10.1056/NEJMoa1204471			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122QT	23574118	Green Accepted			2022-12-24	WOS:000317333600006
J	Commisso, C; Davidson, SM; Soydaner-Azeloglu, RG; Parker, SJ; Kamphorst, JJ; Hackett, S; Grabocka, E; Nofal, M; Drebin, JA; Thompson, CB; Rabinowitz, JD; Metallo, CM; Vander Heiden, MG; Bar-Sagi, D				Commisso, Cosimo; Davidson, Shawn M.; Soydaner-Azeloglu, Rengin G.; Parker, Seth J.; Kamphorst, Jurre J.; Hackett, Sean; Grabocka, Elda; Nofal, Michel; Drebin, Jeffrey A.; Thompson, Craig B.; Rabinowitz, Joshua D.; Metallo, Christian M.; Vander Heiden, Matthew G.; Bar-Sagi, Dafna			Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells	NATURE			English	Article							MASS ISOTOPOMER DISTRIBUTIONS; K-RAS; GLUTAMINE-METABOLISM; H-RAS; CANCER; SRC; FIBROBLASTS; CARCINOMA; PATHWAYS; GROWTH	Macropinocytosis is a highly conserved endocytic process by which extracellular fluid and its contents are internalized into cells through large, heterogeneous vesicles known as macropinosomes. Oncogenic Ras proteins have been shown to stimulate macropinocytosis but the functional contribution of this uptake mechanism to the transformed phenotype remains unknown(1-3). Here we show that Ras-transformed cells use macropinocytosis to transport extracellular protein into the cell. The internalized protein undergoes proteolytic degradation, yielding amino acids including glutamine that can enter central carbon metabolism. Accordingly, the dependence of Ras-transformed cells on free extracellular glutamine for growth can be suppressed by the macropinocytic uptake of protein. Consistent with macropinocytosis representing an important route of nutrient uptake in tumours, its pharmacological inhibition compromises the growth of Ras-transformed pancreatic tumour xenografts. These results identify macropinocytosis as a mechanism by which cancer cells support their unique metabolic needs and point to the possible exploitation of this process in the design of anticancer therapies.	[Commisso, Cosimo; Soydaner-Azeloglu, Rengin G.; Grabocka, Elda; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Davidson, Shawn M.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Davidson, Shawn M.; Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Parker, Seth J.; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kamphorst, Jurre J.; Hackett, Sean; Nofal, Michel; Rabinowitz, Joshua D.] Princeton Univ, Carl Icahn Lab, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Drebin, Jeffrey A.] Hosp Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	New York University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Princeton University; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Bar-Sagi, D (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	dafna.bar-sagi@nyumc.org	Metallo, Christian/HCH-3476-2022; Rabinowitz, Joshua/GPP-4019-2022	Metallo, Christian/0000-0003-2404-3040; Rabinowitz, Joshua/0000-0002-1247-4727; Bar-Sagi, Dafna/0000-0003-2597-8948; Kamphorst, Jurre/0000-0002-2042-5474; Parker, Seth/0000-0001-7971-8848; Grabocka, E/0000-0001-7196-8498	National Institutes of Health (NIH) [R01CA055360, 5 P30CA016087-32]; Canadian Institutes of Health Research; AACR provided by the Pancreatic Cancer Action Network; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; Smith Family; Stern family; Broad Institute; National Cancer Institute [P01-CA117969, P30-CA14051-39]; Hope Funds for Cancer Research Fellowship [HFCR-11-03-01]; Stand Up To Cancer (SU2C) Pancreatic Cancer Dream Team Award; NICHD; NATIONAL CANCER INSTITUTE [R01CA105463, P30CA016087, P01CA117969, P30CA014051, P01CA104838, R01CA055360, R01CA163591] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AACR provided by the Pancreatic Cancer Action Network; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; Smith Family; Stern family; Broad Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hope Funds for Cancer Research Fellowship; Stand Up To Cancer (SU2C) Pancreatic Cancer Dream Team Award; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to members of the Bar-Sagi laboratory for their comments and discussions, and N. Fehrenbacher and M. Philips for sharing cell lines. This work was supported National Institutes of Health (NIH) grant R01CA055360 to D.B.-S. C.C. was supported by a Canadian Institutes of Health Research postdoctoral fellowship and an AACR postdoctoral fellowship provided by the Pancreatic Cancer Action Network. M.G.V.H. acknowledges support from the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, the Smith Family, the Stern family, the Broad Institute and the National Cancer Institute (P01-CA117969 and P30-CA14051-39). J.J.K. was supported by a Hope Funds for Cancer Research Fellowship (HFCR-11-03-01). C.B.T., J.A.D. and J.D.R. acknowledge support by the Stand Up To Cancer (SU2C) Pancreatic Cancer Dream Team Award. All animal care and procedures were approved by the Institutional Animal Care and Use Committee at NYU School of Medicine. The Histopathology Core of NYU School of Medicine is partially supported by the National Institutes of Health (grant 5 P30CA016087-32). Troma I, an antibody that recognizes CK8, was contributed by P. Brulet and R. Kemler and made available by the Developmental Studies Hybridoma Bank under the auspices of the NICHD.	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; AOKI K, 1995, CANCER RES, V55, P3810; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BOS JL, 1989, CANCER RES, V49, P4682; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; HIRAI H, 1990, GENE DEV, V4, P2342, DOI 10.1101/gad.4.12b.2342; HOLM E, 1995, CANCER RES, V55, P1373; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; KNOWLES MA, 1993, CANCER RES, V53, P133; LopezCrapez E, 1997, CLIN CHEM, V43, P936; Mates JM, 2009, INT J BIOCHEM CELL B, V41, P2051, DOI 10.1016/j.biocel.2009.03.003; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Reis RCM, 1998, EUR J CELL BIOL, V75, P192, DOI 10.1016/S0171-9335(98)80061-7; Stehle G, 1997, CRIT REV ONCOL HEMAT, V26, P77, DOI 10.1016/S1040-8428(97)00015-2; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Veithen A, 1996, J CELL SCI, V109, P2005; Wagner M, 2001, GENE DEV, V15, P286, DOI 10.1101/gad.184701; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; WU MC, 1978, INT J CANCER, V22, P728, DOI 10.1002/ijc.2910220615	31	968	994	12	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					633	+		10.1038/nature12138	http://dx.doi.org/10.1038/nature12138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23665962	Green Submitted, Green Accepted			2022-12-24	WOS:000319556100047
J	Allanore, A; Yin, L; Sadoway, DR				Allanore, Antoine; Yin, Lan; Sadoway, Donald R.			A new anode material for oxygen evolution in molten oxide electrolysis	NATURE			English	Article							IRON-OXIDE; CORROSION; CHROMIUM	Molten oxide electrolysis (MOE) is an electrometallurgical technique that enables the direct production of metal in the liquid state from oxide feedstock(1,2), and compared with traditional methods of extractive metallurgy offers both a substantial simplification of the process and a significant reduction in energy consumption(3). MOE is also considered a promising route for mitigation of CO2 emissions in steelmaking(3-5), production of metals free of carbon(6), and generation of oxygen for extra-terrestrial exploration(7,8). Until now, MOE has been demonstrated using anode materials that are consumable (graphite for use with ferro-alloys and titanium(6,9)) or unaffordable for terrestrial applications (iridium for use with iron(10,11)). To enable metal production without process carbon, MOE requires an anode material that resists depletion while sustaining oxygen evolution. The challenges for iron production are threefold. First, the process temperature is in excess of 1,538 degrees Celsius (ref. 10). Second, under anodic polarization most metals inevitably corrode in such conditions(11-13). Third, iron oxide undergoes spontaneous reduction on contact with most refractory metals(14) and even carbon. Here we show that anodes comprising chromium-based alloys exhibit limited consumption during iron extraction and oxygen evolution by MOE. The anode stability is due to the formation of an electronically conductive solid solution of chromium(III) and aluminium oxides in the corundum structure. These findings make practicable larger-scale evaluation of MOE for the production of steel, and potentially provide a key material component enabling mitigation of greenhouse-gas emissions while producing metal of superior metallurgical quality.	[Allanore, Antoine; Yin, Lan; Sadoway, Donald R.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Allanore, A (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	allanore@mit.edu	Sadoway, Donald/AAE-7708-2019; Yin, Lan/G-7513-2014	Sadoway, Donald/0000-0003-1978-8654; Allanore, Antoine/0000-0002-2594-0264	American Iron and Steel Institute	American Iron and Steel Institute	The financial support of the American Iron and Steel Institute is acknowledged; we thank H. Kim and J. Paramore for assistance with the experimental set-up and for discussions.	Aiken R. H, 1906, US patent, Patent No. [816. 142, 816142]; Birat JP, 2009, REV METALL-PARIS, V106, P325, DOI 10.1051/metal/2009060; Carton A, 2006, J ELECTROCHEM SOC, V153, pB121, DOI 10.1149/1.2165745; Di Martino J, 2004, CORROS SCI, V46, P1865, DOI 10.1016/j.corsci.2003.10.025; EGERTON TA, 1974, J CATAL, V33, P299, DOI 10.1016/0021-9517(74)90274-7; ESIN OA, 1956, ZH FIZ KHIM+, V30, P3; Halper M., 2011, TIME, V177, P7; International Energy Agency, 2010, EN TECHN PERSP, P179; Kim H, 2011, J ELECTROCHEM SOC, V158, pE101, DOI 10.1149/1.3623446; Macdonald DD, 2011, ELECTROCHIM ACTA, V56, P1761, DOI 10.1016/j.electacta.2010.11.005; Nguyen T, 2006, LIGHT MET, P385; Oppenheim M. J., 1968, MINERAL MAG, V36, P1104; Sadoway D. R., 1991, JOM-US, V43, P15, DOI DOI 10.1007/BF03220614; Sadoway DR, 2001, JOM-J MIN MET MAT S, V53, P34, DOI 10.1007/s11837-001-0206-5; Sanderson F., NATURE; Takahashi N, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174302; Wang DH, 2011, J ELECTROCHEM SOC, V158, pE51, DOI 10.1149/1.3560477; Winand R., 1977, INT S MOLT SALT EL M, P42	18	121	140	14	445	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					353	+		10.1038/nature12134	http://dx.doi.org/10.1038/nature12134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23657254	Green Submitted			2022-12-24	WOS:000318952000034
J	Pfeiffer, BE; Foster, DJ				Pfeiffer, Brad E.; Foster, David J.			Hippocampal place-cell sequences depict future paths to remembered goals	NATURE			English	Article							PHASE PRECESSION; MEMORY; REPLAY; NAVIGATION; CA3; INFORMATION; EXPERIENCE; STRIATUM; DYNAMICS; PREDICTS	Effective navigation requires planning extended routes to remembered goal locations. Hippocampal place cells have been proposed to have a role in navigational planning, but direct evidence has been lacking. Here we show that before goal-directed navigation in an open arena, the rat hippocampus generates brief sequences encoding spatial trajectories strongly biased to progress from the subject's current location to a known goal location. These sequences predict immediate future behaviour, even in cases in which the specific combination of start and goal locations is novel. These results indicate that hippocampal sequence events characterized previously in linearly constrained environments as 'replay' are also capable of supporting a goal-directed, trajectory-finding mechanism, which identifies important places and relevant behavioural paths, at specific times when memory retrieval is required, and in a manner that could be used to control subsequent navigational behaviour.	[Pfeiffer, Brad E.; Foster, David J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Foster, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	david.foster@jhu.edu			Alfred P. Sloan Foundation; Brain and Behavior Research Foundation (NARSAD); National Institutes of Health [MH085823]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085823] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Brain and Behavior Research Foundation (NARSAD)(NARSAD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Alfred P. Sloan Foundation, The Brain and Behavior Research Foundation (NARSAD Young Investigator Grant) and the National Institutes of Health grant MH085823.	Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Foster DJ, 2012, CURR OPIN NEUROBIOL, V22, P294, DOI 10.1016/j.conb.2011.12.005; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Gerstner W, 1997, J COMPUT NEUROSCI, V4, P79, DOI 10.1023/A:1008820728122; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hok V, 2007, J NEUROSCI, V27, P472, DOI 10.1523/JNEUROSCI.2864-06.2007; Jackson J, 2007, HIPPOCAMPUS, V17, P1209, DOI 10.1002/hipo.20359; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER RU, 1989, J NEUROSCI, V9, P4101; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Olypher AV, 2002, NEUROSCIENCE, V111, P553, DOI 10.1016/S0306-4522(01)00586-3; POUCET B, 1983, ANIM BEHAV, V31, P594, DOI 10.1016/S0003-3472(83)80083-9; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Sutton R. S., 1990, NEURAL NETWORKS CONT; Tolman E.C., 1932, PURPOSIVE BEHAV ANIM; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	50	615	620	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					74	+		10.1038/nature12112	http://dx.doi.org/10.1038/nature12112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23594744	Green Accepted			2022-12-24	WOS:000318221500036
J	Baca, SC; Prandi, D; Lawrence, MS; Mosquera, JM; Romanel, A; Drier, Y; Park, K; Kitabayashi, N; MacDonald, TY; Ghandi, M; Van Allen, E; Kryukov, GV; Sboner, A; Theurillat, JP; Soong, TD; Nickerson, E; Auclair, D; Tewari, A; Beltran, H; Onofrio, RC; Boysen, G; Guiducci, C; Barbieri, CE; Cibulskis, K; Sivachenko, A; Carter, SL; Saksena, G; Voet, D; Ramos, AH; Winckler, W; Cipicchio, M; Ardlie, K; Kantoff, PW; Berger, MF; Gabriel, SB; Golub, TR; Meyerson, M; Lander, ES; Elemento, O; Getz, G; Demichelis, F; Rubin, MA; Garraway, LA				Baca, Sylvan C.; Prandi, Davide; Lawrence, Michael S.; Mosquera, Juan Miguel; Romanel, Alessandro; Drier, Yotam; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Ghandi, Mahmoud; Van Allen, Eliezer; Kryukov, Gregory V.; Sboner, Andrea; Theurillat, Jean-Philippe; Soong, T. David; Nickerson, Elizabeth; Auclair, Daniel; Tewari, Ashutosh; Beltran, Himisha; Onofrio, Robert C.; Boysen, Gunther; Guiducci, Candace; Barbieri, Christopher E.; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Winckler, Wendy; Cipicchio, Michelle; Ardlie, Kristin; Kantoff, Philip W.; Berger, Michael F.; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Elemento, Olivier; Getz, Gad; Demichelis, Francesca; Rubin, Mark A.; Garraway, Levi A.			Punctuated Evolution of Prostate Cancer Genomes	CELL			English	Article							TMPRSS2-ERG FUSION; REARRANGEMENTS; CHD1; MUTATIONS; EVENT	The analysis of exonic DNA from prostate cancers has identified recurrently mutated genes, but the spectrum of genome-wide alterations has not been profiled extensively in this disease. We sequenced the genomes of 57 prostate tumors and matched normal tissues to characterize somatic alterations and to study how they accumulate during oncogenesis and progression. By modeling the genesis of genomic rearrangements, we identified abundant DNA translocations and deletions that arise in a highly interdependent manner. This phenomenon, which we term "chromoplexy," frequently accounts for the dysregulation of prostate cancer genes and appears to disrupt multiple cancer genes coordinately. Our modeling suggests that chromoplexy may induce considerable genomic derangement over relatively few events in prostate cancer and other neoplasms, supporting a model of punctuated cancer evolution. By characterizing the clonal hierarchy of genomic lesions in prostate tumors, we charted a path of oncogenic events along which chromoplexy may drive prostate carcinogenesis.	[Baca, Sylvan C.; Kryukov, Gregory V.; Ramos, Alex H.; Kantoff, Philip W.; Meyerson, Matthew; Lander, Eric S.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Baca, Sylvan C.; Lawrence, Michael S.; Drier, Yotam; Ghandi, Mahmoud; Van Allen, Eliezer; Kryukov, Gregory V.; Theurillat, Jean-Philippe; Nickerson, Elizabeth; Auclair, Daniel; Onofrio, Robert C.; Guiducci, Candace; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Winckler, Wendy; Cipicchio, Michelle; Ardlie, Kristin; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Baca, Sylvan C.; Van Allen, Eliezer; Kantoff, Philip W.; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Golub, Todd R.; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Prandi, Davide; Romanel, Alessandro; Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, I-38123 Povo, Trento, Italy; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Mosquera, Juan Miguel; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Sboner, Andrea; Boysen, Gunther; Barbieri, Christopher E.; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Sboner, Andrea; Soong, T. David; Elemento, Olivier; Demichelis, Francesca] Weill Cornell Med Coll, Dept Physiol & Biophys, Inst Computat Biomed, New York, NY 10065 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Lefrak Ctr Robot Surg, New York, NY 10065 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Ctr Prostate Canc Res & Clin Care, New York, NY 10065 USA; [Tewari, Ashutosh; Barbieri, Christopher E.; Rubin, Mark A.] Weill Cornell Med Coll, Brady Fdn Dept Urol, New York, NY 10065 USA; [Beltran, Himisha] Weill Cornell Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY 10065 USA; [Kryukov, Gregory V.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Trento; Weizmann Institute of Science; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Demichelis, F (corresponding author), Univ Trento, Ctr Integrat Biol, I-38123 Povo, Trento, Italy.	demichelis@science.unitn.it; levi_garraway@dfci.harvard.edu	Lawrence, Michael/AAC-8202-2020; Kryukov, Gregory V/A-9592-2008; Cibulskis, Kristian/AAC-7380-2019; Drier, Yotam/K-5208-2012; Sboner, Andrea/C-6487-2008; Demichelis, Francesca/J-9829-2016; Romanel, Alessandro/J-8864-2018	Drier, Yotam/0000-0003-1725-2995; Sboner, Andrea/0000-0001-6915-3070; Demichelis, Francesca/0000-0002-8266-8631; Romanel, Alessandro/0000-0003-4855-8620; Rubin, Mark/0000-0002-8321-9950; Ghandi, Mahmoud/0000-0003-1897-2265; Kantoff, Philip/0000-0001-7275-0597; Cibulskis, Kristian/0000-0003-1343-1582; Romanel, Alessandro/0000-0002-2376-8552; Boysen, Gunther/0000-0002-7610-6085; Meyerson, Matthew/0000-0002-9133-8108; Van Allen, Eliezer/0000-0002-0201-4444; Kryukov, Gregory/0000-0002-6131-9483; Barbieri, Christopher/0000-0002-0381-1947; Prandi, Davide/0000-0001-9885-6074	US National Human Genome Research Institute (NHGRI) Large Scale Sequencing Program [U54 HG003067]; Kohlberg Foundation; Starr Cancer Consortium; Prostate Cancer Foundation; US Department of Defense Synergy Awards [PC101020]; Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health [NIH]) [P50 CA090381]; US National Cancer Institute, Early Detection Research Network [U01CA111275]; NCI EDRN; US National Cancer Institute [R01 CA125612]; Fondazione Trentina per la Ricerca sui Tumori; Swiss Science Foundation [PASMP3_134379/1]; National Institute of General Medical Sciences [T32GM007753]; US NIH Director's New Innovator Award [DP2OD002750]; Novartis;  [PC094516]; NATIONAL CANCER INSTITUTE [U01CA162148, R33CA155554, U01CA111275, R01CA125612, P50CA090381] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	US National Human Genome Research Institute (NHGRI) Large Scale Sequencing Program; Kohlberg Foundation; Starr Cancer Consortium; Prostate Cancer Foundation; US Department of Defense Synergy Awards(United States Department of Defense); Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health [NIH])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute, Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI EDRN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondazione Trentina per la Ricerca sui Tumori; Swiss Science Foundation(Swiss National Science Foundation (SNSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US NIH Director's New Innovator Award; Novartis(Novartis); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Broad Institute Genome Sequencing Platform for their part in this work. This study was supported by the US National Human Genome Research Institute (NHGRI) Large Scale Sequencing Program (U54 HG003067 to the Broad Institute, E.S.L.), the Kohlberg Foundation (L.A.G.), the Starr Cancer Consortium (M.A.R., F.D., A.T., G.G., and L.A.G.), the Prostate Cancer Foundation (M.A.R.), US Department of Defense Synergy Awards (PC101020 to F.D., L.A.G., and M.A.R.) and a New Investigator Award (PC094516 to F.D.), the Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health [NIH] P50 CA090381), the US National Cancer Institute, Early Detection Research Network (U01CA111275 and NCI EDRN to F.D. and M.A.R.), the US National Cancer Institute (R01 CA125612 to F.D. and M.A.R.), the Fondazione Trentina per la Ricerca sui Tumori (F.D.), the Swiss Science Foundation (PASMP3_134379/1 to J.-P.T.), the National Institute of General Medical Sciences (T32GM007753 to S.C.B.), and a US NIH Director's New Innovator Award (DP2OD002750 to L.A.G.). L.A.G. is an equity holder and consultant in Foundation Medicine, a consultant to Novartis and Millenium/Takeda, and a recipient of a grant from Novartis.	Baca Sylvan C, 2012, Front Endocrinol (Lausanne), V3, P69, DOI 10.3389/fendo.2012.00069; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Burrow AA, 2010, NUCLEIC ACIDS RES, V38, P2865, DOI 10.1093/nar/gkp1245; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; EMMERTBUCK MR, 1995, CANCER RES, V55, P2959; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GOULD S J, 1977, Paleobiology, V3, P115; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Halvorsen OJ, 2003, CLIN CANCER RES, V9, P1474; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu W, 2012, ONCOGENE, V31, P3939, DOI 10.1038/onc.2011.554; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024	38	825	844	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					666	677		10.1016/j.cell.2013.03.021	http://dx.doi.org/10.1016/j.cell.2013.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622249	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000318063500018
J	Kim, J; Xiao, H; Bonanno, JB; Kalyanaraman, C; Brown, S; Tang, XY; Al-Obaidi, NF; Patskovsky, Y; Babbitt, PC; Jacobson, MP; Lee, YS; Almo, SC				Kim, Jungwook; Xiao, Hui; Bonanno, Jeffrey B.; Kalyanaraman, Chakrapani; Brown, Shoshana; Tang, Xiangying; Al-Obaidi, Nawar F.; Patskovsky, Yury; Babbitt, Patricia C.; Jacobson, Matthew P.; Lee, Young-Sam; Almo, Steven C.			Structure-guided discovery of the metabolite carboxy-SAM that modulates tRNA function	NATURE			English	Article							URIDINE-5-OXYACETIC ACID; CHORISMIC ACID; METHYLTRANSFERASE; DATABASE; MODEL; DNA; PREPHENATE; REVEALS; ENZYME; TIME	The identification of novel metabolites and the characterization of their biological functions are major challenges in biology. X-ray crystallography can reveal unanticipated ligands that persist through purification and crystallization. These adventitious protein-ligand complexes provide insights into new activities, pathways and regulatory mechanisms. We describe a new metabolite, carboxy-S-adenosyl-L-methionine (Cx-SAM), its biosynthetic pathway and its role in transfer RNA modification. The structure of CmoA, a member of the SAM-dependent methyltransferase superfamily, revealed a ligand consistent with Cx-SAM in the catalytic site. Mechanistic analyses showed an unprecedented role for prephenate as the carboxyl donor and the involvement of a unique ylide intermediate as the carboxyl acceptor in the CmoA-mediated conversion of SAM to Cx-SAM. A second member of the SAM-dependent methyltransferase superfamily, CmoB, recognizes Cx-SAM and acts as a carboxymethyltransferase to convert 5-hydroxyuridine into 5-oxyacetyl uridine at the wobble position of multiple tRNAs in Gram-negative bacteria(1), resulting in expanded codon-recognition properties(2,3). CmoA and CmoB represent the first documented synthase and transferase for Cx-SAM. These findings reveal new functional diversity in the SAM-dependent methyltransferase superfamily and expand the metabolic and biological contributions of SAM-based biochemistry. These discoveries highlight the value of structural genomics approaches in identifying ligands within the context of their physiologically relevant macromolecular binding partners, and in revealing their functions.	[Kim, Jungwook; Bonanno, Jeffrey B.; Tang, Xiangying; Al-Obaidi, Nawar F.; Patskovsky, Yury; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Xiao, Hui] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Kalyanaraman, Chakrapani; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Brown, Shoshana; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Lee, Young-Sam] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Almo, Steven C.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Yeshiva University; Albert Einstein College of Medicine	Kim, J (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	jungwook.kim@einstein.yu.edu; steve.almo@einstein.yu.edu	Kim, Jungwook/AAP-1322-2020; Jacobson, Matthew/Y-5161-2018	Kim, Jungwook/0000-0001-5213-9299; Jacobson, Matthew/0000-0001-6262-655X; Al Obaidi, Nawar/0000-0002-3659-9233	US National Institutes of Health [GM094662, GM093342]; Albert Einstein Cancer Center; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [P30-EB-009998]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094662, U54GM093342] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Parker and C. T. Walsh for providing the Aerobacter aerogenes 62-1 strain. We are indebted to V. Schramm and J. Gerlt for critical discussions and reading of the manuscript. This work was supported by US National Institutes of Health grants GM094662 (to S. C. A.), GM093342 (to S. C. A., M. P. J. and P. C. B.) and the Albert Einstein Cancer Center. This publication was made possible by the Center for Synchrotron Biosciences grant P30-EB-009998 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract no. DE-AC02-98CH10886.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Binda O, 2011, CHEMBIOCHEM, V12, P330, DOI 10.1002/cbic.201000433; BJORK GR, 1980, J MOL BIOL, V140, P391, DOI 10.1016/0022-2836(80)90391-5; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; CROSBY J, 1970, J CHEM SOC B, P671, DOI 10.1039/j29700000671; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Dalhoff C, 2006, NAT CHEM BIOL, V2, P31, DOI 10.1038/nchembio754; Dalhoff C, 2006, NAT PROTOC, V1, P1879, DOI 10.1038/nprot.2006.253; DOPHEIDE TA, 1972, J BIOL CHEM, V247, P4447; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIBSON F, 1964, BIOCHEM J, V90, P256, DOI 10.1042/bj0900256; HAGERVALL TG, 1990, J BACTERIOL, V172, P252, DOI 10.1128/JB.172.1.252-259.1990; Horowitz S, 2011, J BIOL CHEM, V286, P18658, DOI 10.1074/jbc.M111.232876; Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186; Kowtoniuk WE, 2009, P NATL ACAD SCI USA, V106, P7768, DOI 10.1073/pnas.0900528106; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lim K, 2001, PROTEINS, V45, P397, DOI 10.1002/prot.10004; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nasvall SJ, 2007, RNA, V13, P2151, DOI 10.1261/rna.731007; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; Parker JB, 2012, BIOCHEMISTRY-US, V51, P3241, DOI 10.1021/bi300254u; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Punta M., 2008, NUCLEIC ACIDS RES, V40, pD290; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Van Vleet J, 2010, BBA-PROTEINS PROTEOM, V1804, P752, DOI 10.1016/j.bbapap.2009.11.018; Vevodova J, 2004, J MOL BIOL, V344, P419, DOI 10.1016/j.jmb.2004.09.020; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P498, DOI 10.1038/nsmb1242	36	57	59	0	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					123	+		10.1038/nature12180	http://dx.doi.org/10.1038/nature12180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23676670	Green Submitted, Green Accepted			2022-12-24	WOS:000319947800046
J	Sly, PD; Gangell, CL; Chen, LP; Ware, RS; Ranganathan, S; Mott, LS; Murray, CP; Stick, SM				Sly, Peter D.; Gangell, Catherine L.; Chen, Linping; Ware, Robert S.; Ranganathan, Sarath; Mott, Lauren S.; Murray, Conor P.; Stick, Stephen M.		AREST CF Investigators	Risk Factors for Bronchiectasis in Children with Cystic Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; LOWER AIRWAY INFLAMMATION; STRUCTURAL LUNG INJURY; PULMONARY INFLAMMATION; YOUNG-CHILDREN; NEUTROPHIL ELASTASE; INFANTS; DISEASE; EXACERBATION; INFECTION	BACKGROUND Bronchiectasis develops early in the course of cystic fibrosis, being detectable in infants as young as 10 weeks of age, and is persistent and progressive. We sought to determine risk factors for the onset of bronchiectasis, using data collected by the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) intensive surveillance program. METHODS We examined data from 127 consecutive infants who received a diagnosis of cystic fibrosis after newborn screening. Chest computed tomography (CT) and bronchoalveolar lavage (BAL) were performed, while the children were in stable clinical condition, at 3 months and 1, 2, and 3 years of age. Longitudinal data were used to determine risk factors associated with the detection of bronchiectasis from 3 months to 3 years of age. RESULTS The point prevalence of bronchiectasis at each visit increased from 29.3% at 3 months of age to 61.5% at 3 years of age. In multivariate analyses, risk factors for bronchiectasis were presentation with meconium ileus (odds ratio, 3.17; 95% confidence interval [CI], 1.51 to 6.66; P = 0.002), respiratory symptoms at the time of CT and BAL (odds ratio, 2.27; 95% CI, 1.24 to 4.14; P = 0.008), free neutrophil elastase activity in BAL fluid (odds ratio, 3.02; 95% CI, 1.70 to 5.35; P<0.001), and gas trapping on expiratory CT (odds ratio, 2.05; 95% CI, 1.17 to 3.59; P = 0.01). Free neutrophil elastase activity in BAL fluid at 3 months of age was associated with persistent bronchiectasis (present on two or more sequential scans), with the odds seven times as high at 12 months of age and four times as high at 3 years of age. CONCLUSIONS Neutrophil elastase activity in BAL fluid in early life was associated with early bronchiectasis in children with cystic fibrosis.	[Sly, Peter D.; Gangell, Catherine L.; Chen, Linping; Ware, Robert S.] Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Ware, Robert S.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Ranganathan, Sarath] Univ Melbourne, Royal Childrens Hosp, Dept Resp Med, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ranganathan, Sarath] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Mott, Lauren S.; Stick, Stephen M.] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; [Murray, Conor P.] Princess Margaret Hosp Children, Dept Diagnost Imaging, Perth, WA, Australia; [Mott, Lauren S.; Stick, Stephen M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia	University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia	Sly, PD (corresponding author), Royal Childrens Hosp, Queensland Childrens Med Res Inst, Level 4,Fdn Bldg,Herston Rd, Herston, Qld 4029, Australia.	p.sly@uq.edu.au	Ware, Robert S./B-2024-2014; Stick, Stephen/GZG-7584-2022; Sly, Peter D/F-1486-2010; Stick, Stephen/O-5683-2014; Stick, Stephen/AAA-5945-2021	Ware, Robert S./0000-0002-6129-6736; Sly, Peter D/0000-0001-6305-2201; Stick, Stephen/0000-0002-5386-8482; Ranganathan, Sarath/0000-0002-6975-0307	National Health and Medical Research Council of Australia; Cystic Fibrosis Foundation Therapeutics	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation)	Funded by the National Health and Medical Research Council of Australia and Cystic Fibrosis Foundation Therapeutics.	Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Brennan S, 2005, THORAX, V60, P159, DOI 10.1136/thx.2004.026419; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; de Jong PA, 2004, EUR RESPIR J, V23, P93, DOI 10.1183/09031936.03.00006603; de Long PA, 2005, AM J RESP CRIT CARE, V172, P218, DOI 10.1164/rccm.200410-1311OC; Elborn JS, 2012, EUR RESPIR J, V40, P969, DOI 10.1183/09031936.00194611; Gangell C, 2011, CLIN INFECT DIS, V53, P425, DOI 10.1093/cid/cir399; Kapur N, 2011, CHEST, V139, P1445, DOI 10.1378/chest.10-1763; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; Kuraki T, 2002, AM J RESP CRIT CARE, V166, P496, DOI 10.1164/rccm.2103118; Laguna TA, 2012, PEDIATR PULM, V47, P856, DOI 10.1002/ppul.22525; Lands LC, 2007, COCHRANE DB SYST REV, V4; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; Long FR, 2004, J PEDIATR-US, V144, P154, DOI 10.1016/j.jpeds.2003.09.026; Martinez TM, 2005, AM J RESP CRIT CARE, V172, P1133, DOI 10.1164/rccm.200412-1665OC; Mott LS, 2012, THORAX, V67, P509, DOI 10.1136/thoraxjnl-2011-200912; Mott LS, 2013, J PEDIAT; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Ranganathan SC, 2011, THORAX, V66, P408, DOI 10.1136/thx.2010.139493; Reeves EP, 2012, J CYST FIBROS, V11, P100, DOI 10.1016/j.jcf.2011.09.010; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Stockley RA, 1999, AM J RESP CRIT CARE, V160, pS49, DOI 10.1164/ajrccm.160.supplement_1.13; Tremblay Guy M, 2003, Curr Opin Investig Drugs, V4, P556; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954	27	408	410	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1963	1970		10.1056/NEJMoa1301725	http://dx.doi.org/10.1056/NEJMoa1301725			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194KD	23692169	Green Published			2022-12-24	WOS:000322630700006
J	Xie, W; Schultz, MD; Lister, R; Hou, ZG; Rajagopal, N; Ray, P; Whitaker, JW; Tian, S; Hawkins, RD; Leung, D; Yang, HB; Wang, T; Lee, AY; Swanson, SA; Zhang, JC; Zhu, Y; Kim, A; Nery, JR; Urich, MA; Kuan, S; Yen, CA; Klugman, S; Yu, PZ; Suknuntha, K; Propson, NE; Chen, HM; Edsall, LE; Wagner, U; Li, Y; Ye, Z; Kulkarni, A; Xuan, ZY; Chung, WY; Chi, NC; Antosiewicz-Bourget, JE; Slukvin, I; Stewart, R; Zhang, MQ; Wang, W; Thomson, JA; Ecker, JR; Ren, B				Xie, Wei; Schultz, Matthew D.; Lister, Ryan; Hou, Zhonggang; Rajagopal, Nisha; Ray, Pradipta; Whitaker, John W.; Tian, Shulan; Hawkins, R. David; Leung, Danny; Yang, Hongbo; Wang, Tao; Lee, Ah Young; Swanson, Scott A.; Zhang, Jiuchun; Zhu, Yun; Kim, Audrey; Nery, Joseph R.; Urich, Mark A.; Kuan, Samantha; Yen, Chia-an; Klugman, Sarit; Yu, Pengzhi; Suknuntha, Kran; Propson, Nicholas E.; Chen, Huaming; Edsall, Lee E.; Wagner, Ulrich; Li, Yan; Ye, Zhen; Kulkarni, Ashwinikumar; Xuan, Zhenyu; Chung, Wen-Yu; Chi, Neil C.; Antosiewicz-Bourget, Jessica E.; Slukvin, Igor; Stewart, Ron; Zhang, Michael Q.; Wang, Wei; Thomson, James A.; Ecker, Joseph R.; Ren, Bing			Epigenomic Analysis of Multilineage Differentiation of Human Embryonic Stem Cells	CELL			English	Article							DNA METHYLATION; DEVELOPMENTAL REGULATORS; GENOME; CHROMATIN; MOUSE; PLURIPOTENT; POLYCOMB; STATE; GENES; METHYLOME	Epigenetic mechanisms have been proposed to play crucial roles in mammalian development, but their precise functions are only partially understood. To investigate epigenetic regulation of embryonic development, we differentiated human embryonic stem cells into mesendoderm, neural progenitor cells, trophoblast-like cells, and mesenchymal stem cells and systematically characterized DNA methylation, chromatin modifications, and the transcriptome in each lineage. We found that promoters that are active in early developmental stages tend to be CG rich and mainly engage H3K27me3 upon silencing in nonexpressing lineages. By contrast, promoters for genes expressed preferentially at later stages are often CG poor and primarily employ DNA methylation upon repression. Interestingly, the early developmental regulatory genes are often located in large genomic domains that are generally devoid of DNA methylation in most lineages, which we termed DNA methylation valleys (DMVs). Our results suggest that distinct epigenetic mechanisms regulate early and late stages of ES cell differentiation.	[Xie, Wei; Rajagopal, Nisha; Hawkins, R. David; Leung, Danny; Lee, Ah Young; Kim, Audrey; Kuan, Samantha; Yen, Chia-an; Klugman, Sarit; Edsall, Lee E.; Wagner, Ulrich; Li, Yan; Ye, Zhen; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Schultz, Matthew D.; Lister, Ryan; Nery, Joseph R.; Urich, Mark A.; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, Genom Anal Lab, La Jolla, CA 92037 USA; [Hou, Zhonggang; Tian, Shulan; Swanson, Scott A.; Zhang, Jiuchun; Yu, Pengzhi; Propson, Nicholas E.; Antosiewicz-Bourget, Jessica E.; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Whitaker, John W.; Wang, Tao; Zhu, Yun; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Wang, Wei] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yang, Hongbo; Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Zhang, Jiuchun; Slukvin, Igor] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Slukvin, Igor; Thomson, James A.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53715 USA; [Thomson, James A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Ray, Pradipta; Kulkarni, Ashwinikumar; Xuan, Zhenyu; Chung, Wen-Yu; Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Suknuntha, Kran; Slukvin, Igor] Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53792 USA; [Zhang, Michael Q.] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China	Ludwig Institute for Cancer Research; Howard Hughes Medical Institute; Salk Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Santa Barbara; University of Texas System; University of Texas Dallas; University of Wisconsin System; University of Wisconsin Madison; Tsinghua University	Thomson, JA (corresponding author), Morgridge Inst Res, Madison, WI 53707 USA.	jthomson@morgridgeinstitute.org; ecker@salk.edu; biren@ucsd.edu	Kulkarni, Ashwinikumar/M-7057-2019; Zhang, Jiuchun/C-7021-2012; Ecker, Joseph R/B-9144-2008; Xie, Wei/J-1380-2017; Wang, Tao/E-5900-2015; Suknuntha, Kran/AAA-1777-2019; Lister, Ryan/B-5168-2012; Nery, Joseph/AAE-8422-2019; Yu, Pengzhi/I-3182-2016	Kulkarni, Ashwinikumar/0000-0003-0951-2427; Ecker, Joseph R/0000-0001-5799-5895; Xie, Wei/0000-0003-2126-3849; Wang, Tao/0000-0002-1646-6863; Suknuntha, Kran/0000-0002-6648-8235; Lister, Ryan/0000-0001-6637-7239; Nery, Joseph/0000-0003-0153-5659; Leung, Danny Chi Yeu/0000-0002-2472-894X; Xuan, Zhenyu/0000-0001-9344-8493; Chen, Huaming/0000-0001-5289-7882; Yu, Pengzhi/0000-0001-7637-404X; Edsall, Lee Elizabeth/0000-0002-0326-2829; Whitaker, John W./0000-0002-0585-9119; Ray, Pradipta/0000-0003-0931-4201	NIH [U01 ES017166, R01 HG001696, P01 GM081629]; NSFC [91019016]; CIRM [RN2-00905-1]; NIH/NHLBI; American Heart Association [12POST12050080]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107442, U01HL099773] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); CIRM(California Institute for Regenerative Medicine); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the NIH Epigenome Roadmap Project (U01 ES017166) and also in part by NSFC 91019016 and NIH R01 HG001696 (M.Q.Z.), NIH P01 GM081629 (J.A.T.), and CIRM RN2-00905-1 (B. R.). J.R.E. is a Howard Hughes Medical Institute and Gordon and Betty Moore Investigator. N. C. C. is funded by grants from the NIH/NHLBI. H. Y. is funded by grants from the American Heart Association (12POST12050080). We thank Drs. Tomek Swigut and Joanna Wysocka for sharing the zebrafish enhancer reporter vector. We thank Dr. John Stamatoyannopoulos for generating and providing access to the DNase-seq data sets. We also thank members of the Ren lab for helpful comments of the manuscript. B. R., J.A.T., J. R. E., W. W., and M. Q. Z. designed and supervised the research. Z. H., J. Z., P. Y., N. E. P., K. S., J. E. A.-B., and I. S. performed/supervised the H1 differentiation experiments. W. X., R. D. H., D. L., A. Y. L., A. K., S. Kuan, C. Y., and S. Klugman performed ChIP-seq experiments. R. L. and J. R. N. performed MethylC-seq experiments. M. A. U., Y. L., and Y. Z. performed RNA-seq experiments. H. Y. and N. C. C. performed/supervised the enhancer-reporter assay in zebrafish. W. X., M. D. S., N. R., P. R., J. W. W., S. T., T. W., S. A. S., Y. Z., R. L., H. C., L. E. E., U. W., A. K., Z. X., W. Y. C., and R. S. analyzed data. W. X., B. R., and R. S. prepared the manuscript. B. R., J. A. T., J. R. E., W. W., and M. Q. Z. are equally responsible for the analysis results. M. D. S., R. L., Z. H., N. R., P. R., J. W. W., S. T., R. D. H., and D. L. contributed equally to this work.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leung DC, 2012, TRENDS BIOCHEM SCI, V37, P127, DOI 10.1016/j.tibs.2011.11.006; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	57	510	521	11	136	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1134	1148		10.1016/j.cell.2013.04.022	http://dx.doi.org/10.1016/j.cell.2013.04.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23664764	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000319456800019
J	Paddon, CJ; Westfall, PJ; Pitera, DJ; Benjamin, K; Fisher, K; McPhee, D; Leavell, MD; Tai, A; Main, A; Eng, D; Polichuk, DR; Teoh, KH; Reed, DW; Treynor, T; Lenihan, J; Fleck, M; Bajad, S; Dang, G; Dengrove, D; Diola, D; Dorin, G; Ellens, KW; Fickes, S; Galazzo, J; Gaucher, SP; Geistlinger, T; Henry, R; Hepp, M; Horning, T; Iqbal, T; Jiang, H; Kizer, L; Lieu, B; Melis, D; Moss, N; Regentin, R; Secrest, S; Tsuruta, H; Vazquez, R; Westblade, LF; Xu, L; Yu, M; Zhang, Y; Zhao, L; Lievense, J; Covello, PS; Keasling, JD; Reiling, KK; Renninger, NS; Newman, JD				Paddon, C. J.; Westfall, P. J.; Pitera, D. J.; Benjamin, K.; Fisher, K.; McPhee, D.; Leavell, M. D.; Tai, A.; Main, A.; Eng, D.; Polichuk, D. R.; Teoh, K. H.; Reed, D. W.; Treynor, T.; Lenihan, J.; Fleck, M.; Bajad, S.; Dang, G.; Dengrove, D.; Diola, D.; Dorin, G.; Ellens, K. W.; Fickes, S.; Galazzo, J.; Gaucher, S. P.; Geistlinger, T.; Henry, R.; Hepp, M.; Horning, T.; Iqbal, T.; Jiang, H.; Kizer, L.; Lieu, B.; Melis, D.; Moss, N.; Regentin, R.; Secrest, S.; Tsuruta, H.; Vazquez, R.; Westblade, L. F.; Xu, L.; Yu, M.; Zhang, Y.; Zhao, L.; Lievense, J.; Covello, P. S.; Keasling, J. D.; Reiling, K. K.; Renninger, N. S.; Newman, J. D.			High-level semi-synthetic production of the potent antimalarial artemisinin	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DIHYDROARTEMISINIC ACID; MOLECULAR-CLONING; DRUG ARTEMISININ; GENE DISRUPTION; CYTOCHROME B(5); BIOSYNTHESIS; ANNUA; REDUCTASE; YEAST	In 2010 there were more than 200 million cases of malaria, and at least 655,000 deaths(1). The World Health Organization has recommended artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum. Artemisinin is a sesquiterpene endoperoxide with potent antimalarial properties, produced by the plant Artemisia annua. However, the supply of plant-derived artemisinin is unstable, resulting in shortages and price fluctuations, complicating production planning by ACT manufacturers(2). A stable source of affordable artemisinin is required. Here we use synthetic biology to develop strains of Saccharomyces cerevisiae (baker's yeast) for high-yielding biological production of artemisinic acid, a precursor of artemisinin. Previous attempts to produce commercially relevant concentrations of artemisinic acid were unsuccessful, allowing production of only 1.6 grams per litre of artemisinic acid(3). Here we demonstrate the complete biosynthetic pathway, including the discovery of a plant dehydrogenase and a second cytochrome that provide an efficient biosynthetic route to artemisinic acid, with fermentation titres of 25 grams per litre of artemisinic acid. Furthermore, we have developed a practical, efficient and scalable chemical process for the conversion of artemisinic acid to artemisinin using a chemical source of singlet oxygen, thus avoiding the need for specialized photochemical equipment. The strains and processes described here form the basis of a viable industrial process for the production of semi-synthetic artemisinin to stabilize the supply of artemisinin for derivatization into active pharmaceutical ingredients (for example, artesunate) for incorporation into ACTs. Because all intellectual property rights have been provided free of charge, this technology has the potential to increase provision of first-line antimalarial treatments to the developing world at a reduced average annual price.	[Paddon, C. J.; Westfall, P. J.; Pitera, D. J.; Benjamin, K.; Fisher, K.; McPhee, D.; Leavell, M. D.; Tai, A.; Main, A.; Eng, D.; Treynor, T.; Lenihan, J.; Fleck, M.; Bajad, S.; Dang, G.; Dengrove, D.; Diola, D.; Dorin, G.; Fickes, S.; Galazzo, J.; Gaucher, S. P.; Geistlinger, T.; Henry, R.; Horning, T.; Iqbal, T.; Jiang, H.; Kizer, L.; Lieu, B.; Melis, D.; Moss, N.; Regentin, R.; Secrest, S.; Tsuruta, H.; Vazquez, R.; Westblade, L. F.; Xu, L.; Yu, M.; Zhao, L.; Lievense, J.; Reiling, K. K.; Renninger, N. S.; Newman, J. D.] Amyris Inc, Emeryville, CA 94608 USA; [Polichuk, D. R.; Teoh, K. H.; Reed, D. W.; Ellens, K. W.; Hepp, M.; Zhang, Y.; Covello, P. S.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Keasling, J. D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, J. D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, J. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, J. D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA	National Research Council Canada; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Paddon, CJ (corresponding author), Amyris Inc, 5885 Hollis St,Suite 100, Emeryville, CA 94608 USA.	paddon@amyris.com; newman@amyris.com	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Paddon, Christopher/0000-0003-4182-2855; Benjamin, Kirsten/0000-0003-4267-1972; Reed, Darwin/0000-0001-8038-8647	Institute for OneWorld Health	Institute for OneWorld Health	We thank D. Rathbone for advice on native A. annua ADH1 expression, and our friends and colleagues at Sanofi, especially D. Thibaut, C. Lehmann, C. Masson-Brocard, B. Dumas, P. Baduel and H. Farret. We also thank J. Rine, P. Ortiz de Montellano and H. van Dijken for many conversations. This research was conducted under the sponsorship of the Institute for OneWorld Health through generous support of the Bill & Melinda Gates Foundation for this non-profit project.	[Anonymous], MED CHEM BIOACTIVE N; Asadollahi MA, 2008, BIOTECHNOL BIOENG, V99, P666, DOI 10.1002/bit.21581; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Boehme K., 1992, INORG CHEM, V31, P3468; Daugulis AJ, 1997, CURR OPIN BIOTECH, V8, P169, DOI 10.1016/S0958-1669(97)80097-3; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Hale V, 2007, AM J TROP MED HYG, V77, P198, DOI 10.4269/ajtmh.2007.77.198; Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129; HAYNES RK, 1990, J CHEM SOC CHEM COMM, P451, DOI 10.1039/c39900000451; Kim BJ, 2006, ORG PREP PROCED INT, V38, P1, DOI 10.1080/00304940609355981; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Nam JW, 2007, J EXP BOT, V58, P1421, DOI 10.1093/jxb/erm005; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Polichuk DR, 2010, PHYTOCHEMISTRY, V71, P1264, DOI 10.1016/j.phytochem.2010.04.026; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roth R. J., 1991, US Patent, Patent No. 4992561; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Sy LK, 2002, TETRAHEDRON, V58, P909, DOI 10.1016/S0040-4020(01)01192-9; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; van Hoek P, 2000, BIOTECHNOL BIOENG, V68, P517; Vorachek-Warren MK, 2004, YEAST, V21, P163, DOI 10.1002/yea.1074; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	29	1198	1378	101	1404	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					528	+		10.1038/nature12051	http://dx.doi.org/10.1038/nature12051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23575629	Bronze			2022-12-24	WOS:000317984400046
J	Xiong, FZ; Tentner, AR; Huang, P; Gelas, A; Mosaliganti, KR; Souhait, L; Rannou, N; Swinburne, IA; Obholzer, ND; Cowgill, PD; Schier, AF; Megason, SG				Xiong, Fengzhu; Tentner, Andrea R.; Huang, Peng; Gelas, Arnaud; Mosaliganti, Kishore R.; Souhait, Lydie; Rannou, Nicolas; Swinburne, Ian A.; Obholzer, Nikolaus D.; Cowgill, Paul D.; Schier, Alexander F.; Megason, Sean G.			Specified Neural Progenitors Sort to Form Sharp Domains after Noisy Shh Signaling	CELL			English	Article							SONIC-HEDGEHOG; SPINAL-CORD; HOMEODOMAIN PROTEIN; MORPHOGEN GRADIENT; FLOOR PLATE; IN-VIVO; CELL; TUBE; SPECIFICATION; EXPRESSION	Sharply delineated domains of cell types arise in developing tissues under instruction of inductive signal (morphogen) gradients, which specify distinct cell fates at different signal levels. The translation of a morphogen gradient into discrete spatial domains relies on precise signal responses at stable cell positions. However, cells in developing tissues undergoing morphogenesis and proliferation often experience complex movements, which may affect their morphogen exposure, specification, and positioning. How is a clear pattern achieved with cells moving around? Using in toto imaging of the zebrafish neural tube, we analyzed specification patterns and movement trajectories of neural progenitors. We found that specified progenitors of different fates are spatially mixed following heterogeneous Sonic Hedgehog signaling responses. Cell sorting then rearranges them into sharply bordered domains. Ectopically induced motor neuron progenitors also robustly sort to correct locations. Our results reveal that cell sorting acts to correct imprecision of spatial patterning by noisy inductive signals.	[Xiong, Fengzhu; Tentner, Andrea R.; Gelas, Arnaud; Mosaliganti, Kishore R.; Souhait, Lydie; Rannou, Nicolas; Swinburne, Ian A.; Obholzer, Nikolaus D.; Cowgill, Paul D.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Huang, Peng; Schier, Alexander F.] Harvard Univ, Broad Inst, Harvard Stem Cell Inst, Dept Mol & Cellular Biol,Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Megason, SG (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	megason@hms.harvard.edu	XIONG, FENGZHU/A-9590-2015; Huang, Peng/U-8384-2019	XIONG, FENGZHU/0000-0002-6153-0254; Huang, Peng/0000-0001-7954-8869; Schier, Alexander Franz/0000-0001-7645-5325	NIH [HG004071, DC010791]; graduate program of Biological Sciences in Dental Medicine at Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K25HD071969, R01HD067140] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012097, R01DC010791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); graduate program of Biological Sciences in Dental Medicine at Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. D'India for fish care, H. Otsuna for movie making, R. Koster, D. Meyer, U. Strahle, B. Appel, S. Higashijima, S. Lin, and L. Zon for sharing reagents, D. Tulga and T. Hiscock for technical assistance, and Q. Mao, R. Noche, A. Green, Y. Chen, W. Ma, R. Ward, A. McMahon, M. Kirschner, C. Cepko, and T. Mitchison for comments. This work is supported by NIH grants HG004071 and DC010791. F.X. is also supported by the graduate program of Biological Sciences in Dental Medicine at Harvard University. F.X. and S.G.M. conceived this study. F.X., A.R.T., and P.H. performed the experiments. F.X. analyzed the data. A.G., K.R.M., L.S., and N.R. provided tools and assistance for data analysis. P.H., I.A.S., N.D.O., P.D.C, and A.F.S. provided reagents and technical assistance. F.X. and S.G.M. wrote the manuscript. All authors discussed the manuscript and contributed to writing.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Clarke J, 2009, CURR OPIN NEUROBIOL, V19, P134, DOI 10.1016/j.conb.2009.04.010; Das RM, 2012, EMBO REP, V13, P1030, DOI 10.1038/embor.2012.159; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Huang P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002762; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jessen JR, 1998, P NATL ACAD SCI USA, V95, P5121, DOI 10.1073/pnas.95.9.5121; Kay RR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001503; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; KORZH V, 1993, DEVELOPMENT, V118, P417; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lander AD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002022; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lek M, 2010, DEVELOPMENT, V137, P4051, DOI 10.1242/dev.054288; Lele Z, 2002, DEVELOPMENT, V129, P3281; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; Lin JT, 2012, J COMP NEUROL, V520, P1509, DOI 10.1002/cne.22808; MARTI E, 1995, DEVELOPMENT, V121, P2537; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Nicol A, 1999, J CELL SCI, V112, P3923; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; Schaffer M, 2005, MECH DEVELOP, V122, P43, DOI 10.1016/j.mod.2004.09.002; SCHOENWOLF GC, 1991, DEVELOPMENT, P157; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Smith JL, 1997, TRENDS NEUROSCI, V20, P510, DOI 10.1016/S0166-2236(97)01121-1; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Takamiya M, 2006, DEV DYNAM, V235, P978, DOI 10.1002/dvdy.20720; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wendik B, 2004, DEV BIOL, V268, P372, DOI 10.1016/j.ydbio.2003.12.026; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yamaguchi Y, 2011, J CELL BIOL, V195, P1047, DOI 10.1083/jcb.201104057	52	102	102	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					550	561		10.1016/j.cell.2013.03.023	http://dx.doi.org/10.1016/j.cell.2013.03.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622240	Green Accepted, Bronze			2022-12-24	WOS:000318063500009
J	Baubec, T; Ivanek, R; Lienert, F; Schubeler, D				Baubec, Tuncay; Ivanek, Robert; Lienert, Florian; Schuebeler, Dirk			Methylation-Dependent and -Independent Genomic Targeting Principles of the MBD Protein Family	CELL			English	Article							EMBRYONIC STEM-CELLS; CPG-BINDING DOMAIN; DNA METHYLATION; TRANSCRIPTIONAL REPRESSOR; GENE-EXPRESSION; NEURONAL MECP2; RETT-SYNDROME; ACTIVE GENES; CHROMATIN; COMPLEX	To gain insight into the cellular readout of DNA methylation, we established a strategy for systematically profiling the genome-wide distribution of chromatin-interacting factors. This enabled us to create genomic maps for the methyl-CpG-binding domain (MBD) family of proteins, including disease-relevant mutants, deletions, and isoforms. In vivo binding of MBD proteins occurs predominantly as a linear function of local methylation density, requiring functional MBD domains and methyl-CPGs. This interaction directs specificity of MBD proteins to methylated, CpG-dense, and inactive regulatory regions. In contrast, binding to unmethylated sites varies between MBD proteins and is mediated via alternative domains or protein-protein interactions. Such targeting is exemplified by NuRD-complex-mediated tethering of MBD2 to a subset of unmethylated, active regulatory regions. Interestingly, MBD3 also occupies these sites, but like MBD2, binding is independent of the presence of hydroxymethylation. These functional binding maps reveal methylation-dependent and -independent binding modes and revise current models of DNA methylation readout through MBD proteins.	[Baubec, Tuncay; Ivanek, Robert; Lienert, Florian; Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Schuebeler, Dirk] Univ Basel, Fac Sci, CH-4003 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch	Ivanek, Robert/A-8852-2008; Baubec, Tuncay/AAQ-8714-2021; Baubec, Tuncay/J-3719-2014	Baubec, Tuncay/0000-0001-8474-6587; Baubec, Tuncay/0000-0001-8474-6587; Ivanek, Robert/0000-0002-8403-056X	EMBO long-term postdoctoral fellowship; Novartis Research Foundation; European Union [FP7-HEALTH-2010-257082, FP7-282510]; European Research Council; SNF Sinergia program; Swiss initiative in Systems Biology	EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Novartis Research Foundation; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); SNF Sinergia program; Swiss initiative in Systems Biology	We are grateful to Sophie Dessus-Babus, Tim Roloff (FMI), Ina Nissen, and Christian Beisel (ETH BSSE) for processing deep sequencing samples. We thank Christiane Wirbelauer and Leslie Hoerner for technical assistance and Michael Stadler, Dimos Gaidatzis, and Lukas Burger for bioinformatic advice and providing tools to process and analyze deep sequencing data. We thank Masaki Okano (RIKEN) for providing TKO cells; FMI facilities for technical support; and Nicolas Thoma (FMI), Matthew Lorincz (UBC Vancouver), Oliver Bell (HHMI/Stanford University), and members of the Schubeler lab for advice and critical comments on the manuscript. T. B. is supported by an EMBO long-term postdoctoral fellowship. Research in the laboratory of D. S. is supported by the Novartis Research Foundation, the European Union (NoE "EpiGeneSys" FP7-HEALTH-2010-257082 and the "Blueprint" consortium FP7-282510), the European Research Council (EpiGePlas), the SNF Sinergia program, and the Swiss initiative in Systems Biology (RTD Cell Plasticity).	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016627; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Scarsdale JN, 2011, NUCLEIC ACIDS RES, V39, P6741, DOI 10.1093/nar/gkr262; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	41	228	238	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					480	492		10.1016/j.cell.2013.03.011	http://dx.doi.org/10.1016/j.cell.2013.03.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582333	Bronze			2022-12-24	WOS:000317349700025
J	Marsh, JA; Hernandez, H; Hall, Z; Ahnert, SE; Perica, T; Robinson, CV; Teichmann, SA				Marsh, Joseph A.; Hernandez, Helena; Hall, Zoe; Ahnert, Sebastian E.; Perica, Tina; Robinson, Carol V.; Teichmann, Sarah A.			Protein Complexes Are under Evolutionary Selection to Assemble via Ordered Pathways	CELL			English	Article							GENE FUSION; GENERATION; NETWORKS; DATABASE	Is the order in which proteins assemble into complexes important for biological function? Here, we seek to address this by searching for evidence of evolutionary selection for ordered protein complex assembly. First, we experimentally characterize the assembly pathways of several heteromeric complexes and show that they can be simply predicted from their three-dimensional structures. Then, by mapping gene fusion events identified from fully sequenced genomes onto protein complex assembly pathways, we demonstrate evolutionary selection for conservation of assembly order. Furthermore, using structural and high-throughput interaction data, we show that fusion tends to optimize assembly by simplifying protein complex topologies. Finally, we observe protein structural constraints on the gene order of fusion that impact the potential for fusion to affect assembly. Together, these results reveal the intimate relationships among protein assembly, quaternary structure, and evolution and demonstrate on a genome-wide scale the biological importance of ordered assembly pathways.	[Marsh, Joseph A.; Teichmann, Sarah A.] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Hernandez, Helena; Hall, Zoe; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Ahnert, Sebastian E.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Perica, Tina] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Teichmann, Sarah A.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	European Molecular Biology Laboratory (EMBL); University of Oxford; University of Cambridge; MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute	Robinson, CV (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, S Parks Rd, Oxford OX1 3QZ, England.	carol.robinson@chem.ox.ac.uk; sarah.teichmann@ebi.ac.uk		Marsh, Joseph/0000-0003-4132-0628; Teichmann, Sarah/0000-0002-6294-6366; robinson, carol/0000-0001-7829-5505; Perica, Tina/0000-0003-3152-8425; Hall, Zoe/0000-0002-1434-8329	Medical Research Council (MRC) [U105161047]; Human Frontier Science Program Organization; MRC Programme Grant; Royal Society; ERC Advanced Grant; Royal Society Professorship; MRC [G1000819, MC_U105161047] Funding Source: UKRI; Medical Research Council [G1000819, MC_U105161047] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program Organization(Human Frontier Science Program); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); ERC Advanced Grant(European Research Council (ERC)); Royal Society Professorship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank I. Schlichting (Max Planck Institute for Medical Research, Heidelberg), G. Waldrop (Louisiana State University), F. Raushel (Texas A&M University), and R. Hausinger (Michigan State University) for providing protein complex samples. We acknowledge E. Boeri-Erba and K. Wright for assistance with the MS experiments, and M. Babu and E. Natan for comments on the manuscript. J.A.M., T. P., and S. A. T. were supported by the Medical Research Council (MRC file reference number U105161047). J.A.M. was supported by a long-term fellowship from the Human Frontier Science Program Organization. H. H. was supported by an MRC Programme Grant. S. E. A. was supported by the Royal Society. C. V. R. was supported by an ERC Advanced Grant and a Royal Society Professorship.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjorklund AK, 2005, J MOL BIOL, V353, P911, DOI 10.1016/j.jmb.2005.08.067; Brooijmans N, 2002, PROTEINS, V48, P645, DOI 10.1002/prot.10139; Buljan M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r74; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Ellis RJ, 2007, ADV EXP MED BIOL, V594, P1; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Enright AJ, 2001, GENOME BIOL, V2; EVANS D R, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1351, DOI 10.1073/pnas.71.4.1351; Fong JH, 2007, J MOL BIOL, V366, P307, DOI 10.1016/j.jmb.2006.11.017; FRIEDMAN FK, 1979, ANNU REV BIOCHEM, V48, P217, DOI 10.1146/annurev.bi.48.070179.001245; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Jabri E, 1996, BIOCHEMISTRY-US, V35, P10616, DOI 10.1021/bi960424z; Kamburov A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-460; Kim WK, 2006, PLOS COMPUT BIOL, V2, P1151, DOI 10.1371/journal.pcbi.0020124; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Lai YT, 2012, SCIENCE, V336, P1129, DOI 10.1126/science.1219351; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; Payne MS, 1997, BIOCHEMISTRY-US, V36, P5447, DOI 10.1021/bi962794t; Perica T, 2012, BIOCHEM SOC T, V40, P475, DOI 10.1042/BST20120056; POULSEN C, 1993, EUR J BIOCHEM, V212, P431, DOI 10.1111/j.1432-1033.1993.tb17679.x; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Reid AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010908; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298	47	156	158	1	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					461	470		10.1016/j.cell.2013.02.044	http://dx.doi.org/10.1016/j.cell.2013.02.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582331	Green Published, hybrid			2022-12-24	WOS:000317349700023
J	Lammermann, T; Afonso, PV; Angermann, BR; Wang, JM; Kastenmuller, W; Parent, CA; Germain, RN				Laemmermann, Tim; Afonso, Philippe V.; Angermann, Bastian R.; Wang, Ji Ming; Kastenmueller, Wolfgang; Parent, Carole A.; Germain, Ronald N.			Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo	NATURE			English	Article							INNATE IMMUNE-RESPONSE; IMAGING REVEALS; HOST-DEFENSE; MICE LACKING; LYMPH-NODES; MIGRATION; RECRUITMENT; RECEPTOR; MOLECULE; LEUKOTRIENE-B4	Neutrophil recruitment from blood to extravascular sites of sterile or infectious tissue damage is a hallmark of early innate immune responses, and the molecular events leading to cell exit from the bloodstream have been well defined(1,2). Once outside the vessel, individual neutrophils often show extremely coordinated chemotaxis and cluster formation reminiscent of the swarming behaviour of insects(3-11). The molecular players that direct this response at the single-cell and population levels within the complexity of an inflamed tissue are unknown. Using two-photon intravital microscopy in mouse models of sterile injury and infection, we show a critical role for intercellular signal relay among neutrophils mediated by the lipid leukotriene B4, which acutely amplifies local cell death signals to enhance the radius of highly directed interstitial neutrophil recruitment. Integrin receptors are dispensable for long-distance migration(12), but have a previously unappreciated role in maintaining dense cellular clusters when congregating neutrophils rearrange the collagenous fibre network of the dermis to form a collagen-free zone at the wound centre. In this newly formed environment, integrins, in concert with neutrophil-derived leukotriene B4 and other chemoattractants, promote local neutrophil interaction while forming a tight wound seal. This wound seal has borders that cease to grow in kinetic concert with late recruitment of monocytes and macrophages at the edge of the displaced collagen fibres. Together, these data provide an initial molecular map of the factors that contribute to neutrophil swarming in the extravascular space of a damaged tissue. They reveal how local events are propagated over large-range distances, and how auto-signalling produces coordinated, self-organized neutrophil-swarming behaviour that isolates the wound or infectious site from surrounding viable tissue.	[Laemmermann, Tim; Angermann, Bastian R.; Kastenmueller, Wolfgang; Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Afonso, Philippe V.; Parent, Carole A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wang, Ji Ming] NCI, Lab Mol Immunoregulat, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Kastenmueller, Wolfgang] Univ Bonn, Inst Mol Med, D-53105 Bonn, Germany; [Kastenmueller, Wolfgang] Univ Bonn, Inst Expt Immunol, D-53105 Bonn, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bonn; University of Bonn	Lammermann, T (corresponding author), NIAID, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	laemmermannt@niaid.nih.gov; rgermain@niaid.nih.gov	Germain, Ronald N./Z-1945-2019; Lämmermann, Tim/AAD-7453-2022; Germain, Ronald/ABE-7090-2020; Afonso, Philippe V/ABB-5692-2021; Afonso, Philippe/D-2234-2014	Afonso, Philippe V/0000-0002-4828-3797; Afonso, Philippe/0000-0002-4828-3797	Human Frontiers Science Program Long-Term Fellowship; Deutsche Forschungsgemeinschaft (DFG); National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011216, ZIABC010725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	Human Frontiers Science Program Long-Term Fellowship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Birnbaumer, R. Fassler, E. Tuomanen, P. M. Murphy, S. Akira, S. Monkley, D. Critchley, R. Wedlich-Soldner and M. Sixt for providing mice for this study, J.G. Egen and J. Tang for assistance with imaging, M. Parsek for providing P. aeruginosa-GFP, J. H. Kehrl, P. M. Murphy, R. Varma and members of the Germain laboratory for discussions. This work was supported by the Intramural Research Program of National Institute of Allergy and Infectious Diseases and National Cancer Institute, National Institutes of Health. T. L. was supported by a Human Frontiers Science Program Long-Term Fellowship. W. K. is presently a member of the Deutsche Forschungsgemeinschaft (DFG)-funded excellence cluster ImmunoSensation, Bonn, Germany.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DIPERSIO JF, 1988, J IMMUNOL, V140, P4315; Faust N, 2000, BLOOD, V96, P719; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Gaiser MR, 2012, P NATL ACAD SCI USA, V109, pE889, DOI 10.1073/pnas.1117674109; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Guggenberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002434; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Liese J., 2012, CELL MICROBIOL; Malawista SE, 2008, P NATL ACAD SCI USA, V105, P17949, DOI 10.1073/pnas.0802572105; McDonald B, 2011, J MOL MED, V89, P1079, DOI 10.1007/s00109-011-0784-9; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Oh Hana, 2008, J Vis Exp, DOI 10.3791/745; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; PALMBLAD J, 1981, BLOOD, V58, P658; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	49	569	576	4	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					371	+		10.1038/nature12175	http://dx.doi.org/10.1038/nature12175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708969	Green Accepted, Green Published			2022-12-24	WOS:000320592900042
J	Zhou, CM; Zhang, TQ; Wang, X; Yu, S; Lan, H; Tang, HB; Feng, ZY; Zozomova-Lihova, J; Wang, JW				Zhou, Chuan-Miao; Zhang, Tian-Qi; Wang, Xi; Yu, Sha; Lan, Heng; Tang, Hongbo; Feng, Zheng-Yan; Zozomova-Lihova, Judita; Wang, Jia-Wei			Molecular Basis of Age-Dependent Vernalization in Cardamine flexuosa	SCIENCE			English	Article							FLOWERING-TIME; MIR156; TRANSITIONS; COMPETENCE; REPRESSOR; CONSTANS; MICRORNA; CONFERS; GENES; FLC	Plants flower in response to many varied cues, such as temperature, photoperiod, and age. The floral transition of Cardamine flexuosa, a herbaceous biennial-to-perennial plant, requires exposure to cold temperature, a treatment known as vernalization. C. flexuosa younger than 5 weeks old are not fully responsive to cold treatment. We demonstrate that the levels of two age-regulated microRNAs, miR156 and miR172, regulate the timing of sensitivity in response to vernalization. Age and vernalization pathways coordinately regulate flowering through modulating the expression of CfSOC1, a flower-promoting MADS-box gene. The related annual Arabidopsis thaliana, which has both vernalization and age pathways, does not possess an age-dependent vernalization response. Thus, the recruitment of age cue in response to environmental signals contributes to the evolution of life cycle in plants.	[Zhou, Chuan-Miao; Zhang, Tian-Qi; Yu, Sha; Lan, Heng; Tang, Hongbo; Feng, Zheng-Yan; Wang, Jia-Wei] Shanghai Inst Biol Sci SIBS, Inst Plant Physiol & Ecol SIPPE, Natl Key Lab Plant Mol Genet NKLPMG, Shanghai 200032, Peoples R China; [Zhang, Tian-Qi; Yu, Sha; Feng, Zheng-Yan] Univ Chinese Acad Sci CAS, Shanghai 200032, Peoples R China; [Wang, Xi; Wang, Jia-Wei] Max Planck Inst MPI Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Zozomova-Lihova, Judita] Slovak Acad Sci, Inst Bot, SK-84523 Bratislava, Slovakia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Slovak Academy of Sciences	Wang, JW (corresponding author), Shanghai Inst Biol Sci SIBS, Inst Plant Physiol & Ecol SIPPE, Natl Key Lab Plant Mol Genet NKLPMG, Shanghai 200032, Peoples R China.	jwwang@sibs.ac.cn	Zozomova-Lihova, Judita/P-3151-2019; Zozomova-Lihova, Judita/B-5011-2011	Zozomova-Lihova, Judita/0000-0002-8950-6643; Zozomova-Lihova, Judita/0000-0002-8950-6643; Wang, Jia-Wei/0000-0003-3885-6296; Zhang, Tian-Qi/0000-0001-8000-4770	National Natural Science Foundation of China [31222029, 912173023]; State Key Basic Research Program of China [2013CB127000]; Shanghai Pujiang Program [12PJ1409900]; Recruitment Program of Global Experts (China); NKLPMG (SIPPE, SIBS); Open Project Program of NKLPMG (SIPPE, SIBS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Program of China(National Basic Research Program of China); Shanghai Pujiang Program(Shanghai Pujiang Program); Recruitment Program of Global Experts (China); NKLPMG (SIPPE, SIBS); Open Project Program of NKLPMG (SIPPE, SIBS)	We thank I. R. Somoza and D. Weigel (MPI, Tubingen) for commenting on the manuscript, S. Bergonzi and G. Coupland (MPI, Koln) for exchanging unpublished results, and Y.-L. Guo (Institute of Botany, CAS, Beijing) for suggestion on phylogenetic analyses. The early phase of the work was conducted at the MM for Developmental Biology, where it was supported by Max Planck Society funds to D. Weigel. The majority of this work was conducted at SIPPE and supported by grants from National Natural Science Foundation of China (31222029 and 912173023), State Key Basic Research Program of China (2013CB127000), Shanghai Pujiang Program (12PJ1409900), Recruitment Program of Global Experts (China), and NKLPMG (SIPPE, SIBS) to J.-W.W., and Open Project Program of NKLPMG (SIPPE, SIBS) to X.W.	Albani MC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003130; Albani MC, 2010, CURR TOP DEV BIOL, V91, P323, DOI 10.1016/S0070-2153(10)91011-9; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Amasino R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-228; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bergonzi S, 2011, J EXP BOT, V62, P4415, DOI 10.1093/jxb/err192; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Lihova J, 2006, AM J BOT, V93, P1206, DOI 10.3732/ajb.93.8.1206; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Poethig RS, 2010, PLANT PHYSIOL, V154, P541, DOI 10.1104/pp.110.161620; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang RH, 2011, PLANT CELL, V23, P1307, DOI 10.1105/tpc.111.083451; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Yang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00260; Yu S, 2013, ELIFE, V2, DOI 10.7554/eLife.00269	30	104	120	5	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1097	1100		10.1126/science.1234340	http://dx.doi.org/10.1126/science.1234340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23723237				2022-12-24	WOS:000319664500045
J	Molina-Cruz, A; Garver, LS; Alabaster, A; Bangiolo, L; Haile, A; Winikor, J; Ortega, C; van Schaijk, BL; Sauerwein, RW; Taylor-Salmon, E; Barillas-Mury, C				Molina-Cruz, Alvaro; Garver, Lindsey S.; Alabaster, Amy; Bangiolo, Lois; Haile, Ashley; Winikor, Jared; Ortega, Corrie; van Schaijk, Ben C. L.; Sauerwein, Robert W.; Taylor-Salmon, Emma; Barillas-Mury, Carolina			The Human Malaria Parasite Pfs47 Gene Mediates Evasion of the Mosquito Immune System	SCIENCE			English	Article							VECTOR ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; SURFACE PROTEIN; SELECTION; FERTILITY; NITRATION; INVASION; PFS48/45	Plasmodium falciparum transmission by Anopheles gambiae mosquitoes is remarkably efficient, resulting in a very high prevalence of human malaria infection in sub-Saharan Africa. A combination of genetic mapping, linkage group selection, and functional genomics was used to identify Pfs47 as a P. falciparum gene that allows the parasite to infect A. gambiae without activating the mosquito immune system. Disruption of Pfs47 greatly reduced parasite survival in the mosquito, and this phenotype could be reverted by genetic complementation of the parasite or by disruption of the mosquito complement-like system. Pfs47 suppresses midgut nitration responses that are critical to activate the complement-like system. We provide direct experimental evidence that immune evasion mediated by Pfs47 is critical for efficient human malaria transmission by A. gambiae.	[Molina-Cruz, Alvaro; Garver, Lindsey S.; Alabaster, Amy; Bangiolo, Lois; Haile, Ashley; Winikor, Jared; Ortega, Corrie; Taylor-Salmon, Emma; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA; [van Schaijk, Ben C. L.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Radboud University Nijmegen	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA.	cbarillas@niaid.nih.gov	Sauerwein, Robert/C-8519-2013		Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. We thank K. Hayton and T. Wellems for advice with the genetic cross, A. Laughinghouse and K. Lee for technical support, and B. Marshall for editorial assistance. This work is subject to U.S. Patent no 61/684,333, filed 17 August 2012, "Transmission-blocking malaria vaccine." There are material transfer agreements or patents restricting use of Pfs48/45 and Pfs47 KO parasites.	Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Carter R, 2007, INT J PARASITOL, V37, P285, DOI 10.1016/j.ijpara.2006.11.013; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Molina-Cruz A, 2012, P NATL ACAD SCI USA, V109, pE1957, DOI 10.1073/pnas.1121183109; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015	15	150	155	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					984	987		10.1126/science.1235264	http://dx.doi.org/10.1126/science.1235264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23661646	Green Accepted			2022-12-24	WOS:000319344100049
J	Casanova-Acebes, M; Pitaval, C; Weiss, LA; Nombela-Arrieta, C; Chevre, R; A-Gonzalez, N; Kunisaki, Y; Zhang, DC; van Rooijen, N; Silberstein, LE; Weber, C; Nagasawa, T; Frenette, PS; Castrillo, A; Hidalgo, A				Casanova-Acebes, Maria; Pitaval, Christophe; Weiss, Linnea A.; Nombela-Arrieta, Cesar; Chevre, Raphael; A-Gonzalez, Noelia; Kunisaki, Yuya; Zhang, Dachuan; van Rooijen, Nico; Silberstein, Leslie E.; Weber, Christian; Nagasawa, Takashi; Frenette, Paul S.; Castrillo, Antonio; Hidalgo, Andres			Rhythmic Modulation of the Hematopoietic Niche through Neutrophil Clearance	CELL			English	Article							STEM-CELL NICHE; BONE-MARROW; G-CSF; PROGENITOR CELLS; P-SELECTIN; INFLAMMATION; CXCR4; MOBILIZATION; RELEASE; MICE	Unique among leukocytes, neutrophils follow daily cycles of release from and migration back into the bone marrow, where they are eliminated. Because removal of dying cells generates homeostatic signals, we explored whether neutrophil elimination triggers circadian events in the steady state. Here, we report that the homeostatic clearance of neutrophils provides cues that modulate the physiology of the bone marrow. We identify a population of CD62L(LO) CXCR4(HI) neutrophils that have "aged'' in the circulation and are eliminated at the end of the resting period in mice. Aged neutrophils infiltrate the bone marrow and promote reductions in the size and function of the hematopoietic niche. Modulation of the niche depends on macrophages and activation of cholesterol-sensing nuclear receptors and is essential for the rhythmic egress of hematopoietic progenitors into the circulation. Our results unveil a process that synchronizes immune and hematopoietic rhythms and expand the ascribed functions of neutrophils beyond inflammation.	[Casanova-Acebes, Maria; Pitaval, Christophe; Weiss, Linnea A.; Chevre, Raphael; A-Gonzalez, Noelia; Hidalgo, Andres] Fdn Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol Atherothrombosis & Imaging, Madrid 28029, Spain; [Nombela-Arrieta, Cesar; Silberstein, Leslie E.] Childrens Hosp, Joint Program Transfus Med, Boston, MA 02115 USA; [Kunisaki, Yuya; Zhang, Dachuan; Frenette, Paul S.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, VUMC, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, D-80539 Munich, Germany; [Nagasawa, Takashi] Kyoto Univ, Core Res Evolut Sci & Technol CREST, Kyoto 6068507, Japan; [Nagasawa, Takashi] Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Nagasawa, Takashi] Japan Sci & Technol Agcy JST, Kyoto 6068507, Japan; [Castrillo, Antonio] UAM Madrid, CSIC, Inst Invest Biomed Alberto Sols, Las Palmas Gran Canaria 35016, Spain; [Castrillo, Antonio] Univ Las Palmas, CSIC, Unidad Asociada Biomed IIBM, Las Palmas Gran Canaria 35016, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Harvard University; Boston Children's Hospital; Yeshiva University; Albert Einstein College of Medicine; Vrije Universiteit Amsterdam; University of Munich; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad de Las Palmas de Gran Canaria	Hidalgo, A (corresponding author), Fdn Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol Atherothrombosis & Imaging, Madrid 28029, Spain.	ahidalgo@cnic.es	Weber, Christian/AAW-2153-2020; Gonzalez, Noelia Alonso/H-4488-2015; Weiss, Linnea A/K-8062-2014; Frenette, Paul S/J-8272-2012; Van Rooijen, Nico/Z-1578-2019; Weiss, Linnea A/AFV-8680-2022; Zhang, Dachuan/GZA-8781-2022; Hidalgo, Andrés/L-5643-2014; Gonzalez, Noelia Alonso/ABC-7381-2021; Acebes, Maria Casanova/AAH-1929-2019	Weber, Christian/0000-0003-4610-8714; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Frenette, Paul S/0000-0003-0862-9922; Hidalgo, Andrés/0000-0001-5513-555X; Gonzalez, Noelia Alonso/0000-0003-0533-5216; Acebes, Maria Casanova/0000-0002-5790-1163; , Linnea/0000-0002-7593-7821; Zhang, Dachuan/0000-0002-1746-275X; Nombela-Arrieta, Cesar/0000-0003-0415-259X; Nagasawa, Takashi/0000-0002-1085-0960	Deutsche Forschungsgemeinschaft (DFG) [WE1913/11-2, SFB914-B8, R01-DK056638, R01-HL69438, SAF2008-00057, SAF2011-29244]; Ramon y Cajal Fellowship [RYC-2007-00697]; MINECO [SAF2009-11037]; Comunidad de Madrid [S2010/BMD-2314]; FP7-People-IRG Program [246655]; Human Frontiers in Science Program long-term fellowship [00194/2008]; Spanish Ministry of Economy and Competitivity; Pro-CNIC Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116340, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ramon y Cajal Fellowship(Spanish Government); MINECO(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); FP7-People-IRG Program; Human Frontiers in Science Program long-term fellowship; Spanish Ministry of Economy and Competitivity(Spanish Government); Pro-CNIC Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Nacher, J. Ogonek, I. Ortega, V. Zorita, M. Leboeuf, J.M. Ligos, and the Cellomics, Microscopy, and Comparative Medicine Units at CNIC for technical support; J. Garaude, D. Lucas, and A. Ramiro for critically reviewing the manuscript; and S. Gonzalez and D. Sanz for reagents. This study was supported by Deutsche Forschungsgemeinschaft (DFG WE1913/11-2 and SFB914-B8) to C.W.; R01-DK056638 and R01-HL69438 to P.S.F.; grants SAF2008-00057 and SAF2011-29244 to A.C.; Ramon y Cajal Fellowship (RYC-2007-00697) and SAF2009-11037 from MINECO, S2010/BMD-2314 from Comunidad de Madrid, and FP7-People-IRG Program (246655) to A.H.; C.N-A. is funded by a Human Frontiers in Science Program long-term fellowship 00194/2008. M.C-A. is supported by a FPI fellowship from the Spanish Ministry of Economy and Competitivity. The Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Economy and Competitivity and the Pro-CNIC Foundation. M.C-A performed experiments and wrote the manuscript; L.A.W., C.P., and N.A-G performed experiments and edited the manuscript. C.N-A., R.C., Y.K., and D.Z. performed experiments; N.V.R., L.E.S., C.W., T.N., P.S.F., and A.C. contributed reagents, discussed experiments and helped in editing the manuscript; A.H. conceived the study, performed experiments and wrote the manuscript. C.P., L.A.W., and C.N-A. contributed equally to this study.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Van Eeden SF, 1997, AM J PHYSIOL-HEART C, V272, pH401, DOI 10.1152/ajpheart.1997.272.1.H401; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534	50	404	408	3	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1025	1035		10.1016/j.cell.2013.04.040	http://dx.doi.org/10.1016/j.cell.2013.04.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706740	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000319456800011
J	Campbell, CS; Desai, A				Campbell, Christopher S.; Desai, Arshad			Tension sensing by Aurora B kinase is independent of survivin-based centromere localization	NATURE			English	Article							PROPER CHROMOSOME SEGREGATION; SACCHAROMYCES-CEREVISIAE; SPINDLE CHECKPOINT; BUDDING YEAST; PROTEIN-KINASE; COMPLEX; INCENP; PHOSPHORYLATION; ORIENTATION; BIORIENTATION	Accurate segregation of the replicated genome requires chromosome biorientation on the spindle. Biorientation is ensured by Aurora B kinase (Ipl1), a member of the four-subunit chromosomal passenger complex (CPC)(1,2). Localization of the CPC to the inner centromere is central to the current model for how tension ensures chromosome biorientation: kinetochore-spindle attachments that are not under tension remain close to the inner centromere and are destabilized by Aurora B phosphorylation, whereas kinetochores under tension are pulled away from the influence of Aurora B, stabilizing their microtubule attachments(3-5). Here we show that an engineered truncation of the Sli15 (known as INCENP in humans) subunit of budding yeast CPC that eliminates association with the inner centromere nevertheless supports proper chromosome segregation during both mitosis and meiosis. Truncated Sli15 suppresses the deletion phenotypes of the innercentromere-targeting proteins survivin (Bir1), borealin (Nbl1), Bub1 and Sgo1 (ref. 6). Unlike wild-type Sli15, truncated Sli15 localizes to pre-anaphase spindle microtubules. Premature targeting of full-length Sli15 to microtubules by preventing Cdk1 (also known as Cdc28) phosphorylation also suppresses the inviability of Bir1 deletion. These results suggest that activation of Aurora B kinase by clustering either on chromatin or on microtubules is sufficient for chromosome biorientation.	[Campbell, Christopher S.; Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA; [Campbell, Christopher S.; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA.	abdesai@ucsd.edu		Campbell, Christopher/0000-0002-3927-344X	National Institutes of Health (NIH) [GM074215]; Damon Runyon Cancer Research Foundation Fellowship [DRG 2007-09]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation Fellowship; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the Desai and Oegema laboratories for discussions; S. Sandall, H. Hu and E. Manrriquez for assistance; B. Ren's laboratory for help with ChIP experiments; S. Biggins, D. Dawson, G. Pereira, G. Barnes, P. Hieter and the Yeast Resource Center for strains and plasmids; and K. Oegema, R. Green and J. DeLuca for comments on the manuscript. This work was supported by a National Institutes of Health (NIH) grant (GM074215) to A. D. and a Damon Runyon Cancer Research Foundation Fellowship (DRG 2007-09) to C.S.C. A.D. receives salary and other support from the Ludwig Institute for Cancer Research.	Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cho US, 2012, NAT STRUCT MOL BIOL, V19, P48, DOI 10.1038/nsmb.2178; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Makrantoni V, 2009, MOL CELL BIOL, V29, P4552, DOI 10.1128/MCB.01911-08; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Ng TM, 2009, MOL BIOL CELL, V20, P3818, DOI 10.1091/mbc.E09-04-0330; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Rozelle DK, 2011, J CELL BIOL, V193, P285, DOI 10.1083/jcb.201011002; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shimogawa MM, 2009, MOL BIOL CELL, V20, P915, DOI 10.1091/mbc.E08-07-0723; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	30	95	95	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2013	497	7447					118	+		10.1038/nature12057	http://dx.doi.org/10.1038/nature12057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23604256	Green Accepted			2022-12-24	WOS:000318221500045
J	Betschinger, J; Nichols, J; Dietmann, S; Corrin, PD; Paddison, PJ; Smith, A				Betschinger, Joerg; Nichols, Jennifer; Dietmann, Sabine; Corrin, Philip D.; Paddison, Patrick J.; Smith, Austin			Exit from Pluripotency Is Gated by Intracellular Redistribution of the bHLH Transcription Factor Tfe3	CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE PLURIPOTENCY; HOGG-DUBE-SYNDROME; SELF-RENEWAL; TUMOR-DEVELOPMENT; TSC2 MUTATION; GENE-PRODUCT; DIFFERENTIATION; FOLLICULIN; PROTEIN	Factors that sustain self-renewal of mouse embryonic stem cells (ESCs) are well described. In contrast, the machinery regulating exit from pluripotency is ill defined. In a large-scale small interfering RNA (siRNA) screen, we found that knockdown of the tumor suppressors Folliculin (Flcn) and Tsc2 prevent ESC commitment. Tsc2 lies upstream of mammalian target of rapamycin (mTOR), whereas Flcn acts downstream and in parallel. Flcn with its interaction partners Fnip1 and Fnip2 drives differentiation by restricting nuclear localization and activity of the bHLH transcription factor Tfe3. Conversely, enforced nuclear Tfe3 enables ESCs to withstand differentiation conditions. Genome-wide location and functional analyses showed that Tfe3 directly integrates into the pluripotency circuitry through transcriptional regulation of Esrrb. These findings identify a cell-intrinsic rheostat for destabilizing ground-state pluripotency to allow lineage commitment. Congruently, stage-specific subcellular relocalization of Tfe3 suggests that Flcn-Fnip1/2 contributes to developmental progression of the pluripotent epiblast in vivo.	[Betschinger, Joerg; Nichols, Jennifer; Dietmann, Sabine; Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Betschinger, Joerg; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England; [Corrin, Philip D.; Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA	University of Cambridge; University of Cambridge; University of Cambridge; Fred Hutchinson Cancer Center	Betschinger, J (corresponding author), Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England.	jb579@cam.ac.uk; austin.smith@cscr.cam.ac.uk		Smith, Austin/0000-0002-3029-4682; Nichols, Jennifer/0000-0002-8650-1388; Dietmann, Sabine./0000-0001-6672-8457; Betschinger, Joerg/0000-0002-2627-8479	Medical Research Council; Wellcome Trust; European Commission [242129]; Human Frontier Science Program fellowship [LT00686/2007-L]; Medical Research Council [MC_PC_12009, G1100526] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program fellowship(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Tuzer Kalkan and Graziano Martello for help, advice, and reagents; Raja Kittappa, Martin Leeb, and Harry Leitch for comments; Ravi Nookala for discussion; Ge Guo for providing OEC-2 EpiSCs; and Sandra Gomez-Lopez and Jose Silva for sharing CreERT2, pDONR221-Klf4, and -Nanog plasmids. We are grateful to Laura Schmidt for generously providing Flcn antibodies and mice; Kathryn Lilley, Mike Deery, and Svenja Hesters of the Cambridge Centre for Proteomics for performing and analyzing mass spectrometry; Rachael Walker for flow cytometry; William Mansfield and Charles-Etienne Dumeau for blastocyst injections; Samuel Jameson and team for husbandry; Peter Humphreys for image quantification; Maike Paramor for ChIP-Seq library generation; and Rosalind Drummond and Melanie Rittirsch for technical assistance. This study was funded by the Medical Research Council, Wellcome Trust, and the European Commission FP7 project SyBOSS (242129). J.B. is recipient of a Human Frontier Science Program fellowship (LT00686/2007-L), P.J.P. is a Pew Scholar in Biomedical Sciences, and A. S. is a Medical Research Council Professor. J.B. performed and interpreted experiments, J.N. performed embryo immunohistochemistry and ESC derivations, S. D. performed bioinformatical analysis, and P. D. C. and P. J. P. provided and assisted with the siRNA-screening platform. A. S. supervised the study and wrote the paper with J.B.	Armah HB, 2010, ARCH PATHOL LAB MED, V134, P124, DOI 10.1043/2008-0391-RSR.1; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Baba M, 2012, BLOOD, V120, P1254, DOI 10.1182/blood-2012-02-410407; Brannon M, 1999, DEVELOPMENT, V126, P3159; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hasumi H, 2008, GENE, V415, P60, DOI 10.1016/j.gene.2008.02.022; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hong SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015793; Huan CM, 2006, NAT IMMUNOL, V7, P1082, DOI 10.1038/ni1378; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kobayashi T, 1999, CANCER RES, V59, P1206; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Nichols J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008128; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Park H, 2012, IMMUNITY, V36, P769, DOI 10.1016/j.immuni.2012.02.019; Percharde M, 2012, GENE DEV, V26, P2286, DOI 10.1101/gad.195545.112; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Piao XH, 2009, BIOCHEM BIOPH RES CO, V389, P16, DOI 10.1016/j.bbrc.2009.08.070; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tarleton HP, 2010, MECH DEVELOP, V127, P107, DOI 10.1016/j.mod.2009.10.002; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Westerman BA, 2011, J EXP MED, V208, P2675, DOI 10.1084/jem.20102037; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yang SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003112; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	50	228	233	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 11	2013	153	2					335	347		10.1016/j.cell.2013.03.012	http://dx.doi.org/10.1016/j.cell.2013.03.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	122WR	23582324	Green Published, hybrid			2022-12-24	WOS:000317349700013
J	Li, Q; Zhou, L; Zhou, MH; Chen, ZP; Li, FR; Wu, HY; Xiang, NJ; Chen, EF; Tang, FY; Wang, DY; Meng, L; Hong, ZH; Tu, WX; Cao, Y; Li, LL; Ding, F; Liu, B; Wang, M; Xie, RH; Gao, RB; Li, XD; Bai, T; Zou, SM; He, J; Hu, JY; Xu, YT; Chai, CL; Wang, SW; Gao, YJ; Jin, LM; Zhang, YP; Luo, HM; Yu, HJ; He, JF; Li, Q; Wang, XJ; Gao, LD; Pang, XH; Liu, GH; Yan, YS; Yuan, H; Shu, YL; Yang, WZ; Wang, Y; Wu, F; Uyeki, TM; Feng, ZJ				Li, Qun; Zhou, Lei; Zhou, Minghao; Chen, Zhiping; Li, Furong; Wu, Huanyu; Xiang, Nijuan; Chen, Enfu; Tang, Fenyang; Wang, Dayan; Meng, Ling; Hong, Zhiheng; Tu, Wenxiao; Cao, Yang; Li, Leilei; Ding, Fan; Liu, Bo; Wang, Mei; Xie, Rongheng; Gao, Rongbao; Li, Xiaodan; Bai, Tian; Zou, Shumei; He, Jun; Hu, Jiayu; Xu, Yangting; Chai, Chengliang; Wang, Shiwen; Gao, Yongjun; Jin, Lianmei; Zhang, Yanping; Luo, Huiming; Yu, Hongjie; He, Jianfeng; Li, Qi; Wang, Xianjun; Gao, Lidong; Pang, Xinghuo; Liu, Guohua; Yan, Yansheng; Yuan, Hui; Shu, Yuelong; Yang, Weizhong; Wang, Yu; Wu, Fan; Uyeki, Timothy M.; Feng, Zijian			Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							A H7N9 VIRUS; TO-PERSON TRANSMISSION; RISK-FACTORS; H5N1 VIRUS; HUMAN ILLNESS; FERRETS; SURVEILLANCE; PROVINCE; DISEASE; MARKET	BackgroundThe first identified cases of avian influenza A(H7N9) virus infection in humans occurred in China during February and March 2013. We analyzed data obtained from field investigations to describe the epidemiologic characteristics of H7N9 cases in China identified as of December 1, 2013. MethodsField investigations were conducted for each confirmed case of H7N9 virus infection. A patient was considered to have a confirmed case if the presence of the H7N9 virus was verified by means of real-time reverse-transcriptase-polymerase-chain-reaction assay (RT-PCR), viral isolation, or serologic testing. Information on demographic characteristics, exposure history, and illness timelines was obtained from patients with confirmed cases. Close contacts were monitored for 7 days for symptoms of illness. Throat swabs were obtained from contacts in whom symptoms developed and were tested for the presence of the H7N9 virus by means of real-time RT-PCR. ResultsAmong 139 persons with confirmed H7N9 virus infection, the median age was 61 years (range, 2 to 91), 71% were male, and 73% were urban residents. Confirmed cases occurred in 12 areas of China. Nine persons were poultry workers, and of 131 persons with available data, 82% had a history of exposure to live animals, including chickens (82%). A total of 137 persons (99%) were hospitalized, 125 (90%) had pneumonia or respiratory failure, and 65 of 103 with available data (63%) were admitted to an intensive care unit. A total of 47 persons (34%) died in the hospital after a median duration of illness of 21 days, 88 were discharged from the hospital, and 2 remain hospitalized in critical condition; 2 patients were not admitted to a hospital. In four family clusters, human-to-human transmission of H7N9 virus could not be ruled out. Excluding secondary cases in clusters, 2675 close contacts of case patients completed the monitoring period; respiratory symptoms developed in 28 of them (1%); all tested negative for H7N9 virus. ConclusionsMost persons with confirmed H7N9 virus infection had severe lower respiratory tract illness, were epidemiologically unrelated, and had a history of recent exposure to poultry. However, limited, nonsustained human-to-human H7N9 virus transmission could not be ruled out in four families. The first cases of human infection with the avian influenza A(H7N9) virus were identified in China in early 2013. This report describes findings for 139 persons with confirmed H7N9 virus infection through December 1, 2013. The first identified cases of human infection with a novel influenza A(H7N9) virus occurred in eastern China during February and March 2013 and were characterized by rapidly progressive pneumonia, respiratory failure, the acute respiratory distress syndrome (ARDS), and fatal outcomes.(1) We analyzed available data from field investigations to characterize the descriptive epidemiology of laboratory-confirmed cases of avian influenza A(H7N9) virus infection in humans that were reported to the Chinese Center for Disease Control and Prevention (China CDC) as of December 1, 2013. In this report, we summarize the epidemiologic findings of case investigations and follow-up monitoring of close contacts of ...	[Li, Qun; Zhou, Lei; Xiang, Nijuan; Meng, Ling; Hong, Zhiheng; Tu, Wenxiao; Cao, Yang; Li, Leilei; Ding, Fan; Liu, Bo; Wang, Mei; Gao, Yongjun; Jin, Lianmei; Zhang, Yanping; Feng, Zijian] Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Wang, Dayan; Gao, Rongbao; Li, Xiaodan; Bai, Tian; Zou, Shumei; Wang, Shiwen; Shu, Yuelong] Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Luo, Huiming; Yu, Hongjie; Yang, Weizhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China; [Xie, Rongheng] Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [Pang, Xinghuo] Beijing Municipal Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhou, Minghao; Tang, Fenyang] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Xu, Yangting] Nanjing Prefecture Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Chen, Zhiping; Chen, Enfu; Chai, Chengliang] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Li, Furong; He, Jun] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Wu, Huanyu; Hu, Jiayu; Wu, Fan] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [He, Jianfeng] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Li, Qi] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Peoples R China; [Wang, Xianjun] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Gao, Lidong] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Liu, Guohua] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Yan, Yansheng] Fujian Prov Ctr Dis Control & Prevent, Fuzhou, Peoples R China; [Yuan, Hui] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang, Peoples R China; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Feng, ZJ (corresponding author), Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing 102206, Peoples R China.	fwu@scdc.sh.cn; fengzj@chinacdc.cn	Yu, Hongjie/GZK-5351-2022; He, Jun/P-8974-2019; zhou, minghao/GZA-7244-2022	He, Jun/0000-0002-0463-7063; 	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions [201202006-01]; National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus [KJYJ-2013-01-02]; Jiangsu Province Health Development Project with Science and Education [ZX201109]; Science and Technology Development Plan of Shandong Province [2009GG10002054]	China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions; National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus; Jiangsu Province Health Development Project with Science and Education; Science and Technology Development Plan of Shandong Province	Supported by the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases, a grant (201202006-01) from Research and Promotion of Key Technology on Health Emergency Preparation and Dispositions, a grant (No. KJYJ-2013-01-02) from the National Ministry of Science and Technology Emergency Research Project on human infection with avian influenza H7N9 virus, a grant (No. ZX201109) from Jiangsu Province Health Development Project with Science and Education, and a grant (No. 2009GG10002054) from Science and Technology Development Plan of Shandong Province.	Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; Ai J, 2013, EUROSURVEILLANCE, V18, P4, DOI 10.2807/1560-7917.ES2013.18.26.20510; [Anonymous], WHO CAS DEF HUM INF; [Anonymous], 2010, MMWR RECOMM REP, V59, P1; [Anonymous], 2010, MMWR RECOMM REP, V59, P993; [Anonymous], 2007, EUROSURVEILLANCE, V12; Bai T, 2013, NEW ENGL J MED, V368, P2339, DOI 10.1056/NEJMc1305865; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chang SY, 2013, LANCET, V381, P1621, DOI 10.1016/S0140-6736(13)60943-5; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Huai Y, 2008, EMERG INFECT DIS, V14, P1819, DOI 10.3201/eid1411.080509; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Lv HK, 2013, EMERG INFECT DIS, V19, P1885, DOI 10.3201/eid1911.130717; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; National Health and Family Planning Commission, GUID CAS CLIN INT DI; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010, MMWR RECOMM REP, V59, P1147; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Riel D, 2013, AM J PATHOL, V183, P1137, DOI 10.1016/j.ajpath.2013.06.011; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; WHO/GIP, 2003, CUM NUMB CONF HUM CA; Xiang NJ, 2013, EMERG INFECT DIS, V19, P1784, DOI 10.3201/eid1911.130865; Xu CL, 2013, EMERG INFECT DIS, V19, P1289, DOI 10.3201/eid1908.130662; Xu L, 2013, J INFECT DIS; Xu W, 2013, CLIN INFECT DIS, V57, P919, DOI 10.1093/cid/cit396; Yu H, 2013, LANCET; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu HJ, 2007, EMERG INFECT DIS, V13, P1061, DOI 10.3201/eid1307.061557; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu HJ, 2012, EMERG INFECT DIS, V18, P758, DOI 10.3201/eid1805.110356; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Zhang C, 2013, EURO SURVEILL, V18; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	51	529	592	6	238	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 6	2014	370	6					520	532		10.1056/NEJMoa1304617	http://dx.doi.org/10.1056/NEJMoa1304617			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA4NT	23614499	Green Accepted			2022-12-24	WOS:000331073500008
J	Arinaminpathy, N; Cordier-Lassalle, T; Vijay, A; Dye, C				Arinaminpathy, Nimalan; Cordier-Lassalle, Thierry; Vijay, Anant; Dye, Christopher			The Global Drug Facility and its role in the market for tuberculosis drugs	LANCET			English	Article							TB; PROCUREMENT; FUND; PLAN	Universal access to high-quality treatment is central to the Global Plan to Stop TB. The Global Drug Facility (GDF) was launched in 2001 to help to achieve this goal, through services including the supply of affordable, quality-assured drugs to countries in need. We assess the scale of GDF drug supplies worldwide and find that the GDF commands a substantial proportion of the market for drugs for first-line and second-line treatment regimens, having supplied, for example, first-line drugs for roughly 35% of cases reported worldwide in 2011. Significant potential remains for GDF expansion, especially in the provision of second-line drugs, which would be aided by future increases in case detection.	[Arinaminpathy, Nimalan] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Cordier-Lassalle, Thierry] WHO, Stop TB Global Drug Facil, CH-1211 Geneva, Switzerland; [Vijay, Anant] WHO, Stop TB Partnership Secretariat, CH-1211 Geneva, Switzerland; [Dye, Christopher] WHO, HIV AIDS TB Malaria & Neglected Trop Dis, CH-1211 Geneva, Switzerland	Princeton University; World Health Organization; World Health Organization; World Health Organization	Arinaminpathy, N (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	nimpathy@princeton.edu	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793; Arinaminpathy, Nimalan/0000-0001-9502-6876	Stop TB Partnership; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	Stop TB Partnership; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NA was partly funded for this analysis by the Stop TB Partnership. TC-L is a staff member of the Stop TB Global Drug Facility and WHO. AV has been a member of the Stop TB Partnership. CD is a staff member of WHO. The authors alone are responsible for the views expressed in this publication, which do not necessarily represent the decisions, policy, or views of WHO.	Bate R, 2013, INT J TUBERC LUNG D, V17, P308, DOI 10.5588/ijtld.12.0355; Butler D, 2012, NATURE, V491, P508, DOI 10.1038/491508a; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Global Drug Facility, ANN REP 2010; Global Drug Facility, 2010, QUAL ASS POL PROC; Hanif SNM, 2011, INT J TUBERC LUNG D, V15, P1274, DOI 10.5588/ijtld.11.0394; Kumaresan J, 2004, INT J TUBERC LUNG D, V8, P130; Matiru R, 2007, B WORLD HEALTH ORGAN, V85, P348, DOI 10.2471/BLT.06.035402; Maxmen A, 2012, NATURE, V490, P13, DOI 10.1038/490013a; Norval PY, 1999, INT J TUBERC LUNG D, V3, pS292; Portero JL, 2003, TROP MED INT HEALTH, V8, P329, DOI 10.1046/j.1365-3156.2003.01032.x; Raviglione MC, 2011, EUR RESPIR J, V37, P978, DOI 10.1183/09031936.00003111; Raviglione MC, 2006, INT J TUBERC LUNG D, V10, P238; Sabot O, 2012, LANCET, V379, pE25, DOI 10.1016/S0140-6736(11)61756-X; Stop TB Partnership, DOTS EXP WORK GROUP; Stop TB Partnership, 2001, GLOB PLAN STOP TB PH; Stop TB Partnership, 2011, FALL SHORT ENS ACC S; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; TB Stop partnership, 2011, GLOB PLAN STOP TB 20; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2003, TUBERCULOSIS, V83, P156, DOI 10.1016/S1472-9792(02)00073-2; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; Word Health Organization, GLOB TUB REP 2012; World Health Organization, 1998, GLOB TUB PROGR REP A; World Health Organization, 2006, ENG ALL HLTH CAR PRO; World Health Organization, 2011, SURV QUAL ANT MED CI; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378	29	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1373	1379		10.1016/S0140-6736(13)60896-X	http://dx.doi.org/10.1016/S0140-6736(13)60896-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	23726162				2022-12-24	WOS:000325975700027
J	Ablasser, A; Goldeck, M; Cavlar, T; Deimling, T; Witte, G; Rohl, I; Hopfner, KP; Ludwig, J; Hornung, V				Ablasser, Andrea; Goldeck, Marion; Cavlar, Taner; Deimling, Tobias; Witte, Gregor; Roehl, Ingo; Hopfner, Karl-Peter; Ludwig, Janos; Hornung, Veit			cGAS produces a 2 '-5 '-linked cyclic dinucleotide second messenger that activates STING	NATURE			English	Article							GMP-AMP SYNTHASE; C-DI-GMP; CYTOSOLIC DNA; RECOGNITION; ADAPTER; REVEALS; DISEASE; SIGNALS; BINDING; SENSOR	Detection of cytoplasmic DNA represents one of the most fundamental mechanisms of the innate immune system to sense the presence of microbial pathogens(1). Moreover, erroneous detection of endogenous DNA by the same sensing mechanisms has an important pathophysiological role in certain sterile inflammatory conditions(2,3). The endoplasmic-reticulum-resident protein STING is critically required for the initiation of type I interferon signalling upon detection of cytosolic DNA of both exogenous and endogenous origin(4-8). Next to its pivotal role in DNA sensing, STING also serves as a direct receptor for the detection of cyclic dinucleotides, which function as second messenger molecules in bacteria(9-13). DNA recognition, however, is triggered in an indirect fashion that depends on a recently characterized cytoplasmic nucleotidyl transferase, termed cGAMP synthase (cGAS), which upon interaction with DNA synthesizes a dinucleotide molecule that in turn binds to and activates STING(14,15). We here show in vivo and in vitro that the cGAS-catalysed reaction product is distinct from previously characterized cyclic dinucleotides. Using a combinatorial approach based on mass spectrometry, enzymatic digestion, NMR analysis and chemical synthesis we demonstrate that cGAS produces a cyclic GMP-AMP dinucleotide, which comprises a 2'-5' and a 3'-5' phosphodiester linkage. Gp(2'-5') Ap(3'-5')>. We found that the presence of this 2'-5' linkage was required to exert potent activation of human STING. Moreover, we show that cGAS first catalyses the synthesis of a linear 2'-5'-linked dinucleotide, which is then subject to cGAS-dependent cyclization in a second step through a 3'-5' phosphodiester linkage. This 13-membered ring structure defines a novel class of second messenger molecules, extending the family of 2'-5'-linked antiviral biomolecules.	[Ablasser, Andrea; Goldeck, Marion; Cavlar, Taner; Ludwig, Janos; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Deimling, Tobias; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Deimling, Tobias; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Roehl, Ingo] Axolabs GmbH, D-95326 Kulmbach, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Bonn; University of Munich; University of Munich; University of Munich	Ablasser, A (corresponding author), Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.	andrea.ablasser@uni-bonn.de; veit.hornung@uni-bonn.de	Hopfner, Karl-Peter/B-6864-2014; Witte, Gregor/B-4635-2011; Ludwig, Janos/I-3544-2013; Hornung, Veit/C-3565-2012; Goldeck, Marion/AAX-5599-2020	Hopfner, Karl-Peter/0000-0002-4528-8357; Witte, Gregor/0000-0003-0313-0962; Hornung, Veit/0000-0002-4150-194X; Goldeck, Marion/0000-0003-1899-4763	National Institutes of Health [U19AI083025]; European Research Council [322869, ERC 243046]; Center for Integrated Protein Science Munich (CIPSM); German Research Foundation [SFB670]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Center for Integrated Protein Science Munich (CIPSM); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Pelegrin for providing us with LL171 cells. K.-P. H. is supported by the National Institutes of Health (U19AI083025), the European Research Council Advanced Grant 322869, and the Center for Integrated Protein Science Munich (CIPSM). A. A. and V. H. are members of the excellence cluster ImmunoSensation. V. H. is supported by grants from the German Research Foundation (SFB670) and the European Research Council (ERC 243046).	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gaffney BL, 2010, ORG LETT, V12, P3269, DOI 10.1021/ol101236b; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	24	858	914	14	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					380	+		10.1038/nature12306	http://dx.doi.org/10.1038/nature12306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23722158	Green Accepted			2022-12-24	WOS:000320592900044
J	Yang, HJ; Rudge, DG; Koos, JD; Vaidialingam, B; Yang, HJ; Pavletich, NP				Yang, Haijuan; Rudge, Derek G.; Koos, Joseph D.; Vaidialingam, Bhamini; Yang, Hyo J.; Pavletich, Nikola P.			mTOR kinase structure, mechanism and regulation	NATURE			English	Article							P70 S6 KINASE; MAMMALIAN TARGET; CELL-GROWTH; BINDING PARTNER; RAG GTPASES; RAPAMYCIN; RAPTOR; TOR; RHEB; PATHWAY	The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein kinase, controls cell growth in response to nutrients and growth factors and is frequently deregulated in cancer. Here we report co-crystal structures of a complex of truncated mTOR and mammalian lethal with SEC13 protein 8 (mLST8) with an ATP transition state mimic and with ATP-site inhibitors. The structures reveal an intrinsically active kinase conformation, with catalytic residues and a catalytic mechanism remarkably similar to canonical protein kinases. The active site is highly recessed owing to the FKBP12-rapamycin-binding (FRB) domain and an inhibitory helix protruding from the catalytic cleft. mTOR-activating mutations map to the structural framework that holds these elements in place, indicating that the kinase is controlled by restricted access. In vitro biochemistry shows that the FRB domain acts as a gatekeeper, with its rapamycin-binding site interacting with substrates to grant them access to the restricted active site. Rapamycin-FKBP12 inhibits the kinase by directly blocking substrate recruitment and by further restricting active-site access. The structures also reveal active-site residues and conformational changes that underlie inhibitor potency and specificity.	[Yang, Haijuan; Rudge, Derek G.; Koos, Joseph D.; Vaidialingam, Bhamini; Yang, Hyo J.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pavletin@mskcc.org		Koos, Joseph/0000-0001-9613-7949; Yang, Hyo/0000-0001-5279-3194	Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. King for mass spectroscopic analysis, H. Erdjument-Bromage for N-terminal sequencing, the staff of the Advanced Photon Source ID24 beamlines for help with data collection and D. Tzvetkova-Robev for help with protein expression in HEK293 cells. This work was supported by the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao ZQ, 2011, STRUCTURE, V19, P675, DOI 10.1016/j.str.2011.02.016; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sekulic A, 2000, CANCER RES, V60, P3504; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	53	635	671	6	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					217	+		10.1038/nature12122	http://dx.doi.org/10.1038/nature12122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23636326	Green Accepted			2022-12-24	WOS:000318558200031
J	DeSilva, JM; Holt, KG; Churchill, SE; Carlson, KJ; Walker, CS; Zipfel, B; Berger, LR				DeSilva, Jeremy M.; Holt, Kenneth G.; Churchill, Steven E.; Carlson, Kristian J.; Walker, Christopher S.; Zipfel, Bernhard; Berger, Lee R.			The Lower Limb and Mechanics of Walking in Australopithecus sediba	SCIENCE			English	Article							PATELLOFEMORAL PAIN; FOOT MORPHOLOGY; HOMININ FOOT; GENUS HOMO; AFARENSIS; EVOLUTION; FEMUR; FEET; PROPORTIONS; LOCOMOTION	The discovery of a relatively complete Australopithecus sediba adult female skeleton permits a detailed locomotor analysis in which joint systems can be integrated to form a comprehensive picture of gait kinematics in this late australopith. Here we describe the lower limb anatomy of Au. sediba and hypothesize that this species walked with a fully extended leg and with an inverted foot during the swing phase of bipedal walking. Initial contact of the lateral foot with the ground resulted in a large pronatory torque around the joints of the foot that caused extreme medial weight transfer (hyperpronation) into the toe-off phase of the gait cycle (late pronation). These bipedal mechanics are different from those often reconstructed for other australopiths and suggest that there may have been several forms of bipedalism during the Plio-Pleistocene.	[DeSilva, Jeremy M.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [DeSilva, Jeremy M.; Churchill, Steven E.; Carlson, Kristian J.; Zipfel, Bernhard; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Holt, Kenneth G.] Boston Univ, Dept Phys Therapy & Athlet Training, Sargent Coll, Boston, MA 02215 USA; [Churchill, Steven E.; Walker, Christopher S.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Zipfel, Bernhard] Univ Witwatersrand, Sch Geosci, Bernard Price Inst Palaeontol Res, ZA-2050 Johannesburg, South Africa	Boston University; University of Witwatersrand; Boston University; Duke University; Indiana University System; Indiana University Bloomington; University of Witwatersrand	DeSilva, JM (corresponding author), Boston Univ, Dept Anthropol, 232 Bay State Rd, Boston, MA 02215 USA.	jdesilva@bu.edu	Walker, Christopher/AAY-1966-2021; Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; Walker, Christopher/0000-0002-5173-2784; Zipfel, Bernhard/0000-0002-4251-884X	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation; Evolutionary Studies Institute; University of the Witwatersrand; University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society; Leakey Foundation; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation, Boston University; Duke University; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families	South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation(National Research Foundation - South Africa); Evolutionary Studies Institute; University of the Witwatersrand; University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society(National Geographic Society); Leakey Foundation; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; A. H. Schultz Foundation, Boston University; Duke University; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families	We thank the South African Heritage Resource agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the South African Department of Science and Technology and the African Origins Platform (AOP), the South African National Research Foundation, the Evolutionary Studies Institute, the University of the Witwatersrand, the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Leakey Foundation, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the A. H. Schultz Foundation, Boston University, Duke University, a Ray A. Rothrock '77 Fellowship and International Research Travel Assistance Grant of Texas A&M University, and the Oppenheimer and Ackerman families and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; the Gauteng Government, Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We thank the VIP lab of the Palaeosciences Centre and the Microfocus X-ray CT facility of the Palaeosciences Centre at Wits; and for funding these facilities, we thank the University of the Witwatersrand Office of Research and the National Research Foundation Strategic Research Infrastructure Grant and AOP funding programs. For access to comparative specimens, we thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; A. Kwekason, P. Msemwa, and the Tanzania Commission for Science and Technology; B. Billings, Fossil Primate Access Advisory and the School of Anatomical Sciences at the University of the Witwatersrand; S. Potze, L. C. Kgasi, and the Ditsong Museum; Y. Haile-Selassie, L. Jellema, and the Cleveland Museum of Natural History; J. Chupasko and the Harvard Museum of Comparative Zoology; D. Pilbeam, M. Morgan, O. Herschensohn, J. Rousseau, and the Harvard Museum of Archeology and Ethnology; E. Westwig and the American Museum of Natural History; M. Wolpoff and the Department of Anthropology at the University of Michigan; and O. Lovejoy (Kent State University). For technical and material support, we thank Duke University and the University of Zurich 2009 and 2010 Field Schools. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given significant support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated medical CT scanning of the specimens. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens, by bona fide scientists.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; ASFAW B, 1985, AM J PHYS ANTHROPOL, V68, P535, DOI 10.1002/ajpa.1330680409; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; BENNETT MB, 1990, J ANAT, V171, P131; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; CLARK WEL, 1947, J ANAT, V81, P300; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; DeSilva JM, 2010, AM J PHYS ANTHROPOL, V141, P245, DOI 10.1002/ajpa.21140; Dugan J, 2009, J HUM EVOL, V57, P773, DOI 10.1016/j.jhevol.2009.07.006; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; ENG JJ, 1993, PHYS THER, V73, P62, DOI 10.1093/ptj/73.2.62; GEBO DL, 1992, AM J PHYS ANTHROPOL, V89, P29, DOI 10.1002/ajpa.1330890105; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Gross KD, 2007, ARTHRITIS RHEUM, V56, P2993, DOI 10.1002/art.22850; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HEIPLE KG, 1971, AM J PHYS ANTHROPOL, V35, P75, DOI 10.1002/ajpa.1330350109; Holt K., 1995, REHABILITATION FOOT, P241; Irish JD, 2013, SCIENCE, V340, DOI 10.1126/science.1233062; Khamis S, 2007, GAIT POSTURE, V25, P127, DOI 10.1016/j.gaitpost.2006.02.005; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kirby KA, 2001, J AM PODIAT MED ASSN, V91, P465, DOI 10.7547/87507315-91-9-465; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; LATIMER B, 1990, AM J PHYS ANTHROPOL, V82, P125, DOI 10.1002/ajpa.1330820202; Lovejoy CO, 2007, GAIT POSTURE, V25, P325, DOI 10.1016/j.gaitpost.2006.05.001; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; Michaud T. C., 2005, FUNCTIONAL SOFT TISS, P399; Organ JM, 2006, J HUM EVOL, V51, P113, DOI 10.1016/j.jhevol.2006.01.007; OUZOUNIAN TJ, 1989, FOOT ANKLE, V10, P140, DOI 10.1177/107110078901000305; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; POWERS CM, 1995, J ORTHOP SPORT PHYS, V22, P155, DOI 10.2519/jospt.1995.22.4.155; ROTHBART BA, 1988, J MANIP PHYSIOL THER, V11, P373; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Senut B., 1985, P193; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Tardieu C, 2006, AM J PHYS ANTHROPOL, V130, P491, DOI 10.1002/ajpa.20373; Tardieu C., 1981, PRIMATE EVOLUTIONARY, P68, DOI DOI 10.1016/J.ORTHRES.2003.09.003; Tardieu C, 2010, EVOL ANTHROPOL, V19, P174, DOI 10.1002/evan.20276; TIBERIO D, 1987, Journal of Orthopaedic and Sports Physical Therapy, V9, P160; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; WANNER JA, 1977, AM J PHYS ANTHROPOL, V47, P99, DOI 10.1002/ajpa.1330470117; Ward CV, 2011, SCIENCE, V331, P750, DOI 10.1126/science.1201463; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Wong L, 2008, J AM PODIAT MED ASSN, V98, P112, DOI 10.7547/0980112; Wunderlich R.E., 1999, THESIS STATE U NEW Y; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	51	96	98	1	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1232999	10.1126/science.1232999	http://dx.doi.org/10.1126/science.1232999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580534	Green Published			2022-12-24	WOS:000317341400003
J	Douglas, IJ; Langham, J; Bhaskaran, K; Brauer, R; Smeeth, L				Douglas, Ian J.; Langham, Julia; Bhaskaran, Krishnan; Brauer, Ruth; Smeeth, Liam			Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE	Objective To measure the association between orlistat and acute liver injury. Design Self controlled case series study. Setting Population based primary care setting, United Kingdom. Participants 94 695 patients receiving orlistat and registered in the UK Clinical Practice Research Datalink and linked with Hospital Episode Statistics data between 1999 and 2011. Main outcome measure Relative incidence of acute liver injury comparing periods when patients were receiving orlistat with periods of non-usage. Results Among 94 695 patients who received orlistat, 988 cases of acute liver injury were identified, with 335 confirmed as definite cases and 653 as probable cases. For all cases an increased incidence of liver injury was detected during the 90 day period before orlistat was first started, with an incidence rate ratio of 1.50 (95% confidence interval 1.10 to 2.06). The incidence remained raised during the first 30 days of treatment (2.21, 1.43 to 3.42), before returning to baseline levels with prolonged treatment. When the risk during the first 90 days of treatment was compared with the 90 days preceding first treatment, the incidence of liver injury was not increased (1.02, 0.67 to 1.56). An analysis restricted to definite cases showed no evidence of an increased risk of liver injury during treatment. Conclusion The incidence of acute liver injury was higher in the periods both immediately before and immediately after the start of orlistat treatment. This suggests that the observed increased risks of liver injury linked to the start of treatment may reflect changes in health status associated with the decision to begin treatment rather than any causal effect of the drug.	[Douglas, Ian J.; Langham, Julia; Bhaskaran, Krishnan; Brauer, Ruth; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Douglas, IJ (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	ian.douglas@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Brauer, Ruth/0000-0001-8934-347X; Bhaskaran, Krishnan/0000-0001-5364-8757	Medical Research Council methodology fellowship; National Institute for Health Research postdoctoral fellowship; Wellcome Trust; MRC [G0802403] Funding Source: UKRI; Medical Research Council [MR/K006584/1, G0802403] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish	Medical Research Council methodology fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research postdoctoral fellowship(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available from the corresponding author) and declare: IJD is funded by a Medical Research Council methodology fellowship, KB is funded by a National Institute for Health Research postdoctoral fellowship, and LS is funded by a Wellcome Trust fellowship; IJD holds stock in GlaxoSmithKline and consults for GlaxoSmithKline, Takeda, and Gilead on topics not related to orlistat; LS consults for GlaxoSmithKline on topics not related to orlistat; and no other relationships or activities that could appear to have influenced the submitted work. The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Diehl AM, 2010, GASTROENTEROL CLIN N, V39, P57, DOI 10.1016/j.gtc.2009.12.001; Food and Drug Administration, 2010, QUEST ANS ORL SEV LI; Food and Drug Administration, 2010, DRUG SAF COMM COMPL; Food and Drug Administration, 2009, ORL MARK ALL XEN EAR; Guerciolini R, 1997, INT J OBESITY, V21, pS12; Hospital Episode Statistics, 2012, HOSP EP STAT ONL; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Morris M, 2012, OBESITY FACTS, V5, P485, DOI 10.1159/000341589; Office for National Statistics, 2000, SER MB6, V2, P149; Pratt NL, 2010, DRUG AGING, V27, P885, DOI 10.2165/11584490-000000000-00000; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342	13	39	42	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 12	2013	346								f1936	10.1136/bmj.f1936	http://dx.doi.org/10.1136/bmj.f1936			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126AB	23585064	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000317582400001
J	Ibrahim, MX; Sayin, VI; Akula, MK; Liu, M; Fong, LG; Young, SG; Bergo, MO				Ibrahim, Mohamed X.; Sayin, Volkan I.; Akula, Murali K.; Liu, Meng; Fong, Loren G.; Young, Stephen G.; Bergo, Martin O.			Targeting Isoprenylcysteine Methylation Ameliorates Disease in a Mouse Model of Progeria	SCIENCE			English	Article							HUTCHINSON-GILFORD PROGERIA; PRELAMIN-A; SYNDROME MUTATION; CELL BIOLOGY; MICE; ZMPSTE24; RAS; FIBROBLASTS; DEFICIENCY; PHENOTYPES	Several progeroid disorders, including Hutchinson-Gilford progeria syndrome (HGPS) and restrictive dermopathy (ZMPSTE24 deficiency), arise when a farnesylated and methylated form of prelamin A accumulates at the nuclear envelope. Here, we found that a hypomorphic allele of isoprenylcysteine carboxyl methyltransferase (ICMT) increased body weight, normalized grip strength, and prevented bone fractures and death in Zmpste24-deficient mice. The reduced ICMT activity caused prelamin A mislocalization within the nucleus and triggered prelamin A-dependent activation of AKT-mammalian target of rapamycin (mTOR) signaling, which abolished the premature senescence of Zmpste24-deficient fibroblasts. ICMT inhibition increased AKT-mTOR signaling and proliferation and delayed senescence in human HGPS fibroblasts but did not reduce the levels of misshapen nuclei in mouse and human cells. Thus, targeting ICMT might be useful for treating prelamin A-associated progeroid disorders.	[Ibrahim, Mohamed X.; Sayin, Volkan I.; Akula, Murali K.; Liu, Meng; Bergo, Martin O.] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Canc Ctr, Inst Med,Sahlgrenska Acad, S-41390 Gothenburg, Sweden; [Liu, Meng] Univ Gothenburg, Dept Clin Chem & Transfus Med, Inst Biomed, Sahlgrenska Acad, S-41345 Gothenburg, Sweden; [Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Gothenburg; University of Gothenburg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bergo, MO (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Canc Ctr, Inst Med,Sahlgrenska Acad, S-41390 Gothenburg, Sweden.	martin.bergo@gu.se	Ibrahim, Mohamed x./T-5479-2019	Ibrahim, Mohamed x./0000-0002-7762-1580; Young, Stephen/0000-0001-7270-3176; akula, naga venkata muralikrishna/0000-0002-6418-8300; Liu, Viktor/0000-0003-2865-034X	European Research Council; Swedish Cancer Society; Swedish Research Council; Swedish Children's Cancer Fund; Vastra Gotalandsregionen; Ingabritt and Arne Lundberg's Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, R01HL086683, R01HL089781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children's Cancer Fund; Vastra Gotalandsregionen; Ingabritt and Arne Lundberg's Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Proteomics and Imaging Core Facilities at the Sahlgrenska Academy; M. Dalin, P. Lindahl, and J. Nilsson for comments; C. Karlsson and P. Iranmanesh for technical assistance; and S. Ordway for editing the manuscript. This study was supported by a Starting Investigator Grant from the European Research Council; and by grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Children's Cancer Fund, Vastra Gotalandsregionen, and the Ingabritt and Arne Lundberg's Research Foundation (to M.O.B). Data are available in the supplementary materials.	Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Couzin-Frankel J, 2012, SCIENCE, V337, P1594, DOI 10.1126/science.337.6102.1594; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Gordon LB, 2012, J CELL BIOL, V199, P9, DOI 10.1083/jcb.201207072; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Svensson AW, 2006, METHOD ENZYMOL, V407, P144, DOI 10.1016/S0076-6879(05)07013-8; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, BBA-MOL CELL BIOL L, V1781, P36, DOI 10.1016/j.bbalip.2007.11.003; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	22	79	81	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1330	1333		10.1126/science.1238880	http://dx.doi.org/10.1126/science.1238880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23686339	Green Accepted			2022-12-24	WOS:000320320200045
J	Hepworth, MR; Monticelli, LA; Fung, TC; Ziegler, CGK; Grunberg, S; Sinha, R; Mantegazza, AR; Ma, HL; Crawford, A; Angelosanto, JM; Wherry, EJ; Koni, PA; Bushman, FD; Elson, CO; Eberl, G; Artis, D; Sonnenberg, GF				Hepworth, Matthew R.; Monticelli, Laurel A.; Fung, Thomas C.; Ziegler, Carly G. K.; Grunberg, Stephanie; Sinha, Rohini; Mantegazza, Adriana R.; Ma, Hak-Ling; Crawford, Alison; Angelosanto, Jill M.; Wherry, E. John; Koni, Pandelakis A.; Bushman, Frederic D.; Elson, Charles O.; Eberl, Gerard; Artis, David; Sonnenberg, Gregory F.			Innate lymphoid cells regulate CD4(+) T-cell responses to intestinal commensal bacteria	NATURE			English	Article							TISSUE HOMEOSTASIS; ACTIVATION; IDENTITY; FATE	Innate lymphoid cells (ILCs) are a recently characterized family of immune cells that have critical roles in cytokine-mediated regulation of intestinal epithelial cell barrier integrity(1-10). Alterations in ILC responses are associated with multiple chronic human diseases, including inflammatory bowel disease, implicating a role for ILCs in disease pathogenesis(3,8,11-13). Owing to an inability to target ILCs selectively, experimental studies assessing ILC function have predominantly used mice lacking adaptive immune cells(1-10). However, in lymphocyte-sufficient hosts ILCs are vastly outnumbered by CD4(+) T cells, which express similar profiles of effector cytokines. Therefore, the function of ILCs in the presence of adaptive immunity and their potential to influence adaptive immune cell responses remain unknown. To test this, we used genetic or antibody-mediated depletion strategies to target murine ILCs in the presence of an adaptive immune system. We show that loss of retinoic-acid-receptor-related orphan receptor-gamma t-positive (ROR gamma t(+)) ILCs was associated with dysregulated adaptive immune cell responses against commensal bacteria and low-grade systemic inflammation. Remarkably, ILC-mediated regulation of adaptive immune cells occurred independently of interleukin (IL)-17A, IL-22 or IL-23. Genome-wide transcriptional profiling and functional analyses revealed that ROR gamma t(+) ILCs express major histocompatibility complex class II (MHCII) and can process and present antigen. However, rather than inducing T-cell proliferation, ILCs acted to limit commensal bacteria-specific CD4(+) T-cell responses. Consistent with this, selective deletion of MHCII in murine ROR gamma t(+) ILCs resulted in dysregulated commensal bacteria-dependent CD4(+) T-cell responses that promoted spontaneous intestinal inflammation. These data identify that ILCs maintain intestinal homeostasis through MHCII-dependent interactions with CD4(+) T cells that limit pathological adaptive immune cell responses to commensal bacteria.	[Hepworth, Matthew R.; Fung, Thomas C.; Sonnenberg, Gregory F.] Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Hepworth, Matthew R.; Monticelli, Laurel A.; Fung, Thomas C.; Crawford, Alison; Angelosanto, Jill M.; Wherry, E. John; Artis, David; Sonnenberg, Gregory F.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Monticelli, Laurel A.; Fung, Thomas C.; Grunberg, Stephanie; Sinha, Rohini; Crawford, Alison; Angelosanto, Jill M.; Wherry, E. John; Bushman, Frederic D.; Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Ziegler, Carly G. K.] Mem Sloan Kettering Canc Ctr, ImmunoDynam Grp, Program Computat Biol, New York, NY 10065 USA; [Ziegler, Carly G. K.] Mem Sloan Kettering Canc Ctr, ImmunoDynam Grp, Program Immunol, New York, NY 10065 USA; [Mantegazza, Adriana R.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mantegazza, Adriana R.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Ma, Hak-Ling] Pfizer Worldwide R&D, Biotherapeut Res & Dev, Inflammat & Immunol Res Unit, Cambridge, MA 02140 USA; [Koni, Pandelakis A.] Georgia Hlth Sci Univ, Ctr Canc, Canc Immunol Inflammat & Tolerance Program, Augusta, GA 30912 USA; [Elson, Charles O.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France; [Eberl, Gerard] CNRS, URA 1961, F-75724 Paris, France; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pfizer; University System of Georgia; Augusta University; University of Alabama System; University of Alabama Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Pennsylvania	Sonnenberg, GF (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA.	gfield@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; crawford, alison/AAS-3155-2020; Eberl, Gerard/A-1160-2013; Crawford, Alison/N-3234-2014	Ziegler, Carly/0000-0002-8279-7150; Koni, Pandelakis/0000-0002-0892-4764; Hepworth, Matthew/0000-0002-9613-7858; Bushman, Frederic/0000-0003-4740-4056; Mantegazza, Adriana/0000-0002-7583-0231; Eberl, Gerard/0000-0002-1119-5638; Crawford, Alison/0000-0002-4591-6341; Artis, David/0000-0002-1753-4100	National Institutes of Health [AI061570, AI087990, AI074878, AI095776, AI102942, AI095466, AI095608, AI097333, T32-AI055428, DK071176, DP5OD012116]; Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund; NCI Comprehensive Cancer Center [2-P30 CA016520]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095776, R01AI061570, R01AI097333, R21AI087990, R21AI083480, U01AI095608, R01AI102942, R01AI074878, T32AI055428, R01AI095466, T32AI007532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, P01DK071176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NCI Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Sonnenberg and Artis laboratories for discussions and critical reading of the manuscript. We also thank H. L. Ma, L. A. Fouser, S. Olland, R. Zollner, K. Lam and A. Root at Pfizer for critical discussions, valuable advice and the preparation of IL-22 antibodies; M. M. Elloso at Janssen Research and Development for critical discussions, valuable advice and the preparation of IL-17 and IL-23 antibodies; and M. S. Marks for providing the E-alpha protein and Y-Ae antibody. The research is supported by the National Institutes of Health (AI061570, AI087990, AI074878, AI095776, AI102942, AI095466, AI095608 and AI097333 to D. A.; T32-AI055428 to L. A. M.; DK071176 to C.O.E.; and DP5OD012116 to G. F. S.), the Crohn's and Colitis Foundation of America (to D. A.) and the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (to D. A.). We also thank the Matthew J. Ryan Veterinary Hospital Pathology Lab, the National Institute of Diabetes and Digestive and Kidney Disease Center for the Molecular Studies in Digestive and Liver Disease Molecular Pathology and Imaging Core (P30DK50306), the Penn Microarray Facility and the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory (partially supported by NCI Comprehensive Cancer Center Support Grant (2-P30 CA016520)) for technical advice and support. Human tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Ciccia F, 2012, ARTHRITIS RHEUM-US, V64, P1869, DOI 10.1002/art.34355; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	32	491	516	2	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					113	+		10.1038/nature12240	http://dx.doi.org/10.1038/nature12240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23698371	Green Accepted			2022-12-24	WOS:000319947800044
J	Daniel, R; Rubens, JR; Sarpeshkar, R; Lu, TK				Daniel, Ramiz; Rubens, Jacob R.; Sarpeshkar, Rahul; Lu, Timothy K.			Synthetic analog computation in living cells	NATURE			English	Article							BIOLOGY; CIRCUIT; NETWORK; MOTIFS	A central goal of synthetic biology is to achieve multi-signal integration and processing in living cells for diagnostic, therapeutic and biotechnology applications(1). Digital logic has been used to build small-scale circuits, but other frameworks may be needed for efficient computation in the resource-limited environments of cells(2,3). Here we demonstrate that synthetic analog gene circuits can be engineered to execute sophisticated computational functions in living cells using just three transcription factors. Such synthetic analog gene circuits exploit feedback to implement logarithmically linear sensing, addition, ratiometric and power-law computations. The circuits exhibit Weber's law behaviour as in natural biological systems(4), operate over a wide dynamic range of up to four orders of magnitude and can be designed to have tunable transfer functions. Our circuits can be composed to implement higher-order functions that are well described by both intricate biochemical models and simple mathematical functions. By exploiting analog building-block functions that are already naturally present in cells(3,5), this approach efficiently implements arithmetic operations and complex functions in the logarithmic domain. Such circuits may lead to new applications for synthetic biology and biotechnology that require complex computations with limited parts, need wide-dynamic-range biosensing or would benefit from the fine control of gene expression.	[Daniel, Ramiz; Sarpeshkar, Rahul] MIT, Elect Res Lab, Analog Circuits & Biol Syst Grp, Cambridge, MA 02139 USA; [Daniel, Ramiz; Rubens, Jacob R.; Lu, Timothy K.] MIT, Elect Res Lab, Synthet Biol Grp, Cambridge, MA 02139 USA; [Daniel, Ramiz; Rubens, Jacob R.; Sarpeshkar, Rahul; Lu, Timothy K.] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Rubens, Jacob R.; Sarpeshkar, Rahul; Lu, Timothy K.] MIT, MIT Microbiol Program, Cambridge, MA 02139 USA; [Sarpeshkar, Rahul; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Sarpeshkar, Rahul; Lu, Timothy K.] MIT, MIT Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Sarpeshkar, Rahul] MIT, MIT Biophys Program, Cambridge, MA 02139 USA; [Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sarpeshkar, R (corresponding author), MIT, Elect Res Lab, Analog Circuits & Biol Syst Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rahuls@mit.edu; timlu@mit.edu		Lu, Timothy/0000-0002-3918-8923; /0000-0003-1304-0151	campus collaboration initiative from Lincoln Labs; US National Science Foundation [1124247]; Office of Naval Research [N000141110725]; Direct For Computer & Info Scie & Enginr [1124247] Funding Source: National Science Foundation	campus collaboration initiative from Lincoln Labs; US National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We would like to thank J. Nungesser for assistance with figures and members of the Lu and Sarpeshkar laboratories for discussions. This work was supported in part by a campus collaboration initiative from Lincoln Labs (R.D. and R.S.), the US National Science Foundation (R.D., J.R.R., R.S. and T.K.L.) under grant number 1124247, and the Office of Naval Research (J.R.R. and T.K.L.) under grant number N000141110725.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chen YY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-240; Clark B, 2006, CURR BIOL, V16, pR585, DOI 10.1016/j.cub.2006.07.007; Daniel R, 2011, BIOMED CIRC SYST C, P333, DOI 10.1109/BioCAS.2011.6107795; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2009, MOL CELL, V36, P724, DOI 10.1016/j.molcel.2009.11.032; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Madar D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-111; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Sarpeshkar R., 2010, ULTRALOW POWER BIOEL, P753; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tavakoli M, 2005, IEEE J SOLID-ST CIRC, V40, P536, DOI 10.1109/JSSC.2004.841015; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	270	293	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					619	+		10.1038/nature12148	http://dx.doi.org/10.1038/nature12148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23676681				2022-12-24	WOS:000319556100044
J	Moore, JD; Deschenes, M; Furuta, T; Huber, D; Smear, MC; Demers, M; Kleinfeld, D				Moore, Jeffrey D.; Deschenes, Martin; Furuta, Takahiro; Huber, Daniel; Smear, Matthew C.; Demers, Maxime; Kleinfeld, David			Hierarchy of orofacial rhythms revealed through whisking and breathing	NATURE			English	Article							VIBRISSA MOVEMENT; MOTOR CORTEX; MOTONEURONS; NEURONS; RAT; MODULATION; INGESTION; PATTERNS; MEDULLA; NUCLEUS	Whisking and sniffing are predominant aspects of exploratory behaviour in rodents. Yet the neural mechanisms that generate and coordinate these and other orofacial motor patterns remain largely uncharacterized. Here we use anatomical, behavioural, electrophysiological and pharmacological tools to show that whisking and sniffing are coordinated by respiratory centres in the ventral medulla. We delineate a distinct region in the ventral medulla that provides rhythmic input to the facial motor neurons that drive protraction of the vibrissae. Neuronal output from this region is reset at each inspiration by direct input from the pre-Botzinger complex, such that high-frequency sniffing has a one-to-one relationship with whisking, whereas basal respiration is accompanied by intervening whisks that occur between breaths. We conjecture that the respiratory nuclei, which project to other premotor regions for oral and facial control, function as a master clock for behaviours that coordinate with breathing.	[Moore, Jeffrey D.; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Deschenes, Martin; Demers, Maxime] Ctr Rech Univ Laval Robert Giffard, Dept Psychiat & Neurosci, Quebec City, PQ G1J 2G3, Canada; [Furuta, Takahiro] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Sakyo Ku, Kyoto 6068501, Japan; [Huber, Daniel; Smear, Matthew C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Laval University; Kyoto University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Deschenes, M (corresponding author), Ctr Rech Univ Laval Robert Giffard, Dept Psychiat & Neurosci, 2601 Canardiere, Quebec City, PQ G1J 2G3, Canada.	martin.deschenes@crulrg.ulaval.ca; dk@physics.ucsd.edu	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679	Canadian Institutes of Health Research [MT-5877]; Howard Hughes Medical Institute; Japan Society for the Promotion of Science (KAKENHI) [23135519, 24500409]; National Institutes of Health [NS058668, NS066664, NS047101]; US-Israeli Binational Science Foundation [2003222]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058668, F31NS066664, P30NS047101] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israeli Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kepecs and F. Wang for sharing unpublished work, and these colleagues as well as M. S. Fee, J. L. Feldman, H. J. Karten, P. M. Knutsen, D. W. Matthews and K. Svoboda for discussions. We also thank K. Svoboda for sponsorship of the mouse experiments, M. Agrochao and B. el Jundi for assistance with these experiments, T. Ito and D. L. Oliver for use of their GlyT2 probe, K. K. Baldwin for the gift of the Sindbis viral vector and K. Yang for assistance with behavioural training. We are grateful to the Canadian Institutes of Health Research (grant MT-5877), the Howard Hughes Medical Institute, the Japan Society for the Promotion of Science (KAKENHI grants 23135519 and 24500409), the National Institutes of Health (grants NS058668, NS066664 and NS047101) and the US-Israeli Binational Science Foundation (grant 2003222).	Alheid GF, 2008, RESP PHYSIOL NEUROBI, V164, P3, DOI 10.1016/j.resp.2008.07.014; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; BIEGER D, 1987, J COMP NEUROL, V262, P546, DOI 10.1002/cne.902620408; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Brecht M, 2012, CURR OPIN NEUROBIOL, V22, P259, DOI 10.1016/j.conb.2011.12.003; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chen ZX, 2001, AM J PHYSIOL-REG I, V280, pR1085, DOI 10.1152/ajpregu.2001.280.4.R1085; Depuy SD, 2011, J NEUROSCI, V31, P1981, DOI 10.1523/JNEUROSCI.4639-10.2011; Deschenes M, 2003, J NEUROSCI, V23, P6778; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; Doi A, 2008, RESP PHYSIOL NEUROBI, V164, P96, DOI 10.1016/j.resp.2008.06.007; DORFL J, 1982, J ANAT, V135, P147; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; FUKUDA Y, 1982, JPN J PHYSIOL, V32, P387; Furuta T, 2008, J NEUROSCI, V28, P1789, DOI 10.1523/JNEUROSCI.4627-07.2008; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Garcia AJ, 2011, PROG BRAIN RES, V188, P31, DOI 10.1016/B978-0-444-53825-3.00008-5; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; Haidarliu S, 2012, ANAT REC, V295, P1181, DOI 10.1002/ar.22501; Harish O, 2010, J NEUROPHYSIOL, V103, P2684, DOI 10.1152/jn.01016.2009; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; HUANGFU D, 1993, NEUROSCI LETT, V151, P224, DOI 10.1016/0304-3940(93)90025-G; ISOKAWAAKESSON M, 1987, EXP BRAIN RES, V65, P385; Ito T, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00135; KLEIN BG, 1985, J COMP NEUROL, V232, P55, DOI 10.1002/cne.902320106; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; LAWSON EE, 1991, J APPL PHYSIOL, V70, P2742, DOI 10.1152/jappl.1991.70.6.2742; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Onimaru H, 2006, J NEUROPHYSIOL, V96, P55, DOI 10.1152/jn.01175.2005; Ono T, 1998, J NEUROPHYSIOL, V80, P48, DOI 10.1152/jn.1998.80.1.48; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Saito Y, 2003, BRAIN DEV-JPN, V25, P338, DOI 10.1016/S0387-7604(03)00008-1; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; SHERREY JH, 1977, ELECTROEN CLIN NEURO, V43, P218, DOI 10.1016/0013-4694(77)90129-8; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Takatoh J, 2013, NEURON, V77, P346, DOI 10.1016/j.neuron.2012.11.010; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Travers JB, 2000, EXP BRAIN RES, V130, P78, DOI 10.1007/s002219900223; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VANDERMAELEN CP, 1980, NATURE, V287, P346, DOI 10.1038/287346a0; Vincent S. B., 1912, BEHAV MONOGR, V1, P7; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WELZL H, 1977, PHYSIOL BEHAV, V18, P751, DOI 10.1016/0031-9384(77)90079-8	57	182	183	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					205	+		10.1038/nature12076	http://dx.doi.org/10.1038/nature12076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23624373	Green Accepted			2022-12-24	WOS:000318558200029
J	Ma, KY; Chirarattananon, P; Fuller, SB; Wood, RJ				Ma, Kevin Y.; Chirarattananon, Pakpong; Fuller, Sawyer B.; Wood, Robert J.			Controlled Flight of a Biologically Inspired, Insect-Scale Robot	SCIENCE			English	Article							MICRO-AIR VEHICLES; DROSOPHILA-MELANOGASTER; WING ROTATION; AERODYNAMICS; STABILITY; MANEUVERS; MECHANICS; DIPTERA; SYSTEMS; SPEED	Flies are among the most agile flying creatures on Earth. To mimic this aerial prowess in a similarly sized robot requires tiny, high-efficiency mechanical components that pose miniaturization challenges governed by force-scaling laws, suggesting unconventional solutions for propulsion, actuation, and manufacturing. To this end, we developed high-power-density piezoelectric flight muscles and a manufacturing methodology capable of rapidly prototyping articulated, flexure-based sub-millimeter mechanisms. We built an 80-milligram, insect-scale, flapping-wing robot modeled loosely on the morphology of flies. Using a modular approach to flight control that relies on limited information about the robot's dynamics, we demonstrated tethered but unconstrained stable hovering and basic controlled flight maneuvers. The result validates a sufficient suite of innovations for achieving artificial, insect-like flight.	[Ma, Kevin Y.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Ma, KY (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	kevinma@seas.harvard.edu	Chirarattananon, Pakpong/N-3910-2016	Chirarattananon, Pakpong/0000-0003-0142-8394	National Science Foundation [CCF-0926148]; Office of Naval Research [N00014-08-1-0919]; Wyss Institute for Biologically Inspired Engineering	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Wyss Institute for Biologically Inspired Engineering	This material is based on work supported by the National Science Foundation under grant CCF-0926148, the Office of Naval Research under grant N00014-08-1-0919, and the Wyss Institute for Biologically Inspired Engineering. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Abzug MJ., 2005, AIRPLANE STABILITY C, V2nd ed, P121; Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Cheng B, 2011, J EXP BIOL, V214, P4092, DOI 10.1242/jeb.062760; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Dudley R, 2002, BIOMECHANICS INSECT; Ellington CP, 1999, J EXP BIOL, V202, P3439; ENNOS AR, 1989, J EXP BIOL, V142, P49; ENNOS AR, 1988, J EXP BIOL, V140, P161; Finio BM, 2011, IEEE INT C INT ROBOT, P1107, DOI 10.1109/IROS.2011.6048067; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Hoburg W., 2009, P AIAA INF AER C AIA; Karpelson M, 2008, IEEE INT CONF ROBOT, P779, DOI 10.1109/ROBOT.2008.4543300; Ma KY, 2012, IEEE INT C INT ROBOT, P1133, DOI 10.1109/IROS.2012.6386192; Oppenheimer M W, 2010, P 48 AIAA AER SCI M; Orlowski CT, 2012, PROG AEROSP SCI, V51, P18, DOI 10.1016/j.paerosci.2012.01.001; Ristroph L, 2010, P NATL ACAD SCI USA, V107, P4820, DOI 10.1073/pnas.1000615107; Taylor GK, 2001, BIOL REV, V76, P449, DOI 10.1017/S1464793101005759; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; TRIMMER WSN, 1989, SENSOR ACTUATOR, V19, P267, DOI 10.1016/0250-6874(89)87079-9; Whitney JP, 2010, J FLUID MECH, V660, P197, DOI 10.1017/S002211201000265X; Wood RJ, 2012, INT J ROBOT RES, V31, P1292, DOI 10.1177/0278364912455073; Wood RJ, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885509; Wood RJ, 2005, SENSOR ACTUAT A-PHYS, V119, P476, DOI 10.1016/j.sna.2004.10.024; Wood RJ, 2008, IEEE T ROBOT, V24, P341, DOI 10.1109/TRO.2008.916997; ZANKER JM, 1988, PHYSIOL ENTOMOL, V13, P351, DOI 10.1111/j.1365-3032.1988.tb00485.x	29	641	668	72	894	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					603	607		10.1126/science.1231806	http://dx.doi.org/10.1126/science.1231806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641114				2022-12-24	WOS:000318268900046
J	de Roode, JC; Lefevre, T; Hunter, MD				de Roode, Jacobus C.; Lefevre, Thierry; Hunter, Mark D.			Self-Medication in Animals	SCIENCE			English	Editorial Material							TOXINS; RESIN		[de Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Lefevre, Thierry] Inst Rech Dev, Malad Infect & Vecteurs Ecol Genet Evolut Control, F-34394 Montpellier, France; [Hunter, Mark D.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Emory University; Institut de Recherche pour le Developpement (IRD); University of Michigan System; University of Michigan	de Roode, JC (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	jderood@emory.edu	Lefèvre, Thierry/E-2157-2011	Lefèvre, Thierry/0000-0002-9736-6142; Hunter, Mark/0000-0003-3761-8237				Castella G, 2008, ANIM BEHAV, V75, P1591, DOI 10.1016/j.anbehav.2007.10.014; de Roode JC, 2011, J EVOLUTION BIOL, V24, P712, DOI 10.1111/j.1420-9101.2010.02213.x; FOSTER MA, 1992, J ANIM ECOL, V61, P509, DOI 10.2307/5606; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Huffman MA, 2003, P NUTR SOC, V62, P371, DOI 10.1079/PNS2003257; Janzen D.H., 1978, P73; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Lefevre T, 2010, ECOL LETT, V13, P1485, DOI 10.1111/j.1461-0248.2010.01537.x; Lozano GA, 1998, ADV STUD BEHAV, V27, P291; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Raubenheimer D, 2009, INTEGR COMP BIOL, V49, P329, DOI 10.1093/icb/icp050; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Suarez-Rodriguez M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0931	15	151	153	5	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					150	151		10.1126/science.1235824	http://dx.doi.org/10.1126/science.1235824			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580516				2022-12-24	WOS:000317341400040
J	Li, WB; Notani, D; Ma, Q; Tanasa, B; Nunez, E; Chen, AY; Merkurjev, D; Zhang, J; Ohgi, K; Song, XY; Oh, S; Kim, HS; Glass, CK; Rosenfeld, MG				Li, Wenbo; Notani, Dimple; Ma, Qi; Tanasa, Bogdan; Nunez, Esperanza; Chen, Aaron Yun; Merkurjev, Daria; Zhang, Jie; Ohgi, Kenneth; Song, Xiaoyuan; Oh, Soohwan; Kim, Hong-Sook; Glass, Christopher K.; Rosenfeld, Michael G.			Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation	NATURE			English	Article							LONG NONCODING RNA; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; CHROMATIN; PRINCIPLES; ALPHA; INSIGHTS; MEDIATOR	The functional importance of gene enhancers in regulated gene expression is well established(1-3). In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells(4-6), bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs)(7-9). However, it has remained unclear whether these eRNAs are functional or merely a reflection of enhancer activation. Here we report that in human breast cancer cells 17 beta-oestradiol (E2)-bound oestrogen receptor alpha (ER-alpha) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes. These induced eRNAs, as functional transcripts, seem to exert important roles for the observed ligand-dependent induction of target coding genes, increasing the strength of specific enhancer-promoter looping initiated by ER-alpha binding. Cohesin, present on many ER-alpha-regulated enhancers even before ligand treatment, apparently contributes to E2-dependent gene activation, at least in part by stabilizing E2/ER-alpha/eRNA-induced enhancer-promoter looping. Our data indicate that eRNAs are likely to have important functions in many regulated programs of gene transcription.	[Li, Wenbo; Notani, Dimple; Ma, Qi; Tanasa, Bogdan; Nunez, Esperanza; Chen, Aaron Yun; Merkurjev, Daria; Zhang, Jie; Ohgi, Kenneth; Song, Xiaoyuan; Oh, Soohwan; Kim, Hong-Sook; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Ma, Qi; Merkurjev, Daria] Univ Calif San Diego, Grad Program Bioinformat, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, Grad Program, La Jolla, CA 92037 USA; [Oh, Soohwan] Univ Calif San Diego, Grad Program Biol Sci, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Ma, Qi/C-9716-2015; li, wenbo/GZM-8930-2022; Glass, Christopher/AAI-3933-2021; , songxy/P-1094-2014	Glass, Christopher/0000-0003-4344-3592; , songxy/0000-0002-9011-5033; Notani, Dimple/0000-0002-9460-8070; Ma, Qi/0000-0002-8705-4460	UCSD Cancer Center [P30 CA23100]; Department of Defense (DoD) [BC110381, BC103858]; DoD;  [DK 039949];  [DK018477];  [NS034934];  [HL065445];  [CA173903]; NATIONAL CANCER INSTITUTE [T32CA009523, P30CA023100, R01CA173903, R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039949, R01DK039949, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	UCSD Cancer Center; Department of Defense (DoD)(United States Department of Defense); DoD(United States Department of Defense); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Hutt for help with statistical analyses; M. Ghassemian from the University of California, San Diego (UCSD) Biomolecular/Proteomics Mass Spectrometry Facility for assistance with mass spectrometry; C. Nelson for cell culture assistance; J. Hightower for assistance with figure and manuscript preparation. We thank H. Chang for providing the BoxB, lambda N-GAL4 constructs. We acknowledge the UCSD Cancer Center Specialized Support Grant P30 CA23100 for confocal microscopy. W. L. and D.N. are supported by Department of Defense (DoD) postdoctoral fellowships, BC110381 and BC103858, respectively. M. G. R. is an investigator with the Howard Hughes Medical Institute. This work was supported by grants DK 039949, DK018477, NS034934, HL065445, CA173903 to C. K. G., and from the DoD.	Abukhdeir AM, 2006, BREAST CANCER RES TR, V99, P23, DOI 10.1007/s10549-006-9177-0; Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Newman JJ, 2010, COLD SH Q B, V75, P227, DOI 10.1101/sqb.2010.75.016; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Rueden CT, 2007, BIOTECHNIQUES, V43, P31, DOI 10.2144/000112511; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Servant N, 2012, BIOINFORMATICS, V28, P2843, DOI 10.1093/bioinformatics/bts521; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; White AK, 2011, P NATL ACAD SCI USA, V108, P13999, DOI 10.1073/pnas.1019446108; Zhong JF, 2008, LAB CHIP, V8, P68, DOI 10.1039/b712116d	40	652	670	4	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					516	+		10.1038/nature12210	http://dx.doi.org/10.1038/nature12210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728302	Green Accepted			2022-12-24	WOS:000320929400059
J	Rivkin, E; Almeida, SM; Ceccarelli, DF; Juang, YC; MacLean, TA; Srikumar, T; Huang, H; Dunham, WH; Fukumura, R; Xie, G; Gondo, Y; Raught, B; Gingras, AC; Sicheri, F; Cordes, SP				Rivkin, Elena; Almeida, Stephanie M.; Ceccarelli, Derek F.; Juang, Yu-Chi; MacLean, Teresa A.; Srikumar, Tharan; Huang, Hao; Dunham, Wade H.; Fukumura, Ryutaro; Xie, Gang; Gondo, Yoichi; Raught, Brian; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.			The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis	NATURE			English	Article							KAPPA-B ACTIVATION; DU-CHAT-SYNDROME; POLYUBIQUITIN CHAINS; SIGNALING PATHWAY; MOUSE; INFLAMMATION; DERMATITIS; MUTATIONS; SHARPIN; COMPLEX	A complex interaction of signalling events, including the Wnt pathway, regulates sprouting of blood vessels from pre-existing vasculature during angiogenesis. Here we show that two distinct mutations in the (uro) chordate-specific gumby (also called Fam105b) gene cause an embryonic angiogenic phenotype in gumby mice. Gumby interacts with disheveled 2 (DVL2), is expressed in canonical Wnt-responsive endothelial cells and encodes an ovarian tumour domain class of deubiquitinase that specifically cleaves linear ubiquitin linkages. A crystal structure of gumby in complex with linear diubiquitin reveals how the identified mutations adversely affect substrate binding and catalytic function in line with the severity of their angiogenic phenotypes. Gumby interacts with HOIP (also called RNF31), a key component of the linear ubiquitin assemblycomplex, and decreases linear ubiquitination and activation of NF-kappa B-dependent transcription. This work provides support for the biological importance of linear (de) ubiquitination in angiogenesis, craniofacial and neural development and in modulating Wnt signalling.	[Rivkin, Elena; Almeida, Stephanie M.; Ceccarelli, Derek F.; Juang, Yu-Chi; MacLean, Teresa A.; Huang, Hao; Dunham, Wade H.; Xie, Gang; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Rivkin, Elena; Almeida, Stephanie M.; MacLean, Teresa A.; Dunham, Wade H.; Gingras, Anne-Claude; Sicheri, Frank; Cordes, Sabine P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Srikumar, Tharan; Raught, Brian] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Srikumar, Tharan; Raught, Brian] Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Fukumura, Ryutaro; Gondo, Yoichi] RIKEN BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki 3050074, Japan	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; RIKEN	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@lunenfeld.ca; cordes@lunenfeld.ca	Sicheri, Frank/F-8856-2013; Srikumar, Tharan/Q-5642-2016; Gingras, Anne-Claude/ABA-8341-2020; Gondo, Yoichi/A-5375-2016; Cordes, Sabine P/A-5423-2012; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Gondo, Yoichi/0000-0003-2184-6489; Gingras, Anne-Claude/0000-0002-6090-4437; Ceccarelli, Derek/0000-0002-2674-9234	JSPS KAKENHI [15200032, 21240043]; Canadian Institutes for Health Research [MOP119289, MOP123433, MOP57795, MOP 97966, IHO 94384, MOP 111199]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We thank T. Saunders and the Michigan University Transgenic Core facility for generating gumby BAC transgenic mice; K. Iwai for HOIL and HOIP constructs; K. Nakajima for NF-kappa B and AP2 reporter constructs; B. Alman and C. C. Hui for TOPGAL reporter mice; J. Woodgett for TOPFLASH, FOPFLASH and PRL vectors; T. Pawson for WNT3A expressing L-cells; M. Barrios-Ramos for help with fluorometry; J. Culotti and C. C. Hui for critical feedback; and I. Kourinov and staff at NE-CAT for collecting diffraction data set. B. R. holds the Canada research chair in proteomics and molecular medicine. A.-C. G. holds the Canada research chair in Functional Proteomics. F. S. holds the Canada research chair in Structural Principles of Signal Transduction. S. M. A. and T. S. were supported by CIHR predoctoral student fellowships. This work was supported by operating funds from the JSPS KAKENHI (grant numbers 15200032 to Y.G. and 21240043 to Y.G. and R. F.), and Canadian Institutes for Health Research to B. R. (MOP119289), A.-C. G. (MOP123433), F. S. (MOP57795) and S. P. C. (MOP 97966, IHO 94384 and MOP 111199).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; AMBULOS NP, 1987, GENE, V51, P281, DOI 10.1016/0378-1119(87)90317-9; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Cirone P, 2008, ANGIOGENESIS, V11, P347, DOI 10.1007/s10456-008-9116-2; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dunham WH, 2011, PROTEOMICS, V11, P2603, DOI 10.1002/pmic.201000571; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; HOGENESCH H, 1993, AM J PATHOL, V143, P972; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kean MJ, 2012, METHODS, V57, P400, DOI 10.1016/j.ymeth.2012.06.002; Kim FA, 2005, MECH DEVELOP, V122, P1300, DOI 10.1016/j.mod.2005.08.001; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mainardi PC, 2006, EUR J MED GENET, V49, P363, DOI 10.1016/j.ejmg.2005.12.004; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; Mar L, 2005, J NEUROSCI, V25, P11787, DOI 10.1523/JNEUROSCI.3813-05.2005; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsumoto ML, 2012, J MOL BIOL, V418, P134, DOI 10.1016/j.jmb.2011.12.053; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762	49	193	206	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 20	2013	498	7454					318	+		10.1038/nature12296	http://dx.doi.org/10.1038/nature12296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23708998	Green Accepted			2022-12-24	WOS:000320592900031
J	Zaidi, S; Choi, M; Wakimoto, H; Ma, LJ; Jiang, JM; Overton, JD; Romano-Adesman, A; Bjornson, RD; Breitbart, RE; Brown, KK; Carriero, NJ; Cheung, YH; Deanfield, J; DePalma, S; Fakhro, KA; Glessner, J; Hakonarson, H; Italia, MJ; Kaltman, JR; Kaski, J; Kim, R; Kline, JK; Lee, T; Leipzig, J; Lopez, A; Mane, SM; Mitchell, LE; Newburger, JW; Parfenov, M; Pe'er, I; Porter, G; Roberts, AE; Sachidanandam, R; Sanders, SJ; Seiden, HS; State, MW; Subramanian, S; Tikhonova, IR; Wang, W; Warburton, D; White, PS; Williams, IA; Zhao, HY; Seidman, JG; Brueckner, M; Chung, WK; Gelb, BD; Goldmuntz, E; Seidman, CE; Lifton, RP				Zaidi, Samir; Choi, Murim; Wakimoto, Hiroko; Ma, Lijiang; Jiang, Jianming; Overton, John D.; Romano-Adesman, Angela; Bjornson, Robert D.; Breitbart, Roger E.; Brown, Kerry K.; Carriero, Nicholas J.; Cheung, Yee Him; Deanfield, John; DePalma, Steve; Fakhro, Khalid A.; Glessner, Joseph; Hakonarson, Hakon; Italia, Michael J.; Kaltman, Jonathan R.; Kaski, Juan; Kim, Richard; Kline, Jennie K.; Lee, Teresa; Leipzig, Jeremy; Lopez, Alexander; Mane, Shrikant M.; Mitchell, Laura E.; Newburger, Jane W.; Parfenov, Michael; Pe'er, Itsik; Porter, George; Roberts, Amy E.; Sachidanandam, Ravi; Sanders, Stephan J.; Seiden, Howard S.; State, Mathew W.; Subramanian, Sailakshmi; Tikhonova, Irina R.; Wang, Wei; Warburton, Dorothy; White, Peter S.; Williams, Ismee A.; Zhao, Hongyu; Seidman, Jonathan G.; Brueckner, Martina; Chung, Wendy K.; Gelb, Bruce D.; Goldmuntz, Elizabeth; Seidman, Christine E.; Lifton, Richard P.			De novo mutations in histone-modifying genes in congenital heart disease	NATURE			English	Article							COPY-NUMBER VARIANTS; AUTISM SPECTRUM; FAMILY; RISK	Congenital heart disease (CHD) is the most frequent birth defect, affecting 0.8% of live births(1). Many cases occur sporadically and impair reproductive fitness, suggesting a role for de novo mutations. Here we compare the incidence of de novo mutations in 362 severe CHD cases and 264 controls by analysing exome sequencing of parent-offspring trios. CHD cases show a significant excess of protein-altering de novo mutations in genes expressed in the developing heart, with an odds ratio of 7.5 for damaging (premature termination, frameshift, splice site) mutations. Similar odds ratios are seen across the main classes of severe CHD. We find a marked excess of de novo mutations in genes involved in the production, removal or reading of histone 3 lysine 4 (H3K4) methylation, or ubiquitination of H2BK120, which is required for H3K4 methylation(2-4). There are also two de novo mutations in SMAD2, which regulates H3K27 methylation in the embryonic left-right organizer(5). The combination of both activating (H3K4 methylation) and inactivating (H3K27 methylation) chromatin marks characterizes 'poised' promoters and enhancers, which regulate expression of key developmental genes(6). These findings implicate de novo point mutations in several hundreds of genes that collectively contribute to approximately 10% of severe CHD.	[Zaidi, Samir; Choi, Murim; Overton, John D.; Fakhro, Khalid A.; Lopez, Alexander; Mane, Shrikant M.; Sanders, Stephan J.; State, Mathew W.; Tikhonova, Irina R.; Zhao, Hongyu; Brueckner, Martina; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06504 USA; [Zaidi, Samir; Choi, Murim; Fakhro, Khalid A.; Lifton, Richard P.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Wakimoto, Hiroko; Jiang, Jianming; Brown, Kerry K.; DePalma, Steve; Parfenov, Michael; Seidman, Jonathan G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ma, Lijiang; Lee, Teresa; Warburton, Dorothy; Williams, Ismee A.; Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Jiang, Jianming; Seidman, Christine E.] Harvard Univ, Howard Hughes Med Inst, Boston, MA 02115 USA; [Overton, John D.; Lopez, Alexander; Mane, Shrikant M.; Tikhonova, Irina R.; Lifton, Richard P.] Yale Ctr Mendelian Genom, New Haven, CT 06510 USA; [Overton, John D.; Bjornson, Robert D.; Carriero, Nicholas J.; Lopez, Alexander; Mane, Shrikant M.; Tikhonova, Irina R.; Lifton, Richard P.] Yale Univ, Yale Ctr Genome Anal, New Haven, CT 06511 USA; [Romano-Adesman, Angela] Steven & Alexandra Cohen Childrens Med Ctr New Yo, New Hyde Pk, NY 11040 USA; [Bjornson, Robert D.; Carriero, Nicholas J.] Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA; [Breitbart, Roger E.; Newburger, Jane W.; Roberts, Amy E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Cheung, Yee Him] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA; [Deanfield, John; Kaski, Juan] Great Ormond St Hosp Sick Children, Univ Coll London, Dept Cardiol, London WC1N 3JH, England; [Glessner, Joseph; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; White, Peter S.; Goldmuntz, Elizabeth] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Italia, Michael J.; Leipzig, Jeremy; Wang, Wei; White, Peter S.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Kaltman, Jonathan R.] NHLBI, NIH, Bethesda, MD 20892 USA; [Kim, Richard] Univ So Calif, Keck Sch Med, Sect Cardiothorac Surg, Los Angeles, CA 90089 USA; [Kline, Jennie K.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Mitchell, Laura E.] Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10032 USA; [Porter, George] Univ Rochester, Sch Med & Dent, Med Ctr, Dept Pediat, Rochester, NY 14611 USA; [Sachidanandam, Ravi; Subramanian, Sailakshmi; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Sanders, Stephan J.; State, Mathew W.] Yale Univ, Dept Psychiat, Ctr Child Study, Program Neurogenet, New Haven, CT 06510 USA; [Seiden, Howard S.; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Wang, Wei] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Warburton, Dorothy] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA; [Brueckner, Martina] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Goldmuntz, Elizabeth] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA; [Seidman, Christine E.] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Harvard University; Harvard Medical School; Columbia University; Harvard University; Howard Hughes Medical Institute; Yale University; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Yale University; Harvard University; Boston Children's Hospital; Columbia University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Southern California; Columbia University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Columbia University; University of Rochester; Icahn School of Medicine at Mount Sinai; Yale University; Icahn School of Medicine at Mount Sinai; New Jersey Institute of Technology; Columbia University; Yale University; Yale University; Columbia University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Brigham & Women's Hospital; Yale University	Brueckner, M (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06504 USA.	martina.brueckner@yale.edu; wkc15@cumc.columbia.edu; bruce.gelb@mssm.edu; goldmuntz@email.chop.edu; csediman@genetics.med.harvard.edu; richard.lifton@yale.edu	Wang, Guilin/G-8794-2018; sachidanandam, ravi/Q-6916-2019; State, Matthew/W-2256-2019; Choi, Murim/AAP-9120-2021; Sanders, Stephan/S-8645-2019; Kaski, Juan Pablo/AAX-8649-2020; George A, Porter/E-7315-2013; jiang, jianming/B-3421-2012	sachidanandam, ravi/0000-0001-9844-4459; Kaski, Juan Pablo/0000-0002-0014-9927; George A, Porter/0000-0003-0726-9988; jiang, jianming/0000-0003-3251-2716; DePalma, Steven/0000-0002-0381-5016; State, Matthew/0000-0003-1624-8302; Deanfield, John/0000-0001-8806-6052; Sanders, Stephan/0000-0001-9112-5148; Glessner, Joseph/0000-0001-5131-2811; Italia, Michael/0000-0002-6941-6181; Choi, Murim/0000-0002-9195-1455; Subramanian, Sai Lakshmi/0000-0003-1384-0722; Leipzig, Jeremy/0000-0001-7224-9620	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Cardiac Genomics Consortium [U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162]; Simons Foundation for Autism Research; NIH Centers for Mendelian Genomics [5U54HG006504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL123238, U01HL098163, U01HL098123, U01HL098147, U01HL098162, U01HL098188, U01HL098153] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006546, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Cardiac Genomics Consortium; Simons Foundation for Autism Research; NIH Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to the patients and families who participated in this research. We thank the following team members for contributions to patient recruitment: D. Awad, K. Celia, D. Etwaru, R. Korsin, A. Lanz, E. Marquez, J. K. Sond, A. Wilpers, R. Yee (Columbia Medical School); K. Boardman, J. Geva, J. Gorham, B. McDonough, A. Monafo, J. Stryker (Harvard Medical School); N. Cross (Yale School of Medicine); S. M. Edman, J. L. Garbarini, J. E. Tusi, S. H. Woyciechowski (Children's Hospital of Philadelphia); J. Ellashek and N. Tran (Children's Hospital of Los Angeles); K. Flack (University College London); D. Gruber, N. Stellato (Steve and Alexandra Cohen Children's Medical Center of New York); D. Guevara, A. Julian, M. Mac Neal, C. Mintz (Icahn School of Medicine at Mount Sinai); and E. Taillie (University of Rochester School of Medicine and Dentistry). We also thank V. Spotlow, P. Candrea, K. Pavlik and M. Sotiropoulos for their expert production of exome sequences. We thank B. Bernstein and R. Ryan (Massachusetts General Hospital) and B. Bruneau (Gladstone Institute and University of California, San Francisco) for discussions. This work was supported by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Cardiac Genomics Consortium (U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162) and in part by the Simons Foundation for Autism Research and the NIH Centers for Mendelian Genomics (5U54HG006504).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Gendron RL, 2000, DEV DYNAM, V218, P300, DOI 10.1002/(SICI)1097-0177(200006)218:2<300::AID-DVDY5>3.0.CO;2-K; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vorstman JAS, 2013, SCHIZOPHR RES, V143, P55, DOI 10.1016/j.schres.2012.10.010; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035	30	589	601	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					220	+		10.1038/nature12141	http://dx.doi.org/10.1038/nature12141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23665959	Green Accepted, Green Submitted			2022-12-24	WOS:000320283400046
J	Ley, TJ; Miller, C; Ding, L; Raphael, BJ; Mungall, AJ; Robertson, AG; Hoadley, K; Triche, TJ; Laird, PW; Baty, JD; Fulton, LL; Fulton, R; Heath, SE; Kalicki-Veizer, J; Kandoth, C; Klco, JM; Koboldt, DC; Kanchi, KL; Kulkarni, S; Lamprecht, TL; Larson, DE; Lin, L; Lu, C; McLellan, MD; McMichael, JF; Payton, J; Schmidt, H; Spencer, DH; Tomasson, MH; Wallis, JW; Wartman, LD; Watson, MA; Welch, J; Wendl, MC; Ally, A; Balasundaram, M; Birol, I; Butterfield, Y; Chiu, R; Chu, A; Chuah, E; Chun, HJ; Corbett, R; Dhalla, N; Guin, R; He, A; Hirst, C; Hirst, M; Holt, RA; Jones, S; Karsan, A; Lee, D; Li, HI; Marra, MA; Mayo, M; Moore, RA; Mungall, K; Parker, J; Pleasance, E; Plettner, P; Schein, J; Stoll, D; Swanson, L; Tam, A; Thiessen, N; Varhol, R; Wye, N; Zhao, YJ; Gabriel, S; Getz, G; Sougnez, C; Zou, LH; Leiserson, MDM; Vandin, F; Wu, HT; Applebaum, F; Baylin, SB; Akbani, R; Broom, BM; Chen, K; Motter, TC; Nguyen, K; Weinstein, JN; Zhang, NZ; Ferguson, ML; Adams, C; Black, A; Bowen, J; Gastier-Foster, J; Grossman, T; Lichten-Berg, T; Wise, L; Davidsen, T; Demchok, JA; Shaw, KRM; Sheth, M; Sofia, HJ; Yang, LM; Downing, JR; Eley, G; Alonso, S; Ayala, B; Baboud, J; Backus, M; Barletta, SP; Berton, DL; Chu, AL; Girshik, S; Jensen, MA; Kahn, A; Kothiyal, P; Nicholls, MC; Pihl, TD; Pot, DA; Raman, R; Sanbhadti, RN; Snyder, EE; Srinivasan, D; Walton, JS; Wan, YH; Wang, ZN; Issa, JPJ; Le Beau, M; Carroll, M; Kantarjian, H; Kornblau, S; Bootwalla, MS; Lai, PH; Shen, H; Van den Berg, DJ; Weisenberger, DJ; Link, DC; Walter, MJ; Ozenberger, BA; Mardis, ER; Westervelt, P; Graubert, TA; DiPersio, JF; Wilson, RK				Ley, Timothy J.; Miller, Christopher; Ding, Li; Raphael, Benjamin J.; Mungall, Andrew J.; Robertson, A. Gordon; Hoadley, Katherine; Triche, Timothy J., Jr.; Laird, Peter W.; Baty, Jack D.; Fulton, Lucinda L.; Fulton, Robert; Heath, Sharon E.; Kalicki-Veizer, Joelle; Kandoth, Cyriac; Klco, Jeffery M.; Koboldt, Daniel C.; Kanchi, Krishna-Latha; Kulkarni, Shashikant; Lamprecht, Tamara L.; Larson, David E.; Lin, Ling; Lu, Charles; McLellan, Michael D.; McMichael, Joshua F.; Payton, Jacqueline; Schmidt, Heather; Spencer, David H.; Tomasson, Michael H.; Wallis, John W.; Wartman, Lukas D.; Watson, Mark A.; Welch, John; Wendl, Michael C.; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron; Chiu, Readman; Chu, Andy; Chuah, Eric; Chun, Hye-Jung; Corbett, Richard; Dhalla, Noreen; Guin, Ranabir; He, An; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Jones, Steven; Karsan, Aly; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Karen; Parker, Jeremy; Pleasance, Erin; Plettner, Patrick; Schein, Jacquie; Stoll, Dominik; Swanson, Lucas; Tam, Angela; Thiessen, Nina; Varhol, Richard; Wye, Natasja; Zhao, Yongjun; Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Zou, Lihua; Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta; Applebaum, Frederick; Baylin, Stephen B.; Akbani, Rehan; Broom, Bradley M.; Chen, Ken; Motter, Thomas C.; Nguyen, Khanh; Weinstein, John N.; Zhang, Nianziang; Ferguson, Martin L.; Adams, Christopher; Black, Aaron; Bowen, Jay; Gastier-Foster, Julie; Grossman, Thomas; Lichten-Berg, Tara; Wise, Lisa; Davidsen, Tanja; Demchok, John A.; Shaw, Kenna R. Mills; Sheth, Margi; Sofia, Heidi J.; Yang, Liming; Downing, James R.; Eley, Greg; Alonso, Shelley; Ayala, Brenda; Baboud, Julien; Backus, Mark; Barletta, Sean P.; Berton, Dominique L.; Chu, Anna L.; Girshik, Stanley; Jensen, Mark A.; Kahn, Ari; Kothiyal, Prachi; Nicholls, Matthew C.; Pihl, Todd D.; Pot, David A.; Raman, Rohini; Sanbhadti, Rashmi N.; Snyder, Eric E.; Srinivasan, Deepak; Walton, Jes-Sica; Wan, Yunhu; Wang, Zhining; Issa, Jean-Pierre J.; Le Beau, Michelle; Carroll, Martin; Kantarjian, Hagop; Kornblau, Steven; Bootwalla, Moiz S.; Lai, Phillip H.; Shen, Hui; Van den Berg, David J.; Weisenberger, Daniel J.; Link, Daniel C.; Walter, Matthew J.; Ozenberger, Bradley A.; Mardis, Elaine R.; Westervelt, Peter; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.		Canc Genome Atlas Res Network	Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPY NUMBER ALTERATIONS; EXPRESSION PROFILES; MONOSOMAL KARYOTYPE; MICRORNA EXPRESSION; MUTATIONS; CANCER; GENE; HYPERMETHYLATION; TRANSCRIPTION; EVOLUTION	BACKGROUND Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are undefined. The relationships between patterns of mutations and epigenetic phenotypes are not yet clear. METHODS We analyzed the genomes of 200 clinically annotated adult cases of de novo AML, using either whole-genome sequencing (50 cases) or whole-exome sequencing (150 cases), along with RNA and microRNA sequencing and DNA-methylation analysis. RESULTS AML genomes have fewer mutations than most other adult cancers, with an average of only 13 mutations found in genes. Of these, an average of 5 are in genes that are recurrently mutated in AML. A total of 23 genes were significantly mutated, and another 237 were mutated in two or more samples. Nearly all samples had at least 1 nonsynonymous mutation in one of nine categories of genes that are almost certainly relevant for pathogenesis, including transcription-factor fusions (18% of cases), the gene encoding nucleophosmin (NPM1) (27%), tumor-suppressor genes (16%), DNA-methylation-related genes (44%), signaling genes (59%), chromatin-modifying genes (30%), myeloid transcription-factor genes (22%), cohesin-complex genes (13%), and spliceosome-complex genes (14%). Patterns of cooperation and mutual exclusivity suggested strong biologic relationships among several of the genes and categories. CONCLUSIONS We identified at least one potential driver mutation in nearly all AML samples and found that a complex interplay of genetic events contributes to AML pathogenesis in individual patients. The databases from this study are widely available to serve as a foundation for further investigations of AML pathogenesis, classification, and risk stratification.	[Ley, Timothy J.; Miller, Christopher; Ding, Li; Fulton, Lucinda L.; Fulton, Robert; Kalicki-Veizer, Joelle; Kandoth, Cyriac; Koboldt, Daniel C.; Kanchi, Krishna-Latha; Larson, David E.; Lin, Ling; Lu, Charles; McLellan, Michael D.; McMichael, Joshua F.; Schmidt, Heather; Wallis, John W.; Wendl, Michael C.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63110 USA; [Ley, Timothy J.; Tomasson, Michael H.; Link, Daniel C.; Walter, Matthew J.; Westervelt, Peter; Graubert, Timothy A.; DiPersio, John F.] Siteman Canc Ctr, St Louis, MO USA; [Raphael, Benjamin J.; Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta] Brown Univ, Providence, RI 02912 USA; [Raphael, Benjamin J.; Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta] Ctr Computat Mol Biol, Providence, RI USA; [Mungall, Andrew J.; Robertson, A. Gordon; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron; Chiu, Readman; Chu, Andy; Chuah, Eric; Chun, Hye-Jung; Corbett, Richard; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Jones, Steven; Karsan, Aly; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Karen; Parker, Jeremy; Pleasance, Erin; Plettner, Patrick; Schein, Jacquie; Stoll, Dominik; Swanson, Lucas; Tam, Angela; Thiessen, Nina; Varhol, Richard; Wye, Natasja; Zhao, Yongjun] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Hoadley, Katherine] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Triche, Timothy J., Jr.; Laird, Peter W.; Bootwalla, Moiz S.; Lai, Phillip H.; Shen, Hui; Van den Berg, David J.; Weisenberger, Daniel J.] Univ So Calif, Epigenome Ctr, Los Angeles, CA USA; [Baty, Jack D.; Heath, Sharon E.; Klco, Jeffery M.; Kulkarni, Shashikant; Lamprecht, Tamara L.; Payton, Jacqueline; Spencer, David H.; Tomasson, Michael H.; Wartman, Lukas D.; Watson, Mark A.; Welch, John; Link, Daniel C.; Walter, Matthew J.; Westervelt, Peter; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, St Louis, MO 63110 USA; [Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Zou, Lihua] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Applebaum, Frederick] Fred Hutchinson Canc Res Ctr, Div Med Oncol, Seattle Canc Care Alliance, Seattle, WA 98104 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Baltimore, MD USA; [Akbani, Rehan; Broom, Bradley M.; Chen, Ken; Motter, Thomas C.; Nguyen, Khanh; Weinstein, John N.; Zhang, Nianziang; Kantarjian, Hagop; Kornblau, Steven] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ferguson, Martin L.] MLF Consulting, Boston, MA USA; [Adams, Christopher; Black, Aaron; Bowen, Jay; Gastier-Foster, Julie; Grossman, Thomas; Lichten-Berg, Tara; Wise, Lisa] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Davidsen, Tanja; Demchok, John A.; Shaw, Kenna R. Mills; Sheth, Margi; Yang, Liming] NCI, Bethesda, MD 20892 USA; [Sofia, Heidi J.; Ozenberger, Bradley A.] NHGRI, Bethesda, MD 20892 USA; [Downing, James R.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Eley, Greg] Sciementis LLC, Statham, GA USA; [Alonso, Shelley; Ayala, Brenda; Baboud, Julien; Backus, Mark; Barletta, Sean P.; Berton, Dominique L.; Chu, Anna L.; Girshik, Stanley; Jensen, Mark A.; Kahn, Ari; Kothiyal, Prachi; Nicholls, Matthew C.; Pihl, Todd D.; Pot, David A.; Raman, Rohini; Sanbhadti, Rashmi N.; Snyder, Eric E.; Srinivasan, Deepak; Walton, Jes-Sica; Wan, Yunhu; Wang, Zhining] SRA Int, Fairfax, VA USA; [Issa, Jean-Pierre J.] Temple Univ, Philadelphia, PA 19122 USA; [Le Beau, Michelle] Univ Chicago, Chicago, IL 60637 USA; [Carroll, Martin] Univ Penn, Philadelphia, PA 19104 USA	Washington University (WUSTL); Siteman Cancer Center; Brown University; British Columbia Cancer Agency; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); St Jude Children's Research Hospital; SRA International; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Chicago; University of Pennsylvania	Ley, TJ (corresponding author), Washington Univ, Sch Med, Div Oncol, Stem Cell Biol Sect, Campus Box 8007,660 S Euclid Ave, St Louis, MO 63110 USA.	timley@wustl.edu	Walter, Matthew J/S-7758-2018; Birol, Inanc/G-5440-2011; Karsan, Aly/K-2067-2015; Shen, Hui/AAO-4387-2020; Weisenberger, Daniel/AAA-8314-2020; Wilson, Richard K./AAF-4139-2019; Hirst, Martin/B-7684-2016; Mungall, Andrew J./U-7067-2018; Mardis, Elaine/W-2202-2019; Downing, James R./N-8102-2018; Akbani, Rehan/AAG-1490-2019; Marra, Marco A/B-5987-2008; Laird, Peter W/G-8683-2012; Schein, Jacquie E/G-3674-2015; Klco, Jeffery/M-9717-2018; Jones, Steven J/C-3621-2009; Miller, Christopher A./A-1060-2009; Holt, Robert A/C-3303-2009; Van Den Berg, David J/G-8598-2017; Chen, Ken/AAU-1432-2021	Birol, Inanc/0000-0003-0950-7839; Weisenberger, Daniel/0000-0001-8303-2603; Wilson, Richard K./0000-0002-1992-1358; Mungall, Andrew J./0000-0002-0905-2742; Marra, Marco A/0000-0001-7146-7175; Laird, Peter W/0000-0001-9117-3641; Klco, Jeffery/0000-0003-2961-6960; Jones, Steven J/0000-0003-3394-2208; Miller, Christopher A./0000-0003-4266-6700; Holt, Robert A/0000-0002-7259-1247; Van Den Berg, David J/0000-0002-5404-5218; Chen, Ken/0000-0003-4013-5279; Shen, Hui/0000-0001-9767-4084; Parker, Jeremy/0000-0001-8319-5891; Kandoth, Cyriac/0000-0002-1345-3573; Issa, Jean-Pierre/0000-0003-2258-5030; Triche, Tim/0000-0001-5665-946X; MCLELLAN, MICHAEL/0000-0002-2703-8784; Weinstein, John/0000-0001-9401-6908; Tomasson, Michael/0000-0003-4518-7123; Pot, David/0000-0002-1480-9826; Graubert, Timothy/0000-0002-7710-1171; Hoadley, Katherine/0000-0002-1216-477X; Bowen, Jay/0000-0001-6861-9043; Stoll, Dominik/0000-0003-0701-4301; Larson, David/0000-0001-7934-5906; Westover, Tamara/0000-0002-1000-6698; Jensen, Mark/0000-0001-5215-101X	National Institutes of Health [U24CA143845, U24CA143858, U24CA144025, U24CA143882, U24CA143866, U24CA143867, U24CA143848, U24CA143840, U24CA143835, U24CA143799, U24CA143883, U24CA143843, U54HG003067, U54HG003079, U54HG003273, P01CA101937]; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA083962, P30CA016672, U24CA143835, U24CA143840, U24CA143882, U24CA143858, U24CA143845, U24CA143848, U24CA143883, R01CA162086, U24CA143799, U24CA144025, U24CA143866, U24CA143843, U24CA143867, P01CA101937] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG003067, R01HG005690, U54HG003273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Institutes of Health (U24CA143845, U24CA143858, U24CA144025, U24CA143882, U24CA143866, U24CA143867, U24CA143848, U24CA143840, U24CA143835, U24CA143799, U24CA143883, U24CA143843, U54HG003067, U54HG003079, U54HG003273, and P01CA101937).; Funded by the National Institutes of Health.	Bacher U, 2010, CURR OPIN ONCOL, V22, P646, DOI 10.1097/CCO.0b013e32833ed806; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Breems DA, 2008, J CLIN ONCOL, V26, P4791, DOI 10.1200/JCO.2008.16.0259; Bryant A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-8; Bullinger L, 2010, LEUKEMIA, V24, P438, DOI 10.1038/leu.2009.263; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Faraoni I, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-26; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Ju XL, 2009, PEDIATR HEMAT ONCOL, V26, P1, DOI 10.1080/08880010802378338; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lv M, 2012, LEUKEMIA, V26, P769, DOI 10.1038/leu.2011.273; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; Ovcharenko D, 2011, EXP HEMATOL, V39, P1030, DOI 10.1016/j.exphem.2011.07.008; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rowley JD, 2008, BLOOD, V112, P2183, DOI 10.1182/blood-2008-04-097931; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Suela J, 2007, CYTOGENET GENOME RES, V118, P304, DOI 10.1159/000108314; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Valleron W, 2012, LEUKEMIA, V26, P2052, DOI 10.1038/leu.2012.111; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117	49	3128	3186	20	380	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2059	2074		10.1056/NEJMoa1301689	http://dx.doi.org/10.1056/NEJMoa1301689			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23634996	Green Accepted, Green Published			2022-12-24	WOS:000319574200004
J	Nystedt, B; Street, NR; Wetterbom, A; Zuccolo, A; Lin, YC; Scofield, DG; Vezzi, F; Delhomme, N; Giacomello, S; Alexeyenko, A; Vicedomini, R; Sahlin, K; Sherwood, E; Elfstrand, M; Gramzow, L; Holmberg, K; Hallman, J; Keech, O; Klasson, L; Koriabine, M; Kucukoglu, M; Kaller, M; Luthman, J; Lysholm, F; Niittyla, T; Olson, A; Rilakovic, N; Ritland, C; Rossello, JA; Sena, J; Svensson, T; Talavera-Lopez, C; Theissen, G; Tuominen, H; Vanneste, K; Wu, ZQ; Zhang, B; Zerbe, P; Arvestad, L; Bhalerao, R; Bohlmann, J; Bousquet, J; Gil, RG; Hvidsten, TR; de Jong, P; MacKay, J; Morgante, M; Ritland, K; Sundberg, B; Thompson, SL; Van de Peer, Y; Andersson, B; Nilsson, O; Ingvarsson, PK; Lundeberg, J; Jansson, S				Nystedt, Bjorn; Street, Nathaniel R.; Wetterbom, Anna; Zuccolo, Andrea; Lin, Yao-Cheng; Scofield, Douglas G.; Vezzi, Francesco; Delhomme, Nicolas; Giacomello, Stefania; Alexeyenko, Andrey; Vicedomini, Riccardo; Sahlin, Kristoffer; Sherwood, Ellen; Elfstrand, Malin; Gramzow, Lydia; Holmberg, Kristina; Hallman, Jimmie; Keech, Olivier; Klasson, Lisa; Koriabine, Maxim; Kucukoglu, Melis; Kaller, Max; Luthman, Johannes; Lysholm, Fredrik; Niittyla, Totte; Olson, Ake; Rilakovic, Nemanja; Ritland, Carol; Rossello, Josep A.; Sena, Juliana; Svensson, Thomas; Talavera-Lopez, Carlos; Theissen, Guenter; Tuominen, Hannele; Vanneste, Kevin; Wu, Zhi-Qiang; Zhang, Bo; Zerbe, Philipp; Arvestad, Lars; Bhalerao, Rishikesh; Bohlmann, Joerg; Bousquet, Jean; Gil, Rosario Garcia; Hvidsten, Torgeir R.; de Jong, Pieter; MacKay, John; Morgante, Michele; Ritland, Kermit; Sundberg, Bjorn; Thompson, Stacey Lee; Van de Peer, Yves; Andersson, Bjorn; Nilsson, Ove; Ingvarsson, Par K.; Lundeberg, Joakim; Jansson, Stefan			The Norway spruce genome sequence and conifer genome evolution	NATURE			English	Article							LONG NONCODING RNAS; TRANSPOSABLE ELEMENTS; SIZE VARIATION; GENE FAMILY; RECOMBINATION; PLANTS; AMPLIFICATION; POLYPLOIDY; COMPLEXITY; SLOW	Conifers have dominated forests for more than 200 million years and are of huge ecological and economic importance. Here we present the draft assembly of the 20-gigabase genome of Norway spruce (Picea abies), the first available for any gymnosperm. The number of well-supported genes (28,354) is similar to the >100 times smaller genome of Arabidopsis thaliana, and there is no evidence of a recent whole-genome duplication in the gymnosperm lineage. Instead, the large genome size seems to result from the slow and steady accumulation of a diverse set of long-terminal repeat transposable elements, possibly owing to the lack of an efficient elimination mechanism. Comparative sequencing of Pinus sylvestris, Abies sibirica, Juniperus communis, Taxus baccata and Gnetum gnemon reveals that the transposable element diversity is shared among extant conifers. Expression of 24-nucleotide small RNAs, previously implicated in transposable element silencing, is tissue-specific and much lower than in other plants. We further identify numerous long (>10,000 base pairs) introns, gene-like fragments, uncharacterized long non-coding RNAs and short RNAs. This opens up new genomic avenues for conifer forestry and breeding.	[Nystedt, Bjorn; Sherwood, Ellen] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-17121 Solna, Sweden; [Street, Nathaniel R.; Scofield, Douglas G.; Delhomme, Nicolas; Keech, Olivier; Tuominen, Hannele; Zhang, Bo; Hvidsten, Torgeir R.; Jansson, Stefan] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Wetterbom, Anna; Luthman, Johannes; Lysholm, Fredrik; Talavera-Lopez, Carlos; Andersson, Bjorn] Karolinska Inst, Sci Life Lab, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Zuccolo, Andrea; Giacomello, Stefania; Vicedomini, Riccardo; Morgante, Michele] Ist Genom Applicata, I-33100 Udine, Italy; [Zuccolo, Andrea] Scuola Super Sant Anna, Inst Life Sci, I-56127 Pisa, Italy; [Lin, Yao-Cheng; Vanneste, Kevin; Van de Peer, Yves] Univ Ghent, Dept Plant Syst Biol VIB, B-9052 Ghent, Belgium; [Lin, Yao-Cheng; Vanneste, Kevin; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Scofield, Douglas G.; Wu, Zhi-Qiang; Thompson, Stacey Lee; Ingvarsson, Par K.] Umea Univ, Dept Ecol & Environm Sci, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Vezzi, Francesco; Sahlin, Kristoffer; Arvestad, Lars] KTH Royal Inst Technol, Sch Comp Sci & Commun, Sci Life Lab, S-17121 Solna, Sweden; [Giacomello, Stefania; Vicedomini, Riccardo; Morgante, Michele] Univ Udine, I-33100 Udine, Italy; [Alexeyenko, Andrey; Holmberg, Kristina; Hallman, Jimmie; Kaller, Max; Rilakovic, Nemanja; Lundeberg, Joakim] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, S-17121 Solna, Sweden; [Elfstrand, Malin; Olson, Ake] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Forest Mycol & Plant Pathol, S-75007 Uppsala, Sweden; [Gramzow, Lydia; Theissen, Guenter] Univ Jena, Dept Genet, D-07743 Jena, Germany; [Klasson, Lisa] Uppsala Univ, Dept Cell & Mol Biol, S-75237 Uppsala, Sweden; [Koriabine, Maxim; de Jong, Pieter] Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; [Kucukoglu, Melis; Niittyla, Totte; Bhalerao, Rishikesh; Gil, Rosario Garcia; Sundberg, Bjorn; Nilsson, Ove] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Ritland, Carol; Bohlmann, Joerg; Ritland, Kermit] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Rossello, Josep A.] Univ Valencia, Jardi Bot, Valencia 46008, Spain; [Rossello, Josep A.] Carl Faust Fdn, Marimurtra Bot Garden, Blanes 17300, Spain; [Sena, Juliana; Bousquet, Jean; MacKay, John] Univ Laval, Canada Res Chair Forest & Environm Genom, Ctr Forest Res, Quebec City, PQ G1V 0A6, Canada; [Sena, Juliana; Bousquet, Jean; MacKay, John] Univ Laval, Inst Syst & Integrat Biol, Quebec City, PQ G1V 0A6, Canada; [Svensson, Thomas] Karolinska Inst, Sci Life Lab, Dept Biosci & Nutr, S-17121 Solna, Sweden; [Zerbe, Philipp; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Arvestad, Lars] Stockholm Univ, Swedish E Sci Res Ctr, Dept Numer Anal & Comp Sci, S-17121 Solna, Sweden; [Hvidsten, Torgeir R.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Stockholm University; Umea University; Karolinska Institutet; Scuola Superiore Sant'Anna; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Umea University; Royal Institute of Technology; University of Udine; Royal Institute of Technology; Swedish University of Agricultural Sciences; Friedrich Schiller University of Jena; Uppsala University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Swedish University of Agricultural Sciences; Umea University; University of British Columbia; University of Valencia; Laval University; Laval University; Karolinska Institutet; University of British Columbia; Stockholm University; Norwegian University of Life Sciences	Nilsson, O (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden.	ove.nilsson@slu.se; par.ingvarsson@emg.umu.se; joakim.lundeberg@scilifelab.se; stefan.jansson@umu.se	Tuominen, Hannele/E-7263-2013; Van de Peer, Yves/AAE-7666-2019; Zuccolo, Andrea/H-5636-2019; Sahlin, Kristoffer/H-4683-2019; Alexeyenko, Andrey/F-1924-2016; Jansson, Stefan/A-1119-2009; MacKay, John/M-6978-2014; Tuominen, Hannele/D-9563-2014; Ingvarsson, Pär/G-2748-2010; Hvidsten, Torgeir R./A-3409-2009; , wuzhiqiang/C-7843-2017; Vicedomini, Riccardo/AGE-3108-2022; Delhomme, Nicolas/B-9187-2015; Van de Peer, Yves/D-4388-2009; Zerbe, Philipp/H-8348-2015; Scofield, Douglas G/B-4246-2009; LIN, Yao-Cheng/B-4394-2008; Andersson, Bjorn/G-9832-2013; Wu, Zhiqiang/CAG-6688-2022; Street, Nathaniel Robert/B-3920-2008	Tuominen, Hannele/0000-0002-4949-3702; Van de Peer, Yves/0000-0003-4327-3730; Zuccolo, Andrea/0000-0001-7574-0714; Sahlin, Kristoffer/0000-0001-7378-2320; Alexeyenko, Andrey/0000-0001-8812-6481; Jansson, Stefan/0000-0002-7906-6891; MacKay, John/0000-0002-4883-195X; Tuominen, Hannele/0000-0002-4949-3702; Hvidsten, Torgeir R./0000-0001-6097-2539; , wuzhiqiang/0000-0002-4238-7317; Vicedomini, Riccardo/0000-0002-7706-0998; Delhomme, Nicolas/0000-0002-3053-0796; Van de Peer, Yves/0000-0003-4327-3730; Zerbe, Philipp/0000-0001-5163-9523; Scofield, Douglas G/0000-0001-5235-6461; LIN, Yao-Cheng/0000-0002-9390-795X; Andersson, Bjorn/0000-0002-4624-0259; Wu, Zhiqiang/0000-0002-4238-7317; Street, Nathaniel Robert/0000-0001-6031-005X; Ingvarsson, Par/0000-0001-9225-7521; Nilsson, Ove/0000-0002-1033-1909; Elfstrand, Malin/0000-0002-0214-5284; Talavera-Lopez, Carlos/0000-0001-8590-2393; Giacomello, Stefania/0000-0003-0738-1574; Svensson, Thomas/0000-0002-9190-2979; Bhalerao, Rishikesh/0000-0003-4384-7036; Arvestad, Lars/0000-0001-5341-1733; Gramzow, Lydia/0000-0003-1919-6077; Niittyla, Totte/0000-0001-8029-1503; MORGANTE, Michele/0000-0003-2591-2156; Kucukoglu Topcu, Melis/0000-0002-2655-7398; Klasson, Lisa/0000-0002-5874-7153; Nystedt, Bjorn/0000-0001-7809-7664	Knut and Alice Wallenberg Foundation; Swedish Research Council (VR); Swedish Governmental Agency for Innovation Systems (Vinnova); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Swedish foundation for Strategic Research (SSF); Government of Canada through Genome Canada; Genome British Columbia; Genome Quebec; Science for Life Laboratory; National Genomics Infrastructure (NGI), Sweden	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Swedish Governmental Agency for Innovation Systems (Vinnova)(Vinnova); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Government of Canada through Genome Canada(Genome Canada); Genome British Columbia; Genome Quebec; Science for Life Laboratory; National Genomics Infrastructure (NGI), Sweden	The authors would like to acknowledge support from the Knut and Alice Wallenberg Foundation. Additional funding was provided in particular by the Swedish Research Council (VR), the Swedish Governmental Agency for Innovation Systems (Vinnova), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), the Swedish foundation for Strategic Research (SSF), the Government of Canada through Genome Canada, by Genome British Columbia, and by Genome Quebec, Science for Life Laboratory and the National Genomics Infrastructure (NGI), Sweden. We also acknowledge Skogforsk for the P. abies genetic material, UPPMAX for computational infrastructure, CLC Bio for assembly software development and Lucigen for fosmid-pool method development.	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Buschiazzo E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-8; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Flory W. S., 1936, J ARNOLD ARBORETUM, V17, P82; Garcia-Gil MR, 2008, J MOL EVOL, V67, P222, DOI 10.1007/s00239-008-9135-z; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jaramillo-Correa JP, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-22; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Klintenas M, 2012, NEW PHYTOL, V196, P1260, DOI 10.1111/j.1469-8137.2012.04332.x; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Mackenzie S.A., 2007, PLANT MITOCHONDRIA, P36; Magbanua ZV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016214; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Morse AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004332; Murray BG, 1998, ANN BOT-LONDON, V82, P3, DOI 10.1006/anbo.1998.0764; Pavy N, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-84; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Raj M, 2005, SILVAE GENET, V54, P126, DOI 10.1515/sg-2005-0020; Ralph SG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-484; Sahlin K, 2012, BIOINFORMATICS, V28, P2215, DOI 10.1093/bioinformatics/bts441; Sanmiguel P, 1998, ANN BOT-LONDON, V82, P37, DOI 10.1006/anbo.1998.0746; SAVARD L, 1994, P NATL ACAD SCI USA, V91, P5163, DOI 10.1073/pnas.91.11.5163; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stewart WN, 1993, PALEOBOTANY AND THE; Van de Peer Y, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-113; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031002; Vicedomini R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S6; Vicient CM, 1999, PLANT CELL, V11, P1769, DOI 10.1105/tpc.11.9.1769; Vitte C, 2003, MOL BIOL EVOL, V20, P528, DOI 10.1093/molbev/msg055; Wan LC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-146; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang JH, 2013, PLANTA, V237, P89, DOI 10.1007/s00425-012-1753-4	50	950	985	14	484	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					579	584		10.1038/nature12211	http://dx.doi.org/10.1038/nature12211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23698360	Green Published, hybrid			2022-12-24	WOS:000319556100035
J	Hansen, SG; Sacha, JB; Hughes, CM; Ford, JC; Burwitz, BJ; Scholz, I; Gilbride, RM; Lewis, MS; Gilliam, AN; Ventura, AB; Malouli, D; Xu, GW; Richards, R; Whizin, N; Reed, JS; Hammond, KB; Fischer, M; Turner, JM; Legasse, AW; Axthelm, MK; Edlefsen, PT; Nelson, JA; Lifson, JD; Fruh, K; Picker, LJ				Hansen, Scott G.; Sacha, Jonah B.; Hughes, Colette M.; Ford, Julia C.; Burwitz, Benjamin J.; Scholz, Isabel; Gilbride, Roxanne M.; Lewis, Matthew S.; Gilliam, Awbrey N.; Ventura, Abigail B.; Malouli, Daniel; Xu, Guangwu; Richards, Rebecca; Whizin, Nathan; Reed, Jason S.; Hammond, Katherine B.; Fischer, Miranda; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Edlefsen, Paul T.; Nelson, Joy A.; Lifson, Jeffrey D.; Frueh, Klaus; Picker, Louis J.			Cytomegalovirus Vectors Violate CD8(+) T Cell Epitope Recognition Paradigms	SCIENCE			English	Article							MHC-CLASS-I; COMPLEX CLASS-II; HLA CLASS-I; MAMU-B-ASTERISK-08-POSITIVE MACAQUES; ACCESSORY MOLECULES; VIRAL INTERFERENCE; RHESUS-MONKEYS; MEMORY; LYMPHOCYTES; AIDS	CD8(+) T cell responses focus on a small fraction of pathogen-or vaccine-encoded peptides, and for some pathogens, these restricted recognition hierarchies limit the effectiveness of antipathogen immunity. We found that simian immunodeficiency virus (SIV) protein-expressing rhesus cytomegalovirus (RhCMV) vectors elicit SIV-specific CD8(+) T cells that recognize unusual, diverse, and highly promiscuous epitopes, including dominant responses to epitopes restricted by class II major histocompatibility complex (MHC) molecules. Induction of canonical Sly epitope-specific CD8(+) T cell responses is suppressed by the RhCMV-encoded Rh189 gene (corresponding to human CMV US11), and the promiscuous MHC class I- and class II-restricted CD8(+) T cell responses occur only in the absence of the Rh157.5, Rh157.4, and Rh157.6 (human CMV U1128, U1130, and U1131) genes. Thus, CMV vectors can be genetically programmed to achieve distinct patterns of CD8(+) T cell epitope recognition.	[Hansen, Scott G.; Sacha, Jonah B.; Hughes, Colette M.; Ford, Julia C.; Burwitz, Benjamin J.; Scholz, Isabel; Gilbride, Roxanne M.; Lewis, Matthew S.; Gilliam, Awbrey N.; Ventura, Abigail B.; Malouli, Daniel; Xu, Guangwu; Richards, Rebecca; Whizin, Nathan; Reed, Jason S.; Hammond, Katherine B.; Fischer, Miranda; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Joy A.; Frueh, Klaus; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Hansen, Scott G.; Sacha, Jonah B.; Hughes, Colette M.; Ford, Julia C.; Burwitz, Benjamin J.; Scholz, Isabel; Gilbride, Roxanne M.; Lewis, Matthew S.; Gilliam, Awbrey N.; Ventura, Abigail B.; Malouli, Daniel; Xu, Guangwu; Richards, Rebecca; Whizin, Nathan; Reed, Jason S.; Hammond, Katherine B.; Fischer, Miranda; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Joy A.; Frueh, Klaus; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Populat Sci Program, Seattle, WA 98109 USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Computat Biol Program, Seattle, WA 98109 USA; [Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.	pickerl@ohsu.edu	Malouli, Daniel/AAX-1855-2021	Malouli, Daniel/0000-0003-1287-7283; Frueh, Klaus/0000-0001-8014-3877	NIH [P01 AI094417, RO1 AI060392, RO1 AI059457, P51 OD 011092, HHSN261200800001E]; Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Program); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060392, R01AI059457, P01AI094417] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092, U24OD010850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Program); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Morrow, A. Khan, K. Broderick, and D. Weiner for providing and administering the electroporated DNA/gag + IL-12 vaccines; G. Spies and B. Moss for the MVA/gag vector; M. Chiuchiulo and C. Parks for the Ad5/gag vector; P. Barry for the original GFP-expressing RhCMV 68-1 virus and the RhCMV 68-1 BAC; T. Shenk for providing the repaired RhCMV 68-1.2 BAC; D. Watkins for MHC-I typing; D. O'Connor and R. Wiseman for MHC-II typing; R. Geleziunas, J. Hesselgesser, and Gilead Science Inc. fur providing antiretruviral drugs; A. Townsend for help with the graphics; and J. Hines, A. Bhusari, R. Derrah, D. Dull, D. Morrow, E. McDonald, C. Kahl, S. Hagen, M. Jarvis, A. Sylwester, and L. Boshears for technical or administrative assistance. The data presented in this paper are tabulated in the main paper and the supplementary materials. Supported by NIH grants P01 AI094417, RO1 AI060392, RO1 AI059457, and P51 OD 011092 and contract HHSN261200800001E, the Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Program), and the International AIDS Vaccine Initiative. L.J.P., K.F., and S.G.H. have applied for a patent entitled "CMV Glycoproteins and Recombinant Vectors" (PCT/US2011/029930) and have filed a provisional patent application entitled "Cytomegalovirus Vectors Enabling Control of T Cell Targeting" (application 61772962). Oregon Health & Science University (OHSU) and L.J.P., S.G.H., K.F., and J.A.N. have a significant financial interest in TomegaVax Inc., a company that may have a commercial interest in the results of this research and technology. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services or NIH, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Busche A, 2013, J IMMUNOL, V190, P2767, DOI 10.4049/jimmunol.1200966; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Chelvanayagam G, 1997, HUM IMMUNOL, V58, P61, DOI 10.1016/S0198-8859(97)00185-7; Cline AN, 2005, J MED PRIMATOL, V34, P303; Corradin C, 1991, Int Rev Immunol, V7, P139; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Egan MA, 2005, AIDS RES HUM RETROV, V21, P629, DOI 10.1089/aid.2005.21.629; Gainey MD, 2012, P NATL ACAD SCI USA, V109, pE3260, DOI 10.1073/pnas.1217111109; Gao HH, 2013, ARCH VIROL, V158, P173, DOI 10.1007/s00705-012-1378-8; Giraldo-Vela JP, 2008, J VIROL, V82, P859, DOI 10.1128/JVI.01816-07; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hansen SG, 2003, J VIROL, V77, P6620, DOI 10.1128/JVI.77.12.6620-6636.2003; Heemskerk MHM, 2001, P NATL ACAD SCI USA, V98, P6806, DOI 10.1073/pnas.111162298; Hirosawa T, 2011, CANCER SCI, V102, P1281, DOI 10.1111/j.1349-7006.2011.01949.x; Hofstetter AR, 2011, CURR OPIN IMMUNOL, V23, P104, DOI 10.1016/j.coi.2010.09.009; Irvine Kari, 2006, Expert Rev Clin Immunol, V2, P135, DOI 10.1586/1744666X.2.1.135; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Laddy DJ, 2009, J VIROL, V83, P4624, DOI 10.1128/JVI.02335-08; Lilja AE, 2008, P NATL ACAD SCI USA, V105, P19950, DOI 10.1073/pnas.0811063106; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; LUSTGARTEN J, 1991, EUR J IMMUNOL, V21, P2507, DOI 10.1002/eji.1830211030; Manley TJ, 2004, BLOOD, V104, P1075, DOI 10.1182/blood-2003-06-1937; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; MIZUOCHI T, 1988, J EXP MED, V168, P437, DOI 10.1084/jem.168.1.437; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Munks MW, 2007, J IMMUNOL, V178, P7235, DOI 10.4049/jimmunol.178.11.7235; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Oxford KL, 2008, VIROLOGY, V373, P181, DOI 10.1016/j.virol.2007.10.040; Pande NT, 2005, J VIROL, V79, P5786, DOI 10.1128/JVI.79.9.5786-5798.2005; Pearce EL, 2004, J IMMUNOL, V173, P2494, DOI 10.4049/jimmunol.173.4.2494; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; RIDDELL SR, 1991, J IMMUNOL, V146, P2795; Rist M, 2009, BLOOD, V114, P2244, DOI 10.1182/blood-2009-05-222596; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; Shimizu T, 1997, EUR J IMMUNOL, V27, P500, DOI 10.1002/eji.1830270222; Snyder CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009681; Southwood S, 1998, J IMMUNOL, V160, P3363; SUZUKI H, 1994, J IMMUNOL, V153, P4496; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Viola A, 1997, J EXP MED, V186, P1775, DOI 10.1084/jem.186.10.1775; VOSS G, 1992, J VIROL METHODS, V39, P185, DOI 10.1016/0166-0934(92)90137-3; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang D, 2005, J VIROL, V79, P10330, DOI 10.1128/JVI.79.16.10330-10338.2005; Wolfe D. A., 1973, NONPARAMETRIC STAT M; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	69	320	342	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2013	340	6135					940	+	1237874	10.1126/science.1237874	http://dx.doi.org/10.1126/science.1237874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704576	Green Accepted			2022-12-24	WOS:000319344100036
J	Caron, SJC; Ruta, V; Abbott, LF; Axel, R				Caron, Sophie J. C.; Ruta, Vanessa; Abbott, L. F.; Axel, Richard			Random convergence of olfactory inputs in the Drosophila mushroom body	NATURE			English	Article							IMAGING REVEALS; NEURONS; MAP; REPRESENTATION; ABLATION	The mushroom body in the fruitfly Drosophila melanogaster is an associative brain centre that translates odour representations into learned behavioural responses(1). Kenyon cells, the intrinsic neurons of the mushroom body, integrate input from olfactory glomeruli to encode odours as sparse distributed patterns of neural activity(2,3). We have developed anatomic tracing techniques to identify the glomerular origin of the inputs that converge onto 200 individual Kenyon cells. Here we show that each Kenyon cell integrates input from a different and apparently random combination of glomeruli. The glomerular inputs to individual Kenyon cells show no discernible organization with respect to their odour tuning, anatomic features or developmental origins. Moreover, different classes of Kenyon cells do not seem to preferentially integrate inputs from specific combinations of glomeruli. This organization of glomerular connections to the mushroom body could allow the fly to contextualize novel sensory experiences, a feature consistent with the role of this brain centre in mediating learned olfactory associations and behaviours.	[Caron, Sophie J. C.; Abbott, L. F.; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Ruta, Vanessa] Rockefeller Univ, Lab Neurophysiol & Behav, New York, NY 10065 USA; [Abbott, L. F.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Axel, Richard] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Rockefeller University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		CARON, SOPHIE/0000-0002-9230-2983; Axel, Richard/0000-0002-3141-4076; Ruta, Vanessa/0000-0002-4963-2768	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute; Swartz Foundation; Gatsby Foundation; Pew Charitable Trusts; McKnight Foundation; New York Stem Cell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swartz Foundation; Gatsby Foundation; Pew Charitable Trusts; McKnight Foundation; New York Stem Cell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Bargmann, T. Jessell, F. Maderspacher, L. Paninski and members of the Axel laboratory for comments on the manuscript; C. Franqui for assistance with fly work; and P. Kisloff, M. Gutierrez and A. Nemes for assistance with general laboratory concerns and the preparation of this manuscript. This work was funded in part by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (R. A.). Further financial support was provided by the Howard Hughes Medical Institute (R. A.), by the Swartz and Gatsby Foundations (L. F. A.) and by the Pew Charitable Trusts, McKnight Foundation, and New York Stem Cell Foundation (V.R.).	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Butcher NJ, 2012, J COMP NEUROL, V520, P2185, DOI 10.1002/cne.23037; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Leiss F, 2009, J COMP NEUROL, V517, P808, DOI 10.1002/cne.22184; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461; Yusuyama K, 2002, J COMP NEUROL, V445, P211, DOI 10.1002/cne.10155	28	221	223	0	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					113	+		10.1038/nature12063	http://dx.doi.org/10.1038/nature12063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615618	Green Published, Green Accepted			2022-12-24	WOS:000318221500044
J	Le Sage, D; Arai, K; Glenn, DR; DeVience, SJ; Pham, LM; Rahn-Lee, L; Lukin, MD; Yacoby, A; Komeili, A; Walsworth, RL				Le Sage, D.; Arai, K.; Glenn, D. R.; DeVience, S. J.; Pham, L. M.; Rahn-Lee, L.; Lukin, M. D.; Yacoby, A.; Komeili, A.; Walsworth, R. L.			Optical magnetic imaging of living cells	NATURE			English	Article							MAGNETOTACTIC BACTERIA; SPIN; RESONANCE; ELECTRON	Magnetic imaging is a powerful tool for probing biological and physical systems. However, existing techniques either have poor spatial resolution compared to optical microscopy and are hence not generally applicable to imaging of sub-cellular structure (for example, magnetic resonance imaging(1)), or entail operating conditions that preclude application to living biological samples while providing submicrometre resolution (for example, scanning superconducting quantum interference device microscopy(2), electron holography(3) and magnetic resonance force microscopy(4)). Here we demonstrate magnetic imaging of living cells (magnetotactic bacteria) under ambient laboratory conditions and with sub-cellular spatial resolution (400 nanometres), using an optically detected magnetic field imaging array consisting of a nanometre-scale layer of nitrogen-vacancy colour centres implanted at the surface of a diamond chip. With the bacteria placed on the diamond surface, we optically probe the nitrogen-vacancy quantum spin states and rapidly reconstruct images of the vector components of the magnetic field created by chains of magnetic nanoparticles (magnetosomes) produced in the bacteria. We also spatially correlate these magnetic field maps with optical images acquired in the same apparatus. Wide-field microscopy allows parallel optical and magnetic imaging of multiple cells in a population with submicrometre resolution and a field of view in excess of 100 micrometres. Scanning electron microscope images of the bacteria confirm that the correlated optical and magnetic images can be used to locate and characterize the magnetosomes in each bacterium. Our results provide a new capability for imaging bio-magnetic structures in living cells under ambient conditions with high spatial resolution, and will enable the mapping of a wide range of magnetic signals within cells and cellular networks(5,6).	[Le Sage, D.; Glenn, D. R.; Walsworth, R. L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Le Sage, D.; Glenn, D. R.; Lukin, M. D.; Yacoby, A.; Walsworth, R. L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Arai, K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Glenn, D. R.; Walsworth, R. L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [DeVience, S. J.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Pham, L. M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rahn-Lee, L.; Komeili, A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; University of California System; University of California Berkeley	Walsworth, RL (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	rwalsworth@cfa.harvard.edu	DeVience, Stephen J/D-7274-2012	DeVience, Stephen J/0000-0003-3142-7296; Arai, Keigo/0000-0002-7676-5726; Le Sage, David/0000-0003-1678-9491	David and Lucille Packard Foundation Fellowship in Science and Engineering; National Institutes of Health [R01GM084122]; NSF; DARPA QuASAR programme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084122] Funding Source: NIH RePORTER	David and Lucille Packard Foundation Fellowship in Science and Engineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DARPA QuASAR programme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Qian for discussions about related experiments using a scanning SQUID microscope in the laboratory of K. A. Moler, J. W. Lichtman and R. Schalek for access to the SEM, S. G. Turney for access to the water-immersion objective and advice regarding cell immobilization, and P. R. Hemmer and H. Park for technical discussions. A. K. was supported by a David and Lucille Packard Foundation Fellowship in Science and Engineering and by the National Institutes of Health (R01GM084122). This work was supported by the NSF and the DARPA QuASAR programme.	Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Dobson J, 2004, ANN NY ACAD SCI, V1012, P183, DOI 10.1196/annals.1306.016; Draper O, 2011, MOL MICROBIOL, V82, P342, DOI 10.1111/j.1365-2958.2011.07815.x; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Finkler A, 2010, NANO LETT, V10, P1046, DOI 10.1021/nl100009r; Grinolds MS, 2013, NAT PHYS, V9, P215, DOI [10.1038/NPHYS2543, 10.1038/nphys2543]; Hall LT, 2010, P NATL ACAD SCI USA, V107, P18777, DOI 10.1073/pnas.1002562107; Hanson R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087601; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Krichevsky A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2405730; Lam KP, 2010, CHEM GEOL, V270, P110, DOI 10.1016/j.chemgeo.2009.11.009; Le Sage D, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.121202; Lee SC, 2009, MAGN RESON IMAGING, V27, P828, DOI 10.1016/j.mri.2009.01.002; Maletinsky P, 2012, NAT NANOTECHNOL, V7, P320, DOI [10.1038/nnano.2012.50, 10.1038/NNANO.2012.50]; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Matsunaga T, 2007, TRENDS BIOTECHNOL, V25, P182, DOI 10.1016/j.tibtech.2007.02.002; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; MOSKOWITZ BM, 1993, EARTH PLANET SC LETT, V120, P283, DOI 10.1016/0012-821X(93)90245-5; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Pham LM, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/045021; Posfai M, 2009, ELEMENTS, V5, P235, DOI 10.2113/gselements.5.4.235; PROKSCH RB, 1995, APPL PHYS LETT, V66, P2582, DOI 10.1063/1.113508; Qian L., 2011, APS MARCH M 2011; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Zurkiya O, 2008, MAGN RESON MED, V59, P1225, DOI 10.1002/mrm.21606	32	423	433	20	552	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					486	U105		10.1038/nature12072	http://dx.doi.org/10.1038/nature12072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619694	Green Submitted, Green Accepted			2022-12-24	WOS:000317984400037
J	Dai, L; Korolev, KS; Gore, J				Dai, Lei; Korolev, Kirill S.; Gore, Jeff			Slower recovery in space before collapse of connected populations	NATURE			English	Article							EARLY-WARNING SIGNALS; REGIME SHIFTS; CATASTROPHIC SHIFTS; TIPPING POINT; ECOSYSTEMS; INDICATOR; DYNAMICS; FOREST	Slower recovery from perturbations near a tipping point and its indirect signatures in fluctuation patterns have been suggested to foreshadow catastrophes in a wide variety of systems(1,2). Recent studies of populations in the field and in the laboratory have used time-series data to confirm some of the theoretically predicted early warning indicators, such as an increase in recovery time or in the size and timescale of fluctuations(3-6). However, the predictive power of temporal warning signals is limited by the demand for long-term observations. Large-scale spatial data are more accessible, but the performance of warning signals in spatially extended systems(7-10) needs to be examined empirically(3,11-13). Here we use spatially extended yeast populations, an experimental system with a fold bifurcation (tipping point)(6), to evaluate early warning signals based on spatio-temporal fluctuations and to identify a novel spatial warning indicator. We found that two leading indicators based on fluctuations increased before collapse of connected populations; however, the magnitudes of the increases were smaller than those observed in isolated populations, possibly because local variation is reduced by dispersal. Furthermore, we propose a generic indicator based on deterministic spatial patterns, which we call 'recovery length'. As the spatial counterpart of recovery time(14), recovery length is the distance necessary for connected populations to recover from spatial perturbations. In our experiments, recovery length increased substantially before population collapse, suggesting that the spatial scale of recovery can provide a superior warning signal before tipping points in spatially extended systems.	[Dai, Lei; Korolev, Kirill S.; Gore, Jeff] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dai, L (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	dailei@mit.edu; gore@mit.edu			Whitaker Health Sciences Fund Fellowship; Pappalardo Fellowship; NIH [NIH R00 GM085279-02, NIH DP2]; NSF CAREER Award; Sloan Research Fellowship; Pew Scholars Program; Allen Investigator Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM085279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP2AG044279] Funding Source: NIH RePORTER	Whitaker Health Sciences Fund Fellowship; Pappalardo Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Sloan Research Fellowship(Alfred P. Sloan Foundation); Pew Scholars Program; Allen Investigator Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank D. Vorselen, T. Krieger, D. Seekell, M. Pace and members of the Gore laboratory (A. Sanchez, M. Datta, E. Yurtsev, T. Artemova, K. Axelrod and A. Chen) for comments on the manuscript. T. Krieger performed initial simulations for the connected populations. Y. Zhang and O. Ornek collected preliminary data for the experiment to measure recovery length. This work was supported by a Whitaker Health Sciences Fund Fellowship (to L.D.), a Pappalardo Fellowship (to K.S.K.), an NIH R00 Pathways to Independence Award (NIH R00 GM085279-02), an NIH New Innovator Award (NIH DP2), an NSF CAREER Award, a Sloan Research Fellowship, the Pew Scholars Program and the Allen Investigator Program.	Boettiger C, 2012, P ROY SOC B-BIOL SCI, V279, P4734, DOI 10.1098/rspb.2012.2085; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Carpenter SR, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00016.1; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; DECARLO LT, 1993, BEHAV RES THER, V31, P781, DOI 10.1016/0005-7967(93)90009-J; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Fernandez A, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09014; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Isbell F., 2013, ECOL LETT; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; OUYANG Q, 1991, NATURE, V352, P610, DOI 10.1038/352610a0; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sole R. V., 1995, Complexity, V1, P13; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723	33	128	137	3	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					355	+		10.1038/nature12071	http://dx.doi.org/10.1038/nature12071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23575630	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000317599200036
J	Weiskopf, K; Ring, AM; Ho, CCM; Volkmer, JP; Levin, AM; Volkmer, AK; Ozkan, E; Fernhoff, NB; van de Rijn, M; Weissman, IL; Garcia, KC				Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Levin, Aron M.; Volkmer, Anne Kathrin; Oezkan, Engin; Fernhoff, Nathaniel B.; van de Rijn, Matt; Weissman, Irving L.; Garcia, K. Christopher			Engineered SIRP alpha Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies	SCIENCE			English	Article							SIGNAL-REGULATORY-PROTEIN; STEM-CELLS; CD47; RECEPTOR; THERAPY; CLEARANCE; RITUXIMAB; EFFICACY; TARGET; SAFETY	CD47 is an antiphagocytic signal that cancer cells employ to inhibit macrophage-mediated destruction. Here, we modified the binding domain of human SIRP alpha, the receptor for CD47, for use as a CD47 antagonist. We engineered high-affinity SIRP alpha variants with about a 50,000-fold increased affinity for human CD47 relative to wild-type SIRP alpha. As high-affinity SIRP alpha monomers, they potently antagonized CD47 on cancer cells but did not induce macrophage phagocytosis on their own. Instead, they exhibited remarkable synergy with all tumor-specific monoclonal antibodies tested by increasing phagocytosis in vitro and enhancing antitumor responses in vivo. This "one-two punch" directs immune responses against tumor cells while lowering the threshold for macrophage activation, thereby providing a universal method for augmenting the efficacy of therapeutic anticancer antibodies.	[Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.; Garcia, K. Christopher] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA; [Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M.; Volkmer, Jens-Peter; Volkmer, Anne Kathrin; Fernhoff, Nathaniel B.; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Ring, Aaron M.; Ho, Chia Chi M.; Levin, Aron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Volkmer, Anne Kathrin] Univ Dusseldorf, Dept Obstet & Gynaecol, Dusseldorf, Germany; [van de Rijn, Matt; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Heinrich Heine University Dusseldorf; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Ozkan, Engin/0000-0002-0263-6729; Ring, Aaron/0000-0003-3699-2446; van de Rijn, Matt/0000-0002-1909-9739	National Cancer Institute [F30CA168059, CA139490]; National Institute of Diabetes and Digestive and Kidney Diseases [F30DK094541]; Stanford Medical Scientist Training Program [NIH-GM07365]; Stanford University SPARK Program; Deutsche Forschungsgemeinschaft [VO 1976/1]; Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund; Virginia and D. K. Ludwig Fund for Cancer Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA139490, F30CA168059, R01CA112270, R01CA086017, R01CA177684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanford Medical Scientist Training Program; Stanford University SPARK Program(Stanford University); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund; Virginia and D. K. Ludwig Fund for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank members of the Weissman and Garcia laboratories for helpful advice and discussions. The authors thank R. Majeti, J. Liu, and the CD47 Disease Team for discussions and for providing antibodies to CD47. The authors thank T. Storm, L. Jerabek, H. Contreras-Trujillo, A. McCarty, S. Jaiswal, B. di Robilant, S. Varma, T. Naik, S. Willingham, H. Kohrt, N. Goriatcheva, D. Waghray, and S. Fischer for technical assistance, discussions, and reagents. The data presented in this paper are tabulated in the main paper and the supplementary materials. Atomic coordinates and structure factors of the FD6:CD47 complex (PDB code 4KJY) have been deposited in the Protein Data Bank. Research reported in this publication was supported by the National Cancer Institute (F30CA168059 to K. W. and CA139490 to I. L. W.), the National Institute of Diabetes and Digestive and Kidney Diseases (F30DK094541 to A. M. R.), the Stanford Medical Scientist Training Program (NIH-GM07365 to K. W. and A. M. R.), the Stanford University SPARK Program (to K. W. and A. M. R.), the Deutsche Forschungsgemeinschaft (VO 1976/1 to A. K. V.), the Joseph and Laurie Lacob Gynecologic/Ovarian Cancer Fund (to I. L. W), the Virginia and D. K. Ludwig Fund for Cancer Research (to I. L. W.), and the Howard Hughes Medical Institute (to K. C. G.). The content of this manuscript is solely the responsibility of the authors. K. W., A. M. R., A. M. L., I. L. W., and K. C. G. have filed a patent describing the high-affinity SIRP alpha reagents.	Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Brooke G, 2004, J IMMUNOL, V173, P2562, DOI 10.4049/jimmunol.173.4.2562; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Lapalombella R, 2008, CLIN CANCER RES, V14, P569, DOI 10.1158/1078-0432.CCR-07-1006; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Maloney DG, 1997, BLOOD, V90, P2188; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Reichert JM, 2012, DRUG DISCOV TODAY, V17, P954, DOI 10.1016/j.drudis.2012.04.006; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; STANCOVSKI I, 1991, P NATL ACAD SCI USA, V88, P8691, DOI 10.1073/pnas.88.19.8691; Tabrizi MA, 2007, DRUG DISCOV TODAY, V12, P540, DOI 10.1016/j.drudis.2007.05.010; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Theocharides APA, 2012, J EXP MED, V209, P1883, DOI 10.1084/jem.20120502; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	30	292	352	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	2013	341	6141					88	91		10.1126/science.1238856	http://dx.doi.org/10.1126/science.1238856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176GL	23722425	Green Accepted			2022-12-24	WOS:000321291700055
J	Law, JA; Du, JM; Hale, CJ; Feng, SH; Krajewski, K; Palanca, AMS; Strahl, BD; Patel, DJ; Jacobsen, SE				Law, Julie A.; Du, Jiamu; Hale, Christopher J.; Feng, Suhua; Krajewski, Krzysztof; Palanca, Ana Marie S.; Strahl, Brian D.; Patel, Dinshaw J.; Jacobsen, Steven E.			Polymerase IV occupancy at RNA-directed DNA methylation sites requires SHH1	NATURE			English	Article							ARABIDOPSIS; ASSOCIATION; ARGONAUTE4; PATTERNS; BINDING	DNA methylation is an epigenetic modification that has critical roles in gene silencing, development and genome integrity. In Arabidopsis, DNA methylation is established by DOMAINS REARRANGED METHYLTRANSFERASE 2 (DRM2) and targeted by 24-nucleotide small interfering RNAs (siRNAs) through a pathway termed RNA-directed DNA methylation (RdDM)(1). This pathway requires two plant-specific RNA polymerases: Pol-IV, which functions to initiate siRNA biogenesis, and Pol-V, which functions to generate scaffold transcripts that recruit downstream RdDM factors(1,2). To understand the mechanisms controlling Pol-IV targeting we investigated the function of SAWADEE HOMEODOMAIN HOMOLOG 1 (SHH1)(3,4), a Pol-IV-interacting protein(3). Here we show that SHH1 acts upstream in the RdDM pathway to enable siRNA production from a large subset of the most active RdDM targets, and that SHH1 is required for Pol-IV occupancy at these same loci. We also show that the SHH1 SAWADEE domain is a novel chromatin-binding module that adopts a unique tandem Tudor-like fold and functions as a dual lysine reader, probing for both unmethylated K4 and methylated K9 modifications on the histone 3 (H3) tail. Finally, we show that key residues within both lysine-binding pockets of SHH1 are required in vivo to maintain siRNA and DNA methylation levels as well as Pol-IV occupancy at RdDM targets, demonstrating a central role for methylated H3K9 binding in SHH1 function and providing the first insights into the mechanism of Pol-IV targeting. Given the parallels between methylation systems in plants and mammals(1,5), a further understanding of this early targeting step may aid our ability to control the expression of endogenous and newly introduced genes, which has broad implications for agriculture and gene therapy.	[Law, Julie A.; Hale, Christopher J.; Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Du, Jiamu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Krajewski, Krzysztof; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Palanca, Ana Marie S.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; Salk Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	pateld@mskcc.org; jacobsen@ucla.edu	Du, Jiamu/I-1334-2013; Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Law, Julie A/A-9566-2011; Du, Jiamu/G-3308-2010; Strahl, Brian D/C-7601-2012	Du, Jiamu/0000-0002-1337-0786; Law, Julie A/0000-0001-7472-7753; Krajewski, Krzysztof/0000-0001-7159-617X; Strahl, Brian D/0000-0002-4947-6259	Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; NIH [GM60398, GM85394]; Damon Runyon postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085394, R01GM060398, R37GM060398] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the staff of beamlines 24ID-C/E at the Argonne National Laboratory and X29A at the Brookhaven National Laboratory for support in diffraction data collection, to M. Akhavan and S. Fuchs for technical assistance, and to the UCLA BSCRC BioSequencing Core Facility for DNA sequencing. This work was supported by funds from the Abby Rockefeller Mauze Trust and Maloris and STARR Foundations to D.J.P. Work in the Jacobsen laboratory was supported by NIH grant GM60398. C.J.H. is supported by the Damon Runyon postdoctoral fellowship. S. F. is a Special Fellow of the Leukemia & Lymphoma Society. B. D. S. is supported by NIH grant GM85394. S.E.J. is an Investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Cairns J, 2011, BIOINFORMATICS, V27, P713, DOI 10.1093/bioinformatics/btq685; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng SH, 2011, METHODS MOL BIOL, V733, P223, DOI 10.1007/978-1-61779-089-8_16; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Heisel SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002871; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Johnson LM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000280; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002195; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Liu J, 2011, CELL RES, V21, P1691, DOI 10.1038/cr.2011.173; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Olovnikov I, 2012, CURR OPIN GENET DEV, V22, P164, DOI 10.1016/j.gde.2012.01.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	36	221	229	3	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					385	+		10.1038/nature12178	http://dx.doi.org/10.1038/nature12178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23636332	Green Accepted, Green Submitted			2022-12-24	WOS:000320592900045
J	Ji, X; Zhou, Y; Pandit, S; Huang, JE; Li, HR; Lin, CY; Xiao, R; Burge, CB; Fu, XD				Ji, Xiong; Zhou, Yu; Pandit, Shatakshi; Huang, Jie; Li, Hairi; Lin, Charles Y.; Xiao, Rui; Burge, Christopher B.; Fu, Xiang-Dong			SR Proteins Collaborate with 7SK and Promoter-Associated Nascent RNA to Release Paused Polymerase	CELL			English	Article							TRANSCRIPTION ELONGATION; SPLICING FACTORS; GENE-EXPRESSION; P-TEFB; HIV-1 TAT; COMPLEX; RECRUITMENT; ACTIVATION; ENHANCERS; DYNAMICS	RNAP II is frequently paused near gene promoters in mammals, and its transition to productive elongation requires active recruitment of P-TEFb, a cyclin-dependent kinase for RNAP II and other key transcription elongation factors. A fraction of P-TEFb is sequestered in an inhibitory complex containing the 7SK noncoding RNA, but it has been unclear how P-TEFb is switched from the 7SK complex to RNAP II during transcription activation. We report that SRSF2 (also known as SC35, an SR-splicing factor) is part of the 7SK complex assembled at gene promoters and plays a direct role in transcription pause release. We demonstrate RNA-dependent, coordinated release of SRSF2 and P-TEFb from the 7SK complex and transcription activation via SRSF2 binding to promoter-associated nascent RNA. These findings reveal an unanticipated SR protein function, a role for promoter-proximal nascent RNA in gene activation, and an analogous mechanism to HIV Tat/TAR for activating cellular genes.	[Ji, Xiong; Huang, Jie; Fu, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Zhou, Yu; Pandit, Shatakshi; Li, Hairi; Xiao, Rui; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Fu, Xiang-Dong] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Lin, Charles Y.; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA	Wuhan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	Fu, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	xdfu@ucsd.edu	Pandit, Sakshi/I-3152-2014; Zhou, Yu/AAP-9964-2021; Burge, Christopher B./AAH-2177-2020	Zhou, Yu/0000-0002-2102-9377; Xiao, Rui/0000-0002-9477-1054; Huang, Jie/0000-0003-3842-6181	China 973 program [2011CB811300, 2012CB910800]; China 111 project [B06018]; NIH [GM049369, GM052872, HG004659]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052872, R01GM049369] Funding Source: NIH RePORTER	China 973 program(National Basic Research Program of China); China 111 project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. David H. Price for anti-cyclin T1 and anti-LARP7 antibodies, to Dr. Qiang Zhou for luciferase reporters, to Drs. Wen Liu and Wenbo Li for sharing many reagents, to Dr. Zefeng Wang for expert help on the PUF system, and to Dr. Pingping Wang for artwork. We are extremely indebted to Drs. Chris Glass, Manuel Ares Jr., and Joan Steitz for critical comments on the manuscript. This work was supported by the China 973 program (2011CB811300 and 2012CB910800), the China 111 project (B06018), and NIH grants (GM049369, GM052872, HG004659) to X.-D.F.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; BERKHOUT B, 1990, CELL, V62, P757, DOI 10.1016/0092-8674(90)90120-4; Byun JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1652; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; CHAMPLIN DT, 1991, GENE DEV, V5, P1611, DOI 10.1101/gad.5.9.1611; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; D'Orso I, 2010, NAT STRUCT MOL BIOL, V17, P815, DOI 10.1038/nsmb.1827; Daubner GM, 2012, EMBO J, V31, P162, DOI 10.1038/emboj.2011.367; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Prasanth KV, 2010, MOL BIOL CELL, V21, P4184, DOI 10.1091/mbc.E10-02-0105; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sawarkar R, 2012, CELL, V149, P807, DOI 10.1016/j.cell.2012.02.061; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Singer RH, 1997, CELL, V91, P291, DOI 10.1016/S0092-8674(00)80411-0; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Young TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001010; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zobeck KL, 2010, MOL CELL, V40, P965, DOI 10.1016/j.molcel.2010.11.022	49	218	223	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					855	868		10.1016/j.cell.2013.04.028	http://dx.doi.org/10.1016/j.cell.2013.04.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663783	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000318844000014
J	Loffredo, FS; Steinhauser, ML; Jay, SM; Gannon, J; Pancoast, JR; Yalamanchi, P; Sinha, M; Dall'Osso, C; Khong, D; Shadrach, JL; Miller, CM; Singer, BS; Stewart, A; Psychogios, N; Gerszten, RE; Hartigan, AJ; Kim, MJ; Serwold, T; Wagers, AJ; Lee, RT				Loffredo, Francesco S.; Steinhauser, Matthew L.; Jay, Steven M.; Gannon, Joseph; Pancoast, James R.; Yalamanchi, Pratyusha; Sinha, Manisha; Dall'Osso, Claudia; Khong, Danika; Shadrach, Jennifer L.; Miller, Christine M.; Singer, Britta S.; Stewart, Alex; Psychogios, Nikolaos; Gerszten, Robert E.; Hartigan, Adam J.; Kim, Mi-Jeong; Serwold, Thomas; Wagers, Amy J.; Lee, Richard T.			Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy	CELL			English	Article							DIASTOLIC HEART-FAILURE; HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE; BLOOD-PRESSURE; MYOSTATIN; PROTEIN; MICE; REJUVENATION; EPIDEMIOLOGY; CARDIOLOGY	The most common form of heart failure occurs with normal systolic function and often involves cardiac hypertrophy in the elderly. To clarify the biological mechanisms that drive cardiac hypertrophy in aging, we tested the influence of circulating factors using heterochronic parabiosis, a surgical technique in which joining of animals of different ages leads to a shared circulation. After 4 weeks of exposure to the circulation of young mice, cardiac hypertrophy in old mice dramatically regressed, accompanied by reduced cardiomyocyte size and molecular remodeling. Reversal of age-related hypertrophy was not attributable to hemodynamic or behavioral effects of parabiosis, implicating a blood-borne factor. Using modified aptamer-based proteomics, we identified the TGF-beta superfamily member GDF11 as a circulating factor in young mice that declines with age. Treatment of old mice to restore GDF11 to youthful levels recapitulated the effects of parabiosis and reversed age-related hypertrophy, revealing a therapeutic opportunity for cardiac aging.	[Loffredo, Francesco S.; Jay, Steven M.; Sinha, Manisha; Dall'Osso, Claudia; Khong, Danika; Shadrach, Jennifer L.; Miller, Christine M.; Hartigan, Adam J.; Kim, Mi-Jeong; Serwold, Thomas; Wagers, Amy J.; Lee, Richard T.] Brigham & Womens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Loffredo, Francesco S.; Steinhauser, Matthew L.; Jay, Steven M.; Gannon, Joseph; Pancoast, James R.; Yalamanchi, Pratyusha; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Sinha, Manisha; Dall'Osso, Claudia; Khong, Danika; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Sinha, Manisha; Dall'Osso, Claudia; Khong, Danika; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Miller, Christine M.; Hartigan, Adam J.; Kim, Mi-Jeong; Serwold, Thomas; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Singer, Britta S.; Stewart, Alex] SomaLogic Inc, Boulder, CO 80301 USA; [Psychogios, Nikolaos; Gerszten, Robert E.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts General Hospital	Wagers, AJ (corresponding author), Brigham & Womens Hosp, Harvard Stem Cell Inst, 75 Francis St, Boston, MA 02115 USA.	amy_wagers@harvard.edu; rlee@partners.org	Loffredo, Francesco S/F-6638-2014; Loffredo, Francesco/P-1389-2019; Steinhauser, Matthew L./GVT-6393-2022; Jay, Steven/ABD-4344-2021	Loffredo, Francesco S/0000-0001-5911-780X; Loffredo, Francesco/0000-0001-5911-780X; Steinhauser, Matthew L./0000-0001-5287-9246; Jay, Steven/0000-0002-3827-5988; Lee, Richard/0000-0003-4687-1381; Khong, Danika/0000-0002-2128-8619; Psychogios, Nikolaos/0000-0002-2747-6012; Yalamanchi, Pratyusha/0000-0003-0776-3759	NIH [P30DK036836, 1RO1 AG033053, 1DP2 OD004345, 5U01 HL100402, R01 AG032977 1R01 AG040019, KO8 DK090147]; American Heart Association; Glenn Foundation; Watkins Cardiovascular Leadership Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL112905, U01HL100402, K99HL112905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, K08DK090147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040019, R01AG033053, R01AG032977] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Glenn Foundation; Watkins Cardiovascular Leadership Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge the HSCI and DRC (NIH Award Number P30DK036836) Flow Cytometry Cores for excellent cytometry support. This work was funded in part by grants from the American Heart Association to F.S.L. (postdoctoral fellowship) and M.L.S. (AHA FTF), Glenn Foundation and NIH (1RO1 AG033053, 1DP2 OD004345, and 5U01 HL100402) to A.J.W., NIH (R01 AG032977 1R01 AG040019) to R.T.L., and NIH (KO8 DK090147) to M.L.S. M.L.S. is supported by the Watkins Cardiovascular Leadership Award. A.J.W. is an Early Career Scientist of the Howard Hughes Medical Institute. Content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding agencies. SOMAscan and SOMAmers are trademarks of Soma Logic, Inc.	Aurigemma GP, 2006, NEW ENGL J MED, V355, P308, DOI 10.1056/NEJMe068128; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; FINERTY JC, 1952, PHYSIOL REV, V32, P277, DOI 10.1152/physrev.1952.32.3.277; Foryst-Ludwig A, 2011, AM J PHYSIOL-HEART C, V301, pH115, DOI 10.1152/ajpheart.01222.2010; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Jackson MF, 2012, J ENDOCRINOL, V213, P263, DOI 10.1530/JOE-11-0455; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kitzman DW, 2007, CLIN GERIATR MED, V23, P83, DOI 10.1016/j.cger.2006.09.002; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Pietramaggiori G, 2009, J INVEST DERMATOL, V129, P2265, DOI 10.1038/jid.2009.60; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	38	628	701	10	224	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					828	839		10.1016/j.cell.2013.04.015	http://dx.doi.org/10.1016/j.cell.2013.04.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663781	Green Accepted, Bronze			2022-12-24	WOS:000318844000012
J	Vickers, AJ; Ulmert, D; Sjoberg, DD; Bennette, CJ; Bjork, T; Gerdtsson, A; Manjer, J; Nilsson, PM; Dahlin, A; Bjartell, A; Scardino, PT; Lilja, H				Vickers, Andrew J.; Ulmert, David; Sjoberg, Daniel D.; Bennette, Caroline J.; Bjork, Thomas; Gerdtsson, Axel; Manjer, Jonas; Nilsson, Peter M.; Dahlin, Anders; Bjartell, Anders; Scardino, Peter T.; Lilja, Hans			Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REFERENCE RANGES; MEN; SERUM; DIAGNOSIS; MORTALITY; REPRODUCIBILITY; PREDICTION; MUTATIONS; REGISTER; PLASMA	Objective To determine the association between concentration of prostate specific antigen (PSA) at age 40-55 and subsequent risk of prostate cancer metastasis and mortality in an unscreened population to evaluate when to start screening for prostate cancer and whether rescreening could be risk stratified. Design Case-control study with 1: 3 matching nested within a highly representative population based cohort study. Setting Malmo Preventive Project, Sweden. Participants 21 277 Swedish men aged 27-52 (74% of the eligible population) who provided blood at baseline in 1974-84, and 4922 men invited to provide a second sample six years later. Rates of PSA testing remained extremely low during median follow-up of 27 years. Main outcome measures Metastasis or death from prostate cancer ascertained by review of case notes. Results Risk of death from prostate cancer was associated with baseline PSA: 44% (95% confidence interval 34% to 53%) of deaths occurred in men with a PSA concentration in the highest 10th of the distribution of concentrations at age 45-49 (>= 1.6 mu g/L), with a similar proportion for the highest 10th at age 51-55 (>= 2.4 mu g/L: 44%, 32% to 56%). Although a 25-30 year risk of prostate cancer metastasis could not be ruled out by concentrations below the median at age 45-49 (0.68 mu g/L) or 51-55 (0.85 mu g/L), the 15 year risk remained low at 0.09% (0.03% to 0.23%) at age 45-49 and 0.28% (0.11% to 0.66%) at age 51-55, suggesting that longer intervals between screening would be appropriate in this group. Conclusion Measurement of PSA concentration in early midlife can identify a small group of men at increased risk of prostate cancer metastasis several decades later. Careful surveillance is warranted in these men. Given existing data on the risk of death by PSA concentration at age 60, these results suggest that three lifetime PSA tests (mid to late 40s, early 50s, and 60) are probably sufficient for at least half of men.	[Vickers, Andrew J.; Sjoberg, Daniel D.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Ulmert, David; Scardino, Peter T.; Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Urol Surg, New York, NY 10065 USA; [Ulmert, David; Bjork, Thomas; Gerdtsson, Axel; Bjartell, Anders] Lund Univ, Dept Urol, Skane Univ Hosp, Malmo, Sweden; [Bennette, Caroline J.] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Manjer, Jonas] Lund Univ, Dept Surg, Skane Univ Hosp, Malmo, Sweden; [Nilsson, Peter M.] Lund Univ, Dept Med, Skane Univ Hosp, Malmo, Sweden; [Dahlin, Anders] Lund Univ, Dept Clin Microbiol, Skane Univ Hosp, Malmo, Sweden; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10065 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med GU Oncol, New York, NY 10065 USA; [Lilja, Hans] Lund Univ, Dept Lab Med & Clin Sci Malmo, Skane Univ Hosp, Malmo, Sweden; [Lilja, Hans] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Lund University; Skane University Hospital; University of Washington; University of Washington Seattle; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Lund University; Skane University Hospital; University of Oxford	Lilja, H (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave,Box 213, New York, NY 10065 USA.	liljah@mskcc.org	Lilja, Hans/S-9703-2019	Lilja, Hans/0000-0001-5871-7846; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Gerdtsson, Axel/0000-0003-4033-5078; Vickers, Andrew/0000-0003-1525-6503; Sjoberg, Daniel/0000-0003-0862-2018	National Cancer Institute [R33 CA 127768-03, P50-CA92629]; Swedish Cancer Society [11-0624]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford, Fundacion Federico SA; MSKCC PCPR (Prevention Control and Population Research Program) Goldstein Grant; NATIONAL CANCER INSTITUTE [P30CA008748, P50CA092629, R33CA127768] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford, Fundacion Federico SA; MSKCC PCPR (Prevention Control and Population Research Program) Goldstein Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Cancer Institute (grant No R33 CA 127768-03, P50-CA92629); Swedish Cancer Society (11-0624); the Sidney Kimmel Center for Prostate and Urologic Cancers; David H Koch through the Prostate Cancer Foundation, the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford, Fundacion Federico SA, and MSKCC PCPR (Prevention Control and Population Research Program) Goldstein Grant. DU was supported by the David H Koch Young Investigator Award from the Prostate Cancer Foundation.	ANDERSON JR, 1995, UROLOGY, V46, P54, DOI 10.1016/S0090-4295(99)80158-7; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bul M, 2011, EUR UROL, V59, P498, DOI 10.1016/j.eururo.2011.01.001; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; Connolly D, 2008, CANCER EPIDEM BIOMAR, V17, P271, DOI 10.1158/1055-9965.EPI-07-0515; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jonsson H, 2011, INT J CANCER, V129, P1881, DOI 10.1002/ijc.25846; Kalish LA, 1999, UROLOGY, V54, P1022, DOI 10.1016/S0090-4295(99)00349-0; Kuller LH, 2004, CANCER EPIDEM BIOMAR, V13, P373; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mitra AV, 2011, BJU INT, V107, P28, DOI 10.1111/j.1464-410X.2010.09648.x; Moskowitz CS, 2008, STAT MED, V27, P3191, DOI 10.1002/sim.3151; Orsted DD, 2012, EUR UROL, V61, P865, DOI 10.1016/j.eururo.2011.11.007; Roobol MJ, 2005, UROLOGY, V65, P343, DOI 10.1016/j.urology.2004.09.046; Rubin DB, 2004, MULTIPLE IMPUTATION; Sandblom G, 2003, SCAND J UROL NEPHROL, V37, P112, DOI 10.1080/00365590310008839; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7; Ulmert D, 2006, CLIN CHEM, V52, P235, DOI 10.1373/clinchem.2005.050641; Ulmert D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-6; van Leeuwen PJ, 2012, EUR UROL, V61, P171, DOI 10.1016/j.eururo.2011.08.002; van Leeuwen PJ, 2010, CANCER-AM CANCER SOC, V116, P4857, DOI 10.1002/cncr.25474; Vickers AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4521; WHITTEMORE AS, 1995, J NATL CANCER I, V87, P354, DOI 10.1093/jnci/87.5.354	27	130	130	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2013	346								f2023	10.1136/bmj.f2023	http://dx.doi.org/10.1136/bmj.f2023			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131AO	23596126	Green Published, hybrid			2022-12-24	WOS:000317962900002
J	Famm, K; Litt, B; Tracey, KJ; Boyden, ES; Slaoui, M				Famm, Kristoffer; Litt, Brian; Tracey, Kevin J.; Boyden, Edward S.; Slaoui, Moncef			A jump-start for electroceuticals	NATURE			English	Editorial Material									[Famm, Kristoffer] GlaxoSmithKline, Bioelect Res & Dev, Brentford TW8 9GS, England	GlaxoSmithKline	Famm, K (corresponding author), GlaxoSmithKline, Bioelect Res & Dev, Brentford TW8 9GS, England.	kristoffer.h.famm@gsk.com		Tracey, Kevin J/0000-0003-1884-6314	NIGMS NIH HHS [R01 GM057226] Funding Source: Medline; NINDS NIH HHS [R01 NS048598, U24 NS063930] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048598, U24NS063930] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alivisatos AP, 2013, ACS NANO, V7, P1850, DOI 10.1021/nn4012847; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Chow BY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003101; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/NMETH.1993, 10.1038/nmeth.1993]; KOOPMAN FA, 2012, ARTHRITIS RHEUM S, V64; Rapoport BI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042492; Wang ZL, 2012, ANGEW CHEM INT EDIT, V51, P11700, DOI 10.1002/anie.201201656	10	339	350	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2013	496	7444					159	161		10.1038/496159a	http://dx.doi.org/10.1038/496159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	122VM	23579662	Green Accepted, Green Submitted			2022-12-24	WOS:000317346300017
J	Wu, LF; Candille, SI; Choi, Y; Xie, D; Jiang, LH; Li-Pook-Than, J; Tang, H; Snyder, M				Wu, Linfeng; Candille, Sophie I.; Choi, Yoonha; Xie, Dan; Jiang, Lihua; Li-Pook-Than, Jennifer; Tang, Hua; Snyder, Michael			Variation and genetic control of protein abundance in humans	NATURE			English	Article							EXPRESSION; POPULATION; DATABASE; MAP	Gene expression differs among individuals and populations and is thought to be a major determinant of phenotypic variation. Although variation and genetic loci responsible for RNA expression levels have been analysed extensively in human populations(1-5), our knowledge is limited regarding the differences in human protein abundance and the genetic basis for this difference. Variation in messenger RNA expression is not a perfect surrogate for protein expression because the latter is influenced by an array of post-transcriptional regulatory mechanisms, and, empirically, the correlation between protein and mRNA levels is generally modest(6,7). Here we used isobaric tag-based quantitative mass spectrometry to determine relative protein levels of 5,953 genes in lymphoblastoid cell lines from 95 diverse individuals genotyped in the HapMap Project(8,9). We found that protein levels are heritable molecular phenotypes that exhibit considerable variation between individuals, populations and sexes. Levels of specific sets of proteins involved in the same biological process covary among individuals, indicating that these processes are tightly regulated at the protein level. We identified cis-pQTLs (protein quantitative trait loci), including variants not detected by previous transcriptome studies. This study demonstrates the feasibility of high-throughput human proteome quantification that, when integrated with DNA variation and transcriptome information, adds a new dimension to the characterization of gene expression regulation.	[Wu, Linfeng; Candille, Sophie I.; Choi, Yoonha; Xie, Dan; Jiang, Lihua; Li-Pook-Than, Jennifer; Tang, Hua; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	huatang@stanford.edu; mpsnyder@stanford.edu		Snyder, Michael/0000-0003-0784-7987; Tang, Hua/0000-0002-0177-8864	NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Montgomery for providing gene-level RNA sequencing measurements of CEU LCLs. This work was supported by NIH grants to M.S. and H.T.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Agam G, 2009, BIOCHEM SOC T, V37, P1121, DOI 10.1042/BST0371121; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bonnevie-Nielsen V, 2005, AM J HUM GENET, V76, P623, DOI 10.1086/429391; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Li JJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000910; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639	24	246	250	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					79	82		10.1038/nature12223	http://dx.doi.org/10.1038/nature12223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23676674	Green Accepted			2022-12-24	WOS:000321285600037
J	Floyd, SR; Pacold, ME; Huang, QY; Clarke, SM; Lam, FC; Cannell, IG; Bryson, BD; Rameseder, J; Lee, MJ; Blake, EJ; Fydrych, A; Ho, R; Greenberger, BA; Chen, GC; Maffa, A; Del Rosario, AM; Root, DE; Carpenter, AE; Hahn, WC; Sabatini, DM; Chen, CC; White, FM; Bradner, JE; Yaffe, MB				Floyd, Scott R.; Pacold, Michael E.; Huang, Qiuying; Clarke, Scott M.; Lam, Fred C.; Cannell, Ian G.; Bryson, Bryan D.; Rameseder, Jonathan; Lee, Michael J.; Blake, Emily J.; Fydrych, Anna; Ho, Richard; Greenberger, Benjamin A.; Chen, Grace C.; Maffa, Amanda; Del Rosario, Amanda M.; Root, David E.; Carpenter, Anne E.; Hahn, William C.; Sabatini, David M.; Chen, Clark C.; White, Forest M.; Bradner, James E.; Yaffe, Michael B.			The bromodomain protein Brd4 insulates chromatin from DNA damage signalling	NATURE			English	Article							P-TEFB; GAMMA-H2AX; ACTIVATION; TRANSCRIPTION; REPAIR; BREAKS	DNA damage activates a signalling network that blocks cell-cycle progression, recruits DNA repair factors and/or triggers senescence or programmed cell death(1). Alterations in chromatin structure are implicated in the initiation and propagation of the DNA damage response(2). Here we further investigate the role of chromatin structure in the DNA damage response by monitoring ionizing-radiation-induced signalling and response events with a high-content multiplex RNA-mediated interference screen of chromatin-modifying and -interacting genes. We discover that an isoform of Brd4, a bromodomain and extra-terminal (BET) family member, functions as an endogenous inhibitor of DNA damage response signalling by recruiting the condensin II chromatin remodelling complex to acetylated histones through bromodomain interactions. Loss of this isoform results in relaxed chromatin structure, rapid cell-cycle checkpoint recovery and enhanced survival after irradiation, whereas functional gain of this isoform compacted chromatin, attenuated DNA damage response signalling and enhanced radiation-induced lethality. These data implicate Brd4, previously known for its role in transcriptional control, as an insulator of chromatin that can modulate the signalling response to DNA damage.	[Floyd, Scott R.; Pacold, Michael E.; Huang, Qiuying; Clarke, Scott M.; Lam, Fred C.; Cannell, Ian G.; Bryson, Bryan D.; Rameseder, Jonathan; Lee, Michael J.; Blake, Emily J.; Fydrych, Anna; Ho, Richard; Greenberger, Benjamin A.; Chen, Grace C.; Maffa, Amanda; Del Rosario, Amanda M.; White, Forest M.; Yaffe, Michael B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Floyd, Scott R.] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02215 USA; [Pacold, Michael E.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Pacold, Michael E.; Sabatini, David M.] Whitehead Inst, Cambridge, MA 02139 USA; [Root, David E.; Carpenter, Anne E.; Hahn, William C.; Sabatini, David M.; Bradner, James E.; Yaffe, Michael B.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Hahn, William C.; Chen, Clark C.; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chen, Clark C.; Yaffe, Michael B.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [White, Forest M.; Yaffe, Michael B.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Yaffe, Michael B.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu	Cannell, Ian/AAL-7852-2020; Carpenter, Anne/C-4982-2008; Chen, Clark C/C-8714-2013	Cannell, Ian/0000-0001-5832-9210; Carpenter, Anne/0000-0003-1555-8261; Chen, Clark C/0000-0001-6258-9277; /0000-0002-1446-7256; floyd, scott/0000-0002-8067-2426; Greenberger, Benjamin/0000-0002-2262-5867; White, Forest/0000-0002-1545-1651; Lee, Michael/0000-0003-3378-6196	Koch Institute; Center for Environmental Health Sciences National Institutes of Health [P30-CA14051, ES-002109]; SPARC; Holman Pathway Research Resident Seed Grant; American Society for Radiation Oncology Junior Faculty Career Research Training Award; Burroughs Wellcome Career Award for Medical Scientists;  [R01-ES15339];  [1-U54-CA112967-04];  [R21-NS063917]; NATIONAL CANCER INSTITUTE [U54CA112967, P30CA014051, K08CA158149, R21CA109661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109, R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063917] Funding Source: NIH RePORTER	Koch Institute; Center for Environmental Health Sciences National Institutes of Health; SPARC; Holman Pathway Research Resident Seed Grant; American Society for Radiation Oncology Junior Faculty Career Research Training Award; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Le, T. R. Jones and M. Vokes for assistance with screening and image analysis. We thank C. Whittaker, S. Hoersch and M. Moran for computing and data analysis assistance; C. Reinhardt, C. Ellson and A. Gardino for manuscript editing; and P. Filippakopoulos and S. Knapp for discussions. This work was partially supported by the Koch Institute and Center for Environmental Health Sciences National Institutes of Health Core Grants P30-CA14051 and ES-002109; and by grants R01-ES15339, 1-U54-CA112967-04 and R21-NS063917; a SPARC grant to M.B.Y.; and a Holman Pathway Research Resident Seed Grant, American Society for Radiation Oncology Junior Faculty Career Research Training Award, Klarman Scholar, Koch Institute Clinical Investigator Award, and Burroughs Wellcome Career Award for Medical Scientists to S.R.F.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Carey M., 2007, CSH PROTOC, V2007; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Lee HS, 2010, EMBO J, V29, P1434, DOI 10.1038/emboj.2010.27; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Wu N, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-5; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	22	212	239	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					246	+		10.1038/nature12147	http://dx.doi.org/10.1038/nature12147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23728299	Green Accepted, Green Submitted			2022-12-24	WOS:000320283400052
J	Chou, R; Wasson, N				Chou, Roger; Wasson, Ngoc			Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							PLATELET RATIO INDEX; CHRONIC VIRAL-HEPATITIS; SERUM HYALURONIC-ACID; STEPWISE COMBINATION ALGORITHMS; ALANINE AMINOTRANSFERASE RATIO; PREDICTS ADVANCED FIBROSIS; STANDARD LABORATORY TESTS; SIMPLE NONINVASIVE INDEX; LIVER FIBROSIS; BIOCHEMICAL MARKERS	Background: Many blood tests have been proposed as alternatives to liver biopsy for identifying fibrosis or cirrhosis. Purpose: To evaluate the diagnostic accuracy of blood tests to identify fibrosis or cirrhosis in patients with hepatitis C virus (HCV) infection. Data Sources: MEDLINE (1947 to January 2013), the Cochrane Library, and reference lists. Study Selection: Studies that compared the diagnostic accuracy of blood tests with that of liver biopsy. Data Extraction: Investigators abstracted and checked study details and quality by using predefined criteria. Data Synthesis: 172 studies evaluated diagnostic accuracy. For identifying clinically significant fibrosis, the platelet count, age-platelet index, aspartate aminotransferase-platelet ratio index (APRI), FibroIndex, FibroTest, and Forns index had median positive likelihood ratios of 5 to 10 at commonly used cutoffs and areas under the receiver-operating characteristic curve (AUROCs) of 0.70 or greater (range, 0.71 to 0.86). For identifying cirrhosis, the plate-let count, age-platelet index, APRI, and Hepascore had median positive likelihood ratios of 5 to 10 and AUROCs of 0.80 or greater (range, 0.80 to 0.91). The Goteborg University Cirrhosis Index and the Lok index had slightly lower positive likelihood ratios (4.8 and 4.4, respectively). In direct comparisons, the APRI was associated with a slightly lower AUROC than the FibroTest for identifying fibrosis and a substantially higher AUROC than the aspartate aminotransferase-alanine aminotransferase ratio for identifying fibrosis or cirrhosis. Limitation: Only English-language articles were included, and most studies had methodological limitations, including failure to describe blinded interpretation of liver biopsy specimens and inadequate description of enrollment methods. Conclusion: Many blood tests are moderately useful for identifying clinically significant fibrosis or cirrhosis in HCV-infected patients.	[Chou, Roger; Wasson, Ngoc] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Mail Code BICC, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610	AHRQ, Rockville, Maryland [290-2007-10057-I]; Agency for Healthcare Research and Quality	AHRQ, Rockville, Maryland; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.; By AHRQ (contract 290-2007-10057-I, task order 8), Rockville, Maryland.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Adler M, 2008, HEPATOLOGY, V47, P762, DOI 10.1002/hep.22085; *AG HLTH RES QUAL, 2012, AHRQ PUBL, V10; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Alsatie M, 2007, J CLIN GASTROENTEROL, V41, P416, DOI 10.1097/01.mcg.0000225593.93577.64; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Anderson FH, 2000, HEPATOL RES, V18, P63, DOI 10.1016/S1386-6346(99)00085-6; Andriulli A, 2004, J VIRAL HEPATITIS, V11, P536, DOI 10.1111/j.1365-2893.2004.00519.x; [Anonymous], 1997, HEPATOLOGY, V26, pS2; Arabul M, 2012, TURK J GASTROENTEROL, V23, P538, DOI 10.4318/tjg.2012.0358; Arain SA, 2011, SAUDI MED J, V32, P1241; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P331, DOI 10.1080/15321810701603476; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P155, DOI 10.1080/15321810701212088; Attallah AM, 2013, ANN HEPATOL, V12, P44, DOI 10.1016/S1665-2681(19)31384-5; Attallah Abdelfattah M, 2011, Egypt J Immunol, V18, P33; Attallah AM, 2012, CLIN CHIM ACTA, V413, P1725, DOI 10.1016/j.cca.2012.06.031; Attallah AM, 2011, HEPATOL RES, V41, P1075, DOI 10.1111/j.1872-034X.2011.00862.x; Attallah AM, 2006, CLIN CHIM ACTA, V369, P66, DOI 10.1016/j.cca.2006.01.004; Attallah AM, 2006, HEPATOL RES, V34, P163, DOI 10.1016/j.hepres.2005.12.004; Bain VG, 2004, J VIRAL HEPATITIS, V11, P375, DOI 10.1111/j.1365-2893.2004.00520.x; Becker L, 2009, CLIN GASTROENTEROL H, V7, P696, DOI 10.1016/j.cgh.2009.01.010; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bejarano G, 2009, REV ESP ENFERM DIG, V101, P325, DOI 10.4321/s1130-01082009000500004; Ben Jazia E, 2009, INFECT DIS CLIN PRAC, V17, P385; Berg T, 2004, HEPATOLOGY, V39, P1456, DOI 10.1002/hep.20226; Boeker KHW, 2002, CLIN CHIM ACTA, V316, P71, DOI 10.1016/S0009-8981(01)00730-6; Bonacini M, 1997, AM J GASTROENTEROL, V92, P1302; Borroni G, 2006, ALIMENT PHARM THER, V24, P797, DOI 10.1111/j.1365-2036.2006.03034.x; Bota S, 2011, HEPAT MON, V11, P548; Bourliere M, 2008, ALIMENT PHARM THER, V28, P458, DOI 10.1111/j.1365-2036.2008.03742.x; Bourliere M, 2006, J VIRAL HEPATITIS, V13, P659, DOI 10.1111/j.1365-2893.2006.00736.x; Boursier J, 2012, HEPATOLOGY, V55, P58, DOI 10.1002/hep.24654; Boursier J, 2011, AM J GASTROENTEROL, V106, P1255, DOI 10.1038/ajg.2011.100; Boursier J, 2009, EUR J GASTROEN HEPAT, V21, P28, DOI 10.1097/MEG.0b013e32830cebd7; Burton MJ, 2011, SOUTH MED J, V104, P309, DOI 10.1097/SMJ.0b013e318213cf52; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Cales P, 2008, LIVER INT, V28, P1352, DOI 10.1111/j.1478-3231.2008.01789.x; Cales P, 2010, CLIN BIOCHEM, V43, P1315, DOI 10.1016/j.clinbiochem.2010.08.010; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Castera L, 2010, J HEPATOL, V52, P191, DOI 10.1016/j.jhep.2009.11.008; Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x; Cheong JY, 2011, DIGEST DIS SCI, V56, P555, DOI 10.1007/s10620-010-1305-3; Cheung KJ, 2011, EUR J GASTROEN HEPAT, V23, P701, DOI 10.1097/MEG.0b013e3283471b74; Cheung RC, 2008, J CLIN GASTROENTEROL, V42, P827, DOI 10.1097/MCG.0b013e318046ea9a; CHOU R, 2012, COMP EFFECTIVENESS R; Christensen C, 2006, J VIRAL HEPATITIS, V13, P652, DOI 10.1111/j.1365-2893.2006.00743.x; Chrysanthos NV, 2006, EUR J GASTROEN HEPAT, V18, P389, DOI 10.1097/00042737-200604000-00012; Cobbold JFL, 2010, J VIRAL HEPATITIS, V17, P537, DOI 10.1111/j.1365-2893.2009.01209.x; Colletta C, 2005, HEPATOLOGY, V42, P838, DOI 10.1002/hep.20814; Colli A, 2005, WORLD J GASTROENTERO, V11, P7318, DOI 10.3748/wjg.v11.i46.7318; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Crisan D, 2012, HEPAT MON, V12, P177, DOI 10.5812/hepatmon.853; Cross TJS, 2010, J VIRAL HEPATITIS, V17, P546, DOI 10.1111/j.1365-2893.2009.01210.x; Cross TJS, 2009, EUR J GASTROEN HEPAT, V21, P730, DOI 10.1097/MEG.0b013e32830dfcb3; da Silva RG, 2008, BRAZ J INFECT DIS, V12, P15, DOI 10.1590/S1413-86702008000100005; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Deghady A, 2012, GENET TEST MOL BIOMA, V16, P531, DOI 10.1089/gtmb.2011.0098; Dinesen L, 2008, DIGEST LIVER DIS, V40, P743, DOI 10.1016/j.dld.2008.01.013; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Ehsan N, 2008, ARAB J GASTROENTEROL, V9, P7; El-Gindy Iman, 2003, Egypt J Immunol, V10, P27; El-Mezayen HA, 2013, EUR J GASTROEN HEPAT, V25, P69, DOI 10.1097/MEG.0b013e3283594924; El-Sayed Rokaya, 2011, Trop Gastroenterol, V32, P267; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; el-Shorbagy Eman, 2004, J Egypt Soc Parasitol, V34, P459; Fabris C, 2008, CLIN CHEM LAB MED, V46, P253, DOI 10.1515/CCLM.2008.051; Amorim TGF, 2012, ANN HEPATOL, V11, P855; Ferraioli G, 2012, AM J ROENTGENOL, V199, P19, DOI 10.2214/AJR.11.7517; Fontana RJ, 2008, HEPATOLOGY, V47, P789, DOI 10.1002/hep.22099; Fontanges T, 2008, GASTROEN CLIN BIOL, V32, P858, DOI 10.1016/j.gcb.2008.05.019; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Fouad SA, 2012, WORLD J GASTROENTERO, V18, P2988, DOI 10.3748/wjg.v18.i23.2988; Friedrich-Rust M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-103; Gabrielli GB, 1997, CLIN CHIM ACTA, V265, P21, DOI 10.1016/S0009-8981(97)00103-4; Gara N, 2013, CLIN GASTROENTEROL H, V11, P303, DOI 10.1016/j.cgh.2012.10.044; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giannini E, 2003, ARCH INTERN MED, V163, P218, DOI 10.1001/archinte.163.2.218; Giannini E, 2003, HEPATOLOGY, V38, P1312, DOI 10.1053/jhep.2003.50500; Giannini EG, 2006, J CLIN GASTROENTEROL, V40, P521, DOI 10.1097/00004836-200607000-00011; Gordon A, 2005, J GASTROEN HEPATOL, V20, P825, DOI 10.1111/j.1440-1746.2005.03828.x; Grigorescu M, 2007, J GASTROINTEST LIVER, V16, P31; Guechot J, 1996, CLIN CHEM, V42, P558; GUECHOT J, 1994, J HEPATOL, V20, P388, DOI 10.1016/S0168-8278(94)80013-8; Guechot J, 2012, CLIN CHEM LAB MED, V50, P693, DOI 10.1515/cclm-2011-0858; Guechot J, 2010, CLIN CHIM ACTA, V411, P86, DOI 10.1016/j.cca.2009.10.011; Guzelbulut F, 2011, TURK J GASTROENTEROL, V22, P279, DOI 10.4318/tjg.2011.0213; Halfon P, 2006, AM J GASTROENTEROL, V101, P547, DOI 10.1111/j.1572-0241.2006.00411.x; Halfon P, 2007, HEPATOLOGY, V46, P280, DOI 10.1002/hep.21717; Halfon P, 2007, J HEPATOL, V46, P395, DOI 10.1016/j.jhep.2006.09.020; Halfon Philippe, 2005, Comp Hepatol, V4, P6, DOI 10.1186/1476-5926-4-6; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hsieh YY, 2012, WORLD J GASTROENTERO, V18, P746, DOI 10.3748/wjg.v18.i8.746; Hsieh Yung-Yu, 2009, Chang Gung Med J, V32, P614; Iacobellis A, 2005, ALIMENT PHARM THER, V22, P769, DOI 10.1111/j.1365-2036.2005.02633.x; Iacobellis A, 2005, AM J GASTROENTEROL, V100, P868, DOI 10.1111/j.1572-0241.2005.40881.x; Ichino N, 2010, WORLD J GASTROENTERO, V16, P4809, DOI 10.3748/wjg.v16.i38.4809; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Imperiale TF, 2000, AM J GASTROENTEROL, V95, P2328, DOI 10.1111/j.1572-0241.2000.02322.x; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Islam S, 2005, SCAND J GASTROENTERO, V40, P867, DOI 10.1080/00365520510015674; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jeffers Lennox J, 2007, Gastroenterol Hepatol (N Y), V3, P367; Kalantari H, 2011, HEPAT RES TREAT, V2011, DOI DOI 10.1155/2011/972759]; Kaul V, 2002, AM J GASTROENTEROL, V97, P2623, DOI 10.1111/j.1572-0241.2002.06040.x; Khairy M, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.6718; Khan Dilshad Ahmad, 2008, J Ayub Med Coll Abbottabad, V20, P122; Khokhar N, 2003, J Pak Med Assoc, V53, P101; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Koda M, 2007, HEPATOLOGY, V45, P297, DOI 10.1002/hep.21520; Lackner C, 2006, HEPATOLOGY, V43, P378, DOI 10.1002/hep.21037; Lackner C, 2005, HEPATOLOGY, V41, P1376, DOI 10.1002/hep.20717; Lambert J, 2008, CLIN CHEM, V54, P1372, DOI 10.1373/clinchem.2007.097923; Le Calvez S, 2004, HEPATOLOGY, V39, P862, DOI 10.1002/hep.20099; Leroy V, 2004, AM J GASTROENTEROL, V99, P271, DOI 10.1111/j.1572-0241.2004.04055.x; Leroy V, 2008, CLIN BIOCHEM, V41, P1368, DOI 10.1016/j.clinbiochem.2008.06.020; Leroy V, 2007, J HEPATOL, V46, P775, DOI 10.1016/j.jhep.2006.12.013; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Liu CH, 2006, LIVER INT, V26, P1087, DOI 10.1111/j.1478-3231.2006.01355.x; Lo Iacono O, 1998, ALIMENT PHARM THERAP, V12, P1091; Loaeza-del-Castillo A, 2008, ANN HEPATOL, V7, P350, DOI 10.1016/S1665-2681(19)31836-8; Lok ASF, 2005, HEPATOLOGY, V42, P282, DOI 10.1002/hep.20772; Lu SN, 2006, CANCER-AM CANCER SOC, V107, P2212, DOI 10.1002/cncr.22242; Luo JC, 2002, HEPATO-GASTROENTEROL, V49, P478; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Martinez SM, 2011, ALIMENT PHARM THER, V33, P138, DOI 10.1111/j.1365-2036.2010.04500.x; McHutchison JG, 2000, J GASTROEN HEPATOL, V15, P945, DOI 10.1046/j.1440-1746.2000.02233.x; Metwally MA, 2007, DIGEST DIS SCI, V52, P582, DOI 10.1007/s10620-006-9366-z; Morali G, 2007, ISR MED ASSOC J, V9, P588; Morra R, 2007, ALIMENT PHARM THER, V26, P847, DOI 10.1111/j.1365-2036.2007.03427.x; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Mossong Joel, 2011, Bull Soc Sci Med Grand Duche Luxemb, P19; Murawaki Y, 2001, J GASTROEN HEPATOL, V16, P777, DOI 10.1046/j.1440-1746.2001.02515.x; Murawaki Y, 2001, J GASTROENTEROL, V36, P399, DOI 10.1007/s005350170084; Myers RP, 2003, DIGEST DIS SCI, V48, P146, DOI 10.1023/A:1021702902681; Myers RP, 2002, AM J GASTROENTEROL, V97, P2419, DOI 10.1111/j.1572-0241.2002.05997.x; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Obrador BD, 2006, EUR J GASTROEN HEPAT, V18, P57, DOI 10.1097/00042737-200601000-00010; Obuchowski NA, 2005, ACAD RADIOL, V12, P1198, DOI 10.1016/j.acra.2005.05.013; Ohta T, 2006, ACTA MED OKAYAMA, V60, P77; Omran Mohamed M, 2011, Arab J Gastroenterol, V12, P74, DOI 10.1016/j.ajg.2011.04.006; Paggi S, 2008, J HEPATOL, V49, P564, DOI 10.1016/j.jhep.2008.07.007; Parise ER, 2006, LIVER INT, V26, P1095, DOI 10.1111/j.1478-3231.2006.01356.x; Park G, 2005, AM J GASTROENTEROL, V100, P1623, DOI 10.1111/j.1572-0241.2005.50006_6.x; Park GJH, 2000, J GASTROEN HEPATOL, V15, P386, DOI 10.1046/j.1440-1746.2000.02172.x; Park JJ, 2011, HEPATO-GASTROENTEROL, V58, P1321, DOI 10.5754/hge11041; Park Joong-Won, 2005, Korean J Gastroenterol, V45, P217; Park SH, 2011, CLIN BIOCHEM, V44, P1396, DOI 10.1016/j.clinbiochem.2011.08.1151; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Patel K, 2009, J VIRAL HEPATITIS, V16, P178, DOI 10.1111/j.1365-2893.2008.01062.x; Patel K, 2004, J HEPATOL, V41, P935, DOI 10.1016/j.jhep.2004.08.008; Pham B, 2005, J CLIN EPIDEMIOL, V58, P769, DOI 10.1016/j.jclinepi.2004.08.021; Plevris JN, 2000, EUR J GASTROEN HEPAT, V12, P1121, DOI 10.1097/00042737-200012100-00009; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Poynard T, 2003, HEPATOLOGY, V38, P481, DOI 10.1053/jhep.2003.50319; Poynard T, 2002, J VIRAL HEPATITIS, V9, P128, DOI 10.1046/j.1365-2893.2002.00341.x; Poynard T, 1997, J VIRAL HEPATITIS, V4, P199, DOI 10.1046/j.1365-2893.1997.00141.x; Poynard T, 2007, CLIN CHEM, V53, P1615, DOI 10.1373/clinchem.2007.085795; Poynard T, 2010, ANTIVIR THER, V15, P617, DOI 10.3851/IMP1570; Pradat P, 2002, HEPATOLOGY, V36, P973, DOI 10.1053/jhep.2002.35530; Reedy DW, 1998, DIGEST DIS SCI, V43, P2156, DOI 10.1023/A:1018888021118; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Renou C, 2001, AM J GASTROENTEROL, V96, P1657, DOI 10.1111/j.1572-0241.2001.03830.x; Romagnuolo J, 2001, AM J GASTROENTEROL, V96, P3165, DOI 10.1111/j.1572-0241.2001.05275.x; Romera M, 2006, REV ESP ENFERM DIG, V98, P161, DOI 10.4321/s1130-01082006000300002; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Rossi E, 2003, CLIN CHEM, V49, P450, DOI 10.1373/49.3.450; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Said Yosra, 2010, Tunis Med, V88, P573; Saitou Y, 2005, WORLD J GASTROENTERO, V11, P476, DOI 10.3748/wjg.v11.i4.476; Schiano TD, 2005, CLIN GASTROENTEROL H, V3, P930, DOI 10.1016/S1542-3565(05)00541-0; Schneider ARJ, 2006, CLIN EXP PHARMACOL P, V33, P300, DOI 10.1111/j.1440-1681.2006.04365.x; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Sebastiani G, 2012, ALIMENT PHARM THER, V35, P92, DOI 10.1111/j.1365-2036.2011.04897.x; Sebastiani G, 2011, ALIMENT PHARM THER, V34, P1202, DOI 10.1111/j.1365-2036.2011.04861.x; Sebastiani G, 2009, HEPATOLOGY, V49, P1821, DOI 10.1002/hep.22859; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Shaheen AAM, 2007, HEPATOLOGY, V46, P912, DOI 10.1002/hep.21835; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Shlomai A, 2013, J VIRAL HEPATITIS, V20, P95, DOI 10.1111/j.1365-2893.2012.01628.x; Silva ISS, 2004, J GASTROEN HEPATOL, V19, P314, DOI 10.1111/j.1440-1746.2003.03256.x; Sirli R, 2010, HEPAT MON, V10, P88; Snyder N, 2007, CLIN CHIM ACTA, V381, P119, DOI 10.1016/j.cca.2007.02.046; Snyder N, 2006, J CLIN GASTROENTEROL, V40, P535, DOI 10.1097/00004836-200607000-00013; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Stibbe KJM, 2011, SCAND J GASTROENTERO, V46, P962, DOI 10.3109/00365521.2011.574725; Sud A, 2004, HEPATOLOGY, V39, P1239, DOI 10.1002/hep.20207; Testa R, 2006, J INTERN MED, V260, P142, DOI 10.1111/j.1365-2796.2006.01673.x; Thabut D, 2003, HEPATOLOGY, V37, P1220, DOI 10.1053/jhep.2003.50109; Trocme C, 2006, J VIRAL HEPATITIS, V13, P643, DOI 10.1111/j.1365-2893.2006.00730.x; Usluer G, 2012, EUR J CLIN MICROBIOL, V31, P1873, DOI 10.1007/s10096-011-1513-6; Uyar C, 2010, INDIAN J PATHOL MICR, V53, P470, DOI 10.4103/0377-4929.68281; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Viana MSVB, 2009, ANN HEPATOL, V8, P26, DOI 10.1016/S1665-2681(19)31807-1; Verbaan H, 1997, SCAND J GASTROENTERO, V32, P494, DOI 10.3109/00365529709025088; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Walsh KM, 2000, J HEPATOL, V32, P325, DOI 10.1016/S0168-8278(00)80079-3; Walsh KM, 1999, DIGEST DIS SCI, V44, P624, DOI 10.1023/A:1026630129025; Walsh KM, 1999, EUR J GASTROEN HEPAT, V11, P827, DOI 10.1097/00042737-199908000-00003; West J, 2010, GASTROENTEROLOGY, V139, P1230, DOI 10.1053/j.gastro.2010.06.015; Westin J, 2008, SCAND J GASTROENTERO, V43, P73, DOI 10.1080/00365520701514461; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WILLIAMS ALB, 1988, GASTROENTEROLOGY, V95, P734, DOI 10.1016/S0016-5085(88)80022-2; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091; Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x; Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1002/hep.510230607; Yilmaz Y, 2011, HEPAT MON, V11, P103; Zaman A, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.06.044; Zarski JP, 2012, J HEPATOL, V56, P55, DOI 10.1016/j.jhep.2011.05.024; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960; ZWEIG MH, 1993, CLIN CHEM, V39, P561	215	240	245	2	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2013	158	11					807	+		10.7326/0003-4819-158-11-201306040-00005	http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00005			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164AA	23732714				2022-12-24	WOS:000320379800004
J	Wang, XF; Ha, T				Wang, Xuefeng; Ha, Taekjip			Defining Single Molecular Forces Required to Activate Integrin and Notch Signaling	SCIENCE			English	Article							LIGAND ENDOCYTOSIS; MECHANICAL FORCE; TRACTION FORCE; CELL; TENSION; MECHANOTRANSDUCTION; DNA	Cell-cell and cell-matrix mechanical interactions through membrane receptors direct a wide range of cellular functions and orchestrate the development of mutticeltular organisms. To define the single molecular forces required to activate signaling through a ligand-receptor bond, we developed the tension gauge tether (TGT) approach in which the ligand is immobilized to a surface through a rupturable tether before receptor engagement. TGT serves as an autonomous gauge to restrict the receptor-ligand tension. Using a range of tethers with tunable tension tolerances, we show that cells apply a universal peak tension of about 40 piconewtons (pN) to single integrin-ligand bonds during initial adhesion. We find that less than 12 pN is required to activate Notch receptors. TGT can also provide a defined molecular mechanical cue to regulate cellular functions.	[Wang, Xuefeng; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA; [Wang, Xuefeng; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Ctr Phys Living Cells, Dept Phys, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009; Wang, Xuefeng/G-1663-2011	Ha, Taekjip/0000-0003-2195-6258; Wang, Xuefeng/0000-0002-3301-3196	National Science Foundation through the Physics Frontiers Center Program [0822613]	National Science Foundation through the Physics Frontiers Center Program	We thank I. D. Bernstein for the generous gift of DLL1. We also appreciate the genetically modified CHO-K1 cull line for Notch study provided by M. B. Elowitz. We thank Q. Xu, N. Wang, and Y. Wang for carefully reading the manuscript. Funding was provided by the National Science Foundation through the Physics Frontiers Center Program (0822613). T.H. is an investigator with the Howard Hughes Medical Institute.	Albrecht C, 2003, SCIENCE, V301, P367, DOI 10.1126/science.1084713; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Hatch K, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011920; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li Z, 2009, NANO LETT, V9, P3575, DOI 10.1021/nl901774m; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parks AL, 2000, DEVELOPMENT, V127, P1373; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Shergill B, 2012, DEV CELL, V22, P1313, DOI 10.1016/j.devcel.2012.04.007; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stabley DR, 2012, NAT METHODS, V9, P64, DOI [10.1038/NMETH.1747, 10.1038/nmeth.1747]; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	31	318	326	14	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					991	994		10.1126/science.1231041	http://dx.doi.org/10.1126/science.1231041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23704575	Green Accepted			2022-12-24	WOS:000319344100051
J	Yang, CF; Chiang, MC; Gray, DC; Prabhakaran, M; Alvarado, M; Juntti, SA; Unger, EK; Wells, JA; Shah, NM				Yang, Cindy F.; Chiang, Michael C.; Gray, Daniel C.; Prabhakaran, Mahalakshmi; Alvarado, Maricruz; Juntti, Scott A.; Unger, Elizabeth K.; Wells, James A.; Shah, Nirao M.			Sexually Dimorphic Neurons in the Ventromedial Hypothalamus Govern Mating in Both Sexes and Aggression in Males	CELL			English	Article							PROGESTERONE-RECEPTOR IMMUNOREACTIVITY; FEMALE GUINEA-PIGS; MALE-RATS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; LORDOSIS REFLEX; REPRODUCTIVE-BEHAVIOR; EFFERENT CONNECTIONS; OVARIECTOMIZED RATS; MEDIAL AMYGDALA	Sexual dimorphisms in the brain underlie behavioral sex differences, but the function of individual sexually dimorphic neuronal populations is poorly understood. Neuronal sexual dimorphisms typically represent quantitative differences in cell number, gene expression, or other features, and it is unknown whether these dimorphisms control sex-typical behavior exclusively in one sex or in both sexes. The progesterone receptor (PR) controls female sexual behavior, and we find many sex differences in number, distribution, or projections of PR-expressing neurons in the adult mouse brain. Using a genetic strategy we developed, we have ablated one such dimorphic PR-expressing neuronal population located in the ventromedial hypothalamus (VMH). Ablation of these neurons in females greatly diminishes sexual receptivity. Strikingly, the corresponding ablation in males reduces mating and aggression. Our findings reveal the functions of a molecularly defined, sexually dimorphic neuronal population in the brain. Moreover, we show that sexually dimorphic neurons can control distinct sex-typical behaviors in both sexes.	[Yang, Cindy F.; Juntti, Scott A.; Shah, Nirao M.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Yang, Cindy F.; Chiang, Michael C.; Prabhakaran, Mahalakshmi; Alvarado, Maricruz; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Gray, Daniel C.; Wells, James A.] Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Unger, Elizabeth K.; Shah, Nirao M.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shah, NM (corresponding author), Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA.	nms@ucsf.edu	Core, Vector/CAF-4832-2022; Wells, Jim A/O-9854-2016	Unger, Elizabeth/0000-0002-8235-7534; Juntti, Scott/0000-0001-7634-1395; Yang, Cindy/0000-0001-6144-4658	Genentech Graduate Fellowship; National Science Foundation Graduate Fellowship; National Institutes of Health (NIH) [F31N5078959]; Brain and Behavior Research Foundation Program in Biomedical Breakthrough Research; Ellison Medical Foundation; NIH [R01N5049488, DP1MH099900]; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488, F31NS078959, R01NS083872] Funding Source: NIH RePORTER	Genentech Graduate Fellowship; National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation Program in Biomedical Breakthrough Research; Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Saper for sharing reagents; A. Lasek and U. Heberlein for a practical on stereotaxis; R. Axel for discussions; R. Axel, T. Clandinin, H. Ingraham, S. Lomvardas, C. Saper, and members of the Shah lab for comments on the manuscript; and N. Agarwal, A. Wang, and M. Bonus for technical support. This work was supported by a Genentech Graduate Fellowship (C.F.Y.); a National Science Foundation Graduate Fellowship (S.A.J.); the National Institutes of Health (NIH) grant F31N5078959 (E.K.U.); the Brain and Behavior Research Foundation Program in Biomedical Breakthrough Research, Ellison Medical Foundation; and NIH grants R01N5049488 and DP1MH099900 (N.M.S.).	Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Bard P, 1928, AM J PHYSIOL, V84, P490, DOI 10.1152/ajplegacy.1928.84.3.490; BARDE I, 2001, CURRENT PROTOCOLS NE; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BLAUSTEIN JD, 1980, NEUROENDOCRINOLOGY, V31, P403, DOI 10.1159/000123110; BLAUSTEIN JD, 1979, BRAIN RES, V169, P481, DOI 10.1016/0006-8993(79)90398-6; Blaustein JD, 2008, ANNU REV PSYCHOL, V59, P93, DOI 10.1146/annurev.psych.59.103006.093556; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Brown TJ, 1996, BRAIN RES, V725, P37, DOI 10.1016/0006-8993(96)00241-7; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Chappell PE, 1997, ENDOCRINOLOGY, V138, P4147, DOI 10.1210/en.138.10.4147; CLEMENTE CD, 1973, ANNU REV PHYSIOL, V35, P329, DOI 10.1146/annurev.ph.35.030173.001553; COHEN RS, 1992, PROG NEUROBIOL, V38, P423, DOI 10.1016/0301-0082(92)90045-G; COLPAERT FC, 1976, BEHAV BIOL, V16, P117, DOI 10.1016/S0091-6773(76)91225-6; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Darwin G., 1871, P423; De Vries GJ, 2006, NEUROSCIENCE, V138, P947, DOI 10.1016/j.neuroscience.2005.07.050; De Vries GJ, 1998, BEHAV BRAIN RES, V92, P205, DOI 10.1016/S0166-4328(97)00192-7; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; DEVRIES GJ, 1990, J NEUROENDOCRINOL, V2, P1, DOI 10.1111/j.1365-2826.1990.tb00385.x; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dugger BN, 2007, HORM BEHAV, V51, P195, DOI 10.1016/j.yhbeh.2006.10.001; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Flanagan-Cato LM, 2006, HORM BEHAV, V50, P52, DOI 10.1016/j.yhbeh.2006.01.012; Flanagan-Cato LM, 2011, FRONT NEUROENDOCRIN, V32, P124, DOI 10.1016/j.yfrne.2011.02.008; Gagnidze K, 2010, PROG BRAIN RES, V186, P97, DOI 10.1016/B978-0-444-53630-3.00007-5; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; GOY RW, 1963, J REPROD FERTIL, V5, P23, DOI 10.1530/jrf.0.0050023; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Grgurevic N, 2012, HORM BEHAV, V61, P719, DOI 10.1016/j.yhbeh.2012.03.008; GROSSMAN SP, 1972, J COMP PHYSIOL PSYCH, V78, P274, DOI 10.1037/h0032284; Harvey W., 1651, WORKS W HARVEY, P186; HESS WR, 1955, ARCH NEURO PSYCHIATR, V73, P127, DOI 10.1001/archneurpsyc.1955.02330080005003; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kelley DB, 1997, CURR OPIN NEUROBIOL, V7, P839, DOI 10.1016/S0959-4388(97)80144-4; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; KONISHI M, 1989, NEURON, V3, P541, DOI 10.1016/0896-6273(89)90264-X; KOW LM, 1985, BRAIN RES, V341, P26, DOI 10.1016/0006-8993(85)91468-4; KRIEGER MS, 1979, J COMP NEUROL, V183, P785, DOI 10.1002/cne.901830408; KRUK MR, 1979, BEHAVIOUR, V70, P292, DOI 10.1163/156853979X00106; Kudwa AE, 2009, PHYSIOL BEHAV, V97, P146, DOI 10.1016/j.physbeh.2009.02.023; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; LAVAQUE TJ, 1975, PHYSIOL BEHAV, V14, P59, DOI 10.1016/0031-9384(75)90142-0; Leal S, 1998, J COMP NEUROL, V401, P65, DOI 10.1002/(SICI)1096-9861(19981109)401:1<65::AID-CNE5>3.0.CO;2-D; LEEDY MG, 1985, BEHAV NEUROSCI, V99, P936, DOI 10.1037/0735-7044.99.5.936; Levine JE, 2001, FRONT NEUROENDOCRIN, V22, P69, DOI 10.1006/frne.2001.0210; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Mani SK, 1997, HORM BEHAV, V31, P244, DOI 10.1006/hbeh.1997.1393; MANI SK, 1994, ENDOCRINOLOGY, V135, P1409, DOI 10.1210/en.135.4.1409; MANI SK, 1994, SCIENCE, V265, P1246, DOI 10.1126/science.7915049; MATHEWS D, 1977, HORM BEHAV, V8, P40, DOI 10.1016/0018-506X(77)90019-8; MATHEWS D, 1977, PHYSIOL BEHAV, V19, P319, DOI 10.1016/0031-9384(77)90345-6; MATSUMOTO A, 1986, NEUROENDOCRINOLOGY, V42, P232, DOI 10.1159/000124445; MATSUMOTO A, 1983, ENDOCRINOL JAPON, V30, P277; MAXWELL IH, 1986, CANCER RES, V46, P4660; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McGILL THOMAS E., 1962, BEHAVIOUR, V19, P341, DOI 10.1163/156853962X00087; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Morris JA, 2008, J COMP NEUROL, V506, P851, DOI 10.1002/cne.21536; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; NYBY J, 1977, ANIM BEHAV, V25, P333, DOI 10.1016/0003-3472(77)90009-4; OGAWA S, 1994, J NEUROSCI, V14, P1766, DOI 10.1523/JNEUROSCI.14-03-01766.1994; OLIVIER B, 1974, BRAIN RES, V65, P521, DOI 10.1016/0006-8993(74)90241-8; OLSTER DH, 1990, J NEUROBIOL, V21, P768, DOI 10.1002/neu.480210510; Patisaul HB, 2008, ENDOCRINOLOGY, V149, P397, DOI 10.1210/en.2007-0666; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; Phelps SM, 1998, HORM BEHAV, V34, P294, DOI 10.1006/hbeh.1998.1485; POLLIO G, 1993, MOL BRAIN RES, V19, P135, DOI 10.1016/0169-328X(93)90158-L; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; Quadros PS, 2008, DEV NEUROBIOL, V68, P1378, DOI 10.1002/dneu.20664; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; REEVES AG, 1969, ARCH NEUROL-CHICAGO, V20, P616, DOI 10.1001/archneur.1969.00480120062005; RICCIARDI KHN, 1994, J NEUROENDOCRINOL, V6, P135, DOI 10.1111/j.1365-2826.1994.tb00564.x; Robarts DW, 2007, HORM BEHAV, V51, P104, DOI 10.1016/j.yhbeh.2006.08.009; RUBIN BS, 1983, NEUROENDOCRINOLOGY, V37, P218, DOI 10.1159/000123546; SAKUMA Y, 1979, AM J PHYSIOL, V237, pR278, DOI 10.1152/ajpregu.1979.237.5.R278; SAPER CB, 1976, J COMP NEUROL, V169, P409, DOI 10.1002/cne.901690403; Schneider JS, 2009, BEHAV BRAIN RES, V199, P340, DOI 10.1016/j.bbr.2008.12.019; Schneider JS, 2005, ENDOCRINOLOGY, V146, P4340, DOI 10.1210/en.2005-0490; Schober J, 2011, HORM BEHAV, V59, P689, DOI 10.1016/j.yhbeh.2010.10.005; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SMITH RL, 1995, J VIROL, V69, P4593, DOI 10.1128/JVI.69.8.4593-4599.1995; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Swaab D., 2003, HUMAN HYPOTHALAMUS 1, P239; Tsutsui K, 2012, CEREBELLUM, V11, P414, DOI 10.1007/s12311-011-0341-7; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Wheatley MD, 1944, ARCH NEURO PSYCHIATR, V52, P296, DOI 10.1001/archneurpsyc.1944.02290340043004; WITT DM, 1995, PHYSIOL BEHAV, V57, P307, DOI 10.1016/0031-9384(94)00247-3; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	108	340	343	3	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					896	909		10.1016/j.cell.2013.04.017	http://dx.doi.org/10.1016/j.cell.2013.04.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663785	Green Accepted, Bronze			2022-12-24	WOS:000318844000017
J	Roca, FJ; Ramakrishnan, L				Roca, Francisco J.; Ramakrishnan, Lalita			TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species	CELL			English	Article							TUMOR-NECROSIS-FACTOR; CELL-DEATH; PERMEABILITY TRANSITION; INFLAMMATORY RESPONSE; PROGRAMMED NECROSIS; TUBERCULOSIS; ZEBRAFISH; APOPTOSIS; KINASE; LOCUS	Tumor necrosis factor (TNF) constitutes a critical host defense against tuberculosis, but its excess is also implicated in tuberculosis pathogenesis in zebrafish and humans. Using the zebrafish, we elucidate the pathways by which TNF mediates tuberculosis pathogenesis. TNF excess induces mitochondrial reactive oxygen species (ROS) in infected macrophages through RIP1-RIP3-dependent pathways. While initially increasing macrophage microbicidal activity, ROS rapidly induce programmed necrosis (necroptosis) and release mycobacteria into the growth-permissive extracellular milieu. TNF-induced necroptosis occurs through two pathways: modulation of mitochondrial cyclophilin D, implicated in mitochondrial permeability transition pore formation, and acid sphingomyelinase-mediated ceramide production. Combined genetic blockade of cyclophilin D and acid sphingomyelinase renders the high TNF state hyperresistant by preventing macrophage necrosis while preserving increased microbicidal activity. Similarly, the cyclophilin D-inhibiting drug alisporivir and the acid sphingomyelinase-inactivating drug, desipramine, synergize to reverse susceptibility, suggesting the therapeutic potential of these orally active drugs against tuberculosis and possibly other TNF-mediated diseases.	[Roca, Francisco J.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@uw.edu		Ramakrishnan, Lalita/0000-0003-0692-5533	NIH; NWRCE for Biodefense and Emerging Infectious Diseases Research; educational ministry of Spain; NIH Director's Pioneer Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036396, R37AI054503] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006782] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWRCE for Biodefense and Emerging Infectious Diseases Research; educational ministry of Spain; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. Lei and Novartis for the gifts of necrosulfonamide and alisporivir, respectively, C.-T. Yang for the Tg(mpeg1: YFP) zebrafish line; A. Oberst and D. Tobin for advice and discussion; C. Cosma for advice on statistical analysis; A. Pagan, J. Szumowski, C. Cosma, A. Oberst, D. Tobin, and K. Takaki for manuscript review; and J. Cameron for fish facility management. Funded by grants from the NIH and the NWRCE for Biodefense and Emerging Infectious Diseases Research (L.R.), and a postdoctoral fellowship from the educational ministry of Spain (F.J.R). L.R. is a recipient of the NIH Director's Pioneer Award.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Berg RD, 2012, TRENDS MOL MED, V18, P689, DOI 10.1016/j.molmed.2012.10.002; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cirillo SLG, 2009, INFECT IMMUN, V77, P2557, DOI 10.1128/IAI.01481-08; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; CROMPTON M, 1988, BIOCHEM J, V255, P357; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Galluzzi L, 2011, INT REV CEL MOL BIO, V289, P1, DOI 10.1016/B978-0-12-386039-2.00001-8; He SN, 2012, J PATHOL, V227, P431, DOI 10.1002/path.4013; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Keystone EC, 2010, J RHEUMATOL, V37, P27, DOI 10.3899/jrheum.091463; Kim HJ, 2010, ARCH PHARM RES, V33, P1813, DOI 10.1007/s12272-010-1114-4; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kweon SM, 2001, BIOSCIENCE REP, V21, P341, DOI 10.1023/A:1013290316939; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Schoeman JF, 1997, PEDIATRICS, V99, P226, DOI 10.1542/peds.99.2.226; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sohn H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002435; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su FY, 2007, ZEBRAFISH, V4, P187, DOI 10.1089/zeb.2007.0505; Subbian S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-4; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takaki K, 2012, CELL REP, V2, P175, DOI 10.1016/j.celrep.2012.06.008; Thon L, 2005, FASEB J, V19, P1945, DOI 10.1096/fj.05-3726com; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	60	373	389	3	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					521	534		10.1016/j.cell.2013.03.022	http://dx.doi.org/10.1016/j.cell.2013.03.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23582643	Green Accepted, Bronze			2022-12-24	WOS:000318063500007
J	Salimpoor, VN; van den Bosch, I; Kovacevic, N; McIntosh, AR; Dagher, A; Zatorre, RJ				Salimpoor, Valorie N.; van den Bosch, Iris; Kovacevic, Natasa; McIntosh, Anthony Randal; Dagher, Alain; Zatorre, Robert J.			Interactions Between the Nucleus Accumbens and Auditory Cortices Predict Music Reward Value	SCIENCE			English	Article							DOPAMINE; ERRORS; BRAIN; STRIATUM; CORTEX	We used functional magnetic resonance imaging to investigate neural processes when music gains reward value the first time it is heard. The degree of activity in the mesolimbic striatal regions, especially the nucleus accumbens, during music listening was the best predictor of the amount listeners were willing to spend on previously unheard music in an auction paradigm. Importantly, the auditory cortices, amygdala, and ventromedial prefrontal regions showed increased activity during listening conditions requiring valuation, but did not predict reward value, which was instead predicted by increasing functional connectivity of these regions with the nucleus accumbens as the reward value increased. Thus, aesthetic rewards arise from the interaction between mesolimbic reward circuitry and cortical networks involved in perceptual analysis and valuation.	[Salimpoor, Valorie N.; Dagher, Alain; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Salimpoor, Valorie N.; Kovacevic, Natasa; McIntosh, Anthony Randal] Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Salimpoor, Valorie N.; Zatorre, Robert J.] BRAMS Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada; [van den Bosch, Iris] Univ Utrecht, NL-3508 TC Utrecht, Netherlands	McGill University; University of Toronto; University Toronto Affiliates; Baycrest; Universite de Montreal; Utrecht University	Salimpoor, VN (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	vsalimpoor@research.baycrest.org		McIntosh, Anthony/0000-0002-1784-5662	Canadian Institutes for Health Research; Canada Fund for Innovation; Natural Science and Engineering Research Council (CREATE); Montreal Neurological Institute (MNI); Centre for Interdisciplinary Research in Music Media and Technology	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Fund for Innovation(Canada Foundation for Innovation); Natural Science and Engineering Research Council (CREATE); Montreal Neurological Institute (MNI); Centre for Interdisciplinary Research in Music Media and Technology	Funding for this work was provided via grants from the Canadian Institutes for Health Research and the Canada Fund for Innovation (to R.J.Z.) and awards from the Natural Science and Engineering Research Council (CREATE), Montreal Neurological Institute (MNI), and the Centre for Interdisciplinary Research in Music Media and Technology (to V.N.S.). We thank the staff of the MNI McConnell Brain Imaging Centre. The authors have no conflicts of interest to report.	BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Bharucha J. J., 1994, MUSICAL PERCEPTIONS, P213; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Huron D.B., 2006, SWEET ANTICIPATION M; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Kuss K, 2013, SOC COGN AFFECT NEUR, V8, P216, DOI 10.1093/scan/nsr088; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; MELIS MR, 1995, NEUROSCI BIOBEHAV R, V19, P19, DOI 10.1016/0149-7634(94)00020-2; Meyer L., 1956, EMOTION MEANING MUSI; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zatorre RJ, 2012, SPRINGER HANDB AUDIT, V43, P261, DOI 10.1007/978-1-4614-2314-0_10	26	323	333	7	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					216	219		10.1126/science.1231059	http://dx.doi.org/10.1126/science.1231059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580531				2022-12-24	WOS:000317341400060
J	Roychoudhuri, R; Hirahara, K; Mousavi, K; Clever, D; Klebanoff, CA; Bonelli, M; Sciume, G; Zare, H; Vahedi, G; Dema, B; Yu, ZY; Liu, H; Takahashi, H; Rao, M; Muranski, P; Crompton, JG; Punkosdy, G; Bedognetti, D; Wang, E; Hoffmann, V; Rivera, J; Marincola, FM; Nakamura, A; Sartorelli, V; Kanno, Y; Gattinoni, L; Muto, A; Igarashi, K; O'Shea, JJ; Restifo, NP				Roychoudhuri, Rahul; Hirahara, Kiyoshi; Mousavi, Kambiz; Clever, David; Klebanoff, Christopher A.; Bonelli, Michael; Sciume, Giuseppe; Zare, Hossein; Vahedi, Golnaz; Dema, Barbara; Yu, Zhiya; Liu, Hui; Takahashi, Hayato; Rao, Mahadev; Muranski, Pawel; Crompton, Joseph G.; Punkosdy, George; Bedognetti, Davide; Wang, Ena; Hoffmann, Victoria; Rivera, Juan; Marincola, Francesco M.; Nakamura, Atsushi; Sartorelli, Vittorio; Kanno, Yuka; Gattinoni, Luca; Muto, Akihiko; Igarashi, Kazuhiko; O'Shea, John J.; Restifo, Nicholas P.			BACH2 represses effector programs to stabilize T-reg-mediated immune homeostasis	NATURE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; CELL-DIFFERENTIATION; SUSCEPTIBILITY LOCI; RISK LOCI; B-CELLS; TRANSCRIPTION; DISEASE; INTERLEUKIN-4; METAANALYSIS	Through their functional diversification, distinct lineages of CD4(+) T cells can act to either drive or constrain immune-mediated pathology. Transcription factors are critical in the generation of cellular diversity, and negative regulators antagonistic to alternate fates often act in conjunction with positive regulators to stabilize lineage commitment(1). Genetic polymorphisms within a single locus encoding the transcription factor BACH2 are associated with numerous autoimmune and allergic diseases including asthma(2), Crohn's disease(3,4), coeliac disease(5), vitiligo(6), multiple sclerosis(7) and type 1 diabetes(8). Although these associations point to a shared mechanism underlying susceptibility to diverse immune-mediated diseases, a function for BACH2 in the maintenance of immune homeostasis has not been established. Here, by studying mice in which the Bach2 gene is disrupted, we define BACH2 as a broad regulator of immune activation that stabilizes immunoregulatory capacity while repressing the differentiation programs of multiple effector lineages in CD4(+) T cells. BACH2 was required for efficient formation of regulatory (T-reg) cells and consequently for suppression of lethal inflammation in a manner that was T-reg-cell-dependent. Assessment of the genome-wide function of BACH2, however, revealed that it represses genes associated with effector cell differentiation. Consequently, its absence during T-reg polarization resulted in inappropriate diversion to effector lineages. In addition, BACH2 constrained full effector differentiation within T(H)1, T(H)2 and T(H)17 cell lineages. These findings identify BACH2 as a key regulator of CD4(+) T-cell differentiation that prevents inflammatory disease by controlling the balance between tolerance and immunity.	[Roychoudhuri, Rahul; Clever, David; Klebanoff, Christopher A.; Yu, Zhiya; Rao, Mahadev; Muranski, Pawel; Crompton, Joseph G.; Gattinoni, Luca; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hirahara, Kiyoshi; Bonelli, Michael; Sciume, Giuseppe; Vahedi, Golnaz; Takahashi, Hayato; Kanno, Yuka; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA; [Mousavi, Kambiz; Zare, Hossein; Sartorelli, Vittorio] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Dema, Barbara; Rivera, Juan] NIAMS, Lab Mol Immunogenet, NIH, Bethesda, MD 20892 USA; [Liu, Hui; Bedognetti, Davide; Wang, Ena; Marincola, Francesco M.] NIH, Dept Transfus Med, Bethesda, MD 20892 USA; [Punkosdy, George] NIAID, NIH, Bethesda, MD 20892 USA; [Hoffmann, Victoria] NIH, Div Vet Resources, Bethesda, MD 20892 USA; [Marincola, Francesco M.] Sidra Med & Res Ctr, Doha, Qatar; [Nakamura, Atsushi; Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; [Muto, Akihiko; Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi 9808575, Japan; [Restifo, Nicholas P.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; Sidra Medical & Research Center; Tohoku University; Japan Science & Technology Agency (JST); National Institutes of Health (NIH) - USA	Roychoudhuri, R (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	roychoudhuri@mail.nih.gov; osheajo@mail.nih.gov; restifo@nih.gov	Hirahara, Kiyoshi/E-2460-2017; Roychoudhuri, Rahul/A-7442-2010; Sciume, Giuseppe/K-8985-2016; Kanno, Yuka/B-5802-2013; Gattinoni, Luca/A-2281-2008; Bedognetti, Davide/GLQ-9410-2022; Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas Phillip/Z-1614-2019; Dema, Barbara/AAM-2354-2020; Takahashi, Hayato/AAV-7707-2021; zare, hossein/ABB-5871-2021; Bedognetti, Davide/ADI-1011-2022	Hirahara, Kiyoshi/0000-0002-9128-9449; Roychoudhuri, Rahul/0000-0002-5392-1853; Sciume, Giuseppe/0000-0003-0131-512X; Kanno, Yuka/0000-0001-5668-9319; Gattinoni, Luca/0000-0003-2239-3282; Takahashi, Hayato/0000-0001-6768-8821; Igarashi, Kazuhiko/0000-0002-2470-2475; Crompton, Joseph/0000-0001-9325-2909; Restifo, Nicholas P./0000-0003-4229-4580; Bonelli, Michael/0000-0002-6122-7482; Bedognetti, Davide/0000-0002-5857-773X; Clever, David/0000-0002-9137-8177; Klebanoff, Christopher/0000-0001-9645-3896; Sartorelli, Vittorio/0000-0002-9284-3675	Intramural Research Programs of the National Cancer Institute (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIH Center for Regenerative Medicine; JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH; NATIONAL CANCER INSTITUTE [Z01BC011037] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041165, ZIAAR041164, ZIAAR041159] Funding Source: NIH RePORTER	Intramural Research Programs of the National Cancer Institute (NIH); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH Center for Regenerative Medicine; JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the Intramural Research Programs of the National Cancer Institute (NIH) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the NIH Center for Regenerative Medicine and the JSPS Research Fellowship for Japanese Biomedical and Behavioural Researchers at NIH. We thank D. N. Roychoudhuri, D. C. Macallan, G. E. Griffin, S. A. Rosenberg, M. S. Rao, Y. Ji, D. Palmer, M. Sukumar, G. Fabozzi, K. Hanada, E. Lugli, J. H. Pan and N. Van Panhuys for discussions, A. Mixon and S. Farid for cell sorting, G. McMullen for mouse handling and Y. Luo, Y. Wakabayashi, J. Zhu, G. Gutierrez-Cruz and H. W. Sun for help with sequencing and analysis.	Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Christodoulou K., 2012, GUT; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	264	275	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	2013	498	7455					506	+		10.1038/nature12199	http://dx.doi.org/10.1038/nature12199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171LH	23728300	Green Accepted			2022-12-24	WOS:000320929400057
J	Rigotti, M; Barak, O; Warden, MR; Wang, XJ; Daw, ND; Miller, EK; Fusi, S				Rigotti, Mattia; Barak, Omri; Warden, Melissa R.; Wang, Xiao-Jing; Daw, Nathaniel D.; Miller, Earl K.; Fusi, Stefano			The importance of mixed selectivity in complex cognitive tasks	NATURE			English	Article							INFORMATION; CORTEX; MODEL	Single-neuron activity in the prefrontal cortex (PFC) is tuned to mixtures of multiple task-related aspects. Such mixed selectivity is highly heterogeneous, seemingly disordered and therefore difficult to interpret. We analysed the neural activity recorded in monkeys during an object sequence memory task to identify a role of mixed selectivity in subserving the cognitive functions ascribed to the PFC. We show that mixed selectivity neurons encode distributed information about all task-relevant aspects. Each aspect can be decoded from the population of neurons even when single-cell selectivity to that aspect is eliminated. Moreover, mixed selectivity offers a significant computational advantage over specialized responses in terms of the repertoire of input-output functions implementable by readout neurons. This advantage originates from the highly diverse nonlinear selectivity to mixtures of task-relevant variables, a signature of high-dimensional neural representations. Crucially, this dimensionality is predictive of animal behaviour as it collapses in error trials. Our findings recommend a shift of focus for future studies from neurons that have easily interpretable response tuning to the widely observed, but rarely analysed, mixed selectivity neurons.	[Rigotti, Mattia; Barak, Omri; Fusi, Stefano] Columbia Univ Coll Phys & Surg, Ctr Theoret Neurosci, New York, NY 10032 USA; [Rigotti, Mattia; Wang, Xiao-Jing; Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Rigotti, Mattia; Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10003 USA; [Warden, Melissa R.; Miller, Earl K.] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Warden, Melissa R.; Miller, Earl K.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Warden, Melissa R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Wang, Xiao-Jing] Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06525 USA	Columbia University; New York University; New York University; Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Stanford University; Yale University	Fusi, S (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Theoret Neurosci, 630 W 168th St, New York, NY 10032 USA.	sf2237@columbia.edu	Rigotti, Mattia/H-7252-2019; Fusi, Stefano/E-9109-2011; Miller, Earl K./AAE-8187-2019; Wang, Xiao-Jing/D-2722-2009; Warden, Melissa R/M-9300-2016	Rigotti, Mattia/0000-0001-6466-2810; Fusi, Stefano/0000-0002-3035-6652; Miller, Earl K./0000-0002-0582-6958; Warden, Melissa R/0000-0003-2240-3997; Barak, Omri/0000-0002-7894-6344	Gatsby Foundation; Swartz Foundation; Kavli Foundation; Swiss National Science Foundation [PBSKP3-133357]; Janggen-Poehn Foundation; McKnight Foundation; McDonnell Foundation; NIMH [5-R37-MH087027-04]; Picower Foundation; Brain & Behavior Research Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH087027, R01MH091174] Funding Source: NIH RePORTER	Gatsby Foundation; Swartz Foundation; Kavli Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Janggen-Poehn Foundation; McKnight Foundation; McDonnell Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Picower Foundation; Brain & Behavior Research Foundation(NARSAD); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to L.F. Abbott for comments on the manuscript and for discussions. Work supported by the Gatsby Foundation, the Swartz Foundation and the Kavli Foundation. M.R. is supported by Swiss National Science Foundation grant PBSKP3-133357 and the Janggen-Poehn Foundation; N.D.D. is supported by the McKnight Foundation and the McDonnell Foundation; E.K.M. is supported by NIMH grant 5-R37-MH087027-04 and The Picower Foundation; M.R.W. from the Brain & Behavior Research Foundation and the NARSAD Young Investigator grant.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Barak O, 2013, J NEUROSCI, V33, P3844, DOI 10.1523/JNEUROSCI.2753-12.2013; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Klampfl S, 2012, J NEUROPHYSIOL, V108, P1366, DOI 10.1152/jn.00935.2011; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Pascanu R, 2011, NEURAL NETWORKS, V24, P199, DOI 10.1016/j.neunet.2010.10.003; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070; Warden MR, 2010, J NEUROSCI, V30, P15801, DOI 10.1523/JNEUROSCI.1569-10.2010; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	23	694	698	5	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					585	590		10.1038/nature12160	http://dx.doi.org/10.1038/nature12160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23685452	Green Submitted, Green Accepted			2022-12-24	WOS:000319556100036
J	Sanders, TA; Llagostera, E; Barna, M				Sanders, Timothy A.; Llagostera, Esther; Barna, Maria			Specialized filopodia direct long-range transport of SHH during vertebrate tissue patterning	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; SONIC-HEDGEHOG; MYOSIN-X; F-ACTIN; CHOLESTEROL MODIFICATION; CHICK LIMB; IN-VIVO; CELLS; CYTONEMES; PATHWAY	The ability of signalling proteins to traverse tissues containing tightly packed cells is of fundamental importance for cell specification and tissue development; however, how this is achieved at a cellular level remains poorly understood(1). For more than a century, the vertebrate limb bud has served as a model for studying cell signalling during embryonic development(2). Here we optimize single-cell real-time imaging to delineate the cellular mechanisms for how signalling proteins, such as sonic hedgehog (SHH), that possess membrane-bound covalent lipid modifications traverse long distances within the vertebrate limb bud in vivo. By directly imaging SHH ligand production under native regulatory control in chick (Gallus gallus) embryos, our findings show that SHH is unexpectedly produced in the form of a particle that remains associated with the cell via long cytoplasmic extensions that span several cell diameters. We show that these cellular extensions are a specialized class of actin-based filopodia with novel cytoskeletal features that have not been previously described. Notably, particles containing SHH travel along these extensions with a net anterograde movement within the field of SHH cell signalling. We further show that in SHH-responding cells, specific subsets of SHH co-receptors, including cell adhesion molecule downregulated by oncogenes (CDO) and brother of CDO (BOC), actively distribute and co-localize in specific micro-domains within filopodial extensions, far from the cell body. Stabilized interactions are formed between filopodia containing SHH ligand and those containing co-receptors over a long range. These results suggest that contact-mediated release propagated by specialized filopodia contributes to the delivery of SHH at a distance. Together, these studies identify an important mode of communication between cells that considerably extends our understanding of ligand movement and reception during vertebrate tissue patterning.	[Sanders, Timothy A.; Llagostera, Esther; Barna, Maria] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Sanders, Timothy A.] Univ Calif San Francisco, Div Neonatol, Dept Pediat, San Francisco, CA 94158 USA; [Llagostera, Esther; Barna, Maria] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Llagostera, Esther; Barna, Maria] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Barna, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	mbarna@stanford.edu			Spanish Ministry of Education and Science; Program for Breakthrough Biomedical Research, UCSF; March of Dimes Basil O'Connor Scholar Research Award; National Institute of Arthritis and Musculoskeletal and Skin Disease, part of NIH [NIH R21AR062262]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062262] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); Program for Breakthrough Biomedical Research, UCSF; March of Dimes Basil O'Connor Scholar Research Award(March of Dimes); National Institute of Arthritis and Musculoskeletal and Skin Disease, part of NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Mullins for discussion on the actin cytoskeleton, as well as G. Martin and members of the Barna laboratory for discussion and critical reading of the manuscript. We thank K. Cabaltera for technical assistance. This work was supported by Spanish Ministry of Education and Science (E.L.), Program for Breakthrough Biomedical Research, UCSF (M.B.), the March of Dimes Basil O'Connor Scholar Research Award (M.B.), and the National Institute of Arthritis and Musculoskeletal and Skin Disease, part of NIH, under award number NIH R21AR062262 (M.B.).	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Breitsprecher D, 2011, J CELL SCI, V124, P3305, DOI 10.1242/jcs.086934; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Callejo Ainhoa, 2007, V397, P91; Cao DH, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-142; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Hamburger V., 1951, J MORPHOL, V195, P231; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Ingham PW, 2001, SCIENCE, V294, P1879, DOI 10.1126/science.1064115; Kaddoum L, 2010, BIOTECHNIQUES, V49, P727, DOI 10.2144/000113512; Kavran JM, 2010, J BIOL CHEM, V285, P24584, DOI 10.1074/jbc.M110.131680; KELLEY RO, 1978, J EMBRYOL EXP MORPH, V46, P99; Kerber ML, 2011, J CELL SCI, V124, P3733, DOI 10.1242/jcs.023549; Krull CE, 2004, DEV DYNAM, V229, P433, DOI 10.1002/dvdy.10473; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Maas SA, 2011, DEV DYNAM, V240, P1212, DOI 10.1002/dvdy.22634; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MILLER J, 1995, DEVELOPMENT, V121, P2501; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pinaud F, 2011, P NATL ACAD SCI USA, V108, pE201, DOI 10.1073/pnas.1101929108; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Vincent S, 2003, NAT BIOTECHNOL, V21, P936, DOI 10.1038/nbt844; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Yang Y, 1997, DEVELOPMENT, V124, P4393; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	57	257	258	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					628	+		10.1038/nature12157	http://dx.doi.org/10.1038/nature12157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23624372	Green Accepted			2022-12-24	WOS:000319556100046
J	Kouzine, F; Wojtowicz, D; Yamane, A; Resch, W; Kieffer-Kwon, KR; Bandle, R; Nelson, S; Nakahashi, H; Awasthi, P; Feigenbaum, L; Menoni, H; Hoeijmakers, J; Vermeulen, W; Ge, H; Przytycka, TM; Levens, D; Casellas, R				Kouzine, Fedor; Wojtowicz, Damian; Yamane, Arito; Resch, Wolfgang; Kieffer-Kwon, Kyong-Rim; Bandle, Russell; Nelson, Steevenson; Nakahashi, Hirotaka; Awasthi, Parirokh; Feigenbaum, Lionel; Menoni, Herve; Hoeijmakers, Jan; Vermeulen, Wim; Ge, Hui; Przytycka, Teresa M.; Levens, David; Casellas, Rafael			Global Regulation of Promoter Melting in Naive Lymphocytes	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS IIE; IN-VIVO; C-MYC; BASAL TRANSCRIPTION; HUMAN GENOME; QUADRUPLEX STRUCTURES; HISTONE ACETYLATION; ACTIVE PROMOTERS	Lymphocyte activation is initiated by a global increase in messenger RNA synthesis. However, the mechanisms driving transcriptome amplification during the immune response are unknown. By monitoring single-stranded DNA genome wide, we show that the genome of naive cells is poised for rapid activation. In G(0), similar to 90% of promoters from genes to be expressed in cycling lymphocytes are polymerase loaded but unmelted and support only basal transcription. Furthermore, the transition from abortive to productive elongation is kinetically limiting, causing polymerases to accumulate nearer to transcription start sites. Resting lymphocytes also limit the expression of the transcription factor IIH complex, including XPB and XPD helicases involved in promoter melting and open complex extension. To date, two rate-limiting steps have been shown to control global gene expression in eukaryotes: preinitiation complex assembly and polymerase pausing. Our studies identify promoter melting as a third key regulatory step and propose that this mechanism ensures a prompt lymphocyte response to invading pathogens.	[Kouzine, Fedor; Bandle, Russell; Levens, David] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wojtowicz, Damian; Przytycka, Teresa M.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Kieffer-Kwon, Kyong-Rim; Nelson, Steevenson; Nakahashi, Hirotaka; Casellas, Rafael] NIAMS, NIH, Bethesda, MD 20892 USA; [Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Awasthi, Parirokh; Feigenbaum, Lionel] NCI, Sci Applicat Int Corp, NIH, Bethesda, MD 20892 USA; [Wojtowicz, Damian] Univ Warsaw, Inst Informat, PL-02098 Warsaw, Poland; [Menoni, Herve; Hoeijmakers, Jan; Vermeulen, Wim] Erasmus MC, Dept Genet, NL-3015 GE Rotterdam, Netherlands; [Ge, Hui] Ascentgene Inc, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Warsaw; Erasmus University Rotterdam; Erasmus MC	Levens, D (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	levens@helix.nih.gov; casellar@mail.nih.gov	Hoeijmakers, Jan/AAX-6972-2021; Levens, David/C-9216-2009; Vermeulen, Wim/W-8708-2019; Wojtowicz, Damian/AAF-2007-2022; Wojtowicz, Damian/AFG-8518-2022; Yamane, Arito/A-2959-2013	Levens, David/0000-0002-7616-922X; Vermeulen, Wim/0000-0003-3616-734X; Wojtowicz, Damian/0000-0002-4274-6383; Wojtowicz, Damian/0000-0002-4274-6383; Przytycka, Teresa/0000-0002-6261-277X; Menoni, Herve/0000-0002-5302-4933; Resch, Wolfgang/0000-0001-7594-5963	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS); National Cancer Institute (Center for Cancer Research); National Library of Medicine of the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041186, ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200887] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS); National Cancer Institute (Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine of the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank G. Gutierrez for technical assistance with the genome analyzer; J. Simone and J. Lay for bone marrow sorts; J. Qian and K. Zaal for the B cell confocal micrographs; and C. Benham for SIDD mapping. We thank the Casellas and Levens lab members for critically reading the manuscript. We also thank A. Hoofring from the National Institutes of Health (NIH) Medical Arts for designing the pictures shown in Figure 6D. This work was supported in part by the Intramural Research Program of National Institute of Arthritis and Musculoskeletal and Skin Diseases (NAIMS), the National Cancer Institute (Center for Cancer Research), and the National Library of Medicine of the NIH. This study utilized the high-performance computational capabilities of the Helix Systems at the NIH (http://helix.nih.gov). All animal experiments were performed according to the NIH guidelines for laboratory animals and were approved by the Scientific Committee of the NIAMS Animal Facilities. For questions regarding computational analysis, please contact T.M.P. (przytyck@ncbi.nlm.nih.gov).	Assfalg R, 2012, NUCLEIC ACIDS RES, V40, P650, DOI 10.1093/nar/gkr746; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Benham CJ, 2004, J COMPUT BIOL, V11, P519, DOI 10.1089/cmb.2004.11.519; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Calvo KR, 2008, BLOOD, V112, P3818, DOI 10.1182/blood-2008-02-138933; Cer RZ, 2011, NUCLEIC ACIDS RES, V39, pD383, DOI 10.1093/nar/gkq1170; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; Di Virgilio M., 2013, SCIENCE; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Giglia-Mari G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000220; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guzman E, 1999, MOL CELL BIOL, V19, P5652; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; JAEHNING JA, 1975, CELL, V4, P51, DOI 10.1016/0092-8674(75)90133-6; Jenne A, 1999, BIOTECHNIQUES, V26, P249, DOI 10.2144/99262bm15; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; Khil PP, 2012, GENOME RES, V22, P957, DOI 10.1101/gr.130583.111; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Kouzine F, 2004, NAT STRUCT MOL BIOL, V11, P1092, DOI 10.1038/nsmb848; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Lutz R, 2001, NUCLEIC ACIDS RES, V29, P3873, DOI 10.1093/nar/29.18.3873; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; MELCHERS F, 1984, CELL, V37, P715, DOI 10.1016/0092-8674(84)90407-0; MIRKOVITCH J, 1992, MOL BIOL CELL, V3, P1085, DOI 10.1091/mbc.3.10.1085; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; POGO BGT, 1967, J CELL BIOL, V35, P477, DOI 10.1083/jcb.35.2.477; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Raghavan SC, 2006, BIOESSAYS, V28, P480, DOI 10.1002/bies.20353; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; SAWAI M, 1990, EXP CELL RES, V187, P4, DOI 10.1016/0014-4827(90)90108-M; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shklover J, 2010, NUCLEIC ACIDS RES, V38, P2369, DOI 10.1093/nar/gkp1208; SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z; STERNER DE, 1995, MOL CELL BIOL, V15, P5716; TU CPD, 1980, GENE, V10, P177, DOI 10.1016/0378-1119(80)90135-3; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yafe A, 2008, NUCLEIC ACIDS RES, V36, P3916, DOI 10.1093/nar/gkn340; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou ZX, 2013, GENOME RES, V23, P705, DOI 10.1101/gr.146357.112	75	110	110	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					988	999		10.1016/j.cell.2013.04.033	http://dx.doi.org/10.1016/j.cell.2013.04.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706737	Green Accepted, Bronze			2022-12-24	WOS:000319456800008
J	Margolin, DH; Kousi, M; Chan, YM; Lim, ET; Schmahmann, JD; Hadjivassiliou, M; Hall, JE; Adam, I; Dwyer, A; Plummer, L; Aldrin, SV; O'Rourke, J; Kirby, A; Lage, K; Milunsky, A; Milunsky, JM; Chan, J; Hedley-Whyte, ET; Daly, MJ; Katsanis, N; Seminara, SB				Margolin, David H.; Kousi, Maria; Chan, Yee-Ming; Lim, Elaine T.; Schmahmann, Jeremy D.; Hadjivassiliou, Marios; Hall, Janet E.; Adam, Ibrahim; Dwyer, Andrew; Plummer, Lacey; Aldrin, Stephanie V.; O'Rourke, Julia; Kirby, Andrew; Lage, Kasper; Milunsky, Aubrey; Milunsky, Jeff M.; Chan, Jennifer; Hedley-Whyte, E. Tessa; Daly, Mark J.; Katsanis, Nicholas; Seminara, Stephanie B.			Ataxia, Dementia, and Hypogonadotropism Caused by Disordered Ubiquitination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; BARDET-BIEDL-SYNDROME; FAMILIAL CEREBELLAR-ATAXIA; TRIALLELIC INHERITANCE; PARKINSONS-DISEASE; HOLMES TYPE; HYPOGONADISM; DEFICIENCY; PROTEIN; DEGENERATION	BACKGROUND The combination of ataxia and hypogonadism was first described more than a century ago, but its genetic basis has remained elusive. METHODS We performed whole-exome sequencing in a patient with ataxia and hypogonadotropic hypogonadism, followed by targeted sequencing of candidate genes in similarly affected patients. Neurologic and reproductive endocrine phenotypes were characterized in detail. The effects of sequence variants and the presence of an epistatic interaction were tested in a zebrafish model. RESULTS Digenic homozygous mutations in RNF216 and OTUD4, which encode a ubiquitin E3 ligase and a deubiquitinase, respectively, were found in three affected siblings in a consanguineous family. Additional screening identified compound heterozygous truncating mutations in RNF216 in an unrelated patient and single heterozygous deleterious mutations in four other patients. Knockdown of rnf216 or otud4 in zebrafish embryos induced defects in the eye, optic tectum, and cerebellum; combinatorial suppression of both genes exacerbated these phenotypes, which were rescued by nonmutant, but not mutant, human RNF216 or OTUD4 messenger RNA. All patients had progressive ataxia and dementia. Neuronal loss was observed in cerebellar pathways and the hippocampus; surviving hippocampal neurons contained ubiquitin-immunoreactive intranuclear inclusions. Defects were detected at the hypothalamic and pituitary levels of the reproductive endocrine axis. CONCLUSIONS The syndrome of hypogonadotropic hypogonadism, ataxia, and dementia can be caused by inactivating mutations in RNF216 or by the combination of mutations in RNF216 and OTUD4. These findings link disordered ubiquitination to neurodegeneration and reproductive dysfunction and highlight the power of whole-exome sequencing in combination with functional studies to unveil genetic interactions that cause disease.	[Margolin, David H.; Schmahmann, Jeremy D.] Massachusetts Gen Hosp, Dept Neurol, Harvard Reprod Sci Ctr, Boston, MA 02115 USA; [Chan, Yee-Ming; Hall, Janet E.; Dwyer, Andrew; Plummer, Lacey; Aldrin, Stephanie V.; O'Rourke, Julia; Seminara, Stephanie B.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02115 USA; [Lim, Elaine T.; Kirby, Andrew; Lage, Kasper; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02115 USA; [Lage, Kasper] Massachusetts Gen Hosp, Dept Med, Pediat Surg Res Labs, Boston, MA 02115 USA; [Hedley-Whyte, E. Tessa] Massachusetts Gen Hosp, Dept Neuropathol, Boston, MA 02115 USA; [Chan, Yee-Ming] Boston Childrens Hosp, Div Endocrinol, Dept Med, Boston, MA USA; [Chan, Jennifer] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Milunsky, Aubrey; Milunsky, Jeff M.] Ctr Human Genet, Cambridge, MA USA; [Kousi, Maria; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Hadjivassiliou, Marios] Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England; [Adam, Ibrahim] Specialty Hosp, Amman, Jordan; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lage, Kasper] Univ Copenhagen, Ctr Prot Res, Copenhagen, Denmark	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Duke University; Duke University; University of Sheffield; Technical University of Denmark; University of Copenhagen	Seminara, SB (corresponding author), Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02115 USA.	katsanis@cellbio.duke.edu; seminara.stephanie@mgh.harvard.edu	Lim, Elaine/H-9032-2016; Hedley-Whyte, E Tessa/AAJ-9975-2021; Daly, Mark J/B-2453-2017; Dwyer, Andrew A./D-8099-2012; Hall, Janet E/F-3516-2019; Schmahmann, Jeremy/ABF-1215-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Daly, Mark J/0000-0002-0949-8752; Dwyer, Andrew A./0000-0002-7023-6794; Hall, Janet E/0000-0003-4644-3061; Schmahmann, Jeremy/0000-0003-0706-5125; Milunsky, Aubrey/0000-0003-2114-4823; Katsanis, Nicholas/0000-0002-2480-0171; Lim, Teng Ting/0000-0003-3651-0654	National Institutes of Health; Eunice K. Shriver National Institute for Child Health and Human Development [K24 HD067388, R01 HD043341, R01 HD042601, U54 HD028138]; National Institute of Diabetes and Digestive and Kidney Diseases [P50 DK096415]; Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources; National Center for Advancing Translational Sciences [UL1TR025758, M01RR01066]; Harvard University; National Human Genome Research Institute to the Broad Institute [U54 HG003967]; National Heart, Lung, and Blood Institute for the Exome Sequencing Project [HL102923, HL102924, HL102925, HL102926, HL103010]; Charles A. King Trust postdoctoral fellowship; Career Development Award from Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028138, K24HD067388, R01HD042601, R01HD043341] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL103010, RC2HL102923, UC2HL102926, RC2HL102924, UC2HL102923, UC2HL102924, RC2HL103010, UC2HL102925, RC2HL102925, RC2HL102926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice K. Shriver National Institute for Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Harvard University; National Human Genome Research Institute to the Broad Institute; National Heart, Lung, and Blood Institute for the Exome Sequencing Project; Charles A. King Trust postdoctoral fellowship; Career Development Award from Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.; Supported by grants from the Eunice K. Shriver National Institute for Child Health and Human Development (K24 HD067388, R01 HD043341, R01 HD042601, and U54 HD028138); from the National Institute of Diabetes and Digestive and Kidney Diseases (P50 DK096415); by Harvard Catalyst and the Harvard Clinical and Translational Science Center (funded by the National Center for Research Resources and the National Center for Advancing Translational Sciences [UL1TR025758 and M01RR01066] and Harvard University and its affiliated academic health care centers); by a grant from the National Human Genome Research Institute to the Broad Institute (U54 HG003967); and by grants from the National Heart, Lung, and Blood Institute for the Exome Sequencing Project (HL102923, HL102924, HL102925, HL102926, and HL103010). Dr. Chan is the recipient of a Charles A. King Trust postdoctoral fellowship and a Career Development Award from Boston Children's Hospital.	ABS R, 1990, J NEUROL SCI, V98, P259, DOI 10.1016/0022-510X(90)90267-Q; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aerts S, 2006, NAT BIOTECHNOL, V24, P719, DOI 10.1038/nbt0606-719d; [Anonymous], 2011, MOL CELL ENDOCRINOL, V346, P4; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; BERCIANO J, 1982, J NEUROL NEUROSUR PS, V45, P747, DOI 10.1136/jnnp.45.8.747; BERCIANO J, 1983, J NEUROL NEUROSUR PS, V46, P472; Chen DY, 2002, J BIOL CHEM, V277, P15985, DOI 10.1074/jbc.M108675200; Chuang TH, 2004, NAT IMMUNOL, V5, P968, DOI 10.1038/ni0904-968; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; de Pontual L, 2009, P NATL ACAD SCI USA, V106, P13921, DOI 10.1073/pnas.0901219106; DEMICHELE G, 1990, CLIN NEUROL NEUROSUR, V92, P67, DOI 10.1016/0303-8467(90)90010-3; DEMICHELE G, 1993, CLIN NEUROL NEUROSUR, V95, P23, DOI 10.1016/0303-8467(93)90087-W; Durcan TM, 2012, J BIOL CHEM, V287, P531, DOI 10.1074/jbc.M111.288449; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; FOK ACK, 1989, J NEUROL NEUROSUR PS, V52, P407, DOI 10.1136/jnnp.52.3.407; Holmes G, 1907, BRAIN, V30, P466; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Kumar P, 2012, J NEUROCHEM, V120, P350, DOI 10.1111/j.1471-4159.2011.07588.x; Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36; Lavoie HB, 1998, J CLIN ENDOCR METAB, V83, P241, DOI 10.1210/jc.83.1.241; Longoni M, 2012, AM J MED GENET A, V158A, P3148, DOI 10.1002/ajmg.a.35665; LOWENTHAL A, 1979, J NEUROL, V222, P75, DOI 10.1007/BF00313001; Miah SMS, 2011, J IMMUNOL, V186, P2959, DOI 10.4049/jimmunol.1000112; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nozu K, 2008, J MED GENET, V45, P182, DOI 10.1136/jmg.2007.052944; Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3; Quinton R, 1999, CLIN ENDOCRINOL, V51, P525, DOI 10.1046/j.1365-2265.1999.00859.x; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Seminara SB, 2002, J CLIN ENDOCR METAB, V87, P1607, DOI 10.1210/jc.87.4.1607; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Vielhaber S, 2000, CLIN NEUROL NEUROSUR, V102, P102, DOI 10.1016/S0303-8467(00)00068-8; VOLPE R, 1963, J CLIN ENDOCR METAB, V23, P107, DOI 10.1210/jcem-23-1-107; Zaghloul NA, 2011, METHOD CELL BIOL, V105, P257, DOI 10.1016/B978-0-12-381320-6.00011-4	40	136	141	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1992	2003		10.1056/NEJMoa1215993	http://dx.doi.org/10.1056/NEJMoa1215993			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148TJ	23656588	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000319270200001
J	Tubo, NJ; Pagan, AJ; Taylor, JJ; Nelson, RW; Linehan, JL; Ertelt, JM; Huseby, ES; Way, SS; Jenkins, MK				Tubo, Noah J.; Pagan, Antonio J.; Taylor, Justin J.; Nelson, Ryan W.; Linehan, Jonathan L.; Ertelt, James M.; Huseby, Eric S.; Way, Sing Sing; Jenkins, Marc K.			Single Naive CD4(+) T Cells from a Diverse Repertoire Produce Different Effector Cell Types during Infection	CELL			English	Article							LISTERIA-MONOCYTOGENES INFECTION; FOLLICULAR HELPER-CELL; MEDIATED-IMMUNITY; IN-VIVO; VIRAL-INFECTION; TRANSGENIC MICE; ANTIGEN; TCR; EXPRESSION; RESPONSES	A naive CD4(+) T cell population specific for a microbial peptide:major histocompatibility complex II ligand (p:MHCII) typically consists of about 100 cells, each with a different T cell receptor (TCR). Following infection, this population produces a consistent ratio of effector cells that activate microbicidal functions of macrophages or help B cells make antibodies. We studied the mechanism that underlies this division of labor by tracking the progeny of single naive T cells. Different naive cells produced distinct ratios of macrophage and B cell helpers but yielded the characteristic ratio when averaged together. The effector cell pattern produced by a given naive cell correlated with the TCR-p:MHCII dwell time or the amount of p:MHCII. Thus, the consistent production of effector cell subsets by a polyclonal population of naive cells results from averaging the diverse behaviors of individual clones, which are instructed in part by the strength of TCR signaling.	[Tubo, Noah J.; Pagan, Antonio J.; Taylor, Justin J.; Nelson, Ryan W.; Linehan, Jonathan L.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; [Ertelt, James M.; Way, Sing Sing] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Dept Pediat, Minneapolis, MN 55455 USA; [Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Worcester	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.eau	Jenkins, Marc K/G-1063-2012; Pagan, Antonio/AAB-1604-2019	Jenkins, Marc K/0000-0001-8009-7655; Nelson, Ryan/0000-0003-2327-9481; Way, Sing Sing/0000-0001-8948-1952	National Institutes of Health [R01-AI39614, R37-AI27998, R01-AI66018, T32-HD060536, T32-AI07313, F30-DK093242, R01-AI087830, R01-AI100934]; Kunze Fellowship; Irvington Fellowship from the Cancer Research Institute; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060536] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035296, R37AI027998, R01AI039614, R01AI103760, T32AI007313, R01AI087830, R56AI066018, R01AI100934, R01AI066018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095077, F30DK093242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kunze Fellowship; Irvington Fellowship from the Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Walter and R. Speier for technical assistance and T. Martin and the University of Minnesota Flow Cytometry Facility for cell sorting. This work was supported by grants from the National Institutes of Health (R01-AI39614, R37-AI27998, and R01-AI66018 to M.K.J.; T32-HD060536 to N.J.T.; T32-AI07313 to A.J.P.; F30-DK093242 to R.W.N.; R01-AI087830 and R01-AI100934 to S.S.W.; and T32-AI07313 to J.L.L.). This work was also supported by the Kunze Fellowship (to A.J.P.), the Irvington Fellowship from the Cancer Research Institute (to J.J.T.), and the Burroughs Wellcome Fund (to S.S.W.).	Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Derby MA, 2001, INT IMMUNOL, V13, P817, DOI 10.1093/intimm/13.6.817; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Johanns TM, 2010, J IMMUNOL, V184, P869, DOI 10.4049/jimmunol.0901804; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; PARISH CR, 1972, J EXP MED, V135, P298, DOI 10.1084/jem.135.2.298; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; TASWELL C, 1981, J IMMUNOL, V126, P1614; UTZ U, 1993, NATURE, V364, P243, DOI 10.1038/364243a0; Vanguri V, 2013, P NATL ACAD SCI USA, V110, P288, DOI 10.1073/pnas.1208328110; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	57	310	314	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					785	796		10.1016/j.cell.2013.04.007	http://dx.doi.org/10.1016/j.cell.2013.04.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663778	Green Accepted, Bronze			2022-12-24	WOS:000318844000009
J	Xu, K; Zhang, MH; Zhao, Q; Yu, F; Guo, H; Wang, CY; He, FY; Ding, JP; Zhang, P				Xu, Ke; Zhang, Minhua; Zhao, Qin; Yu, Fang; Guo, Hui; Wang, Chengyuan; He, Fangyuan; Ding, Jianping; Zhang, Peng			Crystal structure of a folate energy-coupling factor transporter from Lactobacillus brevis	NATURE			English	Article							ABC TRANSPORTER; MALTOSE TRANSPORTER; BINDING-PROTEIN; PROKARYOTES; MECHANISM; INTERMEDIATE; COMPLEX	ATP-binding cassette (ABC) transporters, composed of importers and exporters, form one of the biggest protein superfamilies that transport a variety of substrates across the membrane, powered by ATP hydrolysis. Most ABC transporters are composed of two transmembrane domains and two cytoplasmic nucleotide-binding domains. Also, importers from prokaryotes usually have extra solute-binding proteins in the periplasm that are responsible for the binding of substrates(1,2). Structures of importers have been reported that suggested a two-state model for the transport mechanism(3-11). Energy-coupling factor (ECF) transporters belong to a new class of ATP-binding cassette importers. Each ECF transporter comprises an energy-coupling module consisting of a transmembrane T protein (EcfT), two nucleotide-binding proteins (EcfA and EcfA'), and another transmembrane substrate-specific binding S protein(12-14) (EcfS). Despite the similarities with ABC transporters, ECF transporters have different organizational and functional properties. The lack of solute-binding proteins in ECF transporters differentiates them clearly from the canonical ABC importers(15). Previously reported structures of the EcfS proteins RibU and ThiT clearly demonstrated the binding site of substrate riboflavin and thiamine, respectively(16,17). However, the organization of the four different components and the transport mechanism of ECF transporters remain unknown. Here we present the structure of an intact folate ECF transporter from Lactobacillus brevis at a resolution of 3 angstrom. This structure was captured in an inward-facing, nucleotide-free conformation with no bound substrate. The folate-binding protein FolT is nearly parallel to the membrane and is bound almost entirely by EcfT, which adopts an L shape and connects to EcfA and EcfA' through two coupling helices. Two conserved XRX motifs from the coupling helices of EcfT have a vital role in energy coupling by docking into EcfA-EcfA'. We propose a transport model that involves a substantial conformational change of FolT.	[Xu, Ke; Zhang, Minhua; Zhao, Qin; Guo, Hui; Wang, Chengyuan; He, Fangyuan; Zhang, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China; [Yu, Fang; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Zhang, Peng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, CAS Key Lab Synthet Biol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, P (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	pengzhang01@sibs.ac.cn		ding, jian ping/0000-0001-7029-7346; zhang, peng/0000-0003-0408-2923	Ministry of Science and Technology of China [2013CB127000]; Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012OHTP, 2009CSP001, 2011KIP101, KSCX2-EW-J-12]; Shanghai 'Pujiang Talent' programme [11PJ1411300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai 'Pujiang Talent' programme	We thank X. Chen and G. Zhao for reading the manuscript and the staff members of Shanghai Synchrotron Radiation Facility for technical assistance in data collection. This work was supported by grants from the Ministry of Science and Technology of China (2013CB127000), the Shanghai Institutes for Biological Sciences, the Chinese Academy of Sciences (2012OHTP, 2009CSP001, 2011KIP101, KSCX2-EW-J-12) and the Shanghai 'Pujiang Talent' programme (11PJ1411300).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berntsson RPA, 2012, P NATL ACAD SCI USA, V109, P13990, DOI 10.1073/pnas.1203219109; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Eitinger T, 2011, FEMS MICROBIOL REV, V35, P3, DOI 10.1111/j.1574-6976.2010.00230.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erkens GB, 2012, BIOCHEMISTRY-US, V51, P4390, DOI 10.1021/bi300504v; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Eudes A, 2008, J BACTERIOL, V190, P7591, DOI 10.1128/JB.01070-08; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; ter Beek J, 2011, J BIOL CHEM, V286, P5471, DOI 10.1074/jbc.M110.199224; Zhang P, 2010, NATURE, V468, P717, DOI 10.1038/nature09488	27	72	75	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					268	+		10.1038/nature12046	http://dx.doi.org/10.1038/nature12046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23584589				2022-12-24	WOS:000318558200042
J	Borucki, WJ; Agol, E; Fressin, F; Kaltenegger, L; Rowe, J; Isaacson, H; Fischer, D; Batalha, N; Lissauer, JJ; Marcy, GW; Fabrycky, D; Desert, JM; Bryson, ST; Barclay, T; Bastien, F; Boss, A; Brugamyer, E; Buchhave, LA; Burke, C; Caldwell, DA; Carter, J; Charbonneau, D; Crepp, JR; Christensen-Dalsgaard, J; Christiansen, JL; Ciardi, D; Cochran, WD; DeVore, E; Doyle, L; Dupree, AK; Endl, M; Everett, ME; Ford, EB; Fortney, J; Gautier, TN; Geary, JC; Gould, A; Haas, M; Henze, C; Howard, AW; Howell, SB; Huber, D; Jenkins, JM; Kjeldsen, H; Kolbl, R; Kolodziejczak, J; Latham, DW; Lee, BL; Lopez, E; Mullally, F; Orosz, JA; Prsa, A; Quintana, EV; Sanchis-Ojeda, R; Sasselov, D; Seader, S; Shporer, A; Steffen, JH; Still, M; Tenenbaum, P; Thompson, SE; Torres, G; Twicken, JD; Welsh, WF; Winn, JN				Borucki, William J.; Agol, Eric; Fressin, Francois; Kaltenegger, Lisa; Rowe, Jason; Isaacson, Howard; Fischer, Debra; Batalha, Natalie; Lissauer, Jack J.; Marcy, Geoffrey W.; Fabrycky, Daniel; Desert, Jean-Michel; Bryson, Stephen T.; Barclay, Thomas; Bastien, Fabienne; Boss, Alan; Brugamyer, Erik; Buchhave, Lars A.; Burke, Chris; Caldwell, Douglas A.; Carter, Josh; Charbonneau, David; Crepp, Justin R.; Christensen-Dalsgaard, Jorgen; Christiansen, Jessie L.; Ciardi, David; Cochran, William D.; DeVore, Edna; Doyle, Laurance; Dupree, Andrea K.; Endl, Michael; Everett, Mark E.; Ford, Eric B.; Fortney, Jonathan; Gautier, Thomas N., III; Geary, John C.; Gould, Alan; Haas, Michael; Henze, Christopher; Howard, Andrew W.; Howell, Steve B.; Huber, Daniel; Jenkins, Jon M.; Kjeldsen, Hans; Kolbl, Rea; Kolodziejczak, Jeffery; Latham, David W.; Lee, Brian L.; Lopez, Eric; Mullally, Fergal; Orosz, Jerome A.; Prsa, Andrej; Quintana, Elisa V.; Sanchis-Ojeda, Roberto; Sasselov, Dimitar; Seader, Shawn; Shporer, Avi; Steffen, Jason H.; Still, Martin; Tenenbaum, Peter; Thompson, Susan E.; Torres, Guillermo; Twicken, Joseph D.; Welsh, William F.; Winn, Joshua N.			Kepler-62: A Five-Planet System with Planets of 1.4 and 1.6 Earth Radii in the Habitable Zone	SCIENCE			English	Article							SUN-LIKE STAR; TRANSITING PLANET; CANDIDATES; SCIENCE; MASS; II.	We present the detection of five planets-Kepler-62b, c, d, e, and f-of size 1.31, 0.54, 1.95, 1.61 and 1.41 Earth radii (R-circle plus), orbiting a K2V star at periods of 5.7, 12.4, 18.2, 122.4, and 267.3 days, respectively. The outermost planets, Kepler-62e and -62f, are super-Earth-size (1.25 R-circle plus < planet radius <= 2.0 R-circle plus) planets in the habitable zone of their host star, respectively receiving 1.2 +/- 0.2 times and 0.41 +/- 0.05 times the solar flux at Earth's orbit. Theoretical models of Kepler-62e and -62f for a stellar age of similar to 7 billion years suggest that both planets could be solid, either with a rocky composition or composed of mostly solid water in their bulk.	[Borucki, William J.; Batalha, Natalie; Lissauer, Jack J.; Bryson, Stephen T.; Haas, Michael; Henze, Christopher; Howell, Steve B.; Huber, Daniel] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Agol, Eric; Lee, Brian L.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Fressin, Francois; Kaltenegger, Lisa; Desert, Jean-Michel; Carter, Josh; Charbonneau, David; Dupree, Andrea K.; Geary, John C.; Latham, David W.; Sasselov, Dimitar; Torres, Guillermo] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Kaltenegger, Lisa] Max Planck Inst Astron, D-69115 Heidelberg, Germany; [Rowe, Jason; Burke, Chris; Caldwell, Douglas A.; Christiansen, Jessie L.; DeVore, Edna; Doyle, Laurance; Jenkins, Jon M.; Mullally, Fergal; Quintana, Elisa V.; Seader, Shawn; Tenenbaum, Peter; Thompson, Susan E.; Twicken, Joseph D.] SETI Inst, Mountain View, CA 94043 USA; [Isaacson, Howard; Marcy, Geoffrey W.; Kolbl, Rea] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Fischer, Debra] Yale Univ, New Haven, CT 06520 USA; [Fabrycky, Daniel; Fortney, Jonathan; Lopez, Eric; Shporer, Avi] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Fabrycky, Daniel] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Barclay, Thomas; Still, Martin] Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Bastien, Fabienne] Vanderbilt Univ, Nashville, TN 37235 USA; [Boss, Alan] Carnegie Inst Sci, Washington, DC 20015 USA; [Brugamyer, Erik; Cochran, William D.; Endl, Michael] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Crepp, Justin R.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Crepp, Justin R.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Christensen-Dalsgaard, Jorgen; Kjeldsen, Hans] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark; [Ciardi, David] CALTECH, Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Everett, Mark E.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Ford, Eric B.] Univ Florida, Gainesville, FL 32611 USA; [Gautier, Thomas N., III] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Gould, Alan] Lawrence Hall Sci, Berkeley, CA 94720 USA; [Howard, Andrew W.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Kolodziejczak, Jeffery] George C Marshall Space Flight Ctr, Huntsville, AL 35805 USA; [Orosz, Jerome A.; Welsh, William F.] San Diego State Univ, San Diego, CA 92182 USA; [Prsa, Andrej] Villanova Univ, Villanova, PA 19085 USA; [Shporer, Avi] Las Cumbres Observ Global Telescope, Goleta, CA 93117 USA; [Steffen, Jason H.] Northwestern Univ, Evanston, IL 60208 USA; [Sanchis-Ojeda, Roberto; Winn, Joshua N.] MIT, Cambridge, MA 02139 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Max Planck Society; University of California System; University of California Berkeley; Yale University; University of California System; University of California Santa Cruz; University of Chicago; Vanderbilt University; Carnegie Institution for Science; University of Texas System; University of Texas Austin; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; California Institute of Technology; University of Notre Dame; Aarhus University; California Institute of Technology; National Optical Astronomy Observatory; State University System of Florida; University of Florida; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; California State University System; San Diego State University; Villanova University; Northwestern University; Massachusetts Institute of Technology (MIT)	Borucki, WJ (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	william.j.borucki@nasa.gov	Caldwell, Douglas A/L-7911-2014; Ford, Eric B./AAB-5479-2019; Steffen, Jason H./A-4320-2013; Welsh, William/AAS-3445-2021; Howard, Andrew/D-4148-2015; Buchhave, Lars A./ABF-2000-2020; Kaltenegger, Lisa/F-1176-2018; Shporer, Avi/Y-2777-2019; Cochran, William D/M-4421-2014; Huber, Daniel/AAE-9440-2019; Fischer, Debra A/C-1639-2014; Fortney, Jonathan/F-8813-2014	Caldwell, Douglas A/0000-0003-1963-9616; Ford, Eric B./0000-0001-6545-639X; Howard, Andrew/0000-0001-8638-0320; Buchhave, Lars A./0000-0003-1605-5666; Kaltenegger, Lisa/0000-0002-0436-1802; Shporer, Avi/0000-0002-1836-3120; Cochran, William D/0000-0001-9662-3496; Huber, Daniel/0000-0001-8832-4488; Fischer, Debra A/0000-0003-2221-0861; Rowe, Jason/0000-0002-5904-1865; Dupree, Andrea/0000-0002-8985-8489; Ciardi, David/0000-0002-5741-3047; Burke, Christopher/0000-0002-7754-9486; Steffen, Jason/0000-0003-2202-3847; Fabrycky, Daniel/0000-0003-3750-0183; Fortney, Jonathan/0000-0002-9843-4354; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Barclay, Thomas/0000-0001-7139-2724; Latham, David/0000-0001-9911-7388; Agol, Eric/0000-0002-0802-9145; Batalha, Natalie/0000-0002-7030-9519; Christiansen, Jessie/0000-0002-8035-4778	NASA's Science Mission Directorate; W. M. Keck Foundation; Deutsche Forschungsgemeinschaft [ENP Ka 3142/1-1]; NASA Astrobiology Institute; Danish National Research Foundation; ASTERISK project; European Research Council [267864]; NASA through the Kepler Participating Scientist Program (PSP); NSF [AST-1109928, AST-0645416]; NASA [ADAP12-0172]; NASA PSP [NNX08AR04G, NNX12AF73G]; NASA; Division Of Astronomical Sciences [1109928] Funding Source: National Science Foundation	NASA's Science Mission Directorate; W. M. Keck Foundation(W.M. Keck Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NASA Astrobiology Institute; Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK project; European Research Council(European Research Council (ERC)European Commission); NASA through the Kepler Participating Scientist Program (PSP); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NASA PSP; NASA(National Aeronautics & Space Administration (NASA)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Kepler was competitively selected as the 10th Discovery mission. Funding for this mission is provided by NASA's Science Mission Directorate. Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership of the California Institute of Technology, the University of California, and NASA. The Keck Observatory was made possible by the generous financial support of the W. M. Keck Foundation. L.K. acknowledges support from Deutsche Forschungsgemeinschaft grants ENP Ka 3142/1-1 and NASA Astrobiology Institute. Funding for the Stellar Astrophysics Centre is provided by the Danish National Research Foundation. The research is supported by the ASTERISK project (Asteroseismic Investigations with SONG and Kepler) funded by European Research Council grant 267864. W. F. W. and J.A.O. acknowledge support from NASA through the Kepler Participating Scientist Program (PSP) and from NSF grant AST-1109928. D.F. acknowledges support from NASA ADAP12-0172. O.R.S.-O. and J.N.W. are supported by the Kepler PSP through grant NNX12AC76G. E.F. is partially supported by NASA PSP grants NNX08AR04G and NNX12AF73G. E.A. acknowledges NSF career grant AST-0645416. We also thank the Spitzer staff at IPAC and in particular N. Silbermann for checking and scheduling the Spitzer observations. The Spitzer Space Telescope is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. We thank the many people who gave so generously of their time to make this mission a success. All data products are available to the public at the Mikulski Archive for Space Telescopes, http://stdatu.stsci.edu/kepler.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Argabright VS, 2008, P SOC PHOTO-OPT INS, V7010, pL102, DOI 10.1117/12.789913; Ballard S, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/200; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Batalha NM, 2010, ASTROPHYS J LETT, V713, pL109, DOI 10.1088/2041-8205/713/2/L109; Borucki W., 2009, P IAU, V4, pS253; Borucki WJ, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/120; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Carter JA, 2012, SCIENCE, V337, P556, DOI 10.1126/science.1223269; Desert JM, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/200913093; Fressin F, 2012, NATURE, V482, P195, DOI 10.1038/nature10780; Fressin F, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/5; Gautier TN, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/15; Hatzes AP, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/75; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Howell SB, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/123; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Kaltenegger L, 2011, ASTROPHYS J LETT, V736, DOI 10.1088/2041-8205/736/2/L25; KASTING JF, 1993, ICARUS, V101, P108, DOI 10.1006/icar.1993.1010; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Rogers LA, 2010, ASTROPHYS J, V716, P1208, DOI 10.1088/0004-637X/716/2/1208; Selsis F, 2007, ASTRON ASTROPHYS, V476, P1373, DOI 10.1051/0004-6361:20078091; Torres G, 2004, ASTROPHYS J, V614, P979, DOI 10.1086/423734; Torres G., 2011, ASTROPHYS J, V700, P1589; Williams D. M., 2002, INT J ASTROBIOL, V1, P61, DOI [10.1017/S1473550402001064, DOI 10.1017/S1473550402001064]	26	153	154	0	572	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					587	590		10.1126/science.1234702	http://dx.doi.org/10.1126/science.1234702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23599262	Green Submitted, Green Accepted			2022-12-24	WOS:000318268900042
J	Pelechano, V; Wei, W; Steinmetz, LM				Pelechano, Vicent; Wei, Wu; Steinmetz, Lars M.			Extensive transcriptional heterogeneity revealed by isoform profiling	NATURE			English	Article							GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; YEAST; POLYADENYLATION; ORGANIZATION; TRANSLATION; SWITCH	Transcript function is determined by sequence elements arranged on an individual RNA molecule. Variation in transcripts can affect messenger RNA stability, localization and translation(1), or produce truncated proteins that differ in localization(2) or function(3). Given the existence of overlapping, variable transcript isoforms, determining the functional impact of the transcriptome requires identification of full-length transcripts, rather than just the genomic regions that are transcribed(4,5). Here, by jointly determining both transcript ends for millions of RNA molecules, we reveal an extensive layer of isoform diversity previously hidden among overlapping RNA molecules. Variation in transcript boundaries seems to be the rule rather than the exception, even within a single population of yeast cells. Over 26 major transcript isoforms per protein-coding gene were expressed in yeast. Hundreds of short coding RNAs and truncated versions of proteins are concomitantly encoded by alternative transcript isoforms, increasing protein diversity. In addition, approximately 70% of genes express alternative isoforms that vary in post-transcriptional regulatory elements, and tandem genes frequently produce overlapping or even bicistronic transcripts. This extensive transcript diversity is generated by a relatively simple eukaryotic genome with limited splicing, and within a genetically homogeneous population of cells. Our findings have implications for genome compaction, evolution and phenotypic diversity between single cells. These data also indicate that isoform diversity as well as RNA abundance should be considered when assessing the functional repertoire of genomes.	[Pelechano, Vicent; Wei, Wu; Steinmetz, Lars M.] European Mol Biol Lab EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Wei, Wu; Steinmetz, Lars M.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	European Molecular Biology Laboratory (EMBL); Stanford University	Steinmetz, LM (corresponding author), European Mol Biol Lab EMBL, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Pelechano, Vicent/ABF-2597-2020; Pelechano, Vicent/A-8431-2011; Wei, Wu/AAC-8285-2020	Pelechano, Vicent/0000-0002-9415-788X; Pelechano, Vicent/0000-0002-9415-788X; Wei, Wu/0000-0001-5643-8739; Steinmetz, Lars/0000-0002-3962-2865	National Institutes of Health; EMBO fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO fellowship(European Molecular Biology Organization (EMBO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Aiyar for help in editing and refining the manuscript. We thank W. Huber, C. Zhu, A. I. Jarvelin, S. Clauder-Munster, J. Zaugg, S. Adjalley, G. Lin and the members of the Steinmetz laboratory for helpful discussions and critical comments on the manuscript. We thank V. N. Gladyshev and C. Pineau for sharing published data. This study was technically supported by the EMBL Genomics Core Facility. This study was financially supported by the National Institutes of Health (to L.M.S.). V. P. was supported by an EMBO fellowship.	CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; CHATTON B, 1988, J BIOL CHEM, V263, P52; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Fournier CT, 2012, J PROTEOME RES, V11, P5712, DOI 10.1021/pr300538f; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Majumdar S, 2004, EUR J BIOCHEM, V271, P753, DOI 10.1111/j.1432-1033.2003.03974.x; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; Ruan XA, 2012, METHODS MOL BIOL, V809, P535, DOI 10.1007/978-1-61779-376-9_35; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Ungewitter E, 2010, GENE DEV, V24, P2408, DOI 10.1101/gad.1987810; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wilkening S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1249; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	27	264	267	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					127	+		10.1038/nature12121	http://dx.doi.org/10.1038/nature12121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23615609	Green Accepted			2022-12-24	WOS:000318221500047
J	Christensen, J; Gronborg, TK; Sorensen, MJ; Schendel, D; Parner, ET; Pedersen, LH; Vestergaard, M				Christensen, Jakob; Gronborg, Therese Koops; Sorensen, Merete Juul; Schendel, Diana; Parner, Erik Thorlund; Pedersen, Lars Henning; Vestergaard, Mogens			Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEHAVIORAL ALTERATIONS; ANIMAL-MODEL; ACID; CHILDREN; PREGNANCY; REGISTRATION; WOMEN; BIRTH; AGE	Importance Valproate is used for the treatment of epilepsy and other neuropsychological disorders and may be the only treatment option for women of childbearing potential. However, prenatal exposure to valproate may increase the risk of autism. Objective To determine whether prenatal exposure to valproate is associated with an increased risk of autism in offspring. Design, Setting, and Participants Population-based study of all children born alive in Denmark from 1996 to 2006. National registers were used to identify children exposed to valproate during pregnancy and diagnosed with autism spectrum disorders (childhood autism [autistic disorder], Asperger syndrome, atypical autism, and other or unspecified pervasive developmental disorders). We analyzed the risks associated with all autism spectrum disorders as well as childhood autism. Data were analyzed by Cox regression adjusting for potential confounders (maternal age at conception, paternal age at conception, parental psychiatric history, gestational age, birth weight, sex, congenital malformations, and parity). Children were followed up from birth until the day of autism spectrum disorder diagnosis, death, emigration, or December 31, 2010, whichever came first. Main Outcomes and Measures Absolute risk (cumulative incidence) and the hazard ratio (HR) of autism spectrum disorder and childhood autism in children after exposure to valproate in pregnancy. Results Of 655 615 children born from 1996 through 2006, 5437 were identified with autism spectrum disorder, including 2067 with childhood autism. The mean age of the children at end of follow-up was 8.84 years (range, 4-14; median, 8.85). The estimated absolute risk after 14 years of follow-up was 1.53% (95% CI, 1.47%-1.58%) for autism spectrum disorder and 0.48% (95% CI, 0.46%-0.51%) for childhood autism. Overall, the 508 children exposed to valproate had an absolute risk of 4.42% (95% CI, 2.59%-7.46%) for autism spectrum disorder (adjusted HR, 2.9 [95% CI, 1.7-4.9]) and an absolute risk of 2.50% (95% CI, 1.30%-4.81%) for childhood autism (adjusted HR, 5.2 [95% CI, 2.7-10.0]). When restricting the cohort to the 6584 children born to women with epilepsy, the absolute risk of autism spectrum disorder among 432 children exposed to valproate was 4.15% (95% CI, 2.20%-7.81%) (adjusted HR, 1.7 [95% CI, 0.9-3.2]), and the absolute risk of childhood autism was 2.95% (95% CI, 1.42%-6.11%) (adjusted HR, 2.9 [95% CI, 1.4-6.0]) vs 2.44% (95% CI, 1.88%-3.16%) for autism spectrum disorder and 1.02% (95% CI, 0.70%-1.49%) for childhood autism among 6152 children not exposed to valproate. Conclusions and Relevance Maternal use of valproate during pregnancy was associated with a significantly increased risk of autism spectrum disorder and childhood autism in the offspring, even after adjusting for maternal epilepsy. For women of childbearing potential who use antiepileptic medications, these findings must be balanced against the treatment benefits for women who require valproate for epilepsy control. JAMA. 2013;309(16):1696-1703 www.jama.com	[Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Clin Pharmacol, DK-8000 Aarhus C, Denmark; [Gronborg, Therese Koops; Parner, Erik Thorlund] Aarhus Univ, Inst Publ Hlth, Dept Biostat, Aarhus, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Inst Clin Med, Dept Obstet & Gynaecol, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Inst Publ Hlth, Res Unit, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Inst Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Sorensen, Merete Juul] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, Risskov, Denmark; [Schendel, Diana] Ctr Dis Control & Prevent, Atlanta, GA USA	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Centers for Disease Control & Prevention - USA	Christensen, J (corresponding author), Aarhus Univ Hosp, Dept Neurol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	jakob@farm.au.dk	Parner, Erik Thorlund/F-5532-2010; Vestergaard, Mogens/M-9333-2014	Parner, Erik Thorlund/0000-0003-3661-1922; Vestergaard, Mogens/0000-0001-8830-2174; Schendel, Diana/0000-0002-8588-1227; Christensen, Jakob/0000-0002-9385-6435	UCB Nordic; Danish Epilepsy Association; Danish Council for Independent Research; European Research Council (European Union) [260242]; Danish Medical Research Council [09-072986]	UCB Nordic(UCB Pharma SA); Danish Epilepsy Association; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); European Research Council (European Union)(European Research Council (ERC)European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Christensen reported receiving honoraria for serving on the scientific advisory boards of UCB Nordic and Eisai AB; receiving lecture honoraria from UCB Nordic and Eisai AB; and receiving travel funding from UCB Nordic. Dr Parner reported receiving grants from Autism Speaks and the National Institutes of Health. No other authors reported disclosures.; Dr Christensen receives research support from the Danish Epilepsy Association. Dr Pedersen is supported by a Sapere Aude-Postdoctoral grant from the Danish Council for Independent Research. This study was supported by grants from the European Research Council (the European Union Seventh Framework Programme, ERC-2010-StG No. 260242) and the Danish Medical Research Council (09-072986).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Bromley RL, 2013, J NEUROL NEUROSUR PS, V84, P637, DOI 10.1136/jnnp-2012-304270; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Holmes GL, 2007, EPILEPSY BEHAV, V11, P270, DOI 10.1016/j.yebeh.2007.08.022; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Markram K, 2008, NEUROPSYCHOPHARMACOL, V33, P901, DOI 10.1038/sj.npp.1301453; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Meador KJ, 2007, EPILEPSY BEHAV, V11, P292, DOI 10.1016/j.yebeh.2007.08.009; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Olesen AW, 2004, ACTA OBSTET GYN SCAN, V83, P1039, DOI 10.1111/j.0001-6349.2004.00193.x; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Schmidt RJ, 2012, AM J CLIN NUTR, V96, P80, DOI 10.3945/ajcn.110.004416; Schneider T, 2006, NEUROPSYCHOPHARMACOL, V31, P36, DOI 10.1038/sj.npp.1300767; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Sui L, 2012, BRAIN RES BULL, V87, P556, DOI 10.1016/j.brainresbull.2012.01.011; Suren P, 2013, JAMA-J AM MED ASSOC, V309, P570, DOI 10.1001/jama.2012.155925; Symons MJ, 2002, J CLIN EPIDEMIOL, V55, P893, DOI 10.1016/S0895-4356(02)00443-2; Tamura T, 2005, PEDIATRICS, V116, P703, DOI 10.1542/peds.2004-2189; Vajda FJE, 2006, EUR J NEUROL, V13, P645, DOI 10.1111/j.1468-1331.2006.01359.x; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; WHO Collaborating Centre for Drug Statistics Methodology (WHOCC), DEF DAIL DOS DEF GEN	36	672	700	4	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2013	309	16					1696	1703		10.1001/jama.2013.2270	http://dx.doi.org/10.1001/jama.2013.2270			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	130IG	23613074	Green Accepted			2022-12-24	WOS:000317906700026
J	Weekes, MP; Tan, SYL; Poole, E; Talbot, S; Antrobus, R; Smith, DL; Montag, C; Gygi, SP; Sinclair, JH; Lehner, PJ				Weekes, Michael P.; Tan, Shireen Y. L.; Poole, Emma; Talbot, Suzanne; Antrobus, Robin; Smith, Duncan L.; Montag, Christina; Gygi, Steven P.; Sinclair, John H.; Lehner, Paul J.			Latency-Associated Degradation of the MRP1 Drug Transporter During Latent Human Cytomegalovirus Infection	SCIENCE			English	Article							MULTIDRUG-RESISTANCE; DENDRITIC CELLS; GENE-EXPRESSION; REACTIVATION; RECEPTOR; FAMILY; MODEL	The reactivation of latent human cytomegalovirus (HCMV) infection after transplantation is associated with high morbidity and mortality. In vivo, myeloid cells and their progenitors are an important site of HCMV latency, whose establishment and/or maintenance require expression of the viral transcript UL138. Using stable isotope labeling by amino acids in cell culture-based mass spectrometry, we found a dramatic UL138-mediated loss of cell surface multidrug resistance-associated protein-1 (MRP1) and the reduction of substrate export by this transporter. Latency-associated loss of MRP1 and accumulation of the cytotoxic drug vincristine, an MRP1 substrate, depleted virus from naturally latent CD14(+) and CD34(+) progenitors, all of which are in vivo sites of latency. The UL138-mediated loss of MRP1 provides a marker for detecting latent HCMV infection and a therapeutic target for eliminating latently infected cells before transplantation.	[Weekes, Michael P.; Tan, Shireen Y. L.; Talbot, Suzanne; Antrobus, Robin; Lehner, Paul J.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Poole, Emma; Sinclair, John H.] Univ Cambridge, Sch Clin, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Smith, Duncan L.] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Montag, Christina] Charite, Childrens Hosp, Lab Mol Biol, D-10117 Berlin, Germany; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Paterson Institute for Cancer Research; University of Manchester; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School	Lehner, PJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	pjl30@cam.ac.uk		Poole, Emma/0000-0003-3904-6121; Lehner, Paul Joseph/0000-0001-9383-1054; Weekes, Michael/0000-0003-3196-5545	Cambridge Institute for Medical Research; Wellcome Trust [093966/Z/10/Z, 084957/Z/08/Z]; Agency for Science, Technology and Research, Singapore; MRC [G0701279]; NIHR Cambridge Biomedical Research Centre; Medical Research Council [MR/K021087/1, G0701279] Funding Source: researchfish; MRC [MR/K021087/1] Funding Source: UKRI	Cambridge Institute for Medical Research; Wellcome Trust(Wellcome Trust); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to M. Reeves for discussions and cells. All data are tabulated in the main paper and the supplementary materials. This work was supported by a Next Generation Fellowship from the Cambridge Institute for Medical Research and a Wellcome Trust Fellowship (093966/Z/10/Z) to M.P.W.; a grant from the Agency for Science, Technology and Research, Singapore to S.Y.L.T.; an MRC Programme grant (G0701279) to J.H.S.; and a Wellcome Trust Senior Fellowship (084957/Z/08/Z) to P.J.L. This work was also supported by the NIHR Cambridge Biomedical Research Centre, and the Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award. P.J.L., J.H.S., M.P.W., and R.A. are authors on patent application PCT/GB2012/051094 filed by Cambridge Enterprise, entitled "Detection and depletion of HCMV infected cells."	ALMQUIST KC, 1995, CANCER RES, V55, P102; Avdic S, 2011, J VIROL, V85, P7465, DOI 10.1128/JVI.00088-11; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Goodrum F, 2007, BLOOD, V110, P937, DOI 10.1182/blood-2007-01-070078; Grainger L, 2010, J VIROL, V84, P9472, DOI 10.1128/JVI.00855-10; Hahn G, 1998, P NATL ACAD SCI USA, V95, P3937, DOI 10.1073/pnas.95.7.3937; Hargett D, 2010, P NATL ACAD SCI USA, V107, P20039, DOI 10.1073/pnas.1014509107; Huang MM, 2012, J VIROL, V86, P8507, DOI 10.1128/JVI.00598-12; Jin J, 2009, INT J CANCER, V124, P233, DOI 10.1002/ijc.23892; KONDO K, 1994, P NATL ACAD SCI USA, V91, P11879, DOI 10.1073/pnas.91.25.11879; MARQUARDT D, 1990, CANCER RES, V50, P1426; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Montag C, 2011, J VIROL, V85, P11409, DOI 10.1128/JVI.05028-11; Nichols WG, 2002, J INFECT DIS, V185, P273, DOI 10.1086/338624; Petrucelli A, 2009, J VIROL, V83, P5615, DOI 10.1128/JVI.01989-08; Rajagopal A, 2002, CANCER RES, V62, P391; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; Sinclair J, 2010, BBA-GENE REGUL MECH, V1799, P286, DOI 10.1016/j.bbagrm.2009.08.001; Slobedman B, 2010, FUTURE MICROBIOL, V5, P883, DOI 10.2217/FMB.10.58; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; van de Ven R, 2006, J IMMUNOL, V176, P5191, DOI 10.4049/jimmunol.176.9.5191; Weekes MP, 2012, J PROTEOME RES, V11, P1475, DOI 10.1021/pr201135e	27	103	110	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129					199	202		10.1126/science.1235047	http://dx.doi.org/10.1126/science.1235047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580527	Green Accepted			2022-12-24	WOS:000317341400056
J	Zheng, HJ; Wisedchaisri, G; Gonen, T				Zheng, Hongjin; Wisedchaisri, Goragot; Gonen, Tamir			Crystal structure of a nitrate/nitrite exchanger	NATURE			English	Article							MAJOR FACILITATOR SUPERFAMILY; ESCHERICHIA-COLI; NITRATE UPTAKE; NITRITE TRANSPORT; MECHANISM; NARK; DENITRIFICATION; CHANNEL; PROTEIN; SYSTEM	Mineral nitrogen in nature is often found in the form of nitrate (NO3-). Numerous microorganisms evolved to assimilate nitrate and use it as a major source of mineral nitrogen uptake(1). Nitrate, which is central in nitrogen metabolism, is first reduced to nitrite (NO2-) through a two-electron reduction reaction(2,3). The accumulation of cellular nitrite can be harmful because nitrite can be reduced to the cytotoxic nitric oxide. Instead, nitrite is rapidly removed from the cell by channels and transporters, or reduced to ammonium or dinitrogen through the action of assimilatory enzymes(3). Despite decades of effort no structure is currently available for any nitrate transport protein and the mechanism by which nitrate is transported remains largely unknown. Here we report the structure of a bacterial nitrate/nitrite transport protein, NarK, from Escherichia coli, with and without substrate. The structures reveal a positively charged substrate-translocation pathway lacking protonatable residues, suggesting that NarK functions as a nitrate/nitrite exchanger and that protons are unlikely to be co-transported. Conserved arginine residues comprise the substrate-binding pocket, which is formed by association of helices from the two halves of NarK. Key residues that are important for substrate recognition and transport are identified and related to extensive mutagenesis and functional studies. We propose that NarK exchanges nitrate for nitrite by a rocker switch mechanism facilitated by inter-domain hydrogen bond networks.	[Zheng, Hongjin; Wisedchaisri, Goragot; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Gonen, T (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	gonent@janelia.hhmi.org		Wisedchaisri, Goragot/0000-0002-6967-5925	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Howard Hughes Medical Institute	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank E. McCleskey for critically reading this manuscript and for discussions. We thank D. Cawley for development and production of monoclonal antibodies, and staff at the Advanced Light Source, Lawrence Berkeley National Laboratory for assistance with X-ray data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract no. DE-AC02-05CH11231. Research in the Gonen laboratory is funded by the Howard Hughes Medical Institute.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; [Anonymous], PYMOL MOL GRAPH SYST; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DEMOSS JA, 1991, J BACTERIOL, V173, P3303, DOI 10.1128/jb.173.11.3303-3310.1991; Einsle O, 2004, BIOL CHEM, V385, P875, DOI 10.1515/BC.2004.115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fokin AV, 2000, BIOORG KHIM+, V26, P571; Harlow E., 1988, ANTIBODIES LAB MANUA; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jia W, 2005, BIOCHEM SOC T, V33, P159, DOI 10.1042/BST0330159; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lu W, 2012, P NATL ACAD SCI USA, V109, P18395, DOI 10.1073/pnas.1210793109; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin LZ, 2012, P NATL ACAD SCI USA, V109, P13434, DOI 10.1073/pnas.1116633109; ROWE JJ, 1994, MOL MICROBIOL, V12, P579, DOI 10.1111/j.1365-2958.1994.tb01044.x; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Trueman LJ, 1996, GENE, V175, P223, DOI 10.1016/0378-1119(96)00154-0; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	34	78	81	5	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					647	+		10.1038/nature12139	http://dx.doi.org/10.1038/nature12139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23665960	Green Accepted, Green Submitted			2022-12-24	WOS:000319556100050
J	Shu, J; Wu, C; Wu, YT; Li, ZY; Shao, SD; Zhao, WH; Tang, X; Yang, H; Shen, LJ; Zuo, XH; Yang, WF; Shi, Y; Chi, XC; Zhang, HQ; Gao, G; Shu, YM; Yuan, KH; He, WW; Tang, C; Zhao, Y; Deng, HK				Shu, Jian; Wu, Chen; Wu, Yetao; Li, Zhiyuan; Shao, Sida; Zhao, Wenhui; Tang, Xing; Yang, Huan; Shen, Lijun; Zuo, Xiaohan; Yang, Weifeng; Shi, Yan; Chi, Xiaochun; Zhang, Hongquan; Gao, Ge; Shu, Youmin; Yuan, Kehu; He, Weiwu; Tang, Chao; Zhao, Yang; Deng, Hongkui			Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers	CELL			English	Article							EMBRYONIC STEM-CELLS; PRIMITIVE ENDODERM; DIRECT CONVERSION; HUMAN FIBROBLASTS; DIFFERENTIATION; OCT4; EXPRESSION; GENERATION; GENE; DEDIFFERENTIATION	The reprogramming factors that induce pluripotency have been identified primarily from embryonic stem cell (ESC)-enriched, pluripotency-associated factors. Here, we report that, during mouse somatic cell reprogramming, pluripotency can be induced with lineage specifiers that are pluripotency rivals to suppress ESC identity, most of which are not enriched in ESCs. We found that OCT4 and SOX2, the core regulators of pluripotency, can be replaced by lineage specifiers that are involved in mesendo-dermal (ME) specification and in ectodermal (ECT) specification, respectively. OCT4 and its substitutes attenuated the elevated expression of a group of ECT genes, whereas SOX2 and its substitutes curtailed a group of ME genes during reprogramming. Surprisingly, the two counteracting lineage specifiers can synergistically induce pluripotency in the absence of both OCT4 and SOX2. Our study suggests a "seesaw model'' in which a balance that is established using pluripotency factors and/or counteracting lineage specifiers can facilitate reprogramming.	[Shu, Jian; Shao, Sida; Zhao, Wenhui; Shen, Lijun; Yang, Weifeng; Zhao, Yang; Deng, Hongkui] Peking Univ, Coll Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Li, Zhiyuan; Tang, Chao] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Shu, Jian; Wu, Chen; Wu, Yetao; Zhao, Wenhui; Yang, Huan; Zuo, Xiaohan; Tang, Chao; Zhao, Yang; Deng, Hongkui] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Tang, Xing; Gao, Ge] Peking Univ, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Coll Life Sci, Beijing 100871, Peoples R China; [Chi, Xiaochun; Zhang, Hongquan] Peking Univ, Sch Basic Med Sci, Lab Stem Cells Dev & Reprod Med, Beijing 100191, Peoples R China; [Wu, Chen; Wu, Yetao; Yang, Huan; Zuo, Xiaohan; Shi, Yan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Li, Zhiyuan] Univ Calif San Francisco, Biophys Grad Program, San Francisco, CA 94158 USA; [Shu, Youmin; Yuan, Kehu; He, Weiwu] OriGene Technol, Rockville, MD 20850 USA	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; University Town of Shenzhen; University of California System; University of California San Francisco	Tang, C (corresponding author), Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China.	tangc@pku.edu.cn; hongkui_deng@pku.edu.cn	Gao, Ge/F-3615-2012; Zhang, Xiaoming/L-2904-2013; li, zhiyuan/M-8378-2013	li, zhiyuan/0000-0001-6662-2636; Tang, Chao/0000-0003-1474-3705; Yang, Huan/0000-0001-8345-9957	National Basic Research Program of China (973 program) [2012CB966401, 2009CB941101, 2010CB945204, 2009CB918500]; Key New Drug Creation and Manufacturing Program [2011ZX09102-010-03]; National Natural Science Foundation of China [90919031, 11021463]; 111 project; NSF [CMMI-0941355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER	National Basic Research Program of China (973 program)(National Basic Research Program of China); Key New Drug Creation and Manufacturing Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chengyan Wang and Xiaolei Yin for helpful discussions. We also thank Haisong Liu, Jiancheng Wang, Zhiyuan Hou, Ren Li, Fangfang Zhu, Dongyi Xu, and Xing Zhang for technical assistance. J.S., C.W., and Y.W. conducted most of the experiments in this study. Z.L. performed the computer analysis and mathematical model analysis. H.D., Y.Z., and C.T. conceived of and supervised the study. This work was supported by grants from the National Basic Research Program of China (973 program grant numbers 2012CB966401, 2009CB941101, 2010CB945204, and 2009CB918500), the Key New Drug Creation and Manufacturing Program (grant numbers 2011ZX09102-010-03), the National Natural Science Foundation of China (grant numbers 90919031 and 11021463), the 111 project, and NSF (CMMI-0941355).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cao Q, 2012, DEVELOPMENT, V139, P3950, DOI 10.1242/dev.082024; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tontsch S, 2001, MECH DEVELOP, V108, P165, DOI 10.1016/S0925-4773(01)00477-4; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	52	206	225	10	215	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					963	975		10.1016/j.cell.2013.05.001	http://dx.doi.org/10.1016/j.cell.2013.05.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23706735	Green Accepted, Bronze			2022-12-24	WOS:000319456800006
J	Getz, G; Gabriel, SB; Cibulskis, K; Lander, E; Sivachenko, A; Sougnez, C; Lawrence, M; Kandoth, C; Dooling, D; Fulton, R; Fulton, L; Kalicki-Veizer, J; McLellan, MD; O'Laughlin, M; Schmidt, H; Wilson, RK; Ye, K; Ding, L; Mardis, ER; Ally, A; Balasundaram, M; Birol, I; Butterfield, YSN; Carlsen, R; Carter, C; Chu, A; Chuah, E; Chun, HJE; Dhalla, N; Guin, R; Hirst, C; Holt, RA; Jones, SJM; Lee, D; Li, HI; Marra, MA; Mayo, M; Moore, RA; Mungall, AJ; Plettner, P; Schein, JE; Sipahimalani, P; Tam, A; Varhol, RJ; Robertson, AG; Pashtan, I; Saksena, G; Onofrio, RC; Schumacher, SE; Tabak, B; Carter, SL; Hernandez, B; Gentry, J; Salvesen, HB; Ardlie, K; Getz, G; Winckler, W; Beroukhim, R; Gabriel, SB; Meyerson, M; Hadjipanayis, A; Lee, S; Mahadeshwar, HS; Park, P; Protopopov, A; Ren, XJ; Seth, S; Song, XZ; Tang, JB; Xi, RB; Yang, LX; Zeng, D; Kucherlapati, R; Chin, L; Zhang, JH; Auman, JT; Balu, S; Bodenheimer, T; Buda, E; Hayes, DN; Hoyle, AP; Jefferys, SR; Jones, CD; Meng, SW; Mieczkowski, PA; Mose, LE; Parker, JS; Perou, CM; Roach, J; Shi, Y; Simons, JV; Soloway, MG; Tan, DH; Topal, MD; Waring, S; Wu, JY; Hoadley, KA; Baylin, SB; Bootwalla, MS; Lai, PH; Triche, TJ; Van Den Berg, D; Weisenberger, DJ; Laird, PW; Shen, H; Chin, L; Zhang, JH; Getz, G; Cho, J; DiCara, D; Frazer, S; Heiman, D; Jing, R; Lin, P; Mallard, W; Stojanov, P; Voet, D; Zhang, HL; Zou, LH; Noble, M; Lawrence, M; Reynolds, SM; Shmulevich, I; Aksoy, BA; Antipin, Y; Ciriello, G; Dresdner, G; Gao, JJ; Gross, B; Jacobsen, A; Ladanyi, M; Reva, B; Sander, C; Sinha, R; Sumer, SO; Taylor, BS; Cerami, E; Weinhold, N; Schultz, N; Shen, RL; Benz, S; Goldstein, T; Haussler, D; Ng, S; Szeto, C; Stuart, J; Benz, CC; Yau, C; Zhang, W; Annala, M; Broom, BM; Casasent, TD; Ju, ZL; Liang, H; Liu, GY; Lu, YL; Unruh, AK; Wakefield, C; Weinstein, JN; Zhang, NX; Liu, YX; Broaddus, R; Akbani, R; Mills, GB; Adams, C; Barr, T; Black, AD; Bowen, J; Deardurff, J; Frick, J; Gastier-Foster, JM; Grossman, T; Harper, HA; Hart-Kothari, M; Helsel, C; Hobensack, A; Kuck, H; Kneile, K; Leraas, K; Lichtenberg, TM; McAllister, C; Pyatt, RE; Ramirez, NC; Tabler, TR; Vanhoose, N; White, P; Wise, L; Zmuda, E; Barnabas, N; Berry-Green, C; Blanc, V; Boice, L; Button, M; Farkas, A; Green, A; MacKenzie, J; Nicholson, D; Kalloger, SE; Gilks, CB; Karlan, BY; Lester, J; Orsulic, S; Borowsky, M; Cadungog, M; Czerwinski, C; Huelsenbeck-Dill, L; Iacocca, M; Petrelli, N; Petrelli, N; Witkin, G; Nemirovich-Danchenko, E; Potapova, O; Rotin, D; Berchuck, A; Birrer, M; DiSaia, P; Monovich, L; Curley, E; Gardner, J; Mallery, D; Penny, R; Dowdy, SC; Winterhoff, B; Dao, L; Gostout, B; Meuter, A; Teoman, A; Dao, F; Olvera, N; Bogomolniy, F; Garg, K; Soslow, RA; Levine, DA; Abramov, M; Bartlett, JMS; Kodeeswaran, S; Parfitt, J; Moiseenko, F; Clarke, BA; Goodman, MT; Carney, ME; Matsuno, RK; Fisher, J; Huang, M; Rathmell, WK; Thorne, L; Van Le, L; Dhir, R; Edwards, R; Elishaev, E; Zorn, K; Broaddus, R; Goodfellow, PJ; Mutch, D; Schultz, N; Liu, YX; Akbani, R; Cherniack, AD; Cerami, E; Weinhold, N; Shen, H; Hoadley, KA; Kahn, AB; Bell, DW; Pollock, PM; Wang, C; Wheeler, DA; Shinbrot, E; Karlan, BY; Berchuck, A; Dowdy, SC; Winterhoff, B; Goodman, MT; Robertson, AG; Beroukhim, R; Pashtan, I; Salvesen, HB; Laird, PW; Noble, M; Stuart, J; Ding, L; Kandoth, C; Gilks, CB; Soslow, RA; Goodfellow, PJ; Mutch, D; Broaddus, R; Zhang, W; Mills, GB; Kucherlapati, R; Mardis, ER; Levine, DA; Ayala, B; Chu, AL; Jensen, MA; Kothiyal, P; Pihl, TD; Pontius, J; Pot, DA; Snyder, EE; Srinivasan, D; Kahn, AB; Shaw, KRM; Sheth, M; Davidsen, T; Eley, G; Ferguson, ML; Demchok, JA; Yang, LM; Guyer, MS; Ozenberger, BA; Sofia, HJ; Kandoth, C; Schultz, N; Cherniack, AD; Akbani, R; Liu, YX; Shen, H; Robertson, AG; Pashtan, I; Shen, R; Benz, CC; Yau, C; Laird, PW; Ding, L; Zhang, W; Mills, GB; Kucherlapati, R; Mardis, ER; Levine, DA				Getz, Gad; Gabriel, Stacey B.; Cibulskis, Kristian; Lander, Eric; Sivachenko, Andrey; Sougnez, Carrie; Lawrence, Mike; Kandoth, Cyriac; Dooling, David; Fulton, Robert; Fulton, Lucinda; Kalicki-Veizer, Joelle; McLellan, Michael D.; O'Laughlin, Michelle; Schmidt, Heather; Wilson, Richard K.; Ye, Kai; Ding, Li; Mardis, Elaine R.; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Holt, Robert A.; Jones, Steven J. M.; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Plettner, Patrick; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Varhol, Richard J.; Robertson, A. Gordon; Pashtan, Itai; Saksena, Gordon; Onofrio, Robert C.; Schumacher, Steven E.; Tabak, Barbara; Carter, Scott L.; Hernandez, Bryan; Gentry, Jeff; Salvesen, Helga B.; Ardlie, Kristin; Getz, Gad; Winckler, Wendy; Beroukhim, Rameen; Gabriel, Stacey B.; Meyerson, Matthew; Hadjipanayis, Angela; Lee, Semin; Mahadeshwar, Harshad S.; Park, Peter; Protopopov, Alexei; Ren, Xiaojia; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Xi, Ruibin; Yang, Lixing; Zeng, Dong; Kucherlapati, Raju; Chin, Lynda; Zhang, Jianhua; Auman, J. Todd; Balu, Saianand; Bodenheimer, Tom; Buda, Elizabeth; Hayes, D. Neil; Hoyle, Alan P.; Jefferys, Stuart R.; Jones, Corbin D.; Meng, Shaowu; Mieczkowski, Piotr A.; Mose, Lisle E.; Parker, Joel S.; Perou, Charles M.; Roach, Jeff; Shi, Yan; Simons, Janae V.; Soloway, Mathew G.; Tan, Donghui; Topal, Michael D.; Waring, Scot; Wu, Junyuan; Hoadley, Katherine A.; Baylin, Stephen B.; Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy J., Jr.; Van Den Berg, DavidJ.; Weisenberger, Daniel J.; Laird, Peter W.; Shen, Hui; Chin, Lynda; Zhang, Jianhua; Getz, Gad; Cho, Juok; DiCara, Daniel; Frazer, Scott; Heiman, David; Jing, Rui; Lin, Pei; Mallard, Will; Stojanov, Petar; Voet, Doug; Zhang, Hailei; Zou, Lihua; Noble, Michael; Lawrence, Mike; Reynolds, Sheila M.; Shmulevich, Ilya; Aksoy, B. Arman; Antipin, Yevgeniy; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Ladanyi, Marc; Reva, Boris; Sander, Chris; Sinha, Rileen; Sumer, S. Onur; Taylor, Barry S.; Cerami, Ethan; Weinhold, Nils; Schultz, Nikolaus; Shen, Ronglai; Benz, Stephen; Goldstein, Ted; Haussler, David; Sam Ng; Szeto, Christopher; Stuart, Joshua; Benz, Christopher C.; Yau, Christina; Zhang, Wei; Annala, Matti; Broom, Bradley M.; Casasent, Tod D.; Ju, Zhenlin; Liang, Han; Liu, Guoyan; Lu, Yiling; Unruh, Anna K.; Wakefield, Chris; Weinstein, John N.; Zhang, Nianxiang; Liu, Yuexin; Broaddus, Russell; Akbani, Rehan; Mills, Gordon B.; Adams, Christopher; Barr, Thomas; Black, Aaron D.; Bowen, Jay; Deardurff, John; Frick, Jessica; Gastier-Foster, Julie M.; Grossman, Thomas; Harper, Hollie A.; Hart-Kothari, Melissa; Helsel, Carmen; Hobensack, Aaron; Kuck, Harkness; Kneile, Kelley; Leraas, KristenM.; Lichtenberg, Tara M.; McAllister, Cynthia; Pyatt, Robert E.; Ramirez, Nilsa C.; Tabler, Teresa R.; Vanhoose, Nathan; White, Peter; Wise, Lisa; Zmuda, Erik; Barnabas, Nandita; Berry-Green, Charlenia; Blanc, Victoria; Boice, Lori; Button, Michael; Farkas, Adam; Green, Alex; MacKenzie, Jean; Nicholson, Dana; Kalloger, Steve E.; Gilks, C. Blake; Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Borowsky, Mark; Cadungog, Mark; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Iacocca, Mary; Petrelli, Nicholas; Petrelli, Nicholas; Witkin, Gary; Nemirovich-Danchenko, Elena; Potapova, Olga; Rotin, Daniil; Berchuck, Andrew; Birrer, Michael; DiSaia, Phillip; Monovich, Laura; Curley, Erin; Gardner, Johanna; Mallery, David; Penny, Robert; Dowdy, Sean C.; Winterhoff, Boris; Dao, Linda; Gostout, Bobbie; Meuter, Alexandra; Teoman, Attila; Dao, Fanny; Olvera, Narciso; Bogomolniy, Faina; Garg, Karuna; Soslow, Robert A.; Levine, Douglas A.; Abramov, Mikhail; Bartlett, John M. S.; Kodeeswaran, Sugy; Parfitt, Jeremy; Moiseenko, Fedor; Clarke, Blaise A.; Goodman, Marc T.; Carney, Michael E.; Matsuno, Rayna K.; Fisher, Jennifer; Huang, Mei; Rathmell, W. Kimryn; Thorne, Leigh; Van Le, Linda; Dhir, Rajiv; Edwards, Robert; Elishaev, Esther; Zorn, Kristin; Broaddus, Russell; Goodfellow, Paul J.; Mutch, David; Schultz, Nikolaus; Liu, Yuexin; Akbani, Rehan; Cherniack, Andrew D.; Cerami, Ethan; Weinhold, Nils; Shen, Hui; Hoadley, Katherine A.; Kahn, Ari B.; Bell, Daphne W.; Pollock, Pamela M.; Wang, Chen; Wheeler, David A.; Shinbrot, Eve; Karlan, Beth Y.; Berchuck, Andrew; Dowdy, Sean C.; Winterhoff, Boris; Goodman, Marc T.; Robertson, A. Gordon; Beroukhim, Rameen; Pashtan, Itai; Salvesen, Helga B.; Laird, Peter W.; Noble, Michael; Stuart, Joshua; Ding, Li; Kandoth, Cyriac; Gilks, C. Blake; Soslow, Robert A.; Goodfellow, Paul J.; Mutch, David; Broaddus, Russell; Zhang, Wei; Mills, Gordon B.; Kucherlapati, Raju; Mardis, Elaine R.; Levine, Douglas A.; Ayala, Brenda; Chu, Anna L.; Jensen, Mark A.; Kothiyal, Prachi; Pihl, Todd D.; Pontius, Joan; Pot, David A.; Snyder, Eric E.; Srinivasan, Deepak; Kahn, Ari B.; Shaw, Kenna R. Mills; Sheth, Margi; Davidsen, Tanja; Eley, Greg; Ferguson, Martin L.; Demchok, John A.; Yang, Liming; Guyer, Mark S.; Ozenberger, Bradley A.; Sofia, Heidi J.; Kandoth, Cyriac; Schultz, Nikolaus; Cherniack, Andrew D.; Akbani, Rehan; Liu, Yuexin; Shen, Hui; Robertson, A. Gordon; Pashtan, Itai; Shen, Ronglai; Benz, Christopher C.; Yau, Christina; Laird, Peter W.; Ding, Li; Zhang, Wei; Mills, Gordon B.; Kucherlapati, Raju; Mardis, Elaine R.; Levine, Douglas A.		Canc Genome Atlas Res Network	Integrated genomic characterization of endometrial carcinoma	NATURE			English	Article							MICROSATELLITE INSTABILITY; SOMATIC MUTATIONS; HIGH-FREQUENCY; LUNG-CANCER; PROTEIN; PIK3R1; TUMORS; GRADE; MODEL	We performed an integrated genomic, transcriptomic and proteomic characterization of 373 endometrial carcinomas using array- and sequencing-based technologies. Uterine seroustumours and similar to 25% of high-grade endometrioid tumours had extensive copy number alterations, few DNA methylation changes, low oestrogen receptor/progesterone receptor levels, and frequent TP53 mutations. Most endometrioid tumours had few copy number alterations or TP53 mutations, but frequent mutations in PTEN, CTNNB1, PIK3CA, ARID1A and KRAS and novel mutations in the SWI/SNF chromatin remodelling complex gene ARID5B. A subset of endometrioid tumours that we identified had a markedly increased transversion mutation frequency and newly identified hotspot mutations in POLE. Our results classified endometrial cancers into four categories: POLE ultramutated, microsatellite instability hypermutated, copy-number low, and copy-number high. Uterine serous carcinomas share genomic features with ovarian serous and basal-like breast carcinomas. We demonstrated that the genomic features of endometrial carcinomas permit a reclassification that may affect post-surgical adjuvant treatment for women with aggressive tumours.	[Getz, Gad; Gabriel, Stacey B.; Cibulskis, Kristian; Lander, Eric; Sivachenko, Andrey; Sougnez, Carrie; Lawrence, Mike; Pashtan, Itai; Saksena, Gordon; Onofrio, Robert C.; Schumacher, Steven E.; Tabak, Barbara; Carter, Scott L.; Hernandez, Bryan; Gentry, Jeff; Salvesen, Helga B.; Ardlie, Kristin; Winckler, Wendy; Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda; Cho, Juok; DiCara, Daniel; Frazer, Scott; Heiman, David; Jing, Rui; Lin, Pei; Mallard, Will; Stojanov, Petar; Voet, Doug; Zhang, Hailei; Zou, Lihua; Noble, Michael; Cherniack, Andrew D.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02139 USA; [Kandoth, Cyriac; Dooling, David; Fulton, Robert; Fulton, Lucinda; Kalicki-Veizer, Joelle; McLellan, Michael D.; O'Laughlin, Michelle; Schmidt, Heather; Wilson, Richard K.; Ye, Kai; Ding, Li; Mardis, Elaine R.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Mardis, Elaine R.; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Holt, Robert A.; Jones, Steven J. M.; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Plettner, Patrick; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Varhol, Richard J.; Robertson, A. Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02215 USA; Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Hadjipanayis, Angela; Ren, Xiaojia; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lee, Semin; Park, Peter; Xi, Ruibin; Yang, Lixing] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Mahadeshwar, Harshad S.; Protopopov, Alexei; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Zeng, Dong; Zhang, Jianhua] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Inst Appl Canc Sci, Houston, TX 77054 USA; [Park, Peter] Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Balu, Saianand; Bodenheimer, Tom; Buda, Elizabeth; Hayes, D. Neil; Hoyle, Alan P.; Jefferys, Stuart R.; Meng, Shaowu; Mose, Lisle E.; Parker, Joel S.; Perou, Charles M.; Shi, Yan; Simons, Janae V.; Soloway, Mathew G.; Tan, Donghui; Topal, Michael D.; Waring, Scot; Wu, Junyuan; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hayes, D. Neil] Univ N Carolina, Div Med Oncol, Dept Internal Med, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Mieczkowski, Piotr A.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Perou, Charles M.; Topal, Michael D.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Roach, Jeff] Univ N Carolina, Res Comp Ctr, Chapel Hill, NC 27599 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Canc Biol Div, Baltimore, MD 21231 USA; [Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy J., Jr.; Van Den Berg, DavidJ.; Weisenberger, Daniel J.; Laird, Peter W.; Shen, Hui] Univ So Calif, Epigenome Ctr, Los Angeles, CA 90089 USA; [Reynolds, Sheila M.; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Aksoy, B. Arman; Antipin, Yevgeniy; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Reva, Boris; Sander, Chris; Sinha, Rileen; Sumer, S. Onur; Cerami, Ethan; Weinhold, Nils; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Taylor, Barry S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Benz, Stephen; Goldstein, Ted; Haussler, David; Sam Ng; Szeto, Christopher; Stuart, Joshua] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Benz, Stephen; Goldstein, Ted; Sam Ng; Szeto, Christopher; Stuart, Joshua] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Yau, Christina] Buck Inst Age Res, Novato, CA 94945 USA; [Zhang, Wei; Annala, Matti; Liu, Guoyan; Liu, Yuexin] Univ Texas MD Anderson Canc Ctr, Canc Genom Core Lab, Houston, TX 77054 USA; [Liu, Guoyan; Liu, Yuexin; Broaddus, Russell] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Tampere Univ Technol, FI-33720 Tampere, Finland; [Bootwalla, Moiz S.; Van Den Berg, DavidJ.; Weisenberger, Daniel J.; Broom, Bradley M.; Ju, Zhenlin; Liang, Han; Unruh, Anna K.; Wakefield, Chris; Akbani, Rehan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Adams, Christopher; Barr, Thomas; Black, Aaron D.; Bowen, Jay; Deardurff, John; Frick, Jessica; Gastier-Foster, Julie M.; Grossman, Thomas; Harper, Hollie A.; Hart-Kothari, Melissa; Helsel, Carmen; Hobensack, Aaron; Kuck, Harkness; Kneile, Kelley; Leraas, KristenM.; Lichtenberg, Tara M.; McAllister, Cynthia; Pyatt, Robert E.; Ramirez, Nilsa C.; Tabler, Teresa R.; Vanhoose, Nathan; White, Peter; Wise, Lisa; Zmuda, Erik] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.; Ramirez, Nilsa C.; Goodfellow, Paul J.] Ohio State Univ, Columbus, OH 43210 USA; [Barnabas, Nandita; Berry-Green, Charlenia; Blanc, Victoria; Button, Michael; Farkas, Adam; Green, Alex; MacKenzie, Jean; Nicholson, Dana] Asterand, Detroit, MI 48202 USA; [Boice, Lori; Fisher, Jennifer; Huang, Mei; Thorne, Leigh; Van Le, Linda] Univ N Carolina, Chapel Hill, NC 27599 USA; [Kalloger, Steve E.; Gilks, C. Blake] British Columbia Canc Agcy, OvCaRe British Columbia, Vancouver, BC V5Z 4E6, Canada; [Kalloger, Steve E.; Gilks, C. Blake] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Borowsky, Mark; Cadungog, Mark; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Iacocca, Mary; Petrelli, Nicholas; Witkin, Gary] Helen F Graham Canc Ctr Christiana Care, Newark, DC 19713 USA; [Nemirovich-Danchenko, Elena; Potapova, Olga; Rotin, Daniil] Cureline Inc, San Francisco, CA 94080 USA; [Berchuck, Andrew] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA; [Birrer, Michael] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [DiSaia, Phillip] Univ Calif Irvine, Med Ctr, Orange, CA 92868 USA; [Monovich, Laura] Nationwide Childrens Hosp, Res Inst, GOG Tissue Bank, Columbus, OH 43205 USA; [Curley, Erin; Gardner, Johanna; Mallery, David; Penny, Robert] Int Genom Consortium, Phoenix, AZ 85004 USA; [Dowdy, Sean C.; Winterhoff, Boris; Gostout, Bobbie; Meuter, Alexandra; Teoman, Attila] Mayo Clin, Div Gynecol Oncol, Dept OB Gyn, Rochester, MN 55905 USA; [Dao, Linda] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA; [Dao, Fanny; Olvera, Narciso; Bogomolniy, Faina; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10065 USA; [Garg, Karuna; Soslow, Robert A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Abramov, Mikhail] NN Blokhin Russian Canc Res Ctr RAMS, Moscow 115478, Russia; [Bartlett, John M. S.; Kodeeswaran, Sugy] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [Parfitt, Jeremy] London Hlth Sci Ctr, Ontario Tumour Bank, London, ON N6A 5A5, Canada; [Moiseenko, Fedor] St Petersburg Acad Univ, St Petersburg 199034, Russia; [Clarke, Blaise A.; Demchok, John A.; Yang, Liming] Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2C4, Canada; [Goodman, Marc T.; Carney, Michael E.; Matsuno, Rayna K.; Eley, Greg] Univ Hawaii, Honolulu, HI 96813 USA; [Goodman, Marc T.] Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA; [Dhir, Rajiv; Edwards, Robert; Elishaev, Esther; Zorn, Kristin] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Goodfellow, Paul J.; Mutch, David] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Kahn, Ari B.; Ayala, Brenda; Chu, Anna L.; Jensen, Mark A.; Kothiyal, Prachi; Pihl, Todd D.; Pontius, Joan; Pot, David A.; Snyder, Eric E.; Srinivasan, Deepak] SRA Int, Fairfax, VA 22033 USA; [Bell, Daphne W.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Pollock, Pamela M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Wang, Chen] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN 55905 USA; [Wheeler, David A.; Shinbrot, Eve] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Shaw, Kenna R. Mills; Sheth, Margi; Davidsen, Tanja] NCI, Canc Genome Atlas Program Off, NIH, Bethesda, MD 20892 USA; Scimentis LLC, Atlanta, GA 30666 USA; [Ferguson, Martin L.] MLF Consulting, Arlington, MD 02474 USA; [Guyer, Mark S.; Ozenberger, Bradley A.; Sofia, Heidi J.] NHGRI, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); British Columbia Cancer Agency; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Bergen; Haukeland University Hospital; University of Bergen; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Boston Children's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; Institute for Systems Biology (ISB); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tampere University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; British Columbia Cancer Agency; University of British Columbia; Cedars Sinai Medical Center; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California Irvine; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; International Genomics Consortium; Mayo Clinic; Mayo Clinic; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; London Health Sciences Centre; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Hawaii System; Cedars Sinai Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); SRA International; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Queensland University of Technology (QUT); Mayo Clinic; Baylor College of Medicine; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Getz, G (corresponding author), MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02139 USA.		Schein, Jacquie E/G-3674-2015; Kucherlapati, Raju/ABC-8807-2021; Lee, Semin/S-2629-2016; Akbani, Rehan/AAG-1490-2019; Mungall, Andrew J./U-7067-2018; Moiseenko, Fedor/E-1775-2014; Shen, Hui/AAO-4387-2020; Reva, Boris/AAB-8932-2022; Perou, Charles M/H-9934-2014; Schumacher, Steven/E-9821-2013; Wilson, Richard K./AAF-4139-2019; Weisenberger, Daniel/AAA-8314-2020; wang, chen/GWM-9481-2022; , Pathology Services Core/CEZ-2246-2022; Holt, Robert A/C-3303-2009; Parker, Joel/AAG-1108-2019; Ye, Kai/GSD-9856-2022; Skanderup, Anders Jacobsen/K-1081-2013; Ye, Kai/B-3640-2012; Birol, Inanc/G-5440-2011; Schultz, Nikolaus/ABE-6347-2020; Mardis, Elaine/W-2202-2019; Seth, Sahil/I-5809-2019; salvesen, Helga B/C-1187-2017; Cibulskis, Kristian/AAC-7380-2019; Jones, Steven J/C-3621-2009; Ladanyi, Marc/AAG-8585-2019; Van Den Berg, David J/G-8598-2017; Cherniack, Andrew D./AAY-8132-2020; Shinbrot, Eve/V-2784-2019; Cherniack, Andrew/AAC-5310-2019; Wheeler, David A/M-9740-2018; Stojanov, Petar/GQI-4462-2022; Wang, Chen/B-3244-2011; Gao, JianJiong/B-5673-2016; Reva, Boris A./B-6436-2014; White, Peter/E-4301-2011; Laird, Peter W/G-8683-2012; Auman, James/AAY-7748-2020; Marra, Marco A/B-5987-2008	Lee, Semin/0000-0002-9015-6046; Mungall, Andrew J./0000-0002-0905-2742; Moiseenko, Fedor/0000-0003-2544-9042; Perou, Charles M/0000-0001-9827-2247; Schumacher, Steven/0000-0002-6819-5647; Wilson, Richard K./0000-0002-1992-1358; Weisenberger, Daniel/0000-0001-8303-2603; Holt, Robert A/0000-0002-7259-1247; Ye, Kai/0000-0002-2851-6741; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Birol, Inanc/0000-0003-0950-7839; Seth, Sahil/0000-0003-4579-3959; salvesen, Helga B/0000-0002-4438-8831; Jones, Steven J/0000-0003-3394-2208; Van Den Berg, David J/0000-0002-5404-5218; Cherniack, Andrew D./0000-0003-0470-0111; Shinbrot, Eve/0000-0002-8879-3150; Wheeler, David A/0000-0002-9056-6299; Stojanov, Petar/0000-0001-7815-776X; Wang, Chen/0000-0003-2638-3081; Gao, JianJiong/0000-0002-5739-1781; Reva, Boris A./0000-0002-8805-389X; White, Peter/0000-0002-5218-5903; Laird, Peter W/0000-0001-9117-3641; Marra, Marco A/0000-0001-7146-7175; Jensen, Mark/0000-0001-5215-101X; Heiman, David/0000-0001-7895-4259; Soslow, Robert/0000-0002-7269-5898; Sinha, Rileen/0000-0001-5497-5055; Zorn, Kristin/0000-0003-2143-8979; Weinstein, John/0000-0001-9401-6908; Pot, David/0000-0002-1480-9826; Clarke, Blaise/0000-0002-2585-8391; Auman, James/0000-0002-9328-8829; Casasent, Anna/0000-0002-7857-179X; Bowen, Jay/0000-0001-6861-9043; Schultz, Nikolaus/0000-0002-0131-4904; Pollock, Pamela/0000-0001-8420-1026; Mieczkowski, Piotr/0000-0003-2418-0096; Triche, Tim/0000-0001-5665-946X; Benz, Stephen/0000-0002-4067-0602; Rotin, Daniil/0000-0003-3386-0077; Meyerson, Matthew/0000-0002-9133-8108; Bootwalla, Moiz/0000-0001-6158-7114; Shen, Hui/0000-0001-9767-4084; Levine, Douglas/0000-0003-1038-8232; Stuart, Joshua/0000-0002-2171-565X; Hoadley, Katherine/0000-0002-1216-477X; MCLELLAN, MICHAEL/0000-0002-2703-8784; Ciriello, Giovanni/0000-0003-2021-8683; Xi, Ruibin/0000-0001-7545-7361; Cibulskis, Kristian/0000-0003-1343-1582; Goodman, Marc/0000-0002-4839-3021; Liang, Han/0000-0001-7633-286X; Kandoth, Cyriac/0000-0002-1345-3573	US National Institutes of Health [5U24CA143799-04, 5U24CA143835-04, 5U24CA143840-04, 5U24CA143843-04, 5U24CA143845-04, 5U24CA143848-04, 5U24CA143858-04, 5U24CA143866-04, 5U24CA143867-04, 5U24CA143882-04, 5U24CA143883-04, 5U24CA144025-04, U54HG003067-11, U54HG003079-10, U54HG003273-10]; NATIONAL CANCER INSTITUTE [P30CA016086, P50CA098258, U24CA144025, P30CA008748, U24CA143858, U24CA143882, P30CA016672, U24CA143840, U24CA143883, R01CA180006, U24CA143799, U24CA143866, U24CA143845, U24CA143848, U24CA143843, P30CA016056, U24CA143835, U24CA143867] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003079, ZIAHG200338, U54HG003273] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We wish to thank all patients and families who contributed to this study. We thank M. Sheth and L. Lund for administrative coordination of TCGA activities, G. Monemvasitis for editing the manuscript, and C. Gunter for critical reading of the manuscript. This work was supported by the following grants from the US National Institutes of Health: 5U24CA143799-04, 5U24CA143835-04, 5U24CA143840-04, 5U24CA143843-04, 5U24CA143845-04, 5U24CA143848-04, 5U24CA143858-04, 5U24CA143866-04, 5U24CA143867-04, 5U24CA143882-04, 5U24CA143883-04, 5U24CA144025-04, U54HG003067-11, U54HG003079-10 and U54HG003273-10.	Bartosch C, 2011, ADV ANAT PATHOL, V18, P415, DOI 10.1097/PAP.0b013e318234ab18; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Byron SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030801; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Clarke BA, 2010, J CLIN PATHOL, V63, P410, DOI 10.1136/jcp.2009.071225; Cowin PA, 2012, CANCER RES, V72, P4060, DOI 10.1158/0008-5472.CAN-12-0203; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Fleming GF, 2010, GYNECOL ONCOL, V116, P15, DOI 10.1016/j.ygyno.2009.09.025; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gilks C.B., 2012, AM J SURG PATHOL, V91, p248A; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Lax S F, 1997, Verh Dtsch Ges Pathol, V81, P228; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Levine RL, 1998, CANCER RES, V58, P3254; Li JN, 2005, GASTROENTEROLOGY, V128, P1907, DOI 10.1053/j.gastro.2005.02.067; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sutton G, 2005, GYNECOL ONCOL, V97, P755, DOI 10.1016/j.ygyno.2005.03.011; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Yemelyanova A, 2009, AM J SURG PATHOL, V33, P1504, DOI 10.1097/PAS.0b013e3181ac35f5; Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	40	2798	2859	20	344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					67	73		10.1038/nature12113	http://dx.doi.org/10.1038/nature12113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636398	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-24	WOS:000318221500035
J	Churchill, SE; Holliday, TW; Carlson, KJ; Jashashvili, T; Macias, ME; Mathews, S; Sparling, TL; Schmid, P; de Ruiter, DJ; Berger, LR				Churchill, Steven E.; Holliday, Trenton W.; Carlson, Kristian J.; Jashashvili, Tea; Macias, Marisa E.; Mathews, Sandra; Sparling, Tawnee L.; Schmid, Peter; de Ruiter, Darryl J.; Berger, Lee R.			The Upper Limb of Australopithecus sediba	SCIENCE			English	Article							LOCOMOTOR ANATOMY; BODY PROPORTIONS; PARTIAL SKELETON; HADAR FORMATION; HOMO-HABILIS; AFARENSIS; HOMINID; BIOMECHANICS; MORPHOLOGY; ONTOGENY	The evolution of the human upper limb involved a change in function from its use for both locomotion and prehension (as in apes) to a predominantly prehensile and manipulative role. Well-preserved forelimb remains of 1.98-million-year-old Australopithecus sediba from Malapa, South Africa, contribute to our understanding of this evolutionary transition. Whereas other aspects of their postcranial anatomy evince mosaic combinations of primitive (australopith-like) and derived (Homo-like) features, the upper limbs (excluding the hand and wrist) of the Malapa hominins are predominantly primitive and suggest the retention of substantial climbing and suspensory ability. The use of the forelimb primarily for prehension and manipulation appears to arise later, likely with the emergence of Homo erectus.	[Churchill, Steven E.; Macias, Marisa E.; Sparling, Tawnee L.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Churchill, Steven E.; Holliday, Trenton W.; Carlson, Kristian J.; Jashashvili, Tea; Schmid, Peter; de Ruiter, Darryl J.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Holliday, Trenton W.] Tulane Univ, Dept Anthropol, New Orleans, LA 70118 USA; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Jashashvili, Tea] Georgian Natl Museum, GE-0105 Tbilisi, Georgia; [Mathews, Sandra; Schmid, Peter] Univ Zurich, Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA	Duke University; University of Witwatersrand; Tulane University; Indiana University System; Indiana University Bloomington; University of Zurich; Texas A&M University System; Texas A&M University College Station	Churchill, SE (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Box 90383, Durham, NC 27708 USA.	churchy@duke.edu	Churchill, Steven/AAA-9386-2022; Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; de Ruiter, Darryl/0000-0003-1183-0352; Sparling, Tawnee/0000-0001-5237-0984	Gauteng Provincial Government; South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation (NRF); Evolutionary Studies Institute (University of the Witwatersrand); University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society; Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; Claude Leon Foundation; Strategic Planning and Resource Allocation Committee of the University of the Witwatersrand; A. H. Schultz Foundation; Duke University; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	Gauteng Provincial Government; South African Department of Science and Technology; African Origins Platform (AOP); South African National Research Foundation (NRF)(National Research Foundation - South Africa); Evolutionary Studies Institute (University of the Witwatersrand); University of the Witwatersrand's Vice Chancellor's Discretionary Fund; National Geographic Society(National Geographic Society); Palaeontological Scientific Trust; Andrew W. Mellon Foundation; Ford Foundation; U.S. Diplomatic Mission to South Africa; French Embassy of South Africa; Claude Leon Foundation; Strategic Planning and Resource Allocation Committee of the University of the Witwatersrand; A. H. Schultz Foundation; Duke University; Ray A. Rothrock '77 Fellowship; Texas AM University; Oppenheimer and Ackerman families; University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences; Bernard Price Institute for Palaeontology	We thank the South African Heritage Resource agency for the permits to work at the Malapa site; the Nash family for granting access to the Malapa site and continued support of research on their reserve; the Gauteng Provincial Government, the South African Department of Science and Technology, the African Origins Platform (AOP), the South African National Research Foundation (NRF), the Evolutionary Studies Institute (University of the Witwatersrand), the University of the Witwatersrand's Vice Chancellor's Discretionary Fund, the National Geographic Society, the Palaeontological Scientific Trust, the Andrew W. Mellon Foundation, the Ford Foundation, the U.S. Diplomatic Mission to South Africa, the French Embassy of South Africa, the Claude Leon Foundation, the Strategic Planning and Resource Allocation Committee of the University of the Witwatersrand, the A. H. Schultz Foundation, Duke University, the Ray A. Rothrock '77 Fellowship and International Research Travel Assistance Grant of Texas A&M University, and the Oppenheimer and Ackerman families and Sir Richard Branson for funding; the University of the Witwatersrand's Schools of Geosciences and Anatomical Sciences and the Bernard Price Institute for Palaeontology for support and facilities; Gauteng Department of Agriculture, Conservation and Environment and the Cradle of Humankind Management Authority; and our respective universities for ongoing support. We thank the Virtual Image Processing Laboratory and the Microfocus X-ray Computed Tomography Facility of the Palaeosciences Centre at the University of the Witwatersrand; for funding these facilities, we thank the University of the Witwatersrand Office of Research and the NRF SRIG (Strategic Research Infrastructure Grant) and AOP funding programs. For access to comparative specimens, we thank E. Mbua, P. Kiura, V. Iminjili, and the National Museums of Kenya; B. Billings, B. Zipfel, and the School of Anatomical Sciences at the University of the Witwatersrand; S. Potze and L. C. Kgasi at the Ditsong Museum; E. Westwig at the American Museum of Natural History; L. Gordon at the National Museum of Natural History; and M. Ponce de Le~n and C. Zollikofer at the Anthropological Institute and Museum. For technical and material support we thank, Duke University, the University of Zurich 2009 and 2010 Field Schools, A. B. Taylor, C. E. Terhune, and C. E. Wall. Numerous individuals have been involved in the ongoing preparation and excavation of these fossils, including C. Dube, C. Kemp, M. Kgasi, M. Languza, J. Malaza, G. Mokoma, P. Mukanela, T. Nemvhundi, M. Ngcamphalala, S. Jirah, S. Tshabalala, and C. Yates. Other individuals who have given major support to this project include B. de Klerk, W. Lawrence, C. Steininger, B. Kuhn, L. Pollarolo, B. Zipfel, J. Kretzen, D. Conforti, J. McCaffery, C. Dlamini, H. Visser, R. McCrae-Samuel, B. Nkosi, B. Louw, L. Backwell, F. Thackeray, and M. Peltier. J. Smilg facilitated computed tomography scanning of the specimens. The Au. sediba specimens are archived at the Evolutionary Studies Institute at the University of the Witwatersrand. All data used in this study are available upon request, including access to the original specimens, by bona fide scientists.	Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; ASHTON E. H., 1964, PROC ZOOL SOC LONDON, V142, P49; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Carretero JM, 1999, J HUM EVOL, V37, P459, DOI 10.1006/jhev.1999.0342; Clarke RJ, 1998, S AFR J SCI, V94, P460; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Drapeau MSM, 2008, J HUM EVOL, V55, P86, DOI 10.1016/j.jhevol.2008.01.005; Drapeau MSM, 2005, J HUM EVOL, V48, P593, DOI 10.1016/j.jhevol.2005.02.005; Graves WW, 1921, AM J PHYS ANTHROPOL, V4, P111, DOI 10.1002/ajpa.1330040202; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Green DJ, 2012, SCIENCE, V338, P514, DOI 10.1126/science.1227123; Haeusler M, 2004, J HUM EVOL, V46, P433, DOI 10.1016/j.jhevol.2004.01.004; Haile-Selassie Y, 2010, P NATL ACAD SCI USA, V107, P12121, DOI 10.1073/pnas.1004527107; HUNT KD, 1991, AM J PHYS ANTHROPOL, V86, P521, DOI 10.1002/ajpa.1330860408; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Larson SG, 1996, J HUM EVOL, V31, P239, DOI 10.1006/jhev.1996.0059; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Leakey R.E., 1989, P167; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; LOVEJOY CO, 1982, AM J PHYS ANTHROPOL, V57, P637, DOI 10.1002/ajpa.1330570409; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; Melillo S. M., 2011, THESIS STANFORD U; OHMAN JC, 1986, AM J PHYS ANTHROPOL, V70, P209, DOI 10.1002/ajpa.1330700208; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Reno PL, 2005, CURR ANTHROPOL, V46, P575, DOI 10.1086/431528; Richmond B., 2009, PAL SOC M PALEOANTHR, V2009; Richmond BG, 2002, J HUM EVOL, V43, P529, DOI 10.1006/jhev.2002.0594; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; Ruff Christopher B., 1993, P234; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Sobush DC, 1996, J ORTHOP SPORT PHYS, V23, P39, DOI 10.2519/jospt.1996.23.1.39; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Toussaint M, 2003, S AFR J SCI, V99, P215; Voisin JL, 2010, ANTHROPOLOGIE, V114, P354, DOI 10.1016/j.anthro.2010.05.005; Walker Alan, 1993, P95; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Young NM, 2008, AM J PHYS ANTHROPOL, V136, P247, DOI 10.1002/ajpa.20799; Young NM, 2010, P NATL ACAD SCI USA, V107, P3400, DOI 10.1073/pnas.0911856107	48	75	76	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2013	340	6129							1233477	10.1126/science.1233477	http://dx.doi.org/10.1126/science.1233477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122TQ	23580536				2022-12-24	WOS:000317341400005
J	Hunninghake, GM; Hatabu, H; Okajima, Y; Gao, W; Dupuis, J; Latourelle, JC; Nishino, M; Araki, T; Zazueta, OE; Kurugol, S; Ross, JC; Estepar, RS; Murphy, E; Steele, MP; Loyd, JE; Schwarz, MI; Fingerlin, TE; Rosas, IO; Washko, GR; O'Connor, GT; Schwartz, DA				Hunninghake, Gary M.; Hatabu, Hiroto; Okajima, Yuka; Gao, Wei; Dupuis, Josee; Latourelle, Jeanne C.; Nishino, Mizuki; Araki, Tetsuro; Zazueta, Oscar E.; Kurugol, Sila; Ross, James C.; Estepar, Raul San Jose; Murphy, Elissa; Steele, Mark P.; Loyd, James E.; Schwarz, Marvin I.; Fingerlin, Tasha E.; Rosas, Ivan O.; Washko, George R.; O'Connor, George T.; Schwartz, David A.			MUC5B Promoter Polymorphism and Interstitial Lung Abnormalities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; PATHOLOGICAL FEATURES; REFERENCE VALUES; CLINICAL-COURSE; POPULATION; PREVALENCE; CAPACITY; SMOKING; DISEASE; SAMPLE	Background A common promoter polymorphism (rs35705950) in MUC5B, the gene encoding mucin 5B, is associated with idiopathic pulmonary fibrosis. It is not known whether this polymorphism is associated with interstitial lung disease in the general population. Methods We performed a blinded assessment of interstitial lung abnormalities detected in 2633 participants in the Framingham Heart Study by means of volumetric chest computed tomography (CT). We evaluated the relationship between the abnormalities and the genotype at the rs35705950 locus. Results Of the 2633 chest CT scans that were evaluated, interstitial lung abnormalities were present in 177 (7%). Participants with such abnormalities were more likely to have shortness of breath and chronic cough and reduced measures of total lung and diffusion capacity, as compared with participants without such abnormalities. After adjustment for covariates, for each copy of the minor rs35705950 allele, the odds of interstitial lung abnormalities were 2.8 times greater (95% confidence interval [CI], 2.0 to 3.9; P<0.001), and the odds of definite CT evidence of pulmonary fibrosis were 6.3 times greater (95% CI, 3.1 to 12.7; P<0.001). Although the evidence of an association between the MUC5B genotype and interstitial lung abnormalities was greater among participants who were older than 50 years of age, a history of cigarette smoking did not appear to influence the association. Conclusions The MUC5B promoter polymorphism was found to be associated with interstitial lung disease in the general population. Although this association was more apparent in older persons, it did not appear to be influenced by cigarette smoking.	[Hunninghake, Gary M.; Zazueta, Oscar E.; Rosas, Ivan O.; Washko, George R.] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Hatabu, Hiroto; Okajima, Yuka; Nishino, Mizuki; Araki, Tetsuro] Brigham & Womens Hosp, Ctr Pulm Funct Imaging, Boston, MA 02115 USA; [Hatabu, Hiroto; Okajima, Yuka; Nishino, Mizuki; Araki, Tetsuro; Estepar, Raul San Jose] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Kurugol, Sila; Ross, James C.; Estepar, Raul San Jose] Brigham & Womens Hosp, Dept Radiol, Surg Planning Lab, Boston, MA 02115 USA; [Ross, James C.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Hunninghake, Gary M.; Zazueta, Oscar E.; Rosas, Ivan O.; Washko, George R.] Harvard Univ, Sch Med, Boston, MA USA; [Gao, Wei; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Latourelle, Jeanne C.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Latourelle, Jeanne C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [O'Connor, George T.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Gao, Wei; Dupuis, Josee; O'Connor, George T.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Murphy, Elissa; Schwarz, Marvin I.; Schwartz, David A.] Univ Colorado, Dept Med, Ctr Pulm, Denver, CO USA; [Fingerlin, Tasha E.] Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA; [Steele, Mark P.; Loyd, James E.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Vanderbilt University	Hunninghake, GM (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, 75 Francis St, Boston, MA 02115 USA.	ghunninghake@partners.org; david.schwartz@ucdenver.edu	Zazueta, Oscar/GQQ-7506-2022; San Jose Estepar, Raul/AAQ-5657-2020	San Jose Estepar, Raul/0000-0002-3677-1996; Kurugol, Sila/0000-0002-5081-4569; Latourelle, Jeanne/0000-0002-4218-9572; Loyd, James/0000-0002-5042-7390; O'Connor, George/0000-0002-6476-3926; Dupuis, Josee/0000-0003-2871-3603; Zazueta, Oscar E/0000-0001-5374-3906	National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K23CA157631, R21CA116271] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092222, R01HL097163, K25HL104085, RC2HL101715, R01HL116473, P01HL092870, R01HL095393, R01HL111024, R01HL107246, K23HL089353] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Funded by the National Institutes of Health and others; ClinicalTrials.gov number NCT00005121.	BITTERMAN PB, 1986, NEW ENGL J MED, V314, P1343, DOI 10.1056/NEJM198605223142103; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; de Leon AD, 2011, CHEST, V140, P753, DOI 10.1378/chest.10-2865; Doyle TJ, 2012, AM J RESP CRIT CARE, V185, P756, DOI 10.1164/rccm.201109-1618OC; El-Chemaly S, 2011, CHEST, V139, P1203, DOI 10.1378/chest.10-2048; FERRIS BG, 1978, B EUR PHYSIOPATH RES, V14, P145; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOURIHANE DO, 1966, BMJ-BRIT MED J, V1, P1069, DOI 10.1136/bmj.1.5495.1069; IWAI K, 1994, AM J RESP CRIT CARE, V150, P670, DOI 10.1164/ajrccm.150.3.8087336; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P407, DOI 10.1164/rccm.200812-1966OC; Lee HY, 2012, CHEST, V142, P1577, DOI 10.1378/chest.11-2812; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Perez ERF, 2010, CHEST, V137, P129, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ross JC, 2009, LECT NOTES COMPUT SC, V5762, P690, DOI 10.1007/978-3-642-04271-3_84; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Uh Hae-Won, 2009, BMC Proc, V3 Suppl 7, pS123; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Xu JF, 2012, AM J RESP CRIT CARE, V185, P547, DOI 10.1164/rccm.201108-1574OC	25	264	265	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 6	2013	368	23					2192	2200		10.1056/NEJMoa1216076	http://dx.doi.org/10.1056/NEJMoa1216076			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158DN	23692170	Green Accepted			2022-12-24	WOS:000319948900007
J	Gardner, AS; Moholdt, G; Cogley, JG; Wouters, B; Arendt, AA; Wahr, J; Berthier, E; Hock, R; Pfeffer, WT; Kaser, G; Ligtenberg, SRM; Bolch, T; Sharp, MJ; Hagen, JO; van den Broeke, MR; Paul, F				Gardner, Alex S.; Moholdt, Geir; Cogley, J. Graham; Wouters, Bert; Arendt, Anthony A.; Wahr, John; Berthier, Etienne; Hock, Regine; Pfeffer, W. Tad; Kaser, Georg; Ligtenberg, Stefan R. M.; Bolch, Tobias; Sharp, Martin J.; Hagen, Jon Ove; van den Broeke, Michiel R.; Paul, Frank			A Reconciled Estimate of Glacier Contributions to Sea Level Rise: 2003 to 2009	SCIENCE			English	Article							ICESAT LASER ALTIMETRY; MASS-BALANCE; CAPS; GREENLAND; AMERICA	Glaciers distinct from the Greenland and Antarctic Ice Sheets are losing large amounts of water to the world's oceans. However, estimates of their contribution to sea level rise disagree. We provide a consensus estimate by standardizing existing, and creating new, mass-budget estimates from satellite gravimetry and altimetry and from local glaciological records. In many regions, local measurements are more negative than satellite-based estimates. All regions lost mass during 2003-2009, with the largest losses from Arctic Canada, Alaska, coastal Greenland, the southern Andes, and high-mountain Asia, but there was little loss from glaciers in Antarctica. Over this period, the global mass budget was -259 +/- 28 gigatons per year, equivalent to the combined loss from both ice sheets and accounting for 29 +/- 13% of the observed sea level rise.	[Gardner, Alex S.] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Gardner, Alex S.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Moholdt, Geir] Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Cogley, J. Graham] Trent Univ, Dept Geog, Peterborough, ON K9J 7B8, Canada; [Wouters, Bert; Wahr, John] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wouters, Bert] Bristol Glaciol Ctr, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Arendt, Anthony A.; Hock, Regine] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Wahr, John] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Berthier, Etienne] Univ Toulouse, LEGOS, CNRS, F-31400 Toulouse, France; [Hock, Regine] Uppsala Univ, Dept Earth Sci, SE-75105 Uppsala, Sweden; [Pfeffer, W. Tad] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Kaser, Georg] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; [Ligtenberg, Stefan R. M.; van den Broeke, Michiel R.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3508 TA Utrecht, Netherlands; [Bolch, Tobias; Paul, Frank] Univ Zurich, Dept Geog, CH-8057 Zurich, Switzerland; [Bolch, Tobias] Tech Univ Dresden, Inst Kartog, D-01062 Dresden, Germany; [Sharp, Martin J.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Hagen, Jon Ove] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway	Clark University; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Scripps Institution of Oceanography; Trent University; University of Colorado System; University of Colorado Boulder; University of Bristol; University of Alaska System; University of Alaska Fairbanks; University of Colorado System; University of Colorado Boulder; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Uppsala University; University of Colorado System; University of Colorado Boulder; University of Innsbruck; Utrecht University; University of Zurich; Technische Universitat Dresden; University of Alberta; University of Oslo	Gardner, AS (corresponding author), Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA.	agardner@clarku.edu	Van den Broeke, Michiel R./F-7867-2011; Ligtenberg, Stefan/AAF-8290-2020; Hock, Regine/C-6179-2013; Berthier, Etienne/B-8900-2009; Bolch, Tobias/A-1935-2008; Wouters, Bert/AAA-4254-2019; Bolch, Tobias/ABE-6635-2020; Wouters, Bert/A-5301-2017	Van den Broeke, Michiel R./0000-0003-4662-7565; Berthier, Etienne/0000-0001-5978-9155; Bolch, Tobias/0000-0002-8201-5059; Wouters, Bert/0000-0002-1086-2435; Bolch, Tobias/0000-0002-8201-5059; Wouters, Bert/0000-0002-1086-2435; Gardner, Alex/0000-0002-8394-8889; Hock, Regine/0000-0001-8336-9441	Natural Sciences and Engineering Research Council of Canada; NASA [NNX09AE52G, NNX11AF41G, NNX11A023G]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [FP7-PEOPLE-2011-IOF-301260]; TOSCA program of the French Space Agency (CNES); NSF [ANT-1043649]; Austrian Science Fund (FWF) [P25362-N26]; Deutsche Forschungsgemeinschaft (DFG) [BO 3199/2-1]; European Space Agency project Glaciers_cci [4000101778/10/I-AM]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NASA(National Aeronautics & Space Administration (NASA)); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; TOSCA program of the French Space Agency (CNES); NSF(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Space Agency project Glaciers_cci	We thank K. Matsuo, M. Huss, T. Jacob, A. Kaab, S. Luthcke, A. Willsman, M. Willis, and I. Sasgen for updated or early access to regional estimates of glacier mass change; M. Flanner, T. Jacob, and S. Swenson for helping with analysis of the hydrologic models; A. Bliss, N. Molg, C. Nuth, P. Rastner, M. Willis, and G. Wolken for providing regional areas of ocean-terminating glacier basins; J. Lenaerts and J. van Angelen for providing RACMO2 output for Greenland and Antarctica; J. Box and C. Chen for making available Greenland Ice Sheet snowline estimates; G. A, R. Riva, and P. Stocchi for providing glacial isostatic adjustment models; and C. Starr and the NASA/Goddard Space Flight Center Scientific Visualization Studio for help with Fig. 1. This work was supported by funding to A. S. G. and M. J. S. from the Natural Sciences and Engineering Research Council of Canada, G. M. from NASA award NNX09AE52G, B. W. from a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-2011-IOF-301260), E. B. from the TOSCA program of the French Space Agency (CNES), R. H. from NASA grants NNX11AF41G and NNX11A023G and NSF grant ANT-1043649, G. K. from Austrian Science Fund (FWF) grant P25362-N26, T. B. from the Deutsche Forschungsgemeinschaft (DFG, BO 3199/2-1), and F. P. from European Space Agency project Glaciers_cci (4000101778/10/I-AM).	Arendt A., 2012, RANDOLPH GLACIER INV; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Bliss A, 2013, ANN GLACIOL, V54, P191, DOI 10.3189/2013AoG63A377; Bolch T, 2013, GEOPHYS RES LETT, V40, P875, DOI 10.1002/grl.50270; Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Cogley JG, 1998, J GLACIOL, V44, P315, DOI 10.3189/S0022143000002641; Dyurgerov M., 2005, 55 U COL I ARCT AL S; Dyurgerov MB, 1997, ARCTIC ALPINE RES, V29, P379, DOI 10.2307/1551986; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/NGEO1450, 10.1038/ngeo1450]; Gardner A, 2012, CRYOSPHERE, V6, P1103, DOI 10.5194/tc-6-1103-2012; Gardner AS, 2011, NATURE, V473, P357, DOI 10.1038/nature10089; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; Ivins ER, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007607; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Kaser G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027511; Ligtenberg SRM, 2011, CRYOSPHERE, V5, P809, DOI 10.5194/tc-5-809-2011; Luthcke SB, 2008, J GLACIOL, V54, P767, DOI 10.3189/002214308787779933; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Melkonian A. K., 2012, CRYOSPHERE DISCUSS, V6, P3503; Moholdt G, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051466; Moholdt G, 2010, REMOTE SENS ENVIRON, V114, P2756, DOI 10.1016/j.rse.2010.06.008; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rastner P, 2012, CRYOSPHERE, V6, P1483, DOI 10.5194/tc-6-1483-2012; Rignot E, 2003, SCIENCE, V302, P434, DOI 10.1126/science.1087393; Rinne EJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF001972; Sasgen I, 2012, J GEODYN, V59-60, P49, DOI 10.1016/j.jog.2012.03.004; Schiefer E, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030780; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Willis MJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053136; Willis MJ, 2012, REMOTE SENS ENVIRON, V117, P184, DOI 10.1016/j.rse.2011.09.017; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zemp M, 2009, ANN GLACIOL, V50, P101, DOI 10.3189/172756409787769591	35	872	926	19	429	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2013	340	6134					852	857		10.1126/science.1234532	http://dx.doi.org/10.1126/science.1234532			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145EM	23687045	Green Accepted			2022-12-24	WOS:000318997400041
J	Salichos, L; Rokas, A				Salichos, Leonidas; Rokas, Antonis			Inferring ancient divergences requires genes with strong phylogenetic signals	NATURE			English	Article							EVOLUTION; SEQUENCE; PHYLOGENOMICS; INCONGRUENCE; INFERENCE; NETWORKS; MODEL; POWER; TAXA; TREE	To tackle incongruence, the topological conflict between different gene trees, phylogenomic studies couple concatenation with practices such as rogue taxon removal or the use of slowly evolving genes. Phylogenomic analysis of 1,070 orthologues from 23 yeast genomes identified 1,070 distinct gene trees, which were all incongruent with the phylogeny inferred from concatenation. Incongruence severity increased for shorter internodes located deeper in the phylogeny. Notably, whereas most practices had little or negative impact on the yeast phylogeny, the use of genes or internodes with high average internode support significantly improved the robustness of inference. We obtained similar results in analyses of vertebrate and metazoan phylogenomic data sets. These results question the exclusive reliance on concatenation and associated practices, and argue that selecting genes with strong phylogenetic signals and demonstrating the absence of significant incongruence are essential for accurately reconstructing ancient divergences.	[Salichos, Leonidas; Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Rokas, A (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	antonis.rokas@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551	National Science Foundation [DEB-0844968]	National Science Foundation(National Science Foundation (NSF))	We thank K. Polzin for providing a script that identified alignment sites that contained single substitutions between amino acids that differ in their physicochemical properties. We thank members of the Rokas laboratory and B. O'Meara for valuable comments on this work. This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University. This work was supported by the National Science Foundation (DEB-0844968).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Belinky F, 2010, MOL BIOL EVOL, V27, P441, DOI 10.1093/molbev/msp263; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bryant D., 2003, BIOCONSENSUS, P163; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hess J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022783; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Kumar S, 2012, MOL BIOL EVOL, V29, P457, DOI 10.1093/molbev/msr202; League GP, 2012, FEMS YEAST RES, V12, P859, DOI 10.1111/j.1567-1364.2012.00828.x; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Mossel E, 2004, MATH BIOSCI, V187, P189, DOI 10.1016/j.mbs.2003.10.004; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; RODRIGO AG, 1993, NEW ZEAL J BOT, V31, P257, DOI 10.1080/0028825X.1993.10419503; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yu Y, 2012, PLOS GENET, V8, P456, DOI 10.1371/journal.pgen.1002660; Zwickl D., 2006, GARLI GENETIC ALGORI	63	421	426	1	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					327	+		10.1038/nature12130	http://dx.doi.org/10.1038/nature12130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23657258				2022-12-24	WOS:000318952000029
J	Maxson, JE; Gotlib, J; Pollyea, DA; Fleischman, AG; Agarwal, A; Eide, CA; Bottomly, D; Wilmot, B; McWeeney, SK; Tognon, CE; Pond, JB; Collins, RH; Goueli, B; Oh, ST; Deininger, MW; Chang, BH; Loriaux, MM; Druker, BJ; Tyner, JW				Maxson, Julia E.; Gotlib, Jason; Pollyea, Daniel A.; Fleischman, Angela G.; Agarwal, Anupriya; Eide, Christopher A.; Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K.; Tognon, Cristina E.; Pond, J. Blake; Collins, Robert H.; Goueli, Basem; Oh, Stephen T.; Deininger, Michael W.; Chang, Bill H.; Loriaux, Marc M.; Druker, Brian J.; Tyner, Jeffrey W.			Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING-FACTOR; SEVERE CONGENITAL NEUTROPENIA; ACUTE MYELOID-LEUKEMIA; TYROSINE KINASE JAK2; FACTOR-RECEPTOR; MYELOPROLIFERATIVE-DISORDERS; ACTIVATING MUTATION; POLYCYTHEMIA-VERA; C-KIT; MICE	Background The molecular causes of many hematologic cancers remain unclear. Among these cancers are chronic neutrophilic leukemia (CNL) and atypical (BCR-ABL1-negative) chronic myeloid leukemia (CML), both of which are diagnosed on the basis of neoplastic expansion of granulocytic cells and exclusion of genetic drivers that are known to occur in other myeloproliferative neoplasms and myeloproliferative-myelodysplastic overlap neoplasms. Methods To identify potential genetic drivers in these disorders, we used an integrated approach of deep sequencing coupled with the screening of primary leukemia cells obtained from patients with CNL or atypical CML against panels of tyrosine kinase-specific small interfering RNAs or small-molecule kinase inhibitors. We validated candidate oncogenes using in vitro transformation assays, and drug sensitivities were validated with the use of assays of primary-cell colonies. Results We identified activating mutations in the gene encoding the receptor for colony-stimulating factor 3 (CSF3R) in 16 of 27 patients (59%) with CNL or atypical CML. These mutations segregate within two distinct regions of CSF3R and lead to preferential downstream kinase signaling through SRC family-TNK2 or JAK kinases and differential sensitivity to kinase inhibitors. A patient with CNL carrying a JAK-activating CSF3R mutation had marked clinical improvement after the administration of the JAK1/2 inhibitor ruxolitinib. Conclusions Mutations in CSF3R are common in patients with CNL or atypical CML and represent a potentially useful criterion for diagnosing these neoplasms. (Funded by the Leukemia and Lymphoma Society and others.)	[Maxson, Julia E.; Fleischman, Angela G.; Agarwal, Anupriya; Eide, Christopher A.; Tognon, Cristina E.; Druker, Brian J.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA; [Maxson, Julia E.; Fleischman, Angela G.; Agarwal, Anupriya; Eide, Christopher A.; Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K.; Tognon, Cristina E.; Chang, Bill H.; Loriaux, Marc M.; Druker, Brian J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97239 USA; [McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Portland, OR 97239 USA; [Chang, Bill H.] Oregon Hlth & Sci Univ, Div Pediat Hematol & Oncol, Dept Pediat, Portland, OR 97239 USA; [Loriaux, Marc M.] Oregon Hlth & Sci Univ, Dept Anat Pathol, Portland, OR 97239 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Gotlib, Jason] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Pollyea, Daniel A.] Univ Colorado, Sch Med, Div Hematol Oncol & Bone Marrow Transplantat, Aurora, CO USA; [Pond, J. Blake; Collins, Robert H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Goueli, Basem] St Lukes Reg Canc Ctr, Duluth, MN USA; [Oh, Stephen T.] Washington Univ, Sch Med, Dept Med, Div Hematol, St Louis, MO 63130 USA; [Deininger, Michael W.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Stanford Cancer Institute; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, BRB 511,Mailcode L592,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	tynerj@ohsu.edu		Eide, Christopher/0000-0001-8835-8928; Fleischman, Angela/0000-0002-3701-6079; Tyner, Jeffrey/0000-0002-2133-0960; Druker, Brian/0000-0001-8331-8206; McWeeney, Shannon/0000-0001-8333-6607; Chang, Bill/0000-0003-3783-1820	Leukemia and Lymphoma Society; Training Program in Molecular Hematology [5T32HL007781-20]; Charles and Ann Johnson Foundation; National Cancer Institute [1-K99-CA151670-01A1, 5P30CA069533-13, 4 R00CA151457-03]; National Center for Advancing Translational Sciences [5UL1RR024140]; National Heart, Lung, and Blood Institute [K08 HL106576]; St. Baldricks Foundation; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; NATIONAL CANCER INSTITUTE [R00CA151457, K99CA151670, P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL106576, T32HL007781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Training Program in Molecular Hematology; Charles and Ann Johnson Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); St. Baldricks Foundation; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the Leukemia and Lymphoma Society and others.; Supported in part by grants from the Leukemia and Lymphoma Society, the Training Program in Molecular Hematology (5T32HL007781-20, to Dr. Maxson), the Charles and Ann Johnson Foundation (to Dr. Gotlib), the National Cancer Institute (1-K99-CA151670-01A1, to Dr. Agarwal), the National Center for Advancing Translational Sciences (5UL1RR024140) and the National Cancer Institute (5P30CA069533-13) (both to Mr. Bottomly and Drs. Wilmot and McWeeney), the National Heart, Lung, and Blood Institute (K08 HL106576, to Dr. Oh), and the St. Baldricks Foundation (to Dr. Chang), and by grants from the V Foundation for Cancer Research, Gabrielle's Angel Foundation for Cancer Research, the William Lawrence and Blanche Hughes Fund, and the National Cancer Institute (4 R00CA151457-03) (all to Dr. Tyner). Dr. Druker is an investigator of the Howard Hughes Medical Institute, and Dr. Deininger is a Scholar in Clinical Research of the Leukemia and Lymphoma Society.	Bain BJ, 2008, WHO CLASSIFICATION T, P38; Baxter EJ, 2005, LANCET, V366, P122; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beekman R, 2012, BLOOD, V119, P5071, DOI 10.1182/blood-2012-01-406116; Beekman R, 2010, BLOOD, V115, P5131, DOI 10.1182/blood-2010-01-234120; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Corey SJ, 1998, J BIOL CHEM, V273, P3230, DOI 10.1074/jbc.273.6.3230; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Froberg MK, 1998, LEUKEMIA, V12, P623, DOI 10.1038/sj.leu.2400938; Futami M, 2011, BLOOD, V118, P1077, DOI 10.1182/blood-2009-12-261636; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Hermans MHA, 1998, BLOOD, V92, P32, DOI 10.1182/blood.V92.1.32.413k42_32_39; Hernandez JM, 2000, ANN ONCOL, V11, P441, DOI 10.1023/A:1008393002748; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kunter G, 2011, EXP HEMATOL, V39, P1136, DOI 10.1016/j.exphem.2011.08.013; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Matano S, 1997, AM J HEMATOL, V54, P72, DOI 10.1002/(SICI)1096-8652(199701)54:1<72::AID-AJH11>3.0.CO;2-C; Mitsui T, 2003, BLOOD, V101, P2990, DOI 10.1182/blood.V101.8.2990; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Plo I, 2009, J EXP MED, V206, P1701, DOI 10.1084/jem.20090693; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Tyner JW, 2013, CANCER RES, V73, P285, DOI 10.1158/0008-5472.CAN-12-1906; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; van de Geijn GJM, 2004, BLOOD, V104, P667, DOI 10.1182/blood-2003-08-2913; Vardiman JW, 2008, WHO CLASSIFICATION T, P80; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Zhu QS, 2004, BLOOD, V103, P3305, DOI 10.1182/blood-2003-06-1861	41	351	393	4	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1781	1790		10.1056/NEJMoa1214514	http://dx.doi.org/10.1056/NEJMoa1214514			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656643	Green Accepted, Bronze			2022-12-24	WOS:000318540000006
J	Hochreiter-Hufford, AE; Lee, CS; Kinchen, JM; Sokolowski, JD; Arandjelovic, S; Call, JA; Klibanov, AL; Yan, Z; Mandell, JW; Ravichandran, KS				Hochreiter-Hufford, Amelia E.; Lee, Chang Sup; Kinchen, Jason M.; Sokolowski, Jennifer D.; Arandjelovic, Sanja; Call, Jarrod A.; Klibanov, Alexander L.; Yan, Zhen; Mandell, James W.; Ravichandran, Kodi S.			Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; ENGULFMENT RECEPTOR; IN-VIVO; FIND-ME; EXPRESSION; DROSOPHILA; MOUSE; PROTEIN; GENE	Skeletal muscle arises from the fusion of precursor myoblasts into multinucleated myofibres(1,2). Although conserved transcription factors and signalling proteins involved in myogenesis have been identified, upstream regulators are less well understood. Here we report an unexpected discovery that the membrane protein BAI1, previously linked to recognition of apoptotic cells by phagocytes(3), promotes myoblast fusion. Endogenous BAI1 expression increased during myoblast fusion, and BAI1 overexpression enhanced myoblast fusion by means of signalling through ELMO/Dock180/Rac1 proteins(4). During myoblast fusion, a fraction of myoblasts within the population underwent apoptosis and exposed phosphatidylserine, an established ligand for BAI1 (ref. 3). Blocking apoptosis potently impaired myoblast fusion, and adding back apoptotic myoblasts restored fusion. Furthermore, primary human myoblasts could be induced to form myotubes by adding apoptotic myoblasts, even under normal growth conditions. Mechanistically, apoptotic cells did not directly fuse with the healthy myoblasts, rather the apoptotic cells induced a contact-dependent signalling with neighbours to promote fusion among the healthy myoblasts. In vivo, myofibres from Bai1(-/-) mice are smaller than those from wild-type littermates. Muscle regeneration after injury was also impaired in Bai1(-/-) mice, highlighting a role for BAI1 in mammalian myogenesis. Collectively, these data identify apoptotic cells as a new type of cue that induces signalling via the phosphatidylserine receptor BAI1 to promote fusion of healthy myoblasts, with important implications for muscle development and repair.	[Hochreiter-Hufford, Amelia E.; Lee, Chang Sup; Kinchen, Jason M.; Arandjelovic, Sanja; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Hochreiter-Hufford, Amelia E.; Lee, Chang Sup; Kinchen, Jason M.; Arandjelovic, Sanja; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Hochreiter-Hufford, Amelia E.; Lee, Chang Sup; Kinchen, Jason M.; Sokolowski, Jennifer D.; Arandjelovic, Sanja; Mandell, James W.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Sokolowski, Jennifer D.; Mandell, James W.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Call, Jarrod A.; Klibanov, Alexander L.; Yan, Zhen] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Call, Jarrod A.; Klibanov, Alexander L.; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	Ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021	Call, Jarrod/0000-0002-1094-4940; Ravichandran, Kodi/0000-0001-9049-1410; Yan, Zhen/0000-0002-4826-9813; Kinchen, Jason/0000-0001-8430-2265	National Institute of General Medical Sciences/National Institutes of Health; Center for Cell Clearance at the University of Virginia; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, R01GM064709] Funding Source: NIH RePORTER	National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Center for Cell Clearance at the University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Ravichandran laboratory for their valuable suggestions at many stages of this work. We also thank L. Haney, A. Bruce and A. Dutta for technical suggestions and assistance and M. Hufford and A. Fond for help with statistical analysis. We thank members of the University of Virginia Flow Cytometry Core, Research Histology Core, and Gene Targeting and Transgenic Facility for cell sorting, histological services and transgenic mouse generation. This work was supported by a grant from the National Institute of General Medical Sciences/National Institutes of Health and the Center for Cell Clearance at the University of Virginia.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bialek P, 2011, PHYSIOL GENOMICS, V43, P1075, DOI 10.1152/physiolgenomics.00247.2010; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Cornelison DDW, 2008, J CELL BIOCHEM, V105, P663, DOI 10.1002/jcb.21892; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Jeong J, 2011, BIOCHEM BIOPH RES CO, V414, P9, DOI 10.1016/j.bbrc.2011.08.128; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Phaneuf S, 2001, MED SCI SPORT EXER, V33, P393, DOI 10.1097/00005768-200103000-00010; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Sokolowski JD, 2011, BRAIN BEHAV IMMUN, V25, P915, DOI 10.1016/j.bbi.2010.09.021; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200	31	200	206	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					263	+		10.1038/nature12135	http://dx.doi.org/10.1038/nature12135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23615608	Green Accepted			2022-12-24	WOS:000318558200041
J	Jiang, L; Zhang, J; Wang, JJ; Wang, L; Zhang, L; Li, GQ; Yang, XD; Ma, X; Sun, X; Cai, J; Zhang, J; Huang, XX; Yu, M; Wang, XG; Liu, F; Wu, CI; He, C; Zhang, B; Ci, WM; Liu, J				Jiang, Lan; Zhang, Jing; Wang, Jing-Jing; Wang, Lu; Zhang, Li; Li, Guoqiang; Yang, Xiaodan; Ma, Xin; Sun, Xin; Cai, Jun; Zhang, Jun; Huang, Xingxu; Yu, Miao; Wang, Xuegeng; Liu, Feng; Wu, Chung-I; He, Chuan; Zhang, Bo; Ci, Weimin; Liu, Jiang			Sperm, but Not Oocyte, DNA Methylome Is Inherited by Zebrafish Early Embryos	CELL			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; GENOMIC METHYLATION; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; EXPRESSION	5-methylcytosine is a major epigenetic modification that is sometimes called "the fifth nucleotide.'' However, our knowledge of how offspring inherit the DNA methylonne from parents is limited. We generated nine single-base resolution DNA methylomes, including zebrafish gametes and early embryos. The oocyte methylome is significantly hypomethylated compared to sperm. Strikingly, the paternal DNA methylation pattern is maintained throughout early embryogenesis. The maternal DNA methylation pattern is maintained until the 16-cell stage. Then, the oocyte methylome is gradually discarded through cell division and is progressively reprogrammed to a pattern similar to that of the sperm methylonne. The passive demethylation rate and the de novo methylation rate are similar in the maternal DNA. By the midblastula stage, the embryo's methylome is virtually identical to the sperm methylome. Moreover, inheritance of the sperm methylonne facilitates the epigenetic regulation of embryogenesis. Therefore, besides DNA sequences, sperm DNA methylome is also inherited in zebrafish early embryos.	[Jiang, Lan; Zhang, Jing; Wang, Jing-Jing; Wang, Lu; Zhang, Li; Li, Guoqiang; Ma, Xin; Sun, Xin; Cai, Jun; Wu, Chung-I; Ci, Weimin; Liu, Jiang] Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China; [Yang, Xiaodan; Liu, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Jiang, Lan; Wang, Jing-Jing; Wang, Lu; Li, Guoqiang; Ma, Xin] Beijing Univ, Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Jun; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Yu, Miao; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yu, Miao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Wang, Xuegeng; Zhang, Bo] Peking Univ, Key Lab Cell Proliferat, Beijing 100871, Peoples R China; [Wang, Xuegeng; Zhang, Bo] Peking Univ, Coll Life Sci, Differentiat Minist Educ, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Peking University; Nanjing University; University of Chicago; University of Chicago; Peking University; Peking University	Ci, WM (corresponding author), Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China.	ciwm@big.ac.cn; liuj@big.ac.cn	Li, Guoqiang/K-2850-2016; jiang, lan/C-1077-2009; Jiang, Lan/K-6869-2014; Zhang, Jing/F-4707-2015; Wang, Xuegeng/AAF-6714-2020; WANG, JINGYI/GSJ-1241-2022; Liu, Feng/B-9985-2015; wang, jing/GRS-7509-2022; Wang, Lu/I-8245-2018; jiang, lan/T-3965-2019; Ci, Weimin/AAS-5984-2021	Li, Guoqiang/0000-0001-5303-5707; jiang, lan/0000-0003-2008-9631; Jiang, Lan/0000-0003-2008-9631; Zhang, Jing/0000-0001-5903-6487; Wang, Xuegeng/0000-0003-4159-5402; Liu, Feng/0000-0003-3228-0943; Wang, Lu/0000-0002-8896-0115; Ci, Weimin/0000-0002-4111-5360; Ma, Xin/0000-0001-6383-8706; huang, xingxu/0000-0001-8934-1247; Liu, Jiang/0000-0002-5687-5047	973 Program of China [2011CB510101]; National Natural Science Foundation of China (NSFC) [91219104, 81171902]; CAS [XDA01040407]; 100 Talents Project; NSFC [91231112, 31171244, 31200958]; CAS Excellent Youth Scholars [KSCX2-EW-Q-5-2]; National Institutes of Health [HG006827]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); 100 Talents Project(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); CAS Excellent Youth Scholars; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants to J.L. from the 973 Program of China (2011CB510101), National Natural Science Foundation of China (NSFC) (91219104 and 81171902), CAS (XDA01040407), and 100 Talents Project. W.C. is supported by NSFC (91231112 and 31171244) and CAS Excellent Youth Scholars (KSCX2-EW-Q-5-2). J.Z. is supported by NSFC (31200958). C.H. is supported by National Institutes of Health (HG006827). Sarah F. Reichard and Li Lan contributed to the editing.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang HG, 2003, CLONING STEM CELLS, V5, P333, DOI 10.1089/153623003772032835; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korzh V, 2009, ZEBRAFISH, V6, P295, DOI 10.1089/zeb.2008.0573; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MacKay AB, 2007, GENOME, V50, P778, DOI 10.1139/G07-055; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; ONEILL GT, 1991, MOL REPROD DEV, V30, P214, DOI 10.1002/mrd.1080300308; Prince VE, 1998, DEVELOPMENT, V125, P407; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robertson AB, 2012, NAT PROTOC, V7, P340, DOI 10.1038/nprot.2011.443; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Veenstra GJC, 2001, BBA-GENE STRUCT EXPR, V1521, P39, DOI 10.1016/S0167-4781(01)00280-9; Walker Charline, 2009, J Vis Exp, DOI 10.3791/1396; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; YASUDA GK, 1992, TRENDS GENET, V8, P124; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	45	310	334	6	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					773	784		10.1016/j.cell.2013.04.041	http://dx.doi.org/10.1016/j.cell.2013.04.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663777	Bronze, Green Accepted			2022-12-24	WOS:000318844000008
J	Sun, QW; Csorba, T; Skourti-Stathaki, K; Proudfoot, NJ; Dean, C				Sun, Qianwen; Csorba, Tibor; Skourti-Stathaki, Konstantina; Proudfoot, Nicholas J.; Dean, Caroline			R-Loop Stabilization Represses Antisense Transcription at the Arabidopsis FLC Locus	SCIENCE			English	Article							NATURAL VARIATION; RNA-BINDING; VERNALIZATION; REGIONS	Roles for long noncoding RNAs (lncRNAs) in gene expression are emerging, but regulation of the lncRNA itself is poorly understood. We have identified a homeodomain protein, AtNDX, that regulates COOLAIR, a set of antisense transcripts originating from the 3' end of Arabidopsis FLOWERING LOCUS C (FLC). AtNDX associates with single-stranded DNA rather than double-stranded DNA non-sequence-specifically in vitro, and localizes to a heterochromatic region in the COOLAIR promoter in vivo. Single-stranded DNA was detected in vivo as part of an RNA-DNA hybrid, or R-loop, that covers the COOLAIR promoter. R-loop stabilization mediated by AtNDX inhibits COOLAIR transcription, which in turn modifies FLC expression. Differential stabilization of R-loops could be a general mechanism influencing gene expression in many organisms.	[Sun, Qianwen; Csorba, Tibor; Dean, Caroline] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Skourti-Stathaki, Konstantina; Proudfoot, Nicholas J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Oxford	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Csorba, Tibor/A-2359-2014	Csorba, Tibor/0000-0003-4185-1496; Proudfoot, Nicholas/0000-0001-8646-3222; Dean, Caroline/0000-0002-6555-3525; Sun, Qianwen/0000-0003-0111-5400	Wellcome Trust; UK Biotechnology and Biological Sciences Research Council (BBSRC); European Research Council; BBSRC [BBS/E/J/000CA369] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA369] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all the members of the Dean lab for useful discussions; G. Calder and S. Rosa for help with microscopy; and the Nottingham Arabidopsis Stock Centre (NASC) and Institut National de la Recherche Agronomique (INRA) for Arabidopsis lines. Supported by a Wellcome Trust programme grant (K.S.-S. and N.J.P.). The Dean lab is supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) and a European Research Council advanced investigator grant. C.D. holds stock in Mendel Biotechnology.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Coustham V, 2012, SCIENCE, V337, P584, DOI 10.1126/science.1221881; Crevillen P, 2013, EMBO J, V32, P140, DOI 10.1038/emboj.2012.324; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Finnegan EJ, 2005, PLANT J, V44, P420, DOI 10.1111/j.1365-313X.2005.02541.x; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Jorgensen JE, 1999, PLANT MOL BIOL, V40, P65, DOI 10.1023/A:1026463506376; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Rondon AG, 2010, BBA-GENE REGUL MECH, V1799, P533, DOI 10.1016/j.bbagrm.2010.06.002; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	26	239	250	3	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					619	621		10.1126/science.1234848	http://dx.doi.org/10.1126/science.1234848			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641115	Green Accepted			2022-12-24	WOS:000318268900050
J	Amemiya, CT; Alfoldi, J; Lee, AP; Fan, SH; Philippe, H; MacCallum, I; Braasch, I; Manousaki, T; Schneider, I; Rohner, N; Organ, C; Chalopin, D; Smith, JJ; Robinson, M; Dorrington, RA; Gerdol, M; Aken, B; Biscotti, MA; Barucca, M; Baurain, D; Berlin, AM; Blatch, GL; Buonocore, F; Burmester, T; Campbell, MS; Canapa, A; Cannon, JP; Christoffels, A; De Moro, G; Edkins, AL; Fan, L; Fausto, AM; Feiner, N; Forconi, M; Gamieldien, J; Gnerre, S; Gnirke, A; Goldstone, JV; Haerty, W; Hahn, ME; Hesse, U; Hoffmann, S; Johnson, J; Karchner, SI; Kuraku, S; Lara, M; Levin, JZ; Litman, GW; Mauceli, E; Miyake, T; Mueller, MG; Nelson, DR; Nitsche, A; Olmo, E; Ota, T; Pallavicini, A; Panji, S; Picone, B; Ponting, CP; Prohaska, SJ; Przybylski, D; Saha, NR; Ravi, V; Ribeiro, FJ; Sauka-Spengler, T; Scapigliati, G; Searle, SMJ; Sharpe, T; Simakov, O; Stadler, PF; Stegeman, JJ; Sumiyama, K; Tabbaa, D; Tafer, H; Turner-Maier, J; van Heusden, P; White, S; Williams, L; Yandell, M; Brinkmann, H; Volff, JN; Tabin, CJ; Shubin, N; Schartl, M; Jaffe, DB; Postlethwait, JH; Venkatesh, B; Di Palma, F; Lander, ES; Meyer, A; Lindblad-Toh, K				Amemiya, Chris T.; Alfoeldi, Jessica; Lee, Alison P.; Fan, Shaohua; Philippe, Herve; MacCallum, Iain; Braasch, Ingo; Manousaki, Tereza; Schneider, Igor; Rohner, Nicolas; Organ, Chris; Chalopin, Domitille; Smith, Jeramiah J.; Robinson, Mark; Dorrington, Rosemary A.; Gerdol, Marco; Aken, Bronwen; Biscotti, Maria Assunta; Barucca, Marco; Baurain, Denis; Berlin, Aaron M.; Blatch, Gregory L.; Buonocore, Francesco; Burmester, Thorsten; Campbell, Michael S.; Canapa, Adriana; Cannon, John P.; Christoffels, Alan; De Moro, Gianluca; Edkins, Adrienne L.; Fan, Lin; Fausto, Anna Maria; Feiner, Nathalie; Forconi, Mariko; Gamieldien, Junaid; Gnerre, Sante; Gnirke, Andreas; Goldstone, Jared V.; Haerty, Wilfried; Hahn, Mark E.; Hesse, Uljana; Hoffmann, Steve; Johnson, Jeremy; Karchner, Sibel I.; Kuraku, Shigehiro; Lara, Marcia; Levin, Joshua Z.; Litman, Gary W.; Mauceli, Evan; Miyake, Tsutomu; Mueller, M. Gail; Nelson, David R.; Nitsche, Anne; Olmo, Ettore; Ota, Tatsuya; Pallavicini, Alberto; Panji, Sumir; Picone, Barbara; Ponting, Chris P.; Prohaska, Sonja J.; Przybylski, Dariusz; Saha, Nil Ratan; Ravi, Vydianathan; Ribeiro, Filipe J.; Sauka-Spengler, Tatjana; Scapigliati, Giuseppe; Searle, Stephen M. J.; Sharpe, Ted; Simakov, Oleg; Stadler, Peter F.; Stegeman, John J.; Sumiyama, Kenta; Tabbaa, Diana; Tafer, Hakim; Turner-Maier, Jason; van Heusden, Peter; White, Simon; Williams, Louise; Yandell, Mark; Brinkmann, Henner; Volff, Jean-Nicolas; Tabin, Clifford J.; Shubin, Neil; Schartl, Manfred; Jaffe, David B.; Postlethwait, John H.; Venkatesh, Byrappa; Di Palma, Federica; Lander, Eric S.; Meyer, Axel; Lindblad-Toh, Kerstin			The African coelacanth genome provides insights into tetrapod evolution	NATURE			English	Article							MITOCHONDRIAL GENOME; LIVING FOSSIL; SEQUENCE; MODEL; GENES; TRANSCRIPTION; CHROMOSOMES; RETENTION; REVEALS; ORIGIN	The discovery of a living coelacanth specimen in 1938 was remarkable, as this lineage of lobe-finned fish was thought to have become extinct 70 million years ago. The modern coelacanth looks remarkably similar to many of its ancient relatives, and its evolutionary proximity to our own fish ancestors provides a glimpse of the fish that first walked on land. Here we report the genome sequence of the African coelacanth, Latimeria chalumnae. Through a phylogenomic analysis, we conclude that the lungfish, and not the coelacanth, is the closest living relative of tetrapods. Coelacanth protein-coding genes are significantly more slowly evolving than those of tetrapods, unlike other genomic features. Analyses of changes in genes and regulatory elements during the vertebrate adaptation to land highlight genes involved in immunity, nitrogen excretion and the development of fins, tail, ear, eye, brain and olfaction. Functional assays of enhancers involved in the fin-to-limb transition and in the emergence of extra-embryonic tissues show the importance of the coelacanth genome as a blueprint for understanding tetrapod evolution.	[Amemiya, Chris T.; Robinson, Mark; Saha, Nil Ratan] Benaroya Res Inst, Mol Genet Program, Seattle, WA 98101 USA; [Amemiya, Chris T.] Univ Washington, Dept Biol, Seattle, WA 98105 USA; [Alfoeldi, Jessica; MacCallum, Iain; Berlin, Aaron M.; Fan, Lin; Gnerre, Sante; Gnirke, Andreas; Johnson, Jeremy; Lara, Marcia; Levin, Joshua Z.; Mauceli, Evan; Przybylski, Dariusz; Ribeiro, Filipe J.; Sharpe, Ted; Tabbaa, Diana; Turner-Maier, Jason; Williams, Louise; Jaffe, David B.; Di Palma, Federica; Lander, Eric S.; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lee, Alison P.; Ravi, Vydianathan; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore 138673, Singapore; [Fan, Shaohua; Manousaki, Tereza; Feiner, Nathalie; Kuraku, Shigehiro; Simakov, Oleg; Meyer, Axel] Univ Konstanz, Dept Biol, D-78464 Constance, Germany; [Philippe, Herve; Brinkmann, Henner] Univ Montreal, Ctr Robert Cedergren, Dept Biochim, Montreal, PQ H3T 1J4, Canada; [Braasch, Ingo; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Manousaki, Tereza; Meyer, Axel] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78464 Constance, Germany; [Schneider, Igor] Fed Univ Para, Inst Ciencias Biol, BR-66075110 Belem, Para, Brazil; [Rohner, Nicolas; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Organ, Chris] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Chalopin, Domitille; Volff, Jean-Nicolas] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69007 Lyon, France; [Smith, Jeramiah J.] Univ Kentucky, Dept Biol, Lexington, KY 40506 USA; [Dorrington, Rosemary A.; Blatch, Gregory L.; Edkins, Adrienne L.] Rhodes Univ, Dept Biochem Microbiol & Biotechnol, Biomed Biotechnol Res Unit BioBRU, ZA-6139 Grahamstown, South Africa; [Gerdol, Marco; De Moro, Gianluca; Pallavicini, Alberto] Univ Trieste, Dept Life Sci, I-34128 Trieste, Italy; [Aken, Bronwen; Searle, Stephen M. J.; White, Simon] Wellcome Trust Sanger Inst, Dept Informat, Hinxton CB10 1SA, S Cambs, England; [Biscotti, Maria Assunta; Barucca, Marco; Canapa, Adriana; Forconi, Mariko; Olmo, Ettore] Polytech Univ Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy; [Baurain, Denis] Univ Liege, Dept Life Sci, B-4000 Liege, Belgium; [Blatch, Gregory L.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [Buonocore, Francesco; Fausto, Anna Maria; Scapigliati, Giuseppe] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, I-01100 Viterbo, Italy; [Burmester, Thorsten] Univ Hamburg, Dept Biol, D-20146 Hamburg, Germany; [Campbell, Michael S.; Yandell, Mark] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Cannon, John P.; Litman, Gary W.] Univ S Florida, Morsani Coll Med, Childrens Res Inst, Dept Pediat, St Petersburg, FL 33701 USA; [Christoffels, Alan; Gamieldien, Junaid; Hesse, Uljana; Panji, Sumir; Picone, Barbara; van Heusden, Peter] Univ Western Cape, South African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Feiner, Nathalie; Meyer, Axel] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, D-78464 Constance, Germany; [Goldstone, Jared V.; Hahn, Mark E.; Karchner, Sibel I.; Stegeman, John J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Haerty, Wilfried; Ponting, Chris P.] Univ Oxford, MRC Funct Genom Unit, Oxford OX1 3PT, England; [Hoffmann, Steve] Univ Leipzig, LIFE Res Ctr Civilizat Dis, Transcriptome Bioinformat Grp, D-04109 Leipzig, Germany; [Miyake, Tsutomu] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Mueller, M. Gail] Univ S Florida, All Childrens Hosp, Dept Mol Genet, St Petersburg, FL 33701 USA; [Nelson, David R.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Nitsche, Anne; Stadler, Peter F.; Tafer, Hakim] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Ota, Tatsuya] Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama 2400193, Japan; [Prohaska, Sonja J.] Univ Leipzig, Dept Comp Sci, Computat EvoDevo Grp, D-04109 Leipzig, Germany; [Sauka-Spengler, Tatjana] Univ Oxford, Weatherall Inst Mol Med, Oxford OX1 2JD, England; [Simakov, Oleg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Sumiyama, Kenta] Natl Inst Genet, Divis Populat Genet, Mishima, Shizuoka 4118540, Japan; [Shubin, Neil] Univ Chicago, Chicago, IL 60637 USA; [Schartl, Manfred] Univ Wurzburg, Dept Physiol Chem, D-97070 Wurzburg, Germany; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75123 Uppsala, Sweden	Benaroya Research Institute; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Konstanz; Universite de Montreal; University of Oregon; University of Konstanz; Universidade Federal do Para; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Kentucky; Rhodes University; University of Trieste; Wellcome Trust Sanger Institute; Marche Polytechnic University; University of Liege; Victoria University; Tuscia University; University of Hamburg; Utah System of Higher Education; University of Utah; State University System of Florida; University of South Florida; University of the Western Cape; Max Planck Society; University of Konstanz; Woods Hole Oceanographic Institution; University of Oxford; Leipzig University; Keio University; State University System of Florida; University of South Florida; University of Tennessee System; University of Tennessee Health Science Center; Leipzig University; Graduate University for Advanced Studies - Japan; Leipzig University; University of Oxford; European Molecular Biology Laboratory (EMBL); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Chicago; University of Wurzburg; Uppsala University	Amemiya, CT (corresponding author), Benaroya Res Inst, Mol Genet Program, Seattle, WA 98101 USA.	camemiya@benaroyaresearch.org; jalfoldi@broadinstitute.org; axel.meyer@uni-konstanz.de; kersli@broadinstitute.org	Buonocore, Francesco/AAA-5236-2020; Simakov, Oleg/G-4572-2015; Pallavicini, Alberto/H-9281-2019; Ravi, Vydianathan/B-2759-2009; Hoffmann, Steve/E-1438-2013; Braasch, Ingo/A-6948-2010; Edkins, Adrienne L/C-8704-2012; Christoffels, Alan/C-3269-2014; Sumiyama, Kenta/ABD-5577-2020; Picone, barbara/C-9349-2018; Feiner, Nathalie/C-8538-2014; Baurain, Denis/S-4048-2019; Blatch, Gregory Lloyd/Q-5900-2019; Pallavicini, Alberto/J-4158-2012; Kuraku, Shigehiro/B-2801-2009; Schneider, Igor/K-6164-2012; Stadler, Peter F. F/L-7857-2015; Sumiyama, Kenta/L-5902-2013; Gerdol, Marco/D-2115-2013; Meyer, Axel/C-9826-2009; Burmester, Thorsten/I-7225-2013; Berlin, Aaron M/AFY-6549-2022; Lee, Alison/HCH-1286-2022; Hahn, Mark/AAV-7516-2020; Fausto, Anna Maria/AAB-6778-2020; Ponting, Chris/AAV-2621-2021; Simakov, Oleg/AAV-2494-2020	Simakov, Oleg/0000-0002-3585-4511; Pallavicini, Alberto/0000-0001-7174-4603; Ravi, Vydianathan/0000-0003-0807-7697; Braasch, Ingo/0000-0003-4766-611X; Edkins, Adrienne L/0000-0002-3615-6651; Christoffels, Alan/0000-0002-0420-2916; Sumiyama, Kenta/0000-0001-8785-5439; Picone, barbara/0000-0002-6987-7121; Baurain, Denis/0000-0003-2388-6185; Blatch, Gregory Lloyd/0000-0003-0778-8577; Pallavicini, Alberto/0000-0001-7174-4603; Kuraku, Shigehiro/0000-0003-1464-8388; Schneider, Igor/0000-0002-9046-7338; Stadler, Peter F. F/0000-0002-5016-5191; Sumiyama, Kenta/0000-0001-8785-5439; Gerdol, Marco/0000-0001-6411-0813; Meyer, Axel/0000-0002-0888-8193; Burmester, Thorsten/0000-0002-5772-7863; Berlin, Aaron M/0000-0002-0714-2808; Lee, Alison/0000-0002-3773-1021; Hahn, Mark/0000-0003-4358-2082; Simakov, Oleg/0000-0002-3585-4511; Nelson, David/0000-0003-0583-5421; Levin, Joshua/0000-0002-0170-3598; Ponting, Chris/0000-0003-0202-7816; White, Simon/0000-0001-6375-2363; Ota, Tatsuya/0000-0002-1115-5169; Smith, Jeramiah/0000-0001-5333-5531; Buonocore, Francesco/0000-0001-8045-5651; Rohner, Nicolas/0000-0003-3248-2772; De Moro, Gianluca/0000-0002-5542-0278; Venkatesh, Byrappa/0000-0003-3620-0277; Schartl, Manfred/0000-0001-9882-5948; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Tafer, Hakim/0000-0002-6252-9802; Goldstone, Jared/0000-0002-9618-4961; scapigliati, giuseppe/0000-0001-9730-9394; Di-Palma, Federica/0000-0002-4394-0102; FAUSTO, Anna Maria/0000-0001-5800-7473; Haerty, Wilfried/0000-0003-0111-191X; Hesse, Uljana/0000-0001-8746-4702; Ribeiro, Filipe/0000-0003-3843-7702; van Heusden, Peter/0000-0001-6553-5274; Aken, Bronwen/0000-0002-3032-4095	South African National Department of Science and Technology; National Human Genome Research Institute (NHGRI); European Science Foundation; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI; MRC [MC_U137761446] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; Medical Research Council [MC_U137761446] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR032670] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG003474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006272, P42ES007381] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116, R24OD011199] Funding Source: NIH RePORTER	South African National Department of Science and Technology; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Science Foundation(European Science Foundation (ESF)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Acquisition and storage of Latimeria chalumnae samples was supported by grants from the African Coelacanth Ecosystem Programme of the South African National Department of Science and Technology. Generation of the Latimeria chalumnae and Protopterus annectens sequences by the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University was supported by grants from the National Human Genome Research Institute (NHGRI). K.L.T. is the recipient of a EURYI award from the European Science Foundation. We would also like to thank the Genomics Sequencing Platform of the Broad Institute for sequencing the L. chalumnae genome and L. chalumnae and P. annectens transcriptomes, S. Ahamada, R. Stobbs and the Association pour le Protection de Gombesa (APG) for their help in obtaining coelacanth samples, Y. Zhao for the use of data from Rana chensinensis, and L. Gaffney, C. Hamilton and J. Westlund for assistance with figure preparation.	Amemiya CT, 2010, P NATL ACAD SCI USA, V107, P3622, DOI 10.1073/pnas.0914312107; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; BOGART JP, 1994, J HERED, V85, P322, DOI 10.1093/oxfordjournals.jhered.a111470; Braasch I, 2011, P NATL ACAD SCI USA, V108, pE47, DOI 10.1073/pnas.1101594108; Brinkmann H, 2004, P NATL ACAD SCI USA, V101, P4900, DOI 10.1073/pnas.0400609101; Canapa A, 2012, J EXP ZOOL PART B, V318B, P404, DOI 10.1002/jez.b.22455; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CARROLL RL, 1988, VERTEBRATE PALEONTOL; Erdmann MV, 1998, NATURE, V395, P335, DOI 10.1038/26376; Gekas C, 2010, INT J DEV BIOL, V54, P1089, DOI 10.1387/ijdb.103070cg; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gregory T. Ryan, 2005, P3; Haberle J, 2011, HUM MUTAT, V32, P579, DOI 10.1002/humu.21406; Holder MT, 1999, P NATL ACAD SCI USA, V96, P12616, DOI 10.1073/pnas.96.22.12616; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Jovelin R, 2010, J EXP ZOOL PART B, V314B, P33, DOI 10.1002/jez.b.21307; Larsson TA, 2007, GEN COMP ENDOCR, V150, P337, DOI 10.1016/j.ygcen.2006.09.002; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; MEYER A, 1992, J MOL EVOL, V35, P102; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Noonan JP, 2004, GENOME RES, V14, P2397, DOI 10.1101/gr.2972804; Nulens R., 2010, LATIMERIA SPP SMITHI, V3; Ota T, 2003, P NATL ACAD SCI USA, V100, P2501, DOI 10.1073/pnas.0538029100; Pallavicini A., BMC GENOMIC IN PRESS; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Scotti M, 2012, DEVELOPMENT, V139, P731, DOI 10.1242/dev.075408; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Smith JJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-219; Smith JJ, 2012, MOL BIOL EVOL, V29, P985, DOI 10.1093/molbev/msr267; Smith JLB, 1939, NATURE, V143, P455, DOI 10.1038/143455a0; Smith JLB, 1956, OLD FOURLEGS STORY C; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; TAJIMA F, 1993, GENETICS, V135, P599; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Voss SR, 2011, GENOME RES, V21, P1306, DOI 10.1101/gr.116491.110; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zardoya R, 1997, GENETICS, V146, P995; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137; Zhu M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1764; Zimmer, 1999, WATERS EDGE FISH FIN; [No title captured]	49	462	477	14	426	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2013	496	7445					311	316		10.1038/nature12027	http://dx.doi.org/10.1038/nature12027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126FV	23598338	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-24	WOS:000317599200027
J	Marx, V				Marx, Vivien			A BETTER BREW	NATURE			English	Editorial Material							CELL CULTURE											Buganim Y, 2012, CELL CYCLE, V11, P4485, DOI 10.4161/cc.22665; Daquinag A. C., 2013, TISSUE ENG PART C-ME, P336; Goral VN, 2013, LAB CHIP, V13, P1039, DOI 10.1039/c2lc41102d; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Villa-Diaz LG, 2013, STEM CELLS, V31, P1, DOI 10.1002/stem.1260	7	365	380	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2013	496	7444					253	258		10.1038/496253a	http://dx.doi.org/10.1038/496253a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122VM	23765498	Bronze			2022-12-24	WOS:000317346300050
J	Schiffman, M; Castle, PE; Jeronimo, J; Rodriguez, AC; Wacholder, S				Schiffman, Mark; Castle, Philip E.; Jeronimo, Jose; Rodriguez, Ana C.; Wacholder, Sholom			Human papillomavirus and cervical cancer	LANCET			English	Review							ATYPICAL SQUAMOUS-CELLS; LIQUID-BASED CYTOLOGY; INTRAEPITHELIAL NEOPLASIA GRADE-2; CARCINOMA IN-SITU; INTERNATIONAL INCIDENCE RATES; ASCUS-LSIL TRIAGE; HYBRID CAPTURE 2; RISK-FACTORS; FOLLOW-UP; COST-EFFECTIVENESS	Cervical cancer is the second most common cancer in women, worldwide, and knowledge regarding its cause and pathogenesis is expanding rapidly. Persistent infection with one of about 15 genotypes of carcinogenic human papillomavirus (HPV) causes almost all cases. There are four major steps in cervical cancer development: infection of metaplastic epithelium at the cervical transformation zone, viral persistence, progression of persistently infected epithelium to cervical precancer, and invasion through the basement membrane of the epithelium. Infection is extremely common in young women in their first decade of sexual. activity. Persistent infections and precancer are established, typically within 5-10 years, from less than 10% of new infections. Invasive cancer arises over many years, even decades, in a minority of women with precancer, with a peak or plateau in risk at about 35-55 years of age. Each genotype of HPV acts as an independent infection, with differing carcinogenic risks linked to evolutionary species. Our understanding has led to improved prevention and clinical management strategies, including improved screening tests and vaccines. The new HPV-oriented model of cervical carcinogenesis should gradually replace older morphological models based only on cytology and histology. If applied wisely, HPV-related technology can minimise the incidence of cervical cancer, and the morbidity and mortality it causes, even in low-resource settings.	NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schiffman, M (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA.	schiffmm@mail.nih.gov	Schiffman, Mark/B-9766-2015; Castle, Philip/AAP-6395-2020; franceschi, silvia/M-2452-2014	Castle, Philip/0000-0003-1082-6554; Crosbie, Emma/0000-0003-0284-8630; franceschi, silvia/0000-0003-4181-8071	Department of Health [NIHR-CS-012-009] Funding Source: Medline	Department of Health		Altekruse SF, 2003, AM J OBSTET GYNECOL, V188, P657, DOI 10.1067/mob.2003.132; Arbyn M, 2005, GYNECOL ONCOL, V99, pS7, DOI 10.1016/j.ygyno.2005.07.033; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Bais AG, 2007, INT J CANCER, V120, P1505, DOI 10.1002/ijc.22484; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; BRINTON LA, IN PRESS PRINCIPLES; Bulk S, 2006, BRIT J CANCER, V94, P171, DOI 10.1038/sj.bjc.6602915; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Carozzi FM, 2005, AM J CLIN PATHOL, V124, P716, DOI 10.1309/84E5WHJQHK83BGQD; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Castle PE, 2002, CANCER-AM CANCER SOC, V95, P2145, DOI 10.1002/cncr.10927; Castle PE, 2006, CANCER RES, V66, P1218, DOI 10.1158/0008-5472.CAN-05-3066; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Castle PE, 2005, JNCI-J NATL CANCER I, V97, P1066, DOI 10.1093/jnci/dji186; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; CASTLE PE, IN PRESS AM J OBSTET; Castle PE, 2007, AM J CLIN PATHOL, V127, P805, DOI 10.1309/PT3PNC1QL2F4D2VL; Chang A R, 1990, Cytopathology, V1, P321, DOI 10.1111/j.1365-2303.1990.tb00369.x; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Cox JT, 1999, LANCET, V353, P857, DOI 10.1016/S0140-6736(98)00392-4; Cox JT, 2003, AM J OBSTET GYNECOL, V188, P1406, DOI 10.1067/mob.2003.461; Cuzick J, 2003, LANCET, V362, P1871, DOI 10.1016/S0140-6736(03)14955-0; Cuzick J, 2006, VACCINE, V24, P90, DOI 10.1016/j.vaccine.2006.05.122; Davey DD, 2004, ARCH PATHOL LAB MED, V128, P1224; Davey E, 2006, LANCET, V367, P122, DOI 10.1016/S0140-6736(06)67961-0; Davey E, 2007, BRIT MED J, V335, P31, DOI 10.1136/bmj.39219.645475.55; de Gonzalez AB, 2004, BRIT J CANCER, V90, P1787, DOI 10.1038/sj.bjc.6601764; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Dobbs SP, 2000, BRIT J OBSTET GYNAEC, V107, P1298, DOI 10.1111/j.1471-0528.2000.tb11623.x; Doeberitz MV, 2002, EUR J CANCER, V38, P2229, DOI 10.1016/S0959-8049(02)00462-8; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Dunn ST, 2007, J VIROL METHODS, V143, P45, DOI 10.1016/j.jviromet.2007.02.006; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Ferris DG, 2006, AM J OBSTET GYNECOL, V194, P704, DOI 10.1016/j.ajog.2005.10.204; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Fox R, 2006, CYTOPATHOLOGY, V17, P175, DOI 10.1111/j.1365-2303.2006.00302.x; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; French DP, 2004, BRIT J CANCER, V91, P1887, DOI 10.1038/sj.bjc.6602224; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Gambhira R, 2006, CANCER RES, V66, P11120, DOI 10.1158/0008-5472.CAN-06-2560; Garcia F, 2003, OBSTET GYNECOL, V102, P266, DOI 10.1016/S0029-7844(03)00517-9; Garcia-Closas R, 2005, INT J CANCER, V117, P629, DOI 10.1002/ijc.21193; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; Goldhaber-Fiebert Jeremy D, 2006, Cost Eff Resour Alloc, V4, P13, DOI 10.1186/1478-7547-4-13; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2006, VACCINE, V24, P164, DOI 10.1016/j.vaccine.2006.05.114; Green J, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002225.PUB2; Guido R, 2003, AM J OBSTET GYNECOL, V188, P1401, DOI 10.1067/mob.2003.456; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; Harris TG, 2005, JAMA-J AM MED ASSOC, V293, P1471, DOI 10.1001/jama.293.12.1471; Harro CD, 2001, JNCI-J NATL CANCER I, V93, P284, DOI 10.1093/jnci/93.4.284; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 1999, AM J OBSTET GYNECOL, V180, P571, DOI 10.1016/S0002-9378(99)70256-5; HILDESHEIM A, IN PRESS JAMA; Hogewoning CJA, 2003, INT J CANCER, V107, P811, DOI 10.1002/ijc.11474; *IN COLL EP STUD C, 2006, INT J CANCER, V119, P1108; *IN COLL EP STUD C, 2006, INT J CANCER, V118, P1481; Inglis S, 2006, VACCINE, V24, P99, DOI 10.1016/j.vaccine.2006.05.119; Jacobson DL, 1999, INT J GYNECOL OBSTET, V66, P7, DOI 10.1016/S0020-7292(99)00037-5; JERONIMO J, 2007, AM J OBSTET GYNECOL, V197; Josefsson AM, 2000, LANCET, V355, P2189, DOI 10.1016/S0140-6736(00)02401-6; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kahn JA, 2007, HEALTH PSYCHOL, V26, P192, DOI 10.1037/0278-6133.26.2.192; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Khan MJ, 2005, CANCER-AM CANCER SOC, V104, P61, DOI 10.1002/cncr.21129; KINLEN LJ, 1978, LANCET, V2, P463; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Kiviat N B, 1992, IARC Sci Publ, P59; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Kovacic MB, 2006, CANCER RES, V66, P10112, DOI 10.1158/0008-5472.CAN-06-1812; Kreimer AR, 2006, CANCER EPIDEM BIOMAR, V15, P908, DOI 10.1158/1055-9965.EPI-05-0845; Kulasingam SL, 2006, JNCI-J NATL CANCER I, V98, P92, DOI 10.1093/jnci/djj009; KURMAN RJ, 1988, AM J OBSTET GYNECOL, V159, P293, DOI 10.1016/S0002-9378(88)80070-X; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lorincz AT, 2002, LANCET, V360, P228, DOI 10.1016/S0140-6736(02)09463-1; Malpica A, 2005, GYNECOL ONCOL, V99, pS38, DOI 10.1016/j.ygyno.2005.07.040; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Mendez F, 2005, J INFECT DIS, V192, P1158, DOI 10.1086/444391; Molden T, 2005, CANCER EPIDEM BIOMAR, V14, P367, DOI 10.1158/1055-9965.EPI-04-0410; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Moscicki AB, 2004, LANCET, V364, P1678, DOI 10.1016/S0140-6736(04)17354-6; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Newall AT, 2007, LANCET INFECT DIS, V7, P289, DOI 10.1016/S1473-3099(07)70083-X; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Pagliusi SR, 2006, VACCINE, V24, P193, DOI 10.1016/j.vaccine.2006.06.016; Palefsky JM, 2006, VACCINE, V24, P140, DOI 10.1016/j.vaccine.2006.05.120; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Pirami L, 1997, J CLIN PATHOL, V50, P600, DOI 10.1136/jcp.50.7.600; Plante M, 2005, GYNECOL ONCOL, V98, P3, DOI 10.1016/j.ygyno.2005.04.014; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P5, DOI 10.1097/01.lgt.0000192694.85549.3d; Prokopczyk B, 1997, J NATL CANCER I, V89, P868, DOI 10.1093/jnci/89.12.868; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Richardson H, 2005, CANCER EPIDEM BIOMAR, V14, P1149, DOI 10.1158/1055-9965.EPI-04-0230; RICHART RM, 1969, AM J OBSTET GYNECOL, V105, P386, DOI 10.1016/0002-9378(69)90268-3; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rodriguez AC, 2007, SEX TRANSM DIS, V34, P494, DOI 10.1097/01.olq.0000251241.03088.a0; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; ROSE RC, 1993, J VIROL, V67, P1936, DOI 10.1128/JVI.67.4.1936-1944.1993; Sangiva-Lugoma G, 2006, INT J CANCER, V119, P1389, DOI 10.1002/ijc.21972; Sankaranarayanan R, 2005, INT J CANCER, V116, P617, DOI 10.1002/ijc.21050; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Santos CL, 2004, INT J GYNECOL OBSTET, V87, P44, DOI 10.1016/j.ijgo.2004.06.014; Sarian LO, 2005, J MED SCREEN, V12, P142, DOI 10.1258/0969141054855328; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Sawaya GF, 2003, NEW ENGL J MED, V349, P1501, DOI 10.1056/NEJMoa035419; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171; Schiffman M, 2005, J NATL CANCER I, V97, P147, DOI 10.1093/jnci/dji014; Schiffman M, 2000, ACTA CYTOL, V44, P726, DOI 10.1159/000328554; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2005, AM J CLIN PATHOL, V124, P722, DOI 10.1309/E067X0L1U3CY37NW; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schiller JT, 2006, VACCINE, V24, P147, DOI 10.1016/j.vaccine.2006.05.123; Seamans Yancy, 2006, BMC Womens Health, V6, P2, DOI 10.1186/1472-6874-6-2; Shepherd R., 2011, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD001035, DOI 10.1002/14651858.CD001035]; Sherman Mark E, 2003, J Natl Cancer Inst Monogr, P72; Sherman ME, 2005, CANCER-AM CANCER SOC, V103, P1258, DOI 10.1002/cncr.20877; Sherman ME, 2003, CANCER EPIDEM BIOMAR, V12, P1038; Sherman ME, 2003, CANCER EPIDEM BIOMAR, V12, P372; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Solomon D, 2007, CA-CANCER J CLIN, V57, P105, DOI 10.3322/canjclin.57.2.105; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Stoler MH, 2007, AM J CLIN PATHOL, V127, P1; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Szarewski A, 1996, LANCET, V347, P941, DOI 10.1016/S0140-6736(96)91417-8; Tavassoli FA, 2003, PATHOLOGY GENETICS T, P259; van Doorn LJ, 2002, J CLIN MICROBIOL, V40, P979, DOI 10.1128/JCM.40.3.979-983.2002; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Viscidi RP, 2004, CANCER EPIDEM BIOMAR, V13, P324, DOI 10.1158/1055-9965.EPI-03-0166; Walker JL, 2006, AM J OBSTET GYNECOL, V195, P341, DOI 10.1016/j.ajog.2006.02.047; Wang SS, 2003, BRIT J CANCER, V89, P1248, DOI 10.1038/sj.bjc.6601272; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; Wentzensen N, 2006, CANCER-AM CANCER SOC, V107, P2307, DOI 10.1002/cncr.22247; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Woodman CBJ, 2003, LANCET, V361, P40, DOI 10.1016/S0140-6736(03)12120-4; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8; Wright TC, 2003, NEW ENGL J MED, V348, P489, DOI 10.1056/NEJMp020178; Wright TC, 2001, AM J OBSTET GYNECOL, V184, P279, DOI 10.1067/mob.2001.108999; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8; 2005, CERVIX CANC SCREENIN	171	1841	1943	22	466	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2007	370	9590					890	907		10.1016/S0140-6736(07)61416-0	http://dx.doi.org/10.1016/S0140-6736(07)61416-0			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214JH	23618600				2022-12-24	WOS:000249733300033
